primaryid,caseid,drug_seq,role_cod,drugname,prod_ai,val_vbm,route,dose_vbm,cum_dose_chr,cum_dose_unit,dechal,rechal,lot_num,exp_dt,nda_num,dose_amt,dose_unit,dose_form,dose_freq,year_x,quarter_x,pt,drug_rec_act,year_y,quarter_y,caseversion,i_f_code,event_dt,mfr_dt,init_fda_dt,fda_dt,rept_cod,auth_num,mfr_num,mfr_sndr,lit_ref,age,age_cod,age_grp,sex,e_sub,wt,wt_cod,rept_dt,to_mfr,occp_cod,reporter_country,occr_country,year,quarter,age_group
1142235118,11422351,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU/ML, UNK (BEFORE EACH MEAL)",,,,,,,,,,,,2019,Q1,Abdominal distension,,2019,Q1,18,F,20100930.0,20190320.0,20150827,20190329,EXP,,US-PFIZER INC-2015214404,PFIZER,,45.0,YR,,F,Y,73.0,KG,20190329.0,,CN,US,US,2019,Q1,Adult
1142235118,11422351,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU/ML, UNK (BEFORE EACH MEAL)",,,,,,,,,,,,2019,Q1,Cardiac disorder,,2019,Q1,18,F,20100930.0,20190320.0,20150827,20190329,EXP,,US-PFIZER INC-2015214404,PFIZER,,45.0,YR,,F,Y,73.0,KG,20190329.0,,CN,US,US,2019,Q1,Adult
1142235118,11422351,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU/ML, UNK (BEFORE EACH MEAL)",,,,,,,,,,,,2019,Q1,Cardiac failure,,2019,Q1,18,F,20100930.0,20190320.0,20150827,20190329,EXP,,US-PFIZER INC-2015214404,PFIZER,,45.0,YR,,F,Y,73.0,KG,20190329.0,,CN,US,US,2019,Q1,Adult
1142235118,11422351,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU/ML, UNK (BEFORE EACH MEAL)",,,,,,,,,,,,2019,Q1,Cardiac failure congestive,,2019,Q1,18,F,20100930.0,20190320.0,20150827,20190329,EXP,,US-PFIZER INC-2015214404,PFIZER,,45.0,YR,,F,Y,73.0,KG,20190329.0,,CN,US,US,2019,Q1,Adult
1142235118,11422351,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU/ML, UNK (BEFORE EACH MEAL)",,,,,,,,,,,,2019,Q1,Condition aggravated,,2019,Q1,18,F,20100930.0,20190320.0,20150827,20190329,EXP,,US-PFIZER INC-2015214404,PFIZER,,45.0,YR,,F,Y,73.0,KG,20190329.0,,CN,US,US,2019,Q1,Adult
1142235118,11422351,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU/ML, UNK (BEFORE EACH MEAL)",,,,,,,,,,,,2019,Q1,Diabetes mellitus,,2019,Q1,18,F,20100930.0,20190320.0,20150827,20190329,EXP,,US-PFIZER INC-2015214404,PFIZER,,45.0,YR,,F,Y,73.0,KG,20190329.0,,CN,US,US,2019,Q1,Adult
1142235118,11422351,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU/ML, UNK (BEFORE EACH MEAL)",,,,,,,,,,,,2019,Q1,Diarrhoea,,2019,Q1,18,F,20100930.0,20190320.0,20150827,20190329,EXP,,US-PFIZER INC-2015214404,PFIZER,,45.0,YR,,F,Y,73.0,KG,20190329.0,,CN,US,US,2019,Q1,Adult
1142235118,11422351,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU/ML, UNK (BEFORE EACH MEAL)",,,,,,,,,,,,2019,Q1,Drug ineffective for unapproved indication,,2019,Q1,18,F,20100930.0,20190320.0,20150827,20190329,EXP,,US-PFIZER INC-2015214404,PFIZER,,45.0,YR,,F,Y,73.0,KG,20190329.0,,CN,US,US,2019,Q1,Adult
1142235118,11422351,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU/ML, UNK (BEFORE EACH MEAL)",,,,,,,,,,,,2019,Q1,End stage renal disease,,2019,Q1,18,F,20100930.0,20190320.0,20150827,20190329,EXP,,US-PFIZER INC-2015214404,PFIZER,,45.0,YR,,F,Y,73.0,KG,20190329.0,,CN,US,US,2019,Q1,Adult
1142235118,11422351,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU/ML, UNK (BEFORE EACH MEAL)",,,,,,,,,,,,2019,Q1,Heart transplant rejection,,2019,Q1,18,F,20100930.0,20190320.0,20150827,20190329,EXP,,US-PFIZER INC-2015214404,PFIZER,,45.0,YR,,F,Y,73.0,KG,20190329.0,,CN,US,US,2019,Q1,Adult
1142235118,11422351,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU/ML, UNK (BEFORE EACH MEAL)",,,,,,,,,,,,2019,Q1,Hypertension,,2019,Q1,18,F,20100930.0,20190320.0,20150827,20190329,EXP,,US-PFIZER INC-2015214404,PFIZER,,45.0,YR,,F,Y,73.0,KG,20190329.0,,CN,US,US,2019,Q1,Adult
1142235118,11422351,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU/ML, UNK (BEFORE EACH MEAL)",,,,,,,,,,,,2019,Q1,Impaired work ability,,2019,Q1,18,F,20100930.0,20190320.0,20150827,20190329,EXP,,US-PFIZER INC-2015214404,PFIZER,,45.0,YR,,F,Y,73.0,KG,20190329.0,,CN,US,US,2019,Q1,Adult
1142235118,11422351,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU/ML, UNK (BEFORE EACH MEAL)",,,,,,,,,,,,2019,Q1,Malaise,,2019,Q1,18,F,20100930.0,20190320.0,20150827,20190329,EXP,,US-PFIZER INC-2015214404,PFIZER,,45.0,YR,,F,Y,73.0,KG,20190329.0,,CN,US,US,2019,Q1,Adult
1142235118,11422351,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU/ML, UNK (BEFORE EACH MEAL)",,,,,,,,,,,,2019,Q1,Oedema peripheral,,2019,Q1,18,F,20100930.0,20190320.0,20150827,20190329,EXP,,US-PFIZER INC-2015214404,PFIZER,,45.0,YR,,F,Y,73.0,KG,20190329.0,,CN,US,US,2019,Q1,Adult
1142235118,11422351,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU/ML, UNK (BEFORE EACH MEAL)",,,,,,,,,,,,2019,Q1,Pain,,2019,Q1,18,F,20100930.0,20190320.0,20150827,20190329,EXP,,US-PFIZER INC-2015214404,PFIZER,,45.0,YR,,F,Y,73.0,KG,20190329.0,,CN,US,US,2019,Q1,Adult
1142235118,11422351,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU/ML, UNK (BEFORE EACH MEAL)",,,,,,,,,,,,2019,Q1,Pericardial effusion,,2019,Q1,18,F,20100930.0,20190320.0,20150827,20190329,EXP,,US-PFIZER INC-2015214404,PFIZER,,45.0,YR,,F,Y,73.0,KG,20190329.0,,CN,US,US,2019,Q1,Adult
1142235118,11422351,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU/ML, UNK (BEFORE EACH MEAL)",,,,,,,,,,,,2019,Q1,Renal failure,,2019,Q1,18,F,20100930.0,20190320.0,20150827,20190329,EXP,,US-PFIZER INC-2015214404,PFIZER,,45.0,YR,,F,Y,73.0,KG,20190329.0,,CN,US,US,2019,Q1,Adult
1142235118,11422351,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU/ML, UNK (BEFORE EACH MEAL)",,,,,,,,,,,,2019,Q1,Sleep apnoea syndrome,,2019,Q1,18,F,20100930.0,20190320.0,20150827,20190329,EXP,,US-PFIZER INC-2015214404,PFIZER,,45.0,YR,,F,Y,73.0,KG,20190329.0,,CN,US,US,2019,Q1,Adult
1142235118,11422351,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU/ML, UNK (BEFORE EACH MEAL)",,,,,,,,,,,,2019,Q1,Spinal cord injury,,2019,Q1,18,F,20100930.0,20190320.0,20150827,20190329,EXP,,US-PFIZER INC-2015214404,PFIZER,,45.0,YR,,F,Y,73.0,KG,20190329.0,,CN,US,US,2019,Q1,Adult
119308506,11930850,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,, UNK,,,,,,,2019,Q1,Bile duct obstruction,,2019,Q1,6,F,20151114.0,20190225.0,20160120,20190304,EXP,,US-MYLANLABS-2015M1044416,MYLAN,,59.0,YR,,M,Y,69.0,KG,20190304.0,,CN,US,US,2019,Q1,Adult
119308506,11930850,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,, UNK,,,,,,,2019,Q1,Blood bilirubin increased,,2019,Q1,6,F,20151114.0,20190225.0,20160120,20190304,EXP,,US-MYLANLABS-2015M1044416,MYLAN,,59.0,YR,,M,Y,69.0,KG,20190304.0,,CN,US,US,2019,Q1,Adult
119308506,11930850,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,, UNK,,,,,,,2019,Q1,Hyperglycaemia,,2019,Q1,6,F,20151114.0,20190225.0,20160120,20190304,EXP,,US-MYLANLABS-2015M1044416,MYLAN,,59.0,YR,,M,Y,69.0,KG,20190304.0,,CN,US,US,2019,Q1,Adult
119395723,11939572,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2019,Q1,Drug hypersensitivity,,2019,Q1,3,F,,20181226.0,20160122,20190103,PER,,US-PFIZER INC-2016002951,PFIZER,,80.0,YR,,F,Y,,,20190103.0,,MD,US,US,2019,Q1,Elderly
123864194,12386419,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"23 IU,QD",,,U,,,,,23.0,IU,SOLUTION FOR INJECTION,QD,2019,Q1,Exposure during pregnancy,,2019,Q1,4,F,20160125.0,20190110.0,20160519,20190118,EXP,2016-026599,IE-SA-2016SA093002,SANOFI AVENTIS,,34.0,YR,A,F,Y,71.6,KG,20190118.0,,MD,IE,IE,2019,Q1,Young Adult
123864194,12386419,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"23 IU,QD",,,U,,,,,23.0,IU,SOLUTION FOR INJECTION,QD,2019,Q1,Hypoglycaemia,,2019,Q1,4,F,20160125.0,20190110.0,20160519,20190118,EXP,2016-026599,IE-SA-2016SA093002,SANOFI AVENTIS,,34.0,YR,A,F,Y,71.6,KG,20190118.0,,MD,IE,IE,2019,Q1,Young Adult
123864194,12386419,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"23 IU,QD",,,U,,,,,23.0,IU,SOLUTION FOR INJECTION,QD,2019,Q1,Hypoglycaemic seizure,,2019,Q1,4,F,20160125.0,20190110.0,20160519,20190118,EXP,2016-026599,IE-SA-2016SA093002,SANOFI AVENTIS,,34.0,YR,A,F,Y,71.6,KG,20190118.0,,MD,IE,IE,2019,Q1,Young Adult
123864194,12386419,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"47 IU,QD",,,U,,,,,47.0,IU,SOLUTION FOR INJECTION,QD,2019,Q1,Exposure during pregnancy,,2019,Q1,4,F,20160125.0,20190110.0,20160519,20190118,EXP,2016-026599,IE-SA-2016SA093002,SANOFI AVENTIS,,34.0,YR,A,F,Y,71.6,KG,20190118.0,,MD,IE,IE,2019,Q1,Young Adult
123864194,12386419,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"47 IU,QD",,,U,,,,,47.0,IU,SOLUTION FOR INJECTION,QD,2019,Q1,Hypoglycaemia,,2019,Q1,4,F,20160125.0,20190110.0,20160519,20190118,EXP,2016-026599,IE-SA-2016SA093002,SANOFI AVENTIS,,34.0,YR,A,F,Y,71.6,KG,20190118.0,,MD,IE,IE,2019,Q1,Young Adult
123864194,12386419,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"47 IU,QD",,,U,,,,,47.0,IU,SOLUTION FOR INJECTION,QD,2019,Q1,Hypoglycaemic seizure,,2019,Q1,4,F,20160125.0,20190110.0,20160519,20190118,EXP,2016-026599,IE-SA-2016SA093002,SANOFI AVENTIS,,34.0,YR,A,F,Y,71.6,KG,20190118.0,,MD,IE,IE,2019,Q1,Young Adult
123864194,12386419,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"36 IU,QD",,,U,,,,,36.0,IU,SOLUTION FOR INJECTION,QD,2019,Q1,Exposure during pregnancy,,2019,Q1,4,F,20160125.0,20190110.0,20160519,20190118,EXP,2016-026599,IE-SA-2016SA093002,SANOFI AVENTIS,,34.0,YR,A,F,Y,71.6,KG,20190118.0,,MD,IE,IE,2019,Q1,Young Adult
123864194,12386419,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"36 IU,QD",,,U,,,,,36.0,IU,SOLUTION FOR INJECTION,QD,2019,Q1,Hypoglycaemia,,2019,Q1,4,F,20160125.0,20190110.0,20160519,20190118,EXP,2016-026599,IE-SA-2016SA093002,SANOFI AVENTIS,,34.0,YR,A,F,Y,71.6,KG,20190118.0,,MD,IE,IE,2019,Q1,Young Adult
123864194,12386419,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"36 IU,QD",,,U,,,,,36.0,IU,SOLUTION FOR INJECTION,QD,2019,Q1,Hypoglycaemic seizure,,2019,Q1,4,F,20160125.0,20190110.0,20160519,20190118,EXP,2016-026599,IE-SA-2016SA093002,SANOFI AVENTIS,,34.0,YR,A,F,Y,71.6,KG,20190118.0,,MD,IE,IE,2019,Q1,Young Adult
124218525,12421852,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q4H,2019,Q1,Haemorrhagic anaemia,,2019,Q1,5,F,20150831.0,20190218.0,20160531,20190225,PER,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-33991BI",BOEHRINGER INGELHEIM,,72.0,YR,,F,Y,124.73,KG,20190225.0,,CN,US,US,2019,Q1,Elderly
124218525,12421852,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q4H,2019,Q1,Internal haemorrhage,,2019,Q1,5,F,20150831.0,20190218.0,20160531,20190225,PER,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-33991BI",BOEHRINGER INGELHEIM,,72.0,YR,,F,Y,124.73,KG,20190225.0,,CN,US,US,2019,Q1,Elderly
126667122,12666712,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Bile duct obstruction,,2019,Q1,2,F,20151114.0,20190305.0,20160819,20190318,EXP,,US-WEST-WARD PHARMACEUTICALS CORP.-2016-RO-00171RO,HIKMA,,59.0,YR,,M,Y,69.0,KG,20190315.0,,MD,US,US,2019,Q1,Adult
126667122,12666712,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Blood bilirubin increased,,2019,Q1,2,F,20151114.0,20190305.0,20160819,20190318,EXP,,US-WEST-WARD PHARMACEUTICALS CORP.-2016-RO-00171RO,HIKMA,,59.0,YR,,M,Y,69.0,KG,20190315.0,,MD,US,US,2019,Q1,Adult
126667122,12666712,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Hyperglycaemia,,2019,Q1,2,F,20151114.0,20190305.0,20160819,20190318,EXP,,US-WEST-WARD PHARMACEUTICALS CORP.-2016-RO-00171RO,HIKMA,,59.0,YR,,M,Y,69.0,KG,20190315.0,,MD,US,US,2019,Q1,Adult
1296291717,12962917,49,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONE TIME ONLY,,,,,,,,10.0,IU,,QD,2019,Q1,Acute respiratory failure,,2019,Q1,17,F,20160826.0,20190322.0,20161122,20190327,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20190327.0,,MD,US,US,2019,Q1,Elderly
1296291717,12962917,49,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONE TIME ONLY,,,,,,,,10.0,IU,,QD,2019,Q1,Fluid overload,,2019,Q1,17,F,20160826.0,20190322.0,20161122,20190327,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20190327.0,,MD,US,US,2019,Q1,Elderly
1296291717,12962917,49,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONE TIME ONLY,,,,,,,,10.0,IU,,QD,2019,Q1,Haemoptysis,,2019,Q1,17,F,20160826.0,20190322.0,20161122,20190327,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20190327.0,,MD,US,US,2019,Q1,Elderly
1296291717,12962917,49,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONE TIME ONLY,,,,,,,,10.0,IU,,QD,2019,Q1,Hyperkalaemia,,2019,Q1,17,F,20160826.0,20190322.0,20161122,20190327,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20190327.0,,MD,US,US,2019,Q1,Elderly
1296291717,12962917,49,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONE TIME ONLY,,,,,,,,10.0,IU,,QD,2019,Q1,Iron deficiency anaemia,,2019,Q1,17,F,20160826.0,20190322.0,20161122,20190327,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20190327.0,,MD,US,US,2019,Q1,Elderly
1296291717,12962917,49,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONE TIME ONLY,,,,,,,,10.0,IU,,QD,2019,Q1,Pleural effusion,,2019,Q1,17,F,20160826.0,20190322.0,20161122,20190327,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20190327.0,,MD,US,US,2019,Q1,Elderly
1296291717,12962917,49,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONE TIME ONLY,,,,,,,,10.0,IU,,QD,2019,Q1,Pneumonia,,2019,Q1,17,F,20160826.0,20190322.0,20161122,20190327,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20190327.0,,MD,US,US,2019,Q1,Elderly
1296291717,12962917,49,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONE TIME ONLY,,,,,,,,10.0,IU,,QD,2019,Q1,Pulmonary oedema,,2019,Q1,17,F,20160826.0,20190322.0,20161122,20190327,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20190327.0,,MD,US,US,2019,Q1,Elderly
1296291717,12962917,49,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONE TIME ONLY,,,,,,,,10.0,IU,,QD,2019,Q1,Sepsis,,2019,Q1,17,F,20160826.0,20190322.0,20161122,20190327,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20190327.0,,MD,US,US,2019,Q1,Elderly
1296291717,12962917,49,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONE TIME ONLY,,,,,,,,10.0,IU,,QD,2019,Q1,Tumour lysis syndrome,,2019,Q1,17,F,20160826.0,20190322.0,20161122,20190327,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20190327.0,,MD,US,US,2019,Q1,Elderly
1296291717,12962917,50,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,WITH GLUCOSE TESTING,,,,,,,,,,,,2019,Q1,Acute respiratory failure,,2019,Q1,17,F,20160826.0,20190322.0,20161122,20190327,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20190327.0,,MD,US,US,2019,Q1,Elderly
1296291717,12962917,50,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,WITH GLUCOSE TESTING,,,,,,,,,,,,2019,Q1,Fluid overload,,2019,Q1,17,F,20160826.0,20190322.0,20161122,20190327,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20190327.0,,MD,US,US,2019,Q1,Elderly
1296291717,12962917,50,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,WITH GLUCOSE TESTING,,,,,,,,,,,,2019,Q1,Haemoptysis,,2019,Q1,17,F,20160826.0,20190322.0,20161122,20190327,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20190327.0,,MD,US,US,2019,Q1,Elderly
1296291717,12962917,50,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,WITH GLUCOSE TESTING,,,,,,,,,,,,2019,Q1,Hyperkalaemia,,2019,Q1,17,F,20160826.0,20190322.0,20161122,20190327,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20190327.0,,MD,US,US,2019,Q1,Elderly
1296291717,12962917,50,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,WITH GLUCOSE TESTING,,,,,,,,,,,,2019,Q1,Iron deficiency anaemia,,2019,Q1,17,F,20160826.0,20190322.0,20161122,20190327,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20190327.0,,MD,US,US,2019,Q1,Elderly
1296291717,12962917,50,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,WITH GLUCOSE TESTING,,,,,,,,,,,,2019,Q1,Pleural effusion,,2019,Q1,17,F,20160826.0,20190322.0,20161122,20190327,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20190327.0,,MD,US,US,2019,Q1,Elderly
1296291717,12962917,50,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,WITH GLUCOSE TESTING,,,,,,,,,,,,2019,Q1,Pneumonia,,2019,Q1,17,F,20160826.0,20190322.0,20161122,20190327,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20190327.0,,MD,US,US,2019,Q1,Elderly
1296291717,12962917,50,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,WITH GLUCOSE TESTING,,,,,,,,,,,,2019,Q1,Pulmonary oedema,,2019,Q1,17,F,20160826.0,20190322.0,20161122,20190327,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20190327.0,,MD,US,US,2019,Q1,Elderly
1296291717,12962917,50,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,WITH GLUCOSE TESTING,,,,,,,,,,,,2019,Q1,Sepsis,,2019,Q1,17,F,20160826.0,20190322.0,20161122,20190327,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20190327.0,,MD,US,US,2019,Q1,Elderly
1296291717,12962917,50,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,WITH GLUCOSE TESTING,,,,,,,,,,,,2019,Q1,Tumour lysis syndrome,,2019,Q1,17,F,20160826.0,20190322.0,20161122,20190327,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20190327.0,,MD,US,US,2019,Q1,Elderly
131714908,13171490,39,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q1,Acute kidney injury,,2019,Q1,8,F,201501.0,20190116.0,20170201,20190124,EXP,,US-ASTRAZENECA-2017SE09276,ASTRAZENECA,,722.0,MON,,M,Y,79.4,KG,20190124.0,,,US,US,2019,Q1,Elderly
131714908,13171490,39,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q1,Chronic kidney disease,,2019,Q1,8,F,201501.0,20190116.0,20170201,20190124,EXP,,US-ASTRAZENECA-2017SE09276,ASTRAZENECA,,722.0,MON,,M,Y,79.4,KG,20190124.0,,,US,US,2019,Q1,Elderly
131714908,13171490,39,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q1,End stage renal disease,,2019,Q1,8,F,201501.0,20190116.0,20170201,20190124,EXP,,US-ASTRAZENECA-2017SE09276,ASTRAZENECA,,722.0,MON,,M,Y,79.4,KG,20190124.0,,,US,US,2019,Q1,Elderly
131714908,13171490,39,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q1,Nephrogenic anaemia,,2019,Q1,8,F,201501.0,20190116.0,20170201,20190124,EXP,,US-ASTRAZENECA-2017SE09276,ASTRAZENECA,,722.0,MON,,M,Y,79.4,KG,20190124.0,,,US,US,2019,Q1,Elderly
131714908,13171490,39,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q1,Pyelonephritis,,2019,Q1,8,F,201501.0,20190116.0,20170201,20190124,EXP,,US-ASTRAZENECA-2017SE09276,ASTRAZENECA,,722.0,MON,,M,Y,79.4,KG,20190124.0,,,US,US,2019,Q1,Elderly
131714908,13171490,39,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q1,Renal failure,,2019,Q1,8,F,201501.0,20190116.0,20170201,20190124,EXP,,US-ASTRAZENECA-2017SE09276,ASTRAZENECA,,722.0,MON,,M,Y,79.4,KG,20190124.0,,,US,US,2019,Q1,Elderly
131714908,13171490,39,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q1,Renal impairment,,2019,Q1,8,F,201501.0,20190116.0,20170201,20190124,EXP,,US-ASTRAZENECA-2017SE09276,ASTRAZENECA,,722.0,MON,,M,Y,79.4,KG,20190124.0,,,US,US,2019,Q1,Elderly
131714908,13171490,39,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q1,Renal injury,,2019,Q1,8,F,201501.0,20190116.0,20170201,20190124,EXP,,US-ASTRAZENECA-2017SE09276,ASTRAZENECA,,722.0,MON,,M,Y,79.4,KG,20190124.0,,,US,US,2019,Q1,Elderly
137004805,13700480,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q1,Rectal perforation,,2019,Q1,5,F,20170623.0,20190111.0,20170629,20190116,PER,,US-EISAI MEDICAL RESEARCH-EC-2017-028878,EISAI,,80.0,YR,,M,Y,61.9,KG,20190116.0,,MD,US,US,2019,Q1,Elderly
137576484,13757648,7,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,,2,,,,,,,,,,,,,,2019,Q1,Cutaneous vasculitis,,2019,Q1,4,F,20170501.0,20190202.0,20170717,20190214,EXP,DE-BFARM-17235006,DE-ACCORD-053696,ACCORD,,76.0,YR,E,M,Y,97.4,KG,20190214.0,,MD,DE,DE,2019,Q1,Elderly
137576484,13757648,7,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,,2,,,,,,,,,,,,,,2019,Q1,Nephrotic syndrome,,2019,Q1,4,F,20170501.0,20190202.0,20170717,20190214,EXP,DE-BFARM-17235006,DE-ACCORD-053696,ACCORD,,76.0,YR,E,M,Y,97.4,KG,20190214.0,,MD,DE,DE,2019,Q1,Elderly
140996313,14099631,7,SS,Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,,,,,,2019,Q1,Blood glucose increased,,2019,Q1,3,F,201410.0,20190308.0,20171017,20190320,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201710003648,ELI LILLY AND CO,,69.0,YR,,M,Y,90.0,KG,20190320.0,,CN,CN,CN,2019,Q1,Elderly
140996313,14099631,7,SS,Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,,,,,,2019,Q1,Cerebral infarction,,2019,Q1,3,F,201410.0,20190308.0,20171017,20190320,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201710003648,ELI LILLY AND CO,,69.0,YR,,M,Y,90.0,KG,20190320.0,,CN,CN,CN,2019,Q1,Elderly
140996313,14099631,7,SS,Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,,,,,,2019,Q1,Diabetes mellitus,,2019,Q1,3,F,201410.0,20190308.0,20171017,20190320,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201710003648,ELI LILLY AND CO,,69.0,YR,,M,Y,90.0,KG,20190320.0,,CN,CN,CN,2019,Q1,Elderly
140996313,14099631,7,SS,Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,,,,,,2019,Q1,Product dose omission,,2019,Q1,3,F,201410.0,20190308.0,20171017,20190320,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201710003648,ELI LILLY AND CO,,69.0,YR,,M,Y,90.0,KG,20190320.0,,CN,CN,CN,2019,Q1,Elderly
141686063,14168606,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Oral,,35904.0,IU,,,,,,102.0,IU,,QD,2019,Q1,Acute kidney injury,,2019,Q1,3,F,20171010.0,20190129.0,20171108,20190212,EXP,GB-MHRA-ADR 24225544,GB-ACCORD-060710,ACCORD,,78.0,YR,,M,Y,,,20190212.0,,MD,GB,GB,2019,Q1,Elderly
141686063,14168606,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Oral,,35904.0,IU,,,,,,102.0,IU,,QD,2019,Q1,Epididymitis,,2019,Q1,3,F,20171010.0,20190129.0,20171108,20190212,EXP,GB-MHRA-ADR 24225544,GB-ACCORD-060710,ACCORD,,78.0,YR,,M,Y,,,20190212.0,,MD,GB,GB,2019,Q1,Elderly
141686063,14168606,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Oral,,35904.0,IU,,,,,,102.0,IU,,QD,2019,Q1,Feeling hot,,2019,Q1,3,F,20171010.0,20190129.0,20171108,20190212,EXP,GB-MHRA-ADR 24225544,GB-ACCORD-060710,ACCORD,,78.0,YR,,M,Y,,,20190212.0,,MD,GB,GB,2019,Q1,Elderly
141686063,14168606,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Oral,,35904.0,IU,,,,,,102.0,IU,,QD,2019,Q1,Groin pain,,2019,Q1,3,F,20171010.0,20190129.0,20171108,20190212,EXP,GB-MHRA-ADR 24225544,GB-ACCORD-060710,ACCORD,,78.0,YR,,M,Y,,,20190212.0,,MD,GB,GB,2019,Q1,Elderly
141686063,14168606,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Oral,,35904.0,IU,,,,,,102.0,IU,,QD,2019,Q1,Hypotension,,2019,Q1,3,F,20171010.0,20190129.0,20171108,20190212,EXP,GB-MHRA-ADR 24225544,GB-ACCORD-060710,ACCORD,,78.0,YR,,M,Y,,,20190212.0,,MD,GB,GB,2019,Q1,Elderly
143153097,14315309,23,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,40 IU (INTERNATIONAL UNIT),,,,,,,,10.0,IU,INJECTION,QID,2019,Q1,Hepatic failure,,2019,Q1,7,F,20161130.0,20190225.0,20171221,20190228,EXP,,US-CELGENEUS-USA-20170701054,CELGENE,,55.0,YR,,M,Y,122.58,KG,20190228.0,,MD,US,US,2019,Q1,Adult
143153097,14315309,23,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,40 IU (INTERNATIONAL UNIT),,,,,,,,10.0,IU,INJECTION,QID,2019,Q1,Pneumonia,,2019,Q1,7,F,20161130.0,20190225.0,20171221,20190228,EXP,,US-CELGENEUS-USA-20170701054,CELGENE,,55.0,YR,,M,Y,122.58,KG,20190228.0,,MD,US,US,2019,Q1,Adult
143153097,14315309,23,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,40 IU (INTERNATIONAL UNIT),,,,,,,,10.0,IU,INJECTION,QID,2019,Q1,Respiratory failure,,2019,Q1,7,F,20161130.0,20190225.0,20171221,20190228,EXP,,US-CELGENEUS-USA-20170701054,CELGENE,,55.0,YR,,M,Y,122.58,KG,20190228.0,,MD,US,US,2019,Q1,Adult
143153097,14315309,23,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,40 IU (INTERNATIONAL UNIT),,,,,,,,10.0,IU,INJECTION,QID,2019,Q1,Sepsis,,2019,Q1,7,F,20161130.0,20190225.0,20171221,20190228,EXP,,US-CELGENEUS-USA-20170701054,CELGENE,,55.0,YR,,M,Y,122.58,KG,20190228.0,,MD,US,US,2019,Q1,Adult
143276092,14327609,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,"100 IU, DAILY, SOLUTION",,,,U,,,,100.0,IU,,,2019,Q1,Drug interaction,,2019,Q1,2,F,201704.0,20190128.0,20171227,20190208,EXP,,DE-AUROBINDO-AUR-APL-2017-47295,AUROBINDO,,67.0,YR,,F,Y,74.0,KG,20190208.0,,CN,DE,DE,2019,Q1,Elderly
143276092,14327609,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,"100 IU, DAILY, SOLUTION",,,,U,,,,100.0,IU,,,2019,Q1,Rhabdomyolysis,,2019,Q1,2,F,201704.0,20190128.0,20171227,20190208,EXP,,DE-AUROBINDO-AUR-APL-2017-47295,AUROBINDO,,67.0,YR,,F,Y,74.0,KG,20190208.0,,CN,DE,DE,2019,Q1,Elderly
143328553,14332855,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 IU, DAILY, SOLUTION",,,D,,,,,100.0,IU,SOLUTION FOR INJECTION,QD,2019,Q1,Drug interaction,,2019,Q1,3,F,201704.0,20190128.0,20171228,20190208,EXP,,DE-AUROBINDO-AUR-APL-2017-47420,AUROBINDO,,67.0,YR,,F,Y,74.0,KG,20190208.0,,CN,DE,DE,2019,Q1,Elderly
143328553,14332855,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 IU, DAILY, SOLUTION",,,D,,,,,100.0,IU,SOLUTION FOR INJECTION,QD,2019,Q1,Rhabdomyolysis,,2019,Q1,3,F,201704.0,20190128.0,20171228,20190208,EXP,,DE-AUROBINDO-AUR-APL-2017-47420,AUROBINDO,,67.0,YR,,F,Y,74.0,KG,20190208.0,,CN,DE,DE,2019,Q1,Elderly
144843515,14484351,43,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q1,Acute kidney injury,,2019,Q1,5,F,201112.0,20190130.0,20180205,20190204,EXP,,US-ASTRAZENECA-2018SE12552,ASTRAZENECA,,795.0,MON,,M,Y,104.3,KG,20190204.0,,,US,US,2019,Q1,Elderly
144843515,14484351,43,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q1,Chronic kidney disease,,2019,Q1,5,F,201112.0,20190130.0,20180205,20190204,EXP,,US-ASTRAZENECA-2018SE12552,ASTRAZENECA,,795.0,MON,,M,Y,104.3,KG,20190204.0,,,US,US,2019,Q1,Elderly
144843515,14484351,43,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q1,Chronic kidney disease-mineral and bone disorder,,2019,Q1,5,F,201112.0,20190130.0,20180205,20190204,EXP,,US-ASTRAZENECA-2018SE12552,ASTRAZENECA,,795.0,MON,,M,Y,104.3,KG,20190204.0,,,US,US,2019,Q1,Elderly
144843515,14484351,43,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q1,Nephrogenic anaemia,,2019,Q1,5,F,201112.0,20190130.0,20180205,20190204,EXP,,US-ASTRAZENECA-2018SE12552,ASTRAZENECA,,795.0,MON,,M,Y,104.3,KG,20190204.0,,,US,US,2019,Q1,Elderly
144843515,14484351,43,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q1,Renal failure,,2019,Q1,5,F,201112.0,20190130.0,20180205,20190204,EXP,,US-ASTRAZENECA-2018SE12552,ASTRAZENECA,,795.0,MON,,M,Y,104.3,KG,20190204.0,,,US,US,2019,Q1,Elderly
145213734,14521373,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 IU,QD",,,,,,,,30.0,IU,SOLUTION FOR INJECTION,QD,2019,Q1,Exposure during pregnancy,,2019,Q1,4,F,20170706.0,20181221.0,20180212,20190102,EXP,DE-EMA-DD-20171204-NGEVHPROD-114716,DE-SA-2017SA137494,SANOFI AVENTIS,,33.0,YR,A,F,Y,84.0,KG,20190102.0,,CN,DK,DE,2019,Q1,Young Adult
145213734,14521373,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 IU,QD",,,,,,,,30.0,IU,SOLUTION FOR INJECTION,QD,2019,Q1,Hyperglycaemia,,2019,Q1,4,F,20170706.0,20181221.0,20180212,20190102,EXP,DE-EMA-DD-20171204-NGEVHPROD-114716,DE-SA-2017SA137494,SANOFI AVENTIS,,33.0,YR,A,F,Y,84.0,KG,20190102.0,,CN,DK,DE,2019,Q1,Young Adult
145213734,14521373,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 IU,QD",,,,,,,,30.0,IU,SOLUTION FOR INJECTION,QD,2019,Q1,Hypoglycaemia,,2019,Q1,4,F,20170706.0,20181221.0,20180212,20190102,EXP,DE-EMA-DD-20171204-NGEVHPROD-114716,DE-SA-2017SA137494,SANOFI AVENTIS,,33.0,YR,A,F,Y,84.0,KG,20190102.0,,CN,DK,DE,2019,Q1,Young Adult
145213734,14521373,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 IU,QD",,,,,,,,30.0,IU,SOLUTION FOR INJECTION,QD,2019,Q1,Norovirus test positive,,2019,Q1,4,F,20170706.0,20181221.0,20180212,20190102,EXP,DE-EMA-DD-20171204-NGEVHPROD-114716,DE-SA-2017SA137494,SANOFI AVENTIS,,33.0,YR,A,F,Y,84.0,KG,20190102.0,,CN,DK,DE,2019,Q1,Young Adult
145213734,14521373,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 IU,QD",,,,,,,,40.0,IU,SOLUTION FOR INJECTION,QD,2019,Q1,Exposure during pregnancy,,2019,Q1,4,F,20170706.0,20181221.0,20180212,20190102,EXP,DE-EMA-DD-20171204-NGEVHPROD-114716,DE-SA-2017SA137494,SANOFI AVENTIS,,33.0,YR,A,F,Y,84.0,KG,20190102.0,,CN,DK,DE,2019,Q1,Young Adult
145213734,14521373,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 IU,QD",,,,,,,,40.0,IU,SOLUTION FOR INJECTION,QD,2019,Q1,Hyperglycaemia,,2019,Q1,4,F,20170706.0,20181221.0,20180212,20190102,EXP,DE-EMA-DD-20171204-NGEVHPROD-114716,DE-SA-2017SA137494,SANOFI AVENTIS,,33.0,YR,A,F,Y,84.0,KG,20190102.0,,CN,DK,DE,2019,Q1,Young Adult
145213734,14521373,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 IU,QD",,,,,,,,40.0,IU,SOLUTION FOR INJECTION,QD,2019,Q1,Hypoglycaemia,,2019,Q1,4,F,20170706.0,20181221.0,20180212,20190102,EXP,DE-EMA-DD-20171204-NGEVHPROD-114716,DE-SA-2017SA137494,SANOFI AVENTIS,,33.0,YR,A,F,Y,84.0,KG,20190102.0,,CN,DK,DE,2019,Q1,Young Adult
145213734,14521373,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 IU,QD",,,,,,,,40.0,IU,SOLUTION FOR INJECTION,QD,2019,Q1,Norovirus test positive,,2019,Q1,4,F,20170706.0,20181221.0,20180212,20190102,EXP,DE-EMA-DD-20171204-NGEVHPROD-114716,DE-SA-2017SA137494,SANOFI AVENTIS,,33.0,YR,A,F,Y,84.0,KG,20190102.0,,CN,DK,DE,2019,Q1,Young Adult
145213734,14521373,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 U, QD",,,,,,,,,,SOLUTION FOR INJECTION,QD,2019,Q1,Exposure during pregnancy,,2019,Q1,4,F,20170706.0,20181221.0,20180212,20190102,EXP,DE-EMA-DD-20171204-NGEVHPROD-114716,DE-SA-2017SA137494,SANOFI AVENTIS,,33.0,YR,A,F,Y,84.0,KG,20190102.0,,CN,DK,DE,2019,Q1,Young Adult
145213734,14521373,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 U, QD",,,,,,,,,,SOLUTION FOR INJECTION,QD,2019,Q1,Hyperglycaemia,,2019,Q1,4,F,20170706.0,20181221.0,20180212,20190102,EXP,DE-EMA-DD-20171204-NGEVHPROD-114716,DE-SA-2017SA137494,SANOFI AVENTIS,,33.0,YR,A,F,Y,84.0,KG,20190102.0,,CN,DK,DE,2019,Q1,Young Adult
145213734,14521373,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 U, QD",,,,,,,,,,SOLUTION FOR INJECTION,QD,2019,Q1,Hypoglycaemia,,2019,Q1,4,F,20170706.0,20181221.0,20180212,20190102,EXP,DE-EMA-DD-20171204-NGEVHPROD-114716,DE-SA-2017SA137494,SANOFI AVENTIS,,33.0,YR,A,F,Y,84.0,KG,20190102.0,,CN,DK,DE,2019,Q1,Young Adult
145213734,14521373,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 U, QD",,,,,,,,,,SOLUTION FOR INJECTION,QD,2019,Q1,Norovirus test positive,,2019,Q1,4,F,20170706.0,20181221.0,20180212,20190102,EXP,DE-EMA-DD-20171204-NGEVHPROD-114716,DE-SA-2017SA137494,SANOFI AVENTIS,,33.0,YR,A,F,Y,84.0,KG,20190102.0,,CN,DK,DE,2019,Q1,Young Adult
145540338,14554033,24,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,INJECTION,,2019,Q1,Diarrhoea,,2019,Q1,8,F,20180211.0,20190325.0,20180220,20190328,EXP,,CA-CELGENEUS-CAN-20180205858,CELGENE,,77.0,YR,,M,Y,67.6,KG,20190328.0,,OT,CA,CA,2019,Q1,Elderly
145540338,14554033,24,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,INJECTION,,2019,Q1,Klebsiella infection,,2019,Q1,8,F,20180211.0,20190325.0,20180220,20190328,EXP,,CA-CELGENEUS-CAN-20180205858,CELGENE,,77.0,YR,,M,Y,67.6,KG,20190328.0,,OT,CA,CA,2019,Q1,Elderly
145540338,14554033,24,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,INJECTION,,2019,Q1,Lung infection,,2019,Q1,8,F,20180211.0,20190325.0,20180220,20190328,EXP,,CA-CELGENEUS-CAN-20180205858,CELGENE,,77.0,YR,,M,Y,67.6,KG,20190328.0,,OT,CA,CA,2019,Q1,Elderly
145540338,14554033,24,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,INJECTION,,2019,Q1,Sepsis,,2019,Q1,8,F,20180211.0,20190325.0,20180220,20190328,EXP,,CA-CELGENEUS-CAN-20180205858,CELGENE,,77.0,YR,,M,Y,67.6,KG,20190328.0,,OT,CA,CA,2019,Q1,Elderly
145540338,14554033,24,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,INJECTION,,2019,Q1,Septic shock,,2019,Q1,8,F,20180211.0,20190325.0,20180220,20190328,EXP,,CA-CELGENEUS-CAN-20180205858,CELGENE,,77.0,YR,,M,Y,67.6,KG,20190328.0,,OT,CA,CA,2019,Q1,Elderly
145681965,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2019,Q1,Arthralgia,,2019,Q1,5,F,2017.0,20190205.0,20180223,20190215,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20190215.0,,MD,US,US,2019,Q1,Adult
145681965,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2019,Q1,Cataract,,2019,Q1,5,F,2017.0,20190205.0,20180223,20190215,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20190215.0,,MD,US,US,2019,Q1,Adult
145681965,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2019,Q1,Clostridium difficile colitis,,2019,Q1,5,F,2017.0,20190205.0,20180223,20190215,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20190215.0,,MD,US,US,2019,Q1,Adult
145681965,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2019,Q1,Coxsackie viral infection,,2019,Q1,5,F,2017.0,20190205.0,20180223,20190215,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20190215.0,,MD,US,US,2019,Q1,Adult
145681965,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2019,Q1,Dry eye,,2019,Q1,5,F,2017.0,20190205.0,20180223,20190215,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20190215.0,,MD,US,US,2019,Q1,Adult
145681965,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2019,Q1,Dysgeusia,,2019,Q1,5,F,2017.0,20190205.0,20180223,20190215,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20190215.0,,MD,US,US,2019,Q1,Adult
145681965,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2019,Q1,Headache,,2019,Q1,5,F,2017.0,20190205.0,20180223,20190215,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20190215.0,,MD,US,US,2019,Q1,Adult
145681965,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2019,Q1,Hyperhidrosis,,2019,Q1,5,F,2017.0,20190205.0,20180223,20190215,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20190215.0,,MD,US,US,2019,Q1,Adult
145681965,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2019,Q1,Hypoacusis,,2019,Q1,5,F,2017.0,20190205.0,20180223,20190215,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20190215.0,,MD,US,US,2019,Q1,Adult
145681965,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2019,Q1,Hypogammaglobulinaemia,,2019,Q1,5,F,2017.0,20190205.0,20180223,20190215,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20190215.0,,MD,US,US,2019,Q1,Adult
145681965,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2019,Q1,Influenza like illness,,2019,Q1,5,F,2017.0,20190205.0,20180223,20190215,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20190215.0,,MD,US,US,2019,Q1,Adult
145681965,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2019,Q1,Myalgia,,2019,Q1,5,F,2017.0,20190205.0,20180223,20190215,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20190215.0,,MD,US,US,2019,Q1,Adult
145681965,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2019,Q1,Neuropathy peripheral,,2019,Q1,5,F,2017.0,20190205.0,20180223,20190215,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20190215.0,,MD,US,US,2019,Q1,Adult
145681965,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2019,Q1,Pollakiuria,,2019,Q1,5,F,2017.0,20190205.0,20180223,20190215,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20190215.0,,MD,US,US,2019,Q1,Adult
145681965,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2019,Q1,Product administration error,,2019,Q1,5,F,2017.0,20190205.0,20180223,20190215,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20190215.0,,MD,US,US,2019,Q1,Adult
145681965,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2019,Q1,Pyrexia,,2019,Q1,5,F,2017.0,20190205.0,20180223,20190215,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20190215.0,,MD,US,US,2019,Q1,Adult
145681965,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2019,Q1,Rash morbilliform,,2019,Q1,5,F,2017.0,20190205.0,20180223,20190215,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20190215.0,,MD,US,US,2019,Q1,Adult
145681965,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2019,Q1,Stevens-Johnson syndrome,,2019,Q1,5,F,2017.0,20190205.0,20180223,20190215,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20190215.0,,MD,US,US,2019,Q1,Adult
145681965,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2019,Q1,Urinary incontinence,,2019,Q1,5,F,2017.0,20190205.0,20180223,20190215,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20190215.0,,MD,US,US,2019,Q1,Adult
145681965,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2019,Q1,Vision blurred,,2019,Q1,5,F,2017.0,20190205.0,20180223,20190215,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20190215.0,,MD,US,US,2019,Q1,Adult
145681965,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2019,Q1,Vitamin D abnormal,,2019,Q1,5,F,2017.0,20190205.0,20180223,20190215,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20190215.0,,MD,US,US,2019,Q1,Adult
145681965,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2019,Q1,Weight decreased,,2019,Q1,5,F,2017.0,20190205.0,20180223,20190215,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20190215.0,,MD,US,US,2019,Q1,Adult
147759957,14775995,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,5 IU (INTERNATIONAL UNIT),,,,,,,,5.0,IU,UNKNOWN,QD,2019,Q1,Squamous cell carcinoma of the tongue,,2019,Q1,7,F,20180323.0,20190222.0,20180418,20190227,EXP,,IT-CELGENEUS-ITA-20180404331,CELGENE,,46.0,YR,,M,Y,66.0,KG,20190227.0,,OT,IT,IT,2019,Q1,Adult
147759957,14775995,11,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,6 IU (INTERNATIONAL UNIT),,,,,,,,6.0,IU,UNKNOWN,QD,2019,Q1,Squamous cell carcinoma of the tongue,,2019,Q1,7,F,20180323.0,20190222.0,20180418,20190227,EXP,,IT-CELGENEUS-ITA-20180404331,CELGENE,,46.0,YR,,M,Y,66.0,KG,20190227.0,,OT,IT,IT,2019,Q1,Adult
147759957,14775995,12,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,4 IU (INTERNATIONAL UNIT),,,,,,,,4.0,IU,UNKNOWN,QD,2019,Q1,Squamous cell carcinoma of the tongue,,2019,Q1,7,F,20180323.0,20190222.0,20180418,20190227,EXP,,IT-CELGENEUS-ITA-20180404331,CELGENE,,46.0,YR,,M,Y,66.0,KG,20190227.0,,OT,IT,IT,2019,Q1,Adult
147783584,14778358,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,5 UNITS TWO TIMES IN DAY,,,,,,,,,,,,2019,Q1,Chronic kidney disease,,2019,Q1,4,F,20000322.0,20190222.0,20180419,20190301,EXP,,US-ASTRAZENECA-2018SE49082,ASTRAZENECA,,12428.0,DY,,F,Y,,,20190302.0,,,US,US,2019,Q1,Elderly
147783584,14778358,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,5 UNITS TWO TIMES IN DAY,,,,,,,,,,,,2019,Q1,Chronic kidney disease-mineral and bone disorder,,2019,Q1,4,F,20000322.0,20190222.0,20180419,20190301,EXP,,US-ASTRAZENECA-2018SE49082,ASTRAZENECA,,12428.0,DY,,F,Y,,,20190302.0,,,US,US,2019,Q1,Elderly
147783584,14778358,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,5 UNITS TWO TIMES IN DAY,,,,,,,,,,,,2019,Q1,End stage renal disease,,2019,Q1,4,F,20000322.0,20190222.0,20180419,20190301,EXP,,US-ASTRAZENECA-2018SE49082,ASTRAZENECA,,12428.0,DY,,F,Y,,,20190302.0,,,US,US,2019,Q1,Elderly
147783584,14778358,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,5 UNITS TWO TIMES IN DAY,,,,,,,,,,,,2019,Q1,Hyperparathyroidism secondary,,2019,Q1,4,F,20000322.0,20190222.0,20180419,20190301,EXP,,US-ASTRAZENECA-2018SE49082,ASTRAZENECA,,12428.0,DY,,F,Y,,,20190302.0,,,US,US,2019,Q1,Elderly
147783584,14778358,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,5 UNITS TWO TIMES IN DAY,,,,,,,,,,,,2019,Q1,Nephrogenic anaemia,,2019,Q1,4,F,20000322.0,20190222.0,20180419,20190301,EXP,,US-ASTRAZENECA-2018SE49082,ASTRAZENECA,,12428.0,DY,,F,Y,,,20190302.0,,,US,US,2019,Q1,Elderly
147783584,14778358,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,5 UNITS TWO TIMES IN DAY,,,,,,,,,,,,2019,Q1,Renal failure,,2019,Q1,4,F,20000322.0,20190222.0,20180419,20190301,EXP,,US-ASTRAZENECA-2018SE49082,ASTRAZENECA,,12428.0,DY,,F,Y,,,20190302.0,,,US,US,2019,Q1,Elderly
147783584,14778358,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,5 UNITS TWO TIMES IN DAY,,,,,,,,,,,,2019,Q1,Renal injury,,2019,Q1,4,F,20000322.0,20190222.0,20180419,20190301,EXP,,US-ASTRAZENECA-2018SE49082,ASTRAZENECA,,12428.0,DY,,F,Y,,,20190302.0,,,US,US,2019,Q1,Elderly
148277014,14827701,13,C,INSULIN LISPRO(GENETICAL RECOMBINATION),,2,Parenteral,"12 DF, TID",,,U,,,,,12.0,DF,INJECTION,TID,2019,Q1,Atrial fibrillation,,2019,Q1,4,F,20171002.0,20190115.0,20180430,20190121,EXP,,JP-009507513-1803JPN000430J,MERCK,"MURAKAMI R, MIYAWAKI M, KAMIKO I, TSURUMAKI Y, TADA A, MORIMOTO J, ET AL.. O36-7 A CASE OF DESTRUCTIVE THYROIDITIS AFTER ADMINISTRATION OF PEMBROLIZUMAB IN A PATIENT WITH BASEDOW^S DISEASE.. THE 61ST ANNUAL MEETING OF THE JAPAN THYROID ASSOCIATION OF THE JAPANESE ENDOCRI. 2018;94:1259",76.0,YR,,M,Y,73.0,KG,20190121.0,,MD,JP,JP,2019,Q1,Elderly
148277014,14827701,13,C,INSULIN LISPRO(GENETICAL RECOMBINATION),,2,Parenteral,"12 DF, TID",,,U,,,,,12.0,DF,INJECTION,TID,2019,Q1,Malignant neoplasm progression,,2019,Q1,4,F,20171002.0,20190115.0,20180430,20190121,EXP,,JP-009507513-1803JPN000430J,MERCK,"MURAKAMI R, MIYAWAKI M, KAMIKO I, TSURUMAKI Y, TADA A, MORIMOTO J, ET AL.. O36-7 A CASE OF DESTRUCTIVE THYROIDITIS AFTER ADMINISTRATION OF PEMBROLIZUMAB IN A PATIENT WITH BASEDOW^S DISEASE.. THE 61ST ANNUAL MEETING OF THE JAPAN THYROID ASSOCIATION OF THE JAPANESE ENDOCRI. 2018;94:1259",76.0,YR,,M,Y,73.0,KG,20190121.0,,MD,JP,JP,2019,Q1,Elderly
148277014,14827701,13,C,INSULIN LISPRO(GENETICAL RECOMBINATION),,2,Parenteral,"12 DF, TID",,,U,,,,,12.0,DF,INJECTION,TID,2019,Q1,Thyroiditis,,2019,Q1,4,F,20171002.0,20190115.0,20180430,20190121,EXP,,JP-009507513-1803JPN000430J,MERCK,"MURAKAMI R, MIYAWAKI M, KAMIKO I, TSURUMAKI Y, TADA A, MORIMOTO J, ET AL.. O36-7 A CASE OF DESTRUCTIVE THYROIDITIS AFTER ADMINISTRATION OF PEMBROLIZUMAB IN A PATIENT WITH BASEDOW^S DISEASE.. THE 61ST ANNUAL MEETING OF THE JAPAN THYROID ASSOCIATION OF THE JAPANESE ENDOCRI. 2018;94:1259",76.0,YR,,M,Y,73.0,KG,20190121.0,,MD,JP,JP,2019,Q1,Elderly
1483839416,14838394,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q1,Amnesia,,2019,Q1,16,F,20181005.0,20190128.0,20180502,20190211,EXP,,US-ACTELION-A-US2018-169560,ACTELION,,48.0,YR,A,F,Y,71.66,KG,20190211.0,,OT,US,US,2019,Q1,Adult
1483839416,14838394,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q1,Atrial fibrillation,,2019,Q1,16,F,20181005.0,20190128.0,20180502,20190211,EXP,,US-ACTELION-A-US2018-169560,ACTELION,,48.0,YR,A,F,Y,71.66,KG,20190211.0,,OT,US,US,2019,Q1,Adult
1483839416,14838394,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q1,Chronic respiratory failure,,2019,Q1,16,F,20181005.0,20190128.0,20180502,20190211,EXP,,US-ACTELION-A-US2018-169560,ACTELION,,48.0,YR,A,F,Y,71.66,KG,20190211.0,,OT,US,US,2019,Q1,Adult
1483839416,14838394,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q1,Contusion,,2019,Q1,16,F,20181005.0,20190128.0,20180502,20190211,EXP,,US-ACTELION-A-US2018-169560,ACTELION,,48.0,YR,A,F,Y,71.66,KG,20190211.0,,OT,US,US,2019,Q1,Adult
1483839416,14838394,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q1,Cough,,2019,Q1,16,F,20181005.0,20190128.0,20180502,20190211,EXP,,US-ACTELION-A-US2018-169560,ACTELION,,48.0,YR,A,F,Y,71.66,KG,20190211.0,,OT,US,US,2019,Q1,Adult
1483839416,14838394,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q1,Disease progression,,2019,Q1,16,F,20181005.0,20190128.0,20180502,20190211,EXP,,US-ACTELION-A-US2018-169560,ACTELION,,48.0,YR,A,F,Y,71.66,KG,20190211.0,,OT,US,US,2019,Q1,Adult
1483839416,14838394,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q1,Dyspnoea,,2019,Q1,16,F,20181005.0,20190128.0,20180502,20190211,EXP,,US-ACTELION-A-US2018-169560,ACTELION,,48.0,YR,A,F,Y,71.66,KG,20190211.0,,OT,US,US,2019,Q1,Adult
1483839416,14838394,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q1,Dyspnoea exertional,,2019,Q1,16,F,20181005.0,20190128.0,20180502,20190211,EXP,,US-ACTELION-A-US2018-169560,ACTELION,,48.0,YR,A,F,Y,71.66,KG,20190211.0,,OT,US,US,2019,Q1,Adult
1483839416,14838394,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q1,Electrolyte imbalance,,2019,Q1,16,F,20181005.0,20190128.0,20180502,20190211,EXP,,US-ACTELION-A-US2018-169560,ACTELION,,48.0,YR,A,F,Y,71.66,KG,20190211.0,,OT,US,US,2019,Q1,Adult
1483839416,14838394,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q1,Fatigue,,2019,Q1,16,F,20181005.0,20190128.0,20180502,20190211,EXP,,US-ACTELION-A-US2018-169560,ACTELION,,48.0,YR,A,F,Y,71.66,KG,20190211.0,,OT,US,US,2019,Q1,Adult
1483839416,14838394,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q1,Fluid overload,,2019,Q1,16,F,20181005.0,20190128.0,20180502,20190211,EXP,,US-ACTELION-A-US2018-169560,ACTELION,,48.0,YR,A,F,Y,71.66,KG,20190211.0,,OT,US,US,2019,Q1,Adult
1483839416,14838394,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q1,Fluid retention,,2019,Q1,16,F,20181005.0,20190128.0,20180502,20190211,EXP,,US-ACTELION-A-US2018-169560,ACTELION,,48.0,YR,A,F,Y,71.66,KG,20190211.0,,OT,US,US,2019,Q1,Adult
1483839416,14838394,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q1,Headache,,2019,Q1,16,F,20181005.0,20190128.0,20180502,20190211,EXP,,US-ACTELION-A-US2018-169560,ACTELION,,48.0,YR,A,F,Y,71.66,KG,20190211.0,,OT,US,US,2019,Q1,Adult
1483839416,14838394,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q1,Heart rate increased,,2019,Q1,16,F,20181005.0,20190128.0,20180502,20190211,EXP,,US-ACTELION-A-US2018-169560,ACTELION,,48.0,YR,A,F,Y,71.66,KG,20190211.0,,OT,US,US,2019,Q1,Adult
1483839416,14838394,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q1,Hypokalaemia,,2019,Q1,16,F,20181005.0,20190128.0,20180502,20190211,EXP,,US-ACTELION-A-US2018-169560,ACTELION,,48.0,YR,A,F,Y,71.66,KG,20190211.0,,OT,US,US,2019,Q1,Adult
1483839416,14838394,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q1,Laboratory test abnormal,,2019,Q1,16,F,20181005.0,20190128.0,20180502,20190211,EXP,,US-ACTELION-A-US2018-169560,ACTELION,,48.0,YR,A,F,Y,71.66,KG,20190211.0,,OT,US,US,2019,Q1,Adult
1483839416,14838394,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q1,Lactic acidosis,,2019,Q1,16,F,20181005.0,20190128.0,20180502,20190211,EXP,,US-ACTELION-A-US2018-169560,ACTELION,,48.0,YR,A,F,Y,71.66,KG,20190211.0,,OT,US,US,2019,Q1,Adult
1483839416,14838394,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q1,Leukocytosis,,2019,Q1,16,F,20181005.0,20190128.0,20180502,20190211,EXP,,US-ACTELION-A-US2018-169560,ACTELION,,48.0,YR,A,F,Y,71.66,KG,20190211.0,,OT,US,US,2019,Q1,Adult
1483839416,14838394,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q1,Medication error,,2019,Q1,16,F,20181005.0,20190128.0,20180502,20190211,EXP,,US-ACTELION-A-US2018-169560,ACTELION,,48.0,YR,A,F,Y,71.66,KG,20190211.0,,OT,US,US,2019,Q1,Adult
1483839416,14838394,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q1,Oedema,,2019,Q1,16,F,20181005.0,20190128.0,20180502,20190211,EXP,,US-ACTELION-A-US2018-169560,ACTELION,,48.0,YR,A,F,Y,71.66,KG,20190211.0,,OT,US,US,2019,Q1,Adult
1483839416,14838394,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q1,Oxygen saturation decreased,,2019,Q1,16,F,20181005.0,20190128.0,20180502,20190211,EXP,,US-ACTELION-A-US2018-169560,ACTELION,,48.0,YR,A,F,Y,71.66,KG,20190211.0,,OT,US,US,2019,Q1,Adult
1483839416,14838394,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q1,Pain in jaw,,2019,Q1,16,F,20181005.0,20190128.0,20180502,20190211,EXP,,US-ACTELION-A-US2018-169560,ACTELION,,48.0,YR,A,F,Y,71.66,KG,20190211.0,,OT,US,US,2019,Q1,Adult
1483839416,14838394,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q1,Parainfluenzae virus infection,,2019,Q1,16,F,20181005.0,20190128.0,20180502,20190211,EXP,,US-ACTELION-A-US2018-169560,ACTELION,,48.0,YR,A,F,Y,71.66,KG,20190211.0,,OT,US,US,2019,Q1,Adult
1483839416,14838394,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q1,Pneumonia,,2019,Q1,16,F,20181005.0,20190128.0,20180502,20190211,EXP,,US-ACTELION-A-US2018-169560,ACTELION,,48.0,YR,A,F,Y,71.66,KG,20190211.0,,OT,US,US,2019,Q1,Adult
1483839416,14838394,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q1,Product dose omission,,2019,Q1,16,F,20181005.0,20190128.0,20180502,20190211,EXP,,US-ACTELION-A-US2018-169560,ACTELION,,48.0,YR,A,F,Y,71.66,KG,20190211.0,,OT,US,US,2019,Q1,Adult
1483839416,14838394,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q1,Productive cough,,2019,Q1,16,F,20181005.0,20190128.0,20180502,20190211,EXP,,US-ACTELION-A-US2018-169560,ACTELION,,48.0,YR,A,F,Y,71.66,KG,20190211.0,,OT,US,US,2019,Q1,Adult
1483839416,14838394,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q1,Pulmonary hypertension,,2019,Q1,16,F,20181005.0,20190128.0,20180502,20190211,EXP,,US-ACTELION-A-US2018-169560,ACTELION,,48.0,YR,A,F,Y,71.66,KG,20190211.0,,OT,US,US,2019,Q1,Adult
1483839416,14838394,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q1,Renal failure,,2019,Q1,16,F,20181005.0,20190128.0,20180502,20190211,EXP,,US-ACTELION-A-US2018-169560,ACTELION,,48.0,YR,A,F,Y,71.66,KG,20190211.0,,OT,US,US,2019,Q1,Adult
1483839416,14838394,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q1,Rhinovirus infection,,2019,Q1,16,F,20181005.0,20190128.0,20180502,20190211,EXP,,US-ACTELION-A-US2018-169560,ACTELION,,48.0,YR,A,F,Y,71.66,KG,20190211.0,,OT,US,US,2019,Q1,Adult
1483839416,14838394,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q1,Right ventricular failure,,2019,Q1,16,F,20181005.0,20190128.0,20180502,20190211,EXP,,US-ACTELION-A-US2018-169560,ACTELION,,48.0,YR,A,F,Y,71.66,KG,20190211.0,,OT,US,US,2019,Q1,Adult
1483839416,14838394,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q1,Unevaluable event,,2019,Q1,16,F,20181005.0,20190128.0,20180502,20190211,EXP,,US-ACTELION-A-US2018-169560,ACTELION,,48.0,YR,A,F,Y,71.66,KG,20190211.0,,OT,US,US,2019,Q1,Adult
1483839416,14838394,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q1,Viral infection,,2019,Q1,16,F,20181005.0,20190128.0,20180502,20190211,EXP,,US-ACTELION-A-US2018-169560,ACTELION,,48.0,YR,A,F,Y,71.66,KG,20190211.0,,OT,US,US,2019,Q1,Adult
148478654,14847865,39,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2019,Q1,Aspiration,,2019,Q1,4,F,20180131.0,20190226.0,20180504,20190307,EXP,,PHHY2018US076159,NOVARTIS,,59.0,YR,,F,Y,63.0,KG,20190307.0,,OT,US,US,2019,Q1,Adult
148478654,14847865,39,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2019,Q1,Asthenia,,2019,Q1,4,F,20180131.0,20190226.0,20180504,20190307,EXP,,PHHY2018US076159,NOVARTIS,,59.0,YR,,F,Y,63.0,KG,20190307.0,,OT,US,US,2019,Q1,Adult
148478654,14847865,39,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2019,Q1,Diarrhoea,,2019,Q1,4,F,20180131.0,20190226.0,20180504,20190307,EXP,,PHHY2018US076159,NOVARTIS,,59.0,YR,,F,Y,63.0,KG,20190307.0,,OT,US,US,2019,Q1,Adult
148478654,14847865,39,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2019,Q1,Lung infection,,2019,Q1,4,F,20180131.0,20190226.0,20180504,20190307,EXP,,PHHY2018US076159,NOVARTIS,,59.0,YR,,F,Y,63.0,KG,20190307.0,,OT,US,US,2019,Q1,Adult
148478654,14847865,39,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2019,Q1,Respiratory failure,,2019,Q1,4,F,20180131.0,20190226.0,20180504,20190307,EXP,,PHHY2018US076159,NOVARTIS,,59.0,YR,,F,Y,63.0,KG,20190307.0,,OT,US,US,2019,Q1,Adult
1489664941,14896649,60,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 UG/M2, DAILY",,,D,,,,,21.0,UG/M**2,,,2019,Q1,Foetal disorder,,2019,Q1,41,F,20170914.0,20190304.0,20180515,20190314,EXP,,FR-PFIZER INC-2018195935,PFIZER,,1.0,DY,,M,Y,1.89,KG,20190314.0,,OT,FR,FR,2019,Q1,Child
1489664941,14896649,60,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 UG/M2, DAILY",,,D,,,,,21.0,UG/M**2,,,2019,Q1,Low birth weight baby,,2019,Q1,41,F,20170914.0,20190304.0,20180515,20190314,EXP,,FR-PFIZER INC-2018195935,PFIZER,,1.0,DY,,M,Y,1.89,KG,20190314.0,,OT,FR,FR,2019,Q1,Child
1489664941,14896649,60,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 UG/M2, DAILY",,,D,,,,,21.0,UG/M**2,,,2019,Q1,Maternal exposure during pregnancy,,2019,Q1,41,F,20170914.0,20190304.0,20180515,20190314,EXP,,FR-PFIZER INC-2018195935,PFIZER,,1.0,DY,,M,Y,1.89,KG,20190314.0,,OT,FR,FR,2019,Q1,Child
1489664941,14896649,60,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 UG/M2, DAILY",,,D,,,,,21.0,UG/M**2,,,2019,Q1,Neutropenia neonatal,,2019,Q1,41,F,20170914.0,20190304.0,20180515,20190314,EXP,,FR-PFIZER INC-2018195935,PFIZER,,1.0,DY,,M,Y,1.89,KG,20190314.0,,OT,FR,FR,2019,Q1,Child
1489664941,14896649,60,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 UG/M2, DAILY",,,D,,,,,21.0,UG/M**2,,,2019,Q1,Premature baby,,2019,Q1,41,F,20170914.0,20190304.0,20180515,20190314,EXP,,FR-PFIZER INC-2018195935,PFIZER,,1.0,DY,,M,Y,1.89,KG,20190314.0,,OT,FR,FR,2019,Q1,Child
1489664941,14896649,61,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 UG/M2, DAILY",,,D,,,,,7.0,UG/M**2,,,2019,Q1,Foetal disorder,,2019,Q1,41,F,20170914.0,20190304.0,20180515,20190314,EXP,,FR-PFIZER INC-2018195935,PFIZER,,1.0,DY,,M,Y,1.89,KG,20190314.0,,OT,FR,FR,2019,Q1,Child
1489664941,14896649,61,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 UG/M2, DAILY",,,D,,,,,7.0,UG/M**2,,,2019,Q1,Low birth weight baby,,2019,Q1,41,F,20170914.0,20190304.0,20180515,20190314,EXP,,FR-PFIZER INC-2018195935,PFIZER,,1.0,DY,,M,Y,1.89,KG,20190314.0,,OT,FR,FR,2019,Q1,Child
1489664941,14896649,61,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 UG/M2, DAILY",,,D,,,,,7.0,UG/M**2,,,2019,Q1,Maternal exposure during pregnancy,,2019,Q1,41,F,20170914.0,20190304.0,20180515,20190314,EXP,,FR-PFIZER INC-2018195935,PFIZER,,1.0,DY,,M,Y,1.89,KG,20190314.0,,OT,FR,FR,2019,Q1,Child
1489664941,14896649,61,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 UG/M2, DAILY",,,D,,,,,7.0,UG/M**2,,,2019,Q1,Neutropenia neonatal,,2019,Q1,41,F,20170914.0,20190304.0,20180515,20190314,EXP,,FR-PFIZER INC-2018195935,PFIZER,,1.0,DY,,M,Y,1.89,KG,20190314.0,,OT,FR,FR,2019,Q1,Child
1489664941,14896649,61,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 UG/M2, DAILY",,,D,,,,,7.0,UG/M**2,,,2019,Q1,Premature baby,,2019,Q1,41,F,20170914.0,20190304.0,20180515,20190314,EXP,,FR-PFIZER INC-2018195935,PFIZER,,1.0,DY,,M,Y,1.89,KG,20190314.0,,OT,FR,FR,2019,Q1,Child
1491573513,14915735,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q1,Anaemia,,2019,Q1,13,F,20160726.0,20190306.0,20180518,20190319,EXP,,US-ACTELION-A-US2016-142165,ACTELION,,69.0,YR,,F,Y,71.2,KG,20190319.0,,OT,US,US,2019,Q1,Elderly
1491573513,14915735,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q1,Aspartate aminotransferase decreased,,2019,Q1,13,F,20160726.0,20190306.0,20180518,20190319,EXP,,US-ACTELION-A-US2016-142165,ACTELION,,69.0,YR,,F,Y,71.2,KG,20190319.0,,OT,US,US,2019,Q1,Elderly
1491573513,14915735,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q1,Asthenia,,2019,Q1,13,F,20160726.0,20190306.0,20180518,20190319,EXP,,US-ACTELION-A-US2016-142165,ACTELION,,69.0,YR,,F,Y,71.2,KG,20190319.0,,OT,US,US,2019,Q1,Elderly
1491573513,14915735,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q1,Atrial fibrillation,,2019,Q1,13,F,20160726.0,20190306.0,20180518,20190319,EXP,,US-ACTELION-A-US2016-142165,ACTELION,,69.0,YR,,F,Y,71.2,KG,20190319.0,,OT,US,US,2019,Q1,Elderly
1491573513,14915735,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q1,Chest pain,,2019,Q1,13,F,20160726.0,20190306.0,20180518,20190319,EXP,,US-ACTELION-A-US2016-142165,ACTELION,,69.0,YR,,F,Y,71.2,KG,20190319.0,,OT,US,US,2019,Q1,Elderly
1491573513,14915735,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q1,Dizziness,,2019,Q1,13,F,20160726.0,20190306.0,20180518,20190319,EXP,,US-ACTELION-A-US2016-142165,ACTELION,,69.0,YR,,F,Y,71.2,KG,20190319.0,,OT,US,US,2019,Q1,Elderly
1491573513,14915735,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q1,Dizziness postural,,2019,Q1,13,F,20160726.0,20190306.0,20180518,20190319,EXP,,US-ACTELION-A-US2016-142165,ACTELION,,69.0,YR,,F,Y,71.2,KG,20190319.0,,OT,US,US,2019,Q1,Elderly
1491573513,14915735,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q1,Dyspnoea,,2019,Q1,13,F,20160726.0,20190306.0,20180518,20190319,EXP,,US-ACTELION-A-US2016-142165,ACTELION,,69.0,YR,,F,Y,71.2,KG,20190319.0,,OT,US,US,2019,Q1,Elderly
1491573513,14915735,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q1,Fluid overload,,2019,Q1,13,F,20160726.0,20190306.0,20180518,20190319,EXP,,US-ACTELION-A-US2016-142165,ACTELION,,69.0,YR,,F,Y,71.2,KG,20190319.0,,OT,US,US,2019,Q1,Elderly
1491573513,14915735,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q1,Gastrointestinal haemorrhage,,2019,Q1,13,F,20160726.0,20190306.0,20180518,20190319,EXP,,US-ACTELION-A-US2016-142165,ACTELION,,69.0,YR,,F,Y,71.2,KG,20190319.0,,OT,US,US,2019,Q1,Elderly
1491573513,14915735,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q1,Haematocrit decreased,,2019,Q1,13,F,20160726.0,20190306.0,20180518,20190319,EXP,,US-ACTELION-A-US2016-142165,ACTELION,,69.0,YR,,F,Y,71.2,KG,20190319.0,,OT,US,US,2019,Q1,Elderly
1491573513,14915735,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q1,Haemoglobin decreased,,2019,Q1,13,F,20160726.0,20190306.0,20180518,20190319,EXP,,US-ACTELION-A-US2016-142165,ACTELION,,69.0,YR,,F,Y,71.2,KG,20190319.0,,OT,US,US,2019,Q1,Elderly
1491573513,14915735,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q1,Haemorrhage,,2019,Q1,13,F,20160726.0,20190306.0,20180518,20190319,EXP,,US-ACTELION-A-US2016-142165,ACTELION,,69.0,YR,,F,Y,71.2,KG,20190319.0,,OT,US,US,2019,Q1,Elderly
1491573513,14915735,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q1,Headache,,2019,Q1,13,F,20160726.0,20190306.0,20180518,20190319,EXP,,US-ACTELION-A-US2016-142165,ACTELION,,69.0,YR,,F,Y,71.2,KG,20190319.0,,OT,US,US,2019,Q1,Elderly
1491573513,14915735,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q1,Hospitalisation,,2019,Q1,13,F,20160726.0,20190306.0,20180518,20190319,EXP,,US-ACTELION-A-US2016-142165,ACTELION,,69.0,YR,,F,Y,71.2,KG,20190319.0,,OT,US,US,2019,Q1,Elderly
1491573513,14915735,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q1,Hypoglycaemia,,2019,Q1,13,F,20160726.0,20190306.0,20180518,20190319,EXP,,US-ACTELION-A-US2016-142165,ACTELION,,69.0,YR,,F,Y,71.2,KG,20190319.0,,OT,US,US,2019,Q1,Elderly
1491573513,14915735,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q1,Pruritus generalised,,2019,Q1,13,F,20160726.0,20190306.0,20180518,20190319,EXP,,US-ACTELION-A-US2016-142165,ACTELION,,69.0,YR,,F,Y,71.2,KG,20190319.0,,OT,US,US,2019,Q1,Elderly
1491573513,14915735,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q1,Transfusion,,2019,Q1,13,F,20160726.0,20190306.0,20180518,20190319,EXP,,US-ACTELION-A-US2016-142165,ACTELION,,69.0,YR,,F,Y,71.2,KG,20190319.0,,OT,US,US,2019,Q1,Elderly
1491573513,14915735,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q1,Weight increased,,2019,Q1,13,F,20160726.0,20190306.0,20180518,20190319,EXP,,US-ACTELION-A-US2016-142165,ACTELION,,69.0,YR,,F,Y,71.2,KG,20190319.0,,OT,US,US,2019,Q1,Elderly
149406682,14940668,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q1,Cellulitis,,2019,Q1,2,F,20180503.0,20181226.0,20180525,20190107,EXP,,US-ACTELION-A-US2018-172608,ACTELION,,55.0,YR,A,M,Y,,,20190107.0,,PH,US,US,2019,Q1,Adult
149406682,14940668,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q1,Condition aggravated,,2019,Q1,2,F,20180503.0,20181226.0,20180525,20190107,EXP,,US-ACTELION-A-US2018-172608,ACTELION,,55.0,YR,A,M,Y,,,20190107.0,,PH,US,US,2019,Q1,Adult
149406682,14940668,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q1,Escherichia bacteraemia,,2019,Q1,2,F,20180503.0,20181226.0,20180525,20190107,EXP,,US-ACTELION-A-US2018-172608,ACTELION,,55.0,YR,A,M,Y,,,20190107.0,,PH,US,US,2019,Q1,Adult
149406682,14940668,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q1,Osteomyelitis,,2019,Q1,2,F,20180503.0,20181226.0,20180525,20190107,EXP,,US-ACTELION-A-US2018-172608,ACTELION,,55.0,YR,A,M,Y,,,20190107.0,,PH,US,US,2019,Q1,Adult
149406682,14940668,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q1,Pain in extremity,,2019,Q1,2,F,20180503.0,20181226.0,20180525,20190107,EXP,,US-ACTELION-A-US2018-172608,ACTELION,,55.0,YR,A,M,Y,,,20190107.0,,PH,US,US,2019,Q1,Adult
149406682,14940668,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q1,Skin ulcer,,2019,Q1,2,F,20180503.0,20181226.0,20180525,20190107,EXP,,US-ACTELION-A-US2018-172608,ACTELION,,55.0,YR,A,M,Y,,,20190107.0,,PH,US,US,2019,Q1,Adult
149406682,14940668,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q1,Wound haemorrhage,,2019,Q1,2,F,20180503.0,20181226.0,20180525,20190107,EXP,,US-ACTELION-A-US2018-172608,ACTELION,,55.0,YR,A,M,Y,,,20190107.0,,PH,US,US,2019,Q1,Adult
149753274,14975327,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,25 UNITS TID,,,,,,,,,,,,2019,Q1,Cellulitis,,2019,Q1,4,F,20180430.0,20190117.0,20180605,20190124,EXP,,US-ASTRAZENECA-2018SE72104,ASTRAZENECA,,19478.0,DY,,M,Y,,,20190125.0,,MD,US,US,2019,Q1,Elderly
149753274,14975327,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,25 UNITS TID,,,,,,,,,,,,2019,Q1,Sepsis,,2019,Q1,4,F,20180430.0,20190117.0,20180605,20190124,EXP,,US-ASTRAZENECA-2018SE72104,ASTRAZENECA,,19478.0,DY,,M,Y,,,20190125.0,,MD,US,US,2019,Q1,Elderly
149881772,14988177,5,C,LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q1,Pain,,2019,Q1,2,F,,20190130.0,20180608,20190211,PER,,US-PFIZER INC-2017338564,PFIZER,,53.0,YR,,M,Y,,,20190211.0,,CN,US,US,2019,Q1,Adult
149881772,14988177,5,C,LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q1,Product use issue,,2019,Q1,2,F,,20190130.0,20180608,20190211,PER,,US-PFIZER INC-2017338564,PFIZER,,53.0,YR,,M,Y,,,20190211.0,,CN,US,US,2019,Q1,Adult
150168662,15016866,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q1,Chronic kidney disease,,2019,Q1,2,F,2007.0,20190311.0,20180615,20190319,EXP,,GB-ASTRAZENECA-2018SE76205,ASTRAZENECA,,25.0,YR,,M,Y,113.4,KG,20190319.0,,,US,US,2019,Q1,Young Adult
150168662,15016866,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q1,End stage renal disease,,2019,Q1,2,F,2007.0,20190311.0,20180615,20190319,EXP,,GB-ASTRAZENECA-2018SE76205,ASTRAZENECA,,25.0,YR,,M,Y,113.4,KG,20190319.0,,,US,US,2019,Q1,Young Adult
150168662,15016866,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q1,Nephrogenic anaemia,,2019,Q1,2,F,2007.0,20190311.0,20180615,20190319,EXP,,GB-ASTRAZENECA-2018SE76205,ASTRAZENECA,,25.0,YR,,M,Y,113.4,KG,20190319.0,,,US,US,2019,Q1,Young Adult
150168662,15016866,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q1,Renal failure,,2019,Q1,2,F,2007.0,20190311.0,20180615,20190319,EXP,,GB-ASTRAZENECA-2018SE76205,ASTRAZENECA,,25.0,YR,,M,Y,113.4,KG,20190319.0,,,US,US,2019,Q1,Young Adult
150831538,15083153,41,SS,Insulin lispro,INSULIN LISPRO,1,Transplacental,7 MICROGRAM/SQ. METER,,,D,,,,,7.0,UG/M**2,,,2019,Q1,Foetal disorder,,2019,Q1,8,F,2017.0,20190131.0,20180628,20190204,EXP,,FR-AUROBINDO-AUR-APL-2018-033477,AUROBINDO,,1.0,DY,,M,Y,1.89,KG,20190204.0,,PH,FR,FR,2019,Q1,Child
150831538,15083153,41,SS,Insulin lispro,INSULIN LISPRO,1,Transplacental,7 MICROGRAM/SQ. METER,,,D,,,,,7.0,UG/M**2,,,2019,Q1,Foetal exposure during pregnancy,,2019,Q1,8,F,2017.0,20190131.0,20180628,20190204,EXP,,FR-AUROBINDO-AUR-APL-2018-033477,AUROBINDO,,1.0,DY,,M,Y,1.89,KG,20190204.0,,PH,FR,FR,2019,Q1,Child
150831538,15083153,41,SS,Insulin lispro,INSULIN LISPRO,1,Transplacental,7 MICROGRAM/SQ. METER,,,D,,,,,7.0,UG/M**2,,,2019,Q1,Low birth weight baby,,2019,Q1,8,F,2017.0,20190131.0,20180628,20190204,EXP,,FR-AUROBINDO-AUR-APL-2018-033477,AUROBINDO,,1.0,DY,,M,Y,1.89,KG,20190204.0,,PH,FR,FR,2019,Q1,Child
150831538,15083153,41,SS,Insulin lispro,INSULIN LISPRO,1,Transplacental,7 MICROGRAM/SQ. METER,,,D,,,,,7.0,UG/M**2,,,2019,Q1,Neutropenia neonatal,,2019,Q1,8,F,2017.0,20190131.0,20180628,20190204,EXP,,FR-AUROBINDO-AUR-APL-2018-033477,AUROBINDO,,1.0,DY,,M,Y,1.89,KG,20190204.0,,PH,FR,FR,2019,Q1,Child
150831538,15083153,41,SS,Insulin lispro,INSULIN LISPRO,1,Transplacental,7 MICROGRAM/SQ. METER,,,D,,,,,7.0,UG/M**2,,,2019,Q1,Premature baby,,2019,Q1,8,F,2017.0,20190131.0,20180628,20190204,EXP,,FR-AUROBINDO-AUR-APL-2018-033477,AUROBINDO,,1.0,DY,,M,Y,1.89,KG,20190204.0,,PH,FR,FR,2019,Q1,Child
150837629,15083762,39,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,21 UG/M2 DAILY;,,,U,,,,,21.0,UG/M**2,,QD,2019,Q1,Foetal disorder,,2019,Q1,9,F,20170914.0,20190227.0,20180628,20190307,EXP,FR-AFSSAPS-PC20180352,FR-TEVA-2018-FR-918354,TEVA,,1.0,DY,,M,Y,1.89,KG,20190307.0,,OT,FR,FR,2019,Q1,Child
150837629,15083762,39,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,21 UG/M2 DAILY;,,,U,,,,,21.0,UG/M**2,,QD,2019,Q1,Foetal exposure during pregnancy,,2019,Q1,9,F,20170914.0,20190227.0,20180628,20190307,EXP,FR-AFSSAPS-PC20180352,FR-TEVA-2018-FR-918354,TEVA,,1.0,DY,,M,Y,1.89,KG,20190307.0,,OT,FR,FR,2019,Q1,Child
150837629,15083762,39,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,21 UG/M2 DAILY;,,,U,,,,,21.0,UG/M**2,,QD,2019,Q1,Low birth weight baby,,2019,Q1,9,F,20170914.0,20190227.0,20180628,20190307,EXP,FR-AFSSAPS-PC20180352,FR-TEVA-2018-FR-918354,TEVA,,1.0,DY,,M,Y,1.89,KG,20190307.0,,OT,FR,FR,2019,Q1,Child
150837629,15083762,39,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,21 UG/M2 DAILY;,,,U,,,,,21.0,UG/M**2,,QD,2019,Q1,Neutropenia neonatal,,2019,Q1,9,F,20170914.0,20190227.0,20180628,20190307,EXP,FR-AFSSAPS-PC20180352,FR-TEVA-2018-FR-918354,TEVA,,1.0,DY,,M,Y,1.89,KG,20190307.0,,OT,FR,FR,2019,Q1,Child
150837629,15083762,39,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,21 UG/M2 DAILY;,,,U,,,,,21.0,UG/M**2,,QD,2019,Q1,Premature baby,,2019,Q1,9,F,20170914.0,20190227.0,20180628,20190307,EXP,FR-AFSSAPS-PC20180352,FR-TEVA-2018-FR-918354,TEVA,,1.0,DY,,M,Y,1.89,KG,20190307.0,,OT,FR,FR,2019,Q1,Child
150837629,15083762,40,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,7 UG/M2 DAILY;,,,U,,,,,7.0,UG/M**2,,QD,2019,Q1,Foetal disorder,,2019,Q1,9,F,20170914.0,20190227.0,20180628,20190307,EXP,FR-AFSSAPS-PC20180352,FR-TEVA-2018-FR-918354,TEVA,,1.0,DY,,M,Y,1.89,KG,20190307.0,,OT,FR,FR,2019,Q1,Child
150837629,15083762,40,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,7 UG/M2 DAILY;,,,U,,,,,7.0,UG/M**2,,QD,2019,Q1,Foetal exposure during pregnancy,,2019,Q1,9,F,20170914.0,20190227.0,20180628,20190307,EXP,FR-AFSSAPS-PC20180352,FR-TEVA-2018-FR-918354,TEVA,,1.0,DY,,M,Y,1.89,KG,20190307.0,,OT,FR,FR,2019,Q1,Child
150837629,15083762,40,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,7 UG/M2 DAILY;,,,U,,,,,7.0,UG/M**2,,QD,2019,Q1,Low birth weight baby,,2019,Q1,9,F,20170914.0,20190227.0,20180628,20190307,EXP,FR-AFSSAPS-PC20180352,FR-TEVA-2018-FR-918354,TEVA,,1.0,DY,,M,Y,1.89,KG,20190307.0,,OT,FR,FR,2019,Q1,Child
150837629,15083762,40,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,7 UG/M2 DAILY;,,,U,,,,,7.0,UG/M**2,,QD,2019,Q1,Neutropenia neonatal,,2019,Q1,9,F,20170914.0,20190227.0,20180628,20190307,EXP,FR-AFSSAPS-PC20180352,FR-TEVA-2018-FR-918354,TEVA,,1.0,DY,,M,Y,1.89,KG,20190307.0,,OT,FR,FR,2019,Q1,Child
150837629,15083762,40,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,7 UG/M2 DAILY;,,,U,,,,,7.0,UG/M**2,,QD,2019,Q1,Premature baby,,2019,Q1,9,F,20170914.0,20190227.0,20180628,20190307,EXP,FR-AFSSAPS-PC20180352,FR-TEVA-2018-FR-918354,TEVA,,1.0,DY,,M,Y,1.89,KG,20190307.0,,OT,FR,FR,2019,Q1,Child
151142963,15114296,8,SS,BLINDED INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK,QD",,,,,,,,,,SOLUTION FOR INJECTION,QD,2019,Q1,Alanine aminotransferase increased,,2019,Q1,3,F,20180104.0,20190107.0,20180706,20190111,EXP,,PL-SA-2018SA050115,SANOFI AVENTIS,,17.0,YR,T,F,Y,72.0,KG,20190111.0,,MD,PL,PL,2019,Q1,Youth
151142963,15114296,9,SS,BLINDED INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK,QD",,,,,,,,,,SOLUTION FOR INJECTION,QD,2019,Q1,Alanine aminotransferase increased,,2019,Q1,3,F,20180104.0,20190107.0,20180706,20190111,EXP,,PL-SA-2018SA050115,SANOFI AVENTIS,,17.0,YR,T,F,Y,72.0,KG,20190111.0,,MD,PL,PL,2019,Q1,Youth
151171116,15117111,3,PS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 UG/M2, QD",,,U,,,,209196.0,7.0,UG/M**2,,QD,2019,Q1,Foetal disorder,,2019,Q1,6,F,2017.0,20180925.0,20180706,20190130,EXP,,FR-SAKK-2018SA170564AA,SANOFI AVENTIS,,1.0,DY,N,M,Y,1.89,KG,20190130.0,,PH,FR,FR,2019,Q1,Child
151171116,15117111,3,PS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 UG/M2, QD",,,U,,,,209196.0,7.0,UG/M**2,,QD,2019,Q1,Foetal exposure during pregnancy,,2019,Q1,6,F,2017.0,20180925.0,20180706,20190130,EXP,,FR-SAKK-2018SA170564AA,SANOFI AVENTIS,,1.0,DY,N,M,Y,1.89,KG,20190130.0,,PH,FR,FR,2019,Q1,Child
151171116,15117111,3,PS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 UG/M2, QD",,,U,,,,209196.0,7.0,UG/M**2,,QD,2019,Q1,Low birth weight baby,,2019,Q1,6,F,2017.0,20180925.0,20180706,20190130,EXP,,FR-SAKK-2018SA170564AA,SANOFI AVENTIS,,1.0,DY,N,M,Y,1.89,KG,20190130.0,,PH,FR,FR,2019,Q1,Child
151171116,15117111,3,PS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 UG/M2, QD",,,U,,,,209196.0,7.0,UG/M**2,,QD,2019,Q1,Neutropenia neonatal,,2019,Q1,6,F,2017.0,20180925.0,20180706,20190130,EXP,,FR-SAKK-2018SA170564AA,SANOFI AVENTIS,,1.0,DY,N,M,Y,1.89,KG,20190130.0,,PH,FR,FR,2019,Q1,Child
151171116,15117111,3,PS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 UG/M2, QD",,,U,,,,209196.0,7.0,UG/M**2,,QD,2019,Q1,Premature baby,,2019,Q1,6,F,2017.0,20180925.0,20180706,20190130,EXP,,FR-SAKK-2018SA170564AA,SANOFI AVENTIS,,1.0,DY,N,M,Y,1.89,KG,20190130.0,,PH,FR,FR,2019,Q1,Child
151666347,15166634,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,UNK,,,D,,,,,,,,,2019,Q1,Foetal disorder,,2019,Q1,7,F,20170914.0,20190131.0,20180719,20190207,EXP,,PHHY2018FR049315,SANDOZ,,1.0,DY,,M,Y,1.89,KG,20190208.0,,OT,FR,FR,2019,Q1,Child
151666347,15166634,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,UNK,,,D,,,,,,,,,2019,Q1,Foetal exposure during pregnancy,,2019,Q1,7,F,20170914.0,20190131.0,20180719,20190207,EXP,,PHHY2018FR049315,SANDOZ,,1.0,DY,,M,Y,1.89,KG,20190208.0,,OT,FR,FR,2019,Q1,Child
151666347,15166634,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,UNK,,,D,,,,,,,,,2019,Q1,Low birth weight baby,,2019,Q1,7,F,20170914.0,20190131.0,20180719,20190207,EXP,,PHHY2018FR049315,SANDOZ,,1.0,DY,,M,Y,1.89,KG,20190208.0,,OT,FR,FR,2019,Q1,Child
151666347,15166634,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,UNK,,,D,,,,,,,,,2019,Q1,Neutropenia neonatal,,2019,Q1,7,F,20170914.0,20190131.0,20180719,20190207,EXP,,PHHY2018FR049315,SANDOZ,,1.0,DY,,M,Y,1.89,KG,20190208.0,,OT,FR,FR,2019,Q1,Child
151666347,15166634,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,UNK,,,D,,,,,,,,,2019,Q1,Premature baby,,2019,Q1,7,F,20170914.0,20190131.0,20180719,20190207,EXP,,PHHY2018FR049315,SANDOZ,,1.0,DY,,M,Y,1.89,KG,20190208.0,,OT,FR,FR,2019,Q1,Child
151666347,15166634,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"MATERNAL DOSE:21UG/M2,QD",,,D,,,,,,,,,2019,Q1,Foetal disorder,,2019,Q1,7,F,20170914.0,20190131.0,20180719,20190207,EXP,,PHHY2018FR049315,SANDOZ,,1.0,DY,,M,Y,1.89,KG,20190208.0,,OT,FR,FR,2019,Q1,Child
151666347,15166634,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"MATERNAL DOSE:21UG/M2,QD",,,D,,,,,,,,,2019,Q1,Foetal exposure during pregnancy,,2019,Q1,7,F,20170914.0,20190131.0,20180719,20190207,EXP,,PHHY2018FR049315,SANDOZ,,1.0,DY,,M,Y,1.89,KG,20190208.0,,OT,FR,FR,2019,Q1,Child
151666347,15166634,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"MATERNAL DOSE:21UG/M2,QD",,,D,,,,,,,,,2019,Q1,Low birth weight baby,,2019,Q1,7,F,20170914.0,20190131.0,20180719,20190207,EXP,,PHHY2018FR049315,SANDOZ,,1.0,DY,,M,Y,1.89,KG,20190208.0,,OT,FR,FR,2019,Q1,Child
151666347,15166634,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"MATERNAL DOSE:21UG/M2,QD",,,D,,,,,,,,,2019,Q1,Neutropenia neonatal,,2019,Q1,7,F,20170914.0,20190131.0,20180719,20190207,EXP,,PHHY2018FR049315,SANDOZ,,1.0,DY,,M,Y,1.89,KG,20190208.0,,OT,FR,FR,2019,Q1,Child
151666347,15166634,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"MATERNAL DOSE:21UG/M2,QD",,,D,,,,,,,,,2019,Q1,Premature baby,,2019,Q1,7,F,20170914.0,20190131.0,20180719,20190207,EXP,,PHHY2018FR049315,SANDOZ,,1.0,DY,,M,Y,1.89,KG,20190208.0,,OT,FR,FR,2019,Q1,Child
1520081612,15200816,31,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 UG/M2, QD",28.0,UG/M2,D,,,,,21.0,UG/M**2,,QD,2019,Q1,Foetal disorder,,2019,Q1,12,F,20170914.0,20190213.0,20180726,20190222,EXP,FR-EMA-DD-20180628-SAMEERHPDD-112157,FR-SAKK-2018SA153712AA,SANOFI AVENTIS,,1.0,DY,N,M,Y,1.89,KG,20190222.0,,OT,FR,FR,2019,Q1,Child
1520081612,15200816,31,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 UG/M2, QD",28.0,UG/M2,D,,,,,21.0,UG/M**2,,QD,2019,Q1,Foetal exposure during pregnancy,,2019,Q1,12,F,20170914.0,20190213.0,20180726,20190222,EXP,FR-EMA-DD-20180628-SAMEERHPDD-112157,FR-SAKK-2018SA153712AA,SANOFI AVENTIS,,1.0,DY,N,M,Y,1.89,KG,20190222.0,,OT,FR,FR,2019,Q1,Child
1520081612,15200816,31,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 UG/M2, QD",28.0,UG/M2,D,,,,,21.0,UG/M**2,,QD,2019,Q1,Low birth weight baby,,2019,Q1,12,F,20170914.0,20190213.0,20180726,20190222,EXP,FR-EMA-DD-20180628-SAMEERHPDD-112157,FR-SAKK-2018SA153712AA,SANOFI AVENTIS,,1.0,DY,N,M,Y,1.89,KG,20190222.0,,OT,FR,FR,2019,Q1,Child
1520081612,15200816,31,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 UG/M2, QD",28.0,UG/M2,D,,,,,21.0,UG/M**2,,QD,2019,Q1,Neutropenia neonatal,,2019,Q1,12,F,20170914.0,20190213.0,20180726,20190222,EXP,FR-EMA-DD-20180628-SAMEERHPDD-112157,FR-SAKK-2018SA153712AA,SANOFI AVENTIS,,1.0,DY,N,M,Y,1.89,KG,20190222.0,,OT,FR,FR,2019,Q1,Child
1520081612,15200816,31,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 UG/M2, QD",28.0,UG/M2,D,,,,,21.0,UG/M**2,,QD,2019,Q1,Premature baby,,2019,Q1,12,F,20170914.0,20190213.0,20180726,20190222,EXP,FR-EMA-DD-20180628-SAMEERHPDD-112157,FR-SAKK-2018SA153712AA,SANOFI AVENTIS,,1.0,DY,N,M,Y,1.89,KG,20190222.0,,OT,FR,FR,2019,Q1,Child
1520081612,15200816,32,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 UG/M2, QD",28.0,UG/M2,D,,,,,7.0,UG/M**2,,QD,2019,Q1,Foetal disorder,,2019,Q1,12,F,20170914.0,20190213.0,20180726,20190222,EXP,FR-EMA-DD-20180628-SAMEERHPDD-112157,FR-SAKK-2018SA153712AA,SANOFI AVENTIS,,1.0,DY,N,M,Y,1.89,KG,20190222.0,,OT,FR,FR,2019,Q1,Child
1520081612,15200816,32,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 UG/M2, QD",28.0,UG/M2,D,,,,,7.0,UG/M**2,,QD,2019,Q1,Foetal exposure during pregnancy,,2019,Q1,12,F,20170914.0,20190213.0,20180726,20190222,EXP,FR-EMA-DD-20180628-SAMEERHPDD-112157,FR-SAKK-2018SA153712AA,SANOFI AVENTIS,,1.0,DY,N,M,Y,1.89,KG,20190222.0,,OT,FR,FR,2019,Q1,Child
1520081612,15200816,32,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 UG/M2, QD",28.0,UG/M2,D,,,,,7.0,UG/M**2,,QD,2019,Q1,Low birth weight baby,,2019,Q1,12,F,20170914.0,20190213.0,20180726,20190222,EXP,FR-EMA-DD-20180628-SAMEERHPDD-112157,FR-SAKK-2018SA153712AA,SANOFI AVENTIS,,1.0,DY,N,M,Y,1.89,KG,20190222.0,,OT,FR,FR,2019,Q1,Child
1520081612,15200816,32,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 UG/M2, QD",28.0,UG/M2,D,,,,,7.0,UG/M**2,,QD,2019,Q1,Neutropenia neonatal,,2019,Q1,12,F,20170914.0,20190213.0,20180726,20190222,EXP,FR-EMA-DD-20180628-SAMEERHPDD-112157,FR-SAKK-2018SA153712AA,SANOFI AVENTIS,,1.0,DY,N,M,Y,1.89,KG,20190222.0,,OT,FR,FR,2019,Q1,Child
1520081612,15200816,32,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 UG/M2, QD",28.0,UG/M2,D,,,,,7.0,UG/M**2,,QD,2019,Q1,Premature baby,,2019,Q1,12,F,20170914.0,20190213.0,20180726,20190222,EXP,FR-EMA-DD-20180628-SAMEERHPDD-112157,FR-SAKK-2018SA153712AA,SANOFI AVENTIS,,1.0,DY,N,M,Y,1.89,KG,20190222.0,,OT,FR,FR,2019,Q1,Child
152029816,15202981,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 ?G/M2, QD",,,U,,,,,7.0,UG/M**2,UNKNOWN,QD,2019,Q1,Foetal disorder,,2019,Q1,6,F,20170914.0,20190212.0,20180726,20190215,EXP,FR-AFSSAPS-PC20180352,FR-FRESENIUS KABI-FK201808071,FRESENIUS KABI,,1.0,DY,,M,Y,1.0,KG,20190215.0,,OT,GB,FR,2019,Q1,Child
152029816,15202981,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 ?G/M2, QD",,,U,,,,,7.0,UG/M**2,UNKNOWN,QD,2019,Q1,Foetal exposure during pregnancy,,2019,Q1,6,F,20170914.0,20190212.0,20180726,20190215,EXP,FR-AFSSAPS-PC20180352,FR-FRESENIUS KABI-FK201808071,FRESENIUS KABI,,1.0,DY,,M,Y,1.0,KG,20190215.0,,OT,GB,FR,2019,Q1,Child
152029816,15202981,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 ?G/M2, QD",,,U,,,,,7.0,UG/M**2,UNKNOWN,QD,2019,Q1,Low birth weight baby,,2019,Q1,6,F,20170914.0,20190212.0,20180726,20190215,EXP,FR-AFSSAPS-PC20180352,FR-FRESENIUS KABI-FK201808071,FRESENIUS KABI,,1.0,DY,,M,Y,1.0,KG,20190215.0,,OT,GB,FR,2019,Q1,Child
152029816,15202981,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 ?G/M2, QD",,,U,,,,,7.0,UG/M**2,UNKNOWN,QD,2019,Q1,Neutropenia neonatal,,2019,Q1,6,F,20170914.0,20190212.0,20180726,20190215,EXP,FR-AFSSAPS-PC20180352,FR-FRESENIUS KABI-FK201808071,FRESENIUS KABI,,1.0,DY,,M,Y,1.0,KG,20190215.0,,OT,GB,FR,2019,Q1,Child
152029816,15202981,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 ?G/M2, QD",,,U,,,,,7.0,UG/M**2,UNKNOWN,QD,2019,Q1,Premature baby,,2019,Q1,6,F,20170914.0,20190212.0,20180726,20190215,EXP,FR-AFSSAPS-PC20180352,FR-FRESENIUS KABI-FK201808071,FRESENIUS KABI,,1.0,DY,,M,Y,1.0,KG,20190215.0,,OT,GB,FR,2019,Q1,Child
152067545,15206754,9,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"8-10 U, EACH MORNING",,,,,,,,,,,QD,2019,Q1,Blood glucose decreased,,2019,Q1,5,F,20180822.0,20190124.0,20180727,20190130,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201807009613,ELI LILLY AND CO,,65.0,YR,,F,Y,70.0,KG,20190130.0,,CN,CN,CN,2019,Q1,Elderly
152067545,15206754,9,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"8-10 U, EACH MORNING",,,,,,,,,,,QD,2019,Q1,Blood glucose increased,,2019,Q1,5,F,20180822.0,20190124.0,20180727,20190130,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201807009613,ELI LILLY AND CO,,65.0,YR,,F,Y,70.0,KG,20190130.0,,CN,CN,CN,2019,Q1,Elderly
152067545,15206754,9,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"8-10 U, EACH MORNING",,,,,,,,,,,QD,2019,Q1,Dizziness,,2019,Q1,5,F,20180822.0,20190124.0,20180727,20190130,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201807009613,ELI LILLY AND CO,,65.0,YR,,F,Y,70.0,KG,20190130.0,,CN,CN,CN,2019,Q1,Elderly
152067545,15206754,10,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, DAILY AT NOON",,,,,,,,10.0,IU,,QD,2019,Q1,Blood glucose decreased,,2019,Q1,5,F,20180822.0,20190124.0,20180727,20190130,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201807009613,ELI LILLY AND CO,,65.0,YR,,F,Y,70.0,KG,20190130.0,,CN,CN,CN,2019,Q1,Elderly
152067545,15206754,10,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, DAILY AT NOON",,,,,,,,10.0,IU,,QD,2019,Q1,Blood glucose increased,,2019,Q1,5,F,20180822.0,20190124.0,20180727,20190130,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201807009613,ELI LILLY AND CO,,65.0,YR,,F,Y,70.0,KG,20190130.0,,CN,CN,CN,2019,Q1,Elderly
152067545,15206754,10,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, DAILY AT NOON",,,,,,,,10.0,IU,,QD,2019,Q1,Dizziness,,2019,Q1,5,F,20180822.0,20190124.0,20180727,20190130,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201807009613,ELI LILLY AND CO,,65.0,YR,,F,Y,70.0,KG,20190130.0,,CN,CN,CN,2019,Q1,Elderly
152067545,15206754,11,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, DAILY AT NIGHT",,,,,,,,10.0,IU,,QD,2019,Q1,Blood glucose decreased,,2019,Q1,5,F,20180822.0,20190124.0,20180727,20190130,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201807009613,ELI LILLY AND CO,,65.0,YR,,F,Y,70.0,KG,20190130.0,,CN,CN,CN,2019,Q1,Elderly
152067545,15206754,11,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, DAILY AT NIGHT",,,,,,,,10.0,IU,,QD,2019,Q1,Blood glucose increased,,2019,Q1,5,F,20180822.0,20190124.0,20180727,20190130,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201807009613,ELI LILLY AND CO,,65.0,YR,,F,Y,70.0,KG,20190130.0,,CN,CN,CN,2019,Q1,Elderly
152067545,15206754,11,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, DAILY AT NIGHT",,,,,,,,10.0,IU,,QD,2019,Q1,Dizziness,,2019,Q1,5,F,20180822.0,20190124.0,20180727,20190130,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201807009613,ELI LILLY AND CO,,65.0,YR,,F,Y,70.0,KG,20190130.0,,CN,CN,CN,2019,Q1,Elderly
152400108,15240010,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q1,Abdominal pain,,2019,Q1,8,F,201807.0,20190215.0,20180803,20190228,EXP,,US-ACTELION-A-US2018-176381,ACTELION,,64.0,YR,,F,Y,,,20190228.0,,OT,US,US,2019,Q1,Adult
152400108,15240010,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q1,Atelectasis,,2019,Q1,8,F,201807.0,20190215.0,20180803,20190228,EXP,,US-ACTELION-A-US2018-176381,ACTELION,,64.0,YR,,F,Y,,,20190228.0,,OT,US,US,2019,Q1,Adult
152400108,15240010,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q1,Cervix carcinoma,,2019,Q1,8,F,201807.0,20190215.0,20180803,20190228,EXP,,US-ACTELION-A-US2018-176381,ACTELION,,64.0,YR,,F,Y,,,20190228.0,,OT,US,US,2019,Q1,Adult
152400108,15240010,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q1,Chest pain,,2019,Q1,8,F,201807.0,20190215.0,20180803,20190228,EXP,,US-ACTELION-A-US2018-176381,ACTELION,,64.0,YR,,F,Y,,,20190228.0,,OT,US,US,2019,Q1,Adult
152400108,15240010,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q1,Constipation,,2019,Q1,8,F,201807.0,20190215.0,20180803,20190228,EXP,,US-ACTELION-A-US2018-176381,ACTELION,,64.0,YR,,F,Y,,,20190228.0,,OT,US,US,2019,Q1,Adult
152400108,15240010,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q1,Coronary artery bypass,,2019,Q1,8,F,201807.0,20190215.0,20180803,20190228,EXP,,US-ACTELION-A-US2018-176381,ACTELION,,64.0,YR,,F,Y,,,20190228.0,,OT,US,US,2019,Q1,Adult
152400108,15240010,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q1,Coronary artery disease,,2019,Q1,8,F,201807.0,20190215.0,20180803,20190228,EXP,,US-ACTELION-A-US2018-176381,ACTELION,,64.0,YR,,F,Y,,,20190228.0,,OT,US,US,2019,Q1,Adult
152400108,15240010,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q1,Cystitis,,2019,Q1,8,F,201807.0,20190215.0,20180803,20190228,EXP,,US-ACTELION-A-US2018-176381,ACTELION,,64.0,YR,,F,Y,,,20190228.0,,OT,US,US,2019,Q1,Adult
152400108,15240010,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q1,Dizziness,,2019,Q1,8,F,201807.0,20190215.0,20180803,20190228,EXP,,US-ACTELION-A-US2018-176381,ACTELION,,64.0,YR,,F,Y,,,20190228.0,,OT,US,US,2019,Q1,Adult
152400108,15240010,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q1,Dyspnoea,,2019,Q1,8,F,201807.0,20190215.0,20180803,20190228,EXP,,US-ACTELION-A-US2018-176381,ACTELION,,64.0,YR,,F,Y,,,20190228.0,,OT,US,US,2019,Q1,Adult
152400108,15240010,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q1,Explorative laparotomy,,2019,Q1,8,F,201807.0,20190215.0,20180803,20190228,EXP,,US-ACTELION-A-US2018-176381,ACTELION,,64.0,YR,,F,Y,,,20190228.0,,OT,US,US,2019,Q1,Adult
152400108,15240010,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q1,Eye haematoma,,2019,Q1,8,F,201807.0,20190215.0,20180803,20190228,EXP,,US-ACTELION-A-US2018-176381,ACTELION,,64.0,YR,,F,Y,,,20190228.0,,OT,US,US,2019,Q1,Adult
152400108,15240010,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q1,Fluid retention,,2019,Q1,8,F,201807.0,20190215.0,20180803,20190228,EXP,,US-ACTELION-A-US2018-176381,ACTELION,,64.0,YR,,F,Y,,,20190228.0,,OT,US,US,2019,Q1,Adult
152400108,15240010,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q1,Genital disorder female,,2019,Q1,8,F,201807.0,20190215.0,20180803,20190228,EXP,,US-ACTELION-A-US2018-176381,ACTELION,,64.0,YR,,F,Y,,,20190228.0,,OT,US,US,2019,Q1,Adult
152400108,15240010,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q1,Hypotension,,2019,Q1,8,F,201807.0,20190215.0,20180803,20190228,EXP,,US-ACTELION-A-US2018-176381,ACTELION,,64.0,YR,,F,Y,,,20190228.0,,OT,US,US,2019,Q1,Adult
152400108,15240010,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q1,Hypoxia,,2019,Q1,8,F,201807.0,20190215.0,20180803,20190228,EXP,,US-ACTELION-A-US2018-176381,ACTELION,,64.0,YR,,F,Y,,,20190228.0,,OT,US,US,2019,Q1,Adult
152400108,15240010,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q1,Neoplasm,,2019,Q1,8,F,201807.0,20190215.0,20180803,20190228,EXP,,US-ACTELION-A-US2018-176381,ACTELION,,64.0,YR,,F,Y,,,20190228.0,,OT,US,US,2019,Q1,Adult
152400108,15240010,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q1,Ovarian epithelial cancer,,2019,Q1,8,F,201807.0,20190215.0,20180803,20190228,EXP,,US-ACTELION-A-US2018-176381,ACTELION,,64.0,YR,,F,Y,,,20190228.0,,OT,US,US,2019,Q1,Adult
152400108,15240010,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q1,Pain management,,2019,Q1,8,F,201807.0,20190215.0,20180803,20190228,EXP,,US-ACTELION-A-US2018-176381,ACTELION,,64.0,YR,,F,Y,,,20190228.0,,OT,US,US,2019,Q1,Adult
152400108,15240010,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q1,Pelvic mass,,2019,Q1,8,F,201807.0,20190215.0,20180803,20190228,EXP,,US-ACTELION-A-US2018-176381,ACTELION,,64.0,YR,,F,Y,,,20190228.0,,OT,US,US,2019,Q1,Adult
152400108,15240010,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q1,Peripheral swelling,,2019,Q1,8,F,201807.0,20190215.0,20180803,20190228,EXP,,US-ACTELION-A-US2018-176381,ACTELION,,64.0,YR,,F,Y,,,20190228.0,,OT,US,US,2019,Q1,Adult
152400108,15240010,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q1,Presyncope,,2019,Q1,8,F,201807.0,20190215.0,20180803,20190228,EXP,,US-ACTELION-A-US2018-176381,ACTELION,,64.0,YR,,F,Y,,,20190228.0,,OT,US,US,2019,Q1,Adult
152400108,15240010,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q1,Pulmonary arterial hypertension,,2019,Q1,8,F,201807.0,20190215.0,20180803,20190228,EXP,,US-ACTELION-A-US2018-176381,ACTELION,,64.0,YR,,F,Y,,,20190228.0,,OT,US,US,2019,Q1,Adult
152400108,15240010,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q1,Pulmonary embolism,,2019,Q1,8,F,201807.0,20190215.0,20180803,20190228,EXP,,US-ACTELION-A-US2018-176381,ACTELION,,64.0,YR,,F,Y,,,20190228.0,,OT,US,US,2019,Q1,Adult
152400108,15240010,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q1,Pulmonary endarterectomy,,2019,Q1,8,F,201807.0,20190215.0,20180803,20190228,EXP,,US-ACTELION-A-US2018-176381,ACTELION,,64.0,YR,,F,Y,,,20190228.0,,OT,US,US,2019,Q1,Adult
152400108,15240010,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q1,Pulmonary hypertension,,2019,Q1,8,F,201807.0,20190215.0,20180803,20190228,EXP,,US-ACTELION-A-US2018-176381,ACTELION,,64.0,YR,,F,Y,,,20190228.0,,OT,US,US,2019,Q1,Adult
152400108,15240010,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q1,Right ventricular failure,,2019,Q1,8,F,201807.0,20190215.0,20180803,20190228,EXP,,US-ACTELION-A-US2018-176381,ACTELION,,64.0,YR,,F,Y,,,20190228.0,,OT,US,US,2019,Q1,Adult
152400108,15240010,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q1,Salpingo-oophorectomy bilateral,,2019,Q1,8,F,201807.0,20190215.0,20180803,20190228,EXP,,US-ACTELION-A-US2018-176381,ACTELION,,64.0,YR,,F,Y,,,20190228.0,,OT,US,US,2019,Q1,Adult
152400108,15240010,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q1,Tumour excision,,2019,Q1,8,F,201807.0,20190215.0,20180803,20190228,EXP,,US-ACTELION-A-US2018-176381,ACTELION,,64.0,YR,,F,Y,,,20190228.0,,OT,US,US,2019,Q1,Adult
152400108,15240010,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q1,Urinary retention,,2019,Q1,8,F,201807.0,20190215.0,20180803,20190228,EXP,,US-ACTELION-A-US2018-176381,ACTELION,,64.0,YR,,F,Y,,,20190228.0,,OT,US,US,2019,Q1,Adult
152400108,15240010,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q1,Vena cava filter insertion,,2019,Q1,8,F,201807.0,20190215.0,20180803,20190228,EXP,,US-ACTELION-A-US2018-176381,ACTELION,,64.0,YR,,F,Y,,,20190228.0,,OT,US,US,2019,Q1,Adult
152400108,15240010,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q1,Weight increased,,2019,Q1,8,F,201807.0,20190215.0,20180803,20190228,EXP,,US-ACTELION-A-US2018-176381,ACTELION,,64.0,YR,,F,Y,,,20190228.0,,OT,US,US,2019,Q1,Adult
152503766,15250376,3,I,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2019,Q1,Apparent death,,2019,Q1,6,F,201702.0,20181220.0,20180807,20190102,EXP,,US-SA-2018SA210118,SANOFI AVENTIS,,75.0,YR,E,M,Y,,,20190102.0,,CN,US,US,2019,Q1,Elderly
152503766,15250376,3,I,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2019,Q1,Blood glucose fluctuation,,2019,Q1,6,F,201702.0,20181220.0,20180807,20190102,EXP,,US-SA-2018SA210118,SANOFI AVENTIS,,75.0,YR,E,M,Y,,,20190102.0,,CN,US,US,2019,Q1,Elderly
152503766,15250376,3,I,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2019,Q1,Blood glucose increased,,2019,Q1,6,F,201702.0,20181220.0,20180807,20190102,EXP,,US-SA-2018SA210118,SANOFI AVENTIS,,75.0,YR,E,M,Y,,,20190102.0,,CN,US,US,2019,Q1,Elderly
152503766,15250376,3,I,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2019,Q1,Catatonia,,2019,Q1,6,F,201702.0,20181220.0,20180807,20190102,EXP,,US-SA-2018SA210118,SANOFI AVENTIS,,75.0,YR,E,M,Y,,,20190102.0,,CN,US,US,2019,Q1,Elderly
152503766,15250376,3,I,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2019,Q1,Coma,,2019,Q1,6,F,201702.0,20181220.0,20180807,20190102,EXP,,US-SA-2018SA210118,SANOFI AVENTIS,,75.0,YR,E,M,Y,,,20190102.0,,CN,US,US,2019,Q1,Elderly
152503766,15250376,3,I,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2019,Q1,Drug interaction,,2019,Q1,6,F,201702.0,20181220.0,20180807,20190102,EXP,,US-SA-2018SA210118,SANOFI AVENTIS,,75.0,YR,E,M,Y,,,20190102.0,,CN,US,US,2019,Q1,Elderly
152503766,15250376,3,I,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2019,Q1,Glycosylated haemoglobin increased,,2019,Q1,6,F,201702.0,20181220.0,20180807,20190102,EXP,,US-SA-2018SA210118,SANOFI AVENTIS,,75.0,YR,E,M,Y,,,20190102.0,,CN,US,US,2019,Q1,Elderly
152503766,15250376,3,I,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2019,Q1,Hypoacusis,,2019,Q1,6,F,201702.0,20181220.0,20180807,20190102,EXP,,US-SA-2018SA210118,SANOFI AVENTIS,,75.0,YR,E,M,Y,,,20190102.0,,CN,US,US,2019,Q1,Elderly
152503766,15250376,3,I,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2019,Q1,Memory impairment,,2019,Q1,6,F,201702.0,20181220.0,20180807,20190102,EXP,,US-SA-2018SA210118,SANOFI AVENTIS,,75.0,YR,E,M,Y,,,20190102.0,,CN,US,US,2019,Q1,Elderly
152503766,15250376,3,I,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2019,Q1,Off label use,,2019,Q1,6,F,201702.0,20181220.0,20180807,20190102,EXP,,US-SA-2018SA210118,SANOFI AVENTIS,,75.0,YR,E,M,Y,,,20190102.0,,CN,US,US,2019,Q1,Elderly
152503766,15250376,3,I,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2019,Q1,Product use issue,,2019,Q1,6,F,201702.0,20181220.0,20180807,20190102,EXP,,US-SA-2018SA210118,SANOFI AVENTIS,,75.0,YR,E,M,Y,,,20190102.0,,CN,US,US,2019,Q1,Elderly
152503766,15250376,3,I,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2019,Q1,Vision blurred,,2019,Q1,6,F,201702.0,20181220.0,20180807,20190102,EXP,,US-SA-2018SA210118,SANOFI AVENTIS,,75.0,YR,E,M,Y,,,20190102.0,,CN,US,US,2019,Q1,Elderly
152503766,15250376,3,I,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2019,Q1,Visual impairment,,2019,Q1,6,F,201702.0,20181220.0,20180807,20190102,EXP,,US-SA-2018SA210118,SANOFI AVENTIS,,75.0,YR,E,M,Y,,,20190102.0,,CN,US,US,2019,Q1,Elderly
152507295,15250729,36,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 UG/M2, QD",,,D,,,,,21.0,UG/M**2,,QD,2019,Q1,Foetal disorder,,2019,Q1,5,F,2017.0,20190204.0,20180807,20190210,EXP,,PHHY2018FR062856,SANDOZ,,1.0,DY,,M,Y,1.0,KG,20190211.0,,OT,FR,FR,2019,Q1,Child
152507295,15250729,36,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 UG/M2, QD",,,D,,,,,21.0,UG/M**2,,QD,2019,Q1,Foetal exposure during pregnancy,,2019,Q1,5,F,2017.0,20190204.0,20180807,20190210,EXP,,PHHY2018FR062856,SANDOZ,,1.0,DY,,M,Y,1.0,KG,20190211.0,,OT,FR,FR,2019,Q1,Child
152507295,15250729,36,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 UG/M2, QD",,,D,,,,,21.0,UG/M**2,,QD,2019,Q1,Low birth weight baby,,2019,Q1,5,F,2017.0,20190204.0,20180807,20190210,EXP,,PHHY2018FR062856,SANDOZ,,1.0,DY,,M,Y,1.0,KG,20190211.0,,OT,FR,FR,2019,Q1,Child
152507295,15250729,36,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 UG/M2, QD",,,D,,,,,21.0,UG/M**2,,QD,2019,Q1,Neutropenia neonatal,,2019,Q1,5,F,2017.0,20190204.0,20180807,20190210,EXP,,PHHY2018FR062856,SANDOZ,,1.0,DY,,M,Y,1.0,KG,20190211.0,,OT,FR,FR,2019,Q1,Child
152507295,15250729,36,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 UG/M2, QD",,,D,,,,,21.0,UG/M**2,,QD,2019,Q1,Premature baby,,2019,Q1,5,F,2017.0,20190204.0,20180807,20190210,EXP,,PHHY2018FR062856,SANDOZ,,1.0,DY,,M,Y,1.0,KG,20190211.0,,OT,FR,FR,2019,Q1,Child
152577052,15257705,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q1,Hernia repair,,2019,Q1,2,F,20170823.0,20190204.0,20180808,20190214,EXP,,US-ACTELION-A-NJ2018-177009,ACTELION,,64.0,YR,A,M,Y,68.93,KG,20190214.0,,OT,US,US,2019,Q1,Adult
152577052,15257705,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q1,Hypervolaemia,,2019,Q1,2,F,20170823.0,20190204.0,20180808,20190214,EXP,,US-ACTELION-A-NJ2018-177009,ACTELION,,64.0,YR,A,M,Y,68.93,KG,20190214.0,,OT,US,US,2019,Q1,Adult
152616442,15261644,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q1,Acute kidney injury,,2019,Q1,2,F,20170814.0,20180801.0,20180809,20190307,EXP,,US-ASTRAZENECA-2018SE98064,ASTRAZENECA,,20471.0,DY,,M,Y,70.3,KG,20190307.0,,,US,US,2019,Q1,Elderly
152616442,15261644,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q1,Chronic kidney disease,,2019,Q1,2,F,20170814.0,20180801.0,20180809,20190307,EXP,,US-ASTRAZENECA-2018SE98064,ASTRAZENECA,,20471.0,DY,,M,Y,70.3,KG,20190307.0,,,US,US,2019,Q1,Elderly
152616442,15261644,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q1,End stage renal disease,,2019,Q1,2,F,20170814.0,20180801.0,20180809,20190307,EXP,,US-ASTRAZENECA-2018SE98064,ASTRAZENECA,,20471.0,DY,,M,Y,70.3,KG,20190307.0,,,US,US,2019,Q1,Elderly
153683602,15368360,2,I,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, C858466,,,,,SOLUTION FOR INJECTION,,2019,Q1,Drug interaction,,2019,Q1,2,F,20180526.0,20180615.0,20180910,20190301,EXP,,PL-SA-2018SA162466,SANOFI AVENTIS,,60.0,YR,A,F,Y,52.0,KG,20190301.0,,CN,PL,PL,2019,Q1,Adult
153683602,15368360,2,I,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, C858466,,,,,SOLUTION FOR INJECTION,,2019,Q1,Hyperglycaemia,,2019,Q1,2,F,20180526.0,20180615.0,20180910,20190301,EXP,,PL-SA-2018SA162466,SANOFI AVENTIS,,60.0,YR,A,F,Y,52.0,KG,20190301.0,,CN,PL,PL,2019,Q1,Adult
153683602,15368360,2,I,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, C858466,,,,,SOLUTION FOR INJECTION,,2019,Q1,Hypoglycaemia,,2019,Q1,2,F,20180526.0,20180615.0,20180910,20190301,EXP,,PL-SA-2018SA162466,SANOFI AVENTIS,,60.0,YR,A,F,Y,52.0,KG,20190301.0,,CN,PL,PL,2019,Q1,Adult
153683602,15368360,2,I,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, C858466,,,,,SOLUTION FOR INJECTION,,2019,Q1,Osteomyelitis,,2019,Q1,2,F,20180526.0,20180615.0,20180910,20190301,EXP,,PL-SA-2018SA162466,SANOFI AVENTIS,,60.0,YR,A,F,Y,52.0,KG,20190301.0,,CN,PL,PL,2019,Q1,Adult
153683602,15368360,2,I,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, C858466,,,,,SOLUTION FOR INJECTION,,2019,Q1,Wrong product administered,,2019,Q1,2,F,20180526.0,20180615.0,20180910,20190301,EXP,,PL-SA-2018SA162466,SANOFI AVENTIS,,60.0,YR,A,F,Y,52.0,KG,20190301.0,,CN,PL,PL,2019,Q1,Adult
154170654,15417065,4,SS,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Transplacental,,,,U,,,,,,,,,2019,Q1,Foetal disorder,,2019,Q1,4,F,20170914.0,20190113.0,20180924,20190329,EXP,FR-EMA-DD-20180712-SAMEERHPDD-190831,FR-ZYDUS-027032,ZYDUS PHARM,,1.0,DY,N,M,Y,1.89,KG,20190329.0,,PH,FR,FR,2019,Q1,Child
154170654,15417065,4,SS,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Transplacental,,,,U,,,,,,,,,2019,Q1,Foetal exposure during pregnancy,,2019,Q1,4,F,20170914.0,20190113.0,20180924,20190329,EXP,FR-EMA-DD-20180712-SAMEERHPDD-190831,FR-ZYDUS-027032,ZYDUS PHARM,,1.0,DY,N,M,Y,1.89,KG,20190329.0,,PH,FR,FR,2019,Q1,Child
154170654,15417065,4,SS,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Transplacental,,,,U,,,,,,,,,2019,Q1,Low birth weight baby,,2019,Q1,4,F,20170914.0,20190113.0,20180924,20190329,EXP,FR-EMA-DD-20180712-SAMEERHPDD-190831,FR-ZYDUS-027032,ZYDUS PHARM,,1.0,DY,N,M,Y,1.89,KG,20190329.0,,PH,FR,FR,2019,Q1,Child
154170654,15417065,4,SS,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Transplacental,,,,U,,,,,,,,,2019,Q1,Neutropenia neonatal,,2019,Q1,4,F,20170914.0,20190113.0,20180924,20190329,EXP,FR-EMA-DD-20180712-SAMEERHPDD-190831,FR-ZYDUS-027032,ZYDUS PHARM,,1.0,DY,N,M,Y,1.89,KG,20190329.0,,PH,FR,FR,2019,Q1,Child
154170654,15417065,4,SS,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Transplacental,,,,U,,,,,,,,,2019,Q1,Premature baby,,2019,Q1,4,F,20170914.0,20190113.0,20180924,20190329,EXP,FR-EMA-DD-20180712-SAMEERHPDD-190831,FR-ZYDUS-027032,ZYDUS PHARM,,1.0,DY,N,M,Y,1.89,KG,20190329.0,,PH,FR,FR,2019,Q1,Child
154969605,15496960,61,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Addison's disease,,2019,Q1,5,F,20180819.0,20190216.0,20181015,20190220,EXP,,US-ROCHE-2186872,ROCHE,,56.0,YR,,F,Y,73.5,KG,20190220.0,,MD,US,US,2019,Q1,Adult
154969605,15496960,61,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Hyperthyroidism,,2019,Q1,5,F,20180819.0,20190216.0,20181015,20190220,EXP,,US-ROCHE-2186872,ROCHE,,56.0,YR,,F,Y,73.5,KG,20190220.0,,MD,US,US,2019,Q1,Adult
154969605,15496960,61,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Hypothyroidism,,2019,Q1,5,F,20180819.0,20190216.0,20181015,20190220,EXP,,US-ROCHE-2186872,ROCHE,,56.0,YR,,F,Y,73.5,KG,20190220.0,,MD,US,US,2019,Q1,Adult
155184633,15518463,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,, UNK,,,,,,,2019,Q1,Drug abuse,,2019,Q1,3,F,20180927.0,20190206.0,20181017,20190218,EXP,IT-MINISAL02-502630,IT-MYLANLABS-2018M1077439,MYLAN,,82.0,YR,,F,Y,,,20190218.0,,OT,IT,IT,2019,Q1,Elderly
155184633,15518463,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,, UNK,,,,,,,2019,Q1,Hypertension,,2019,Q1,3,F,20180927.0,20190206.0,20181017,20190218,EXP,IT-MINISAL02-502630,IT-MYLANLABS-2018M1077439,MYLAN,,82.0,YR,,F,Y,,,20190218.0,,OT,IT,IT,2019,Q1,Elderly
155184633,15518463,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,, UNK,,,,,,,2019,Q1,Hypoglycaemia,,2019,Q1,3,F,20180927.0,20190206.0,20181017,20190218,EXP,IT-MINISAL02-502630,IT-MYLANLABS-2018M1077439,MYLAN,,82.0,YR,,F,Y,,,20190218.0,,OT,IT,IT,2019,Q1,Elderly
155184633,15518463,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,, UNK,,,,,,,2019,Q1,Overdose,,2019,Q1,3,F,20180927.0,20190206.0,20181017,20190218,EXP,IT-MINISAL02-502630,IT-MYLANLABS-2018M1077439,MYLAN,,82.0,YR,,F,Y,,,20190218.0,,OT,IT,IT,2019,Q1,Elderly
1552629610,15526296,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2019,Q1,Drug abuse,,2019,Q1,10,F,20180927.0,20190220.0,20181018,20190226,EXP,,IT-PFIZER INC-2018419909,PFIZER,,82.0,YR,,F,Y,,,20190226.0,,OT,IT,IT,2019,Q1,Elderly
1552629610,15526296,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2019,Q1,Hypertension,,2019,Q1,10,F,20180927.0,20190220.0,20181018,20190226,EXP,,IT-PFIZER INC-2018419909,PFIZER,,82.0,YR,,F,Y,,,20190226.0,,OT,IT,IT,2019,Q1,Elderly
1552629610,15526296,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2019,Q1,Hypoglycaemia,,2019,Q1,10,F,20180927.0,20190220.0,20181018,20190226,EXP,,IT-PFIZER INC-2018419909,PFIZER,,82.0,YR,,F,Y,,,20190226.0,,OT,IT,IT,2019,Q1,Elderly
1552629610,15526296,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2019,Q1,Overdose,,2019,Q1,10,F,20180927.0,20190220.0,20181018,20190226,EXP,,IT-PFIZER INC-2018419909,PFIZER,,82.0,YR,,F,Y,,,20190226.0,,OT,IT,IT,2019,Q1,Elderly
155339083,15533908,10,SS,insulin lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Hypertension,,2019,Q1,3,F,20180927.0,20190212.0,20181019,20190221,EXP,IT-MINISAL02-502630,IT-BAXTER-2018BAX025506,BAXTER,,82.0,YR,,F,Y,,,20190221.0,,PH,IT,IT,2019,Q1,Elderly
155339083,15533908,10,SS,insulin lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Hypoglycaemia,,2019,Q1,3,F,20180927.0,20190212.0,20181019,20190221,EXP,IT-MINISAL02-502630,IT-BAXTER-2018BAX025506,BAXTER,,82.0,YR,,F,Y,,,20190221.0,,PH,IT,IT,2019,Q1,Elderly
155339083,15533908,10,SS,insulin lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Overdose,,2019,Q1,3,F,20180927.0,20190212.0,20181019,20190221,EXP,IT-MINISAL02-502630,IT-BAXTER-2018BAX025506,BAXTER,,82.0,YR,,F,Y,,,20190221.0,,PH,IT,IT,2019,Q1,Elderly
155475623,15547562,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q1,Hypersensitivity,,2019,Q1,3,F,20161027.0,20181113.0,20181024,20190114,PER,,US-SHIRE-US201808499,SHIRE,"R. CREA, JUI-FU HUANG, NAGHMANA BAJWA AND ALESSANDRO GRINGERI. UNITED STATES POST-MARKETING SAFETY (PMS) STUDY OF RPFVIII IN PATIENTS WITH ACQUIRED HEMOPHILIA A: PRELIMINARY DATA. BLOOD. 2017;130:3686",81.0,YR,,M,Y,98.87,KG,20190114.0,,OT,US,US,2019,Q1,Elderly
155475623,15547562,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q1,Hypersensitivity,,2019,Q1,3,F,20161027.0,20181113.0,20181024,20190114,PER,,US-SHIRE-US201808499,SHIRE,"R. CREA, JUI-FU HUANG, NAGHMANA BAJWA AND ALESSANDRO GRINGERI. UNITED STATES POST-MARKETING SAFETY (PMS) STUDY OF RPFVIII IN PATIENTS WITH ACQUIRED HEMOPHILIA A: PRELIMINARY DATA. BLOOD. 2017;130:3686",81.0,YR,,M,Y,98.87,KG,20190114.0,,OT,US,US,2019,Q1,Elderly
155496923,15549692,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Hypertension,,2019,Q1,3,F,20180927.0,20190217.0,20181025,20190225,EXP,IT-MINISAL02-502630,IT-TEVA-2018-IT-968325,TEVA,,82.0,YR,,F,Y,,,20190225.0,,PH,IT,IT,2019,Q1,Elderly
155496923,15549692,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Hypoglycaemia,,2019,Q1,3,F,20180927.0,20190217.0,20181025,20190225,EXP,IT-MINISAL02-502630,IT-TEVA-2018-IT-968325,TEVA,,82.0,YR,,F,Y,,,20190225.0,,PH,IT,IT,2019,Q1,Elderly
155496923,15549692,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Overdose,,2019,Q1,3,F,20180927.0,20190217.0,20181025,20190225,EXP,IT-MINISAL02-502630,IT-TEVA-2018-IT-968325,TEVA,,82.0,YR,,F,Y,,,20190225.0,,PH,IT,IT,2019,Q1,Elderly
155557632,15555763,23,C,Insulin Lispro,INSULIN LISPRO,1,Other,,,,,,,,,,,INJECTION,,2019,Q1,Acute febrile neutrophilic dermatosis,,2019,Q1,2,F,20170626.0,20190114.0,20181026,20190125,EXP,,US-CELGENEUS-USA-20171108065,CELGENE,,65.0,YR,,F,Y,75.0,KG,20190125.0,,MD,US,US,2019,Q1,Elderly
155557632,15555763,23,C,Insulin Lispro,INSULIN LISPRO,1,Other,,,,,,,,,,,INJECTION,,2019,Q1,Acute kidney injury,,2019,Q1,2,F,20170626.0,20190114.0,20181026,20190125,EXP,,US-CELGENEUS-USA-20171108065,CELGENE,,65.0,YR,,F,Y,75.0,KG,20190125.0,,MD,US,US,2019,Q1,Elderly
155557632,15555763,23,C,Insulin Lispro,INSULIN LISPRO,1,Other,,,,,,,,,,,INJECTION,,2019,Q1,Anaemia,,2019,Q1,2,F,20170626.0,20190114.0,20181026,20190125,EXP,,US-CELGENEUS-USA-20171108065,CELGENE,,65.0,YR,,F,Y,75.0,KG,20190125.0,,MD,US,US,2019,Q1,Elderly
155557632,15555763,23,C,Insulin Lispro,INSULIN LISPRO,1,Other,,,,,,,,,,,INJECTION,,2019,Q1,Febrile neutropenia,,2019,Q1,2,F,20170626.0,20190114.0,20181026,20190125,EXP,,US-CELGENEUS-USA-20171108065,CELGENE,,65.0,YR,,F,Y,75.0,KG,20190125.0,,MD,US,US,2019,Q1,Elderly
155557632,15555763,23,C,Insulin Lispro,INSULIN LISPRO,1,Other,,,,,,,,,,,INJECTION,,2019,Q1,Haemoglobin decreased,,2019,Q1,2,F,20170626.0,20190114.0,20181026,20190125,EXP,,US-CELGENEUS-USA-20171108065,CELGENE,,65.0,YR,,F,Y,75.0,KG,20190125.0,,MD,US,US,2019,Q1,Elderly
155557632,15555763,23,C,Insulin Lispro,INSULIN LISPRO,1,Other,,,,,,,,,,,INJECTION,,2019,Q1,Pancytopenia,,2019,Q1,2,F,20170626.0,20190114.0,20181026,20190125,EXP,,US-CELGENEUS-USA-20171108065,CELGENE,,65.0,YR,,F,Y,75.0,KG,20190125.0,,MD,US,US,2019,Q1,Elderly
155557632,15555763,23,C,Insulin Lispro,INSULIN LISPRO,1,Other,,,,,,,,,,,INJECTION,,2019,Q1,Pyrexia,,2019,Q1,2,F,20170626.0,20190114.0,20181026,20190125,EXP,,US-CELGENEUS-USA-20171108065,CELGENE,,65.0,YR,,F,Y,75.0,KG,20190125.0,,MD,US,US,2019,Q1,Elderly
155557632,15555763,23,C,Insulin Lispro,INSULIN LISPRO,1,Other,,,,,,,,,,,INJECTION,,2019,Q1,Respiratory failure,,2019,Q1,2,F,20170626.0,20190114.0,20181026,20190125,EXP,,US-CELGENEUS-USA-20171108065,CELGENE,,65.0,YR,,F,Y,75.0,KG,20190125.0,,MD,US,US,2019,Q1,Elderly
155658252,15565825,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2019,Q1,Acidosis,,2019,Q1,2,F,2018.0,20190304.0,20181030,20190313,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20190313.0,,MD,US,US,2019,Q1,Elderly
155658252,15565825,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2019,Q1,Acute myocardial infarction,,2019,Q1,2,F,2018.0,20190304.0,20181030,20190313,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20190313.0,,MD,US,US,2019,Q1,Elderly
155658252,15565825,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2019,Q1,Anaemia,,2019,Q1,2,F,2018.0,20190304.0,20181030,20190313,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20190313.0,,MD,US,US,2019,Q1,Elderly
155658252,15565825,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2019,Q1,Aphasia,,2019,Q1,2,F,2018.0,20190304.0,20181030,20190313,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20190313.0,,MD,US,US,2019,Q1,Elderly
155658252,15565825,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2019,Q1,Back pain,,2019,Q1,2,F,2018.0,20190304.0,20181030,20190313,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20190313.0,,MD,US,US,2019,Q1,Elderly
155658252,15565825,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2019,Q1,Clostridium difficile colitis,,2019,Q1,2,F,2018.0,20190304.0,20181030,20190313,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20190313.0,,MD,US,US,2019,Q1,Elderly
155658252,15565825,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2019,Q1,Diarrhoea,,2019,Q1,2,F,2018.0,20190304.0,20181030,20190313,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20190313.0,,MD,US,US,2019,Q1,Elderly
155658252,15565825,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2019,Q1,Gait disturbance,,2019,Q1,2,F,2018.0,20190304.0,20181030,20190313,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20190313.0,,MD,US,US,2019,Q1,Elderly
155658252,15565825,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2019,Q1,Gastroenteritis,,2019,Q1,2,F,2018.0,20190304.0,20181030,20190313,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20190313.0,,MD,US,US,2019,Q1,Elderly
155658252,15565825,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2019,Q1,Gastrointestinal haemorrhage,,2019,Q1,2,F,2018.0,20190304.0,20181030,20190313,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20190313.0,,MD,US,US,2019,Q1,Elderly
155658252,15565825,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2019,Q1,Haematotoxicity,,2019,Q1,2,F,2018.0,20190304.0,20181030,20190313,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20190313.0,,MD,US,US,2019,Q1,Elderly
155658252,15565825,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2019,Q1,Haemorrhagic anaemia,,2019,Q1,2,F,2018.0,20190304.0,20181030,20190313,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20190313.0,,MD,US,US,2019,Q1,Elderly
155658252,15565825,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2019,Q1,Hyperkalaemia,,2019,Q1,2,F,2018.0,20190304.0,20181030,20190313,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20190313.0,,MD,US,US,2019,Q1,Elderly
155658252,15565825,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2019,Q1,Internal haemorrhage,,2019,Q1,2,F,2018.0,20190304.0,20181030,20190313,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20190313.0,,MD,US,US,2019,Q1,Elderly
155658252,15565825,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2019,Q1,Intervertebral disc disorder,,2019,Q1,2,F,2018.0,20190304.0,20181030,20190313,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20190313.0,,MD,US,US,2019,Q1,Elderly
155658252,15565825,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2019,Q1,Lethargy,,2019,Q1,2,F,2018.0,20190304.0,20181030,20190313,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20190313.0,,MD,US,US,2019,Q1,Elderly
155658252,15565825,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2019,Q1,Limb discomfort,,2019,Q1,2,F,2018.0,20190304.0,20181030,20190313,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20190313.0,,MD,US,US,2019,Q1,Elderly
155658252,15565825,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2019,Q1,Metabolic acidosis,,2019,Q1,2,F,2018.0,20190304.0,20181030,20190313,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20190313.0,,MD,US,US,2019,Q1,Elderly
155658252,15565825,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2019,Q1,Pain in extremity,,2019,Q1,2,F,2018.0,20190304.0,20181030,20190313,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20190313.0,,MD,US,US,2019,Q1,Elderly
155658252,15565825,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2019,Q1,Pulmonary oedema,,2019,Q1,2,F,2018.0,20190304.0,20181030,20190313,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20190313.0,,MD,US,US,2019,Q1,Elderly
155658252,15565825,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2019,Q1,Renal failure,,2019,Q1,2,F,2018.0,20190304.0,20181030,20190313,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20190313.0,,MD,US,US,2019,Q1,Elderly
155658252,15565825,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2019,Q1,Respiratory failure,,2019,Q1,2,F,2018.0,20190304.0,20181030,20190313,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20190313.0,,MD,US,US,2019,Q1,Elderly
155658252,15565825,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2019,Q1,Sciatica,,2019,Q1,2,F,2018.0,20190304.0,20181030,20190313,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20190313.0,,MD,US,US,2019,Q1,Elderly
155658252,15565825,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2019,Q1,Sepsis,,2019,Q1,2,F,2018.0,20190304.0,20181030,20190313,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20190313.0,,MD,US,US,2019,Q1,Elderly
155658252,15565825,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2019,Q1,Septic shock,,2019,Q1,2,F,2018.0,20190304.0,20181030,20190313,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20190313.0,,MD,US,US,2019,Q1,Elderly
155658252,15565825,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2019,Q1,Supraventricular tachycardia,,2019,Q1,2,F,2018.0,20190304.0,20181030,20190313,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20190313.0,,MD,US,US,2019,Q1,Elderly
155658252,15565825,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2019,Q1,Thrombocytopenia,,2019,Q1,2,F,2018.0,20190304.0,20181030,20190313,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20190313.0,,MD,US,US,2019,Q1,Elderly
155787142,15578714,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2019,Q1,Hypertension,,2019,Q1,2,F,20180927.0,20190213.0,20181102,20190224,EXP,,IT-APOTEX-2018AP023710,APOTEX,,82.0,YR,,F,Y,,,20190224.0,,CN,IT,IT,2019,Q1,Elderly
155787142,15578714,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2019,Q1,Hypoglycaemia,,2019,Q1,2,F,20180927.0,20190213.0,20181102,20190224,EXP,,IT-APOTEX-2018AP023710,APOTEX,,82.0,YR,,F,Y,,,20190224.0,,CN,IT,IT,2019,Q1,Elderly
155787142,15578714,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2019,Q1,Overdose,,2019,Q1,2,F,20180927.0,20190213.0,20181102,20190224,EXP,,IT-APOTEX-2018AP023710,APOTEX,,82.0,YR,,F,Y,,,20190224.0,,CN,IT,IT,2019,Q1,Elderly
156045065,15604506,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 IU, QD ( (25/75: + 20U 20U / D)",,,U,U,,,,40.0,IU,SOLUTION FOR INJECTION,QD,2019,Q1,Chest pain,,2019,Q1,5,F,,20190311.0,20181110,20190314,EXP,,PHHY2018PT147150,SANDOZ,,54.0,YR,,F,Y,,,20190314.0,,OT,PT,PT,2019,Q1,Adult
156045065,15604506,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 IU, QD ( (25/75: + 20U 20U / D)",,,U,U,,,,40.0,IU,SOLUTION FOR INJECTION,QD,2019,Q1,Headache,,2019,Q1,5,F,,20190311.0,20181110,20190314,EXP,,PHHY2018PT147150,SANDOZ,,54.0,YR,,F,Y,,,20190314.0,,OT,PT,PT,2019,Q1,Adult
156045065,15604506,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 IU, QD ( (25/75: + 20U 20U / D)",,,U,U,,,,40.0,IU,SOLUTION FOR INJECTION,QD,2019,Q1,Ischaemic stroke,,2019,Q1,5,F,,20190311.0,20181110,20190314,EXP,,PHHY2018PT147150,SANDOZ,,54.0,YR,,F,Y,,,20190314.0,,OT,PT,PT,2019,Q1,Adult
156045065,15604506,13,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, QD",,,U,U,,,,,,SOLUTION FOR INJECTION,QD,2019,Q1,Chest pain,,2019,Q1,5,F,,20190311.0,20181110,20190314,EXP,,PHHY2018PT147150,SANDOZ,,54.0,YR,,F,Y,,,20190314.0,,OT,PT,PT,2019,Q1,Adult
156045065,15604506,13,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, QD",,,U,U,,,,,,SOLUTION FOR INJECTION,QD,2019,Q1,Headache,,2019,Q1,5,F,,20190311.0,20181110,20190314,EXP,,PHHY2018PT147150,SANDOZ,,54.0,YR,,F,Y,,,20190314.0,,OT,PT,PT,2019,Q1,Adult
156045065,15604506,13,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, QD",,,U,U,,,,,,SOLUTION FOR INJECTION,QD,2019,Q1,Ischaemic stroke,,2019,Q1,5,F,,20190311.0,20181110,20190314,EXP,,PHHY2018PT147150,SANDOZ,,54.0,YR,,F,Y,,,20190314.0,,OT,PT,PT,2019,Q1,Adult
156131702,15613170,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 IU, QD",1020.0,IU,Y,U, UNK,,,15.0,IU,,QD,2019,Q1,Cold sweat,,2019,Q1,2,F,20180529.0,20190311.0,20181113,20190318,EXP,IT-MINISAL02-482261,IT-MYLANLABS-2018M1086068,MYLAN,,84.0,YR,,M,Y,,,20190318.0,,MD,IT,IT,2019,Q1,Elderly
156131702,15613170,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 IU, QD",1020.0,IU,Y,U, UNK,,,15.0,IU,,QD,2019,Q1,Confusional state,,2019,Q1,2,F,20180529.0,20190311.0,20181113,20190318,EXP,IT-MINISAL02-482261,IT-MYLANLABS-2018M1086068,MYLAN,,84.0,YR,,M,Y,,,20190318.0,,MD,IT,IT,2019,Q1,Elderly
156131702,15613170,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 IU, QD",1020.0,IU,Y,U, UNK,,,15.0,IU,,QD,2019,Q1,Hypoglycaemic coma,,2019,Q1,2,F,20180529.0,20190311.0,20181113,20190318,EXP,IT-MINISAL02-482261,IT-MYLANLABS-2018M1086068,MYLAN,,84.0,YR,,M,Y,,,20190318.0,,MD,IT,IT,2019,Q1,Elderly
156161233,15616123,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q1,Alopecia,,2019,Q1,3,F,201306.0,20190102.0,20181114,20190111,PER,,US-PFIZER INC-2018467294,PFIZER,,57.0,YR,,F,Y,,,20190111.0,,LW,US,US,2019,Q1,Adult
156161233,15616123,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q1,Hair colour changes,,2019,Q1,3,F,201306.0,20190102.0,20181114,20190111,PER,,US-PFIZER INC-2018467294,PFIZER,,57.0,YR,,F,Y,,,20190111.0,,LW,US,US,2019,Q1,Adult
156161233,15616123,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q1,Hair disorder,,2019,Q1,3,F,201306.0,20190102.0,20181114,20190111,PER,,US-PFIZER INC-2018467294,PFIZER,,57.0,YR,,F,Y,,,20190111.0,,LW,US,US,2019,Q1,Adult
156161233,15616123,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q1,Hair texture abnormal,,2019,Q1,3,F,201306.0,20190102.0,20181114,20190111,PER,,US-PFIZER INC-2018467294,PFIZER,,57.0,YR,,F,Y,,,20190111.0,,LW,US,US,2019,Q1,Adult
156161233,15616123,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q1,Madarosis,,2019,Q1,3,F,201306.0,20190102.0,20181114,20190111,PER,,US-PFIZER INC-2018467294,PFIZER,,57.0,YR,,F,Y,,,20190111.0,,LW,US,US,2019,Q1,Adult
156169377,15616937,19,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,2-10 UNITS,,,,,,,,,,UNKNOWN,TID,2019,Q1,Pneumonia fungal,,2019,Q1,7,F,20180919.0,20190228.0,20181114,20190305,EXP,,US-CELGENEUS-USA-20180909031,CELGENE,,77.0,YR,,M,Y,,,20190305.0,,OT,US,US,2019,Q1,Elderly
156169377,15616937,20,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,15 IU (INTERNATIONAL UNIT),,,,,,,,5.0,IU,UNKNOWN,TID,2019,Q1,Pneumonia fungal,,2019,Q1,7,F,20180919.0,20190228.0,20181114,20190305,EXP,,US-CELGENEUS-USA-20180909031,CELGENE,,77.0,YR,,M,Y,,,20190305.0,,OT,US,US,2019,Q1,Elderly
156352283,15635228,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,D,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Abdominal discomfort,,2019,Q1,3,F,20181101.0,20190107.0,20181120,20190118,PER,,US-JNJFOC-20181104689,JANSSEN,,79.0,YR,E,M,Y,,,20190118.0,,CN,US,US,2019,Q1,Elderly
156352283,15635228,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,D,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Prostate cancer metastatic,,2019,Q1,3,F,20181101.0,20190107.0,20181120,20190118,PER,,US-JNJFOC-20181104689,JANSSEN,,79.0,YR,E,M,Y,,,20190118.0,,CN,US,US,2019,Q1,Elderly
156383792,15638379,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 MG, QD",,,,,,,,40.0,MG,,QD,2019,Q1,Chest pain,,2019,Q1,2,F,2018.0,20190214.0,20181120,20190226,EXP,,PT-AMGEN-PRTSP2018165248,AMGEN,,54.0,YR,A,F,Y,110.0,KG,20190225.0,,OT,PT,PT,2019,Q1,Adult
156383792,15638379,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 MG, QD",,,,,,,,40.0,MG,,QD,2019,Q1,Headache,,2019,Q1,2,F,2018.0,20190214.0,20181120,20190226,EXP,,PT-AMGEN-PRTSP2018165248,AMGEN,,54.0,YR,A,F,Y,110.0,KG,20190225.0,,OT,PT,PT,2019,Q1,Adult
156383792,15638379,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 MG, QD",,,,,,,,40.0,MG,,QD,2019,Q1,Ischaemic stroke,,2019,Q1,2,F,2018.0,20190214.0,20181120,20190226,EXP,,PT-AMGEN-PRTSP2018165248,AMGEN,,54.0,YR,A,F,Y,110.0,KG,20190225.0,,OT,PT,PT,2019,Q1,Adult
156444348,15644434,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 IU, QD (QD (25/75: + 20U 20U / D))",,,U,,,,,,,,,2019,Q1,Chest pain,,2019,Q1,8,F,,20190315.0,20181121,20190322,EXP,,PT-ASTRAZENECA-2018SF50815,ASTRAZENECA,,54.0,YR,,F,Y,,,20190322.0,,CN,PT,PT,2019,Q1,Adult
156444348,15644434,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 IU, QD (QD (25/75: + 20U 20U / D))",,,U,,,,,,,,,2019,Q1,Headache,,2019,Q1,8,F,,20190315.0,20181121,20190322,EXP,,PT-ASTRAZENECA-2018SF50815,ASTRAZENECA,,54.0,YR,,F,Y,,,20190322.0,,CN,PT,PT,2019,Q1,Adult
156444348,15644434,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 IU, QD (QD (25/75: + 20U 20U / D))",,,U,,,,,,,,,2019,Q1,Ischaemic stroke,,2019,Q1,8,F,,20190315.0,20181121,20190322,EXP,,PT-ASTRAZENECA-2018SF50815,ASTRAZENECA,,54.0,YR,,F,Y,,,20190322.0,,CN,PT,PT,2019,Q1,Adult
156579644,15657964,10,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"25/75: 40 IU, QD",,,U,,,,209196.0,40.0,IU,SOLUTION FOR INJECTION,QD,2019,Q1,Chest pain,,2019,Q1,4,F,,20190312.0,20181126,20190318,EXP,,PT-SA-2018SA322867,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20190318.0,,OT,PT,PT,2019,Q1,Adult
156579644,15657964,10,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"25/75: 40 IU, QD",,,U,,,,209196.0,40.0,IU,SOLUTION FOR INJECTION,QD,2019,Q1,Headache,,2019,Q1,4,F,,20190312.0,20181126,20190318,EXP,,PT-SA-2018SA322867,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20190318.0,,OT,PT,PT,2019,Q1,Adult
156579644,15657964,10,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"25/75: 40 IU, QD",,,U,,,,209196.0,40.0,IU,SOLUTION FOR INJECTION,QD,2019,Q1,Ischaemic stroke,,2019,Q1,4,F,,20190312.0,20181126,20190318,EXP,,PT-SA-2018SA322867,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20190318.0,,OT,PT,PT,2019,Q1,Adult
156653164,15665316,37,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,4 UNITS,,,,,,,,,,,QD,2019,Q1,Encephalopathy,,2019,Q1,4,F,20181115.0,20190205.0,20181128,20190211,EXP,,US-ROCHE-2218548,ROCHE,,75.0,YR,,M,Y,68.0,KG,20190211.0,,MD,US,US,2019,Q1,Elderly
156653164,15665316,38,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0-8 UNITS,,,,,,,,,,,TID,2019,Q1,Encephalopathy,,2019,Q1,4,F,20181115.0,20190205.0,20181128,20190211,EXP,,US-ROCHE-2218548,ROCHE,,75.0,YR,,M,Y,68.0,KG,20190211.0,,MD,US,US,2019,Q1,Elderly
156659133,15665913,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 INTERNATIONAL UNIT, QD",,,U,, UNK,,,40.0,IU,SOLUTION FOR INJECTION,QD,2019,Q1,Chest pain,,2019,Q1,3,F,,20190213.0,20181128,20190218,EXP,PT-002147023-PHHY2018PT147150,PT-FRESENIUS KABI-FK201812057,FRESENIUS KABI,,54.0,YR,,F,Y,,,20190218.0,,OT,GB,PT,2019,Q1,Adult
156659133,15665913,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 INTERNATIONAL UNIT, QD",,,U,, UNK,,,40.0,IU,SOLUTION FOR INJECTION,QD,2019,Q1,Headache,,2019,Q1,3,F,,20190213.0,20181128,20190218,EXP,PT-002147023-PHHY2018PT147150,PT-FRESENIUS KABI-FK201812057,FRESENIUS KABI,,54.0,YR,,F,Y,,,20190218.0,,OT,GB,PT,2019,Q1,Adult
156659133,15665913,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 INTERNATIONAL UNIT, QD",,,U,, UNK,,,40.0,IU,SOLUTION FOR INJECTION,QD,2019,Q1,Ischaemic stroke,,2019,Q1,3,F,,20190213.0,20181128,20190218,EXP,PT-002147023-PHHY2018PT147150,PT-FRESENIUS KABI-FK201812057,FRESENIUS KABI,,54.0,YR,,F,Y,,,20190218.0,,OT,GB,PT,2019,Q1,Adult
156702895,15670289,13,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"40 INTERNATIONAL UNIT, QD",,,U,U, UNK,,,40.0,IU,SOLUTION FOR INJECTION,QD,2019,Q1,Chest pain,,2019,Q1,5,F,,20190315.0,20181129,20190328,EXP,,PT-MYLANLABS-2018M1088222,MYLAN,,54.0,YR,,F,Y,,,20190328.0,,OT,PT,PT,2019,Q1,Adult
156702895,15670289,13,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"40 INTERNATIONAL UNIT, QD",,,U,U, UNK,,,40.0,IU,SOLUTION FOR INJECTION,QD,2019,Q1,Headache,,2019,Q1,5,F,,20190315.0,20181129,20190328,EXP,,PT-MYLANLABS-2018M1088222,MYLAN,,54.0,YR,,F,Y,,,20190328.0,,OT,PT,PT,2019,Q1,Adult
156702895,15670289,13,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"40 INTERNATIONAL UNIT, QD",,,U,U, UNK,,,40.0,IU,SOLUTION FOR INJECTION,QD,2019,Q1,Ischaemic stroke,,2019,Q1,5,F,,20190315.0,20181129,20190328,EXP,,PT-MYLANLABS-2018M1088222,MYLAN,,54.0,YR,,F,Y,,,20190328.0,,OT,PT,PT,2019,Q1,Adult
156756452,15675645,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"18 UNITS, QD",,,,,,,,,,,QD,2019,Q1,Alanine aminotransferase increased,,2019,Q1,2,F,20181017.0,20190110.0,20181130,20190121,EXP,,"US-VELOXIS PHARMACEUTICALS, INC.-2018VELUS1265",VELOXIS PHARMACEUTICALS,,64.0,YR,,M,Y,91.6,KG,20190121.0,,OT,US,US,2019,Q1,Adult
156756452,15675645,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"18 UNITS, QD",,,,,,,,,,,QD,2019,Q1,Aspartate aminotransferase increased,,2019,Q1,2,F,20181017.0,20190110.0,20181130,20190121,EXP,,"US-VELOXIS PHARMACEUTICALS, INC.-2018VELUS1265",VELOXIS PHARMACEUTICALS,,64.0,YR,,M,Y,91.6,KG,20190121.0,,OT,US,US,2019,Q1,Adult
156869693,15686969,1,PS,Insulin Lispro,INSULIN LISPRO,1,,"2 IU, EACH MORNING",,,U,U,,,20563.0,2.0,IU,,QD,2019,Q1,Diabetic metabolic decompensation,,2019,Q1,3,F,201411.0,20190322.0,20181204,20190322,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,,47.0,YR,,M,Y,,,20190322.0,,CN,CZ,CZ,2019,Q1,Adult
156869693,15686969,1,PS,Insulin Lispro,INSULIN LISPRO,1,,"2 IU, EACH MORNING",,,U,U,,,20563.0,2.0,IU,,QD,2019,Q1,Hypoglycaemia,,2019,Q1,3,F,201411.0,20190322.0,20181204,20190322,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,,47.0,YR,,M,Y,,,20190322.0,,CN,CZ,CZ,2019,Q1,Adult
156869693,15686969,1,PS,Insulin Lispro,INSULIN LISPRO,1,,"2 IU, EACH MORNING",,,U,U,,,20563.0,2.0,IU,,QD,2019,Q1,Pancreatitis,,2019,Q1,3,F,201411.0,20190322.0,20181204,20190322,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,,47.0,YR,,M,Y,,,20190322.0,,CN,CZ,CZ,2019,Q1,Adult
156869693,15686969,1,PS,Insulin Lispro,INSULIN LISPRO,1,,"2 IU, EACH MORNING",,,U,U,,,20563.0,2.0,IU,,QD,2019,Q1,Weight increased,,2019,Q1,3,F,201411.0,20190322.0,20181204,20190322,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,,47.0,YR,,M,Y,,,20190322.0,,CN,CZ,CZ,2019,Q1,Adult
156869693,15686969,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"2 IU, EACH EVENING",,,U,U,,,20563.0,2.0,IU,,QD,2019,Q1,Diabetic metabolic decompensation,,2019,Q1,3,F,201411.0,20190322.0,20181204,20190322,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,,47.0,YR,,M,Y,,,20190322.0,,CN,CZ,CZ,2019,Q1,Adult
156869693,15686969,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"2 IU, EACH EVENING",,,U,U,,,20563.0,2.0,IU,,QD,2019,Q1,Hypoglycaemia,,2019,Q1,3,F,201411.0,20190322.0,20181204,20190322,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,,47.0,YR,,M,Y,,,20190322.0,,CN,CZ,CZ,2019,Q1,Adult
156869693,15686969,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"2 IU, EACH EVENING",,,U,U,,,20563.0,2.0,IU,,QD,2019,Q1,Pancreatitis,,2019,Q1,3,F,201411.0,20190322.0,20181204,20190322,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,,47.0,YR,,M,Y,,,20190322.0,,CN,CZ,CZ,2019,Q1,Adult
156869693,15686969,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"2 IU, EACH EVENING",,,U,U,,,20563.0,2.0,IU,,QD,2019,Q1,Weight increased,,2019,Q1,3,F,201411.0,20190322.0,20181204,20190322,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,,47.0,YR,,M,Y,,,20190322.0,,CN,CZ,CZ,2019,Q1,Adult
156869693,15686969,3,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"2 IU, EACH EVENING",,,U,U,,,20563.0,2.0,IU,,QD,2019,Q1,Diabetic metabolic decompensation,,2019,Q1,3,F,201411.0,20190322.0,20181204,20190322,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,,47.0,YR,,M,Y,,,20190322.0,,CN,CZ,CZ,2019,Q1,Adult
156869693,15686969,3,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"2 IU, EACH EVENING",,,U,U,,,20563.0,2.0,IU,,QD,2019,Q1,Hypoglycaemia,,2019,Q1,3,F,201411.0,20190322.0,20181204,20190322,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,,47.0,YR,,M,Y,,,20190322.0,,CN,CZ,CZ,2019,Q1,Adult
156869693,15686969,3,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"2 IU, EACH EVENING",,,U,U,,,20563.0,2.0,IU,,QD,2019,Q1,Pancreatitis,,2019,Q1,3,F,201411.0,20190322.0,20181204,20190322,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,,47.0,YR,,M,Y,,,20190322.0,,CN,CZ,CZ,2019,Q1,Adult
156869693,15686969,3,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"2 IU, EACH EVENING",,,U,U,,,20563.0,2.0,IU,,QD,2019,Q1,Weight increased,,2019,Q1,3,F,201411.0,20190322.0,20181204,20190322,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,,47.0,YR,,M,Y,,,20190322.0,,CN,CZ,CZ,2019,Q1,Adult
156869693,15686969,4,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"4 IU, EACH MORNING",,,U,U,,,20563.0,4.0,IU,,QD,2019,Q1,Diabetic metabolic decompensation,,2019,Q1,3,F,201411.0,20190322.0,20181204,20190322,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,,47.0,YR,,M,Y,,,20190322.0,,CN,CZ,CZ,2019,Q1,Adult
156869693,15686969,4,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"4 IU, EACH MORNING",,,U,U,,,20563.0,4.0,IU,,QD,2019,Q1,Hypoglycaemia,,2019,Q1,3,F,201411.0,20190322.0,20181204,20190322,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,,47.0,YR,,M,Y,,,20190322.0,,CN,CZ,CZ,2019,Q1,Adult
156869693,15686969,4,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"4 IU, EACH MORNING",,,U,U,,,20563.0,4.0,IU,,QD,2019,Q1,Pancreatitis,,2019,Q1,3,F,201411.0,20190322.0,20181204,20190322,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,,47.0,YR,,M,Y,,,20190322.0,,CN,CZ,CZ,2019,Q1,Adult
156869693,15686969,4,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"4 IU, EACH MORNING",,,U,U,,,20563.0,4.0,IU,,QD,2019,Q1,Weight increased,,2019,Q1,3,F,201411.0,20190322.0,20181204,20190322,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,,47.0,YR,,M,Y,,,20190322.0,,CN,CZ,CZ,2019,Q1,Adult
156869693,15686969,5,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"6 IU, EACH EVENING",,,U,U,,,20563.0,6.0,IU,,QD,2019,Q1,Diabetic metabolic decompensation,,2019,Q1,3,F,201411.0,20190322.0,20181204,20190322,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,,47.0,YR,,M,Y,,,20190322.0,,CN,CZ,CZ,2019,Q1,Adult
156869693,15686969,5,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"6 IU, EACH EVENING",,,U,U,,,20563.0,6.0,IU,,QD,2019,Q1,Hypoglycaemia,,2019,Q1,3,F,201411.0,20190322.0,20181204,20190322,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,,47.0,YR,,M,Y,,,20190322.0,,CN,CZ,CZ,2019,Q1,Adult
156869693,15686969,5,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"6 IU, EACH EVENING",,,U,U,,,20563.0,6.0,IU,,QD,2019,Q1,Pancreatitis,,2019,Q1,3,F,201411.0,20190322.0,20181204,20190322,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,,47.0,YR,,M,Y,,,20190322.0,,CN,CZ,CZ,2019,Q1,Adult
156869693,15686969,5,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"6 IU, EACH EVENING",,,U,U,,,20563.0,6.0,IU,,QD,2019,Q1,Weight increased,,2019,Q1,3,F,201411.0,20190322.0,20181204,20190322,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,,47.0,YR,,M,Y,,,20190322.0,,CN,CZ,CZ,2019,Q1,Adult
156869693,15686969,6,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"6 IU, EACH EVENING",,,U,U,,,20563.0,6.0,IU,,QD,2019,Q1,Diabetic metabolic decompensation,,2019,Q1,3,F,201411.0,20190322.0,20181204,20190322,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,,47.0,YR,,M,Y,,,20190322.0,,CN,CZ,CZ,2019,Q1,Adult
156869693,15686969,6,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"6 IU, EACH EVENING",,,U,U,,,20563.0,6.0,IU,,QD,2019,Q1,Hypoglycaemia,,2019,Q1,3,F,201411.0,20190322.0,20181204,20190322,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,,47.0,YR,,M,Y,,,20190322.0,,CN,CZ,CZ,2019,Q1,Adult
156869693,15686969,6,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"6 IU, EACH EVENING",,,U,U,,,20563.0,6.0,IU,,QD,2019,Q1,Pancreatitis,,2019,Q1,3,F,201411.0,20190322.0,20181204,20190322,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,,47.0,YR,,M,Y,,,20190322.0,,CN,CZ,CZ,2019,Q1,Adult
156869693,15686969,6,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"6 IU, EACH EVENING",,,U,U,,,20563.0,6.0,IU,,QD,2019,Q1,Weight increased,,2019,Q1,3,F,201411.0,20190322.0,20181204,20190322,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,,47.0,YR,,M,Y,,,20190322.0,,CN,CZ,CZ,2019,Q1,Adult
156869693,15686969,7,SS,Insulin Lispro,INSULIN LISPRO,1,,"5 IU, EACH MORNING",,,U,U,,,20563.0,5.0,IU,,QD,2019,Q1,Diabetic metabolic decompensation,,2019,Q1,3,F,201411.0,20190322.0,20181204,20190322,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,,47.0,YR,,M,Y,,,20190322.0,,CN,CZ,CZ,2019,Q1,Adult
156869693,15686969,7,SS,Insulin Lispro,INSULIN LISPRO,1,,"5 IU, EACH MORNING",,,U,U,,,20563.0,5.0,IU,,QD,2019,Q1,Hypoglycaemia,,2019,Q1,3,F,201411.0,20190322.0,20181204,20190322,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,,47.0,YR,,M,Y,,,20190322.0,,CN,CZ,CZ,2019,Q1,Adult
156869693,15686969,7,SS,Insulin Lispro,INSULIN LISPRO,1,,"5 IU, EACH MORNING",,,U,U,,,20563.0,5.0,IU,,QD,2019,Q1,Pancreatitis,,2019,Q1,3,F,201411.0,20190322.0,20181204,20190322,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,,47.0,YR,,M,Y,,,20190322.0,,CN,CZ,CZ,2019,Q1,Adult
156869693,15686969,7,SS,Insulin Lispro,INSULIN LISPRO,1,,"5 IU, EACH MORNING",,,U,U,,,20563.0,5.0,IU,,QD,2019,Q1,Weight increased,,2019,Q1,3,F,201411.0,20190322.0,20181204,20190322,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,,47.0,YR,,M,Y,,,20190322.0,,CN,CZ,CZ,2019,Q1,Adult
156869693,15686969,8,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"7 IU, EACH AFTERNOON",,,U,U,,,20563.0,7.0,IU,,,2019,Q1,Diabetic metabolic decompensation,,2019,Q1,3,F,201411.0,20190322.0,20181204,20190322,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,,47.0,YR,,M,Y,,,20190322.0,,CN,CZ,CZ,2019,Q1,Adult
156869693,15686969,8,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"7 IU, EACH AFTERNOON",,,U,U,,,20563.0,7.0,IU,,,2019,Q1,Hypoglycaemia,,2019,Q1,3,F,201411.0,20190322.0,20181204,20190322,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,,47.0,YR,,M,Y,,,20190322.0,,CN,CZ,CZ,2019,Q1,Adult
156869693,15686969,8,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"7 IU, EACH AFTERNOON",,,U,U,,,20563.0,7.0,IU,,,2019,Q1,Pancreatitis,,2019,Q1,3,F,201411.0,20190322.0,20181204,20190322,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,,47.0,YR,,M,Y,,,20190322.0,,CN,CZ,CZ,2019,Q1,Adult
156869693,15686969,8,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"7 IU, EACH AFTERNOON",,,U,U,,,20563.0,7.0,IU,,,2019,Q1,Weight increased,,2019,Q1,3,F,201411.0,20190322.0,20181204,20190322,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,,47.0,YR,,M,Y,,,20190322.0,,CN,CZ,CZ,2019,Q1,Adult
156869693,15686969,9,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"7 IU, EACH EVENING",,,U,U,,,20563.0,7.0,IU,,QD,2019,Q1,Diabetic metabolic decompensation,,2019,Q1,3,F,201411.0,20190322.0,20181204,20190322,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,,47.0,YR,,M,Y,,,20190322.0,,CN,CZ,CZ,2019,Q1,Adult
156869693,15686969,9,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"7 IU, EACH EVENING",,,U,U,,,20563.0,7.0,IU,,QD,2019,Q1,Hypoglycaemia,,2019,Q1,3,F,201411.0,20190322.0,20181204,20190322,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,,47.0,YR,,M,Y,,,20190322.0,,CN,CZ,CZ,2019,Q1,Adult
156869693,15686969,9,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"7 IU, EACH EVENING",,,U,U,,,20563.0,7.0,IU,,QD,2019,Q1,Pancreatitis,,2019,Q1,3,F,201411.0,20190322.0,20181204,20190322,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,,47.0,YR,,M,Y,,,20190322.0,,CN,CZ,CZ,2019,Q1,Adult
156869693,15686969,9,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"7 IU, EACH EVENING",,,U,U,,,20563.0,7.0,IU,,QD,2019,Q1,Weight increased,,2019,Q1,3,F,201411.0,20190322.0,20181204,20190322,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,,47.0,YR,,M,Y,,,20190322.0,,CN,CZ,CZ,2019,Q1,Adult
156869693,15686969,10,SS,Insulin Lispro,INSULIN LISPRO,1,,"8 IU, EACH MORNING",,,U,U,,,20563.0,8.0,IU,,QD,2019,Q1,Diabetic metabolic decompensation,,2019,Q1,3,F,201411.0,20190322.0,20181204,20190322,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,,47.0,YR,,M,Y,,,20190322.0,,CN,CZ,CZ,2019,Q1,Adult
156869693,15686969,10,SS,Insulin Lispro,INSULIN LISPRO,1,,"8 IU, EACH MORNING",,,U,U,,,20563.0,8.0,IU,,QD,2019,Q1,Hypoglycaemia,,2019,Q1,3,F,201411.0,20190322.0,20181204,20190322,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,,47.0,YR,,M,Y,,,20190322.0,,CN,CZ,CZ,2019,Q1,Adult
156869693,15686969,10,SS,Insulin Lispro,INSULIN LISPRO,1,,"8 IU, EACH MORNING",,,U,U,,,20563.0,8.0,IU,,QD,2019,Q1,Pancreatitis,,2019,Q1,3,F,201411.0,20190322.0,20181204,20190322,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,,47.0,YR,,M,Y,,,20190322.0,,CN,CZ,CZ,2019,Q1,Adult
156869693,15686969,10,SS,Insulin Lispro,INSULIN LISPRO,1,,"8 IU, EACH MORNING",,,U,U,,,20563.0,8.0,IU,,QD,2019,Q1,Weight increased,,2019,Q1,3,F,201411.0,20190322.0,20181204,20190322,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,,47.0,YR,,M,Y,,,20190322.0,,CN,CZ,CZ,2019,Q1,Adult
156869693,15686969,11,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"8 IU, EACH AFTERNOON",,,U,U,,,20563.0,8.0,IU,,,2019,Q1,Diabetic metabolic decompensation,,2019,Q1,3,F,201411.0,20190322.0,20181204,20190322,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,,47.0,YR,,M,Y,,,20190322.0,,CN,CZ,CZ,2019,Q1,Adult
156869693,15686969,11,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"8 IU, EACH AFTERNOON",,,U,U,,,20563.0,8.0,IU,,,2019,Q1,Hypoglycaemia,,2019,Q1,3,F,201411.0,20190322.0,20181204,20190322,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,,47.0,YR,,M,Y,,,20190322.0,,CN,CZ,CZ,2019,Q1,Adult
156869693,15686969,11,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"8 IU, EACH AFTERNOON",,,U,U,,,20563.0,8.0,IU,,,2019,Q1,Pancreatitis,,2019,Q1,3,F,201411.0,20190322.0,20181204,20190322,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,,47.0,YR,,M,Y,,,20190322.0,,CN,CZ,CZ,2019,Q1,Adult
156869693,15686969,11,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"8 IU, EACH AFTERNOON",,,U,U,,,20563.0,8.0,IU,,,2019,Q1,Weight increased,,2019,Q1,3,F,201411.0,20190322.0,20181204,20190322,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,,47.0,YR,,M,Y,,,20190322.0,,CN,CZ,CZ,2019,Q1,Adult
156869693,15686969,12,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"8 IU, EACH EVENING",,,U,U,,,20563.0,8.0,IU,,QD,2019,Q1,Diabetic metabolic decompensation,,2019,Q1,3,F,201411.0,20190322.0,20181204,20190322,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,,47.0,YR,,M,Y,,,20190322.0,,CN,CZ,CZ,2019,Q1,Adult
156869693,15686969,12,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"8 IU, EACH EVENING",,,U,U,,,20563.0,8.0,IU,,QD,2019,Q1,Hypoglycaemia,,2019,Q1,3,F,201411.0,20190322.0,20181204,20190322,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,,47.0,YR,,M,Y,,,20190322.0,,CN,CZ,CZ,2019,Q1,Adult
156869693,15686969,12,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"8 IU, EACH EVENING",,,U,U,,,20563.0,8.0,IU,,QD,2019,Q1,Pancreatitis,,2019,Q1,3,F,201411.0,20190322.0,20181204,20190322,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,,47.0,YR,,M,Y,,,20190322.0,,CN,CZ,CZ,2019,Q1,Adult
156869693,15686969,12,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"8 IU, EACH EVENING",,,U,U,,,20563.0,8.0,IU,,QD,2019,Q1,Weight increased,,2019,Q1,3,F,201411.0,20190322.0,20181204,20190322,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201811012543,ELI LILLY AND CO,,47.0,YR,,M,Y,,,20190322.0,,CN,CZ,CZ,2019,Q1,Adult
156873572,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Acidosis,,2019,Q1,2,F,20160303.0,20190221.0,20181205,20190330,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190330.0,,MD,US,US,2019,Q1,Adult
156873572,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Acute kidney injury,,2019,Q1,2,F,20160303.0,20190221.0,20181205,20190330,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190330.0,,MD,US,US,2019,Q1,Adult
156873572,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Acute respiratory distress syndrome,,2019,Q1,2,F,20160303.0,20190221.0,20181205,20190330,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190330.0,,MD,US,US,2019,Q1,Adult
156873572,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Alkalosis hypochloraemic,,2019,Q1,2,F,20160303.0,20190221.0,20181205,20190330,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190330.0,,MD,US,US,2019,Q1,Adult
156873572,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Anaemia,,2019,Q1,2,F,20160303.0,20190221.0,20181205,20190330,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190330.0,,MD,US,US,2019,Q1,Adult
156873572,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Asthenia,,2019,Q1,2,F,20160303.0,20190221.0,20181205,20190330,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190330.0,,MD,US,US,2019,Q1,Adult
156873572,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Bandaemia,,2019,Q1,2,F,20160303.0,20190221.0,20181205,20190330,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190330.0,,MD,US,US,2019,Q1,Adult
156873572,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Blood creatinine increased,,2019,Q1,2,F,20160303.0,20190221.0,20181205,20190330,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190330.0,,MD,US,US,2019,Q1,Adult
156873572,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Blood urea increased,,2019,Q1,2,F,20160303.0,20190221.0,20181205,20190330,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190330.0,,MD,US,US,2019,Q1,Adult
156873572,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Bronchial haemorrhage,,2019,Q1,2,F,20160303.0,20190221.0,20181205,20190330,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190330.0,,MD,US,US,2019,Q1,Adult
156873572,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Bronchitis chronic,,2019,Q1,2,F,20160303.0,20190221.0,20181205,20190330,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190330.0,,MD,US,US,2019,Q1,Adult
156873572,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Concomitant disease aggravated,,2019,Q1,2,F,20160303.0,20190221.0,20181205,20190330,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190330.0,,MD,US,US,2019,Q1,Adult
156873572,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Constipation,,2019,Q1,2,F,20160303.0,20190221.0,20181205,20190330,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190330.0,,MD,US,US,2019,Q1,Adult
156873572,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Cough,,2019,Q1,2,F,20160303.0,20190221.0,20181205,20190330,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190330.0,,MD,US,US,2019,Q1,Adult
156873572,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Cystic fibrosis,,2019,Q1,2,F,20160303.0,20190221.0,20181205,20190330,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190330.0,,MD,US,US,2019,Q1,Adult
156873572,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Diarrhoea,,2019,Q1,2,F,20160303.0,20190221.0,20181205,20190330,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190330.0,,MD,US,US,2019,Q1,Adult
156873572,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Dysphagia,,2019,Q1,2,F,20160303.0,20190221.0,20181205,20190330,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190330.0,,MD,US,US,2019,Q1,Adult
156873572,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Dyspnoea,,2019,Q1,2,F,20160303.0,20190221.0,20181205,20190330,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190330.0,,MD,US,US,2019,Q1,Adult
156873572,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Fungal disease carrier,,2019,Q1,2,F,20160303.0,20190221.0,20181205,20190330,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190330.0,,MD,US,US,2019,Q1,Adult
156873572,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Gastroenteritis norovirus,,2019,Q1,2,F,20160303.0,20190221.0,20181205,20190330,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190330.0,,MD,US,US,2019,Q1,Adult
156873572,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Gastrointestinal disorder,,2019,Q1,2,F,20160303.0,20190221.0,20181205,20190330,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190330.0,,MD,US,US,2019,Q1,Adult
156873572,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Generalised oedema,,2019,Q1,2,F,20160303.0,20190221.0,20181205,20190330,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190330.0,,MD,US,US,2019,Q1,Adult
156873572,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Glucose tolerance impaired,,2019,Q1,2,F,20160303.0,20190221.0,20181205,20190330,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190330.0,,MD,US,US,2019,Q1,Adult
156873572,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Granulocytosis,,2019,Q1,2,F,20160303.0,20190221.0,20181205,20190330,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190330.0,,MD,US,US,2019,Q1,Adult
156873572,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Haematuria,,2019,Q1,2,F,20160303.0,20190221.0,20181205,20190330,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190330.0,,MD,US,US,2019,Q1,Adult
156873572,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Haemoptysis,,2019,Q1,2,F,20160303.0,20190221.0,20181205,20190330,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190330.0,,MD,US,US,2019,Q1,Adult
156873572,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Hypercapnia,,2019,Q1,2,F,20160303.0,20190221.0,20181205,20190330,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190330.0,,MD,US,US,2019,Q1,Adult
156873572,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Hyperglycaemia,,2019,Q1,2,F,20160303.0,20190221.0,20181205,20190330,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190330.0,,MD,US,US,2019,Q1,Adult
156873572,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Hypernatraemia,,2019,Q1,2,F,20160303.0,20190221.0,20181205,20190330,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190330.0,,MD,US,US,2019,Q1,Adult
156873572,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Hypertension,,2019,Q1,2,F,20160303.0,20190221.0,20181205,20190330,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190330.0,,MD,US,US,2019,Q1,Adult
156873572,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Hypertriglyceridaemia,,2019,Q1,2,F,20160303.0,20190221.0,20181205,20190330,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190330.0,,MD,US,US,2019,Q1,Adult
156873572,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Hypervolaemia,,2019,Q1,2,F,20160303.0,20190221.0,20181205,20190330,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190330.0,,MD,US,US,2019,Q1,Adult
156873572,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Hypokalaemia,,2019,Q1,2,F,20160303.0,20190221.0,20181205,20190330,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190330.0,,MD,US,US,2019,Q1,Adult
156873572,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Hypoxia,,2019,Q1,2,F,20160303.0,20190221.0,20181205,20190330,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190330.0,,MD,US,US,2019,Q1,Adult
156873572,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Ill-defined disorder,,2019,Q1,2,F,20160303.0,20190221.0,20181205,20190330,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190330.0,,MD,US,US,2019,Q1,Adult
156873572,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Infective exacerbation of bronchiectasis,,2019,Q1,2,F,20160303.0,20190221.0,20181205,20190330,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190330.0,,MD,US,US,2019,Q1,Adult
156873572,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Infective pulmonary exacerbation of cystic fibrosis,,2019,Q1,2,F,20160303.0,20190221.0,20181205,20190330,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190330.0,,MD,US,US,2019,Q1,Adult
156873572,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Insomnia,,2019,Q1,2,F,20160303.0,20190221.0,20181205,20190330,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190330.0,,MD,US,US,2019,Q1,Adult
156873572,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Intensive care unit acquired weakness,,2019,Q1,2,F,20160303.0,20190221.0,20181205,20190330,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190330.0,,MD,US,US,2019,Q1,Adult
156873572,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Iron deficiency,,2019,Q1,2,F,20160303.0,20190221.0,20181205,20190330,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190330.0,,MD,US,US,2019,Q1,Adult
156873572,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Leukocytosis,,2019,Q1,2,F,20160303.0,20190221.0,20181205,20190330,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190330.0,,MD,US,US,2019,Q1,Adult
156873572,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Metabolic acidosis,,2019,Q1,2,F,20160303.0,20190221.0,20181205,20190330,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190330.0,,MD,US,US,2019,Q1,Adult
156873572,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Muscle atrophy,,2019,Q1,2,F,20160303.0,20190221.0,20181205,20190330,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190330.0,,MD,US,US,2019,Q1,Adult
156873572,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Paresis,,2019,Q1,2,F,20160303.0,20190221.0,20181205,20190330,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190330.0,,MD,US,US,2019,Q1,Adult
156873572,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Pneumonia,,2019,Q1,2,F,20160303.0,20190221.0,20181205,20190330,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190330.0,,MD,US,US,2019,Q1,Adult
156873572,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Pyrexia,,2019,Q1,2,F,20160303.0,20190221.0,20181205,20190330,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190330.0,,MD,US,US,2019,Q1,Adult
156873572,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Respiratory failure,,2019,Q1,2,F,20160303.0,20190221.0,20181205,20190330,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190330.0,,MD,US,US,2019,Q1,Adult
156873572,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Sepsis,,2019,Q1,2,F,20160303.0,20190221.0,20181205,20190330,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190330.0,,MD,US,US,2019,Q1,Adult
156873572,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Stenotrophomonas test positive,,2019,Q1,2,F,20160303.0,20190221.0,20181205,20190330,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190330.0,,MD,US,US,2019,Q1,Adult
156873572,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Tachycardia,,2019,Q1,2,F,20160303.0,20190221.0,20181205,20190330,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190330.0,,MD,US,US,2019,Q1,Adult
156873572,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Thrombocytosis,,2019,Q1,2,F,20160303.0,20190221.0,20181205,20190330,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190330.0,,MD,US,US,2019,Q1,Adult
156873572,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Weight decreased,,2019,Q1,2,F,20160303.0,20190221.0,20181205,20190330,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190330.0,,MD,US,US,2019,Q1,Adult
156884342,15688434,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"13 UNIT, TID",,,U,,,,,13.0,DF,,TID,2019,Q1,Drug ineffective,,2019,Q1,2,F,20180821.0,20190220.0,20181205,20190220,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-111921,BRISTOL MYERS SQUIBB,,55.0,YR,,F,Y,79.8,KG,20190220.0,,PH,US,US,2019,Q1,Adult
156954562,15695456,5,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2019,Q1,Death,,2019,Q1,2,F,20181120.0,20190111.0,20181206,20190122,EXP,,CO-BAXTER-2018BAX029515,BAXTER,,73.0,YR,,F,Y,67.0,KG,20190122.0,,OT,CO,CO,2019,Q1,Elderly
156954562,15695456,5,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2019,Q1,General physical health deterioration,,2019,Q1,2,F,20181120.0,20190111.0,20181206,20190122,EXP,,CO-BAXTER-2018BAX029515,BAXTER,,73.0,YR,,F,Y,67.0,KG,20190122.0,,OT,CO,CO,2019,Q1,Elderly
156954562,15695456,5,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2019,Q1,Loss of consciousness,,2019,Q1,2,F,20181120.0,20190111.0,20181206,20190122,EXP,,CO-BAXTER-2018BAX029515,BAXTER,,73.0,YR,,F,Y,67.0,KG,20190122.0,,OT,CO,CO,2019,Q1,Elderly
157024612,15702461,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q1,Blood gastrin increased,,2019,Q1,2,F,20171127.0,20190210.0,20181210,20190220,EXP,AT-EMA-20180201-AUTODUP-16589000,AT-ACCORD-094959,ACCORD,,77.0,YR,,M,Y,117.0,KG,20190220.0,,MD,AT,AT,2019,Q1,Elderly
157024612,15702461,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q1,Blood glucose increased,,2019,Q1,2,F,20171127.0,20190210.0,20181210,20190220,EXP,AT-EMA-20180201-AUTODUP-16589000,AT-ACCORD-094959,ACCORD,,77.0,YR,,M,Y,117.0,KG,20190220.0,,MD,AT,AT,2019,Q1,Elderly
157024612,15702461,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q1,Constipation,,2019,Q1,2,F,20171127.0,20190210.0,20181210,20190220,EXP,AT-EMA-20180201-AUTODUP-16589000,AT-ACCORD-094959,ACCORD,,77.0,YR,,M,Y,117.0,KG,20190220.0,,MD,AT,AT,2019,Q1,Elderly
157024612,15702461,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q1,Enteritis,,2019,Q1,2,F,20171127.0,20190210.0,20181210,20190220,EXP,AT-EMA-20180201-AUTODUP-16589000,AT-ACCORD-094959,ACCORD,,77.0,YR,,M,Y,117.0,KG,20190220.0,,MD,AT,AT,2019,Q1,Elderly
157024612,15702461,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q1,Epistaxis,,2019,Q1,2,F,20171127.0,20190210.0,20181210,20190220,EXP,AT-EMA-20180201-AUTODUP-16589000,AT-ACCORD-094959,ACCORD,,77.0,YR,,M,Y,117.0,KG,20190220.0,,MD,AT,AT,2019,Q1,Elderly
157024612,15702461,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q1,Multiple organ dysfunction syndrome,,2019,Q1,2,F,20171127.0,20190210.0,20181210,20190220,EXP,AT-EMA-20180201-AUTODUP-16589000,AT-ACCORD-094959,ACCORD,,77.0,YR,,M,Y,117.0,KG,20190220.0,,MD,AT,AT,2019,Q1,Elderly
157024612,15702461,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q1,Sepsis,,2019,Q1,2,F,20171127.0,20190210.0,20181210,20190220,EXP,AT-EMA-20180201-AUTODUP-16589000,AT-ACCORD-094959,ACCORD,,77.0,YR,,M,Y,117.0,KG,20190220.0,,MD,AT,AT,2019,Q1,Elderly
157107182,15710718,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"18 IU, QD",7380.0,IU,Y,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2019,Q1,Diabetes mellitus,,2019,Q1,2,F,20181018.0,20190107.0,20181211,20190114,EXP,IT-MINISAL02-513006,IT-SAKK-2018SA329734AA,SANOFI AVENTIS,,83.0,YR,E,M,Y,,,20190114.0,,MD,IT,IT,2019,Q1,Elderly
157107182,15710718,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"18 IU, QD",7380.0,IU,Y,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2019,Q1,Hypoglycaemia,,2019,Q1,2,F,20181018.0,20190107.0,20181211,20190114,EXP,IT-MINISAL02-513006,IT-SAKK-2018SA329734AA,SANOFI AVENTIS,,83.0,YR,E,M,Y,,,20190114.0,,MD,IT,IT,2019,Q1,Elderly
157107182,15710718,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"18 IU, QD",7380.0,IU,Y,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2019,Q1,Intentional product misuse,,2019,Q1,2,F,20181018.0,20190107.0,20181211,20190114,EXP,IT-MINISAL02-513006,IT-SAKK-2018SA329734AA,SANOFI AVENTIS,,83.0,YR,E,M,Y,,,20190114.0,,MD,IT,IT,2019,Q1,Elderly
157107182,15710718,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"18 IU, QD",7380.0,IU,Y,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2019,Q1,Malaise,,2019,Q1,2,F,20181018.0,20190107.0,20181211,20190114,EXP,IT-MINISAL02-513006,IT-SAKK-2018SA329734AA,SANOFI AVENTIS,,83.0,YR,E,M,Y,,,20190114.0,,MD,IT,IT,2019,Q1,Elderly
157108252,15710825,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNKNOWN,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Blood glucose decreased,,2019,Q1,2,F,,20190109.0,20181211,20190117,PER,,US-SA-2018SA335308,SANOFI AVENTIS,,75.0,YR,E,F,Y,,,20190117.0,,CN,US,US,2019,Q1,Elderly
157108252,15710825,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNKNOWN,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Gait inability,,2019,Q1,2,F,,20190109.0,20181211,20190117,PER,,US-SA-2018SA335308,SANOFI AVENTIS,,75.0,YR,E,F,Y,,,20190117.0,,CN,US,US,2019,Q1,Elderly
157108252,15710825,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNKNOWN,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Hyperhidrosis,,2019,Q1,2,F,,20190109.0,20181211,20190117,PER,,US-SA-2018SA335308,SANOFI AVENTIS,,75.0,YR,E,F,Y,,,20190117.0,,CN,US,US,2019,Q1,Elderly
157108252,15710825,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNKNOWN,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Inappropriate schedule of product administration,,2019,Q1,2,F,,20190109.0,20181211,20190117,PER,,US-SA-2018SA335308,SANOFI AVENTIS,,75.0,YR,E,F,Y,,,20190117.0,,CN,US,US,2019,Q1,Elderly
157108252,15710825,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNKNOWN,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Malaise,,2019,Q1,2,F,,20190109.0,20181211,20190117,PER,,US-SA-2018SA335308,SANOFI AVENTIS,,75.0,YR,E,F,Y,,,20190117.0,,CN,US,US,2019,Q1,Elderly
157108252,15710825,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNKNOWN,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Tremor,,2019,Q1,2,F,,20190109.0,20181211,20190117,PER,,US-SA-2018SA335308,SANOFI AVENTIS,,75.0,YR,E,F,Y,,,20190117.0,,CN,US,US,2019,Q1,Elderly
157108252,15710825,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNKNOWN,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Wrong product administered,,2019,Q1,2,F,,20190109.0,20181211,20190117,PER,,US-SA-2018SA335308,SANOFI AVENTIS,,75.0,YR,E,F,Y,,,20190117.0,,CN,US,US,2019,Q1,Elderly
157180252,15718025,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2019,Q1,Alopecia,,2019,Q1,2,F,,20190216.0,20181213,20190222,PER,,US-SA-2018SA335812,SANOFI AVENTIS,,61.0,YR,A,F,Y,54.43,KG,20190222.0,,CN,US,US,2019,Q1,Adult
157304364,15730436,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Blood glucose decreased,,2019,Q1,4,F,,20181214.0,20181217,20190319,PER,,US-SA-2018SA337919,SANOFI AVENTIS,,65.0,YR,E,F,Y,,,20190319.0,,CN,US,US,2019,Q1,Elderly
157304364,15730436,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Device operational issue,,2019,Q1,4,F,,20181214.0,20181217,20190319,PER,,US-SA-2018SA337919,SANOFI AVENTIS,,65.0,YR,E,F,Y,,,20190319.0,,CN,US,US,2019,Q1,Elderly
157304364,15730436,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Weight decreased,,2019,Q1,4,F,,20181214.0,20181217,20190319,PER,,US-SA-2018SA337919,SANOFI AVENTIS,,65.0,YR,E,F,Y,,,20190319.0,,CN,US,US,2019,Q1,Elderly
157468454,15746845,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 IU, QD",,,U,U,,,,40.0,IU,,QD,2019,Q1,Headache,,2019,Q1,4,F,,20190213.0,20181220,20190220,EXP,,PHHY2018PT189318,NOVARTIS,,54.0,YR,,F,Y,,,20190220.0,,OT,PT,PT,2019,Q1,Adult
157484642,15748464,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, QD",,,U,, UNKNOWN,,,,,,,2019,Q1,Chest pain,,2019,Q1,2,F,,20181224.0,20181221,20190102,EXP,,PT-TEVA-2018-PT-989694,TEVA,,54.0,YR,,F,Y,,,20190102.0,,OT,PT,PT,2019,Q1,Adult
157484642,15748464,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, QD",,,U,, UNKNOWN,,,,,,,2019,Q1,Ischaemic stroke,,2019,Q1,2,F,,20181224.0,20181221,20190102,EXP,,PT-TEVA-2018-PT-989694,TEVA,,54.0,YR,,F,Y,,,20190102.0,,OT,PT,PT,2019,Q1,Adult
157496582,15749658,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK (VIAL),,,,,,,,,,,,2019,Q1,Alopecia,,2019,Q1,2,F,,20190219.0,20181221,20190227,PER,,US-PFIZER INC-2018524934,PFIZER,,61.0,YR,,F,Y,54.0,KG,20190227.0,,LW,US,US,2019,Q1,Adult
157496582,15749658,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK (VIAL),,,,,,,,,,,,2019,Q1,Hair colour changes,,2019,Q1,2,F,,20190219.0,20181221,20190227,PER,,US-PFIZER INC-2018524934,PFIZER,,61.0,YR,,F,Y,54.0,KG,20190227.0,,LW,US,US,2019,Q1,Adult
157496582,15749658,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK (VIAL),,,,,,,,,,,,2019,Q1,Hair disorder,,2019,Q1,2,F,,20190219.0,20181221,20190227,PER,,US-PFIZER INC-2018524934,PFIZER,,61.0,YR,,F,Y,54.0,KG,20190227.0,,LW,US,US,2019,Q1,Adult
157496582,15749658,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK (VIAL),,,,,,,,,,,,2019,Q1,Hair texture abnormal,,2019,Q1,2,F,,20190219.0,20181221,20190227,PER,,US-PFIZER INC-2018524934,PFIZER,,61.0,YR,,F,Y,54.0,KG,20190227.0,,LW,US,US,2019,Q1,Adult
157496582,15749658,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK (VIAL),,,,,,,,,,,,2019,Q1,Madarosis,,2019,Q1,2,F,,20190219.0,20181221,20190227,PER,,US-PFIZER INC-2018524934,PFIZER,,61.0,YR,,F,Y,54.0,KG,20190227.0,,LW,US,US,2019,Q1,Adult
157502292,15750229,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 UNIT, TID (0-10 UNIT, AC AND QHS)",,,,,,,,,,,TID,2019,Q1,Blood calcium decreased,,2019,Q1,2,F,2018.0,20190102.0,20181221,20190110,EXP,,US-AMGEN-USASP2018180435,AMGEN,,40.0,YR,A,F,Y,83.9,KG,20190110.0,,PH,US,US,2019,Q1,Adult
157502292,15750229,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 UNIT, TID (0-10 UNIT, AC AND QHS)",,,,,,,,,,,TID,2019,Q1,Blood creatinine decreased,,2019,Q1,2,F,2018.0,20190102.0,20181221,20190110,EXP,,US-AMGEN-USASP2018180435,AMGEN,,40.0,YR,A,F,Y,83.9,KG,20190110.0,,PH,US,US,2019,Q1,Adult
157502292,15750229,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 UNIT, TID (0-10 UNIT, AC AND QHS)",,,,,,,,,,,TID,2019,Q1,Blood glucose increased,,2019,Q1,2,F,2018.0,20190102.0,20181221,20190110,EXP,,US-AMGEN-USASP2018180435,AMGEN,,40.0,YR,A,F,Y,83.9,KG,20190110.0,,PH,US,US,2019,Q1,Adult
157502292,15750229,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 UNIT, TID (0-10 UNIT, AC AND QHS)",,,,,,,,,,,TID,2019,Q1,Catheter site infection,,2019,Q1,2,F,2018.0,20190102.0,20181221,20190110,EXP,,US-AMGEN-USASP2018180435,AMGEN,,40.0,YR,A,F,Y,83.9,KG,20190110.0,,PH,US,US,2019,Q1,Adult
157502292,15750229,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 UNIT, TID (0-10 UNIT, AC AND QHS)",,,,,,,,,,,TID,2019,Q1,Creatinine renal clearance decreased,,2019,Q1,2,F,2018.0,20190102.0,20181221,20190110,EXP,,US-AMGEN-USASP2018180435,AMGEN,,40.0,YR,A,F,Y,83.9,KG,20190110.0,,PH,US,US,2019,Q1,Adult
157502292,15750229,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 UNIT, TID (0-10 UNIT, AC AND QHS)",,,,,,,,,,,TID,2019,Q1,Hepatotoxicity,,2019,Q1,2,F,2018.0,20190102.0,20181221,20190110,EXP,,US-AMGEN-USASP2018180435,AMGEN,,40.0,YR,A,F,Y,83.9,KG,20190110.0,,PH,US,US,2019,Q1,Adult
157502292,15750229,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 UNIT, TID (0-10 UNIT, AC AND QHS)",,,,,,,,,,,TID,2019,Q1,Intervertebral disc protrusion,,2019,Q1,2,F,2018.0,20190102.0,20181221,20190110,EXP,,US-AMGEN-USASP2018180435,AMGEN,,40.0,YR,A,F,Y,83.9,KG,20190110.0,,PH,US,US,2019,Q1,Adult
157502292,15750229,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 UNIT, TID (0-10 UNIT, AC AND QHS)",,,,,,,,,,,TID,2019,Q1,Pancytopenia,,2019,Q1,2,F,2018.0,20190102.0,20181221,20190110,EXP,,US-AMGEN-USASP2018180435,AMGEN,,40.0,YR,A,F,Y,83.9,KG,20190110.0,,PH,US,US,2019,Q1,Adult
157654522,15765452,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 U, TID",,,D,,,,,,,SOLUTION FOR INJECTION,Q8H,2019,Q1,Inappropriate schedule of product administration,,2019,Q1,2,F,,20190108.0,20181227,20190116,PER,,US-SA-2018SA387761,SANOFI AVENTIS,,54.0,YR,A,M,Y,,,20190116.0,,CN,US,US,2019,Q1,Adult
157654522,15765452,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 U, TID",,,D,,,,,,,SOLUTION FOR INJECTION,Q8H,2019,Q1,Injection site pain,,2019,Q1,2,F,,20190108.0,20181227,20190116,PER,,US-SA-2018SA387761,SANOFI AVENTIS,,54.0,YR,A,M,Y,,,20190116.0,,CN,US,US,2019,Q1,Adult
157654522,15765452,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 U, TID",,,D,,,,,,,SOLUTION FOR INJECTION,Q8H,2019,Q1,Needle issue,,2019,Q1,2,F,,20190108.0,20181227,20190116,PER,,US-SA-2018SA387761,SANOFI AVENTIS,,54.0,YR,A,M,Y,,,20190116.0,,CN,US,US,2019,Q1,Adult
157814781,15781478,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"5 TO 6 UNITS, BID",,,U,,,,,,,SOLUTION FOR INJECTION,Q12H,2019,Q1,Glycosylated haemoglobin decreased,,2019,Q1,1,I,,20181227.0,20190102,20190102,PER,,US-SA-2018SA397557,SANOFI AVENTIS,,74.0,YR,E,F,Y,,,20190102.0,,CN,US,US,2019,Q1,Elderly
157814781,15781478,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"5 TO 6 UNITS, BID",,,U,,,,,,,SOLUTION FOR INJECTION,Q12H,2019,Q1,Wrong product administered,,2019,Q1,1,I,,20181227.0,20190102,20190102,PER,,US-SA-2018SA397557,SANOFI AVENTIS,,74.0,YR,E,F,Y,,,20190102.0,,CN,US,US,2019,Q1,Elderly
157815419,15781541,20,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,INJECTION,TID,2019,Q1,Acute kidney injury,,2019,Q1,9,F,20181214.0,20190313.0,20190102,20190319,EXP,,US-CELGENEUS-USA-20181207775,CELGENE,,76.0,YR,,M,Y,100.0,KG,20190319.0,,OT,US,US,2019,Q1,Elderly
157815419,15781541,20,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,INJECTION,TID,2019,Q1,Encephalopathy,,2019,Q1,9,F,20181214.0,20190313.0,20190102,20190319,EXP,,US-CELGENEUS-USA-20181207775,CELGENE,,76.0,YR,,M,Y,100.0,KG,20190319.0,,OT,US,US,2019,Q1,Elderly
157815419,15781541,20,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,INJECTION,TID,2019,Q1,Nausea,,2019,Q1,9,F,20181214.0,20190313.0,20190102,20190319,EXP,,US-CELGENEUS-USA-20181207775,CELGENE,,76.0,YR,,M,Y,100.0,KG,20190319.0,,OT,US,US,2019,Q1,Elderly
157815419,15781541,20,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,INJECTION,TID,2019,Q1,Respiratory failure,,2019,Q1,9,F,20181214.0,20190313.0,20190102,20190319,EXP,,US-CELGENEUS-USA-20181207775,CELGENE,,76.0,YR,,M,Y,100.0,KG,20190319.0,,OT,US,US,2019,Q1,Elderly
157815419,15781541,20,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,INJECTION,TID,2019,Q1,Sepsis,,2019,Q1,9,F,20181214.0,20190313.0,20190102,20190319,EXP,,US-CELGENEUS-USA-20181207775,CELGENE,,76.0,YR,,M,Y,100.0,KG,20190319.0,,OT,US,US,2019,Q1,Elderly
157827584,15782758,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,25/75,,,U,,,,,40.0,IU,SOLUTION FOR INJECTION,QD,2019,Q1,Chest pain,,2019,Q1,4,F,,20190204.0,20190102,20190301,EXP,,PT-BAUSCH-BL-2018-036015,BAUSCH AND LOMB,,54.0,YR,,F,Y,,,20190301.0,,OT,PT,PT,2019,Q1,Adult
157827584,15782758,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,25/75,,,U,,,,,40.0,IU,SOLUTION FOR INJECTION,QD,2019,Q1,Headache,,2019,Q1,4,F,,20190204.0,20190102,20190301,EXP,,PT-BAUSCH-BL-2018-036015,BAUSCH AND LOMB,,54.0,YR,,F,Y,,,20190301.0,,OT,PT,PT,2019,Q1,Adult
157827584,15782758,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,25/75,,,U,,,,,40.0,IU,SOLUTION FOR INJECTION,QD,2019,Q1,Ischaemic stroke,,2019,Q1,4,F,,20190204.0,20190102,20190301,EXP,,PT-BAUSCH-BL-2018-036015,BAUSCH AND LOMB,,54.0,YR,,F,Y,,,20190301.0,,OT,PT,PT,2019,Q1,Adult
157836186,15783618,25,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,1-2IU,,,,,,,,,,UNKNOWN,QD,2019,Q1,Abdominal pain,,2019,Q1,6,F,20181207.0,20190321.0,20190102,20190326,EXP,,US-CELGENEUS-USA-20181205189,CELGENE,,70.0,YR,,F,Y,75.8,KG,20190326.0,,OT,US,US,2019,Q1,Elderly
157836186,15783618,25,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,1-2IU,,,,,,,,,,UNKNOWN,QD,2019,Q1,Pulmonary alveolar haemorrhage,,2019,Q1,6,F,20181207.0,20190321.0,20190102,20190326,EXP,,US-CELGENEUS-USA-20181205189,CELGENE,,70.0,YR,,F,Y,75.8,KG,20190326.0,,OT,US,US,2019,Q1,Elderly
157836186,15783618,25,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,1-2IU,,,,,,,,,,UNKNOWN,QD,2019,Q1,Respiratory failure,,2019,Q1,6,F,20181207.0,20190321.0,20190102,20190326,EXP,,US-CELGENEUS-USA-20181205189,CELGENE,,70.0,YR,,F,Y,75.8,KG,20190326.0,,OT,US,US,2019,Q1,Elderly
157836186,15783618,26,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,1-3IU,,,,,,,,,,UNKNOWN,TID,2019,Q1,Abdominal pain,,2019,Q1,6,F,20181207.0,20190321.0,20190102,20190326,EXP,,US-CELGENEUS-USA-20181205189,CELGENE,,70.0,YR,,F,Y,75.8,KG,20190326.0,,OT,US,US,2019,Q1,Elderly
157836186,15783618,26,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,1-3IU,,,,,,,,,,UNKNOWN,TID,2019,Q1,Pulmonary alveolar haemorrhage,,2019,Q1,6,F,20181207.0,20190321.0,20190102,20190326,EXP,,US-CELGENEUS-USA-20181205189,CELGENE,,70.0,YR,,F,Y,75.8,KG,20190326.0,,OT,US,US,2019,Q1,Elderly
157836186,15783618,26,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,1-3IU,,,,,,,,,,UNKNOWN,TID,2019,Q1,Respiratory failure,,2019,Q1,6,F,20181207.0,20190321.0,20190102,20190326,EXP,,US-CELGENEUS-USA-20181205189,CELGENE,,70.0,YR,,F,Y,75.8,KG,20190326.0,,OT,US,US,2019,Q1,Elderly
157856451,15785645,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"31 U, QD",,,U,U, UNKNOWN,,,31.0,DF,,QD,2019,Q1,Exposure during pregnancy,,2019,Q1,1,I,,20181224.0,20190103,20190103,EXP,,JP-NOVOPROD-640280,NOVO NORDISK,"AKIHIKO ANDO ET AL.. A CASE WITH RELAPSED TRANSIENT NEONATAL DIABETES MELLITUS TREATED WITH SULFONYLUREA, ENDING CHRONIC INSULIN REQUIREMENT. EDOCRINOLOGY, DIABETES AND METABOLISM CASE REPORTS. 2018",31.0,YR,A,F,Y,54.0,KG,20190103.0,,OT,JP,JP,2019,Q1,Young Adult
157856451,15785645,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"31 U, QD",,,U,U, UNKNOWN,,,31.0,DF,,QD,2019,Q1,Hospitalisation,,2019,Q1,1,I,,20181224.0,20190103,20190103,EXP,,JP-NOVOPROD-640280,NOVO NORDISK,"AKIHIKO ANDO ET AL.. A CASE WITH RELAPSED TRANSIENT NEONATAL DIABETES MELLITUS TREATED WITH SULFONYLUREA, ENDING CHRONIC INSULIN REQUIREMENT. EDOCRINOLOGY, DIABETES AND METABOLISM CASE REPORTS. 2018",31.0,YR,A,F,Y,54.0,KG,20190103.0,,OT,JP,JP,2019,Q1,Young Adult
157895441,15789544,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Glycosylated haemoglobin decreased,,2019,Q1,1,I,,20181231.0,20190104,20190104,EXP,,US-SA-2019SA000862,SANOFI AVENTIS,,68.0,YR,E,M,Y,,,20190104.0,,CN,US,US,2019,Q1,Elderly
157895441,15789544,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Hospitalisation,,2019,Q1,1,I,,20181231.0,20190104,20190104,EXP,,US-SA-2019SA000862,SANOFI AVENTIS,,68.0,YR,E,M,Y,,,20190104.0,,CN,US,US,2019,Q1,Elderly
157895441,15789544,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Intentional product misuse,,2019,Q1,1,I,,20181231.0,20190104,20190104,EXP,,US-SA-2019SA000862,SANOFI AVENTIS,,68.0,YR,E,M,Y,,,20190104.0,,CN,US,US,2019,Q1,Elderly
157895441,15789544,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Weight decreased,,2019,Q1,1,I,,20181231.0,20190104,20190104,EXP,,US-SA-2019SA000862,SANOFI AVENTIS,,68.0,YR,E,M,Y,,,20190104.0,,CN,US,US,2019,Q1,Elderly
157911371,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q1,Abdominal pain,,2019,Q1,1,I,,20190101.0,20190104,20190104,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190104.0,,OT,CA,CA,2019,Q1,Adult
157911371,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q1,Abscess,,2019,Q1,1,I,,20190101.0,20190104,20190104,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190104.0,,OT,CA,CA,2019,Q1,Adult
157911371,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q1,Adrenal insufficiency,,2019,Q1,1,I,,20190101.0,20190104,20190104,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190104.0,,OT,CA,CA,2019,Q1,Adult
157911371,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q1,Alanine aminotransferase increased,,2019,Q1,1,I,,20190101.0,20190104,20190104,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190104.0,,OT,CA,CA,2019,Q1,Adult
157911371,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q1,Ascites,,2019,Q1,1,I,,20190101.0,20190104,20190104,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190104.0,,OT,CA,CA,2019,Q1,Adult
157911371,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q1,Asthenia,,2019,Q1,1,I,,20190101.0,20190104,20190104,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190104.0,,OT,CA,CA,2019,Q1,Adult
157911371,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q1,Blood alkaline phosphatase increased,,2019,Q1,1,I,,20190101.0,20190104,20190104,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190104.0,,OT,CA,CA,2019,Q1,Adult
157911371,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q1,Blood bilirubin increased,,2019,Q1,1,I,,20190101.0,20190104,20190104,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190104.0,,OT,CA,CA,2019,Q1,Adult
157911371,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q1,Blood potassium decreased,,2019,Q1,1,I,,20190101.0,20190104,20190104,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190104.0,,OT,CA,CA,2019,Q1,Adult
157911371,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q1,Blood pressure diastolic abnormal,,2019,Q1,1,I,,20190101.0,20190104,20190104,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190104.0,,OT,CA,CA,2019,Q1,Adult
157911371,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q1,Blood pressure increased,,2019,Q1,1,I,,20190101.0,20190104,20190104,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190104.0,,OT,CA,CA,2019,Q1,Adult
157911371,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q1,Depression,,2019,Q1,1,I,,20190101.0,20190104,20190104,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190104.0,,OT,CA,CA,2019,Q1,Adult
157911371,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q1,Diverticulitis,,2019,Q1,1,I,,20190101.0,20190104,20190104,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190104.0,,OT,CA,CA,2019,Q1,Adult
157911371,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q1,Endometrial disorder,,2019,Q1,1,I,,20190101.0,20190104,20190104,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190104.0,,OT,CA,CA,2019,Q1,Adult
157911371,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q1,Enterococcus test positive,,2019,Q1,1,I,,20190101.0,20190104,20190104,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190104.0,,OT,CA,CA,2019,Q1,Adult
157911371,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q1,Fibrosis,,2019,Q1,1,I,,20190101.0,20190104,20190104,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190104.0,,OT,CA,CA,2019,Q1,Adult
157911371,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q1,Gamma-glutamyltransferase increased,,2019,Q1,1,I,,20190101.0,20190104,20190104,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190104.0,,OT,CA,CA,2019,Q1,Adult
157911371,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q1,Gastrointestinal disorder,,2019,Q1,1,I,,20190101.0,20190104,20190104,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190104.0,,OT,CA,CA,2019,Q1,Adult
157911371,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q1,Generalised oedema,,2019,Q1,1,I,,20190101.0,20190104,20190104,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190104.0,,OT,CA,CA,2019,Q1,Adult
157911371,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q1,Heart rate increased,,2019,Q1,1,I,,20190101.0,20190104,20190104,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190104.0,,OT,CA,CA,2019,Q1,Adult
157911371,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q1,Hepatic congestion,,2019,Q1,1,I,,20190101.0,20190104,20190104,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190104.0,,OT,CA,CA,2019,Q1,Adult
157911371,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q1,Herpes zoster,,2019,Q1,1,I,,20190101.0,20190104,20190104,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190104.0,,OT,CA,CA,2019,Q1,Adult
157911371,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q1,Hypersensitivity,,2019,Q1,1,I,,20190101.0,20190104,20190104,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190104.0,,OT,CA,CA,2019,Q1,Adult
157911371,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q1,Hypoglycaemia,,2019,Q1,1,I,,20190101.0,20190104,20190104,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190104.0,,OT,CA,CA,2019,Q1,Adult
157911371,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q1,Hypotension,,2019,Q1,1,I,,20190101.0,20190104,20190104,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190104.0,,OT,CA,CA,2019,Q1,Adult
157911371,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q1,Increased appetite,,2019,Q1,1,I,,20190101.0,20190104,20190104,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190104.0,,OT,CA,CA,2019,Q1,Adult
157911371,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q1,Influenza,,2019,Q1,1,I,,20190101.0,20190104,20190104,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190104.0,,OT,CA,CA,2019,Q1,Adult
157911371,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q1,Infusion related reaction,,2019,Q1,1,I,,20190101.0,20190104,20190104,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190104.0,,OT,CA,CA,2019,Q1,Adult
157911371,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q1,Injection site extravasation,,2019,Q1,1,I,,20190101.0,20190104,20190104,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190104.0,,OT,CA,CA,2019,Q1,Adult
157911371,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q1,Intensive care unit acquired weakness,,2019,Q1,1,I,,20190101.0,20190104,20190104,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190104.0,,OT,CA,CA,2019,Q1,Adult
157911371,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q1,Intervertebral disc protrusion,,2019,Q1,1,I,,20190101.0,20190104,20190104,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190104.0,,OT,CA,CA,2019,Q1,Adult
157911371,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q1,Joint effusion,,2019,Q1,1,I,,20190101.0,20190104,20190104,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190104.0,,OT,CA,CA,2019,Q1,Adult
157911371,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q1,Joint swelling,,2019,Q1,1,I,,20190101.0,20190104,20190104,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190104.0,,OT,CA,CA,2019,Q1,Adult
157911371,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q1,Micturition disorder,,2019,Q1,1,I,,20190101.0,20190104,20190104,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190104.0,,OT,CA,CA,2019,Q1,Adult
157911371,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q1,Myelopathy,,2019,Q1,1,I,,20190101.0,20190104,20190104,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190104.0,,OT,CA,CA,2019,Q1,Adult
157911371,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q1,Myopathy,,2019,Q1,1,I,,20190101.0,20190104,20190104,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190104.0,,OT,CA,CA,2019,Q1,Adult
157911371,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q1,Nasopharyngitis,,2019,Q1,1,I,,20190101.0,20190104,20190104,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190104.0,,OT,CA,CA,2019,Q1,Adult
157911371,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q1,Nausea,,2019,Q1,1,I,,20190101.0,20190104,20190104,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190104.0,,OT,CA,CA,2019,Q1,Adult
157911371,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q1,Nerve compression,,2019,Q1,1,I,,20190101.0,20190104,20190104,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190104.0,,OT,CA,CA,2019,Q1,Adult
157911371,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q1,Neuropathy peripheral,,2019,Q1,1,I,,20190101.0,20190104,20190104,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190104.0,,OT,CA,CA,2019,Q1,Adult
157911371,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q1,Neutropenia,,2019,Q1,1,I,,20190101.0,20190104,20190104,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190104.0,,OT,CA,CA,2019,Q1,Adult
157911371,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q1,Osteoarthritis,,2019,Q1,1,I,,20190101.0,20190104,20190104,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190104.0,,OT,CA,CA,2019,Q1,Adult
157911371,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q1,Pancytopenia,,2019,Q1,1,I,,20190101.0,20190104,20190104,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190104.0,,OT,CA,CA,2019,Q1,Adult
157911371,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q1,Peripheral sensorimotor neuropathy,,2019,Q1,1,I,,20190101.0,20190104,20190104,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190104.0,,OT,CA,CA,2019,Q1,Adult
157911371,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q1,Peritonitis,,2019,Q1,1,I,,20190101.0,20190104,20190104,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190104.0,,OT,CA,CA,2019,Q1,Adult
157911371,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q1,Pneumonia,,2019,Q1,1,I,,20190101.0,20190104,20190104,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190104.0,,OT,CA,CA,2019,Q1,Adult
157911371,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q1,Pseudomonal bacteraemia,,2019,Q1,1,I,,20190101.0,20190104,20190104,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190104.0,,OT,CA,CA,2019,Q1,Adult
157911371,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q1,Rheumatoid arthritis,,2019,Q1,1,I,,20190101.0,20190104,20190104,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190104.0,,OT,CA,CA,2019,Q1,Adult
157911371,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q1,Septic shock,,2019,Q1,1,I,,20190101.0,20190104,20190104,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190104.0,,OT,CA,CA,2019,Q1,Adult
157911371,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q1,Therapeutic response decreased,,2019,Q1,1,I,,20190101.0,20190104,20190104,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190104.0,,OT,CA,CA,2019,Q1,Adult
157911371,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q1,Vomiting,,2019,Q1,1,I,,20190101.0,20190104,20190104,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190104.0,,OT,CA,CA,2019,Q1,Adult
157911371,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q1,Weight decreased,,2019,Q1,1,I,,20190101.0,20190104,20190104,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190104.0,,OT,CA,CA,2019,Q1,Adult
157911371,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q1,Weight increased,,2019,Q1,1,I,,20190101.0,20190104,20190104,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190104.0,,OT,CA,CA,2019,Q1,Adult
157943121,15794312,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2-7 UNITS, QD",,,U,,,,,,,,QD,2019,Q1,Diabetic foot,,2019,Q1,1,I,,20190102.0,20190107,20190107,EXP,,GR-SA-2019SA001986,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20190107.0,,CN,GR,GR,2019,Q1,Adult
157943121,15794312,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2-7 UNITS, QD",,,U,,,,,,,,QD,2019,Q1,Diabetic nephropathy,,2019,Q1,1,I,,20190102.0,20190107,20190107,EXP,,GR-SA-2019SA001986,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20190107.0,,CN,GR,GR,2019,Q1,Adult
157943121,15794312,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2-7 UNITS, QD",,,U,,,,,,,,QD,2019,Q1,Epilepsy,,2019,Q1,1,I,,20190102.0,20190107,20190107,EXP,,GR-SA-2019SA001986,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20190107.0,,CN,GR,GR,2019,Q1,Adult
157943121,15794312,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2-7 UNITS, QD",,,U,,,,,,,,QD,2019,Q1,Hypoglycaemia,,2019,Q1,1,I,,20190102.0,20190107,20190107,EXP,,GR-SA-2019SA001986,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20190107.0,,CN,GR,GR,2019,Q1,Adult
157943121,15794312,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2-7 UNITS, QD",,,U,,,,,,,,QD,2019,Q1,Pain in extremity,,2019,Q1,1,I,,20190102.0,20190107,20190107,EXP,,GR-SA-2019SA001986,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20190107.0,,CN,GR,GR,2019,Q1,Adult
157943121,15794312,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"7 U, UNK",,,U,,,,,,,,,2019,Q1,Diabetic foot,,2019,Q1,1,I,,20190102.0,20190107,20190107,EXP,,GR-SA-2019SA001986,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20190107.0,,CN,GR,GR,2019,Q1,Adult
157943121,15794312,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"7 U, UNK",,,U,,,,,,,,,2019,Q1,Diabetic nephropathy,,2019,Q1,1,I,,20190102.0,20190107,20190107,EXP,,GR-SA-2019SA001986,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20190107.0,,CN,GR,GR,2019,Q1,Adult
157943121,15794312,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"7 U, UNK",,,U,,,,,,,,,2019,Q1,Epilepsy,,2019,Q1,1,I,,20190102.0,20190107,20190107,EXP,,GR-SA-2019SA001986,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20190107.0,,CN,GR,GR,2019,Q1,Adult
157943121,15794312,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"7 U, UNK",,,U,,,,,,,,,2019,Q1,Hypoglycaemia,,2019,Q1,1,I,,20190102.0,20190107,20190107,EXP,,GR-SA-2019SA001986,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20190107.0,,CN,GR,GR,2019,Q1,Adult
157943121,15794312,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"7 U, UNK",,,U,,,,,,,,,2019,Q1,Pain in extremity,,2019,Q1,1,I,,20190102.0,20190107,20190107,EXP,,GR-SA-2019SA001986,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20190107.0,,CN,GR,GR,2019,Q1,Adult
158030973,15803097,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,,,,,,,INJECTION,,2019,Q1,Angina pectoris,,2019,Q1,3,F,20170919.0,20190114.0,20190109,20190123,EXP,,US-ELI_LILLY_AND_COMPANY-US201901002168,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20190123.0,,CN,US,US,2019,Q1,Elderly
158030973,15803097,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,,,,,,,INJECTION,,2019,Q1,Arthritis,,2019,Q1,3,F,20170919.0,20190114.0,20190109,20190123,EXP,,US-ELI_LILLY_AND_COMPANY-US201901002168,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20190123.0,,CN,US,US,2019,Q1,Elderly
158030973,15803097,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,,,,,,,INJECTION,,2019,Q1,Blood glucose increased,,2019,Q1,3,F,20170919.0,20190114.0,20190109,20190123,EXP,,US-ELI_LILLY_AND_COMPANY-US201901002168,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20190123.0,,CN,US,US,2019,Q1,Elderly
158030973,15803097,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,,,,,,,INJECTION,,2019,Q1,Breast cancer stage I,,2019,Q1,3,F,20170919.0,20190114.0,20190109,20190123,EXP,,US-ELI_LILLY_AND_COMPANY-US201901002168,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20190123.0,,CN,US,US,2019,Q1,Elderly
158030973,15803097,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,,,,,,,INJECTION,,2019,Q1,Chronic kidney disease,,2019,Q1,3,F,20170919.0,20190114.0,20190109,20190123,EXP,,US-ELI_LILLY_AND_COMPANY-US201901002168,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20190123.0,,CN,US,US,2019,Q1,Elderly
158030973,15803097,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,,,,,,,INJECTION,,2019,Q1,Eczema,,2019,Q1,3,F,20170919.0,20190114.0,20190109,20190123,EXP,,US-ELI_LILLY_AND_COMPANY-US201901002168,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20190123.0,,CN,US,US,2019,Q1,Elderly
158030973,15803097,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,,,,,,,INJECTION,,2019,Q1,Glycosylated haemoglobin increased,,2019,Q1,3,F,20170919.0,20190114.0,20190109,20190123,EXP,,US-ELI_LILLY_AND_COMPANY-US201901002168,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20190123.0,,CN,US,US,2019,Q1,Elderly
158030973,15803097,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,,,,,,,INJECTION,,2019,Q1,Pruritus generalised,,2019,Q1,3,F,20170919.0,20190114.0,20190109,20190123,EXP,,US-ELI_LILLY_AND_COMPANY-US201901002168,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20190123.0,,CN,US,US,2019,Q1,Elderly
158030973,15803097,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,,,,,,,INJECTION,,2019,Q1,Sleep disorder due to a general medical condition,,2019,Q1,3,F,20170919.0,20190114.0,20190109,20190123,EXP,,US-ELI_LILLY_AND_COMPANY-US201901002168,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20190123.0,,CN,US,US,2019,Q1,Elderly
158030973,15803097,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,, C856285C,,,,,INJECTION,,2019,Q1,Angina pectoris,,2019,Q1,3,F,20170919.0,20190114.0,20190109,20190123,EXP,,US-ELI_LILLY_AND_COMPANY-US201901002168,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20190123.0,,CN,US,US,2019,Q1,Elderly
158030973,15803097,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,, C856285C,,,,,INJECTION,,2019,Q1,Arthritis,,2019,Q1,3,F,20170919.0,20190114.0,20190109,20190123,EXP,,US-ELI_LILLY_AND_COMPANY-US201901002168,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20190123.0,,CN,US,US,2019,Q1,Elderly
158030973,15803097,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,, C856285C,,,,,INJECTION,,2019,Q1,Blood glucose increased,,2019,Q1,3,F,20170919.0,20190114.0,20190109,20190123,EXP,,US-ELI_LILLY_AND_COMPANY-US201901002168,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20190123.0,,CN,US,US,2019,Q1,Elderly
158030973,15803097,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,, C856285C,,,,,INJECTION,,2019,Q1,Breast cancer stage I,,2019,Q1,3,F,20170919.0,20190114.0,20190109,20190123,EXP,,US-ELI_LILLY_AND_COMPANY-US201901002168,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20190123.0,,CN,US,US,2019,Q1,Elderly
158030973,15803097,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,, C856285C,,,,,INJECTION,,2019,Q1,Chronic kidney disease,,2019,Q1,3,F,20170919.0,20190114.0,20190109,20190123,EXP,,US-ELI_LILLY_AND_COMPANY-US201901002168,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20190123.0,,CN,US,US,2019,Q1,Elderly
158030973,15803097,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,, C856285C,,,,,INJECTION,,2019,Q1,Eczema,,2019,Q1,3,F,20170919.0,20190114.0,20190109,20190123,EXP,,US-ELI_LILLY_AND_COMPANY-US201901002168,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20190123.0,,CN,US,US,2019,Q1,Elderly
158030973,15803097,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,, C856285C,,,,,INJECTION,,2019,Q1,Glycosylated haemoglobin increased,,2019,Q1,3,F,20170919.0,20190114.0,20190109,20190123,EXP,,US-ELI_LILLY_AND_COMPANY-US201901002168,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20190123.0,,CN,US,US,2019,Q1,Elderly
158030973,15803097,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,, C856285C,,,,,INJECTION,,2019,Q1,Pruritus generalised,,2019,Q1,3,F,20170919.0,20190114.0,20190109,20190123,EXP,,US-ELI_LILLY_AND_COMPANY-US201901002168,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20190123.0,,CN,US,US,2019,Q1,Elderly
158030973,15803097,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,, C856285C,,,,,INJECTION,,2019,Q1,Sleep disorder due to a general medical condition,,2019,Q1,3,F,20170919.0,20190114.0,20190109,20190123,EXP,,US-ELI_LILLY_AND_COMPANY-US201901002168,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20190123.0,,CN,US,US,2019,Q1,Elderly
158030973,15803097,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"60 U, BID",,,,,,,,60.0,IU,INJECTION,BID,2019,Q1,Angina pectoris,,2019,Q1,3,F,20170919.0,20190114.0,20190109,20190123,EXP,,US-ELI_LILLY_AND_COMPANY-US201901002168,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20190123.0,,CN,US,US,2019,Q1,Elderly
158030973,15803097,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"60 U, BID",,,,,,,,60.0,IU,INJECTION,BID,2019,Q1,Arthritis,,2019,Q1,3,F,20170919.0,20190114.0,20190109,20190123,EXP,,US-ELI_LILLY_AND_COMPANY-US201901002168,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20190123.0,,CN,US,US,2019,Q1,Elderly
158030973,15803097,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"60 U, BID",,,,,,,,60.0,IU,INJECTION,BID,2019,Q1,Blood glucose increased,,2019,Q1,3,F,20170919.0,20190114.0,20190109,20190123,EXP,,US-ELI_LILLY_AND_COMPANY-US201901002168,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20190123.0,,CN,US,US,2019,Q1,Elderly
158030973,15803097,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"60 U, BID",,,,,,,,60.0,IU,INJECTION,BID,2019,Q1,Breast cancer stage I,,2019,Q1,3,F,20170919.0,20190114.0,20190109,20190123,EXP,,US-ELI_LILLY_AND_COMPANY-US201901002168,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20190123.0,,CN,US,US,2019,Q1,Elderly
158030973,15803097,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"60 U, BID",,,,,,,,60.0,IU,INJECTION,BID,2019,Q1,Chronic kidney disease,,2019,Q1,3,F,20170919.0,20190114.0,20190109,20190123,EXP,,US-ELI_LILLY_AND_COMPANY-US201901002168,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20190123.0,,CN,US,US,2019,Q1,Elderly
158030973,15803097,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"60 U, BID",,,,,,,,60.0,IU,INJECTION,BID,2019,Q1,Eczema,,2019,Q1,3,F,20170919.0,20190114.0,20190109,20190123,EXP,,US-ELI_LILLY_AND_COMPANY-US201901002168,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20190123.0,,CN,US,US,2019,Q1,Elderly
158030973,15803097,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"60 U, BID",,,,,,,,60.0,IU,INJECTION,BID,2019,Q1,Glycosylated haemoglobin increased,,2019,Q1,3,F,20170919.0,20190114.0,20190109,20190123,EXP,,US-ELI_LILLY_AND_COMPANY-US201901002168,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20190123.0,,CN,US,US,2019,Q1,Elderly
158030973,15803097,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"60 U, BID",,,,,,,,60.0,IU,INJECTION,BID,2019,Q1,Pruritus generalised,,2019,Q1,3,F,20170919.0,20190114.0,20190109,20190123,EXP,,US-ELI_LILLY_AND_COMPANY-US201901002168,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20190123.0,,CN,US,US,2019,Q1,Elderly
158030973,15803097,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"60 U, BID",,,,,,,,60.0,IU,INJECTION,BID,2019,Q1,Sleep disorder due to a general medical condition,,2019,Q1,3,F,20170919.0,20190114.0,20190109,20190123,EXP,,US-ELI_LILLY_AND_COMPANY-US201901002168,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20190123.0,,CN,US,US,2019,Q1,Elderly
158030973,15803097,4,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,U,U,,,,,,INJECTION,,2019,Q1,Angina pectoris,,2019,Q1,3,F,20170919.0,20190114.0,20190109,20190123,EXP,,US-ELI_LILLY_AND_COMPANY-US201901002168,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20190123.0,,CN,US,US,2019,Q1,Elderly
158030973,15803097,4,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,U,U,,,,,,INJECTION,,2019,Q1,Arthritis,,2019,Q1,3,F,20170919.0,20190114.0,20190109,20190123,EXP,,US-ELI_LILLY_AND_COMPANY-US201901002168,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20190123.0,,CN,US,US,2019,Q1,Elderly
158030973,15803097,4,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,U,U,,,,,,INJECTION,,2019,Q1,Blood glucose increased,,2019,Q1,3,F,20170919.0,20190114.0,20190109,20190123,EXP,,US-ELI_LILLY_AND_COMPANY-US201901002168,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20190123.0,,CN,US,US,2019,Q1,Elderly
158030973,15803097,4,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,U,U,,,,,,INJECTION,,2019,Q1,Breast cancer stage I,,2019,Q1,3,F,20170919.0,20190114.0,20190109,20190123,EXP,,US-ELI_LILLY_AND_COMPANY-US201901002168,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20190123.0,,CN,US,US,2019,Q1,Elderly
158030973,15803097,4,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,U,U,,,,,,INJECTION,,2019,Q1,Chronic kidney disease,,2019,Q1,3,F,20170919.0,20190114.0,20190109,20190123,EXP,,US-ELI_LILLY_AND_COMPANY-US201901002168,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20190123.0,,CN,US,US,2019,Q1,Elderly
158030973,15803097,4,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,U,U,,,,,,INJECTION,,2019,Q1,Eczema,,2019,Q1,3,F,20170919.0,20190114.0,20190109,20190123,EXP,,US-ELI_LILLY_AND_COMPANY-US201901002168,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20190123.0,,CN,US,US,2019,Q1,Elderly
158030973,15803097,4,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,U,U,,,,,,INJECTION,,2019,Q1,Glycosylated haemoglobin increased,,2019,Q1,3,F,20170919.0,20190114.0,20190109,20190123,EXP,,US-ELI_LILLY_AND_COMPANY-US201901002168,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20190123.0,,CN,US,US,2019,Q1,Elderly
158030973,15803097,4,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,U,U,,,,,,INJECTION,,2019,Q1,Pruritus generalised,,2019,Q1,3,F,20170919.0,20190114.0,20190109,20190123,EXP,,US-ELI_LILLY_AND_COMPANY-US201901002168,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20190123.0,,CN,US,US,2019,Q1,Elderly
158030973,15803097,4,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,U,U,,,,,,INJECTION,,2019,Q1,Sleep disorder due to a general medical condition,,2019,Q1,3,F,20170919.0,20190114.0,20190109,20190123,EXP,,US-ELI_LILLY_AND_COMPANY-US201901002168,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20190123.0,,CN,US,US,2019,Q1,Elderly
158113492,15811349,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 IU, QD",,,U,U,,,,40.0,IU,SOLUTION FOR INJECTION,QD,2019,Q1,Chest pain,,2019,Q1,2,F,,20190208.0,20190111,20190221,EXP,,PT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-124096,BRISTOL MYERS SQUIBB,,54.0,YR,,F,Y,,,20190221.0,,MD,PT,PT,2019,Q1,Adult
158113492,15811349,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 IU, QD",,,U,U,,,,40.0,IU,SOLUTION FOR INJECTION,QD,2019,Q1,Headache,,2019,Q1,2,F,,20190208.0,20190111,20190221,EXP,,PT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-124096,BRISTOL MYERS SQUIBB,,54.0,YR,,F,Y,,,20190221.0,,MD,PT,PT,2019,Q1,Adult
158113492,15811349,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 IU, QD",,,U,U,,,,40.0,IU,SOLUTION FOR INJECTION,QD,2019,Q1,Ischaemic stroke,,2019,Q1,2,F,,20190208.0,20190111,20190221,EXP,,PT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-124096,BRISTOL MYERS SQUIBB,,54.0,YR,,F,Y,,,20190221.0,,MD,PT,PT,2019,Q1,Adult
158131331,15813133,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,,,2019,Q1,Inappropriate schedule of product administration,,2019,Q1,1,I,,20190107.0,20190111,20190111,PER,,US-SA-2019SA007051,SANOFI AVENTIS,,81.0,YR,E,M,Y,,,20190111.0,,PH,US,US,2019,Q1,Elderly
158134621,15813462,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,,,,20563.0,,,,BID,2019,Q1,Injection site pruritus,,2019,Q1,1,I,20190101.0,20190102.0,20190111,20190111,EXP,,IN-ELI_LILLY_AND_COMPANY-IN201901003339,ELI LILLY AND CO,,54.0,YR,,M,Y,,,20190111.0,,CN,IN,IN,2019,Q1,Adult
158134621,15813462,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,,,,20563.0,,,,BID,2019,Q1,Pruritus generalised,,2019,Q1,1,I,20190101.0,20190102.0,20190111,20190111,EXP,,IN-ELI_LILLY_AND_COMPANY-IN201901003339,ELI LILLY AND CO,,54.0,YR,,M,Y,,,20190111.0,,CN,IN,IN,2019,Q1,Adult
158134621,15813462,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,,,,20563.0,,,,BID,2019,Q1,Rash generalised,,2019,Q1,1,I,20190101.0,20190102.0,20190111,20190111,EXP,,IN-ELI_LILLY_AND_COMPANY-IN201901003339,ELI LILLY AND CO,,54.0,YR,,M,Y,,,20190111.0,,CN,IN,IN,2019,Q1,Adult
158146891,15814689,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q1,Cerebrovascular accident,,2019,Q1,1,I,20180613.0,20180614.0,20190111,20190111,EXP,,US-GILEAD-2018-0345555,GILEAD,,57.0,YR,A,M,Y,102.2,KG,20190111.0,,MD,US,US,2019,Q1,Adult
158146891,15814689,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q1,Deep vein thrombosis,,2019,Q1,1,I,20180613.0,20180614.0,20190111,20190111,EXP,,US-GILEAD-2018-0345555,GILEAD,,57.0,YR,A,M,Y,102.2,KG,20190111.0,,MD,US,US,2019,Q1,Adult
158194083,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Abdominal pain,,2019,Q1,3,F,,20190225.0,20190114,20190308,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190308.0,,CN,CA,CA,2019,Q1,Adult
158194083,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Abscess,,2019,Q1,3,F,,20190225.0,20190114,20190308,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190308.0,,CN,CA,CA,2019,Q1,Adult
158194083,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Adrenal insufficiency,,2019,Q1,3,F,,20190225.0,20190114,20190308,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190308.0,,CN,CA,CA,2019,Q1,Adult
158194083,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Alanine aminotransferase increased,,2019,Q1,3,F,,20190225.0,20190114,20190308,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190308.0,,CN,CA,CA,2019,Q1,Adult
158194083,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Ascites,,2019,Q1,3,F,,20190225.0,20190114,20190308,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190308.0,,CN,CA,CA,2019,Q1,Adult
158194083,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Asthenia,,2019,Q1,3,F,,20190225.0,20190114,20190308,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190308.0,,CN,CA,CA,2019,Q1,Adult
158194083,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Blood alkaline phosphatase increased,,2019,Q1,3,F,,20190225.0,20190114,20190308,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190308.0,,CN,CA,CA,2019,Q1,Adult
158194083,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Blood bilirubin increased,,2019,Q1,3,F,,20190225.0,20190114,20190308,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190308.0,,CN,CA,CA,2019,Q1,Adult
158194083,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Blood potassium decreased,,2019,Q1,3,F,,20190225.0,20190114,20190308,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190308.0,,CN,CA,CA,2019,Q1,Adult
158194083,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Blood pressure diastolic abnormal,,2019,Q1,3,F,,20190225.0,20190114,20190308,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190308.0,,CN,CA,CA,2019,Q1,Adult
158194083,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Blood pressure increased,,2019,Q1,3,F,,20190225.0,20190114,20190308,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190308.0,,CN,CA,CA,2019,Q1,Adult
158194083,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Depression,,2019,Q1,3,F,,20190225.0,20190114,20190308,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190308.0,,CN,CA,CA,2019,Q1,Adult
158194083,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Diverticulitis,,2019,Q1,3,F,,20190225.0,20190114,20190308,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190308.0,,CN,CA,CA,2019,Q1,Adult
158194083,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Endometrial disorder,,2019,Q1,3,F,,20190225.0,20190114,20190308,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190308.0,,CN,CA,CA,2019,Q1,Adult
158194083,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Enterococcus test positive,,2019,Q1,3,F,,20190225.0,20190114,20190308,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190308.0,,CN,CA,CA,2019,Q1,Adult
158194083,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Fibrosis,,2019,Q1,3,F,,20190225.0,20190114,20190308,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190308.0,,CN,CA,CA,2019,Q1,Adult
158194083,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Gamma-glutamyltransferase increased,,2019,Q1,3,F,,20190225.0,20190114,20190308,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190308.0,,CN,CA,CA,2019,Q1,Adult
158194083,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Gastrointestinal disorder,,2019,Q1,3,F,,20190225.0,20190114,20190308,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190308.0,,CN,CA,CA,2019,Q1,Adult
158194083,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Generalised oedema,,2019,Q1,3,F,,20190225.0,20190114,20190308,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190308.0,,CN,CA,CA,2019,Q1,Adult
158194083,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Heart rate increased,,2019,Q1,3,F,,20190225.0,20190114,20190308,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190308.0,,CN,CA,CA,2019,Q1,Adult
158194083,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Hepatic congestion,,2019,Q1,3,F,,20190225.0,20190114,20190308,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190308.0,,CN,CA,CA,2019,Q1,Adult
158194083,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Herpes zoster,,2019,Q1,3,F,,20190225.0,20190114,20190308,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190308.0,,CN,CA,CA,2019,Q1,Adult
158194083,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Hypersensitivity,,2019,Q1,3,F,,20190225.0,20190114,20190308,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190308.0,,CN,CA,CA,2019,Q1,Adult
158194083,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Hypoglycaemia,,2019,Q1,3,F,,20190225.0,20190114,20190308,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190308.0,,CN,CA,CA,2019,Q1,Adult
158194083,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Hypotension,,2019,Q1,3,F,,20190225.0,20190114,20190308,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190308.0,,CN,CA,CA,2019,Q1,Adult
158194083,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Increased appetite,,2019,Q1,3,F,,20190225.0,20190114,20190308,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190308.0,,CN,CA,CA,2019,Q1,Adult
158194083,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Influenza,,2019,Q1,3,F,,20190225.0,20190114,20190308,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190308.0,,CN,CA,CA,2019,Q1,Adult
158194083,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Infusion related reaction,,2019,Q1,3,F,,20190225.0,20190114,20190308,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190308.0,,CN,CA,CA,2019,Q1,Adult
158194083,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Injection site extravasation,,2019,Q1,3,F,,20190225.0,20190114,20190308,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190308.0,,CN,CA,CA,2019,Q1,Adult
158194083,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Intensive care unit acquired weakness,,2019,Q1,3,F,,20190225.0,20190114,20190308,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190308.0,,CN,CA,CA,2019,Q1,Adult
158194083,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Intervertebral disc protrusion,,2019,Q1,3,F,,20190225.0,20190114,20190308,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190308.0,,CN,CA,CA,2019,Q1,Adult
158194083,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Joint effusion,,2019,Q1,3,F,,20190225.0,20190114,20190308,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190308.0,,CN,CA,CA,2019,Q1,Adult
158194083,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Joint swelling,,2019,Q1,3,F,,20190225.0,20190114,20190308,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190308.0,,CN,CA,CA,2019,Q1,Adult
158194083,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Micturition disorder,,2019,Q1,3,F,,20190225.0,20190114,20190308,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190308.0,,CN,CA,CA,2019,Q1,Adult
158194083,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Myelopathy,,2019,Q1,3,F,,20190225.0,20190114,20190308,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190308.0,,CN,CA,CA,2019,Q1,Adult
158194083,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Myopathy,,2019,Q1,3,F,,20190225.0,20190114,20190308,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190308.0,,CN,CA,CA,2019,Q1,Adult
158194083,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Nasopharyngitis,,2019,Q1,3,F,,20190225.0,20190114,20190308,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190308.0,,CN,CA,CA,2019,Q1,Adult
158194083,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Nausea,,2019,Q1,3,F,,20190225.0,20190114,20190308,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190308.0,,CN,CA,CA,2019,Q1,Adult
158194083,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Nerve compression,,2019,Q1,3,F,,20190225.0,20190114,20190308,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190308.0,,CN,CA,CA,2019,Q1,Adult
158194083,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Neuropathy peripheral,,2019,Q1,3,F,,20190225.0,20190114,20190308,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190308.0,,CN,CA,CA,2019,Q1,Adult
158194083,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Neutropenia,,2019,Q1,3,F,,20190225.0,20190114,20190308,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190308.0,,CN,CA,CA,2019,Q1,Adult
158194083,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Osteoarthritis,,2019,Q1,3,F,,20190225.0,20190114,20190308,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190308.0,,CN,CA,CA,2019,Q1,Adult
158194083,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Pancytopenia,,2019,Q1,3,F,,20190225.0,20190114,20190308,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190308.0,,CN,CA,CA,2019,Q1,Adult
158194083,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Peripheral sensorimotor neuropathy,,2019,Q1,3,F,,20190225.0,20190114,20190308,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190308.0,,CN,CA,CA,2019,Q1,Adult
158194083,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Peritonitis,,2019,Q1,3,F,,20190225.0,20190114,20190308,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190308.0,,CN,CA,CA,2019,Q1,Adult
158194083,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Pneumonia,,2019,Q1,3,F,,20190225.0,20190114,20190308,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190308.0,,CN,CA,CA,2019,Q1,Adult
158194083,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Pseudomonal bacteraemia,,2019,Q1,3,F,,20190225.0,20190114,20190308,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190308.0,,CN,CA,CA,2019,Q1,Adult
158194083,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Rheumatoid arthritis,,2019,Q1,3,F,,20190225.0,20190114,20190308,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190308.0,,CN,CA,CA,2019,Q1,Adult
158194083,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Septic shock,,2019,Q1,3,F,,20190225.0,20190114,20190308,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190308.0,,CN,CA,CA,2019,Q1,Adult
158194083,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Therapeutic response decreased,,2019,Q1,3,F,,20190225.0,20190114,20190308,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190308.0,,CN,CA,CA,2019,Q1,Adult
158194083,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Vomiting,,2019,Q1,3,F,,20190225.0,20190114,20190308,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190308.0,,CN,CA,CA,2019,Q1,Adult
158194083,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Weight decreased,,2019,Q1,3,F,,20190225.0,20190114,20190308,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190308.0,,CN,CA,CA,2019,Q1,Adult
158194083,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Weight increased,,2019,Q1,3,F,,20190225.0,20190114,20190308,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190308.0,,CN,CA,CA,2019,Q1,Adult
158197941,15819794,11,C,Lispro insulin,INSULIN LISPRO,1,Subcutaneous,ONCE BEFORE EACH MEAL,,,,,,,,8.0,IU,,,2019,Q1,Gastrointestinal infection,,2019,Q1,1,I,20181217.0,20190103.0,20190114,20190114,EXP,,CO-BAXTER-2019BAX000421,BAXTER,,57.0,YR,,M,Y,61.0,KG,20190114.0,,OT,CO,CO,2019,Q1,Adult
158226702,15822670,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 IU, QD",,,U,U,,,,40.0,IU,SOLUTION FOR INJECTION,QD,2019,Q1,Chest pain,,2019,Q1,2,F,,20190107.0,20190114,20190114,EXP,,PHHY2019PT004008,SANDOZ,,54.0,YR,,F,Y,,,20190114.0,,OT,PT,PT,2019,Q1,Adult
158226702,15822670,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 IU, QD",,,U,U,,,,40.0,IU,SOLUTION FOR INJECTION,QD,2019,Q1,Headache,,2019,Q1,2,F,,20190107.0,20190114,20190114,EXP,,PHHY2019PT004008,SANDOZ,,54.0,YR,,F,Y,,,20190114.0,,OT,PT,PT,2019,Q1,Adult
158226702,15822670,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 IU, QD",,,U,U,,,,40.0,IU,SOLUTION FOR INJECTION,QD,2019,Q1,Ischaemic stroke,,2019,Q1,2,F,,20190107.0,20190114,20190114,EXP,,PHHY2019PT004008,SANDOZ,,54.0,YR,,F,Y,,,20190114.0,,OT,PT,PT,2019,Q1,Adult
158245091,15824509,1,PS,Insulin Lispro,INSULIN LISPRO,1,,"UNK, UNKNOWN",,,U,U,,,20563.0,,,,,2019,Q1,Blood glucose increased,,2019,Q1,1,I,201901.0,20190109.0,20190115,20190115,PER,,US-ELI_LILLY_AND_COMPANY-US201901004645,ELI LILLY AND CO,,76.0,YR,,M,Y,,,20190115.0,,CN,US,US,2019,Q1,Elderly
158245091,15824509,1,PS,Insulin Lispro,INSULIN LISPRO,1,,"UNK, UNKNOWN",,,U,U,,,20563.0,,,,,2019,Q1,Intentional product misuse,,2019,Q1,1,I,201901.0,20190109.0,20190115,20190115,PER,,US-ELI_LILLY_AND_COMPANY-US201901004645,ELI LILLY AND CO,,76.0,YR,,M,Y,,,20190115.0,,CN,US,US,2019,Q1,Elderly
158245091,15824509,1,PS,Insulin Lispro,INSULIN LISPRO,1,,"UNK, UNKNOWN",,,U,U,,,20563.0,,,,,2019,Q1,Wrong technique in product usage process,,2019,Q1,1,I,201901.0,20190109.0,20190115,20190115,PER,,US-ELI_LILLY_AND_COMPANY-US201901004645,ELI LILLY AND CO,,76.0,YR,,M,Y,,,20190115.0,,CN,US,US,2019,Q1,Elderly
158256681,15825668,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"52 IU, QD",1404.0,IU,U,,,,,52.0,IU,SOLUTION FOR INJECTION,QD,2019,Q1,Hypoglycaemia,,2019,Q1,1,I,20180127.0,20190107.0,20190115,20190115,EXP,IT-MINISAL02-519029,IT-SA-2019SA005559,SANOFI AVENTIS,,74.0,YR,E,F,Y,,,20190115.0,,PH,IT,IT,2019,Q1,Elderly
158256681,15825668,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"52 IU, QD",1404.0,IU,U,,,,,52.0,IU,SOLUTION FOR INJECTION,QD,2019,Q1,Sopor,,2019,Q1,1,I,20180127.0,20190107.0,20190115,20190115,EXP,IT-MINISAL02-519029,IT-SA-2019SA005559,SANOFI AVENTIS,,74.0,YR,E,F,Y,,,20190115.0,,PH,IT,IT,2019,Q1,Elderly
158256791,15825679,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Bradycardia,,2019,Q1,1,I,20181006.0,20190107.0,20190115,20190115,EXP,IT-MINISAL02-519980,IT-SA-2019SA003894,SANOFI AVENTIS,,85.0,YR,E,F,Y,,,20190115.0,,MD,IT,IT,2019,Q1,Elderly
158256791,15825679,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Hypoglycaemia,,2019,Q1,1,I,20181006.0,20190107.0,20190115,20190115,EXP,IT-MINISAL02-519980,IT-SA-2019SA003894,SANOFI AVENTIS,,85.0,YR,E,F,Y,,,20190115.0,,MD,IT,IT,2019,Q1,Elderly
158321621,15832162,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,"10 U, UNK",,,U,,,,,,,,,2019,Q1,Arterial occlusive disease,,2019,Q1,1,I,2014.0,20190107.0,20190116,20190116,EXP,,US-SA-2019SA006644,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20190116.0,,CN,US,US,2019,Q1,Adult
158321621,15832162,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,"10 U, UNK",,,U,,,,,,,,,2019,Q1,Blood glucose decreased,,2019,Q1,1,I,2014.0,20190107.0,20190116,20190116,EXP,,US-SA-2019SA006644,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20190116.0,,CN,US,US,2019,Q1,Adult
158321621,15832162,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,"10 U, UNK",,,U,,,,,,,,,2019,Q1,Cardiac failure congestive,,2019,Q1,1,I,2014.0,20190107.0,20190116,20190116,EXP,,US-SA-2019SA006644,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20190116.0,,CN,US,US,2019,Q1,Adult
158321621,15832162,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,"10 U, UNK",,,U,,,,,,,,,2019,Q1,Device occlusion,,2019,Q1,1,I,2014.0,20190107.0,20190116,20190116,EXP,,US-SA-2019SA006644,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20190116.0,,CN,US,US,2019,Q1,Adult
158321621,15832162,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,"10 U, UNK",,,U,,,,,,,,,2019,Q1,Diabetic ulcer,,2019,Q1,1,I,2014.0,20190107.0,20190116,20190116,EXP,,US-SA-2019SA006644,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20190116.0,,CN,US,US,2019,Q1,Adult
158321621,15832162,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,"10 U, UNK",,,U,,,,,,,,,2019,Q1,Limb injury,,2019,Q1,1,I,2014.0,20190107.0,20190116,20190116,EXP,,US-SA-2019SA006644,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20190116.0,,CN,US,US,2019,Q1,Adult
158321621,15832162,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,"10 U, UNK",,,U,,,,,,,,,2019,Q1,Renal failure,,2019,Q1,1,I,2014.0,20190107.0,20190116,20190116,EXP,,US-SA-2019SA006644,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20190116.0,,CN,US,US,2019,Q1,Adult
158363304,15836330,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 UNIT/ML, TID",,,,,,,,,,,TID,2019,Q1,Diarrhoea,,2019,Q1,4,F,20181004.0,20190205.0,20190117,20190211,EXP,,US-AMGEN-USASP2019005187,AMGEN,,60.0,YR,A,F,Y,77.98,KG,20190211.0,,MD,US,US,2019,Q1,Adult
158363304,15836330,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 UNIT/ML, TID",,,,,,,,,,,TID,2019,Q1,Glycosylated haemoglobin increased,,2019,Q1,4,F,20181004.0,20190205.0,20190117,20190211,EXP,,US-AMGEN-USASP2019005187,AMGEN,,60.0,YR,A,F,Y,77.98,KG,20190211.0,,MD,US,US,2019,Q1,Adult
158363304,15836330,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 UNIT/ML, TID",,,,,,,,,,,TID,2019,Q1,Nausea,,2019,Q1,4,F,20181004.0,20190205.0,20190117,20190211,EXP,,US-AMGEN-USASP2019005187,AMGEN,,60.0,YR,A,F,Y,77.98,KG,20190211.0,,MD,US,US,2019,Q1,Adult
158363304,15836330,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 UNIT/ML, TID",,,,,,,,,,,TID,2019,Q1,Vomiting,,2019,Q1,4,F,20181004.0,20190205.0,20190117,20190211,EXP,,US-AMGEN-USASP2019005187,AMGEN,,60.0,YR,A,F,Y,77.98,KG,20190211.0,,MD,US,US,2019,Q1,Adult
158391231,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Acidosis,,2019,Q1,1,I,20160303.0,20171128.0,20190117,20190117,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190117.0,,MD,US,US,2019,Q1,Adult
158391231,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Acute kidney injury,,2019,Q1,1,I,20160303.0,20171128.0,20190117,20190117,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190117.0,,MD,US,US,2019,Q1,Adult
158391231,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Acute respiratory distress syndrome,,2019,Q1,1,I,20160303.0,20171128.0,20190117,20190117,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190117.0,,MD,US,US,2019,Q1,Adult
158391231,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Alkalosis hypochloraemic,,2019,Q1,1,I,20160303.0,20171128.0,20190117,20190117,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190117.0,,MD,US,US,2019,Q1,Adult
158391231,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Anaemia,,2019,Q1,1,I,20160303.0,20171128.0,20190117,20190117,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190117.0,,MD,US,US,2019,Q1,Adult
158391231,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Asthenia,,2019,Q1,1,I,20160303.0,20171128.0,20190117,20190117,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190117.0,,MD,US,US,2019,Q1,Adult
158391231,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Bandaemia,,2019,Q1,1,I,20160303.0,20171128.0,20190117,20190117,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190117.0,,MD,US,US,2019,Q1,Adult
158391231,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Blood creatinine increased,,2019,Q1,1,I,20160303.0,20171128.0,20190117,20190117,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190117.0,,MD,US,US,2019,Q1,Adult
158391231,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Blood urea increased,,2019,Q1,1,I,20160303.0,20171128.0,20190117,20190117,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190117.0,,MD,US,US,2019,Q1,Adult
158391231,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Bronchial haemorrhage,,2019,Q1,1,I,20160303.0,20171128.0,20190117,20190117,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190117.0,,MD,US,US,2019,Q1,Adult
158391231,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Bronchitis chronic,,2019,Q1,1,I,20160303.0,20171128.0,20190117,20190117,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190117.0,,MD,US,US,2019,Q1,Adult
158391231,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Concomitant disease aggravated,,2019,Q1,1,I,20160303.0,20171128.0,20190117,20190117,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190117.0,,MD,US,US,2019,Q1,Adult
158391231,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Constipation,,2019,Q1,1,I,20160303.0,20171128.0,20190117,20190117,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190117.0,,MD,US,US,2019,Q1,Adult
158391231,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Cough,,2019,Q1,1,I,20160303.0,20171128.0,20190117,20190117,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190117.0,,MD,US,US,2019,Q1,Adult
158391231,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Cystic fibrosis,,2019,Q1,1,I,20160303.0,20171128.0,20190117,20190117,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190117.0,,MD,US,US,2019,Q1,Adult
158391231,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Diarrhoea,,2019,Q1,1,I,20160303.0,20171128.0,20190117,20190117,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190117.0,,MD,US,US,2019,Q1,Adult
158391231,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Dysphagia,,2019,Q1,1,I,20160303.0,20171128.0,20190117,20190117,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190117.0,,MD,US,US,2019,Q1,Adult
158391231,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Dyspnoea,,2019,Q1,1,I,20160303.0,20171128.0,20190117,20190117,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190117.0,,MD,US,US,2019,Q1,Adult
158391231,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Fungal disease carrier,,2019,Q1,1,I,20160303.0,20171128.0,20190117,20190117,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190117.0,,MD,US,US,2019,Q1,Adult
158391231,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Gastroenteritis norovirus,,2019,Q1,1,I,20160303.0,20171128.0,20190117,20190117,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190117.0,,MD,US,US,2019,Q1,Adult
158391231,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Gastrointestinal disorder,,2019,Q1,1,I,20160303.0,20171128.0,20190117,20190117,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190117.0,,MD,US,US,2019,Q1,Adult
158391231,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Generalised oedema,,2019,Q1,1,I,20160303.0,20171128.0,20190117,20190117,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190117.0,,MD,US,US,2019,Q1,Adult
158391231,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Glucose tolerance impaired,,2019,Q1,1,I,20160303.0,20171128.0,20190117,20190117,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190117.0,,MD,US,US,2019,Q1,Adult
158391231,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Granulocytosis,,2019,Q1,1,I,20160303.0,20171128.0,20190117,20190117,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190117.0,,MD,US,US,2019,Q1,Adult
158391231,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Haematuria,,2019,Q1,1,I,20160303.0,20171128.0,20190117,20190117,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190117.0,,MD,US,US,2019,Q1,Adult
158391231,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Haemoptysis,,2019,Q1,1,I,20160303.0,20171128.0,20190117,20190117,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190117.0,,MD,US,US,2019,Q1,Adult
158391231,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Hypercapnia,,2019,Q1,1,I,20160303.0,20171128.0,20190117,20190117,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190117.0,,MD,US,US,2019,Q1,Adult
158391231,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Hyperglycaemia,,2019,Q1,1,I,20160303.0,20171128.0,20190117,20190117,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190117.0,,MD,US,US,2019,Q1,Adult
158391231,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Hypernatraemia,,2019,Q1,1,I,20160303.0,20171128.0,20190117,20190117,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190117.0,,MD,US,US,2019,Q1,Adult
158391231,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Hypertension,,2019,Q1,1,I,20160303.0,20171128.0,20190117,20190117,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190117.0,,MD,US,US,2019,Q1,Adult
158391231,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Hypertriglyceridaemia,,2019,Q1,1,I,20160303.0,20171128.0,20190117,20190117,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190117.0,,MD,US,US,2019,Q1,Adult
158391231,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Hypervolaemia,,2019,Q1,1,I,20160303.0,20171128.0,20190117,20190117,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190117.0,,MD,US,US,2019,Q1,Adult
158391231,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Hypokalaemia,,2019,Q1,1,I,20160303.0,20171128.0,20190117,20190117,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190117.0,,MD,US,US,2019,Q1,Adult
158391231,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Hypoxia,,2019,Q1,1,I,20160303.0,20171128.0,20190117,20190117,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190117.0,,MD,US,US,2019,Q1,Adult
158391231,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Ill-defined disorder,,2019,Q1,1,I,20160303.0,20171128.0,20190117,20190117,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190117.0,,MD,US,US,2019,Q1,Adult
158391231,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Infective exacerbation of bronchiectasis,,2019,Q1,1,I,20160303.0,20171128.0,20190117,20190117,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190117.0,,MD,US,US,2019,Q1,Adult
158391231,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Infective pulmonary exacerbation of cystic fibrosis,,2019,Q1,1,I,20160303.0,20171128.0,20190117,20190117,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190117.0,,MD,US,US,2019,Q1,Adult
158391231,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Insomnia,,2019,Q1,1,I,20160303.0,20171128.0,20190117,20190117,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190117.0,,MD,US,US,2019,Q1,Adult
158391231,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Intensive care unit acquired weakness,,2019,Q1,1,I,20160303.0,20171128.0,20190117,20190117,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190117.0,,MD,US,US,2019,Q1,Adult
158391231,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Iron deficiency,,2019,Q1,1,I,20160303.0,20171128.0,20190117,20190117,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190117.0,,MD,US,US,2019,Q1,Adult
158391231,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Leukocytosis,,2019,Q1,1,I,20160303.0,20171128.0,20190117,20190117,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190117.0,,MD,US,US,2019,Q1,Adult
158391231,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Metabolic acidosis,,2019,Q1,1,I,20160303.0,20171128.0,20190117,20190117,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190117.0,,MD,US,US,2019,Q1,Adult
158391231,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Muscle atrophy,,2019,Q1,1,I,20160303.0,20171128.0,20190117,20190117,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190117.0,,MD,US,US,2019,Q1,Adult
158391231,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Paresis,,2019,Q1,1,I,20160303.0,20171128.0,20190117,20190117,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190117.0,,MD,US,US,2019,Q1,Adult
158391231,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Pneumonia,,2019,Q1,1,I,20160303.0,20171128.0,20190117,20190117,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190117.0,,MD,US,US,2019,Q1,Adult
158391231,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Pyrexia,,2019,Q1,1,I,20160303.0,20171128.0,20190117,20190117,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190117.0,,MD,US,US,2019,Q1,Adult
158391231,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Respiratory failure,,2019,Q1,1,I,20160303.0,20171128.0,20190117,20190117,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190117.0,,MD,US,US,2019,Q1,Adult
158391231,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Sepsis,,2019,Q1,1,I,20160303.0,20171128.0,20190117,20190117,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190117.0,,MD,US,US,2019,Q1,Adult
158391231,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Stenotrophomonas test positive,,2019,Q1,1,I,20160303.0,20171128.0,20190117,20190117,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190117.0,,MD,US,US,2019,Q1,Adult
158391231,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Tachycardia,,2019,Q1,1,I,20160303.0,20171128.0,20190117,20190117,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190117.0,,MD,US,US,2019,Q1,Adult
158391231,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Thrombocytosis,,2019,Q1,1,I,20160303.0,20171128.0,20190117,20190117,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190117.0,,MD,US,US,2019,Q1,Adult
158391231,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q1,Weight decreased,,2019,Q1,1,I,20160303.0,20171128.0,20190117,20190117,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190117.0,,MD,US,US,2019,Q1,Adult
158403801,15840380,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q1,Dyspnoea,,2019,Q1,1,I,2018.0,20181228.0,20190118,20190118,EXP,,US-ABBVIE-19K-163-2610249-00,ABBVIE,,44.0,YR,,M,Y,92.62,KG,20190117.0,,CN,US,US,2019,Q1,Adult
158403801,15840380,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q1,Fatigue,,2019,Q1,1,I,2018.0,20181228.0,20190118,20190118,EXP,,US-ABBVIE-19K-163-2610249-00,ABBVIE,,44.0,YR,,M,Y,92.62,KG,20190117.0,,CN,US,US,2019,Q1,Adult
158403801,15840380,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q1,Full blood count decreased,,2019,Q1,1,I,2018.0,20181228.0,20190118,20190118,EXP,,US-ABBVIE-19K-163-2610249-00,ABBVIE,,44.0,YR,,M,Y,92.62,KG,20190117.0,,CN,US,US,2019,Q1,Adult
158423582,15842358,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Blood glucose increased,,2019,Q1,2,F,,20190114.0,20190118,20190121,PER,,US-SA-2019SA013038,SANOFI AVENTIS,,81.0,YR,E,M,Y,,,20190121.0,,CN,US,US,2019,Q1,Elderly
158423582,15842358,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Device operational issue,,2019,Q1,2,F,,20190114.0,20190118,20190121,PER,,US-SA-2019SA013038,SANOFI AVENTIS,,81.0,YR,E,M,Y,,,20190121.0,,CN,US,US,2019,Q1,Elderly
158423582,15842358,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Underdose,,2019,Q1,2,F,,20190114.0,20190118,20190121,PER,,US-SA-2019SA013038,SANOFI AVENTIS,,81.0,YR,E,M,Y,,,20190121.0,,CN,US,US,2019,Q1,Elderly
158443962,15844396,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2019,Q1,Cough,,2019,Q1,2,F,,20190211.0,20190118,20190221,EXP,,US-ELI_LILLY_AND_COMPANY-US201901008372,ELI LILLY AND CO,,72.0,YR,,F,Y,50.0,KG,20190221.0,,PH,US,US,2019,Q1,Elderly
158443962,15844396,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2019,Q1,Dyspnoea,,2019,Q1,2,F,,20190211.0,20190118,20190221,EXP,,US-ELI_LILLY_AND_COMPANY-US201901008372,ELI LILLY AND CO,,72.0,YR,,F,Y,50.0,KG,20190221.0,,PH,US,US,2019,Q1,Elderly
158443962,15844396,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2019,Q1,Hypoxia,,2019,Q1,2,F,,20190211.0,20190118,20190221,EXP,,US-ELI_LILLY_AND_COMPANY-US201901008372,ELI LILLY AND CO,,72.0,YR,,F,Y,50.0,KG,20190221.0,,PH,US,US,2019,Q1,Elderly
158443962,15844396,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2019,Q1,Interstitial lung disease,,2019,Q1,2,F,,20190211.0,20190118,20190221,EXP,,US-ELI_LILLY_AND_COMPANY-US201901008372,ELI LILLY AND CO,,72.0,YR,,F,Y,50.0,KG,20190221.0,,PH,US,US,2019,Q1,Elderly
158443962,15844396,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2019,Q1,Pneumonia,,2019,Q1,2,F,,20190211.0,20190118,20190221,EXP,,US-ELI_LILLY_AND_COMPANY-US201901008372,ELI LILLY AND CO,,72.0,YR,,F,Y,50.0,KG,20190221.0,,PH,US,US,2019,Q1,Elderly
158443962,15844396,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2019,Q1,Pneumonitis,,2019,Q1,2,F,,20190211.0,20190118,20190221,EXP,,US-ELI_LILLY_AND_COMPANY-US201901008372,ELI LILLY AND CO,,72.0,YR,,F,Y,50.0,KG,20190221.0,,PH,US,US,2019,Q1,Elderly
158443962,15844396,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2019,Q1,Productive cough,,2019,Q1,2,F,,20190211.0,20190118,20190221,EXP,,US-ELI_LILLY_AND_COMPANY-US201901008372,ELI LILLY AND CO,,72.0,YR,,F,Y,50.0,KG,20190221.0,,PH,US,US,2019,Q1,Elderly
158443962,15844396,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2019,Q1,Pulmonary fibrosis,,2019,Q1,2,F,,20190211.0,20190118,20190221,EXP,,US-ELI_LILLY_AND_COMPANY-US201901008372,ELI LILLY AND CO,,72.0,YR,,F,Y,50.0,KG,20190221.0,,PH,US,US,2019,Q1,Elderly
158443962,15844396,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2019,Q1,Respiratory rate increased,,2019,Q1,2,F,,20190211.0,20190118,20190221,EXP,,US-ELI_LILLY_AND_COMPANY-US201901008372,ELI LILLY AND CO,,72.0,YR,,F,Y,50.0,KG,20190221.0,,PH,US,US,2019,Q1,Elderly
158479101,15847910,1,PS,Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,,,,20563.0,,,,,2019,Q1,Blood glucose decreased,,2019,Q1,1,I,201701.0,20190110.0,20190121,20190121,EXP,,US-ELI_LILLY_AND_COMPANY-US201901005336,ELI LILLY AND CO,,79.0,YR,,M,Y,,,20190121.0,,CN,US,US,2019,Q1,Elderly
158479101,15847910,1,PS,Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,,,,20563.0,,,,,2019,Q1,Dementia,,2019,Q1,1,I,201701.0,20190110.0,20190121,20190121,EXP,,US-ELI_LILLY_AND_COMPANY-US201901005336,ELI LILLY AND CO,,79.0,YR,,M,Y,,,20190121.0,,CN,US,US,2019,Q1,Elderly
158479101,15847910,1,PS,Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,,,,20563.0,,,,,2019,Q1,Fall,,2019,Q1,1,I,201701.0,20190110.0,20190121,20190121,EXP,,US-ELI_LILLY_AND_COMPANY-US201901005336,ELI LILLY AND CO,,79.0,YR,,M,Y,,,20190121.0,,CN,US,US,2019,Q1,Elderly
158479101,15847910,1,PS,Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,,,,20563.0,,,,,2019,Q1,Hypophagia,,2019,Q1,1,I,201701.0,20190110.0,20190121,20190121,EXP,,US-ELI_LILLY_AND_COMPANY-US201901005336,ELI LILLY AND CO,,79.0,YR,,M,Y,,,20190121.0,,CN,US,US,2019,Q1,Elderly
158492331,15849233,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,GRADUAL INCREASE IN THE INSULIN DOSAGE,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Amyloidosis,,2019,Q1,1,I,201212.0,20190111.0,20190121,20190121,EXP,,JP-SA-2019SA010867,SANOFI AVENTIS,"HAGIWARA S., TANEDA S., FUKUMOTO T., HAGIWARA K., KIKUCHI M., KIMURA T., ET AL.. LOCALIZED SUBCUTANEOUS INSULIN-DERIVED AMYLOIDOSIS EXCISED AFTER EVALUATION USING ULTRASONOGRAPHY IN A PATIENT WITH TYPE 2 DIABETES MELLITUS. CASE REPORTS IN ENDOCRINOLOGY. 2017;UNK:1-3",62.0,YR,A,M,Y,57.5,KG,20190121.0,,OT,JP,JP,2019,Q1,Adult
158492331,15849233,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,GRADUAL INCREASE IN THE INSULIN DOSAGE,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Blood glucose increased,,2019,Q1,1,I,201212.0,20190111.0,20190121,20190121,EXP,,JP-SA-2019SA010867,SANOFI AVENTIS,"HAGIWARA S., TANEDA S., FUKUMOTO T., HAGIWARA K., KIKUCHI M., KIMURA T., ET AL.. LOCALIZED SUBCUTANEOUS INSULIN-DERIVED AMYLOIDOSIS EXCISED AFTER EVALUATION USING ULTRASONOGRAPHY IN A PATIENT WITH TYPE 2 DIABETES MELLITUS. CASE REPORTS IN ENDOCRINOLOGY. 2017;UNK:1-3",62.0,YR,A,M,Y,57.5,KG,20190121.0,,OT,JP,JP,2019,Q1,Adult
158492331,15849233,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,GRADUAL INCREASE IN THE INSULIN DOSAGE,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Condition aggravated,,2019,Q1,1,I,201212.0,20190111.0,20190121,20190121,EXP,,JP-SA-2019SA010867,SANOFI AVENTIS,"HAGIWARA S., TANEDA S., FUKUMOTO T., HAGIWARA K., KIKUCHI M., KIMURA T., ET AL.. LOCALIZED SUBCUTANEOUS INSULIN-DERIVED AMYLOIDOSIS EXCISED AFTER EVALUATION USING ULTRASONOGRAPHY IN A PATIENT WITH TYPE 2 DIABETES MELLITUS. CASE REPORTS IN ENDOCRINOLOGY. 2017;UNK:1-3",62.0,YR,A,M,Y,57.5,KG,20190121.0,,OT,JP,JP,2019,Q1,Adult
158492331,15849233,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,GRADUAL INCREASE IN THE INSULIN DOSAGE,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Glycosylated haemoglobin increased,,2019,Q1,1,I,201212.0,20190111.0,20190121,20190121,EXP,,JP-SA-2019SA010867,SANOFI AVENTIS,"HAGIWARA S., TANEDA S., FUKUMOTO T., HAGIWARA K., KIKUCHI M., KIMURA T., ET AL.. LOCALIZED SUBCUTANEOUS INSULIN-DERIVED AMYLOIDOSIS EXCISED AFTER EVALUATION USING ULTRASONOGRAPHY IN A PATIENT WITH TYPE 2 DIABETES MELLITUS. CASE REPORTS IN ENDOCRINOLOGY. 2017;UNK:1-3",62.0,YR,A,M,Y,57.5,KG,20190121.0,,OT,JP,JP,2019,Q1,Adult
158492331,15849233,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,GRADUAL INCREASE IN THE INSULIN DOSAGE,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Hypoglycaemia,,2019,Q1,1,I,201212.0,20190111.0,20190121,20190121,EXP,,JP-SA-2019SA010867,SANOFI AVENTIS,"HAGIWARA S., TANEDA S., FUKUMOTO T., HAGIWARA K., KIKUCHI M., KIMURA T., ET AL.. LOCALIZED SUBCUTANEOUS INSULIN-DERIVED AMYLOIDOSIS EXCISED AFTER EVALUATION USING ULTRASONOGRAPHY IN A PATIENT WITH TYPE 2 DIABETES MELLITUS. CASE REPORTS IN ENDOCRINOLOGY. 2017;UNK:1-3",62.0,YR,A,M,Y,57.5,KG,20190121.0,,OT,JP,JP,2019,Q1,Adult
158492331,15849233,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,GRADUAL INCREASE IN THE INSULIN DOSAGE,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Mass excision,,2019,Q1,1,I,201212.0,20190111.0,20190121,20190121,EXP,,JP-SA-2019SA010867,SANOFI AVENTIS,"HAGIWARA S., TANEDA S., FUKUMOTO T., HAGIWARA K., KIKUCHI M., KIMURA T., ET AL.. LOCALIZED SUBCUTANEOUS INSULIN-DERIVED AMYLOIDOSIS EXCISED AFTER EVALUATION USING ULTRASONOGRAPHY IN A PATIENT WITH TYPE 2 DIABETES MELLITUS. CASE REPORTS IN ENDOCRINOLOGY. 2017;UNK:1-3",62.0,YR,A,M,Y,57.5,KG,20190121.0,,OT,JP,JP,2019,Q1,Adult
158492331,15849233,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,GRADUAL INCREASE IN THE INSULIN DOSAGE,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Pain,,2019,Q1,1,I,201212.0,20190111.0,20190121,20190121,EXP,,JP-SA-2019SA010867,SANOFI AVENTIS,"HAGIWARA S., TANEDA S., FUKUMOTO T., HAGIWARA K., KIKUCHI M., KIMURA T., ET AL.. LOCALIZED SUBCUTANEOUS INSULIN-DERIVED AMYLOIDOSIS EXCISED AFTER EVALUATION USING ULTRASONOGRAPHY IN A PATIENT WITH TYPE 2 DIABETES MELLITUS. CASE REPORTS IN ENDOCRINOLOGY. 2017;UNK:1-3",62.0,YR,A,M,Y,57.5,KG,20190121.0,,OT,JP,JP,2019,Q1,Adult
158492331,15849233,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,GRADUAL INCREASE IN THE INSULIN DOSAGE,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Tenderness,,2019,Q1,1,I,201212.0,20190111.0,20190121,20190121,EXP,,JP-SA-2019SA010867,SANOFI AVENTIS,"HAGIWARA S., TANEDA S., FUKUMOTO T., HAGIWARA K., KIKUCHI M., KIMURA T., ET AL.. LOCALIZED SUBCUTANEOUS INSULIN-DERIVED AMYLOIDOSIS EXCISED AFTER EVALUATION USING ULTRASONOGRAPHY IN A PATIENT WITH TYPE 2 DIABETES MELLITUS. CASE REPORTS IN ENDOCRINOLOGY. 2017;UNK:1-3",62.0,YR,A,M,Y,57.5,KG,20190121.0,,OT,JP,JP,2019,Q1,Adult
158492331,15849233,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"39 U, QD",,,U,,,,,,,SOLUTION FOR INJECTION,QD,2019,Q1,Amyloidosis,,2019,Q1,1,I,201212.0,20190111.0,20190121,20190121,EXP,,JP-SA-2019SA010867,SANOFI AVENTIS,"HAGIWARA S., TANEDA S., FUKUMOTO T., HAGIWARA K., KIKUCHI M., KIMURA T., ET AL.. LOCALIZED SUBCUTANEOUS INSULIN-DERIVED AMYLOIDOSIS EXCISED AFTER EVALUATION USING ULTRASONOGRAPHY IN A PATIENT WITH TYPE 2 DIABETES MELLITUS. CASE REPORTS IN ENDOCRINOLOGY. 2017;UNK:1-3",62.0,YR,A,M,Y,57.5,KG,20190121.0,,OT,JP,JP,2019,Q1,Adult
158492331,15849233,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"39 U, QD",,,U,,,,,,,SOLUTION FOR INJECTION,QD,2019,Q1,Blood glucose increased,,2019,Q1,1,I,201212.0,20190111.0,20190121,20190121,EXP,,JP-SA-2019SA010867,SANOFI AVENTIS,"HAGIWARA S., TANEDA S., FUKUMOTO T., HAGIWARA K., KIKUCHI M., KIMURA T., ET AL.. LOCALIZED SUBCUTANEOUS INSULIN-DERIVED AMYLOIDOSIS EXCISED AFTER EVALUATION USING ULTRASONOGRAPHY IN A PATIENT WITH TYPE 2 DIABETES MELLITUS. CASE REPORTS IN ENDOCRINOLOGY. 2017;UNK:1-3",62.0,YR,A,M,Y,57.5,KG,20190121.0,,OT,JP,JP,2019,Q1,Adult
158492331,15849233,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"39 U, QD",,,U,,,,,,,SOLUTION FOR INJECTION,QD,2019,Q1,Condition aggravated,,2019,Q1,1,I,201212.0,20190111.0,20190121,20190121,EXP,,JP-SA-2019SA010867,SANOFI AVENTIS,"HAGIWARA S., TANEDA S., FUKUMOTO T., HAGIWARA K., KIKUCHI M., KIMURA T., ET AL.. LOCALIZED SUBCUTANEOUS INSULIN-DERIVED AMYLOIDOSIS EXCISED AFTER EVALUATION USING ULTRASONOGRAPHY IN A PATIENT WITH TYPE 2 DIABETES MELLITUS. CASE REPORTS IN ENDOCRINOLOGY. 2017;UNK:1-3",62.0,YR,A,M,Y,57.5,KG,20190121.0,,OT,JP,JP,2019,Q1,Adult
158492331,15849233,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"39 U, QD",,,U,,,,,,,SOLUTION FOR INJECTION,QD,2019,Q1,Glycosylated haemoglobin increased,,2019,Q1,1,I,201212.0,20190111.0,20190121,20190121,EXP,,JP-SA-2019SA010867,SANOFI AVENTIS,"HAGIWARA S., TANEDA S., FUKUMOTO T., HAGIWARA K., KIKUCHI M., KIMURA T., ET AL.. LOCALIZED SUBCUTANEOUS INSULIN-DERIVED AMYLOIDOSIS EXCISED AFTER EVALUATION USING ULTRASONOGRAPHY IN A PATIENT WITH TYPE 2 DIABETES MELLITUS. CASE REPORTS IN ENDOCRINOLOGY. 2017;UNK:1-3",62.0,YR,A,M,Y,57.5,KG,20190121.0,,OT,JP,JP,2019,Q1,Adult
158492331,15849233,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"39 U, QD",,,U,,,,,,,SOLUTION FOR INJECTION,QD,2019,Q1,Hypoglycaemia,,2019,Q1,1,I,201212.0,20190111.0,20190121,20190121,EXP,,JP-SA-2019SA010867,SANOFI AVENTIS,"HAGIWARA S., TANEDA S., FUKUMOTO T., HAGIWARA K., KIKUCHI M., KIMURA T., ET AL.. LOCALIZED SUBCUTANEOUS INSULIN-DERIVED AMYLOIDOSIS EXCISED AFTER EVALUATION USING ULTRASONOGRAPHY IN A PATIENT WITH TYPE 2 DIABETES MELLITUS. CASE REPORTS IN ENDOCRINOLOGY. 2017;UNK:1-3",62.0,YR,A,M,Y,57.5,KG,20190121.0,,OT,JP,JP,2019,Q1,Adult
158492331,15849233,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"39 U, QD",,,U,,,,,,,SOLUTION FOR INJECTION,QD,2019,Q1,Mass excision,,2019,Q1,1,I,201212.0,20190111.0,20190121,20190121,EXP,,JP-SA-2019SA010867,SANOFI AVENTIS,"HAGIWARA S., TANEDA S., FUKUMOTO T., HAGIWARA K., KIKUCHI M., KIMURA T., ET AL.. LOCALIZED SUBCUTANEOUS INSULIN-DERIVED AMYLOIDOSIS EXCISED AFTER EVALUATION USING ULTRASONOGRAPHY IN A PATIENT WITH TYPE 2 DIABETES MELLITUS. CASE REPORTS IN ENDOCRINOLOGY. 2017;UNK:1-3",62.0,YR,A,M,Y,57.5,KG,20190121.0,,OT,JP,JP,2019,Q1,Adult
158492331,15849233,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"39 U, QD",,,U,,,,,,,SOLUTION FOR INJECTION,QD,2019,Q1,Pain,,2019,Q1,1,I,201212.0,20190111.0,20190121,20190121,EXP,,JP-SA-2019SA010867,SANOFI AVENTIS,"HAGIWARA S., TANEDA S., FUKUMOTO T., HAGIWARA K., KIKUCHI M., KIMURA T., ET AL.. LOCALIZED SUBCUTANEOUS INSULIN-DERIVED AMYLOIDOSIS EXCISED AFTER EVALUATION USING ULTRASONOGRAPHY IN A PATIENT WITH TYPE 2 DIABETES MELLITUS. CASE REPORTS IN ENDOCRINOLOGY. 2017;UNK:1-3",62.0,YR,A,M,Y,57.5,KG,20190121.0,,OT,JP,JP,2019,Q1,Adult
158492331,15849233,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"39 U, QD",,,U,,,,,,,SOLUTION FOR INJECTION,QD,2019,Q1,Tenderness,,2019,Q1,1,I,201212.0,20190111.0,20190121,20190121,EXP,,JP-SA-2019SA010867,SANOFI AVENTIS,"HAGIWARA S., TANEDA S., FUKUMOTO T., HAGIWARA K., KIKUCHI M., KIMURA T., ET AL.. LOCALIZED SUBCUTANEOUS INSULIN-DERIVED AMYLOIDOSIS EXCISED AFTER EVALUATION USING ULTRASONOGRAPHY IN A PATIENT WITH TYPE 2 DIABETES MELLITUS. CASE REPORTS IN ENDOCRINOLOGY. 2017;UNK:1-3",62.0,YR,A,M,Y,57.5,KG,20190121.0,,OT,JP,JP,2019,Q1,Adult
158492331,15849233,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,22 U,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Amyloidosis,,2019,Q1,1,I,201212.0,20190111.0,20190121,20190121,EXP,,JP-SA-2019SA010867,SANOFI AVENTIS,"HAGIWARA S., TANEDA S., FUKUMOTO T., HAGIWARA K., KIKUCHI M., KIMURA T., ET AL.. LOCALIZED SUBCUTANEOUS INSULIN-DERIVED AMYLOIDOSIS EXCISED AFTER EVALUATION USING ULTRASONOGRAPHY IN A PATIENT WITH TYPE 2 DIABETES MELLITUS. CASE REPORTS IN ENDOCRINOLOGY. 2017;UNK:1-3",62.0,YR,A,M,Y,57.5,KG,20190121.0,,OT,JP,JP,2019,Q1,Adult
158492331,15849233,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,22 U,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Blood glucose increased,,2019,Q1,1,I,201212.0,20190111.0,20190121,20190121,EXP,,JP-SA-2019SA010867,SANOFI AVENTIS,"HAGIWARA S., TANEDA S., FUKUMOTO T., HAGIWARA K., KIKUCHI M., KIMURA T., ET AL.. LOCALIZED SUBCUTANEOUS INSULIN-DERIVED AMYLOIDOSIS EXCISED AFTER EVALUATION USING ULTRASONOGRAPHY IN A PATIENT WITH TYPE 2 DIABETES MELLITUS. CASE REPORTS IN ENDOCRINOLOGY. 2017;UNK:1-3",62.0,YR,A,M,Y,57.5,KG,20190121.0,,OT,JP,JP,2019,Q1,Adult
158492331,15849233,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,22 U,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Condition aggravated,,2019,Q1,1,I,201212.0,20190111.0,20190121,20190121,EXP,,JP-SA-2019SA010867,SANOFI AVENTIS,"HAGIWARA S., TANEDA S., FUKUMOTO T., HAGIWARA K., KIKUCHI M., KIMURA T., ET AL.. LOCALIZED SUBCUTANEOUS INSULIN-DERIVED AMYLOIDOSIS EXCISED AFTER EVALUATION USING ULTRASONOGRAPHY IN A PATIENT WITH TYPE 2 DIABETES MELLITUS. CASE REPORTS IN ENDOCRINOLOGY. 2017;UNK:1-3",62.0,YR,A,M,Y,57.5,KG,20190121.0,,OT,JP,JP,2019,Q1,Adult
158492331,15849233,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,22 U,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Glycosylated haemoglobin increased,,2019,Q1,1,I,201212.0,20190111.0,20190121,20190121,EXP,,JP-SA-2019SA010867,SANOFI AVENTIS,"HAGIWARA S., TANEDA S., FUKUMOTO T., HAGIWARA K., KIKUCHI M., KIMURA T., ET AL.. LOCALIZED SUBCUTANEOUS INSULIN-DERIVED AMYLOIDOSIS EXCISED AFTER EVALUATION USING ULTRASONOGRAPHY IN A PATIENT WITH TYPE 2 DIABETES MELLITUS. CASE REPORTS IN ENDOCRINOLOGY. 2017;UNK:1-3",62.0,YR,A,M,Y,57.5,KG,20190121.0,,OT,JP,JP,2019,Q1,Adult
158492331,15849233,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,22 U,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Hypoglycaemia,,2019,Q1,1,I,201212.0,20190111.0,20190121,20190121,EXP,,JP-SA-2019SA010867,SANOFI AVENTIS,"HAGIWARA S., TANEDA S., FUKUMOTO T., HAGIWARA K., KIKUCHI M., KIMURA T., ET AL.. LOCALIZED SUBCUTANEOUS INSULIN-DERIVED AMYLOIDOSIS EXCISED AFTER EVALUATION USING ULTRASONOGRAPHY IN A PATIENT WITH TYPE 2 DIABETES MELLITUS. CASE REPORTS IN ENDOCRINOLOGY. 2017;UNK:1-3",62.0,YR,A,M,Y,57.5,KG,20190121.0,,OT,JP,JP,2019,Q1,Adult
158492331,15849233,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,22 U,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Mass excision,,2019,Q1,1,I,201212.0,20190111.0,20190121,20190121,EXP,,JP-SA-2019SA010867,SANOFI AVENTIS,"HAGIWARA S., TANEDA S., FUKUMOTO T., HAGIWARA K., KIKUCHI M., KIMURA T., ET AL.. LOCALIZED SUBCUTANEOUS INSULIN-DERIVED AMYLOIDOSIS EXCISED AFTER EVALUATION USING ULTRASONOGRAPHY IN A PATIENT WITH TYPE 2 DIABETES MELLITUS. CASE REPORTS IN ENDOCRINOLOGY. 2017;UNK:1-3",62.0,YR,A,M,Y,57.5,KG,20190121.0,,OT,JP,JP,2019,Q1,Adult
158492331,15849233,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,22 U,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Pain,,2019,Q1,1,I,201212.0,20190111.0,20190121,20190121,EXP,,JP-SA-2019SA010867,SANOFI AVENTIS,"HAGIWARA S., TANEDA S., FUKUMOTO T., HAGIWARA K., KIKUCHI M., KIMURA T., ET AL.. LOCALIZED SUBCUTANEOUS INSULIN-DERIVED AMYLOIDOSIS EXCISED AFTER EVALUATION USING ULTRASONOGRAPHY IN A PATIENT WITH TYPE 2 DIABETES MELLITUS. CASE REPORTS IN ENDOCRINOLOGY. 2017;UNK:1-3",62.0,YR,A,M,Y,57.5,KG,20190121.0,,OT,JP,JP,2019,Q1,Adult
158492331,15849233,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,22 U,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Tenderness,,2019,Q1,1,I,201212.0,20190111.0,20190121,20190121,EXP,,JP-SA-2019SA010867,SANOFI AVENTIS,"HAGIWARA S., TANEDA S., FUKUMOTO T., HAGIWARA K., KIKUCHI M., KIMURA T., ET AL.. LOCALIZED SUBCUTANEOUS INSULIN-DERIVED AMYLOIDOSIS EXCISED AFTER EVALUATION USING ULTRASONOGRAPHY IN A PATIENT WITH TYPE 2 DIABETES MELLITUS. CASE REPORTS IN ENDOCRINOLOGY. 2017;UNK:1-3",62.0,YR,A,M,Y,57.5,KG,20190121.0,,OT,JP,JP,2019,Q1,Adult
158495521,15849552,3,C,INSULINE LISPRO,,2,,UNK,,,,, UNK,,,,,INJECTION,,2019,Q1,Joint swelling,,2019,Q1,1,I,20180621.0,20190114.0,20190121,20190121,EXP,NL-LRB-00289885,NL-MYLANLABS-2019M1004099,MYLAN,,49.0,YR,,F,Y,,,20190121.0,,MD,NL,NL,2019,Q1,Adult
158495521,15849552,3,C,INSULINE LISPRO,,2,,UNK,,,,, UNK,,,,,INJECTION,,2019,Q1,Mobility decreased,,2019,Q1,1,I,20180621.0,20190114.0,20190121,20190121,EXP,NL-LRB-00289885,NL-MYLANLABS-2019M1004099,MYLAN,,49.0,YR,,F,Y,,,20190121.0,,MD,NL,NL,2019,Q1,Adult
158495521,15849552,3,C,INSULINE LISPRO,,2,,UNK,,,,, UNK,,,,,INJECTION,,2019,Q1,Pruritus,,2019,Q1,1,I,20180621.0,20190114.0,20190121,20190121,EXP,NL-LRB-00289885,NL-MYLANLABS-2019M1004099,MYLAN,,49.0,YR,,F,Y,,,20190121.0,,MD,NL,NL,2019,Q1,Adult
158495521,15849552,3,C,INSULINE LISPRO,,2,,UNK,,,,, UNK,,,,,INJECTION,,2019,Q1,Urticaria,,2019,Q1,1,I,20180621.0,20190114.0,20190121,20190121,EXP,NL-LRB-00289885,NL-MYLANLABS-2019M1004099,MYLAN,,49.0,YR,,F,Y,,,20190121.0,,MD,NL,NL,2019,Q1,Adult
158501101,15850110,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Blood glucose increased,,2019,Q1,1,I,,20190115.0,20190121,20190121,PER,,US-SA-2019SA013823,SANOFI AVENTIS,,77.0,YR,E,F,Y,,,20190121.0,,CN,US,US,2019,Q1,Elderly
158501101,15850110,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Product dose omission,,2019,Q1,1,I,,20190115.0,20190121,20190121,PER,,US-SA-2019SA013823,SANOFI AVENTIS,,77.0,YR,E,F,Y,,,20190121.0,,CN,US,US,2019,Q1,Elderly
158501351,15850135,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2019,Q1,Blood glucose increased,,2019,Q1,1,I,20190106.0,20190114.0,20190121,20190121,PER,,US-SA-2019SA014473,SANOFI AVENTIS,,72.0,YR,E,F,Y,,,20190121.0,,CN,US,US,2019,Q1,Elderly
158501351,15850135,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2019,Q1,Drug ineffective,,2019,Q1,1,I,20190106.0,20190114.0,20190121,20190121,PER,,US-SA-2019SA014473,SANOFI AVENTIS,,72.0,YR,E,F,Y,,,20190121.0,,CN,US,US,2019,Q1,Elderly
158540391,15854039,7,C,insulin lispro 1-6 units,,2,,,,,,,,,,,,,,2019,Q1,Blister,,2019,Q1,1,I,20190106.0,,20190121,20190121,DIR,,,FDA-CTU,,56.0,YR,,M,N,,,20190121.0,N,PH,US,US,2019,Q1,Adult
158540391,15854039,7,C,insulin lispro 1-6 units,,2,,,,,,,,,,,,,,2019,Q1,Burning sensation,,2019,Q1,1,I,20190106.0,,20190121,20190121,DIR,,,FDA-CTU,,56.0,YR,,M,N,,,20190121.0,N,PH,US,US,2019,Q1,Adult
158540391,15854039,7,C,insulin lispro 1-6 units,,2,,,,,,,,,,,,,,2019,Q1,Diabetic neuropathy,,2019,Q1,1,I,20190106.0,,20190121,20190121,DIR,,,FDA-CTU,,56.0,YR,,M,N,,,20190121.0,N,PH,US,US,2019,Q1,Adult
158540391,15854039,7,C,insulin lispro 1-6 units,,2,,,,,,,,,,,,,,2019,Q1,Infusion site pain,,2019,Q1,1,I,20190106.0,,20190121,20190121,DIR,,,FDA-CTU,,56.0,YR,,M,N,,,20190121.0,N,PH,US,US,2019,Q1,Adult
158540391,15854039,7,C,insulin lispro 1-6 units,,2,,,,,,,,,,,,,,2019,Q1,Infusion site vesicles,,2019,Q1,1,I,20190106.0,,20190121,20190121,DIR,,,FDA-CTU,,56.0,YR,,M,N,,,20190121.0,N,PH,US,US,2019,Q1,Adult
158540391,15854039,7,C,insulin lispro 1-6 units,,2,,,,,,,,,,,,,,2019,Q1,Osteomyelitis,,2019,Q1,1,I,20190106.0,,20190121,20190121,DIR,,,FDA-CTU,,56.0,YR,,M,N,,,20190121.0,N,PH,US,US,2019,Q1,Adult
158540391,15854039,7,C,insulin lispro 1-6 units,,2,,,,,,,,,,,,,,2019,Q1,Staphylococcal infection,,2019,Q1,1,I,20190106.0,,20190121,20190121,DIR,,,FDA-CTU,,56.0,YR,,M,N,,,20190121.0,N,PH,US,US,2019,Q1,Adult
158557503,15855750,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,, UNK,,,,,UNKNOWN,,2019,Q1,Anaemia,,2019,Q1,3,F,20181219.0,20190321.0,20190122,20190325,EXP,FR-AFSSAPS-AM20190038,FR-FRESENIUS KABI-FK201900719,FRESENIUS KABI,,79.0,YR,,M,Y,56.0,KG,20190325.0,,OT,GB,FR,2019,Q1,Elderly
158557503,15855750,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,, UNK,,,,,UNKNOWN,,2019,Q1,Intestinal ischaemia,,2019,Q1,3,F,20181219.0,20190321.0,20190122,20190325,EXP,FR-AFSSAPS-AM20190038,FR-FRESENIUS KABI-FK201900719,FRESENIUS KABI,,79.0,YR,,M,Y,56.0,KG,20190325.0,,OT,GB,FR,2019,Q1,Elderly
158557503,15855750,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,, UNK,,,,,UNKNOWN,,2019,Q1,Thrombocytopenia,,2019,Q1,3,F,20181219.0,20190321.0,20190122,20190325,EXP,FR-AFSSAPS-AM20190038,FR-FRESENIUS KABI-FK201900719,FRESENIUS KABI,,79.0,YR,,M,Y,56.0,KG,20190325.0,,OT,GB,FR,2019,Q1,Elderly
158571321,15857132,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,6 IU PLUS 10 IU PLUS 8 IU,,,Y,,,,,,,,,2019,Q1,Hyperglycaemia,,2019,Q1,1,I,201804.0,20190119.0,20190123,20190123,EXP,,IT-BAUSCH-BL-2019-002048,BAUSCH AND LOMB,,64.0,YR,,F,Y,,,20190123.0,,CN,IT,IT,2019,Q1,Adult
158598872,15859887,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q1,Anaemia,,2019,Q1,2,F,20181231.0,20190213.0,20190123,20190223,EXP,,US-ACTELION-A-NJ2019-185248,ACTELION,,46.0,YR,A,F,Y,63.49,KG,20190223.0,,OT,US,US,2019,Q1,Adult
158598872,15859887,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q1,Cough,,2019,Q1,2,F,20181231.0,20190213.0,20190123,20190223,EXP,,US-ACTELION-A-NJ2019-185248,ACTELION,,46.0,YR,A,F,Y,63.49,KG,20190223.0,,OT,US,US,2019,Q1,Adult
158598872,15859887,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q1,Haemoptysis,,2019,Q1,2,F,20181231.0,20190213.0,20190123,20190223,EXP,,US-ACTELION-A-NJ2019-185248,ACTELION,,46.0,YR,A,F,Y,63.49,KG,20190223.0,,OT,US,US,2019,Q1,Adult
158598872,15859887,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q1,Pneumothorax,,2019,Q1,2,F,20181231.0,20190213.0,20190123,20190223,EXP,,US-ACTELION-A-NJ2019-185248,ACTELION,,46.0,YR,A,F,Y,63.49,KG,20190223.0,,OT,US,US,2019,Q1,Adult
158598872,15859887,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q1,Pulmonary haemorrhage,,2019,Q1,2,F,20181231.0,20190213.0,20190123,20190223,EXP,,US-ACTELION-A-NJ2019-185248,ACTELION,,46.0,YR,A,F,Y,63.49,KG,20190223.0,,OT,US,US,2019,Q1,Adult
158598872,15859887,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q1,Pulmonary hypertension,,2019,Q1,2,F,20181231.0,20190213.0,20190123,20190223,EXP,,US-ACTELION-A-NJ2019-185248,ACTELION,,46.0,YR,A,F,Y,63.49,KG,20190223.0,,OT,US,US,2019,Q1,Adult
158598872,15859887,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q1,Retching,,2019,Q1,2,F,20181231.0,20190213.0,20190123,20190223,EXP,,US-ACTELION-A-NJ2019-185248,ACTELION,,46.0,YR,A,F,Y,63.49,KG,20190223.0,,OT,US,US,2019,Q1,Adult
158598872,15859887,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q1,Vomiting,,2019,Q1,2,F,20181231.0,20190213.0,20190123,20190223,EXP,,US-ACTELION-A-NJ2019-185248,ACTELION,,46.0,YR,A,F,Y,63.49,KG,20190223.0,,OT,US,US,2019,Q1,Adult
158621431,15862143,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2019,Q1,Cytomegalovirus infection,,2019,Q1,1,I,20181217.0,20181221.0,20190124,20190124,EXP,,PHHO2018FR013488,NOVARTIS,,62.0,YR,,M,Y,99.0,KG,20190124.0,,MD,FR,FR,2019,Q1,Adult
158634881,15863488,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,12.0,IU,,QD,2019,Q1,Hyperglycaemia,,2019,Q1,1,I,,20190117.0,20190124,20190124,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-002725",BOEHRINGER INGELHEIM,"OHARA N, KOBAYASHI M, IKEDA Y, NAGANO O, TAKADA T, KODAMA M, ET AL. GLUTAMIC ACID DECARBOXYLASE AUTOANTIBODY-NEGATIVE SLOWLY PROGRESSIVE TYPE 1 DIABETES MELLITUS: A CASE REPORT AND LITERATURE REVIEW. INTERNAL MEDICINE (TOKYO). 2018;57:24:3581-3587.",61.0,YR,,F,Y,37.5,KG,20190124.0,,MD,JP,JP,2019,Q1,Adult
158673031,15867303,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"15 IU, DAILY",,,Y,U,,,20563.0,15.0,IU,,QD,2019,Q1,Hypoglycaemia,,2019,Q1,1,I,20180520.0,20181203.0,20190125,20190125,EXP,IT-MINISAL02-514266,IT-ELI_LILLY_AND_COMPANY-IT201812000448,ELI LILLY AND CO,,82.0,YR,,M,Y,,,20190125.0,,CN,IT,IT,2019,Q1,Elderly
158673031,15867303,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"15 IU, DAILY",,,Y,U,,,20563.0,15.0,IU,,QD,2019,Q1,Medication error,,2019,Q1,1,I,20180520.0,20181203.0,20190125,20190125,EXP,IT-MINISAL02-514266,IT-ELI_LILLY_AND_COMPANY-IT201812000448,ELI LILLY AND CO,,82.0,YR,,M,Y,,,20190125.0,,CN,IT,IT,2019,Q1,Elderly
158673031,15867303,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"15 IU, DAILY",,,Y,U,,,20563.0,15.0,IU,,QD,2019,Q1,Syncope,,2019,Q1,1,I,20180520.0,20181203.0,20190125,20190125,EXP,IT-MINISAL02-514266,IT-ELI_LILLY_AND_COMPANY-IT201812000448,ELI LILLY AND CO,,82.0,YR,,M,Y,,,20190125.0,,CN,IT,IT,2019,Q1,Elderly
158771451,15877145,3,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30-32 IU, 62 IU DAILY",,,,,,,209196.0,,,SOLUTION FOR INJECTION,,2019,Q1,Hypoglycaemia,,2019,Q1,1,I,20150915.0,20190118.0,20190128,20190128,EXP,FR-AFSSAPS-MP20182575,FR-SA-2019SA017334,SANOFI AVENTIS,,78.0,YR,E,M,Y,74.7,KG,20190128.0,,MD,FR,FR,2019,Q1,Elderly
158771451,15877145,3,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30-32 IU, 62 IU DAILY",,,,,,,209196.0,,,SOLUTION FOR INJECTION,,2019,Q1,Hypokalaemia,,2019,Q1,1,I,20150915.0,20190118.0,20190128,20190128,EXP,FR-AFSSAPS-MP20182575,FR-SA-2019SA017334,SANOFI AVENTIS,,78.0,YR,E,M,Y,74.7,KG,20190128.0,,MD,FR,FR,2019,Q1,Elderly
158785681,15878568,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"50 IU, QD",,,,,,,,50.0,IU,,QD,2019,Q1,Immune thrombocytopenic purpura,,2019,Q1,1,I,20181022.0,20190117.0,20190128,20190128,EXP,FR-AFSSAPS-RE20181485,FR-SAKK-2019SA016637AA,SANOFI AVENTIS,,70.0,YR,E,F,Y,91.0,KG,20190128.0,,MD,FR,FR,2019,Q1,Elderly
158815211,15881521,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"30 UNITS AM, 20 UNITS PM",,,U,,,,,,,SOLUTION FOR INJECTION,Q12H,2019,Q1,Dyspnoea,,2019,Q1,1,I,,20190118.0,20190128,20190128,PER,,US-SA-2019SA018966,SANOFI AVENTIS,,75.0,YR,E,M,Y,,,20190128.0,,CN,US,US,2019,Q1,Elderly
158815211,15881521,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"30 UNITS AM, 20 UNITS PM",,,U,,,,,,,SOLUTION FOR INJECTION,Q12H,2019,Q1,Injection site pain,,2019,Q1,1,I,,20190118.0,20190128,20190128,PER,,US-SA-2019SA018966,SANOFI AVENTIS,,75.0,YR,E,M,Y,,,20190128.0,,CN,US,US,2019,Q1,Elderly
158815211,15881521,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"30 UNITS AM, 20 UNITS PM",,,U,,,,,,,SOLUTION FOR INJECTION,Q12H,2019,Q1,Product quality issue,,2019,Q1,1,I,,20190118.0,20190128,20190128,PER,,US-SA-2019SA018966,SANOFI AVENTIS,,75.0,YR,E,M,Y,,,20190128.0,,CN,US,US,2019,Q1,Elderly
158832951,15883295,6,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,,2,Subcutaneous,,,,,,,,,,,,,2019,Q1,Electrolyte imbalance,,2019,Q1,1,I,,20190116.0,20190129,20190129,EXP,DE-BFARM-18005685,DE-ACCORD-103661,ACCORD,,83.0,YR,E,M,Y,70.0,KG,20190129.0,,MD,DE,DE,2019,Q1,Elderly
158832951,15883295,6,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,,2,Subcutaneous,,,,,,,,,,,,,2019,Q1,Pain,,2019,Q1,1,I,,20190116.0,20190129,20190129,EXP,DE-BFARM-18005685,DE-ACCORD-103661,ACCORD,,83.0,YR,E,M,Y,70.0,KG,20190129.0,,MD,DE,DE,2019,Q1,Elderly
158832951,15883295,6,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,,2,Subcutaneous,,,,,,,,,,,,,2019,Q1,Skin ulcer,,2019,Q1,1,I,,20190116.0,20190129,20190129,EXP,DE-BFARM-18005685,DE-ACCORD-103661,ACCORD,,83.0,YR,E,M,Y,70.0,KG,20190129.0,,MD,DE,DE,2019,Q1,Elderly
158836801,15883680,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"14 U, QD, BEFORE EVERY MEAL",,,U,,,,,14.0,DF,,QD,2019,Q1,Acidosis,,2019,Q1,1,I,,20190121.0,20190129,20190129,EXP,,PHHY2019TR017600,SANDOZ,,65.0,YR,,F,Y,,,20190129.0,,OT,TR,TR,2019,Q1,Elderly
158836801,15883680,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"14 U, QD, BEFORE EVERY MEAL",,,U,,,,,14.0,DF,,QD,2019,Q1,Anuria,,2019,Q1,1,I,,20190121.0,20190129,20190129,EXP,,PHHY2019TR017600,SANDOZ,,65.0,YR,,F,Y,,,20190129.0,,OT,TR,TR,2019,Q1,Elderly
158836801,15883680,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"14 U, QD, BEFORE EVERY MEAL",,,U,,,,,14.0,DF,,QD,2019,Q1,Cardio-respiratory arrest,,2019,Q1,1,I,,20190121.0,20190129,20190129,EXP,,PHHY2019TR017600,SANDOZ,,65.0,YR,,F,Y,,,20190129.0,,OT,TR,TR,2019,Q1,Elderly
158836801,15883680,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"14 U, QD, BEFORE EVERY MEAL",,,U,,,,,14.0,DF,,QD,2019,Q1,Confusional state,,2019,Q1,1,I,,20190121.0,20190129,20190129,EXP,,PHHY2019TR017600,SANDOZ,,65.0,YR,,F,Y,,,20190129.0,,OT,TR,TR,2019,Q1,Elderly
158836801,15883680,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"14 U, QD, BEFORE EVERY MEAL",,,U,,,,,14.0,DF,,QD,2019,Q1,Dehydration,,2019,Q1,1,I,,20190121.0,20190129,20190129,EXP,,PHHY2019TR017600,SANDOZ,,65.0,YR,,F,Y,,,20190129.0,,OT,TR,TR,2019,Q1,Elderly
158836801,15883680,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"14 U, QD, BEFORE EVERY MEAL",,,U,,,,,14.0,DF,,QD,2019,Q1,Diarrhoea,,2019,Q1,1,I,,20190121.0,20190129,20190129,EXP,,PHHY2019TR017600,SANDOZ,,65.0,YR,,F,Y,,,20190129.0,,OT,TR,TR,2019,Q1,Elderly
158836801,15883680,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"14 U, QD, BEFORE EVERY MEAL",,,U,,,,,14.0,DF,,QD,2019,Q1,Disorientation,,2019,Q1,1,I,,20190121.0,20190129,20190129,EXP,,PHHY2019TR017600,SANDOZ,,65.0,YR,,F,Y,,,20190129.0,,OT,TR,TR,2019,Q1,Elderly
158836801,15883680,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"14 U, QD, BEFORE EVERY MEAL",,,U,,,,,14.0,DF,,QD,2019,Q1,Drug clearance decreased,,2019,Q1,1,I,,20190121.0,20190129,20190129,EXP,,PHHY2019TR017600,SANDOZ,,65.0,YR,,F,Y,,,20190129.0,,OT,TR,TR,2019,Q1,Elderly
158836801,15883680,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"14 U, QD, BEFORE EVERY MEAL",,,U,,,,,14.0,DF,,QD,2019,Q1,Hypotension,,2019,Q1,1,I,,20190121.0,20190129,20190129,EXP,,PHHY2019TR017600,SANDOZ,,65.0,YR,,F,Y,,,20190129.0,,OT,TR,TR,2019,Q1,Elderly
158836801,15883680,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"14 U, QD, BEFORE EVERY MEAL",,,U,,,,,14.0,DF,,QD,2019,Q1,Hypovolaemia,,2019,Q1,1,I,,20190121.0,20190129,20190129,EXP,,PHHY2019TR017600,SANDOZ,,65.0,YR,,F,Y,,,20190129.0,,OT,TR,TR,2019,Q1,Elderly
158836801,15883680,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"14 U, QD, BEFORE EVERY MEAL",,,U,,,,,14.0,DF,,QD,2019,Q1,Lactic acidosis,,2019,Q1,1,I,,20190121.0,20190129,20190129,EXP,,PHHY2019TR017600,SANDOZ,,65.0,YR,,F,Y,,,20190129.0,,OT,TR,TR,2019,Q1,Elderly
158836801,15883680,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"14 U, QD, BEFORE EVERY MEAL",,,U,,,,,14.0,DF,,QD,2019,Q1,Nausea,,2019,Q1,1,I,,20190121.0,20190129,20190129,EXP,,PHHY2019TR017600,SANDOZ,,65.0,YR,,F,Y,,,20190129.0,,OT,TR,TR,2019,Q1,Elderly
158836801,15883680,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"14 U, QD, BEFORE EVERY MEAL",,,U,,,,,14.0,DF,,QD,2019,Q1,Respiratory failure,,2019,Q1,1,I,,20190121.0,20190129,20190129,EXP,,PHHY2019TR017600,SANDOZ,,65.0,YR,,F,Y,,,20190129.0,,OT,TR,TR,2019,Q1,Elderly
158836801,15883680,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"14 U, QD, BEFORE EVERY MEAL",,,U,,,,,14.0,DF,,QD,2019,Q1,Shock,,2019,Q1,1,I,,20190121.0,20190129,20190129,EXP,,PHHY2019TR017600,SANDOZ,,65.0,YR,,F,Y,,,20190129.0,,OT,TR,TR,2019,Q1,Elderly
158836801,15883680,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"14 U, QD, BEFORE EVERY MEAL",,,U,,,,,14.0,DF,,QD,2019,Q1,Toxicity to various agents,,2019,Q1,1,I,,20190121.0,20190129,20190129,EXP,,PHHY2019TR017600,SANDOZ,,65.0,YR,,F,Y,,,20190129.0,,OT,TR,TR,2019,Q1,Elderly
158836801,15883680,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"14 U, QD, BEFORE EVERY MEAL",,,U,,,,,14.0,DF,,QD,2019,Q1,Vomiting,,2019,Q1,1,I,,20190121.0,20190129,20190129,EXP,,PHHY2019TR017600,SANDOZ,,65.0,YR,,F,Y,,,20190129.0,,OT,TR,TR,2019,Q1,Elderly
158844362,15884436,10,C,LISPRO INSULIN,INSULIN LISPRO,1,,"(IL 200) 24-24-24 U, UNKNOWN FREQ.UNK",,,D,, UNK,,,,,,,2019,Q1,Hypoglycaemia,,2019,Q1,2,F,2013.0,20190215.0,20190129,20190225,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,ZAK P.. A TREATMENT WITH CONCENTRATED PRANDIAL INSULIN LISPRO 200 U/ML IN A PATIENT WITH THE TYPE 2 DIABETES MELLITUS AFTER LIVER TRANSPLANTATION./ LECBA KONCENTROVANYM PRANDIALNIM INZULIMEM LISPRO 200 U/ML U PACIENTKY S DIABETES MELLITUS 2. TYPU PO TRANSPLANTACI JATER. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20190225.0,,MD,CZ,CZ,2019,Q1,Adult
158844362,15884436,10,C,LISPRO INSULIN,INSULIN LISPRO,1,,"(IL 200) 24-24-24 U, UNKNOWN FREQ.UNK",,,D,, UNK,,,,,,,2019,Q1,Increased insulin requirement,,2019,Q1,2,F,2013.0,20190215.0,20190129,20190225,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,ZAK P.. A TREATMENT WITH CONCENTRATED PRANDIAL INSULIN LISPRO 200 U/ML IN A PATIENT WITH THE TYPE 2 DIABETES MELLITUS AFTER LIVER TRANSPLANTATION./ LECBA KONCENTROVANYM PRANDIALNIM INZULIMEM LISPRO 200 U/ML U PACIENTKY S DIABETES MELLITUS 2. TYPU PO TRANSPLANTACI JATER. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20190225.0,,MD,CZ,CZ,2019,Q1,Adult
158844362,15884436,10,C,LISPRO INSULIN,INSULIN LISPRO,1,,"(IL 200) 24-24-24 U, UNKNOWN FREQ.UNK",,,D,, UNK,,,,,,,2019,Q1,Insulin resistance,,2019,Q1,2,F,2013.0,20190215.0,20190129,20190225,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,ZAK P.. A TREATMENT WITH CONCENTRATED PRANDIAL INSULIN LISPRO 200 U/ML IN A PATIENT WITH THE TYPE 2 DIABETES MELLITUS AFTER LIVER TRANSPLANTATION./ LECBA KONCENTROVANYM PRANDIALNIM INZULIMEM LISPRO 200 U/ML U PACIENTKY S DIABETES MELLITUS 2. TYPU PO TRANSPLANTACI JATER. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20190225.0,,MD,CZ,CZ,2019,Q1,Adult
158844362,15884436,10,C,LISPRO INSULIN,INSULIN LISPRO,1,,"(IL 200) 24-24-24 U, UNKNOWN FREQ.UNK",,,D,, UNK,,,,,,,2019,Q1,Liver transplant rejection,,2019,Q1,2,F,2013.0,20190215.0,20190129,20190225,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,ZAK P.. A TREATMENT WITH CONCENTRATED PRANDIAL INSULIN LISPRO 200 U/ML IN A PATIENT WITH THE TYPE 2 DIABETES MELLITUS AFTER LIVER TRANSPLANTATION./ LECBA KONCENTROVANYM PRANDIALNIM INZULIMEM LISPRO 200 U/ML U PACIENTKY S DIABETES MELLITUS 2. TYPU PO TRANSPLANTACI JATER. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20190225.0,,MD,CZ,CZ,2019,Q1,Adult
158844362,15884436,10,C,LISPRO INSULIN,INSULIN LISPRO,1,,"(IL 200) 24-24-24 U, UNKNOWN FREQ.UNK",,,D,, UNK,,,,,,,2019,Q1,Nephrotic syndrome,,2019,Q1,2,F,2013.0,20190215.0,20190129,20190225,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,ZAK P.. A TREATMENT WITH CONCENTRATED PRANDIAL INSULIN LISPRO 200 U/ML IN A PATIENT WITH THE TYPE 2 DIABETES MELLITUS AFTER LIVER TRANSPLANTATION./ LECBA KONCENTROVANYM PRANDIALNIM INZULIMEM LISPRO 200 U/ML U PACIENTKY S DIABETES MELLITUS 2. TYPU PO TRANSPLANTACI JATER. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20190225.0,,MD,CZ,CZ,2019,Q1,Adult
158844362,15884436,10,C,LISPRO INSULIN,INSULIN LISPRO,1,,"(IL 200) 24-24-24 U, UNKNOWN FREQ.UNK",,,D,, UNK,,,,,,,2019,Q1,Proteinuria,,2019,Q1,2,F,2013.0,20190215.0,20190129,20190225,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,ZAK P.. A TREATMENT WITH CONCENTRATED PRANDIAL INSULIN LISPRO 200 U/ML IN A PATIENT WITH THE TYPE 2 DIABETES MELLITUS AFTER LIVER TRANSPLANTATION./ LECBA KONCENTROVANYM PRANDIALNIM INZULIMEM LISPRO 200 U/ML U PACIENTKY S DIABETES MELLITUS 2. TYPU PO TRANSPLANTACI JATER. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20190225.0,,MD,CZ,CZ,2019,Q1,Adult
158844362,15884436,10,C,LISPRO INSULIN,INSULIN LISPRO,1,,"(IL 200) 24-24-24 U, UNKNOWN FREQ.UNK",,,D,, UNK,,,,,,,2019,Q1,Renal failure,,2019,Q1,2,F,2013.0,20190215.0,20190129,20190225,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,ZAK P.. A TREATMENT WITH CONCENTRATED PRANDIAL INSULIN LISPRO 200 U/ML IN A PATIENT WITH THE TYPE 2 DIABETES MELLITUS AFTER LIVER TRANSPLANTATION./ LECBA KONCENTROVANYM PRANDIALNIM INZULIMEM LISPRO 200 U/ML U PACIENTKY S DIABETES MELLITUS 2. TYPU PO TRANSPLANTACI JATER. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20190225.0,,MD,CZ,CZ,2019,Q1,Adult
158844362,15884436,10,C,LISPRO INSULIN,INSULIN LISPRO,1,,"(IL 200) 24-24-24 U, UNKNOWN FREQ.UNK",,,D,, UNK,,,,,,,2019,Q1,Toxicity to various agents,,2019,Q1,2,F,2013.0,20190215.0,20190129,20190225,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,ZAK P.. A TREATMENT WITH CONCENTRATED PRANDIAL INSULIN LISPRO 200 U/ML IN A PATIENT WITH THE TYPE 2 DIABETES MELLITUS AFTER LIVER TRANSPLANTATION./ LECBA KONCENTROVANYM PRANDIALNIM INZULIMEM LISPRO 200 U/ML U PACIENTKY S DIABETES MELLITUS 2. TYPU PO TRANSPLANTACI JATER. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20190225.0,,MD,CZ,CZ,2019,Q1,Adult
158844362,15884436,10,C,LISPRO INSULIN,INSULIN LISPRO,1,,"(IL 200) 24-24-24 U, UNKNOWN FREQ.UNK",,,D,, UNK,,,,,,,2019,Q1,Weight increased,,2019,Q1,2,F,2013.0,20190215.0,20190129,20190225,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,ZAK P.. A TREATMENT WITH CONCENTRATED PRANDIAL INSULIN LISPRO 200 U/ML IN A PATIENT WITH THE TYPE 2 DIABETES MELLITUS AFTER LIVER TRANSPLANTATION./ LECBA KONCENTROVANYM PRANDIALNIM INZULIMEM LISPRO 200 U/ML U PACIENTKY S DIABETES MELLITUS 2. TYPU PO TRANSPLANTACI JATER. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20190225.0,,MD,CZ,CZ,2019,Q1,Adult
158844362,15884436,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,100 U/ML (IL 100) AT 20-20-20 U DOSES UNK,,,D,, UNK,,,,,,,2019,Q1,Hypoglycaemia,,2019,Q1,2,F,2013.0,20190215.0,20190129,20190225,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,ZAK P.. A TREATMENT WITH CONCENTRATED PRANDIAL INSULIN LISPRO 200 U/ML IN A PATIENT WITH THE TYPE 2 DIABETES MELLITUS AFTER LIVER TRANSPLANTATION./ LECBA KONCENTROVANYM PRANDIALNIM INZULIMEM LISPRO 200 U/ML U PACIENTKY S DIABETES MELLITUS 2. TYPU PO TRANSPLANTACI JATER. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20190225.0,,MD,CZ,CZ,2019,Q1,Adult
158844362,15884436,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,100 U/ML (IL 100) AT 20-20-20 U DOSES UNK,,,D,, UNK,,,,,,,2019,Q1,Increased insulin requirement,,2019,Q1,2,F,2013.0,20190215.0,20190129,20190225,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,ZAK P.. A TREATMENT WITH CONCENTRATED PRANDIAL INSULIN LISPRO 200 U/ML IN A PATIENT WITH THE TYPE 2 DIABETES MELLITUS AFTER LIVER TRANSPLANTATION./ LECBA KONCENTROVANYM PRANDIALNIM INZULIMEM LISPRO 200 U/ML U PACIENTKY S DIABETES MELLITUS 2. TYPU PO TRANSPLANTACI JATER. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20190225.0,,MD,CZ,CZ,2019,Q1,Adult
158844362,15884436,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,100 U/ML (IL 100) AT 20-20-20 U DOSES UNK,,,D,, UNK,,,,,,,2019,Q1,Insulin resistance,,2019,Q1,2,F,2013.0,20190215.0,20190129,20190225,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,ZAK P.. A TREATMENT WITH CONCENTRATED PRANDIAL INSULIN LISPRO 200 U/ML IN A PATIENT WITH THE TYPE 2 DIABETES MELLITUS AFTER LIVER TRANSPLANTATION./ LECBA KONCENTROVANYM PRANDIALNIM INZULIMEM LISPRO 200 U/ML U PACIENTKY S DIABETES MELLITUS 2. TYPU PO TRANSPLANTACI JATER. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20190225.0,,MD,CZ,CZ,2019,Q1,Adult
158844362,15884436,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,100 U/ML (IL 100) AT 20-20-20 U DOSES UNK,,,D,, UNK,,,,,,,2019,Q1,Liver transplant rejection,,2019,Q1,2,F,2013.0,20190215.0,20190129,20190225,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,ZAK P.. A TREATMENT WITH CONCENTRATED PRANDIAL INSULIN LISPRO 200 U/ML IN A PATIENT WITH THE TYPE 2 DIABETES MELLITUS AFTER LIVER TRANSPLANTATION./ LECBA KONCENTROVANYM PRANDIALNIM INZULIMEM LISPRO 200 U/ML U PACIENTKY S DIABETES MELLITUS 2. TYPU PO TRANSPLANTACI JATER. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20190225.0,,MD,CZ,CZ,2019,Q1,Adult
158844362,15884436,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,100 U/ML (IL 100) AT 20-20-20 U DOSES UNK,,,D,, UNK,,,,,,,2019,Q1,Nephrotic syndrome,,2019,Q1,2,F,2013.0,20190215.0,20190129,20190225,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,ZAK P.. A TREATMENT WITH CONCENTRATED PRANDIAL INSULIN LISPRO 200 U/ML IN A PATIENT WITH THE TYPE 2 DIABETES MELLITUS AFTER LIVER TRANSPLANTATION./ LECBA KONCENTROVANYM PRANDIALNIM INZULIMEM LISPRO 200 U/ML U PACIENTKY S DIABETES MELLITUS 2. TYPU PO TRANSPLANTACI JATER. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20190225.0,,MD,CZ,CZ,2019,Q1,Adult
158844362,15884436,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,100 U/ML (IL 100) AT 20-20-20 U DOSES UNK,,,D,, UNK,,,,,,,2019,Q1,Proteinuria,,2019,Q1,2,F,2013.0,20190215.0,20190129,20190225,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,ZAK P.. A TREATMENT WITH CONCENTRATED PRANDIAL INSULIN LISPRO 200 U/ML IN A PATIENT WITH THE TYPE 2 DIABETES MELLITUS AFTER LIVER TRANSPLANTATION./ LECBA KONCENTROVANYM PRANDIALNIM INZULIMEM LISPRO 200 U/ML U PACIENTKY S DIABETES MELLITUS 2. TYPU PO TRANSPLANTACI JATER. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20190225.0,,MD,CZ,CZ,2019,Q1,Adult
158844362,15884436,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,100 U/ML (IL 100) AT 20-20-20 U DOSES UNK,,,D,, UNK,,,,,,,2019,Q1,Renal failure,,2019,Q1,2,F,2013.0,20190215.0,20190129,20190225,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,ZAK P.. A TREATMENT WITH CONCENTRATED PRANDIAL INSULIN LISPRO 200 U/ML IN A PATIENT WITH THE TYPE 2 DIABETES MELLITUS AFTER LIVER TRANSPLANTATION./ LECBA KONCENTROVANYM PRANDIALNIM INZULIMEM LISPRO 200 U/ML U PACIENTKY S DIABETES MELLITUS 2. TYPU PO TRANSPLANTACI JATER. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20190225.0,,MD,CZ,CZ,2019,Q1,Adult
158844362,15884436,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,100 U/ML (IL 100) AT 20-20-20 U DOSES UNK,,,D,, UNK,,,,,,,2019,Q1,Toxicity to various agents,,2019,Q1,2,F,2013.0,20190215.0,20190129,20190225,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,ZAK P.. A TREATMENT WITH CONCENTRATED PRANDIAL INSULIN LISPRO 200 U/ML IN A PATIENT WITH THE TYPE 2 DIABETES MELLITUS AFTER LIVER TRANSPLANTATION./ LECBA KONCENTROVANYM PRANDIALNIM INZULIMEM LISPRO 200 U/ML U PACIENTKY S DIABETES MELLITUS 2. TYPU PO TRANSPLANTACI JATER. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20190225.0,,MD,CZ,CZ,2019,Q1,Adult
158844362,15884436,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,100 U/ML (IL 100) AT 20-20-20 U DOSES UNK,,,D,, UNK,,,,,,,2019,Q1,Weight increased,,2019,Q1,2,F,2013.0,20190215.0,20190129,20190225,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,ZAK P.. A TREATMENT WITH CONCENTRATED PRANDIAL INSULIN LISPRO 200 U/ML IN A PATIENT WITH THE TYPE 2 DIABETES MELLITUS AFTER LIVER TRANSPLANTATION./ LECBA KONCENTROVANYM PRANDIALNIM INZULIMEM LISPRO 200 U/ML U PACIENTKY S DIABETES MELLITUS 2. TYPU PO TRANSPLANTACI JATER. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20190225.0,,MD,CZ,CZ,2019,Q1,Adult
158880351,15888035,4,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,,2,Subcutaneous,"NACH BZ, INJECTION / INFUSION SOLUTION",,,,,,,,,,,,2019,Q1,Acute kidney injury,,2019,Q1,1,I,,20190116.0,20190130,20190130,EXP,DE-BFARM-18006533,DE-ACCORD-104163,ACCORD,,67.0,YR,E,F,Y,83.0,KG,20190130.0,,MD,DE,DE,2019,Q1,Elderly
158880351,15888035,4,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,,2,Subcutaneous,"NACH BZ, INJECTION / INFUSION SOLUTION",,,,,,,,,,,,2019,Q1,General physical health deterioration,,2019,Q1,1,I,,20190116.0,20190130,20190130,EXP,DE-BFARM-18006533,DE-ACCORD-104163,ACCORD,,67.0,YR,E,F,Y,83.0,KG,20190130.0,,MD,DE,DE,2019,Q1,Elderly
158896641,15889664,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Arthritis,,2019,Q1,1,I,,20190122.0,20190130,20190130,EXP,,US-SAKK-2019SA022226AA,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20190130.0,,CN,US,US,2019,Q1,Elderly
158896641,15889664,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Gait disturbance,,2019,Q1,1,I,,20190122.0,20190130,20190130,EXP,,US-SAKK-2019SA022226AA,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20190130.0,,CN,US,US,2019,Q1,Elderly
158896641,15889664,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Hypoaesthesia,,2019,Q1,1,I,,20190122.0,20190130,20190130,EXP,,US-SAKK-2019SA022226AA,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20190130.0,,CN,US,US,2019,Q1,Elderly
158896641,15889664,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Infection,,2019,Q1,1,I,,20190122.0,20190130,20190130,EXP,,US-SAKK-2019SA022226AA,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20190130.0,,CN,US,US,2019,Q1,Elderly
158896641,15889664,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Lung disorder,,2019,Q1,1,I,,20190122.0,20190130,20190130,EXP,,US-SAKK-2019SA022226AA,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20190130.0,,CN,US,US,2019,Q1,Elderly
158896641,15889664,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Mass,,2019,Q1,1,I,,20190122.0,20190130,20190130,EXP,,US-SAKK-2019SA022226AA,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20190130.0,,CN,US,US,2019,Q1,Elderly
158896641,15889664,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Musculoskeletal discomfort,,2019,Q1,1,I,,20190122.0,20190130,20190130,EXP,,US-SAKK-2019SA022226AA,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20190130.0,,CN,US,US,2019,Q1,Elderly
158896641,15889664,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Neuralgia,,2019,Q1,1,I,,20190122.0,20190130,20190130,EXP,,US-SAKK-2019SA022226AA,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20190130.0,,CN,US,US,2019,Q1,Elderly
158896641,15889664,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Paralysis,,2019,Q1,1,I,,20190122.0,20190130,20190130,EXP,,US-SAKK-2019SA022226AA,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20190130.0,,CN,US,US,2019,Q1,Elderly
158896641,15889664,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Rib fracture,,2019,Q1,1,I,,20190122.0,20190130,20190130,EXP,,US-SAKK-2019SA022226AA,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20190130.0,,CN,US,US,2019,Q1,Elderly
158896641,15889664,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Trigger finger,,2019,Q1,1,I,,20190122.0,20190130,20190130,EXP,,US-SAKK-2019SA022226AA,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20190130.0,,CN,US,US,2019,Q1,Elderly
158911662,15891166,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,, UNK,,,,,,,2019,Q1,Electrocardiogram QT prolonged,,2019,Q1,2,F,20180530.0,20190321.0,20190130,20190328,EXP,IT-MINISAL02-490375,IT-MYLANLABS-2019M1008346,MYLAN,,75.0,YR,,F,Y,70.0,KG,20190328.0,,PH,IT,IT,2019,Q1,Elderly
158966122,15896612,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN (TOOK LESS THAN PRESCRIBED DOSAGE IN 2017 AND IN EARLY SEP-2018)",,,,,,,20563.0,,,INJECTION,,2019,Q1,Glycosylated haemoglobin increased,,2019,Q1,2,F,201712.0,20190123.0,20190131,20190206,PER,,US-ELI_LILLY_AND_COMPANY-US201901005808,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20190206.0,,CN,US,US,2019,Q1,Elderly
158966122,15896612,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN (TOOK LESS THAN PRESCRIBED DOSAGE IN 2017 AND IN EARLY SEP-2018)",,,,,,,20563.0,,,INJECTION,,2019,Q1,Intentional product misuse,,2019,Q1,2,F,201712.0,20190123.0,20190131,20190206,PER,,US-ELI_LILLY_AND_COMPANY-US201901005808,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20190206.0,,CN,US,US,2019,Q1,Elderly
158966122,15896612,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, C856285C,,20563.0,,,INJECTION,,2019,Q1,Glycosylated haemoglobin increased,,2019,Q1,2,F,201712.0,20190123.0,20190131,20190206,PER,,US-ELI_LILLY_AND_COMPANY-US201901005808,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20190206.0,,CN,US,US,2019,Q1,Elderly
158966122,15896612,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, C856285C,,20563.0,,,INJECTION,,2019,Q1,Intentional product misuse,,2019,Q1,2,F,201712.0,20190123.0,20190131,20190206,PER,,US-ELI_LILLY_AND_COMPANY-US201901005808,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20190206.0,,CN,US,US,2019,Q1,Elderly
158966122,15896612,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"24 U, EACH MORNING (AM)",,,,,,,20563.0,24.0,IU,INJECTION,QD,2019,Q1,Glycosylated haemoglobin increased,,2019,Q1,2,F,201712.0,20190123.0,20190131,20190206,PER,,US-ELI_LILLY_AND_COMPANY-US201901005808,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20190206.0,,CN,US,US,2019,Q1,Elderly
158966122,15896612,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"24 U, EACH MORNING (AM)",,,,,,,20563.0,24.0,IU,INJECTION,QD,2019,Q1,Intentional product misuse,,2019,Q1,2,F,201712.0,20190123.0,20190131,20190206,PER,,US-ELI_LILLY_AND_COMPANY-US201901005808,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20190206.0,,CN,US,US,2019,Q1,Elderly
158966122,15896612,4,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"44 U, DAILY (PM)",,,,,,,20563.0,44.0,IU,INJECTION,QD,2019,Q1,Glycosylated haemoglobin increased,,2019,Q1,2,F,201712.0,20190123.0,20190131,20190206,PER,,US-ELI_LILLY_AND_COMPANY-US201901005808,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20190206.0,,CN,US,US,2019,Q1,Elderly
158966122,15896612,4,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"44 U, DAILY (PM)",,,,,,,20563.0,44.0,IU,INJECTION,QD,2019,Q1,Intentional product misuse,,2019,Q1,2,F,201712.0,20190123.0,20190131,20190206,PER,,US-ELI_LILLY_AND_COMPANY-US201901005808,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20190206.0,,CN,US,US,2019,Q1,Elderly
158973091,15897309,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,4 UNITS TID WITH MEALS,,,,,,,,,,,TID,2019,Q1,Diabetic ketoacidosis,,2019,Q1,1,I,,20190123.0,20190131,20190131,EXP,,US-BAUSCH-BL-2019-002352,BAUSCH AND LOMB,"HOFF R, KOH C. ISOPROTERENOL INDUCED INSULIN RESISTANCE LEADING TO DIABETIC KETOACIDOSIS IN TYPE 1 DIABETES MELLITUS. CASE REPORTS IN ENDOCRINOLOGY. 2018;1-3.",77.0,YR,,F,Y,,,20190131.0,,OT,US,US,2019,Q1,Elderly
158973091,15897309,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,5 UNITS,,,,,,,,,,,,2019,Q1,Diabetic ketoacidosis,,2019,Q1,1,I,,20190123.0,20190131,20190131,EXP,,US-BAUSCH-BL-2019-002352,BAUSCH AND LOMB,"HOFF R, KOH C. ISOPROTERENOL INDUCED INSULIN RESISTANCE LEADING TO DIABETIC KETOACIDOSIS IN TYPE 1 DIABETES MELLITUS. CASE REPORTS IN ENDOCRINOLOGY. 2018;1-3.",77.0,YR,,F,Y,,,20190131.0,,OT,US,US,2019,Q1,Elderly
158974884,15897488,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 IU, QD",,,U,,,,,40.0,IU,SOLUTION FOR INJECTION,QD,2019,Q1,Chest pain,,2019,Q1,4,F,,20190213.0,20190131,20190219,EXP,,PHHY2019PT018415,NOVARTIS,,54.0,YR,,F,Y,,,20190219.0,,OT,PT,PT,2019,Q1,Adult
158974884,15897488,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 IU, QD",,,U,,,,,40.0,IU,SOLUTION FOR INJECTION,QD,2019,Q1,Headache,,2019,Q1,4,F,,20190213.0,20190131,20190219,EXP,,PHHY2019PT018415,NOVARTIS,,54.0,YR,,F,Y,,,20190219.0,,OT,PT,PT,2019,Q1,Adult
158974884,15897488,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 IU, QD",,,U,,,,,40.0,IU,SOLUTION FOR INJECTION,QD,2019,Q1,Ischaemic stroke,,2019,Q1,4,F,,20190213.0,20190131,20190219,EXP,,PHHY2019PT018415,NOVARTIS,,54.0,YR,,F,Y,,,20190219.0,,OT,PT,PT,2019,Q1,Adult
159008131,15900813,3,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,,2,,4 UNITS TID WITH MEALS,,,,,,,,,,,,2019,Q1,Diabetic ketoacidosis,,2019,Q1,1,I,,20190121.0,20190201,20190201,EXP,,US-NEXUS PHARMA-000004,NEXUS PHARMACEUTICALS,"HOFF R, KOH CK. ISOPROTERENOL INDUCED INSULIN RESISTANCE LEADING TO DIABETIC KETOACIDOSIS IN TYPE 1 DIABETES MELLITUS. CASE REP ENDOCRINOL. 2018 DEC 17;2018:4328954.",77.0,YR,,F,Y,,,20190201.0,,OT,US,US,2019,Q1,Elderly
159008131,15900813,3,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,,2,,4 UNITS TID WITH MEALS,,,,,,,,,,,,2019,Q1,Insulin resistance,,2019,Q1,1,I,,20190121.0,20190201,20190201,EXP,,US-NEXUS PHARMA-000004,NEXUS PHARMACEUTICALS,"HOFF R, KOH CK. ISOPROTERENOL INDUCED INSULIN RESISTANCE LEADING TO DIABETIC KETOACIDOSIS IN TYPE 1 DIABETES MELLITUS. CASE REP ENDOCRINOL. 2018 DEC 17;2018:4328954.",77.0,YR,,F,Y,,,20190201.0,,OT,US,US,2019,Q1,Elderly
159044481,15904448,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"14 UNIT, BEFORE EVERY MEAL",,,U,,,,,14.0,DF,,,2019,Q1,Acute kidney injury,,2019,Q1,1,I,,20190121.0,20190204,20190204,EXP,,TR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-007977,BRISTOL MYERS SQUIBB,,65.0,YR,,F,Y,,,20190204.0,,OT,TR,TR,2019,Q1,Elderly
159044481,15904448,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"14 UNIT, BEFORE EVERY MEAL",,,U,,,,,14.0,DF,,,2019,Q1,Cardio-respiratory arrest,,2019,Q1,1,I,,20190121.0,20190204,20190204,EXP,,TR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-007977,BRISTOL MYERS SQUIBB,,65.0,YR,,F,Y,,,20190204.0,,OT,TR,TR,2019,Q1,Elderly
159044481,15904448,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"14 UNIT, BEFORE EVERY MEAL",,,U,,,,,14.0,DF,,,2019,Q1,Lactic acidosis,,2019,Q1,1,I,,20190121.0,20190204,20190204,EXP,,TR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-007977,BRISTOL MYERS SQUIBB,,65.0,YR,,F,Y,,,20190204.0,,OT,TR,TR,2019,Q1,Elderly
159044481,15904448,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"14 UNIT, BEFORE EVERY MEAL",,,U,,,,,14.0,DF,,,2019,Q1,Toxicity to various agents,,2019,Q1,1,I,,20190121.0,20190204,20190204,EXP,,TR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-007977,BRISTOL MYERS SQUIBB,,65.0,YR,,F,Y,,,20190204.0,,OT,TR,TR,2019,Q1,Elderly
159048281,15904828,4,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,,2,,"NK IE, NACH BZ",,,,,,,,,,,,2019,Q1,Fatigue,,2019,Q1,1,I,,20190122.0,20190204,20190204,EXP,DE-BFARM-18007529,DE-ACCORD-105422,ACCORD,,56.0,YR,A,M,Y,,,20190204.0,,PH,DE,DE,2019,Q1,Adult
159048281,15904828,4,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,,2,,"NK IE, NACH BZ",,,,,,,,,,,,2019,Q1,General physical health deterioration,,2019,Q1,1,I,,20190122.0,20190204,20190204,EXP,DE-BFARM-18007529,DE-ACCORD-105422,ACCORD,,56.0,YR,A,M,Y,,,20190204.0,,PH,DE,DE,2019,Q1,Adult
159048281,15904828,4,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,,2,,"NK IE, NACH BZ",,,,,,,,,,,,2019,Q1,Nausea,,2019,Q1,1,I,,20190122.0,20190204,20190204,EXP,DE-BFARM-18007529,DE-ACCORD-105422,ACCORD,,56.0,YR,A,M,Y,,,20190204.0,,PH,DE,DE,2019,Q1,Adult
159052082,15905208,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Hypotension,,2019,Q1,2,F,20190125.0,20190305.0,20190204,20190308,EXP,,US-ROCHE-2254708,ROCHE,,56.0,YR,,F,Y,76.0,KG,20190308.0,,MD,US,US,2019,Q1,Adult
159170551,15917055,6,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,,2,,"NK IE, NACH BZ",,,,,,,,,,,,2019,Q1,Anaemia,,2019,Q1,1,I,,20190124.0,20190205,20190205,EXP,DE-BFARM-18008107,DE-ACCORD-105475,ACCORD,,77.0,YR,E,M,Y,,,20190205.0,,PH,DE,DE,2019,Q1,Elderly
159170551,15917055,6,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,,2,,"NK IE, NACH BZ",,,,,,,,,,,,2019,Q1,Dyspnoea,,2019,Q1,1,I,,20190124.0,20190205,20190205,EXP,DE-BFARM-18008107,DE-ACCORD-105475,ACCORD,,77.0,YR,E,M,Y,,,20190205.0,,PH,DE,DE,2019,Q1,Elderly
159170551,15917055,6,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,,2,,"NK IE, NACH BZ",,,,,,,,,,,,2019,Q1,Haematochezia,,2019,Q1,1,I,,20190124.0,20190205,20190205,EXP,DE-BFARM-18008107,DE-ACCORD-105475,ACCORD,,77.0,YR,E,M,Y,,,20190205.0,,PH,DE,DE,2019,Q1,Elderly
159294641,15929464,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2019,Q1,Drug hypersensitivity,,2019,Q1,1,I,2018.0,20190123.0,20190206,20190206,EXP,,"US-TETRAPHASE PHARMACEUTICALS, INC.-2019TP000030",TETRA,,75.0,YR,,M,Y,103.06,KG,20190206.0,,PH,US,US,2019,Q1,Elderly
159294641,15929464,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2019,Q1,Drug-induced liver injury,,2019,Q1,1,I,2018.0,20190123.0,20190206,20190206,EXP,,"US-TETRAPHASE PHARMACEUTICALS, INC.-2019TP000030",TETRA,,75.0,YR,,M,Y,103.06,KG,20190206.0,,PH,US,US,2019,Q1,Elderly
159294641,15929464,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2019,Q1,Off label use,,2019,Q1,1,I,2018.0,20190123.0,20190206,20190206,EXP,,"US-TETRAPHASE PHARMACEUTICALS, INC.-2019TP000030",TETRA,,75.0,YR,,M,Y,103.06,KG,20190206.0,,PH,US,US,2019,Q1,Elderly
159348321,15934832,3,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q1,Abortion spontaneous,,2019,Q1,1,I,20170430.0,20190127.0,20190207,20190207,EXP,,ES-NOVOPROD-644783,NOVO NORDISK,,17.0,YR,,F,Y,,,20190207.0,,MD,ES,ES,2019,Q1,Youth
159348321,15934832,3,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q1,Exposure during pregnancy,,2019,Q1,1,I,20170430.0,20190127.0,20190207,20190207,EXP,,ES-NOVOPROD-644783,NOVO NORDISK,,17.0,YR,,F,Y,,,20190207.0,,MD,ES,ES,2019,Q1,Youth
159348321,15934832,3,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q1,Off label use,,2019,Q1,1,I,20170430.0,20190127.0,20190207,20190207,EXP,,ES-NOVOPROD-644783,NOVO NORDISK,,17.0,YR,,F,Y,,,20190207.0,,MD,ES,ES,2019,Q1,Youth
159365921,15936592,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,209196.0,,,,,2019,Q1,Delirium,,2019,Q1,1,I,,20190205.0,20190208,20190208,EXP,,NZ-SA-2019SA035522,SANOFI AVENTIS,,79.0,YR,E,F,Y,,,20190208.0,,OT,NZ,NZ,2019,Q1,Elderly
159365921,15936592,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,209196.0,,,,,2019,Q1,Hypoglycaemia,,2019,Q1,1,I,,20190205.0,20190208,20190208,EXP,,NZ-SA-2019SA035522,SANOFI AVENTIS,,79.0,YR,E,F,Y,,,20190208.0,,OT,NZ,NZ,2019,Q1,Elderly
159374031,15937403,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2019,Q1,Abortion spontaneous,,2019,Q1,1,I,20160721.0,20190127.0,20190208,20190208,EXP,,ES-NOVOPROD-645472,NOVO NORDISK,,36.0,YR,,F,Y,,,20190208.0,,MD,ES,ES,2019,Q1,Adult
159374031,15937403,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2019,Q1,Exposure during pregnancy,,2019,Q1,1,I,20160721.0,20190127.0,20190208,20190208,EXP,,ES-NOVOPROD-645472,NOVO NORDISK,,36.0,YR,,F,Y,,,20190208.0,,MD,ES,ES,2019,Q1,Adult
159374031,15937403,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2019,Q1,Off label use,,2019,Q1,1,I,20160721.0,20190127.0,20190208,20190208,EXP,,ES-NOVOPROD-645472,NOVO NORDISK,,36.0,YR,,F,Y,,,20190208.0,,MD,ES,ES,2019,Q1,Adult
159384591,15938459,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q1,Loss of consciousness,,2019,Q1,1,I,20180808.0,20190131.0,20190208,20190208,EXP,,US-EISAI MEDICAL RESEARCH-EC-2019-051580,EISAI,,63.0,YR,,F,Y,129.4,KG,20190208.0,,MD,US,US,2019,Q1,Adult
159451501,15945150,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNKNOWN,,,,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Hypokalaemia,,2019,Q1,1,I,20180602.0,20190204.0,20190211,20190211,EXP,FR-AFSSAPS-TO20190144,FR-SA-2019SA031720,SANOFI AVENTIS,,81.0,YR,E,M,Y,59.0,KG,20190212.0,,PH,FR,FR,2019,Q1,Elderly
159451501,15945150,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNKNOWN,,,,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Pyelonephritis,,2019,Q1,1,I,20180602.0,20190204.0,20190211,20190211,EXP,FR-AFSSAPS-TO20190144,FR-SA-2019SA031720,SANOFI AVENTIS,,81.0,YR,E,M,Y,59.0,KG,20190212.0,,PH,FR,FR,2019,Q1,Elderly
159455361,15945536,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2019,Q1,Blood glucose increased,,2019,Q1,1,I,,20190131.0,20190211,20190211,EXP,,US-SA-2019SA030300,SANOFI AVENTIS,,66.0,YR,E,M,Y,,,20190211.0,,CN,US,US,2019,Q1,Elderly
159455361,15945536,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2019,Q1,Graft versus host disease,,2019,Q1,1,I,,20190131.0,20190211,20190211,EXP,,US-SA-2019SA030300,SANOFI AVENTIS,,66.0,YR,E,M,Y,,,20190211.0,,CN,US,US,2019,Q1,Elderly
159484251,15948425,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"24 IU, QD",360.0,IU,Y,,,,,24.0,IU,SOLUTION FOR INJECTION,QD,2019,Q1,Depressed level of consciousness,,2019,Q1,1,I,20180115.0,20190205.0,20190212,20190212,EXP,IT-MINISAL02-526902,IT-SA-2019SA034960,SANOFI AVENTIS,,86.0,YR,E,M,Y,,,20190212.0,,MD,IT,IT,2019,Q1,Elderly
159484251,15948425,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"24 IU, QD",360.0,IU,Y,,,,,24.0,IU,SOLUTION FOR INJECTION,QD,2019,Q1,Hyperhidrosis,,2019,Q1,1,I,20180115.0,20190205.0,20190212,20190212,EXP,IT-MINISAL02-526902,IT-SA-2019SA034960,SANOFI AVENTIS,,86.0,YR,E,M,Y,,,20190212.0,,MD,IT,IT,2019,Q1,Elderly
159484251,15948425,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"24 IU, QD",360.0,IU,Y,,,,,24.0,IU,SOLUTION FOR INJECTION,QD,2019,Q1,Hypoglycaemia,,2019,Q1,1,I,20180115.0,20190205.0,20190212,20190212,EXP,IT-MINISAL02-526902,IT-SA-2019SA034960,SANOFI AVENTIS,,86.0,YR,E,M,Y,,,20190212.0,,MD,IT,IT,2019,Q1,Elderly
159540801,15954080,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 IU,QD",,,Y,,,,,30.0,IU,,QD,2019,Q1,Exposure during pregnancy,,2019,Q1,1,I,20170205.0,20171124.0,20190213,20190213,EXP,DE-EMA-DD-20171208-MSHETTYP-160006,DE-SA-2017SA236742,SANOFI AVENTIS,,33.0,YR,A,F,Y,84.0,KG,20190213.0,,CN,DE,DE,2019,Q1,Young Adult
159540801,15954080,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 IU,QD",,,Y,,,,,30.0,IU,,QD,2019,Q1,Gastroenteritis norovirus,,2019,Q1,1,I,20170205.0,20171124.0,20190213,20190213,EXP,DE-EMA-DD-20171208-MSHETTYP-160006,DE-SA-2017SA236742,SANOFI AVENTIS,,33.0,YR,A,F,Y,84.0,KG,20190213.0,,CN,DE,DE,2019,Q1,Young Adult
159540801,15954080,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 IU,QD",,,Y,,,,,30.0,IU,,QD,2019,Q1,Hyperglycaemia,,2019,Q1,1,I,20170205.0,20171124.0,20190213,20190213,EXP,DE-EMA-DD-20171208-MSHETTYP-160006,DE-SA-2017SA236742,SANOFI AVENTIS,,33.0,YR,A,F,Y,84.0,KG,20190213.0,,CN,DE,DE,2019,Q1,Young Adult
159540801,15954080,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 IU,QD",,,Y,,,,,30.0,IU,,QD,2019,Q1,Hypoglycaemia,,2019,Q1,1,I,20170205.0,20171124.0,20190213,20190213,EXP,DE-EMA-DD-20171208-MSHETTYP-160006,DE-SA-2017SA236742,SANOFI AVENTIS,,33.0,YR,A,F,Y,84.0,KG,20190213.0,,CN,DE,DE,2019,Q1,Young Adult
159540801,15954080,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 IU,QD",,,Y,,,,,30.0,IU,,QD,2019,Q1,Maternal exposure during breast feeding,,2019,Q1,1,I,20170205.0,20171124.0,20190213,20190213,EXP,DE-EMA-DD-20171208-MSHETTYP-160006,DE-SA-2017SA236742,SANOFI AVENTIS,,33.0,YR,A,F,Y,84.0,KG,20190213.0,,CN,DE,DE,2019,Q1,Young Adult
159540801,15954080,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, QD",,,Y,,,,,,,,QD,2019,Q1,Exposure during pregnancy,,2019,Q1,1,I,20170205.0,20171124.0,20190213,20190213,EXP,DE-EMA-DD-20171208-MSHETTYP-160006,DE-SA-2017SA236742,SANOFI AVENTIS,,33.0,YR,A,F,Y,84.0,KG,20190213.0,,CN,DE,DE,2019,Q1,Young Adult
159540801,15954080,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, QD",,,Y,,,,,,,,QD,2019,Q1,Gastroenteritis norovirus,,2019,Q1,1,I,20170205.0,20171124.0,20190213,20190213,EXP,DE-EMA-DD-20171208-MSHETTYP-160006,DE-SA-2017SA236742,SANOFI AVENTIS,,33.0,YR,A,F,Y,84.0,KG,20190213.0,,CN,DE,DE,2019,Q1,Young Adult
159540801,15954080,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, QD",,,Y,,,,,,,,QD,2019,Q1,Hyperglycaemia,,2019,Q1,1,I,20170205.0,20171124.0,20190213,20190213,EXP,DE-EMA-DD-20171208-MSHETTYP-160006,DE-SA-2017SA236742,SANOFI AVENTIS,,33.0,YR,A,F,Y,84.0,KG,20190213.0,,CN,DE,DE,2019,Q1,Young Adult
159540801,15954080,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, QD",,,Y,,,,,,,,QD,2019,Q1,Hypoglycaemia,,2019,Q1,1,I,20170205.0,20171124.0,20190213,20190213,EXP,DE-EMA-DD-20171208-MSHETTYP-160006,DE-SA-2017SA236742,SANOFI AVENTIS,,33.0,YR,A,F,Y,84.0,KG,20190213.0,,CN,DE,DE,2019,Q1,Young Adult
159540801,15954080,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, QD",,,Y,,,,,,,,QD,2019,Q1,Maternal exposure during breast feeding,,2019,Q1,1,I,20170205.0,20171124.0,20190213,20190213,EXP,DE-EMA-DD-20171208-MSHETTYP-160006,DE-SA-2017SA236742,SANOFI AVENTIS,,33.0,YR,A,F,Y,84.0,KG,20190213.0,,CN,DE,DE,2019,Q1,Young Adult
159548782,15954878,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,20563.0,,,,,2019,Q1,Cough,,2019,Q1,2,F,20190204.0,20190215.0,20190213,20190218,PER,,US-ELI_LILLY_AND_COMPANY-US201902005265,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20190218.0,,CN,US,US,2019,Q1,Elderly
159548782,15954878,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,20563.0,,,,,2019,Q1,Laryngitis,,2019,Q1,2,F,20190204.0,20190215.0,20190213,20190218,PER,,US-ELI_LILLY_AND_COMPANY-US201902005265,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20190218.0,,CN,US,US,2019,Q1,Elderly
159548782,15954878,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,20563.0,,,,,2019,Q1,Nasopharyngitis,,2019,Q1,2,F,20190204.0,20190215.0,20190213,20190218,PER,,US-ELI_LILLY_AND_COMPANY-US201902005265,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20190218.0,,CN,US,US,2019,Q1,Elderly
159630261,15963026,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"28 IU, QD",,,U,,,,,28.0,IU,SOLUTION FOR INJECTION,QD,2019,Q1,Head injury,,2019,Q1,1,I,20180203.0,20190206.0,20190214,20190214,EXP,IT-MINISAL02-527690,IT-SA-2019SA036555,SANOFI AVENTIS,,87.0,YR,E,M,Y,,,20190214.0,,MD,IT,IT,2019,Q1,Elderly
159630261,15963026,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"28 IU, QD",,,U,,,,,28.0,IU,SOLUTION FOR INJECTION,QD,2019,Q1,Hypoglycaemia,,2019,Q1,1,I,20180203.0,20190206.0,20190214,20190214,EXP,IT-MINISAL02-527690,IT-SA-2019SA036555,SANOFI AVENTIS,,87.0,YR,E,M,Y,,,20190214.0,,MD,IT,IT,2019,Q1,Elderly
159630261,15963026,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"28 IU, QD",,,U,,,,,28.0,IU,SOLUTION FOR INJECTION,QD,2019,Q1,Loss of consciousness,,2019,Q1,1,I,20180203.0,20190206.0,20190214,20190214,EXP,IT-MINISAL02-527690,IT-SA-2019SA036555,SANOFI AVENTIS,,87.0,YR,E,M,Y,,,20190214.0,,MD,IT,IT,2019,Q1,Elderly
159632731,15963273,10,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,INJECTION,,2019,Q1,Epstein-Barr virus infection,,2019,Q1,1,I,20181005.0,20190207.0,20190214,20190214,EXP,,US-PFIZER INC-2019060772,PFIZER,,66.0,YR,,M,Y,92.89,KG,20190214.0,,MD,US,US,2019,Q1,Elderly
159632731,15963273,10,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,INJECTION,,2019,Q1,Graft versus host disease,,2019,Q1,1,I,20181005.0,20190207.0,20190214,20190214,EXP,,US-PFIZER INC-2019060772,PFIZER,,66.0,YR,,M,Y,92.89,KG,20190214.0,,MD,US,US,2019,Q1,Elderly
159632731,15963273,10,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,INJECTION,,2019,Q1,Septic shock,,2019,Q1,1,I,20181005.0,20190207.0,20190214,20190214,EXP,,US-PFIZER INC-2019060772,PFIZER,,66.0,YR,,M,Y,92.89,KG,20190214.0,,MD,US,US,2019,Q1,Elderly
159641381,15964138,7,C,LISPRO INSULIN,INSULIN LISPRO,1,,"UNK, QD (60 U/DAY)",,,Y,U,,,,,,,QD,2019,Q1,Drug ineffective,,2019,Q1,1,I,,20190207.0,20190214,20190214,EXP,,RO-MYLANLABS-2019M1013310,MYLAN,"M. RUCSANDRA, T. ANNA, M. DENISA, G. DANIELA, U. ANCA, G. LORETA ET AL. VERY SEVERE HYPERTRIGLYCERIDEMIA-CASE REPORT WITH GENERAL CONSIDERATIONS. ROM. J. DIABETES NUTR. METAB. DIS.. 2018;25(4):425-430",59.0,YR,,M,Y,134.0,KG,20190214.0,,MD,RO,RO,2019,Q1,Adult
159653411,15965341,5,C,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Bradycardia,,2019,Q1,1,I,201901.0,20190206.0,20190215,20190215,EXP,,CO-BAXTER-2019BAX003024,BAXTER,,71.0,YR,,F,Y,96.0,KG,20190215.0,,OT,CO,CO,2019,Q1,Elderly
159653411,15965341,5,C,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Catheter site abscess,,2019,Q1,1,I,201901.0,20190206.0,20190215,20190215,EXP,,CO-BAXTER-2019BAX003024,BAXTER,,71.0,YR,,F,Y,96.0,KG,20190215.0,,OT,CO,CO,2019,Q1,Elderly
159653411,15965341,5,C,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Hypotension,,2019,Q1,1,I,201901.0,20190206.0,20190215,20190215,EXP,,CO-BAXTER-2019BAX003024,BAXTER,,71.0,YR,,F,Y,96.0,KG,20190215.0,,OT,CO,CO,2019,Q1,Elderly
159653411,15965341,5,C,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Multiple organ dysfunction syndrome,,2019,Q1,1,I,201901.0,20190206.0,20190215,20190215,EXP,,CO-BAXTER-2019BAX003024,BAXTER,,71.0,YR,,F,Y,96.0,KG,20190215.0,,OT,CO,CO,2019,Q1,Elderly
159653411,15965341,5,C,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Noninfectious peritonitis,,2019,Q1,1,I,201901.0,20190206.0,20190215,20190215,EXP,,CO-BAXTER-2019BAX003024,BAXTER,,71.0,YR,,F,Y,96.0,KG,20190215.0,,OT,CO,CO,2019,Q1,Elderly
159653411,15965341,5,C,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Shock,,2019,Q1,1,I,201901.0,20190206.0,20190215,20190215,EXP,,CO-BAXTER-2019BAX003024,BAXTER,,71.0,YR,,F,Y,96.0,KG,20190215.0,,OT,CO,CO,2019,Q1,Elderly
159692512,15969251,7,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2019,Q1,Diabetic ketoacidosis,,2019,Q1,2,F,20190204.0,20190226.0,20190215,20190307,EXP,,US-TAKEDA-2019TUS006283,TAKEDA,,77.0,YR,,M,Y,90.0,KG,20190307.0,,MD,US,US,2019,Q1,Elderly
159692512,15969251,7,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2019,Q1,Septic shock,,2019,Q1,2,F,20190204.0,20190226.0,20190215,20190307,EXP,,US-TAKEDA-2019TUS006283,TAKEDA,,77.0,YR,,M,Y,90.0,KG,20190307.0,,MD,US,US,2019,Q1,Elderly
159765622,15976562,5,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2019,Q1,Localised infection,,2019,Q1,2,F,201902.0,20190313.0,20190218,20190322,EXP,,CO-BAXTER-2019BAX003430,BAXTER,,62.0,YR,,M,Y,114.0,KG,20190322.0,,CN,CO,CO,2019,Q1,Adult
159765622,15976562,5,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2019,Q1,PCO2 increased,,2019,Q1,2,F,201902.0,20190313.0,20190218,20190322,EXP,,CO-BAXTER-2019BAX003430,BAXTER,,62.0,YR,,M,Y,114.0,KG,20190322.0,,CN,CO,CO,2019,Q1,Adult
159790471,15979047,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,660.0,IU,Y,,,,,15.0,IU,,QD,2019,Q1,Hypoglycaemic coma,,2019,Q1,1,I,20190127.0,20190212.0,20190219,20190219,EXP,IT-MINISAL02-528728,IT-SA-2019SA041697,SANOFI AVENTIS,,82.0,YR,E,F,Y,,,20190219.0,,MD,IT,IT,2019,Q1,Elderly
159796851,15979685,8,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q1,Atrial fibrillation,,2019,Q1,1,I,20181124.0,,20190217,20190217,DIR,,,FDA-CTU,,77.0,YR,,F,N,74.4,KG,20190217.0,N,PH,US,US,2019,Q1,Elderly
159796851,15979685,8,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q1,Cardiac arrest,,2019,Q1,1,I,20181124.0,,20190217,20190217,DIR,,,FDA-CTU,,77.0,YR,,F,N,74.4,KG,20190217.0,N,PH,US,US,2019,Q1,Elderly
159796851,15979685,8,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q1,Fall,,2019,Q1,1,I,20181124.0,,20190217,20190217,DIR,,,FDA-CTU,,77.0,YR,,F,N,74.4,KG,20190217.0,N,PH,US,US,2019,Q1,Elderly
159796851,15979685,8,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q1,Head injury,,2019,Q1,1,I,20181124.0,,20190217,20190217,DIR,,,FDA-CTU,,77.0,YR,,F,N,74.4,KG,20190217.0,N,PH,US,US,2019,Q1,Elderly
159796851,15979685,8,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q1,Laboratory test interference,,2019,Q1,1,I,20181124.0,,20190217,20190217,DIR,,,FDA-CTU,,77.0,YR,,F,N,74.4,KG,20190217.0,N,PH,US,US,2019,Q1,Elderly
159796851,15979685,8,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q1,Subdural haematoma,,2019,Q1,1,I,20181124.0,,20190217,20190217,DIR,,,FDA-CTU,,77.0,YR,,F,N,74.4,KG,20190217.0,N,PH,US,US,2019,Q1,Elderly
159796851,15979685,8,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q1,Syncope,,2019,Q1,1,I,20181124.0,,20190217,20190217,DIR,,,FDA-CTU,,77.0,YR,,F,N,74.4,KG,20190217.0,N,PH,US,US,2019,Q1,Elderly
159796851,15979685,8,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q1,Torsade de pointes,,2019,Q1,1,I,20181124.0,,20190217,20190217,DIR,,,FDA-CTU,,77.0,YR,,F,N,74.4,KG,20190217.0,N,PH,US,US,2019,Q1,Elderly
159855621,15985562,7,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Back pain,,2019,Q1,1,I,20180515.0,20180515.0,20190220,20190220,PER,,US-LANTHEUS-LMI-2018-00228,LANTHEUS MEDICAL IMAGING,,65.0,YR,,M,Y,,,20190204.0,,CN,US,US,2019,Q1,Elderly
159855621,15985562,7,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Groin pain,,2019,Q1,1,I,20180515.0,20180515.0,20190220,20190220,PER,,US-LANTHEUS-LMI-2018-00228,LANTHEUS MEDICAL IMAGING,,65.0,YR,,M,Y,,,20190204.0,,CN,US,US,2019,Q1,Elderly
159904851,15990485,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"12 U, BID (IN THE MORNING AND AT NIGHT)",,,,,,,20563.0,12.0,IU,,BID,2019,Q1,Oedema,,2019,Q1,1,I,,20190218.0,20190221,20190221,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201902008422,ELI LILLY AND CO,,61.0,YR,,F,Y,80.0,KG,20190221.0,,CN,CN,CN,2019,Q1,Adult
159948011,15994801,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,," UNKNOWN,UNKNOWN",,,,,,,2019,Q1,Hypertension,,2019,Q1,1,I,20180927.0,20190218.0,20190222,20190222,EXP,IT-MINISAL02-502630,IT-DRREDDYS-GER/ITL/19/0107915,DR REDDYS,,82.0,YR,,F,Y,,,20190222.0,,PH,IT,IT,2019,Q1,Elderly
159948011,15994801,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,," UNKNOWN,UNKNOWN",,,,,,,2019,Q1,Hypoglycaemia,,2019,Q1,1,I,20180927.0,20190218.0,20190222,20190222,EXP,IT-MINISAL02-502630,IT-DRREDDYS-GER/ITL/19/0107915,DR REDDYS,,82.0,YR,,F,Y,,,20190222.0,,PH,IT,IT,2019,Q1,Elderly
159948011,15994801,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,," UNKNOWN,UNKNOWN",,,,,,,2019,Q1,Overdose,,2019,Q1,1,I,20180927.0,20190218.0,20190222,20190222,EXP,IT-MINISAL02-502630,IT-DRREDDYS-GER/ITL/19/0107915,DR REDDYS,,82.0,YR,,F,Y,,,20190222.0,,PH,IT,IT,2019,Q1,Elderly
159957333,15995733,29,C,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2019,Q1,Oedema peripheral,,2019,Q1,3,F,20190119.0,20190318.0,20190222,20190325,EXP,,US-CELGENEUS-USA-20190204651,CELGENE,,56.0,YR,,M,Y,97.07,KG,20190325.0,,OT,US,US,2019,Q1,Adult
159966312,15996631,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"0-20 UNITS, 3X/DAY",,,,,,,,,,INJECTION,TID,2019,Q1,Fatigue,,2019,Q1,2,F,20190131.0,20190315.0,20190222,20190320,EXP,,US-PFIZER INC-2019058812,PFIZER,,71.0,YR,,F,Y,74.0,KG,20190320.0,,OT,US,US,2019,Q1,Elderly
159966312,15996631,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"0-20 UNITS, 3X/DAY",,,,,,,,,,INJECTION,TID,2019,Q1,Haemorrhage intracranial,,2019,Q1,2,F,20190131.0,20190315.0,20190222,20190320,EXP,,US-PFIZER INC-2019058812,PFIZER,,71.0,YR,,F,Y,74.0,KG,20190320.0,,OT,US,US,2019,Q1,Elderly
159980351,15998035,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"20 U, PRN",,,,, C900716E,,20563.0,20.0,IU,INJECTION,,2019,Q1,Abnormal behaviour,,2019,Q1,1,I,20190213.0,20190213.0,20190222,20190222,EXP,,US-ELI_LILLY_AND_COMPANY-US201902006367,ELI LILLY AND CO,,57.0,YR,,M,Y,,,20190222.0,,CN,US,US,2019,Q1,Adult
159980351,15998035,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"20 U, PRN",,,,, C900716E,,20563.0,20.0,IU,INJECTION,,2019,Q1,Aggression,,2019,Q1,1,I,20190213.0,20190213.0,20190222,20190222,EXP,,US-ELI_LILLY_AND_COMPANY-US201902006367,ELI LILLY AND CO,,57.0,YR,,M,Y,,,20190222.0,,CN,US,US,2019,Q1,Adult
159980351,15998035,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"20 U, PRN",,,,, C900716E,,20563.0,20.0,IU,INJECTION,,2019,Q1,Altered state of consciousness,,2019,Q1,1,I,20190213.0,20190213.0,20190222,20190222,EXP,,US-ELI_LILLY_AND_COMPANY-US201902006367,ELI LILLY AND CO,,57.0,YR,,M,Y,,,20190222.0,,CN,US,US,2019,Q1,Adult
159980351,15998035,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"20 U, PRN",,,,, C900716E,,20563.0,20.0,IU,INJECTION,,2019,Q1,Blood glucose decreased,,2019,Q1,1,I,20190213.0,20190213.0,20190222,20190222,EXP,,US-ELI_LILLY_AND_COMPANY-US201902006367,ELI LILLY AND CO,,57.0,YR,,M,Y,,,20190222.0,,CN,US,US,2019,Q1,Adult
159980351,15998035,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"20 U, PRN",,,,, C900716E,,20563.0,20.0,IU,INJECTION,,2019,Q1,Blood glucose increased,,2019,Q1,1,I,20190213.0,20190213.0,20190222,20190222,EXP,,US-ELI_LILLY_AND_COMPANY-US201902006367,ELI LILLY AND CO,,57.0,YR,,M,Y,,,20190222.0,,CN,US,US,2019,Q1,Adult
159980351,15998035,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"20 U, PRN",,,,, C900716E,,20563.0,20.0,IU,INJECTION,,2019,Q1,Confusional state,,2019,Q1,1,I,20190213.0,20190213.0,20190222,20190222,EXP,,US-ELI_LILLY_AND_COMPANY-US201902006367,ELI LILLY AND CO,,57.0,YR,,M,Y,,,20190222.0,,CN,US,US,2019,Q1,Adult
159980351,15998035,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"20 U, PRN",,,,, C900716E,,20563.0,20.0,IU,INJECTION,,2019,Q1,Seizure,,2019,Q1,1,I,20190213.0,20190213.0,20190222,20190222,EXP,,US-ELI_LILLY_AND_COMPANY-US201902006367,ELI LILLY AND CO,,57.0,YR,,M,Y,,,20190222.0,,CN,US,US,2019,Q1,Adult
160000541,16000054,4,SS,Lispro,INSULIN LISPRO,1,Unknown,"10 U, EACH MORNING",,,U,U,,,,10.0,IU,,QD,2019,Q1,Blood glucose abnormal,,2019,Q1,1,I,,20190219.0,20190225,20190225,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201902009976,ELI LILLY AND CO,,41.0,YR,,M,Y,73.0,KG,20190225.0,,CN,CN,CN,2019,Q1,Adult
160000541,16000054,4,SS,Lispro,INSULIN LISPRO,1,Unknown,"10 U, EACH MORNING",,,U,U,,,,10.0,IU,,QD,2019,Q1,Blood glucose fluctuation,,2019,Q1,1,I,,20190219.0,20190225,20190225,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201902009976,ELI LILLY AND CO,,41.0,YR,,M,Y,73.0,KG,20190225.0,,CN,CN,CN,2019,Q1,Adult
160000541,16000054,5,SS,Lispro,INSULIN LISPRO,1,Unknown,"8 U, BID (NOON AND EVENING)",,,U,U,,,,8.0,IU,,BID,2019,Q1,Blood glucose abnormal,,2019,Q1,1,I,,20190219.0,20190225,20190225,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201902009976,ELI LILLY AND CO,,41.0,YR,,M,Y,73.0,KG,20190225.0,,CN,CN,CN,2019,Q1,Adult
160000541,16000054,5,SS,Lispro,INSULIN LISPRO,1,Unknown,"8 U, BID (NOON AND EVENING)",,,U,U,,,,8.0,IU,,BID,2019,Q1,Blood glucose fluctuation,,2019,Q1,1,I,,20190219.0,20190225,20190225,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201902009976,ELI LILLY AND CO,,41.0,YR,,M,Y,73.0,KG,20190225.0,,CN,CN,CN,2019,Q1,Adult
160003563,16000356,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U, C458295D,,,,,INJECTION,,2019,Q1,Blood glucose increased,,2019,Q1,3,F,201902.0,20190212.0,20190225,20190327,EXP,,US-ELI_LILLY_AND_COMPANY-US201902005391,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20190327.0,,CN,US,US,2019,Q1,Elderly
160003563,16000356,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U, C458295D,,,,,INJECTION,,2019,Q1,Expired product administered,,2019,Q1,3,F,201902.0,20190212.0,20190225,20190327,EXP,,US-ELI_LILLY_AND_COMPANY-US201902005391,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20190327.0,,CN,US,US,2019,Q1,Elderly
160003563,16000356,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U, C458295D,,,,,INJECTION,,2019,Q1,Wrong product administered,,2019,Q1,3,F,201902.0,20190212.0,20190225,20190327,EXP,,US-ELI_LILLY_AND_COMPANY-US201902005391,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20190327.0,,CN,US,US,2019,Q1,Elderly
160050471,16005047,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK (NK IE, NACH BZ)",,,U,U,,,,,,,,2019,Q1,Anaemia,,2019,Q1,1,I,,20190214.0,20190226,20190226,EXP,,DE-APOTEX-2019AP008328,APOTEX,,77.0,YR,,M,Y,,,20190226.0,,CN,DE,DE,2019,Q1,Elderly
160050471,16005047,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK (NK IE, NACH BZ)",,,U,U,,,,,,,,2019,Q1,Dyspnoea,,2019,Q1,1,I,,20190214.0,20190226,20190226,EXP,,DE-APOTEX-2019AP008328,APOTEX,,77.0,YR,,M,Y,,,20190226.0,,CN,DE,DE,2019,Q1,Elderly
160050471,16005047,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK (NK IE, NACH BZ)",,,U,U,,,,,,,,2019,Q1,Haematochezia,,2019,Q1,1,I,,20190214.0,20190226,20190226,EXP,,DE-APOTEX-2019AP008328,APOTEX,,77.0,YR,,M,Y,,,20190226.0,,CN,DE,DE,2019,Q1,Elderly
160055471,16005547,3,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"20 U, TID",,,Y,U,,,209196.0,,,SOLUTION FOR INJECTION,Q8H,2019,Q1,Diabetes mellitus inadequate control,,2019,Q1,1,I,,20181211.0,20190226,20190226,EXP,,CZ-SA-2018SA341004,SANOFI AVENTIS,ZAK P.. A TREATMENT WITH CONCENTRATED PRANDIAL INSULIN LISPRO 200 U/ML IN A PATIENT WITH TYPE 2 DIABETES MELLITUS AFTER LIVER TRANSPLANTATION.. KAZUISTIKY V DIABETOLOGII.. 2018;16(2):32-4,61.0,YR,A,F,Y,,,20190226.0,,MD,CZ,CZ,2019,Q1,Adult
160055471,16005547,3,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"20 U, TID",,,Y,U,,,209196.0,,,SOLUTION FOR INJECTION,Q8H,2019,Q1,Glycosuria,,2019,Q1,1,I,,20181211.0,20190226,20190226,EXP,,CZ-SA-2018SA341004,SANOFI AVENTIS,ZAK P.. A TREATMENT WITH CONCENTRATED PRANDIAL INSULIN LISPRO 200 U/ML IN A PATIENT WITH TYPE 2 DIABETES MELLITUS AFTER LIVER TRANSPLANTATION.. KAZUISTIKY V DIABETOLOGII.. 2018;16(2):32-4,61.0,YR,A,F,Y,,,20190226.0,,MD,CZ,CZ,2019,Q1,Adult
160055471,16005547,3,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"20 U, TID",,,Y,U,,,209196.0,,,SOLUTION FOR INJECTION,Q8H,2019,Q1,Increased insulin requirement,,2019,Q1,1,I,,20181211.0,20190226,20190226,EXP,,CZ-SA-2018SA341004,SANOFI AVENTIS,ZAK P.. A TREATMENT WITH CONCENTRATED PRANDIAL INSULIN LISPRO 200 U/ML IN A PATIENT WITH TYPE 2 DIABETES MELLITUS AFTER LIVER TRANSPLANTATION.. KAZUISTIKY V DIABETOLOGII.. 2018;16(2):32-4,61.0,YR,A,F,Y,,,20190226.0,,MD,CZ,CZ,2019,Q1,Adult
160055471,16005547,3,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"20 U, TID",,,Y,U,,,209196.0,,,SOLUTION FOR INJECTION,Q8H,2019,Q1,Lipodystrophy acquired,,2019,Q1,1,I,,20181211.0,20190226,20190226,EXP,,CZ-SA-2018SA341004,SANOFI AVENTIS,ZAK P.. A TREATMENT WITH CONCENTRATED PRANDIAL INSULIN LISPRO 200 U/ML IN A PATIENT WITH TYPE 2 DIABETES MELLITUS AFTER LIVER TRANSPLANTATION.. KAZUISTIKY V DIABETOLOGII.. 2018;16(2):32-4,61.0,YR,A,F,Y,,,20190226.0,,MD,CZ,CZ,2019,Q1,Adult
160055471,16005547,3,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"20 U, TID",,,Y,U,,,209196.0,,,SOLUTION FOR INJECTION,Q8H,2019,Q1,Treatment noncompliance,,2019,Q1,1,I,,20181211.0,20190226,20190226,EXP,,CZ-SA-2018SA341004,SANOFI AVENTIS,ZAK P.. A TREATMENT WITH CONCENTRATED PRANDIAL INSULIN LISPRO 200 U/ML IN A PATIENT WITH TYPE 2 DIABETES MELLITUS AFTER LIVER TRANSPLANTATION.. KAZUISTIKY V DIABETOLOGII.. 2018;16(2):32-4,61.0,YR,A,F,Y,,,20190226.0,,MD,CZ,CZ,2019,Q1,Adult
160055471,16005547,3,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"20 U, TID",,,Y,U,,,209196.0,,,SOLUTION FOR INJECTION,Q8H,2019,Q1,Weight increased,,2019,Q1,1,I,,20181211.0,20190226,20190226,EXP,,CZ-SA-2018SA341004,SANOFI AVENTIS,ZAK P.. A TREATMENT WITH CONCENTRATED PRANDIAL INSULIN LISPRO 200 U/ML IN A PATIENT WITH TYPE 2 DIABETES MELLITUS AFTER LIVER TRANSPLANTATION.. KAZUISTIKY V DIABETOLOGII.. 2018;16(2):32-4,61.0,YR,A,F,Y,,,20190226.0,,MD,CZ,CZ,2019,Q1,Adult
160079591,16007959,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Agitation,,2019,Q1,1,I,20181015.0,20181105.0,20190226,20190226,EXP,,US-ROCHE-2212175,ROCHE,,60.0,YR,,M,Y,,,20190226.0,,MD,US,US,2019,Q1,Adult
160079591,16007959,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Blood ketone body increased,,2019,Q1,1,I,20181015.0,20181105.0,20190226,20190226,EXP,,US-ROCHE-2212175,ROCHE,,60.0,YR,,M,Y,,,20190226.0,,MD,US,US,2019,Q1,Adult
160079591,16007959,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Chills,,2019,Q1,1,I,20181015.0,20181105.0,20190226,20190226,EXP,,US-ROCHE-2212175,ROCHE,,60.0,YR,,M,Y,,,20190226.0,,MD,US,US,2019,Q1,Adult
160079591,16007959,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Confusional state,,2019,Q1,1,I,20181015.0,20181105.0,20190226,20190226,EXP,,US-ROCHE-2212175,ROCHE,,60.0,YR,,M,Y,,,20190226.0,,MD,US,US,2019,Q1,Adult
160079591,16007959,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Encephalopathy,,2019,Q1,1,I,20181015.0,20181105.0,20190226,20190226,EXP,,US-ROCHE-2212175,ROCHE,,60.0,YR,,M,Y,,,20190226.0,,MD,US,US,2019,Q1,Adult
160079591,16007959,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Mental disorder,,2019,Q1,1,I,20181015.0,20181105.0,20190226,20190226,EXP,,US-ROCHE-2212175,ROCHE,,60.0,YR,,M,Y,,,20190226.0,,MD,US,US,2019,Q1,Adult
160079591,16007959,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Pyrexia,,2019,Q1,1,I,20181015.0,20181105.0,20190226,20190226,EXP,,US-ROCHE-2212175,ROCHE,,60.0,YR,,M,Y,,,20190226.0,,MD,US,US,2019,Q1,Adult
160079591,16007959,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q1,Seizure,,2019,Q1,1,I,20181015.0,20181105.0,20190226,20190226,EXP,,US-ROCHE-2212175,ROCHE,,60.0,YR,,M,Y,,,20190226.0,,MD,US,US,2019,Q1,Adult
160103791,16010379,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 IU, UNK",,,Y,,,,,15.0,IU,,,2019,Q1,Cold sweat,,2019,Q1,1,I,20180529.0,20180615.0,20190225,20190225,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-057529,BRISTOL MYERS SQUIBB,,84.0,YR,,M,Y,,,20190225.0,,MD,IT,IT,2019,Q1,Elderly
160103791,16010379,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 IU, UNK",,,Y,,,,,15.0,IU,,,2019,Q1,Hypoglycaemic coma,,2019,Q1,1,I,20180529.0,20180615.0,20190225,20190225,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-057529,BRISTOL MYERS SQUIBB,,84.0,YR,,M,Y,,,20190225.0,,MD,IT,IT,2019,Q1,Elderly
160147983,16014798,14,C,INSULINE LISPRO,,2,Subcutaneous,"1 DF, UNK",,,U,,,,,1.0,DF,,,2019,Q1,Hepatitis,,2019,Q1,3,F,20190222.0,20190307.0,20190227,20190313,EXP,,ES-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-019935,BRISTOL MYERS SQUIBB,,60.0,YR,,M,Y,80.0,KG,20190313.0,,OT,ES,ES,2019,Q1,Adult
160173731,16017373,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 DF, QD",12990.0,DF,Y,,,,,30.0,DF,SOLUTION FOR INJECTION,QD,2019,Q1,Dysarthria,,2019,Q1,1,I,20181030.0,20190221.0,20190228,20190228,EXP,IT-MINISAL02-530996,IT-SA-2019SA051624,SANOFI AVENTIS,,74.0,YR,E,M,Y,,,20190228.0,,MD,IT,IT,2019,Q1,Elderly
160173731,16017373,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 DF, QD",12990.0,DF,Y,,,,,30.0,DF,SOLUTION FOR INJECTION,QD,2019,Q1,Facial paralysis,,2019,Q1,1,I,20181030.0,20190221.0,20190228,20190228,EXP,IT-MINISAL02-530996,IT-SA-2019SA051624,SANOFI AVENTIS,,74.0,YR,E,M,Y,,,20190228.0,,MD,IT,IT,2019,Q1,Elderly
160173731,16017373,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 DF, QD",12990.0,DF,Y,,,,,30.0,DF,SOLUTION FOR INJECTION,QD,2019,Q1,Hypoglycaemia,,2019,Q1,1,I,20181030.0,20190221.0,20190228,20190228,EXP,IT-MINISAL02-530996,IT-SA-2019SA051624,SANOFI AVENTIS,,74.0,YR,E,M,Y,,,20190228.0,,MD,IT,IT,2019,Q1,Elderly
160194911,16019491,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,UNKNOWN,,2019,Q1,Anaphylactic reaction,,2019,Q1,1,I,20181016.0,20190219.0,20190228,20190228,EXP,FR-AFSSAPS-TO20190212,FR-FRESENIUS KABI-FK201901915,FRESENIUS KABI,,65.0,YR,,,Y,,,20190228.0,,OT,GB,FR,2019,Q1,Elderly
160194911,16019491,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,UNKNOWN,,2019,Q1,Anaphylactic shock,,2019,Q1,1,I,20181016.0,20190219.0,20190228,20190228,EXP,FR-AFSSAPS-TO20190212,FR-FRESENIUS KABI-FK201901915,FRESENIUS KABI,,65.0,YR,,,Y,,,20190228.0,,OT,GB,FR,2019,Q1,Elderly
160232572,16023257,13,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,3 UNITS,,,,,,,,,,UNKNOWN,BID,2019,Q1,Adenocarcinoma gastric,,2019,Q1,2,F,20190124.0,20190320.0,20190301,20190327,EXP,,CA-CELGENEUS-CAN-20190207854,CELGENE,,70.0,YR,,F,Y,108.9,KG,20190327.0,,PH,CA,CA,2019,Q1,Elderly
160232572,16023257,13,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,3 UNITS,,,,,,,,,,UNKNOWN,BID,2019,Q1,Brain neoplasm,,2019,Q1,2,F,20190124.0,20190320.0,20190301,20190327,EXP,,CA-CELGENEUS-CAN-20190207854,CELGENE,,70.0,YR,,F,Y,108.9,KG,20190327.0,,PH,CA,CA,2019,Q1,Elderly
160232572,16023257,13,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,3 UNITS,,,,,,,,,,UNKNOWN,BID,2019,Q1,Internal haemorrhage,,2019,Q1,2,F,20190124.0,20190320.0,20190301,20190327,EXP,,CA-CELGENEUS-CAN-20190207854,CELGENE,,70.0,YR,,F,Y,108.9,KG,20190327.0,,PH,CA,CA,2019,Q1,Elderly
160244501,16024450,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 U,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Cataract operation,,2019,Q1,1,I,,20190222.0,20190301,20190301,EXP,,CA-SA-2019SA052051,SANOFI AVENTIS,,54.0,YR,A,F,Y,85.0,KG,20190301.0,,CN,CA,CA,2019,Q1,Adult
160244501,16024450,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 U,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Fatigue,,2019,Q1,1,I,,20190222.0,20190301,20190301,EXP,,CA-SA-2019SA052051,SANOFI AVENTIS,,54.0,YR,A,F,Y,85.0,KG,20190301.0,,CN,CA,CA,2019,Q1,Adult
160244501,16024450,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 U,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Increased appetite,,2019,Q1,1,I,,20190222.0,20190301,20190301,EXP,,CA-SA-2019SA052051,SANOFI AVENTIS,,54.0,YR,A,F,Y,85.0,KG,20190301.0,,CN,CA,CA,2019,Q1,Adult
160244501,16024450,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 U,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Nausea,,2019,Q1,1,I,,20190222.0,20190301,20190301,EXP,,CA-SA-2019SA052051,SANOFI AVENTIS,,54.0,YR,A,F,Y,85.0,KG,20190301.0,,CN,CA,CA,2019,Q1,Adult
160244501,16024450,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 U,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Off label use,,2019,Q1,1,I,,20190222.0,20190301,20190301,EXP,,CA-SA-2019SA052051,SANOFI AVENTIS,,54.0,YR,A,F,Y,85.0,KG,20190301.0,,CN,CA,CA,2019,Q1,Adult
160244501,16024450,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 U,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Pollakiuria,,2019,Q1,1,I,,20190222.0,20190301,20190301,EXP,,CA-SA-2019SA052051,SANOFI AVENTIS,,54.0,YR,A,F,Y,85.0,KG,20190301.0,,CN,CA,CA,2019,Q1,Adult
160244501,16024450,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 U,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Thirst,,2019,Q1,1,I,,20190222.0,20190301,20190301,EXP,,CA-SA-2019SA052051,SANOFI AVENTIS,,54.0,YR,A,F,Y,85.0,KG,20190301.0,,CN,CA,CA,2019,Q1,Adult
160344641,16034464,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2019,Q1,Drug effect incomplete,,2019,Q1,1,I,,20161107.0,20190305,20190305,PER,,US-PFIZER INC-2016521477,PFIZER,,81.0,YR,,F,Y,80.73,KG,20190305.0,,MD,US,US,2019,Q1,Elderly
160374141,16037414,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q1,Abdominal pain,,2019,Q1,1,I,20181028.0,20190221.0,20190305,20190305,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-019154,BRISTOL MYERS SQUIBB,,86.0,YR,,M,Y,,,20190305.0,,MD,IT,IT,2019,Q1,Elderly
160374141,16037414,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q1,Anaemia,,2019,Q1,1,I,20181028.0,20190221.0,20190305,20190305,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-019154,BRISTOL MYERS SQUIBB,,86.0,YR,,M,Y,,,20190305.0,,MD,IT,IT,2019,Q1,Elderly
160374141,16037414,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q1,Diarrhoea,,2019,Q1,1,I,20181028.0,20190221.0,20190305,20190305,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-019154,BRISTOL MYERS SQUIBB,,86.0,YR,,M,Y,,,20190305.0,,MD,IT,IT,2019,Q1,Elderly
160374141,16037414,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q1,Gastric ulcer,,2019,Q1,1,I,20181028.0,20190221.0,20190305,20190305,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-019154,BRISTOL MYERS SQUIBB,,86.0,YR,,M,Y,,,20190305.0,,MD,IT,IT,2019,Q1,Elderly
160374141,16037414,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q1,Gastritis,,2019,Q1,1,I,20181028.0,20190221.0,20190305,20190305,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-019154,BRISTOL MYERS SQUIBB,,86.0,YR,,M,Y,,,20190305.0,,MD,IT,IT,2019,Q1,Elderly
160374141,16037414,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q1,Melaena,,2019,Q1,1,I,20181028.0,20190221.0,20190305,20190305,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-019154,BRISTOL MYERS SQUIBB,,86.0,YR,,M,Y,,,20190305.0,,MD,IT,IT,2019,Q1,Elderly
160374141,16037414,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q1,Presyncope,,2019,Q1,1,I,20181028.0,20190221.0,20190305,20190305,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-019154,BRISTOL MYERS SQUIBB,,86.0,YR,,M,Y,,,20190305.0,,MD,IT,IT,2019,Q1,Elderly
160374141,16037414,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q1,Ulcer haemorrhage,,2019,Q1,1,I,20181028.0,20190221.0,20190305,20190305,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-019154,BRISTOL MYERS SQUIBB,,86.0,YR,,M,Y,,,20190305.0,,MD,IT,IT,2019,Q1,Elderly
160374141,16037414,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q1,Vertigo,,2019,Q1,1,I,20181028.0,20190221.0,20190305,20190305,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-019154,BRISTOL MYERS SQUIBB,,86.0,YR,,M,Y,,,20190305.0,,MD,IT,IT,2019,Q1,Elderly
160430401,16043040,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 U, TID,10 UNITS TDS WITH MEALS",,,U,,,,,,,SOLUTION FOR INJECTION,Q8H,2019,Q1,Body mass index increased,,2019,Q1,1,I,,20190226.0,20190306,20190306,EXP,,AU-SA-2019SA055178,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20190306.0,,MD,AU,AU,2019,Q1,Elderly
160430401,16043040,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 U, TID,10 UNITS TDS WITH MEALS",,,U,,,,,,,SOLUTION FOR INJECTION,Q8H,2019,Q1,Fluid retention,,2019,Q1,1,I,,20190226.0,20190306,20190306,EXP,,AU-SA-2019SA055178,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20190306.0,,MD,AU,AU,2019,Q1,Elderly
160430401,16043040,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 U, TID,10 UNITS TDS WITH MEALS",,,U,,,,,,,SOLUTION FOR INJECTION,Q8H,2019,Q1,Glycosylated haemoglobin increased,,2019,Q1,1,I,,20190226.0,20190306,20190306,EXP,,AU-SA-2019SA055178,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20190306.0,,MD,AU,AU,2019,Q1,Elderly
160430401,16043040,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 U, TID,10 UNITS TDS WITH MEALS",,,U,,,,,,,SOLUTION FOR INJECTION,Q8H,2019,Q1,Hypoglycaemia,,2019,Q1,1,I,,20190226.0,20190306,20190306,EXP,,AU-SA-2019SA055178,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20190306.0,,MD,AU,AU,2019,Q1,Elderly
160430401,16043040,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 U, TID,10 UNITS TDS WITH MEALS",,,U,,,,,,,SOLUTION FOR INJECTION,Q8H,2019,Q1,Insulinoma,,2019,Q1,1,I,,20190226.0,20190306,20190306,EXP,,AU-SA-2019SA055178,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20190306.0,,MD,AU,AU,2019,Q1,Elderly
160430401,16043040,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 U, TID,10 UNITS TDS WITH MEALS",,,U,,,,,,,SOLUTION FOR INJECTION,Q8H,2019,Q1,Weight decreased,,2019,Q1,1,I,,20190226.0,20190306,20190306,EXP,,AU-SA-2019SA055178,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20190306.0,,MD,AU,AU,2019,Q1,Elderly
160433312,16043331,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Anxiety disorder,,2019,Q1,2,F,,20190227.0,20190306,20190308,EXP,,US-SA-2019SA058291,SANOFI AVENTIS,,50.0,YR,A,F,Y,,,20190308.0,,CN,US,US,2019,Q1,Adult
160433312,16043331,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Depression,,2019,Q1,2,F,,20190227.0,20190306,20190308,EXP,,US-SA-2019SA058291,SANOFI AVENTIS,,50.0,YR,A,F,Y,,,20190308.0,,CN,US,US,2019,Q1,Adult
160433312,16043331,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Eye disorder,,2019,Q1,2,F,,20190227.0,20190306,20190308,EXP,,US-SA-2019SA058291,SANOFI AVENTIS,,50.0,YR,A,F,Y,,,20190308.0,,CN,US,US,2019,Q1,Adult
160433312,16043331,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Inappropriate schedule of product administration,,2019,Q1,2,F,,20190227.0,20190306,20190308,EXP,,US-SA-2019SA058291,SANOFI AVENTIS,,50.0,YR,A,F,Y,,,20190308.0,,CN,US,US,2019,Q1,Adult
160433312,16043331,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Neuropathy peripheral,,2019,Q1,2,F,,20190227.0,20190306,20190308,EXP,,US-SA-2019SA058291,SANOFI AVENTIS,,50.0,YR,A,F,Y,,,20190308.0,,CN,US,US,2019,Q1,Adult
160433312,16043331,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Sciatica,,2019,Q1,2,F,,20190227.0,20190306,20190308,EXP,,US-SA-2019SA058291,SANOFI AVENTIS,,50.0,YR,A,F,Y,,,20190308.0,,CN,US,US,2019,Q1,Adult
160524951,16052495,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"12 U, BID",,,U,U,,,20563.0,,,,BID,2019,Q1,Cataract,,2019,Q1,1,I,,20190227.0,20190308,20190308,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201903000123,ELI LILLY AND CO,,81.0,YR,,M,Y,75.0,KG,20190308.0,,CN,CN,CN,2019,Q1,Elderly
160524951,16052495,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, DAILY (NOON)",,,U,U,,,20563.0,,,,QD,2019,Q1,Cataract,,2019,Q1,1,I,,20190227.0,20190308,20190308,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201903000123,ELI LILLY AND CO,,81.0,YR,,M,Y,75.0,KG,20190308.0,,CN,CN,CN,2019,Q1,Elderly
160524971,16052497,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,STARTED,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Blood glucose increased,,2019,Q1,1,I,,20190228.0,20190308,20190308,EXP,,JP-SA-2019SA060699,SANOFI AVENTIS,"NAGASE T., KATSURA Y., IWAKI Y., NEMOTO K., SEKINE H., MIWA K., ET AL.,. THE INSULIN BALL. LANCET. 2009;373:184",62.0,YR,A,M,Y,,,20190308.0,,MD,JP,JP,2019,Q1,Adult
160524971,16052497,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,STARTED,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Cutaneous amyloidosis,,2019,Q1,1,I,,20190228.0,20190308,20190308,EXP,,JP-SA-2019SA060699,SANOFI AVENTIS,"NAGASE T., KATSURA Y., IWAKI Y., NEMOTO K., SEKINE H., MIWA K., ET AL.,. THE INSULIN BALL. LANCET. 2009;373:184",62.0,YR,A,M,Y,,,20190308.0,,MD,JP,JP,2019,Q1,Adult
160524971,16052497,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,STARTED,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Diabetes mellitus inadequate control,,2019,Q1,1,I,,20190228.0,20190308,20190308,EXP,,JP-SA-2019SA060699,SANOFI AVENTIS,"NAGASE T., KATSURA Y., IWAKI Y., NEMOTO K., SEKINE H., MIWA K., ET AL.,. THE INSULIN BALL. LANCET. 2009;373:184",62.0,YR,A,M,Y,,,20190308.0,,MD,JP,JP,2019,Q1,Adult
160524971,16052497,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,STARTED,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Glycosylated haemoglobin increased,,2019,Q1,1,I,,20190228.0,20190308,20190308,EXP,,JP-SA-2019SA060699,SANOFI AVENTIS,"NAGASE T., KATSURA Y., IWAKI Y., NEMOTO K., SEKINE H., MIWA K., ET AL.,. THE INSULIN BALL. LANCET. 2009;373:184",62.0,YR,A,M,Y,,,20190308.0,,MD,JP,JP,2019,Q1,Adult
160524971,16052497,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,STARTED,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Hypoglycaemia,,2019,Q1,1,I,,20190228.0,20190308,20190308,EXP,,JP-SA-2019SA060699,SANOFI AVENTIS,"NAGASE T., KATSURA Y., IWAKI Y., NEMOTO K., SEKINE H., MIWA K., ET AL.,. THE INSULIN BALL. LANCET. 2009;373:184",62.0,YR,A,M,Y,,,20190308.0,,MD,JP,JP,2019,Q1,Adult
160524971,16052497,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,STARTED,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Insulin resistance,,2019,Q1,1,I,,20190228.0,20190308,20190308,EXP,,JP-SA-2019SA060699,SANOFI AVENTIS,"NAGASE T., KATSURA Y., IWAKI Y., NEMOTO K., SEKINE H., MIWA K., ET AL.,. THE INSULIN BALL. LANCET. 2009;373:184",62.0,YR,A,M,Y,,,20190308.0,,MD,JP,JP,2019,Q1,Adult
160524971,16052497,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,,GRADUALLY INCREASED,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Blood glucose increased,,2019,Q1,1,I,,20190228.0,20190308,20190308,EXP,,JP-SA-2019SA060699,SANOFI AVENTIS,"NAGASE T., KATSURA Y., IWAKI Y., NEMOTO K., SEKINE H., MIWA K., ET AL.,. THE INSULIN BALL. LANCET. 2009;373:184",62.0,YR,A,M,Y,,,20190308.0,,MD,JP,JP,2019,Q1,Adult
160524971,16052497,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,,GRADUALLY INCREASED,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Cutaneous amyloidosis,,2019,Q1,1,I,,20190228.0,20190308,20190308,EXP,,JP-SA-2019SA060699,SANOFI AVENTIS,"NAGASE T., KATSURA Y., IWAKI Y., NEMOTO K., SEKINE H., MIWA K., ET AL.,. THE INSULIN BALL. LANCET. 2009;373:184",62.0,YR,A,M,Y,,,20190308.0,,MD,JP,JP,2019,Q1,Adult
160524971,16052497,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,,GRADUALLY INCREASED,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Diabetes mellitus inadequate control,,2019,Q1,1,I,,20190228.0,20190308,20190308,EXP,,JP-SA-2019SA060699,SANOFI AVENTIS,"NAGASE T., KATSURA Y., IWAKI Y., NEMOTO K., SEKINE H., MIWA K., ET AL.,. THE INSULIN BALL. LANCET. 2009;373:184",62.0,YR,A,M,Y,,,20190308.0,,MD,JP,JP,2019,Q1,Adult
160524971,16052497,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,,GRADUALLY INCREASED,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Glycosylated haemoglobin increased,,2019,Q1,1,I,,20190228.0,20190308,20190308,EXP,,JP-SA-2019SA060699,SANOFI AVENTIS,"NAGASE T., KATSURA Y., IWAKI Y., NEMOTO K., SEKINE H., MIWA K., ET AL.,. THE INSULIN BALL. LANCET. 2009;373:184",62.0,YR,A,M,Y,,,20190308.0,,MD,JP,JP,2019,Q1,Adult
160524971,16052497,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,,GRADUALLY INCREASED,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Hypoglycaemia,,2019,Q1,1,I,,20190228.0,20190308,20190308,EXP,,JP-SA-2019SA060699,SANOFI AVENTIS,"NAGASE T., KATSURA Y., IWAKI Y., NEMOTO K., SEKINE H., MIWA K., ET AL.,. THE INSULIN BALL. LANCET. 2009;373:184",62.0,YR,A,M,Y,,,20190308.0,,MD,JP,JP,2019,Q1,Adult
160524971,16052497,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,,GRADUALLY INCREASED,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Insulin resistance,,2019,Q1,1,I,,20190228.0,20190308,20190308,EXP,,JP-SA-2019SA060699,SANOFI AVENTIS,"NAGASE T., KATSURA Y., IWAKI Y., NEMOTO K., SEKINE H., MIWA K., ET AL.,. THE INSULIN BALL. LANCET. 2009;373:184",62.0,YR,A,M,Y,,,20190308.0,,MD,JP,JP,2019,Q1,Adult
160524971,16052497,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"94 U, QD (INCREASED THE TOTAL DAILY DOSE OF INSULIN)",,,U,,,,,,,SOLUTION FOR INJECTION,QD,2019,Q1,Blood glucose increased,,2019,Q1,1,I,,20190228.0,20190308,20190308,EXP,,JP-SA-2019SA060699,SANOFI AVENTIS,"NAGASE T., KATSURA Y., IWAKI Y., NEMOTO K., SEKINE H., MIWA K., ET AL.,. THE INSULIN BALL. LANCET. 2009;373:184",62.0,YR,A,M,Y,,,20190308.0,,MD,JP,JP,2019,Q1,Adult
160524971,16052497,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"94 U, QD (INCREASED THE TOTAL DAILY DOSE OF INSULIN)",,,U,,,,,,,SOLUTION FOR INJECTION,QD,2019,Q1,Cutaneous amyloidosis,,2019,Q1,1,I,,20190228.0,20190308,20190308,EXP,,JP-SA-2019SA060699,SANOFI AVENTIS,"NAGASE T., KATSURA Y., IWAKI Y., NEMOTO K., SEKINE H., MIWA K., ET AL.,. THE INSULIN BALL. LANCET. 2009;373:184",62.0,YR,A,M,Y,,,20190308.0,,MD,JP,JP,2019,Q1,Adult
160524971,16052497,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"94 U, QD (INCREASED THE TOTAL DAILY DOSE OF INSULIN)",,,U,,,,,,,SOLUTION FOR INJECTION,QD,2019,Q1,Diabetes mellitus inadequate control,,2019,Q1,1,I,,20190228.0,20190308,20190308,EXP,,JP-SA-2019SA060699,SANOFI AVENTIS,"NAGASE T., KATSURA Y., IWAKI Y., NEMOTO K., SEKINE H., MIWA K., ET AL.,. THE INSULIN BALL. LANCET. 2009;373:184",62.0,YR,A,M,Y,,,20190308.0,,MD,JP,JP,2019,Q1,Adult
160524971,16052497,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"94 U, QD (INCREASED THE TOTAL DAILY DOSE OF INSULIN)",,,U,,,,,,,SOLUTION FOR INJECTION,QD,2019,Q1,Glycosylated haemoglobin increased,,2019,Q1,1,I,,20190228.0,20190308,20190308,EXP,,JP-SA-2019SA060699,SANOFI AVENTIS,"NAGASE T., KATSURA Y., IWAKI Y., NEMOTO K., SEKINE H., MIWA K., ET AL.,. THE INSULIN BALL. LANCET. 2009;373:184",62.0,YR,A,M,Y,,,20190308.0,,MD,JP,JP,2019,Q1,Adult
160524971,16052497,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"94 U, QD (INCREASED THE TOTAL DAILY DOSE OF INSULIN)",,,U,,,,,,,SOLUTION FOR INJECTION,QD,2019,Q1,Hypoglycaemia,,2019,Q1,1,I,,20190228.0,20190308,20190308,EXP,,JP-SA-2019SA060699,SANOFI AVENTIS,"NAGASE T., KATSURA Y., IWAKI Y., NEMOTO K., SEKINE H., MIWA K., ET AL.,. THE INSULIN BALL. LANCET. 2009;373:184",62.0,YR,A,M,Y,,,20190308.0,,MD,JP,JP,2019,Q1,Adult
160524971,16052497,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"94 U, QD (INCREASED THE TOTAL DAILY DOSE OF INSULIN)",,,U,,,,,,,SOLUTION FOR INJECTION,QD,2019,Q1,Insulin resistance,,2019,Q1,1,I,,20190228.0,20190308,20190308,EXP,,JP-SA-2019SA060699,SANOFI AVENTIS,"NAGASE T., KATSURA Y., IWAKI Y., NEMOTO K., SEKINE H., MIWA K., ET AL.,. THE INSULIN BALL. LANCET. 2009;373:184",62.0,YR,A,M,Y,,,20190308.0,,MD,JP,JP,2019,Q1,Adult
160524971,16052497,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,,RAPIDLY DECREASED INSULIN DOSES,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Blood glucose increased,,2019,Q1,1,I,,20190228.0,20190308,20190308,EXP,,JP-SA-2019SA060699,SANOFI AVENTIS,"NAGASE T., KATSURA Y., IWAKI Y., NEMOTO K., SEKINE H., MIWA K., ET AL.,. THE INSULIN BALL. LANCET. 2009;373:184",62.0,YR,A,M,Y,,,20190308.0,,MD,JP,JP,2019,Q1,Adult
160524971,16052497,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,,RAPIDLY DECREASED INSULIN DOSES,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Cutaneous amyloidosis,,2019,Q1,1,I,,20190228.0,20190308,20190308,EXP,,JP-SA-2019SA060699,SANOFI AVENTIS,"NAGASE T., KATSURA Y., IWAKI Y., NEMOTO K., SEKINE H., MIWA K., ET AL.,. THE INSULIN BALL. LANCET. 2009;373:184",62.0,YR,A,M,Y,,,20190308.0,,MD,JP,JP,2019,Q1,Adult
160524971,16052497,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,,RAPIDLY DECREASED INSULIN DOSES,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Diabetes mellitus inadequate control,,2019,Q1,1,I,,20190228.0,20190308,20190308,EXP,,JP-SA-2019SA060699,SANOFI AVENTIS,"NAGASE T., KATSURA Y., IWAKI Y., NEMOTO K., SEKINE H., MIWA K., ET AL.,. THE INSULIN BALL. LANCET. 2009;373:184",62.0,YR,A,M,Y,,,20190308.0,,MD,JP,JP,2019,Q1,Adult
160524971,16052497,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,,RAPIDLY DECREASED INSULIN DOSES,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Glycosylated haemoglobin increased,,2019,Q1,1,I,,20190228.0,20190308,20190308,EXP,,JP-SA-2019SA060699,SANOFI AVENTIS,"NAGASE T., KATSURA Y., IWAKI Y., NEMOTO K., SEKINE H., MIWA K., ET AL.,. THE INSULIN BALL. LANCET. 2009;373:184",62.0,YR,A,M,Y,,,20190308.0,,MD,JP,JP,2019,Q1,Adult
160524971,16052497,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,,RAPIDLY DECREASED INSULIN DOSES,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Hypoglycaemia,,2019,Q1,1,I,,20190228.0,20190308,20190308,EXP,,JP-SA-2019SA060699,SANOFI AVENTIS,"NAGASE T., KATSURA Y., IWAKI Y., NEMOTO K., SEKINE H., MIWA K., ET AL.,. THE INSULIN BALL. LANCET. 2009;373:184",62.0,YR,A,M,Y,,,20190308.0,,MD,JP,JP,2019,Q1,Adult
160524971,16052497,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,,RAPIDLY DECREASED INSULIN DOSES,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Insulin resistance,,2019,Q1,1,I,,20190228.0,20190308,20190308,EXP,,JP-SA-2019SA060699,SANOFI AVENTIS,"NAGASE T., KATSURA Y., IWAKI Y., NEMOTO K., SEKINE H., MIWA K., ET AL.,. THE INSULIN BALL. LANCET. 2009;373:184",62.0,YR,A,M,Y,,,20190308.0,,MD,JP,JP,2019,Q1,Adult
160524971,16052497,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"18 U, QD",,,U,,,,,,,SOLUTION FOR INJECTION,QD,2019,Q1,Blood glucose increased,,2019,Q1,1,I,,20190228.0,20190308,20190308,EXP,,JP-SA-2019SA060699,SANOFI AVENTIS,"NAGASE T., KATSURA Y., IWAKI Y., NEMOTO K., SEKINE H., MIWA K., ET AL.,. THE INSULIN BALL. LANCET. 2009;373:184",62.0,YR,A,M,Y,,,20190308.0,,MD,JP,JP,2019,Q1,Adult
160524971,16052497,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"18 U, QD",,,U,,,,,,,SOLUTION FOR INJECTION,QD,2019,Q1,Cutaneous amyloidosis,,2019,Q1,1,I,,20190228.0,20190308,20190308,EXP,,JP-SA-2019SA060699,SANOFI AVENTIS,"NAGASE T., KATSURA Y., IWAKI Y., NEMOTO K., SEKINE H., MIWA K., ET AL.,. THE INSULIN BALL. LANCET. 2009;373:184",62.0,YR,A,M,Y,,,20190308.0,,MD,JP,JP,2019,Q1,Adult
160524971,16052497,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"18 U, QD",,,U,,,,,,,SOLUTION FOR INJECTION,QD,2019,Q1,Diabetes mellitus inadequate control,,2019,Q1,1,I,,20190228.0,20190308,20190308,EXP,,JP-SA-2019SA060699,SANOFI AVENTIS,"NAGASE T., KATSURA Y., IWAKI Y., NEMOTO K., SEKINE H., MIWA K., ET AL.,. THE INSULIN BALL. LANCET. 2009;373:184",62.0,YR,A,M,Y,,,20190308.0,,MD,JP,JP,2019,Q1,Adult
160524971,16052497,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"18 U, QD",,,U,,,,,,,SOLUTION FOR INJECTION,QD,2019,Q1,Glycosylated haemoglobin increased,,2019,Q1,1,I,,20190228.0,20190308,20190308,EXP,,JP-SA-2019SA060699,SANOFI AVENTIS,"NAGASE T., KATSURA Y., IWAKI Y., NEMOTO K., SEKINE H., MIWA K., ET AL.,. THE INSULIN BALL. LANCET. 2009;373:184",62.0,YR,A,M,Y,,,20190308.0,,MD,JP,JP,2019,Q1,Adult
160524971,16052497,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"18 U, QD",,,U,,,,,,,SOLUTION FOR INJECTION,QD,2019,Q1,Hypoglycaemia,,2019,Q1,1,I,,20190228.0,20190308,20190308,EXP,,JP-SA-2019SA060699,SANOFI AVENTIS,"NAGASE T., KATSURA Y., IWAKI Y., NEMOTO K., SEKINE H., MIWA K., ET AL.,. THE INSULIN BALL. LANCET. 2009;373:184",62.0,YR,A,M,Y,,,20190308.0,,MD,JP,JP,2019,Q1,Adult
160524971,16052497,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"18 U, QD",,,U,,,,,,,SOLUTION FOR INJECTION,QD,2019,Q1,Insulin resistance,,2019,Q1,1,I,,20190228.0,20190308,20190308,EXP,,JP-SA-2019SA060699,SANOFI AVENTIS,"NAGASE T., KATSURA Y., IWAKI Y., NEMOTO K., SEKINE H., MIWA K., ET AL.,. THE INSULIN BALL. LANCET. 2009;373:184",62.0,YR,A,M,Y,,,20190308.0,,MD,JP,JP,2019,Q1,Adult
160524971,16052497,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,,(TOTAL OF 66 UNITS OF INSULIN),,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Blood glucose increased,,2019,Q1,1,I,,20190228.0,20190308,20190308,EXP,,JP-SA-2019SA060699,SANOFI AVENTIS,"NAGASE T., KATSURA Y., IWAKI Y., NEMOTO K., SEKINE H., MIWA K., ET AL.,. THE INSULIN BALL. LANCET. 2009;373:184",62.0,YR,A,M,Y,,,20190308.0,,MD,JP,JP,2019,Q1,Adult
160524971,16052497,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,,(TOTAL OF 66 UNITS OF INSULIN),,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Cutaneous amyloidosis,,2019,Q1,1,I,,20190228.0,20190308,20190308,EXP,,JP-SA-2019SA060699,SANOFI AVENTIS,"NAGASE T., KATSURA Y., IWAKI Y., NEMOTO K., SEKINE H., MIWA K., ET AL.,. THE INSULIN BALL. LANCET. 2009;373:184",62.0,YR,A,M,Y,,,20190308.0,,MD,JP,JP,2019,Q1,Adult
160524971,16052497,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,,(TOTAL OF 66 UNITS OF INSULIN),,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Diabetes mellitus inadequate control,,2019,Q1,1,I,,20190228.0,20190308,20190308,EXP,,JP-SA-2019SA060699,SANOFI AVENTIS,"NAGASE T., KATSURA Y., IWAKI Y., NEMOTO K., SEKINE H., MIWA K., ET AL.,. THE INSULIN BALL. LANCET. 2009;373:184",62.0,YR,A,M,Y,,,20190308.0,,MD,JP,JP,2019,Q1,Adult
160524971,16052497,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,,(TOTAL OF 66 UNITS OF INSULIN),,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Glycosylated haemoglobin increased,,2019,Q1,1,I,,20190228.0,20190308,20190308,EXP,,JP-SA-2019SA060699,SANOFI AVENTIS,"NAGASE T., KATSURA Y., IWAKI Y., NEMOTO K., SEKINE H., MIWA K., ET AL.,. THE INSULIN BALL. LANCET. 2009;373:184",62.0,YR,A,M,Y,,,20190308.0,,MD,JP,JP,2019,Q1,Adult
160524971,16052497,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,,(TOTAL OF 66 UNITS OF INSULIN),,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Hypoglycaemia,,2019,Q1,1,I,,20190228.0,20190308,20190308,EXP,,JP-SA-2019SA060699,SANOFI AVENTIS,"NAGASE T., KATSURA Y., IWAKI Y., NEMOTO K., SEKINE H., MIWA K., ET AL.,. THE INSULIN BALL. LANCET. 2009;373:184",62.0,YR,A,M,Y,,,20190308.0,,MD,JP,JP,2019,Q1,Adult
160524971,16052497,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,,(TOTAL OF 66 UNITS OF INSULIN),,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Insulin resistance,,2019,Q1,1,I,,20190228.0,20190308,20190308,EXP,,JP-SA-2019SA060699,SANOFI AVENTIS,"NAGASE T., KATSURA Y., IWAKI Y., NEMOTO K., SEKINE H., MIWA K., ET AL.,. THE INSULIN BALL. LANCET. 2009;373:184",62.0,YR,A,M,Y,,,20190308.0,,MD,JP,JP,2019,Q1,Adult
160585891,16058589,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 IU, QD",570.0,IU,Y,,,,,15.0,IU,SOLUTION FOR INJECTION,QD,2019,Q1,Hypoglycaemia,,2019,Q1,1,I,20190207.0,20190304.0,20190311,20190311,EXP,IT-MINISAL02-533119,IT-SA-2019SA061347,SANOFI AVENTIS,,86.0,YR,E,F,Y,,,20190311.0,,MD,IT,IT,2019,Q1,Elderly
160585891,16058589,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 IU, QD",570.0,IU,Y,,,,,15.0,IU,SOLUTION FOR INJECTION,QD,2019,Q1,Loss of consciousness,,2019,Q1,1,I,20190207.0,20190304.0,20190311,20190311,EXP,IT-MINISAL02-533119,IT-SA-2019SA061347,SANOFI AVENTIS,,86.0,YR,E,F,Y,,,20190311.0,,MD,IT,IT,2019,Q1,Elderly
160585891,16058589,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 IU, QD",570.0,IU,Y,,,,,15.0,IU,SOLUTION FOR INJECTION,QD,2019,Q1,Presyncope,,2019,Q1,1,I,20190207.0,20190304.0,20190311,20190311,EXP,IT-MINISAL02-533119,IT-SA-2019SA061347,SANOFI AVENTIS,,86.0,YR,E,F,Y,,,20190311.0,,MD,IT,IT,2019,Q1,Elderly
160670921,16067092,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"4 IU, AT EACH MEAL",,,U,,,,,4.0,IU,SOLUTION FOR INJECTION,,2019,Q1,Blood glucose fluctuation,,2019,Q1,1,I,,20190307.0,20190313,20190313,EXP,,IT-SA-2019SA066496,SANOFI AVENTIS,"BONORA BM, AVOGARO A, FADINI GP. EXPOSURE TO INSULIN DEGLUDEC DURING PREGNANCY: REPORT OF A SMALL SERIES AND REVIEW OF THE LITERATURE. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION. 2019;42(3):345-349",26.0,YR,A,F,Y,,,20190313.0,,OT,IT,IT,2019,Q1,Young Adult
160670921,16067092,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"4 IU, AT EACH MEAL",,,U,,,,,4.0,IU,SOLUTION FOR INJECTION,,2019,Q1,Diabetes mellitus inadequate control,,2019,Q1,1,I,,20190307.0,20190313,20190313,EXP,,IT-SA-2019SA066496,SANOFI AVENTIS,"BONORA BM, AVOGARO A, FADINI GP. EXPOSURE TO INSULIN DEGLUDEC DURING PREGNANCY: REPORT OF A SMALL SERIES AND REVIEW OF THE LITERATURE. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION. 2019;42(3):345-349",26.0,YR,A,F,Y,,,20190313.0,,OT,IT,IT,2019,Q1,Young Adult
160670921,16067092,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"4 IU, AT EACH MEAL",,,U,,,,,4.0,IU,SOLUTION FOR INJECTION,,2019,Q1,Exposure during pregnancy,,2019,Q1,1,I,,20190307.0,20190313,20190313,EXP,,IT-SA-2019SA066496,SANOFI AVENTIS,"BONORA BM, AVOGARO A, FADINI GP. EXPOSURE TO INSULIN DEGLUDEC DURING PREGNANCY: REPORT OF A SMALL SERIES AND REVIEW OF THE LITERATURE. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION. 2019;42(3):345-349",26.0,YR,A,F,Y,,,20190313.0,,OT,IT,IT,2019,Q1,Young Adult
160670921,16067092,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"4 IU, AT EACH MEAL",,,U,,,,,4.0,IU,SOLUTION FOR INJECTION,,2019,Q1,Hypoglycaemia,,2019,Q1,1,I,,20190307.0,20190313,20190313,EXP,,IT-SA-2019SA066496,SANOFI AVENTIS,"BONORA BM, AVOGARO A, FADINI GP. EXPOSURE TO INSULIN DEGLUDEC DURING PREGNANCY: REPORT OF A SMALL SERIES AND REVIEW OF THE LITERATURE. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION. 2019;42(3):345-349",26.0,YR,A,F,Y,,,20190313.0,,OT,IT,IT,2019,Q1,Young Adult
160670921,16067092,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"4 IU, AT EACH MEAL",,,U,,,,,4.0,IU,SOLUTION FOR INJECTION,,2019,Q1,Mitral valve stenosis,,2019,Q1,1,I,,20190307.0,20190313,20190313,EXP,,IT-SA-2019SA066496,SANOFI AVENTIS,"BONORA BM, AVOGARO A, FADINI GP. EXPOSURE TO INSULIN DEGLUDEC DURING PREGNANCY: REPORT OF A SMALL SERIES AND REVIEW OF THE LITERATURE. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION. 2019;42(3):345-349",26.0,YR,A,F,Y,,,20190313.0,,OT,IT,IT,2019,Q1,Young Adult
160736761,16073676,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2019,Q1,Acute kidney injury,,2019,Q1,1,I,2018.0,20190304.0,20190314,20190314,EXP,,US-AMGEN-USASP2019038290,AMGEN,,65.0,YR,E,F,Y,,,20190314.0,,MD,US,US,2019,Q1,Elderly
160736761,16073676,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2019,Q1,Aphasia,,2019,Q1,1,I,2018.0,20190304.0,20190314,20190314,EXP,,US-AMGEN-USASP2019038290,AMGEN,,65.0,YR,E,F,Y,,,20190314.0,,MD,US,US,2019,Q1,Elderly
160736761,16073676,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2019,Q1,Clostridium difficile colitis,,2019,Q1,1,I,2018.0,20190304.0,20190314,20190314,EXP,,US-AMGEN-USASP2019038290,AMGEN,,65.0,YR,E,F,Y,,,20190314.0,,MD,US,US,2019,Q1,Elderly
160736761,16073676,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2019,Q1,Drug ineffective,,2019,Q1,1,I,2018.0,20190304.0,20190314,20190314,EXP,,US-AMGEN-USASP2019038290,AMGEN,,65.0,YR,E,F,Y,,,20190314.0,,MD,US,US,2019,Q1,Elderly
160736761,16073676,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2019,Q1,Haemorrhagic anaemia,,2019,Q1,1,I,2018.0,20190304.0,20190314,20190314,EXP,,US-AMGEN-USASP2019038290,AMGEN,,65.0,YR,E,F,Y,,,20190314.0,,MD,US,US,2019,Q1,Elderly
160736761,16073676,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2019,Q1,Hepatic steatosis,,2019,Q1,1,I,2018.0,20190304.0,20190314,20190314,EXP,,US-AMGEN-USASP2019038290,AMGEN,,65.0,YR,E,F,Y,,,20190314.0,,MD,US,US,2019,Q1,Elderly
160736761,16073676,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2019,Q1,Myocardial infarction,,2019,Q1,1,I,2018.0,20190304.0,20190314,20190314,EXP,,US-AMGEN-USASP2019038290,AMGEN,,65.0,YR,E,F,Y,,,20190314.0,,MD,US,US,2019,Q1,Elderly
160736761,16073676,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2019,Q1,Pneumonia,,2019,Q1,1,I,2018.0,20190304.0,20190314,20190314,EXP,,US-AMGEN-USASP2019038290,AMGEN,,65.0,YR,E,F,Y,,,20190314.0,,MD,US,US,2019,Q1,Elderly
160736761,16073676,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2019,Q1,Pulmonary oedema,,2019,Q1,1,I,2018.0,20190304.0,20190314,20190314,EXP,,US-AMGEN-USASP2019038290,AMGEN,,65.0,YR,E,F,Y,,,20190314.0,,MD,US,US,2019,Q1,Elderly
160736761,16073676,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2019,Q1,Respiratory failure,,2019,Q1,1,I,2018.0,20190304.0,20190314,20190314,EXP,,US-AMGEN-USASP2019038290,AMGEN,,65.0,YR,E,F,Y,,,20190314.0,,MD,US,US,2019,Q1,Elderly
160736761,16073676,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2019,Q1,Sciatica,,2019,Q1,1,I,2018.0,20190304.0,20190314,20190314,EXP,,US-AMGEN-USASP2019038290,AMGEN,,65.0,YR,E,F,Y,,,20190314.0,,MD,US,US,2019,Q1,Elderly
160736761,16073676,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2019,Q1,Sepsis,,2019,Q1,1,I,2018.0,20190304.0,20190314,20190314,EXP,,US-AMGEN-USASP2019038290,AMGEN,,65.0,YR,E,F,Y,,,20190314.0,,MD,US,US,2019,Q1,Elderly
160736761,16073676,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2019,Q1,Septic shock,,2019,Q1,1,I,2018.0,20190304.0,20190314,20190314,EXP,,US-AMGEN-USASP2019038290,AMGEN,,65.0,YR,E,F,Y,,,20190314.0,,MD,US,US,2019,Q1,Elderly
160736761,16073676,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2019,Q1,Supraventricular tachycardia,,2019,Q1,1,I,2018.0,20190304.0,20190314,20190314,EXP,,US-AMGEN-USASP2019038290,AMGEN,,65.0,YR,E,F,Y,,,20190314.0,,MD,US,US,2019,Q1,Elderly
160736761,16073676,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2019,Q1,Thrombocytopenia,,2019,Q1,1,I,2018.0,20190304.0,20190314,20190314,EXP,,US-AMGEN-USASP2019038290,AMGEN,,65.0,YR,E,F,Y,,,20190314.0,,MD,US,US,2019,Q1,Elderly
160736761,16073676,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2019,Q1,Tricuspid valve incompetence,,2019,Q1,1,I,2018.0,20190304.0,20190314,20190314,EXP,,US-AMGEN-USASP2019038290,AMGEN,,65.0,YR,E,F,Y,,,20190314.0,,MD,US,US,2019,Q1,Elderly
160790612,16079061,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,DOSE; 10-12 UNITS,,,,,,,,,,,TID,2019,Q1,Acute kidney injury,,2019,Q1,2,F,20190304.0,20190305.0,20190315,20190320,EXP,,PL-ABBVIE-19P-129-2705720-00,ABBVIE,,74.0,YR,,F,Y,90.0,KG,20190320.0,,MD,PL,PL,2019,Q1,Elderly
160888961,16088896,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,33.0 DOSAGE FORM,,,D,,,,,,,,,2019,Q1,Abdominal discomfort,,2019,Q1,1,I,,20190315.0,20190319,20190319,EXP,,PHHY2019CA060093,NOVARTIS,,58.0,YR,,F,Y,,,20190319.0,,OT,CA,CA,2019,Q1,Adult
160888961,16088896,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,33.0 DOSAGE FORM,,,D,,,,,,,,,2019,Q1,Abdominal distension,,2019,Q1,1,I,,20190315.0,20190319,20190319,EXP,,PHHY2019CA060093,NOVARTIS,,58.0,YR,,F,Y,,,20190319.0,,OT,CA,CA,2019,Q1,Adult
160888961,16088896,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,33.0 DOSAGE FORM,,,D,,,,,,,,,2019,Q1,Abdominal pain,,2019,Q1,1,I,,20190315.0,20190319,20190319,EXP,,PHHY2019CA060093,NOVARTIS,,58.0,YR,,F,Y,,,20190319.0,,OT,CA,CA,2019,Q1,Adult
160888961,16088896,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,33.0 DOSAGE FORM,,,D,,,,,,,,,2019,Q1,Abdominal rigidity,,2019,Q1,1,I,,20190315.0,20190319,20190319,EXP,,PHHY2019CA060093,NOVARTIS,,58.0,YR,,F,Y,,,20190319.0,,OT,CA,CA,2019,Q1,Adult
160888961,16088896,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,33.0 DOSAGE FORM,,,D,,,,,,,,,2019,Q1,Abdominal tenderness,,2019,Q1,1,I,,20190315.0,20190319,20190319,EXP,,PHHY2019CA060093,NOVARTIS,,58.0,YR,,F,Y,,,20190319.0,,OT,CA,CA,2019,Q1,Adult
160888961,16088896,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,33.0 DOSAGE FORM,,,D,,,,,,,,,2019,Q1,Alopecia,,2019,Q1,1,I,,20190315.0,20190319,20190319,EXP,,PHHY2019CA060093,NOVARTIS,,58.0,YR,,F,Y,,,20190319.0,,OT,CA,CA,2019,Q1,Adult
160888961,16088896,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,33.0 DOSAGE FORM,,,D,,,,,,,,,2019,Q1,Anxiety,,2019,Q1,1,I,,20190315.0,20190319,20190319,EXP,,PHHY2019CA060093,NOVARTIS,,58.0,YR,,F,Y,,,20190319.0,,OT,CA,CA,2019,Q1,Adult
160888961,16088896,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,33.0 DOSAGE FORM,,,D,,,,,,,,,2019,Q1,Arthralgia,,2019,Q1,1,I,,20190315.0,20190319,20190319,EXP,,PHHY2019CA060093,NOVARTIS,,58.0,YR,,F,Y,,,20190319.0,,OT,CA,CA,2019,Q1,Adult
160888961,16088896,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,33.0 DOSAGE FORM,,,D,,,,,,,,,2019,Q1,Blood glucose decreased,,2019,Q1,1,I,,20190315.0,20190319,20190319,EXP,,PHHY2019CA060093,NOVARTIS,,58.0,YR,,F,Y,,,20190319.0,,OT,CA,CA,2019,Q1,Adult
160888961,16088896,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,33.0 DOSAGE FORM,,,D,,,,,,,,,2019,Q1,Blood glucose increased,,2019,Q1,1,I,,20190315.0,20190319,20190319,EXP,,PHHY2019CA060093,NOVARTIS,,58.0,YR,,F,Y,,,20190319.0,,OT,CA,CA,2019,Q1,Adult
160888961,16088896,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,33.0 DOSAGE FORM,,,D,,,,,,,,,2019,Q1,Blood phosphorus decreased,,2019,Q1,1,I,,20190315.0,20190319,20190319,EXP,,PHHY2019CA060093,NOVARTIS,,58.0,YR,,F,Y,,,20190319.0,,OT,CA,CA,2019,Q1,Adult
160888961,16088896,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,33.0 DOSAGE FORM,,,D,,,,,,,,,2019,Q1,Blood pressure decreased,,2019,Q1,1,I,,20190315.0,20190319,20190319,EXP,,PHHY2019CA060093,NOVARTIS,,58.0,YR,,F,Y,,,20190319.0,,OT,CA,CA,2019,Q1,Adult
160888961,16088896,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,33.0 DOSAGE FORM,,,D,,,,,,,,,2019,Q1,Blood pressure increased,,2019,Q1,1,I,,20190315.0,20190319,20190319,EXP,,PHHY2019CA060093,NOVARTIS,,58.0,YR,,F,Y,,,20190319.0,,OT,CA,CA,2019,Q1,Adult
160888961,16088896,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,33.0 DOSAGE FORM,,,D,,,,,,,,,2019,Q1,Blood sodium decreased,,2019,Q1,1,I,,20190315.0,20190319,20190319,EXP,,PHHY2019CA060093,NOVARTIS,,58.0,YR,,F,Y,,,20190319.0,,OT,CA,CA,2019,Q1,Adult
160888961,16088896,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,33.0 DOSAGE FORM,,,D,,,,,,,,,2019,Q1,Blood urine present,,2019,Q1,1,I,,20190315.0,20190319,20190319,EXP,,PHHY2019CA060093,NOVARTIS,,58.0,YR,,F,Y,,,20190319.0,,OT,CA,CA,2019,Q1,Adult
160888961,16088896,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,33.0 DOSAGE FORM,,,D,,,,,,,,,2019,Q1,Breath odour,,2019,Q1,1,I,,20190315.0,20190319,20190319,EXP,,PHHY2019CA060093,NOVARTIS,,58.0,YR,,F,Y,,,20190319.0,,OT,CA,CA,2019,Q1,Adult
160888961,16088896,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,33.0 DOSAGE FORM,,,D,,,,,,,,,2019,Q1,Bronchitis,,2019,Q1,1,I,,20190315.0,20190319,20190319,EXP,,PHHY2019CA060093,NOVARTIS,,58.0,YR,,F,Y,,,20190319.0,,OT,CA,CA,2019,Q1,Adult
160888961,16088896,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,33.0 DOSAGE FORM,,,D,,,,,,,,,2019,Q1,Confusional state,,2019,Q1,1,I,,20190315.0,20190319,20190319,EXP,,PHHY2019CA060093,NOVARTIS,,58.0,YR,,F,Y,,,20190319.0,,OT,CA,CA,2019,Q1,Adult
160888961,16088896,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,33.0 DOSAGE FORM,,,D,,,,,,,,,2019,Q1,Constipation,,2019,Q1,1,I,,20190315.0,20190319,20190319,EXP,,PHHY2019CA060093,NOVARTIS,,58.0,YR,,F,Y,,,20190319.0,,OT,CA,CA,2019,Q1,Adult
160888961,16088896,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,33.0 DOSAGE FORM,,,D,,,,,,,,,2019,Q1,Death,,2019,Q1,1,I,,20190315.0,20190319,20190319,EXP,,PHHY2019CA060093,NOVARTIS,,58.0,YR,,F,Y,,,20190319.0,,OT,CA,CA,2019,Q1,Adult
160888961,16088896,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,33.0 DOSAGE FORM,,,D,,,,,,,,,2019,Q1,Dehydration,,2019,Q1,1,I,,20190315.0,20190319,20190319,EXP,,PHHY2019CA060093,NOVARTIS,,58.0,YR,,F,Y,,,20190319.0,,OT,CA,CA,2019,Q1,Adult
160888961,16088896,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,33.0 DOSAGE FORM,,,D,,,,,,,,,2019,Q1,Delirium,,2019,Q1,1,I,,20190315.0,20190319,20190319,EXP,,PHHY2019CA060093,NOVARTIS,,58.0,YR,,F,Y,,,20190319.0,,OT,CA,CA,2019,Q1,Adult
160888961,16088896,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,33.0 DOSAGE FORM,,,D,,,,,,,,,2019,Q1,Diarrhoea,,2019,Q1,1,I,,20190315.0,20190319,20190319,EXP,,PHHY2019CA060093,NOVARTIS,,58.0,YR,,F,Y,,,20190319.0,,OT,CA,CA,2019,Q1,Adult
160888961,16088896,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,33.0 DOSAGE FORM,,,D,,,,,,,,,2019,Q1,Disorientation,,2019,Q1,1,I,,20190315.0,20190319,20190319,EXP,,PHHY2019CA060093,NOVARTIS,,58.0,YR,,F,Y,,,20190319.0,,OT,CA,CA,2019,Q1,Adult
160888961,16088896,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,33.0 DOSAGE FORM,,,D,,,,,,,,,2019,Q1,Dysarthria,,2019,Q1,1,I,,20190315.0,20190319,20190319,EXP,,PHHY2019CA060093,NOVARTIS,,58.0,YR,,F,Y,,,20190319.0,,OT,CA,CA,2019,Q1,Adult
160888961,16088896,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,33.0 DOSAGE FORM,,,D,,,,,,,,,2019,Q1,Dysstasia,,2019,Q1,1,I,,20190315.0,20190319,20190319,EXP,,PHHY2019CA060093,NOVARTIS,,58.0,YR,,F,Y,,,20190319.0,,OT,CA,CA,2019,Q1,Adult
160888961,16088896,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,33.0 DOSAGE FORM,,,D,,,,,,,,,2019,Q1,Dysuria,,2019,Q1,1,I,,20190315.0,20190319,20190319,EXP,,PHHY2019CA060093,NOVARTIS,,58.0,YR,,F,Y,,,20190319.0,,OT,CA,CA,2019,Q1,Adult
160888961,16088896,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,33.0 DOSAGE FORM,,,D,,,,,,,,,2019,Q1,Electrolyte imbalance,,2019,Q1,1,I,,20190315.0,20190319,20190319,EXP,,PHHY2019CA060093,NOVARTIS,,58.0,YR,,F,Y,,,20190319.0,,OT,CA,CA,2019,Q1,Adult
160888961,16088896,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,33.0 DOSAGE FORM,,,D,,,,,,,,,2019,Q1,Epigastric discomfort,,2019,Q1,1,I,,20190315.0,20190319,20190319,EXP,,PHHY2019CA060093,NOVARTIS,,58.0,YR,,F,Y,,,20190319.0,,OT,CA,CA,2019,Q1,Adult
160888961,16088896,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,33.0 DOSAGE FORM,,,D,,,,,,,,,2019,Q1,Eye injury,,2019,Q1,1,I,,20190315.0,20190319,20190319,EXP,,PHHY2019CA060093,NOVARTIS,,58.0,YR,,F,Y,,,20190319.0,,OT,CA,CA,2019,Q1,Adult
160888961,16088896,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,33.0 DOSAGE FORM,,,D,,,,,,,,,2019,Q1,Fall,,2019,Q1,1,I,,20190315.0,20190319,20190319,EXP,,PHHY2019CA060093,NOVARTIS,,58.0,YR,,F,Y,,,20190319.0,,OT,CA,CA,2019,Q1,Adult
160888961,16088896,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,33.0 DOSAGE FORM,,,D,,,,,,,,,2019,Q1,Feeling abnormal,,2019,Q1,1,I,,20190315.0,20190319,20190319,EXP,,PHHY2019CA060093,NOVARTIS,,58.0,YR,,F,Y,,,20190319.0,,OT,CA,CA,2019,Q1,Adult
160888961,16088896,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,33.0 DOSAGE FORM,,,D,,,,,,,,,2019,Q1,Flatulence,,2019,Q1,1,I,,20190315.0,20190319,20190319,EXP,,PHHY2019CA060093,NOVARTIS,,58.0,YR,,F,Y,,,20190319.0,,OT,CA,CA,2019,Q1,Adult
160888961,16088896,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,33.0 DOSAGE FORM,,,D,,,,,,,,,2019,Q1,Fluid retention,,2019,Q1,1,I,,20190315.0,20190319,20190319,EXP,,PHHY2019CA060093,NOVARTIS,,58.0,YR,,F,Y,,,20190319.0,,OT,CA,CA,2019,Q1,Adult
160888961,16088896,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,33.0 DOSAGE FORM,,,D,,,,,,,,,2019,Q1,Functional gastrointestinal disorder,,2019,Q1,1,I,,20190315.0,20190319,20190319,EXP,,PHHY2019CA060093,NOVARTIS,,58.0,YR,,F,Y,,,20190319.0,,OT,CA,CA,2019,Q1,Adult
160888961,16088896,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,33.0 DOSAGE FORM,,,D,,,,,,,,,2019,Q1,Gait disturbance,,2019,Q1,1,I,,20190315.0,20190319,20190319,EXP,,PHHY2019CA060093,NOVARTIS,,58.0,YR,,F,Y,,,20190319.0,,OT,CA,CA,2019,Q1,Adult
160888961,16088896,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,33.0 DOSAGE FORM,,,D,,,,,,,,,2019,Q1,Gastrointestinal sounds abnormal,,2019,Q1,1,I,,20190315.0,20190319,20190319,EXP,,PHHY2019CA060093,NOVARTIS,,58.0,YR,,F,Y,,,20190319.0,,OT,CA,CA,2019,Q1,Adult
160888961,16088896,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,33.0 DOSAGE FORM,,,D,,,,,,,,,2019,Q1,Gastrooesophageal reflux disease,,2019,Q1,1,I,,20190315.0,20190319,20190319,EXP,,PHHY2019CA060093,NOVARTIS,,58.0,YR,,F,Y,,,20190319.0,,OT,CA,CA,2019,Q1,Adult
160888961,16088896,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,33.0 DOSAGE FORM,,,D,,,,,,,,,2019,Q1,Glucose urine present,,2019,Q1,1,I,,20190315.0,20190319,20190319,EXP,,PHHY2019CA060093,NOVARTIS,,58.0,YR,,F,Y,,,20190319.0,,OT,CA,CA,2019,Q1,Adult
160888961,16088896,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,33.0 DOSAGE FORM,,,D,,,,,,,,,2019,Q1,Hepatic encephalopathy,,2019,Q1,1,I,,20190315.0,20190319,20190319,EXP,,PHHY2019CA060093,NOVARTIS,,58.0,YR,,F,Y,,,20190319.0,,OT,CA,CA,2019,Q1,Adult
160888961,16088896,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,33.0 DOSAGE FORM,,,D,,,,,,,,,2019,Q1,Hepatic enzyme increased,,2019,Q1,1,I,,20190315.0,20190319,20190319,EXP,,PHHY2019CA060093,NOVARTIS,,58.0,YR,,F,Y,,,20190319.0,,OT,CA,CA,2019,Q1,Adult
160888961,16088896,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,33.0 DOSAGE FORM,,,D,,,,,,,,,2019,Q1,Hepatomegaly,,2019,Q1,1,I,,20190315.0,20190319,20190319,EXP,,PHHY2019CA060093,NOVARTIS,,58.0,YR,,F,Y,,,20190319.0,,OT,CA,CA,2019,Q1,Adult
160888961,16088896,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,33.0 DOSAGE FORM,,,D,,,,,,,,,2019,Q1,Hypothyroidism,,2019,Q1,1,I,,20190315.0,20190319,20190319,EXP,,PHHY2019CA060093,NOVARTIS,,58.0,YR,,F,Y,,,20190319.0,,OT,CA,CA,2019,Q1,Adult
160888961,16088896,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,33.0 DOSAGE FORM,,,D,,,,,,,,,2019,Q1,Incoherent,,2019,Q1,1,I,,20190315.0,20190319,20190319,EXP,,PHHY2019CA060093,NOVARTIS,,58.0,YR,,F,Y,,,20190319.0,,OT,CA,CA,2019,Q1,Adult
160888961,16088896,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,33.0 DOSAGE FORM,,,D,,,,,,,,,2019,Q1,Infection,,2019,Q1,1,I,,20190315.0,20190319,20190319,EXP,,PHHY2019CA060093,NOVARTIS,,58.0,YR,,F,Y,,,20190319.0,,OT,CA,CA,2019,Q1,Adult
160888961,16088896,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,33.0 DOSAGE FORM,,,D,,,,,,,,,2019,Q1,Influenza,,2019,Q1,1,I,,20190315.0,20190319,20190319,EXP,,PHHY2019CA060093,NOVARTIS,,58.0,YR,,F,Y,,,20190319.0,,OT,CA,CA,2019,Q1,Adult
160888961,16088896,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,33.0 DOSAGE FORM,,,D,,,,,,,,,2019,Q1,Injection site erythema,,2019,Q1,1,I,,20190315.0,20190319,20190319,EXP,,PHHY2019CA060093,NOVARTIS,,58.0,YR,,F,Y,,,20190319.0,,OT,CA,CA,2019,Q1,Adult
160888961,16088896,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,33.0 DOSAGE FORM,,,D,,,,,,,,,2019,Q1,Injection site pain,,2019,Q1,1,I,,20190315.0,20190319,20190319,EXP,,PHHY2019CA060093,NOVARTIS,,58.0,YR,,F,Y,,,20190319.0,,OT,CA,CA,2019,Q1,Adult
160888961,16088896,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,33.0 DOSAGE FORM,,,D,,,,,,,,,2019,Q1,Injection site reaction,,2019,Q1,1,I,,20190315.0,20190319,20190319,EXP,,PHHY2019CA060093,NOVARTIS,,58.0,YR,,F,Y,,,20190319.0,,OT,CA,CA,2019,Q1,Adult
160888961,16088896,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,33.0 DOSAGE FORM,,,D,,,,,,,,,2019,Q1,Malaise,,2019,Q1,1,I,,20190315.0,20190319,20190319,EXP,,PHHY2019CA060093,NOVARTIS,,58.0,YR,,F,Y,,,20190319.0,,OT,CA,CA,2019,Q1,Adult
160888961,16088896,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,33.0 DOSAGE FORM,,,D,,,,,,,,,2019,Q1,Malignant neoplasm progression,,2019,Q1,1,I,,20190315.0,20190319,20190319,EXP,,PHHY2019CA060093,NOVARTIS,,58.0,YR,,F,Y,,,20190319.0,,OT,CA,CA,2019,Q1,Adult
160888961,16088896,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,33.0 DOSAGE FORM,,,D,,,,,,,,,2019,Q1,Memory impairment,,2019,Q1,1,I,,20190315.0,20190319,20190319,EXP,,PHHY2019CA060093,NOVARTIS,,58.0,YR,,F,Y,,,20190319.0,,OT,CA,CA,2019,Q1,Adult
160888961,16088896,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,33.0 DOSAGE FORM,,,D,,,,,,,,,2019,Q1,Musculoskeletal pain,,2019,Q1,1,I,,20190315.0,20190319,20190319,EXP,,PHHY2019CA060093,NOVARTIS,,58.0,YR,,F,Y,,,20190319.0,,OT,CA,CA,2019,Q1,Adult
160888961,16088896,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,33.0 DOSAGE FORM,,,D,,,,,,,,,2019,Q1,Nasopharyngitis,,2019,Q1,1,I,,20190315.0,20190319,20190319,EXP,,PHHY2019CA060093,NOVARTIS,,58.0,YR,,F,Y,,,20190319.0,,OT,CA,CA,2019,Q1,Adult
160888961,16088896,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,33.0 DOSAGE FORM,,,D,,,,,,,,,2019,Q1,Needle issue,,2019,Q1,1,I,,20190315.0,20190319,20190319,EXP,,PHHY2019CA060093,NOVARTIS,,58.0,YR,,F,Y,,,20190319.0,,OT,CA,CA,2019,Q1,Adult
160888961,16088896,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,33.0 DOSAGE FORM,,,D,,,,,,,,,2019,Q1,Pneumonia bacterial,,2019,Q1,1,I,,20190315.0,20190319,20190319,EXP,,PHHY2019CA060093,NOVARTIS,,58.0,YR,,F,Y,,,20190319.0,,OT,CA,CA,2019,Q1,Adult
160888961,16088896,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,33.0 DOSAGE FORM,,,D,,,,,,,,,2019,Q1,Pollakiuria,,2019,Q1,1,I,,20190315.0,20190319,20190319,EXP,,PHHY2019CA060093,NOVARTIS,,58.0,YR,,F,Y,,,20190319.0,,OT,CA,CA,2019,Q1,Adult
160888961,16088896,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,33.0 DOSAGE FORM,,,D,,,,,,,,,2019,Q1,Polyuria,,2019,Q1,1,I,,20190315.0,20190319,20190319,EXP,,PHHY2019CA060093,NOVARTIS,,58.0,YR,,F,Y,,,20190319.0,,OT,CA,CA,2019,Q1,Adult
160888961,16088896,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,33.0 DOSAGE FORM,,,D,,,,,,,,,2019,Q1,Pyrexia,,2019,Q1,1,I,,20190315.0,20190319,20190319,EXP,,PHHY2019CA060093,NOVARTIS,,58.0,YR,,F,Y,,,20190319.0,,OT,CA,CA,2019,Q1,Adult
160888961,16088896,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,33.0 DOSAGE FORM,,,D,,,,,,,,,2019,Q1,Rash macular,,2019,Q1,1,I,,20190315.0,20190319,20190319,EXP,,PHHY2019CA060093,NOVARTIS,,58.0,YR,,F,Y,,,20190319.0,,OT,CA,CA,2019,Q1,Adult
160888961,16088896,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,33.0 DOSAGE FORM,,,D,,,,,,,,,2019,Q1,Rhinorrhoea,,2019,Q1,1,I,,20190315.0,20190319,20190319,EXP,,PHHY2019CA060093,NOVARTIS,,58.0,YR,,F,Y,,,20190319.0,,OT,CA,CA,2019,Q1,Adult
160888961,16088896,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,33.0 DOSAGE FORM,,,D,,,,,,,,,2019,Q1,Rotator cuff syndrome,,2019,Q1,1,I,,20190315.0,20190319,20190319,EXP,,PHHY2019CA060093,NOVARTIS,,58.0,YR,,F,Y,,,20190319.0,,OT,CA,CA,2019,Q1,Adult
160888961,16088896,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,33.0 DOSAGE FORM,,,D,,,,,,,,,2019,Q1,Sinus congestion,,2019,Q1,1,I,,20190315.0,20190319,20190319,EXP,,PHHY2019CA060093,NOVARTIS,,58.0,YR,,F,Y,,,20190319.0,,OT,CA,CA,2019,Q1,Adult
160888961,16088896,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,33.0 DOSAGE FORM,,,D,,,,,,,,,2019,Q1,Swelling,,2019,Q1,1,I,,20190315.0,20190319,20190319,EXP,,PHHY2019CA060093,NOVARTIS,,58.0,YR,,F,Y,,,20190319.0,,OT,CA,CA,2019,Q1,Adult
160888961,16088896,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,33.0 DOSAGE FORM,,,D,,,,,,,,,2019,Q1,Tenderness,,2019,Q1,1,I,,20190315.0,20190319,20190319,EXP,,PHHY2019CA060093,NOVARTIS,,58.0,YR,,F,Y,,,20190319.0,,OT,CA,CA,2019,Q1,Adult
160888961,16088896,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,33.0 DOSAGE FORM,,,D,,,,,,,,,2019,Q1,Type 1 diabetes mellitus,,2019,Q1,1,I,,20190315.0,20190319,20190319,EXP,,PHHY2019CA060093,NOVARTIS,,58.0,YR,,F,Y,,,20190319.0,,OT,CA,CA,2019,Q1,Adult
160888961,16088896,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,33.0 DOSAGE FORM,,,D,,,,,,,,,2019,Q1,Urinary incontinence,,2019,Q1,1,I,,20190315.0,20190319,20190319,EXP,,PHHY2019CA060093,NOVARTIS,,58.0,YR,,F,Y,,,20190319.0,,OT,CA,CA,2019,Q1,Adult
160888961,16088896,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,33.0 DOSAGE FORM,,,D,,,,,,,,,2019,Q1,Urinary tract infection,,2019,Q1,1,I,,20190315.0,20190319,20190319,EXP,,PHHY2019CA060093,NOVARTIS,,58.0,YR,,F,Y,,,20190319.0,,OT,CA,CA,2019,Q1,Adult
160888961,16088896,5,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,33.0 DOSAGE FORM,,,D,,,,,,,,,2019,Q1,Weight decreased,,2019,Q1,1,I,,20190315.0,20190319,20190319,EXP,,PHHY2019CA060093,NOVARTIS,,58.0,YR,,F,Y,,,20190319.0,,OT,CA,CA,2019,Q1,Adult
160954681,16095468,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2019,Q1,Anaemia,,2019,Q1,1,I,20161101.0,20170118.0,20190320,20190320,EXP,DE-EMA-DD-20171206-SGALIPALLIP-165730,PHHY2017DE008738,NOVARTIS,,64.0,YR,,M,Y,85.2,KG,20190320.0,,MD,DE,DE,2019,Q1,Adult
160954681,16095468,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2019,Q1,C-reactive protein increased,,2019,Q1,1,I,20161101.0,20170118.0,20190320,20190320,EXP,DE-EMA-DD-20171206-SGALIPALLIP-165730,PHHY2017DE008738,NOVARTIS,,64.0,YR,,M,Y,85.2,KG,20190320.0,,MD,DE,DE,2019,Q1,Adult
160954681,16095468,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2019,Q1,Cough,,2019,Q1,1,I,20161101.0,20170118.0,20190320,20190320,EXP,DE-EMA-DD-20171206-SGALIPALLIP-165730,PHHY2017DE008738,NOVARTIS,,64.0,YR,,M,Y,85.2,KG,20190320.0,,MD,DE,DE,2019,Q1,Adult
160954681,16095468,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2019,Q1,Fatigue,,2019,Q1,1,I,20161101.0,20170118.0,20190320,20190320,EXP,DE-EMA-DD-20171206-SGALIPALLIP-165730,PHHY2017DE008738,NOVARTIS,,64.0,YR,,M,Y,85.2,KG,20190320.0,,MD,DE,DE,2019,Q1,Adult
160954681,16095468,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2019,Q1,General physical condition abnormal,,2019,Q1,1,I,20161101.0,20170118.0,20190320,20190320,EXP,DE-EMA-DD-20171206-SGALIPALLIP-165730,PHHY2017DE008738,NOVARTIS,,64.0,YR,,M,Y,85.2,KG,20190320.0,,MD,DE,DE,2019,Q1,Adult
160954681,16095468,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2019,Q1,Hypothyroidism,,2019,Q1,1,I,20161101.0,20170118.0,20190320,20190320,EXP,DE-EMA-DD-20171206-SGALIPALLIP-165730,PHHY2017DE008738,NOVARTIS,,64.0,YR,,M,Y,85.2,KG,20190320.0,,MD,DE,DE,2019,Q1,Adult
160954681,16095468,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2019,Q1,Pneumonia,,2019,Q1,1,I,20161101.0,20170118.0,20190320,20190320,EXP,DE-EMA-DD-20171206-SGALIPALLIP-165730,PHHY2017DE008738,NOVARTIS,,64.0,YR,,M,Y,85.2,KG,20190320.0,,MD,DE,DE,2019,Q1,Adult
160954681,16095468,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2019,Q1,Sinusitis,,2019,Q1,1,I,20161101.0,20170118.0,20190320,20190320,EXP,DE-EMA-DD-20171206-SGALIPALLIP-165730,PHHY2017DE008738,NOVARTIS,,64.0,YR,,M,Y,85.2,KG,20190320.0,,MD,DE,DE,2019,Q1,Adult
160984232,16098423,8,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q1,Acute kidney injury,,2019,Q1,2,F,,20190318.0,20190321,20190322,EXP,,PT-TEVA-2019-PT-1028643,TEVA,"GOUVEIA C, DUQUE S, CAMPOS L. LIPOT IMIA POR HIPOVOLEMIA - UM CASO DE IATROTROGENIA A EMPA GLIFLO ZINA?. BY MARIANA ROCHA. 2019;.",71.0,YR,,M,Y,,,20190322.0,,MD,PT,PT,2019,Q1,Elderly
160984232,16098423,8,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q1,Arrhythmia,,2019,Q1,2,F,,20190318.0,20190321,20190322,EXP,,PT-TEVA-2019-PT-1028643,TEVA,"GOUVEIA C, DUQUE S, CAMPOS L. LIPOT IMIA POR HIPOVOLEMIA - UM CASO DE IATROTROGENIA A EMPA GLIFLO ZINA?. BY MARIANA ROCHA. 2019;.",71.0,YR,,M,Y,,,20190322.0,,MD,PT,PT,2019,Q1,Elderly
160984232,16098423,8,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q1,Bradycardia,,2019,Q1,2,F,,20190318.0,20190321,20190322,EXP,,PT-TEVA-2019-PT-1028643,TEVA,"GOUVEIA C, DUQUE S, CAMPOS L. LIPOT IMIA POR HIPOVOLEMIA - UM CASO DE IATROTROGENIA A EMPA GLIFLO ZINA?. BY MARIANA ROCHA. 2019;.",71.0,YR,,M,Y,,,20190322.0,,MD,PT,PT,2019,Q1,Elderly
160984232,16098423,8,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q1,Dehydration,,2019,Q1,2,F,,20190318.0,20190321,20190322,EXP,,PT-TEVA-2019-PT-1028643,TEVA,"GOUVEIA C, DUQUE S, CAMPOS L. LIPOT IMIA POR HIPOVOLEMIA - UM CASO DE IATROTROGENIA A EMPA GLIFLO ZINA?. BY MARIANA ROCHA. 2019;.",71.0,YR,,M,Y,,,20190322.0,,MD,PT,PT,2019,Q1,Elderly
160984232,16098423,8,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q1,Dizziness,,2019,Q1,2,F,,20190318.0,20190321,20190322,EXP,,PT-TEVA-2019-PT-1028643,TEVA,"GOUVEIA C, DUQUE S, CAMPOS L. LIPOT IMIA POR HIPOVOLEMIA - UM CASO DE IATROTROGENIA A EMPA GLIFLO ZINA?. BY MARIANA ROCHA. 2019;.",71.0,YR,,M,Y,,,20190322.0,,MD,PT,PT,2019,Q1,Elderly
160984232,16098423,8,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q1,Hypotension,,2019,Q1,2,F,,20190318.0,20190321,20190322,EXP,,PT-TEVA-2019-PT-1028643,TEVA,"GOUVEIA C, DUQUE S, CAMPOS L. LIPOT IMIA POR HIPOVOLEMIA - UM CASO DE IATROTROGENIA A EMPA GLIFLO ZINA?. BY MARIANA ROCHA. 2019;.",71.0,YR,,M,Y,,,20190322.0,,MD,PT,PT,2019,Q1,Elderly
160984232,16098423,8,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q1,Syncope,,2019,Q1,2,F,,20190318.0,20190321,20190322,EXP,,PT-TEVA-2019-PT-1028643,TEVA,"GOUVEIA C, DUQUE S, CAMPOS L. LIPOT IMIA POR HIPOVOLEMIA - UM CASO DE IATROTROGENIA A EMPA GLIFLO ZINA?. BY MARIANA ROCHA. 2019;.",71.0,YR,,M,Y,,,20190322.0,,MD,PT,PT,2019,Q1,Elderly
161012832,16101283,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"80 IU, DAILY",,,U,U, C600772A,,20563.0,80.0,IU,INJECTION,QD,2019,Q1,Influenza,,2019,Q1,2,F,20190303.0,20190318.0,20190321,20190327,EXP,,US-ELI_LILLY_AND_COMPANY-US201903003350,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20190327.0,,CN,US,US,2019,Q1,Adult
161012832,16101283,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"80 IU, DAILY",,,U,U, C600772A,,20563.0,80.0,IU,INJECTION,QD,2019,Q1,Malaise,,2019,Q1,2,F,20190303.0,20190318.0,20190321,20190327,EXP,,US-ELI_LILLY_AND_COMPANY-US201903003350,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20190327.0,,CN,US,US,2019,Q1,Adult
161061741,16106174,2,SS,Liprolog Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,U, ASKU,,,,,,,2019,Q1,Diarrhoea haemorrhagic,,2019,Q1,1,I,,20190313.0,20190322,20190322,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201903007207,ELI LILLY AND CO,,52.0,YR,,M,Y,,,20190322.0,,CN,DE,DE,2019,Q1,Adult
161108291,16110829,13,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q1,Cholelithiasis,,2019,Q1,1,I,,20190322.0,20190325,20190325,EXP,,US-GILEAD-2019-0398365,GILEAD,,61.0,YR,A,F,Y,,,20190325.0,,OT,US,US,2019,Q1,Adult
161108291,16110829,13,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q1,Lung cancer metastatic,,2019,Q1,1,I,,20190322.0,20190325,20190325,EXP,,US-GILEAD-2019-0398365,GILEAD,,61.0,YR,A,F,Y,,,20190325.0,,OT,US,US,2019,Q1,Adult
161108291,16110829,13,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q1,Sedation complication,,2019,Q1,1,I,,20190322.0,20190325,20190325,EXP,,US-GILEAD-2019-0398365,GILEAD,,61.0,YR,A,F,Y,,,20190325.0,,OT,US,US,2019,Q1,Adult
161119662,16111966,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, QD",,,Y,,,,,,,SOLUTION FOR INJECTION,QD,2019,Q1,Abdominal pain upper,,2019,Q1,2,F,20190304.0,20190320.0,20190325,20190329,EXP,,TW-SA-2019SA075472,SANOFI AVENTIS,,30.0,YR,A,F,Y,64.7,KG,20190328.0,,OT,TW,TW,2019,Q1,Young Adult
161119662,16111966,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, QD",,,Y,,,,,,,SOLUTION FOR INJECTION,QD,2019,Q1,Angiomyolipoma,,2019,Q1,2,F,20190304.0,20190320.0,20190325,20190329,EXP,,TW-SA-2019SA075472,SANOFI AVENTIS,,30.0,YR,A,F,Y,64.7,KG,20190328.0,,OT,TW,TW,2019,Q1,Young Adult
161119662,16111966,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, QD",,,Y,,,,,,,SOLUTION FOR INJECTION,QD,2019,Q1,Flank pain,,2019,Q1,2,F,20190304.0,20190320.0,20190325,20190329,EXP,,TW-SA-2019SA075472,SANOFI AVENTIS,,30.0,YR,A,F,Y,64.7,KG,20190328.0,,OT,TW,TW,2019,Q1,Young Adult
161119662,16111966,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, QD",,,Y,,,,,,,SOLUTION FOR INJECTION,QD,2019,Q1,Hyperglycaemia,,2019,Q1,2,F,20190304.0,20190320.0,20190325,20190329,EXP,,TW-SA-2019SA075472,SANOFI AVENTIS,,30.0,YR,A,F,Y,64.7,KG,20190328.0,,OT,TW,TW,2019,Q1,Young Adult
161119662,16111966,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, QD",,,Y,,,,,,,SOLUTION FOR INJECTION,QD,2019,Q1,Hyponatraemia,,2019,Q1,2,F,20190304.0,20190320.0,20190325,20190329,EXP,,TW-SA-2019SA075472,SANOFI AVENTIS,,30.0,YR,A,F,Y,64.7,KG,20190328.0,,OT,TW,TW,2019,Q1,Young Adult
161119662,16111966,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, QD",,,Y,,,,,,,SOLUTION FOR INJECTION,QD,2019,Q1,Leukocytosis,,2019,Q1,2,F,20190304.0,20190320.0,20190325,20190329,EXP,,TW-SA-2019SA075472,SANOFI AVENTIS,,30.0,YR,A,F,Y,64.7,KG,20190328.0,,OT,TW,TW,2019,Q1,Young Adult
161119662,16111966,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, QD",,,Y,,,,,,,SOLUTION FOR INJECTION,QD,2019,Q1,Oliguria,,2019,Q1,2,F,20190304.0,20190320.0,20190325,20190329,EXP,,TW-SA-2019SA075472,SANOFI AVENTIS,,30.0,YR,A,F,Y,64.7,KG,20190328.0,,OT,TW,TW,2019,Q1,Young Adult
161119662,16111966,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, QD",,,Y,,,,,,,SOLUTION FOR INJECTION,QD,2019,Q1,Pain,,2019,Q1,2,F,20190304.0,20190320.0,20190325,20190329,EXP,,TW-SA-2019SA075472,SANOFI AVENTIS,,30.0,YR,A,F,Y,64.7,KG,20190328.0,,OT,TW,TW,2019,Q1,Young Adult
161119662,16111966,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, QD",,,Y,,,,,,,SOLUTION FOR INJECTION,QD,2019,Q1,Pyrexia,,2019,Q1,2,F,20190304.0,20190320.0,20190325,20190329,EXP,,TW-SA-2019SA075472,SANOFI AVENTIS,,30.0,YR,A,F,Y,64.7,KG,20190328.0,,OT,TW,TW,2019,Q1,Young Adult
161155181,16115518,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Other,UNK,,,,,,,,,,INJECTION,,2019,Q1,Lung disorder,,2019,Q1,1,I,,20190318.0,20190325,20190325,EXP,,JP-TAKEDA-2019TJP006407,TAKEDA,"HASEGAWA I, KAMBAYASHI T, TSUSHIMA H. A CASE OF LANSOPRAZOLE-INDUCED LUNG INJURY. ANNALS OF THE JAPANESE RESPIRATORY SOCIETY. 2019;8(1):47-51",63.0,YR,,M,Y,60.9,KG,20190326.0,,MD,JP,JP,2019,Q1,Adult
161161081,16116108,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNKNOWN,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Altered state of consciousness,,2019,Q1,1,I,20171004.0,20180102.0,20190326,20190326,EXP,FR-AFSSAPS-PB20172586,FR-SA-2018SA004210,SANOFI AVENTIS,,37.0,YR,A,M,Y,,,20190325.0,,MD,FR,FR,2019,Q1,Adult
161161081,16116108,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNKNOWN,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Hypoglycaemia,,2019,Q1,1,I,20171004.0,20180102.0,20190326,20190326,EXP,FR-AFSSAPS-PB20172586,FR-SA-2018SA004210,SANOFI AVENTIS,,37.0,YR,A,M,Y,,,20190325.0,,MD,FR,FR,2019,Q1,Adult
161161081,16116108,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNKNOWN,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q1,Speech disorder,,2019,Q1,1,I,20171004.0,20180102.0,20190326,20190326,EXP,FR-AFSSAPS-PB20172586,FR-SA-2018SA004210,SANOFI AVENTIS,,37.0,YR,A,M,Y,,,20190325.0,,MD,FR,FR,2019,Q1,Adult
161166251,16116625,10,SS,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,"UNK UNK, QD (25/75: + 20U 20U / D)",,,U,,,,,,,,,2019,Q1,Chest pain,,2019,Q1,1,I,,20190315.0,20190326,20190326,EXP,PT-EMA-DD-20181213-KUMARVN_P-153457,PT-ACCORD-115341,ACCORD,,54.0,YR,,F,Y,,,20190326.0,,OT,PT,PT,2019,Q1,Adult
161166251,16116625,10,SS,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,"UNK UNK, QD (25/75: + 20U 20U / D)",,,U,,,,,,,,,2019,Q1,Ischaemic stroke,,2019,Q1,1,I,,20190315.0,20190326,20190326,EXP,PT-EMA-DD-20181213-KUMARVN_P-153457,PT-ACCORD-115341,ACCORD,,54.0,YR,,F,Y,,,20190326.0,,OT,PT,PT,2019,Q1,Adult
161175381,16117538,8,C,Insulin Lispro,INSULIN LISPRO,1,Other,,,,,,,,,,,SOLUTION,,2019,Q1,Skin lesion,,2019,Q1,1,I,20181021.0,20190319.0,20190326,20190326,EXP,,US-CELGENEUS-USA-20190307369,CELGENE,,75.0,YR,,M,Y,133.0,KG,20190326.0,,OT,US,US,2019,Q1,Elderly
161211851,16121185,3,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,,2,Unknown,"(IL 200) 24-24-24 U,",,,,,,,,,,FORMULATION UNKNOWN,,2019,Q1,Hypoglycaemia,,2019,Q1,1,I,2013.0,20190314.0,20190327,20190327,EXP,CZ-EMA-DD-20181204-SINGH_N3-203033,CZ-ACCORD-114900,ACCORD,,61.0,YR,,F,Y,,,20190327.0,,OT,CZ,CZ,2019,Q1,Adult
161211851,16121185,3,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,,2,Unknown,"(IL 200) 24-24-24 U,",,,,,,,,,,FORMULATION UNKNOWN,,2019,Q1,Increased insulin requirement,,2019,Q1,1,I,2013.0,20190314.0,20190327,20190327,EXP,CZ-EMA-DD-20181204-SINGH_N3-203033,CZ-ACCORD-114900,ACCORD,,61.0,YR,,F,Y,,,20190327.0,,OT,CZ,CZ,2019,Q1,Adult
161211851,16121185,3,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,,2,Unknown,"(IL 200) 24-24-24 U,",,,,,,,,,,FORMULATION UNKNOWN,,2019,Q1,Insulin resistance,,2019,Q1,1,I,2013.0,20190314.0,20190327,20190327,EXP,CZ-EMA-DD-20181204-SINGH_N3-203033,CZ-ACCORD-114900,ACCORD,,61.0,YR,,F,Y,,,20190327.0,,OT,CZ,CZ,2019,Q1,Adult
161211851,16121185,3,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,,2,Unknown,"(IL 200) 24-24-24 U,",,,,,,,,,,FORMULATION UNKNOWN,,2019,Q1,Liver transplant rejection,,2019,Q1,1,I,2013.0,20190314.0,20190327,20190327,EXP,CZ-EMA-DD-20181204-SINGH_N3-203033,CZ-ACCORD-114900,ACCORD,,61.0,YR,,F,Y,,,20190327.0,,OT,CZ,CZ,2019,Q1,Adult
161211851,16121185,3,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,,2,Unknown,"(IL 200) 24-24-24 U,",,,,,,,,,,FORMULATION UNKNOWN,,2019,Q1,Nephrotic syndrome,,2019,Q1,1,I,2013.0,20190314.0,20190327,20190327,EXP,CZ-EMA-DD-20181204-SINGH_N3-203033,CZ-ACCORD-114900,ACCORD,,61.0,YR,,F,Y,,,20190327.0,,OT,CZ,CZ,2019,Q1,Adult
161211851,16121185,3,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,,2,Unknown,"(IL 200) 24-24-24 U,",,,,,,,,,,FORMULATION UNKNOWN,,2019,Q1,Proteinuria,,2019,Q1,1,I,2013.0,20190314.0,20190327,20190327,EXP,CZ-EMA-DD-20181204-SINGH_N3-203033,CZ-ACCORD-114900,ACCORD,,61.0,YR,,F,Y,,,20190327.0,,OT,CZ,CZ,2019,Q1,Adult
161211851,16121185,3,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,,2,Unknown,"(IL 200) 24-24-24 U,",,,,,,,,,,FORMULATION UNKNOWN,,2019,Q1,Renal failure,,2019,Q1,1,I,2013.0,20190314.0,20190327,20190327,EXP,CZ-EMA-DD-20181204-SINGH_N3-203033,CZ-ACCORD-114900,ACCORD,,61.0,YR,,F,Y,,,20190327.0,,OT,CZ,CZ,2019,Q1,Adult
161211851,16121185,3,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,,2,Unknown,"(IL 200) 24-24-24 U,",,,,,,,,,,FORMULATION UNKNOWN,,2019,Q1,Weight increased,,2019,Q1,1,I,2013.0,20190314.0,20190327,20190327,EXP,CZ-EMA-DD-20181204-SINGH_N3-203033,CZ-ACCORD-114900,ACCORD,,61.0,YR,,F,Y,,,20190327.0,,OT,CZ,CZ,2019,Q1,Adult
161228991,16122899,16,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,,U,,,,,,,,2019,Q1,Agranulocytosis,,2019,Q1,1,I,20161014.0,20181122.0,20190327,20190327,EXP,,CA-APOPHARMA INC-2018AP025935,APOTEX,,31.0,YR,,F,Y,48.0,KG,20190327.0,,MD,CA,CA,2019,Q1,Young Adult
161228991,16122899,16,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,,U,,,,,,,,2019,Q1,Cardiogenic shock,,2019,Q1,1,I,20161014.0,20181122.0,20190327,20190327,EXP,,CA-APOPHARMA INC-2018AP025935,APOTEX,,31.0,YR,,F,Y,48.0,KG,20190327.0,,MD,CA,CA,2019,Q1,Young Adult
161228991,16122899,16,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,,U,,,,,,,,2019,Q1,Septic shock,,2019,Q1,1,I,20161014.0,20181122.0,20190327,20190327,EXP,,CA-APOPHARMA INC-2018AP025935,APOTEX,,31.0,YR,,F,Y,48.0,KG,20190327.0,,MD,CA,CA,2019,Q1,Young Adult
161228991,16122899,16,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,,U,,,,,,,,2019,Q1,Streptococcal bacteraemia,,2019,Q1,1,I,20161014.0,20181122.0,20190327,20190327,EXP,,CA-APOPHARMA INC-2018AP025935,APOTEX,,31.0,YR,,F,Y,48.0,KG,20190327.0,,MD,CA,CA,2019,Q1,Young Adult
161236881,16123688,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q1,Dizziness,,2019,Q1,1,I,,20190318.0,20190327,20190327,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. HYPOVOLAEMIC LIPOTHYMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABETES. 2019;14 (1) SUPPL:47-122",71.0,YR,,M,Y,,,20190327.0,,OT,PT,PT,2019,Q1,Elderly
161236881,16123688,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q1,Renal injury,,2019,Q1,1,I,,20190318.0,20190327,20190327,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. HYPOVOLAEMIC LIPOTHYMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABETES. 2019;14 (1) SUPPL:47-122",71.0,YR,,M,Y,,,20190327.0,,OT,PT,PT,2019,Q1,Elderly
161236881,16123688,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q1,Syncope,,2019,Q1,1,I,,20190318.0,20190327,20190327,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. HYPOVOLAEMIC LIPOTHYMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABETES. 2019;14 (1) SUPPL:47-122",71.0,YR,,M,Y,,,20190327.0,,OT,PT,PT,2019,Q1,Elderly
161298281,16129828,11,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q1,Arrhythmia,,2019,Q1,1,I,,20190322.0,20190328,20190328,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20190328.0,,OT,TR,TR,2019,Q1,Elderly
161298281,16129828,11,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q1,Bradycardia,,2019,Q1,1,I,,20190322.0,20190328,20190328,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20190328.0,,OT,TR,TR,2019,Q1,Elderly
161298281,16129828,11,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q1,Dehydration,,2019,Q1,1,I,,20190322.0,20190328,20190328,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20190328.0,,OT,TR,TR,2019,Q1,Elderly
161298281,16129828,11,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q1,Dizziness,,2019,Q1,1,I,,20190322.0,20190328,20190328,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20190328.0,,OT,TR,TR,2019,Q1,Elderly
161298281,16129828,11,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q1,Hypotension,,2019,Q1,1,I,,20190322.0,20190328,20190328,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20190328.0,,OT,TR,TR,2019,Q1,Elderly
161298281,16129828,11,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q1,Hypovolaemia,,2019,Q1,1,I,,20190322.0,20190328,20190328,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20190328.0,,OT,TR,TR,2019,Q1,Elderly
161298281,16129828,11,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q1,Oedema peripheral,,2019,Q1,1,I,,20190322.0,20190328,20190328,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20190328.0,,OT,TR,TR,2019,Q1,Elderly
161298281,16129828,11,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q1,Presyncope,,2019,Q1,1,I,,20190322.0,20190328,20190328,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20190328.0,,OT,TR,TR,2019,Q1,Elderly
161298281,16129828,11,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q1,Pulmonary congestion,,2019,Q1,1,I,,20190322.0,20190328,20190328,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20190328.0,,OT,TR,TR,2019,Q1,Elderly
161298281,16129828,11,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q1,Renal disorder,,2019,Q1,1,I,,20190322.0,20190328,20190328,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLEMIA ? A CASE OF EMPAGLIFLOZIN IATROGENY?. REVISTA PORTUGUESA DE DIABETES.. 2019;14(1)SUP:47-122:1-2",71.0,YR,E,M,Y,,,20190328.0,,OT,TR,TR,2019,Q1,Elderly
161309251,16130925,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,,,,,,,,,2019,Q1,Cardio-respiratory arrest,,2019,Q1,1,I,20190319.0,20190326.0,20190328,20190328,EXP,,PHHY2019IT070232,SANDOZ,,56.0,YR,,F,Y,,,20190328.0,,OT,IT,IT,2019,Q1,Adult
161309251,16130925,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,,,,,,,,,2019,Q1,Coma,,2019,Q1,1,I,20190319.0,20190326.0,20190328,20190328,EXP,,PHHY2019IT070232,SANDOZ,,56.0,YR,,F,Y,,,20190328.0,,OT,IT,IT,2019,Q1,Adult
161309251,16130925,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,,,,,,,,,2019,Q1,Overdose,,2019,Q1,1,I,20190319.0,20190326.0,20190328,20190328,EXP,,PHHY2019IT070232,SANDOZ,,56.0,YR,,F,Y,,,20190328.0,,OT,IT,IT,2019,Q1,Adult
161309251,16130925,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,,,,,,,,,2019,Q1,Respiratory failure,,2019,Q1,1,I,20190319.0,20190326.0,20190328,20190328,EXP,,PHHY2019IT070232,SANDOZ,,56.0,YR,,F,Y,,,20190328.0,,OT,IT,IT,2019,Q1,Adult
161363221,16136322,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q1,Acute kidney injury,,2019,Q1,1,I,,20190322.0,20190329,20190329,EXP,,PT-ASTRAZENECA-2019SE49086,ASTRAZENECA,,71.0,YR,,M,Y,,,20190329.0,,MD,PT,PT,2019,Q1,Elderly
161363221,16136322,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q1,Arrhythmia,,2019,Q1,1,I,,20190322.0,20190329,20190329,EXP,,PT-ASTRAZENECA-2019SE49086,ASTRAZENECA,,71.0,YR,,M,Y,,,20190329.0,,MD,PT,PT,2019,Q1,Elderly
161363221,16136322,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q1,Bradycardia,,2019,Q1,1,I,,20190322.0,20190329,20190329,EXP,,PT-ASTRAZENECA-2019SE49086,ASTRAZENECA,,71.0,YR,,M,Y,,,20190329.0,,MD,PT,PT,2019,Q1,Elderly
161363221,16136322,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q1,Dehydration,,2019,Q1,1,I,,20190322.0,20190329,20190329,EXP,,PT-ASTRAZENECA-2019SE49086,ASTRAZENECA,,71.0,YR,,M,Y,,,20190329.0,,MD,PT,PT,2019,Q1,Elderly
161363221,16136322,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q1,Hypotension,,2019,Q1,1,I,,20190322.0,20190329,20190329,EXP,,PT-ASTRAZENECA-2019SE49086,ASTRAZENECA,,71.0,YR,,M,Y,,,20190329.0,,MD,PT,PT,2019,Q1,Elderly
161363221,16136322,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q1,Presyncope,,2019,Q1,1,I,,20190322.0,20190329,20190329,EXP,,PT-ASTRAZENECA-2019SE49086,ASTRAZENECA,,71.0,YR,,M,Y,,,20190329.0,,MD,PT,PT,2019,Q1,Elderly
161363221,16136322,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q1,Syncope,,2019,Q1,1,I,,20190322.0,20190329,20190329,EXP,,PT-ASTRAZENECA-2019SE49086,ASTRAZENECA,,71.0,YR,,M,Y,,,20190329.0,,MD,PT,PT,2019,Q1,Elderly
98352043,9835204,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q1,Myocardial infarction,,2019,Q1,3,F,20131204.0,20190319.0,20140122,20190327,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-19895960,BRISTOL MYERS SQUIBB,,76.0,YR,,M,Y,91.61,KG,20190327.0,,OT,US,US,2019,Q1,Elderly
98352043,9835204,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q1,Troponin I increased,,2019,Q1,3,F,20131204.0,20190319.0,20140122,20190327,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-19895960,BRISTOL MYERS SQUIBB,,76.0,YR,,M,Y,91.61,KG,20190327.0,,OT,US,US,2019,Q1,Elderly
98352043,9835204,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q1,Ventricular arrhythmia,,2019,Q1,3,F,20131204.0,20190319.0,20140122,20190327,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-19895960,BRISTOL MYERS SQUIBB,,76.0,YR,,M,Y,91.61,KG,20190327.0,,OT,US,US,2019,Q1,Elderly
102038872,10203887,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK,UNK",,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Atrioventricular block,,2019,Q2,2,F,,20190401.0,20140529,20190408,EXP,,US-SA-2014SA065836,SANOFI AVENTIS,,58.0,YR,A,M,Y,,,20190408.0,,CN,US,US,2019,Q2,Adult
102038872,10203887,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK,UNK",,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Expired product administered,,2019,Q2,2,F,,20190401.0,20140529,20190408,EXP,,US-SA-2014SA065836,SANOFI AVENTIS,,58.0,YR,A,M,Y,,,20190408.0,,CN,US,US,2019,Q2,Adult
102038872,10203887,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK,UNK",,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Glycosylated haemoglobin increased,,2019,Q2,2,F,,20190401.0,20140529,20190408,EXP,,US-SA-2014SA065836,SANOFI AVENTIS,,58.0,YR,A,M,Y,,,20190408.0,,CN,US,US,2019,Q2,Adult
102038872,10203887,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK,UNK",,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Inability to afford medication,,2019,Q2,2,F,,20190401.0,20140529,20190408,EXP,,US-SA-2014SA065836,SANOFI AVENTIS,,58.0,YR,A,M,Y,,,20190408.0,,CN,US,US,2019,Q2,Adult
102038872,10203887,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK,UNK",,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Muscle spasms,,2019,Q2,2,F,,20190401.0,20140529,20190408,EXP,,US-SA-2014SA065836,SANOFI AVENTIS,,58.0,YR,A,M,Y,,,20190408.0,,CN,US,US,2019,Q2,Adult
102038872,10203887,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK,UNK",,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Product storage error,,2019,Q2,2,F,,20190401.0,20140529,20190408,EXP,,US-SA-2014SA065836,SANOFI AVENTIS,,58.0,YR,A,M,Y,,,20190408.0,,CN,US,US,2019,Q2,Adult
102038872,10203887,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK,UNK",,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Weight decreased,,2019,Q2,2,F,,20190401.0,20140529,20190408,EXP,,US-SA-2014SA065836,SANOFI AVENTIS,,58.0,YR,A,M,Y,,,20190408.0,,CN,US,US,2019,Q2,Adult
1142235119,11422351,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU/ML, UNK (BEFORE EACH MEAL)",,,,,,,,,,,,2019,Q2,Abdominal distension,,2019,Q2,19,F,20100930.0,20190411.0,20150827,20190418,EXP,,US-PFIZER INC-2015214404,PFIZER,,45.0,YR,,F,Y,73.0,KG,20190418.0,,CN,US,US,2019,Q2,Adult
1142235119,11422351,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU/ML, UNK (BEFORE EACH MEAL)",,,,,,,,,,,,2019,Q2,Cardiac disorder,,2019,Q2,19,F,20100930.0,20190411.0,20150827,20190418,EXP,,US-PFIZER INC-2015214404,PFIZER,,45.0,YR,,F,Y,73.0,KG,20190418.0,,CN,US,US,2019,Q2,Adult
1142235119,11422351,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU/ML, UNK (BEFORE EACH MEAL)",,,,,,,,,,,,2019,Q2,Cardiac failure,,2019,Q2,19,F,20100930.0,20190411.0,20150827,20190418,EXP,,US-PFIZER INC-2015214404,PFIZER,,45.0,YR,,F,Y,73.0,KG,20190418.0,,CN,US,US,2019,Q2,Adult
1142235119,11422351,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU/ML, UNK (BEFORE EACH MEAL)",,,,,,,,,,,,2019,Q2,Cardiac failure congestive,,2019,Q2,19,F,20100930.0,20190411.0,20150827,20190418,EXP,,US-PFIZER INC-2015214404,PFIZER,,45.0,YR,,F,Y,73.0,KG,20190418.0,,CN,US,US,2019,Q2,Adult
1142235119,11422351,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU/ML, UNK (BEFORE EACH MEAL)",,,,,,,,,,,,2019,Q2,Condition aggravated,,2019,Q2,19,F,20100930.0,20190411.0,20150827,20190418,EXP,,US-PFIZER INC-2015214404,PFIZER,,45.0,YR,,F,Y,73.0,KG,20190418.0,,CN,US,US,2019,Q2,Adult
1142235119,11422351,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU/ML, UNK (BEFORE EACH MEAL)",,,,,,,,,,,,2019,Q2,Diabetes mellitus,,2019,Q2,19,F,20100930.0,20190411.0,20150827,20190418,EXP,,US-PFIZER INC-2015214404,PFIZER,,45.0,YR,,F,Y,73.0,KG,20190418.0,,CN,US,US,2019,Q2,Adult
1142235119,11422351,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU/ML, UNK (BEFORE EACH MEAL)",,,,,,,,,,,,2019,Q2,Diarrhoea,,2019,Q2,19,F,20100930.0,20190411.0,20150827,20190418,EXP,,US-PFIZER INC-2015214404,PFIZER,,45.0,YR,,F,Y,73.0,KG,20190418.0,,CN,US,US,2019,Q2,Adult
1142235119,11422351,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU/ML, UNK (BEFORE EACH MEAL)",,,,,,,,,,,,2019,Q2,Drug ineffective for unapproved indication,,2019,Q2,19,F,20100930.0,20190411.0,20150827,20190418,EXP,,US-PFIZER INC-2015214404,PFIZER,,45.0,YR,,F,Y,73.0,KG,20190418.0,,CN,US,US,2019,Q2,Adult
1142235119,11422351,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU/ML, UNK (BEFORE EACH MEAL)",,,,,,,,,,,,2019,Q2,End stage renal disease,,2019,Q2,19,F,20100930.0,20190411.0,20150827,20190418,EXP,,US-PFIZER INC-2015214404,PFIZER,,45.0,YR,,F,Y,73.0,KG,20190418.0,,CN,US,US,2019,Q2,Adult
1142235119,11422351,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU/ML, UNK (BEFORE EACH MEAL)",,,,,,,,,,,,2019,Q2,Heart transplant rejection,,2019,Q2,19,F,20100930.0,20190411.0,20150827,20190418,EXP,,US-PFIZER INC-2015214404,PFIZER,,45.0,YR,,F,Y,73.0,KG,20190418.0,,CN,US,US,2019,Q2,Adult
1142235119,11422351,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU/ML, UNK (BEFORE EACH MEAL)",,,,,,,,,,,,2019,Q2,Hypertension,,2019,Q2,19,F,20100930.0,20190411.0,20150827,20190418,EXP,,US-PFIZER INC-2015214404,PFIZER,,45.0,YR,,F,Y,73.0,KG,20190418.0,,CN,US,US,2019,Q2,Adult
1142235119,11422351,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU/ML, UNK (BEFORE EACH MEAL)",,,,,,,,,,,,2019,Q2,Impaired work ability,,2019,Q2,19,F,20100930.0,20190411.0,20150827,20190418,EXP,,US-PFIZER INC-2015214404,PFIZER,,45.0,YR,,F,Y,73.0,KG,20190418.0,,CN,US,US,2019,Q2,Adult
1142235119,11422351,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU/ML, UNK (BEFORE EACH MEAL)",,,,,,,,,,,,2019,Q2,Insomnia,,2019,Q2,19,F,20100930.0,20190411.0,20150827,20190418,EXP,,US-PFIZER INC-2015214404,PFIZER,,45.0,YR,,F,Y,73.0,KG,20190418.0,,CN,US,US,2019,Q2,Adult
1142235119,11422351,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU/ML, UNK (BEFORE EACH MEAL)",,,,,,,,,,,,2019,Q2,Malaise,,2019,Q2,19,F,20100930.0,20190411.0,20150827,20190418,EXP,,US-PFIZER INC-2015214404,PFIZER,,45.0,YR,,F,Y,73.0,KG,20190418.0,,CN,US,US,2019,Q2,Adult
1142235119,11422351,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU/ML, UNK (BEFORE EACH MEAL)",,,,,,,,,,,,2019,Q2,Oedema peripheral,,2019,Q2,19,F,20100930.0,20190411.0,20150827,20190418,EXP,,US-PFIZER INC-2015214404,PFIZER,,45.0,YR,,F,Y,73.0,KG,20190418.0,,CN,US,US,2019,Q2,Adult
1142235119,11422351,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU/ML, UNK (BEFORE EACH MEAL)",,,,,,,,,,,,2019,Q2,Pain,,2019,Q2,19,F,20100930.0,20190411.0,20150827,20190418,EXP,,US-PFIZER INC-2015214404,PFIZER,,45.0,YR,,F,Y,73.0,KG,20190418.0,,CN,US,US,2019,Q2,Adult
1142235119,11422351,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU/ML, UNK (BEFORE EACH MEAL)",,,,,,,,,,,,2019,Q2,Pericardial effusion,,2019,Q2,19,F,20100930.0,20190411.0,20150827,20190418,EXP,,US-PFIZER INC-2015214404,PFIZER,,45.0,YR,,F,Y,73.0,KG,20190418.0,,CN,US,US,2019,Q2,Adult
1142235119,11422351,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU/ML, UNK (BEFORE EACH MEAL)",,,,,,,,,,,,2019,Q2,Renal failure,,2019,Q2,19,F,20100930.0,20190411.0,20150827,20190418,EXP,,US-PFIZER INC-2015214404,PFIZER,,45.0,YR,,F,Y,73.0,KG,20190418.0,,CN,US,US,2019,Q2,Adult
1142235119,11422351,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU/ML, UNK (BEFORE EACH MEAL)",,,,,,,,,,,,2019,Q2,Sleep apnoea syndrome,,2019,Q2,19,F,20100930.0,20190411.0,20150827,20190418,EXP,,US-PFIZER INC-2015214404,PFIZER,,45.0,YR,,F,Y,73.0,KG,20190418.0,,CN,US,US,2019,Q2,Adult
1142235119,11422351,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 IU/ML, UNK (BEFORE EACH MEAL)",,,,,,,,,,,,2019,Q2,Spinal cord injury,,2019,Q2,19,F,20100930.0,20190411.0,20150827,20190418,EXP,,US-PFIZER INC-2015214404,PFIZER,,45.0,YR,,F,Y,73.0,KG,20190418.0,,CN,US,US,2019,Q2,Adult
117468092,11746809,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,100 U/ML,,,,,,,20563.0,27.1,IU,,QD,2019,Q2,Diabetic nephropathy,,2019,Q2,2,F,201002.0,20190328.0,20151117,20190405,EXP,,IL-ELI_LILLY_AND_COMPANY-IL201511004982,ELI LILLY AND CO,,31.0,YR,,F,Y,56.0,KG,20190405.0,,CN,IL,IL,2019,Q2,Young Adult
117468092,11746809,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,100 U/ML,,,,,,,20563.0,27.1,IU,,QD,2019,Q2,Haemoglobin decreased,,2019,Q2,2,F,201002.0,20190328.0,20151117,20190405,EXP,,IL-ELI_LILLY_AND_COMPANY-IL201511004982,ELI LILLY AND CO,,31.0,YR,,F,Y,56.0,KG,20190405.0,,CN,IL,IL,2019,Q2,Young Adult
117468092,11746809,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,100 U/ML,,,,,,,20563.0,27.1,IU,,QD,2019,Q2,Laryngitis,,2019,Q2,2,F,201002.0,20190328.0,20151117,20190405,EXP,,IL-ELI_LILLY_AND_COMPANY-IL201511004982,ELI LILLY AND CO,,31.0,YR,,F,Y,56.0,KG,20190405.0,,CN,IL,IL,2019,Q2,Young Adult
117468092,11746809,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,100 U/ML,,,,,,,20563.0,27.1,IU,,QD,2019,Q2,Maternal exposure during pregnancy,,2019,Q2,2,F,201002.0,20190328.0,20151117,20190405,EXP,,IL-ELI_LILLY_AND_COMPANY-IL201511004982,ELI LILLY AND CO,,31.0,YR,,F,Y,56.0,KG,20190405.0,,CN,IL,IL,2019,Q2,Young Adult
117468092,11746809,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,100 U/ML,,,,,,,20563.0,27.1,IU,,QD,2019,Q2,Pruritus,,2019,Q2,2,F,201002.0,20190328.0,20151117,20190405,EXP,,IL-ELI_LILLY_AND_COMPANY-IL201511004982,ELI LILLY AND CO,,31.0,YR,,F,Y,56.0,KG,20190405.0,,CN,IL,IL,2019,Q2,Young Adult
117468092,11746809,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,100 U/ML,,,,,,,20563.0,27.1,IU,,QD,2019,Q2,Uterine rupture,,2019,Q2,2,F,201002.0,20190328.0,20151117,20190405,EXP,,IL-ELI_LILLY_AND_COMPANY-IL201511004982,ELI LILLY AND CO,,31.0,YR,,F,Y,56.0,KG,20190405.0,,CN,IL,IL,2019,Q2,Young Adult
127116319,12711631,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q2,Condition aggravated,,2019,Q2,9,F,20160307.0,20181017.0,20160902,20190430,PER,,PHHO2016US012688,NOVARTIS,,18.0,YR,,F,Y,56.2,KG,20190430.0,,MD,US,US,2019,Q2,Youth
127116319,12711631,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q2,Cough,,2019,Q2,9,F,20160307.0,20181017.0,20160902,20190430,PER,,PHHO2016US012688,NOVARTIS,,18.0,YR,,F,Y,56.2,KG,20190430.0,,MD,US,US,2019,Q2,Youth
127116319,12711631,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q2,Cystic fibrosis,,2019,Q2,9,F,20160307.0,20181017.0,20160902,20190430,PER,,PHHO2016US012688,NOVARTIS,,18.0,YR,,F,Y,56.2,KG,20190430.0,,MD,US,US,2019,Q2,Youth
127116319,12711631,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q2,Decreased appetite,,2019,Q2,9,F,20160307.0,20181017.0,20160902,20190430,PER,,PHHO2016US012688,NOVARTIS,,18.0,YR,,F,Y,56.2,KG,20190430.0,,MD,US,US,2019,Q2,Youth
127116319,12711631,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q2,Diarrhoea,,2019,Q2,9,F,20160307.0,20181017.0,20160902,20190430,PER,,PHHO2016US012688,NOVARTIS,,18.0,YR,,F,Y,56.2,KG,20190430.0,,MD,US,US,2019,Q2,Youth
127116319,12711631,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q2,Dyspnoea,,2019,Q2,9,F,20160307.0,20181017.0,20160902,20190430,PER,,PHHO2016US012688,NOVARTIS,,18.0,YR,,F,Y,56.2,KG,20190430.0,,MD,US,US,2019,Q2,Youth
127116319,12711631,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q2,Fatigue,,2019,Q2,9,F,20160307.0,20181017.0,20160902,20190430,PER,,PHHO2016US012688,NOVARTIS,,18.0,YR,,F,Y,56.2,KG,20190430.0,,MD,US,US,2019,Q2,Youth
127116319,12711631,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q2,Headache,,2019,Q2,9,F,20160307.0,20181017.0,20160902,20190430,PER,,PHHO2016US012688,NOVARTIS,,18.0,YR,,F,Y,56.2,KG,20190430.0,,MD,US,US,2019,Q2,Youth
127116319,12711631,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q2,Infective pulmonary exacerbation of cystic fibrosis,,2019,Q2,9,F,20160307.0,20181017.0,20160902,20190430,PER,,PHHO2016US012688,NOVARTIS,,18.0,YR,,F,Y,56.2,KG,20190430.0,,MD,US,US,2019,Q2,Youth
127116319,12711631,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q2,Musculoskeletal chest pain,,2019,Q2,9,F,20160307.0,20181017.0,20160902,20190430,PER,,PHHO2016US012688,NOVARTIS,,18.0,YR,,F,Y,56.2,KG,20190430.0,,MD,US,US,2019,Q2,Youth
127116319,12711631,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q2,Pyrexia,,2019,Q2,9,F,20160307.0,20181017.0,20160902,20190430,PER,,PHHO2016US012688,NOVARTIS,,18.0,YR,,F,Y,56.2,KG,20190430.0,,MD,US,US,2019,Q2,Youth
127116319,12711631,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q2,Sputum increased,,2019,Q2,9,F,20160307.0,20181017.0,20160902,20190430,PER,,PHHO2016US012688,NOVARTIS,,18.0,YR,,F,Y,56.2,KG,20190430.0,,MD,US,US,2019,Q2,Youth
127116319,12711631,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q2,Weight decreased,,2019,Q2,9,F,20160307.0,20181017.0,20160902,20190430,PER,,PHHO2016US012688,NOVARTIS,,18.0,YR,,F,Y,56.2,KG,20190430.0,,MD,US,US,2019,Q2,Youth
129258883,12925888,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK,PRN",,,U,,,,,,,,,2019,Q2,Hospitalisation,,2019,Q2,3,F,20160918.0,20190530.0,20161108,20190606,PER,,US-SA-2016SA174734,SANOFI AVENTIS,,70.0,YR,E,M,Y,,,20190606.0,,MD,US,US,2019,Q2,Elderly
129258883,12925888,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK,PRN",,,U,,,,,,,,,2019,Q2,Therapeutic response unexpected,,2019,Q2,3,F,20160918.0,20190530.0,20161108,20190606,PER,,US-SA-2016SA174734,SANOFI AVENTIS,,70.0,YR,E,M,Y,,,20190606.0,,MD,US,US,2019,Q2,Elderly
129975892,12997589,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, Q6H",,,U,,,,,,,,QID,2019,Q2,Acute respiratory distress syndrome,,2019,Q2,2,F,20161129.0,20190405.0,20161205,20190411,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-103511,BRISTOL MYERS SQUIBB,,66.0,YR,,F,Y,,,20190411.0,,OT,US,US,2019,Q2,Elderly
136391784,13639178,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,1000 INTERNATIONAL UNIT,,,U,,,,,1000.0,IU,,,2019,Q2,Dyspnoea,,2019,Q2,4,F,20170410.0,20190408.0,20170609,20190410,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-048501,BRISTOL MYERS SQUIBB,,87.0,YR,,M,Y,,,20190410.0,,CN,FR,FR,2019,Q2,Elderly
136391784,13639178,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,1000 INTERNATIONAL UNIT,,,U,,,,,1000.0,IU,,,2019,Q2,Lung adenocarcinoma,,2019,Q2,4,F,20170410.0,20190408.0,20170609,20190410,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-048501,BRISTOL MYERS SQUIBB,,87.0,YR,,M,Y,,,20190410.0,,CN,FR,FR,2019,Q2,Elderly
136391784,13639178,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,1000 INTERNATIONAL UNIT,,,U,,,,,1000.0,IU,,,2019,Q2,Pleural effusion,,2019,Q2,4,F,20170410.0,20190408.0,20170609,20190410,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-048501,BRISTOL MYERS SQUIBB,,87.0,YR,,M,Y,,,20190410.0,,CN,FR,FR,2019,Q2,Elderly
136391784,13639178,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,1000 INTERNATIONAL UNIT,,,U,,,,,1000.0,IU,,,2019,Q2,Respiratory distress,,2019,Q2,4,F,20170410.0,20190408.0,20170609,20190410,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-048501,BRISTOL MYERS SQUIBB,,87.0,YR,,M,Y,,,20190410.0,,CN,FR,FR,2019,Q2,Elderly
137004806,13700480,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Large intestine perforation,,2019,Q2,6,F,20170623.0,20190419.0,20170629,20190422,PER,,US-EISAI MEDICAL RESEARCH-EC-2017-028878,EISAI,,80.0,YR,,M,Y,61.9,KG,20190422.0,,MD,US,US,2019,Q2,Elderly
138394939,13839493,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1-6 UNIT,,,,,,,,,,,,2019,Q2,Atrial fibrillation,,2019,Q2,9,F,20170626.0,20190403.0,20170807,20190405,EXP,,US-ROCHE-1956870,ROCHE,,78.0,YR,,M,Y,,,20190405.0,,MD,US,US,2019,Q2,Elderly
138394939,13839493,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1-6 UNIT,,,,,,,,,,,,2019,Q2,Neutropenia,,2019,Q2,9,F,20170626.0,20190403.0,20170807,20190405,EXP,,US-ROCHE-1956870,ROCHE,,78.0,YR,,M,Y,,,20190405.0,,MD,US,US,2019,Q2,Elderly
138394939,13839493,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1-6 UNIT,,,,,,,,,,,,2019,Q2,Urosepsis,,2019,Q2,9,F,20170626.0,20190403.0,20170807,20190405,EXP,,US-ROCHE-1956870,ROCHE,,78.0,YR,,M,Y,,,20190405.0,,MD,US,US,2019,Q2,Elderly
138394939,13839493,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1-4 UNIT,,,,,,,,,,,,2019,Q2,Atrial fibrillation,,2019,Q2,9,F,20170626.0,20190403.0,20170807,20190405,EXP,,US-ROCHE-1956870,ROCHE,,78.0,YR,,M,Y,,,20190405.0,,MD,US,US,2019,Q2,Elderly
138394939,13839493,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1-4 UNIT,,,,,,,,,,,,2019,Q2,Neutropenia,,2019,Q2,9,F,20170626.0,20190403.0,20170807,20190405,EXP,,US-ROCHE-1956870,ROCHE,,78.0,YR,,M,Y,,,20190405.0,,MD,US,US,2019,Q2,Elderly
138394939,13839493,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1-4 UNIT,,,,,,,,,,,,2019,Q2,Urosepsis,,2019,Q2,9,F,20170626.0,20190403.0,20170807,20190405,EXP,,US-ROCHE-1956870,ROCHE,,78.0,YR,,M,Y,,,20190405.0,,MD,US,US,2019,Q2,Elderly
138425602,13842560,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Pancreatic carcinoma,,2019,Q2,2,F,20140303.0,20190418.0,20170808,20190425,EXP,,US-ASTRAZENECA-2017SE79011,ASTRAZENECA,,19825.0,DY,,M,Y,131.5,KG,20190425.0,,,US,US,2019,Q2,Elderly
138425602,13842560,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Pancreatitis chronic,,2019,Q2,2,F,20140303.0,20190418.0,20170808,20190425,EXP,,US-ASTRAZENECA-2017SE79011,ASTRAZENECA,,19825.0,DY,,M,Y,131.5,KG,20190425.0,,,US,US,2019,Q2,Elderly
139028443,13902844,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"36 IU,UNK",,,Y,,,,,36.0,IU,SOLUTION FOR INJECTION,,2019,Q2,Abdominal pain,,2019,Q2,3,F,20160210.0,20190522.0,20170824,20190530,EXP,,ES-SA-2017SA152132,SANOFI AVENTIS,,40.0,YR,A,F,Y,89.0,KG,20190530.0,,MD,ES,ES,2019,Q2,Adult
139028443,13902844,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"36 IU,UNK",,,Y,,,,,36.0,IU,SOLUTION FOR INJECTION,,2019,Q2,Blood glucose abnormal,,2019,Q2,3,F,20160210.0,20190522.0,20170824,20190530,EXP,,ES-SA-2017SA152132,SANOFI AVENTIS,,40.0,YR,A,F,Y,89.0,KG,20190530.0,,MD,ES,ES,2019,Q2,Adult
139028443,13902844,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"36 IU,UNK",,,Y,,,,,36.0,IU,SOLUTION FOR INJECTION,,2019,Q2,Exposure during pregnancy,,2019,Q2,3,F,20160210.0,20190522.0,20170824,20190530,EXP,,ES-SA-2017SA152132,SANOFI AVENTIS,,40.0,YR,A,F,Y,89.0,KG,20190530.0,,MD,ES,ES,2019,Q2,Adult
139028443,13902844,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"36 IU,UNK",,,Y,,,,,36.0,IU,SOLUTION FOR INJECTION,,2019,Q2,Hypoglycaemia,,2019,Q2,3,F,20160210.0,20190522.0,20170824,20190530,EXP,,ES-SA-2017SA152132,SANOFI AVENTIS,,40.0,YR,A,F,Y,89.0,KG,20190530.0,,MD,ES,ES,2019,Q2,Adult
139028443,13902844,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"36 IU,UNK",,,Y,,,,,36.0,IU,SOLUTION FOR INJECTION,,2019,Q2,Metrorrhagia,,2019,Q2,3,F,20160210.0,20190522.0,20170824,20190530,EXP,,ES-SA-2017SA152132,SANOFI AVENTIS,,40.0,YR,A,F,Y,89.0,KG,20190530.0,,MD,ES,ES,2019,Q2,Adult
139028443,13902844,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK,UNK",,,Y,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Abdominal pain,,2019,Q2,3,F,20160210.0,20190522.0,20170824,20190530,EXP,,ES-SA-2017SA152132,SANOFI AVENTIS,,40.0,YR,A,F,Y,89.0,KG,20190530.0,,MD,ES,ES,2019,Q2,Adult
139028443,13902844,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK,UNK",,,Y,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Blood glucose abnormal,,2019,Q2,3,F,20160210.0,20190522.0,20170824,20190530,EXP,,ES-SA-2017SA152132,SANOFI AVENTIS,,40.0,YR,A,F,Y,89.0,KG,20190530.0,,MD,ES,ES,2019,Q2,Adult
139028443,13902844,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK,UNK",,,Y,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Exposure during pregnancy,,2019,Q2,3,F,20160210.0,20190522.0,20170824,20190530,EXP,,ES-SA-2017SA152132,SANOFI AVENTIS,,40.0,YR,A,F,Y,89.0,KG,20190530.0,,MD,ES,ES,2019,Q2,Adult
139028443,13902844,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK,UNK",,,Y,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Hypoglycaemia,,2019,Q2,3,F,20160210.0,20190522.0,20170824,20190530,EXP,,ES-SA-2017SA152132,SANOFI AVENTIS,,40.0,YR,A,F,Y,89.0,KG,20190530.0,,MD,ES,ES,2019,Q2,Adult
139028443,13902844,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK,UNK",,,Y,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Metrorrhagia,,2019,Q2,3,F,20160210.0,20190522.0,20170824,20190530,EXP,,ES-SA-2017SA152132,SANOFI AVENTIS,,40.0,YR,A,F,Y,89.0,KG,20190530.0,,MD,ES,ES,2019,Q2,Adult
1411224615,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q2,Abdominal pain,,2019,Q2,15,F,20170708.0,20190429.0,20171020,20190510,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,,F,Y,55.78,KG,20190511.0,,OT,US,US,2019,Q2,Adult
1411224615,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q2,Acute respiratory failure,,2019,Q2,15,F,20170708.0,20190429.0,20171020,20190510,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,,F,Y,55.78,KG,20190511.0,,OT,US,US,2019,Q2,Adult
1411224615,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q2,Alopecia,,2019,Q2,15,F,20170708.0,20190429.0,20171020,20190510,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,,F,Y,55.78,KG,20190511.0,,OT,US,US,2019,Q2,Adult
1411224615,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q2,Asthenia,,2019,Q2,15,F,20170708.0,20190429.0,20171020,20190510,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,,F,Y,55.78,KG,20190511.0,,OT,US,US,2019,Q2,Adult
1411224615,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q2,Atrial fibrillation,,2019,Q2,15,F,20170708.0,20190429.0,20171020,20190510,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,,F,Y,55.78,KG,20190511.0,,OT,US,US,2019,Q2,Adult
1411224615,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q2,Atrial flutter,,2019,Q2,15,F,20170708.0,20190429.0,20171020,20190510,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,,F,Y,55.78,KG,20190511.0,,OT,US,US,2019,Q2,Adult
1411224615,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q2,Atrial tachycardia,,2019,Q2,15,F,20170708.0,20190429.0,20171020,20190510,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,,F,Y,55.78,KG,20190511.0,,OT,US,US,2019,Q2,Adult
1411224615,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q2,Back pain,,2019,Q2,15,F,20170708.0,20190429.0,20171020,20190510,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,,F,Y,55.78,KG,20190511.0,,OT,US,US,2019,Q2,Adult
1411224615,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q2,Blood urea increased,,2019,Q2,15,F,20170708.0,20190429.0,20171020,20190510,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,,F,Y,55.78,KG,20190511.0,,OT,US,US,2019,Q2,Adult
1411224615,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q2,Brain natriuretic peptide increased,,2019,Q2,15,F,20170708.0,20190429.0,20171020,20190510,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,,F,Y,55.78,KG,20190511.0,,OT,US,US,2019,Q2,Adult
1411224615,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q2,Cardiac failure congestive,,2019,Q2,15,F,20170708.0,20190429.0,20171020,20190510,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,,F,Y,55.78,KG,20190511.0,,OT,US,US,2019,Q2,Adult
1411224615,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q2,Cardiomegaly,,2019,Q2,15,F,20170708.0,20190429.0,20171020,20190510,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,,F,Y,55.78,KG,20190511.0,,OT,US,US,2019,Q2,Adult
1411224615,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q2,Cardiomyopathy,,2019,Q2,15,F,20170708.0,20190429.0,20171020,20190510,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,,F,Y,55.78,KG,20190511.0,,OT,US,US,2019,Q2,Adult
1411224615,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q2,Cellulitis,,2019,Q2,15,F,20170708.0,20190429.0,20171020,20190510,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,,F,Y,55.78,KG,20190511.0,,OT,US,US,2019,Q2,Adult
1411224615,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q2,Cerebrovascular accident,,2019,Q2,15,F,20170708.0,20190429.0,20171020,20190510,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,,F,Y,55.78,KG,20190511.0,,OT,US,US,2019,Q2,Adult
1411224615,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q2,Chest pain,,2019,Q2,15,F,20170708.0,20190429.0,20171020,20190510,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,,F,Y,55.78,KG,20190511.0,,OT,US,US,2019,Q2,Adult
1411224615,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q2,Clostridium difficile infection,,2019,Q2,15,F,20170708.0,20190429.0,20171020,20190510,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,,F,Y,55.78,KG,20190511.0,,OT,US,US,2019,Q2,Adult
1411224615,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q2,Condition aggravated,,2019,Q2,15,F,20170708.0,20190429.0,20171020,20190510,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,,F,Y,55.78,KG,20190511.0,,OT,US,US,2019,Q2,Adult
1411224615,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q2,Crepitations,,2019,Q2,15,F,20170708.0,20190429.0,20171020,20190510,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,,F,Y,55.78,KG,20190511.0,,OT,US,US,2019,Q2,Adult
1411224615,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q2,Death,,2019,Q2,15,F,20170708.0,20190429.0,20171020,20190510,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,,F,Y,55.78,KG,20190511.0,,OT,US,US,2019,Q2,Adult
1411224615,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q2,Diarrhoea,,2019,Q2,15,F,20170708.0,20190429.0,20171020,20190510,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,,F,Y,55.78,KG,20190511.0,,OT,US,US,2019,Q2,Adult
1411224615,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q2,Dyspnoea,,2019,Q2,15,F,20170708.0,20190429.0,20171020,20190510,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,,F,Y,55.78,KG,20190511.0,,OT,US,US,2019,Q2,Adult
1411224615,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q2,Ear pain,,2019,Q2,15,F,20170708.0,20190429.0,20171020,20190510,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,,F,Y,55.78,KG,20190511.0,,OT,US,US,2019,Q2,Adult
1411224615,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q2,Facial paralysis,,2019,Q2,15,F,20170708.0,20190429.0,20171020,20190510,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,,F,Y,55.78,KG,20190511.0,,OT,US,US,2019,Q2,Adult
1411224615,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q2,Fall,,2019,Q2,15,F,20170708.0,20190429.0,20171020,20190510,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,,F,Y,55.78,KG,20190511.0,,OT,US,US,2019,Q2,Adult
1411224615,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q2,Gastric disorder,,2019,Q2,15,F,20170708.0,20190429.0,20171020,20190510,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,,F,Y,55.78,KG,20190511.0,,OT,US,US,2019,Q2,Adult
1411224615,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q2,Gastrointestinal obstruction,,2019,Q2,15,F,20170708.0,20190429.0,20171020,20190510,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,,F,Y,55.78,KG,20190511.0,,OT,US,US,2019,Q2,Adult
1411224615,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q2,Haemoglobin decreased,,2019,Q2,15,F,20170708.0,20190429.0,20171020,20190510,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,,F,Y,55.78,KG,20190511.0,,OT,US,US,2019,Q2,Adult
1411224615,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q2,Hernia repair,,2019,Q2,15,F,20170708.0,20190429.0,20171020,20190510,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,,F,Y,55.78,KG,20190511.0,,OT,US,US,2019,Q2,Adult
1411224615,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q2,Hypokinesia,,2019,Q2,15,F,20170708.0,20190429.0,20171020,20190510,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,,F,Y,55.78,KG,20190511.0,,OT,US,US,2019,Q2,Adult
1411224615,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q2,Hypotension,,2019,Q2,15,F,20170708.0,20190429.0,20171020,20190510,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,,F,Y,55.78,KG,20190511.0,,OT,US,US,2019,Q2,Adult
1411224615,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q2,Nausea,,2019,Q2,15,F,20170708.0,20190429.0,20171020,20190510,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,,F,Y,55.78,KG,20190511.0,,OT,US,US,2019,Q2,Adult
1411224615,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q2,Neutropenia,,2019,Q2,15,F,20170708.0,20190429.0,20171020,20190510,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,,F,Y,55.78,KG,20190511.0,,OT,US,US,2019,Q2,Adult
1411224615,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q2,Non-cardiac chest pain,,2019,Q2,15,F,20170708.0,20190429.0,20171020,20190510,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,,F,Y,55.78,KG,20190511.0,,OT,US,US,2019,Q2,Adult
1411224615,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q2,Oesophageal food impaction,,2019,Q2,15,F,20170708.0,20190429.0,20171020,20190510,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,,F,Y,55.78,KG,20190511.0,,OT,US,US,2019,Q2,Adult
1411224615,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q2,Orthopnoea,,2019,Q2,15,F,20170708.0,20190429.0,20171020,20190510,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,,F,Y,55.78,KG,20190511.0,,OT,US,US,2019,Q2,Adult
1411224615,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q2,Oxygen saturation decreased,,2019,Q2,15,F,20170708.0,20190429.0,20171020,20190510,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,,F,Y,55.78,KG,20190511.0,,OT,US,US,2019,Q2,Adult
1411224615,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q2,Pain in extremity,,2019,Q2,15,F,20170708.0,20190429.0,20171020,20190510,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,,F,Y,55.78,KG,20190511.0,,OT,US,US,2019,Q2,Adult
1411224615,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q2,Pericardial effusion,,2019,Q2,15,F,20170708.0,20190429.0,20171020,20190510,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,,F,Y,55.78,KG,20190511.0,,OT,US,US,2019,Q2,Adult
1411224615,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q2,Pyrexia,,2019,Q2,15,F,20170708.0,20190429.0,20171020,20190510,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,,F,Y,55.78,KG,20190511.0,,OT,US,US,2019,Q2,Adult
1411224615,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q2,Sepsis,,2019,Q2,15,F,20170708.0,20190429.0,20171020,20190510,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,,F,Y,55.78,KG,20190511.0,,OT,US,US,2019,Q2,Adult
1411224615,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q2,Skin ulcer,,2019,Q2,15,F,20170708.0,20190429.0,20171020,20190510,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,,F,Y,55.78,KG,20190511.0,,OT,US,US,2019,Q2,Adult
1411224615,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q2,Systemic lupus erythematosus,,2019,Q2,15,F,20170708.0,20190429.0,20171020,20190510,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,,F,Y,55.78,KG,20190511.0,,OT,US,US,2019,Q2,Adult
1411224615,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q2,Urinary tract infection,,2019,Q2,15,F,20170708.0,20190429.0,20171020,20190510,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,,F,Y,55.78,KG,20190511.0,,OT,US,US,2019,Q2,Adult
1411224615,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q2,Vomiting,,2019,Q2,15,F,20170708.0,20190429.0,20171020,20190510,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,,F,Y,55.78,KG,20190511.0,,OT,US,US,2019,Q2,Adult
1411224615,14112246,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q2,Wound drainage,,2019,Q2,15,F,20170708.0,20190429.0,20171020,20190510,EXP,,US-ACTELION-A-NJ2017-159837,ACTELION,,43.0,YR,,F,Y,55.78,KG,20190511.0,,OT,US,US,2019,Q2,Adult
142810548,14281054,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,QHS,,,U,,,,,,,,,2019,Q2,Abdominal pain,,2019,Q2,8,F,20170405.0,20190604.0,20171213,20190614,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-033144,BRISTOL MYERS SQUIBB,,46.0,YR,,F,Y,,,20190614.0,,MD,CA,CA,2019,Q2,Adult
142810548,14281054,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,QHS,,,U,,,,,,,,,2019,Q2,Adverse event,,2019,Q2,8,F,20170405.0,20190604.0,20171213,20190614,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-033144,BRISTOL MYERS SQUIBB,,46.0,YR,,F,Y,,,20190614.0,,MD,CA,CA,2019,Q2,Adult
142810548,14281054,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,QHS,,,U,,,,,,,,,2019,Q2,Blood alkaline phosphatase increased,,2019,Q2,8,F,20170405.0,20190604.0,20171213,20190614,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-033144,BRISTOL MYERS SQUIBB,,46.0,YR,,F,Y,,,20190614.0,,MD,CA,CA,2019,Q2,Adult
142810548,14281054,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,QHS,,,U,,,,,,,,,2019,Q2,Cystitis,,2019,Q2,8,F,20170405.0,20190604.0,20171213,20190614,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-033144,BRISTOL MYERS SQUIBB,,46.0,YR,,F,Y,,,20190614.0,,MD,CA,CA,2019,Q2,Adult
142810548,14281054,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,QHS,,,U,,,,,,,,,2019,Q2,Hepatic steatosis,,2019,Q2,8,F,20170405.0,20190604.0,20171213,20190614,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-033144,BRISTOL MYERS SQUIBB,,46.0,YR,,F,Y,,,20190614.0,,MD,CA,CA,2019,Q2,Adult
142810548,14281054,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,QHS,,,U,,,,,,,,,2019,Q2,Hospitalisation,,2019,Q2,8,F,20170405.0,20190604.0,20171213,20190614,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-033144,BRISTOL MYERS SQUIBB,,46.0,YR,,F,Y,,,20190614.0,,MD,CA,CA,2019,Q2,Adult
142810548,14281054,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,QHS,,,U,,,,,,,,,2019,Q2,Impaired healing,,2019,Q2,8,F,20170405.0,20190604.0,20171213,20190614,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-033144,BRISTOL MYERS SQUIBB,,46.0,YR,,F,Y,,,20190614.0,,MD,CA,CA,2019,Q2,Adult
142810548,14281054,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,QHS,,,U,,,,,,,,,2019,Q2,Lower respiratory tract infection,,2019,Q2,8,F,20170405.0,20190604.0,20171213,20190614,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-033144,BRISTOL MYERS SQUIBB,,46.0,YR,,F,Y,,,20190614.0,,MD,CA,CA,2019,Q2,Adult
142810548,14281054,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,QHS,,,U,,,,,,,,,2019,Q2,Malaise,,2019,Q2,8,F,20170405.0,20190604.0,20171213,20190614,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-033144,BRISTOL MYERS SQUIBB,,46.0,YR,,F,Y,,,20190614.0,,MD,CA,CA,2019,Q2,Adult
142810548,14281054,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,QHS,,,U,,,,,,,,,2019,Q2,Myocardial infarction,,2019,Q2,8,F,20170405.0,20190604.0,20171213,20190614,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-033144,BRISTOL MYERS SQUIBB,,46.0,YR,,F,Y,,,20190614.0,,MD,CA,CA,2019,Q2,Adult
142810548,14281054,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,QHS,,,U,,,,,,,,,2019,Q2,Nasopharyngitis,,2019,Q2,8,F,20170405.0,20190604.0,20171213,20190614,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-033144,BRISTOL MYERS SQUIBB,,46.0,YR,,F,Y,,,20190614.0,,MD,CA,CA,2019,Q2,Adult
142810548,14281054,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,QHS,,,U,,,,,,,,,2019,Q2,Pancreatic cyst,,2019,Q2,8,F,20170405.0,20190604.0,20171213,20190614,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-033144,BRISTOL MYERS SQUIBB,,46.0,YR,,F,Y,,,20190614.0,,MD,CA,CA,2019,Q2,Adult
142810548,14281054,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,QHS,,,U,,,,,,,,,2019,Q2,Pneumonia,,2019,Q2,8,F,20170405.0,20190604.0,20171213,20190614,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-033144,BRISTOL MYERS SQUIBB,,46.0,YR,,F,Y,,,20190614.0,,MD,CA,CA,2019,Q2,Adult
142810548,14281054,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,QHS,,,U,,,,,,,,,2019,Q2,Productive cough,,2019,Q2,8,F,20170405.0,20190604.0,20171213,20190614,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-033144,BRISTOL MYERS SQUIBB,,46.0,YR,,F,Y,,,20190614.0,,MD,CA,CA,2019,Q2,Adult
142810548,14281054,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,QHS,,,U,,,,,,,,,2019,Q2,Upper respiratory tract infection,,2019,Q2,8,F,20170405.0,20190604.0,20171213,20190614,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-033144,BRISTOL MYERS SQUIBB,,46.0,YR,,F,Y,,,20190614.0,,MD,CA,CA,2019,Q2,Adult
142810548,14281054,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,QHS,,,U,,,,,,,,,2019,Q2,Urinary tract infection,,2019,Q2,8,F,20170405.0,20190604.0,20171213,20190614,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-033144,BRISTOL MYERS SQUIBB,,46.0,YR,,F,Y,,,20190614.0,,MD,CA,CA,2019,Q2,Adult
142810548,14281054,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,QHS,,,U,,,,,,,,,2019,Q2,Wheezing,,2019,Q2,8,F,20170405.0,20190604.0,20171213,20190614,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-033144,BRISTOL MYERS SQUIBB,,46.0,YR,,F,Y,,,20190614.0,,MD,CA,CA,2019,Q2,Adult
1455403310,14554033,24,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,INJECTION,,2019,Q2,Diarrhoea,,2019,Q2,10,F,20180211.0,20190620.0,20180220,20190624,EXP,,CA-CELGENEUS-CAN-20180205858,CELGENE,,77.0,YR,,M,Y,67.6,KG,20190624.0,,OT,CA,CA,2019,Q2,Elderly
1455403310,14554033,24,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,INJECTION,,2019,Q2,Klebsiella infection,,2019,Q2,10,F,20180211.0,20190620.0,20180220,20190624,EXP,,CA-CELGENEUS-CAN-20180205858,CELGENE,,77.0,YR,,M,Y,67.6,KG,20190624.0,,OT,CA,CA,2019,Q2,Elderly
1455403310,14554033,24,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,INJECTION,,2019,Q2,Lung infection,,2019,Q2,10,F,20180211.0,20190620.0,20180220,20190624,EXP,,CA-CELGENEUS-CAN-20180205858,CELGENE,,77.0,YR,,M,Y,67.6,KG,20190624.0,,OT,CA,CA,2019,Q2,Elderly
1455403310,14554033,24,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,INJECTION,,2019,Q2,Sepsis,,2019,Q2,10,F,20180211.0,20190620.0,20180220,20190624,EXP,,CA-CELGENEUS-CAN-20180205858,CELGENE,,77.0,YR,,M,Y,67.6,KG,20190624.0,,OT,CA,CA,2019,Q2,Elderly
1455403310,14554033,24,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,INJECTION,,2019,Q2,Septic shock,,2019,Q2,10,F,20180211.0,20190620.0,20180220,20190624,EXP,,CA-CELGENEUS-CAN-20180205858,CELGENE,,77.0,YR,,M,Y,67.6,KG,20190624.0,,OT,CA,CA,2019,Q2,Elderly
146067834,14606783,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2019,Q2,Abdominal pain,,2019,Q2,4,F,20150912.0,20190515.0,20180307,20190520,EXP,,SE-ROCHE-1634898,ROCHE,,73.0,YR,,F,Y,72.2,KG,20190520.0,,MD,SE,SE,2019,Q2,Elderly
146067834,14606783,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2019,Q2,Atrial fibrillation,,2019,Q2,4,F,20150912.0,20190515.0,20180307,20190520,EXP,,SE-ROCHE-1634898,ROCHE,,73.0,YR,,F,Y,72.2,KG,20190520.0,,MD,SE,SE,2019,Q2,Elderly
146067834,14606783,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2019,Q2,Colorectal cancer,,2019,Q2,4,F,20150912.0,20190515.0,20180307,20190520,EXP,,SE-ROCHE-1634898,ROCHE,,73.0,YR,,F,Y,72.2,KG,20190520.0,,MD,SE,SE,2019,Q2,Elderly
146067834,14606783,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2019,Q2,Colorectal cancer metastatic,,2019,Q2,4,F,20150912.0,20190515.0,20180307,20190520,EXP,,SE-ROCHE-1634898,ROCHE,,73.0,YR,,F,Y,72.2,KG,20190520.0,,MD,SE,SE,2019,Q2,Elderly
146067834,14606783,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2019,Q2,Escherichia sepsis,,2019,Q2,4,F,20150912.0,20190515.0,20180307,20190520,EXP,,SE-ROCHE-1634898,ROCHE,,73.0,YR,,F,Y,72.2,KG,20190520.0,,MD,SE,SE,2019,Q2,Elderly
146067834,14606783,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2019,Q2,Listeria sepsis,,2019,Q2,4,F,20150912.0,20190515.0,20180307,20190520,EXP,,SE-ROCHE-1634898,ROCHE,,73.0,YR,,F,Y,72.2,KG,20190520.0,,MD,SE,SE,2019,Q2,Elderly
146067834,14606783,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2019,Q2,Urinary tract infection,,2019,Q2,4,F,20150912.0,20190515.0,20180307,20190520,EXP,,SE-ROCHE-1634898,ROCHE,,73.0,YR,,F,Y,72.2,KG,20190520.0,,MD,SE,SE,2019,Q2,Elderly
146933685,14693368,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Chronic kidney disease,,2019,Q2,5,F,2008.0,20190508.0,20180329,20190516,EXP,,US-ASTRAZENECA-2018SE37195,ASTRAZENECA,,58.0,YR,,F,Y,68.9,KG,20190516.0,,,US,US,2019,Q2,Adult
146933685,14693368,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,End stage renal disease,,2019,Q2,5,F,2008.0,20190508.0,20180329,20190516,EXP,,US-ASTRAZENECA-2018SE37195,ASTRAZENECA,,58.0,YR,,F,Y,68.9,KG,20190516.0,,,US,US,2019,Q2,Adult
146933685,14693368,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Renal failure,,2019,Q2,5,F,2008.0,20190508.0,20180329,20190516,EXP,,US-ASTRAZENECA-2018SE37195,ASTRAZENECA,,58.0,YR,,F,Y,68.9,KG,20190516.0,,,US,US,2019,Q2,Adult
146933685,14693368,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Renal injury,,2019,Q2,5,F,2008.0,20190508.0,20180329,20190516,EXP,,US-ASTRAZENECA-2018SE37195,ASTRAZENECA,,58.0,YR,,F,Y,68.9,KG,20190516.0,,,US,US,2019,Q2,Adult
146997985,14699798,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q2,Acute kidney injury,,2019,Q2,5,F,20110627.0,20190508.0,20180330,20190509,EXP,,US-PFIZER INC-2018129976,PFIZER,,37.0,YR,,F,Y,,,20190509.0,,LW,US,US,2019,Q2,Adult
146997985,14699798,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q2,Chronic kidney disease,,2019,Q2,5,F,20110627.0,20190508.0,20180330,20190509,EXP,,US-PFIZER INC-2018129976,PFIZER,,37.0,YR,,F,Y,,,20190509.0,,LW,US,US,2019,Q2,Adult
147112412,14711241,10,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,1 DOSAGE FORMS,,,,,,,,1.0,DF,INJECTION,,2019,Q2,Cholangitis,,2019,Q2,2,F,20171016.0,20190510.0,20180403,20190516,EXP,,JP-CELGENEUS-JPN-20180311068,CELGENE,,74.0,YR,,M,Y,62.0,KG,20190516.0,,MD,JP,JP,2019,Q2,Elderly
147154314,14715431,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q2,Acute kidney injury,,2019,Q2,4,F,20110627.0,20190430.0,20180404,20190510,PER,,US-TAKEDA-2018TEU001954,TAKEDA,,37.0,YR,,F,Y,,,20190511.0,,LW,US,US,2019,Q2,Adult
147154314,14715431,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q2,Chronic kidney disease,,2019,Q2,4,F,20110627.0,20190430.0,20180404,20190510,PER,,US-TAKEDA-2018TEU001954,TAKEDA,,37.0,YR,,F,Y,,,20190511.0,,LW,US,US,2019,Q2,Adult
147783585,14778358,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,5 UNITS TWO TIMES IN DAY,,,,,,,,,,,,2019,Q2,Chronic kidney disease,,2019,Q2,5,F,20000322.0,20190408.0,20180419,20190419,EXP,,US-ASTRAZENECA-2018SE49082,ASTRAZENECA,,15913.0,DY,,F,Y,,,20190419.0,,,US,US,2019,Q2,Elderly
147783585,14778358,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,5 UNITS TWO TIMES IN DAY,,,,,,,,,,,,2019,Q2,Chronic kidney disease-mineral and bone disorder,,2019,Q2,5,F,20000322.0,20190408.0,20180419,20190419,EXP,,US-ASTRAZENECA-2018SE49082,ASTRAZENECA,,15913.0,DY,,F,Y,,,20190419.0,,,US,US,2019,Q2,Elderly
147783585,14778358,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,5 UNITS TWO TIMES IN DAY,,,,,,,,,,,,2019,Q2,End stage renal disease,,2019,Q2,5,F,20000322.0,20190408.0,20180419,20190419,EXP,,US-ASTRAZENECA-2018SE49082,ASTRAZENECA,,15913.0,DY,,F,Y,,,20190419.0,,,US,US,2019,Q2,Elderly
147783585,14778358,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,5 UNITS TWO TIMES IN DAY,,,,,,,,,,,,2019,Q2,Hyperparathyroidism secondary,,2019,Q2,5,F,20000322.0,20190408.0,20180419,20190419,EXP,,US-ASTRAZENECA-2018SE49082,ASTRAZENECA,,15913.0,DY,,F,Y,,,20190419.0,,,US,US,2019,Q2,Elderly
147783585,14778358,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,5 UNITS TWO TIMES IN DAY,,,,,,,,,,,,2019,Q2,Nephrogenic anaemia,,2019,Q2,5,F,20000322.0,20190408.0,20180419,20190419,EXP,,US-ASTRAZENECA-2018SE49082,ASTRAZENECA,,15913.0,DY,,F,Y,,,20190419.0,,,US,US,2019,Q2,Elderly
147783585,14778358,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,5 UNITS TWO TIMES IN DAY,,,,,,,,,,,,2019,Q2,Renal failure,,2019,Q2,5,F,20000322.0,20190408.0,20180419,20190419,EXP,,US-ASTRAZENECA-2018SE49082,ASTRAZENECA,,15913.0,DY,,F,Y,,,20190419.0,,,US,US,2019,Q2,Elderly
147783585,14778358,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,5 UNITS TWO TIMES IN DAY,,,,,,,,,,,,2019,Q2,Renal injury,,2019,Q2,5,F,20000322.0,20190408.0,20180419,20190419,EXP,,US-ASTRAZENECA-2018SE49082,ASTRAZENECA,,15913.0,DY,,F,Y,,,20190419.0,,,US,US,2019,Q2,Elderly
148071925,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q2,Acute kidney injury,,2019,Q2,5,F,20170105.0,20190607.0,20180425,20190621,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20190621.0,,OT,US,US,2019,Q2,Adult
148071925,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q2,Alanine aminotransferase increased,,2019,Q2,5,F,20170105.0,20190607.0,20180425,20190621,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20190621.0,,OT,US,US,2019,Q2,Adult
148071925,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q2,Aspartate aminotransferase increased,,2019,Q2,5,F,20170105.0,20190607.0,20180425,20190621,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20190621.0,,OT,US,US,2019,Q2,Adult
148071925,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q2,Blood magnesium decreased,,2019,Q2,5,F,20170105.0,20190607.0,20180425,20190621,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20190621.0,,OT,US,US,2019,Q2,Adult
148071925,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q2,Blood potassium increased,,2019,Q2,5,F,20170105.0,20190607.0,20180425,20190621,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20190621.0,,OT,US,US,2019,Q2,Adult
148071925,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q2,Chest discomfort,,2019,Q2,5,F,20170105.0,20190607.0,20180425,20190621,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20190621.0,,OT,US,US,2019,Q2,Adult
148071925,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q2,Condition aggravated,,2019,Q2,5,F,20170105.0,20190607.0,20180425,20190621,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20190621.0,,OT,US,US,2019,Q2,Adult
148071925,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q2,Diarrhoea,,2019,Q2,5,F,20170105.0,20190607.0,20180425,20190621,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20190621.0,,OT,US,US,2019,Q2,Adult
148071925,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q2,Dizziness,,2019,Q2,5,F,20170105.0,20190607.0,20180425,20190621,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20190621.0,,OT,US,US,2019,Q2,Adult
148071925,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q2,Dyspnoea,,2019,Q2,5,F,20170105.0,20190607.0,20180425,20190621,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20190621.0,,OT,US,US,2019,Q2,Adult
148071925,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q2,Flank pain,,2019,Q2,5,F,20170105.0,20190607.0,20180425,20190621,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20190621.0,,OT,US,US,2019,Q2,Adult
148071925,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q2,Fluid retention,,2019,Q2,5,F,20170105.0,20190607.0,20180425,20190621,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20190621.0,,OT,US,US,2019,Q2,Adult
148071925,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q2,Headache,,2019,Q2,5,F,20170105.0,20190607.0,20180425,20190621,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20190621.0,,OT,US,US,2019,Q2,Adult
148071925,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q2,Hypokalaemia,,2019,Q2,5,F,20170105.0,20190607.0,20180425,20190621,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20190621.0,,OT,US,US,2019,Q2,Adult
148071925,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q2,Hypovolaemia,,2019,Q2,5,F,20170105.0,20190607.0,20180425,20190621,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20190621.0,,OT,US,US,2019,Q2,Adult
148071925,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q2,Hypoxia,,2019,Q2,5,F,20170105.0,20190607.0,20180425,20190621,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20190621.0,,OT,US,US,2019,Q2,Adult
148071925,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q2,Malaise,,2019,Q2,5,F,20170105.0,20190607.0,20180425,20190621,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20190621.0,,OT,US,US,2019,Q2,Adult
148071925,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q2,Mental status changes,,2019,Q2,5,F,20170105.0,20190607.0,20180425,20190621,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20190621.0,,OT,US,US,2019,Q2,Adult
148071925,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q2,Nausea,,2019,Q2,5,F,20170105.0,20190607.0,20180425,20190621,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20190621.0,,OT,US,US,2019,Q2,Adult
148071925,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q2,Nephrolithiasis,,2019,Q2,5,F,20170105.0,20190607.0,20180425,20190621,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20190621.0,,OT,US,US,2019,Q2,Adult
148071925,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q2,Oxygen saturation decreased,,2019,Q2,5,F,20170105.0,20190607.0,20180425,20190621,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20190621.0,,OT,US,US,2019,Q2,Adult
148071925,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q2,Pain in extremity,,2019,Q2,5,F,20170105.0,20190607.0,20180425,20190621,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20190621.0,,OT,US,US,2019,Q2,Adult
148071925,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q2,Paraesthesia oral,,2019,Q2,5,F,20170105.0,20190607.0,20180425,20190621,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20190621.0,,OT,US,US,2019,Q2,Adult
148071925,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q2,Presyncope,,2019,Q2,5,F,20170105.0,20190607.0,20180425,20190621,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20190621.0,,OT,US,US,2019,Q2,Adult
148071925,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q2,Productive cough,,2019,Q2,5,F,20170105.0,20190607.0,20180425,20190621,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20190621.0,,OT,US,US,2019,Q2,Adult
148071925,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q2,Pulmonary arterial hypertension,,2019,Q2,5,F,20170105.0,20190607.0,20180425,20190621,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20190621.0,,OT,US,US,2019,Q2,Adult
148071925,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q2,Pyrexia,,2019,Q2,5,F,20170105.0,20190607.0,20180425,20190621,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20190621.0,,OT,US,US,2019,Q2,Adult
148071925,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q2,Sinusitis,,2019,Q2,5,F,20170105.0,20190607.0,20180425,20190621,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20190621.0,,OT,US,US,2019,Q2,Adult
148071925,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q2,Urinary tract infection,,2019,Q2,5,F,20170105.0,20190607.0,20180425,20190621,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20190621.0,,OT,US,US,2019,Q2,Adult
148071925,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q2,Viral infection,,2019,Q2,5,F,20170105.0,20190607.0,20180425,20190621,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20190621.0,,OT,US,US,2019,Q2,Adult
148071925,14807192,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q2,White blood cell count increased,,2019,Q2,5,F,20170105.0,20190607.0,20180425,20190621,EXP,,US-ACTELION-A-US2016-143905,ACTELION,,64.0,YR,,F,Y,71.66,KG,20190621.0,,OT,US,US,2019,Q2,Adult
148466073,14846607,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Acute kidney injury,,2019,Q2,3,F,201606.0,20190327.0,20180504,20190401,EXP,,US-ASTRAZENECA-2018SE55610,ASTRAZENECA,,276.0,MON,,F,Y,61.2,KG,20190401.0,,,US,US,2019,Q2,Elderly
148466073,14846607,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Chronic kidney disease,,2019,Q2,3,F,201606.0,20190327.0,20180504,20190401,EXP,,US-ASTRAZENECA-2018SE55610,ASTRAZENECA,,276.0,MON,,F,Y,61.2,KG,20190401.0,,,US,US,2019,Q2,Elderly
148466073,14846607,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,End stage renal disease,,2019,Q2,3,F,201606.0,20190327.0,20180504,20190401,EXP,,US-ASTRAZENECA-2018SE55610,ASTRAZENECA,,276.0,MON,,F,Y,61.2,KG,20190401.0,,,US,US,2019,Q2,Elderly
148466073,14846607,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Renal failure,,2019,Q2,3,F,201606.0,20190327.0,20180504,20190401,EXP,,US-ASTRAZENECA-2018SE55610,ASTRAZENECA,,276.0,MON,,F,Y,61.2,KG,20190401.0,,,US,US,2019,Q2,Elderly
148478656,14847865,39,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2019,Q2,Aspiration,,2019,Q2,6,F,20180131.0,20190422.0,20180504,20190430,PER,,PHHY2018US076159,NOVARTIS,,59.0,YR,,F,Y,63.0,KG,20190430.0,,OT,US,US,2019,Q2,Adult
148478656,14847865,39,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2019,Q2,Asthenia,,2019,Q2,6,F,20180131.0,20190422.0,20180504,20190430,PER,,PHHY2018US076159,NOVARTIS,,59.0,YR,,F,Y,63.0,KG,20190430.0,,OT,US,US,2019,Q2,Adult
148478656,14847865,39,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2019,Q2,Diarrhoea,,2019,Q2,6,F,20180131.0,20190422.0,20180504,20190430,PER,,PHHY2018US076159,NOVARTIS,,59.0,YR,,F,Y,63.0,KG,20190430.0,,OT,US,US,2019,Q2,Adult
148478656,14847865,39,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2019,Q2,Lung infection,,2019,Q2,6,F,20180131.0,20190422.0,20180504,20190430,PER,,PHHY2018US076159,NOVARTIS,,59.0,YR,,F,Y,63.0,KG,20190430.0,,OT,US,US,2019,Q2,Adult
1491573514,14915735,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q2,Acute respiratory failure,,2019,Q2,14,F,20160726.0,20190612.0,20180518,20190626,EXP,,US-ACTELION-A-US2016-142165,ACTELION,,69.0,YR,,F,Y,71.2,KG,20190627.0,,OT,US,US,2019,Q2,Elderly
1491573514,14915735,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q2,Anaemia,,2019,Q2,14,F,20160726.0,20190612.0,20180518,20190626,EXP,,US-ACTELION-A-US2016-142165,ACTELION,,69.0,YR,,F,Y,71.2,KG,20190627.0,,OT,US,US,2019,Q2,Elderly
1491573514,14915735,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q2,Aspartate aminotransferase decreased,,2019,Q2,14,F,20160726.0,20190612.0,20180518,20190626,EXP,,US-ACTELION-A-US2016-142165,ACTELION,,69.0,YR,,F,Y,71.2,KG,20190627.0,,OT,US,US,2019,Q2,Elderly
1491573514,14915735,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q2,Asthenia,,2019,Q2,14,F,20160726.0,20190612.0,20180518,20190626,EXP,,US-ACTELION-A-US2016-142165,ACTELION,,69.0,YR,,F,Y,71.2,KG,20190627.0,,OT,US,US,2019,Q2,Elderly
1491573514,14915735,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q2,Atrial fibrillation,,2019,Q2,14,F,20160726.0,20190612.0,20180518,20190626,EXP,,US-ACTELION-A-US2016-142165,ACTELION,,69.0,YR,,F,Y,71.2,KG,20190627.0,,OT,US,US,2019,Q2,Elderly
1491573514,14915735,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q2,Cardiac failure congestive,,2019,Q2,14,F,20160726.0,20190612.0,20180518,20190626,EXP,,US-ACTELION-A-US2016-142165,ACTELION,,69.0,YR,,F,Y,71.2,KG,20190627.0,,OT,US,US,2019,Q2,Elderly
1491573514,14915735,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q2,Chest pain,,2019,Q2,14,F,20160726.0,20190612.0,20180518,20190626,EXP,,US-ACTELION-A-US2016-142165,ACTELION,,69.0,YR,,F,Y,71.2,KG,20190627.0,,OT,US,US,2019,Q2,Elderly
1491573514,14915735,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q2,Chronic kidney disease,,2019,Q2,14,F,20160726.0,20190612.0,20180518,20190626,EXP,,US-ACTELION-A-US2016-142165,ACTELION,,69.0,YR,,F,Y,71.2,KG,20190627.0,,OT,US,US,2019,Q2,Elderly
1491573514,14915735,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q2,Dizziness,,2019,Q2,14,F,20160726.0,20190612.0,20180518,20190626,EXP,,US-ACTELION-A-US2016-142165,ACTELION,,69.0,YR,,F,Y,71.2,KG,20190627.0,,OT,US,US,2019,Q2,Elderly
1491573514,14915735,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q2,Dizziness postural,,2019,Q2,14,F,20160726.0,20190612.0,20180518,20190626,EXP,,US-ACTELION-A-US2016-142165,ACTELION,,69.0,YR,,F,Y,71.2,KG,20190627.0,,OT,US,US,2019,Q2,Elderly
1491573514,14915735,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q2,Dyspnoea,,2019,Q2,14,F,20160726.0,20190612.0,20180518,20190626,EXP,,US-ACTELION-A-US2016-142165,ACTELION,,69.0,YR,,F,Y,71.2,KG,20190627.0,,OT,US,US,2019,Q2,Elderly
1491573514,14915735,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q2,Fatigue,,2019,Q2,14,F,20160726.0,20190612.0,20180518,20190626,EXP,,US-ACTELION-A-US2016-142165,ACTELION,,69.0,YR,,F,Y,71.2,KG,20190627.0,,OT,US,US,2019,Q2,Elderly
1491573514,14915735,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q2,Fluid overload,,2019,Q2,14,F,20160726.0,20190612.0,20180518,20190626,EXP,,US-ACTELION-A-US2016-142165,ACTELION,,69.0,YR,,F,Y,71.2,KG,20190627.0,,OT,US,US,2019,Q2,Elderly
1491573514,14915735,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q2,Gastrointestinal haemorrhage,,2019,Q2,14,F,20160726.0,20190612.0,20180518,20190626,EXP,,US-ACTELION-A-US2016-142165,ACTELION,,69.0,YR,,F,Y,71.2,KG,20190627.0,,OT,US,US,2019,Q2,Elderly
1491573514,14915735,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q2,Haematocrit decreased,,2019,Q2,14,F,20160726.0,20190612.0,20180518,20190626,EXP,,US-ACTELION-A-US2016-142165,ACTELION,,69.0,YR,,F,Y,71.2,KG,20190627.0,,OT,US,US,2019,Q2,Elderly
1491573514,14915735,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q2,Haemoglobin decreased,,2019,Q2,14,F,20160726.0,20190612.0,20180518,20190626,EXP,,US-ACTELION-A-US2016-142165,ACTELION,,69.0,YR,,F,Y,71.2,KG,20190627.0,,OT,US,US,2019,Q2,Elderly
1491573514,14915735,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q2,Haemorrhage,,2019,Q2,14,F,20160726.0,20190612.0,20180518,20190626,EXP,,US-ACTELION-A-US2016-142165,ACTELION,,69.0,YR,,F,Y,71.2,KG,20190627.0,,OT,US,US,2019,Q2,Elderly
1491573514,14915735,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q2,Headache,,2019,Q2,14,F,20160726.0,20190612.0,20180518,20190626,EXP,,US-ACTELION-A-US2016-142165,ACTELION,,69.0,YR,,F,Y,71.2,KG,20190627.0,,OT,US,US,2019,Q2,Elderly
1491573514,14915735,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q2,Hospitalisation,,2019,Q2,14,F,20160726.0,20190612.0,20180518,20190626,EXP,,US-ACTELION-A-US2016-142165,ACTELION,,69.0,YR,,F,Y,71.2,KG,20190627.0,,OT,US,US,2019,Q2,Elderly
1491573514,14915735,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q2,Hypoglycaemia,,2019,Q2,14,F,20160726.0,20190612.0,20180518,20190626,EXP,,US-ACTELION-A-US2016-142165,ACTELION,,69.0,YR,,F,Y,71.2,KG,20190627.0,,OT,US,US,2019,Q2,Elderly
1491573514,14915735,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q2,Malaise,,2019,Q2,14,F,20160726.0,20190612.0,20180518,20190626,EXP,,US-ACTELION-A-US2016-142165,ACTELION,,69.0,YR,,F,Y,71.2,KG,20190627.0,,OT,US,US,2019,Q2,Elderly
1491573514,14915735,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q2,Mitral valve stenosis,,2019,Q2,14,F,20160726.0,20190612.0,20180518,20190626,EXP,,US-ACTELION-A-US2016-142165,ACTELION,,69.0,YR,,F,Y,71.2,KG,20190627.0,,OT,US,US,2019,Q2,Elderly
1491573514,14915735,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q2,Peripheral arterial occlusive disease,,2019,Q2,14,F,20160726.0,20190612.0,20180518,20190626,EXP,,US-ACTELION-A-US2016-142165,ACTELION,,69.0,YR,,F,Y,71.2,KG,20190627.0,,OT,US,US,2019,Q2,Elderly
1491573514,14915735,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q2,Pruritus generalised,,2019,Q2,14,F,20160726.0,20190612.0,20180518,20190626,EXP,,US-ACTELION-A-US2016-142165,ACTELION,,69.0,YR,,F,Y,71.2,KG,20190627.0,,OT,US,US,2019,Q2,Elderly
1491573514,14915735,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q2,Pulmonary hypertension,,2019,Q2,14,F,20160726.0,20190612.0,20180518,20190626,EXP,,US-ACTELION-A-US2016-142165,ACTELION,,69.0,YR,,F,Y,71.2,KG,20190627.0,,OT,US,US,2019,Q2,Elderly
1491573514,14915735,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q2,Somnolence,,2019,Q2,14,F,20160726.0,20190612.0,20180518,20190626,EXP,,US-ACTELION-A-US2016-142165,ACTELION,,69.0,YR,,F,Y,71.2,KG,20190627.0,,OT,US,US,2019,Q2,Elderly
1491573514,14915735,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q2,Transfusion,,2019,Q2,14,F,20160726.0,20190612.0,20180518,20190626,EXP,,US-ACTELION-A-US2016-142165,ACTELION,,69.0,YR,,F,Y,71.2,KG,20190627.0,,OT,US,US,2019,Q2,Elderly
1491573514,14915735,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q2,Weight increased,,2019,Q2,14,F,20160726.0,20190612.0,20180518,20190626,EXP,,US-ACTELION-A-US2016-142165,ACTELION,,69.0,YR,,F,Y,71.2,KG,20190627.0,,OT,US,US,2019,Q2,Elderly
149293459,14929345,7,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2019,Q2,Anaemia,,2019,Q2,9,F,20180329.0,20190403.0,20180523,20190410,EXP,,US-CELGENEUS-USA-20180507359,CELGENE,,78.0,YR,,M,Y,87.71,KG,20190410.0,,MD,US,US,2019,Q2,Elderly
149293459,14929345,7,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2019,Q2,Confusional state,,2019,Q2,9,F,20180329.0,20190403.0,20180523,20190410,EXP,,US-CELGENEUS-USA-20180507359,CELGENE,,78.0,YR,,M,Y,87.71,KG,20190410.0,,MD,US,US,2019,Q2,Elderly
149293459,14929345,7,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2019,Q2,Hypoglycaemia,,2019,Q2,9,F,20180329.0,20190403.0,20180523,20190410,EXP,,US-CELGENEUS-USA-20180507359,CELGENE,,78.0,YR,,M,Y,87.71,KG,20190410.0,,MD,US,US,2019,Q2,Elderly
149293459,14929345,7,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2019,Q2,Hypoxia,,2019,Q2,9,F,20180329.0,20190403.0,20180523,20190410,EXP,,US-CELGENEUS-USA-20180507359,CELGENE,,78.0,YR,,M,Y,87.71,KG,20190410.0,,MD,US,US,2019,Q2,Elderly
149293459,14929345,7,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2019,Q2,Platelet count decreased,,2019,Q2,9,F,20180329.0,20190403.0,20180523,20190410,EXP,,US-CELGENEUS-USA-20180507359,CELGENE,,78.0,YR,,M,Y,87.71,KG,20190410.0,,MD,US,US,2019,Q2,Elderly
149293459,14929345,7,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2019,Q2,Sepsis,,2019,Q2,9,F,20180329.0,20190403.0,20180523,20190410,EXP,,US-CELGENEUS-USA-20180507359,CELGENE,,78.0,YR,,M,Y,87.71,KG,20190410.0,,MD,US,US,2019,Q2,Elderly
149645863,14964586,24,C,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2019,Q2,Autoimmune hepatitis,,2019,Q2,3,F,20170619.0,20190603.0,20180601,20190611,EXP,,JP-CELGENEUS-JPN-20180507948,CELGENE,,79.0,YR,,M,Y,54.8,KG,20190611.0,,OT,JP,JP,2019,Q2,Elderly
149766266,14976626,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,U,,,,,,,BID,2019,Q2,Acute kidney injury,,2019,Q2,6,F,201804.0,20190411.0,20180605,20190424,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,81.0,YR,,M,Y,102.04,KG,20190424.0,,OT,US,US,2019,Q2,Elderly
149766266,14976626,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,U,,,,,,,BID,2019,Q2,Anaemia,,2019,Q2,6,F,201804.0,20190411.0,20180605,20190424,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,81.0,YR,,M,Y,102.04,KG,20190424.0,,OT,US,US,2019,Q2,Elderly
149766266,14976626,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,U,,,,,,,BID,2019,Q2,Antimicrobial susceptibility test,,2019,Q2,6,F,201804.0,20190411.0,20180605,20190424,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,81.0,YR,,M,Y,102.04,KG,20190424.0,,OT,US,US,2019,Q2,Elderly
149766266,14976626,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,U,,,,,,,BID,2019,Q2,Asthenia,,2019,Q2,6,F,201804.0,20190411.0,20180605,20190424,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,81.0,YR,,M,Y,102.04,KG,20190424.0,,OT,US,US,2019,Q2,Elderly
149766266,14976626,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,U,,,,,,,BID,2019,Q2,Bacteraemia,,2019,Q2,6,F,201804.0,20190411.0,20180605,20190424,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,81.0,YR,,M,Y,102.04,KG,20190424.0,,OT,US,US,2019,Q2,Elderly
149766266,14976626,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,U,,,,,,,BID,2019,Q2,Bacterial infection,,2019,Q2,6,F,201804.0,20190411.0,20180605,20190424,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,81.0,YR,,M,Y,102.04,KG,20190424.0,,OT,US,US,2019,Q2,Elderly
149766266,14976626,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,U,,,,,,,BID,2019,Q2,Balance disorder,,2019,Q2,6,F,201804.0,20190411.0,20180605,20190424,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,81.0,YR,,M,Y,102.04,KG,20190424.0,,OT,US,US,2019,Q2,Elderly
149766266,14976626,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,U,,,,,,,BID,2019,Q2,Cardiac arrest,,2019,Q2,6,F,201804.0,20190411.0,20180605,20190424,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,81.0,YR,,M,Y,102.04,KG,20190424.0,,OT,US,US,2019,Q2,Elderly
149766266,14976626,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,U,,,,,,,BID,2019,Q2,Cardiac disorder,,2019,Q2,6,F,201804.0,20190411.0,20180605,20190424,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,81.0,YR,,M,Y,102.04,KG,20190424.0,,OT,US,US,2019,Q2,Elderly
149766266,14976626,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,U,,,,,,,BID,2019,Q2,Cardiac failure congestive,,2019,Q2,6,F,201804.0,20190411.0,20180605,20190424,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,81.0,YR,,M,Y,102.04,KG,20190424.0,,OT,US,US,2019,Q2,Elderly
149766266,14976626,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,U,,,,,,,BID,2019,Q2,Chronic obstructive pulmonary disease,,2019,Q2,6,F,201804.0,20190411.0,20180605,20190424,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,81.0,YR,,M,Y,102.04,KG,20190424.0,,OT,US,US,2019,Q2,Elderly
149766266,14976626,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,U,,,,,,,BID,2019,Q2,Condition aggravated,,2019,Q2,6,F,201804.0,20190411.0,20180605,20190424,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,81.0,YR,,M,Y,102.04,KG,20190424.0,,OT,US,US,2019,Q2,Elderly
149766266,14976626,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,U,,,,,,,BID,2019,Q2,Diarrhoea,,2019,Q2,6,F,201804.0,20190411.0,20180605,20190424,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,81.0,YR,,M,Y,102.04,KG,20190424.0,,OT,US,US,2019,Q2,Elderly
149766266,14976626,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,U,,,,,,,BID,2019,Q2,Disease progression,,2019,Q2,6,F,201804.0,20190411.0,20180605,20190424,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,81.0,YR,,M,Y,102.04,KG,20190424.0,,OT,US,US,2019,Q2,Elderly
149766266,14976626,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,U,,,,,,,BID,2019,Q2,Dizziness,,2019,Q2,6,F,201804.0,20190411.0,20180605,20190424,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,81.0,YR,,M,Y,102.04,KG,20190424.0,,OT,US,US,2019,Q2,Elderly
149766266,14976626,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,U,,,,,,,BID,2019,Q2,Dyspnoea exertional,,2019,Q2,6,F,201804.0,20190411.0,20180605,20190424,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,81.0,YR,,M,Y,102.04,KG,20190424.0,,OT,US,US,2019,Q2,Elderly
149766266,14976626,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,U,,,,,,,BID,2019,Q2,Fatigue,,2019,Q2,6,F,201804.0,20190411.0,20180605,20190424,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,81.0,YR,,M,Y,102.04,KG,20190424.0,,OT,US,US,2019,Q2,Elderly
149766266,14976626,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,U,,,,,,,BID,2019,Q2,Food poisoning,,2019,Q2,6,F,201804.0,20190411.0,20180605,20190424,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,81.0,YR,,M,Y,102.04,KG,20190424.0,,OT,US,US,2019,Q2,Elderly
149766266,14976626,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,U,,,,,,,BID,2019,Q2,Loss of consciousness,,2019,Q2,6,F,201804.0,20190411.0,20180605,20190424,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,81.0,YR,,M,Y,102.04,KG,20190424.0,,OT,US,US,2019,Q2,Elderly
149766266,14976626,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,U,,,,,,,BID,2019,Q2,Lung disorder,,2019,Q2,6,F,201804.0,20190411.0,20180605,20190424,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,81.0,YR,,M,Y,102.04,KG,20190424.0,,OT,US,US,2019,Q2,Elderly
149766266,14976626,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,U,,,,,,,BID,2019,Q2,Peripheral swelling,,2019,Q2,6,F,201804.0,20190411.0,20180605,20190424,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,81.0,YR,,M,Y,102.04,KG,20190424.0,,OT,US,US,2019,Q2,Elderly
149766266,14976626,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,U,,,,,,,BID,2019,Q2,Product dose omission,,2019,Q2,6,F,201804.0,20190411.0,20180605,20190424,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,81.0,YR,,M,Y,102.04,KG,20190424.0,,OT,US,US,2019,Q2,Elderly
149766266,14976626,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,U,,,,,,,BID,2019,Q2,Pulmonary arterial hypertension,,2019,Q2,6,F,201804.0,20190411.0,20180605,20190424,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,81.0,YR,,M,Y,102.04,KG,20190424.0,,OT,US,US,2019,Q2,Elderly
149766266,14976626,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,U,,,,,,,BID,2019,Q2,Respiratory failure,,2019,Q2,6,F,201804.0,20190411.0,20180605,20190424,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,81.0,YR,,M,Y,102.04,KG,20190424.0,,OT,US,US,2019,Q2,Elderly
149766266,14976626,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,U,,,,,,,BID,2019,Q2,Sepsis,,2019,Q2,6,F,201804.0,20190411.0,20180605,20190424,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,81.0,YR,,M,Y,102.04,KG,20190424.0,,OT,US,US,2019,Q2,Elderly
149766266,14976626,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,U,,,,,,,BID,2019,Q2,Urinary tract infection,,2019,Q2,6,F,201804.0,20190411.0,20180605,20190424,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,81.0,YR,,M,Y,102.04,KG,20190424.0,,OT,US,US,2019,Q2,Elderly
149766266,14976626,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,U,,,,,,,BID,2019,Q2,Urosepsis,,2019,Q2,6,F,201804.0,20190411.0,20180605,20190424,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,81.0,YR,,M,Y,102.04,KG,20190424.0,,OT,US,US,2019,Q2,Elderly
149766266,14976626,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,U,,,,,,,BID,2019,Q2,Viral infection,,2019,Q2,6,F,201804.0,20190411.0,20180605,20190424,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,81.0,YR,,M,Y,102.04,KG,20190424.0,,OT,US,US,2019,Q2,Elderly
149766266,14976626,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,U,,,,,,,BID,2019,Q2,Vomiting,,2019,Q2,6,F,201804.0,20190411.0,20180605,20190424,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,81.0,YR,,M,Y,102.04,KG,20190424.0,,OT,US,US,2019,Q2,Elderly
149766266,14976626,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,U,,,,,,,BID,2019,Q2,Wheezing,,2019,Q2,6,F,201804.0,20190411.0,20180605,20190424,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,81.0,YR,,M,Y,102.04,KG,20190424.0,,OT,US,US,2019,Q2,Elderly
149766266,14976626,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 U/ML,,,,U,,,,,,,,2019,Q2,Acute kidney injury,,2019,Q2,6,F,201804.0,20190411.0,20180605,20190424,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,81.0,YR,,M,Y,102.04,KG,20190424.0,,OT,US,US,2019,Q2,Elderly
149766266,14976626,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 U/ML,,,,U,,,,,,,,2019,Q2,Anaemia,,2019,Q2,6,F,201804.0,20190411.0,20180605,20190424,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,81.0,YR,,M,Y,102.04,KG,20190424.0,,OT,US,US,2019,Q2,Elderly
149766266,14976626,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 U/ML,,,,U,,,,,,,,2019,Q2,Antimicrobial susceptibility test,,2019,Q2,6,F,201804.0,20190411.0,20180605,20190424,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,81.0,YR,,M,Y,102.04,KG,20190424.0,,OT,US,US,2019,Q2,Elderly
149766266,14976626,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 U/ML,,,,U,,,,,,,,2019,Q2,Asthenia,,2019,Q2,6,F,201804.0,20190411.0,20180605,20190424,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,81.0,YR,,M,Y,102.04,KG,20190424.0,,OT,US,US,2019,Q2,Elderly
149766266,14976626,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 U/ML,,,,U,,,,,,,,2019,Q2,Bacteraemia,,2019,Q2,6,F,201804.0,20190411.0,20180605,20190424,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,81.0,YR,,M,Y,102.04,KG,20190424.0,,OT,US,US,2019,Q2,Elderly
149766266,14976626,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 U/ML,,,,U,,,,,,,,2019,Q2,Bacterial infection,,2019,Q2,6,F,201804.0,20190411.0,20180605,20190424,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,81.0,YR,,M,Y,102.04,KG,20190424.0,,OT,US,US,2019,Q2,Elderly
149766266,14976626,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 U/ML,,,,U,,,,,,,,2019,Q2,Balance disorder,,2019,Q2,6,F,201804.0,20190411.0,20180605,20190424,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,81.0,YR,,M,Y,102.04,KG,20190424.0,,OT,US,US,2019,Q2,Elderly
149766266,14976626,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 U/ML,,,,U,,,,,,,,2019,Q2,Cardiac arrest,,2019,Q2,6,F,201804.0,20190411.0,20180605,20190424,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,81.0,YR,,M,Y,102.04,KG,20190424.0,,OT,US,US,2019,Q2,Elderly
149766266,14976626,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 U/ML,,,,U,,,,,,,,2019,Q2,Cardiac disorder,,2019,Q2,6,F,201804.0,20190411.0,20180605,20190424,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,81.0,YR,,M,Y,102.04,KG,20190424.0,,OT,US,US,2019,Q2,Elderly
149766266,14976626,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 U/ML,,,,U,,,,,,,,2019,Q2,Cardiac failure congestive,,2019,Q2,6,F,201804.0,20190411.0,20180605,20190424,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,81.0,YR,,M,Y,102.04,KG,20190424.0,,OT,US,US,2019,Q2,Elderly
149766266,14976626,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 U/ML,,,,U,,,,,,,,2019,Q2,Chronic obstructive pulmonary disease,,2019,Q2,6,F,201804.0,20190411.0,20180605,20190424,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,81.0,YR,,M,Y,102.04,KG,20190424.0,,OT,US,US,2019,Q2,Elderly
149766266,14976626,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 U/ML,,,,U,,,,,,,,2019,Q2,Condition aggravated,,2019,Q2,6,F,201804.0,20190411.0,20180605,20190424,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,81.0,YR,,M,Y,102.04,KG,20190424.0,,OT,US,US,2019,Q2,Elderly
149766266,14976626,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 U/ML,,,,U,,,,,,,,2019,Q2,Diarrhoea,,2019,Q2,6,F,201804.0,20190411.0,20180605,20190424,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,81.0,YR,,M,Y,102.04,KG,20190424.0,,OT,US,US,2019,Q2,Elderly
149766266,14976626,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 U/ML,,,,U,,,,,,,,2019,Q2,Disease progression,,2019,Q2,6,F,201804.0,20190411.0,20180605,20190424,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,81.0,YR,,M,Y,102.04,KG,20190424.0,,OT,US,US,2019,Q2,Elderly
149766266,14976626,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 U/ML,,,,U,,,,,,,,2019,Q2,Dizziness,,2019,Q2,6,F,201804.0,20190411.0,20180605,20190424,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,81.0,YR,,M,Y,102.04,KG,20190424.0,,OT,US,US,2019,Q2,Elderly
149766266,14976626,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 U/ML,,,,U,,,,,,,,2019,Q2,Dyspnoea exertional,,2019,Q2,6,F,201804.0,20190411.0,20180605,20190424,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,81.0,YR,,M,Y,102.04,KG,20190424.0,,OT,US,US,2019,Q2,Elderly
149766266,14976626,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 U/ML,,,,U,,,,,,,,2019,Q2,Fatigue,,2019,Q2,6,F,201804.0,20190411.0,20180605,20190424,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,81.0,YR,,M,Y,102.04,KG,20190424.0,,OT,US,US,2019,Q2,Elderly
149766266,14976626,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 U/ML,,,,U,,,,,,,,2019,Q2,Food poisoning,,2019,Q2,6,F,201804.0,20190411.0,20180605,20190424,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,81.0,YR,,M,Y,102.04,KG,20190424.0,,OT,US,US,2019,Q2,Elderly
149766266,14976626,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 U/ML,,,,U,,,,,,,,2019,Q2,Loss of consciousness,,2019,Q2,6,F,201804.0,20190411.0,20180605,20190424,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,81.0,YR,,M,Y,102.04,KG,20190424.0,,OT,US,US,2019,Q2,Elderly
149766266,14976626,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 U/ML,,,,U,,,,,,,,2019,Q2,Lung disorder,,2019,Q2,6,F,201804.0,20190411.0,20180605,20190424,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,81.0,YR,,M,Y,102.04,KG,20190424.0,,OT,US,US,2019,Q2,Elderly
149766266,14976626,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 U/ML,,,,U,,,,,,,,2019,Q2,Peripheral swelling,,2019,Q2,6,F,201804.0,20190411.0,20180605,20190424,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,81.0,YR,,M,Y,102.04,KG,20190424.0,,OT,US,US,2019,Q2,Elderly
149766266,14976626,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 U/ML,,,,U,,,,,,,,2019,Q2,Product dose omission,,2019,Q2,6,F,201804.0,20190411.0,20180605,20190424,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,81.0,YR,,M,Y,102.04,KG,20190424.0,,OT,US,US,2019,Q2,Elderly
149766266,14976626,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 U/ML,,,,U,,,,,,,,2019,Q2,Pulmonary arterial hypertension,,2019,Q2,6,F,201804.0,20190411.0,20180605,20190424,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,81.0,YR,,M,Y,102.04,KG,20190424.0,,OT,US,US,2019,Q2,Elderly
149766266,14976626,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 U/ML,,,,U,,,,,,,,2019,Q2,Respiratory failure,,2019,Q2,6,F,201804.0,20190411.0,20180605,20190424,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,81.0,YR,,M,Y,102.04,KG,20190424.0,,OT,US,US,2019,Q2,Elderly
149766266,14976626,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 U/ML,,,,U,,,,,,,,2019,Q2,Sepsis,,2019,Q2,6,F,201804.0,20190411.0,20180605,20190424,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,81.0,YR,,M,Y,102.04,KG,20190424.0,,OT,US,US,2019,Q2,Elderly
149766266,14976626,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 U/ML,,,,U,,,,,,,,2019,Q2,Urinary tract infection,,2019,Q2,6,F,201804.0,20190411.0,20180605,20190424,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,81.0,YR,,M,Y,102.04,KG,20190424.0,,OT,US,US,2019,Q2,Elderly
149766266,14976626,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 U/ML,,,,U,,,,,,,,2019,Q2,Urosepsis,,2019,Q2,6,F,201804.0,20190411.0,20180605,20190424,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,81.0,YR,,M,Y,102.04,KG,20190424.0,,OT,US,US,2019,Q2,Elderly
149766266,14976626,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 U/ML,,,,U,,,,,,,,2019,Q2,Viral infection,,2019,Q2,6,F,201804.0,20190411.0,20180605,20190424,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,81.0,YR,,M,Y,102.04,KG,20190424.0,,OT,US,US,2019,Q2,Elderly
149766266,14976626,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 U/ML,,,,U,,,,,,,,2019,Q2,Vomiting,,2019,Q2,6,F,201804.0,20190411.0,20180605,20190424,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,81.0,YR,,M,Y,102.04,KG,20190424.0,,OT,US,US,2019,Q2,Elderly
149766266,14976626,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 U/ML,,,,U,,,,,,,,2019,Q2,Wheezing,,2019,Q2,6,F,201804.0,20190411.0,20180605,20190424,EXP,,US-ACTELION-A-NJ2015-121282,ACTELION,,81.0,YR,,M,Y,102.04,KG,20190424.0,,OT,US,US,2019,Q2,Elderly
150423284,15042328,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNIT/ML,,,,,,,,,,,,2019,Q2,Chronic kidney disease,,2019,Q2,4,F,20120119.0,20190325.0,20180621,20190403,EXP,,US-ASTRAZENECA-2018SE77565,ASTRAZENECA,,26119.0,DY,,F,Y,93.0,KG,20190403.0,,,US,US,2019,Q2,Elderly
150423284,15042328,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNIT/ML,,,,,,,,,,,,2019,Q2,Chronic kidney disease-mineral and bone disorder,,2019,Q2,4,F,20120119.0,20190325.0,20180621,20190403,EXP,,US-ASTRAZENECA-2018SE77565,ASTRAZENECA,,26119.0,DY,,F,Y,93.0,KG,20190403.0,,,US,US,2019,Q2,Elderly
150423284,15042328,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNIT/ML,,,,,,,,,,,,2019,Q2,Renal failure,,2019,Q2,4,F,20120119.0,20190325.0,20180621,20190403,EXP,,US-ASTRAZENECA-2018SE77565,ASTRAZENECA,,26119.0,DY,,F,Y,93.0,KG,20190403.0,,,US,US,2019,Q2,Elderly
150423284,15042328,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNIT/ML,,,,,,,,,,,,2019,Q2,Renal impairment,,2019,Q2,4,F,20120119.0,20190325.0,20180621,20190403,EXP,,US-ASTRAZENECA-2018SE77565,ASTRAZENECA,,26119.0,DY,,F,Y,93.0,KG,20190403.0,,,US,US,2019,Q2,Elderly
151065592,15106559,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Inappropriate schedule of product administration,,2019,Q2,2,F,,20190513.0,20180704,20190517,PER,,US-SA-2018SA167345,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20190517.0,,CN,US,US,2019,Q2,Adult
151065592,15106559,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Product dosage form confusion,,2019,Q2,2,F,,20190513.0,20180704,20190517,PER,,US-SA-2018SA167345,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20190517.0,,CN,US,US,2019,Q2,Adult
151065592,15106559,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Product storage error,,2019,Q2,2,F,,20190513.0,20180704,20190517,PER,,US-SA-2018SA167345,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20190517.0,,CN,US,US,2019,Q2,Adult
151065592,15106559,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Wrong product administered,,2019,Q2,2,F,,20190513.0,20180704,20190517,PER,,US-SA-2018SA167345,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20190517.0,,CN,US,US,2019,Q2,Adult
154647372,15464737,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,INJECT 144 UNITS UNDER THE SKIN TID WITH MEALIS,,,,,,,,,,,,2019,Q2,Catheterisation cardiac,,2019,Q2,2,F,20180523.0,20190409.0,20181004,20190412,EXP,,US-BAYER-2018-107557,BAYER,,59.0,YR,A,F,Y,,,20190412.0,,OT,US,US,2019,Q2,Adult
154647372,15464737,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,INJECT 144 UNITS UNDER THE SKIN TID WITH MEALIS,,,,,,,,,,,,2019,Q2,Chest pain,,2019,Q2,2,F,20180523.0,20190409.0,20181004,20190412,EXP,,US-BAYER-2018-107557,BAYER,,59.0,YR,A,F,Y,,,20190412.0,,OT,US,US,2019,Q2,Adult
154647372,15464737,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,INJECT 144 UNITS UNDER THE SKIN TID WITH MEALIS,,,,,,,,,,,,2019,Q2,Death,,2019,Q2,2,F,20180523.0,20190409.0,20181004,20190412,EXP,,US-BAYER-2018-107557,BAYER,,59.0,YR,A,F,Y,,,20190412.0,,OT,US,US,2019,Q2,Adult
154647372,15464737,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,INJECT 144 UNITS UNDER THE SKIN TID WITH MEALIS,,,,,,,,,,,,2019,Q2,Dizziness,,2019,Q2,2,F,20180523.0,20190409.0,20181004,20190412,EXP,,US-BAYER-2018-107557,BAYER,,59.0,YR,A,F,Y,,,20190412.0,,OT,US,US,2019,Q2,Adult
154647372,15464737,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,INJECT 144 UNITS UNDER THE SKIN TID WITH MEALIS,,,,,,,,,,,,2019,Q2,Dyspnoea,,2019,Q2,2,F,20180523.0,20190409.0,20181004,20190412,EXP,,US-BAYER-2018-107557,BAYER,,59.0,YR,A,F,Y,,,20190412.0,,OT,US,US,2019,Q2,Adult
154647372,15464737,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,INJECT 144 UNITS UNDER THE SKIN TID WITH MEALIS,,,,,,,,,,,,2019,Q2,Headache,,2019,Q2,2,F,20180523.0,20190409.0,20181004,20190412,EXP,,US-BAYER-2018-107557,BAYER,,59.0,YR,A,F,Y,,,20190412.0,,OT,US,US,2019,Q2,Adult
154657453,15465745,15,C,insulin lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2019,Q2,Jejunal ulcer,,2019,Q2,3,F,20180719.0,20190403.0,20181004,20190415,EXP,,HU-CELGENEUS-HUN-20180909306,CELGENE,,63.0,YR,,M,Y,74.0,KG,20190415.0,,MD,HU,HU,2019,Q2,Adult
1549343210,15493432,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2019,Q2,Acute kidney injury,,2019,Q2,10,F,20180419.0,20190603.0,20181012,20190612,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20190612.0,,MD,DE,DE,2019,Q2,Elderly
1549343210,15493432,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2019,Q2,Colitis,,2019,Q2,10,F,20180419.0,20190603.0,20181012,20190612,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20190612.0,,MD,DE,DE,2019,Q2,Elderly
1549343210,15493432,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2019,Q2,Device related infection,,2019,Q2,10,F,20180419.0,20190603.0,20181012,20190612,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20190612.0,,MD,DE,DE,2019,Q2,Elderly
1549343210,15493432,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2019,Q2,Heparin-induced thrombocytopenia,,2019,Q2,10,F,20180419.0,20190603.0,20181012,20190612,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20190612.0,,MD,DE,DE,2019,Q2,Elderly
1549343210,15493432,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2019,Q2,Hyperglycaemia,,2019,Q2,10,F,20180419.0,20190603.0,20181012,20190612,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20190612.0,,MD,DE,DE,2019,Q2,Elderly
1549343210,15493432,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2019,Q2,Malignant neoplasm progression,,2019,Q2,10,F,20180419.0,20190603.0,20181012,20190612,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20190612.0,,MD,DE,DE,2019,Q2,Elderly
1549343210,15493432,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2019,Q2,Meningitis,,2019,Q2,10,F,20180419.0,20190603.0,20181012,20190612,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20190612.0,,MD,DE,DE,2019,Q2,Elderly
1549343210,15493432,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2019,Q2,Metastases to meninges,,2019,Q2,10,F,20180419.0,20190603.0,20181012,20190612,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20190612.0,,MD,DE,DE,2019,Q2,Elderly
1549343210,15493432,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2019,Q2,Retinal detachment,,2019,Q2,10,F,20180419.0,20190603.0,20181012,20190612,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20190612.0,,MD,DE,DE,2019,Q2,Elderly
1549343210,15493432,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2019,Q2,Retinopathy,,2019,Q2,10,F,20180419.0,20190603.0,20181012,20190612,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20190612.0,,MD,DE,DE,2019,Q2,Elderly
1549343210,15493432,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2019,Q2,Urosepsis,,2019,Q2,10,F,20180419.0,20190603.0,20181012,20190612,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20190612.0,,MD,DE,DE,2019,Q2,Elderly
154969606,15496960,67,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Addison's disease,,2019,Q2,6,F,20180819.0,20190514.0,20181015,20190517,EXP,,US-ROCHE-2186872,ROCHE,,56.0,YR,,F,Y,73.5,KG,20190517.0,,MD,US,US,2019,Q2,Adult
154969606,15496960,67,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Hyperthyroidism,,2019,Q2,6,F,20180819.0,20190514.0,20181015,20190517,EXP,,US-ROCHE-2186872,ROCHE,,56.0,YR,,F,Y,73.5,KG,20190517.0,,MD,US,US,2019,Q2,Adult
154969606,15496960,67,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Hypothyroidism,,2019,Q2,6,F,20180819.0,20190514.0,20181015,20190517,EXP,,US-ROCHE-2186872,ROCHE,,56.0,YR,,F,Y,73.5,KG,20190517.0,,MD,US,US,2019,Q2,Adult
155184635,15518463,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,, UNK,,,,,,,2019,Q2,Drug abuse,,2019,Q2,5,F,20180927.0,20190516.0,20181017,20190523,EXP,IT-MINISAL02-502630,IT-MYLANLABS-2018M1077439,MYLAN,,82.0,YR,,F,Y,,,20190523.0,,PH,IT,IT,2019,Q2,Elderly
155184635,15518463,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,, UNK,,,,,,,2019,Q2,Hypertension,,2019,Q2,5,F,20180927.0,20190516.0,20181017,20190523,EXP,IT-MINISAL02-502630,IT-MYLANLABS-2018M1077439,MYLAN,,82.0,YR,,F,Y,,,20190523.0,,PH,IT,IT,2019,Q2,Elderly
155184635,15518463,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,, UNK,,,,,,,2019,Q2,Hypoglycaemia,,2019,Q2,5,F,20180927.0,20190516.0,20181017,20190523,EXP,IT-MINISAL02-502630,IT-MYLANLABS-2018M1077439,MYLAN,,82.0,YR,,F,Y,,,20190523.0,,PH,IT,IT,2019,Q2,Elderly
155184635,15518463,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,, UNK,,,,,,,2019,Q2,Overdose,,2019,Q2,5,F,20180927.0,20190516.0,20181017,20190523,EXP,IT-MINISAL02-502630,IT-MYLANLABS-2018M1077439,MYLAN,,82.0,YR,,F,Y,,,20190523.0,,PH,IT,IT,2019,Q2,Elderly
155475624,15547562,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Hypersensitivity,,2019,Q2,4,F,20161027.0,20181113.0,20181024,20190508,EXP,,US-SHIRE-US201808499,SHIRE,"R. CREA, JUI-FU HUANG, NAGHMANA BAJWA AND ALESSANDRO GRINGERI. UNITED STATES POST-MARKETING SAFETY (PMS) STUDY OF RPFVIII IN PATIENTS WITH ACQUIRED HEMOPHILIA A: PRELIMINARY DATA. BLOOD. 2017;130:3686",81.0,YR,,M,Y,98.87,KG,20190508.0,,OT,US,US,2019,Q2,Elderly
155475624,15547562,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Hypersensitivity,,2019,Q2,4,F,20161027.0,20181113.0,20181024,20190508,EXP,,US-SHIRE-US201808499,SHIRE,"R. CREA, JUI-FU HUANG, NAGHMANA BAJWA AND ALESSANDRO GRINGERI. UNITED STATES POST-MARKETING SAFETY (PMS) STUDY OF RPFVIII IN PATIENTS WITH ACQUIRED HEMOPHILIA A: PRELIMINARY DATA. BLOOD. 2017;130:3686",81.0,YR,,M,Y,98.87,KG,20190508.0,,OT,US,US,2019,Q2,Elderly
155658253,15565825,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2019,Q2,Acidosis,,2019,Q2,3,F,2018.0,20190604.0,20181030,20190614,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20190614.0,,MD,US,US,2019,Q2,Elderly
155658253,15565825,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2019,Q2,Acute myocardial infarction,,2019,Q2,3,F,2018.0,20190604.0,20181030,20190614,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20190614.0,,MD,US,US,2019,Q2,Elderly
155658253,15565825,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2019,Q2,Anaemia,,2019,Q2,3,F,2018.0,20190604.0,20181030,20190614,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20190614.0,,MD,US,US,2019,Q2,Elderly
155658253,15565825,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2019,Q2,Aphasia,,2019,Q2,3,F,2018.0,20190604.0,20181030,20190614,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20190614.0,,MD,US,US,2019,Q2,Elderly
155658253,15565825,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2019,Q2,Back pain,,2019,Q2,3,F,2018.0,20190604.0,20181030,20190614,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20190614.0,,MD,US,US,2019,Q2,Elderly
155658253,15565825,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2019,Q2,Blood loss anaemia,,2019,Q2,3,F,2018.0,20190604.0,20181030,20190614,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20190614.0,,MD,US,US,2019,Q2,Elderly
155658253,15565825,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2019,Q2,Clostridium difficile colitis,,2019,Q2,3,F,2018.0,20190604.0,20181030,20190614,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20190614.0,,MD,US,US,2019,Q2,Elderly
155658253,15565825,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2019,Q2,Diarrhoea,,2019,Q2,3,F,2018.0,20190604.0,20181030,20190614,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20190614.0,,MD,US,US,2019,Q2,Elderly
155658253,15565825,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2019,Q2,Gait disturbance,,2019,Q2,3,F,2018.0,20190604.0,20181030,20190614,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20190614.0,,MD,US,US,2019,Q2,Elderly
155658253,15565825,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2019,Q2,Gastroenteritis,,2019,Q2,3,F,2018.0,20190604.0,20181030,20190614,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20190614.0,,MD,US,US,2019,Q2,Elderly
155658253,15565825,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2019,Q2,Gastrointestinal haemorrhage,,2019,Q2,3,F,2018.0,20190604.0,20181030,20190614,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20190614.0,,MD,US,US,2019,Q2,Elderly
155658253,15565825,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2019,Q2,Haematotoxicity,,2019,Q2,3,F,2018.0,20190604.0,20181030,20190614,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20190614.0,,MD,US,US,2019,Q2,Elderly
155658253,15565825,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2019,Q2,Hyperkalaemia,,2019,Q2,3,F,2018.0,20190604.0,20181030,20190614,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20190614.0,,MD,US,US,2019,Q2,Elderly
155658253,15565825,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2019,Q2,Internal haemorrhage,,2019,Q2,3,F,2018.0,20190604.0,20181030,20190614,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20190614.0,,MD,US,US,2019,Q2,Elderly
155658253,15565825,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2019,Q2,Intervertebral disc disorder,,2019,Q2,3,F,2018.0,20190604.0,20181030,20190614,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20190614.0,,MD,US,US,2019,Q2,Elderly
155658253,15565825,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2019,Q2,Lethargy,,2019,Q2,3,F,2018.0,20190604.0,20181030,20190614,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20190614.0,,MD,US,US,2019,Q2,Elderly
155658253,15565825,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2019,Q2,Limb discomfort,,2019,Q2,3,F,2018.0,20190604.0,20181030,20190614,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20190614.0,,MD,US,US,2019,Q2,Elderly
155658253,15565825,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2019,Q2,Metabolic acidosis,,2019,Q2,3,F,2018.0,20190604.0,20181030,20190614,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20190614.0,,MD,US,US,2019,Q2,Elderly
155658253,15565825,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2019,Q2,Pain in extremity,,2019,Q2,3,F,2018.0,20190604.0,20181030,20190614,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20190614.0,,MD,US,US,2019,Q2,Elderly
155658253,15565825,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2019,Q2,Pulmonary oedema,,2019,Q2,3,F,2018.0,20190604.0,20181030,20190614,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20190614.0,,MD,US,US,2019,Q2,Elderly
155658253,15565825,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2019,Q2,Renal failure,,2019,Q2,3,F,2018.0,20190604.0,20181030,20190614,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20190614.0,,MD,US,US,2019,Q2,Elderly
155658253,15565825,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2019,Q2,Respiratory failure,,2019,Q2,3,F,2018.0,20190604.0,20181030,20190614,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20190614.0,,MD,US,US,2019,Q2,Elderly
155658253,15565825,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2019,Q2,Sciatica,,2019,Q2,3,F,2018.0,20190604.0,20181030,20190614,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20190614.0,,MD,US,US,2019,Q2,Elderly
155658253,15565825,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2019,Q2,Sepsis,,2019,Q2,3,F,2018.0,20190604.0,20181030,20190614,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20190614.0,,MD,US,US,2019,Q2,Elderly
155658253,15565825,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2019,Q2,Septic shock,,2019,Q2,3,F,2018.0,20190604.0,20181030,20190614,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20190614.0,,MD,US,US,2019,Q2,Elderly
155658253,15565825,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2019,Q2,Supraventricular tachycardia,,2019,Q2,3,F,2018.0,20190604.0,20181030,20190614,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20190614.0,,MD,US,US,2019,Q2,Elderly
155658253,15565825,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2019,Q2,Thrombocytopenia,,2019,Q2,3,F,2018.0,20190604.0,20181030,20190614,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20190614.0,,MD,US,US,2019,Q2,Elderly
155972392,15597239,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 UNK, UNK (UNITS/ML)",,,U,,,,,,,,,2019,Q2,Chills,,2019,Q2,2,F,,20190327.0,20181108,20190402,EXP,,PHHY2018US144215,SANDOZ,,64.0,YR,,M,Y,,,20190402.0,,OT,US,US,2019,Q2,Adult
155972392,15597239,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 UNK, UNK (UNITS/ML)",,,U,,,,,,,,,2019,Q2,Endocarditis,,2019,Q2,2,F,,20190327.0,20181108,20190402,EXP,,PHHY2018US144215,SANDOZ,,64.0,YR,,M,Y,,,20190402.0,,OT,US,US,2019,Q2,Adult
155972392,15597239,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 UNK, UNK (UNITS/ML)",,,U,,,,,,,,,2019,Q2,Nocardiosis,,2019,Q2,2,F,,20190327.0,20181108,20190402,EXP,,PHHY2018US144215,SANDOZ,,64.0,YR,,M,Y,,,20190402.0,,OT,US,US,2019,Q2,Adult
155972392,15597239,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 UNK, UNK (UNITS/ML)",,,U,,,,,,,,,2019,Q2,Pain in extremity,,2019,Q2,2,F,,20190327.0,20181108,20190402,EXP,,PHHY2018US144215,SANDOZ,,64.0,YR,,M,Y,,,20190402.0,,OT,US,US,2019,Q2,Adult
155972392,15597239,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 UNK, UNK (UNITS/ML)",,,U,,,,,,,,,2019,Q2,Pyrexia,,2019,Q2,2,F,,20190327.0,20181108,20190402,EXP,,PHHY2018US144215,SANDOZ,,64.0,YR,,M,Y,,,20190402.0,,OT,US,US,2019,Q2,Adult
155972392,15597239,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 UNK, UNK (UNITS/ML)",,,U,,,,,,,,,2019,Q2,Tricuspid valve incompetence,,2019,Q2,2,F,,20190327.0,20181108,20190402,EXP,,PHHY2018US144215,SANDOZ,,64.0,YR,,M,Y,,,20190402.0,,OT,US,US,2019,Q2,Adult
156169379,15616937,19,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,2-10 UNITS,,,,,,,,,,UNKNOWN,TID,2019,Q2,Candida pneumonia,,2019,Q2,9,F,20180919.0,20190508.0,20181114,20190514,EXP,,US-CELGENEUS-USA-20180909031,CELGENE,,77.0,YR,,M,Y,,,20190514.0,,OT,US,US,2019,Q2,Elderly
156169379,15616937,19,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,2-10 UNITS,,,,,,,,,,UNKNOWN,TID,2019,Q2,Pneumonia fungal,,2019,Q2,9,F,20180919.0,20190508.0,20181114,20190514,EXP,,US-CELGENEUS-USA-20180909031,CELGENE,,77.0,YR,,M,Y,,,20190514.0,,OT,US,US,2019,Q2,Elderly
156169379,15616937,20,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,15 IU (INTERNATIONAL UNIT),,,,,,,,5.0,IU,UNKNOWN,TID,2019,Q2,Candida pneumonia,,2019,Q2,9,F,20180919.0,20190508.0,20181114,20190514,EXP,,US-CELGENEUS-USA-20180909031,CELGENE,,77.0,YR,,M,Y,,,20190514.0,,OT,US,US,2019,Q2,Elderly
156169379,15616937,20,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,15 IU (INTERNATIONAL UNIT),,,,,,,,5.0,IU,UNKNOWN,TID,2019,Q2,Pneumonia fungal,,2019,Q2,9,F,20180919.0,20190508.0,20181114,20190514,EXP,,US-CELGENEUS-USA-20180909031,CELGENE,,77.0,YR,,M,Y,,,20190514.0,,OT,US,US,2019,Q2,Elderly
156176192,15617619,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Asthenia,,2019,Q2,2,F,20181109.0,20190515.0,20181114,20190520,PER,,US-EISAI MEDICAL RESEARCH-EC-2018-047713,EISAI,,66.0,YR,,F,Y,82.7,KG,20190520.0,,MD,US,US,2019,Q2,Elderly
156176192,15617619,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Hyperglycaemia,,2019,Q2,2,F,20181109.0,20190515.0,20181114,20190520,PER,,US-EISAI MEDICAL RESEARCH-EC-2018-047713,EISAI,,66.0,YR,,F,Y,82.7,KG,20190520.0,,MD,US,US,2019,Q2,Elderly
156176192,15617619,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Neutropenia,,2019,Q2,2,F,20181109.0,20190515.0,20181114,20190520,PER,,US-EISAI MEDICAL RESEARCH-EC-2018-047713,EISAI,,66.0,YR,,F,Y,82.7,KG,20190520.0,,MD,US,US,2019,Q2,Elderly
1561839711,15618397,1,PS,Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, DAILY",,,U,,,,20563.0,,,,QD,2019,Q2,Chest pain,,2019,Q2,11,F,,20190329.0,20181114,20190410,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201811005909,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20190410.0,,CN,PT,PT,2019,Q2,Adult
1561839711,15618397,1,PS,Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, DAILY",,,U,,,,20563.0,,,,QD,2019,Q2,Headache,,2019,Q2,11,F,,20190329.0,20181114,20190410,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201811005909,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20190410.0,,CN,PT,PT,2019,Q2,Adult
1561839711,15618397,1,PS,Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, DAILY",,,U,,,,20563.0,,,,QD,2019,Q2,Ischaemic stroke,,2019,Q2,11,F,,20190329.0,20181114,20190410,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201811005909,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20190410.0,,CN,PT,PT,2019,Q2,Adult
1561839711,15618397,2,SS,Lispro,INSULIN LISPRO,1,Unknown,"40 [IU], DAILY",,,U,,,,20563.0,40.0,IU,,QD,2019,Q2,Chest pain,,2019,Q2,11,F,,20190329.0,20181114,20190410,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201811005909,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20190410.0,,CN,PT,PT,2019,Q2,Adult
1561839711,15618397,2,SS,Lispro,INSULIN LISPRO,1,Unknown,"40 [IU], DAILY",,,U,,,,20563.0,40.0,IU,,QD,2019,Q2,Headache,,2019,Q2,11,F,,20190329.0,20181114,20190410,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201811005909,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20190410.0,,CN,PT,PT,2019,Q2,Adult
1561839711,15618397,2,SS,Lispro,INSULIN LISPRO,1,Unknown,"40 [IU], DAILY",,,U,,,,20563.0,40.0,IU,,QD,2019,Q2,Ischaemic stroke,,2019,Q2,11,F,,20190329.0,20181114,20190410,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201811005909,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20190410.0,,CN,PT,PT,2019,Q2,Adult
156226083,15622608,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNKNOWN,,,,,,,,,,,,2019,Q2,Pleural effusion,,2019,Q2,3,F,20180831.0,20190617.0,20181115,20190624,EXP,,DE-PFIZER INC-2018468641,PFIZER,,77.0,YR,,F,Y,,,20190624.0,,MD,DE,DE,2019,Q2,Elderly
1564428128,15644281,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"40 IU, 1X/DAY ((25/75: + 20U 20U DAILY)",,,U,,,,,40.0,IU,SOLUTION FOR INJECTION,QD,2019,Q2,Chest pain,,2019,Q2,28,F,,20190611.0,20181121,20190625,EXP,,PT-PFIZER INC-2018477132,PFIZER,,54.0,YR,,F,Y,,,20190625.0,,CN,PT,PT,2019,Q2,Adult
1564428128,15644281,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"40 IU, 1X/DAY ((25/75: + 20U 20U DAILY)",,,U,,,,,40.0,IU,SOLUTION FOR INJECTION,QD,2019,Q2,Headache,,2019,Q2,28,F,,20190611.0,20181121,20190625,EXP,,PT-PFIZER INC-2018477132,PFIZER,,54.0,YR,,F,Y,,,20190625.0,,CN,PT,PT,2019,Q2,Adult
1564428128,15644281,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"40 IU, 1X/DAY ((25/75: + 20U 20U DAILY)",,,U,,,,,40.0,IU,SOLUTION FOR INJECTION,QD,2019,Q2,Ischaemic stroke,,2019,Q2,28,F,,20190611.0,20181121,20190625,EXP,,PT-PFIZER INC-2018477132,PFIZER,,54.0,YR,,F,Y,,,20190625.0,,CN,PT,PT,2019,Q2,Adult
156579647,15657964,12,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,(25/75: + 20U 20U / D)) QD,,,U,,,,209196.0,40.0,IU,SOLUTION FOR INJECTION,QD,2019,Q2,Chest pain,,2019,Q2,7,F,,20190611.0,20181126,20190621,EXP,,PT-SA-2018SA322867,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20190621.0,,OT,PT,PT,2019,Q2,Adult
156579647,15657964,12,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,(25/75: + 20U 20U / D)) QD,,,U,,,,209196.0,40.0,IU,SOLUTION FOR INJECTION,QD,2019,Q2,Headache,,2019,Q2,7,F,,20190611.0,20181126,20190621,EXP,,PT-SA-2018SA322867,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20190621.0,,OT,PT,PT,2019,Q2,Adult
156579647,15657964,12,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,(25/75: + 20U 20U / D)) QD,,,U,,,,209196.0,40.0,IU,SOLUTION FOR INJECTION,QD,2019,Q2,Ischaemic stroke,,2019,Q2,7,F,,20190611.0,20181126,20190621,EXP,,PT-SA-2018SA322867,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20190621.0,,OT,PT,PT,2019,Q2,Adult
156620013,15662001,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 DF, UNK",,,D,, UNKNOWN,,,300.0,DF,INJECTION,,2019,Q2,Acute kidney injury,,2019,Q2,3,F,20180419.0,20190617.0,20181127,20190619,EXP,,PHHY2018DE166582,SANDOZ,,71.0,YR,,M,Y,,,20190619.0,,MD,DE,DE,2019,Q2,Elderly
156620013,15662001,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 DF, UNK",,,D,, UNKNOWN,,,300.0,DF,INJECTION,,2019,Q2,Colitis,,2019,Q2,3,F,20180419.0,20190617.0,20181127,20190619,EXP,,PHHY2018DE166582,SANDOZ,,71.0,YR,,M,Y,,,20190619.0,,MD,DE,DE,2019,Q2,Elderly
156620013,15662001,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 DF, UNK",,,D,, UNKNOWN,,,300.0,DF,INJECTION,,2019,Q2,Device related infection,,2019,Q2,3,F,20180419.0,20190617.0,20181127,20190619,EXP,,PHHY2018DE166582,SANDOZ,,71.0,YR,,M,Y,,,20190619.0,,MD,DE,DE,2019,Q2,Elderly
156620013,15662001,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 DF, UNK",,,D,, UNKNOWN,,,300.0,DF,INJECTION,,2019,Q2,Heparin-induced thrombocytopenia,,2019,Q2,3,F,20180419.0,20190617.0,20181127,20190619,EXP,,PHHY2018DE166582,SANDOZ,,71.0,YR,,M,Y,,,20190619.0,,MD,DE,DE,2019,Q2,Elderly
156620013,15662001,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 DF, UNK",,,D,, UNKNOWN,,,300.0,DF,INJECTION,,2019,Q2,Hyperglycaemia,,2019,Q2,3,F,20180419.0,20190617.0,20181127,20190619,EXP,,PHHY2018DE166582,SANDOZ,,71.0,YR,,M,Y,,,20190619.0,,MD,DE,DE,2019,Q2,Elderly
156620013,15662001,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 DF, UNK",,,D,, UNKNOWN,,,300.0,DF,INJECTION,,2019,Q2,Malignant neoplasm progression,,2019,Q2,3,F,20180419.0,20190617.0,20181127,20190619,EXP,,PHHY2018DE166582,SANDOZ,,71.0,YR,,M,Y,,,20190619.0,,MD,DE,DE,2019,Q2,Elderly
156620013,15662001,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 DF, UNK",,,D,, UNKNOWN,,,300.0,DF,INJECTION,,2019,Q2,Meningitis,,2019,Q2,3,F,20180419.0,20190617.0,20181127,20190619,EXP,,PHHY2018DE166582,SANDOZ,,71.0,YR,,M,Y,,,20190619.0,,MD,DE,DE,2019,Q2,Elderly
156620013,15662001,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 DF, UNK",,,D,, UNKNOWN,,,300.0,DF,INJECTION,,2019,Q2,Metastases to meninges,,2019,Q2,3,F,20180419.0,20190617.0,20181127,20190619,EXP,,PHHY2018DE166582,SANDOZ,,71.0,YR,,M,Y,,,20190619.0,,MD,DE,DE,2019,Q2,Elderly
156620013,15662001,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 DF, UNK",,,D,, UNKNOWN,,,300.0,DF,INJECTION,,2019,Q2,Retinal detachment,,2019,Q2,3,F,20180419.0,20190617.0,20181127,20190619,EXP,,PHHY2018DE166582,SANDOZ,,71.0,YR,,M,Y,,,20190619.0,,MD,DE,DE,2019,Q2,Elderly
156620013,15662001,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 DF, UNK",,,D,, UNKNOWN,,,300.0,DF,INJECTION,,2019,Q2,Retinopathy,,2019,Q2,3,F,20180419.0,20190617.0,20181127,20190619,EXP,,PHHY2018DE166582,SANDOZ,,71.0,YR,,M,Y,,,20190619.0,,MD,DE,DE,2019,Q2,Elderly
156620013,15662001,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 DF, UNK",,,D,, UNKNOWN,,,300.0,DF,INJECTION,,2019,Q2,Urosepsis,,2019,Q2,3,F,20180419.0,20190617.0,20181127,20190619,EXP,,PHHY2018DE166582,SANDOZ,,71.0,YR,,M,Y,,,20190619.0,,MD,DE,DE,2019,Q2,Elderly
156653167,15665316,37,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,4 UNITS,,,,,,,,,,,QD,2019,Q2,Encephalopathy,,2019,Q2,7,F,20181116.0,20190614.0,20181128,20190619,EXP,,US-ROCHE-2218548,ROCHE,,75.0,YR,,M,Y,68.0,KG,20190619.0,,MD,US,US,2019,Q2,Elderly
156653167,15665316,38,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0-8 UNITS,,,,,,,,,,,TID,2019,Q2,Encephalopathy,,2019,Q2,7,F,20181116.0,20190614.0,20181128,20190619,EXP,,US-ROCHE-2218548,ROCHE,,75.0,YR,,M,Y,68.0,KG,20190619.0,,MD,US,US,2019,Q2,Elderly
156659134,15665913,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 INTERNATIONAL UNIT, QD",,,U,, UNK,,,40.0,IU,SOLUTION FOR INJECTION,QD,2019,Q2,Chest pain,,2019,Q2,4,F,,20190605.0,20181128,20190611,EXP,PT-002147023-PHHY2018PT147150,PT-FRESENIUS KABI-FK201812057,FRESENIUS KABI,,54.0,YR,,F,Y,,,20190611.0,,OT,GB,PT,2019,Q2,Adult
156659134,15665913,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 INTERNATIONAL UNIT, QD",,,U,, UNK,,,40.0,IU,SOLUTION FOR INJECTION,QD,2019,Q2,Headache,,2019,Q2,4,F,,20190605.0,20181128,20190611,EXP,PT-002147023-PHHY2018PT147150,PT-FRESENIUS KABI-FK201812057,FRESENIUS KABI,,54.0,YR,,F,Y,,,20190611.0,,OT,GB,PT,2019,Q2,Adult
156659134,15665913,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 INTERNATIONAL UNIT, QD",,,U,, UNK,,,40.0,IU,SOLUTION FOR INJECTION,QD,2019,Q2,Ischaemic stroke,,2019,Q2,4,F,,20190605.0,20181128,20190611,EXP,PT-002147023-PHHY2018PT147150,PT-FRESENIUS KABI-FK201812057,FRESENIUS KABI,,54.0,YR,,F,Y,,,20190611.0,,OT,GB,PT,2019,Q2,Adult
156702899,15670289,15,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 INTERNATIONAL UNIT, QD,(25/75: + 20U 20U / D)",,,U,U, UNK,,,40.0,IU,SOLUTION FOR INJECTION,QD,2019,Q2,Chest pain,,2019,Q2,9,F,,20190612.0,20181129,20190620,EXP,,PT-MYLANLABS-2018M1088222,MYLAN,,54.0,YR,,F,Y,,,20190620.0,,OT,PT,PT,2019,Q2,Adult
156702899,15670289,15,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 INTERNATIONAL UNIT, QD,(25/75: + 20U 20U / D)",,,U,U, UNK,,,40.0,IU,SOLUTION FOR INJECTION,QD,2019,Q2,Headache,,2019,Q2,9,F,,20190612.0,20181129,20190620,EXP,,PT-MYLANLABS-2018M1088222,MYLAN,,54.0,YR,,F,Y,,,20190620.0,,OT,PT,PT,2019,Q2,Adult
156702899,15670289,15,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 INTERNATIONAL UNIT, QD,(25/75: + 20U 20U / D)",,,U,U, UNK,,,40.0,IU,SOLUTION FOR INJECTION,QD,2019,Q2,Ischaemic stroke,,2019,Q2,9,F,,20190612.0,20181129,20190620,EXP,,PT-MYLANLABS-2018M1088222,MYLAN,,54.0,YR,,F,Y,,,20190620.0,,OT,PT,PT,2019,Q2,Adult
156860802,15686080,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"8 U, BID",,,,,,,,,,SOLUTION FOR INJECTION,Q12H,2019,Q2,Bronchitis,,2019,Q2,2,F,20190421.0,20190507.0,20181204,20190515,PER,,US-SA-2018SA325642,SANOFI AVENTIS,,79.0,YR,E,F,Y,,,20190515.0,,CN,US,US,2019,Q2,Elderly
156860802,15686080,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"8 U, BID",,,,,,,,,,SOLUTION FOR INJECTION,Q12H,2019,Q2,Cough,,2019,Q2,2,F,20190421.0,20190507.0,20181204,20190515,PER,,US-SA-2018SA325642,SANOFI AVENTIS,,79.0,YR,E,F,Y,,,20190515.0,,CN,US,US,2019,Q2,Elderly
156860802,15686080,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"8 U, BID",,,,,,,,,,SOLUTION FOR INJECTION,Q12H,2019,Q2,Oropharyngeal discomfort,,2019,Q2,2,F,20190421.0,20190507.0,20181204,20190515,PER,,US-SA-2018SA325642,SANOFI AVENTIS,,79.0,YR,E,F,Y,,,20190515.0,,CN,US,US,2019,Q2,Elderly
156873575,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Acidosis,,2019,Q2,5,F,20160303.0,20190529.0,20181205,20190610,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190610.0,,MD,US,US,2019,Q2,Adult
156873575,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Acute kidney injury,,2019,Q2,5,F,20160303.0,20190529.0,20181205,20190610,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190610.0,,MD,US,US,2019,Q2,Adult
156873575,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Acute respiratory distress syndrome,,2019,Q2,5,F,20160303.0,20190529.0,20181205,20190610,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190610.0,,MD,US,US,2019,Q2,Adult
156873575,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Alkalosis hypochloraemic,,2019,Q2,5,F,20160303.0,20190529.0,20181205,20190610,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190610.0,,MD,US,US,2019,Q2,Adult
156873575,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Anaemia,,2019,Q2,5,F,20160303.0,20190529.0,20181205,20190610,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190610.0,,MD,US,US,2019,Q2,Adult
156873575,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Asthenia,,2019,Q2,5,F,20160303.0,20190529.0,20181205,20190610,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190610.0,,MD,US,US,2019,Q2,Adult
156873575,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Bandaemia,,2019,Q2,5,F,20160303.0,20190529.0,20181205,20190610,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190610.0,,MD,US,US,2019,Q2,Adult
156873575,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Blood creatinine increased,,2019,Q2,5,F,20160303.0,20190529.0,20181205,20190610,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190610.0,,MD,US,US,2019,Q2,Adult
156873575,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Blood urea increased,,2019,Q2,5,F,20160303.0,20190529.0,20181205,20190610,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190610.0,,MD,US,US,2019,Q2,Adult
156873575,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Bronchial haemorrhage,,2019,Q2,5,F,20160303.0,20190529.0,20181205,20190610,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190610.0,,MD,US,US,2019,Q2,Adult
156873575,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Bronchitis chronic,,2019,Q2,5,F,20160303.0,20190529.0,20181205,20190610,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190610.0,,MD,US,US,2019,Q2,Adult
156873575,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Concomitant disease aggravated,,2019,Q2,5,F,20160303.0,20190529.0,20181205,20190610,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190610.0,,MD,US,US,2019,Q2,Adult
156873575,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Constipation,,2019,Q2,5,F,20160303.0,20190529.0,20181205,20190610,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190610.0,,MD,US,US,2019,Q2,Adult
156873575,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Cough,,2019,Q2,5,F,20160303.0,20190529.0,20181205,20190610,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190610.0,,MD,US,US,2019,Q2,Adult
156873575,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Cystic fibrosis,,2019,Q2,5,F,20160303.0,20190529.0,20181205,20190610,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190610.0,,MD,US,US,2019,Q2,Adult
156873575,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Diarrhoea,,2019,Q2,5,F,20160303.0,20190529.0,20181205,20190610,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190610.0,,MD,US,US,2019,Q2,Adult
156873575,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Dysphagia,,2019,Q2,5,F,20160303.0,20190529.0,20181205,20190610,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190610.0,,MD,US,US,2019,Q2,Adult
156873575,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Dyspnoea,,2019,Q2,5,F,20160303.0,20190529.0,20181205,20190610,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190610.0,,MD,US,US,2019,Q2,Adult
156873575,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Fungal disease carrier,,2019,Q2,5,F,20160303.0,20190529.0,20181205,20190610,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190610.0,,MD,US,US,2019,Q2,Adult
156873575,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Gastroenteritis norovirus,,2019,Q2,5,F,20160303.0,20190529.0,20181205,20190610,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190610.0,,MD,US,US,2019,Q2,Adult
156873575,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Gastrointestinal disorder,,2019,Q2,5,F,20160303.0,20190529.0,20181205,20190610,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190610.0,,MD,US,US,2019,Q2,Adult
156873575,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Generalised oedema,,2019,Q2,5,F,20160303.0,20190529.0,20181205,20190610,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190610.0,,MD,US,US,2019,Q2,Adult
156873575,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Glucose tolerance impaired,,2019,Q2,5,F,20160303.0,20190529.0,20181205,20190610,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190610.0,,MD,US,US,2019,Q2,Adult
156873575,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Granulocytosis,,2019,Q2,5,F,20160303.0,20190529.0,20181205,20190610,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190610.0,,MD,US,US,2019,Q2,Adult
156873575,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Haematuria,,2019,Q2,5,F,20160303.0,20190529.0,20181205,20190610,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190610.0,,MD,US,US,2019,Q2,Adult
156873575,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Haemoptysis,,2019,Q2,5,F,20160303.0,20190529.0,20181205,20190610,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190610.0,,MD,US,US,2019,Q2,Adult
156873575,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Hypercapnia,,2019,Q2,5,F,20160303.0,20190529.0,20181205,20190610,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190610.0,,MD,US,US,2019,Q2,Adult
156873575,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Hyperglycaemia,,2019,Q2,5,F,20160303.0,20190529.0,20181205,20190610,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190610.0,,MD,US,US,2019,Q2,Adult
156873575,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Hypernatraemia,,2019,Q2,5,F,20160303.0,20190529.0,20181205,20190610,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190610.0,,MD,US,US,2019,Q2,Adult
156873575,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Hypertension,,2019,Q2,5,F,20160303.0,20190529.0,20181205,20190610,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190610.0,,MD,US,US,2019,Q2,Adult
156873575,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Hypertriglyceridaemia,,2019,Q2,5,F,20160303.0,20190529.0,20181205,20190610,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190610.0,,MD,US,US,2019,Q2,Adult
156873575,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Hypervolaemia,,2019,Q2,5,F,20160303.0,20190529.0,20181205,20190610,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190610.0,,MD,US,US,2019,Q2,Adult
156873575,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Hypokalaemia,,2019,Q2,5,F,20160303.0,20190529.0,20181205,20190610,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190610.0,,MD,US,US,2019,Q2,Adult
156873575,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Hypoxia,,2019,Q2,5,F,20160303.0,20190529.0,20181205,20190610,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190610.0,,MD,US,US,2019,Q2,Adult
156873575,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Ill-defined disorder,,2019,Q2,5,F,20160303.0,20190529.0,20181205,20190610,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190610.0,,MD,US,US,2019,Q2,Adult
156873575,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Infective exacerbation of bronchiectasis,,2019,Q2,5,F,20160303.0,20190529.0,20181205,20190610,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190610.0,,MD,US,US,2019,Q2,Adult
156873575,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Infective pulmonary exacerbation of cystic fibrosis,,2019,Q2,5,F,20160303.0,20190529.0,20181205,20190610,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190610.0,,MD,US,US,2019,Q2,Adult
156873575,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Insomnia,,2019,Q2,5,F,20160303.0,20190529.0,20181205,20190610,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190610.0,,MD,US,US,2019,Q2,Adult
156873575,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Intensive care unit acquired weakness,,2019,Q2,5,F,20160303.0,20190529.0,20181205,20190610,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190610.0,,MD,US,US,2019,Q2,Adult
156873575,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Iron deficiency,,2019,Q2,5,F,20160303.0,20190529.0,20181205,20190610,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190610.0,,MD,US,US,2019,Q2,Adult
156873575,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Leukocytosis,,2019,Q2,5,F,20160303.0,20190529.0,20181205,20190610,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190610.0,,MD,US,US,2019,Q2,Adult
156873575,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Metabolic acidosis,,2019,Q2,5,F,20160303.0,20190529.0,20181205,20190610,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190610.0,,MD,US,US,2019,Q2,Adult
156873575,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Muscle atrophy,,2019,Q2,5,F,20160303.0,20190529.0,20181205,20190610,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190610.0,,MD,US,US,2019,Q2,Adult
156873575,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Paresis,,2019,Q2,5,F,20160303.0,20190529.0,20181205,20190610,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190610.0,,MD,US,US,2019,Q2,Adult
156873575,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Pneumonia,,2019,Q2,5,F,20160303.0,20190529.0,20181205,20190610,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190610.0,,MD,US,US,2019,Q2,Adult
156873575,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Pyrexia,,2019,Q2,5,F,20160303.0,20190529.0,20181205,20190610,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190610.0,,MD,US,US,2019,Q2,Adult
156873575,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Respiratory failure,,2019,Q2,5,F,20160303.0,20190529.0,20181205,20190610,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190610.0,,MD,US,US,2019,Q2,Adult
156873575,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Sepsis,,2019,Q2,5,F,20160303.0,20190529.0,20181205,20190610,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190610.0,,MD,US,US,2019,Q2,Adult
156873575,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Stenotrophomonas test positive,,2019,Q2,5,F,20160303.0,20190529.0,20181205,20190610,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190610.0,,MD,US,US,2019,Q2,Adult
156873575,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Tachycardia,,2019,Q2,5,F,20160303.0,20190529.0,20181205,20190610,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190610.0,,MD,US,US,2019,Q2,Adult
156873575,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Thrombocytosis,,2019,Q2,5,F,20160303.0,20190529.0,20181205,20190610,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190610.0,,MD,US,US,2019,Q2,Adult
156873575,15687357,74,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Weight decreased,,2019,Q2,5,F,20160303.0,20190529.0,20181205,20190610,PER,,PHHY2017US177182,SANDOZ,,37.0,YR,,M,Y,68.44,KG,20190610.0,,MD,US,US,2019,Q2,Adult
156977272,15697727,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q2,Impaired healing,,2019,Q2,2,F,20180821.0,20190401.0,20181207,20190412,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-112066,BRISTOL MYERS SQUIBB,,57.0,YR,,M,Y,,,20190412.0,,MD,DE,DE,2019,Q2,Adult
156977272,15697727,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q2,Necrotising fasciitis,,2019,Q2,2,F,20180821.0,20190401.0,20181207,20190412,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-112066,BRISTOL MYERS SQUIBB,,57.0,YR,,M,Y,,,20190412.0,,MD,DE,DE,2019,Q2,Adult
156977272,15697727,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q2,Wound dehiscence,,2019,Q2,2,F,20180821.0,20190401.0,20181207,20190412,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-112066,BRISTOL MYERS SQUIBB,,57.0,YR,,M,Y,,,20190412.0,,MD,DE,DE,2019,Q2,Adult
157041065,15704106,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, (25/75: 40 IU, QD)",,,U,U,,,,,,,QD,2019,Q2,Chest pain,,2019,Q2,5,F,,20190402.0,20181210,20190410,EXP,,PHHY2018PT173656,NOVARTIS,,54.0,YR,,F,Y,,,20190410.0,,OT,PT,PT,2019,Q2,Adult
157041065,15704106,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, (25/75: 40 IU, QD)",,,U,U,,,,,,,QD,2019,Q2,Headache,,2019,Q2,5,F,,20190402.0,20181210,20190410,EXP,,PHHY2018PT173656,NOVARTIS,,54.0,YR,,F,Y,,,20190410.0,,OT,PT,PT,2019,Q2,Adult
157041065,15704106,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, (25/75: 40 IU, QD)",,,U,U,,,,,,,QD,2019,Q2,Ischaemic stroke,,2019,Q2,5,F,,20190402.0,20181210,20190410,EXP,,PHHY2018PT173656,NOVARTIS,,54.0,YR,,F,Y,,,20190410.0,,OT,PT,PT,2019,Q2,Adult
157391175,15739117,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,U,,,,,,,,2019,Q2,Dysphagia,,2019,Q2,5,F,20181209.0,20190524.0,20181219,20190606,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20190606.0,,MD,SE,SE,2019,Q2,Elderly
157391175,15739117,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,U,,,,,,,,2019,Q2,Dyspnoea,,2019,Q2,5,F,20181209.0,20190524.0,20181219,20190606,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20190606.0,,MD,SE,SE,2019,Q2,Elderly
157391175,15739117,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,U,,,,,,,,2019,Q2,Subarachnoid haemorrhage,,2019,Q2,5,F,20181209.0,20190524.0,20181219,20190606,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20190606.0,,MD,SE,SE,2019,Q2,Elderly
157391175,15739117,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,U,,,,,,,,2019,Q2,Tachycardia,,2019,Q2,5,F,20181209.0,20190524.0,20181219,20190606,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20190606.0,,MD,SE,SE,2019,Q2,Elderly
157448492,15744849,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q2,Impaired healing,,2019,Q2,2,F,20180821.0,20190417.0,20181220,20190425,EXP,,PHHY2018DE189583,SANDOZ,,57.0,YR,,M,Y,,,20190426.0,,OT,DE,DE,2019,Q2,Adult
157448492,15744849,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q2,Necrotising fasciitis,,2019,Q2,2,F,20180821.0,20190417.0,20181220,20190425,EXP,,PHHY2018DE189583,SANDOZ,,57.0,YR,,M,Y,,,20190426.0,,OT,DE,DE,2019,Q2,Adult
157448492,15744849,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q2,Wound dehiscence,,2019,Q2,2,F,20180821.0,20190417.0,20181220,20190425,EXP,,PHHY2018DE189583,SANDOZ,,57.0,YR,,M,Y,,,20190426.0,,OT,DE,DE,2019,Q2,Adult
157496583,15749658,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK (VIAL),,,,,,,,,,,,2019,Q2,Alopecia,,2019,Q2,3,F,20131205.0,20190423.0,20181221,20190502,PER,,US-PFIZER INC-2018524934,PFIZER,,62.0,YR,,F,Y,54.0,KG,20190502.0,,LW,US,US,2019,Q2,Adult
157496583,15749658,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK (VIAL),,,,,,,,,,,,2019,Q2,Hair colour changes,,2019,Q2,3,F,20131205.0,20190423.0,20181221,20190502,PER,,US-PFIZER INC-2018524934,PFIZER,,62.0,YR,,F,Y,54.0,KG,20190502.0,,LW,US,US,2019,Q2,Adult
157496583,15749658,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK (VIAL),,,,,,,,,,,,2019,Q2,Hair disorder,,2019,Q2,3,F,20131205.0,20190423.0,20181221,20190502,PER,,US-PFIZER INC-2018524934,PFIZER,,62.0,YR,,F,Y,54.0,KG,20190502.0,,LW,US,US,2019,Q2,Adult
157496583,15749658,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK (VIAL),,,,,,,,,,,,2019,Q2,Hair texture abnormal,,2019,Q2,3,F,20131205.0,20190423.0,20181221,20190502,PER,,US-PFIZER INC-2018524934,PFIZER,,62.0,YR,,F,Y,54.0,KG,20190502.0,,LW,US,US,2019,Q2,Adult
157496583,15749658,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK (VIAL),,,,,,,,,,,,2019,Q2,Madarosis,,2019,Q2,3,F,20131205.0,20190423.0,20181221,20190502,PER,,US-PFIZER INC-2018524934,PFIZER,,62.0,YR,,F,Y,54.0,KG,20190502.0,,LW,US,US,2019,Q2,Adult
157561234,15756123,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 IU, QD",,,U,U, UNKNOWN,,,40.0,IU,,QD,2019,Q2,Chest pain,,2019,Q2,4,F,,20190329.0,20181224,20190403,EXP,,PT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-118258,BRISTOL MYERS SQUIBB,,54.0,YR,,F,Y,,,20190403.0,,OT,PT,PT,2019,Q2,Adult
157561234,15756123,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 IU, QD",,,U,U, UNKNOWN,,,40.0,IU,,QD,2019,Q2,Headache,,2019,Q2,4,F,,20190329.0,20181224,20190403,EXP,,PT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-118258,BRISTOL MYERS SQUIBB,,54.0,YR,,F,Y,,,20190403.0,,OT,PT,PT,2019,Q2,Adult
157561234,15756123,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 IU, QD",,,U,U, UNKNOWN,,,40.0,IU,,QD,2019,Q2,Ischaemic stroke,,2019,Q2,4,F,,20190329.0,20181224,20190403,EXP,,PT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-118258,BRISTOL MYERS SQUIBB,,54.0,YR,,F,Y,,,20190403.0,,OT,PT,PT,2019,Q2,Adult
157797726,15779772,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, UNK",,,U,,,,,1.0,DF,,,2019,Q2,Blood thyroid stimulating hormone increased,,2019,Q2,6,F,20181218.0,20190319.0,20190102,20190401,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-121478,BRISTOL MYERS SQUIBB,,64.0,YR,,M,Y,,,20190401.0,,CN,DE,DE,2019,Q2,Adult
157797726,15779772,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, UNK",,,U,,,,,1.0,DF,,,2019,Q2,Constipation,,2019,Q2,6,F,20181218.0,20190319.0,20190102,20190401,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-121478,BRISTOL MYERS SQUIBB,,64.0,YR,,M,Y,,,20190401.0,,CN,DE,DE,2019,Q2,Adult
157797726,15779772,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, UNK",,,U,,,,,1.0,DF,,,2019,Q2,Dry skin,,2019,Q2,6,F,20181218.0,20190319.0,20190102,20190401,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-121478,BRISTOL MYERS SQUIBB,,64.0,YR,,M,Y,,,20190401.0,,CN,DE,DE,2019,Q2,Adult
157797726,15779772,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, UNK",,,U,,,,,1.0,DF,,,2019,Q2,Epistaxis,,2019,Q2,6,F,20181218.0,20190319.0,20190102,20190401,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-121478,BRISTOL MYERS SQUIBB,,64.0,YR,,M,Y,,,20190401.0,,CN,DE,DE,2019,Q2,Adult
157797726,15779772,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, UNK",,,U,,,,,1.0,DF,,,2019,Q2,Fatigue,,2019,Q2,6,F,20181218.0,20190319.0,20190102,20190401,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-121478,BRISTOL MYERS SQUIBB,,64.0,YR,,M,Y,,,20190401.0,,CN,DE,DE,2019,Q2,Adult
157797726,15779772,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, UNK",,,U,,,,,1.0,DF,,,2019,Q2,Headache,,2019,Q2,6,F,20181218.0,20190319.0,20190102,20190401,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-121478,BRISTOL MYERS SQUIBB,,64.0,YR,,M,Y,,,20190401.0,,CN,DE,DE,2019,Q2,Adult
157797726,15779772,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, UNK",,,U,,,,,1.0,DF,,,2019,Q2,Myalgia,,2019,Q2,6,F,20181218.0,20190319.0,20190102,20190401,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-121478,BRISTOL MYERS SQUIBB,,64.0,YR,,M,Y,,,20190401.0,,CN,DE,DE,2019,Q2,Adult
157797726,15779772,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, UNK",,,U,,,,,1.0,DF,,,2019,Q2,Myocardial infarction,,2019,Q2,6,F,20181218.0,20190319.0,20190102,20190401,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-121478,BRISTOL MYERS SQUIBB,,64.0,YR,,M,Y,,,20190401.0,,CN,DE,DE,2019,Q2,Adult
157797726,15779772,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, UNK",,,U,,,,,1.0,DF,,,2019,Q2,Pulmonary oedema,,2019,Q2,6,F,20181218.0,20190319.0,20190102,20190401,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-121478,BRISTOL MYERS SQUIBB,,64.0,YR,,M,Y,,,20190401.0,,CN,DE,DE,2019,Q2,Adult
157827586,15782758,16,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"25/75, (25/75; PLUS 20U 20U/D)",,,U,,,,,40.0,IU,SOLUTION FOR INJECTION,QD,2019,Q2,Chest pain,,2019,Q2,6,F,,20190619.0,20190102,20190627,EXP,,PT-BAUSCH-BL-2018-036015,BAUSCH AND LOMB,,54.0,YR,,F,Y,,,20190627.0,,OT,PT,PT,2019,Q2,Adult
157827586,15782758,16,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"25/75, (25/75; PLUS 20U 20U/D)",,,U,,,,,40.0,IU,SOLUTION FOR INJECTION,QD,2019,Q2,Headache,,2019,Q2,6,F,,20190619.0,20190102,20190627,EXP,,PT-BAUSCH-BL-2018-036015,BAUSCH AND LOMB,,54.0,YR,,F,Y,,,20190627.0,,OT,PT,PT,2019,Q2,Adult
157827586,15782758,16,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"25/75, (25/75; PLUS 20U 20U/D)",,,U,,,,,40.0,IU,SOLUTION FOR INJECTION,QD,2019,Q2,Ischaemic stroke,,2019,Q2,6,F,,20190619.0,20190102,20190627,EXP,,PT-BAUSCH-BL-2018-036015,BAUSCH AND LOMB,,54.0,YR,,F,Y,,,20190627.0,,OT,PT,PT,2019,Q2,Adult
158113493,15811349,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 IU, QD",,,U,U,,,,40.0,IU,SOLUTION FOR INJECTION,QD,2019,Q2,Chest pain,,2019,Q2,3,F,,20190329.0,20190111,20190429,EXP,,PT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-124096,BRISTOL MYERS SQUIBB,,54.0,YR,,F,Y,,,20190429.0,,MD,PT,PT,2019,Q2,Adult
158113493,15811349,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 IU, QD",,,U,U,,,,40.0,IU,SOLUTION FOR INJECTION,QD,2019,Q2,Headache,,2019,Q2,3,F,,20190329.0,20190111,20190429,EXP,,PT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-124096,BRISTOL MYERS SQUIBB,,54.0,YR,,F,Y,,,20190429.0,,MD,PT,PT,2019,Q2,Adult
158113493,15811349,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 IU, QD",,,U,U,,,,40.0,IU,SOLUTION FOR INJECTION,QD,2019,Q2,Ischaemic stroke,,2019,Q2,3,F,,20190329.0,20190111,20190429,EXP,,PT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-124096,BRISTOL MYERS SQUIBB,,54.0,YR,,F,Y,,,20190429.0,,MD,PT,PT,2019,Q2,Adult
158194084,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Abdominal pain,,2019,Q2,4,F,,20190618.0,20190114,20190627,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190627.0,,CN,CA,CA,2019,Q2,Adult
158194084,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Abscess,,2019,Q2,4,F,,20190618.0,20190114,20190627,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190627.0,,CN,CA,CA,2019,Q2,Adult
158194084,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Adrenal insufficiency,,2019,Q2,4,F,,20190618.0,20190114,20190627,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190627.0,,CN,CA,CA,2019,Q2,Adult
158194084,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Alanine aminotransferase increased,,2019,Q2,4,F,,20190618.0,20190114,20190627,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190627.0,,CN,CA,CA,2019,Q2,Adult
158194084,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Ascites,,2019,Q2,4,F,,20190618.0,20190114,20190627,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190627.0,,CN,CA,CA,2019,Q2,Adult
158194084,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Asthenia,,2019,Q2,4,F,,20190618.0,20190114,20190627,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190627.0,,CN,CA,CA,2019,Q2,Adult
158194084,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Blood alkaline phosphatase increased,,2019,Q2,4,F,,20190618.0,20190114,20190627,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190627.0,,CN,CA,CA,2019,Q2,Adult
158194084,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Blood bilirubin increased,,2019,Q2,4,F,,20190618.0,20190114,20190627,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190627.0,,CN,CA,CA,2019,Q2,Adult
158194084,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Blood potassium decreased,,2019,Q2,4,F,,20190618.0,20190114,20190627,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190627.0,,CN,CA,CA,2019,Q2,Adult
158194084,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Blood pressure diastolic abnormal,,2019,Q2,4,F,,20190618.0,20190114,20190627,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190627.0,,CN,CA,CA,2019,Q2,Adult
158194084,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Blood pressure increased,,2019,Q2,4,F,,20190618.0,20190114,20190627,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190627.0,,CN,CA,CA,2019,Q2,Adult
158194084,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Depression,,2019,Q2,4,F,,20190618.0,20190114,20190627,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190627.0,,CN,CA,CA,2019,Q2,Adult
158194084,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Diverticulitis,,2019,Q2,4,F,,20190618.0,20190114,20190627,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190627.0,,CN,CA,CA,2019,Q2,Adult
158194084,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Endometrial disorder,,2019,Q2,4,F,,20190618.0,20190114,20190627,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190627.0,,CN,CA,CA,2019,Q2,Adult
158194084,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Enterococcus test positive,,2019,Q2,4,F,,20190618.0,20190114,20190627,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190627.0,,CN,CA,CA,2019,Q2,Adult
158194084,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Fibrosis,,2019,Q2,4,F,,20190618.0,20190114,20190627,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190627.0,,CN,CA,CA,2019,Q2,Adult
158194084,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Gamma-glutamyltransferase increased,,2019,Q2,4,F,,20190618.0,20190114,20190627,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190627.0,,CN,CA,CA,2019,Q2,Adult
158194084,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Gastrointestinal disorder,,2019,Q2,4,F,,20190618.0,20190114,20190627,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190627.0,,CN,CA,CA,2019,Q2,Adult
158194084,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Generalised oedema,,2019,Q2,4,F,,20190618.0,20190114,20190627,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190627.0,,CN,CA,CA,2019,Q2,Adult
158194084,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Heart rate increased,,2019,Q2,4,F,,20190618.0,20190114,20190627,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190627.0,,CN,CA,CA,2019,Q2,Adult
158194084,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Hepatic congestion,,2019,Q2,4,F,,20190618.0,20190114,20190627,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190627.0,,CN,CA,CA,2019,Q2,Adult
158194084,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Herpes zoster,,2019,Q2,4,F,,20190618.0,20190114,20190627,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190627.0,,CN,CA,CA,2019,Q2,Adult
158194084,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Hypersensitivity,,2019,Q2,4,F,,20190618.0,20190114,20190627,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190627.0,,CN,CA,CA,2019,Q2,Adult
158194084,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Hypoglycaemia,,2019,Q2,4,F,,20190618.0,20190114,20190627,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190627.0,,CN,CA,CA,2019,Q2,Adult
158194084,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Hypotension,,2019,Q2,4,F,,20190618.0,20190114,20190627,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190627.0,,CN,CA,CA,2019,Q2,Adult
158194084,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Increased appetite,,2019,Q2,4,F,,20190618.0,20190114,20190627,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190627.0,,CN,CA,CA,2019,Q2,Adult
158194084,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Influenza,,2019,Q2,4,F,,20190618.0,20190114,20190627,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190627.0,,CN,CA,CA,2019,Q2,Adult
158194084,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Infusion related reaction,,2019,Q2,4,F,,20190618.0,20190114,20190627,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190627.0,,CN,CA,CA,2019,Q2,Adult
158194084,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Injection site extravasation,,2019,Q2,4,F,,20190618.0,20190114,20190627,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190627.0,,CN,CA,CA,2019,Q2,Adult
158194084,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Intensive care unit acquired weakness,,2019,Q2,4,F,,20190618.0,20190114,20190627,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190627.0,,CN,CA,CA,2019,Q2,Adult
158194084,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Intervertebral disc protrusion,,2019,Q2,4,F,,20190618.0,20190114,20190627,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190627.0,,CN,CA,CA,2019,Q2,Adult
158194084,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Joint effusion,,2019,Q2,4,F,,20190618.0,20190114,20190627,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190627.0,,CN,CA,CA,2019,Q2,Adult
158194084,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Joint swelling,,2019,Q2,4,F,,20190618.0,20190114,20190627,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190627.0,,CN,CA,CA,2019,Q2,Adult
158194084,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Micturition disorder,,2019,Q2,4,F,,20190618.0,20190114,20190627,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190627.0,,CN,CA,CA,2019,Q2,Adult
158194084,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Myelopathy,,2019,Q2,4,F,,20190618.0,20190114,20190627,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190627.0,,CN,CA,CA,2019,Q2,Adult
158194084,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Myopathy,,2019,Q2,4,F,,20190618.0,20190114,20190627,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190627.0,,CN,CA,CA,2019,Q2,Adult
158194084,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Nasopharyngitis,,2019,Q2,4,F,,20190618.0,20190114,20190627,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190627.0,,CN,CA,CA,2019,Q2,Adult
158194084,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Nausea,,2019,Q2,4,F,,20190618.0,20190114,20190627,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190627.0,,CN,CA,CA,2019,Q2,Adult
158194084,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Nerve compression,,2019,Q2,4,F,,20190618.0,20190114,20190627,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190627.0,,CN,CA,CA,2019,Q2,Adult
158194084,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Neuropathy peripheral,,2019,Q2,4,F,,20190618.0,20190114,20190627,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190627.0,,CN,CA,CA,2019,Q2,Adult
158194084,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Neutropenia,,2019,Q2,4,F,,20190618.0,20190114,20190627,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190627.0,,CN,CA,CA,2019,Q2,Adult
158194084,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Osteoarthritis,,2019,Q2,4,F,,20190618.0,20190114,20190627,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190627.0,,CN,CA,CA,2019,Q2,Adult
158194084,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Pancytopenia,,2019,Q2,4,F,,20190618.0,20190114,20190627,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190627.0,,CN,CA,CA,2019,Q2,Adult
158194084,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Peripheral sensorimotor neuropathy,,2019,Q2,4,F,,20190618.0,20190114,20190627,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190627.0,,CN,CA,CA,2019,Q2,Adult
158194084,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Peritonitis,,2019,Q2,4,F,,20190618.0,20190114,20190627,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190627.0,,CN,CA,CA,2019,Q2,Adult
158194084,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Pneumonia,,2019,Q2,4,F,,20190618.0,20190114,20190627,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190627.0,,CN,CA,CA,2019,Q2,Adult
158194084,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Pseudomonal bacteraemia,,2019,Q2,4,F,,20190618.0,20190114,20190627,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190627.0,,CN,CA,CA,2019,Q2,Adult
158194084,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Rheumatoid arthritis,,2019,Q2,4,F,,20190618.0,20190114,20190627,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190627.0,,CN,CA,CA,2019,Q2,Adult
158194084,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Septic shock,,2019,Q2,4,F,,20190618.0,20190114,20190627,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190627.0,,CN,CA,CA,2019,Q2,Adult
158194084,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Therapeutic response decreased,,2019,Q2,4,F,,20190618.0,20190114,20190627,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190627.0,,CN,CA,CA,2019,Q2,Adult
158194084,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Vomiting,,2019,Q2,4,F,,20190618.0,20190114,20190627,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190627.0,,CN,CA,CA,2019,Q2,Adult
158194084,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Weight decreased,,2019,Q2,4,F,,20190618.0,20190114,20190627,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190627.0,,CN,CA,CA,2019,Q2,Adult
158194084,15819408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Weight increased,,2019,Q2,4,F,,20190618.0,20190114,20190627,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20190627.0,,CN,CA,CA,2019,Q2,Adult
158391232,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Acidosis,,2019,Q2,2,F,20160303.0,20190221.0,20190117,20190430,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190430.0,,MD,US,US,2019,Q2,Adult
158391232,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Acute kidney injury,,2019,Q2,2,F,20160303.0,20190221.0,20190117,20190430,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190430.0,,MD,US,US,2019,Q2,Adult
158391232,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Acute respiratory distress syndrome,,2019,Q2,2,F,20160303.0,20190221.0,20190117,20190430,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190430.0,,MD,US,US,2019,Q2,Adult
158391232,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Alkalosis hypochloraemic,,2019,Q2,2,F,20160303.0,20190221.0,20190117,20190430,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190430.0,,MD,US,US,2019,Q2,Adult
158391232,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Anaemia,,2019,Q2,2,F,20160303.0,20190221.0,20190117,20190430,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190430.0,,MD,US,US,2019,Q2,Adult
158391232,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Asthenia,,2019,Q2,2,F,20160303.0,20190221.0,20190117,20190430,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190430.0,,MD,US,US,2019,Q2,Adult
158391232,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Bandaemia,,2019,Q2,2,F,20160303.0,20190221.0,20190117,20190430,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190430.0,,MD,US,US,2019,Q2,Adult
158391232,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Blood creatinine increased,,2019,Q2,2,F,20160303.0,20190221.0,20190117,20190430,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190430.0,,MD,US,US,2019,Q2,Adult
158391232,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Blood urea increased,,2019,Q2,2,F,20160303.0,20190221.0,20190117,20190430,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190430.0,,MD,US,US,2019,Q2,Adult
158391232,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Bronchial haemorrhage,,2019,Q2,2,F,20160303.0,20190221.0,20190117,20190430,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190430.0,,MD,US,US,2019,Q2,Adult
158391232,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Bronchitis chronic,,2019,Q2,2,F,20160303.0,20190221.0,20190117,20190430,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190430.0,,MD,US,US,2019,Q2,Adult
158391232,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Concomitant disease aggravated,,2019,Q2,2,F,20160303.0,20190221.0,20190117,20190430,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190430.0,,MD,US,US,2019,Q2,Adult
158391232,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Constipation,,2019,Q2,2,F,20160303.0,20190221.0,20190117,20190430,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190430.0,,MD,US,US,2019,Q2,Adult
158391232,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Cough,,2019,Q2,2,F,20160303.0,20190221.0,20190117,20190430,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190430.0,,MD,US,US,2019,Q2,Adult
158391232,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Cystic fibrosis,,2019,Q2,2,F,20160303.0,20190221.0,20190117,20190430,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190430.0,,MD,US,US,2019,Q2,Adult
158391232,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Diarrhoea,,2019,Q2,2,F,20160303.0,20190221.0,20190117,20190430,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190430.0,,MD,US,US,2019,Q2,Adult
158391232,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Dysphagia,,2019,Q2,2,F,20160303.0,20190221.0,20190117,20190430,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190430.0,,MD,US,US,2019,Q2,Adult
158391232,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Dyspnoea,,2019,Q2,2,F,20160303.0,20190221.0,20190117,20190430,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190430.0,,MD,US,US,2019,Q2,Adult
158391232,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Fungal disease carrier,,2019,Q2,2,F,20160303.0,20190221.0,20190117,20190430,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190430.0,,MD,US,US,2019,Q2,Adult
158391232,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Gastroenteritis norovirus,,2019,Q2,2,F,20160303.0,20190221.0,20190117,20190430,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190430.0,,MD,US,US,2019,Q2,Adult
158391232,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Gastrointestinal disorder,,2019,Q2,2,F,20160303.0,20190221.0,20190117,20190430,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190430.0,,MD,US,US,2019,Q2,Adult
158391232,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Generalised oedema,,2019,Q2,2,F,20160303.0,20190221.0,20190117,20190430,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190430.0,,MD,US,US,2019,Q2,Adult
158391232,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Glucose tolerance impaired,,2019,Q2,2,F,20160303.0,20190221.0,20190117,20190430,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190430.0,,MD,US,US,2019,Q2,Adult
158391232,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Granulocytosis,,2019,Q2,2,F,20160303.0,20190221.0,20190117,20190430,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190430.0,,MD,US,US,2019,Q2,Adult
158391232,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Haematuria,,2019,Q2,2,F,20160303.0,20190221.0,20190117,20190430,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190430.0,,MD,US,US,2019,Q2,Adult
158391232,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Haemoptysis,,2019,Q2,2,F,20160303.0,20190221.0,20190117,20190430,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190430.0,,MD,US,US,2019,Q2,Adult
158391232,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Hypercapnia,,2019,Q2,2,F,20160303.0,20190221.0,20190117,20190430,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190430.0,,MD,US,US,2019,Q2,Adult
158391232,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Hyperglycaemia,,2019,Q2,2,F,20160303.0,20190221.0,20190117,20190430,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190430.0,,MD,US,US,2019,Q2,Adult
158391232,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Hypernatraemia,,2019,Q2,2,F,20160303.0,20190221.0,20190117,20190430,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190430.0,,MD,US,US,2019,Q2,Adult
158391232,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Hypertension,,2019,Q2,2,F,20160303.0,20190221.0,20190117,20190430,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190430.0,,MD,US,US,2019,Q2,Adult
158391232,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Hypertriglyceridaemia,,2019,Q2,2,F,20160303.0,20190221.0,20190117,20190430,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190430.0,,MD,US,US,2019,Q2,Adult
158391232,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Hypervolaemia,,2019,Q2,2,F,20160303.0,20190221.0,20190117,20190430,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190430.0,,MD,US,US,2019,Q2,Adult
158391232,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Hypokalaemia,,2019,Q2,2,F,20160303.0,20190221.0,20190117,20190430,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190430.0,,MD,US,US,2019,Q2,Adult
158391232,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Hypoxia,,2019,Q2,2,F,20160303.0,20190221.0,20190117,20190430,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190430.0,,MD,US,US,2019,Q2,Adult
158391232,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Ill-defined disorder,,2019,Q2,2,F,20160303.0,20190221.0,20190117,20190430,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190430.0,,MD,US,US,2019,Q2,Adult
158391232,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Infective exacerbation of bronchiectasis,,2019,Q2,2,F,20160303.0,20190221.0,20190117,20190430,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190430.0,,MD,US,US,2019,Q2,Adult
158391232,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Infective pulmonary exacerbation of cystic fibrosis,,2019,Q2,2,F,20160303.0,20190221.0,20190117,20190430,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190430.0,,MD,US,US,2019,Q2,Adult
158391232,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Insomnia,,2019,Q2,2,F,20160303.0,20190221.0,20190117,20190430,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190430.0,,MD,US,US,2019,Q2,Adult
158391232,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Intensive care unit acquired weakness,,2019,Q2,2,F,20160303.0,20190221.0,20190117,20190430,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190430.0,,MD,US,US,2019,Q2,Adult
158391232,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Iron deficiency,,2019,Q2,2,F,20160303.0,20190221.0,20190117,20190430,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190430.0,,MD,US,US,2019,Q2,Adult
158391232,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Leukocytosis,,2019,Q2,2,F,20160303.0,20190221.0,20190117,20190430,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190430.0,,MD,US,US,2019,Q2,Adult
158391232,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Metabolic acidosis,,2019,Q2,2,F,20160303.0,20190221.0,20190117,20190430,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190430.0,,MD,US,US,2019,Q2,Adult
158391232,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Muscle atrophy,,2019,Q2,2,F,20160303.0,20190221.0,20190117,20190430,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190430.0,,MD,US,US,2019,Q2,Adult
158391232,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Paresis,,2019,Q2,2,F,20160303.0,20190221.0,20190117,20190430,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190430.0,,MD,US,US,2019,Q2,Adult
158391232,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Pneumonia,,2019,Q2,2,F,20160303.0,20190221.0,20190117,20190430,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190430.0,,MD,US,US,2019,Q2,Adult
158391232,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Pyrexia,,2019,Q2,2,F,20160303.0,20190221.0,20190117,20190430,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190430.0,,MD,US,US,2019,Q2,Adult
158391232,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Respiratory failure,,2019,Q2,2,F,20160303.0,20190221.0,20190117,20190430,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190430.0,,MD,US,US,2019,Q2,Adult
158391232,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Sepsis,,2019,Q2,2,F,20160303.0,20190221.0,20190117,20190430,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190430.0,,MD,US,US,2019,Q2,Adult
158391232,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Stenotrophomonas test positive,,2019,Q2,2,F,20160303.0,20190221.0,20190117,20190430,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190430.0,,MD,US,US,2019,Q2,Adult
158391232,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Tachycardia,,2019,Q2,2,F,20160303.0,20190221.0,20190117,20190430,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190430.0,,MD,US,US,2019,Q2,Adult
158391232,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Thrombocytosis,,2019,Q2,2,F,20160303.0,20190221.0,20190117,20190430,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190430.0,,MD,US,US,2019,Q2,Adult
158391232,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q2,Weight decreased,,2019,Q2,2,F,20160303.0,20190221.0,20190117,20190430,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190430.0,,MD,US,US,2019,Q2,Adult
158440357,15844035,47,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2019,Q2,Cardiac disorder,,2019,Q2,7,F,20181126.0,20190620.0,20190118,20190625,EXP,,PHHY2018FR197254,SANDOZ,,68.0,YR,,F,Y,83.3,KG,20190625.0,,MD,FR,FR,2019,Q2,Elderly
158440357,15844035,47,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2019,Q2,Diabetes mellitus inadequate control,,2019,Q2,7,F,20181126.0,20190620.0,20190118,20190625,EXP,,PHHY2018FR197254,SANDOZ,,68.0,YR,,F,Y,83.3,KG,20190625.0,,MD,FR,FR,2019,Q2,Elderly
158440357,15844035,47,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2019,Q2,Haematuria,,2019,Q2,7,F,20181126.0,20190620.0,20190118,20190625,EXP,,PHHY2018FR197254,SANDOZ,,68.0,YR,,F,Y,83.3,KG,20190625.0,,MD,FR,FR,2019,Q2,Elderly
158440357,15844035,47,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2019,Q2,Hypertension,,2019,Q2,7,F,20181126.0,20190620.0,20190118,20190625,EXP,,PHHY2018FR197254,SANDOZ,,68.0,YR,,F,Y,83.3,KG,20190625.0,,MD,FR,FR,2019,Q2,Elderly
158440357,15844035,47,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2019,Q2,Hypomagnesaemia,,2019,Q2,7,F,20181126.0,20190620.0,20190118,20190625,EXP,,PHHY2018FR197254,SANDOZ,,68.0,YR,,F,Y,83.3,KG,20190625.0,,MD,FR,FR,2019,Q2,Elderly
158440357,15844035,47,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2019,Q2,Nausea,,2019,Q2,7,F,20181126.0,20190620.0,20190118,20190625,EXP,,PHHY2018FR197254,SANDOZ,,68.0,YR,,F,Y,83.3,KG,20190625.0,,MD,FR,FR,2019,Q2,Elderly
158440357,15844035,47,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2019,Q2,Overdose,,2019,Q2,7,F,20181126.0,20190620.0,20190118,20190625,EXP,,PHHY2018FR197254,SANDOZ,,68.0,YR,,F,Y,83.3,KG,20190625.0,,MD,FR,FR,2019,Q2,Elderly
158440357,15844035,47,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2019,Q2,Pyelonephritis,,2019,Q2,7,F,20181126.0,20190620.0,20190118,20190625,EXP,,PHHY2018FR197254,SANDOZ,,68.0,YR,,F,Y,83.3,KG,20190625.0,,MD,FR,FR,2019,Q2,Elderly
158440357,15844035,47,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2019,Q2,Renal impairment,,2019,Q2,7,F,20181126.0,20190620.0,20190118,20190625,EXP,,PHHY2018FR197254,SANDOZ,,68.0,YR,,F,Y,83.3,KG,20190625.0,,MD,FR,FR,2019,Q2,Elderly
158440357,15844035,47,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2019,Q2,Serum sickness,,2019,Q2,7,F,20181126.0,20190620.0,20190118,20190625,EXP,,PHHY2018FR197254,SANDOZ,,68.0,YR,,F,Y,83.3,KG,20190625.0,,MD,FR,FR,2019,Q2,Elderly
158561172,15856117,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"STRENGTH: 100 UNITS/ML 3 ML; VIAL MED CORRECTIVE SCALE, WMHS",,,,,,,,,,,,2019,Q2,Lower gastrointestinal haemorrhage,,2019,Q2,2,F,20160322.0,20190508.0,20190123,20190512,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-002903",BOEHRINGER INGELHEIM,,79.0,YR,,M,Y,,,20190512.0,,CN,US,US,2019,Q2,Elderly
158844363,15884436,10,C,LISPRO INSULIN,INSULIN LISPRO,1,,"(IL 200) 24-24-24 U, UNKNOWN FREQ.UNK",,,D,, UNK,,,,,,,2019,Q2,Hypoglycaemia,,2019,Q2,3,F,2013.0,20190506.0,20190129,20190510,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,ZAK P.. A TREATMENT WITH CONCENTRATED PRANDIAL INSULIN LISPRO 200 U/ML IN A PATIENT WITH THE TYPE 2 DIABETES MELLITUS AFTER LIVER TRANSPLANTATION./ LECBA KONCENTROVANYM PRANDIALNIM INZULIMEM LISPRO 200 U/ML U PACIENTKY S DIABETES MELLITUS 2. TYPU PO TRANSPLANTACI JATER. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20190510.0,,MD,CZ,CZ,2019,Q2,Adult
158844363,15884436,10,C,LISPRO INSULIN,INSULIN LISPRO,1,,"(IL 200) 24-24-24 U, UNKNOWN FREQ.UNK",,,D,, UNK,,,,,,,2019,Q2,Increased insulin requirement,,2019,Q2,3,F,2013.0,20190506.0,20190129,20190510,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,ZAK P.. A TREATMENT WITH CONCENTRATED PRANDIAL INSULIN LISPRO 200 U/ML IN A PATIENT WITH THE TYPE 2 DIABETES MELLITUS AFTER LIVER TRANSPLANTATION./ LECBA KONCENTROVANYM PRANDIALNIM INZULIMEM LISPRO 200 U/ML U PACIENTKY S DIABETES MELLITUS 2. TYPU PO TRANSPLANTACI JATER. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20190510.0,,MD,CZ,CZ,2019,Q2,Adult
158844363,15884436,10,C,LISPRO INSULIN,INSULIN LISPRO,1,,"(IL 200) 24-24-24 U, UNKNOWN FREQ.UNK",,,D,, UNK,,,,,,,2019,Q2,Insulin resistance,,2019,Q2,3,F,2013.0,20190506.0,20190129,20190510,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,ZAK P.. A TREATMENT WITH CONCENTRATED PRANDIAL INSULIN LISPRO 200 U/ML IN A PATIENT WITH THE TYPE 2 DIABETES MELLITUS AFTER LIVER TRANSPLANTATION./ LECBA KONCENTROVANYM PRANDIALNIM INZULIMEM LISPRO 200 U/ML U PACIENTKY S DIABETES MELLITUS 2. TYPU PO TRANSPLANTACI JATER. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20190510.0,,MD,CZ,CZ,2019,Q2,Adult
158844363,15884436,10,C,LISPRO INSULIN,INSULIN LISPRO,1,,"(IL 200) 24-24-24 U, UNKNOWN FREQ.UNK",,,D,, UNK,,,,,,,2019,Q2,Liver transplant rejection,,2019,Q2,3,F,2013.0,20190506.0,20190129,20190510,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,ZAK P.. A TREATMENT WITH CONCENTRATED PRANDIAL INSULIN LISPRO 200 U/ML IN A PATIENT WITH THE TYPE 2 DIABETES MELLITUS AFTER LIVER TRANSPLANTATION./ LECBA KONCENTROVANYM PRANDIALNIM INZULIMEM LISPRO 200 U/ML U PACIENTKY S DIABETES MELLITUS 2. TYPU PO TRANSPLANTACI JATER. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20190510.0,,MD,CZ,CZ,2019,Q2,Adult
158844363,15884436,10,C,LISPRO INSULIN,INSULIN LISPRO,1,,"(IL 200) 24-24-24 U, UNKNOWN FREQ.UNK",,,D,, UNK,,,,,,,2019,Q2,Nephrotic syndrome,,2019,Q2,3,F,2013.0,20190506.0,20190129,20190510,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,ZAK P.. A TREATMENT WITH CONCENTRATED PRANDIAL INSULIN LISPRO 200 U/ML IN A PATIENT WITH THE TYPE 2 DIABETES MELLITUS AFTER LIVER TRANSPLANTATION./ LECBA KONCENTROVANYM PRANDIALNIM INZULIMEM LISPRO 200 U/ML U PACIENTKY S DIABETES MELLITUS 2. TYPU PO TRANSPLANTACI JATER. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20190510.0,,MD,CZ,CZ,2019,Q2,Adult
158844363,15884436,10,C,LISPRO INSULIN,INSULIN LISPRO,1,,"(IL 200) 24-24-24 U, UNKNOWN FREQ.UNK",,,D,, UNK,,,,,,,2019,Q2,Proteinuria,,2019,Q2,3,F,2013.0,20190506.0,20190129,20190510,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,ZAK P.. A TREATMENT WITH CONCENTRATED PRANDIAL INSULIN LISPRO 200 U/ML IN A PATIENT WITH THE TYPE 2 DIABETES MELLITUS AFTER LIVER TRANSPLANTATION./ LECBA KONCENTROVANYM PRANDIALNIM INZULIMEM LISPRO 200 U/ML U PACIENTKY S DIABETES MELLITUS 2. TYPU PO TRANSPLANTACI JATER. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20190510.0,,MD,CZ,CZ,2019,Q2,Adult
158844363,15884436,10,C,LISPRO INSULIN,INSULIN LISPRO,1,,"(IL 200) 24-24-24 U, UNKNOWN FREQ.UNK",,,D,, UNK,,,,,,,2019,Q2,Renal failure,,2019,Q2,3,F,2013.0,20190506.0,20190129,20190510,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,ZAK P.. A TREATMENT WITH CONCENTRATED PRANDIAL INSULIN LISPRO 200 U/ML IN A PATIENT WITH THE TYPE 2 DIABETES MELLITUS AFTER LIVER TRANSPLANTATION./ LECBA KONCENTROVANYM PRANDIALNIM INZULIMEM LISPRO 200 U/ML U PACIENTKY S DIABETES MELLITUS 2. TYPU PO TRANSPLANTACI JATER. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20190510.0,,MD,CZ,CZ,2019,Q2,Adult
158844363,15884436,10,C,LISPRO INSULIN,INSULIN LISPRO,1,,"(IL 200) 24-24-24 U, UNKNOWN FREQ.UNK",,,D,, UNK,,,,,,,2019,Q2,Toxicity to various agents,,2019,Q2,3,F,2013.0,20190506.0,20190129,20190510,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,ZAK P.. A TREATMENT WITH CONCENTRATED PRANDIAL INSULIN LISPRO 200 U/ML IN A PATIENT WITH THE TYPE 2 DIABETES MELLITUS AFTER LIVER TRANSPLANTATION./ LECBA KONCENTROVANYM PRANDIALNIM INZULIMEM LISPRO 200 U/ML U PACIENTKY S DIABETES MELLITUS 2. TYPU PO TRANSPLANTACI JATER. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20190510.0,,MD,CZ,CZ,2019,Q2,Adult
158844363,15884436,10,C,LISPRO INSULIN,INSULIN LISPRO,1,,"(IL 200) 24-24-24 U, UNKNOWN FREQ.UNK",,,D,, UNK,,,,,,,2019,Q2,Weight increased,,2019,Q2,3,F,2013.0,20190506.0,20190129,20190510,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,ZAK P.. A TREATMENT WITH CONCENTRATED PRANDIAL INSULIN LISPRO 200 U/ML IN A PATIENT WITH THE TYPE 2 DIABETES MELLITUS AFTER LIVER TRANSPLANTATION./ LECBA KONCENTROVANYM PRANDIALNIM INZULIMEM LISPRO 200 U/ML U PACIENTKY S DIABETES MELLITUS 2. TYPU PO TRANSPLANTACI JATER. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20190510.0,,MD,CZ,CZ,2019,Q2,Adult
158844363,15884436,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,100 U/ML (IL 100) AT 20-20-20 U DOSES UNK,,,D,, UNK,,,,,,,2019,Q2,Hypoglycaemia,,2019,Q2,3,F,2013.0,20190506.0,20190129,20190510,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,ZAK P.. A TREATMENT WITH CONCENTRATED PRANDIAL INSULIN LISPRO 200 U/ML IN A PATIENT WITH THE TYPE 2 DIABETES MELLITUS AFTER LIVER TRANSPLANTATION./ LECBA KONCENTROVANYM PRANDIALNIM INZULIMEM LISPRO 200 U/ML U PACIENTKY S DIABETES MELLITUS 2. TYPU PO TRANSPLANTACI JATER. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20190510.0,,MD,CZ,CZ,2019,Q2,Adult
158844363,15884436,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,100 U/ML (IL 100) AT 20-20-20 U DOSES UNK,,,D,, UNK,,,,,,,2019,Q2,Increased insulin requirement,,2019,Q2,3,F,2013.0,20190506.0,20190129,20190510,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,ZAK P.. A TREATMENT WITH CONCENTRATED PRANDIAL INSULIN LISPRO 200 U/ML IN A PATIENT WITH THE TYPE 2 DIABETES MELLITUS AFTER LIVER TRANSPLANTATION./ LECBA KONCENTROVANYM PRANDIALNIM INZULIMEM LISPRO 200 U/ML U PACIENTKY S DIABETES MELLITUS 2. TYPU PO TRANSPLANTACI JATER. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20190510.0,,MD,CZ,CZ,2019,Q2,Adult
158844363,15884436,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,100 U/ML (IL 100) AT 20-20-20 U DOSES UNK,,,D,, UNK,,,,,,,2019,Q2,Insulin resistance,,2019,Q2,3,F,2013.0,20190506.0,20190129,20190510,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,ZAK P.. A TREATMENT WITH CONCENTRATED PRANDIAL INSULIN LISPRO 200 U/ML IN A PATIENT WITH THE TYPE 2 DIABETES MELLITUS AFTER LIVER TRANSPLANTATION./ LECBA KONCENTROVANYM PRANDIALNIM INZULIMEM LISPRO 200 U/ML U PACIENTKY S DIABETES MELLITUS 2. TYPU PO TRANSPLANTACI JATER. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20190510.0,,MD,CZ,CZ,2019,Q2,Adult
158844363,15884436,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,100 U/ML (IL 100) AT 20-20-20 U DOSES UNK,,,D,, UNK,,,,,,,2019,Q2,Liver transplant rejection,,2019,Q2,3,F,2013.0,20190506.0,20190129,20190510,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,ZAK P.. A TREATMENT WITH CONCENTRATED PRANDIAL INSULIN LISPRO 200 U/ML IN A PATIENT WITH THE TYPE 2 DIABETES MELLITUS AFTER LIVER TRANSPLANTATION./ LECBA KONCENTROVANYM PRANDIALNIM INZULIMEM LISPRO 200 U/ML U PACIENTKY S DIABETES MELLITUS 2. TYPU PO TRANSPLANTACI JATER. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20190510.0,,MD,CZ,CZ,2019,Q2,Adult
158844363,15884436,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,100 U/ML (IL 100) AT 20-20-20 U DOSES UNK,,,D,, UNK,,,,,,,2019,Q2,Nephrotic syndrome,,2019,Q2,3,F,2013.0,20190506.0,20190129,20190510,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,ZAK P.. A TREATMENT WITH CONCENTRATED PRANDIAL INSULIN LISPRO 200 U/ML IN A PATIENT WITH THE TYPE 2 DIABETES MELLITUS AFTER LIVER TRANSPLANTATION./ LECBA KONCENTROVANYM PRANDIALNIM INZULIMEM LISPRO 200 U/ML U PACIENTKY S DIABETES MELLITUS 2. TYPU PO TRANSPLANTACI JATER. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20190510.0,,MD,CZ,CZ,2019,Q2,Adult
158844363,15884436,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,100 U/ML (IL 100) AT 20-20-20 U DOSES UNK,,,D,, UNK,,,,,,,2019,Q2,Proteinuria,,2019,Q2,3,F,2013.0,20190506.0,20190129,20190510,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,ZAK P.. A TREATMENT WITH CONCENTRATED PRANDIAL INSULIN LISPRO 200 U/ML IN A PATIENT WITH THE TYPE 2 DIABETES MELLITUS AFTER LIVER TRANSPLANTATION./ LECBA KONCENTROVANYM PRANDIALNIM INZULIMEM LISPRO 200 U/ML U PACIENTKY S DIABETES MELLITUS 2. TYPU PO TRANSPLANTACI JATER. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20190510.0,,MD,CZ,CZ,2019,Q2,Adult
158844363,15884436,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,100 U/ML (IL 100) AT 20-20-20 U DOSES UNK,,,D,, UNK,,,,,,,2019,Q2,Renal failure,,2019,Q2,3,F,2013.0,20190506.0,20190129,20190510,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,ZAK P.. A TREATMENT WITH CONCENTRATED PRANDIAL INSULIN LISPRO 200 U/ML IN A PATIENT WITH THE TYPE 2 DIABETES MELLITUS AFTER LIVER TRANSPLANTATION./ LECBA KONCENTROVANYM PRANDIALNIM INZULIMEM LISPRO 200 U/ML U PACIENTKY S DIABETES MELLITUS 2. TYPU PO TRANSPLANTACI JATER. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20190510.0,,MD,CZ,CZ,2019,Q2,Adult
158844363,15884436,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,100 U/ML (IL 100) AT 20-20-20 U DOSES UNK,,,D,, UNK,,,,,,,2019,Q2,Toxicity to various agents,,2019,Q2,3,F,2013.0,20190506.0,20190129,20190510,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,ZAK P.. A TREATMENT WITH CONCENTRATED PRANDIAL INSULIN LISPRO 200 U/ML IN A PATIENT WITH THE TYPE 2 DIABETES MELLITUS AFTER LIVER TRANSPLANTATION./ LECBA KONCENTROVANYM PRANDIALNIM INZULIMEM LISPRO 200 U/ML U PACIENTKY S DIABETES MELLITUS 2. TYPU PO TRANSPLANTACI JATER. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20190510.0,,MD,CZ,CZ,2019,Q2,Adult
158844363,15884436,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,100 U/ML (IL 100) AT 20-20-20 U DOSES UNK,,,D,, UNK,,,,,,,2019,Q2,Weight increased,,2019,Q2,3,F,2013.0,20190506.0,20190129,20190510,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,ZAK P.. A TREATMENT WITH CONCENTRATED PRANDIAL INSULIN LISPRO 200 U/ML IN A PATIENT WITH THE TYPE 2 DIABETES MELLITUS AFTER LIVER TRANSPLANTATION./ LECBA KONCENTROVANYM PRANDIALNIM INZULIMEM LISPRO 200 U/ML U PACIENTKY S DIABETES MELLITUS 2. TYPU PO TRANSPLANTACI JATER. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20190510.0,,MD,CZ,CZ,2019,Q2,Adult
158896642,15889664,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Gait disturbance,,2019,Q2,2,F,,20190122.0,20190130,20190619,EXP,,US-SAKK-2019SA022226AA,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20190619.0,,CN,US,US,2019,Q2,Elderly
158896642,15889664,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Hypoaesthesia,,2019,Q2,2,F,,20190122.0,20190130,20190619,EXP,,US-SAKK-2019SA022226AA,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20190619.0,,CN,US,US,2019,Q2,Elderly
158896642,15889664,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Infection,,2019,Q2,2,F,,20190122.0,20190130,20190619,EXP,,US-SAKK-2019SA022226AA,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20190619.0,,CN,US,US,2019,Q2,Elderly
158896642,15889664,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Mass,,2019,Q2,2,F,,20190122.0,20190130,20190619,EXP,,US-SAKK-2019SA022226AA,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20190619.0,,CN,US,US,2019,Q2,Elderly
158896642,15889664,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Musculoskeletal discomfort,,2019,Q2,2,F,,20190122.0,20190130,20190619,EXP,,US-SAKK-2019SA022226AA,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20190619.0,,CN,US,US,2019,Q2,Elderly
158896642,15889664,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Neuralgia,,2019,Q2,2,F,,20190122.0,20190130,20190619,EXP,,US-SAKK-2019SA022226AA,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20190619.0,,CN,US,US,2019,Q2,Elderly
158896642,15889664,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Osteoarthritis,,2019,Q2,2,F,,20190122.0,20190130,20190619,EXP,,US-SAKK-2019SA022226AA,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20190619.0,,CN,US,US,2019,Q2,Elderly
158896642,15889664,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Paralysis,,2019,Q2,2,F,,20190122.0,20190130,20190619,EXP,,US-SAKK-2019SA022226AA,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20190619.0,,CN,US,US,2019,Q2,Elderly
158896642,15889664,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Pneumothorax,,2019,Q2,2,F,,20190122.0,20190130,20190619,EXP,,US-SAKK-2019SA022226AA,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20190619.0,,CN,US,US,2019,Q2,Elderly
158896642,15889664,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Rib fracture,,2019,Q2,2,F,,20190122.0,20190130,20190619,EXP,,US-SAKK-2019SA022226AA,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20190619.0,,CN,US,US,2019,Q2,Elderly
158896642,15889664,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Trigger finger,,2019,Q2,2,F,,20190122.0,20190130,20190619,EXP,,US-SAKK-2019SA022226AA,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20190619.0,,CN,US,US,2019,Q2,Elderly
159052083,15905208,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Hypotension,,2019,Q2,3,F,20190125.0,20190626.0,20190204,20190629,EXP,,US-ROCHE-2254708,ROCHE,,56.0,YR,,F,Y,76.0,KG,20190629.0,,MD,US,US,2019,Q2,Adult
159258825,15925882,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 INTERNATIONAL UNIT,,,,, UNK,,,10.0,IU,INJECTION,,2019,Q2,Acute kidney injury,,2019,Q2,5,F,20180723.0,20190510.0,20190206,20190516,EXP,IT-MINISAL02-491705,IT-MYLANLABS-2019M1011067,MYLAN,,65.0,YR,,F,Y,70.0,KG,20190516.0,,PH,IT,IT,2019,Q2,Elderly
159258825,15925882,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 INTERNATIONAL UNIT,,,,, UNK,,,10.0,IU,INJECTION,,2019,Q2,Electrolyte imbalance,,2019,Q2,5,F,20180723.0,20190510.0,20190206,20190516,EXP,IT-MINISAL02-491705,IT-MYLANLABS-2019M1011067,MYLAN,,65.0,YR,,F,Y,70.0,KG,20190516.0,,PH,IT,IT,2019,Q2,Elderly
159258825,15925882,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 INTERNATIONAL UNIT,,,,, UNK,,,10.0,IU,INJECTION,,2019,Q2,Renal failure,,2019,Q2,5,F,20180723.0,20190510.0,20190206,20190516,EXP,IT-MINISAL02-491705,IT-MYLANLABS-2019M1011067,MYLAN,,65.0,YR,,F,Y,70.0,KG,20190516.0,,PH,IT,IT,2019,Q2,Elderly
159258825,15925882,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 INTERNATIONAL UNIT,,,,, UNK,,,10.0,IU,INJECTION,,2019,Q2,Renal tubular disorder,,2019,Q2,5,F,20180723.0,20190510.0,20190206,20190516,EXP,IT-MINISAL02-491705,IT-MYLANLABS-2019M1011067,MYLAN,,65.0,YR,,F,Y,70.0,KG,20190516.0,,PH,IT,IT,2019,Q2,Elderly
159258825,15925882,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 INTERNATIONAL UNIT,,,,, UNK,,,10.0,IU,INJECTION,,2019,Q2,Tubulointerstitial nephritis,,2019,Q2,5,F,20180723.0,20190510.0,20190206,20190516,EXP,IT-MINISAL02-491705,IT-MYLANLABS-2019M1011067,MYLAN,,65.0,YR,,F,Y,70.0,KG,20190516.0,,PH,IT,IT,2019,Q2,Elderly
159287373,15928737,27,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Acute kidney injury,,2019,Q2,3,F,20150907.0,20190411.0,20190206,20190417,EXP,,US-ASTRAZENECA-2018SF14393,ASTRAZENECA,,24442.0,DY,,F,Y,,,20190417.0,,,US,US,2019,Q2,Elderly
159287373,15928737,27,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Chronic kidney disease,,2019,Q2,3,F,20150907.0,20190411.0,20190206,20190417,EXP,,US-ASTRAZENECA-2018SF14393,ASTRAZENECA,,24442.0,DY,,F,Y,,,20190417.0,,,US,US,2019,Q2,Elderly
159287373,15928737,27,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Death,,2019,Q2,3,F,20150907.0,20190411.0,20190206,20190417,EXP,,US-ASTRAZENECA-2018SF14393,ASTRAZENECA,,24442.0,DY,,F,Y,,,20190417.0,,,US,US,2019,Q2,Elderly
159287373,15928737,27,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,End stage renal disease,,2019,Q2,3,F,20150907.0,20190411.0,20190206,20190417,EXP,,US-ASTRAZENECA-2018SF14393,ASTRAZENECA,,24442.0,DY,,F,Y,,,20190417.0,,,US,US,2019,Q2,Elderly
159287373,15928737,27,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Renal failure,,2019,Q2,3,F,20150907.0,20190411.0,20190206,20190417,EXP,,US-ASTRAZENECA-2018SF14393,ASTRAZENECA,,24442.0,DY,,F,Y,,,20190417.0,,,US,US,2019,Q2,Elderly
159393002,15939300,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Acute kidney injury,,2019,Q2,2,F,2011.0,20190603.0,20190208,20190611,EXP,,US-ASTRAZENECA-2019SE21143,ASTRAZENECA,,60.0,YR,,M,Y,72.6,KG,20190611.0,,,US,US,2019,Q2,Adult
159393002,15939300,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Chronic kidney disease,,2019,Q2,2,F,2011.0,20190603.0,20190208,20190611,EXP,,US-ASTRAZENECA-2019SE21143,ASTRAZENECA,,60.0,YR,,M,Y,72.6,KG,20190611.0,,,US,US,2019,Q2,Adult
159393002,15939300,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,End stage renal disease,,2019,Q2,2,F,2011.0,20190603.0,20190208,20190611,EXP,,US-ASTRAZENECA-2019SE21143,ASTRAZENECA,,60.0,YR,,M,Y,72.6,KG,20190611.0,,,US,US,2019,Q2,Adult
159393002,15939300,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Hyperparathyroidism secondary,,2019,Q2,2,F,2011.0,20190603.0,20190208,20190611,EXP,,US-ASTRAZENECA-2019SE21143,ASTRAZENECA,,60.0,YR,,M,Y,72.6,KG,20190611.0,,,US,US,2019,Q2,Adult
159393002,15939300,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Nephrogenic anaemia,,2019,Q2,2,F,2011.0,20190603.0,20190208,20190611,EXP,,US-ASTRAZENECA-2019SE21143,ASTRAZENECA,,60.0,YR,,M,Y,72.6,KG,20190611.0,,,US,US,2019,Q2,Adult
159393002,15939300,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Renal failure,,2019,Q2,2,F,2011.0,20190603.0,20190208,20190611,EXP,,US-ASTRAZENECA-2019SE21143,ASTRAZENECA,,60.0,YR,,M,Y,72.6,KG,20190611.0,,,US,US,2019,Q2,Adult
159427444,15942744,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Acute kidney injury,,2019,Q2,4,F,201606.0,20190516.0,20190209,20190523,EXP,,US-ASTRAZENECA-2018SF22217,ASTRAZENECA,,911.0,MON,,M,Y,,,20190523.0,,,US,US,2019,Q2,Elderly
159427444,15942744,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Chronic kidney disease,,2019,Q2,4,F,201606.0,20190516.0,20190209,20190523,EXP,,US-ASTRAZENECA-2018SF22217,ASTRAZENECA,,911.0,MON,,M,Y,,,20190523.0,,,US,US,2019,Q2,Elderly
159427444,15942744,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Renal failure,,2019,Q2,4,F,201606.0,20190516.0,20190209,20190523,EXP,,US-ASTRAZENECA-2018SF22217,ASTRAZENECA,,911.0,MON,,M,Y,,,20190523.0,,,US,US,2019,Q2,Elderly
159427444,15942744,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Renal injury,,2019,Q2,4,F,201606.0,20190516.0,20190209,20190523,EXP,,US-ASTRAZENECA-2018SF22217,ASTRAZENECA,,911.0,MON,,M,Y,,,20190523.0,,,US,US,2019,Q2,Elderly
159540802,15954080,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 IU,QD",,,Y,,,,,30.0,IU,,QD,2019,Q2,Exposure during pregnancy,,2019,Q2,2,F,20170205.0,20190516.0,20190213,20190523,EXP,DE-EMA-DD-20171208-MSHETTYP-160006,DE-SA-2017SA236742,SANOFI AVENTIS,,33.0,YR,A,F,Y,84.0,KG,20190523.0,,CN,DE,DE,2019,Q2,Young Adult
159540802,15954080,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 IU,QD",,,Y,,,,,30.0,IU,,QD,2019,Q2,Gastroenteritis norovirus,,2019,Q2,2,F,20170205.0,20190516.0,20190213,20190523,EXP,DE-EMA-DD-20171208-MSHETTYP-160006,DE-SA-2017SA236742,SANOFI AVENTIS,,33.0,YR,A,F,Y,84.0,KG,20190523.0,,CN,DE,DE,2019,Q2,Young Adult
159540802,15954080,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 IU,QD",,,Y,,,,,30.0,IU,,QD,2019,Q2,Hyperglycaemia,,2019,Q2,2,F,20170205.0,20190516.0,20190213,20190523,EXP,DE-EMA-DD-20171208-MSHETTYP-160006,DE-SA-2017SA236742,SANOFI AVENTIS,,33.0,YR,A,F,Y,84.0,KG,20190523.0,,CN,DE,DE,2019,Q2,Young Adult
159540802,15954080,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 IU,QD",,,Y,,,,,30.0,IU,,QD,2019,Q2,Hypoglycaemia,,2019,Q2,2,F,20170205.0,20190516.0,20190213,20190523,EXP,DE-EMA-DD-20171208-MSHETTYP-160006,DE-SA-2017SA236742,SANOFI AVENTIS,,33.0,YR,A,F,Y,84.0,KG,20190523.0,,CN,DE,DE,2019,Q2,Young Adult
159540802,15954080,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 IU,QD",,,Y,,,,,30.0,IU,,QD,2019,Q2,Maternal exposure during breast feeding,,2019,Q2,2,F,20170205.0,20190516.0,20190213,20190523,EXP,DE-EMA-DD-20171208-MSHETTYP-160006,DE-SA-2017SA236742,SANOFI AVENTIS,,33.0,YR,A,F,Y,84.0,KG,20190523.0,,CN,DE,DE,2019,Q2,Young Adult
159540802,15954080,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 IU, QD",,,Y,,,,,40.0,IU,,QD,2019,Q2,Exposure during pregnancy,,2019,Q2,2,F,20170205.0,20190516.0,20190213,20190523,EXP,DE-EMA-DD-20171208-MSHETTYP-160006,DE-SA-2017SA236742,SANOFI AVENTIS,,33.0,YR,A,F,Y,84.0,KG,20190523.0,,CN,DE,DE,2019,Q2,Young Adult
159540802,15954080,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 IU, QD",,,Y,,,,,40.0,IU,,QD,2019,Q2,Gastroenteritis norovirus,,2019,Q2,2,F,20170205.0,20190516.0,20190213,20190523,EXP,DE-EMA-DD-20171208-MSHETTYP-160006,DE-SA-2017SA236742,SANOFI AVENTIS,,33.0,YR,A,F,Y,84.0,KG,20190523.0,,CN,DE,DE,2019,Q2,Young Adult
159540802,15954080,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 IU, QD",,,Y,,,,,40.0,IU,,QD,2019,Q2,Hyperglycaemia,,2019,Q2,2,F,20170205.0,20190516.0,20190213,20190523,EXP,DE-EMA-DD-20171208-MSHETTYP-160006,DE-SA-2017SA236742,SANOFI AVENTIS,,33.0,YR,A,F,Y,84.0,KG,20190523.0,,CN,DE,DE,2019,Q2,Young Adult
159540802,15954080,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 IU, QD",,,Y,,,,,40.0,IU,,QD,2019,Q2,Hypoglycaemia,,2019,Q2,2,F,20170205.0,20190516.0,20190213,20190523,EXP,DE-EMA-DD-20171208-MSHETTYP-160006,DE-SA-2017SA236742,SANOFI AVENTIS,,33.0,YR,A,F,Y,84.0,KG,20190523.0,,CN,DE,DE,2019,Q2,Young Adult
159540802,15954080,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 IU, QD",,,Y,,,,,40.0,IU,,QD,2019,Q2,Maternal exposure during breast feeding,,2019,Q2,2,F,20170205.0,20190516.0,20190213,20190523,EXP,DE-EMA-DD-20171208-MSHETTYP-160006,DE-SA-2017SA236742,SANOFI AVENTIS,,33.0,YR,A,F,Y,84.0,KG,20190523.0,,CN,DE,DE,2019,Q2,Young Adult
159540802,15954080,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 U, QD",,,Y,,,,,,,,QD,2019,Q2,Exposure during pregnancy,,2019,Q2,2,F,20170205.0,20190516.0,20190213,20190523,EXP,DE-EMA-DD-20171208-MSHETTYP-160006,DE-SA-2017SA236742,SANOFI AVENTIS,,33.0,YR,A,F,Y,84.0,KG,20190523.0,,CN,DE,DE,2019,Q2,Young Adult
159540802,15954080,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 U, QD",,,Y,,,,,,,,QD,2019,Q2,Gastroenteritis norovirus,,2019,Q2,2,F,20170205.0,20190516.0,20190213,20190523,EXP,DE-EMA-DD-20171208-MSHETTYP-160006,DE-SA-2017SA236742,SANOFI AVENTIS,,33.0,YR,A,F,Y,84.0,KG,20190523.0,,CN,DE,DE,2019,Q2,Young Adult
159540802,15954080,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 U, QD",,,Y,,,,,,,,QD,2019,Q2,Hyperglycaemia,,2019,Q2,2,F,20170205.0,20190516.0,20190213,20190523,EXP,DE-EMA-DD-20171208-MSHETTYP-160006,DE-SA-2017SA236742,SANOFI AVENTIS,,33.0,YR,A,F,Y,84.0,KG,20190523.0,,CN,DE,DE,2019,Q2,Young Adult
159540802,15954080,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 U, QD",,,Y,,,,,,,,QD,2019,Q2,Hypoglycaemia,,2019,Q2,2,F,20170205.0,20190516.0,20190213,20190523,EXP,DE-EMA-DD-20171208-MSHETTYP-160006,DE-SA-2017SA236742,SANOFI AVENTIS,,33.0,YR,A,F,Y,84.0,KG,20190523.0,,CN,DE,DE,2019,Q2,Young Adult
159540802,15954080,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 U, QD",,,Y,,,,,,,,QD,2019,Q2,Maternal exposure during breast feeding,,2019,Q2,2,F,20170205.0,20190516.0,20190213,20190523,EXP,DE-EMA-DD-20171208-MSHETTYP-160006,DE-SA-2017SA236742,SANOFI AVENTIS,,33.0,YR,A,F,Y,84.0,KG,20190523.0,,CN,DE,DE,2019,Q2,Young Adult
159570435,15957043,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Infusion related reaction,,2019,Q2,5,F,20190129.0,20190430.0,20190213,20190506,EXP,,TR-ROCHE-2261674,ROCHE,,66.0,YR,,M,Y,71.0,KG,20190506.0,,MD,TR,TR,2019,Q2,Elderly
159570435,15957043,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Polyneuropathy,,2019,Q2,5,F,20190129.0,20190430.0,20190213,20190506,EXP,,TR-ROCHE-2261674,ROCHE,,66.0,YR,,M,Y,71.0,KG,20190506.0,,MD,TR,TR,2019,Q2,Elderly
159692514,15969251,8,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2019,Q2,Diabetic ketoacidosis,,2019,Q2,4,F,20190204.0,20190621.0,20190215,20190626,EXP,,US-TAKEDA-2019TUS006283,TAKEDA,,77.0,YR,,M,Y,90.0,KG,20190626.0,,MD,US,US,2019,Q2,Elderly
159692514,15969251,8,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2019,Q2,Septic shock,,2019,Q2,4,F,20190204.0,20190621.0,20190215,20190626,EXP,,US-TAKEDA-2019TUS006283,TAKEDA,,77.0,YR,,M,Y,90.0,KG,20190626.0,,MD,US,US,2019,Q2,Elderly
159987883,15998788,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Acute kidney injury,,2019,Q2,3,F,20140525.0,20190403.0,20190223,20190412,EXP,,US-ASTRAZENECA-2018SF65268,ASTRAZENECA,,11210.0,DY,,F,Y,80.2,KG,20190412.0,,,US,US,2019,Q2,Elderly
159987883,15998788,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Chronic kidney disease,,2019,Q2,3,F,20140525.0,20190403.0,20190223,20190412,EXP,,US-ASTRAZENECA-2018SF65268,ASTRAZENECA,,11210.0,DY,,F,Y,80.2,KG,20190412.0,,,US,US,2019,Q2,Elderly
159987883,15998788,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,End stage renal disease,,2019,Q2,3,F,20140525.0,20190403.0,20190223,20190412,EXP,,US-ASTRAZENECA-2018SF65268,ASTRAZENECA,,11210.0,DY,,F,Y,80.2,KG,20190412.0,,,US,US,2019,Q2,Elderly
159987883,15998788,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Renal failure,,2019,Q2,3,F,20140525.0,20190403.0,20190223,20190412,EXP,,US-ASTRAZENECA-2018SF65268,ASTRAZENECA,,11210.0,DY,,F,Y,80.2,KG,20190412.0,,,US,US,2019,Q2,Elderly
159987883,15998788,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Renal injury,,2019,Q2,3,F,20140525.0,20190403.0,20190223,20190412,EXP,,US-ASTRAZENECA-2018SF65268,ASTRAZENECA,,11210.0,DY,,F,Y,80.2,KG,20190412.0,,,US,US,2019,Q2,Elderly
160068975,16006897,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Acute kidney injury,,2019,Q2,5,F,2006.0,20190617.0,20190222,20190625,EXP,,US-ASTRAZENECA-2018SF22114,ASTRAZENECA,,53.0,YR,,F,Y,90.3,KG,20190625.0,,,US,US,2019,Q2,Adult
160068975,16006897,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Chronic kidney disease,,2019,Q2,5,F,2006.0,20190617.0,20190222,20190625,EXP,,US-ASTRAZENECA-2018SF22114,ASTRAZENECA,,53.0,YR,,F,Y,90.3,KG,20190625.0,,,US,US,2019,Q2,Adult
160068975,16006897,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,End stage renal disease,,2019,Q2,5,F,2006.0,20190617.0,20190222,20190625,EXP,,US-ASTRAZENECA-2018SF22114,ASTRAZENECA,,53.0,YR,,F,Y,90.3,KG,20190625.0,,,US,US,2019,Q2,Adult
160068975,16006897,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Renal failure,,2019,Q2,5,F,2006.0,20190617.0,20190222,20190625,EXP,,US-ASTRAZENECA-2018SF22114,ASTRAZENECA,,53.0,YR,,F,Y,90.3,KG,20190625.0,,,US,US,2019,Q2,Adult
160068975,16006897,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Renal injury,,2019,Q2,5,F,2006.0,20190617.0,20190222,20190625,EXP,,US-ASTRAZENECA-2018SF22114,ASTRAZENECA,,53.0,YR,,F,Y,90.3,KG,20190625.0,,,US,US,2019,Q2,Adult
160068975,16006897,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Tubulointerstitial nephritis,,2019,Q2,5,F,2006.0,20190617.0,20190222,20190625,EXP,,US-ASTRAZENECA-2018SF22114,ASTRAZENECA,,53.0,YR,,F,Y,90.3,KG,20190625.0,,,US,US,2019,Q2,Adult
1601002811,16010028,13,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 IU, QD (QD (25/75: + 20U 20U / D))",,,U,, UNK,,,40.0,IU,SOLUTION FOR INJECTION,QD,2019,Q2,Chest pain,,2019,Q2,11,F,,20190607.0,20190225,20190626,EXP,,PT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-112421,BRISTOL MYERS SQUIBB,,54.0,YR,,F,Y,110.0,KG,20190626.0,,CN,PT,PT,2019,Q2,Adult
1601002811,16010028,13,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 IU, QD (QD (25/75: + 20U 20U / D))",,,U,, UNK,,,40.0,IU,SOLUTION FOR INJECTION,QD,2019,Q2,Headache,,2019,Q2,11,F,,20190607.0,20190225,20190626,EXP,,PT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-112421,BRISTOL MYERS SQUIBB,,54.0,YR,,F,Y,110.0,KG,20190626.0,,CN,PT,PT,2019,Q2,Adult
1601002811,16010028,13,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 IU, QD (QD (25/75: + 20U 20U / D))",,,U,, UNK,,,40.0,IU,SOLUTION FOR INJECTION,QD,2019,Q2,Ischaemic stroke,,2019,Q2,11,F,,20190607.0,20190225,20190626,EXP,,PT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-112421,BRISTOL MYERS SQUIBB,,54.0,YR,,F,Y,110.0,KG,20190626.0,,CN,PT,PT,2019,Q2,Adult
160129552,16012955,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q2,Acute kidney injury,,2019,Q2,2,F,2011.0,20190604.0,20190227,20190610,EXP,,US-PFIZER INC-2019088083,PFIZER,,60.0,YR,,M,Y,,,20190610.0,,LW,US,US,2019,Q2,Adult
160129552,16012955,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q2,Chronic kidney disease,,2019,Q2,2,F,2011.0,20190604.0,20190227,20190610,EXP,,US-PFIZER INC-2019088083,PFIZER,,60.0,YR,,M,Y,,,20190610.0,,LW,US,US,2019,Q2,Adult
160129552,16012955,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q2,End stage renal disease,,2019,Q2,2,F,2011.0,20190604.0,20190227,20190610,EXP,,US-PFIZER INC-2019088083,PFIZER,,60.0,YR,,M,Y,,,20190610.0,,LW,US,US,2019,Q2,Adult
160173732,16017373,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 DF, QD",12990.0,DF,Y,,,,,30.0,DF,SOLUTION FOR INJECTION,QD,2019,Q2,Dysarthria,,2019,Q2,2,F,20181030.0,20190529.0,20190228,20190605,EXP,IT-MINISAL02-530996,IT-SA-2019SA051624,SANOFI AVENTIS,,74.0,YR,E,M,Y,,,20190605.0,,MD,IT,IT,2019,Q2,Elderly
160173732,16017373,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 DF, QD",12990.0,DF,Y,,,,,30.0,DF,SOLUTION FOR INJECTION,QD,2019,Q2,Facial paralysis,,2019,Q2,2,F,20181030.0,20190529.0,20190228,20190605,EXP,IT-MINISAL02-530996,IT-SA-2019SA051624,SANOFI AVENTIS,,74.0,YR,E,M,Y,,,20190605.0,,MD,IT,IT,2019,Q2,Elderly
160173732,16017373,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 DF, QD",12990.0,DF,Y,,,,,30.0,DF,SOLUTION FOR INJECTION,QD,2019,Q2,Hypoglycaemia,,2019,Q2,2,F,20181030.0,20190529.0,20190228,20190605,EXP,IT-MINISAL02-530996,IT-SA-2019SA051624,SANOFI AVENTIS,,74.0,YR,E,M,Y,,,20190605.0,,MD,IT,IT,2019,Q2,Elderly
160223931,16022393,7,C,lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Abdominal pain,,2019,Q2,1,I,20190225.0,,20190301,20190301,DIR,,,FDA-CTU,,79.0,YR,,M,N,87.1,KG,20190301.0,N,PH,US,US,2019,Q2,Elderly
160223931,16022393,7,C,lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Faeces discoloured,,2019,Q2,1,I,20190225.0,,20190301,20190301,DIR,,,FDA-CTU,,79.0,YR,,M,N,87.1,KG,20190301.0,N,PH,US,US,2019,Q2,Elderly
160223931,16022393,7,C,lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Haematochezia,,2019,Q2,1,I,20190225.0,,20190301,20190301,DIR,,,FDA-CTU,,79.0,YR,,M,N,87.1,KG,20190301.0,N,PH,US,US,2019,Q2,Elderly
160223931,16022393,7,C,lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Haemoglobin decreased,,2019,Q2,1,I,20190225.0,,20190301,20190301,DIR,,,FDA-CTU,,79.0,YR,,M,N,87.1,KG,20190301.0,N,PH,US,US,2019,Q2,Elderly
160223931,16022393,7,C,lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Platelet count decreased,,2019,Q2,1,I,20190225.0,,20190301,20190301,DIR,,,FDA-CTU,,79.0,YR,,M,N,87.1,KG,20190301.0,N,PH,US,US,2019,Q2,Elderly
160244502,16024450,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 U,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Cataract operation,,2019,Q2,2,F,,20190522.0,20190301,20190529,EXP,,CA-SA-2019SA052051,SANOFI AVENTIS,,54.0,YR,A,F,Y,85.0,KG,20190529.0,,CN,CA,CA,2019,Q2,Adult
160244502,16024450,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 U,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Fatigue,,2019,Q2,2,F,,20190522.0,20190301,20190529,EXP,,CA-SA-2019SA052051,SANOFI AVENTIS,,54.0,YR,A,F,Y,85.0,KG,20190529.0,,CN,CA,CA,2019,Q2,Adult
160244502,16024450,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 U,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Inappropriate schedule of product administration,,2019,Q2,2,F,,20190522.0,20190301,20190529,EXP,,CA-SA-2019SA052051,SANOFI AVENTIS,,54.0,YR,A,F,Y,85.0,KG,20190529.0,,CN,CA,CA,2019,Q2,Adult
160244502,16024450,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 U,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Increased appetite,,2019,Q2,2,F,,20190522.0,20190301,20190529,EXP,,CA-SA-2019SA052051,SANOFI AVENTIS,,54.0,YR,A,F,Y,85.0,KG,20190529.0,,CN,CA,CA,2019,Q2,Adult
160244502,16024450,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 U,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Nausea,,2019,Q2,2,F,,20190522.0,20190301,20190529,EXP,,CA-SA-2019SA052051,SANOFI AVENTIS,,54.0,YR,A,F,Y,85.0,KG,20190529.0,,CN,CA,CA,2019,Q2,Adult
160244502,16024450,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 U,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Off label use,,2019,Q2,2,F,,20190522.0,20190301,20190529,EXP,,CA-SA-2019SA052051,SANOFI AVENTIS,,54.0,YR,A,F,Y,85.0,KG,20190529.0,,CN,CA,CA,2019,Q2,Adult
160244502,16024450,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 U,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Pollakiuria,,2019,Q2,2,F,,20190522.0,20190301,20190529,EXP,,CA-SA-2019SA052051,SANOFI AVENTIS,,54.0,YR,A,F,Y,85.0,KG,20190529.0,,CN,CA,CA,2019,Q2,Adult
160244502,16024450,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 U,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Thirst,,2019,Q2,2,F,,20190522.0,20190301,20190529,EXP,,CA-SA-2019SA052051,SANOFI AVENTIS,,54.0,YR,A,F,Y,85.0,KG,20190529.0,,CN,CA,CA,2019,Q2,Adult
160244633,16024463,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, 3X/DAY",,,,,,,,,,INJECTION,TID,2019,Q2,Abdominal discomfort,,2019,Q2,3,F,201003.0,20190506.0,20190301,20190515,EXP,,US-PFIZER INC-2016111934,PFIZER,,73.0,YR,,F,Y,,,20190515.0,,MD,US,US,2019,Q2,Elderly
160244633,16024463,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, 3X/DAY",,,,,,,,,,INJECTION,TID,2019,Q2,Aortic arteriosclerosis,,2019,Q2,3,F,201003.0,20190506.0,20190301,20190515,EXP,,US-PFIZER INC-2016111934,PFIZER,,73.0,YR,,F,Y,,,20190515.0,,MD,US,US,2019,Q2,Elderly
160244633,16024463,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, 3X/DAY",,,,,,,,,,INJECTION,TID,2019,Q2,Aortic valve stenosis,,2019,Q2,3,F,201003.0,20190506.0,20190301,20190515,EXP,,US-PFIZER INC-2016111934,PFIZER,,73.0,YR,,F,Y,,,20190515.0,,MD,US,US,2019,Q2,Elderly
160244633,16024463,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, 3X/DAY",,,,,,,,,,INJECTION,TID,2019,Q2,Arteriosclerosis coronary artery,,2019,Q2,3,F,201003.0,20190506.0,20190301,20190515,EXP,,US-PFIZER INC-2016111934,PFIZER,,73.0,YR,,F,Y,,,20190515.0,,MD,US,US,2019,Q2,Elderly
160244633,16024463,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, 3X/DAY",,,,,,,,,,INJECTION,TID,2019,Q2,Asthenia,,2019,Q2,3,F,201003.0,20190506.0,20190301,20190515,EXP,,US-PFIZER INC-2016111934,PFIZER,,73.0,YR,,F,Y,,,20190515.0,,MD,US,US,2019,Q2,Elderly
160244633,16024463,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, 3X/DAY",,,,,,,,,,INJECTION,TID,2019,Q2,Cataract,,2019,Q2,3,F,201003.0,20190506.0,20190301,20190515,EXP,,US-PFIZER INC-2016111934,PFIZER,,73.0,YR,,F,Y,,,20190515.0,,MD,US,US,2019,Q2,Elderly
160244633,16024463,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, 3X/DAY",,,,,,,,,,INJECTION,TID,2019,Q2,Constipation,,2019,Q2,3,F,201003.0,20190506.0,20190301,20190515,EXP,,US-PFIZER INC-2016111934,PFIZER,,73.0,YR,,F,Y,,,20190515.0,,MD,US,US,2019,Q2,Elderly
160244633,16024463,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, 3X/DAY",,,,,,,,,,INJECTION,TID,2019,Q2,Decreased appetite,,2019,Q2,3,F,201003.0,20190506.0,20190301,20190515,EXP,,US-PFIZER INC-2016111934,PFIZER,,73.0,YR,,F,Y,,,20190515.0,,MD,US,US,2019,Q2,Elderly
160244633,16024463,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, 3X/DAY",,,,,,,,,,INJECTION,TID,2019,Q2,Diarrhoea,,2019,Q2,3,F,201003.0,20190506.0,20190301,20190515,EXP,,US-PFIZER INC-2016111934,PFIZER,,73.0,YR,,F,Y,,,20190515.0,,MD,US,US,2019,Q2,Elderly
160244633,16024463,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, 3X/DAY",,,,,,,,,,INJECTION,TID,2019,Q2,Drug withdrawal syndrome,,2019,Q2,3,F,201003.0,20190506.0,20190301,20190515,EXP,,US-PFIZER INC-2016111934,PFIZER,,73.0,YR,,F,Y,,,20190515.0,,MD,US,US,2019,Q2,Elderly
160244633,16024463,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, 3X/DAY",,,,,,,,,,INJECTION,TID,2019,Q2,Essential hypertension,,2019,Q2,3,F,201003.0,20190506.0,20190301,20190515,EXP,,US-PFIZER INC-2016111934,PFIZER,,73.0,YR,,F,Y,,,20190515.0,,MD,US,US,2019,Q2,Elderly
160244633,16024463,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, 3X/DAY",,,,,,,,,,INJECTION,TID,2019,Q2,Fatigue,,2019,Q2,3,F,201003.0,20190506.0,20190301,20190515,EXP,,US-PFIZER INC-2016111934,PFIZER,,73.0,YR,,F,Y,,,20190515.0,,MD,US,US,2019,Q2,Elderly
160244633,16024463,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, 3X/DAY",,,,,,,,,,INJECTION,TID,2019,Q2,Hepatic steatosis,,2019,Q2,3,F,201003.0,20190506.0,20190301,20190515,EXP,,US-PFIZER INC-2016111934,PFIZER,,73.0,YR,,F,Y,,,20190515.0,,MD,US,US,2019,Q2,Elderly
160244633,16024463,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, 3X/DAY",,,,,,,,,,INJECTION,TID,2019,Q2,Lethargy,,2019,Q2,3,F,201003.0,20190506.0,20190301,20190515,EXP,,US-PFIZER INC-2016111934,PFIZER,,73.0,YR,,F,Y,,,20190515.0,,MD,US,US,2019,Q2,Elderly
160244633,16024463,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, 3X/DAY",,,,,,,,,,INJECTION,TID,2019,Q2,Malaise,,2019,Q2,3,F,201003.0,20190506.0,20190301,20190515,EXP,,US-PFIZER INC-2016111934,PFIZER,,73.0,YR,,F,Y,,,20190515.0,,MD,US,US,2019,Q2,Elderly
160244633,16024463,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, 3X/DAY",,,,,,,,,,INJECTION,TID,2019,Q2,Mitral valve incompetence,,2019,Q2,3,F,201003.0,20190506.0,20190301,20190515,EXP,,US-PFIZER INC-2016111934,PFIZER,,73.0,YR,,F,Y,,,20190515.0,,MD,US,US,2019,Q2,Elderly
160244633,16024463,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, 3X/DAY",,,,,,,,,,INJECTION,TID,2019,Q2,Musculoskeletal discomfort,,2019,Q2,3,F,201003.0,20190506.0,20190301,20190515,EXP,,US-PFIZER INC-2016111934,PFIZER,,73.0,YR,,F,Y,,,20190515.0,,MD,US,US,2019,Q2,Elderly
160244633,16024463,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, 3X/DAY",,,,,,,,,,INJECTION,TID,2019,Q2,Nausea,,2019,Q2,3,F,201003.0,20190506.0,20190301,20190515,EXP,,US-PFIZER INC-2016111934,PFIZER,,73.0,YR,,F,Y,,,20190515.0,,MD,US,US,2019,Q2,Elderly
160244633,16024463,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, 3X/DAY",,,,,,,,,,INJECTION,TID,2019,Q2,Neurogenic bladder,,2019,Q2,3,F,201003.0,20190506.0,20190301,20190515,EXP,,US-PFIZER INC-2016111934,PFIZER,,73.0,YR,,F,Y,,,20190515.0,,MD,US,US,2019,Q2,Elderly
160244633,16024463,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, 3X/DAY",,,,,,,,,,INJECTION,TID,2019,Q2,Palpitations,,2019,Q2,3,F,201003.0,20190506.0,20190301,20190515,EXP,,US-PFIZER INC-2016111934,PFIZER,,73.0,YR,,F,Y,,,20190515.0,,MD,US,US,2019,Q2,Elderly
160244633,16024463,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, 3X/DAY",,,,,,,,,,INJECTION,TID,2019,Q2,Radiculopathy,,2019,Q2,3,F,201003.0,20190506.0,20190301,20190515,EXP,,US-PFIZER INC-2016111934,PFIZER,,73.0,YR,,F,Y,,,20190515.0,,MD,US,US,2019,Q2,Elderly
160244633,16024463,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, 3X/DAY",,,,,,,,,,INJECTION,TID,2019,Q2,Rhinitis,,2019,Q2,3,F,201003.0,20190506.0,20190301,20190515,EXP,,US-PFIZER INC-2016111934,PFIZER,,73.0,YR,,F,Y,,,20190515.0,,MD,US,US,2019,Q2,Elderly
160244633,16024463,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, 3X/DAY",,,,,,,,,,INJECTION,TID,2019,Q2,Somnolence,,2019,Q2,3,F,201003.0,20190506.0,20190301,20190515,EXP,,US-PFIZER INC-2016111934,PFIZER,,73.0,YR,,F,Y,,,20190515.0,,MD,US,US,2019,Q2,Elderly
160244633,16024463,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, 3X/DAY",,,,,,,,,,INJECTION,TID,2019,Q2,Supraventricular tachycardia,,2019,Q2,3,F,201003.0,20190506.0,20190301,20190515,EXP,,US-PFIZER INC-2016111934,PFIZER,,73.0,YR,,F,Y,,,20190515.0,,MD,US,US,2019,Q2,Elderly
160244633,16024463,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, 3X/DAY",,,,,,,,,,INJECTION,TID,2019,Q2,Transaminases increased,,2019,Q2,3,F,201003.0,20190506.0,20190301,20190515,EXP,,US-PFIZER INC-2016111934,PFIZER,,73.0,YR,,F,Y,,,20190515.0,,MD,US,US,2019,Q2,Elderly
160244633,16024463,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, 3X/DAY",,,,,,,,,,INJECTION,TID,2019,Q2,Umbilical hernia,,2019,Q2,3,F,201003.0,20190506.0,20190301,20190515,EXP,,US-PFIZER INC-2016111934,PFIZER,,73.0,YR,,F,Y,,,20190515.0,,MD,US,US,2019,Q2,Elderly
160244633,16024463,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, 3X/DAY",,,,,,,,,,INJECTION,TID,2019,Q2,Weight decreased,,2019,Q2,3,F,201003.0,20190506.0,20190301,20190515,EXP,,US-PFIZER INC-2016111934,PFIZER,,73.0,YR,,F,Y,,,20190515.0,,MD,US,US,2019,Q2,Elderly
160403682,16040368,2,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Diabetic ketoacidosis,,2019,Q2,2,F,20181118.0,20190329.0,20190306,20190405,EXP,,"SE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-009165",BOEHRINGER INGELHEIM,,63.0,YR,,F,Y,68.7,KG,20190405.0,,OT,SE,SE,2019,Q2,Adult
160430402,16043040,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 U, TID,10 UNITS TDS WITH MEALS",,,U,,,,,,,SOLUTION FOR INJECTION,Q8H,2019,Q2,Body mass index increased,,2019,Q2,2,F,,20190509.0,20190306,20190514,EXP,,AU-SA-2019SA055178,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20190514.0,,MD,AU,AU,2019,Q2,Elderly
160430402,16043040,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 U, TID,10 UNITS TDS WITH MEALS",,,U,,,,,,,SOLUTION FOR INJECTION,Q8H,2019,Q2,Fluid retention,,2019,Q2,2,F,,20190509.0,20190306,20190514,EXP,,AU-SA-2019SA055178,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20190514.0,,MD,AU,AU,2019,Q2,Elderly
160430402,16043040,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 U, TID,10 UNITS TDS WITH MEALS",,,U,,,,,,,SOLUTION FOR INJECTION,Q8H,2019,Q2,Glycosylated haemoglobin increased,,2019,Q2,2,F,,20190509.0,20190306,20190514,EXP,,AU-SA-2019SA055178,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20190514.0,,MD,AU,AU,2019,Q2,Elderly
160430402,16043040,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 U, TID,10 UNITS TDS WITH MEALS",,,U,,,,,,,SOLUTION FOR INJECTION,Q8H,2019,Q2,Hypoglycaemia,,2019,Q2,2,F,,20190509.0,20190306,20190514,EXP,,AU-SA-2019SA055178,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20190514.0,,MD,AU,AU,2019,Q2,Elderly
160430402,16043040,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 U, TID,10 UNITS TDS WITH MEALS",,,U,,,,,,,SOLUTION FOR INJECTION,Q8H,2019,Q2,Insulinoma,,2019,Q2,2,F,,20190509.0,20190306,20190514,EXP,,AU-SA-2019SA055178,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20190514.0,,MD,AU,AU,2019,Q2,Elderly
160430402,16043040,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 U, TID,10 UNITS TDS WITH MEALS",,,U,,,,,,,SOLUTION FOR INJECTION,Q8H,2019,Q2,Weight decreased,,2019,Q2,2,F,,20190509.0,20190306,20190514,EXP,,AU-SA-2019SA055178,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20190514.0,,MD,AU,AU,2019,Q2,Elderly
160471332,16047133,21,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,0-20 UNITS; TID,,,,,,,,,,INJECTION,BID,2019,Q2,Fatigue,,2019,Q2,2,F,20190131.0,20190325.0,20190307,20190402,EXP,,US-BAXTER-2019BAX004433,BAXTER,,71.0,YR,,F,Y,74.0,KG,20190402.0,,MD,US,US,2019,Q2,Elderly
160471332,16047133,21,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,0-20 UNITS; TID,,,,,,,,,,INJECTION,BID,2019,Q2,Subdural haematoma,,2019,Q2,2,F,20190131.0,20190325.0,20190307,20190402,EXP,,US-BAXTER-2019BAX004433,BAXTER,,71.0,YR,,F,Y,74.0,KG,20190402.0,,MD,US,US,2019,Q2,Elderly
160486626,16048662,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"6 UNITS IN THE MORNING, 7 UNITS AT NOON, AND 14 UNITS AT SUPPERTIME",,,U,,,,,,,SOLUTION FOR INJECTION,Q8H,2019,Q2,Blood glucose decreased,,2019,Q2,6,F,,20190613.0,20190307,20190625,PER,,US-SA-2019SA062514,SANOFI AVENTIS,,88.0,YR,E,F,Y,,,20190625.0,,CN,US,US,2019,Q2,Elderly
160486626,16048662,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"6 UNITS IN THE MORNING, 7 UNITS AT NOON, AND 14 UNITS AT SUPPERTIME",,,U,,,,,,,SOLUTION FOR INJECTION,Q8H,2019,Q2,Device operational issue,,2019,Q2,6,F,,20190613.0,20190307,20190625,PER,,US-SA-2019SA062514,SANOFI AVENTIS,,88.0,YR,E,F,Y,,,20190625.0,,CN,US,US,2019,Q2,Elderly
160486626,16048662,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"6 UNITS IN THE MORNING, 7 UNITS AT NOON, AND 14 UNITS AT SUPPERTIME",,,U,,,,,,,SOLUTION FOR INJECTION,Q8H,2019,Q2,Fatigue,,2019,Q2,6,F,,20190613.0,20190307,20190625,PER,,US-SA-2019SA062514,SANOFI AVENTIS,,88.0,YR,E,F,Y,,,20190625.0,,CN,US,US,2019,Q2,Elderly
160524972,16052497,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,TID (TOTAL DOSE OF INSULIN: 66 U),,,U,,,,,,,SOLUTION FOR INJECTION,Q8H,2019,Q2,Blood glucose increased,,2019,Q2,2,F,200508.0,20190412.0,20190308,20190418,EXP,,JP-SA-2019SA060699,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20190418.0,,MD,JP,JP,2019,Q2,Adult
160524972,16052497,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,TID (TOTAL DOSE OF INSULIN: 66 U),,,U,,,,,,,SOLUTION FOR INJECTION,Q8H,2019,Q2,Cutaneous amyloidosis,,2019,Q2,2,F,200508.0,20190412.0,20190308,20190418,EXP,,JP-SA-2019SA060699,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20190418.0,,MD,JP,JP,2019,Q2,Adult
160524972,16052497,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,TID (TOTAL DOSE OF INSULIN: 66 U),,,U,,,,,,,SOLUTION FOR INJECTION,Q8H,2019,Q2,Diabetes mellitus inadequate control,,2019,Q2,2,F,200508.0,20190412.0,20190308,20190418,EXP,,JP-SA-2019SA060699,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20190418.0,,MD,JP,JP,2019,Q2,Adult
160524972,16052497,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,TID (TOTAL DOSE OF INSULIN: 66 U),,,U,,,,,,,SOLUTION FOR INJECTION,Q8H,2019,Q2,Glycosylated haemoglobin increased,,2019,Q2,2,F,200508.0,20190412.0,20190308,20190418,EXP,,JP-SA-2019SA060699,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20190418.0,,MD,JP,JP,2019,Q2,Adult
160524972,16052497,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,TID (TOTAL DOSE OF INSULIN: 66 U),,,U,,,,,,,SOLUTION FOR INJECTION,Q8H,2019,Q2,Hypoglycaemia,,2019,Q2,2,F,200508.0,20190412.0,20190308,20190418,EXP,,JP-SA-2019SA060699,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20190418.0,,MD,JP,JP,2019,Q2,Adult
160524972,16052497,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,TID (TOTAL DOSE OF INSULIN: 66 U),,,U,,,,,,,SOLUTION FOR INJECTION,Q8H,2019,Q2,Injection site induration,,2019,Q2,2,F,200508.0,20190412.0,20190308,20190418,EXP,,JP-SA-2019SA060699,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20190418.0,,MD,JP,JP,2019,Q2,Adult
160524972,16052497,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,TID (TOTAL DOSE OF INSULIN: 66 U),,,U,,,,,,,SOLUTION FOR INJECTION,Q8H,2019,Q2,Insulin resistance,,2019,Q2,2,F,200508.0,20190412.0,20190308,20190418,EXP,,JP-SA-2019SA060699,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20190418.0,,MD,JP,JP,2019,Q2,Adult
160524972,16052497,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,TOTAL DOSE OF INSULIN: 94 U,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Blood glucose increased,,2019,Q2,2,F,200508.0,20190412.0,20190308,20190418,EXP,,JP-SA-2019SA060699,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20190418.0,,MD,JP,JP,2019,Q2,Adult
160524972,16052497,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,TOTAL DOSE OF INSULIN: 94 U,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Cutaneous amyloidosis,,2019,Q2,2,F,200508.0,20190412.0,20190308,20190418,EXP,,JP-SA-2019SA060699,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20190418.0,,MD,JP,JP,2019,Q2,Adult
160524972,16052497,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,TOTAL DOSE OF INSULIN: 94 U,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Diabetes mellitus inadequate control,,2019,Q2,2,F,200508.0,20190412.0,20190308,20190418,EXP,,JP-SA-2019SA060699,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20190418.0,,MD,JP,JP,2019,Q2,Adult
160524972,16052497,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,TOTAL DOSE OF INSULIN: 94 U,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Glycosylated haemoglobin increased,,2019,Q2,2,F,200508.0,20190412.0,20190308,20190418,EXP,,JP-SA-2019SA060699,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20190418.0,,MD,JP,JP,2019,Q2,Adult
160524972,16052497,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,TOTAL DOSE OF INSULIN: 94 U,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Hypoglycaemia,,2019,Q2,2,F,200508.0,20190412.0,20190308,20190418,EXP,,JP-SA-2019SA060699,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20190418.0,,MD,JP,JP,2019,Q2,Adult
160524972,16052497,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,TOTAL DOSE OF INSULIN: 94 U,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Injection site induration,,2019,Q2,2,F,200508.0,20190412.0,20190308,20190418,EXP,,JP-SA-2019SA060699,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20190418.0,,MD,JP,JP,2019,Q2,Adult
160524972,16052497,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,TOTAL DOSE OF INSULIN: 94 U,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Insulin resistance,,2019,Q2,2,F,200508.0,20190412.0,20190308,20190418,EXP,,JP-SA-2019SA060699,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20190418.0,,MD,JP,JP,2019,Q2,Adult
160524972,16052497,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"94 U, QD",,,U,,,,,,,SOLUTION FOR INJECTION,QD,2019,Q2,Blood glucose increased,,2019,Q2,2,F,200508.0,20190412.0,20190308,20190418,EXP,,JP-SA-2019SA060699,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20190418.0,,MD,JP,JP,2019,Q2,Adult
160524972,16052497,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"94 U, QD",,,U,,,,,,,SOLUTION FOR INJECTION,QD,2019,Q2,Cutaneous amyloidosis,,2019,Q2,2,F,200508.0,20190412.0,20190308,20190418,EXP,,JP-SA-2019SA060699,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20190418.0,,MD,JP,JP,2019,Q2,Adult
160524972,16052497,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"94 U, QD",,,U,,,,,,,SOLUTION FOR INJECTION,QD,2019,Q2,Diabetes mellitus inadequate control,,2019,Q2,2,F,200508.0,20190412.0,20190308,20190418,EXP,,JP-SA-2019SA060699,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20190418.0,,MD,JP,JP,2019,Q2,Adult
160524972,16052497,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"94 U, QD",,,U,,,,,,,SOLUTION FOR INJECTION,QD,2019,Q2,Glycosylated haemoglobin increased,,2019,Q2,2,F,200508.0,20190412.0,20190308,20190418,EXP,,JP-SA-2019SA060699,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20190418.0,,MD,JP,JP,2019,Q2,Adult
160524972,16052497,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"94 U, QD",,,U,,,,,,,SOLUTION FOR INJECTION,QD,2019,Q2,Hypoglycaemia,,2019,Q2,2,F,200508.0,20190412.0,20190308,20190418,EXP,,JP-SA-2019SA060699,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20190418.0,,MD,JP,JP,2019,Q2,Adult
160524972,16052497,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"94 U, QD",,,U,,,,,,,SOLUTION FOR INJECTION,QD,2019,Q2,Injection site induration,,2019,Q2,2,F,200508.0,20190412.0,20190308,20190418,EXP,,JP-SA-2019SA060699,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20190418.0,,MD,JP,JP,2019,Q2,Adult
160524972,16052497,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"94 U, QD",,,U,,,,,,,SOLUTION FOR INJECTION,QD,2019,Q2,Insulin resistance,,2019,Q2,2,F,200508.0,20190412.0,20190308,20190418,EXP,,JP-SA-2019SA060699,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20190418.0,,MD,JP,JP,2019,Q2,Adult
160524972,16052497,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"18 U, QD",,,U,,,,,,,SOLUTION FOR INJECTION,QD,2019,Q2,Blood glucose increased,,2019,Q2,2,F,200508.0,20190412.0,20190308,20190418,EXP,,JP-SA-2019SA060699,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20190418.0,,MD,JP,JP,2019,Q2,Adult
160524972,16052497,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"18 U, QD",,,U,,,,,,,SOLUTION FOR INJECTION,QD,2019,Q2,Cutaneous amyloidosis,,2019,Q2,2,F,200508.0,20190412.0,20190308,20190418,EXP,,JP-SA-2019SA060699,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20190418.0,,MD,JP,JP,2019,Q2,Adult
160524972,16052497,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"18 U, QD",,,U,,,,,,,SOLUTION FOR INJECTION,QD,2019,Q2,Diabetes mellitus inadequate control,,2019,Q2,2,F,200508.0,20190412.0,20190308,20190418,EXP,,JP-SA-2019SA060699,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20190418.0,,MD,JP,JP,2019,Q2,Adult
160524972,16052497,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"18 U, QD",,,U,,,,,,,SOLUTION FOR INJECTION,QD,2019,Q2,Glycosylated haemoglobin increased,,2019,Q2,2,F,200508.0,20190412.0,20190308,20190418,EXP,,JP-SA-2019SA060699,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20190418.0,,MD,JP,JP,2019,Q2,Adult
160524972,16052497,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"18 U, QD",,,U,,,,,,,SOLUTION FOR INJECTION,QD,2019,Q2,Hypoglycaemia,,2019,Q2,2,F,200508.0,20190412.0,20190308,20190418,EXP,,JP-SA-2019SA060699,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20190418.0,,MD,JP,JP,2019,Q2,Adult
160524972,16052497,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"18 U, QD",,,U,,,,,,,SOLUTION FOR INJECTION,QD,2019,Q2,Injection site induration,,2019,Q2,2,F,200508.0,20190412.0,20190308,20190418,EXP,,JP-SA-2019SA060699,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20190418.0,,MD,JP,JP,2019,Q2,Adult
160524972,16052497,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"18 U, QD",,,U,,,,,,,SOLUTION FOR INJECTION,QD,2019,Q2,Insulin resistance,,2019,Q2,2,F,200508.0,20190412.0,20190308,20190418,EXP,,JP-SA-2019SA060699,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20190418.0,,MD,JP,JP,2019,Q2,Adult
160524972,16052497,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,TOTAL DOSE OF INSULIN: 66 U,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Blood glucose increased,,2019,Q2,2,F,200508.0,20190412.0,20190308,20190418,EXP,,JP-SA-2019SA060699,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20190418.0,,MD,JP,JP,2019,Q2,Adult
160524972,16052497,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,TOTAL DOSE OF INSULIN: 66 U,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Cutaneous amyloidosis,,2019,Q2,2,F,200508.0,20190412.0,20190308,20190418,EXP,,JP-SA-2019SA060699,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20190418.0,,MD,JP,JP,2019,Q2,Adult
160524972,16052497,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,TOTAL DOSE OF INSULIN: 66 U,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Diabetes mellitus inadequate control,,2019,Q2,2,F,200508.0,20190412.0,20190308,20190418,EXP,,JP-SA-2019SA060699,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20190418.0,,MD,JP,JP,2019,Q2,Adult
160524972,16052497,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,TOTAL DOSE OF INSULIN: 66 U,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Glycosylated haemoglobin increased,,2019,Q2,2,F,200508.0,20190412.0,20190308,20190418,EXP,,JP-SA-2019SA060699,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20190418.0,,MD,JP,JP,2019,Q2,Adult
160524972,16052497,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,TOTAL DOSE OF INSULIN: 66 U,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Hypoglycaemia,,2019,Q2,2,F,200508.0,20190412.0,20190308,20190418,EXP,,JP-SA-2019SA060699,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20190418.0,,MD,JP,JP,2019,Q2,Adult
160524972,16052497,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,TOTAL DOSE OF INSULIN: 66 U,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Injection site induration,,2019,Q2,2,F,200508.0,20190412.0,20190308,20190418,EXP,,JP-SA-2019SA060699,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20190418.0,,MD,JP,JP,2019,Q2,Adult
160524972,16052497,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,TOTAL DOSE OF INSULIN: 66 U,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Insulin resistance,,2019,Q2,2,F,200508.0,20190412.0,20190308,20190418,EXP,,JP-SA-2019SA060699,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20190418.0,,MD,JP,JP,2019,Q2,Adult
160654472,16065447,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q2,Abdominal distension,,2019,Q2,2,F,201708.0,20190410.0,20190313,20190415,EXP,,US-SA-2019SA066355,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20190415.0,,OT,US,US,2019,Q2,Young Adult
160654472,16065447,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q2,Abdominal pain,,2019,Q2,2,F,201708.0,20190410.0,20190313,20190415,EXP,,US-SA-2019SA066355,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20190415.0,,OT,US,US,2019,Q2,Young Adult
160654472,16065447,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q2,Ascites,,2019,Q2,2,F,201708.0,20190410.0,20190313,20190415,EXP,,US-SA-2019SA066355,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20190415.0,,OT,US,US,2019,Q2,Young Adult
160654472,16065447,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q2,Back pain,,2019,Q2,2,F,201708.0,20190410.0,20190313,20190415,EXP,,US-SA-2019SA066355,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20190415.0,,OT,US,US,2019,Q2,Young Adult
160654472,16065447,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q2,Blood pressure systolic decreased,,2019,Q2,2,F,201708.0,20190410.0,20190313,20190415,EXP,,US-SA-2019SA066355,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20190415.0,,OT,US,US,2019,Q2,Young Adult
160654472,16065447,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q2,Cough,,2019,Q2,2,F,201708.0,20190410.0,20190313,20190415,EXP,,US-SA-2019SA066355,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20190415.0,,OT,US,US,2019,Q2,Young Adult
160654472,16065447,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q2,Cytogenetic abnormality,,2019,Q2,2,F,201708.0,20190410.0,20190313,20190415,EXP,,US-SA-2019SA066355,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20190415.0,,OT,US,US,2019,Q2,Young Adult
160654472,16065447,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q2,Cytomegalovirus viraemia,,2019,Q2,2,F,201708.0,20190410.0,20190313,20190415,EXP,,US-SA-2019SA066355,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20190415.0,,OT,US,US,2019,Q2,Young Adult
160654472,16065447,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q2,Decreased appetite,,2019,Q2,2,F,201708.0,20190410.0,20190313,20190415,EXP,,US-SA-2019SA066355,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20190415.0,,OT,US,US,2019,Q2,Young Adult
160654472,16065447,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q2,Diarrhoea,,2019,Q2,2,F,201708.0,20190410.0,20190313,20190415,EXP,,US-SA-2019SA066355,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20190415.0,,OT,US,US,2019,Q2,Young Adult
160654472,16065447,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q2,Dyspepsia,,2019,Q2,2,F,201708.0,20190410.0,20190313,20190415,EXP,,US-SA-2019SA066355,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20190415.0,,OT,US,US,2019,Q2,Young Adult
160654472,16065447,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q2,Dyspnoea,,2019,Q2,2,F,201708.0,20190410.0,20190313,20190415,EXP,,US-SA-2019SA066355,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20190415.0,,OT,US,US,2019,Q2,Young Adult
160654472,16065447,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q2,Gastritis,,2019,Q2,2,F,201708.0,20190410.0,20190313,20190415,EXP,,US-SA-2019SA066355,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20190415.0,,OT,US,US,2019,Q2,Young Adult
160654472,16065447,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q2,Hypotension,,2019,Q2,2,F,201708.0,20190410.0,20190313,20190415,EXP,,US-SA-2019SA066355,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20190415.0,,OT,US,US,2019,Q2,Young Adult
160654472,16065447,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q2,Hypoxia,,2019,Q2,2,F,201708.0,20190410.0,20190313,20190415,EXP,,US-SA-2019SA066355,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20190415.0,,OT,US,US,2019,Q2,Young Adult
160654472,16065447,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q2,Lung consolidation,,2019,Q2,2,F,201708.0,20190410.0,20190313,20190415,EXP,,US-SA-2019SA066355,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20190415.0,,OT,US,US,2019,Q2,Young Adult
160654472,16065447,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q2,Malnutrition,,2019,Q2,2,F,201708.0,20190410.0,20190313,20190415,EXP,,US-SA-2019SA066355,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20190415.0,,OT,US,US,2019,Q2,Young Adult
160654472,16065447,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q2,Metastatic gastric cancer,,2019,Q2,2,F,201708.0,20190410.0,20190313,20190415,EXP,,US-SA-2019SA066355,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20190415.0,,OT,US,US,2019,Q2,Young Adult
160654472,16065447,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q2,Pneumonia,,2019,Q2,2,F,201708.0,20190410.0,20190313,20190415,EXP,,US-SA-2019SA066355,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20190415.0,,OT,US,US,2019,Q2,Young Adult
160654472,16065447,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q2,Product use in unapproved indication,,2019,Q2,2,F,201708.0,20190410.0,20190313,20190415,EXP,,US-SA-2019SA066355,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20190415.0,,OT,US,US,2019,Q2,Young Adult
160654472,16065447,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q2,Pulmonary embolism,,2019,Q2,2,F,201708.0,20190410.0,20190313,20190415,EXP,,US-SA-2019SA066355,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20190415.0,,OT,US,US,2019,Q2,Young Adult
160654472,16065447,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q2,Tachycardia,,2019,Q2,2,F,201708.0,20190410.0,20190313,20190415,EXP,,US-SA-2019SA066355,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20190415.0,,OT,US,US,2019,Q2,Young Adult
160660623,16066062,7,SS,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Drug abuse,,2019,Q2,3,F,20180927.0,20190322.0,20190313,20190403,EXP,IT-MINISAL02-502630,IT-ACCORD-112523,ACCORD,,82.0,YR,,F,Y,,,20190403.0,,PH,IT,IT,2019,Q2,Elderly
160660623,16066062,7,SS,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Hypertension,,2019,Q2,3,F,20180927.0,20190322.0,20190313,20190403,EXP,IT-MINISAL02-502630,IT-ACCORD-112523,ACCORD,,82.0,YR,,F,Y,,,20190403.0,,PH,IT,IT,2019,Q2,Elderly
160660623,16066062,7,SS,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Hypoglycaemia,,2019,Q2,3,F,20180927.0,20190322.0,20190313,20190403,EXP,IT-MINISAL02-502630,IT-ACCORD-112523,ACCORD,,82.0,YR,,F,Y,,,20190403.0,,PH,IT,IT,2019,Q2,Elderly
160660623,16066062,7,SS,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Overdose,,2019,Q2,3,F,20180927.0,20190322.0,20190313,20190403,EXP,IT-MINISAL02-502630,IT-ACCORD-112523,ACCORD,,82.0,YR,,F,Y,,,20190403.0,,PH,IT,IT,2019,Q2,Elderly
160694133,16069413,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,N,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Blood glucose increased,,2019,Q2,3,F,,20190515.0,20190313,20190527,PER,,US-SA-2019SA068715,SANOFI AVENTIS,,61.0,YR,A,F,Y,,,20190528.0,,CN,US,US,2019,Q2,Adult
160694133,16069413,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,N,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Drug ineffective,,2019,Q2,3,F,,20190515.0,20190313,20190527,PER,,US-SA-2019SA068715,SANOFI AVENTIS,,61.0,YR,A,F,Y,,,20190528.0,,CN,US,US,2019,Q2,Adult
160694133,16069413,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,N,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Fatigue,,2019,Q2,3,F,,20190515.0,20190313,20190527,PER,,US-SA-2019SA068715,SANOFI AVENTIS,,61.0,YR,A,F,Y,,,20190528.0,,CN,US,US,2019,Q2,Adult
160694133,16069413,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,N,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Headache,,2019,Q2,3,F,,20190515.0,20190313,20190527,PER,,US-SA-2019SA068715,SANOFI AVENTIS,,61.0,YR,A,F,Y,,,20190528.0,,CN,US,US,2019,Q2,Adult
160694133,16069413,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,N,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Malaise,,2019,Q2,3,F,,20190515.0,20190313,20190527,PER,,US-SA-2019SA068715,SANOFI AVENTIS,,61.0,YR,A,F,Y,,,20190528.0,,CN,US,US,2019,Q2,Adult
160694133,16069413,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,N,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Nausea,,2019,Q2,3,F,,20190515.0,20190313,20190527,PER,,US-SA-2019SA068715,SANOFI AVENTIS,,61.0,YR,A,F,Y,,,20190528.0,,CN,US,US,2019,Q2,Adult
160694133,16069413,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,N,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Nightmare,,2019,Q2,3,F,,20190515.0,20190313,20190527,PER,,US-SA-2019SA068715,SANOFI AVENTIS,,61.0,YR,A,F,Y,,,20190528.0,,CN,US,US,2019,Q2,Adult
160694133,16069413,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,N,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Suicidal ideation,,2019,Q2,3,F,,20190515.0,20190313,20190527,PER,,US-SA-2019SA068715,SANOFI AVENTIS,,61.0,YR,A,F,Y,,,20190528.0,,CN,US,US,2019,Q2,Adult
160694133,16069413,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,N,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Thirst,,2019,Q2,3,F,,20190515.0,20190313,20190527,PER,,US-SA-2019SA068715,SANOFI AVENTIS,,61.0,YR,A,F,Y,,,20190528.0,,CN,US,US,2019,Q2,Adult
160715875,16071587,15,C,INSULIN LISPRO HUMAN,,2,,,,,,,,,,,,,,2019,Q2,Hepatic encephalopathy,,2019,Q2,5,F,20181204.0,20190424.0,20190314,20190425,PER,,US-EISAI MEDICAL RESEARCH-EC-2018-048932,EISAI,,68.0,YR,,M,Y,124.6,KG,20190425.0,,MD,US,US,2019,Q2,Elderly
160715875,16071587,15,C,INSULIN LISPRO HUMAN,,2,,,,,,,,,,,,,,2019,Q2,Pulmonary embolism,,2019,Q2,5,F,20181204.0,20190424.0,20190314,20190425,PER,,US-EISAI MEDICAL RESEARCH-EC-2018-048932,EISAI,,68.0,YR,,M,Y,124.6,KG,20190425.0,,MD,US,US,2019,Q2,Elderly
160784522,16078452,8,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNKNOWN,,,U,,,,,,,,,2019,Q2,Apparent death,,2019,Q2,2,F,2010.0,20190326.0,20190315,20190403,EXP,,BR-SA-2019SA070163,SANOFI AVENTIS,,62.0,YR,A,M,Y,80.0,KG,20190403.0,,CN,BR,BR,2019,Q2,Adult
160784522,16078452,8,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNKNOWN,,,U,,,,,,,,,2019,Q2,Benign prostatic hyperplasia,,2019,Q2,2,F,2010.0,20190326.0,20190315,20190403,EXP,,BR-SA-2019SA070163,SANOFI AVENTIS,,62.0,YR,A,M,Y,80.0,KG,20190403.0,,CN,BR,BR,2019,Q2,Adult
160784522,16078452,8,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNKNOWN,,,U,,,,,,,,,2019,Q2,Blood glucose increased,,2019,Q2,2,F,2010.0,20190326.0,20190315,20190403,EXP,,BR-SA-2019SA070163,SANOFI AVENTIS,,62.0,YR,A,M,Y,80.0,KG,20190403.0,,CN,BR,BR,2019,Q2,Adult
160784522,16078452,8,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNKNOWN,,,U,,,,,,,,,2019,Q2,Diabetes mellitus inadequate control,,2019,Q2,2,F,2010.0,20190326.0,20190315,20190403,EXP,,BR-SA-2019SA070163,SANOFI AVENTIS,,62.0,YR,A,M,Y,80.0,KG,20190403.0,,CN,BR,BR,2019,Q2,Adult
160784522,16078452,8,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNKNOWN,,,U,,,,,,,,,2019,Q2,Fall,,2019,Q2,2,F,2010.0,20190326.0,20190315,20190403,EXP,,BR-SA-2019SA070163,SANOFI AVENTIS,,62.0,YR,A,M,Y,80.0,KG,20190403.0,,CN,BR,BR,2019,Q2,Adult
160784522,16078452,8,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNKNOWN,,,U,,,,,,,,,2019,Q2,Head injury,,2019,Q2,2,F,2010.0,20190326.0,20190315,20190403,EXP,,BR-SA-2019SA070163,SANOFI AVENTIS,,62.0,YR,A,M,Y,80.0,KG,20190403.0,,CN,BR,BR,2019,Q2,Adult
160784522,16078452,8,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNKNOWN,,,U,,,,,,,,,2019,Q2,Inappropriate schedule of product administration,,2019,Q2,2,F,2010.0,20190326.0,20190315,20190403,EXP,,BR-SA-2019SA070163,SANOFI AVENTIS,,62.0,YR,A,M,Y,80.0,KG,20190403.0,,CN,BR,BR,2019,Q2,Adult
160784522,16078452,8,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNKNOWN,,,U,,,,,,,,,2019,Q2,Injury,,2019,Q2,2,F,2010.0,20190326.0,20190315,20190403,EXP,,BR-SA-2019SA070163,SANOFI AVENTIS,,62.0,YR,A,M,Y,80.0,KG,20190403.0,,CN,BR,BR,2019,Q2,Adult
160784522,16078452,8,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNKNOWN,,,U,,,,,,,,,2019,Q2,Lower limb fracture,,2019,Q2,2,F,2010.0,20190326.0,20190315,20190403,EXP,,BR-SA-2019SA070163,SANOFI AVENTIS,,62.0,YR,A,M,Y,80.0,KG,20190403.0,,CN,BR,BR,2019,Q2,Adult
160784522,16078452,8,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNKNOWN,,,U,,,,,,,,,2019,Q2,Memory impairment,,2019,Q2,2,F,2010.0,20190326.0,20190315,20190403,EXP,,BR-SA-2019SA070163,SANOFI AVENTIS,,62.0,YR,A,M,Y,80.0,KG,20190403.0,,CN,BR,BR,2019,Q2,Adult
160784522,16078452,8,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNKNOWN,,,U,,,,,,,,,2019,Q2,Prostatic operation,,2019,Q2,2,F,2010.0,20190326.0,20190315,20190403,EXP,,BR-SA-2019SA070163,SANOFI AVENTIS,,62.0,YR,A,M,Y,80.0,KG,20190403.0,,CN,BR,BR,2019,Q2,Adult
160784522,16078452,8,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNKNOWN,,,U,,,,,,,,,2019,Q2,Rib fracture,,2019,Q2,2,F,2010.0,20190326.0,20190315,20190403,EXP,,BR-SA-2019SA070163,SANOFI AVENTIS,,62.0,YR,A,M,Y,80.0,KG,20190403.0,,CN,BR,BR,2019,Q2,Adult
160784522,16078452,8,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNKNOWN,,,U,,,,,,,,,2019,Q2,Swelling face,,2019,Q2,2,F,2010.0,20190326.0,20190315,20190403,EXP,,BR-SA-2019SA070163,SANOFI AVENTIS,,62.0,YR,A,M,Y,80.0,KG,20190403.0,,CN,BR,BR,2019,Q2,Adult
160819525,16081952,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Acute kidney injury,,2019,Q2,5,F,2018.0,20190430.0,20190317,20190508,EXP,,"PT-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-010890",BOEHRINGER INGELHEIM,"GOUVEIA C, DUQUE S, CAMPOS L. LIPOTHYMIA BY HYPOVOLEMIA- A CASE OF IATROGENY TO EMPAGLIFLOZIN. REVISTA PORTUGUESA DE DIABTES. 2019;14 (1):74.",71.0,YR,,M,Y,,,20190508.0,,MD,PT,PT,2019,Q2,Elderly
160819525,16081952,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Arrhythmia,,2019,Q2,5,F,2018.0,20190430.0,20190317,20190508,EXP,,"PT-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-010890",BOEHRINGER INGELHEIM,"GOUVEIA C, DUQUE S, CAMPOS L. LIPOTHYMIA BY HYPOVOLEMIA- A CASE OF IATROGENY TO EMPAGLIFLOZIN. REVISTA PORTUGUESA DE DIABTES. 2019;14 (1):74.",71.0,YR,,M,Y,,,20190508.0,,MD,PT,PT,2019,Q2,Elderly
160819525,16081952,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Atrial fibrillation,,2019,Q2,5,F,2018.0,20190430.0,20190317,20190508,EXP,,"PT-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-010890",BOEHRINGER INGELHEIM,"GOUVEIA C, DUQUE S, CAMPOS L. LIPOTHYMIA BY HYPOVOLEMIA- A CASE OF IATROGENY TO EMPAGLIFLOZIN. REVISTA PORTUGUESA DE DIABTES. 2019;14 (1):74.",71.0,YR,,M,Y,,,20190508.0,,MD,PT,PT,2019,Q2,Elderly
160819525,16081952,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Bradycardia,,2019,Q2,5,F,2018.0,20190430.0,20190317,20190508,EXP,,"PT-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-010890",BOEHRINGER INGELHEIM,"GOUVEIA C, DUQUE S, CAMPOS L. LIPOTHYMIA BY HYPOVOLEMIA- A CASE OF IATROGENY TO EMPAGLIFLOZIN. REVISTA PORTUGUESA DE DIABTES. 2019;14 (1):74.",71.0,YR,,M,Y,,,20190508.0,,MD,PT,PT,2019,Q2,Elderly
160819525,16081952,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Dehydration,,2019,Q2,5,F,2018.0,20190430.0,20190317,20190508,EXP,,"PT-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-010890",BOEHRINGER INGELHEIM,"GOUVEIA C, DUQUE S, CAMPOS L. LIPOTHYMIA BY HYPOVOLEMIA- A CASE OF IATROGENY TO EMPAGLIFLOZIN. REVISTA PORTUGUESA DE DIABTES. 2019;14 (1):74.",71.0,YR,,M,Y,,,20190508.0,,MD,PT,PT,2019,Q2,Elderly
160819525,16081952,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Dizziness,,2019,Q2,5,F,2018.0,20190430.0,20190317,20190508,EXP,,"PT-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-010890",BOEHRINGER INGELHEIM,"GOUVEIA C, DUQUE S, CAMPOS L. LIPOTHYMIA BY HYPOVOLEMIA- A CASE OF IATROGENY TO EMPAGLIFLOZIN. REVISTA PORTUGUESA DE DIABTES. 2019;14 (1):74.",71.0,YR,,M,Y,,,20190508.0,,MD,PT,PT,2019,Q2,Elderly
160819525,16081952,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Haematocrit increased,,2019,Q2,5,F,2018.0,20190430.0,20190317,20190508,EXP,,"PT-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-010890",BOEHRINGER INGELHEIM,"GOUVEIA C, DUQUE S, CAMPOS L. LIPOTHYMIA BY HYPOVOLEMIA- A CASE OF IATROGENY TO EMPAGLIFLOZIN. REVISTA PORTUGUESA DE DIABTES. 2019;14 (1):74.",71.0,YR,,M,Y,,,20190508.0,,MD,PT,PT,2019,Q2,Elderly
160819525,16081952,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Haemoglobin increased,,2019,Q2,5,F,2018.0,20190430.0,20190317,20190508,EXP,,"PT-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-010890",BOEHRINGER INGELHEIM,"GOUVEIA C, DUQUE S, CAMPOS L. LIPOTHYMIA BY HYPOVOLEMIA- A CASE OF IATROGENY TO EMPAGLIFLOZIN. REVISTA PORTUGUESA DE DIABTES. 2019;14 (1):74.",71.0,YR,,M,Y,,,20190508.0,,MD,PT,PT,2019,Q2,Elderly
160819525,16081952,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Hypotension,,2019,Q2,5,F,2018.0,20190430.0,20190317,20190508,EXP,,"PT-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-010890",BOEHRINGER INGELHEIM,"GOUVEIA C, DUQUE S, CAMPOS L. LIPOTHYMIA BY HYPOVOLEMIA- A CASE OF IATROGENY TO EMPAGLIFLOZIN. REVISTA PORTUGUESA DE DIABTES. 2019;14 (1):74.",71.0,YR,,M,Y,,,20190508.0,,MD,PT,PT,2019,Q2,Elderly
160819525,16081952,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Hypovolaemia,,2019,Q2,5,F,2018.0,20190430.0,20190317,20190508,EXP,,"PT-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-010890",BOEHRINGER INGELHEIM,"GOUVEIA C, DUQUE S, CAMPOS L. LIPOTHYMIA BY HYPOVOLEMIA- A CASE OF IATROGENY TO EMPAGLIFLOZIN. REVISTA PORTUGUESA DE DIABTES. 2019;14 (1):74.",71.0,YR,,M,Y,,,20190508.0,,MD,PT,PT,2019,Q2,Elderly
160819525,16081952,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Left atrial dilatation,,2019,Q2,5,F,2018.0,20190430.0,20190317,20190508,EXP,,"PT-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-010890",BOEHRINGER INGELHEIM,"GOUVEIA C, DUQUE S, CAMPOS L. LIPOTHYMIA BY HYPOVOLEMIA- A CASE OF IATROGENY TO EMPAGLIFLOZIN. REVISTA PORTUGUESA DE DIABTES. 2019;14 (1):74.",71.0,YR,,M,Y,,,20190508.0,,MD,PT,PT,2019,Q2,Elderly
160819525,16081952,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Mucosal dryness,,2019,Q2,5,F,2018.0,20190430.0,20190317,20190508,EXP,,"PT-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-010890",BOEHRINGER INGELHEIM,"GOUVEIA C, DUQUE S, CAMPOS L. LIPOTHYMIA BY HYPOVOLEMIA- A CASE OF IATROGENY TO EMPAGLIFLOZIN. REVISTA PORTUGUESA DE DIABTES. 2019;14 (1):74.",71.0,YR,,M,Y,,,20190508.0,,MD,PT,PT,2019,Q2,Elderly
160819525,16081952,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Presyncope,,2019,Q2,5,F,2018.0,20190430.0,20190317,20190508,EXP,,"PT-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-010890",BOEHRINGER INGELHEIM,"GOUVEIA C, DUQUE S, CAMPOS L. LIPOTHYMIA BY HYPOVOLEMIA- A CASE OF IATROGENY TO EMPAGLIFLOZIN. REVISTA PORTUGUESA DE DIABTES. 2019;14 (1):74.",71.0,YR,,M,Y,,,20190508.0,,MD,PT,PT,2019,Q2,Elderly
160819525,16081952,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Skin disorder,,2019,Q2,5,F,2018.0,20190430.0,20190317,20190508,EXP,,"PT-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-010890",BOEHRINGER INGELHEIM,"GOUVEIA C, DUQUE S, CAMPOS L. LIPOTHYMIA BY HYPOVOLEMIA- A CASE OF IATROGENY TO EMPAGLIFLOZIN. REVISTA PORTUGUESA DE DIABTES. 2019;14 (1):74.",71.0,YR,,M,Y,,,20190508.0,,MD,PT,PT,2019,Q2,Elderly
160819525,16081952,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Syncope,,2019,Q2,5,F,2018.0,20190430.0,20190317,20190508,EXP,,"PT-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-010890",BOEHRINGER INGELHEIM,"GOUVEIA C, DUQUE S, CAMPOS L. LIPOTHYMIA BY HYPOVOLEMIA- A CASE OF IATROGENY TO EMPAGLIFLOZIN. REVISTA PORTUGUESA DE DIABTES. 2019;14 (1):74.",71.0,YR,,M,Y,,,20190508.0,,MD,PT,PT,2019,Q2,Elderly
160933013,16093301,3,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Amnesia,,2019,Q2,3,F,20190111.0,20190328.0,20190320,20190404,EXP,,US-ABBVIE-19S-163-2706438-00,ABBVIE,,58.0,YR,,F,Y,49.94,KG,20190404.0,,CN,US,US,2019,Q2,Adult
160933013,16093301,3,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Chills,,2019,Q2,3,F,20190111.0,20190328.0,20190320,20190404,EXP,,US-ABBVIE-19S-163-2706438-00,ABBVIE,,58.0,YR,,F,Y,49.94,KG,20190404.0,,CN,US,US,2019,Q2,Adult
160933013,16093301,3,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Fall,,2019,Q2,3,F,20190111.0,20190328.0,20190320,20190404,EXP,,US-ABBVIE-19S-163-2706438-00,ABBVIE,,58.0,YR,,F,Y,49.94,KG,20190404.0,,CN,US,US,2019,Q2,Adult
160933013,16093301,3,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Headache,,2019,Q2,3,F,20190111.0,20190328.0,20190320,20190404,EXP,,US-ABBVIE-19S-163-2706438-00,ABBVIE,,58.0,YR,,F,Y,49.94,KG,20190404.0,,CN,US,US,2019,Q2,Adult
160933013,16093301,3,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Pain,,2019,Q2,3,F,20190111.0,20190328.0,20190320,20190404,EXP,,US-ABBVIE-19S-163-2706438-00,ABBVIE,,58.0,YR,,F,Y,49.94,KG,20190404.0,,CN,US,US,2019,Q2,Adult
160933013,16093301,3,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Pancreatic cyst,,2019,Q2,3,F,20190111.0,20190328.0,20190320,20190404,EXP,,US-ABBVIE-19S-163-2706438-00,ABBVIE,,58.0,YR,,F,Y,49.94,KG,20190404.0,,CN,US,US,2019,Q2,Adult
160933013,16093301,3,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Pancreatic leak,,2019,Q2,3,F,20190111.0,20190328.0,20190320,20190404,EXP,,US-ABBVIE-19S-163-2706438-00,ABBVIE,,58.0,YR,,F,Y,49.94,KG,20190404.0,,CN,US,US,2019,Q2,Adult
160933013,16093301,3,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Pyrexia,,2019,Q2,3,F,20190111.0,20190328.0,20190320,20190404,EXP,,US-ABBVIE-19S-163-2706438-00,ABBVIE,,58.0,YR,,F,Y,49.94,KG,20190404.0,,CN,US,US,2019,Q2,Adult
160933013,16093301,4,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Amnesia,,2019,Q2,3,F,20190111.0,20190328.0,20190320,20190404,EXP,,US-ABBVIE-19S-163-2706438-00,ABBVIE,,58.0,YR,,F,Y,49.94,KG,20190404.0,,CN,US,US,2019,Q2,Adult
160933013,16093301,4,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Chills,,2019,Q2,3,F,20190111.0,20190328.0,20190320,20190404,EXP,,US-ABBVIE-19S-163-2706438-00,ABBVIE,,58.0,YR,,F,Y,49.94,KG,20190404.0,,CN,US,US,2019,Q2,Adult
160933013,16093301,4,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Fall,,2019,Q2,3,F,20190111.0,20190328.0,20190320,20190404,EXP,,US-ABBVIE-19S-163-2706438-00,ABBVIE,,58.0,YR,,F,Y,49.94,KG,20190404.0,,CN,US,US,2019,Q2,Adult
160933013,16093301,4,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Headache,,2019,Q2,3,F,20190111.0,20190328.0,20190320,20190404,EXP,,US-ABBVIE-19S-163-2706438-00,ABBVIE,,58.0,YR,,F,Y,49.94,KG,20190404.0,,CN,US,US,2019,Q2,Adult
160933013,16093301,4,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Pain,,2019,Q2,3,F,20190111.0,20190328.0,20190320,20190404,EXP,,US-ABBVIE-19S-163-2706438-00,ABBVIE,,58.0,YR,,F,Y,49.94,KG,20190404.0,,CN,US,US,2019,Q2,Adult
160933013,16093301,4,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Pancreatic cyst,,2019,Q2,3,F,20190111.0,20190328.0,20190320,20190404,EXP,,US-ABBVIE-19S-163-2706438-00,ABBVIE,,58.0,YR,,F,Y,49.94,KG,20190404.0,,CN,US,US,2019,Q2,Adult
160933013,16093301,4,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Pancreatic leak,,2019,Q2,3,F,20190111.0,20190328.0,20190320,20190404,EXP,,US-ABBVIE-19S-163-2706438-00,ABBVIE,,58.0,YR,,F,Y,49.94,KG,20190404.0,,CN,US,US,2019,Q2,Adult
160933013,16093301,4,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Pyrexia,,2019,Q2,3,F,20190111.0,20190328.0,20190320,20190404,EXP,,US-ABBVIE-19S-163-2706438-00,ABBVIE,,58.0,YR,,F,Y,49.94,KG,20190404.0,,CN,US,US,2019,Q2,Adult
160954682,16095468,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2019,Q2,Anaemia,,2019,Q2,2,F,20161101.0,20190510.0,20190320,20190518,EXP,DE-EMA-DD-20171206-SGALIPALLIP-165730,PHHY2017DE008738,NOVARTIS,,64.0,YR,,M,Y,85.2,KG,20190518.0,,MD,DE,DE,2019,Q2,Adult
160954682,16095468,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2019,Q2,C-reactive protein increased,,2019,Q2,2,F,20161101.0,20190510.0,20190320,20190518,EXP,DE-EMA-DD-20171206-SGALIPALLIP-165730,PHHY2017DE008738,NOVARTIS,,64.0,YR,,M,Y,85.2,KG,20190518.0,,MD,DE,DE,2019,Q2,Adult
160954682,16095468,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2019,Q2,Cough,,2019,Q2,2,F,20161101.0,20190510.0,20190320,20190518,EXP,DE-EMA-DD-20171206-SGALIPALLIP-165730,PHHY2017DE008738,NOVARTIS,,64.0,YR,,M,Y,85.2,KG,20190518.0,,MD,DE,DE,2019,Q2,Adult
160954682,16095468,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2019,Q2,Fatigue,,2019,Q2,2,F,20161101.0,20190510.0,20190320,20190518,EXP,DE-EMA-DD-20171206-SGALIPALLIP-165730,PHHY2017DE008738,NOVARTIS,,64.0,YR,,M,Y,85.2,KG,20190518.0,,MD,DE,DE,2019,Q2,Adult
160954682,16095468,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2019,Q2,General physical condition abnormal,,2019,Q2,2,F,20161101.0,20190510.0,20190320,20190518,EXP,DE-EMA-DD-20171206-SGALIPALLIP-165730,PHHY2017DE008738,NOVARTIS,,64.0,YR,,M,Y,85.2,KG,20190518.0,,MD,DE,DE,2019,Q2,Adult
160954682,16095468,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2019,Q2,Hypothyroidism,,2019,Q2,2,F,20161101.0,20190510.0,20190320,20190518,EXP,DE-EMA-DD-20171206-SGALIPALLIP-165730,PHHY2017DE008738,NOVARTIS,,64.0,YR,,M,Y,85.2,KG,20190518.0,,MD,DE,DE,2019,Q2,Adult
160954682,16095468,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2019,Q2,Pneumonia,,2019,Q2,2,F,20161101.0,20190510.0,20190320,20190518,EXP,DE-EMA-DD-20171206-SGALIPALLIP-165730,PHHY2017DE008738,NOVARTIS,,64.0,YR,,M,Y,85.2,KG,20190518.0,,MD,DE,DE,2019,Q2,Adult
160954682,16095468,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2019,Q2,Sinusitis,,2019,Q2,2,F,20161101.0,20190510.0,20190320,20190518,EXP,DE-EMA-DD-20171206-SGALIPALLIP-165730,PHHY2017DE008738,NOVARTIS,,64.0,YR,,M,Y,85.2,KG,20190518.0,,MD,DE,DE,2019,Q2,Adult
160956883,16095688,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 U, QD",,,U,,,,,,,,QD,2019,Q2,Exposure during pregnancy,,2019,Q2,3,F,20181226.0,20190328.0,20190320,20190409,EXP,,MX-SA-2019SA072463,SANOFI AVENTIS,,27.0,YR,A,F,Y,59.0,KG,20190409.0,,OT,MX,MX,2019,Q2,Young Adult
160984233,16098423,9,C,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Acute kidney injury,,2019,Q2,3,F,,20190513.0,20190321,20190523,EXP,,PT-TEVA-2019-PT-1028643,TEVA,GOUVEIA C. LIPOTIMIA POR HIPOVOLEMIA - UM CASO DE IATROGENIA A EMPAGLIFLOZINA?. REVISTA PORTUGUESA DE DIABETES. 2019;17:74.,71.0,YR,,M,Y,,,20190523.0,,MD,PT,PT,2019,Q2,Elderly
160984233,16098423,9,C,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Arrhythmia,,2019,Q2,3,F,,20190513.0,20190321,20190523,EXP,,PT-TEVA-2019-PT-1028643,TEVA,GOUVEIA C. LIPOTIMIA POR HIPOVOLEMIA - UM CASO DE IATROGENIA A EMPAGLIFLOZINA?. REVISTA PORTUGUESA DE DIABETES. 2019;17:74.,71.0,YR,,M,Y,,,20190523.0,,MD,PT,PT,2019,Q2,Elderly
160984233,16098423,9,C,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Bradycardia,,2019,Q2,3,F,,20190513.0,20190321,20190523,EXP,,PT-TEVA-2019-PT-1028643,TEVA,GOUVEIA C. LIPOTIMIA POR HIPOVOLEMIA - UM CASO DE IATROGENIA A EMPAGLIFLOZINA?. REVISTA PORTUGUESA DE DIABETES. 2019;17:74.,71.0,YR,,M,Y,,,20190523.0,,MD,PT,PT,2019,Q2,Elderly
160984233,16098423,9,C,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Dehydration,,2019,Q2,3,F,,20190513.0,20190321,20190523,EXP,,PT-TEVA-2019-PT-1028643,TEVA,GOUVEIA C. LIPOTIMIA POR HIPOVOLEMIA - UM CASO DE IATROGENIA A EMPAGLIFLOZINA?. REVISTA PORTUGUESA DE DIABETES. 2019;17:74.,71.0,YR,,M,Y,,,20190523.0,,MD,PT,PT,2019,Q2,Elderly
160984233,16098423,9,C,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Dizziness,,2019,Q2,3,F,,20190513.0,20190321,20190523,EXP,,PT-TEVA-2019-PT-1028643,TEVA,GOUVEIA C. LIPOTIMIA POR HIPOVOLEMIA - UM CASO DE IATROGENIA A EMPAGLIFLOZINA?. REVISTA PORTUGUESA DE DIABETES. 2019;17:74.,71.0,YR,,M,Y,,,20190523.0,,MD,PT,PT,2019,Q2,Elderly
160984233,16098423,9,C,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Hypotension,,2019,Q2,3,F,,20190513.0,20190321,20190523,EXP,,PT-TEVA-2019-PT-1028643,TEVA,GOUVEIA C. LIPOTIMIA POR HIPOVOLEMIA - UM CASO DE IATROGENIA A EMPAGLIFLOZINA?. REVISTA PORTUGUESA DE DIABETES. 2019;17:74.,71.0,YR,,M,Y,,,20190523.0,,MD,PT,PT,2019,Q2,Elderly
160984233,16098423,9,C,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Syncope,,2019,Q2,3,F,,20190513.0,20190321,20190523,EXP,,PT-TEVA-2019-PT-1028643,TEVA,GOUVEIA C. LIPOTIMIA POR HIPOVOLEMIA - UM CASO DE IATROGENIA A EMPAGLIFLOZINA?. REVISTA PORTUGUESA DE DIABETES. 2019;17:74.,71.0,YR,,M,Y,,,20190523.0,,MD,PT,PT,2019,Q2,Elderly
161022954,16102295,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Acute kidney injury,,2019,Q2,4,F,2018.0,20190510.0,20190321,20190516,EXP,,PHHY2019PT063216,SANDOZ,,71.0,YR,,M,Y,,,20190516.0,,OT,PT,PT,2019,Q2,Elderly
161022954,16102295,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Arrhythmia,,2019,Q2,4,F,2018.0,20190510.0,20190321,20190516,EXP,,PHHY2019PT063216,SANDOZ,,71.0,YR,,M,Y,,,20190516.0,,OT,PT,PT,2019,Q2,Elderly
161022954,16102295,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Atrial fibrillation,,2019,Q2,4,F,2018.0,20190510.0,20190321,20190516,EXP,,PHHY2019PT063216,SANDOZ,,71.0,YR,,M,Y,,,20190516.0,,OT,PT,PT,2019,Q2,Elderly
161022954,16102295,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Bradycardia,,2019,Q2,4,F,2018.0,20190510.0,20190321,20190516,EXP,,PHHY2019PT063216,SANDOZ,,71.0,YR,,M,Y,,,20190516.0,,OT,PT,PT,2019,Q2,Elderly
161022954,16102295,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Dehydration,,2019,Q2,4,F,2018.0,20190510.0,20190321,20190516,EXP,,PHHY2019PT063216,SANDOZ,,71.0,YR,,M,Y,,,20190516.0,,OT,PT,PT,2019,Q2,Elderly
161022954,16102295,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Dizziness,,2019,Q2,4,F,2018.0,20190510.0,20190321,20190516,EXP,,PHHY2019PT063216,SANDOZ,,71.0,YR,,M,Y,,,20190516.0,,OT,PT,PT,2019,Q2,Elderly
161022954,16102295,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Haematocrit increased,,2019,Q2,4,F,2018.0,20190510.0,20190321,20190516,EXP,,PHHY2019PT063216,SANDOZ,,71.0,YR,,M,Y,,,20190516.0,,OT,PT,PT,2019,Q2,Elderly
161022954,16102295,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Haemoglobin increased,,2019,Q2,4,F,2018.0,20190510.0,20190321,20190516,EXP,,PHHY2019PT063216,SANDOZ,,71.0,YR,,M,Y,,,20190516.0,,OT,PT,PT,2019,Q2,Elderly
161022954,16102295,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Hypotension,,2019,Q2,4,F,2018.0,20190510.0,20190321,20190516,EXP,,PHHY2019PT063216,SANDOZ,,71.0,YR,,M,Y,,,20190516.0,,OT,PT,PT,2019,Q2,Elderly
161022954,16102295,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Hypovolaemia,,2019,Q2,4,F,2018.0,20190510.0,20190321,20190516,EXP,,PHHY2019PT063216,SANDOZ,,71.0,YR,,M,Y,,,20190516.0,,OT,PT,PT,2019,Q2,Elderly
161022954,16102295,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Left atrial dilatation,,2019,Q2,4,F,2018.0,20190510.0,20190321,20190516,EXP,,PHHY2019PT063216,SANDOZ,,71.0,YR,,M,Y,,,20190516.0,,OT,PT,PT,2019,Q2,Elderly
161022954,16102295,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Mucosal dryness,,2019,Q2,4,F,2018.0,20190510.0,20190321,20190516,EXP,,PHHY2019PT063216,SANDOZ,,71.0,YR,,M,Y,,,20190516.0,,OT,PT,PT,2019,Q2,Elderly
161022954,16102295,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Presyncope,,2019,Q2,4,F,2018.0,20190510.0,20190321,20190516,EXP,,PHHY2019PT063216,SANDOZ,,71.0,YR,,M,Y,,,20190516.0,,OT,PT,PT,2019,Q2,Elderly
161022954,16102295,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Skin disorder,,2019,Q2,4,F,2018.0,20190510.0,20190321,20190516,EXP,,PHHY2019PT063216,SANDOZ,,71.0,YR,,M,Y,,,20190516.0,,OT,PT,PT,2019,Q2,Elderly
161022954,16102295,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Syncope,,2019,Q2,4,F,2018.0,20190510.0,20190321,20190516,EXP,,PHHY2019PT063216,SANDOZ,,71.0,YR,,M,Y,,,20190516.0,,OT,PT,PT,2019,Q2,Elderly
161155182,16115518,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Other,UNK,,,,,,,,,,INJECTION,,2019,Q2,Lung disorder,,2019,Q2,2,F,,20190411.0,20190325,20190418,EXP,,JP-TAKEDA-2019TJP006407,TAKEDA,"HASEGAWA I, KAMBAYASHI T, TSUSHIMA H. A CASE OF LANSOPRAZOLE-INDUCED LUNG INJURY. ANNALS OF THE JAPANESE RESPIRATORY SOCIETY. 2019;8(1):47-51",63.0,YR,,M,Y,60.9,KG,20190419.0,,MD,JP,JP,2019,Q2,Adult
161166252,16116625,10,SS,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,"UNK UNK, QD (25/75: + 20U 20U / D)",,,U,,,,,,,,,2019,Q2,Chest pain,,2019,Q2,2,F,,20190502.0,20190326,20190508,EXP,PT-EMA-DD-20181213-KUMARVN_P-153457,PT-ACCORD-115341,ACCORD,,54.0,YR,,F,Y,,,20190508.0,,OT,PT,PT,2019,Q2,Adult
161166252,16116625,10,SS,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,"UNK UNK, QD (25/75: + 20U 20U / D)",,,U,,,,,,,,,2019,Q2,Ischaemic stroke,,2019,Q2,2,F,,20190502.0,20190326,20190508,EXP,PT-EMA-DD-20181213-KUMARVN_P-153457,PT-ACCORD-115341,ACCORD,,54.0,YR,,F,Y,,,20190508.0,,OT,PT,PT,2019,Q2,Adult
161175384,16117538,8,C,Insulin Lispro,INSULIN LISPRO,1,Other,,,,,,,,,,,SOLUTION,,2019,Q2,Febrile neutropenia,,2019,Q2,4,F,20180917.0,20190527.0,20190326,20190606,EXP,,US-CELGENEUS-USA-20190307369,CELGENE,,75.0,YR,,M,Y,135.0,KG,20190606.0,,OT,US,US,2019,Q2,Elderly
161175384,16117538,8,C,Insulin Lispro,INSULIN LISPRO,1,Other,,,,,,,,,,,SOLUTION,,2019,Q2,Skin lesion,,2019,Q2,4,F,20180917.0,20190527.0,20190326,20190606,EXP,,US-CELGENEUS-USA-20190307369,CELGENE,,75.0,YR,,M,Y,135.0,KG,20190606.0,,OT,US,US,2019,Q2,Elderly
161175384,16117538,8,C,Insulin Lispro,INSULIN LISPRO,1,Other,,,,,,,,,,,SOLUTION,,2019,Q2,Thrombosis,,2019,Q2,4,F,20180917.0,20190527.0,20190326,20190606,EXP,,US-CELGENEUS-USA-20190307369,CELGENE,,75.0,YR,,M,Y,135.0,KG,20190606.0,,OT,US,US,2019,Q2,Elderly
161363222,16136322,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Acute kidney injury,,2019,Q2,2,F,,20190509.0,20190329,20190517,EXP,,PT-ASTRAZENECA-2019SE49086,ASTRAZENECA,,71.0,YR,,M,Y,,,20190517.0,,MD,PT,PT,2019,Q2,Elderly
161363222,16136322,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Arrhythmia,,2019,Q2,2,F,,20190509.0,20190329,20190517,EXP,,PT-ASTRAZENECA-2019SE49086,ASTRAZENECA,,71.0,YR,,M,Y,,,20190517.0,,MD,PT,PT,2019,Q2,Elderly
161363222,16136322,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Atrial fibrillation,,2019,Q2,2,F,,20190509.0,20190329,20190517,EXP,,PT-ASTRAZENECA-2019SE49086,ASTRAZENECA,,71.0,YR,,M,Y,,,20190517.0,,MD,PT,PT,2019,Q2,Elderly
161363222,16136322,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Bradycardia,,2019,Q2,2,F,,20190509.0,20190329,20190517,EXP,,PT-ASTRAZENECA-2019SE49086,ASTRAZENECA,,71.0,YR,,M,Y,,,20190517.0,,MD,PT,PT,2019,Q2,Elderly
161363222,16136322,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Dehydration,,2019,Q2,2,F,,20190509.0,20190329,20190517,EXP,,PT-ASTRAZENECA-2019SE49086,ASTRAZENECA,,71.0,YR,,M,Y,,,20190517.0,,MD,PT,PT,2019,Q2,Elderly
161363222,16136322,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Dizziness,,2019,Q2,2,F,,20190509.0,20190329,20190517,EXP,,PT-ASTRAZENECA-2019SE49086,ASTRAZENECA,,71.0,YR,,M,Y,,,20190517.0,,MD,PT,PT,2019,Q2,Elderly
161363222,16136322,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Haematocrit increased,,2019,Q2,2,F,,20190509.0,20190329,20190517,EXP,,PT-ASTRAZENECA-2019SE49086,ASTRAZENECA,,71.0,YR,,M,Y,,,20190517.0,,MD,PT,PT,2019,Q2,Elderly
161363222,16136322,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Haemoglobin increased,,2019,Q2,2,F,,20190509.0,20190329,20190517,EXP,,PT-ASTRAZENECA-2019SE49086,ASTRAZENECA,,71.0,YR,,M,Y,,,20190517.0,,MD,PT,PT,2019,Q2,Elderly
161363222,16136322,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Hypotension,,2019,Q2,2,F,,20190509.0,20190329,20190517,EXP,,PT-ASTRAZENECA-2019SE49086,ASTRAZENECA,,71.0,YR,,M,Y,,,20190517.0,,MD,PT,PT,2019,Q2,Elderly
161363222,16136322,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Hypovolaemia,,2019,Q2,2,F,,20190509.0,20190329,20190517,EXP,,PT-ASTRAZENECA-2019SE49086,ASTRAZENECA,,71.0,YR,,M,Y,,,20190517.0,,MD,PT,PT,2019,Q2,Elderly
161363222,16136322,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Left atrial dilatation,,2019,Q2,2,F,,20190509.0,20190329,20190517,EXP,,PT-ASTRAZENECA-2019SE49086,ASTRAZENECA,,71.0,YR,,M,Y,,,20190517.0,,MD,PT,PT,2019,Q2,Elderly
161363222,16136322,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Mucosal dryness,,2019,Q2,2,F,,20190509.0,20190329,20190517,EXP,,PT-ASTRAZENECA-2019SE49086,ASTRAZENECA,,71.0,YR,,M,Y,,,20190517.0,,MD,PT,PT,2019,Q2,Elderly
161363222,16136322,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Presyncope,,2019,Q2,2,F,,20190509.0,20190329,20190517,EXP,,PT-ASTRAZENECA-2019SE49086,ASTRAZENECA,,71.0,YR,,M,Y,,,20190517.0,,MD,PT,PT,2019,Q2,Elderly
161363222,16136322,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Skin disorder,,2019,Q2,2,F,,20190509.0,20190329,20190517,EXP,,PT-ASTRAZENECA-2019SE49086,ASTRAZENECA,,71.0,YR,,M,Y,,,20190517.0,,MD,PT,PT,2019,Q2,Elderly
161363222,16136322,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Syncope,,2019,Q2,2,F,,20190509.0,20190329,20190517,EXP,,PT-ASTRAZENECA-2019SE49086,ASTRAZENECA,,71.0,YR,,M,Y,,,20190517.0,,MD,PT,PT,2019,Q2,Elderly
161384801,16138480,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 DF, QD",,,Y,,,,,10.0,DF,SOLUTION FOR INJECTION,QD,2019,Q2,Bradycardia,,2019,Q2,1,I,20180422.0,20190322.0,20190401,20190401,EXP,IT-MINISAL02-531811,IT-SA-2019SA081460,SANOFI AVENTIS,,69.0,YR,E,M,Y,,,20190401.0,,MD,IT,IT,2019,Q2,Elderly
161384801,16138480,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 DF, QD",,,Y,,,,,10.0,DF,SOLUTION FOR INJECTION,QD,2019,Q2,Hypoglycaemia,,2019,Q2,1,I,20180422.0,20190322.0,20190401,20190401,EXP,IT-MINISAL02-531811,IT-SA-2019SA081460,SANOFI AVENTIS,,69.0,YR,E,M,Y,,,20190401.0,,MD,IT,IT,2019,Q2,Elderly
161384801,16138480,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 DF, QD",,,Y,,,,,10.0,DF,SOLUTION FOR INJECTION,QD,2019,Q2,Syncope,,2019,Q2,1,I,20180422.0,20190322.0,20190401,20190401,EXP,IT-MINISAL02-531811,IT-SA-2019SA081460,SANOFI AVENTIS,,69.0,YR,E,M,Y,,,20190401.0,,MD,IT,IT,2019,Q2,Elderly
161398181,16139818,9,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,,2,Subcutaneous,,,,,,,,,,,,,2019,Q2,Hyperkalaemia,Hyperkalaemia,2019,Q2,1,I,20180828.0,20190318.0,20190401,20190401,EXP,FR-AFSSAPS-TO20190297,FR-ALVOGEN-2019-ALVOGEN-099139,ALVOGEN,,73.0,YR,,F,Y,,,20190401.0,,PH,FR,FR,2019,Q2,Elderly
161425321,16142532,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,U,U,,,,,,,,2019,Q2,Diabetes mellitus,,2019,Q2,1,I,,20190325.0,20190401,20190401,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201903014256,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20190401.0,,CN,CN,CN,2019,Q2,Adult
161425321,16142532,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,U,U,,,,,,,,2019,Q2,Hypoaesthesia,,2019,Q2,1,I,,20190325.0,20190401,20190401,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201903014256,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20190401.0,,CN,CN,CN,2019,Q2,Adult
161425321,16142532,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,U,U,,,,,,,,2019,Q2,Myopia,,2019,Q2,1,I,,20190325.0,20190401,20190401,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201903014256,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20190401.0,,CN,CN,CN,2019,Q2,Adult
161477353,16147735,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Acute kidney injury,,2019,Q2,3,F,2018.0,20190521.0,20190402,20190531,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20190531.0,,MD,PT,PT,2019,Q2,Elderly
161477353,16147735,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Arrhythmia,,2019,Q2,3,F,2018.0,20190521.0,20190402,20190531,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20190531.0,,MD,PT,PT,2019,Q2,Elderly
161477353,16147735,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Atrial fibrillation,,2019,Q2,3,F,2018.0,20190521.0,20190402,20190531,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20190531.0,,MD,PT,PT,2019,Q2,Elderly
161477353,16147735,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Bradycardia,,2019,Q2,3,F,2018.0,20190521.0,20190402,20190531,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20190531.0,,MD,PT,PT,2019,Q2,Elderly
161477353,16147735,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Dehydration,,2019,Q2,3,F,2018.0,20190521.0,20190402,20190531,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20190531.0,,MD,PT,PT,2019,Q2,Elderly
161477353,16147735,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Dizziness,,2019,Q2,3,F,2018.0,20190521.0,20190402,20190531,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20190531.0,,MD,PT,PT,2019,Q2,Elderly
161477353,16147735,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Haematocrit increased,,2019,Q2,3,F,2018.0,20190521.0,20190402,20190531,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20190531.0,,MD,PT,PT,2019,Q2,Elderly
161477353,16147735,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Haemoglobin increased,,2019,Q2,3,F,2018.0,20190521.0,20190402,20190531,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20190531.0,,MD,PT,PT,2019,Q2,Elderly
161477353,16147735,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Hypotension,,2019,Q2,3,F,2018.0,20190521.0,20190402,20190531,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20190531.0,,MD,PT,PT,2019,Q2,Elderly
161477353,16147735,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Hypovolaemia,,2019,Q2,3,F,2018.0,20190521.0,20190402,20190531,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20190531.0,,MD,PT,PT,2019,Q2,Elderly
161477353,16147735,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Left atrial dilatation,,2019,Q2,3,F,2018.0,20190521.0,20190402,20190531,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20190531.0,,MD,PT,PT,2019,Q2,Elderly
161477353,16147735,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Mucosal dryness,,2019,Q2,3,F,2018.0,20190521.0,20190402,20190531,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20190531.0,,MD,PT,PT,2019,Q2,Elderly
161477353,16147735,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Presyncope,,2019,Q2,3,F,2018.0,20190521.0,20190402,20190531,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20190531.0,,MD,PT,PT,2019,Q2,Elderly
161477353,16147735,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Skin disorder,,2019,Q2,3,F,2018.0,20190521.0,20190402,20190531,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20190531.0,,MD,PT,PT,2019,Q2,Elderly
161477353,16147735,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Syncope,,2019,Q2,3,F,2018.0,20190521.0,20190402,20190531,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20190531.0,,MD,PT,PT,2019,Q2,Elderly
161482952,16148295,14,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,1-2 IU,,,,,,,,,,UNKNOWN,QD,2019,Q2,Febrile neutropenia,,2019,Q2,2,F,20190124.0,20190404.0,20190402,20190411,EXP,,US-CELGENEUS-USA-20190201237,CELGENE,,72.0,YR,,M,Y,83.0,KG,20190411.0,,OT,US,US,2019,Q2,Elderly
161482952,16148295,15,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,1-3 IU,,,,,,,,,,UNKNOWN,QD,2019,Q2,Febrile neutropenia,,2019,Q2,2,F,20190124.0,20190404.0,20190402,20190411,EXP,,US-CELGENEUS-USA-20190201237,CELGENE,,72.0,YR,,M,Y,83.0,KG,20190411.0,,OT,US,US,2019,Q2,Elderly
161483762,16148376,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,UNSPECIFIED,,2019,Q2,Arteriosclerosis,,2019,Q2,2,F,2019.0,20190404.0,20190402,20190415,EXP,,PL-JNJFOC-20190343026,JANSSEN,,62.0,YR,A,M,Y,95.0,KG,20190415.0,,MD,PL,PL,2019,Q2,Adult
161483762,16148376,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,UNSPECIFIED,,2019,Q2,Cerebrovascular accident,,2019,Q2,2,F,2019.0,20190404.0,20190402,20190415,EXP,,PL-JNJFOC-20190343026,JANSSEN,,62.0,YR,A,M,Y,95.0,KG,20190415.0,,MD,PL,PL,2019,Q2,Adult
161497612,16149761,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, TID",,,U,,,,,,,,TID,2019,Q2,Blood glucose increased,,2019,Q2,2,F,20190214.0,20190530.0,20190402,20190607,EXP,,PHEH2019US013462,NOVARTIS,,60.0,YR,,F,Y,,,20190607.0,,CN,COUNTRY NOT SPECIFIED,US,2019,Q2,Adult
161497612,16149761,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, TID",,,U,,,,,,,,TID,2019,Q2,Blood potassium increased,,2019,Q2,2,F,20190214.0,20190530.0,20190402,20190607,EXP,,PHEH2019US013462,NOVARTIS,,60.0,YR,,F,Y,,,20190607.0,,CN,COUNTRY NOT SPECIFIED,US,2019,Q2,Adult
161497612,16149761,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, TID",,,U,,,,,,,,TID,2019,Q2,Blood pressure increased,,2019,Q2,2,F,20190214.0,20190530.0,20190402,20190607,EXP,,PHEH2019US013462,NOVARTIS,,60.0,YR,,F,Y,,,20190607.0,,CN,COUNTRY NOT SPECIFIED,US,2019,Q2,Adult
161497612,16149761,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, TID",,,U,,,,,,,,TID,2019,Q2,Dehydration,,2019,Q2,2,F,20190214.0,20190530.0,20190402,20190607,EXP,,PHEH2019US013462,NOVARTIS,,60.0,YR,,F,Y,,,20190607.0,,CN,COUNTRY NOT SPECIFIED,US,2019,Q2,Adult
161497612,16149761,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, TID",,,U,,,,,,,,TID,2019,Q2,Diarrhoea,,2019,Q2,2,F,20190214.0,20190530.0,20190402,20190607,EXP,,PHEH2019US013462,NOVARTIS,,60.0,YR,,F,Y,,,20190607.0,,CN,COUNTRY NOT SPECIFIED,US,2019,Q2,Adult
161497612,16149761,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, TID",,,U,,,,,,,,TID,2019,Q2,Drug hypersensitivity,,2019,Q2,2,F,20190214.0,20190530.0,20190402,20190607,EXP,,PHEH2019US013462,NOVARTIS,,60.0,YR,,F,Y,,,20190607.0,,CN,COUNTRY NOT SPECIFIED,US,2019,Q2,Adult
161497612,16149761,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, TID",,,U,,,,,,,,TID,2019,Q2,Feeling abnormal,,2019,Q2,2,F,20190214.0,20190530.0,20190402,20190607,EXP,,PHEH2019US013462,NOVARTIS,,60.0,YR,,F,Y,,,20190607.0,,CN,COUNTRY NOT SPECIFIED,US,2019,Q2,Adult
161497612,16149761,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, TID",,,U,,,,,,,,TID,2019,Q2,Gait disturbance,,2019,Q2,2,F,20190214.0,20190530.0,20190402,20190607,EXP,,PHEH2019US013462,NOVARTIS,,60.0,YR,,F,Y,,,20190607.0,,CN,COUNTRY NOT SPECIFIED,US,2019,Q2,Adult
161497612,16149761,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, TID",,,U,,,,,,,,TID,2019,Q2,Gait inability,,2019,Q2,2,F,20190214.0,20190530.0,20190402,20190607,EXP,,PHEH2019US013462,NOVARTIS,,60.0,YR,,F,Y,,,20190607.0,,CN,COUNTRY NOT SPECIFIED,US,2019,Q2,Adult
161497612,16149761,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, TID",,,U,,,,,,,,TID,2019,Q2,Haematocrit decreased,,2019,Q2,2,F,20190214.0,20190530.0,20190402,20190607,EXP,,PHEH2019US013462,NOVARTIS,,60.0,YR,,F,Y,,,20190607.0,,CN,COUNTRY NOT SPECIFIED,US,2019,Q2,Adult
161497612,16149761,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, TID",,,U,,,,,,,,TID,2019,Q2,Haemoglobin decreased,,2019,Q2,2,F,20190214.0,20190530.0,20190402,20190607,EXP,,PHEH2019US013462,NOVARTIS,,60.0,YR,,F,Y,,,20190607.0,,CN,COUNTRY NOT SPECIFIED,US,2019,Q2,Adult
161497612,16149761,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, TID",,,U,,,,,,,,TID,2019,Q2,Heart rate increased,,2019,Q2,2,F,20190214.0,20190530.0,20190402,20190607,EXP,,PHEH2019US013462,NOVARTIS,,60.0,YR,,F,Y,,,20190607.0,,CN,COUNTRY NOT SPECIFIED,US,2019,Q2,Adult
161497612,16149761,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, TID",,,U,,,,,,,,TID,2019,Q2,Hypoaesthesia,,2019,Q2,2,F,20190214.0,20190530.0,20190402,20190607,EXP,,PHEH2019US013462,NOVARTIS,,60.0,YR,,F,Y,,,20190607.0,,CN,COUNTRY NOT SPECIFIED,US,2019,Q2,Adult
161497612,16149761,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, TID",,,U,,,,,,,,TID,2019,Q2,Influenza like illness,,2019,Q2,2,F,20190214.0,20190530.0,20190402,20190607,EXP,,PHEH2019US013462,NOVARTIS,,60.0,YR,,F,Y,,,20190607.0,,CN,COUNTRY NOT SPECIFIED,US,2019,Q2,Adult
161497612,16149761,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, TID",,,U,,,,,,,,TID,2019,Q2,Malaise,,2019,Q2,2,F,20190214.0,20190530.0,20190402,20190607,EXP,,PHEH2019US013462,NOVARTIS,,60.0,YR,,F,Y,,,20190607.0,,CN,COUNTRY NOT SPECIFIED,US,2019,Q2,Adult
161497612,16149761,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, TID",,,U,,,,,,,,TID,2019,Q2,Mean cell volume decreased,,2019,Q2,2,F,20190214.0,20190530.0,20190402,20190607,EXP,,PHEH2019US013462,NOVARTIS,,60.0,YR,,F,Y,,,20190607.0,,CN,COUNTRY NOT SPECIFIED,US,2019,Q2,Adult
161497612,16149761,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, TID",,,U,,,,,,,,TID,2019,Q2,Nausea,,2019,Q2,2,F,20190214.0,20190530.0,20190402,20190607,EXP,,PHEH2019US013462,NOVARTIS,,60.0,YR,,F,Y,,,20190607.0,,CN,COUNTRY NOT SPECIFIED,US,2019,Q2,Adult
161497612,16149761,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, TID",,,U,,,,,,,,TID,2019,Q2,Oedema,,2019,Q2,2,F,20190214.0,20190530.0,20190402,20190607,EXP,,PHEH2019US013462,NOVARTIS,,60.0,YR,,F,Y,,,20190607.0,,CN,COUNTRY NOT SPECIFIED,US,2019,Q2,Adult
161497612,16149761,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, TID",,,U,,,,,,,,TID,2019,Q2,Pain,,2019,Q2,2,F,20190214.0,20190530.0,20190402,20190607,EXP,,PHEH2019US013462,NOVARTIS,,60.0,YR,,F,Y,,,20190607.0,,CN,COUNTRY NOT SPECIFIED,US,2019,Q2,Adult
161497612,16149761,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, TID",,,U,,,,,,,,TID,2019,Q2,Platelet count increased,,2019,Q2,2,F,20190214.0,20190530.0,20190402,20190607,EXP,,PHEH2019US013462,NOVARTIS,,60.0,YR,,F,Y,,,20190607.0,,CN,COUNTRY NOT SPECIFIED,US,2019,Q2,Adult
161497612,16149761,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, TID",,,U,,,,,,,,TID,2019,Q2,Red cell distribution width increased,,2019,Q2,2,F,20190214.0,20190530.0,20190402,20190607,EXP,,PHEH2019US013462,NOVARTIS,,60.0,YR,,F,Y,,,20190607.0,,CN,COUNTRY NOT SPECIFIED,US,2019,Q2,Adult
161497612,16149761,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, TID",,,U,,,,,,,,TID,2019,Q2,Swelling,,2019,Q2,2,F,20190214.0,20190530.0,20190402,20190607,EXP,,PHEH2019US013462,NOVARTIS,,60.0,YR,,F,Y,,,20190607.0,,CN,COUNTRY NOT SPECIFIED,US,2019,Q2,Adult
161497612,16149761,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, TID",,,U,,,,,,,,TID,2019,Q2,Vomiting,,2019,Q2,2,F,20190214.0,20190530.0,20190402,20190607,EXP,,PHEH2019US013462,NOVARTIS,,60.0,YR,,F,Y,,,20190607.0,,CN,COUNTRY NOT SPECIFIED,US,2019,Q2,Adult
161501921,16150192,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"28 IU, EACH MORNING",,,,,,,,28.0,IU,,QD,2019,Q2,Blood glucose increased,,2019,Q2,1,I,2015.0,20190328.0,20190403,20190403,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201903016303,ELI LILLY AND CO,,52.0,YR,,F,Y,55.0,KG,20190403.0,,CN,CN,CN,2019,Q2,Adult
161501921,16150192,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"28 IU, EACH MORNING",,,,,,,,28.0,IU,,QD,2019,Q2,Discomfort,,2019,Q2,1,I,2015.0,20190328.0,20190403,20190403,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201903016303,ELI LILLY AND CO,,52.0,YR,,F,Y,55.0,KG,20190403.0,,CN,CN,CN,2019,Q2,Adult
161501921,16150192,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"28 IU, EACH MORNING",,,,,,,,28.0,IU,,QD,2019,Q2,Retinal haemorrhage,,2019,Q2,1,I,2015.0,20190328.0,20190403,20190403,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201903016303,ELI LILLY AND CO,,52.0,YR,,F,Y,55.0,KG,20190403.0,,CN,CN,CN,2019,Q2,Adult
161501921,16150192,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"20 IU, EACH EVENING",,,,,,,,20.0,IU,,QD,2019,Q2,Blood glucose increased,,2019,Q2,1,I,2015.0,20190328.0,20190403,20190403,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201903016303,ELI LILLY AND CO,,52.0,YR,,F,Y,55.0,KG,20190403.0,,CN,CN,CN,2019,Q2,Adult
161501921,16150192,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"20 IU, EACH EVENING",,,,,,,,20.0,IU,,QD,2019,Q2,Discomfort,,2019,Q2,1,I,2015.0,20190328.0,20190403,20190403,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201903016303,ELI LILLY AND CO,,52.0,YR,,F,Y,55.0,KG,20190403.0,,CN,CN,CN,2019,Q2,Adult
161501921,16150192,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"20 IU, EACH EVENING",,,,,,,,20.0,IU,,QD,2019,Q2,Retinal haemorrhage,,2019,Q2,1,I,2015.0,20190328.0,20190403,20190403,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201903016303,ELI LILLY AND CO,,52.0,YR,,F,Y,55.0,KG,20190403.0,,CN,CN,CN,2019,Q2,Adult
161512721,16151272,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,, UNKNOWN,,,,,SOLUTION FOR INJECTION,,2019,Q2,Abdominal pain upper,,2019,Q2,1,I,20190226.0,20190325.0,20190402,20190402,EXP,FI-FIMEA-20190316,FI-TEVA-2019-FI-1031442,TEVA,,69.0,YR,,F,Y,,,20190403.0,,MD,FI,FI,2019,Q2,Elderly
161512721,16151272,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,, UNKNOWN,,,,,SOLUTION FOR INJECTION,,2019,Q2,Alanine aminotransferase increased,,2019,Q2,1,I,20190226.0,20190325.0,20190402,20190402,EXP,FI-FIMEA-20190316,FI-TEVA-2019-FI-1031442,TEVA,,69.0,YR,,F,Y,,,20190403.0,,MD,FI,FI,2019,Q2,Elderly
161512721,16151272,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,, UNKNOWN,,,,,SOLUTION FOR INJECTION,,2019,Q2,Aspartate aminotransferase increased,,2019,Q2,1,I,20190226.0,20190325.0,20190402,20190402,EXP,FI-FIMEA-20190316,FI-TEVA-2019-FI-1031442,TEVA,,69.0,YR,,F,Y,,,20190403.0,,MD,FI,FI,2019,Q2,Elderly
161512721,16151272,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,, UNKNOWN,,,,,SOLUTION FOR INJECTION,,2019,Q2,Bilirubin conjugated increased,,2019,Q2,1,I,20190226.0,20190325.0,20190402,20190402,EXP,FI-FIMEA-20190316,FI-TEVA-2019-FI-1031442,TEVA,,69.0,YR,,F,Y,,,20190403.0,,MD,FI,FI,2019,Q2,Elderly
161512721,16151272,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,, UNKNOWN,,,,,SOLUTION FOR INJECTION,,2019,Q2,Blood alkaline phosphatase increased,,2019,Q2,1,I,20190226.0,20190325.0,20190402,20190402,EXP,FI-FIMEA-20190316,FI-TEVA-2019-FI-1031442,TEVA,,69.0,YR,,F,Y,,,20190403.0,,MD,FI,FI,2019,Q2,Elderly
161512721,16151272,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,, UNKNOWN,,,,,SOLUTION FOR INJECTION,,2019,Q2,Blood bilirubin increased,,2019,Q2,1,I,20190226.0,20190325.0,20190402,20190402,EXP,FI-FIMEA-20190316,FI-TEVA-2019-FI-1031442,TEVA,,69.0,YR,,F,Y,,,20190403.0,,MD,FI,FI,2019,Q2,Elderly
161512721,16151272,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,, UNKNOWN,,,,,SOLUTION FOR INJECTION,,2019,Q2,Gamma-glutamyltransferase increased,,2019,Q2,1,I,20190226.0,20190325.0,20190402,20190402,EXP,FI-FIMEA-20190316,FI-TEVA-2019-FI-1031442,TEVA,,69.0,YR,,F,Y,,,20190403.0,,MD,FI,FI,2019,Q2,Elderly
161512721,16151272,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,, UNKNOWN,,,,,SOLUTION FOR INJECTION,,2019,Q2,Jaundice,,2019,Q2,1,I,20190226.0,20190325.0,20190402,20190402,EXP,FI-FIMEA-20190316,FI-TEVA-2019-FI-1031442,TEVA,,69.0,YR,,F,Y,,,20190403.0,,MD,FI,FI,2019,Q2,Elderly
161512721,16151272,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,, UNKNOWN,,,,,SOLUTION FOR INJECTION,,2019,Q2,Pruritus,,2019,Q2,1,I,20190226.0,20190325.0,20190402,20190402,EXP,FI-FIMEA-20190316,FI-TEVA-2019-FI-1031442,TEVA,,69.0,YR,,F,Y,,,20190403.0,,MD,FI,FI,2019,Q2,Elderly
161526081,16152608,3,C,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Acute myocardial infarction,,2019,Q2,1,I,20181224.0,20190322.0,20190403,20190403,EXP,,CO-BAXTER-2019BAX006047,BAXTER,,44.0,YR,,F,Y,79.0,KG,20190403.0,,CN,CO,CO,2019,Q2,Adult
161526081,16152608,3,C,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Cardiac failure,,2019,Q2,1,I,20181224.0,20190322.0,20190403,20190403,EXP,,CO-BAXTER-2019BAX006047,BAXTER,,44.0,YR,,F,Y,79.0,KG,20190403.0,,CN,CO,CO,2019,Q2,Adult
161526081,16152608,3,C,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Peritoneal dialysis complication,,2019,Q2,1,I,20181224.0,20190322.0,20190403,20190403,EXP,,CO-BAXTER-2019BAX006047,BAXTER,,44.0,YR,,F,Y,79.0,KG,20190403.0,,CN,CO,CO,2019,Q2,Adult
161541371,16154137,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Abdominal pain,,2019,Q2,1,I,,20190319.0,20190403,20190403,PER,,US-009507513-1904USA000356,MERCK,,60.0,YR,,F,Y,,,20190403.0,,CN,US,US,2019,Q2,Adult
161544872,16154487,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNKNOWN,,,D,,,,209196.0,,,SOLUTION FOR INJECTION,,2019,Q2,Apparent death,,2019,Q2,2,F,,20190405.0,20190403,20190410,EXP,,GB-SA-2019SA084415,SANOFI AVENTIS,,40.0,YR,A,M,Y,,,20190410.0,,CN,GB,GB,2019,Q2,Adult
161544872,16154487,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNKNOWN,,,D,,,,209196.0,,,SOLUTION FOR INJECTION,,2019,Q2,Blood glucose decreased,,2019,Q2,2,F,,20190405.0,20190403,20190410,EXP,,GB-SA-2019SA084415,SANOFI AVENTIS,,40.0,YR,A,M,Y,,,20190410.0,,CN,GB,GB,2019,Q2,Adult
161544872,16154487,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNKNOWN,,,D,,,,209196.0,,,SOLUTION FOR INJECTION,,2019,Q2,Road traffic accident,,2019,Q2,2,F,,20190405.0,20190403,20190410,EXP,,GB-SA-2019SA084415,SANOFI AVENTIS,,40.0,YR,A,M,Y,,,20190410.0,,CN,GB,GB,2019,Q2,Adult
161544872,16154487,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNKNOWN,,,D,,,,209196.0,,,SOLUTION FOR INJECTION,,2019,Q2,Wrong product administered,,2019,Q2,2,F,,20190405.0,20190403,20190410,EXP,,GB-SA-2019SA084415,SANOFI AVENTIS,,40.0,YR,A,M,Y,,,20190410.0,,CN,GB,GB,2019,Q2,Adult
161548645,16154864,1,PS,Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,,,2019,Q2,Acute kidney injury,,2019,Q2,5,F,2018.0,20190524.0,20190403,20190605,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20190605.0,,CN,PT,PT,2019,Q2,Elderly
161548645,16154864,1,PS,Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,,,2019,Q2,Arrhythmia,,2019,Q2,5,F,2018.0,20190524.0,20190403,20190605,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20190605.0,,CN,PT,PT,2019,Q2,Elderly
161548645,16154864,1,PS,Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,,,2019,Q2,Atrial fibrillation,,2019,Q2,5,F,2018.0,20190524.0,20190403,20190605,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20190605.0,,CN,PT,PT,2019,Q2,Elderly
161548645,16154864,1,PS,Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,,,2019,Q2,Bradycardia,,2019,Q2,5,F,2018.0,20190524.0,20190403,20190605,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20190605.0,,CN,PT,PT,2019,Q2,Elderly
161548645,16154864,1,PS,Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,,,2019,Q2,Dehydration,,2019,Q2,5,F,2018.0,20190524.0,20190403,20190605,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20190605.0,,CN,PT,PT,2019,Q2,Elderly
161548645,16154864,1,PS,Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,,,2019,Q2,Dizziness,,2019,Q2,5,F,2018.0,20190524.0,20190403,20190605,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20190605.0,,CN,PT,PT,2019,Q2,Elderly
161548645,16154864,1,PS,Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,,,2019,Q2,Haematocrit increased,,2019,Q2,5,F,2018.0,20190524.0,20190403,20190605,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20190605.0,,CN,PT,PT,2019,Q2,Elderly
161548645,16154864,1,PS,Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,,,2019,Q2,Haemoglobin increased,,2019,Q2,5,F,2018.0,20190524.0,20190403,20190605,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20190605.0,,CN,PT,PT,2019,Q2,Elderly
161548645,16154864,1,PS,Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,,,2019,Q2,Hypotension,,2019,Q2,5,F,2018.0,20190524.0,20190403,20190605,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20190605.0,,CN,PT,PT,2019,Q2,Elderly
161548645,16154864,1,PS,Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,,,2019,Q2,Hypovolaemia,,2019,Q2,5,F,2018.0,20190524.0,20190403,20190605,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20190605.0,,CN,PT,PT,2019,Q2,Elderly
161548645,16154864,1,PS,Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,,,2019,Q2,Left atrial dilatation,,2019,Q2,5,F,2018.0,20190524.0,20190403,20190605,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20190605.0,,CN,PT,PT,2019,Q2,Elderly
161548645,16154864,1,PS,Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,,,2019,Q2,Mucosal dryness,,2019,Q2,5,F,2018.0,20190524.0,20190403,20190605,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20190605.0,,CN,PT,PT,2019,Q2,Elderly
161548645,16154864,1,PS,Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,,,2019,Q2,Presyncope,,2019,Q2,5,F,2018.0,20190524.0,20190403,20190605,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20190605.0,,CN,PT,PT,2019,Q2,Elderly
161548645,16154864,1,PS,Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,,,2019,Q2,Skin disorder,,2019,Q2,5,F,2018.0,20190524.0,20190403,20190605,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20190605.0,,CN,PT,PT,2019,Q2,Elderly
161548645,16154864,1,PS,Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,,,2019,Q2,Syncope,,2019,Q2,5,F,2018.0,20190524.0,20190403,20190605,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20190605.0,,CN,PT,PT,2019,Q2,Elderly
161550151,16155015,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"14 IU, EACH MORNING",,,,,,,,14.0,IU,,QD,2019,Q2,Blood glucose abnormal,,2019,Q2,1,I,,20190328.0,20190403,20190403,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201903016020,ELI LILLY AND CO,,57.0,YR,,M,Y,62.0,KG,20190403.0,,CN,CN,CN,2019,Q2,Adult
161550151,16155015,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"14 IU, EACH MORNING",,,,,,,,14.0,IU,,QD,2019,Q2,Hypoglycaemia,,2019,Q2,1,I,,20190328.0,20190403,20190403,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201903016020,ELI LILLY AND CO,,57.0,YR,,M,Y,62.0,KG,20190403.0,,CN,CN,CN,2019,Q2,Adult
161550151,16155015,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"14 IU, EACH MORNING",,,,,,,,14.0,IU,,QD,2019,Q2,Pulmonary mass,,2019,Q2,1,I,,20190328.0,20190403,20190403,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201903016020,ELI LILLY AND CO,,57.0,YR,,M,Y,62.0,KG,20190403.0,,CN,CN,CN,2019,Q2,Adult
161550151,16155015,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"14 IU, EACH MORNING",,,,,,,,14.0,IU,,QD,2019,Q2,Vascular skin disorder,,2019,Q2,1,I,,20190328.0,20190403,20190403,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201903016020,ELI LILLY AND CO,,57.0,YR,,M,Y,62.0,KG,20190403.0,,CN,CN,CN,2019,Q2,Adult
161550151,16155015,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"6 IU, BID(NOON AND NIGHT)",,,,,,,,6.0,IU,,BID,2019,Q2,Blood glucose abnormal,,2019,Q2,1,I,,20190328.0,20190403,20190403,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201903016020,ELI LILLY AND CO,,57.0,YR,,M,Y,62.0,KG,20190403.0,,CN,CN,CN,2019,Q2,Adult
161550151,16155015,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"6 IU, BID(NOON AND NIGHT)",,,,,,,,6.0,IU,,BID,2019,Q2,Hypoglycaemia,,2019,Q2,1,I,,20190328.0,20190403,20190403,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201903016020,ELI LILLY AND CO,,57.0,YR,,M,Y,62.0,KG,20190403.0,,CN,CN,CN,2019,Q2,Adult
161550151,16155015,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"6 IU, BID(NOON AND NIGHT)",,,,,,,,6.0,IU,,BID,2019,Q2,Pulmonary mass,,2019,Q2,1,I,,20190328.0,20190403,20190403,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201903016020,ELI LILLY AND CO,,57.0,YR,,M,Y,62.0,KG,20190403.0,,CN,CN,CN,2019,Q2,Adult
161550151,16155015,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"6 IU, BID(NOON AND NIGHT)",,,,,,,,6.0,IU,,BID,2019,Q2,Vascular skin disorder,,2019,Q2,1,I,,20190328.0,20190403,20190403,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201903016020,ELI LILLY AND CO,,57.0,YR,,M,Y,62.0,KG,20190403.0,,CN,CN,CN,2019,Q2,Adult
161583453,16158345,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"4 IU, TID(MORNING, NOON, NIGHT)",,,,,,,,4.0,IU,,TID,2019,Q2,Blood glucose decreased,,2019,Q2,3,F,201903.0,20190401.0,20190404,20190409,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201904001658,ELI LILLY AND CO,,87.0,YR,,F,Y,60.0,KG,20190409.0,,CN,CN,CN,2019,Q2,Elderly
161583453,16158345,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"4 IU, TID(MORNING, NOON, NIGHT)",,,,,,,,4.0,IU,,TID,2019,Q2,Blood glucose increased,,2019,Q2,3,F,201903.0,20190401.0,20190404,20190409,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201904001658,ELI LILLY AND CO,,87.0,YR,,F,Y,60.0,KG,20190409.0,,CN,CN,CN,2019,Q2,Elderly
161583453,16158345,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"4 IU, TID(MORNING, NOON, NIGHT)",,,,,,,,4.0,IU,,TID,2019,Q2,Product dose omission,,2019,Q2,3,F,201903.0,20190401.0,20190404,20190409,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201904001658,ELI LILLY AND CO,,87.0,YR,,F,Y,60.0,KG,20190409.0,,CN,CN,CN,2019,Q2,Elderly
161583453,16158345,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"5-6 IU, TID (MORNING,NOON, NIGHT)",,,,,,,,6.0,IU,,TID,2019,Q2,Blood glucose decreased,,2019,Q2,3,F,201903.0,20190401.0,20190404,20190409,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201904001658,ELI LILLY AND CO,,87.0,YR,,F,Y,60.0,KG,20190409.0,,CN,CN,CN,2019,Q2,Elderly
161583453,16158345,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"5-6 IU, TID (MORNING,NOON, NIGHT)",,,,,,,,6.0,IU,,TID,2019,Q2,Blood glucose increased,,2019,Q2,3,F,201903.0,20190401.0,20190404,20190409,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201904001658,ELI LILLY AND CO,,87.0,YR,,F,Y,60.0,KG,20190409.0,,CN,CN,CN,2019,Q2,Elderly
161583453,16158345,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"5-6 IU, TID (MORNING,NOON, NIGHT)",,,,,,,,6.0,IU,,TID,2019,Q2,Product dose omission,,2019,Q2,3,F,201903.0,20190401.0,20190404,20190409,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201904001658,ELI LILLY AND CO,,87.0,YR,,F,Y,60.0,KG,20190409.0,,CN,CN,CN,2019,Q2,Elderly
161590298,16159029,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2019,Q2,Abdominal pain,,2019,Q2,8,F,20190102.0,20190610.0,20190404,20190618,EXP,,PHHO2019US000774,SANDOZ,,51.0,YR,,M,Y,85.4,KG,20190618.0,,OT,US,US,2019,Q2,Adult
161590298,16159029,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2019,Q2,Acute kidney injury,,2019,Q2,8,F,20190102.0,20190610.0,20190404,20190618,EXP,,PHHO2019US000774,SANDOZ,,51.0,YR,,M,Y,85.4,KG,20190618.0,,OT,US,US,2019,Q2,Adult
161590298,16159029,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2019,Q2,Chondrocalcinosis pyrophosphate,,2019,Q2,8,F,20190102.0,20190610.0,20190404,20190618,EXP,,PHHO2019US000774,SANDOZ,,51.0,YR,,M,Y,85.4,KG,20190618.0,,OT,US,US,2019,Q2,Adult
161590298,16159029,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2019,Q2,Chronic kidney disease,,2019,Q2,8,F,20190102.0,20190610.0,20190404,20190618,EXP,,PHHO2019US000774,SANDOZ,,51.0,YR,,M,Y,85.4,KG,20190618.0,,OT,US,US,2019,Q2,Adult
161590298,16159029,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2019,Q2,Diarrhoea,,2019,Q2,8,F,20190102.0,20190610.0,20190404,20190618,EXP,,PHHO2019US000774,SANDOZ,,51.0,YR,,M,Y,85.4,KG,20190618.0,,OT,US,US,2019,Q2,Adult
161590298,16159029,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2019,Q2,Dyspnoea,,2019,Q2,8,F,20190102.0,20190610.0,20190404,20190618,EXP,,PHHO2019US000774,SANDOZ,,51.0,YR,,M,Y,85.4,KG,20190618.0,,OT,US,US,2019,Q2,Adult
161590298,16159029,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2019,Q2,Flank pain,,2019,Q2,8,F,20190102.0,20190610.0,20190404,20190618,EXP,,PHHO2019US000774,SANDOZ,,51.0,YR,,M,Y,85.4,KG,20190618.0,,OT,US,US,2019,Q2,Adult
161590298,16159029,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2019,Q2,Hydronephrosis,,2019,Q2,8,F,20190102.0,20190610.0,20190404,20190618,EXP,,PHHO2019US000774,SANDOZ,,51.0,YR,,M,Y,85.4,KG,20190618.0,,OT,US,US,2019,Q2,Adult
161590298,16159029,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2019,Q2,Hyperkalaemia,,2019,Q2,8,F,20190102.0,20190610.0,20190404,20190618,EXP,,PHHO2019US000774,SANDOZ,,51.0,YR,,M,Y,85.4,KG,20190618.0,,OT,US,US,2019,Q2,Adult
161590298,16159029,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2019,Q2,Melaena,,2019,Q2,8,F,20190102.0,20190610.0,20190404,20190618,EXP,,PHHO2019US000774,SANDOZ,,51.0,YR,,M,Y,85.4,KG,20190618.0,,OT,US,US,2019,Q2,Adult
161590298,16159029,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2019,Q2,Nephrolithiasis,,2019,Q2,8,F,20190102.0,20190610.0,20190404,20190618,EXP,,PHHO2019US000774,SANDOZ,,51.0,YR,,M,Y,85.4,KG,20190618.0,,OT,US,US,2019,Q2,Adult
161590298,16159029,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2019,Q2,Pyelonephritis,,2019,Q2,8,F,20190102.0,20190610.0,20190404,20190618,EXP,,PHHO2019US000774,SANDOZ,,51.0,YR,,M,Y,85.4,KG,20190618.0,,OT,US,US,2019,Q2,Adult
161590298,16159029,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2019,Q2,Pyuria,,2019,Q2,8,F,20190102.0,20190610.0,20190404,20190618,EXP,,PHHO2019US000774,SANDOZ,,51.0,YR,,M,Y,85.4,KG,20190618.0,,OT,US,US,2019,Q2,Adult
161590298,16159029,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2019,Q2,Sepsis,,2019,Q2,8,F,20190102.0,20190610.0,20190404,20190618,EXP,,PHHO2019US000774,SANDOZ,,51.0,YR,,M,Y,85.4,KG,20190618.0,,OT,US,US,2019,Q2,Adult
161590298,16159029,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2019,Q2,Ureterolithiasis,,2019,Q2,8,F,20190102.0,20190610.0,20190404,20190618,EXP,,PHHO2019US000774,SANDOZ,,51.0,YR,,M,Y,85.4,KG,20190618.0,,OT,US,US,2019,Q2,Adult
161590298,16159029,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2019,Q2,Urinary tract infection,,2019,Q2,8,F,20190102.0,20190610.0,20190404,20190618,EXP,,PHHO2019US000774,SANDOZ,,51.0,YR,,M,Y,85.4,KG,20190618.0,,OT,US,US,2019,Q2,Adult
161590298,16159029,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2019,Q2,Vomiting,,2019,Q2,8,F,20190102.0,20190610.0,20190404,20190618,EXP,,PHHO2019US000774,SANDOZ,,51.0,YR,,M,Y,85.4,KG,20190618.0,,OT,US,US,2019,Q2,Adult
161607622,16160762,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,0-5 UNITS AND MILD CORRECTIVE SCALE,,,,,,,,,,,,2019,Q2,Haemoptysis,,2019,Q2,2,F,20190323.0,20190402.0,20190405,20190409,EXP,,US-ROCHE-2292788,ROCHE,,68.0,YR,,M,Y,80.1,KG,20190409.0,,MD,US,US,2019,Q2,Elderly
161618733,16161873,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2019,Q2,Acute kidney injury,,2019,Q2,3,F,2018.0,20190521.0,20190405,20190527,EXP,,PT-SA-2019SA092645,SANOFI AVENTIS,,71.0,YR,E,M,Y,,,20190527.0,,MD,PT,PT,2019,Q2,Elderly
161618733,16161873,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2019,Q2,Arrhythmia,,2019,Q2,3,F,2018.0,20190521.0,20190405,20190527,EXP,,PT-SA-2019SA092645,SANOFI AVENTIS,,71.0,YR,E,M,Y,,,20190527.0,,MD,PT,PT,2019,Q2,Elderly
161618733,16161873,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2019,Q2,Atrial fibrillation,,2019,Q2,3,F,2018.0,20190521.0,20190405,20190527,EXP,,PT-SA-2019SA092645,SANOFI AVENTIS,,71.0,YR,E,M,Y,,,20190527.0,,MD,PT,PT,2019,Q2,Elderly
161618733,16161873,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2019,Q2,Bradycardia,,2019,Q2,3,F,2018.0,20190521.0,20190405,20190527,EXP,,PT-SA-2019SA092645,SANOFI AVENTIS,,71.0,YR,E,M,Y,,,20190527.0,,MD,PT,PT,2019,Q2,Elderly
161618733,16161873,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2019,Q2,Dehydration,,2019,Q2,3,F,2018.0,20190521.0,20190405,20190527,EXP,,PT-SA-2019SA092645,SANOFI AVENTIS,,71.0,YR,E,M,Y,,,20190527.0,,MD,PT,PT,2019,Q2,Elderly
161618733,16161873,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2019,Q2,Dizziness,,2019,Q2,3,F,2018.0,20190521.0,20190405,20190527,EXP,,PT-SA-2019SA092645,SANOFI AVENTIS,,71.0,YR,E,M,Y,,,20190527.0,,MD,PT,PT,2019,Q2,Elderly
161618733,16161873,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2019,Q2,Haematocrit increased,,2019,Q2,3,F,2018.0,20190521.0,20190405,20190527,EXP,,PT-SA-2019SA092645,SANOFI AVENTIS,,71.0,YR,E,M,Y,,,20190527.0,,MD,PT,PT,2019,Q2,Elderly
161618733,16161873,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2019,Q2,Haemoglobin increased,,2019,Q2,3,F,2018.0,20190521.0,20190405,20190527,EXP,,PT-SA-2019SA092645,SANOFI AVENTIS,,71.0,YR,E,M,Y,,,20190527.0,,MD,PT,PT,2019,Q2,Elderly
161618733,16161873,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2019,Q2,Hypotension,,2019,Q2,3,F,2018.0,20190521.0,20190405,20190527,EXP,,PT-SA-2019SA092645,SANOFI AVENTIS,,71.0,YR,E,M,Y,,,20190527.0,,MD,PT,PT,2019,Q2,Elderly
161618733,16161873,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2019,Q2,Hypovolaemia,,2019,Q2,3,F,2018.0,20190521.0,20190405,20190527,EXP,,PT-SA-2019SA092645,SANOFI AVENTIS,,71.0,YR,E,M,Y,,,20190527.0,,MD,PT,PT,2019,Q2,Elderly
161618733,16161873,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2019,Q2,Left atrial dilatation,,2019,Q2,3,F,2018.0,20190521.0,20190405,20190527,EXP,,PT-SA-2019SA092645,SANOFI AVENTIS,,71.0,YR,E,M,Y,,,20190527.0,,MD,PT,PT,2019,Q2,Elderly
161618733,16161873,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2019,Q2,Mucosal dryness,,2019,Q2,3,F,2018.0,20190521.0,20190405,20190527,EXP,,PT-SA-2019SA092645,SANOFI AVENTIS,,71.0,YR,E,M,Y,,,20190527.0,,MD,PT,PT,2019,Q2,Elderly
161618733,16161873,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2019,Q2,Presyncope,,2019,Q2,3,F,2018.0,20190521.0,20190405,20190527,EXP,,PT-SA-2019SA092645,SANOFI AVENTIS,,71.0,YR,E,M,Y,,,20190527.0,,MD,PT,PT,2019,Q2,Elderly
161618733,16161873,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2019,Q2,Skin disorder,,2019,Q2,3,F,2018.0,20190521.0,20190405,20190527,EXP,,PT-SA-2019SA092645,SANOFI AVENTIS,,71.0,YR,E,M,Y,,,20190527.0,,MD,PT,PT,2019,Q2,Elderly
161618733,16161873,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2019,Q2,Syncope,,2019,Q2,3,F,2018.0,20190521.0,20190405,20190527,EXP,,PT-SA-2019SA092645,SANOFI AVENTIS,,71.0,YR,E,M,Y,,,20190527.0,,MD,PT,PT,2019,Q2,Elderly
161630591,16163059,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Anti-GAD antibody positive,,2019,Q2,1,I,2011.0,20170221.0,20190405,20190405,PER,,JP-SAKK-BA201701010001,SANOFI AVENTIS,"SUGIYAMA T, KISHI S, ISOGAWA A, IMAI M, SHIBA M, KIKUSHIMA H, FUSE Y. A CASE OF LOCAL SUBCUTANEOUS AMYLOID DEPOSITION WITH POSITIVITY FOR ANTI-GAD ANTIBODY. THE 54TH KANTO-KOSHINETSU REGIONAL MEETING OF THE JAPAN DIABETES SOCIETY. 2017;UNK:206",76.0,YR,E,F,Y,,,20190405.0,,MD,JP,JP,2019,Q2,Elderly
161630591,16163059,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Cutaneous amyloidosis,,2019,Q2,1,I,2011.0,20170221.0,20190405,20190405,PER,,JP-SAKK-BA201701010001,SANOFI AVENTIS,"SUGIYAMA T, KISHI S, ISOGAWA A, IMAI M, SHIBA M, KIKUSHIMA H, FUSE Y. A CASE OF LOCAL SUBCUTANEOUS AMYLOID DEPOSITION WITH POSITIVITY FOR ANTI-GAD ANTIBODY. THE 54TH KANTO-KOSHINETSU REGIONAL MEETING OF THE JAPAN DIABETES SOCIETY. 2017;UNK:206",76.0,YR,E,F,Y,,,20190405.0,,MD,JP,JP,2019,Q2,Elderly
161630591,16163059,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Hyperglycaemia,,2019,Q2,1,I,2011.0,20170221.0,20190405,20190405,PER,,JP-SAKK-BA201701010001,SANOFI AVENTIS,"SUGIYAMA T, KISHI S, ISOGAWA A, IMAI M, SHIBA M, KIKUSHIMA H, FUSE Y. A CASE OF LOCAL SUBCUTANEOUS AMYLOID DEPOSITION WITH POSITIVITY FOR ANTI-GAD ANTIBODY. THE 54TH KANTO-KOSHINETSU REGIONAL MEETING OF THE JAPAN DIABETES SOCIETY. 2017;UNK:206",76.0,YR,E,F,Y,,,20190405.0,,MD,JP,JP,2019,Q2,Elderly
161637021,16163702,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"66 U, TID",,,,,,,209196.0,,,SOLUTION FOR INJECTION,Q8H,2019,Q2,Cardiac failure congestive,,2019,Q2,1,I,,20190401.0,20190405,20190405,EXP,,US-SA-2019SA092042,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20190405.0,,CN,US,US,2019,Q2,Elderly
161637337,16163733,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q2,Acute kidney injury,,2019,Q2,7,F,2018.0,20190527.0,20190405,20190530,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20190530.0,,MD,PT,PT,2019,Q2,Elderly
161637337,16163733,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q2,Arrhythmia,,2019,Q2,7,F,2018.0,20190527.0,20190405,20190530,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20190530.0,,MD,PT,PT,2019,Q2,Elderly
161637337,16163733,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q2,Atrial fibrillation,,2019,Q2,7,F,2018.0,20190527.0,20190405,20190530,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20190530.0,,MD,PT,PT,2019,Q2,Elderly
161637337,16163733,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q2,Bradycardia,,2019,Q2,7,F,2018.0,20190527.0,20190405,20190530,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20190530.0,,MD,PT,PT,2019,Q2,Elderly
161637337,16163733,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q2,Dehydration,,2019,Q2,7,F,2018.0,20190527.0,20190405,20190530,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20190530.0,,MD,PT,PT,2019,Q2,Elderly
161637337,16163733,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q2,Dizziness,,2019,Q2,7,F,2018.0,20190527.0,20190405,20190530,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20190530.0,,MD,PT,PT,2019,Q2,Elderly
161637337,16163733,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q2,Haematocrit increased,,2019,Q2,7,F,2018.0,20190527.0,20190405,20190530,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20190530.0,,MD,PT,PT,2019,Q2,Elderly
161637337,16163733,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q2,Haemoglobin increased,,2019,Q2,7,F,2018.0,20190527.0,20190405,20190530,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20190530.0,,MD,PT,PT,2019,Q2,Elderly
161637337,16163733,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q2,Hypotension,,2019,Q2,7,F,2018.0,20190527.0,20190405,20190530,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20190530.0,,MD,PT,PT,2019,Q2,Elderly
161637337,16163733,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q2,Hypovolaemia,,2019,Q2,7,F,2018.0,20190527.0,20190405,20190530,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20190530.0,,MD,PT,PT,2019,Q2,Elderly
161637337,16163733,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q2,Left atrial dilatation,,2019,Q2,7,F,2018.0,20190527.0,20190405,20190530,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20190530.0,,MD,PT,PT,2019,Q2,Elderly
161637337,16163733,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q2,Mucosal dryness,,2019,Q2,7,F,2018.0,20190527.0,20190405,20190530,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20190530.0,,MD,PT,PT,2019,Q2,Elderly
161637337,16163733,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q2,Presyncope,,2019,Q2,7,F,2018.0,20190527.0,20190405,20190530,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20190530.0,,MD,PT,PT,2019,Q2,Elderly
161637337,16163733,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q2,Skin disorder,,2019,Q2,7,F,2018.0,20190527.0,20190405,20190530,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20190530.0,,MD,PT,PT,2019,Q2,Elderly
161637337,16163733,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q2,Syncope,,2019,Q2,7,F,2018.0,20190527.0,20190405,20190530,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20190530.0,,MD,PT,PT,2019,Q2,Elderly
161637337,16163733,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2019,Q2,Acute kidney injury,,2019,Q2,7,F,2018.0,20190527.0,20190405,20190530,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20190530.0,,MD,PT,PT,2019,Q2,Elderly
161637337,16163733,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2019,Q2,Arrhythmia,,2019,Q2,7,F,2018.0,20190527.0,20190405,20190530,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20190530.0,,MD,PT,PT,2019,Q2,Elderly
161637337,16163733,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2019,Q2,Atrial fibrillation,,2019,Q2,7,F,2018.0,20190527.0,20190405,20190530,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20190530.0,,MD,PT,PT,2019,Q2,Elderly
161637337,16163733,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2019,Q2,Bradycardia,,2019,Q2,7,F,2018.0,20190527.0,20190405,20190530,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20190530.0,,MD,PT,PT,2019,Q2,Elderly
161637337,16163733,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2019,Q2,Dehydration,,2019,Q2,7,F,2018.0,20190527.0,20190405,20190530,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20190530.0,,MD,PT,PT,2019,Q2,Elderly
161637337,16163733,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2019,Q2,Dizziness,,2019,Q2,7,F,2018.0,20190527.0,20190405,20190530,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20190530.0,,MD,PT,PT,2019,Q2,Elderly
161637337,16163733,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2019,Q2,Haematocrit increased,,2019,Q2,7,F,2018.0,20190527.0,20190405,20190530,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20190530.0,,MD,PT,PT,2019,Q2,Elderly
161637337,16163733,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2019,Q2,Haemoglobin increased,,2019,Q2,7,F,2018.0,20190527.0,20190405,20190530,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20190530.0,,MD,PT,PT,2019,Q2,Elderly
161637337,16163733,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2019,Q2,Hypotension,,2019,Q2,7,F,2018.0,20190527.0,20190405,20190530,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20190530.0,,MD,PT,PT,2019,Q2,Elderly
161637337,16163733,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2019,Q2,Hypovolaemia,,2019,Q2,7,F,2018.0,20190527.0,20190405,20190530,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20190530.0,,MD,PT,PT,2019,Q2,Elderly
161637337,16163733,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2019,Q2,Left atrial dilatation,,2019,Q2,7,F,2018.0,20190527.0,20190405,20190530,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20190530.0,,MD,PT,PT,2019,Q2,Elderly
161637337,16163733,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2019,Q2,Mucosal dryness,,2019,Q2,7,F,2018.0,20190527.0,20190405,20190530,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20190530.0,,MD,PT,PT,2019,Q2,Elderly
161637337,16163733,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2019,Q2,Presyncope,,2019,Q2,7,F,2018.0,20190527.0,20190405,20190530,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20190530.0,,MD,PT,PT,2019,Q2,Elderly
161637337,16163733,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2019,Q2,Skin disorder,,2019,Q2,7,F,2018.0,20190527.0,20190405,20190530,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20190530.0,,MD,PT,PT,2019,Q2,Elderly
161637337,16163733,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2019,Q2,Syncope,,2019,Q2,7,F,2018.0,20190527.0,20190405,20190530,EXP,,PT-PFIZER INC-2019149489,PFIZER,"GOUVEIA, C.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20190530.0,,MD,PT,PT,2019,Q2,Elderly
161718541,16171854,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"11 [IU], SINGLE",,,,,,,20563.0,11.0,IU,,,2019,Q2,Bradyphrenia,,2019,Q2,1,I,20190228.0,20190327.0,20190408,20190408,EXP,IT-MINISAL02-539676,IT-ELI_LILLY_AND_COMPANY-IT201904000283,ELI LILLY AND CO,,77.0,YR,,F,Y,,,20190408.0,,CN,IT,IT,2019,Q2,Elderly
161718541,16171854,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"11 [IU], SINGLE",,,,,,,20563.0,11.0,IU,,,2019,Q2,Disorientation,,2019,Q2,1,I,20190228.0,20190327.0,20190408,20190408,EXP,IT-MINISAL02-539676,IT-ELI_LILLY_AND_COMPANY-IT201904000283,ELI LILLY AND CO,,77.0,YR,,F,Y,,,20190408.0,,CN,IT,IT,2019,Q2,Elderly
161718541,16171854,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"11 [IU], SINGLE",,,,,,,20563.0,11.0,IU,,,2019,Q2,Hypoglycaemia,,2019,Q2,1,I,20190228.0,20190327.0,20190408,20190408,EXP,IT-MINISAL02-539676,IT-ELI_LILLY_AND_COMPANY-IT201904000283,ELI LILLY AND CO,,77.0,YR,,F,Y,,,20190408.0,,CN,IT,IT,2019,Q2,Elderly
161718541,16171854,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"11 [IU], SINGLE",,,,,,,20563.0,11.0,IU,,,2019,Q2,Movement disorder,,2019,Q2,1,I,20190228.0,20190327.0,20190408,20190408,EXP,IT-MINISAL02-539676,IT-ELI_LILLY_AND_COMPANY-IT201904000283,ELI LILLY AND CO,,77.0,YR,,F,Y,,,20190408.0,,CN,IT,IT,2019,Q2,Elderly
161718541,16171854,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"11 [IU], SINGLE",,,,,,,20563.0,11.0,IU,,,2019,Q2,Sopor,,2019,Q2,1,I,20190228.0,20190327.0,20190408,20190408,EXP,IT-MINISAL02-539676,IT-ELI_LILLY_AND_COMPANY-IT201904000283,ELI LILLY AND CO,,77.0,YR,,F,Y,,,20190408.0,,CN,IT,IT,2019,Q2,Elderly
161736701,16173670,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,1998.0,IU,,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2019,Q2,Hypoglycaemia,,2019,Q2,1,I,20190325.0,20190405.0,20190409,20190409,EXP,IT-MINISAL02-540222,IT-SA-2019SA096721,SANOFI AVENTIS,,83.0,YR,E,F,Y,,,20190409.0,,MD,IT,IT,2019,Q2,Elderly
161736701,16173670,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,1998.0,IU,,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2019,Q2,Loss of consciousness,,2019,Q2,1,I,20190325.0,20190405.0,20190409,20190409,EXP,IT-MINISAL02-540222,IT-SA-2019SA096721,SANOFI AVENTIS,,83.0,YR,E,F,Y,,,20190409.0,,MD,IT,IT,2019,Q2,Elderly
161736701,16173670,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,1998.0,IU,,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2019,Q2,Overdose,,2019,Q2,1,I,20190325.0,20190405.0,20190409,20190409,EXP,IT-MINISAL02-540222,IT-SA-2019SA096721,SANOFI AVENTIS,,83.0,YR,E,F,Y,,,20190409.0,,MD,IT,IT,2019,Q2,Elderly
161755921,16175592,11,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,100 UNIT/ML,,,,,,,,,,UNKNOWN,TID,2019,Q2,Pancytopenia,,2019,Q2,1,I,20190312.0,20190327.0,20190409,20190409,PER,,US-CELGENEUS-USA-20190311106,CELGENE,,71.0,YR,,F,Y,,,20190409.0,,MD,US,US,2019,Q2,Elderly
161758983,16175898,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q2,Acute kidney injury,,2019,Q2,3,F,20190306.0,20190430.0,20190409,20190507,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-034339,BRISTOL MYERS SQUIBB,,53.0,YR,,M,Y,86.0,KG,20190507.0,,OT,US,US,2019,Q2,Adult
161758983,16175898,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q2,Confusional state,,2019,Q2,3,F,20190306.0,20190430.0,20190409,20190507,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-034339,BRISTOL MYERS SQUIBB,,53.0,YR,,M,Y,86.0,KG,20190507.0,,OT,US,US,2019,Q2,Adult
161758983,16175898,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q2,Hypercalcaemia,,2019,Q2,3,F,20190306.0,20190430.0,20190409,20190507,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-034339,BRISTOL MYERS SQUIBB,,53.0,YR,,M,Y,86.0,KG,20190507.0,,OT,US,US,2019,Q2,Adult
161758983,16175898,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q2,Left ventricular dysfunction,,2019,Q2,3,F,20190306.0,20190430.0,20190409,20190507,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-034339,BRISTOL MYERS SQUIBB,,53.0,YR,,M,Y,86.0,KG,20190507.0,,OT,US,US,2019,Q2,Adult
161758983,16175898,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q2,Pericardial effusion,,2019,Q2,3,F,20190306.0,20190430.0,20190409,20190507,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-034339,BRISTOL MYERS SQUIBB,,53.0,YR,,M,Y,86.0,KG,20190507.0,,OT,US,US,2019,Q2,Adult
161758983,16175898,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q2,Pneumonia,,2019,Q2,3,F,20190306.0,20190430.0,20190409,20190507,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-034339,BRISTOL MYERS SQUIBB,,53.0,YR,,M,Y,86.0,KG,20190507.0,,OT,US,US,2019,Q2,Adult
161758983,16175898,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q2,Respiratory failure,,2019,Q2,3,F,20190306.0,20190430.0,20190409,20190507,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-034339,BRISTOL MYERS SQUIBB,,53.0,YR,,M,Y,86.0,KG,20190507.0,,OT,US,US,2019,Q2,Adult
161758983,16175898,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q2,Sepsis,,2019,Q2,3,F,20190306.0,20190430.0,20190409,20190507,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-034339,BRISTOL MYERS SQUIBB,,53.0,YR,,M,Y,86.0,KG,20190507.0,,OT,US,US,2019,Q2,Adult
161768032,16176803,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 U, TID",,,,U,,,,,,,TID,2019,Q2,Abdominal pain,,2019,Q2,2,F,20180302.0,20190429.0,20190409,20190507,EXP,,US-ACTELION-A-NJ2018-168747,ACTELION,,68.0,YR,,F,Y,,,20190507.0,,PH,US,US,2019,Q2,Elderly
161768032,16176803,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 U, TID",,,,U,,,,,,,TID,2019,Q2,Acquired cystic kidney disease,,2019,Q2,2,F,20180302.0,20190429.0,20190409,20190507,EXP,,US-ACTELION-A-NJ2018-168747,ACTELION,,68.0,YR,,F,Y,,,20190507.0,,PH,US,US,2019,Q2,Elderly
161768032,16176803,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 U, TID",,,,U,,,,,,,TID,2019,Q2,Chest pain,,2019,Q2,2,F,20180302.0,20190429.0,20190409,20190507,EXP,,US-ACTELION-A-NJ2018-168747,ACTELION,,68.0,YR,,F,Y,,,20190507.0,,PH,US,US,2019,Q2,Elderly
161768032,16176803,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 U, TID",,,,U,,,,,,,TID,2019,Q2,Death,,2019,Q2,2,F,20180302.0,20190429.0,20190409,20190507,EXP,,US-ACTELION-A-NJ2018-168747,ACTELION,,68.0,YR,,F,Y,,,20190507.0,,PH,US,US,2019,Q2,Elderly
161768032,16176803,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 U, TID",,,,U,,,,,,,TID,2019,Q2,Dyspnoea,,2019,Q2,2,F,20180302.0,20190429.0,20190409,20190507,EXP,,US-ACTELION-A-NJ2018-168747,ACTELION,,68.0,YR,,F,Y,,,20190507.0,,PH,US,US,2019,Q2,Elderly
161768032,16176803,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 U, TID",,,,U,,,,,,,TID,2019,Q2,Gastrooesophageal reflux disease,,2019,Q2,2,F,20180302.0,20190429.0,20190409,20190507,EXP,,US-ACTELION-A-NJ2018-168747,ACTELION,,68.0,YR,,F,Y,,,20190507.0,,PH,US,US,2019,Q2,Elderly
161768032,16176803,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 U, TID",,,,U,,,,,,,TID,2019,Q2,Lung consolidation,,2019,Q2,2,F,20180302.0,20190429.0,20190409,20190507,EXP,,US-ACTELION-A-NJ2018-168747,ACTELION,,68.0,YR,,F,Y,,,20190507.0,,PH,US,US,2019,Q2,Elderly
161768032,16176803,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 U, TID",,,,U,,,,,,,TID,2019,Q2,Musculoskeletal pain,,2019,Q2,2,F,20180302.0,20190429.0,20190409,20190507,EXP,,US-ACTELION-A-NJ2018-168747,ACTELION,,68.0,YR,,F,Y,,,20190507.0,,PH,US,US,2019,Q2,Elderly
161768032,16176803,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 U, TID",,,,U,,,,,,,TID,2019,Q2,Pneumonia,,2019,Q2,2,F,20180302.0,20190429.0,20190409,20190507,EXP,,US-ACTELION-A-NJ2018-168747,ACTELION,,68.0,YR,,F,Y,,,20190507.0,,PH,US,US,2019,Q2,Elderly
161768032,16176803,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 U, TID",,,,U,,,,,,,TID,2019,Q2,Product dose omission,,2019,Q2,2,F,20180302.0,20190429.0,20190409,20190507,EXP,,US-ACTELION-A-NJ2018-168747,ACTELION,,68.0,YR,,F,Y,,,20190507.0,,PH,US,US,2019,Q2,Elderly
161768032,16176803,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 U, TID",,,,U,,,,,,,TID,2019,Q2,Splenic lesion,,2019,Q2,2,F,20180302.0,20190429.0,20190409,20190507,EXP,,US-ACTELION-A-NJ2018-168747,ACTELION,,68.0,YR,,F,Y,,,20190507.0,,PH,US,US,2019,Q2,Elderly
161778165,16177816,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q2,Acute kidney injury,,2019,Q2,5,F,2018.0,20190531.0,20190410,20190610,EXP,,PT-009507513-1904PRT000791,MERCK,"GOUVEIA C. DUQUE S, CAMPOS L. LIPOTYMIA BY HYPOVOLEMIA-A CASE OF IATROGENIA TO EMPAGLIFLOZINA?. MARIANA ROCHA. 2019",71.0,YR,,M,Y,,,20190610.0,,MD,PT,PT,2019,Q2,Elderly
161778165,16177816,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q2,Arrhythmia,,2019,Q2,5,F,2018.0,20190531.0,20190410,20190610,EXP,,PT-009507513-1904PRT000791,MERCK,"GOUVEIA C. DUQUE S, CAMPOS L. LIPOTYMIA BY HYPOVOLEMIA-A CASE OF IATROGENIA TO EMPAGLIFLOZINA?. MARIANA ROCHA. 2019",71.0,YR,,M,Y,,,20190610.0,,MD,PT,PT,2019,Q2,Elderly
161778165,16177816,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q2,Atrial fibrillation,,2019,Q2,5,F,2018.0,20190531.0,20190410,20190610,EXP,,PT-009507513-1904PRT000791,MERCK,"GOUVEIA C. DUQUE S, CAMPOS L. LIPOTYMIA BY HYPOVOLEMIA-A CASE OF IATROGENIA TO EMPAGLIFLOZINA?. MARIANA ROCHA. 2019",71.0,YR,,M,Y,,,20190610.0,,MD,PT,PT,2019,Q2,Elderly
161778165,16177816,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q2,Bradycardia,,2019,Q2,5,F,2018.0,20190531.0,20190410,20190610,EXP,,PT-009507513-1904PRT000791,MERCK,"GOUVEIA C. DUQUE S, CAMPOS L. LIPOTYMIA BY HYPOVOLEMIA-A CASE OF IATROGENIA TO EMPAGLIFLOZINA?. MARIANA ROCHA. 2019",71.0,YR,,M,Y,,,20190610.0,,MD,PT,PT,2019,Q2,Elderly
161778165,16177816,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q2,Dehydration,,2019,Q2,5,F,2018.0,20190531.0,20190410,20190610,EXP,,PT-009507513-1904PRT000791,MERCK,"GOUVEIA C. DUQUE S, CAMPOS L. LIPOTYMIA BY HYPOVOLEMIA-A CASE OF IATROGENIA TO EMPAGLIFLOZINA?. MARIANA ROCHA. 2019",71.0,YR,,M,Y,,,20190610.0,,MD,PT,PT,2019,Q2,Elderly
161778165,16177816,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q2,Dizziness,,2019,Q2,5,F,2018.0,20190531.0,20190410,20190610,EXP,,PT-009507513-1904PRT000791,MERCK,"GOUVEIA C. DUQUE S, CAMPOS L. LIPOTYMIA BY HYPOVOLEMIA-A CASE OF IATROGENIA TO EMPAGLIFLOZINA?. MARIANA ROCHA. 2019",71.0,YR,,M,Y,,,20190610.0,,MD,PT,PT,2019,Q2,Elderly
161778165,16177816,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q2,Haematocrit increased,,2019,Q2,5,F,2018.0,20190531.0,20190410,20190610,EXP,,PT-009507513-1904PRT000791,MERCK,"GOUVEIA C. DUQUE S, CAMPOS L. LIPOTYMIA BY HYPOVOLEMIA-A CASE OF IATROGENIA TO EMPAGLIFLOZINA?. MARIANA ROCHA. 2019",71.0,YR,,M,Y,,,20190610.0,,MD,PT,PT,2019,Q2,Elderly
161778165,16177816,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q2,Haemoglobin increased,,2019,Q2,5,F,2018.0,20190531.0,20190410,20190610,EXP,,PT-009507513-1904PRT000791,MERCK,"GOUVEIA C. DUQUE S, CAMPOS L. LIPOTYMIA BY HYPOVOLEMIA-A CASE OF IATROGENIA TO EMPAGLIFLOZINA?. MARIANA ROCHA. 2019",71.0,YR,,M,Y,,,20190610.0,,MD,PT,PT,2019,Q2,Elderly
161778165,16177816,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q2,Hypotension,,2019,Q2,5,F,2018.0,20190531.0,20190410,20190610,EXP,,PT-009507513-1904PRT000791,MERCK,"GOUVEIA C. DUQUE S, CAMPOS L. LIPOTYMIA BY HYPOVOLEMIA-A CASE OF IATROGENIA TO EMPAGLIFLOZINA?. MARIANA ROCHA. 2019",71.0,YR,,M,Y,,,20190610.0,,MD,PT,PT,2019,Q2,Elderly
161778165,16177816,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q2,Hypovolaemia,,2019,Q2,5,F,2018.0,20190531.0,20190410,20190610,EXP,,PT-009507513-1904PRT000791,MERCK,"GOUVEIA C. DUQUE S, CAMPOS L. LIPOTYMIA BY HYPOVOLEMIA-A CASE OF IATROGENIA TO EMPAGLIFLOZINA?. MARIANA ROCHA. 2019",71.0,YR,,M,Y,,,20190610.0,,MD,PT,PT,2019,Q2,Elderly
161778165,16177816,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q2,Left atrial dilatation,,2019,Q2,5,F,2018.0,20190531.0,20190410,20190610,EXP,,PT-009507513-1904PRT000791,MERCK,"GOUVEIA C. DUQUE S, CAMPOS L. LIPOTYMIA BY HYPOVOLEMIA-A CASE OF IATROGENIA TO EMPAGLIFLOZINA?. MARIANA ROCHA. 2019",71.0,YR,,M,Y,,,20190610.0,,MD,PT,PT,2019,Q2,Elderly
161778165,16177816,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q2,Mucosal dryness,,2019,Q2,5,F,2018.0,20190531.0,20190410,20190610,EXP,,PT-009507513-1904PRT000791,MERCK,"GOUVEIA C. DUQUE S, CAMPOS L. LIPOTYMIA BY HYPOVOLEMIA-A CASE OF IATROGENIA TO EMPAGLIFLOZINA?. MARIANA ROCHA. 2019",71.0,YR,,M,Y,,,20190610.0,,MD,PT,PT,2019,Q2,Elderly
161778165,16177816,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q2,Presyncope,,2019,Q2,5,F,2018.0,20190531.0,20190410,20190610,EXP,,PT-009507513-1904PRT000791,MERCK,"GOUVEIA C. DUQUE S, CAMPOS L. LIPOTYMIA BY HYPOVOLEMIA-A CASE OF IATROGENIA TO EMPAGLIFLOZINA?. MARIANA ROCHA. 2019",71.0,YR,,M,Y,,,20190610.0,,MD,PT,PT,2019,Q2,Elderly
161778165,16177816,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q2,Skin disorder,,2019,Q2,5,F,2018.0,20190531.0,20190410,20190610,EXP,,PT-009507513-1904PRT000791,MERCK,"GOUVEIA C. DUQUE S, CAMPOS L. LIPOTYMIA BY HYPOVOLEMIA-A CASE OF IATROGENIA TO EMPAGLIFLOZINA?. MARIANA ROCHA. 2019",71.0,YR,,M,Y,,,20190610.0,,MD,PT,PT,2019,Q2,Elderly
161778165,16177816,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q2,Syncope,,2019,Q2,5,F,2018.0,20190531.0,20190410,20190610,EXP,,PT-009507513-1904PRT000791,MERCK,"GOUVEIA C. DUQUE S, CAMPOS L. LIPOTYMIA BY HYPOVOLEMIA-A CASE OF IATROGENIA TO EMPAGLIFLOZINA?. MARIANA ROCHA. 2019",71.0,YR,,M,Y,,,20190610.0,,MD,PT,PT,2019,Q2,Elderly
161778165,16177816,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2019,Q2,Acute kidney injury,,2019,Q2,5,F,2018.0,20190531.0,20190410,20190610,EXP,,PT-009507513-1904PRT000791,MERCK,"GOUVEIA C. DUQUE S, CAMPOS L. LIPOTYMIA BY HYPOVOLEMIA-A CASE OF IATROGENIA TO EMPAGLIFLOZINA?. MARIANA ROCHA. 2019",71.0,YR,,M,Y,,,20190610.0,,MD,PT,PT,2019,Q2,Elderly
161778165,16177816,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2019,Q2,Arrhythmia,,2019,Q2,5,F,2018.0,20190531.0,20190410,20190610,EXP,,PT-009507513-1904PRT000791,MERCK,"GOUVEIA C. DUQUE S, CAMPOS L. LIPOTYMIA BY HYPOVOLEMIA-A CASE OF IATROGENIA TO EMPAGLIFLOZINA?. MARIANA ROCHA. 2019",71.0,YR,,M,Y,,,20190610.0,,MD,PT,PT,2019,Q2,Elderly
161778165,16177816,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2019,Q2,Atrial fibrillation,,2019,Q2,5,F,2018.0,20190531.0,20190410,20190610,EXP,,PT-009507513-1904PRT000791,MERCK,"GOUVEIA C. DUQUE S, CAMPOS L. LIPOTYMIA BY HYPOVOLEMIA-A CASE OF IATROGENIA TO EMPAGLIFLOZINA?. MARIANA ROCHA. 2019",71.0,YR,,M,Y,,,20190610.0,,MD,PT,PT,2019,Q2,Elderly
161778165,16177816,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2019,Q2,Bradycardia,,2019,Q2,5,F,2018.0,20190531.0,20190410,20190610,EXP,,PT-009507513-1904PRT000791,MERCK,"GOUVEIA C. DUQUE S, CAMPOS L. LIPOTYMIA BY HYPOVOLEMIA-A CASE OF IATROGENIA TO EMPAGLIFLOZINA?. MARIANA ROCHA. 2019",71.0,YR,,M,Y,,,20190610.0,,MD,PT,PT,2019,Q2,Elderly
161778165,16177816,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2019,Q2,Dehydration,,2019,Q2,5,F,2018.0,20190531.0,20190410,20190610,EXP,,PT-009507513-1904PRT000791,MERCK,"GOUVEIA C. DUQUE S, CAMPOS L. LIPOTYMIA BY HYPOVOLEMIA-A CASE OF IATROGENIA TO EMPAGLIFLOZINA?. MARIANA ROCHA. 2019",71.0,YR,,M,Y,,,20190610.0,,MD,PT,PT,2019,Q2,Elderly
161778165,16177816,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2019,Q2,Dizziness,,2019,Q2,5,F,2018.0,20190531.0,20190410,20190610,EXP,,PT-009507513-1904PRT000791,MERCK,"GOUVEIA C. DUQUE S, CAMPOS L. LIPOTYMIA BY HYPOVOLEMIA-A CASE OF IATROGENIA TO EMPAGLIFLOZINA?. MARIANA ROCHA. 2019",71.0,YR,,M,Y,,,20190610.0,,MD,PT,PT,2019,Q2,Elderly
161778165,16177816,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2019,Q2,Haematocrit increased,,2019,Q2,5,F,2018.0,20190531.0,20190410,20190610,EXP,,PT-009507513-1904PRT000791,MERCK,"GOUVEIA C. DUQUE S, CAMPOS L. LIPOTYMIA BY HYPOVOLEMIA-A CASE OF IATROGENIA TO EMPAGLIFLOZINA?. MARIANA ROCHA. 2019",71.0,YR,,M,Y,,,20190610.0,,MD,PT,PT,2019,Q2,Elderly
161778165,16177816,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2019,Q2,Haemoglobin increased,,2019,Q2,5,F,2018.0,20190531.0,20190410,20190610,EXP,,PT-009507513-1904PRT000791,MERCK,"GOUVEIA C. DUQUE S, CAMPOS L. LIPOTYMIA BY HYPOVOLEMIA-A CASE OF IATROGENIA TO EMPAGLIFLOZINA?. MARIANA ROCHA. 2019",71.0,YR,,M,Y,,,20190610.0,,MD,PT,PT,2019,Q2,Elderly
161778165,16177816,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2019,Q2,Hypotension,,2019,Q2,5,F,2018.0,20190531.0,20190410,20190610,EXP,,PT-009507513-1904PRT000791,MERCK,"GOUVEIA C. DUQUE S, CAMPOS L. LIPOTYMIA BY HYPOVOLEMIA-A CASE OF IATROGENIA TO EMPAGLIFLOZINA?. MARIANA ROCHA. 2019",71.0,YR,,M,Y,,,20190610.0,,MD,PT,PT,2019,Q2,Elderly
161778165,16177816,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2019,Q2,Hypovolaemia,,2019,Q2,5,F,2018.0,20190531.0,20190410,20190610,EXP,,PT-009507513-1904PRT000791,MERCK,"GOUVEIA C. DUQUE S, CAMPOS L. LIPOTYMIA BY HYPOVOLEMIA-A CASE OF IATROGENIA TO EMPAGLIFLOZINA?. MARIANA ROCHA. 2019",71.0,YR,,M,Y,,,20190610.0,,MD,PT,PT,2019,Q2,Elderly
161778165,16177816,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2019,Q2,Left atrial dilatation,,2019,Q2,5,F,2018.0,20190531.0,20190410,20190610,EXP,,PT-009507513-1904PRT000791,MERCK,"GOUVEIA C. DUQUE S, CAMPOS L. LIPOTYMIA BY HYPOVOLEMIA-A CASE OF IATROGENIA TO EMPAGLIFLOZINA?. MARIANA ROCHA. 2019",71.0,YR,,M,Y,,,20190610.0,,MD,PT,PT,2019,Q2,Elderly
161778165,16177816,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2019,Q2,Mucosal dryness,,2019,Q2,5,F,2018.0,20190531.0,20190410,20190610,EXP,,PT-009507513-1904PRT000791,MERCK,"GOUVEIA C. DUQUE S, CAMPOS L. LIPOTYMIA BY HYPOVOLEMIA-A CASE OF IATROGENIA TO EMPAGLIFLOZINA?. MARIANA ROCHA. 2019",71.0,YR,,M,Y,,,20190610.0,,MD,PT,PT,2019,Q2,Elderly
161778165,16177816,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2019,Q2,Presyncope,,2019,Q2,5,F,2018.0,20190531.0,20190410,20190610,EXP,,PT-009507513-1904PRT000791,MERCK,"GOUVEIA C. DUQUE S, CAMPOS L. LIPOTYMIA BY HYPOVOLEMIA-A CASE OF IATROGENIA TO EMPAGLIFLOZINA?. MARIANA ROCHA. 2019",71.0,YR,,M,Y,,,20190610.0,,MD,PT,PT,2019,Q2,Elderly
161778165,16177816,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2019,Q2,Skin disorder,,2019,Q2,5,F,2018.0,20190531.0,20190410,20190610,EXP,,PT-009507513-1904PRT000791,MERCK,"GOUVEIA C. DUQUE S, CAMPOS L. LIPOTYMIA BY HYPOVOLEMIA-A CASE OF IATROGENIA TO EMPAGLIFLOZINA?. MARIANA ROCHA. 2019",71.0,YR,,M,Y,,,20190610.0,,MD,PT,PT,2019,Q2,Elderly
161778165,16177816,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2019,Q2,Syncope,,2019,Q2,5,F,2018.0,20190531.0,20190410,20190610,EXP,,PT-009507513-1904PRT000791,MERCK,"GOUVEIA C. DUQUE S, CAMPOS L. LIPOTYMIA BY HYPOVOLEMIA-A CASE OF IATROGENIA TO EMPAGLIFLOZINA?. MARIANA ROCHA. 2019",71.0,YR,,M,Y,,,20190610.0,,MD,PT,PT,2019,Q2,Elderly
161787831,16178783,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,2-2-2 IU,,,Y,,,,,,,SOLUTION FOR INJECTION,QD,2019,Q2,Diabetes mellitus,,2019,Q2,1,I,201502.0,20181129.0,20190410,20190410,EXP,,CZ-SAKK-2018SA330338AA,SANOFI AVENTIS,MAULE P.. FIASP - A NOVEL OPTION OF INFLUENCING POSTPRANDIAL GLYCAEMIA. KAZUISTIKY V DIABETOLOGII. 2018;3:30-32,47.0,YR,A,M,Y,,,20190410.0,,MD,CZ,CZ,2019,Q2,Adult
161787831,16178783,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,2-2-2 IU,,,Y,,,,,,,SOLUTION FOR INJECTION,QD,2019,Q2,Hypoglycaemia,,2019,Q2,1,I,201502.0,20181129.0,20190410,20190410,EXP,,CZ-SAKK-2018SA330338AA,SANOFI AVENTIS,MAULE P.. FIASP - A NOVEL OPTION OF INFLUENCING POSTPRANDIAL GLYCAEMIA. KAZUISTIKY V DIABETOLOGII. 2018;3:30-32,47.0,YR,A,M,Y,,,20190410.0,,MD,CZ,CZ,2019,Q2,Adult
161787831,16178783,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,2-2-2 IU,,,Y,,,,,,,SOLUTION FOR INJECTION,QD,2019,Q2,Pancreatitis,,2019,Q2,1,I,201502.0,20181129.0,20190410,20190410,EXP,,CZ-SAKK-2018SA330338AA,SANOFI AVENTIS,MAULE P.. FIASP - A NOVEL OPTION OF INFLUENCING POSTPRANDIAL GLYCAEMIA. KAZUISTIKY V DIABETOLOGII. 2018;3:30-32,47.0,YR,A,M,Y,,,20190410.0,,MD,CZ,CZ,2019,Q2,Adult
161845091,16184509,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 DF, TOTAL",3.0,DF,D,,,,209196.0,3.0,DF,SOLUTION FOR INJECTION,,2019,Q2,Drug abuse,,2019,Q2,1,I,20180526.0,20180607.0,20190411,20190411,EXP,IT-MINISAL02-479868,IT-SA-2018SA154102,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20190411.0,,MD,IT,IT,2019,Q2,Adult
161845091,16184509,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 DF, TOTAL",3.0,DF,D,,,,209196.0,3.0,DF,SOLUTION FOR INJECTION,,2019,Q2,Hypoglycaemia,,2019,Q2,1,I,20180526.0,20180607.0,20190411,20190411,EXP,IT-MINISAL02-479868,IT-SA-2018SA154102,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20190411.0,,MD,IT,IT,2019,Q2,Adult
161845091,16184509,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 DF, TOTAL",3.0,DF,D,,,,209196.0,3.0,DF,SOLUTION FOR INJECTION,,2019,Q2,Sopor,,2019,Q2,1,I,20180526.0,20180607.0,20190411,20190411,EXP,IT-MINISAL02-479868,IT-SA-2018SA154102,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20190411.0,,MD,IT,IT,2019,Q2,Adult
161845091,16184509,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 DF, TOTAL",3.0,DF,D,,,,209196.0,3.0,DF,SOLUTION FOR INJECTION,,2019,Q2,Suicide attempt,,2019,Q2,1,I,20180526.0,20180607.0,20190411,20190411,EXP,IT-MINISAL02-479868,IT-SA-2018SA154102,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20190411.0,,MD,IT,IT,2019,Q2,Adult
161863131,16186313,1,PS,Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,D,,,,20563.0,,,,,2019,Q2,Blood glucose decreased,,2019,Q2,1,I,,20190405.0,20190411,20190411,EXP,,GB-ELI_LILLY_AND_COMPANY-GB201904004375,ELI LILLY AND CO,,40.0,YR,,M,Y,,,20190411.0,,CN,GB,GB,2019,Q2,Adult
161863131,16186313,1,PS,Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,D,,,,20563.0,,,,,2019,Q2,Road traffic accident,,2019,Q2,1,I,,20190405.0,20190411,20190411,EXP,,GB-ELI_LILLY_AND_COMPANY-GB201904004375,ELI LILLY AND CO,,40.0,YR,,M,Y,,,20190411.0,,CN,GB,GB,2019,Q2,Adult
161863131,16186313,1,PS,Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,D,,,,20563.0,,,,,2019,Q2,Wrong product administered,,2019,Q2,1,I,,20190405.0,20190411,20190411,EXP,,GB-ELI_LILLY_AND_COMPANY-GB201904004375,ELI LILLY AND CO,,40.0,YR,,M,Y,,,20190411.0,,CN,GB,GB,2019,Q2,Adult
161863131,16186313,2,SS,Lispro,INSULIN LISPRO,1,Unknown,35 [IU],,,D,,,,20563.0,35.0,IU,,,2019,Q2,Blood glucose decreased,,2019,Q2,1,I,,20190405.0,20190411,20190411,EXP,,GB-ELI_LILLY_AND_COMPANY-GB201904004375,ELI LILLY AND CO,,40.0,YR,,M,Y,,,20190411.0,,CN,GB,GB,2019,Q2,Adult
161863131,16186313,2,SS,Lispro,INSULIN LISPRO,1,Unknown,35 [IU],,,D,,,,20563.0,35.0,IU,,,2019,Q2,Road traffic accident,,2019,Q2,1,I,,20190405.0,20190411,20190411,EXP,,GB-ELI_LILLY_AND_COMPANY-GB201904004375,ELI LILLY AND CO,,40.0,YR,,M,Y,,,20190411.0,,CN,GB,GB,2019,Q2,Adult
161863131,16186313,2,SS,Lispro,INSULIN LISPRO,1,Unknown,35 [IU],,,D,,,,20563.0,35.0,IU,,,2019,Q2,Wrong product administered,,2019,Q2,1,I,,20190405.0,20190411,20190411,EXP,,GB-ELI_LILLY_AND_COMPANY-GB201904004375,ELI LILLY AND CO,,40.0,YR,,M,Y,,,20190411.0,,CN,GB,GB,2019,Q2,Adult
161866653,16186665,29,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,100 UNIT/ML,,,,,,,,,,INJECTION,,2019,Q2,Acute myocardial infarction,,2019,Q2,3,F,20190329.0,20190425.0,20190411,20190503,EXP,,US-CELGENEUS-USA-20190402307,CELGENE,,70.0,YR,,M,Y,,,20190503.0,,MD,US,US,2019,Q2,Elderly
161866653,16186665,29,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,100 UNIT/ML,,,,,,,,,,INJECTION,,2019,Q2,Intracardiac thrombus,,2019,Q2,3,F,20190329.0,20190425.0,20190411,20190503,EXP,,US-CELGENEUS-USA-20190402307,CELGENE,,70.0,YR,,M,Y,,,20190503.0,,MD,US,US,2019,Q2,Elderly
161866653,16186665,29,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,100 UNIT/ML,,,,,,,,,,INJECTION,,2019,Q2,Ischaemic cardiomyopathy,,2019,Q2,3,F,20190329.0,20190425.0,20190411,20190503,EXP,,US-CELGENEUS-USA-20190402307,CELGENE,,70.0,YR,,M,Y,,,20190503.0,,MD,US,US,2019,Q2,Elderly
161927641,16192764,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q2,Chronic kidney disease,,2019,Q2,1,I,2006.0,20190405.0,20190412,20190412,EXP,,US-ASTRAZENECA-2019SE53801,ASTRAZENECA,,53.0,YR,,F,Y,,,20190413.0,,,US,US,2019,Q2,Adult
161927641,16192764,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q2,End stage renal disease,,2019,Q2,1,I,2006.0,20190405.0,20190412,20190412,EXP,,US-ASTRAZENECA-2019SE53801,ASTRAZENECA,,53.0,YR,,F,Y,,,20190413.0,,,US,US,2019,Q2,Adult
161927641,16192764,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q2,Kidney infection,,2019,Q2,1,I,2006.0,20190405.0,20190412,20190412,EXP,,US-ASTRAZENECA-2019SE53801,ASTRAZENECA,,53.0,YR,,F,Y,,,20190413.0,,,US,US,2019,Q2,Adult
161927641,16192764,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q2,Renal failure,,2019,Q2,1,I,2006.0,20190405.0,20190412,20190412,EXP,,US-ASTRAZENECA-2019SE53801,ASTRAZENECA,,53.0,YR,,F,Y,,,20190413.0,,,US,US,2019,Q2,Adult
161927641,16192764,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q2,Tubulointerstitial nephritis,,2019,Q2,1,I,2006.0,20190405.0,20190412,20190412,EXP,,US-ASTRAZENECA-2019SE53801,ASTRAZENECA,,53.0,YR,,F,Y,,,20190413.0,,,US,US,2019,Q2,Adult
161975831,16197583,7,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Gastrointestinal haemorrhage,,2019,Q2,1,I,20190407.0,,20190414,20190414,DIR,,,FDA-CTU,,30.0,YR,,M,N,98.5,KG,20190414.0,N,PH,US,US,2019,Q2,Young Adult
161994312,16199431,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Acute respiratory failure,,2019,Q2,2,F,2018.0,20190514.0,20190415,20190529,EXP,,US-ACTELION-A-NJ2019-184656,ACTELION,,69.0,YR,,F,Y,,,20190529.0,,PH,US,US,2019,Q2,Elderly
161994312,16199431,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Condition aggravated,,2019,Q2,2,F,2018.0,20190514.0,20190415,20190529,EXP,,US-ACTELION-A-NJ2019-184656,ACTELION,,69.0,YR,,F,Y,,,20190529.0,,PH,US,US,2019,Q2,Elderly
161994312,16199431,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Dialysis,,2019,Q2,2,F,2018.0,20190514.0,20190415,20190529,EXP,,US-ACTELION-A-NJ2019-184656,ACTELION,,69.0,YR,,F,Y,,,20190529.0,,PH,US,US,2019,Q2,Elderly
161994312,16199431,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Dyspnoea,,2019,Q2,2,F,2018.0,20190514.0,20190415,20190529,EXP,,US-ACTELION-A-NJ2019-184656,ACTELION,,69.0,YR,,F,Y,,,20190529.0,,PH,US,US,2019,Q2,Elderly
161994312,16199431,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Haemodialysis,,2019,Q2,2,F,2018.0,20190514.0,20190415,20190529,EXP,,US-ACTELION-A-NJ2019-184656,ACTELION,,69.0,YR,,F,Y,,,20190529.0,,PH,US,US,2019,Q2,Elderly
161994312,16199431,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Hypotension,,2019,Q2,2,F,2018.0,20190514.0,20190415,20190529,EXP,,US-ACTELION-A-NJ2019-184656,ACTELION,,69.0,YR,,F,Y,,,20190529.0,,PH,US,US,2019,Q2,Elderly
161994312,16199431,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Lung disorder,,2019,Q2,2,F,2018.0,20190514.0,20190415,20190529,EXP,,US-ACTELION-A-NJ2019-184656,ACTELION,,69.0,YR,,F,Y,,,20190529.0,,PH,US,US,2019,Q2,Elderly
161994312,16199431,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Malaise,,2019,Q2,2,F,2018.0,20190514.0,20190415,20190529,EXP,,US-ACTELION-A-NJ2019-184656,ACTELION,,69.0,YR,,F,Y,,,20190529.0,,PH,US,US,2019,Q2,Elderly
161994312,16199431,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Nasal congestion,,2019,Q2,2,F,2018.0,20190514.0,20190415,20190529,EXP,,US-ACTELION-A-NJ2019-184656,ACTELION,,69.0,YR,,F,Y,,,20190529.0,,PH,US,US,2019,Q2,Elderly
161994312,16199431,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Respiratory tract infection,,2019,Q2,2,F,2018.0,20190514.0,20190415,20190529,EXP,,US-ACTELION-A-NJ2019-184656,ACTELION,,69.0,YR,,F,Y,,,20190529.0,,PH,US,US,2019,Q2,Elderly
161994312,16199431,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Somnolence,,2019,Q2,2,F,2018.0,20190514.0,20190415,20190529,EXP,,US-ACTELION-A-NJ2019-184656,ACTELION,,69.0,YR,,F,Y,,,20190529.0,,PH,US,US,2019,Q2,Elderly
161997662,16199766,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2019,Q2,Diabetic foot,,2019,Q2,2,F,20190404.0,20190424.0,20190415,20190504,EXP,,BR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-036992,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,96.0,KG,20190504.0,,OT,BR,BR,2019,Q2,Elderly
161997662,16199766,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2019,Q2,Epiglottic oedema,,2019,Q2,2,F,20190404.0,20190424.0,20190415,20190504,EXP,,BR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-036992,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,96.0,KG,20190504.0,,OT,BR,BR,2019,Q2,Elderly
162038171,16203817,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Atrioventricular block,,2019,Q2,1,I,20190405.0,20190408.0,20190416,20190416,EXP,,FR-ASTRAZENECA-2019SE55814,ASTRAZENECA,,26058.0,DY,,M,Y,,,20190416.0,,PH,FR,FR,2019,Q2,Elderly
162039181,16203918,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"12 DOSAGE FORM, EACH MORNING",,,N,U,,,20563.0,12.0,DF,,QD,2019,Q2,Dyspnoea,,2019,Q2,1,I,,20190411.0,20190416,20190416,EXP,,IN-ELI_LILLY_AND_COMPANY-IN201904007782,ELI LILLY AND CO,,40.0,YR,,F,Y,,,20190416.0,,CN,IN,IN,2019,Q2,Adult
162039181,16203918,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"12 DOSAGE FORM, EACH MORNING",,,N,U,,,20563.0,12.0,DF,,QD,2019,Q2,Hyperglycaemia,,2019,Q2,1,I,,20190411.0,20190416,20190416,EXP,,IN-ELI_LILLY_AND_COMPANY-IN201904007782,ELI LILLY AND CO,,40.0,YR,,F,Y,,,20190416.0,,CN,IN,IN,2019,Q2,Adult
162039181,16203918,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"12 DOSAGE FORM, EACH MORNING",,,N,U,,,20563.0,12.0,DF,,QD,2019,Q2,Hypothyroidism,,2019,Q2,1,I,,20190411.0,20190416,20190416,EXP,,IN-ELI_LILLY_AND_COMPANY-IN201904007782,ELI LILLY AND CO,,40.0,YR,,F,Y,,,20190416.0,,CN,IN,IN,2019,Q2,Adult
162039181,16203918,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"12 DOSAGE FORM, EACH MORNING",,,N,U,,,20563.0,12.0,DF,,QD,2019,Q2,Pyrexia,,2019,Q2,1,I,,20190411.0,20190416,20190416,EXP,,IN-ELI_LILLY_AND_COMPANY-IN201904007782,ELI LILLY AND CO,,40.0,YR,,F,Y,,,20190416.0,,CN,IN,IN,2019,Q2,Adult
162039181,16203918,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"12 DOSAGE FORM, EACH MORNING",,,N,U,,,20563.0,12.0,DF,,QD,2019,Q2,Swelling,,2019,Q2,1,I,,20190411.0,20190416,20190416,EXP,,IN-ELI_LILLY_AND_COMPANY-IN201904007782,ELI LILLY AND CO,,40.0,YR,,F,Y,,,20190416.0,,CN,IN,IN,2019,Q2,Adult
162039181,16203918,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"14 DOSAGE FORM, EACH EVENING",,,N,U,,,20563.0,14.0,DF,,QD,2019,Q2,Dyspnoea,,2019,Q2,1,I,,20190411.0,20190416,20190416,EXP,,IN-ELI_LILLY_AND_COMPANY-IN201904007782,ELI LILLY AND CO,,40.0,YR,,F,Y,,,20190416.0,,CN,IN,IN,2019,Q2,Adult
162039181,16203918,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"14 DOSAGE FORM, EACH EVENING",,,N,U,,,20563.0,14.0,DF,,QD,2019,Q2,Hyperglycaemia,,2019,Q2,1,I,,20190411.0,20190416,20190416,EXP,,IN-ELI_LILLY_AND_COMPANY-IN201904007782,ELI LILLY AND CO,,40.0,YR,,F,Y,,,20190416.0,,CN,IN,IN,2019,Q2,Adult
162039181,16203918,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"14 DOSAGE FORM, EACH EVENING",,,N,U,,,20563.0,14.0,DF,,QD,2019,Q2,Hypothyroidism,,2019,Q2,1,I,,20190411.0,20190416,20190416,EXP,,IN-ELI_LILLY_AND_COMPANY-IN201904007782,ELI LILLY AND CO,,40.0,YR,,F,Y,,,20190416.0,,CN,IN,IN,2019,Q2,Adult
162039181,16203918,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"14 DOSAGE FORM, EACH EVENING",,,N,U,,,20563.0,14.0,DF,,QD,2019,Q2,Pyrexia,,2019,Q2,1,I,,20190411.0,20190416,20190416,EXP,,IN-ELI_LILLY_AND_COMPANY-IN201904007782,ELI LILLY AND CO,,40.0,YR,,F,Y,,,20190416.0,,CN,IN,IN,2019,Q2,Adult
162039181,16203918,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"14 DOSAGE FORM, EACH EVENING",,,N,U,,,20563.0,14.0,DF,,QD,2019,Q2,Swelling,,2019,Q2,1,I,,20190411.0,20190416,20190416,EXP,,IN-ELI_LILLY_AND_COMPANY-IN201904007782,ELI LILLY AND CO,,40.0,YR,,F,Y,,,20190416.0,,CN,IN,IN,2019,Q2,Adult
162070788,16207078,3,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Liver injury,,2019,Q2,8,F,20190412.0,20190625.0,20190417,20190627,EXP,,DE-ROCHE-2304241,ROCHE,,61.0,YR,,M,Y,103.2,KG,20190627.0,,MD,DE,DE,2019,Q2,Adult
162129382,16212938,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q2,Pleural effusion,,2019,Q2,2,F,20180831.0,20190610.0,20190418,20190613,EXP,,PHHY2019DE086867,SANDOZ,,77.0,YR,,F,Y,,,20190613.0,,,DE,DE,2019,Q2,Elderly
162140851,16214085,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q2,Gastrointestinal haemorrhage,,2019,Q2,1,I,20190308.0,20190409.0,20190418,20190418,EXP,,US-BAYER-2019-071999,BAYER,,76.0,YR,E,M,Y,10.4,KG,20190418.0,,MD,US,US,2019,Q2,Elderly
162176412,16217641,4,C,LISPRO INSULIN,INSULIN LISPRO,1,,"10 IU, TID",,,U,,,,,10.0,IU,,Q8H,2019,Q2,Blood glucose increased,,2019,Q2,2,F,201807.0,20190424.0,20190419,20190501,EXP,,CO-SA-2019SA103536,SANOFI AVENTIS,,52.0,YR,A,F,Y,,,20190501.0,,CN,CO,CO,2019,Q2,Adult
162176412,16217641,4,C,LISPRO INSULIN,INSULIN LISPRO,1,,"10 IU, TID",,,U,,,,,10.0,IU,,Q8H,2019,Q2,Breast mass,,2019,Q2,2,F,201807.0,20190424.0,20190419,20190501,EXP,,CO-SA-2019SA103536,SANOFI AVENTIS,,52.0,YR,A,F,Y,,,20190501.0,,CN,CO,CO,2019,Q2,Adult
162176412,16217641,4,C,LISPRO INSULIN,INSULIN LISPRO,1,,"10 IU, TID",,,U,,,,,10.0,IU,,Q8H,2019,Q2,Cellulitis,,2019,Q2,2,F,201807.0,20190424.0,20190419,20190501,EXP,,CO-SA-2019SA103536,SANOFI AVENTIS,,52.0,YR,A,F,Y,,,20190501.0,,CN,CO,CO,2019,Q2,Adult
162176412,16217641,4,C,LISPRO INSULIN,INSULIN LISPRO,1,,"10 IU, TID",,,U,,,,,10.0,IU,,Q8H,2019,Q2,Cystitis,,2019,Q2,2,F,201807.0,20190424.0,20190419,20190501,EXP,,CO-SA-2019SA103536,SANOFI AVENTIS,,52.0,YR,A,F,Y,,,20190501.0,,CN,CO,CO,2019,Q2,Adult
162176412,16217641,4,C,LISPRO INSULIN,INSULIN LISPRO,1,,"10 IU, TID",,,U,,,,,10.0,IU,,Q8H,2019,Q2,Diabetic coma,,2019,Q2,2,F,201807.0,20190424.0,20190419,20190501,EXP,,CO-SA-2019SA103536,SANOFI AVENTIS,,52.0,YR,A,F,Y,,,20190501.0,,CN,CO,CO,2019,Q2,Adult
162176412,16217641,4,C,LISPRO INSULIN,INSULIN LISPRO,1,,"10 IU, TID",,,U,,,,,10.0,IU,,Q8H,2019,Q2,Diarrhoea,,2019,Q2,2,F,201807.0,20190424.0,20190419,20190501,EXP,,CO-SA-2019SA103536,SANOFI AVENTIS,,52.0,YR,A,F,Y,,,20190501.0,,CN,CO,CO,2019,Q2,Adult
162176412,16217641,4,C,LISPRO INSULIN,INSULIN LISPRO,1,,"10 IU, TID",,,U,,,,,10.0,IU,,Q8H,2019,Q2,Dysuria,,2019,Q2,2,F,201807.0,20190424.0,20190419,20190501,EXP,,CO-SA-2019SA103536,SANOFI AVENTIS,,52.0,YR,A,F,Y,,,20190501.0,,CN,CO,CO,2019,Q2,Adult
162176412,16217641,4,C,LISPRO INSULIN,INSULIN LISPRO,1,,"10 IU, TID",,,U,,,,,10.0,IU,,Q8H,2019,Q2,Haemoglobin decreased,,2019,Q2,2,F,201807.0,20190424.0,20190419,20190501,EXP,,CO-SA-2019SA103536,SANOFI AVENTIS,,52.0,YR,A,F,Y,,,20190501.0,,CN,CO,CO,2019,Q2,Adult
162176971,16217697,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Inappropriate schedule of product administration,,2019,Q2,1,I,,20190416.0,20190419,20190419,PER,,US-SA-2019SA108401,SANOFI AVENTIS,,74.0,YR,E,F,Y,,,20190419.0,,CN,US,US,2019,Q2,Elderly
162176971,16217697,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Injury associated with device,,2019,Q2,1,I,,20190416.0,20190419,20190419,PER,,US-SA-2019SA108401,SANOFI AVENTIS,,74.0,YR,E,F,Y,,,20190419.0,,CN,US,US,2019,Q2,Elderly
162176971,16217697,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Product dose omission,,2019,Q2,1,I,,20190416.0,20190419,20190419,PER,,US-SA-2019SA108401,SANOFI AVENTIS,,74.0,YR,E,F,Y,,,20190419.0,,CN,US,US,2019,Q2,Elderly
162176971,16217697,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Product storage error,,2019,Q2,1,I,,20190416.0,20190419,20190419,PER,,US-SA-2019SA108401,SANOFI AVENTIS,,74.0,YR,E,F,Y,,,20190419.0,,CN,US,US,2019,Q2,Elderly
162180352,16218035,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q2,Acute kidney injury,,2019,Q2,2,F,2018.0,20190527.0,20190419,20190604,EXP,,PHHY2019PT089405,SANDOZ,,71.0,YR,,M,Y,,,20190604.0,,OT,PT,PT,2019,Q2,Elderly
162180352,16218035,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q2,Arrhythmia,,2019,Q2,2,F,2018.0,20190527.0,20190419,20190604,EXP,,PHHY2019PT089405,SANDOZ,,71.0,YR,,M,Y,,,20190604.0,,OT,PT,PT,2019,Q2,Elderly
162180352,16218035,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q2,Atrial fibrillation,,2019,Q2,2,F,2018.0,20190527.0,20190419,20190604,EXP,,PHHY2019PT089405,SANDOZ,,71.0,YR,,M,Y,,,20190604.0,,OT,PT,PT,2019,Q2,Elderly
162180352,16218035,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q2,Bradycardia,,2019,Q2,2,F,2018.0,20190527.0,20190419,20190604,EXP,,PHHY2019PT089405,SANDOZ,,71.0,YR,,M,Y,,,20190604.0,,OT,PT,PT,2019,Q2,Elderly
162180352,16218035,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q2,Dehydration,,2019,Q2,2,F,2018.0,20190527.0,20190419,20190604,EXP,,PHHY2019PT089405,SANDOZ,,71.0,YR,,M,Y,,,20190604.0,,OT,PT,PT,2019,Q2,Elderly
162180352,16218035,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q2,Dizziness,,2019,Q2,2,F,2018.0,20190527.0,20190419,20190604,EXP,,PHHY2019PT089405,SANDOZ,,71.0,YR,,M,Y,,,20190604.0,,OT,PT,PT,2019,Q2,Elderly
162180352,16218035,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q2,Haematocrit increased,,2019,Q2,2,F,2018.0,20190527.0,20190419,20190604,EXP,,PHHY2019PT089405,SANDOZ,,71.0,YR,,M,Y,,,20190604.0,,OT,PT,PT,2019,Q2,Elderly
162180352,16218035,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q2,Haemoglobin increased,,2019,Q2,2,F,2018.0,20190527.0,20190419,20190604,EXP,,PHHY2019PT089405,SANDOZ,,71.0,YR,,M,Y,,,20190604.0,,OT,PT,PT,2019,Q2,Elderly
162180352,16218035,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q2,Hypotension,,2019,Q2,2,F,2018.0,20190527.0,20190419,20190604,EXP,,PHHY2019PT089405,SANDOZ,,71.0,YR,,M,Y,,,20190604.0,,OT,PT,PT,2019,Q2,Elderly
162180352,16218035,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q2,Hypovolaemia,,2019,Q2,2,F,2018.0,20190527.0,20190419,20190604,EXP,,PHHY2019PT089405,SANDOZ,,71.0,YR,,M,Y,,,20190604.0,,OT,PT,PT,2019,Q2,Elderly
162180352,16218035,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q2,Left atrial dilatation,,2019,Q2,2,F,2018.0,20190527.0,20190419,20190604,EXP,,PHHY2019PT089405,SANDOZ,,71.0,YR,,M,Y,,,20190604.0,,OT,PT,PT,2019,Q2,Elderly
162180352,16218035,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q2,Mucosal dryness,,2019,Q2,2,F,2018.0,20190527.0,20190419,20190604,EXP,,PHHY2019PT089405,SANDOZ,,71.0,YR,,M,Y,,,20190604.0,,OT,PT,PT,2019,Q2,Elderly
162180352,16218035,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q2,Presyncope,,2019,Q2,2,F,2018.0,20190527.0,20190419,20190604,EXP,,PHHY2019PT089405,SANDOZ,,71.0,YR,,M,Y,,,20190604.0,,OT,PT,PT,2019,Q2,Elderly
162180352,16218035,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q2,Skin disorder,,2019,Q2,2,F,2018.0,20190527.0,20190419,20190604,EXP,,PHHY2019PT089405,SANDOZ,,71.0,YR,,M,Y,,,20190604.0,,OT,PT,PT,2019,Q2,Elderly
162180352,16218035,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q2,Syncope,,2019,Q2,2,F,2018.0,20190527.0,20190419,20190604,EXP,,PHHY2019PT089405,SANDOZ,,71.0,YR,,M,Y,,,20190604.0,,OT,PT,PT,2019,Q2,Elderly
162187312,16218731,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q2,Cerebellar infarction,,2019,Q2,2,F,20170518.0,20190502.0,20190419,20190508,EXP,,US-AMGEN-USACT2019060234,AMGEN,,70.0,YR,E,M,Y,73.6,KG,20190508.0,,MD,US,US,2019,Q2,Elderly
162187312,16218731,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q2,End stage renal disease,,2019,Q2,2,F,20170518.0,20190502.0,20190419,20190508,EXP,,US-AMGEN-USACT2019060234,AMGEN,,70.0,YR,E,M,Y,73.6,KG,20190508.0,,MD,US,US,2019,Q2,Elderly
162187312,16218731,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q2,Intraventricular haemorrhage,,2019,Q2,2,F,20170518.0,20190502.0,20190419,20190508,EXP,,US-AMGEN-USACT2019060234,AMGEN,,70.0,YR,E,M,Y,73.6,KG,20190508.0,,MD,US,US,2019,Q2,Elderly
162187312,16218731,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q2,Metabolic encephalopathy,,2019,Q2,2,F,20170518.0,20190502.0,20190419,20190508,EXP,,US-AMGEN-USACT2019060234,AMGEN,,70.0,YR,E,M,Y,73.6,KG,20190508.0,,MD,US,US,2019,Q2,Elderly
162187312,16218731,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q2,Multiple organ dysfunction syndrome,,2019,Q2,2,F,20170518.0,20190502.0,20190419,20190508,EXP,,US-AMGEN-USACT2019060234,AMGEN,,70.0,YR,E,M,Y,73.6,KG,20190508.0,,MD,US,US,2019,Q2,Elderly
162187312,16218731,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q2,Osteomyelitis,,2019,Q2,2,F,20170518.0,20190502.0,20190419,20190508,EXP,,US-AMGEN-USACT2019060234,AMGEN,,70.0,YR,E,M,Y,73.6,KG,20190508.0,,MD,US,US,2019,Q2,Elderly
162187312,16218731,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q2,Pneumonia aspiration,,2019,Q2,2,F,20170518.0,20190502.0,20190419,20190508,EXP,,US-AMGEN-USACT2019060234,AMGEN,,70.0,YR,E,M,Y,73.6,KG,20190508.0,,MD,US,US,2019,Q2,Elderly
162187312,16218731,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q2,Respiratory failure,,2019,Q2,2,F,20170518.0,20190502.0,20190419,20190508,EXP,,US-AMGEN-USACT2019060234,AMGEN,,70.0,YR,E,M,Y,73.6,KG,20190508.0,,MD,US,US,2019,Q2,Elderly
162187312,16218731,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q2,Sepsis,,2019,Q2,2,F,20170518.0,20190502.0,20190419,20190508,EXP,,US-AMGEN-USACT2019060234,AMGEN,,70.0,YR,E,M,Y,73.6,KG,20190508.0,,MD,US,US,2019,Q2,Elderly
162212033,16221203,9,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,40 IU (INTERNATIONAL UNIT),,,,,,,,40.0,IU,INJECTION,TID,2019,Q2,Constipation,,2019,Q2,3,F,20190311.0,20190506.0,20190422,20190514,PER,,US-CELGENEUS-USA-20190405861,CELGENE,,62.0,YR,,F,Y,49.94,KG,20190514.0,,MD,US,US,2019,Q2,Adult
162212033,16221203,9,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,40 IU (INTERNATIONAL UNIT),,,,,,,,40.0,IU,INJECTION,TID,2019,Q2,Gastric haemorrhage,,2019,Q2,3,F,20190311.0,20190506.0,20190422,20190514,PER,,US-CELGENEUS-USA-20190405861,CELGENE,,62.0,YR,,F,Y,49.94,KG,20190514.0,,MD,US,US,2019,Q2,Adult
162212033,16221203,9,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,40 IU (INTERNATIONAL UNIT),,,,,,,,40.0,IU,INJECTION,TID,2019,Q2,Hypersomnia,,2019,Q2,3,F,20190311.0,20190506.0,20190422,20190514,PER,,US-CELGENEUS-USA-20190405861,CELGENE,,62.0,YR,,F,Y,49.94,KG,20190514.0,,MD,US,US,2019,Q2,Adult
162234071,16223407,3,C,LISPRO INSULIN,INSULIN LISPRO,1,,"UNK, SINGLE",,,,,,,,,,,,2019,Q2,Back pain,,2019,Q2,1,I,,20190415.0,20190422,20190422,EXP,,US-PFIZER INC-2019169167,PFIZER,,36.0,YR,,M,Y,101.2,KG,20190422.0,,OT,US,US,2019,Q2,Adult
162234071,16223407,3,C,LISPRO INSULIN,INSULIN LISPRO,1,,"UNK, SINGLE",,,,,,,,,,,,2019,Q2,Product prescribing issue,,2019,Q2,1,I,,20190415.0,20190422,20190422,EXP,,US-PFIZER INC-2019169167,PFIZER,,36.0,YR,,M,Y,101.2,KG,20190422.0,,OT,US,US,2019,Q2,Adult
162267011,16226701,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,63 U,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Arthralgia,,2019,Q2,1,I,201901.0,20190301.0,20190423,20190423,EXP,,US-SA-2019SA060990,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20190423.0,,CN,US,US,2019,Q2,Elderly
162267011,16226701,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,63 U,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Blood glucose increased,,2019,Q2,1,I,201901.0,20190301.0,20190423,20190423,EXP,,US-SA-2019SA060990,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20190423.0,,CN,US,US,2019,Q2,Elderly
162267011,16226701,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,63 U,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Cough,,2019,Q2,1,I,201901.0,20190301.0,20190423,20190423,EXP,,US-SA-2019SA060990,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20190423.0,,CN,US,US,2019,Q2,Elderly
162267011,16226701,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,63 U,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Gait disturbance,,2019,Q2,1,I,201901.0,20190301.0,20190423,20190423,EXP,,US-SA-2019SA060990,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20190423.0,,CN,US,US,2019,Q2,Elderly
162267011,16226701,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,63 U,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,General physical condition decreased,,2019,Q2,1,I,201901.0,20190301.0,20190423,20190423,EXP,,US-SA-2019SA060990,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20190423.0,,CN,US,US,2019,Q2,Elderly
162267011,16226701,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,63 U,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Hemiplegia,,2019,Q2,1,I,201901.0,20190301.0,20190423,20190423,EXP,,US-SA-2019SA060990,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20190423.0,,CN,US,US,2019,Q2,Elderly
162267011,16226701,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,63 U,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Motor dysfunction,,2019,Q2,1,I,201901.0,20190301.0,20190423,20190423,EXP,,US-SA-2019SA060990,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20190423.0,,CN,US,US,2019,Q2,Elderly
162267011,16226701,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,63 U,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Seizure,,2019,Q2,1,I,201901.0,20190301.0,20190423,20190423,EXP,,US-SA-2019SA060990,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20190423.0,,CN,US,US,2019,Q2,Elderly
162267011,16226701,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,63 U,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Sleep disorder,,2019,Q2,1,I,201901.0,20190301.0,20190423,20190423,EXP,,US-SA-2019SA060990,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20190423.0,,CN,US,US,2019,Q2,Elderly
162267011,16226701,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,63 U,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q2,Speech disorder,,2019,Q2,1,I,201901.0,20190301.0,20190423,20190423,EXP,,US-SA-2019SA060990,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20190423.0,,CN,US,US,2019,Q2,Elderly
162405143,16240514,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DOSAGE FORM,,,U,U, UNK,,,300.0,DF,INJECTION,,2019,Q2,Acute kidney injury,,2019,Q2,3,F,20180419.0,20190429.0,20190425,20190502,EXP,,DE-MYLANLABS-2019M1037770,MYLAN,,71.0,YR,,M,Y,,,20190502.0,,CN,DE,DE,2019,Q2,Elderly
162405143,16240514,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DOSAGE FORM,,,U,U, UNK,,,300.0,DF,INJECTION,,2019,Q2,Colitis,,2019,Q2,3,F,20180419.0,20190429.0,20190425,20190502,EXP,,DE-MYLANLABS-2019M1037770,MYLAN,,71.0,YR,,M,Y,,,20190502.0,,CN,DE,DE,2019,Q2,Elderly
162405143,16240514,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DOSAGE FORM,,,U,U, UNK,,,300.0,DF,INJECTION,,2019,Q2,Device related infection,,2019,Q2,3,F,20180419.0,20190429.0,20190425,20190502,EXP,,DE-MYLANLABS-2019M1037770,MYLAN,,71.0,YR,,M,Y,,,20190502.0,,CN,DE,DE,2019,Q2,Elderly
162405143,16240514,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DOSAGE FORM,,,U,U, UNK,,,300.0,DF,INJECTION,,2019,Q2,Heparin-induced thrombocytopenia,,2019,Q2,3,F,20180419.0,20190429.0,20190425,20190502,EXP,,DE-MYLANLABS-2019M1037770,MYLAN,,71.0,YR,,M,Y,,,20190502.0,,CN,DE,DE,2019,Q2,Elderly
162405143,16240514,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DOSAGE FORM,,,U,U, UNK,,,300.0,DF,INJECTION,,2019,Q2,Hyperglycaemia,,2019,Q2,3,F,20180419.0,20190429.0,20190425,20190502,EXP,,DE-MYLANLABS-2019M1037770,MYLAN,,71.0,YR,,M,Y,,,20190502.0,,CN,DE,DE,2019,Q2,Elderly
162405143,16240514,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DOSAGE FORM,,,U,U, UNK,,,300.0,DF,INJECTION,,2019,Q2,Malignant neoplasm progression,,2019,Q2,3,F,20180419.0,20190429.0,20190425,20190502,EXP,,DE-MYLANLABS-2019M1037770,MYLAN,,71.0,YR,,M,Y,,,20190502.0,,CN,DE,DE,2019,Q2,Elderly
162405143,16240514,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DOSAGE FORM,,,U,U, UNK,,,300.0,DF,INJECTION,,2019,Q2,Meningitis,,2019,Q2,3,F,20180419.0,20190429.0,20190425,20190502,EXP,,DE-MYLANLABS-2019M1037770,MYLAN,,71.0,YR,,M,Y,,,20190502.0,,CN,DE,DE,2019,Q2,Elderly
162405143,16240514,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DOSAGE FORM,,,U,U, UNK,,,300.0,DF,INJECTION,,2019,Q2,Metastases to meninges,,2019,Q2,3,F,20180419.0,20190429.0,20190425,20190502,EXP,,DE-MYLANLABS-2019M1037770,MYLAN,,71.0,YR,,M,Y,,,20190502.0,,CN,DE,DE,2019,Q2,Elderly
162405143,16240514,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DOSAGE FORM,,,U,U, UNK,,,300.0,DF,INJECTION,,2019,Q2,Retinal detachment,,2019,Q2,3,F,20180419.0,20190429.0,20190425,20190502,EXP,,DE-MYLANLABS-2019M1037770,MYLAN,,71.0,YR,,M,Y,,,20190502.0,,CN,DE,DE,2019,Q2,Elderly
162405143,16240514,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DOSAGE FORM,,,U,U, UNK,,,300.0,DF,INJECTION,,2019,Q2,Retinopathy,,2019,Q2,3,F,20180419.0,20190429.0,20190425,20190502,EXP,,DE-MYLANLABS-2019M1037770,MYLAN,,71.0,YR,,M,Y,,,20190502.0,,CN,DE,DE,2019,Q2,Elderly
162405143,16240514,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DOSAGE FORM,,,U,U, UNK,,,300.0,DF,INJECTION,,2019,Q2,Urosepsis,,2019,Q2,3,F,20180419.0,20190429.0,20190425,20190502,EXP,,DE-MYLANLABS-2019M1037770,MYLAN,,71.0,YR,,M,Y,,,20190502.0,,CN,DE,DE,2019,Q2,Elderly
162434811,16243481,10,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Cholelithiasis,,2019,Q2,1,I,20190220.0,,20190322,20190322,DIR,,,FDA-CTU,,61.0,YR,,F,N,,,20190322.0,Y,PH,US,US,2019,Q2,Adult
162434811,16243481,10,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Fatigue,,2019,Q2,1,I,20190220.0,,20190322,20190322,DIR,,,FDA-CTU,,61.0,YR,,F,N,,,20190322.0,Y,PH,US,US,2019,Q2,Adult
162434811,16243481,10,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Lung cancer metastatic,,2019,Q2,1,I,20190220.0,,20190322,20190322,DIR,,,FDA-CTU,,61.0,YR,,F,N,,,20190322.0,Y,PH,US,US,2019,Q2,Adult
162434811,16243481,10,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Malignant neoplasm progression,,2019,Q2,1,I,20190220.0,,20190322,20190322,DIR,,,FDA-CTU,,61.0,YR,,F,N,,,20190322.0,Y,PH,US,US,2019,Q2,Adult
162434811,16243481,10,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Pain,,2019,Q2,1,I,20190220.0,,20190322,20190322,DIR,,,FDA-CTU,,61.0,YR,,F,N,,,20190322.0,Y,PH,US,US,2019,Q2,Adult
162434811,16243481,10,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Sedation,,2019,Q2,1,I,20190220.0,,20190322,20190322,DIR,,,FDA-CTU,,61.0,YR,,F,N,,,20190322.0,Y,PH,US,US,2019,Q2,Adult
162469591,16246959,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q2,Abdominal pain,,2019,Q2,1,I,,20190415.0,20190427,20190427,EXP,,CA-APOTEX-2019AP012252,APOTEX,,72.0,YR,,F,Y,,,20190427.0,,CN,CA,CA,2019,Q2,Elderly
162469591,16246959,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q2,Dehydration,,2019,Q2,1,I,,20190415.0,20190427,20190427,EXP,,CA-APOTEX-2019AP012252,APOTEX,,72.0,YR,,F,Y,,,20190427.0,,CN,CA,CA,2019,Q2,Elderly
162469591,16246959,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q2,Pyrexia,,2019,Q2,1,I,,20190415.0,20190427,20190427,EXP,,CA-APOTEX-2019AP012252,APOTEX,,72.0,YR,,F,Y,,,20190427.0,,CN,CA,CA,2019,Q2,Elderly
162469591,16246959,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q2,Small intestinal obstruction,,2019,Q2,1,I,,20190415.0,20190427,20190427,EXP,,CA-APOTEX-2019AP012252,APOTEX,,72.0,YR,,F,Y,,,20190427.0,,CN,CA,CA,2019,Q2,Elderly
162469591,16246959,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q2,Urinary tract obstruction,,2019,Q2,1,I,,20190415.0,20190427,20190427,EXP,,CA-APOTEX-2019AP012252,APOTEX,,72.0,YR,,F,Y,,,20190427.0,,CN,CA,CA,2019,Q2,Elderly
162473601,16247360,10,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Cholelithiasis,,2019,Q2,1,I,20190220.0,,20190322,20190322,DIR,,,FDA-CTU,,61.0,YR,,F,N,,,20190322.0,Y,PH,US,US,2019,Q2,Adult
162473601,16247360,10,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Disease progression,,2019,Q2,1,I,20190220.0,,20190322,20190322,DIR,,,FDA-CTU,,61.0,YR,,F,N,,,20190322.0,Y,PH,US,US,2019,Q2,Adult
162473601,16247360,10,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Lung cancer metastatic,,2019,Q2,1,I,20190220.0,,20190322,20190322,DIR,,,FDA-CTU,,61.0,YR,,F,N,,,20190322.0,Y,PH,US,US,2019,Q2,Adult
162500221,16250022,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,U,U,,,20563.0,,,,,2019,Q2,Blood glucose increased,,2019,Q2,1,I,,20190322.0,20190429,20190429,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201903012683,ELI LILLY AND CO,,33.0,YR,,M,Y,,,20190429.0,,CN,CN,CN,2019,Q2,Young Adult
162535922,16253592,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q2,Diabetes mellitus inadequate control,,2019,Q2,2,F,2017.0,20190417.0,20190430,20190503,EXP,,CZ-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-041668,BRISTOL MYERS SQUIBB,TUHACKOVA M. ATYPICAL HYPOGLYCEMIA IN A TYPE 2 DIABETIC TREATED WITH ORAL ANTIDIABETICS. KAZUISTIKY V DIABETOLOGII. 2019;1:6-7,63.0,YR,,M,Y,,,20190503.0,,OT,CZ,CZ,2019,Q2,Adult
162535922,16253592,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q2,Glycosylated haemoglobin increased,,2019,Q2,2,F,2017.0,20190417.0,20190430,20190503,EXP,,CZ-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-041668,BRISTOL MYERS SQUIBB,TUHACKOVA M. ATYPICAL HYPOGLYCEMIA IN A TYPE 2 DIABETIC TREATED WITH ORAL ANTIDIABETICS. KAZUISTIKY V DIABETOLOGII. 2019;1:6-7,63.0,YR,,M,Y,,,20190503.0,,OT,CZ,CZ,2019,Q2,Adult
162535922,16253592,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q2,Hypoglycaemia,,2019,Q2,2,F,2017.0,20190417.0,20190430,20190503,EXP,,CZ-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-041668,BRISTOL MYERS SQUIBB,TUHACKOVA M. ATYPICAL HYPOGLYCEMIA IN A TYPE 2 DIABETIC TREATED WITH ORAL ANTIDIABETICS. KAZUISTIKY V DIABETOLOGII. 2019;1:6-7,63.0,YR,,M,Y,,,20190503.0,,OT,CZ,CZ,2019,Q2,Adult
162667811,16266781,37,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2019,Q2,Sepsis,,2019,Q2,1,I,20170329.0,20190424.0,20190502,20190502,PER,,US-SA-2019SA117325,SANOFI AVENTIS,,63.0,YR,A,M,Y,,,20190502.0,,OT,US,US,2019,Q2,Adult
162795241,16279524,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Acute kidney injury,,2019,Q2,1,I,20170609.0,20190423.0,20190507,20190507,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-041608,BRISTOL MYERS SQUIBB,,66.0,YR,,M,Y,,,20190507.0,,OT,US,US,2019,Q2,Elderly
162795241,16279524,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Acute respiratory failure,,2019,Q2,1,I,20170609.0,20190423.0,20190507,20190507,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-041608,BRISTOL MYERS SQUIBB,,66.0,YR,,M,Y,,,20190507.0,,OT,US,US,2019,Q2,Elderly
162795241,16279524,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Anaemia,,2019,Q2,1,I,20170609.0,20190423.0,20190507,20190507,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-041608,BRISTOL MYERS SQUIBB,,66.0,YR,,M,Y,,,20190507.0,,OT,US,US,2019,Q2,Elderly
162795241,16279524,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Arthralgia,,2019,Q2,1,I,20170609.0,20190423.0,20190507,20190507,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-041608,BRISTOL MYERS SQUIBB,,66.0,YR,,M,Y,,,20190507.0,,OT,US,US,2019,Q2,Elderly
162795241,16279524,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Bladder outlet obstruction,,2019,Q2,1,I,20170609.0,20190423.0,20190507,20190507,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-041608,BRISTOL MYERS SQUIBB,,66.0,YR,,M,Y,,,20190507.0,,OT,US,US,2019,Q2,Elderly
162795241,16279524,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Bladder spasm,,2019,Q2,1,I,20170609.0,20190423.0,20190507,20190507,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-041608,BRISTOL MYERS SQUIBB,,66.0,YR,,M,Y,,,20190507.0,,OT,US,US,2019,Q2,Elderly
162795241,16279524,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Constipation,,2019,Q2,1,I,20170609.0,20190423.0,20190507,20190507,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-041608,BRISTOL MYERS SQUIBB,,66.0,YR,,M,Y,,,20190507.0,,OT,US,US,2019,Q2,Elderly
162795241,16279524,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Cytomegalovirus infection,,2019,Q2,1,I,20170609.0,20190423.0,20190507,20190507,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-041608,BRISTOL MYERS SQUIBB,,66.0,YR,,M,Y,,,20190507.0,,OT,US,US,2019,Q2,Elderly
162795241,16279524,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Delayed graft function,,2019,Q2,1,I,20170609.0,20190423.0,20190507,20190507,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-041608,BRISTOL MYERS SQUIBB,,66.0,YR,,M,Y,,,20190507.0,,OT,US,US,2019,Q2,Elderly
162795241,16279524,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Dyspnoea exertional,,2019,Q2,1,I,20170609.0,20190423.0,20190507,20190507,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-041608,BRISTOL MYERS SQUIBB,,66.0,YR,,M,Y,,,20190507.0,,OT,US,US,2019,Q2,Elderly
162795241,16279524,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Escherichia bacteraemia,,2019,Q2,1,I,20170609.0,20190423.0,20190507,20190507,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-041608,BRISTOL MYERS SQUIBB,,66.0,YR,,M,Y,,,20190507.0,,OT,US,US,2019,Q2,Elderly
162795241,16279524,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Fluid overload,,2019,Q2,1,I,20170609.0,20190423.0,20190507,20190507,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-041608,BRISTOL MYERS SQUIBB,,66.0,YR,,M,Y,,,20190507.0,,OT,US,US,2019,Q2,Elderly
162795241,16279524,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Gastrointestinal haemorrhage,,2019,Q2,1,I,20170609.0,20190423.0,20190507,20190507,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-041608,BRISTOL MYERS SQUIBB,,66.0,YR,,M,Y,,,20190507.0,,OT,US,US,2019,Q2,Elderly
162795241,16279524,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Gout,,2019,Q2,1,I,20170609.0,20190423.0,20190507,20190507,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-041608,BRISTOL MYERS SQUIBB,,66.0,YR,,M,Y,,,20190507.0,,OT,US,US,2019,Q2,Elderly
162795241,16279524,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Hydronephrosis,,2019,Q2,1,I,20170609.0,20190423.0,20190507,20190507,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-041608,BRISTOL MYERS SQUIBB,,66.0,YR,,M,Y,,,20190507.0,,OT,US,US,2019,Q2,Elderly
162795241,16279524,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Hyperglycaemia,,2019,Q2,1,I,20170609.0,20190423.0,20190507,20190507,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-041608,BRISTOL MYERS SQUIBB,,66.0,YR,,M,Y,,,20190507.0,,OT,US,US,2019,Q2,Elderly
162795241,16279524,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Hyperphosphataemia,,2019,Q2,1,I,20170609.0,20190423.0,20190507,20190507,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-041608,BRISTOL MYERS SQUIBB,,66.0,YR,,M,Y,,,20190507.0,,OT,US,US,2019,Q2,Elderly
162795241,16279524,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Hypertension,,2019,Q2,1,I,20170609.0,20190423.0,20190507,20190507,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-041608,BRISTOL MYERS SQUIBB,,66.0,YR,,M,Y,,,20190507.0,,OT,US,US,2019,Q2,Elderly
162795241,16279524,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Hypomagnesaemia,,2019,Q2,1,I,20170609.0,20190423.0,20190507,20190507,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-041608,BRISTOL MYERS SQUIBB,,66.0,YR,,M,Y,,,20190507.0,,OT,US,US,2019,Q2,Elderly
162795241,16279524,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,International normalised ratio increased,,2019,Q2,1,I,20170609.0,20190423.0,20190507,20190507,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-041608,BRISTOL MYERS SQUIBB,,66.0,YR,,M,Y,,,20190507.0,,OT,US,US,2019,Q2,Elderly
162795241,16279524,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Leukocytosis,,2019,Q2,1,I,20170609.0,20190423.0,20190507,20190507,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-041608,BRISTOL MYERS SQUIBB,,66.0,YR,,M,Y,,,20190507.0,,OT,US,US,2019,Q2,Elderly
162795241,16279524,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Lung infiltration,,2019,Q2,1,I,20170609.0,20190423.0,20190507,20190507,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-041608,BRISTOL MYERS SQUIBB,,66.0,YR,,M,Y,,,20190507.0,,OT,US,US,2019,Q2,Elderly
162795241,16279524,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Mental status changes,,2019,Q2,1,I,20170609.0,20190423.0,20190507,20190507,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-041608,BRISTOL MYERS SQUIBB,,66.0,YR,,M,Y,,,20190507.0,,OT,US,US,2019,Q2,Elderly
162795241,16279524,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Metabolic acidosis,,2019,Q2,1,I,20170609.0,20190423.0,20190507,20190507,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-041608,BRISTOL MYERS SQUIBB,,66.0,YR,,M,Y,,,20190507.0,,OT,US,US,2019,Q2,Elderly
162795241,16279524,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Oedema peripheral,,2019,Q2,1,I,20170609.0,20190423.0,20190507,20190507,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-041608,BRISTOL MYERS SQUIBB,,66.0,YR,,M,Y,,,20190507.0,,OT,US,US,2019,Q2,Elderly
162795241,16279524,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Pneumocystis jirovecii pneumonia,,2019,Q2,1,I,20170609.0,20190423.0,20190507,20190507,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-041608,BRISTOL MYERS SQUIBB,,66.0,YR,,M,Y,,,20190507.0,,OT,US,US,2019,Q2,Elderly
162795241,16279524,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Pyrexia,,2019,Q2,1,I,20170609.0,20190423.0,20190507,20190507,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-041608,BRISTOL MYERS SQUIBB,,66.0,YR,,M,Y,,,20190507.0,,OT,US,US,2019,Q2,Elderly
162795241,16279524,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Respiratory failure,,2019,Q2,1,I,20170609.0,20190423.0,20190507,20190507,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-041608,BRISTOL MYERS SQUIBB,,66.0,YR,,M,Y,,,20190507.0,,OT,US,US,2019,Q2,Elderly
162795241,16279524,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Retroperitoneal haematoma,,2019,Q2,1,I,20170609.0,20190423.0,20190507,20190507,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-041608,BRISTOL MYERS SQUIBB,,66.0,YR,,M,Y,,,20190507.0,,OT,US,US,2019,Q2,Elderly
162795241,16279524,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Urinary tract infection,,2019,Q2,1,I,20170609.0,20190423.0,20190507,20190507,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-041608,BRISTOL MYERS SQUIBB,,66.0,YR,,M,Y,,,20190507.0,,OT,US,US,2019,Q2,Elderly
162795241,16279524,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Urinary tract infection pseudomonal,,2019,Q2,1,I,20170609.0,20190423.0,20190507,20190507,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-041608,BRISTOL MYERS SQUIBB,,66.0,YR,,M,Y,,,20190507.0,,OT,US,US,2019,Q2,Elderly
162795241,16279524,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Wound infection,,2019,Q2,1,I,20170609.0,20190423.0,20190507,20190507,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-041608,BRISTOL MYERS SQUIBB,,66.0,YR,,M,Y,,,20190507.0,,OT,US,US,2019,Q2,Elderly
162795771,16279577,38,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,International normalised ratio increased,,2019,Q2,1,I,20170621.0,20190423.0,20190507,20190507,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-044370,BRISTOL MYERS SQUIBB,,66.0,YR,,M,Y,,,20190507.0,,OT,US,US,2019,Q2,Elderly
162833622,16283362,1,PS,Liprolog Lispro,INSULIN LISPRO,1,Subcutaneous,"20 U, TID",,,Y,,,,20563.0,20.0,IU,,TID,2019,Q2,Blood glucose increased,,2019,Q2,2,F,,20190611.0,20190507,20190620,EXP,,GB-ELI_LILLY_AND_COMPANY-GB201905000923,ELI LILLY AND CO,,30.0,YR,,M,Y,62.0,KG,20190620.0,,CN,GB,GB,2019,Q2,Young Adult
162833622,16283362,1,PS,Liprolog Lispro,INSULIN LISPRO,1,Subcutaneous,"20 U, TID",,,Y,,,,20563.0,20.0,IU,,TID,2019,Q2,Diabetic ketoacidosis,,2019,Q2,2,F,,20190611.0,20190507,20190620,EXP,,GB-ELI_LILLY_AND_COMPANY-GB201905000923,ELI LILLY AND CO,,30.0,YR,,M,Y,62.0,KG,20190620.0,,CN,GB,GB,2019,Q2,Young Adult
162833622,16283362,1,PS,Liprolog Lispro,INSULIN LISPRO,1,Subcutaneous,"20 U, TID",,,Y,,,,20563.0,20.0,IU,,TID,2019,Q2,Malaise,,2019,Q2,2,F,,20190611.0,20190507,20190620,EXP,,GB-ELI_LILLY_AND_COMPANY-GB201905000923,ELI LILLY AND CO,,30.0,YR,,M,Y,62.0,KG,20190620.0,,CN,GB,GB,2019,Q2,Young Adult
162843465,16284346,5,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2019,Q2,Abdominal discomfort,,2019,Q2,5,F,20190425.0,20190618.0,20190508,20190623,EXP,,US-BIOGEN-2019BI00733005,BIOGEN,,47.0,YR,,M,Y,,,20190623.0,,CN,US,US,2019,Q2,Adult
162843465,16284346,5,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2019,Q2,Blood glucose decreased,,2019,Q2,5,F,20190425.0,20190618.0,20190508,20190623,EXP,,US-BIOGEN-2019BI00733005,BIOGEN,,47.0,YR,,M,Y,,,20190623.0,,CN,US,US,2019,Q2,Adult
162843465,16284346,5,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2019,Q2,Blood glucose increased,,2019,Q2,5,F,20190425.0,20190618.0,20190508,20190623,EXP,,US-BIOGEN-2019BI00733005,BIOGEN,,47.0,YR,,M,Y,,,20190623.0,,CN,US,US,2019,Q2,Adult
162843465,16284346,5,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2019,Q2,Diarrhoea,,2019,Q2,5,F,20190425.0,20190618.0,20190508,20190623,EXP,,US-BIOGEN-2019BI00733005,BIOGEN,,47.0,YR,,M,Y,,,20190623.0,,CN,US,US,2019,Q2,Adult
162843465,16284346,5,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2019,Q2,Faeces discoloured,,2019,Q2,5,F,20190425.0,20190618.0,20190508,20190623,EXP,,US-BIOGEN-2019BI00733005,BIOGEN,,47.0,YR,,M,Y,,,20190623.0,,CN,US,US,2019,Q2,Adult
162843465,16284346,5,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2019,Q2,Loss of consciousness,,2019,Q2,5,F,20190425.0,20190618.0,20190508,20190623,EXP,,US-BIOGEN-2019BI00733005,BIOGEN,,47.0,YR,,M,Y,,,20190623.0,,CN,US,US,2019,Q2,Adult
162843465,16284346,5,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2019,Q2,Product dose omission,,2019,Q2,5,F,20190425.0,20190618.0,20190508,20190623,EXP,,US-BIOGEN-2019BI00733005,BIOGEN,,47.0,YR,,M,Y,,,20190623.0,,CN,US,US,2019,Q2,Adult
162843465,16284346,5,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2019,Q2,Weight decreased,,2019,Q2,5,F,20190425.0,20190618.0,20190508,20190623,EXP,,US-BIOGEN-2019BI00733005,BIOGEN,,47.0,YR,,M,Y,,,20190623.0,,CN,US,US,2019,Q2,Adult
162858481,16285848,3,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Chronic respiratory failure,,2019,Q2,1,I,20190316.0,,20190403,20190403,DIR,,,FDA-CTU,,69.0,YR,,F,N,,,20190403.0,Y,PH,US,US,2019,Q2,Elderly
162858481,16285848,3,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Condition aggravated,,2019,Q2,1,I,20190316.0,,20190403,20190403,DIR,,,FDA-CTU,,69.0,YR,,F,N,,,20190403.0,Y,PH,US,US,2019,Q2,Elderly
162866691,16286669,20,C,Insulin lispro,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q2,Anaemia,,2019,Q2,1,I,20170501.0,20190423.0,20190508,20190508,EXP,,US-AMNEAL PHARMACEUTICALS COMPANY GMBH-2019AGH00040,AMNEAL,,42.0,YR,,M,Y,,,20190508.0,,OT,US,US,2019,Q2,Adult
162866691,16286669,20,C,Insulin lispro,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q2,Concomitant disease aggravated,,2019,Q2,1,I,20170501.0,20190423.0,20190508,20190508,EXP,,US-AMNEAL PHARMACEUTICALS COMPANY GMBH-2019AGH00040,AMNEAL,,42.0,YR,,M,Y,,,20190508.0,,OT,US,US,2019,Q2,Adult
162866691,16286669,20,C,Insulin lispro,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q2,Diabetes mellitus,,2019,Q2,1,I,20170501.0,20190423.0,20190508,20190508,EXP,,US-AMNEAL PHARMACEUTICALS COMPANY GMBH-2019AGH00040,AMNEAL,,42.0,YR,,M,Y,,,20190508.0,,OT,US,US,2019,Q2,Adult
162866691,16286669,20,C,Insulin lispro,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q2,Fatigue,,2019,Q2,1,I,20170501.0,20190423.0,20190508,20190508,EXP,,US-AMNEAL PHARMACEUTICALS COMPANY GMBH-2019AGH00040,AMNEAL,,42.0,YR,,M,Y,,,20190508.0,,OT,US,US,2019,Q2,Adult
162866691,16286669,20,C,Insulin lispro,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q2,Hypertension,,2019,Q2,1,I,20170501.0,20190423.0,20190508,20190508,EXP,,US-AMNEAL PHARMACEUTICALS COMPANY GMBH-2019AGH00040,AMNEAL,,42.0,YR,,M,Y,,,20190508.0,,OT,US,US,2019,Q2,Adult
162866691,16286669,20,C,Insulin lispro,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q2,Incision site pain,,2019,Q2,1,I,20170501.0,20190423.0,20190508,20190508,EXP,,US-AMNEAL PHARMACEUTICALS COMPANY GMBH-2019AGH00040,AMNEAL,,42.0,YR,,M,Y,,,20190508.0,,OT,US,US,2019,Q2,Adult
162866691,16286669,20,C,Insulin lispro,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q2,Leukopenia,,2019,Q2,1,I,20170501.0,20190423.0,20190508,20190508,EXP,,US-AMNEAL PHARMACEUTICALS COMPANY GMBH-2019AGH00040,AMNEAL,,42.0,YR,,M,Y,,,20190508.0,,OT,US,US,2019,Q2,Adult
162879901,16287990,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Acidosis,,2019,Q2,1,I,20160522.0,20190430.0,20190508,20190508,EXP,,US-MYLANLABS-2019M1044062,MYLAN,,63.0,YR,,F,Y,,,20190508.0,,OT,US,US,2019,Q2,Adult
162879901,16287990,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Acute kidney injury,,2019,Q2,1,I,20160522.0,20190430.0,20190508,20190508,EXP,,US-MYLANLABS-2019M1044062,MYLAN,,63.0,YR,,F,Y,,,20190508.0,,OT,US,US,2019,Q2,Adult
162879901,16287990,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Anaemia,,2019,Q2,1,I,20160522.0,20190430.0,20190508,20190508,EXP,,US-MYLANLABS-2019M1044062,MYLAN,,63.0,YR,,F,Y,,,20190508.0,,OT,US,US,2019,Q2,Adult
162879901,16287990,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Azotaemia,,2019,Q2,1,I,20160522.0,20190430.0,20190508,20190508,EXP,,US-MYLANLABS-2019M1044062,MYLAN,,63.0,YR,,F,Y,,,20190508.0,,OT,US,US,2019,Q2,Adult
162879901,16287990,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Blood creatinine increased,,2019,Q2,1,I,20160522.0,20190430.0,20190508,20190508,EXP,,US-MYLANLABS-2019M1044062,MYLAN,,63.0,YR,,F,Y,,,20190508.0,,OT,US,US,2019,Q2,Adult
162879901,16287990,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Delayed graft function,,2019,Q2,1,I,20160522.0,20190430.0,20190508,20190508,EXP,,US-MYLANLABS-2019M1044062,MYLAN,,63.0,YR,,F,Y,,,20190508.0,,OT,US,US,2019,Q2,Adult
162879901,16287990,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Dose calculation error,,2019,Q2,1,I,20160522.0,20190430.0,20190508,20190508,EXP,,US-MYLANLABS-2019M1044062,MYLAN,,63.0,YR,,F,Y,,,20190508.0,,OT,US,US,2019,Q2,Adult
162879901,16287990,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Haematuria,,2019,Q2,1,I,20160522.0,20190430.0,20190508,20190508,EXP,,US-MYLANLABS-2019M1044062,MYLAN,,63.0,YR,,F,Y,,,20190508.0,,OT,US,US,2019,Q2,Adult
162879901,16287990,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Hyperglycaemia,,2019,Q2,1,I,20160522.0,20190430.0,20190508,20190508,EXP,,US-MYLANLABS-2019M1044062,MYLAN,,63.0,YR,,F,Y,,,20190508.0,,OT,US,US,2019,Q2,Adult
162879901,16287990,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Hyperkalaemia,,2019,Q2,1,I,20160522.0,20190430.0,20190508,20190508,EXP,,US-MYLANLABS-2019M1044062,MYLAN,,63.0,YR,,F,Y,,,20190508.0,,OT,US,US,2019,Q2,Adult
162879901,16287990,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Hypertension,,2019,Q2,1,I,20160522.0,20190430.0,20190508,20190508,EXP,,US-MYLANLABS-2019M1044062,MYLAN,,63.0,YR,,F,Y,,,20190508.0,,OT,US,US,2019,Q2,Adult
162879901,16287990,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Hypervolaemia,,2019,Q2,1,I,20160522.0,20190430.0,20190508,20190508,EXP,,US-MYLANLABS-2019M1044062,MYLAN,,63.0,YR,,F,Y,,,20190508.0,,OT,US,US,2019,Q2,Adult
162879901,16287990,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Hypotension,,2019,Q2,1,I,20160522.0,20190430.0,20190508,20190508,EXP,,US-MYLANLABS-2019M1044062,MYLAN,,63.0,YR,,F,Y,,,20190508.0,,OT,US,US,2019,Q2,Adult
162879901,16287990,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Musculoskeletal disorder,,2019,Q2,1,I,20160522.0,20190430.0,20190508,20190508,EXP,,US-MYLANLABS-2019M1044062,MYLAN,,63.0,YR,,F,Y,,,20190508.0,,OT,US,US,2019,Q2,Adult
162879901,16287990,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Oedema peripheral,,2019,Q2,1,I,20160522.0,20190430.0,20190508,20190508,EXP,,US-MYLANLABS-2019M1044062,MYLAN,,63.0,YR,,F,Y,,,20190508.0,,OT,US,US,2019,Q2,Adult
162879901,16287990,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Procedural pain,,2019,Q2,1,I,20160522.0,20190430.0,20190508,20190508,EXP,,US-MYLANLABS-2019M1044062,MYLAN,,63.0,YR,,F,Y,,,20190508.0,,OT,US,US,2019,Q2,Adult
162879901,16287990,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Pulmonary congestion,,2019,Q2,1,I,20160522.0,20190430.0,20190508,20190508,EXP,,US-MYLANLABS-2019M1044062,MYLAN,,63.0,YR,,F,Y,,,20190508.0,,OT,US,US,2019,Q2,Adult
162879901,16287990,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Pyuria,,2019,Q2,1,I,20160522.0,20190430.0,20190508,20190508,EXP,,US-MYLANLABS-2019M1044062,MYLAN,,63.0,YR,,F,Y,,,20190508.0,,OT,US,US,2019,Q2,Adult
162879901,16287990,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Urinary tract infection,,2019,Q2,1,I,20160522.0,20190430.0,20190508,20190508,EXP,,US-MYLANLABS-2019M1044062,MYLAN,,63.0,YR,,F,Y,,,20190508.0,,OT,US,US,2019,Q2,Adult
162879901,16287990,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Urine flow decreased,,2019,Q2,1,I,20160522.0,20190430.0,20190508,20190508,EXP,,US-MYLANLABS-2019M1044062,MYLAN,,63.0,YR,,F,Y,,,20190508.0,,OT,US,US,2019,Q2,Adult
162901421,16290142,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Chronic respiratory failure,,2019,Q2,1,I,20190316.0,,20190403,20190403,DIR,,,FDA-CTU,,69.0,YR,,F,N,,,20190403.0,Y,PH,US,US,2019,Q2,Elderly
162901421,16290142,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Condition aggravated,,2019,Q2,1,I,20190316.0,,20190403,20190403,DIR,,,FDA-CTU,,69.0,YR,,F,N,,,20190403.0,Y,PH,US,US,2019,Q2,Elderly
162910781,16291078,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,20.0,IU,FORMULATION UNKNOWN,QD,2019,Q2,Acute kidney injury,,2019,Q2,1,I,20171230.0,20180105.0,20190509,20190509,EXP,,US-ASTELLAS-2018US001183,ASTELLAS,,49.0,YR,,F,Y,108.0,KG,20190509.0,,MD,US,US,2019,Q2,Adult
162910781,16291078,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,20.0,IU,FORMULATION UNKNOWN,QD,2019,Q2,Febrile neutropenia,,2019,Q2,1,I,20171230.0,20180105.0,20190509,20190509,EXP,,US-ASTELLAS-2018US001183,ASTELLAS,,49.0,YR,,F,Y,108.0,KG,20190509.0,,MD,US,US,2019,Q2,Adult
162918881,16291888,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"24 INTERNATIONAL UNIT, DAILY",7800.0,IU,Y,U,,,20563.0,24.0,IU,,QD,2019,Q2,Confusional state,,2019,Q2,1,I,20190330.0,20190429.0,20190509,20190509,EXP,IT-MINISAL02-546458,IT-ELI_LILLY_AND_COMPANY-IT201904016075,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20190509.0,,CN,IT,IT,2019,Q2,Elderly
162918881,16291888,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"24 INTERNATIONAL UNIT, DAILY",7800.0,IU,Y,U,,,20563.0,24.0,IU,,QD,2019,Q2,Hypoglycaemia,,2019,Q2,1,I,20190330.0,20190429.0,20190509,20190509,EXP,IT-MINISAL02-546458,IT-ELI_LILLY_AND_COMPANY-IT201904016075,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20190509.0,,CN,IT,IT,2019,Q2,Elderly
163008486,16300848,41,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q2,Acute myocardial infarction,,2019,Q2,6,F,20170327.0,20190612.0,20190510,20190618,EXP,,US-PFIZER INC-2019195079,PFIZER,,63.0,YR,,M,Y,,,20190618.0,,OT,US,US,2019,Q2,Adult
163008486,16300848,41,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q2,Delayed graft function,,2019,Q2,6,F,20170327.0,20190612.0,20190510,20190618,EXP,,US-PFIZER INC-2019195079,PFIZER,,63.0,YR,,M,Y,,,20190618.0,,OT,US,US,2019,Q2,Adult
163008486,16300848,41,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q2,Graft thrombosis,,2019,Q2,6,F,20170327.0,20190612.0,20190510,20190618,EXP,,US-PFIZER INC-2019195079,PFIZER,,63.0,YR,,M,Y,,,20190618.0,,OT,US,US,2019,Q2,Adult
163008486,16300848,41,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q2,Mental status changes,,2019,Q2,6,F,20170327.0,20190612.0,20190510,20190618,EXP,,US-PFIZER INC-2019195079,PFIZER,,63.0,YR,,M,Y,,,20190618.0,,OT,US,US,2019,Q2,Adult
163008486,16300848,41,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q2,Sepsis,,2019,Q2,6,F,20170327.0,20190612.0,20190510,20190618,EXP,,US-PFIZER INC-2019195079,PFIZER,,63.0,YR,,M,Y,,,20190618.0,,OT,US,US,2019,Q2,Adult
163008486,16300848,41,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q2,Transplant rejection,,2019,Q2,6,F,20170327.0,20190612.0,20190510,20190618,EXP,,US-PFIZER INC-2019195079,PFIZER,,63.0,YR,,M,Y,,,20190618.0,,OT,US,US,2019,Q2,Adult
163096992,16309699,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, Q4H",,,U,,,,,,,,,2019,Q2,Pneumonia,,2019,Q2,2,F,20190129.0,20190625.0,20190514,20190627,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-046864,BRISTOL MYERS SQUIBB,,59.0,YR,,M,Y,,,20190627.0,,OT,US,US,2019,Q2,Adult
163096992,16309699,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, Q4H",,,U,,,,,,,,,2019,Q2,Pulmonary cavitation,,2019,Q2,2,F,20190129.0,20190625.0,20190514,20190627,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-046864,BRISTOL MYERS SQUIBB,,59.0,YR,,M,Y,,,20190627.0,,OT,US,US,2019,Q2,Adult
163096992,16309699,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, Q4H",,,U,,,,,,,,,2019,Q2,Respiratory failure,,2019,Q2,2,F,20190129.0,20190625.0,20190514,20190627,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-046864,BRISTOL MYERS SQUIBB,,59.0,YR,,M,Y,,,20190627.0,,OT,US,US,2019,Q2,Adult
163125212,16312521,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, QD",,,U,,,,,,,,QD,2019,Q2,Alanine aminotransferase increased,,2019,Q2,2,F,20190508.0,20190509.0,20190515,20190520,EXP,,CO-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-046891,BRISTOL MYERS SQUIBB,,40.0,YR,,M,Y,,,20190520.0,,OT,CO,CO,2019,Q2,Adult
163125212,16312521,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, QD",,,U,,,,,,,,QD,2019,Q2,Aspartate aminotransferase increased,,2019,Q2,2,F,20190508.0,20190509.0,20190515,20190520,EXP,,CO-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-046891,BRISTOL MYERS SQUIBB,,40.0,YR,,M,Y,,,20190520.0,,OT,CO,CO,2019,Q2,Adult
163125212,16312521,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, QD",,,U,,,,,,,,QD,2019,Q2,Blood alkaline phosphatase increased,,2019,Q2,2,F,20190508.0,20190509.0,20190515,20190520,EXP,,CO-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-046891,BRISTOL MYERS SQUIBB,,40.0,YR,,M,Y,,,20190520.0,,OT,CO,CO,2019,Q2,Adult
163125212,16312521,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, QD",,,U,,,,,,,,QD,2019,Q2,Hypotension,,2019,Q2,2,F,20190508.0,20190509.0,20190515,20190520,EXP,,CO-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-046891,BRISTOL MYERS SQUIBB,,40.0,YR,,M,Y,,,20190520.0,,OT,CO,CO,2019,Q2,Adult
163125212,16312521,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, QD",,,U,,,,,,,,QD,2019,Q2,Sinus bradycardia,,2019,Q2,2,F,20190508.0,20190509.0,20190515,20190520,EXP,,CO-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-046891,BRISTOL MYERS SQUIBB,,40.0,YR,,M,Y,,,20190520.0,,OT,CO,CO,2019,Q2,Adult
163156781,16315678,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,U,,,,,,,,2019,Q2,Concomitant disease aggravated,,2019,Q2,1,I,,20190507.0,20190515,20190515,EXP,,PHHY2019CZ108980,SANDOZ,"TUHACKOVA M, BROZ J, KVAPIL M. ATYPICAL HYPOGLYCAEMIA IN A TYPE 2 DIABETES MELLITUS PATIENT TREATED WITH ORAL ANTIDIABETICS. KAZUISTIKY V DIABETOLOGII. 2019;17 (1):6-7",63.0,YR,,M,Y,,,20190515.0,,OT,CZ,CZ,2019,Q2,Adult
163156781,16315678,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,U,,,,,,,,2019,Q2,Hypoglycaemia,,2019,Q2,1,I,,20190507.0,20190515,20190515,EXP,,PHHY2019CZ108980,SANDOZ,"TUHACKOVA M, BROZ J, KVAPIL M. ATYPICAL HYPOGLYCAEMIA IN A TYPE 2 DIABETES MELLITUS PATIENT TREATED WITH ORAL ANTIDIABETICS. KAZUISTIKY V DIABETOLOGII. 2019;17 (1):6-7",63.0,YR,,M,Y,,,20190515.0,,OT,CZ,CZ,2019,Q2,Adult
163156781,16315678,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,U,,,,,,,,2019,Q2,Therapy non-responder,,2019,Q2,1,I,,20190507.0,20190515,20190515,EXP,,PHHY2019CZ108980,SANDOZ,"TUHACKOVA M, BROZ J, KVAPIL M. ATYPICAL HYPOGLYCAEMIA IN A TYPE 2 DIABETES MELLITUS PATIENT TREATED WITH ORAL ANTIDIABETICS. KAZUISTIKY V DIABETOLOGII. 2019;17 (1):6-7",63.0,YR,,M,Y,,,20190515.0,,OT,CZ,CZ,2019,Q2,Adult
163232842,16323284,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 DF, QD",,,Y,,,,,5.0,DF,SOLUTION FOR INJECTION,QD,2019,Q2,Hyperhidrosis,,2019,Q2,2,F,20190503.0,20190521.0,20190517,20190528,EXP,IT-MINISAL02-547935,IT-SA-2019SA132469,SANOFI AVENTIS,,81.0,YR,E,M,Y,,,20190528.0,,MD,IT,IT,2019,Q2,Elderly
163232842,16323284,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 DF, QD",,,Y,,,,,5.0,DF,SOLUTION FOR INJECTION,QD,2019,Q2,Hypoglycaemia,,2019,Q2,2,F,20190503.0,20190521.0,20190517,20190528,EXP,IT-MINISAL02-547935,IT-SA-2019SA132469,SANOFI AVENTIS,,81.0,YR,E,M,Y,,,20190528.0,,MD,IT,IT,2019,Q2,Elderly
163232842,16323284,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 DF, QD",,,Y,,,,,5.0,DF,SOLUTION FOR INJECTION,QD,2019,Q2,Hyporesponsive to stimuli,,2019,Q2,2,F,20190503.0,20190521.0,20190517,20190528,EXP,IT-MINISAL02-547935,IT-SA-2019SA132469,SANOFI AVENTIS,,81.0,YR,E,M,Y,,,20190528.0,,MD,IT,IT,2019,Q2,Elderly
163232842,16323284,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 DF, QD",,,Y,,,,,5.0,DF,SOLUTION FOR INJECTION,QD,2019,Q2,Overdose,,2019,Q2,2,F,20190503.0,20190521.0,20190517,20190528,EXP,IT-MINISAL02-547935,IT-SA-2019SA132469,SANOFI AVENTIS,,81.0,YR,E,M,Y,,,20190528.0,,MD,IT,IT,2019,Q2,Elderly
163240902,16324090,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,44.0,DF,,,2019,Q2,Acute kidney injury,,2019,Q2,2,F,,20190530.0,20190517,20190603,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002120",BOEHRINGER INGELHEIM,"NAKAYAMA Y, UEHARA M, TERUYA M, HOMMA K, YABIKU T, TERUYA T, ETAL. P1-29-6 A CASE OF ADRENOCORTICAL CARCINOMA ACCOMPANIED BY HYPERCORTISOLEMIA IN WHICH SEPSIS LED TO A SUDDEN FATAL OUTCOME.. THE 92ND ANNUAL MEETING OF THE JAPAN ENDOCRINE SOCIETY. 2019 MAY 09;NONE:NONE-NONE.",56.0,YR,,M,Y,,,20190603.0,,MD,JP,JP,2019,Q2,Adult
163240902,16324090,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,44.0,DF,,,2019,Q2,Cellulitis,,2019,Q2,2,F,,20190530.0,20190517,20190603,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002120",BOEHRINGER INGELHEIM,"NAKAYAMA Y, UEHARA M, TERUYA M, HOMMA K, YABIKU T, TERUYA T, ETAL. P1-29-6 A CASE OF ADRENOCORTICAL CARCINOMA ACCOMPANIED BY HYPERCORTISOLEMIA IN WHICH SEPSIS LED TO A SUDDEN FATAL OUTCOME.. THE 92ND ANNUAL MEETING OF THE JAPAN ENDOCRINE SOCIETY. 2019 MAY 09;NONE:NONE-NONE.",56.0,YR,,M,Y,,,20190603.0,,MD,JP,JP,2019,Q2,Adult
163240902,16324090,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,44.0,DF,,,2019,Q2,Drug-induced liver injury,,2019,Q2,2,F,,20190530.0,20190517,20190603,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002120",BOEHRINGER INGELHEIM,"NAKAYAMA Y, UEHARA M, TERUYA M, HOMMA K, YABIKU T, TERUYA T, ETAL. P1-29-6 A CASE OF ADRENOCORTICAL CARCINOMA ACCOMPANIED BY HYPERCORTISOLEMIA IN WHICH SEPSIS LED TO A SUDDEN FATAL OUTCOME.. THE 92ND ANNUAL MEETING OF THE JAPAN ENDOCRINE SOCIETY. 2019 MAY 09;NONE:NONE-NONE.",56.0,YR,,M,Y,,,20190603.0,,MD,JP,JP,2019,Q2,Adult
163240902,16324090,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,44.0,DF,,,2019,Q2,Hepatic failure,,2019,Q2,2,F,,20190530.0,20190517,20190603,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002120",BOEHRINGER INGELHEIM,"NAKAYAMA Y, UEHARA M, TERUYA M, HOMMA K, YABIKU T, TERUYA T, ETAL. P1-29-6 A CASE OF ADRENOCORTICAL CARCINOMA ACCOMPANIED BY HYPERCORTISOLEMIA IN WHICH SEPSIS LED TO A SUDDEN FATAL OUTCOME.. THE 92ND ANNUAL MEETING OF THE JAPAN ENDOCRINE SOCIETY. 2019 MAY 09;NONE:NONE-NONE.",56.0,YR,,M,Y,,,20190603.0,,MD,JP,JP,2019,Q2,Adult
163240902,16324090,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,44.0,DF,,,2019,Q2,Multiple organ dysfunction syndrome,,2019,Q2,2,F,,20190530.0,20190517,20190603,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002120",BOEHRINGER INGELHEIM,"NAKAYAMA Y, UEHARA M, TERUYA M, HOMMA K, YABIKU T, TERUYA T, ETAL. P1-29-6 A CASE OF ADRENOCORTICAL CARCINOMA ACCOMPANIED BY HYPERCORTISOLEMIA IN WHICH SEPSIS LED TO A SUDDEN FATAL OUTCOME.. THE 92ND ANNUAL MEETING OF THE JAPAN ENDOCRINE SOCIETY. 2019 MAY 09;NONE:NONE-NONE.",56.0,YR,,M,Y,,,20190603.0,,MD,JP,JP,2019,Q2,Adult
163240902,16324090,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,44.0,DF,,,2019,Q2,Renal failure,,2019,Q2,2,F,,20190530.0,20190517,20190603,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002120",BOEHRINGER INGELHEIM,"NAKAYAMA Y, UEHARA M, TERUYA M, HOMMA K, YABIKU T, TERUYA T, ETAL. P1-29-6 A CASE OF ADRENOCORTICAL CARCINOMA ACCOMPANIED BY HYPERCORTISOLEMIA IN WHICH SEPSIS LED TO A SUDDEN FATAL OUTCOME.. THE 92ND ANNUAL MEETING OF THE JAPAN ENDOCRINE SOCIETY. 2019 MAY 09;NONE:NONE-NONE.",56.0,YR,,M,Y,,,20190603.0,,MD,JP,JP,2019,Q2,Adult
163240902,16324090,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,44.0,DF,,,2019,Q2,Septic shock,,2019,Q2,2,F,,20190530.0,20190517,20190603,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-002120",BOEHRINGER INGELHEIM,"NAKAYAMA Y, UEHARA M, TERUYA M, HOMMA K, YABIKU T, TERUYA T, ETAL. P1-29-6 A CASE OF ADRENOCORTICAL CARCINOMA ACCOMPANIED BY HYPERCORTISOLEMIA IN WHICH SEPSIS LED TO A SUDDEN FATAL OUTCOME.. THE 92ND ANNUAL MEETING OF THE JAPAN ENDOCRINE SOCIETY. 2019 MAY 09;NONE:NONE-NONE.",56.0,YR,,M,Y,,,20190603.0,,MD,JP,JP,2019,Q2,Adult
163253381,16325338,3,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,3.0,IU,,QD,2019,Q2,Acute myocardial infarction,,2019,Q2,1,I,20190420.0,20190424.0,20190517,20190517,EXP,,CO-ABBVIE-19S-036-2760345-00,ABBVIE,,60.0,YR,,F,Y,55.0,KG,20190517.0,,MD,CO,CO,2019,Q2,Adult
163253381,16325338,3,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,3.0,IU,,QD,2019,Q2,Cardiac failure,,2019,Q2,1,I,20190420.0,20190424.0,20190517,20190517,EXP,,CO-ABBVIE-19S-036-2760345-00,ABBVIE,,60.0,YR,,F,Y,55.0,KG,20190517.0,,MD,CO,CO,2019,Q2,Adult
163253381,16325338,3,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,3.0,IU,,QD,2019,Q2,Pulmonary oedema,,2019,Q2,1,I,20190420.0,20190424.0,20190517,20190517,EXP,,CO-ABBVIE-19S-036-2760345-00,ABBVIE,,60.0,YR,,F,Y,55.0,KG,20190517.0,,MD,CO,CO,2019,Q2,Adult
163303841,16330384,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,1-12 UNITS BEFORE MEAL S AND NIGHTLY,,,U,,,,,,,,,2019,Q2,Asthenia,,2019,Q2,1,I,201904.0,20190513.0,20190520,20190520,EXP,,US-SA-2019SA134160,SANOFI AVENTIS,,67.0,YR,E,M,Y,85.7,KG,20190520.0,,MD,US,US,2019,Q2,Elderly
163303841,16330384,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,1-12 UNITS BEFORE MEAL S AND NIGHTLY,,,U,,,,,,,,,2019,Q2,Blood creatine phosphokinase increased,,2019,Q2,1,I,201904.0,20190513.0,20190520,20190520,EXP,,US-SA-2019SA134160,SANOFI AVENTIS,,67.0,YR,E,M,Y,85.7,KG,20190520.0,,MD,US,US,2019,Q2,Elderly
163303841,16330384,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,1-12 UNITS BEFORE MEAL S AND NIGHTLY,,,U,,,,,,,,,2019,Q2,Bronchial hyperreactivity,,2019,Q2,1,I,201904.0,20190513.0,20190520,20190520,EXP,,US-SA-2019SA134160,SANOFI AVENTIS,,67.0,YR,E,M,Y,85.7,KG,20190520.0,,MD,US,US,2019,Q2,Elderly
163303841,16330384,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,1-12 UNITS BEFORE MEAL S AND NIGHTLY,,,U,,,,,,,,,2019,Q2,Bronchial secretion retention,,2019,Q2,1,I,201904.0,20190513.0,20190520,20190520,EXP,,US-SA-2019SA134160,SANOFI AVENTIS,,67.0,YR,E,M,Y,85.7,KG,20190520.0,,MD,US,US,2019,Q2,Elderly
163303841,16330384,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,1-12 UNITS BEFORE MEAL S AND NIGHTLY,,,U,,,,,,,,,2019,Q2,Bronchial wall thickening,,2019,Q2,1,I,201904.0,20190513.0,20190520,20190520,EXP,,US-SA-2019SA134160,SANOFI AVENTIS,,67.0,YR,E,M,Y,85.7,KG,20190520.0,,MD,US,US,2019,Q2,Elderly
163303841,16330384,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,1-12 UNITS BEFORE MEAL S AND NIGHTLY,,,U,,,,,,,,,2019,Q2,Cardiac disorder,,2019,Q2,1,I,201904.0,20190513.0,20190520,20190520,EXP,,US-SA-2019SA134160,SANOFI AVENTIS,,67.0,YR,E,M,Y,85.7,KG,20190520.0,,MD,US,US,2019,Q2,Elderly
163303841,16330384,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,1-12 UNITS BEFORE MEAL S AND NIGHTLY,,,U,,,,,,,,,2019,Q2,Cough,,2019,Q2,1,I,201904.0,20190513.0,20190520,20190520,EXP,,US-SA-2019SA134160,SANOFI AVENTIS,,67.0,YR,E,M,Y,85.7,KG,20190520.0,,MD,US,US,2019,Q2,Elderly
163303841,16330384,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,1-12 UNITS BEFORE MEAL S AND NIGHTLY,,,U,,,,,,,,,2019,Q2,Ejection fraction decreased,,2019,Q2,1,I,201904.0,20190513.0,20190520,20190520,EXP,,US-SA-2019SA134160,SANOFI AVENTIS,,67.0,YR,E,M,Y,85.7,KG,20190520.0,,MD,US,US,2019,Q2,Elderly
163303841,16330384,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,1-12 UNITS BEFORE MEAL S AND NIGHTLY,,,U,,,,,,,,,2019,Q2,Endocarditis fibroplastica,,2019,Q2,1,I,201904.0,20190513.0,20190520,20190520,EXP,,US-SA-2019SA134160,SANOFI AVENTIS,,67.0,YR,E,M,Y,85.7,KG,20190520.0,,MD,US,US,2019,Q2,Elderly
163303841,16330384,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,1-12 UNITS BEFORE MEAL S AND NIGHTLY,,,U,,,,,,,,,2019,Q2,Hepatic cyst,,2019,Q2,1,I,201904.0,20190513.0,20190520,20190520,EXP,,US-SA-2019SA134160,SANOFI AVENTIS,,67.0,YR,E,M,Y,85.7,KG,20190520.0,,MD,US,US,2019,Q2,Elderly
163303841,16330384,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,1-12 UNITS BEFORE MEAL S AND NIGHTLY,,,U,,,,,,,,,2019,Q2,Hypereosinophilic syndrome,,2019,Q2,1,I,201904.0,20190513.0,20190520,20190520,EXP,,US-SA-2019SA134160,SANOFI AVENTIS,,67.0,YR,E,M,Y,85.7,KG,20190520.0,,MD,US,US,2019,Q2,Elderly
163303841,16330384,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,1-12 UNITS BEFORE MEAL S AND NIGHTLY,,,U,,,,,,,,,2019,Q2,Leukocytosis,,2019,Q2,1,I,201904.0,20190513.0,20190520,20190520,EXP,,US-SA-2019SA134160,SANOFI AVENTIS,,67.0,YR,E,M,Y,85.7,KG,20190520.0,,MD,US,US,2019,Q2,Elderly
163303841,16330384,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,1-12 UNITS BEFORE MEAL S AND NIGHTLY,,,U,,,,,,,,,2019,Q2,Muscle disorder,,2019,Q2,1,I,201904.0,20190513.0,20190520,20190520,EXP,,US-SA-2019SA134160,SANOFI AVENTIS,,67.0,YR,E,M,Y,85.7,KG,20190520.0,,MD,US,US,2019,Q2,Elderly
163303841,16330384,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,1-12 UNITS BEFORE MEAL S AND NIGHTLY,,,U,,,,,,,,,2019,Q2,Muscular weakness,,2019,Q2,1,I,201904.0,20190513.0,20190520,20190520,EXP,,US-SA-2019SA134160,SANOFI AVENTIS,,67.0,YR,E,M,Y,85.7,KG,20190520.0,,MD,US,US,2019,Q2,Elderly
163303841,16330384,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,1-12 UNITS BEFORE MEAL S AND NIGHTLY,,,U,,,,,,,,,2019,Q2,Myalgia,,2019,Q2,1,I,201904.0,20190513.0,20190520,20190520,EXP,,US-SA-2019SA134160,SANOFI AVENTIS,,67.0,YR,E,M,Y,85.7,KG,20190520.0,,MD,US,US,2019,Q2,Elderly
163303841,16330384,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,1-12 UNITS BEFORE MEAL S AND NIGHTLY,,,U,,,,,,,,,2019,Q2,Pain,,2019,Q2,1,I,201904.0,20190513.0,20190520,20190520,EXP,,US-SA-2019SA134160,SANOFI AVENTIS,,67.0,YR,E,M,Y,85.7,KG,20190520.0,,MD,US,US,2019,Q2,Elderly
163303841,16330384,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,1-12 UNITS BEFORE MEAL S AND NIGHTLY,,,U,,,,,,,,,2019,Q2,Pericardial effusion,,2019,Q2,1,I,201904.0,20190513.0,20190520,20190520,EXP,,US-SA-2019SA134160,SANOFI AVENTIS,,67.0,YR,E,M,Y,85.7,KG,20190520.0,,MD,US,US,2019,Q2,Elderly
163303841,16330384,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,1-12 UNITS BEFORE MEAL S AND NIGHTLY,,,U,,,,,,,,,2019,Q2,Syncope,,2019,Q2,1,I,201904.0,20190513.0,20190520,20190520,EXP,,US-SA-2019SA134160,SANOFI AVENTIS,,67.0,YR,E,M,Y,85.7,KG,20190520.0,,MD,US,US,2019,Q2,Elderly
163303841,16330384,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,1-12 UNITS BEFORE MEAL S AND NIGHTLY,,,U,,,,,,,,,2019,Q2,Wheezing,,2019,Q2,1,I,201904.0,20190513.0,20190520,20190520,EXP,,US-SA-2019SA134160,SANOFI AVENTIS,,67.0,YR,E,M,Y,85.7,KG,20190520.0,,MD,US,US,2019,Q2,Elderly
163305092,16330509,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 DF, BEFORE EACH MEAL",,,,,,,,5.0,DF,FORMULATION UNKNOWN,,2019,Q2,Blood creatinine increased,,2019,Q2,2,F,20190226.0,20190612.0,20190520,20190619,EXP,,CO-ASTELLAS-2019US009553,ASTELLAS,,46.0,YR,,M,Y,62.0,KG,20190619.0,,CN,CO,CO,2019,Q2,Adult
163305092,16330509,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 DF, BEFORE EACH MEAL",,,,,,,,5.0,DF,FORMULATION UNKNOWN,,2019,Q2,Dehydration,,2019,Q2,2,F,20190226.0,20190612.0,20190520,20190619,EXP,,CO-ASTELLAS-2019US009553,ASTELLAS,,46.0,YR,,M,Y,62.0,KG,20190619.0,,CN,CO,CO,2019,Q2,Adult
163305092,16330509,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 DF, BEFORE EACH MEAL",,,,,,,,5.0,DF,FORMULATION UNKNOWN,,2019,Q2,Gastroenteritis,,2019,Q2,2,F,20190226.0,20190612.0,20190520,20190619,EXP,,CO-ASTELLAS-2019US009553,ASTELLAS,,46.0,YR,,M,Y,62.0,KG,20190619.0,,CN,CO,CO,2019,Q2,Adult
163305092,16330509,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 DF, BEFORE EACH MEAL",,,,,,,,5.0,DF,FORMULATION UNKNOWN,,2019,Q2,Gingivitis,,2019,Q2,2,F,20190226.0,20190612.0,20190520,20190619,EXP,,CO-ASTELLAS-2019US009553,ASTELLAS,,46.0,YR,,M,Y,62.0,KG,20190619.0,,CN,CO,CO,2019,Q2,Adult
163305092,16330509,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 DF, BEFORE EACH MEAL",,,,,,,,5.0,DF,FORMULATION UNKNOWN,,2019,Q2,Haemorrhoids,,2019,Q2,2,F,20190226.0,20190612.0,20190520,20190619,EXP,,CO-ASTELLAS-2019US009553,ASTELLAS,,46.0,YR,,M,Y,62.0,KG,20190619.0,,CN,CO,CO,2019,Q2,Adult
163305092,16330509,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 DF, BEFORE EACH MEAL",,,,,,,,5.0,DF,FORMULATION UNKNOWN,,2019,Q2,Kidney infection,,2019,Q2,2,F,20190226.0,20190612.0,20190520,20190619,EXP,,CO-ASTELLAS-2019US009553,ASTELLAS,,46.0,YR,,M,Y,62.0,KG,20190619.0,,CN,CO,CO,2019,Q2,Adult
163305092,16330509,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 DF, BEFORE EACH MEAL",,,,,,,,5.0,DF,FORMULATION UNKNOWN,,2019,Q2,Product use in unapproved indication,,2019,Q2,2,F,20190226.0,20190612.0,20190520,20190619,EXP,,CO-ASTELLAS-2019US009553,ASTELLAS,,46.0,YR,,M,Y,62.0,KG,20190619.0,,CN,CO,CO,2019,Q2,Adult
163305092,16330509,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 DF, BEFORE EACH MEAL",,,,,,,,5.0,DF,FORMULATION UNKNOWN,,2019,Q2,Renal impairment,,2019,Q2,2,F,20190226.0,20190612.0,20190520,20190619,EXP,,CO-ASTELLAS-2019US009553,ASTELLAS,,46.0,YR,,M,Y,62.0,KG,20190619.0,,CN,CO,CO,2019,Q2,Adult
163305092,16330509,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 DF, BEFORE EACH MEAL",,,,,,,,5.0,DF,FORMULATION UNKNOWN,,2019,Q2,Swelling,,2019,Q2,2,F,20190226.0,20190612.0,20190520,20190619,EXP,,CO-ASTELLAS-2019US009553,ASTELLAS,,46.0,YR,,M,Y,62.0,KG,20190619.0,,CN,CO,CO,2019,Q2,Adult
163305092,16330509,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 DF, BEFORE EACH MEAL",,,,,,,,5.0,DF,FORMULATION UNKNOWN,,2019,Q2,Toothache,,2019,Q2,2,F,20190226.0,20190612.0,20190520,20190619,EXP,,CO-ASTELLAS-2019US009553,ASTELLAS,,46.0,YR,,M,Y,62.0,KG,20190619.0,,CN,CO,CO,2019,Q2,Adult
163308091,16330809,12,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Clonus,,2019,Q2,1,I,20190212.0,,20190517,20190517,DIR,,,FDA-CTU,,72.0,YR,,M,N,83.7,KG,20190517.0,N,PH,US,US,2019,Q2,Elderly
163308091,16330809,12,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Female sexual arousal disorder,,2019,Q2,1,I,20190212.0,,20190517,20190517,DIR,,,FDA-CTU,,72.0,YR,,M,N,83.7,KG,20190517.0,N,PH,US,US,2019,Q2,Elderly
163308091,16330809,12,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Serotonin syndrome,,2019,Q2,1,I,20190212.0,,20190517,20190517,DIR,,,FDA-CTU,,72.0,YR,,M,N,83.7,KG,20190517.0,N,PH,US,US,2019,Q2,Elderly
163314522,16331452,3,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,209196.0,,,,,2019,Q2,Acute kidney injury,,2019,Q2,2,F,2018.0,20190514.0,20190520,20190527,EXP,,PT-SA-2019SA132016,SANOFI AVENTIS,"GOUVEIA C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,E,M,Y,,,20190527.0,,,COUNTRY NOT SPECIFIED,PT,2019,Q2,Elderly
163314522,16331452,3,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,209196.0,,,,,2019,Q2,Arrhythmia,,2019,Q2,2,F,2018.0,20190514.0,20190520,20190527,EXP,,PT-SA-2019SA132016,SANOFI AVENTIS,"GOUVEIA C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,E,M,Y,,,20190527.0,,,COUNTRY NOT SPECIFIED,PT,2019,Q2,Elderly
163314522,16331452,3,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,209196.0,,,,,2019,Q2,Atrial fibrillation,,2019,Q2,2,F,2018.0,20190514.0,20190520,20190527,EXP,,PT-SA-2019SA132016,SANOFI AVENTIS,"GOUVEIA C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,E,M,Y,,,20190527.0,,,COUNTRY NOT SPECIFIED,PT,2019,Q2,Elderly
163314522,16331452,3,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,209196.0,,,,,2019,Q2,Bradycardia,,2019,Q2,2,F,2018.0,20190514.0,20190520,20190527,EXP,,PT-SA-2019SA132016,SANOFI AVENTIS,"GOUVEIA C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,E,M,Y,,,20190527.0,,,COUNTRY NOT SPECIFIED,PT,2019,Q2,Elderly
163314522,16331452,3,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,209196.0,,,,,2019,Q2,Dehydration,,2019,Q2,2,F,2018.0,20190514.0,20190520,20190527,EXP,,PT-SA-2019SA132016,SANOFI AVENTIS,"GOUVEIA C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,E,M,Y,,,20190527.0,,,COUNTRY NOT SPECIFIED,PT,2019,Q2,Elderly
163314522,16331452,3,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,209196.0,,,,,2019,Q2,Dizziness,,2019,Q2,2,F,2018.0,20190514.0,20190520,20190527,EXP,,PT-SA-2019SA132016,SANOFI AVENTIS,"GOUVEIA C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,E,M,Y,,,20190527.0,,,COUNTRY NOT SPECIFIED,PT,2019,Q2,Elderly
163314522,16331452,3,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,209196.0,,,,,2019,Q2,Haematocrit increased,,2019,Q2,2,F,2018.0,20190514.0,20190520,20190527,EXP,,PT-SA-2019SA132016,SANOFI AVENTIS,"GOUVEIA C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,E,M,Y,,,20190527.0,,,COUNTRY NOT SPECIFIED,PT,2019,Q2,Elderly
163314522,16331452,3,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,209196.0,,,,,2019,Q2,Haemoglobin increased,,2019,Q2,2,F,2018.0,20190514.0,20190520,20190527,EXP,,PT-SA-2019SA132016,SANOFI AVENTIS,"GOUVEIA C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,E,M,Y,,,20190527.0,,,COUNTRY NOT SPECIFIED,PT,2019,Q2,Elderly
163314522,16331452,3,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,209196.0,,,,,2019,Q2,Hypotension,,2019,Q2,2,F,2018.0,20190514.0,20190520,20190527,EXP,,PT-SA-2019SA132016,SANOFI AVENTIS,"GOUVEIA C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,E,M,Y,,,20190527.0,,,COUNTRY NOT SPECIFIED,PT,2019,Q2,Elderly
163314522,16331452,3,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,209196.0,,,,,2019,Q2,Hypovolaemia,,2019,Q2,2,F,2018.0,20190514.0,20190520,20190527,EXP,,PT-SA-2019SA132016,SANOFI AVENTIS,"GOUVEIA C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,E,M,Y,,,20190527.0,,,COUNTRY NOT SPECIFIED,PT,2019,Q2,Elderly
163314522,16331452,3,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,209196.0,,,,,2019,Q2,Left atrial dilatation,,2019,Q2,2,F,2018.0,20190514.0,20190520,20190527,EXP,,PT-SA-2019SA132016,SANOFI AVENTIS,"GOUVEIA C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,E,M,Y,,,20190527.0,,,COUNTRY NOT SPECIFIED,PT,2019,Q2,Elderly
163314522,16331452,3,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,209196.0,,,,,2019,Q2,Mucosal dryness,,2019,Q2,2,F,2018.0,20190514.0,20190520,20190527,EXP,,PT-SA-2019SA132016,SANOFI AVENTIS,"GOUVEIA C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,E,M,Y,,,20190527.0,,,COUNTRY NOT SPECIFIED,PT,2019,Q2,Elderly
163314522,16331452,3,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,209196.0,,,,,2019,Q2,Presyncope,,2019,Q2,2,F,2018.0,20190514.0,20190520,20190527,EXP,,PT-SA-2019SA132016,SANOFI AVENTIS,"GOUVEIA C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,E,M,Y,,,20190527.0,,,COUNTRY NOT SPECIFIED,PT,2019,Q2,Elderly
163314522,16331452,3,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,209196.0,,,,,2019,Q2,Skin disorder,,2019,Q2,2,F,2018.0,20190514.0,20190520,20190527,EXP,,PT-SA-2019SA132016,SANOFI AVENTIS,"GOUVEIA C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,E,M,Y,,,20190527.0,,,COUNTRY NOT SPECIFIED,PT,2019,Q2,Elderly
163314522,16331452,3,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,209196.0,,,,,2019,Q2,Syncope,,2019,Q2,2,F,2018.0,20190514.0,20190520,20190527,EXP,,PT-SA-2019SA132016,SANOFI AVENTIS,"GOUVEIA C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,E,M,Y,,,20190527.0,,,COUNTRY NOT SPECIFIED,PT,2019,Q2,Elderly
163316551,16331655,15,C,Insulin Lispro Dci,,2,Oral,6 UNITS DAILY 3 TIMES BEFORE MEAL,,,,,,,,,,,,2019,Q2,Urinary tract infection,,2019,Q2,1,I,20181217.0,20190130.0,20190520,20190520,PER,,US-ACADIA PHARMACEUTICALS INC.-ACA-2019-011659,ACADIA PHARMACEUTICALS,,77.0,YR,,F,Y,78.0,KG,20190520.0,,OT,US,US,2019,Q2,Elderly
163358451,16335845,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,209196.0,,,SOLUTION FOR INJECTION,,2019,Q2,Disability,,2019,Q2,1,I,1970.0,20190510.0,20190521,20190521,EXP,,US-SA-2019SA130757,SANOFI AVENTIS,,68.0,YR,E,M,Y,,,20190521.0,,CN,US,US,2019,Q2,Elderly
163358451,16335845,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,209196.0,,,SOLUTION FOR INJECTION,,2019,Q2,Hypertension,,2019,Q2,1,I,1970.0,20190510.0,20190521,20190521,EXP,,US-SA-2019SA130757,SANOFI AVENTIS,,68.0,YR,E,M,Y,,,20190521.0,,CN,US,US,2019,Q2,Elderly
163358451,16335845,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,209196.0,,,SOLUTION FOR INJECTION,,2019,Q2,Hypoacusis,,2019,Q2,1,I,1970.0,20190510.0,20190521,20190521,EXP,,US-SA-2019SA130757,SANOFI AVENTIS,,68.0,YR,E,M,Y,,,20190521.0,,CN,US,US,2019,Q2,Elderly
163358451,16335845,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,209196.0,,,SOLUTION FOR INJECTION,,2019,Q2,Loss of consciousness,,2019,Q2,1,I,1970.0,20190510.0,20190521,20190521,EXP,,US-SA-2019SA130757,SANOFI AVENTIS,,68.0,YR,E,M,Y,,,20190521.0,,CN,US,US,2019,Q2,Elderly
163358451,16335845,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,209196.0,,,SOLUTION FOR INJECTION,,2019,Q2,Nervousness,,2019,Q2,1,I,1970.0,20190510.0,20190521,20190521,EXP,,US-SA-2019SA130757,SANOFI AVENTIS,,68.0,YR,E,M,Y,,,20190521.0,,CN,US,US,2019,Q2,Elderly
163358451,16335845,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,209196.0,,,SOLUTION FOR INJECTION,,2019,Q2,Pain,,2019,Q2,1,I,1970.0,20190510.0,20190521,20190521,EXP,,US-SA-2019SA130757,SANOFI AVENTIS,,68.0,YR,E,M,Y,,,20190521.0,,CN,US,US,2019,Q2,Elderly
163358451,16335845,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,209196.0,,,SOLUTION FOR INJECTION,,2019,Q2,Road traffic accident,,2019,Q2,1,I,1970.0,20190510.0,20190521,20190521,EXP,,US-SA-2019SA130757,SANOFI AVENTIS,,68.0,YR,E,M,Y,,,20190521.0,,CN,US,US,2019,Q2,Elderly
163358451,16335845,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,209196.0,,,SOLUTION FOR INJECTION,,2019,Q2,Unevaluable event,,2019,Q2,1,I,1970.0,20190510.0,20190521,20190521,EXP,,US-SA-2019SA130757,SANOFI AVENTIS,,68.0,YR,E,M,Y,,,20190521.0,,CN,US,US,2019,Q2,Elderly
163368381,16336838,4,C,INSULIN LISPRO RECOMBINANT,INSULIN LISPRO,1,,14 IU IN THE MORNING AND 12 IU AT NIGHT AT USUAL,,,U,,,,,,,INJECTION,,2019,Q2,Asthenia,,2019,Q2,1,I,,20190514.0,20190521,20190521,EXP,,CN-SA-2019SA134463,SANOFI AVENTIS,"YE L., WANG Y., WANG S., GUO C.,. PHARMACEUTICAL MONITORING FOR PATIENTS WITH DIABETIC NEPHROPATHY WITH FUNDAL HAEMORRHAGE. PUBLIC MEDICAL FORUM MAGAZINE. 2019;23(16):2350-2352",66.0,YR,E,M,Y,75.0,KG,20190521.0,,PH,CN,CN,2019,Q2,Elderly
163368381,16336838,4,C,INSULIN LISPRO RECOMBINANT,INSULIN LISPRO,1,,14 IU IN THE MORNING AND 12 IU AT NIGHT AT USUAL,,,U,,,,,,,INJECTION,,2019,Q2,Cardiac discomfort,,2019,Q2,1,I,,20190514.0,20190521,20190521,EXP,,CN-SA-2019SA134463,SANOFI AVENTIS,"YE L., WANG Y., WANG S., GUO C.,. PHARMACEUTICAL MONITORING FOR PATIENTS WITH DIABETIC NEPHROPATHY WITH FUNDAL HAEMORRHAGE. PUBLIC MEDICAL FORUM MAGAZINE. 2019;23(16):2350-2352",66.0,YR,E,M,Y,75.0,KG,20190521.0,,PH,CN,CN,2019,Q2,Elderly
163368381,16336838,4,C,INSULIN LISPRO RECOMBINANT,INSULIN LISPRO,1,,14 IU IN THE MORNING AND 12 IU AT NIGHT AT USUAL,,,U,,,,,,,INJECTION,,2019,Q2,Chronic kidney disease,,2019,Q2,1,I,,20190514.0,20190521,20190521,EXP,,CN-SA-2019SA134463,SANOFI AVENTIS,"YE L., WANG Y., WANG S., GUO C.,. PHARMACEUTICAL MONITORING FOR PATIENTS WITH DIABETIC NEPHROPATHY WITH FUNDAL HAEMORRHAGE. PUBLIC MEDICAL FORUM MAGAZINE. 2019;23(16):2350-2352",66.0,YR,E,M,Y,75.0,KG,20190521.0,,PH,CN,CN,2019,Q2,Elderly
163368381,16336838,4,C,INSULIN LISPRO RECOMBINANT,INSULIN LISPRO,1,,14 IU IN THE MORNING AND 12 IU AT NIGHT AT USUAL,,,U,,,,,,,INJECTION,,2019,Q2,Diabetic nephropathy,,2019,Q2,1,I,,20190514.0,20190521,20190521,EXP,,CN-SA-2019SA134463,SANOFI AVENTIS,"YE L., WANG Y., WANG S., GUO C.,. PHARMACEUTICAL MONITORING FOR PATIENTS WITH DIABETIC NEPHROPATHY WITH FUNDAL HAEMORRHAGE. PUBLIC MEDICAL FORUM MAGAZINE. 2019;23(16):2350-2352",66.0,YR,E,M,Y,75.0,KG,20190521.0,,PH,CN,CN,2019,Q2,Elderly
163368381,16336838,4,C,INSULIN LISPRO RECOMBINANT,INSULIN LISPRO,1,,14 IU IN THE MORNING AND 12 IU AT NIGHT AT USUAL,,,U,,,,,,,INJECTION,,2019,Q2,Protein urine,,2019,Q2,1,I,,20190514.0,20190521,20190521,EXP,,CN-SA-2019SA134463,SANOFI AVENTIS,"YE L., WANG Y., WANG S., GUO C.,. PHARMACEUTICAL MONITORING FOR PATIENTS WITH DIABETIC NEPHROPATHY WITH FUNDAL HAEMORRHAGE. PUBLIC MEDICAL FORUM MAGAZINE. 2019;23(16):2350-2352",66.0,YR,E,M,Y,75.0,KG,20190521.0,,PH,CN,CN,2019,Q2,Elderly
163368381,16336838,4,C,INSULIN LISPRO RECOMBINANT,INSULIN LISPRO,1,,14 IU IN THE MORNING AND 12 IU AT NIGHT AT USUAL,,,U,,,,,,,INJECTION,,2019,Q2,Renal impairment,,2019,Q2,1,I,,20190514.0,20190521,20190521,EXP,,CN-SA-2019SA134463,SANOFI AVENTIS,"YE L., WANG Y., WANG S., GUO C.,. PHARMACEUTICAL MONITORING FOR PATIENTS WITH DIABETIC NEPHROPATHY WITH FUNDAL HAEMORRHAGE. PUBLIC MEDICAL FORUM MAGAZINE. 2019;23(16):2350-2352",66.0,YR,E,M,Y,75.0,KG,20190521.0,,PH,CN,CN,2019,Q2,Elderly
163368381,16336838,4,C,INSULIN LISPRO RECOMBINANT,INSULIN LISPRO,1,,14 IU IN THE MORNING AND 12 IU AT NIGHT AT USUAL,,,U,,,,,,,INJECTION,,2019,Q2,Retinal haemorrhage,,2019,Q2,1,I,,20190514.0,20190521,20190521,EXP,,CN-SA-2019SA134463,SANOFI AVENTIS,"YE L., WANG Y., WANG S., GUO C.,. PHARMACEUTICAL MONITORING FOR PATIENTS WITH DIABETIC NEPHROPATHY WITH FUNDAL HAEMORRHAGE. PUBLIC MEDICAL FORUM MAGAZINE. 2019;23(16):2350-2352",66.0,YR,E,M,Y,75.0,KG,20190521.0,,PH,CN,CN,2019,Q2,Elderly
163377472,16337747,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, QD",,,U,,,,,,,,QD,2019,Q2,Alanine aminotransferase increased,,2019,Q2,2,F,20190508.0,20190524.0,20190521,20190603,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-048593,BRISTOL MYERS SQUIBB,,40.0,YR,,M,Y,,,20190603.0,,OT,US,US,2019,Q2,Adult
163377472,16337747,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, QD",,,U,,,,,,,,QD,2019,Q2,Aspartate aminotransferase increased,,2019,Q2,2,F,20190508.0,20190524.0,20190521,20190603,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-048593,BRISTOL MYERS SQUIBB,,40.0,YR,,M,Y,,,20190603.0,,OT,US,US,2019,Q2,Adult
163377472,16337747,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, QD",,,U,,,,,,,,QD,2019,Q2,Blood alkaline phosphatase increased,,2019,Q2,2,F,20190508.0,20190524.0,20190521,20190603,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-048593,BRISTOL MYERS SQUIBB,,40.0,YR,,M,Y,,,20190603.0,,OT,US,US,2019,Q2,Adult
163377472,16337747,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, QD",,,U,,,,,,,,QD,2019,Q2,Hypotension,,2019,Q2,2,F,20190508.0,20190524.0,20190521,20190603,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-048593,BRISTOL MYERS SQUIBB,,40.0,YR,,M,Y,,,20190603.0,,OT,US,US,2019,Q2,Adult
163377472,16337747,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, QD",,,U,,,,,,,,QD,2019,Q2,Sinus bradycardia,,2019,Q2,2,F,20190508.0,20190524.0,20190521,20190603,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-048593,BRISTOL MYERS SQUIBB,,40.0,YR,,M,Y,,,20190603.0,,OT,US,US,2019,Q2,Adult
163495711,16349571,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"12 INTERNATIONAL UNIT, TID",,,U,U,,,20563.0,12.0,IU,,TID,2019,Q2,Diabetes mellitus inadequate control,,2019,Q2,1,I,,20190517.0,20190523,20190523,EXP,,LT-ELI_LILLY_AND_COMPANY-LT201905010981,ELI LILLY AND CO,,51.0,YR,,F,Y,,,20190523.0,,OT,LT,LT,2019,Q2,Adult
163495711,16349571,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"12 INTERNATIONAL UNIT, TID",,,U,U,,,20563.0,12.0,IU,,TID,2019,Q2,Diabetic foot,,2019,Q2,1,I,,20190517.0,20190523,20190523,EXP,,LT-ELI_LILLY_AND_COMPANY-LT201905010981,ELI LILLY AND CO,,51.0,YR,,F,Y,,,20190523.0,,OT,LT,LT,2019,Q2,Adult
163495711,16349571,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"12 INTERNATIONAL UNIT, TID",,,U,U,,,20563.0,12.0,IU,,TID,2019,Q2,Glycosylated haemoglobin increased,,2019,Q2,1,I,,20190517.0,20190523,20190523,EXP,,LT-ELI_LILLY_AND_COMPANY-LT201905010981,ELI LILLY AND CO,,51.0,YR,,F,Y,,,20190523.0,,OT,LT,LT,2019,Q2,Adult
163495711,16349571,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"12 INTERNATIONAL UNIT, TID",,,U,U,,,20563.0,12.0,IU,,TID,2019,Q2,Hypoglycaemia,,2019,Q2,1,I,,20190517.0,20190523,20190523,EXP,,LT-ELI_LILLY_AND_COMPANY-LT201905010981,ELI LILLY AND CO,,51.0,YR,,F,Y,,,20190523.0,,OT,LT,LT,2019,Q2,Adult
163495711,16349571,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"12 INTERNATIONAL UNIT, TID",,,U,U,,,20563.0,12.0,IU,,TID,2019,Q2,Osteomyelitis,,2019,Q2,1,I,,20190517.0,20190523,20190523,EXP,,LT-ELI_LILLY_AND_COMPANY-LT201905010981,ELI LILLY AND CO,,51.0,YR,,F,Y,,,20190523.0,,OT,LT,LT,2019,Q2,Adult
163495711,16349571,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"12 INTERNATIONAL UNIT, TID",,,U,U,,,20563.0,12.0,IU,,TID,2019,Q2,Pain in extremity,,2019,Q2,1,I,,20190517.0,20190523,20190523,EXP,,LT-ELI_LILLY_AND_COMPANY-LT201905010981,ELI LILLY AND CO,,51.0,YR,,F,Y,,,20190523.0,,OT,LT,LT,2019,Q2,Adult
163549381,16354938,15,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,,,,,,,,,2019,Q2,Agranulocytosis,,2019,Q2,1,I,20161014.0,20161019.0,20190524,20190524,EXP,,CA-APOPHARMA-2016AP013546,APOTEX,,31.0,YR,A,F,Y,45.0,KG,20190524.0,,MD,CA,CA,2019,Q2,Young Adult
163549381,16354938,15,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,,,,,,,,,2019,Q2,Cardiogenic shock,,2019,Q2,1,I,20161014.0,20161019.0,20190524,20190524,EXP,,CA-APOPHARMA-2016AP013546,APOTEX,,31.0,YR,A,F,Y,45.0,KG,20190524.0,,MD,CA,CA,2019,Q2,Young Adult
163549381,16354938,15,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,,,,,,,,,2019,Q2,Septic shock,,2019,Q2,1,I,20161014.0,20161019.0,20190524,20190524,EXP,,CA-APOPHARMA-2016AP013546,APOTEX,,31.0,YR,A,F,Y,45.0,KG,20190524.0,,MD,CA,CA,2019,Q2,Young Adult
163549381,16354938,15,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,,,,,,,,,2019,Q2,Streptococcal bacteraemia,,2019,Q2,1,I,20161014.0,20161019.0,20190524,20190524,EXP,,CA-APOPHARMA-2016AP013546,APOTEX,,31.0,YR,A,F,Y,45.0,KG,20190524.0,,MD,CA,CA,2019,Q2,Young Adult
163565971,16356597,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNKNOWN,,,U,, 8F078A,,209196.0,,,,,2019,Q2,Blood glucose fluctuation,,2019,Q2,1,I,2019.0,20190522.0,20190527,20190527,EXP,SE-MPA-2019-003407,SE-SA-2019SA141616,SANOFI AVENTIS,,24.0,YR,A,F,Y,,,20190527.0,,CN,SE,SE,2019,Q2,Young Adult
163565971,16356597,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNKNOWN,,,U,, 8F078A,,209196.0,,,,,2019,Q2,Fatigue,,2019,Q2,1,I,2019.0,20190522.0,20190527,20190527,EXP,SE-MPA-2019-003407,SE-SA-2019SA141616,SANOFI AVENTIS,,24.0,YR,A,F,Y,,,20190527.0,,CN,SE,SE,2019,Q2,Young Adult
163565971,16356597,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNKNOWN,,,U,, 8F078A,,209196.0,,,,,2019,Q2,Hyperglycaemia,,2019,Q2,1,I,2019.0,20190522.0,20190527,20190527,EXP,SE-MPA-2019-003407,SE-SA-2019SA141616,SANOFI AVENTIS,,24.0,YR,A,F,Y,,,20190527.0,,CN,SE,SE,2019,Q2,Young Adult
163565971,16356597,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNKNOWN,,,U,, 8F078A,,209196.0,,,,,2019,Q2,Hypoglycaemia,,2019,Q2,1,I,2019.0,20190522.0,20190527,20190527,EXP,SE-MPA-2019-003407,SE-SA-2019SA141616,SANOFI AVENTIS,,24.0,YR,A,F,Y,,,20190527.0,,CN,SE,SE,2019,Q2,Young Adult
163565971,16356597,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNKNOWN,,,U,, 8F078A,,209196.0,,,,,2019,Q2,Therapeutic product effect variable,,2019,Q2,1,I,2019.0,20190522.0,20190527,20190527,EXP,SE-MPA-2019-003407,SE-SA-2019SA141616,SANOFI AVENTIS,,24.0,YR,A,F,Y,,,20190527.0,,CN,SE,SE,2019,Q2,Young Adult
163565971,16356597,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNKNOWN,,,U,, 8F078A,,209196.0,,,,,2019,Q2,Weight increased,,2019,Q2,1,I,2019.0,20190522.0,20190527,20190527,EXP,SE-MPA-2019-003407,SE-SA-2019SA141616,SANOFI AVENTIS,,24.0,YR,A,F,Y,,,20190527.0,,CN,SE,SE,2019,Q2,Young Adult
163620791,16362079,5,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Anaphylactic reaction,,2019,Q2,1,I,20190317.0,,20190422,20190422,DIR,,,FDA-CTU,,36.0,YR,,M,N,93.3,KG,20190418.0,N,PH,US,US,2019,Q2,Adult
163620791,16362079,5,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Infusion related reaction,,2019,Q2,1,I,20190317.0,,20190422,20190422,DIR,,,FDA-CTU,,36.0,YR,,M,N,93.3,KG,20190418.0,N,PH,US,US,2019,Q2,Adult
163638381,16363838,1,PS,Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,Y,U,,,20563.0,,,,,2019,Q2,Dyspnoea,,2019,Q2,1,I,20190313.0,20190523.0,20190528,20190528,EXP,,SE-ELI_LILLY_AND_COMPANY-SE201905012385,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20190528.0,,CN,SE,SE,2019,Q2,Adult
163638381,16363838,1,PS,Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,Y,U,,,20563.0,,,,,2019,Q2,Pharyngeal swelling,,2019,Q2,1,I,20190313.0,20190523.0,20190528,20190528,EXP,,SE-ELI_LILLY_AND_COMPANY-SE201905012385,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20190528.0,,CN,SE,SE,2019,Q2,Adult
163777751,16377775,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"45 DF, QD",,,Y,,,,,45.0,DF,SOLUTION FOR INJECTION,QD,2019,Q2,Anaemia,,2019,Q2,1,I,20190318.0,20190523.0,20190531,20190531,EXP,IT-MINISAL02-550487,IT-SA-2019SA143191,SANOFI AVENTIS,,44.0,YR,A,M,Y,,,20190531.0,,MD,IT,IT,2019,Q2,Adult
163777751,16377775,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"45 DF, QD",,,Y,,,,,45.0,DF,SOLUTION FOR INJECTION,QD,2019,Q2,Hypoglycaemia,,2019,Q2,1,I,20190318.0,20190523.0,20190531,20190531,EXP,IT-MINISAL02-550487,IT-SA-2019SA143191,SANOFI AVENTIS,,44.0,YR,A,M,Y,,,20190531.0,,MD,IT,IT,2019,Q2,Adult
163777751,16377775,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"45 DF, QD",,,Y,,,,,45.0,DF,SOLUTION FOR INJECTION,QD,2019,Q2,International normalised ratio increased,,2019,Q2,1,I,20190318.0,20190523.0,20190531,20190531,EXP,IT-MINISAL02-550487,IT-SA-2019SA143191,SANOFI AVENTIS,,44.0,YR,A,M,Y,,,20190531.0,,MD,IT,IT,2019,Q2,Adult
163777751,16377775,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"45 DF, QD",,,Y,,,,,45.0,DF,SOLUTION FOR INJECTION,QD,2019,Q2,Medication error,,2019,Q2,1,I,20190318.0,20190523.0,20190531,20190531,EXP,IT-MINISAL02-550487,IT-SA-2019SA143191,SANOFI AVENTIS,,44.0,YR,A,M,Y,,,20190531.0,,MD,IT,IT,2019,Q2,Adult
163784961,16378496,13,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Angioedema,,2019,Q2,1,I,20190407.0,,20190411,20190411,DIR,,,FDA-CTU,,79.0,YR,,M,N,95.3,KG,20190411.0,N,,US,US,2019,Q2,Elderly
163784961,16378496,13,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,General physical health deterioration,,2019,Q2,1,I,20190407.0,,20190411,20190411,DIR,,,FDA-CTU,,79.0,YR,,M,N,95.3,KG,20190411.0,N,,US,US,2019,Q2,Elderly
163784961,16378496,13,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Pneumonia,,2019,Q2,1,I,20190407.0,,20190411,20190411,DIR,,,FDA-CTU,,79.0,YR,,M,N,95.3,KG,20190411.0,N,,US,US,2019,Q2,Elderly
163784961,16378496,13,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Renal failure,,2019,Q2,1,I,20190407.0,,20190411,20190411,DIR,,,FDA-CTU,,79.0,YR,,M,N,95.3,KG,20190411.0,N,,US,US,2019,Q2,Elderly
163784961,16378496,13,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Thrombocytopenia,,2019,Q2,1,I,20190407.0,,20190411,20190411,DIR,,,FDA-CTU,,79.0,YR,,M,N,95.3,KG,20190411.0,N,,US,US,2019,Q2,Elderly
163786761,16378676,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 IU, DAILY",,,U,,,,209196.0,30.0,IU,SOLUTION FOR INJECTION,QD,2019,Q2,Hypoglycaemia,,2019,Q2,1,I,2015.0,20190522.0,20190531,20190531,EXP,ES-EMA-DD-20190516-HV_A-143329,ES-SA-2019SA141660,SANOFI AVENTIS,,26.0,YR,A,F,Y,90.1,KG,20190531.0,,CN,ES,ES,2019,Q2,Young Adult
163786761,16378676,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 IU, DAILY",,,U,,,,209196.0,30.0,IU,SOLUTION FOR INJECTION,QD,2019,Q2,Maternal exposure during pregnancy,,2019,Q2,1,I,2015.0,20190522.0,20190531,20190531,EXP,ES-EMA-DD-20190516-HV_A-143329,ES-SA-2019SA141660,SANOFI AVENTIS,,26.0,YR,A,F,Y,90.1,KG,20190531.0,,CN,ES,ES,2019,Q2,Young Adult
163786761,16378676,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 IU, DAILY",,,U,,,,209196.0,30.0,IU,SOLUTION FOR INJECTION,QD,2019,Q2,Prolonged labour,,2019,Q2,1,I,2015.0,20190522.0,20190531,20190531,EXP,ES-EMA-DD-20190516-HV_A-143329,ES-SA-2019SA141660,SANOFI AVENTIS,,26.0,YR,A,F,Y,90.1,KG,20190531.0,,CN,ES,ES,2019,Q2,Young Adult
163849181,16384918,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,Y,,,,209196.0,,,SOLUTION FOR INJECTION,,2019,Q2,Dyspnoea,,2019,Q2,1,I,20190313.0,20190517.0,20190603,20190603,EXP,,SE-SA-2019SA136611,SANOFI AVENTIS,,58.0,YR,A,M,Y,,,20190603.0,,MD,SE,SE,2019,Q2,Adult
163849181,16384918,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,Y,,,,209196.0,,,SOLUTION FOR INJECTION,,2019,Q2,Pharyngeal swelling,,2019,Q2,1,I,20190313.0,20190517.0,20190603,20190603,EXP,,SE-SA-2019SA136611,SANOFI AVENTIS,,58.0,YR,A,M,Y,,,20190603.0,,MD,SE,SE,2019,Q2,Adult
163862672,16386267,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"12 U, BID (MORNING AND NIGHT)",,,,,,,20563.0,12.0,IU,,BID,2019,Q2,Blood glucose abnormal,,2019,Q2,2,F,,20190604.0,20190603,20190610,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201905012667,ELI LILLY AND CO,,47.0,YR,,F,Y,62.0,KG,20190610.0,,CN,CN,CN,2019,Q2,Adult
163862672,16386267,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"12 U, BID (MORNING AND NIGHT)",,,,,,,20563.0,12.0,IU,,BID,2019,Q2,Hypoglycaemia,,2019,Q2,2,F,,20190604.0,20190603,20190610,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201905012667,ELI LILLY AND CO,,47.0,YR,,F,Y,62.0,KG,20190610.0,,CN,CN,CN,2019,Q2,Adult
163862672,16386267,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"12 U, BID (MORNING AND NIGHT)",,,,,,,20563.0,12.0,IU,,BID,2019,Q2,Syncope,,2019,Q2,2,F,,20190604.0,20190603,20190610,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201905012667,ELI LILLY AND CO,,47.0,YR,,F,Y,62.0,KG,20190610.0,,CN,CN,CN,2019,Q2,Adult
163862672,16386267,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"10 U, DAILY (AFTERNOON)",,,,,,,20563.0,10.0,IU,,QD,2019,Q2,Blood glucose abnormal,,2019,Q2,2,F,,20190604.0,20190603,20190610,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201905012667,ELI LILLY AND CO,,47.0,YR,,F,Y,62.0,KG,20190610.0,,CN,CN,CN,2019,Q2,Adult
163862672,16386267,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"10 U, DAILY (AFTERNOON)",,,,,,,20563.0,10.0,IU,,QD,2019,Q2,Hypoglycaemia,,2019,Q2,2,F,,20190604.0,20190603,20190610,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201905012667,ELI LILLY AND CO,,47.0,YR,,F,Y,62.0,KG,20190610.0,,CN,CN,CN,2019,Q2,Adult
163862672,16386267,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"10 U, DAILY (AFTERNOON)",,,,,,,20563.0,10.0,IU,,QD,2019,Q2,Syncope,,2019,Q2,2,F,,20190604.0,20190603,20190610,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201905012667,ELI LILLY AND CO,,47.0,YR,,F,Y,62.0,KG,20190610.0,,CN,CN,CN,2019,Q2,Adult
163881481,16388148,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0-10 UNITS,,,,,,,,,,,,2019,Q2,Bacteraemia,,2019,Q2,1,I,20180206.0,20180208.0,20190604,20190604,EXP,,US-ROCHE-2072922,ROCHE,,67.0,YR,,M,Y,94.1,KG,20190604.0,,MD,US,US,2019,Q2,Elderly
163881481,16388148,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0-10 UNITS,,,,,,,,,,,,2019,Q2,Device related sepsis,,2019,Q2,1,I,20180206.0,20180208.0,20190604,20190604,EXP,,US-ROCHE-2072922,ROCHE,,67.0,YR,,M,Y,94.1,KG,20190604.0,,MD,US,US,2019,Q2,Elderly
163881481,16388148,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0-10 UNITS,,,,,,,,,,,,2019,Q2,Pyrexia,,2019,Q2,1,I,20180206.0,20180208.0,20190604,20190604,EXP,,US-ROCHE-2072922,ROCHE,,67.0,YR,,M,Y,94.1,KG,20190604.0,,MD,US,US,2019,Q2,Elderly
163882811,16388281,9,C,Insulin lispro 4 units SQ TID,,2,,,,,,,,,,,,,,2019,Q2,Liver function test increased,,2019,Q2,1,I,20190530.0,,20190601,20190601,DIR,,,FDA-CTU,,48.0,YR,,F,N,88.0,KG,20190601.0,N,OT,US,US,2019,Q2,Adult
163905491,16390549,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"UNK, ROUTE: INJECTION",,,,,,,,,,,,2019,Q2,Cardio-respiratory arrest,,2019,Q2,1,I,20170906.0,20180530.0,20190604,20190604,EXP,,US-EMD SERONO-E2B_90045840,EMD SERONO INC,,78.0,YR,,M,Y,60.0,KG,20190604.0,,OT,US,US,2019,Q2,Elderly
163906523,16390652,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q2,Dyspnoea,,2019,Q2,3,F,20190513.0,20190607.0,20190604,20190620,PER,,US-ACTELION-A-NJ2019-190948,ACTELION,,71.0,YR,,M,Y,94.33,KG,20190621.0,,OT,US,US,2019,Q2,Elderly
163906523,16390652,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q2,Dyspnoea exertional,,2019,Q2,3,F,20190513.0,20190607.0,20190604,20190620,PER,,US-ACTELION-A-NJ2019-190948,ACTELION,,71.0,YR,,M,Y,94.33,KG,20190621.0,,OT,US,US,2019,Q2,Elderly
163906523,16390652,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q2,Product dose omission,,2019,Q2,3,F,20190513.0,20190607.0,20190604,20190620,PER,,US-ACTELION-A-NJ2019-190948,ACTELION,,71.0,YR,,M,Y,94.33,KG,20190621.0,,OT,US,US,2019,Q2,Elderly
163906523,16390652,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q2,Pulmonary hypertension,,2019,Q2,3,F,20190513.0,20190607.0,20190604,20190620,PER,,US-ACTELION-A-NJ2019-190948,ACTELION,,71.0,YR,,M,Y,94.33,KG,20190621.0,,OT,US,US,2019,Q2,Elderly
163950451,16395045,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 IU, BEFORE MEALS",,,,,,,,20.0,IU,,,2019,Q2,Anaemia,,2019,Q2,1,I,20190514.0,20190524.0,20190605,20190605,EXP,,US-NOVOPROD-665590,NOVO NORDISK,,43.0,YR,,F,Y,,,20190605.0,,CN,US,US,2019,Q2,Adult
164026703,16402670,21,C,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2019,Q2,Atrial fibrillation,,2019,Q2,3,F,20181123.0,20190531.0,20190607,20190607,EXP,,US-CELGENEUS-USA-20190600396,CELGENE,,77.0,YR,,F,Y,69.76,KG,20190607.0,,MD,US,US,2019,Q2,Elderly
164026703,16402670,21,C,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2019,Q2,Failure to thrive,,2019,Q2,3,F,20181123.0,20190531.0,20190607,20190607,EXP,,US-CELGENEUS-USA-20190600396,CELGENE,,77.0,YR,,F,Y,69.76,KG,20190607.0,,MD,US,US,2019,Q2,Elderly
164026703,16402670,21,C,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2019,Q2,Pericarditis,,2019,Q2,3,F,20181123.0,20190531.0,20190607,20190607,EXP,,US-CELGENEUS-USA-20190600396,CELGENE,,77.0,YR,,F,Y,69.76,KG,20190607.0,,MD,US,US,2019,Q2,Elderly
164051991,16405199,19,C,INSULIN LISPRO PROT + LISPRO (HUMALOG MIX 75/25),,2,,,,,,,,,,,,,,2019,Q2,Drug ineffective,,2019,Q2,1,I,20190424.0,,20190502,20190502,DIR,,,FDA-CTU,,50.0,YR,,M,N,174.18,KG,20190502.0,N,,US,US,2019,Q2,Adult
164051991,16405199,19,C,INSULIN LISPRO PROT + LISPRO (HUMALOG MIX 75/25),,2,,,,,,,,,,,,,,2019,Q2,Extra dose administered,,2019,Q2,1,I,20190424.0,,20190502,20190502,DIR,,,FDA-CTU,,50.0,YR,,M,N,174.18,KG,20190502.0,N,,US,US,2019,Q2,Adult
164051991,16405199,19,C,INSULIN LISPRO PROT + LISPRO (HUMALOG MIX 75/25),,2,,,,,,,,,,,,,,2019,Q2,Product substitution issue,,2019,Q2,1,I,20190424.0,,20190502,20190502,DIR,,,FDA-CTU,,50.0,YR,,M,N,174.18,KG,20190502.0,N,,US,US,2019,Q2,Adult
164175341,16417534,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,Y,,,,20563.0,,,,,2019,Q2,Obstructive airways disorder,,2019,Q2,1,I,20190313.0,20190524.0,20190611,20190611,EXP,,SE-ELI_LILLY_AND_COMPANY-SE201905014185,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20190611.0,,CN,SE,SE,2019,Q2,Adult
164175341,16417534,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,Y,,,,20563.0,,,,,2019,Q2,Pharyngeal swelling,,2019,Q2,1,I,20190313.0,20190524.0,20190611,20190611,EXP,,SE-ELI_LILLY_AND_COMPANY-SE201905014185,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20190611.0,,CN,SE,SE,2019,Q2,Adult
164234821,16423482,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"6 INTERNATIONAL UNIT, DAILY",,,U,U,,,20563.0,6.0,IU,,QD,2019,Q2,Confusional state,,2019,Q2,1,I,20190529.0,20190603.0,20190612,20190612,EXP,IT-MINISAL02-553695,IT-ELI_LILLY_AND_COMPANY-IT201906001128,ELI LILLY AND CO,,77.0,YR,,F,Y,,,20190612.0,,CN,IT,IT,2019,Q2,Elderly
164234821,16423482,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"6 INTERNATIONAL UNIT, DAILY",,,U,U,,,20563.0,6.0,IU,,QD,2019,Q2,Hypoglycaemia,,2019,Q2,1,I,20190529.0,20190603.0,20190612,20190612,EXP,IT-MINISAL02-553695,IT-ELI_LILLY_AND_COMPANY-IT201906001128,ELI LILLY AND CO,,77.0,YR,,F,Y,,,20190612.0,,CN,IT,IT,2019,Q2,Elderly
164247872,16424787,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 IU, 3X/DAY (THREE TIMES DAILY BEFORE MEALS)",,,,,,,,4.0,IU,,TID,2019,Q2,Death,,2019,Q2,2,F,20190608.0,20190624.0,20190613,20190627,EXP,,US-PFIZER INC-2016346860,PFIZER,,73.0,YR,,M,Y,,,20190627.0,,MD,US,US,2019,Q2,Elderly
164268601,16426860,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,6.0,IU,SOLUTION FOR INJECTION,QD,2019,Q2,Confusional state,,2019,Q2,1,I,20190529.0,20190606.0,20190613,20190613,EXP,IT-MINISAL02-553695,IT-SA-2019SA156268,SANOFI AVENTIS,,77.0,YR,E,F,Y,,,20190613.0,,PH,IT,IT,2019,Q2,Elderly
164268601,16426860,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,6.0,IU,SOLUTION FOR INJECTION,QD,2019,Q2,Hypoglycaemia,,2019,Q2,1,I,20190529.0,20190606.0,20190613,20190613,EXP,IT-MINISAL02-553695,IT-SA-2019SA156268,SANOFI AVENTIS,,77.0,YR,E,F,Y,,,20190613.0,,PH,IT,IT,2019,Q2,Elderly
164277291,16427729,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"34 INTERNATIONAL UNIT, TID",,,U,U, C919107B,,20563.0,34.0,IU,,TID,2019,Q2,Blood glucose abnormal,,2019,Q2,1,I,,20190604.0,20190613,20190613,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201906002271,ELI LILLY AND CO,,57.0,YR,,F,Y,51.0,KG,20190613.0,,CN,CN,CN,2019,Q2,Adult
164277291,16427729,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"34 INTERNATIONAL UNIT, TID",,,U,U, C919107B,,20563.0,34.0,IU,,TID,2019,Q2,Hepatic cirrhosis,,2019,Q2,1,I,,20190604.0,20190613,20190613,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201906002271,ELI LILLY AND CO,,57.0,YR,,F,Y,51.0,KG,20190613.0,,CN,CN,CN,2019,Q2,Adult
164277291,16427729,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"34 INTERNATIONAL UNIT, TID",,,U,U, C919107B,,20563.0,34.0,IU,,TID,2019,Q2,Oedema,,2019,Q2,1,I,,20190604.0,20190613,20190613,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201906002271,ELI LILLY AND CO,,57.0,YR,,F,Y,51.0,KG,20190613.0,,CN,CN,CN,2019,Q2,Adult
164277291,16427729,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"24 INTERNATIONAL UNIT, EACH MORNING",,,U,U, C919107B,,20563.0,24.0,IU,,QD,2019,Q2,Blood glucose abnormal,,2019,Q2,1,I,,20190604.0,20190613,20190613,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201906002271,ELI LILLY AND CO,,57.0,YR,,F,Y,51.0,KG,20190613.0,,CN,CN,CN,2019,Q2,Adult
164277291,16427729,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"24 INTERNATIONAL UNIT, EACH MORNING",,,U,U, C919107B,,20563.0,24.0,IU,,QD,2019,Q2,Hepatic cirrhosis,,2019,Q2,1,I,,20190604.0,20190613,20190613,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201906002271,ELI LILLY AND CO,,57.0,YR,,F,Y,51.0,KG,20190613.0,,CN,CN,CN,2019,Q2,Adult
164277291,16427729,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"24 INTERNATIONAL UNIT, EACH MORNING",,,U,U, C919107B,,20563.0,24.0,IU,,QD,2019,Q2,Oedema,,2019,Q2,1,I,,20190604.0,20190613,20190613,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201906002271,ELI LILLY AND CO,,57.0,YR,,F,Y,51.0,KG,20190613.0,,CN,CN,CN,2019,Q2,Adult
164277291,16427729,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"18 INTERNATIONAL UNIT, DAILY AT NIGHT",,,U,U, C919107B,,20563.0,18.0,IU,,QD,2019,Q2,Blood glucose abnormal,,2019,Q2,1,I,,20190604.0,20190613,20190613,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201906002271,ELI LILLY AND CO,,57.0,YR,,F,Y,51.0,KG,20190613.0,,CN,CN,CN,2019,Q2,Adult
164277291,16427729,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"18 INTERNATIONAL UNIT, DAILY AT NIGHT",,,U,U, C919107B,,20563.0,18.0,IU,,QD,2019,Q2,Hepatic cirrhosis,,2019,Q2,1,I,,20190604.0,20190613,20190613,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201906002271,ELI LILLY AND CO,,57.0,YR,,F,Y,51.0,KG,20190613.0,,CN,CN,CN,2019,Q2,Adult
164277291,16427729,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"18 INTERNATIONAL UNIT, DAILY AT NIGHT",,,U,U, C919107B,,20563.0,18.0,IU,,QD,2019,Q2,Oedema,,2019,Q2,1,I,,20190604.0,20190613,20190613,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201906002271,ELI LILLY AND CO,,57.0,YR,,F,Y,51.0,KG,20190613.0,,CN,CN,CN,2019,Q2,Adult
164280861,16428086,1,PS,Liprolog Lispro,INSULIN LISPRO,1,Unknown,"UNK, EVERY 8 HRS",,,U,U,,,20563.0,,,,Q8H,2019,Q2,Decreased appetite,,2019,Q2,1,I,201812.0,20190607.0,20190613,20190613,EXP,PL-URPL-2-15-2019,PL-ELI_LILLY_AND_COMPANY-PL201906004788,ELI LILLY AND CO,,59.0,YR,,F,Y,,,20190613.0,,CN,PL,PL,2019,Q2,Adult
164280861,16428086,1,PS,Liprolog Lispro,INSULIN LISPRO,1,Unknown,"UNK, EVERY 8 HRS",,,U,U,,,20563.0,,,,Q8H,2019,Q2,Dyspnoea,,2019,Q2,1,I,201812.0,20190607.0,20190613,20190613,EXP,PL-URPL-2-15-2019,PL-ELI_LILLY_AND_COMPANY-PL201906004788,ELI LILLY AND CO,,59.0,YR,,F,Y,,,20190613.0,,CN,PL,PL,2019,Q2,Adult
164280861,16428086,1,PS,Liprolog Lispro,INSULIN LISPRO,1,Unknown,"UNK, EVERY 8 HRS",,,U,U,,,20563.0,,,,Q8H,2019,Q2,Heart rate increased,,2019,Q2,1,I,201812.0,20190607.0,20190613,20190613,EXP,PL-URPL-2-15-2019,PL-ELI_LILLY_AND_COMPANY-PL201906004788,ELI LILLY AND CO,,59.0,YR,,F,Y,,,20190613.0,,CN,PL,PL,2019,Q2,Adult
164280861,16428086,1,PS,Liprolog Lispro,INSULIN LISPRO,1,Unknown,"UNK, EVERY 8 HRS",,,U,U,,,20563.0,,,,Q8H,2019,Q2,Hyperhidrosis,,2019,Q2,1,I,201812.0,20190607.0,20190613,20190613,EXP,PL-URPL-2-15-2019,PL-ELI_LILLY_AND_COMPANY-PL201906004788,ELI LILLY AND CO,,59.0,YR,,F,Y,,,20190613.0,,CN,PL,PL,2019,Q2,Adult
164330001,16433000,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,UNSPECIFIED,,2019,Q2,Inappropriate schedule of product administration,,2019,Q2,1,I,20190510.0,20190607.0,20190614,20190614,PER,,US-JNJFOC-20190610629,JANSSEN,,62.0,YR,A,M,Y,,,20190614.0,,PH,US,US,2019,Q2,Adult
164386321,16438632,6,SS,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Acute kidney injury,,2019,Q2,1,I,2018.0,20190605.0,20190617,20190617,EXP,PT-EMA-DD-20190508-HV_A-123303,PT-ACCORD-132410,ACCORD,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABETES. 2019;14(1):74-P050",71.0,YR,E,M,Y,,,20190617.0,,OT,PT,PT,2019,Q2,Elderly
164386321,16438632,6,SS,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Arrhythmia,,2019,Q2,1,I,2018.0,20190605.0,20190617,20190617,EXP,PT-EMA-DD-20190508-HV_A-123303,PT-ACCORD-132410,ACCORD,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABETES. 2019;14(1):74-P050",71.0,YR,E,M,Y,,,20190617.0,,OT,PT,PT,2019,Q2,Elderly
164386321,16438632,6,SS,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Atrial fibrillation,,2019,Q2,1,I,2018.0,20190605.0,20190617,20190617,EXP,PT-EMA-DD-20190508-HV_A-123303,PT-ACCORD-132410,ACCORD,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABETES. 2019;14(1):74-P050",71.0,YR,E,M,Y,,,20190617.0,,OT,PT,PT,2019,Q2,Elderly
164386321,16438632,6,SS,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Bradycardia,,2019,Q2,1,I,2018.0,20190605.0,20190617,20190617,EXP,PT-EMA-DD-20190508-HV_A-123303,PT-ACCORD-132410,ACCORD,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABETES. 2019;14(1):74-P050",71.0,YR,E,M,Y,,,20190617.0,,OT,PT,PT,2019,Q2,Elderly
164386321,16438632,6,SS,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Dehydration,,2019,Q2,1,I,2018.0,20190605.0,20190617,20190617,EXP,PT-EMA-DD-20190508-HV_A-123303,PT-ACCORD-132410,ACCORD,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABETES. 2019;14(1):74-P050",71.0,YR,E,M,Y,,,20190617.0,,OT,PT,PT,2019,Q2,Elderly
164386321,16438632,6,SS,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Dizziness,,2019,Q2,1,I,2018.0,20190605.0,20190617,20190617,EXP,PT-EMA-DD-20190508-HV_A-123303,PT-ACCORD-132410,ACCORD,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABETES. 2019;14(1):74-P050",71.0,YR,E,M,Y,,,20190617.0,,OT,PT,PT,2019,Q2,Elderly
164386321,16438632,6,SS,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Haematocrit increased,,2019,Q2,1,I,2018.0,20190605.0,20190617,20190617,EXP,PT-EMA-DD-20190508-HV_A-123303,PT-ACCORD-132410,ACCORD,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABETES. 2019;14(1):74-P050",71.0,YR,E,M,Y,,,20190617.0,,OT,PT,PT,2019,Q2,Elderly
164386321,16438632,6,SS,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Haemoglobin increased,,2019,Q2,1,I,2018.0,20190605.0,20190617,20190617,EXP,PT-EMA-DD-20190508-HV_A-123303,PT-ACCORD-132410,ACCORD,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABETES. 2019;14(1):74-P050",71.0,YR,E,M,Y,,,20190617.0,,OT,PT,PT,2019,Q2,Elderly
164386321,16438632,6,SS,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Hypotension,,2019,Q2,1,I,2018.0,20190605.0,20190617,20190617,EXP,PT-EMA-DD-20190508-HV_A-123303,PT-ACCORD-132410,ACCORD,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABETES. 2019;14(1):74-P050",71.0,YR,E,M,Y,,,20190617.0,,OT,PT,PT,2019,Q2,Elderly
164386321,16438632,6,SS,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Hypovolaemia,,2019,Q2,1,I,2018.0,20190605.0,20190617,20190617,EXP,PT-EMA-DD-20190508-HV_A-123303,PT-ACCORD-132410,ACCORD,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABETES. 2019;14(1):74-P050",71.0,YR,E,M,Y,,,20190617.0,,OT,PT,PT,2019,Q2,Elderly
164386321,16438632,6,SS,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Left atrial dilatation,,2019,Q2,1,I,2018.0,20190605.0,20190617,20190617,EXP,PT-EMA-DD-20190508-HV_A-123303,PT-ACCORD-132410,ACCORD,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABETES. 2019;14(1):74-P050",71.0,YR,E,M,Y,,,20190617.0,,OT,PT,PT,2019,Q2,Elderly
164386321,16438632,6,SS,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Mucosal dryness,,2019,Q2,1,I,2018.0,20190605.0,20190617,20190617,EXP,PT-EMA-DD-20190508-HV_A-123303,PT-ACCORD-132410,ACCORD,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABETES. 2019;14(1):74-P050",71.0,YR,E,M,Y,,,20190617.0,,OT,PT,PT,2019,Q2,Elderly
164386321,16438632,6,SS,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Presyncope,,2019,Q2,1,I,2018.0,20190605.0,20190617,20190617,EXP,PT-EMA-DD-20190508-HV_A-123303,PT-ACCORD-132410,ACCORD,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABETES. 2019;14(1):74-P050",71.0,YR,E,M,Y,,,20190617.0,,OT,PT,PT,2019,Q2,Elderly
164386321,16438632,6,SS,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Skin disorder,,2019,Q2,1,I,2018.0,20190605.0,20190617,20190617,EXP,PT-EMA-DD-20190508-HV_A-123303,PT-ACCORD-132410,ACCORD,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABETES. 2019;14(1):74-P050",71.0,YR,E,M,Y,,,20190617.0,,OT,PT,PT,2019,Q2,Elderly
164386321,16438632,6,SS,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q2,Syncope,,2019,Q2,1,I,2018.0,20190605.0,20190617,20190617,EXP,PT-EMA-DD-20190508-HV_A-123303,PT-ACCORD-132410,ACCORD,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABETES. 2019;14(1):74-P050",71.0,YR,E,M,Y,,,20190617.0,,OT,PT,PT,2019,Q2,Elderly
164386321,16438632,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Acute kidney injury,,2019,Q2,1,I,2018.0,20190605.0,20190617,20190617,EXP,PT-EMA-DD-20190508-HV_A-123303,PT-ACCORD-132410,ACCORD,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABETES. 2019;14(1):74-P050",71.0,YR,E,M,Y,,,20190617.0,,OT,PT,PT,2019,Q2,Elderly
164386321,16438632,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Arrhythmia,,2019,Q2,1,I,2018.0,20190605.0,20190617,20190617,EXP,PT-EMA-DD-20190508-HV_A-123303,PT-ACCORD-132410,ACCORD,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABETES. 2019;14(1):74-P050",71.0,YR,E,M,Y,,,20190617.0,,OT,PT,PT,2019,Q2,Elderly
164386321,16438632,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Atrial fibrillation,,2019,Q2,1,I,2018.0,20190605.0,20190617,20190617,EXP,PT-EMA-DD-20190508-HV_A-123303,PT-ACCORD-132410,ACCORD,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABETES. 2019;14(1):74-P050",71.0,YR,E,M,Y,,,20190617.0,,OT,PT,PT,2019,Q2,Elderly
164386321,16438632,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Bradycardia,,2019,Q2,1,I,2018.0,20190605.0,20190617,20190617,EXP,PT-EMA-DD-20190508-HV_A-123303,PT-ACCORD-132410,ACCORD,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABETES. 2019;14(1):74-P050",71.0,YR,E,M,Y,,,20190617.0,,OT,PT,PT,2019,Q2,Elderly
164386321,16438632,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Dehydration,,2019,Q2,1,I,2018.0,20190605.0,20190617,20190617,EXP,PT-EMA-DD-20190508-HV_A-123303,PT-ACCORD-132410,ACCORD,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABETES. 2019;14(1):74-P050",71.0,YR,E,M,Y,,,20190617.0,,OT,PT,PT,2019,Q2,Elderly
164386321,16438632,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Dizziness,,2019,Q2,1,I,2018.0,20190605.0,20190617,20190617,EXP,PT-EMA-DD-20190508-HV_A-123303,PT-ACCORD-132410,ACCORD,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABETES. 2019;14(1):74-P050",71.0,YR,E,M,Y,,,20190617.0,,OT,PT,PT,2019,Q2,Elderly
164386321,16438632,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Haematocrit increased,,2019,Q2,1,I,2018.0,20190605.0,20190617,20190617,EXP,PT-EMA-DD-20190508-HV_A-123303,PT-ACCORD-132410,ACCORD,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABETES. 2019;14(1):74-P050",71.0,YR,E,M,Y,,,20190617.0,,OT,PT,PT,2019,Q2,Elderly
164386321,16438632,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Haemoglobin increased,,2019,Q2,1,I,2018.0,20190605.0,20190617,20190617,EXP,PT-EMA-DD-20190508-HV_A-123303,PT-ACCORD-132410,ACCORD,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABETES. 2019;14(1):74-P050",71.0,YR,E,M,Y,,,20190617.0,,OT,PT,PT,2019,Q2,Elderly
164386321,16438632,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Hypotension,,2019,Q2,1,I,2018.0,20190605.0,20190617,20190617,EXP,PT-EMA-DD-20190508-HV_A-123303,PT-ACCORD-132410,ACCORD,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABETES. 2019;14(1):74-P050",71.0,YR,E,M,Y,,,20190617.0,,OT,PT,PT,2019,Q2,Elderly
164386321,16438632,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Hypovolaemia,,2019,Q2,1,I,2018.0,20190605.0,20190617,20190617,EXP,PT-EMA-DD-20190508-HV_A-123303,PT-ACCORD-132410,ACCORD,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABETES. 2019;14(1):74-P050",71.0,YR,E,M,Y,,,20190617.0,,OT,PT,PT,2019,Q2,Elderly
164386321,16438632,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Left atrial dilatation,,2019,Q2,1,I,2018.0,20190605.0,20190617,20190617,EXP,PT-EMA-DD-20190508-HV_A-123303,PT-ACCORD-132410,ACCORD,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABETES. 2019;14(1):74-P050",71.0,YR,E,M,Y,,,20190617.0,,OT,PT,PT,2019,Q2,Elderly
164386321,16438632,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Mucosal dryness,,2019,Q2,1,I,2018.0,20190605.0,20190617,20190617,EXP,PT-EMA-DD-20190508-HV_A-123303,PT-ACCORD-132410,ACCORD,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABETES. 2019;14(1):74-P050",71.0,YR,E,M,Y,,,20190617.0,,OT,PT,PT,2019,Q2,Elderly
164386321,16438632,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Presyncope,,2019,Q2,1,I,2018.0,20190605.0,20190617,20190617,EXP,PT-EMA-DD-20190508-HV_A-123303,PT-ACCORD-132410,ACCORD,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABETES. 2019;14(1):74-P050",71.0,YR,E,M,Y,,,20190617.0,,OT,PT,PT,2019,Q2,Elderly
164386321,16438632,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Skin disorder,,2019,Q2,1,I,2018.0,20190605.0,20190617,20190617,EXP,PT-EMA-DD-20190508-HV_A-123303,PT-ACCORD-132410,ACCORD,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABETES. 2019;14(1):74-P050",71.0,YR,E,M,Y,,,20190617.0,,OT,PT,PT,2019,Q2,Elderly
164386321,16438632,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q2,Syncope,,2019,Q2,1,I,2018.0,20190605.0,20190617,20190617,EXP,PT-EMA-DD-20190508-HV_A-123303,PT-ACCORD-132410,ACCORD,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABETES. 2019;14(1):74-P050",71.0,YR,E,M,Y,,,20190617.0,,OT,PT,PT,2019,Q2,Elderly
164480241,16448024,7,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q2,Acute generalised exanthematous pustulosis,,2019,Q2,1,I,,20190607.0,20190619,20190619,EXP,,CA-APOTEX-2019AP016390,APOTEX,,50.0,YR,,F,Y,66.0,KG,20190619.0,,CN,CA,CA,2019,Q2,Adult
164480241,16448024,7,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q2,Blood bilirubin increased,,2019,Q2,1,I,,20190607.0,20190619,20190619,EXP,,CA-APOTEX-2019AP016390,APOTEX,,50.0,YR,,F,Y,66.0,KG,20190619.0,,CN,CA,CA,2019,Q2,Adult
164480241,16448024,7,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q2,Drug hypersensitivity,,2019,Q2,1,I,,20190607.0,20190619,20190619,EXP,,CA-APOTEX-2019AP016390,APOTEX,,50.0,YR,,F,Y,66.0,KG,20190619.0,,CN,CA,CA,2019,Q2,Adult
164480241,16448024,7,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q2,Transaminases increased,,2019,Q2,1,I,,20190607.0,20190619,20190619,EXP,,CA-APOTEX-2019AP016390,APOTEX,,50.0,YR,,F,Y,66.0,KG,20190619.0,,CN,CA,CA,2019,Q2,Adult
164498691,16449869,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,WITH EVERY MEAL,,,,,,,,5.0,UL,,,2019,Q2,Arteriovenous fistula thrombosis,,2019,Q2,1,I,20190527.0,20190617.0,20190619,20190619,EXP,,CO-ABBVIE-19S-036-2825598-00,ABBVIE,,25.0,YR,,M,Y,65.0,KG,20190619.0,,CN,CO,CO,2019,Q2,Young Adult
164498691,16449869,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,WITH EVERY MEAL,,,,,,,,5.0,UL,,,2019,Q2,Malaise,,2019,Q2,1,I,20190527.0,20190617.0,20190619,20190619,EXP,,CO-ABBVIE-19S-036-2825598-00,ABBVIE,,25.0,YR,,M,Y,65.0,KG,20190619.0,,CN,CO,CO,2019,Q2,Young Adult
164498691,16449869,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,WITH EVERY MEAL,,,,,,,,5.0,UL,,,2019,Q2,Pulmonary embolism,,2019,Q2,1,I,20190527.0,20190617.0,20190619,20190619,EXP,,CO-ABBVIE-19S-036-2825598-00,ABBVIE,,25.0,YR,,M,Y,65.0,KG,20190619.0,,CN,CO,CO,2019,Q2,Young Adult
164545042,16454504,28,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,20 INTERNATIONAL UNITS MILLIONS,,,,,,,,20.0,IU,INJECTION,,2019,Q2,Delirium,,2019,Q2,2,F,20190606.0,20190607.0,20190619,20190619,EXP,,US-CELGENEUS-USA-20190606794,CELGENE,,77.0,YR,,M,Y,83.8,KG,20190619.0,,MD,US,US,2019,Q2,Elderly
164545042,16454504,28,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,20 INTERNATIONAL UNITS MILLIONS,,,,,,,,20.0,IU,INJECTION,,2019,Q2,Fatigue,,2019,Q2,2,F,20190606.0,20190607.0,20190619,20190619,EXP,,US-CELGENEUS-USA-20190606794,CELGENE,,77.0,YR,,M,Y,83.8,KG,20190619.0,,MD,US,US,2019,Q2,Elderly
164545042,16454504,28,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,20 INTERNATIONAL UNITS MILLIONS,,,,,,,,20.0,IU,INJECTION,,2019,Q2,Hyperglycaemia,,2019,Q2,2,F,20190606.0,20190607.0,20190619,20190619,EXP,,US-CELGENEUS-USA-20190606794,CELGENE,,77.0,YR,,M,Y,83.8,KG,20190619.0,,MD,US,US,2019,Q2,Elderly
164545811,16454581,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,, UNK,,,,,,,2019,Q2,Dysphagia,,2019,Q2,1,I,20181209.0,20190610.0,20190619,20190619,EXP,,SE-MYLANLABS-2019M1057100,MYLAN,,82.0,YR,,M,Y,79.0,KG,20190619.0,,MD,SE,SE,2019,Q2,Elderly
164545811,16454581,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,, UNK,,,,,,,2019,Q2,Dyspnoea,,2019,Q2,1,I,20181209.0,20190610.0,20190619,20190619,EXP,,SE-MYLANLABS-2019M1057100,MYLAN,,82.0,YR,,M,Y,79.0,KG,20190619.0,,MD,SE,SE,2019,Q2,Elderly
164654321,16465432,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE; FREQ: 4 DAY; INTERVAL:1,,,,,,,,,,,,2019,Q2,Platelet count decreased,,2019,Q2,1,I,20160324.0,20160412.0,20190621,20190621,PER,,US-PFIZER INC-3254078,PFIZER,,70.0,YR,,M,Y,88.0,KG,20190621.0,,OT,US,US,2019,Q2,Elderly
164742581,16474258,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Dyspnoea,,2019,Q2,1,I,20190407.0,,20190515,20190515,DIR,,,FDA-CTU,,70.0,YR,,F,N,,,20190515.0,Y,PH,US,US,2019,Q2,Elderly
164742581,16474258,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q2,Haemodialysis,,2019,Q2,1,I,20190407.0,,20190515,20190515,DIR,,,FDA-CTU,,70.0,YR,,F,N,,,20190515.0,Y,PH,US,US,2019,Q2,Elderly
164747891,16474789,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"6 U, QD",,,U,,,,,,,SOLUTION FOR INJECTION,QD,2019,Q2,Tuberculosis,,2019,Q2,1,I,20190615.0,20190617.0,20190625,20190625,EXP,,MX-SA-2019SA166208,SANOFI AVENTIS,,55.0,YR,A,F,Y,49.0,KG,20190625.0,,CN,MX,MX,2019,Q2,Adult
164800551,16480055,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"10 INTERNATIONAL UNIT, EACH MORNING",,,U,U,,,20563.0,10.0,IU,,QD,2019,Q2,Spinal stenosis,,2019,Q2,1,I,201903.0,20190618.0,20190626,20190626,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201906009282,ELI LILLY AND CO,,62.0,YR,,M,Y,,,20190626.0,,CN,CN,CN,2019,Q2,Adult
164800551,16480055,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"10 INTERNATIONAL UNIT, EACH MORNING",,,U,U,,,20563.0,10.0,IU,,QD,2019,Q2,Swelling,,2019,Q2,1,I,201903.0,20190618.0,20190626,20190626,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201906009282,ELI LILLY AND CO,,62.0,YR,,M,Y,,,20190626.0,,CN,CN,CN,2019,Q2,Adult
164800551,16480055,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"8 INTERNATIONAL UNIT, DAILY AT NOON",,,U,U,,,20563.0,8.0,IU,,QD,2019,Q2,Spinal stenosis,,2019,Q2,1,I,201903.0,20190618.0,20190626,20190626,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201906009282,ELI LILLY AND CO,,62.0,YR,,M,Y,,,20190626.0,,CN,CN,CN,2019,Q2,Adult
164800551,16480055,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"8 INTERNATIONAL UNIT, DAILY AT NOON",,,U,U,,,20563.0,8.0,IU,,QD,2019,Q2,Swelling,,2019,Q2,1,I,201903.0,20190618.0,20190626,20190626,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201906009282,ELI LILLY AND CO,,62.0,YR,,M,Y,,,20190626.0,,CN,CN,CN,2019,Q2,Adult
164800551,16480055,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"8 INTERNATIONAL UNIT, DAILY AT NOON",,,U,U,,,20563.0,12.0,IU,,QD,2019,Q2,Spinal stenosis,,2019,Q2,1,I,201903.0,20190618.0,20190626,20190626,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201906009282,ELI LILLY AND CO,,62.0,YR,,M,Y,,,20190626.0,,CN,CN,CN,2019,Q2,Adult
164800551,16480055,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"8 INTERNATIONAL UNIT, DAILY AT NOON",,,U,U,,,20563.0,12.0,IU,,QD,2019,Q2,Swelling,,2019,Q2,1,I,201903.0,20190618.0,20190626,20190626,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201906009282,ELI LILLY AND CO,,62.0,YR,,M,Y,,,20190626.0,,CN,CN,CN,2019,Q2,Adult
164800551,16480055,4,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"15 INTERNATIONAL UNIT, BID AT MORNING AND EVENING",,,U,U,,,20563.0,15.0,IU,,BID,2019,Q2,Spinal stenosis,,2019,Q2,1,I,201903.0,20190618.0,20190626,20190626,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201906009282,ELI LILLY AND CO,,62.0,YR,,M,Y,,,20190626.0,,CN,CN,CN,2019,Q2,Adult
164800551,16480055,4,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"15 INTERNATIONAL UNIT, BID AT MORNING AND EVENING",,,U,U,,,20563.0,15.0,IU,,BID,2019,Q2,Swelling,,2019,Q2,1,I,201903.0,20190618.0,20190626,20190626,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201906009282,ELI LILLY AND CO,,62.0,YR,,M,Y,,,20190626.0,,CN,CN,CN,2019,Q2,Adult
164800551,16480055,5,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"10 INTERNATIONAL UNIT, DAILY AT NOON",,,U,U,,,20563.0,10.0,IU,,QD,2019,Q2,Spinal stenosis,,2019,Q2,1,I,201903.0,20190618.0,20190626,20190626,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201906009282,ELI LILLY AND CO,,62.0,YR,,M,Y,,,20190626.0,,CN,CN,CN,2019,Q2,Adult
164800551,16480055,5,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"10 INTERNATIONAL UNIT, DAILY AT NOON",,,U,U,,,20563.0,10.0,IU,,QD,2019,Q2,Swelling,,2019,Q2,1,I,201903.0,20190618.0,20190626,20190626,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201906009282,ELI LILLY AND CO,,62.0,YR,,M,Y,,,20190626.0,,CN,CN,CN,2019,Q2,Adult
164800551,16480055,6,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"13 INTERNATIONAL UNIT, BID",,,U,U,,,20563.0,13.0,IU,,BID,2019,Q2,Spinal stenosis,,2019,Q2,1,I,201903.0,20190618.0,20190626,20190626,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201906009282,ELI LILLY AND CO,,62.0,YR,,M,Y,,,20190626.0,,CN,CN,CN,2019,Q2,Adult
164800551,16480055,6,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"13 INTERNATIONAL UNIT, BID",,,U,U,,,20563.0,13.0,IU,,BID,2019,Q2,Swelling,,2019,Q2,1,I,201903.0,20190618.0,20190626,20190626,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201906009282,ELI LILLY AND CO,,62.0,YR,,M,Y,,,20190626.0,,CN,CN,CN,2019,Q2,Adult
164819571,16481957,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2019,Q2,Hip fracture,,2019,Q2,1,I,20190617.0,20190618.0,20190627,20190627,EXP,,US-SA-2019SA169775,SANOFI AVENTIS,,65.0,YR,E,F,Y,,,20190627.0,,CN,US,US,2019,Q2,Elderly
164819571,16481957,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2019,Q2,Type 2 diabetes mellitus,,2019,Q2,1,I,20190617.0,20190618.0,20190627,20190627,EXP,,US-SA-2019SA169775,SANOFI AVENTIS,,65.0,YR,E,F,Y,,,20190627.0,,CN,US,US,2019,Q2,Elderly
164824881,16482488,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,10 UNIT INJECTION THRICE DAILY,,,U,,,,,,,,TID,2019,Q2,Central nervous system lymphoma,,2019,Q2,1,I,,20190617.0,20190627,20190627,EXP,,US-TEVA-2019-US-1067948,TEVA,"GO JA, MANDUJANO-SANCHEZ JI, VICKERS A, SADAKA A, ORTIZ J, BERRY S, ET AL. PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA OF THE OPTIC CHIASM. CAN-J-OPHTHALMOL 2019;54(3):E134-E140.",61.0,YR,,F,Y,,,20190627.0,,OT,US,US,2019,Q2,Adult
164824881,16482488,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,10 UNIT INJECTION THRICE DAILY,,,U,,,,,,,,TID,2019,Q2,Post transplant lymphoproliferative disorder,,2019,Q2,1,I,,20190617.0,20190627,20190627,EXP,,US-TEVA-2019-US-1067948,TEVA,"GO JA, MANDUJANO-SANCHEZ JI, VICKERS A, SADAKA A, ORTIZ J, BERRY S, ET AL. PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA OF THE OPTIC CHIASM. CAN-J-OPHTHALMOL 2019;54(3):E134-E140.",61.0,YR,,F,Y,,,20190627.0,,OT,US,US,2019,Q2,Adult
98352044,9835204,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q2,Myocardial infarction,,2019,Q2,4,F,20131204.0,20190411.0,20140122,20190419,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-19895960,BRISTOL MYERS SQUIBB,,76.0,YR,,M,Y,91.61,KG,20190419.0,,OT,US,US,2019,Q2,Elderly
98352044,9835204,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q2,Ventricular arrhythmia,,2019,Q2,4,F,20131204.0,20190411.0,20140122,20190419,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-19895960,BRISTOL MYERS SQUIBB,,76.0,YR,,M,Y,91.61,KG,20190419.0,,OT,US,US,2019,Q2,Elderly
109982194,10998219,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK (1 UNIT PER 12 GRAMS AS DIRECTED),,,,,,,,,,,,2019,Q3,Diabetic coma,,2019,Q3,4,F,20050414.0,20190702.0,20150408,20190712,EXP,,US-PFIZER INC-2015119344,PFIZER,,44.0,YR,,M,Y,75.0,KG,20190712.0,,OT,US,US,2019,Q3,Adult
109982194,10998219,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK (1 UNIT PER 12 GRAMS AS DIRECTED),,,,,,,,,,,,2019,Q3,Off label use,,2019,Q3,4,F,20050414.0,20190702.0,20150408,20190712,EXP,,US-PFIZER INC-2015119344,PFIZER,,44.0,YR,,M,Y,75.0,KG,20190712.0,,OT,US,US,2019,Q3,Adult
109982194,10998219,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK (1 UNIT PER 12 GRAMS AS DIRECTED),,,,,,,,,,,,2019,Q3,Product use in unapproved indication,,2019,Q3,4,F,20050414.0,20190702.0,20150408,20190712,EXP,,US-PFIZER INC-2015119344,PFIZER,,44.0,YR,,M,Y,75.0,KG,20190712.0,,OT,US,US,2019,Q3,Adult
109982194,10998219,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK (1 UNIT PER 12 GRAMS AS DIRECTED),,,,,,,,,,,,2019,Q3,Steroid diabetes,,2019,Q3,4,F,20050414.0,20190702.0,20150408,20190712,EXP,,US-PFIZER INC-2015119344,PFIZER,,44.0,YR,,M,Y,75.0,KG,20190712.0,,OT,US,US,2019,Q3,Adult
127175553,12717555,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"21 DF,QD",,,,,,,,21.0,IU,SOLUTION FOR INJECTION,QD,2019,Q3,Anembryonic gestation,,2019,Q3,3,F,20160411.0,20190703.0,20160906,20190715,EXP,,FI-SA-2016SA157551,SANOFI AVENTIS,,30.0,YR,A,F,Y,69.0,KG,20190715.0,,MD,FI,FI,2019,Q3,Young Adult
127175553,12717555,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"21 DF,QD",,,,,,,,21.0,IU,SOLUTION FOR INJECTION,QD,2019,Q3,Exposure during pregnancy,,2019,Q3,3,F,20160411.0,20190703.0,20160906,20190715,EXP,,FI-SA-2016SA157551,SANOFI AVENTIS,,30.0,YR,A,F,Y,69.0,KG,20190715.0,,MD,FI,FI,2019,Q3,Young Adult
136391785,13639178,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,1000 INTERNATIONAL UNIT,,,U,,,,,1000.0,IU,,,2019,Q3,Dyspnoea,,2019,Q3,5,F,20170410.0,20190905.0,20170609,20190914,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-048501,BRISTOL MYERS SQUIBB,,87.0,YR,,M,Y,,,20190914.0,,CN,FR,FR,2019,Q3,Elderly
136391785,13639178,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,1000 INTERNATIONAL UNIT,,,U,,,,,1000.0,IU,,,2019,Q3,General physical health deterioration,,2019,Q3,5,F,20170410.0,20190905.0,20170609,20190914,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-048501,BRISTOL MYERS SQUIBB,,87.0,YR,,M,Y,,,20190914.0,,CN,FR,FR,2019,Q3,Elderly
136391785,13639178,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,1000 INTERNATIONAL UNIT,,,U,,,,,1000.0,IU,,,2019,Q3,Lung adenocarcinoma,,2019,Q3,5,F,20170410.0,20190905.0,20170609,20190914,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-048501,BRISTOL MYERS SQUIBB,,87.0,YR,,M,Y,,,20190914.0,,CN,FR,FR,2019,Q3,Elderly
136391785,13639178,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,1000 INTERNATIONAL UNIT,,,U,,,,,1000.0,IU,,,2019,Q3,Pleural effusion,,2019,Q3,5,F,20170410.0,20190905.0,20170609,20190914,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-048501,BRISTOL MYERS SQUIBB,,87.0,YR,,M,Y,,,20190914.0,,CN,FR,FR,2019,Q3,Elderly
136391785,13639178,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,1000 INTERNATIONAL UNIT,,,U,,,,,1000.0,IU,,,2019,Q3,Respiratory disorder,,2019,Q3,5,F,20170410.0,20190905.0,20170609,20190914,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-048501,BRISTOL MYERS SQUIBB,,87.0,YR,,M,Y,,,20190914.0,,CN,FR,FR,2019,Q3,Elderly
136391785,13639178,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,1000 INTERNATIONAL UNIT,,,U,,,,,1000.0,IU,,,2019,Q3,Respiratory distress,,2019,Q3,5,F,20170410.0,20190905.0,20170609,20190914,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-048501,BRISTOL MYERS SQUIBB,,87.0,YR,,M,Y,,,20190914.0,,CN,FR,FR,2019,Q3,Elderly
138293495,13829349,13,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2019,Q3,Infusion site discharge,,2019,Q3,5,F,,20190705.0,20170803,20190711,EXP,,CA-PFIZER INC-2017332361,PFIZER,,53.0,YR,,F,Y,48.0,KG,20190711.0,,PH,CA,CA,2019,Q3,Adult
138293495,13829349,13,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2019,Q3,Infusion site erythema,,2019,Q3,5,F,,20190705.0,20170803,20190711,EXP,,CA-PFIZER INC-2017332361,PFIZER,,53.0,YR,,F,Y,48.0,KG,20190711.0,,PH,CA,CA,2019,Q3,Adult
138293495,13829349,13,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2019,Q3,Neutrophil count decreased,,2019,Q3,5,F,,20190705.0,20170803,20190711,EXP,,CA-PFIZER INC-2017332361,PFIZER,,53.0,YR,,F,Y,48.0,KG,20190711.0,,PH,CA,CA,2019,Q3,Adult
138415293,13841529,12,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Alopecia,,2019,Q3,3,F,201505.0,20190814.0,20170807,20190819,PER,,US-PFIZER INC-2017241719,PFIZER,,50.0,YR,,F,Y,118.0,KG,20190819.0,,LW,US,US,2019,Q3,Adult
138415293,13841529,12,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Hair colour changes,,2019,Q3,3,F,201505.0,20190814.0,20170807,20190819,PER,,US-PFIZER INC-2017241719,PFIZER,,50.0,YR,,F,Y,118.0,KG,20190819.0,,LW,US,US,2019,Q3,Adult
138415293,13841529,12,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Hair disorder,,2019,Q3,3,F,201505.0,20190814.0,20170807,20190819,PER,,US-PFIZER INC-2017241719,PFIZER,,50.0,YR,,F,Y,118.0,KG,20190819.0,,LW,US,US,2019,Q3,Adult
138415293,13841529,12,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Hair texture abnormal,,2019,Q3,3,F,201505.0,20190814.0,20170807,20190819,PER,,US-PFIZER INC-2017241719,PFIZER,,50.0,YR,,F,Y,118.0,KG,20190819.0,,LW,US,US,2019,Q3,Adult
138415293,13841529,12,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Madarosis,,2019,Q3,3,F,201505.0,20190814.0,20170807,20190819,PER,,US-PFIZER INC-2017241719,PFIZER,,50.0,YR,,F,Y,118.0,KG,20190819.0,,LW,US,US,2019,Q3,Adult
139767014,13976701,16,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2019,Q3,Acute respiratory failure,,2019,Q3,4,F,20170905.0,20171002.0,20170915,20190922,EXP,,US-CELGENEUS-USA-20170903906,CELGENE,,76.0,YR,,F,Y,85.71,KG,20190922.0,,MD,US,US,2019,Q3,Elderly
139767014,13976701,16,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2019,Q3,Blood bilirubin increased,,2019,Q3,4,F,20170905.0,20171002.0,20170915,20190922,EXP,,US-CELGENEUS-USA-20170903906,CELGENE,,76.0,YR,,F,Y,85.71,KG,20190922.0,,MD,US,US,2019,Q3,Elderly
139767014,13976701,16,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2019,Q3,Differentiation syndrome,,2019,Q3,4,F,20170905.0,20171002.0,20170915,20190922,EXP,,US-CELGENEUS-USA-20170903906,CELGENE,,76.0,YR,,F,Y,85.71,KG,20190922.0,,MD,US,US,2019,Q3,Elderly
140191557,14019155,33,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,1 IU (INTERNATIONAL UNIT),,,,,,,,1.0,IU,UNKNOWN,,2019,Q3,Acute kidney injury,Acute kidney injury,2019,Q3,7,F,20170913.0,20180206.0,20170928,20190916,EXP,,US-CELGENEUS-USA-20170904150,CELGENE,,71.0,YR,,M,Y,113.0,KG,20190916.0,,MD,US,US,2019,Q3,Elderly
140191557,14019155,33,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,1 IU (INTERNATIONAL UNIT),,,,,,,,1.0,IU,UNKNOWN,,2019,Q3,Alanine aminotransferase increased,,2019,Q3,7,F,20170913.0,20180206.0,20170928,20190916,EXP,,US-CELGENEUS-USA-20170904150,CELGENE,,71.0,YR,,M,Y,113.0,KG,20190916.0,,MD,US,US,2019,Q3,Elderly
140191557,14019155,33,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,1 IU (INTERNATIONAL UNIT),,,,,,,,1.0,IU,UNKNOWN,,2019,Q3,Aspartate aminotransferase increased,,2019,Q3,7,F,20170913.0,20180206.0,20170928,20190916,EXP,,US-CELGENEUS-USA-20170904150,CELGENE,,71.0,YR,,M,Y,113.0,KG,20190916.0,,MD,US,US,2019,Q3,Elderly
141203145,14120314,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"PER BLOOD GLUCOSE LEVEL, WITH MEALS",,,U,,,,,,,,,2019,Q3,Colitis,,2019,Q3,5,F,20171011.0,20190725.0,20171024,20190806,EXP,,PHHO2017US014657,SANDOZ,,13.0,YR,,F,Y,,,20190806.0,,CN,US,US,2019,Q3,Child
143802563,14380256,10,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Colitis,,2019,Q3,3,F,20171011.0,20190812.0,20180112,20190813,EXP,,US-PFIZER INC-2018012072,PFIZER,,13.0,YR,,F,Y,73.0,KG,20190813.0,,MD,US,US,2019,Q3,Child
143866452,14386645,12,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2019,Q3,Alopecia,,2019,Q3,2,F,201505.0,20190809.0,20180115,20190822,PER,,US-SA-2017SA099562,SANOFI AVENTIS,,50.0,YR,A,F,Y,117.9,KG,20190822.0,,CN,US,US,2019,Q3,Adult
143866452,14386645,12,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2019,Q3,Psychological trauma,,2019,Q3,2,F,201505.0,20190809.0,20180115,20190822,PER,,US-SA-2017SA099562,SANOFI AVENTIS,,50.0,YR,A,F,Y,117.9,KG,20190822.0,,CN,US,US,2019,Q3,Adult
145681966,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2019,Q3,Arthralgia,,2019,Q3,6,F,2017.0,20190722.0,20180223,20190801,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20190801.0,,MD,US,US,2019,Q3,Adult
145681966,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2019,Q3,Cataract,,2019,Q3,6,F,2017.0,20190722.0,20180223,20190801,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20190801.0,,MD,US,US,2019,Q3,Adult
145681966,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2019,Q3,Clostridium difficile colitis,,2019,Q3,6,F,2017.0,20190722.0,20180223,20190801,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20190801.0,,MD,US,US,2019,Q3,Adult
145681966,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2019,Q3,Coxsackie viral infection,,2019,Q3,6,F,2017.0,20190722.0,20180223,20190801,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20190801.0,,MD,US,US,2019,Q3,Adult
145681966,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2019,Q3,Dry eye,,2019,Q3,6,F,2017.0,20190722.0,20180223,20190801,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20190801.0,,MD,US,US,2019,Q3,Adult
145681966,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2019,Q3,Dysgeusia,,2019,Q3,6,F,2017.0,20190722.0,20180223,20190801,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20190801.0,,MD,US,US,2019,Q3,Adult
145681966,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2019,Q3,Headache,,2019,Q3,6,F,2017.0,20190722.0,20180223,20190801,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20190801.0,,MD,US,US,2019,Q3,Adult
145681966,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2019,Q3,Hyperhidrosis,,2019,Q3,6,F,2017.0,20190722.0,20180223,20190801,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20190801.0,,MD,US,US,2019,Q3,Adult
145681966,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2019,Q3,Hypoacusis,,2019,Q3,6,F,2017.0,20190722.0,20180223,20190801,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20190801.0,,MD,US,US,2019,Q3,Adult
145681966,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2019,Q3,Hypogammaglobulinaemia,,2019,Q3,6,F,2017.0,20190722.0,20180223,20190801,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20190801.0,,MD,US,US,2019,Q3,Adult
145681966,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2019,Q3,Influenza like illness,,2019,Q3,6,F,2017.0,20190722.0,20180223,20190801,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20190801.0,,MD,US,US,2019,Q3,Adult
145681966,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2019,Q3,Myalgia,,2019,Q3,6,F,2017.0,20190722.0,20180223,20190801,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20190801.0,,MD,US,US,2019,Q3,Adult
145681966,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2019,Q3,Neuropathy peripheral,,2019,Q3,6,F,2017.0,20190722.0,20180223,20190801,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20190801.0,,MD,US,US,2019,Q3,Adult
145681966,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2019,Q3,Pollakiuria,,2019,Q3,6,F,2017.0,20190722.0,20180223,20190801,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20190801.0,,MD,US,US,2019,Q3,Adult
145681966,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2019,Q3,Product administration error,,2019,Q3,6,F,2017.0,20190722.0,20180223,20190801,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20190801.0,,MD,US,US,2019,Q3,Adult
145681966,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2019,Q3,Pyrexia,,2019,Q3,6,F,2017.0,20190722.0,20180223,20190801,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20190801.0,,MD,US,US,2019,Q3,Adult
145681966,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2019,Q3,Rash morbilliform,,2019,Q3,6,F,2017.0,20190722.0,20180223,20190801,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20190801.0,,MD,US,US,2019,Q3,Adult
145681966,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2019,Q3,Stevens-Johnson syndrome,,2019,Q3,6,F,2017.0,20190722.0,20180223,20190801,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20190801.0,,MD,US,US,2019,Q3,Adult
145681966,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2019,Q3,Urinary incontinence,,2019,Q3,6,F,2017.0,20190722.0,20180223,20190801,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20190801.0,,MD,US,US,2019,Q3,Adult
145681966,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2019,Q3,Vision blurred,,2019,Q3,6,F,2017.0,20190722.0,20180223,20190801,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20190801.0,,MD,US,US,2019,Q3,Adult
145681966,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2019,Q3,Vitamin D abnormal,,2019,Q3,6,F,2017.0,20190722.0,20180223,20190801,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20190801.0,,MD,US,US,2019,Q3,Adult
145681966,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2019,Q3,Weight decreased,,2019,Q3,6,F,2017.0,20190722.0,20180223,20190801,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20190801.0,,MD,US,US,2019,Q3,Adult
146997986,14699798,30,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Acute kidney injury,,2019,Q3,6,F,20110627.0,20190906.0,20180330,20190911,EXP,,US-PFIZER INC-2018129976,PFIZER,,37.0,YR,,F,Y,,,20190911.0,,LW,US,US,2019,Q3,Adult
146997986,14699798,30,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Chronic kidney disease,,2019,Q3,6,F,20110627.0,20190906.0,20180330,20190911,EXP,,US-PFIZER INC-2018129976,PFIZER,,37.0,YR,,F,Y,,,20190911.0,,LW,US,US,2019,Q3,Adult
146997986,14699798,30,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Gastrooesophageal reflux disease,,2019,Q3,6,F,20110627.0,20190906.0,20180330,20190911,EXP,,US-PFIZER INC-2018129976,PFIZER,,37.0,YR,,F,Y,,,20190911.0,,LW,US,US,2019,Q3,Adult
147058225,14705822,74,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q3,Acute kidney injury,,2019,Q3,5,F,20120120.0,20190916.0,20180402,20190924,EXP,,US-ASTRAZENECA-2018SE39110,ASTRAZENECA,,20314.0,DY,,M,Y,70.3,KG,20190924.0,,,US,US,2019,Q3,Elderly
147058225,14705822,74,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q3,Chronic kidney disease,,2019,Q3,5,F,20120120.0,20190916.0,20180402,20190924,EXP,,US-ASTRAZENECA-2018SE39110,ASTRAZENECA,,20314.0,DY,,M,Y,70.3,KG,20190924.0,,,US,US,2019,Q3,Elderly
147058225,14705822,74,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q3,Chronic kidney disease-mineral and bone disorder,,2019,Q3,5,F,20120120.0,20190916.0,20180402,20190924,EXP,,US-ASTRAZENECA-2018SE39110,ASTRAZENECA,,20314.0,DY,,M,Y,70.3,KG,20190924.0,,,US,US,2019,Q3,Elderly
147058225,14705822,74,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q3,End stage renal disease,,2019,Q3,5,F,20120120.0,20190916.0,20180402,20190924,EXP,,US-ASTRAZENECA-2018SE39110,ASTRAZENECA,,20314.0,DY,,M,Y,70.3,KG,20190924.0,,,US,US,2019,Q3,Elderly
147058225,14705822,74,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q3,Nephrogenic anaemia,,2019,Q3,5,F,20120120.0,20190916.0,20180402,20190924,EXP,,US-ASTRAZENECA-2018SE39110,ASTRAZENECA,,20314.0,DY,,M,Y,70.3,KG,20190924.0,,,US,US,2019,Q3,Elderly
147058225,14705822,74,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q3,Renal failure,,2019,Q3,5,F,20120120.0,20190916.0,20180402,20190924,EXP,,US-ASTRAZENECA-2018SE39110,ASTRAZENECA,,20314.0,DY,,M,Y,70.3,KG,20190924.0,,,US,US,2019,Q3,Elderly
147058225,14705822,74,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q3,Renal injury,,2019,Q3,5,F,20120120.0,20190916.0,20180402,20190924,EXP,,US-ASTRAZENECA-2018SE39110,ASTRAZENECA,,20314.0,DY,,M,Y,70.3,KG,20190924.0,,,US,US,2019,Q3,Elderly
147532014,14753201,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 - 3 UNITS, TID",,,U,,,,,,,,Q8H,2019,Q3,Anti-insulin antibody increased,,2019,Q3,4,F,20170404.0,20190822.0,20180412,20190828,EXP,,JP-SA-2018SA106257,SANOFI AVENTIS,"OGURA Y, KONISHI K, NAKAGAWA A, MIZUNUMA Y, SHIMADA K, TAKAGAKI Y, ET AL.. 6 A CASE OF INSULIN ANTIBODY-POSITIVE ADVANCED AGE TYPE 1 DIABETES MELLITUS IN WHICH THERAPY CHANGE TO INJECTING SHORT-ACTING INSULIN TWICE A DAY AND CORRECTION OF ACIDOSIS WERE EFFECTIVE AGAINST FREQUENT HYPOGLYCAEMIA.. THE 29TH HOKURIKU REGIONAL MEETING OF THE JAPAN GERIATRICS SOCIETY (17-NOV-2018). 2018;UNK:15",88.0,YR,E,F,Y,40.0,KG,20190828.0,,,COUNTRY NOT SPECIFIED,JP,2019,Q3,Elderly
147532014,14753201,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 - 3 UNITS, TID",,,U,,,,,,,,Q8H,2019,Q3,Atrioventricular block complete,,2019,Q3,4,F,20170404.0,20190822.0,20180412,20190828,EXP,,JP-SA-2018SA106257,SANOFI AVENTIS,"OGURA Y, KONISHI K, NAKAGAWA A, MIZUNUMA Y, SHIMADA K, TAKAGAKI Y, ET AL.. 6 A CASE OF INSULIN ANTIBODY-POSITIVE ADVANCED AGE TYPE 1 DIABETES MELLITUS IN WHICH THERAPY CHANGE TO INJECTING SHORT-ACTING INSULIN TWICE A DAY AND CORRECTION OF ACIDOSIS WERE EFFECTIVE AGAINST FREQUENT HYPOGLYCAEMIA.. THE 29TH HOKURIKU REGIONAL MEETING OF THE JAPAN GERIATRICS SOCIETY (17-NOV-2018). 2018;UNK:15",88.0,YR,E,F,Y,40.0,KG,20190828.0,,,COUNTRY NOT SPECIFIED,JP,2019,Q3,Elderly
147532014,14753201,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 - 3 UNITS, TID",,,U,,,,,,,,Q8H,2019,Q3,Blood lactic acid increased,,2019,Q3,4,F,20170404.0,20190822.0,20180412,20190828,EXP,,JP-SA-2018SA106257,SANOFI AVENTIS,"OGURA Y, KONISHI K, NAKAGAWA A, MIZUNUMA Y, SHIMADA K, TAKAGAKI Y, ET AL.. 6 A CASE OF INSULIN ANTIBODY-POSITIVE ADVANCED AGE TYPE 1 DIABETES MELLITUS IN WHICH THERAPY CHANGE TO INJECTING SHORT-ACTING INSULIN TWICE A DAY AND CORRECTION OF ACIDOSIS WERE EFFECTIVE AGAINST FREQUENT HYPOGLYCAEMIA.. THE 29TH HOKURIKU REGIONAL MEETING OF THE JAPAN GERIATRICS SOCIETY (17-NOV-2018). 2018;UNK:15",88.0,YR,E,F,Y,40.0,KG,20190828.0,,,COUNTRY NOT SPECIFIED,JP,2019,Q3,Elderly
147532014,14753201,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 - 3 UNITS, TID",,,U,,,,,,,,Q8H,2019,Q3,Blood pH decreased,,2019,Q3,4,F,20170404.0,20190822.0,20180412,20190828,EXP,,JP-SA-2018SA106257,SANOFI AVENTIS,"OGURA Y, KONISHI K, NAKAGAWA A, MIZUNUMA Y, SHIMADA K, TAKAGAKI Y, ET AL.. 6 A CASE OF INSULIN ANTIBODY-POSITIVE ADVANCED AGE TYPE 1 DIABETES MELLITUS IN WHICH THERAPY CHANGE TO INJECTING SHORT-ACTING INSULIN TWICE A DAY AND CORRECTION OF ACIDOSIS WERE EFFECTIVE AGAINST FREQUENT HYPOGLYCAEMIA.. THE 29TH HOKURIKU REGIONAL MEETING OF THE JAPAN GERIATRICS SOCIETY (17-NOV-2018). 2018;UNK:15",88.0,YR,E,F,Y,40.0,KG,20190828.0,,,COUNTRY NOT SPECIFIED,JP,2019,Q3,Elderly
147532014,14753201,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 - 3 UNITS, TID",,,U,,,,,,,,Q8H,2019,Q3,Cardiac failure chronic,,2019,Q3,4,F,20170404.0,20190822.0,20180412,20190828,EXP,,JP-SA-2018SA106257,SANOFI AVENTIS,"OGURA Y, KONISHI K, NAKAGAWA A, MIZUNUMA Y, SHIMADA K, TAKAGAKI Y, ET AL.. 6 A CASE OF INSULIN ANTIBODY-POSITIVE ADVANCED AGE TYPE 1 DIABETES MELLITUS IN WHICH THERAPY CHANGE TO INJECTING SHORT-ACTING INSULIN TWICE A DAY AND CORRECTION OF ACIDOSIS WERE EFFECTIVE AGAINST FREQUENT HYPOGLYCAEMIA.. THE 29TH HOKURIKU REGIONAL MEETING OF THE JAPAN GERIATRICS SOCIETY (17-NOV-2018). 2018;UNK:15",88.0,YR,E,F,Y,40.0,KG,20190828.0,,,COUNTRY NOT SPECIFIED,JP,2019,Q3,Elderly
147532014,14753201,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 - 3 UNITS, TID",,,U,,,,,,,,Q8H,2019,Q3,Decreased appetite,,2019,Q3,4,F,20170404.0,20190822.0,20180412,20190828,EXP,,JP-SA-2018SA106257,SANOFI AVENTIS,"OGURA Y, KONISHI K, NAKAGAWA A, MIZUNUMA Y, SHIMADA K, TAKAGAKI Y, ET AL.. 6 A CASE OF INSULIN ANTIBODY-POSITIVE ADVANCED AGE TYPE 1 DIABETES MELLITUS IN WHICH THERAPY CHANGE TO INJECTING SHORT-ACTING INSULIN TWICE A DAY AND CORRECTION OF ACIDOSIS WERE EFFECTIVE AGAINST FREQUENT HYPOGLYCAEMIA.. THE 29TH HOKURIKU REGIONAL MEETING OF THE JAPAN GERIATRICS SOCIETY (17-NOV-2018). 2018;UNK:15",88.0,YR,E,F,Y,40.0,KG,20190828.0,,,COUNTRY NOT SPECIFIED,JP,2019,Q3,Elderly
147532014,14753201,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 - 3 UNITS, TID",,,U,,,,,,,,Q8H,2019,Q3,Diabetes mellitus inadequate control,,2019,Q3,4,F,20170404.0,20190822.0,20180412,20190828,EXP,,JP-SA-2018SA106257,SANOFI AVENTIS,"OGURA Y, KONISHI K, NAKAGAWA A, MIZUNUMA Y, SHIMADA K, TAKAGAKI Y, ET AL.. 6 A CASE OF INSULIN ANTIBODY-POSITIVE ADVANCED AGE TYPE 1 DIABETES MELLITUS IN WHICH THERAPY CHANGE TO INJECTING SHORT-ACTING INSULIN TWICE A DAY AND CORRECTION OF ACIDOSIS WERE EFFECTIVE AGAINST FREQUENT HYPOGLYCAEMIA.. THE 29TH HOKURIKU REGIONAL MEETING OF THE JAPAN GERIATRICS SOCIETY (17-NOV-2018). 2018;UNK:15",88.0,YR,E,F,Y,40.0,KG,20190828.0,,,COUNTRY NOT SPECIFIED,JP,2019,Q3,Elderly
147532014,14753201,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 - 3 UNITS, TID",,,U,,,,,,,,Q8H,2019,Q3,Dizziness,,2019,Q3,4,F,20170404.0,20190822.0,20180412,20190828,EXP,,JP-SA-2018SA106257,SANOFI AVENTIS,"OGURA Y, KONISHI K, NAKAGAWA A, MIZUNUMA Y, SHIMADA K, TAKAGAKI Y, ET AL.. 6 A CASE OF INSULIN ANTIBODY-POSITIVE ADVANCED AGE TYPE 1 DIABETES MELLITUS IN WHICH THERAPY CHANGE TO INJECTING SHORT-ACTING INSULIN TWICE A DAY AND CORRECTION OF ACIDOSIS WERE EFFECTIVE AGAINST FREQUENT HYPOGLYCAEMIA.. THE 29TH HOKURIKU REGIONAL MEETING OF THE JAPAN GERIATRICS SOCIETY (17-NOV-2018). 2018;UNK:15",88.0,YR,E,F,Y,40.0,KG,20190828.0,,,COUNTRY NOT SPECIFIED,JP,2019,Q3,Elderly
147532014,14753201,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 - 3 UNITS, TID",,,U,,,,,,,,Q8H,2019,Q3,Hyperglycaemia,,2019,Q3,4,F,20170404.0,20190822.0,20180412,20190828,EXP,,JP-SA-2018SA106257,SANOFI AVENTIS,"OGURA Y, KONISHI K, NAKAGAWA A, MIZUNUMA Y, SHIMADA K, TAKAGAKI Y, ET AL.. 6 A CASE OF INSULIN ANTIBODY-POSITIVE ADVANCED AGE TYPE 1 DIABETES MELLITUS IN WHICH THERAPY CHANGE TO INJECTING SHORT-ACTING INSULIN TWICE A DAY AND CORRECTION OF ACIDOSIS WERE EFFECTIVE AGAINST FREQUENT HYPOGLYCAEMIA.. THE 29TH HOKURIKU REGIONAL MEETING OF THE JAPAN GERIATRICS SOCIETY (17-NOV-2018). 2018;UNK:15",88.0,YR,E,F,Y,40.0,KG,20190828.0,,,COUNTRY NOT SPECIFIED,JP,2019,Q3,Elderly
147532014,14753201,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 - 3 UNITS, TID",,,U,,,,,,,,Q8H,2019,Q3,Hypoglycaemia,,2019,Q3,4,F,20170404.0,20190822.0,20180412,20190828,EXP,,JP-SA-2018SA106257,SANOFI AVENTIS,"OGURA Y, KONISHI K, NAKAGAWA A, MIZUNUMA Y, SHIMADA K, TAKAGAKI Y, ET AL.. 6 A CASE OF INSULIN ANTIBODY-POSITIVE ADVANCED AGE TYPE 1 DIABETES MELLITUS IN WHICH THERAPY CHANGE TO INJECTING SHORT-ACTING INSULIN TWICE A DAY AND CORRECTION OF ACIDOSIS WERE EFFECTIVE AGAINST FREQUENT HYPOGLYCAEMIA.. THE 29TH HOKURIKU REGIONAL MEETING OF THE JAPAN GERIATRICS SOCIETY (17-NOV-2018). 2018;UNK:15",88.0,YR,E,F,Y,40.0,KG,20190828.0,,,COUNTRY NOT SPECIFIED,JP,2019,Q3,Elderly
147532014,14753201,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 - 3 UNITS, TID",,,U,,,,,,,,Q8H,2019,Q3,Lactic acidosis,,2019,Q3,4,F,20170404.0,20190822.0,20180412,20190828,EXP,,JP-SA-2018SA106257,SANOFI AVENTIS,"OGURA Y, KONISHI K, NAKAGAWA A, MIZUNUMA Y, SHIMADA K, TAKAGAKI Y, ET AL.. 6 A CASE OF INSULIN ANTIBODY-POSITIVE ADVANCED AGE TYPE 1 DIABETES MELLITUS IN WHICH THERAPY CHANGE TO INJECTING SHORT-ACTING INSULIN TWICE A DAY AND CORRECTION OF ACIDOSIS WERE EFFECTIVE AGAINST FREQUENT HYPOGLYCAEMIA.. THE 29TH HOKURIKU REGIONAL MEETING OF THE JAPAN GERIATRICS SOCIETY (17-NOV-2018). 2018;UNK:15",88.0,YR,E,F,Y,40.0,KG,20190828.0,,,COUNTRY NOT SPECIFIED,JP,2019,Q3,Elderly
147532014,14753201,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 - 3 UNITS, TID",,,U,,,,,,,,Q8H,2019,Q3,Malaise,,2019,Q3,4,F,20170404.0,20190822.0,20180412,20190828,EXP,,JP-SA-2018SA106257,SANOFI AVENTIS,"OGURA Y, KONISHI K, NAKAGAWA A, MIZUNUMA Y, SHIMADA K, TAKAGAKI Y, ET AL.. 6 A CASE OF INSULIN ANTIBODY-POSITIVE ADVANCED AGE TYPE 1 DIABETES MELLITUS IN WHICH THERAPY CHANGE TO INJECTING SHORT-ACTING INSULIN TWICE A DAY AND CORRECTION OF ACIDOSIS WERE EFFECTIVE AGAINST FREQUENT HYPOGLYCAEMIA.. THE 29TH HOKURIKU REGIONAL MEETING OF THE JAPAN GERIATRICS SOCIETY (17-NOV-2018). 2018;UNK:15",88.0,YR,E,F,Y,40.0,KG,20190828.0,,,COUNTRY NOT SPECIFIED,JP,2019,Q3,Elderly
149406683,14940668,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q3,Cellulitis,,2019,Q3,3,F,20180503.0,20190815.0,20180525,20190827,EXP,,US-ACTELION-A-US2018-172608,ACTELION,,55.0,YR,,M,Y,,,20190827.0,,MD,US,US,2019,Q3,Adult
149406683,14940668,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q3,Condition aggravated,,2019,Q3,3,F,20180503.0,20190815.0,20180525,20190827,EXP,,US-ACTELION-A-US2018-172608,ACTELION,,55.0,YR,,M,Y,,,20190827.0,,MD,US,US,2019,Q3,Adult
149406683,14940668,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q3,Death,,2019,Q3,3,F,20180503.0,20190815.0,20180525,20190827,EXP,,US-ACTELION-A-US2018-172608,ACTELION,,55.0,YR,,M,Y,,,20190827.0,,MD,US,US,2019,Q3,Adult
149406683,14940668,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q3,Escherichia bacteraemia,,2019,Q3,3,F,20180503.0,20190815.0,20180525,20190827,EXP,,US-ACTELION-A-US2018-172608,ACTELION,,55.0,YR,,M,Y,,,20190827.0,,MD,US,US,2019,Q3,Adult
149406683,14940668,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q3,Osteomyelitis,,2019,Q3,3,F,20180503.0,20190815.0,20180525,20190827,EXP,,US-ACTELION-A-US2018-172608,ACTELION,,55.0,YR,,M,Y,,,20190827.0,,MD,US,US,2019,Q3,Adult
149406683,14940668,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q3,Pain in extremity,,2019,Q3,3,F,20180503.0,20190815.0,20180525,20190827,EXP,,US-ACTELION-A-US2018-172608,ACTELION,,55.0,YR,,M,Y,,,20190827.0,,MD,US,US,2019,Q3,Adult
149406683,14940668,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q3,Skin ulcer,,2019,Q3,3,F,20180503.0,20190815.0,20180525,20190827,EXP,,US-ACTELION-A-US2018-172608,ACTELION,,55.0,YR,,M,Y,,,20190827.0,,MD,US,US,2019,Q3,Adult
149406683,14940668,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q3,Wound haemorrhage,,2019,Q3,3,F,20180503.0,20190815.0,20180525,20190827,EXP,,US-ACTELION-A-US2018-172608,ACTELION,,55.0,YR,,M,Y,,,20190827.0,,MD,US,US,2019,Q3,Adult
150096672,15009667,5,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"6 INTERNATIONAL UNIT, ONCE A DAY WITH MEALS",,,U,U,,,,6.0,IU,UNK,QD,2019,Q3,Accidental overdose,,2019,Q3,2,F,,20190911.0,20180614,20190925,EXP,,CA-AUROBINDO-AUR-APL-2018-031477,AUROBINDO,,56.0,YR,,M,Y,,,20190925.0,,MD,CA,CA,2019,Q3,Adult
150096672,15009667,5,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"6 INTERNATIONAL UNIT, ONCE A DAY WITH MEALS",,,U,U,,,,6.0,IU,UNK,QD,2019,Q3,Drug interaction,,2019,Q3,2,F,,20190911.0,20180614,20190925,EXP,,CA-AUROBINDO-AUR-APL-2018-031477,AUROBINDO,,56.0,YR,,M,Y,,,20190925.0,,MD,CA,CA,2019,Q3,Adult
150096672,15009667,5,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"6 INTERNATIONAL UNIT, ONCE A DAY WITH MEALS",,,U,U,,,,6.0,IU,UNK,QD,2019,Q3,Hypoglycaemia,,2019,Q3,2,F,,20190911.0,20180614,20190925,EXP,,CA-AUROBINDO-AUR-APL-2018-031477,AUROBINDO,,56.0,YR,,M,Y,,,20190925.0,,MD,CA,CA,2019,Q3,Adult
150096672,15009667,5,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"6 INTERNATIONAL UNIT, ONCE A DAY WITH MEALS",,,U,U,,,,6.0,IU,UNK,QD,2019,Q3,Toxicity to various agents,,2019,Q3,2,F,,20190911.0,20180614,20190925,EXP,,CA-AUROBINDO-AUR-APL-2018-031477,AUROBINDO,,56.0,YR,,M,Y,,,20190925.0,,MD,CA,CA,2019,Q3,Adult
151032323,15103232,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"8 DOSAGE FORM, UNKNOWN",,,U,U,,,,8.0,DF,,,2019,Q3,Drug abuse,,2019,Q3,3,F,20180503.0,20190821.0,20180703,20190829,EXP,IT-MINISAL02-478648,IT-ELI_LILLY_AND_COMPANY-IT201806009637,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20190829.0,,CN,IT,IT,2019,Q3,Elderly
151032323,15103232,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"8 DOSAGE FORM, UNKNOWN",,,U,U,,,,8.0,DF,,,2019,Q3,Loss of consciousness,,2019,Q3,3,F,20180503.0,20190821.0,20180703,20190829,EXP,IT-MINISAL02-478648,IT-ELI_LILLY_AND_COMPANY-IT201806009637,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20190829.0,,CN,IT,IT,2019,Q3,Elderly
151032323,15103232,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,,,,,U,U,,,,,,,,2019,Q3,Drug abuse,,2019,Q3,3,F,20180503.0,20190821.0,20180703,20190829,EXP,IT-MINISAL02-478648,IT-ELI_LILLY_AND_COMPANY-IT201806009637,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20190829.0,,CN,IT,IT,2019,Q3,Elderly
151032323,15103232,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,,,,,U,U,,,,,,,,2019,Q3,Loss of consciousness,,2019,Q3,3,F,20180503.0,20190821.0,20180703,20190829,EXP,IT-MINISAL02-478648,IT-ELI_LILLY_AND_COMPANY-IT201806009637,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20190829.0,,CN,IT,IT,2019,Q3,Elderly
1549343211,15493432,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2019,Q3,Acute kidney injury,,2019,Q3,11,F,20180419.0,20190729.0,20181012,20190807,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20190807.0,,CN,DE,DE,2019,Q3,Elderly
1549343211,15493432,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2019,Q3,Colitis,,2019,Q3,11,F,20180419.0,20190729.0,20181012,20190807,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20190807.0,,CN,DE,DE,2019,Q3,Elderly
1549343211,15493432,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2019,Q3,Device related infection,,2019,Q3,11,F,20180419.0,20190729.0,20181012,20190807,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20190807.0,,CN,DE,DE,2019,Q3,Elderly
1549343211,15493432,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2019,Q3,Heparin-induced thrombocytopenia,,2019,Q3,11,F,20180419.0,20190729.0,20181012,20190807,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20190807.0,,CN,DE,DE,2019,Q3,Elderly
1549343211,15493432,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2019,Q3,Hyperglycaemia,,2019,Q3,11,F,20180419.0,20190729.0,20181012,20190807,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20190807.0,,CN,DE,DE,2019,Q3,Elderly
1549343211,15493432,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2019,Q3,Malignant neoplasm progression,,2019,Q3,11,F,20180419.0,20190729.0,20181012,20190807,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20190807.0,,CN,DE,DE,2019,Q3,Elderly
1549343211,15493432,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2019,Q3,Meningitis,,2019,Q3,11,F,20180419.0,20190729.0,20181012,20190807,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20190807.0,,CN,DE,DE,2019,Q3,Elderly
1549343211,15493432,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2019,Q3,Metastases to meninges,,2019,Q3,11,F,20180419.0,20190729.0,20181012,20190807,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20190807.0,,CN,DE,DE,2019,Q3,Elderly
1549343211,15493432,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2019,Q3,Retinal detachment,,2019,Q3,11,F,20180419.0,20190729.0,20181012,20190807,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20190807.0,,CN,DE,DE,2019,Q3,Elderly
1549343211,15493432,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2019,Q3,Retinopathy,,2019,Q3,11,F,20180419.0,20190729.0,20181012,20190807,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20190807.0,,CN,DE,DE,2019,Q3,Elderly
1549343211,15493432,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2019,Q3,Urosepsis,,2019,Q3,11,F,20180419.0,20190729.0,20181012,20190807,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20190807.0,,CN,DE,DE,2019,Q3,Elderly
155475625,15547562,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q3,Hypersensitivity,,2019,Q3,5,F,20161027.0,20181113.0,20181024,20190726,EXP,,US-SHIRE-US201808499,SHIRE,,81.0,YR,,M,Y,98.87,KG,20190726.0,,OT,US,US,2019,Q3,Elderly
155475625,15547562,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q3,Hypersensitivity,,2019,Q3,5,F,20161027.0,20181113.0,20181024,20190726,EXP,,US-SHIRE-US201808499,SHIRE,,81.0,YR,,M,Y,98.87,KG,20190726.0,,OT,US,US,2019,Q3,Elderly
155674913,15567491,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2019,Q3,Urosepsis,,2019,Q3,3,F,20180818.0,20190717.0,20181030,20190722,EXP,,PHHO2018US009569,NOVARTIS,,74.0,YR,,F,Y,102.0,KG,20190722.0,,MD,US,US,2019,Q3,Elderly
155908834,15590883,4,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,6 UNITS WITH MEALS,,,,,,,,,,,,2019,Q3,Immunodeficiency,,2019,Q3,4,F,,20190912.0,20181107,20190924,EXP,,CA-TEVA-2018-CA-973422,TEVA,"GUNARATNE K, AUSTIN E, WU PE. UNINTENTIONAL SULFONYLUREA TOXICITY DUE TO A DRUG-DRUG INTERACTION: A CASE REPORT. BMC-RES-NOTES 2018;11(1):331.",56.0,YR,,M,Y,,,20190924.0,,OT,CA,CA,2019,Q3,Adult
155908834,15590883,4,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,6 UNITS WITH MEALS,,,,,,,,,,,,2019,Q3,Pneumonia fungal,,2019,Q3,4,F,,20190912.0,20181107,20190924,EXP,,CA-TEVA-2018-CA-973422,TEVA,"GUNARATNE K, AUSTIN E, WU PE. UNINTENTIONAL SULFONYLUREA TOXICITY DUE TO A DRUG-DRUG INTERACTION: A CASE REPORT. BMC-RES-NOTES 2018;11(1):331.",56.0,YR,,M,Y,,,20190924.0,,OT,CA,CA,2019,Q3,Adult
155909124,15590912,8,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,6 UNITS WITH MEALS,,,Y,,,,,,,,,2019,Q3,Drug interaction,,2019,Q3,4,F,,20190905.0,20181107,20190913,EXP,,CA-TEVA-2018-CA-972682,TEVA,"GUNARATNE K, AUSTIN E, WU PE. UNINTENTIONAL SULFONYLUREA TOXICITY DUE TO A DRUG-DRUG INTERACTION: A CASE REPORT. BMC-RES-NOTES 2018;11(1):331.",56.0,YR,,M,Y,,,20190913.0,,OT,CA,CA,2019,Q3,Adult
155909124,15590912,8,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,6 UNITS WITH MEALS,,,Y,,,,,,,,,2019,Q3,Hallucination,,2019,Q3,4,F,,20190905.0,20181107,20190913,EXP,,CA-TEVA-2018-CA-972682,TEVA,"GUNARATNE K, AUSTIN E, WU PE. UNINTENTIONAL SULFONYLUREA TOXICITY DUE TO A DRUG-DRUG INTERACTION: A CASE REPORT. BMC-RES-NOTES 2018;11(1):331.",56.0,YR,,M,Y,,,20190913.0,,OT,CA,CA,2019,Q3,Adult
155909124,15590912,8,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,6 UNITS WITH MEALS,,,Y,,,,,,,,,2019,Q3,Hypoglycaemia,,2019,Q3,4,F,,20190905.0,20181107,20190913,EXP,,CA-TEVA-2018-CA-972682,TEVA,"GUNARATNE K, AUSTIN E, WU PE. UNINTENTIONAL SULFONYLUREA TOXICITY DUE TO A DRUG-DRUG INTERACTION: A CASE REPORT. BMC-RES-NOTES 2018;11(1):331.",56.0,YR,,M,Y,,,20190913.0,,OT,CA,CA,2019,Q3,Adult
155909124,15590912,8,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,6 UNITS WITH MEALS,,,Y,,,,,,,,,2019,Q3,Overdose,,2019,Q3,4,F,,20190905.0,20181107,20190913,EXP,,CA-TEVA-2018-CA-972682,TEVA,"GUNARATNE K, AUSTIN E, WU PE. UNINTENTIONAL SULFONYLUREA TOXICITY DUE TO A DRUG-DRUG INTERACTION: A CASE REPORT. BMC-RES-NOTES 2018;11(1):331.",56.0,YR,,M,Y,,,20190913.0,,OT,CA,CA,2019,Q3,Adult
155909124,15590912,8,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,6 UNITS WITH MEALS,,,Y,,,,,,,,,2019,Q3,Toxicity to various agents,,2019,Q3,4,F,,20190905.0,20181107,20190913,EXP,,CA-TEVA-2018-CA-972682,TEVA,"GUNARATNE K, AUSTIN E, WU PE. UNINTENTIONAL SULFONYLUREA TOXICITY DUE TO A DRUG-DRUG INTERACTION: A CASE REPORT. BMC-RES-NOTES 2018;11(1):331.",56.0,YR,,M,Y,,,20190913.0,,OT,CA,CA,2019,Q3,Adult
155909124,15590912,9,C,Insulin lispro,INSULIN LISPRO,1,Retrobulbar,,,,Y,,,,,,,,QD,2019,Q3,Drug interaction,,2019,Q3,4,F,,20190905.0,20181107,20190913,EXP,,CA-TEVA-2018-CA-972682,TEVA,"GUNARATNE K, AUSTIN E, WU PE. UNINTENTIONAL SULFONYLUREA TOXICITY DUE TO A DRUG-DRUG INTERACTION: A CASE REPORT. BMC-RES-NOTES 2018;11(1):331.",56.0,YR,,M,Y,,,20190913.0,,OT,CA,CA,2019,Q3,Adult
155909124,15590912,9,C,Insulin lispro,INSULIN LISPRO,1,Retrobulbar,,,,Y,,,,,,,,QD,2019,Q3,Hallucination,,2019,Q3,4,F,,20190905.0,20181107,20190913,EXP,,CA-TEVA-2018-CA-972682,TEVA,"GUNARATNE K, AUSTIN E, WU PE. UNINTENTIONAL SULFONYLUREA TOXICITY DUE TO A DRUG-DRUG INTERACTION: A CASE REPORT. BMC-RES-NOTES 2018;11(1):331.",56.0,YR,,M,Y,,,20190913.0,,OT,CA,CA,2019,Q3,Adult
155909124,15590912,9,C,Insulin lispro,INSULIN LISPRO,1,Retrobulbar,,,,Y,,,,,,,,QD,2019,Q3,Hypoglycaemia,,2019,Q3,4,F,,20190905.0,20181107,20190913,EXP,,CA-TEVA-2018-CA-972682,TEVA,"GUNARATNE K, AUSTIN E, WU PE. UNINTENTIONAL SULFONYLUREA TOXICITY DUE TO A DRUG-DRUG INTERACTION: A CASE REPORT. BMC-RES-NOTES 2018;11(1):331.",56.0,YR,,M,Y,,,20190913.0,,OT,CA,CA,2019,Q3,Adult
155909124,15590912,9,C,Insulin lispro,INSULIN LISPRO,1,Retrobulbar,,,,Y,,,,,,,,QD,2019,Q3,Overdose,,2019,Q3,4,F,,20190905.0,20181107,20190913,EXP,,CA-TEVA-2018-CA-972682,TEVA,"GUNARATNE K, AUSTIN E, WU PE. UNINTENTIONAL SULFONYLUREA TOXICITY DUE TO A DRUG-DRUG INTERACTION: A CASE REPORT. BMC-RES-NOTES 2018;11(1):331.",56.0,YR,,M,Y,,,20190913.0,,OT,CA,CA,2019,Q3,Adult
155909124,15590912,9,C,Insulin lispro,INSULIN LISPRO,1,Retrobulbar,,,,Y,,,,,,,,QD,2019,Q3,Toxicity to various agents,,2019,Q3,4,F,,20190905.0,20181107,20190913,EXP,,CA-TEVA-2018-CA-972682,TEVA,"GUNARATNE K, AUSTIN E, WU PE. UNINTENTIONAL SULFONYLUREA TOXICITY DUE TO A DRUG-DRUG INTERACTION: A CASE REPORT. BMC-RES-NOTES 2018;11(1):331.",56.0,YR,,M,Y,,,20190913.0,,OT,CA,CA,2019,Q3,Adult
1560450611,15604506,15,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 IU, QD ( (25/75: + 20U 20U / D)",,,U,U,,,,40.0,IU,SOLUTION FOR INJECTION,QD,2019,Q3,Chest pain,,2019,Q3,11,F,,20190729.0,20181110,20190801,EXP,,PHHY2018PT147150,NOVARTIS,,54.0,YR,,F,Y,,,20190801.0,,OT,PT,PT,2019,Q3,Adult
1560450611,15604506,15,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 IU, QD ( (25/75: + 20U 20U / D)",,,U,U,,,,40.0,IU,SOLUTION FOR INJECTION,QD,2019,Q3,Headache,,2019,Q3,11,F,,20190729.0,20181110,20190801,EXP,,PHHY2018PT147150,NOVARTIS,,54.0,YR,,F,Y,,,20190801.0,,OT,PT,PT,2019,Q3,Adult
1560450611,15604506,15,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 IU, QD ( (25/75: + 20U 20U / D)",,,U,U,,,,40.0,IU,SOLUTION FOR INJECTION,QD,2019,Q3,Ischaemic stroke,,2019,Q3,11,F,,20190729.0,20181110,20190801,EXP,,PHHY2018PT147150,NOVARTIS,,54.0,YR,,F,Y,,,20190801.0,,OT,PT,PT,2019,Q3,Adult
156176193,15617619,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q3,Asthenia,,2019,Q3,3,F,20181109.0,20190823.0,20181114,20190826,PER,,US-EISAI MEDICAL RESEARCH-EC-2018-047713,EISAI,,66.0,YR,,F,Y,82.7,KG,20190826.0,,MD,US,US,2019,Q3,Elderly
156176193,15617619,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q3,Hyperglycaemia,,2019,Q3,3,F,20181109.0,20190823.0,20181114,20190826,PER,,US-EISAI MEDICAL RESEARCH-EC-2018-047713,EISAI,,66.0,YR,,F,Y,82.7,KG,20190826.0,,MD,US,US,2019,Q3,Elderly
156176193,15617619,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q3,Neutropenia,,2019,Q3,3,F,20181109.0,20190823.0,20181114,20190826,PER,,US-EISAI MEDICAL RESEARCH-EC-2018-047713,EISAI,,66.0,YR,,F,Y,82.7,KG,20190826.0,,MD,US,US,2019,Q3,Elderly
1564428129,15644281,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"40 IU, 1X/DAY ((25/75: + 20U 20U DAILY)",,,U,,,,,40.0,IU,SOLUTION FOR INJECTION,QD,2019,Q3,Chest pain,,2019,Q3,29,F,,20190702.0,20181121,20190716,EXP,,PT-PFIZER INC-2018477132,PFIZER,,54.0,YR,,F,Y,,,20190716.0,,CN,PT,PT,2019,Q3,Adult
1564428129,15644281,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"40 IU, 1X/DAY ((25/75: + 20U 20U DAILY)",,,U,,,,,40.0,IU,SOLUTION FOR INJECTION,QD,2019,Q3,Headache,,2019,Q3,29,F,,20190702.0,20181121,20190716,EXP,,PT-PFIZER INC-2018477132,PFIZER,,54.0,YR,,F,Y,,,20190716.0,,CN,PT,PT,2019,Q3,Adult
1564428129,15644281,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"40 IU, 1X/DAY ((25/75: + 20U 20U DAILY)",,,U,,,,,40.0,IU,SOLUTION FOR INJECTION,QD,2019,Q3,Ischaemic stroke,,2019,Q3,29,F,,20190702.0,20181121,20190716,EXP,,PT-PFIZER INC-2018477132,PFIZER,,54.0,YR,,F,Y,,,20190716.0,,CN,PT,PT,2019,Q3,Adult
156554776,15655477,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 IU (INTERNATIONAL UNIT) DAILY;,,,,,,,,6.0,IU,,QD,2019,Q3,Accidental overdose,,2019,Q3,6,F,,20190826.0,20181126,20190903,EXP,,CA-TEVA-2018-CA-979432,TEVA,,56.0,YR,,M,Y,,,20190903.0,,CN,CA,CA,2019,Q3,Adult
156554776,15655477,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 IU (INTERNATIONAL UNIT) DAILY;,,,,,,,,6.0,IU,,QD,2019,Q3,Corneal perforation,,2019,Q3,6,F,,20190826.0,20181126,20190903,EXP,,CA-TEVA-2018-CA-979432,TEVA,,56.0,YR,,M,Y,,,20190903.0,,CN,CA,CA,2019,Q3,Adult
156554776,15655477,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 IU (INTERNATIONAL UNIT) DAILY;,,,,,,,,6.0,IU,,QD,2019,Q3,Drug interaction,,2019,Q3,6,F,,20190826.0,20181126,20190903,EXP,,CA-TEVA-2018-CA-979432,TEVA,,56.0,YR,,M,Y,,,20190903.0,,CN,CA,CA,2019,Q3,Adult
156554776,15655477,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 IU (INTERNATIONAL UNIT) DAILY;,,,,,,,,6.0,IU,,QD,2019,Q3,Enzyme inhibition,,2019,Q3,6,F,,20190826.0,20181126,20190903,EXP,,CA-TEVA-2018-CA-979432,TEVA,,56.0,YR,,M,Y,,,20190903.0,,CN,CA,CA,2019,Q3,Adult
156554776,15655477,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 IU (INTERNATIONAL UNIT) DAILY;,,,,,,,,6.0,IU,,QD,2019,Q3,Hallucination,,2019,Q3,6,F,,20190826.0,20181126,20190903,EXP,,CA-TEVA-2018-CA-979432,TEVA,,56.0,YR,,M,Y,,,20190903.0,,CN,CA,CA,2019,Q3,Adult
156554776,15655477,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 IU (INTERNATIONAL UNIT) DAILY;,,,,,,,,6.0,IU,,QD,2019,Q3,Hypoglycaemia,,2019,Q3,6,F,,20190826.0,20181126,20190903,EXP,,CA-TEVA-2018-CA-979432,TEVA,,56.0,YR,,M,Y,,,20190903.0,,CN,CA,CA,2019,Q3,Adult
156554776,15655477,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 IU (INTERNATIONAL UNIT) DAILY;,,,,,,,,6.0,IU,,QD,2019,Q3,Keratitis fungal,,2019,Q3,6,F,,20190826.0,20181126,20190903,EXP,,CA-TEVA-2018-CA-979432,TEVA,,56.0,YR,,M,Y,,,20190903.0,,CN,CA,CA,2019,Q3,Adult
156554776,15655477,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 IU (INTERNATIONAL UNIT) DAILY;,,,,,,,,6.0,IU,,QD,2019,Q3,Labelled drug-drug interaction medication error,,2019,Q3,6,F,,20190826.0,20181126,20190903,EXP,,CA-TEVA-2018-CA-979432,TEVA,,56.0,YR,,M,Y,,,20190903.0,,CN,CA,CA,2019,Q3,Adult
156554776,15655477,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 IU (INTERNATIONAL UNIT) DAILY;,,,,,,,,6.0,IU,,QD,2019,Q3,Lethargy,,2019,Q3,6,F,,20190826.0,20181126,20190903,EXP,,CA-TEVA-2018-CA-979432,TEVA,,56.0,YR,,M,Y,,,20190903.0,,CN,CA,CA,2019,Q3,Adult
156554776,15655477,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 IU (INTERNATIONAL UNIT) DAILY;,,,,,,,,6.0,IU,,QD,2019,Q3,Potentiating drug interaction,,2019,Q3,6,F,,20190826.0,20181126,20190903,EXP,,CA-TEVA-2018-CA-979432,TEVA,,56.0,YR,,M,Y,,,20190903.0,,CN,CA,CA,2019,Q3,Adult
156554776,15655477,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 IU (INTERNATIONAL UNIT) DAILY;,,,,,,,,6.0,IU,,QD,2019,Q3,Product use in unapproved indication,,2019,Q3,6,F,,20190826.0,20181126,20190903,EXP,,CA-TEVA-2018-CA-979432,TEVA,,56.0,YR,,M,Y,,,20190903.0,,CN,CA,CA,2019,Q3,Adult
156554776,15655477,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 IU (INTERNATIONAL UNIT) DAILY;,,,,,,,,6.0,IU,,QD,2019,Q3,Toxicity to various agents,,2019,Q3,6,F,,20190826.0,20181126,20190903,EXP,,CA-TEVA-2018-CA-979432,TEVA,,56.0,YR,,M,Y,,,20190903.0,,CN,CA,CA,2019,Q3,Adult
156554776,15655477,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 IU (INTERNATIONAL UNIT) DAILY;,,,,,,,,6.0,IU,,QD,2019,Q3,Visual impairment,,2019,Q3,6,F,,20190826.0,20181126,20190903,EXP,,CA-TEVA-2018-CA-979432,TEVA,,56.0,YR,,M,Y,,,20190903.0,,CN,CA,CA,2019,Q3,Adult
156579648,15657964,12,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,(25/75: + 20U 20U / D)) QD,,,U,,,,209196.0,40.0,IU,SOLUTION FOR INJECTION,QD,2019,Q3,Chest pain,,2019,Q3,8,F,,20190702.0,20181126,20190712,EXP,,PT-SA-2018SA322867,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20190712.0,,OT,PT,PT,2019,Q3,Adult
156579648,15657964,12,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,(25/75: + 20U 20U / D)) QD,,,U,,,,209196.0,40.0,IU,SOLUTION FOR INJECTION,QD,2019,Q3,Headache,,2019,Q3,8,F,,20190702.0,20181126,20190712,EXP,,PT-SA-2018SA322867,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20190712.0,,OT,PT,PT,2019,Q3,Adult
156579648,15657964,12,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,(25/75: + 20U 20U / D)) QD,,,U,,,,209196.0,40.0,IU,SOLUTION FOR INJECTION,QD,2019,Q3,Ischaemic stroke,,2019,Q3,8,F,,20190702.0,20181126,20190712,EXP,,PT-SA-2018SA322867,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20190712.0,,OT,PT,PT,2019,Q3,Adult
156620014,15662001,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 DF, UNK",,,D,, UNKNOWN,,,300.0,DF,INJECTION,,2019,Q3,Acute kidney injury,,2019,Q3,4,F,20180419.0,20190812.0,20181127,20190813,EXP,,PHHY2018DE166582,SANDOZ,,71.0,YR,,M,Y,,,20190814.0,,MD,DE,DE,2019,Q3,Elderly
156620014,15662001,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 DF, UNK",,,D,, UNKNOWN,,,300.0,DF,INJECTION,,2019,Q3,Colitis,,2019,Q3,4,F,20180419.0,20190812.0,20181127,20190813,EXP,,PHHY2018DE166582,SANDOZ,,71.0,YR,,M,Y,,,20190814.0,,MD,DE,DE,2019,Q3,Elderly
156620014,15662001,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 DF, UNK",,,D,, UNKNOWN,,,300.0,DF,INJECTION,,2019,Q3,Device related infection,,2019,Q3,4,F,20180419.0,20190812.0,20181127,20190813,EXP,,PHHY2018DE166582,SANDOZ,,71.0,YR,,M,Y,,,20190814.0,,MD,DE,DE,2019,Q3,Elderly
156620014,15662001,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 DF, UNK",,,D,, UNKNOWN,,,300.0,DF,INJECTION,,2019,Q3,Heparin-induced thrombocytopenia,,2019,Q3,4,F,20180419.0,20190812.0,20181127,20190813,EXP,,PHHY2018DE166582,SANDOZ,,71.0,YR,,M,Y,,,20190814.0,,MD,DE,DE,2019,Q3,Elderly
156620014,15662001,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 DF, UNK",,,D,, UNKNOWN,,,300.0,DF,INJECTION,,2019,Q3,Hyperglycaemia,,2019,Q3,4,F,20180419.0,20190812.0,20181127,20190813,EXP,,PHHY2018DE166582,SANDOZ,,71.0,YR,,M,Y,,,20190814.0,,MD,DE,DE,2019,Q3,Elderly
156620014,15662001,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 DF, UNK",,,D,, UNKNOWN,,,300.0,DF,INJECTION,,2019,Q3,Malignant neoplasm progression,,2019,Q3,4,F,20180419.0,20190812.0,20181127,20190813,EXP,,PHHY2018DE166582,SANDOZ,,71.0,YR,,M,Y,,,20190814.0,,MD,DE,DE,2019,Q3,Elderly
156620014,15662001,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 DF, UNK",,,D,, UNKNOWN,,,300.0,DF,INJECTION,,2019,Q3,Meningitis,,2019,Q3,4,F,20180419.0,20190812.0,20181127,20190813,EXP,,PHHY2018DE166582,SANDOZ,,71.0,YR,,M,Y,,,20190814.0,,MD,DE,DE,2019,Q3,Elderly
156620014,15662001,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 DF, UNK",,,D,, UNKNOWN,,,300.0,DF,INJECTION,,2019,Q3,Metastases to meninges,,2019,Q3,4,F,20180419.0,20190812.0,20181127,20190813,EXP,,PHHY2018DE166582,SANDOZ,,71.0,YR,,M,Y,,,20190814.0,,MD,DE,DE,2019,Q3,Elderly
156620014,15662001,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 DF, UNK",,,D,, UNKNOWN,,,300.0,DF,INJECTION,,2019,Q3,Retinal detachment,,2019,Q3,4,F,20180419.0,20190812.0,20181127,20190813,EXP,,PHHY2018DE166582,SANDOZ,,71.0,YR,,M,Y,,,20190814.0,,MD,DE,DE,2019,Q3,Elderly
156620014,15662001,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 DF, UNK",,,D,, UNKNOWN,,,300.0,DF,INJECTION,,2019,Q3,Retinopathy,,2019,Q3,4,F,20180419.0,20190812.0,20181127,20190813,EXP,,PHHY2018DE166582,SANDOZ,,71.0,YR,,M,Y,,,20190814.0,,MD,DE,DE,2019,Q3,Elderly
156620014,15662001,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 DF, UNK",,,D,, UNKNOWN,,,300.0,DF,INJECTION,,2019,Q3,Urosepsis,,2019,Q3,4,F,20180419.0,20190812.0,20181127,20190813,EXP,,PHHY2018DE166582,SANDOZ,,71.0,YR,,M,Y,,,20190814.0,,MD,DE,DE,2019,Q3,Elderly
157180253,15718025,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2019,Q3,Alopecia,,2019,Q3,3,F,20131205.0,20190704.0,20181213,20190711,PER,,US-SA-2018SA335812,SANOFI AVENTIS,,61.0,YR,A,F,Y,54.43,KG,20190711.0,,CN,US,US,2019,Q3,Adult
157391178,15739117,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,U,,,,,,,,2019,Q3,Arthritis,,2019,Q3,8,F,20181209.0,20190926.0,20181219,20190927,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20190927.0,,OT,SE,SE,2019,Q3,Elderly
157391178,15739117,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,U,,,,,,,,2019,Q3,Dysphagia,,2019,Q3,8,F,20181209.0,20190926.0,20181219,20190927,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20190927.0,,OT,SE,SE,2019,Q3,Elderly
157391178,15739117,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,U,,,,,,,,2019,Q3,Dyspnoea,,2019,Q3,8,F,20181209.0,20190926.0,20181219,20190927,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20190927.0,,OT,SE,SE,2019,Q3,Elderly
157391178,15739117,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,U,,,,,,,,2019,Q3,Fall,,2019,Q3,8,F,20181209.0,20190926.0,20181219,20190927,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20190927.0,,OT,SE,SE,2019,Q3,Elderly
157391178,15739117,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,U,,,,,,,,2019,Q3,Pain in extremity,,2019,Q3,8,F,20181209.0,20190926.0,20181219,20190927,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20190927.0,,OT,SE,SE,2019,Q3,Elderly
157391178,15739117,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,U,,,,,,,,2019,Q3,Scratch,,2019,Q3,8,F,20181209.0,20190926.0,20181219,20190927,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20190927.0,,OT,SE,SE,2019,Q3,Elderly
157391178,15739117,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,U,,,,,,,,2019,Q3,Subarachnoid haemorrhage,,2019,Q3,8,F,20181209.0,20190926.0,20181219,20190927,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20190927.0,,OT,SE,SE,2019,Q3,Elderly
157391178,15739117,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,U,,,,,,,,2019,Q3,Tachycardia,,2019,Q3,8,F,20181209.0,20190926.0,20181219,20190927,EXP,,SE-ACTELION-A-CH2018-183636,ACTELION,,82.0,YR,,M,Y,80.0,KG,20190927.0,,OT,SE,SE,2019,Q3,Elderly
157496584,15749658,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK (VIAL),,,,,,,,,,,,2019,Q3,Alopecia,,2019,Q3,4,F,20131205.0,20190708.0,20181221,20190718,PER,,US-PFIZER INC-2018524934,PFIZER,,62.0,YR,,F,Y,54.0,KG,20190718.0,,LW,US,US,2019,Q3,Adult
157496584,15749658,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK (VIAL),,,,,,,,,,,,2019,Q3,Hair colour changes,,2019,Q3,4,F,20131205.0,20190708.0,20181221,20190718,PER,,US-PFIZER INC-2018524934,PFIZER,,62.0,YR,,F,Y,54.0,KG,20190718.0,,LW,US,US,2019,Q3,Adult
157496584,15749658,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK (VIAL),,,,,,,,,,,,2019,Q3,Hair disorder,,2019,Q3,4,F,20131205.0,20190708.0,20181221,20190718,PER,,US-PFIZER INC-2018524934,PFIZER,,62.0,YR,,F,Y,54.0,KG,20190718.0,,LW,US,US,2019,Q3,Adult
157496584,15749658,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK (VIAL),,,,,,,,,,,,2019,Q3,Hair texture abnormal,,2019,Q3,4,F,20131205.0,20190708.0,20181221,20190718,PER,,US-PFIZER INC-2018524934,PFIZER,,62.0,YR,,F,Y,54.0,KG,20190718.0,,LW,US,US,2019,Q3,Adult
157496584,15749658,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK (VIAL),,,,,,,,,,,,2019,Q3,Madarosis,,2019,Q3,4,F,20131205.0,20190708.0,20181221,20190718,PER,,US-PFIZER INC-2018524934,PFIZER,,62.0,YR,,F,Y,54.0,KG,20190718.0,,LW,US,US,2019,Q3,Adult
157797727,15779772,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, UNK",,,U,,,,,1.0,DF,,,2019,Q3,Blood thyroid stimulating hormone increased,,2019,Q3,7,F,20181218.0,20190910.0,20190102,20190918,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-121478,BRISTOL MYERS SQUIBB,,64.0,YR,,M,Y,,,20190918.0,,CN,DE,DE,2019,Q3,Adult
157797727,15779772,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, UNK",,,U,,,,,1.0,DF,,,2019,Q3,Bronchial carcinoma,,2019,Q3,7,F,20181218.0,20190910.0,20190102,20190918,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-121478,BRISTOL MYERS SQUIBB,,64.0,YR,,M,Y,,,20190918.0,,CN,DE,DE,2019,Q3,Adult
157797727,15779772,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, UNK",,,U,,,,,1.0,DF,,,2019,Q3,Constipation,,2019,Q3,7,F,20181218.0,20190910.0,20190102,20190918,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-121478,BRISTOL MYERS SQUIBB,,64.0,YR,,M,Y,,,20190918.0,,CN,DE,DE,2019,Q3,Adult
157797727,15779772,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, UNK",,,U,,,,,1.0,DF,,,2019,Q3,Dry skin,,2019,Q3,7,F,20181218.0,20190910.0,20190102,20190918,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-121478,BRISTOL MYERS SQUIBB,,64.0,YR,,M,Y,,,20190918.0,,CN,DE,DE,2019,Q3,Adult
157797727,15779772,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, UNK",,,U,,,,,1.0,DF,,,2019,Q3,Epistaxis,,2019,Q3,7,F,20181218.0,20190910.0,20190102,20190918,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-121478,BRISTOL MYERS SQUIBB,,64.0,YR,,M,Y,,,20190918.0,,CN,DE,DE,2019,Q3,Adult
157797727,15779772,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, UNK",,,U,,,,,1.0,DF,,,2019,Q3,Fatigue,,2019,Q3,7,F,20181218.0,20190910.0,20190102,20190918,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-121478,BRISTOL MYERS SQUIBB,,64.0,YR,,M,Y,,,20190918.0,,CN,DE,DE,2019,Q3,Adult
157797727,15779772,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, UNK",,,U,,,,,1.0,DF,,,2019,Q3,Headache,,2019,Q3,7,F,20181218.0,20190910.0,20190102,20190918,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-121478,BRISTOL MYERS SQUIBB,,64.0,YR,,M,Y,,,20190918.0,,CN,DE,DE,2019,Q3,Adult
157797727,15779772,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, UNK",,,U,,,,,1.0,DF,,,2019,Q3,Myalgia,,2019,Q3,7,F,20181218.0,20190910.0,20190102,20190918,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-121478,BRISTOL MYERS SQUIBB,,64.0,YR,,M,Y,,,20190918.0,,CN,DE,DE,2019,Q3,Adult
157797727,15779772,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, UNK",,,U,,,,,1.0,DF,,,2019,Q3,Myocardial infarction,,2019,Q3,7,F,20181218.0,20190910.0,20190102,20190918,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-121478,BRISTOL MYERS SQUIBB,,64.0,YR,,M,Y,,,20190918.0,,CN,DE,DE,2019,Q3,Adult
157797727,15779772,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, UNK",,,U,,,,,1.0,DF,,,2019,Q3,Pulmonary oedema,,2019,Q3,7,F,20181218.0,20190910.0,20190102,20190918,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-121478,BRISTOL MYERS SQUIBB,,64.0,YR,,M,Y,,,20190918.0,,CN,DE,DE,2019,Q3,Adult
1578154110,15781541,20,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,INJECTION,TID,2019,Q3,Acute kidney injury,,2019,Q3,10,F,20181214.0,20190725.0,20190102,20190729,EXP,,US-CELGENEUS-USA-20181207775,CELGENE,,76.0,YR,,M,Y,100.0,KG,20190729.0,,OT,US,US,2019,Q3,Elderly
1578154110,15781541,20,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,INJECTION,TID,2019,Q3,Encephalopathy,,2019,Q3,10,F,20181214.0,20190725.0,20190102,20190729,EXP,,US-CELGENEUS-USA-20181207775,CELGENE,,76.0,YR,,M,Y,100.0,KG,20190729.0,,OT,US,US,2019,Q3,Elderly
1578154110,15781541,20,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,INJECTION,TID,2019,Q3,Nausea,,2019,Q3,10,F,20181214.0,20190725.0,20190102,20190729,EXP,,US-CELGENEUS-USA-20181207775,CELGENE,,76.0,YR,,M,Y,100.0,KG,20190729.0,,OT,US,US,2019,Q3,Elderly
1578154110,15781541,20,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,INJECTION,TID,2019,Q3,Respiratory failure,,2019,Q3,10,F,20181214.0,20190725.0,20190102,20190729,EXP,,US-CELGENEUS-USA-20181207775,CELGENE,,76.0,YR,,M,Y,100.0,KG,20190729.0,,OT,US,US,2019,Q3,Elderly
1578154110,15781541,20,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,100 UNITS/ML,,,,,,,,,,INJECTION,TID,2019,Q3,Sepsis,,2019,Q3,10,F,20181214.0,20190725.0,20190102,20190729,EXP,,US-CELGENEUS-USA-20181207775,CELGENE,,76.0,YR,,M,Y,100.0,KG,20190729.0,,OT,US,US,2019,Q3,Elderly
157827588,15782758,16,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"25/75, (25/75; PLUS 20U 20U/D)",,,U,,,,,40.0,IU,SOLUTION FOR INJECTION,QD,2019,Q3,Chest pain,,2019,Q3,8,F,,20190711.0,20190102,20190719,EXP,,PT-BAUSCH-BL-2018-036015,BAUSCH AND LOMB,,54.0,YR,,F,Y,,,20190719.0,,OT,PT,PT,2019,Q3,Adult
157827588,15782758,16,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"25/75, (25/75; PLUS 20U 20U/D)",,,U,,,,,40.0,IU,SOLUTION FOR INJECTION,QD,2019,Q3,Headache,,2019,Q3,8,F,,20190711.0,20190102,20190719,EXP,,PT-BAUSCH-BL-2018-036015,BAUSCH AND LOMB,,54.0,YR,,F,Y,,,20190719.0,,OT,PT,PT,2019,Q3,Adult
157827588,15782758,16,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"25/75, (25/75; PLUS 20U 20U/D)",,,U,,,,,40.0,IU,SOLUTION FOR INJECTION,QD,2019,Q3,Ischaemic stroke,,2019,Q3,8,F,,20190711.0,20190102,20190719,EXP,,PT-BAUSCH-BL-2018-036015,BAUSCH AND LOMB,,54.0,YR,,F,Y,,,20190719.0,,OT,PT,PT,2019,Q3,Adult
157911372,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q3,Abdominal pain,,2019,Q3,2,F,,20190618.0,20190104,20190701,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190701.0,,OT,CA,CA,2019,Q3,Adult
157911372,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q3,Abscess,,2019,Q3,2,F,,20190618.0,20190104,20190701,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190701.0,,OT,CA,CA,2019,Q3,Adult
157911372,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q3,Adrenal insufficiency,,2019,Q3,2,F,,20190618.0,20190104,20190701,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190701.0,,OT,CA,CA,2019,Q3,Adult
157911372,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q3,Alanine aminotransferase increased,,2019,Q3,2,F,,20190618.0,20190104,20190701,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190701.0,,OT,CA,CA,2019,Q3,Adult
157911372,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q3,Ascites,,2019,Q3,2,F,,20190618.0,20190104,20190701,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190701.0,,OT,CA,CA,2019,Q3,Adult
157911372,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q3,Asthenia,,2019,Q3,2,F,,20190618.0,20190104,20190701,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190701.0,,OT,CA,CA,2019,Q3,Adult
157911372,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q3,Blood alkaline phosphatase increased,,2019,Q3,2,F,,20190618.0,20190104,20190701,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190701.0,,OT,CA,CA,2019,Q3,Adult
157911372,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q3,Blood bilirubin increased,,2019,Q3,2,F,,20190618.0,20190104,20190701,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190701.0,,OT,CA,CA,2019,Q3,Adult
157911372,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q3,Blood potassium decreased,,2019,Q3,2,F,,20190618.0,20190104,20190701,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190701.0,,OT,CA,CA,2019,Q3,Adult
157911372,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q3,Blood pressure diastolic abnormal,,2019,Q3,2,F,,20190618.0,20190104,20190701,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190701.0,,OT,CA,CA,2019,Q3,Adult
157911372,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q3,Blood pressure increased,,2019,Q3,2,F,,20190618.0,20190104,20190701,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190701.0,,OT,CA,CA,2019,Q3,Adult
157911372,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q3,Depression,,2019,Q3,2,F,,20190618.0,20190104,20190701,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190701.0,,OT,CA,CA,2019,Q3,Adult
157911372,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q3,Diverticulitis,,2019,Q3,2,F,,20190618.0,20190104,20190701,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190701.0,,OT,CA,CA,2019,Q3,Adult
157911372,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q3,Endometrial disorder,,2019,Q3,2,F,,20190618.0,20190104,20190701,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190701.0,,OT,CA,CA,2019,Q3,Adult
157911372,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q3,Enterococcus test positive,,2019,Q3,2,F,,20190618.0,20190104,20190701,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190701.0,,OT,CA,CA,2019,Q3,Adult
157911372,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q3,Fibrosis,,2019,Q3,2,F,,20190618.0,20190104,20190701,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190701.0,,OT,CA,CA,2019,Q3,Adult
157911372,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q3,Gamma-glutamyltransferase increased,,2019,Q3,2,F,,20190618.0,20190104,20190701,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190701.0,,OT,CA,CA,2019,Q3,Adult
157911372,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q3,Gastrointestinal disorder,,2019,Q3,2,F,,20190618.0,20190104,20190701,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190701.0,,OT,CA,CA,2019,Q3,Adult
157911372,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q3,Generalised oedema,,2019,Q3,2,F,,20190618.0,20190104,20190701,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190701.0,,OT,CA,CA,2019,Q3,Adult
157911372,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q3,Heart rate increased,,2019,Q3,2,F,,20190618.0,20190104,20190701,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190701.0,,OT,CA,CA,2019,Q3,Adult
157911372,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q3,Hepatic congestion,,2019,Q3,2,F,,20190618.0,20190104,20190701,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190701.0,,OT,CA,CA,2019,Q3,Adult
157911372,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q3,Herpes zoster,,2019,Q3,2,F,,20190618.0,20190104,20190701,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190701.0,,OT,CA,CA,2019,Q3,Adult
157911372,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q3,Hypersensitivity,,2019,Q3,2,F,,20190618.0,20190104,20190701,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190701.0,,OT,CA,CA,2019,Q3,Adult
157911372,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q3,Hypoglycaemia,,2019,Q3,2,F,,20190618.0,20190104,20190701,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190701.0,,OT,CA,CA,2019,Q3,Adult
157911372,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q3,Hypotension,,2019,Q3,2,F,,20190618.0,20190104,20190701,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190701.0,,OT,CA,CA,2019,Q3,Adult
157911372,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q3,Increased appetite,,2019,Q3,2,F,,20190618.0,20190104,20190701,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190701.0,,OT,CA,CA,2019,Q3,Adult
157911372,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q3,Influenza,,2019,Q3,2,F,,20190618.0,20190104,20190701,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190701.0,,OT,CA,CA,2019,Q3,Adult
157911372,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q3,Infusion related reaction,,2019,Q3,2,F,,20190618.0,20190104,20190701,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190701.0,,OT,CA,CA,2019,Q3,Adult
157911372,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q3,Injection site extravasation,,2019,Q3,2,F,,20190618.0,20190104,20190701,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190701.0,,OT,CA,CA,2019,Q3,Adult
157911372,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q3,Intensive care unit acquired weakness,,2019,Q3,2,F,,20190618.0,20190104,20190701,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190701.0,,OT,CA,CA,2019,Q3,Adult
157911372,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q3,Intervertebral disc protrusion,,2019,Q3,2,F,,20190618.0,20190104,20190701,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190701.0,,OT,CA,CA,2019,Q3,Adult
157911372,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q3,Joint effusion,,2019,Q3,2,F,,20190618.0,20190104,20190701,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190701.0,,OT,CA,CA,2019,Q3,Adult
157911372,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q3,Joint swelling,,2019,Q3,2,F,,20190618.0,20190104,20190701,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190701.0,,OT,CA,CA,2019,Q3,Adult
157911372,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q3,Micturition disorder,,2019,Q3,2,F,,20190618.0,20190104,20190701,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190701.0,,OT,CA,CA,2019,Q3,Adult
157911372,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q3,Myelopathy,,2019,Q3,2,F,,20190618.0,20190104,20190701,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190701.0,,OT,CA,CA,2019,Q3,Adult
157911372,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q3,Myopathy,,2019,Q3,2,F,,20190618.0,20190104,20190701,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190701.0,,OT,CA,CA,2019,Q3,Adult
157911372,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q3,Nasopharyngitis,,2019,Q3,2,F,,20190618.0,20190104,20190701,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190701.0,,OT,CA,CA,2019,Q3,Adult
157911372,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q3,Nausea,,2019,Q3,2,F,,20190618.0,20190104,20190701,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190701.0,,OT,CA,CA,2019,Q3,Adult
157911372,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q3,Nerve compression,,2019,Q3,2,F,,20190618.0,20190104,20190701,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190701.0,,OT,CA,CA,2019,Q3,Adult
157911372,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q3,Neuropathy peripheral,,2019,Q3,2,F,,20190618.0,20190104,20190701,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190701.0,,OT,CA,CA,2019,Q3,Adult
157911372,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q3,Neutropenia,,2019,Q3,2,F,,20190618.0,20190104,20190701,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190701.0,,OT,CA,CA,2019,Q3,Adult
157911372,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q3,Osteoarthritis,,2019,Q3,2,F,,20190618.0,20190104,20190701,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190701.0,,OT,CA,CA,2019,Q3,Adult
157911372,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q3,Pancytopenia,,2019,Q3,2,F,,20190618.0,20190104,20190701,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190701.0,,OT,CA,CA,2019,Q3,Adult
157911372,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q3,Peripheral sensorimotor neuropathy,,2019,Q3,2,F,,20190618.0,20190104,20190701,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190701.0,,OT,CA,CA,2019,Q3,Adult
157911372,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q3,Peritonitis,,2019,Q3,2,F,,20190618.0,20190104,20190701,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190701.0,,OT,CA,CA,2019,Q3,Adult
157911372,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q3,Pneumonia,,2019,Q3,2,F,,20190618.0,20190104,20190701,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190701.0,,OT,CA,CA,2019,Q3,Adult
157911372,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q3,Pseudomonal bacteraemia,,2019,Q3,2,F,,20190618.0,20190104,20190701,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190701.0,,OT,CA,CA,2019,Q3,Adult
157911372,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q3,Rheumatoid arthritis,,2019,Q3,2,F,,20190618.0,20190104,20190701,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190701.0,,OT,CA,CA,2019,Q3,Adult
157911372,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q3,Septic shock,,2019,Q3,2,F,,20190618.0,20190104,20190701,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190701.0,,OT,CA,CA,2019,Q3,Adult
157911372,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q3,Therapeutic response decreased,,2019,Q3,2,F,,20190618.0,20190104,20190701,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190701.0,,OT,CA,CA,2019,Q3,Adult
157911372,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q3,Vomiting,,2019,Q3,2,F,,20190618.0,20190104,20190701,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190701.0,,OT,CA,CA,2019,Q3,Adult
157911372,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q3,Weight decreased,,2019,Q3,2,F,,20190618.0,20190104,20190701,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190701.0,,OT,CA,CA,2019,Q3,Adult
157911372,15791137,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, 3X/DAY",,,,,,,,,,,TID,2019,Q3,Weight increased,,2019,Q3,2,F,,20190618.0,20190104,20190701,EXP,,CA-PFIZER INC-2019001808,PFIZER,,62.0,YR,,F,Y,67.0,KG,20190701.0,,OT,CA,CA,2019,Q3,Adult
158391234,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q3,Acidosis,,2019,Q3,4,F,20160303.0,20190529.0,20190117,20190722,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190722.0,,MD,US,US,2019,Q3,Adult
158391234,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q3,Acute kidney injury,,2019,Q3,4,F,20160303.0,20190529.0,20190117,20190722,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190722.0,,MD,US,US,2019,Q3,Adult
158391234,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q3,Acute respiratory distress syndrome,,2019,Q3,4,F,20160303.0,20190529.0,20190117,20190722,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190722.0,,MD,US,US,2019,Q3,Adult
158391234,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q3,Alkalosis hypochloraemic,,2019,Q3,4,F,20160303.0,20190529.0,20190117,20190722,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190722.0,,MD,US,US,2019,Q3,Adult
158391234,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q3,Anaemia,,2019,Q3,4,F,20160303.0,20190529.0,20190117,20190722,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190722.0,,MD,US,US,2019,Q3,Adult
158391234,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q3,Asthenia,,2019,Q3,4,F,20160303.0,20190529.0,20190117,20190722,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190722.0,,MD,US,US,2019,Q3,Adult
158391234,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q3,Bandaemia,,2019,Q3,4,F,20160303.0,20190529.0,20190117,20190722,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190722.0,,MD,US,US,2019,Q3,Adult
158391234,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q3,Blood creatinine increased,,2019,Q3,4,F,20160303.0,20190529.0,20190117,20190722,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190722.0,,MD,US,US,2019,Q3,Adult
158391234,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q3,Blood urea increased,,2019,Q3,4,F,20160303.0,20190529.0,20190117,20190722,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190722.0,,MD,US,US,2019,Q3,Adult
158391234,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q3,Bronchial haemorrhage,,2019,Q3,4,F,20160303.0,20190529.0,20190117,20190722,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190722.0,,MD,US,US,2019,Q3,Adult
158391234,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q3,Bronchitis chronic,,2019,Q3,4,F,20160303.0,20190529.0,20190117,20190722,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190722.0,,MD,US,US,2019,Q3,Adult
158391234,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q3,Concomitant disease aggravated,,2019,Q3,4,F,20160303.0,20190529.0,20190117,20190722,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190722.0,,MD,US,US,2019,Q3,Adult
158391234,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q3,Constipation,,2019,Q3,4,F,20160303.0,20190529.0,20190117,20190722,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190722.0,,MD,US,US,2019,Q3,Adult
158391234,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q3,Cough,,2019,Q3,4,F,20160303.0,20190529.0,20190117,20190722,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190722.0,,MD,US,US,2019,Q3,Adult
158391234,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q3,Cystic fibrosis,,2019,Q3,4,F,20160303.0,20190529.0,20190117,20190722,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190722.0,,MD,US,US,2019,Q3,Adult
158391234,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q3,Diarrhoea,,2019,Q3,4,F,20160303.0,20190529.0,20190117,20190722,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190722.0,,MD,US,US,2019,Q3,Adult
158391234,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q3,Dysphagia,,2019,Q3,4,F,20160303.0,20190529.0,20190117,20190722,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190722.0,,MD,US,US,2019,Q3,Adult
158391234,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q3,Dyspnoea,,2019,Q3,4,F,20160303.0,20190529.0,20190117,20190722,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190722.0,,MD,US,US,2019,Q3,Adult
158391234,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q3,Fungal disease carrier,,2019,Q3,4,F,20160303.0,20190529.0,20190117,20190722,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190722.0,,MD,US,US,2019,Q3,Adult
158391234,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q3,Gastroenteritis norovirus,,2019,Q3,4,F,20160303.0,20190529.0,20190117,20190722,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190722.0,,MD,US,US,2019,Q3,Adult
158391234,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q3,Gastrointestinal disorder,,2019,Q3,4,F,20160303.0,20190529.0,20190117,20190722,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190722.0,,MD,US,US,2019,Q3,Adult
158391234,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q3,Generalised oedema,,2019,Q3,4,F,20160303.0,20190529.0,20190117,20190722,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190722.0,,MD,US,US,2019,Q3,Adult
158391234,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q3,Glucose tolerance impaired,,2019,Q3,4,F,20160303.0,20190529.0,20190117,20190722,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190722.0,,MD,US,US,2019,Q3,Adult
158391234,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q3,Granulocytosis,,2019,Q3,4,F,20160303.0,20190529.0,20190117,20190722,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190722.0,,MD,US,US,2019,Q3,Adult
158391234,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q3,Haematuria,,2019,Q3,4,F,20160303.0,20190529.0,20190117,20190722,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190722.0,,MD,US,US,2019,Q3,Adult
158391234,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q3,Haemoptysis,,2019,Q3,4,F,20160303.0,20190529.0,20190117,20190722,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190722.0,,MD,US,US,2019,Q3,Adult
158391234,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q3,Hypercapnia,,2019,Q3,4,F,20160303.0,20190529.0,20190117,20190722,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190722.0,,MD,US,US,2019,Q3,Adult
158391234,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q3,Hyperglycaemia,,2019,Q3,4,F,20160303.0,20190529.0,20190117,20190722,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190722.0,,MD,US,US,2019,Q3,Adult
158391234,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q3,Hypernatraemia,,2019,Q3,4,F,20160303.0,20190529.0,20190117,20190722,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190722.0,,MD,US,US,2019,Q3,Adult
158391234,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q3,Hypertension,,2019,Q3,4,F,20160303.0,20190529.0,20190117,20190722,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190722.0,,MD,US,US,2019,Q3,Adult
158391234,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q3,Hypertriglyceridaemia,,2019,Q3,4,F,20160303.0,20190529.0,20190117,20190722,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190722.0,,MD,US,US,2019,Q3,Adult
158391234,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q3,Hypervolaemia,,2019,Q3,4,F,20160303.0,20190529.0,20190117,20190722,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190722.0,,MD,US,US,2019,Q3,Adult
158391234,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q3,Hypokalaemia,,2019,Q3,4,F,20160303.0,20190529.0,20190117,20190722,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190722.0,,MD,US,US,2019,Q3,Adult
158391234,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q3,Hypoxia,,2019,Q3,4,F,20160303.0,20190529.0,20190117,20190722,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190722.0,,MD,US,US,2019,Q3,Adult
158391234,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q3,Ill-defined disorder,,2019,Q3,4,F,20160303.0,20190529.0,20190117,20190722,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190722.0,,MD,US,US,2019,Q3,Adult
158391234,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q3,Infective exacerbation of bronchiectasis,,2019,Q3,4,F,20160303.0,20190529.0,20190117,20190722,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190722.0,,MD,US,US,2019,Q3,Adult
158391234,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q3,Infective pulmonary exacerbation of cystic fibrosis,,2019,Q3,4,F,20160303.0,20190529.0,20190117,20190722,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190722.0,,MD,US,US,2019,Q3,Adult
158391234,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q3,Insomnia,,2019,Q3,4,F,20160303.0,20190529.0,20190117,20190722,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190722.0,,MD,US,US,2019,Q3,Adult
158391234,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q3,Intensive care unit acquired weakness,,2019,Q3,4,F,20160303.0,20190529.0,20190117,20190722,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190722.0,,MD,US,US,2019,Q3,Adult
158391234,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q3,Iron deficiency,,2019,Q3,4,F,20160303.0,20190529.0,20190117,20190722,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190722.0,,MD,US,US,2019,Q3,Adult
158391234,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q3,Leukocytosis,,2019,Q3,4,F,20160303.0,20190529.0,20190117,20190722,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190722.0,,MD,US,US,2019,Q3,Adult
158391234,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q3,Metabolic acidosis,,2019,Q3,4,F,20160303.0,20190529.0,20190117,20190722,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190722.0,,MD,US,US,2019,Q3,Adult
158391234,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q3,Muscle atrophy,,2019,Q3,4,F,20160303.0,20190529.0,20190117,20190722,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190722.0,,MD,US,US,2019,Q3,Adult
158391234,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q3,Paresis,,2019,Q3,4,F,20160303.0,20190529.0,20190117,20190722,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190722.0,,MD,US,US,2019,Q3,Adult
158391234,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q3,Pneumonia,,2019,Q3,4,F,20160303.0,20190529.0,20190117,20190722,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190722.0,,MD,US,US,2019,Q3,Adult
158391234,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q3,Pyrexia,,2019,Q3,4,F,20160303.0,20190529.0,20190117,20190722,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190722.0,,MD,US,US,2019,Q3,Adult
158391234,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q3,Respiratory failure,,2019,Q3,4,F,20160303.0,20190529.0,20190117,20190722,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190722.0,,MD,US,US,2019,Q3,Adult
158391234,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q3,Sepsis,,2019,Q3,4,F,20160303.0,20190529.0,20190117,20190722,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190722.0,,MD,US,US,2019,Q3,Adult
158391234,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q3,Stenotrophomonas test positive,,2019,Q3,4,F,20160303.0,20190529.0,20190117,20190722,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190722.0,,MD,US,US,2019,Q3,Adult
158391234,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q3,Tachycardia,,2019,Q3,4,F,20160303.0,20190529.0,20190117,20190722,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190722.0,,MD,US,US,2019,Q3,Adult
158391234,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q3,Thrombocytosis,,2019,Q3,4,F,20160303.0,20190529.0,20190117,20190722,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190722.0,,MD,US,US,2019,Q3,Adult
158391234,15839123,75,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"18 U, UNK",,,D,,,,,18.0,DF,,,2019,Q3,Weight decreased,,2019,Q3,4,F,20160303.0,20190529.0,20190117,20190722,EXP,,US-MYLANLABS-2018M1091264,MYLAN,,37.0,YR,,M,Y,68.44,KG,20190722.0,,MD,US,US,2019,Q3,Adult
158598873,15859887,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q3,Anaemia,,2019,Q3,3,F,20181231.0,20190717.0,20190123,20190729,EXP,,US-ACTELION-A-NJ2019-185248,ACTELION,,46.0,YR,,F,Y,63.49,KG,20190729.0,,OT,US,US,2019,Q3,Adult
158598873,15859887,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q3,Cough,,2019,Q3,3,F,20181231.0,20190717.0,20190123,20190729,EXP,,US-ACTELION-A-NJ2019-185248,ACTELION,,46.0,YR,,F,Y,63.49,KG,20190729.0,,OT,US,US,2019,Q3,Adult
158598873,15859887,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q3,Haemoptysis,,2019,Q3,3,F,20181231.0,20190717.0,20190123,20190729,EXP,,US-ACTELION-A-NJ2019-185248,ACTELION,,46.0,YR,,F,Y,63.49,KG,20190729.0,,OT,US,US,2019,Q3,Adult
158598873,15859887,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q3,Hospitalisation,,2019,Q3,3,F,20181231.0,20190717.0,20190123,20190729,EXP,,US-ACTELION-A-NJ2019-185248,ACTELION,,46.0,YR,,F,Y,63.49,KG,20190729.0,,OT,US,US,2019,Q3,Adult
158598873,15859887,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q3,Pneumothorax,,2019,Q3,3,F,20181231.0,20190717.0,20190123,20190729,EXP,,US-ACTELION-A-NJ2019-185248,ACTELION,,46.0,YR,,F,Y,63.49,KG,20190729.0,,OT,US,US,2019,Q3,Adult
158598873,15859887,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q3,Pulmonary haemorrhage,,2019,Q3,3,F,20181231.0,20190717.0,20190123,20190729,EXP,,US-ACTELION-A-NJ2019-185248,ACTELION,,46.0,YR,,F,Y,63.49,KG,20190729.0,,OT,US,US,2019,Q3,Adult
158598873,15859887,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q3,Pulmonary hypertension,,2019,Q3,3,F,20181231.0,20190717.0,20190123,20190729,EXP,,US-ACTELION-A-NJ2019-185248,ACTELION,,46.0,YR,,F,Y,63.49,KG,20190729.0,,OT,US,US,2019,Q3,Adult
158598873,15859887,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q3,Retching,,2019,Q3,3,F,20181231.0,20190717.0,20190123,20190729,EXP,,US-ACTELION-A-NJ2019-185248,ACTELION,,46.0,YR,,F,Y,63.49,KG,20190729.0,,OT,US,US,2019,Q3,Adult
158598873,15859887,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,U,,,,,,,,2019,Q3,Vomiting,,2019,Q3,3,F,20181231.0,20190717.0,20190123,20190729,EXP,,US-ACTELION-A-NJ2019-185248,ACTELION,,46.0,YR,,F,Y,63.49,KG,20190729.0,,OT,US,US,2019,Q3,Adult
158967095,15896709,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,2-10 UNITS,,,,,,,,,,,QID,2019,Q3,Haemarthrosis,,2019,Q3,5,F,20160907.0,20190712.0,20190131,20190719,PER,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-003759",BOEHRINGER INGELHEIM,,73.0,YR,,F,Y,77.11,KG,20190719.0,,CN,US,US,2019,Q3,Elderly
158967095,15896709,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,2-10 UNITS,,,,,,,,,,,QID,2019,Q3,Haematoma,,2019,Q3,5,F,20160907.0,20190712.0,20190131,20190719,PER,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-003759",BOEHRINGER INGELHEIM,,73.0,YR,,F,Y,77.11,KG,20190719.0,,CN,US,US,2019,Q3,Elderly
158967095,15896709,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,2-10 UNITS,,,,,,,,,,,QID,2019,Q3,Internal haemorrhage,,2019,Q3,5,F,20160907.0,20190712.0,20190131,20190719,PER,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-003759",BOEHRINGER INGELHEIM,,73.0,YR,,F,Y,77.11,KG,20190719.0,,CN,US,US,2019,Q3,Elderly
159384592,15938459,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q3,Loss of consciousness,,2019,Q3,2,F,20180808.0,20190622.0,20190208,20190701,EXP,,US-EISAI MEDICAL RESEARCH-EC-2019-051580,EISAI,,63.0,YR,,F,Y,129.4,KG,20190701.0,,MD,US,US,2019,Q3,Adult
159410375,15941037,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,DAILY DOSE: 100 UNIT/ML,,,,,,,,,,,,2019,Q3,Cerebellar haemorrhage,,2019,Q3,5,F,20160907.0,20190724.0,20190208,20190729,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-005921",BOEHRINGER INGELHEIM,,67.0,YR,,M,Y,122.92,KG,20190730.0,,CN,US,US,2019,Q3,Elderly
159410375,15941037,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,DAILY DOSE: 100 UNIT/ML,,,,,,,,,,,,2019,Q3,Chest pain,,2019,Q3,5,F,20160907.0,20190724.0,20190208,20190729,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-005921",BOEHRINGER INGELHEIM,,67.0,YR,,M,Y,122.92,KG,20190730.0,,CN,US,US,2019,Q3,Elderly
159410375,15941037,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,DAILY DOSE: 100 UNIT/ML,,,,,,,,,,,,2019,Q3,Dyspnoea,,2019,Q3,5,F,20160907.0,20190724.0,20190208,20190729,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-005921",BOEHRINGER INGELHEIM,,67.0,YR,,M,Y,122.92,KG,20190730.0,,CN,US,US,2019,Q3,Elderly
159410375,15941037,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,DAILY DOSE: 100 UNIT/ML,,,,,,,,,,,,2019,Q3,Hemiataxia,,2019,Q3,5,F,20160907.0,20190724.0,20190208,20190729,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-005921",BOEHRINGER INGELHEIM,,67.0,YR,,M,Y,122.92,KG,20190730.0,,CN,US,US,2019,Q3,Elderly
159427445,15942744,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q3,Acute kidney injury,,2019,Q3,5,F,201606.0,20190923.0,20190209,20190927,EXP,,US-ASTRAZENECA-2018SF22217,ASTRAZENECA,,911.0,MON,,M,Y,,,20190927.0,,,US,US,2019,Q3,Elderly
159427445,15942744,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q3,Chronic kidney disease,,2019,Q3,5,F,201606.0,20190923.0,20190209,20190927,EXP,,US-ASTRAZENECA-2018SF22217,ASTRAZENECA,,911.0,MON,,M,Y,,,20190927.0,,,US,US,2019,Q3,Elderly
159427445,15942744,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q3,Renal failure,,2019,Q3,5,F,201606.0,20190923.0,20190209,20190927,EXP,,US-ASTRAZENECA-2018SF22217,ASTRAZENECA,,911.0,MON,,M,Y,,,20190927.0,,,US,US,2019,Q3,Elderly
159427445,15942744,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q3,Renal injury,,2019,Q3,5,F,201606.0,20190923.0,20190209,20190927,EXP,,US-ASTRAZENECA-2018SF22217,ASTRAZENECA,,911.0,MON,,M,Y,,,20190927.0,,,US,US,2019,Q3,Elderly
159692515,15969251,8,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2019,Q3,Diabetic ketoacidosis,,2019,Q3,5,F,20190204.0,20190816.0,20190215,20190820,EXP,,US-TAKEDA-2019TUS006283,TAKEDA,,77.0,YR,,M,Y,90.0,KG,20190820.0,,MD,US,US,2019,Q3,Elderly
1601002813,16010028,15,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 IU, QD (QD (25/75: + 20U 20U / D))",,,U,, UNK,,,40.0,IU,SOLUTION FOR INJECTION,QD,2019,Q3,Chest pain,,2019,Q3,13,F,,20190717.0,20190225,20190729,EXP,,PT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-112421,BRISTOL MYERS SQUIBB,,54.0,YR,,F,Y,110.0,KG,20190729.0,,CN,PT,PT,2019,Q3,Adult
1601002813,16010028,15,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 IU, QD (QD (25/75: + 20U 20U / D))",,,U,, UNK,,,40.0,IU,SOLUTION FOR INJECTION,QD,2019,Q3,Headache,,2019,Q3,13,F,,20190717.0,20190225,20190729,EXP,,PT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-112421,BRISTOL MYERS SQUIBB,,54.0,YR,,F,Y,110.0,KG,20190729.0,,CN,PT,PT,2019,Q3,Adult
1601002813,16010028,15,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 IU, QD (QD (25/75: + 20U 20U / D))",,,U,, UNK,,,40.0,IU,SOLUTION FOR INJECTION,QD,2019,Q3,Infection,,2019,Q3,13,F,,20190717.0,20190225,20190729,EXP,,PT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-112421,BRISTOL MYERS SQUIBB,,54.0,YR,,F,Y,110.0,KG,20190729.0,,CN,PT,PT,2019,Q3,Adult
1601002813,16010028,15,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 IU, QD (QD (25/75: + 20U 20U / D))",,,U,, UNK,,,40.0,IU,SOLUTION FOR INJECTION,QD,2019,Q3,Ischaemic stroke,,2019,Q3,13,F,,20190717.0,20190225,20190729,EXP,,PT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-112421,BRISTOL MYERS SQUIBB,,54.0,YR,,F,Y,110.0,KG,20190729.0,,CN,PT,PT,2019,Q3,Adult
160344642,16034464,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2019,Q3,Therapeutic product effect incomplete,,2019,Q3,2,F,,20190813.0,20190305,20190819,PER,,US-PFIZER INC-2016521477,PFIZER,,81.0,YR,,F,Y,80.73,KG,20190819.0,,MD,US,US,2019,Q3,Elderly
160561432,16056143,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"1.5-5-1.5, TID",,,,,,,,,,,Q8H,2019,Q3,Diabetes mellitus inadequate control,,2019,Q3,2,F,20190218.0,20190620.0,20190311,20190704,EXP,,EG-SA-2019SA062025,SANOFI AVENTIS,,5.0,YR,C,M,Y,,,20190704.0,,CN,EG,EG,2019,Q3,Child
160561432,16056143,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"1.5-5-1.5, TID",,,,,,,,,,,Q8H,2019,Q3,Hyperglycaemia,,2019,Q3,2,F,20190218.0,20190620.0,20190311,20190704,EXP,,EG-SA-2019SA062025,SANOFI AVENTIS,,5.0,YR,C,M,Y,,,20190704.0,,CN,EG,EG,2019,Q3,Child
160561432,16056143,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"1.5-5-1.5, TID",,,,,,,,,,,Q8H,2019,Q3,Product use issue,,2019,Q3,2,F,20190218.0,20190620.0,20190311,20190704,EXP,,EG-SA-2019SA062025,SANOFI AVENTIS,,5.0,YR,C,M,Y,,,20190704.0,,CN,EG,EG,2019,Q3,Child
160561432,16056143,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"1.5-5-1.5, TID",,,,,,,,,,,Q8H,2019,Q3,Seizure,,2019,Q3,2,F,20190218.0,20190620.0,20190311,20190704,EXP,,EG-SA-2019SA062025,SANOFI AVENTIS,,5.0,YR,C,M,Y,,,20190704.0,,CN,EG,EG,2019,Q3,Child
160654473,16065447,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q3,Abdominal distension,,2019,Q3,3,F,201708.0,20190605.0,20190313,20190906,EXP,,US-SA-2019SA066355,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20190906.0,,OT,US,US,2019,Q3,Young Adult
160654473,16065447,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q3,Abdominal pain,,2019,Q3,3,F,201708.0,20190605.0,20190313,20190906,EXP,,US-SA-2019SA066355,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20190906.0,,OT,US,US,2019,Q3,Young Adult
160654473,16065447,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q3,Ascites,,2019,Q3,3,F,201708.0,20190605.0,20190313,20190906,EXP,,US-SA-2019SA066355,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20190906.0,,OT,US,US,2019,Q3,Young Adult
160654473,16065447,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q3,Back pain,,2019,Q3,3,F,201708.0,20190605.0,20190313,20190906,EXP,,US-SA-2019SA066355,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20190906.0,,OT,US,US,2019,Q3,Young Adult
160654473,16065447,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q3,Blood pressure systolic decreased,,2019,Q3,3,F,201708.0,20190605.0,20190313,20190906,EXP,,US-SA-2019SA066355,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20190906.0,,OT,US,US,2019,Q3,Young Adult
160654473,16065447,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q3,Cough,,2019,Q3,3,F,201708.0,20190605.0,20190313,20190906,EXP,,US-SA-2019SA066355,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20190906.0,,OT,US,US,2019,Q3,Young Adult
160654473,16065447,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q3,Cytogenetic abnormality,,2019,Q3,3,F,201708.0,20190605.0,20190313,20190906,EXP,,US-SA-2019SA066355,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20190906.0,,OT,US,US,2019,Q3,Young Adult
160654473,16065447,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q3,Cytomegalovirus viraemia,,2019,Q3,3,F,201708.0,20190605.0,20190313,20190906,EXP,,US-SA-2019SA066355,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20190906.0,,OT,US,US,2019,Q3,Young Adult
160654473,16065447,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q3,Decreased appetite,,2019,Q3,3,F,201708.0,20190605.0,20190313,20190906,EXP,,US-SA-2019SA066355,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20190906.0,,OT,US,US,2019,Q3,Young Adult
160654473,16065447,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q3,Diarrhoea,,2019,Q3,3,F,201708.0,20190605.0,20190313,20190906,EXP,,US-SA-2019SA066355,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20190906.0,,OT,US,US,2019,Q3,Young Adult
160654473,16065447,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q3,Dyspepsia,,2019,Q3,3,F,201708.0,20190605.0,20190313,20190906,EXP,,US-SA-2019SA066355,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20190906.0,,OT,US,US,2019,Q3,Young Adult
160654473,16065447,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q3,Dyspnoea,,2019,Q3,3,F,201708.0,20190605.0,20190313,20190906,EXP,,US-SA-2019SA066355,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20190906.0,,OT,US,US,2019,Q3,Young Adult
160654473,16065447,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q3,Gastritis,,2019,Q3,3,F,201708.0,20190605.0,20190313,20190906,EXP,,US-SA-2019SA066355,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20190906.0,,OT,US,US,2019,Q3,Young Adult
160654473,16065447,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q3,Hypotension,,2019,Q3,3,F,201708.0,20190605.0,20190313,20190906,EXP,,US-SA-2019SA066355,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20190906.0,,OT,US,US,2019,Q3,Young Adult
160654473,16065447,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q3,Hypoxia,,2019,Q3,3,F,201708.0,20190605.0,20190313,20190906,EXP,,US-SA-2019SA066355,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20190906.0,,OT,US,US,2019,Q3,Young Adult
160654473,16065447,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q3,Lung consolidation,,2019,Q3,3,F,201708.0,20190605.0,20190313,20190906,EXP,,US-SA-2019SA066355,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20190906.0,,OT,US,US,2019,Q3,Young Adult
160654473,16065447,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q3,Malnutrition,,2019,Q3,3,F,201708.0,20190605.0,20190313,20190906,EXP,,US-SA-2019SA066355,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20190906.0,,OT,US,US,2019,Q3,Young Adult
160654473,16065447,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q3,Metastatic gastric cancer,,2019,Q3,3,F,201708.0,20190605.0,20190313,20190906,EXP,,US-SA-2019SA066355,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20190906.0,,OT,US,US,2019,Q3,Young Adult
160654473,16065447,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q3,Pneumonia,,2019,Q3,3,F,201708.0,20190605.0,20190313,20190906,EXP,,US-SA-2019SA066355,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20190906.0,,OT,US,US,2019,Q3,Young Adult
160654473,16065447,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q3,Product use in unapproved indication,,2019,Q3,3,F,201708.0,20190605.0,20190313,20190906,EXP,,US-SA-2019SA066355,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20190906.0,,OT,US,US,2019,Q3,Young Adult
160654473,16065447,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q3,Pulmonary embolism,,2019,Q3,3,F,201708.0,20190605.0,20190313,20190906,EXP,,US-SA-2019SA066355,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20190906.0,,OT,US,US,2019,Q3,Young Adult
160654473,16065447,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q3,Tachycardia,,2019,Q3,3,F,201708.0,20190605.0,20190313,20190906,EXP,,US-SA-2019SA066355,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20190906.0,,OT,US,US,2019,Q3,Young Adult
161175385,16117538,8,C,Insulin Lispro,INSULIN LISPRO,1,Other,,,,,,,,,,,SOLUTION,,2019,Q3,Skin lesion,,2019,Q3,5,F,20180917.0,20190913.0,20190326,20190919,EXP,,US-CELGENEUS-USA-20190307369,CELGENE,,75.0,YR,,M,Y,135.0,KG,20190919.0,,OT,US,US,2019,Q3,Elderly
161175385,16117538,8,C,Insulin Lispro,INSULIN LISPRO,1,Other,,,,,,,,,,,SOLUTION,,2019,Q3,Thrombosis,,2019,Q3,5,F,20180917.0,20190913.0,20190326,20190919,EXP,,US-CELGENEUS-USA-20190307369,CELGENE,,75.0,YR,,M,Y,135.0,KG,20190919.0,,OT,US,US,2019,Q3,Elderly
161236885,16123688,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q3,Acute kidney injury,,2019,Q3,5,F,2018.0,20190920.0,20190327,20190926,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"GOUVEIA C. C, DUQUE S. CAMPOS L. LIPOTHYMIA DUE TO HYPOVOLAEMIA - A CASE OF IATROGENESIS TO EMPAGLIFLOZINE. REVISTA PORTUGUESA DE DIABETES. 2019;14 (1):74",71.0,YR,,M,Y,,,20190926.0,,MD,PT,PT,2019,Q3,Elderly
161236885,16123688,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q3,Arrhythmia,,2019,Q3,5,F,2018.0,20190920.0,20190327,20190926,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"GOUVEIA C. C, DUQUE S. CAMPOS L. LIPOTHYMIA DUE TO HYPOVOLAEMIA - A CASE OF IATROGENESIS TO EMPAGLIFLOZINE. REVISTA PORTUGUESA DE DIABETES. 2019;14 (1):74",71.0,YR,,M,Y,,,20190926.0,,MD,PT,PT,2019,Q3,Elderly
161236885,16123688,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q3,Atrial fibrillation,,2019,Q3,5,F,2018.0,20190920.0,20190327,20190926,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"GOUVEIA C. C, DUQUE S. CAMPOS L. LIPOTHYMIA DUE TO HYPOVOLAEMIA - A CASE OF IATROGENESIS TO EMPAGLIFLOZINE. REVISTA PORTUGUESA DE DIABETES. 2019;14 (1):74",71.0,YR,,M,Y,,,20190926.0,,MD,PT,PT,2019,Q3,Elderly
161236885,16123688,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q3,Bradycardia,,2019,Q3,5,F,2018.0,20190920.0,20190327,20190926,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"GOUVEIA C. C, DUQUE S. CAMPOS L. LIPOTHYMIA DUE TO HYPOVOLAEMIA - A CASE OF IATROGENESIS TO EMPAGLIFLOZINE. REVISTA PORTUGUESA DE DIABETES. 2019;14 (1):74",71.0,YR,,M,Y,,,20190926.0,,MD,PT,PT,2019,Q3,Elderly
161236885,16123688,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q3,Dehydration,,2019,Q3,5,F,2018.0,20190920.0,20190327,20190926,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"GOUVEIA C. C, DUQUE S. CAMPOS L. LIPOTHYMIA DUE TO HYPOVOLAEMIA - A CASE OF IATROGENESIS TO EMPAGLIFLOZINE. REVISTA PORTUGUESA DE DIABETES. 2019;14 (1):74",71.0,YR,,M,Y,,,20190926.0,,MD,PT,PT,2019,Q3,Elderly
161236885,16123688,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q3,Dizziness,,2019,Q3,5,F,2018.0,20190920.0,20190327,20190926,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"GOUVEIA C. C, DUQUE S. CAMPOS L. LIPOTHYMIA DUE TO HYPOVOLAEMIA - A CASE OF IATROGENESIS TO EMPAGLIFLOZINE. REVISTA PORTUGUESA DE DIABETES. 2019;14 (1):74",71.0,YR,,M,Y,,,20190926.0,,MD,PT,PT,2019,Q3,Elderly
161236885,16123688,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q3,Drug interaction,,2019,Q3,5,F,2018.0,20190920.0,20190327,20190926,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"GOUVEIA C. C, DUQUE S. CAMPOS L. LIPOTHYMIA DUE TO HYPOVOLAEMIA - A CASE OF IATROGENESIS TO EMPAGLIFLOZINE. REVISTA PORTUGUESA DE DIABETES. 2019;14 (1):74",71.0,YR,,M,Y,,,20190926.0,,MD,PT,PT,2019,Q3,Elderly
161236885,16123688,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q3,Haematocrit increased,,2019,Q3,5,F,2018.0,20190920.0,20190327,20190926,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"GOUVEIA C. C, DUQUE S. CAMPOS L. LIPOTHYMIA DUE TO HYPOVOLAEMIA - A CASE OF IATROGENESIS TO EMPAGLIFLOZINE. REVISTA PORTUGUESA DE DIABETES. 2019;14 (1):74",71.0,YR,,M,Y,,,20190926.0,,MD,PT,PT,2019,Q3,Elderly
161236885,16123688,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q3,Haemoglobin increased,,2019,Q3,5,F,2018.0,20190920.0,20190327,20190926,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"GOUVEIA C. C, DUQUE S. CAMPOS L. LIPOTHYMIA DUE TO HYPOVOLAEMIA - A CASE OF IATROGENESIS TO EMPAGLIFLOZINE. REVISTA PORTUGUESA DE DIABETES. 2019;14 (1):74",71.0,YR,,M,Y,,,20190926.0,,MD,PT,PT,2019,Q3,Elderly
161236885,16123688,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q3,Heart rate irregular,,2019,Q3,5,F,2018.0,20190920.0,20190327,20190926,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"GOUVEIA C. C, DUQUE S. CAMPOS L. LIPOTHYMIA DUE TO HYPOVOLAEMIA - A CASE OF IATROGENESIS TO EMPAGLIFLOZINE. REVISTA PORTUGUESA DE DIABETES. 2019;14 (1):74",71.0,YR,,M,Y,,,20190926.0,,MD,PT,PT,2019,Q3,Elderly
161236885,16123688,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q3,Hypotension,,2019,Q3,5,F,2018.0,20190920.0,20190327,20190926,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"GOUVEIA C. C, DUQUE S. CAMPOS L. LIPOTHYMIA DUE TO HYPOVOLAEMIA - A CASE OF IATROGENESIS TO EMPAGLIFLOZINE. REVISTA PORTUGUESA DE DIABETES. 2019;14 (1):74",71.0,YR,,M,Y,,,20190926.0,,MD,PT,PT,2019,Q3,Elderly
161236885,16123688,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q3,Hypovolaemia,,2019,Q3,5,F,2018.0,20190920.0,20190327,20190926,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"GOUVEIA C. C, DUQUE S. CAMPOS L. LIPOTHYMIA DUE TO HYPOVOLAEMIA - A CASE OF IATROGENESIS TO EMPAGLIFLOZINE. REVISTA PORTUGUESA DE DIABETES. 2019;14 (1):74",71.0,YR,,M,Y,,,20190926.0,,MD,PT,PT,2019,Q3,Elderly
161236885,16123688,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q3,Left atrial dilatation,,2019,Q3,5,F,2018.0,20190920.0,20190327,20190926,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"GOUVEIA C. C, DUQUE S. CAMPOS L. LIPOTHYMIA DUE TO HYPOVOLAEMIA - A CASE OF IATROGENESIS TO EMPAGLIFLOZINE. REVISTA PORTUGUESA DE DIABETES. 2019;14 (1):74",71.0,YR,,M,Y,,,20190926.0,,MD,PT,PT,2019,Q3,Elderly
161236885,16123688,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q3,Mucosal dryness,,2019,Q3,5,F,2018.0,20190920.0,20190327,20190926,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"GOUVEIA C. C, DUQUE S. CAMPOS L. LIPOTHYMIA DUE TO HYPOVOLAEMIA - A CASE OF IATROGENESIS TO EMPAGLIFLOZINE. REVISTA PORTUGUESA DE DIABETES. 2019;14 (1):74",71.0,YR,,M,Y,,,20190926.0,,MD,PT,PT,2019,Q3,Elderly
161236885,16123688,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q3,Presyncope,,2019,Q3,5,F,2018.0,20190920.0,20190327,20190926,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"GOUVEIA C. C, DUQUE S. CAMPOS L. LIPOTHYMIA DUE TO HYPOVOLAEMIA - A CASE OF IATROGENESIS TO EMPAGLIFLOZINE. REVISTA PORTUGUESA DE DIABETES. 2019;14 (1):74",71.0,YR,,M,Y,,,20190926.0,,MD,PT,PT,2019,Q3,Elderly
161236885,16123688,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q3,Skin disorder,,2019,Q3,5,F,2018.0,20190920.0,20190327,20190926,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"GOUVEIA C. C, DUQUE S. CAMPOS L. LIPOTHYMIA DUE TO HYPOVOLAEMIA - A CASE OF IATROGENESIS TO EMPAGLIFLOZINE. REVISTA PORTUGUESA DE DIABETES. 2019;14 (1):74",71.0,YR,,M,Y,,,20190926.0,,MD,PT,PT,2019,Q3,Elderly
161236885,16123688,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q3,Syncope,,2019,Q3,5,F,2018.0,20190920.0,20190327,20190926,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"GOUVEIA C. C, DUQUE S. CAMPOS L. LIPOTHYMIA DUE TO HYPOVOLAEMIA - A CASE OF IATROGENESIS TO EMPAGLIFLOZINE. REVISTA PORTUGUESA DE DIABETES. 2019;14 (1):74",71.0,YR,,M,Y,,,20190926.0,,MD,PT,PT,2019,Q3,Elderly
161363223,16136322,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q3,Acute kidney injury,,2019,Q3,3,F,,20190802.0,20190329,20190809,EXP,,PT-ASTRAZENECA-2019SE49086,ASTRAZENECA,,71.0,YR,,M,Y,,,20190809.0,,OT,PT,PT,2019,Q3,Elderly
161363223,16136322,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q3,Arrhythmia,,2019,Q3,3,F,,20190802.0,20190329,20190809,EXP,,PT-ASTRAZENECA-2019SE49086,ASTRAZENECA,,71.0,YR,,M,Y,,,20190809.0,,OT,PT,PT,2019,Q3,Elderly
161363223,16136322,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q3,Atrial fibrillation,,2019,Q3,3,F,,20190802.0,20190329,20190809,EXP,,PT-ASTRAZENECA-2019SE49086,ASTRAZENECA,,71.0,YR,,M,Y,,,20190809.0,,OT,PT,PT,2019,Q3,Elderly
161363223,16136322,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q3,Bradycardia,,2019,Q3,3,F,,20190802.0,20190329,20190809,EXP,,PT-ASTRAZENECA-2019SE49086,ASTRAZENECA,,71.0,YR,,M,Y,,,20190809.0,,OT,PT,PT,2019,Q3,Elderly
161363223,16136322,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q3,Dehydration,,2019,Q3,3,F,,20190802.0,20190329,20190809,EXP,,PT-ASTRAZENECA-2019SE49086,ASTRAZENECA,,71.0,YR,,M,Y,,,20190809.0,,OT,PT,PT,2019,Q3,Elderly
161363223,16136322,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q3,Dizziness,,2019,Q3,3,F,,20190802.0,20190329,20190809,EXP,,PT-ASTRAZENECA-2019SE49086,ASTRAZENECA,,71.0,YR,,M,Y,,,20190809.0,,OT,PT,PT,2019,Q3,Elderly
161363223,16136322,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q3,Haematocrit increased,,2019,Q3,3,F,,20190802.0,20190329,20190809,EXP,,PT-ASTRAZENECA-2019SE49086,ASTRAZENECA,,71.0,YR,,M,Y,,,20190809.0,,OT,PT,PT,2019,Q3,Elderly
161363223,16136322,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q3,Haemoglobin increased,,2019,Q3,3,F,,20190802.0,20190329,20190809,EXP,,PT-ASTRAZENECA-2019SE49086,ASTRAZENECA,,71.0,YR,,M,Y,,,20190809.0,,OT,PT,PT,2019,Q3,Elderly
161363223,16136322,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q3,Hypotension,,2019,Q3,3,F,,20190802.0,20190329,20190809,EXP,,PT-ASTRAZENECA-2019SE49086,ASTRAZENECA,,71.0,YR,,M,Y,,,20190809.0,,OT,PT,PT,2019,Q3,Elderly
161363223,16136322,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q3,Hypovolaemia,,2019,Q3,3,F,,20190802.0,20190329,20190809,EXP,,PT-ASTRAZENECA-2019SE49086,ASTRAZENECA,,71.0,YR,,M,Y,,,20190809.0,,OT,PT,PT,2019,Q3,Elderly
161363223,16136322,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q3,Left atrial dilatation,,2019,Q3,3,F,,20190802.0,20190329,20190809,EXP,,PT-ASTRAZENECA-2019SE49086,ASTRAZENECA,,71.0,YR,,M,Y,,,20190809.0,,OT,PT,PT,2019,Q3,Elderly
161363223,16136322,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q3,Mucosal dryness,,2019,Q3,3,F,,20190802.0,20190329,20190809,EXP,,PT-ASTRAZENECA-2019SE49086,ASTRAZENECA,,71.0,YR,,M,Y,,,20190809.0,,OT,PT,PT,2019,Q3,Elderly
161363223,16136322,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q3,Presyncope,,2019,Q3,3,F,,20190802.0,20190329,20190809,EXP,,PT-ASTRAZENECA-2019SE49086,ASTRAZENECA,,71.0,YR,,M,Y,,,20190809.0,,OT,PT,PT,2019,Q3,Elderly
161363223,16136322,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q3,Skin disorder,,2019,Q3,3,F,,20190802.0,20190329,20190809,EXP,,PT-ASTRAZENECA-2019SE49086,ASTRAZENECA,,71.0,YR,,M,Y,,,20190809.0,,OT,PT,PT,2019,Q3,Elderly
161363223,16136322,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q3,Syncope,,2019,Q3,3,F,,20190802.0,20190329,20190809,EXP,,PT-ASTRAZENECA-2019SE49086,ASTRAZENECA,,71.0,YR,,M,Y,,,20190809.0,,OT,PT,PT,2019,Q3,Elderly
161548646,16154864,1,PS,Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,20563.0,,,,,2019,Q3,Acute kidney injury,,2019,Q3,6,F,2018.0,20190801.0,20190403,20190809,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20190809.0,,CN,PT,PT,2019,Q3,Elderly
161548646,16154864,1,PS,Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,20563.0,,,,,2019,Q3,Arrhythmia,,2019,Q3,6,F,2018.0,20190801.0,20190403,20190809,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20190809.0,,CN,PT,PT,2019,Q3,Elderly
161548646,16154864,1,PS,Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,20563.0,,,,,2019,Q3,Atrial fibrillation,,2019,Q3,6,F,2018.0,20190801.0,20190403,20190809,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20190809.0,,CN,PT,PT,2019,Q3,Elderly
161548646,16154864,1,PS,Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,20563.0,,,,,2019,Q3,Bradycardia,,2019,Q3,6,F,2018.0,20190801.0,20190403,20190809,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20190809.0,,CN,PT,PT,2019,Q3,Elderly
161548646,16154864,1,PS,Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,20563.0,,,,,2019,Q3,Dehydration,,2019,Q3,6,F,2018.0,20190801.0,20190403,20190809,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20190809.0,,CN,PT,PT,2019,Q3,Elderly
161548646,16154864,1,PS,Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,20563.0,,,,,2019,Q3,Dizziness,,2019,Q3,6,F,2018.0,20190801.0,20190403,20190809,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20190809.0,,CN,PT,PT,2019,Q3,Elderly
161548646,16154864,1,PS,Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,20563.0,,,,,2019,Q3,Haematocrit increased,,2019,Q3,6,F,2018.0,20190801.0,20190403,20190809,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20190809.0,,CN,PT,PT,2019,Q3,Elderly
161548646,16154864,1,PS,Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,20563.0,,,,,2019,Q3,Haemoglobin increased,,2019,Q3,6,F,2018.0,20190801.0,20190403,20190809,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20190809.0,,CN,PT,PT,2019,Q3,Elderly
161548646,16154864,1,PS,Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,20563.0,,,,,2019,Q3,Hypotension,,2019,Q3,6,F,2018.0,20190801.0,20190403,20190809,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20190809.0,,CN,PT,PT,2019,Q3,Elderly
161548646,16154864,1,PS,Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,20563.0,,,,,2019,Q3,Hypovolaemia,,2019,Q3,6,F,2018.0,20190801.0,20190403,20190809,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20190809.0,,CN,PT,PT,2019,Q3,Elderly
161548646,16154864,1,PS,Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,20563.0,,,,,2019,Q3,Left atrial dilatation,,2019,Q3,6,F,2018.0,20190801.0,20190403,20190809,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20190809.0,,CN,PT,PT,2019,Q3,Elderly
161548646,16154864,1,PS,Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,20563.0,,,,,2019,Q3,Mucosal dryness,,2019,Q3,6,F,2018.0,20190801.0,20190403,20190809,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20190809.0,,CN,PT,PT,2019,Q3,Elderly
161548646,16154864,1,PS,Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,20563.0,,,,,2019,Q3,Presyncope,,2019,Q3,6,F,2018.0,20190801.0,20190403,20190809,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20190809.0,,CN,PT,PT,2019,Q3,Elderly
161548646,16154864,1,PS,Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,20563.0,,,,,2019,Q3,Skin disorder,,2019,Q3,6,F,2018.0,20190801.0,20190403,20190809,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20190809.0,,CN,PT,PT,2019,Q3,Elderly
161548646,16154864,1,PS,Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,20563.0,,,,,2019,Q3,Syncope,,2019,Q3,6,F,2018.0,20190801.0,20190403,20190809,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201904001123,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20190809.0,,CN,PT,PT,2019,Q3,Elderly
1615902916,16159029,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2019,Q3,Abdominal pain,,2019,Q3,16,F,20190102.0,20190924.0,20190404,20190930,EXP,,PHHO2019US000774,SANDOZ,,51.0,YR,,M,Y,83.5,KG,20190930.0,,OT,US,US,2019,Q3,Adult
1615902916,16159029,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2019,Q3,Acute kidney injury,,2019,Q3,16,F,20190102.0,20190924.0,20190404,20190930,EXP,,PHHO2019US000774,SANDOZ,,51.0,YR,,M,Y,83.5,KG,20190930.0,,OT,US,US,2019,Q3,Adult
1615902916,16159029,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2019,Q3,Anaemia,,2019,Q3,16,F,20190102.0,20190924.0,20190404,20190930,EXP,,PHHO2019US000774,SANDOZ,,51.0,YR,,M,Y,83.5,KG,20190930.0,,OT,US,US,2019,Q3,Adult
1615902916,16159029,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2019,Q3,Chondrocalcinosis pyrophosphate,,2019,Q3,16,F,20190102.0,20190924.0,20190404,20190930,EXP,,PHHO2019US000774,SANDOZ,,51.0,YR,,M,Y,83.5,KG,20190930.0,,OT,US,US,2019,Q3,Adult
1615902916,16159029,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2019,Q3,Chronic kidney disease,,2019,Q3,16,F,20190102.0,20190924.0,20190404,20190930,EXP,,PHHO2019US000774,SANDOZ,,51.0,YR,,M,Y,83.5,KG,20190930.0,,OT,US,US,2019,Q3,Adult
1615902916,16159029,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2019,Q3,Diarrhoea,,2019,Q3,16,F,20190102.0,20190924.0,20190404,20190930,EXP,,PHHO2019US000774,SANDOZ,,51.0,YR,,M,Y,83.5,KG,20190930.0,,OT,US,US,2019,Q3,Adult
1615902916,16159029,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2019,Q3,Dyspnoea,,2019,Q3,16,F,20190102.0,20190924.0,20190404,20190930,EXP,,PHHO2019US000774,SANDOZ,,51.0,YR,,M,Y,83.5,KG,20190930.0,,OT,US,US,2019,Q3,Adult
1615902916,16159029,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2019,Q3,Flank pain,,2019,Q3,16,F,20190102.0,20190924.0,20190404,20190930,EXP,,PHHO2019US000774,SANDOZ,,51.0,YR,,M,Y,83.5,KG,20190930.0,,OT,US,US,2019,Q3,Adult
1615902916,16159029,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2019,Q3,Hydronephrosis,,2019,Q3,16,F,20190102.0,20190924.0,20190404,20190930,EXP,,PHHO2019US000774,SANDOZ,,51.0,YR,,M,Y,83.5,KG,20190930.0,,OT,US,US,2019,Q3,Adult
1615902916,16159029,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2019,Q3,Hyperkalaemia,,2019,Q3,16,F,20190102.0,20190924.0,20190404,20190930,EXP,,PHHO2019US000774,SANDOZ,,51.0,YR,,M,Y,83.5,KG,20190930.0,,OT,US,US,2019,Q3,Adult
1615902916,16159029,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2019,Q3,Hypomagnesaemia,,2019,Q3,16,F,20190102.0,20190924.0,20190404,20190930,EXP,,PHHO2019US000774,SANDOZ,,51.0,YR,,M,Y,83.5,KG,20190930.0,,OT,US,US,2019,Q3,Adult
1615902916,16159029,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2019,Q3,Infection,,2019,Q3,16,F,20190102.0,20190924.0,20190404,20190930,EXP,,PHHO2019US000774,SANDOZ,,51.0,YR,,M,Y,83.5,KG,20190930.0,,OT,US,US,2019,Q3,Adult
1615902916,16159029,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2019,Q3,Melaena,,2019,Q3,16,F,20190102.0,20190924.0,20190404,20190930,EXP,,PHHO2019US000774,SANDOZ,,51.0,YR,,M,Y,83.5,KG,20190930.0,,OT,US,US,2019,Q3,Adult
1615902916,16159029,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2019,Q3,Nephrolithiasis,,2019,Q3,16,F,20190102.0,20190924.0,20190404,20190930,EXP,,PHHO2019US000774,SANDOZ,,51.0,YR,,M,Y,83.5,KG,20190930.0,,OT,US,US,2019,Q3,Adult
1615902916,16159029,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2019,Q3,Pyelonephritis,,2019,Q3,16,F,20190102.0,20190924.0,20190404,20190930,EXP,,PHHO2019US000774,SANDOZ,,51.0,YR,,M,Y,83.5,KG,20190930.0,,OT,US,US,2019,Q3,Adult
1615902916,16159029,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2019,Q3,Pyuria,,2019,Q3,16,F,20190102.0,20190924.0,20190404,20190930,EXP,,PHHO2019US000774,SANDOZ,,51.0,YR,,M,Y,83.5,KG,20190930.0,,OT,US,US,2019,Q3,Adult
1615902916,16159029,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2019,Q3,Sepsis,,2019,Q3,16,F,20190102.0,20190924.0,20190404,20190930,EXP,,PHHO2019US000774,SANDOZ,,51.0,YR,,M,Y,83.5,KG,20190930.0,,OT,US,US,2019,Q3,Adult
1615902916,16159029,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2019,Q3,Syncope,,2019,Q3,16,F,20190102.0,20190924.0,20190404,20190930,EXP,,PHHO2019US000774,SANDOZ,,51.0,YR,,M,Y,83.5,KG,20190930.0,,OT,US,US,2019,Q3,Adult
1615902916,16159029,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2019,Q3,Ureterolithiasis,,2019,Q3,16,F,20190102.0,20190924.0,20190404,20190930,EXP,,PHHO2019US000774,SANDOZ,,51.0,YR,,M,Y,83.5,KG,20190930.0,,OT,US,US,2019,Q3,Adult
1615902916,16159029,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2019,Q3,Urinary tract infection,,2019,Q3,16,F,20190102.0,20190924.0,20190404,20190930,EXP,,PHHO2019US000774,SANDOZ,,51.0,YR,,M,Y,83.5,KG,20190930.0,,OT,US,US,2019,Q3,Adult
1615902916,16159029,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",1260.0,DF,Y,,,,,30.0,DF,,TID,2019,Q3,Vomiting,,2019,Q3,16,F,20190102.0,20190924.0,20190404,20190930,EXP,,PHHO2019US000774,SANDOZ,,51.0,YR,,M,Y,83.5,KG,20190930.0,,OT,US,US,2019,Q3,Adult
161636932,16163693,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"30 INTERNATIONAL UNIT, DAILY",,,,,,,20563.0,30.0,IU,,QD,2019,Q3,Exposure during pregnancy,,2019,Q3,2,F,20170205.0,20190624.0,20190405,20190704,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201711000808,ELI LILLY AND CO,,33.0,YR,,F,Y,84.0,KG,20190704.0,,OT,DE,DE,2019,Q3,Young Adult
161636932,16163693,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"30 INTERNATIONAL UNIT, DAILY",,,,,,,20563.0,30.0,IU,,QD,2019,Q3,Gastroenteritis norovirus,,2019,Q3,2,F,20170205.0,20190624.0,20190405,20190704,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201711000808,ELI LILLY AND CO,,33.0,YR,,F,Y,84.0,KG,20190704.0,,OT,DE,DE,2019,Q3,Young Adult
161636932,16163693,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"30 INTERNATIONAL UNIT, DAILY",,,,,,,20563.0,30.0,IU,,QD,2019,Q3,Hyperglycaemia,,2019,Q3,2,F,20170205.0,20190624.0,20190405,20190704,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201711000808,ELI LILLY AND CO,,33.0,YR,,F,Y,84.0,KG,20190704.0,,OT,DE,DE,2019,Q3,Young Adult
161636932,16163693,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"30 INTERNATIONAL UNIT, DAILY",,,,,,,20563.0,30.0,IU,,QD,2019,Q3,Hypoglycaemia,,2019,Q3,2,F,20170205.0,20190624.0,20190405,20190704,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201711000808,ELI LILLY AND CO,,33.0,YR,,F,Y,84.0,KG,20190704.0,,OT,DE,DE,2019,Q3,Young Adult
161636932,16163693,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"30 INTERNATIONAL UNIT, DAILY",,,,,,,20563.0,30.0,IU,,QD,2019,Q3,Maternal exposure during breast feeding,,2019,Q3,2,F,20170205.0,20190624.0,20190405,20190704,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201711000808,ELI LILLY AND CO,,33.0,YR,,F,Y,84.0,KG,20190704.0,,OT,DE,DE,2019,Q3,Young Adult
161636932,16163693,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"12 INTERNATIONAL UNIT, DAILY",,,,,,,20563.0,12.0,IU,,QD,2019,Q3,Exposure during pregnancy,,2019,Q3,2,F,20170205.0,20190624.0,20190405,20190704,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201711000808,ELI LILLY AND CO,,33.0,YR,,F,Y,84.0,KG,20190704.0,,OT,DE,DE,2019,Q3,Young Adult
161636932,16163693,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"12 INTERNATIONAL UNIT, DAILY",,,,,,,20563.0,12.0,IU,,QD,2019,Q3,Gastroenteritis norovirus,,2019,Q3,2,F,20170205.0,20190624.0,20190405,20190704,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201711000808,ELI LILLY AND CO,,33.0,YR,,F,Y,84.0,KG,20190704.0,,OT,DE,DE,2019,Q3,Young Adult
161636932,16163693,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"12 INTERNATIONAL UNIT, DAILY",,,,,,,20563.0,12.0,IU,,QD,2019,Q3,Hyperglycaemia,,2019,Q3,2,F,20170205.0,20190624.0,20190405,20190704,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201711000808,ELI LILLY AND CO,,33.0,YR,,F,Y,84.0,KG,20190704.0,,OT,DE,DE,2019,Q3,Young Adult
161636932,16163693,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"12 INTERNATIONAL UNIT, DAILY",,,,,,,20563.0,12.0,IU,,QD,2019,Q3,Hypoglycaemia,,2019,Q3,2,F,20170205.0,20190624.0,20190405,20190704,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201711000808,ELI LILLY AND CO,,33.0,YR,,F,Y,84.0,KG,20190704.0,,OT,DE,DE,2019,Q3,Young Adult
161636932,16163693,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"12 INTERNATIONAL UNIT, DAILY",,,,,,,20563.0,12.0,IU,,QD,2019,Q3,Maternal exposure during breast feeding,,2019,Q3,2,F,20170205.0,20190624.0,20190405,20190704,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201711000808,ELI LILLY AND CO,,33.0,YR,,F,Y,84.0,KG,20190704.0,,OT,DE,DE,2019,Q3,Young Adult
161636932,16163693,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"40 INTERNATIONAL UNIT, DAILY",,,,,,,20563.0,40.0,IU,,QD,2019,Q3,Exposure during pregnancy,,2019,Q3,2,F,20170205.0,20190624.0,20190405,20190704,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201711000808,ELI LILLY AND CO,,33.0,YR,,F,Y,84.0,KG,20190704.0,,OT,DE,DE,2019,Q3,Young Adult
161636932,16163693,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"40 INTERNATIONAL UNIT, DAILY",,,,,,,20563.0,40.0,IU,,QD,2019,Q3,Gastroenteritis norovirus,,2019,Q3,2,F,20170205.0,20190624.0,20190405,20190704,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201711000808,ELI LILLY AND CO,,33.0,YR,,F,Y,84.0,KG,20190704.0,,OT,DE,DE,2019,Q3,Young Adult
161636932,16163693,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"40 INTERNATIONAL UNIT, DAILY",,,,,,,20563.0,40.0,IU,,QD,2019,Q3,Hyperglycaemia,,2019,Q3,2,F,20170205.0,20190624.0,20190405,20190704,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201711000808,ELI LILLY AND CO,,33.0,YR,,F,Y,84.0,KG,20190704.0,,OT,DE,DE,2019,Q3,Young Adult
161636932,16163693,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"40 INTERNATIONAL UNIT, DAILY",,,,,,,20563.0,40.0,IU,,QD,2019,Q3,Hypoglycaemia,,2019,Q3,2,F,20170205.0,20190624.0,20190405,20190704,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201711000808,ELI LILLY AND CO,,33.0,YR,,F,Y,84.0,KG,20190704.0,,OT,DE,DE,2019,Q3,Young Adult
161636932,16163693,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"40 INTERNATIONAL UNIT, DAILY",,,,,,,20563.0,40.0,IU,,QD,2019,Q3,Maternal exposure during breast feeding,,2019,Q3,2,F,20170205.0,20190624.0,20190405,20190704,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201711000808,ELI LILLY AND CO,,33.0,YR,,F,Y,84.0,KG,20190704.0,,OT,DE,DE,2019,Q3,Young Adult
161636932,16163693,4,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"30 INTERNATIONAL UNIT, DAILY",,,,,,,20563.0,30.0,IU,,QD,2019,Q3,Exposure during pregnancy,,2019,Q3,2,F,20170205.0,20190624.0,20190405,20190704,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201711000808,ELI LILLY AND CO,,33.0,YR,,F,Y,84.0,KG,20190704.0,,OT,DE,DE,2019,Q3,Young Adult
161636932,16163693,4,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"30 INTERNATIONAL UNIT, DAILY",,,,,,,20563.0,30.0,IU,,QD,2019,Q3,Gastroenteritis norovirus,,2019,Q3,2,F,20170205.0,20190624.0,20190405,20190704,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201711000808,ELI LILLY AND CO,,33.0,YR,,F,Y,84.0,KG,20190704.0,,OT,DE,DE,2019,Q3,Young Adult
161636932,16163693,4,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"30 INTERNATIONAL UNIT, DAILY",,,,,,,20563.0,30.0,IU,,QD,2019,Q3,Hyperglycaemia,,2019,Q3,2,F,20170205.0,20190624.0,20190405,20190704,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201711000808,ELI LILLY AND CO,,33.0,YR,,F,Y,84.0,KG,20190704.0,,OT,DE,DE,2019,Q3,Young Adult
161636932,16163693,4,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"30 INTERNATIONAL UNIT, DAILY",,,,,,,20563.0,30.0,IU,,QD,2019,Q3,Hypoglycaemia,,2019,Q3,2,F,20170205.0,20190624.0,20190405,20190704,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201711000808,ELI LILLY AND CO,,33.0,YR,,F,Y,84.0,KG,20190704.0,,OT,DE,DE,2019,Q3,Young Adult
161636932,16163693,4,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"30 INTERNATIONAL UNIT, DAILY",,,,,,,20563.0,30.0,IU,,QD,2019,Q3,Maternal exposure during breast feeding,,2019,Q3,2,F,20170205.0,20190624.0,20190405,20190704,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201711000808,ELI LILLY AND CO,,33.0,YR,,F,Y,84.0,KG,20190704.0,,OT,DE,DE,2019,Q3,Young Adult
161636932,16163693,5,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"30 INTERNATIONAL UNIT, DAILY",,,,,,,20563.0,30.0,IU,,QD,2019,Q3,Exposure during pregnancy,,2019,Q3,2,F,20170205.0,20190624.0,20190405,20190704,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201711000808,ELI LILLY AND CO,,33.0,YR,,F,Y,84.0,KG,20190704.0,,OT,DE,DE,2019,Q3,Young Adult
161636932,16163693,5,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"30 INTERNATIONAL UNIT, DAILY",,,,,,,20563.0,30.0,IU,,QD,2019,Q3,Gastroenteritis norovirus,,2019,Q3,2,F,20170205.0,20190624.0,20190405,20190704,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201711000808,ELI LILLY AND CO,,33.0,YR,,F,Y,84.0,KG,20190704.0,,OT,DE,DE,2019,Q3,Young Adult
161636932,16163693,5,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"30 INTERNATIONAL UNIT, DAILY",,,,,,,20563.0,30.0,IU,,QD,2019,Q3,Hyperglycaemia,,2019,Q3,2,F,20170205.0,20190624.0,20190405,20190704,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201711000808,ELI LILLY AND CO,,33.0,YR,,F,Y,84.0,KG,20190704.0,,OT,DE,DE,2019,Q3,Young Adult
161636932,16163693,5,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"30 INTERNATIONAL UNIT, DAILY",,,,,,,20563.0,30.0,IU,,QD,2019,Q3,Hypoglycaemia,,2019,Q3,2,F,20170205.0,20190624.0,20190405,20190704,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201711000808,ELI LILLY AND CO,,33.0,YR,,F,Y,84.0,KG,20190704.0,,OT,DE,DE,2019,Q3,Young Adult
161636932,16163693,5,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"30 INTERNATIONAL UNIT, DAILY",,,,,,,20563.0,30.0,IU,,QD,2019,Q3,Maternal exposure during breast feeding,,2019,Q3,2,F,20170205.0,20190624.0,20190405,20190704,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201711000808,ELI LILLY AND CO,,33.0,YR,,F,Y,84.0,KG,20190704.0,,OT,DE,DE,2019,Q3,Young Adult
161686873,16168687,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2019,Q3,Anaemia,,2019,Q3,3,F,20161101.0,20190622.0,20190408,20190702,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-032212,BRISTOL MYERS SQUIBB,,64.0,YR,,M,Y,85.2,KG,20190702.0,,OT,DE,DE,2019,Q3,Adult
161686873,16168687,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2019,Q3,C-reactive protein increased,,2019,Q3,3,F,20161101.0,20190622.0,20190408,20190702,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-032212,BRISTOL MYERS SQUIBB,,64.0,YR,,M,Y,85.2,KG,20190702.0,,OT,DE,DE,2019,Q3,Adult
161686873,16168687,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2019,Q3,Cough,,2019,Q3,3,F,20161101.0,20190622.0,20190408,20190702,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-032212,BRISTOL MYERS SQUIBB,,64.0,YR,,M,Y,85.2,KG,20190702.0,,OT,DE,DE,2019,Q3,Adult
161686873,16168687,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2019,Q3,Diarrhoea,,2019,Q3,3,F,20161101.0,20190622.0,20190408,20190702,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-032212,BRISTOL MYERS SQUIBB,,64.0,YR,,M,Y,85.2,KG,20190702.0,,OT,DE,DE,2019,Q3,Adult
161686873,16168687,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2019,Q3,Dizziness,,2019,Q3,3,F,20161101.0,20190622.0,20190408,20190702,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-032212,BRISTOL MYERS SQUIBB,,64.0,YR,,M,Y,85.2,KG,20190702.0,,OT,DE,DE,2019,Q3,Adult
161686873,16168687,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2019,Q3,Dyspnoea,,2019,Q3,3,F,20161101.0,20190622.0,20190408,20190702,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-032212,BRISTOL MYERS SQUIBB,,64.0,YR,,M,Y,85.2,KG,20190702.0,,OT,DE,DE,2019,Q3,Adult
161686873,16168687,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2019,Q3,Fatigue,,2019,Q3,3,F,20161101.0,20190622.0,20190408,20190702,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-032212,BRISTOL MYERS SQUIBB,,64.0,YR,,M,Y,85.2,KG,20190702.0,,OT,DE,DE,2019,Q3,Adult
161686873,16168687,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2019,Q3,General physical condition abnormal,,2019,Q3,3,F,20161101.0,20190622.0,20190408,20190702,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-032212,BRISTOL MYERS SQUIBB,,64.0,YR,,M,Y,85.2,KG,20190702.0,,OT,DE,DE,2019,Q3,Adult
161686873,16168687,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2019,Q3,Hypothyroidism,,2019,Q3,3,F,20161101.0,20190622.0,20190408,20190702,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-032212,BRISTOL MYERS SQUIBB,,64.0,YR,,M,Y,85.2,KG,20190702.0,,OT,DE,DE,2019,Q3,Adult
161686873,16168687,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2019,Q3,Pain,,2019,Q3,3,F,20161101.0,20190622.0,20190408,20190702,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-032212,BRISTOL MYERS SQUIBB,,64.0,YR,,M,Y,85.2,KG,20190702.0,,OT,DE,DE,2019,Q3,Adult
161686873,16168687,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2019,Q3,Pneumonia,,2019,Q3,3,F,20161101.0,20190622.0,20190408,20190702,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-032212,BRISTOL MYERS SQUIBB,,64.0,YR,,M,Y,85.2,KG,20190702.0,,OT,DE,DE,2019,Q3,Adult
161686873,16168687,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2019,Q3,Sinusitis,,2019,Q3,3,F,20161101.0,20190622.0,20190408,20190702,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-032212,BRISTOL MYERS SQUIBB,,64.0,YR,,M,Y,85.2,KG,20190702.0,,OT,DE,DE,2019,Q3,Adult
161778166,16177816,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q3,Acute kidney injury,,2019,Q3,6,F,2018.0,20190806.0,20190410,20190813,EXP,,PT-009507513-1904PRT000791,MERCK,"GOUVEIA C. DUQUE S, CAMPOS L. LIPOTYMIA BY HYPOVOLEMIA-A CASE OF IATROGENIA TO EMPAGLIFLOZINA?. MARIANA ROCHA. 2019",71.0,YR,,M,Y,,,20190813.0,,MD,PT,PT,2019,Q3,Elderly
161778166,16177816,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q3,Arrhythmia,,2019,Q3,6,F,2018.0,20190806.0,20190410,20190813,EXP,,PT-009507513-1904PRT000791,MERCK,"GOUVEIA C. DUQUE S, CAMPOS L. LIPOTYMIA BY HYPOVOLEMIA-A CASE OF IATROGENIA TO EMPAGLIFLOZINA?. MARIANA ROCHA. 2019",71.0,YR,,M,Y,,,20190813.0,,MD,PT,PT,2019,Q3,Elderly
161778166,16177816,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q3,Atrial fibrillation,,2019,Q3,6,F,2018.0,20190806.0,20190410,20190813,EXP,,PT-009507513-1904PRT000791,MERCK,"GOUVEIA C. DUQUE S, CAMPOS L. LIPOTYMIA BY HYPOVOLEMIA-A CASE OF IATROGENIA TO EMPAGLIFLOZINA?. MARIANA ROCHA. 2019",71.0,YR,,M,Y,,,20190813.0,,MD,PT,PT,2019,Q3,Elderly
161778166,16177816,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q3,Bradycardia,,2019,Q3,6,F,2018.0,20190806.0,20190410,20190813,EXP,,PT-009507513-1904PRT000791,MERCK,"GOUVEIA C. DUQUE S, CAMPOS L. LIPOTYMIA BY HYPOVOLEMIA-A CASE OF IATROGENIA TO EMPAGLIFLOZINA?. MARIANA ROCHA. 2019",71.0,YR,,M,Y,,,20190813.0,,MD,PT,PT,2019,Q3,Elderly
161778166,16177816,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q3,Dehydration,,2019,Q3,6,F,2018.0,20190806.0,20190410,20190813,EXP,,PT-009507513-1904PRT000791,MERCK,"GOUVEIA C. DUQUE S, CAMPOS L. LIPOTYMIA BY HYPOVOLEMIA-A CASE OF IATROGENIA TO EMPAGLIFLOZINA?. MARIANA ROCHA. 2019",71.0,YR,,M,Y,,,20190813.0,,MD,PT,PT,2019,Q3,Elderly
161778166,16177816,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q3,Dizziness,,2019,Q3,6,F,2018.0,20190806.0,20190410,20190813,EXP,,PT-009507513-1904PRT000791,MERCK,"GOUVEIA C. DUQUE S, CAMPOS L. LIPOTYMIA BY HYPOVOLEMIA-A CASE OF IATROGENIA TO EMPAGLIFLOZINA?. MARIANA ROCHA. 2019",71.0,YR,,M,Y,,,20190813.0,,MD,PT,PT,2019,Q3,Elderly
161778166,16177816,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q3,Haematocrit increased,,2019,Q3,6,F,2018.0,20190806.0,20190410,20190813,EXP,,PT-009507513-1904PRT000791,MERCK,"GOUVEIA C. DUQUE S, CAMPOS L. LIPOTYMIA BY HYPOVOLEMIA-A CASE OF IATROGENIA TO EMPAGLIFLOZINA?. MARIANA ROCHA. 2019",71.0,YR,,M,Y,,,20190813.0,,MD,PT,PT,2019,Q3,Elderly
161778166,16177816,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q3,Haemoglobin increased,,2019,Q3,6,F,2018.0,20190806.0,20190410,20190813,EXP,,PT-009507513-1904PRT000791,MERCK,"GOUVEIA C. DUQUE S, CAMPOS L. LIPOTYMIA BY HYPOVOLEMIA-A CASE OF IATROGENIA TO EMPAGLIFLOZINA?. MARIANA ROCHA. 2019",71.0,YR,,M,Y,,,20190813.0,,MD,PT,PT,2019,Q3,Elderly
161778166,16177816,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q3,Hypotension,,2019,Q3,6,F,2018.0,20190806.0,20190410,20190813,EXP,,PT-009507513-1904PRT000791,MERCK,"GOUVEIA C. DUQUE S, CAMPOS L. LIPOTYMIA BY HYPOVOLEMIA-A CASE OF IATROGENIA TO EMPAGLIFLOZINA?. MARIANA ROCHA. 2019",71.0,YR,,M,Y,,,20190813.0,,MD,PT,PT,2019,Q3,Elderly
161778166,16177816,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q3,Hypovolaemia,,2019,Q3,6,F,2018.0,20190806.0,20190410,20190813,EXP,,PT-009507513-1904PRT000791,MERCK,"GOUVEIA C. DUQUE S, CAMPOS L. LIPOTYMIA BY HYPOVOLEMIA-A CASE OF IATROGENIA TO EMPAGLIFLOZINA?. MARIANA ROCHA. 2019",71.0,YR,,M,Y,,,20190813.0,,MD,PT,PT,2019,Q3,Elderly
161778166,16177816,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q3,Left atrial dilatation,,2019,Q3,6,F,2018.0,20190806.0,20190410,20190813,EXP,,PT-009507513-1904PRT000791,MERCK,"GOUVEIA C. DUQUE S, CAMPOS L. LIPOTYMIA BY HYPOVOLEMIA-A CASE OF IATROGENIA TO EMPAGLIFLOZINA?. MARIANA ROCHA. 2019",71.0,YR,,M,Y,,,20190813.0,,MD,PT,PT,2019,Q3,Elderly
161778166,16177816,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q3,Mucosal dryness,,2019,Q3,6,F,2018.0,20190806.0,20190410,20190813,EXP,,PT-009507513-1904PRT000791,MERCK,"GOUVEIA C. DUQUE S, CAMPOS L. LIPOTYMIA BY HYPOVOLEMIA-A CASE OF IATROGENIA TO EMPAGLIFLOZINA?. MARIANA ROCHA. 2019",71.0,YR,,M,Y,,,20190813.0,,MD,PT,PT,2019,Q3,Elderly
161778166,16177816,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q3,Presyncope,,2019,Q3,6,F,2018.0,20190806.0,20190410,20190813,EXP,,PT-009507513-1904PRT000791,MERCK,"GOUVEIA C. DUQUE S, CAMPOS L. LIPOTYMIA BY HYPOVOLEMIA-A CASE OF IATROGENIA TO EMPAGLIFLOZINA?. MARIANA ROCHA. 2019",71.0,YR,,M,Y,,,20190813.0,,MD,PT,PT,2019,Q3,Elderly
161778166,16177816,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q3,Skin disorder,,2019,Q3,6,F,2018.0,20190806.0,20190410,20190813,EXP,,PT-009507513-1904PRT000791,MERCK,"GOUVEIA C. DUQUE S, CAMPOS L. LIPOTYMIA BY HYPOVOLEMIA-A CASE OF IATROGENIA TO EMPAGLIFLOZINA?. MARIANA ROCHA. 2019",71.0,YR,,M,Y,,,20190813.0,,MD,PT,PT,2019,Q3,Elderly
161778166,16177816,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q3,Syncope,,2019,Q3,6,F,2018.0,20190806.0,20190410,20190813,EXP,,PT-009507513-1904PRT000791,MERCK,"GOUVEIA C. DUQUE S, CAMPOS L. LIPOTYMIA BY HYPOVOLEMIA-A CASE OF IATROGENIA TO EMPAGLIFLOZINA?. MARIANA ROCHA. 2019",71.0,YR,,M,Y,,,20190813.0,,MD,PT,PT,2019,Q3,Elderly
161778166,16177816,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2019,Q3,Acute kidney injury,,2019,Q3,6,F,2018.0,20190806.0,20190410,20190813,EXP,,PT-009507513-1904PRT000791,MERCK,"GOUVEIA C. DUQUE S, CAMPOS L. LIPOTYMIA BY HYPOVOLEMIA-A CASE OF IATROGENIA TO EMPAGLIFLOZINA?. MARIANA ROCHA. 2019",71.0,YR,,M,Y,,,20190813.0,,MD,PT,PT,2019,Q3,Elderly
161778166,16177816,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2019,Q3,Arrhythmia,,2019,Q3,6,F,2018.0,20190806.0,20190410,20190813,EXP,,PT-009507513-1904PRT000791,MERCK,"GOUVEIA C. DUQUE S, CAMPOS L. LIPOTYMIA BY HYPOVOLEMIA-A CASE OF IATROGENIA TO EMPAGLIFLOZINA?. MARIANA ROCHA. 2019",71.0,YR,,M,Y,,,20190813.0,,MD,PT,PT,2019,Q3,Elderly
161778166,16177816,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2019,Q3,Atrial fibrillation,,2019,Q3,6,F,2018.0,20190806.0,20190410,20190813,EXP,,PT-009507513-1904PRT000791,MERCK,"GOUVEIA C. DUQUE S, CAMPOS L. LIPOTYMIA BY HYPOVOLEMIA-A CASE OF IATROGENIA TO EMPAGLIFLOZINA?. MARIANA ROCHA. 2019",71.0,YR,,M,Y,,,20190813.0,,MD,PT,PT,2019,Q3,Elderly
161778166,16177816,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2019,Q3,Bradycardia,,2019,Q3,6,F,2018.0,20190806.0,20190410,20190813,EXP,,PT-009507513-1904PRT000791,MERCK,"GOUVEIA C. DUQUE S, CAMPOS L. LIPOTYMIA BY HYPOVOLEMIA-A CASE OF IATROGENIA TO EMPAGLIFLOZINA?. MARIANA ROCHA. 2019",71.0,YR,,M,Y,,,20190813.0,,MD,PT,PT,2019,Q3,Elderly
161778166,16177816,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2019,Q3,Dehydration,,2019,Q3,6,F,2018.0,20190806.0,20190410,20190813,EXP,,PT-009507513-1904PRT000791,MERCK,"GOUVEIA C. DUQUE S, CAMPOS L. LIPOTYMIA BY HYPOVOLEMIA-A CASE OF IATROGENIA TO EMPAGLIFLOZINA?. MARIANA ROCHA. 2019",71.0,YR,,M,Y,,,20190813.0,,MD,PT,PT,2019,Q3,Elderly
161778166,16177816,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2019,Q3,Dizziness,,2019,Q3,6,F,2018.0,20190806.0,20190410,20190813,EXP,,PT-009507513-1904PRT000791,MERCK,"GOUVEIA C. DUQUE S, CAMPOS L. LIPOTYMIA BY HYPOVOLEMIA-A CASE OF IATROGENIA TO EMPAGLIFLOZINA?. MARIANA ROCHA. 2019",71.0,YR,,M,Y,,,20190813.0,,MD,PT,PT,2019,Q3,Elderly
161778166,16177816,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2019,Q3,Haematocrit increased,,2019,Q3,6,F,2018.0,20190806.0,20190410,20190813,EXP,,PT-009507513-1904PRT000791,MERCK,"GOUVEIA C. DUQUE S, CAMPOS L. LIPOTYMIA BY HYPOVOLEMIA-A CASE OF IATROGENIA TO EMPAGLIFLOZINA?. MARIANA ROCHA. 2019",71.0,YR,,M,Y,,,20190813.0,,MD,PT,PT,2019,Q3,Elderly
161778166,16177816,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2019,Q3,Haemoglobin increased,,2019,Q3,6,F,2018.0,20190806.0,20190410,20190813,EXP,,PT-009507513-1904PRT000791,MERCK,"GOUVEIA C. DUQUE S, CAMPOS L. LIPOTYMIA BY HYPOVOLEMIA-A CASE OF IATROGENIA TO EMPAGLIFLOZINA?. MARIANA ROCHA. 2019",71.0,YR,,M,Y,,,20190813.0,,MD,PT,PT,2019,Q3,Elderly
161778166,16177816,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2019,Q3,Hypotension,,2019,Q3,6,F,2018.0,20190806.0,20190410,20190813,EXP,,PT-009507513-1904PRT000791,MERCK,"GOUVEIA C. DUQUE S, CAMPOS L. LIPOTYMIA BY HYPOVOLEMIA-A CASE OF IATROGENIA TO EMPAGLIFLOZINA?. MARIANA ROCHA. 2019",71.0,YR,,M,Y,,,20190813.0,,MD,PT,PT,2019,Q3,Elderly
161778166,16177816,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2019,Q3,Hypovolaemia,,2019,Q3,6,F,2018.0,20190806.0,20190410,20190813,EXP,,PT-009507513-1904PRT000791,MERCK,"GOUVEIA C. DUQUE S, CAMPOS L. LIPOTYMIA BY HYPOVOLEMIA-A CASE OF IATROGENIA TO EMPAGLIFLOZINA?. MARIANA ROCHA. 2019",71.0,YR,,M,Y,,,20190813.0,,MD,PT,PT,2019,Q3,Elderly
161778166,16177816,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2019,Q3,Left atrial dilatation,,2019,Q3,6,F,2018.0,20190806.0,20190410,20190813,EXP,,PT-009507513-1904PRT000791,MERCK,"GOUVEIA C. DUQUE S, CAMPOS L. LIPOTYMIA BY HYPOVOLEMIA-A CASE OF IATROGENIA TO EMPAGLIFLOZINA?. MARIANA ROCHA. 2019",71.0,YR,,M,Y,,,20190813.0,,MD,PT,PT,2019,Q3,Elderly
161778166,16177816,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2019,Q3,Mucosal dryness,,2019,Q3,6,F,2018.0,20190806.0,20190410,20190813,EXP,,PT-009507513-1904PRT000791,MERCK,"GOUVEIA C. DUQUE S, CAMPOS L. LIPOTYMIA BY HYPOVOLEMIA-A CASE OF IATROGENIA TO EMPAGLIFLOZINA?. MARIANA ROCHA. 2019",71.0,YR,,M,Y,,,20190813.0,,MD,PT,PT,2019,Q3,Elderly
161778166,16177816,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2019,Q3,Presyncope,,2019,Q3,6,F,2018.0,20190806.0,20190410,20190813,EXP,,PT-009507513-1904PRT000791,MERCK,"GOUVEIA C. DUQUE S, CAMPOS L. LIPOTYMIA BY HYPOVOLEMIA-A CASE OF IATROGENIA TO EMPAGLIFLOZINA?. MARIANA ROCHA. 2019",71.0,YR,,M,Y,,,20190813.0,,MD,PT,PT,2019,Q3,Elderly
161778166,16177816,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2019,Q3,Skin disorder,,2019,Q3,6,F,2018.0,20190806.0,20190410,20190813,EXP,,PT-009507513-1904PRT000791,MERCK,"GOUVEIA C. DUQUE S, CAMPOS L. LIPOTYMIA BY HYPOVOLEMIA-A CASE OF IATROGENIA TO EMPAGLIFLOZINA?. MARIANA ROCHA. 2019",71.0,YR,,M,Y,,,20190813.0,,MD,PT,PT,2019,Q3,Elderly
161778166,16177816,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2019,Q3,Syncope,,2019,Q3,6,F,2018.0,20190806.0,20190410,20190813,EXP,,PT-009507513-1904PRT000791,MERCK,"GOUVEIA C. DUQUE S, CAMPOS L. LIPOTYMIA BY HYPOVOLEMIA-A CASE OF IATROGENIA TO EMPAGLIFLOZINA?. MARIANA ROCHA. 2019",71.0,YR,,M,Y,,,20190813.0,,MD,PT,PT,2019,Q3,Elderly
161927642,16192764,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Acute kidney injury,,2019,Q3,2,F,2006.0,20190812.0,20190412,20190820,EXP,,US-ASTRAZENECA-2019SE53801,ASTRAZENECA,,53.0,YR,,F,Y,,,20190820.0,,,US,US,2019,Q3,Adult
161927642,16192764,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Chronic kidney disease,,2019,Q3,2,F,2006.0,20190812.0,20190412,20190820,EXP,,US-ASTRAZENECA-2019SE53801,ASTRAZENECA,,53.0,YR,,F,Y,,,20190820.0,,,US,US,2019,Q3,Adult
161927642,16192764,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,End stage renal disease,,2019,Q3,2,F,2006.0,20190812.0,20190412,20190820,EXP,,US-ASTRAZENECA-2019SE53801,ASTRAZENECA,,53.0,YR,,F,Y,,,20190820.0,,,US,US,2019,Q3,Adult
161927642,16192764,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Renal failure,,2019,Q3,2,F,2006.0,20190812.0,20190412,20190820,EXP,,US-ASTRAZENECA-2019SE53801,ASTRAZENECA,,53.0,YR,,F,Y,,,20190820.0,,,US,US,2019,Q3,Adult
161927642,16192764,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Tubulointerstitial nephritis,,2019,Q3,2,F,2006.0,20190812.0,20190412,20190820,EXP,,US-ASTRAZENECA-2019SE53801,ASTRAZENECA,,53.0,YR,,F,Y,,,20190820.0,,,US,US,2019,Q3,Adult
162524487,16252448,22,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"UNK, PRN",,,U,,,,,,,,,2019,Q3,Acute respiratory failure,,2019,Q3,7,F,20190311.0,20190829.0,20190429,20190905,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-029430,BRISTOL MYERS SQUIBB,,62.0,YR,,F,Y,,,20190905.0,,OT,US,US,2019,Q3,Adult
162524487,16252448,22,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"UNK, PRN",,,U,,,,,,,,,2019,Q3,Anaemia,,2019,Q3,7,F,20190311.0,20190829.0,20190429,20190905,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-029430,BRISTOL MYERS SQUIBB,,62.0,YR,,F,Y,,,20190905.0,,OT,US,US,2019,Q3,Adult
162524487,16252448,22,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"UNK, PRN",,,U,,,,,,,,,2019,Q3,Atrial fibrillation,,2019,Q3,7,F,20190311.0,20190829.0,20190429,20190905,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-029430,BRISTOL MYERS SQUIBB,,62.0,YR,,F,Y,,,20190905.0,,OT,US,US,2019,Q3,Adult
162524487,16252448,22,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"UNK, PRN",,,U,,,,,,,,,2019,Q3,Influenza A virus test positive,,2019,Q3,7,F,20190311.0,20190829.0,20190429,20190905,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-029430,BRISTOL MYERS SQUIBB,,62.0,YR,,F,Y,,,20190905.0,,OT,US,US,2019,Q3,Adult
162524487,16252448,22,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"UNK, PRN",,,U,,,,,,,,,2019,Q3,Malignant neoplasm progression,,2019,Q3,7,F,20190311.0,20190829.0,20190429,20190905,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-029430,BRISTOL MYERS SQUIBB,,62.0,YR,,F,Y,,,20190905.0,,OT,US,US,2019,Q3,Adult
162524487,16252448,22,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"UNK, PRN",,,U,,,,,,,,,2019,Q3,Pneumonia,,2019,Q3,7,F,20190311.0,20190829.0,20190429,20190905,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-029430,BRISTOL MYERS SQUIBB,,62.0,YR,,F,Y,,,20190905.0,,OT,US,US,2019,Q3,Adult
162843466,16284346,6,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2019,Q3,Abdominal discomfort,,2019,Q3,6,F,20190425.0,20190919.0,20190508,20190926,EXP,,US-BIOGEN-2019BI00733005,BIOGEN,,47.0,YR,,M,Y,112.59,KG,20190926.0,,CN,US,US,2019,Q3,Adult
162843466,16284346,6,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2019,Q3,Blood glucose decreased,,2019,Q3,6,F,20190425.0,20190919.0,20190508,20190926,EXP,,US-BIOGEN-2019BI00733005,BIOGEN,,47.0,YR,,M,Y,112.59,KG,20190926.0,,CN,US,US,2019,Q3,Adult
162843466,16284346,6,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2019,Q3,Blood glucose increased,,2019,Q3,6,F,20190425.0,20190919.0,20190508,20190926,EXP,,US-BIOGEN-2019BI00733005,BIOGEN,,47.0,YR,,M,Y,112.59,KG,20190926.0,,CN,US,US,2019,Q3,Adult
162843466,16284346,6,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2019,Q3,Diarrhoea,,2019,Q3,6,F,20190425.0,20190919.0,20190508,20190926,EXP,,US-BIOGEN-2019BI00733005,BIOGEN,,47.0,YR,,M,Y,112.59,KG,20190926.0,,CN,US,US,2019,Q3,Adult
162843466,16284346,6,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2019,Q3,Faeces discoloured,,2019,Q3,6,F,20190425.0,20190919.0,20190508,20190926,EXP,,US-BIOGEN-2019BI00733005,BIOGEN,,47.0,YR,,M,Y,112.59,KG,20190926.0,,CN,US,US,2019,Q3,Adult
162843466,16284346,6,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2019,Q3,Loss of consciousness,,2019,Q3,6,F,20190425.0,20190919.0,20190508,20190926,EXP,,US-BIOGEN-2019BI00733005,BIOGEN,,47.0,YR,,M,Y,112.59,KG,20190926.0,,CN,US,US,2019,Q3,Adult
162843466,16284346,6,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2019,Q3,Product dose omission,,2019,Q3,6,F,20190425.0,20190919.0,20190508,20190926,EXP,,US-BIOGEN-2019BI00733005,BIOGEN,,47.0,YR,,M,Y,112.59,KG,20190926.0,,CN,US,US,2019,Q3,Adult
162843466,16284346,6,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2019,Q3,Weight decreased,,2019,Q3,6,F,20190425.0,20190919.0,20190508,20190926,EXP,,US-BIOGEN-2019BI00733005,BIOGEN,,47.0,YR,,M,Y,112.59,KG,20190926.0,,CN,US,US,2019,Q3,Adult
162910782,16291078,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,20.0,IU,FORMULATION UNKNOWN,QD,2019,Q3,Acute kidney injury,,2019,Q3,2,F,20171230.0,20190709.0,20190509,20190715,EXP,,US-ASTELLAS-2018US001183,ASTELLAS,,49.0,YR,,F,Y,108.0,KG,20190715.0,,MD,US,US,2019,Q3,Adult
162910782,16291078,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,20.0,IU,FORMULATION UNKNOWN,QD,2019,Q3,Febrile neutropenia,,2019,Q3,2,F,20171230.0,20190709.0,20190509,20190715,EXP,,US-ASTELLAS-2018US001183,ASTELLAS,,49.0,YR,,F,Y,108.0,KG,20190715.0,,MD,US,US,2019,Q3,Adult
162926853,16292685,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q3,Death,,2019,Q3,3,F,20190501.0,20190709.0,20190509,20190710,EXP,,US-ABBVIE-19K-163-2776608-00,ABBVIE,,56.0,YR,,F,Y,68.1,KG,20190710.0,,MD,US,US,2019,Q3,Adult
163638382,16363838,1,PS,Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,Y,U,,,20563.0,,,,,2019,Q3,Dyspnoea,,2019,Q3,2,F,20190313.0,20190724.0,20190528,20190802,EXP,,SE-ELI_LILLY_AND_COMPANY-SE201905012385,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20190802.0,,CN,SE,SE,2019,Q3,Adult
163638382,16363838,1,PS,Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,Y,U,,,20563.0,,,,,2019,Q3,Pharyngeal swelling,,2019,Q3,2,F,20190313.0,20190724.0,20190528,20190802,EXP,,SE-ELI_LILLY_AND_COMPANY-SE201905012385,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20190802.0,,CN,SE,SE,2019,Q3,Adult
163906524,16390652,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Diarrhoea,,2019,Q3,4,F,20190513.0,20190911.0,20190604,20190923,PER,,US-ACTELION-A-NJ2019-190948,ACTELION,,71.0,YR,,M,Y,94.33,KG,20190923.0,,OT,US,US,2019,Q3,Elderly
163906524,16390652,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Dyspnoea,,2019,Q3,4,F,20190513.0,20190911.0,20190604,20190923,PER,,US-ACTELION-A-NJ2019-190948,ACTELION,,71.0,YR,,M,Y,94.33,KG,20190923.0,,OT,US,US,2019,Q3,Elderly
163906524,16390652,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Dyspnoea exertional,,2019,Q3,4,F,20190513.0,20190911.0,20190604,20190923,PER,,US-ACTELION-A-NJ2019-190948,ACTELION,,71.0,YR,,M,Y,94.33,KG,20190923.0,,OT,US,US,2019,Q3,Elderly
163906524,16390652,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Flushing,,2019,Q3,4,F,20190513.0,20190911.0,20190604,20190923,PER,,US-ACTELION-A-NJ2019-190948,ACTELION,,71.0,YR,,M,Y,94.33,KG,20190923.0,,OT,US,US,2019,Q3,Elderly
163906524,16390652,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Headache,,2019,Q3,4,F,20190513.0,20190911.0,20190604,20190923,PER,,US-ACTELION-A-NJ2019-190948,ACTELION,,71.0,YR,,M,Y,94.33,KG,20190923.0,,OT,US,US,2019,Q3,Elderly
163906524,16390652,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Myalgia,,2019,Q3,4,F,20190513.0,20190911.0,20190604,20190923,PER,,US-ACTELION-A-NJ2019-190948,ACTELION,,71.0,YR,,M,Y,94.33,KG,20190923.0,,OT,US,US,2019,Q3,Elderly
163906524,16390652,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Nausea,,2019,Q3,4,F,20190513.0,20190911.0,20190604,20190923,PER,,US-ACTELION-A-NJ2019-190948,ACTELION,,71.0,YR,,M,Y,94.33,KG,20190923.0,,OT,US,US,2019,Q3,Elderly
163906524,16390652,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Pain in jaw,,2019,Q3,4,F,20190513.0,20190911.0,20190604,20190923,PER,,US-ACTELION-A-NJ2019-190948,ACTELION,,71.0,YR,,M,Y,94.33,KG,20190923.0,,OT,US,US,2019,Q3,Elderly
163906524,16390652,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Product dose omission,,2019,Q3,4,F,20190513.0,20190911.0,20190604,20190923,PER,,US-ACTELION-A-NJ2019-190948,ACTELION,,71.0,YR,,M,Y,94.33,KG,20190923.0,,OT,US,US,2019,Q3,Elderly
163906524,16390652,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Pulmonary hypertension,,2019,Q3,4,F,20190513.0,20190911.0,20190604,20190923,PER,,US-ACTELION-A-NJ2019-190948,ACTELION,,71.0,YR,,M,Y,94.33,KG,20190923.0,,OT,US,US,2019,Q3,Elderly
163995573,16399557,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,20 IU BEFORE MEALS,,,,,,,,20.0,IU,,,2019,Q3,Anaemia,,2019,Q3,3,F,20190507.0,20190621.0,20190606,20190703,EXP,,US-AMNEAL PHARMACEUTICALS-2019AMN00647,AMNEAL,,43.0,YR,,F,Y,103.4,KG,20190703.0,,CN,US,US,2019,Q3,Adult
163995573,16399557,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,20 IU BEFORE MEALS,,,,,,,,20.0,IU,,,2019,Q3,Vaginal haemorrhage,,2019,Q3,3,F,20190507.0,20190621.0,20190606,20190703,EXP,,US-AMNEAL PHARMACEUTICALS-2019AMN00647,AMNEAL,,43.0,YR,,F,Y,103.4,KG,20190703.0,,CN,US,US,2019,Q3,Adult
164010532,16401053,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,INJECTION,,2019,Q3,Cellulitis,,2019,Q3,2,F,20181025.0,20190628.0,20190606,20190702,EXP,,GB-GILEAD-2019-0412193,GILEAD,,85.0,YR,E,M,Y,,,20190702.0,,CN,GB,GB,2019,Q3,Elderly
164017373,16401737,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q3,Chronic kidney disease,,2019,Q3,3,F,2016.0,20190903.0,20190606,20190906,EXP,,US-ASTRAZENECA-2018SF65861,ASTRAZENECA,,53.0,YR,,F,Y,145.2,KG,20190906.0,,,US,US,2019,Q3,Adult
164017373,16401737,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q3,Rebound acid hypersecretion,,2019,Q3,3,F,2016.0,20190903.0,20190606,20190906,EXP,,US-ASTRAZENECA-2018SF65861,ASTRAZENECA,,53.0,YR,,F,Y,145.2,KG,20190906.0,,,US,US,2019,Q3,Adult
164017373,16401737,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q3,Renal failure,,2019,Q3,3,F,2016.0,20190903.0,20190606,20190906,EXP,,US-ASTRAZENECA-2018SF65861,ASTRAZENECA,,53.0,YR,,F,Y,145.2,KG,20190906.0,,,US,US,2019,Q3,Adult
164017373,16401737,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q3,Renal injury,,2019,Q3,3,F,2016.0,20190903.0,20190606,20190906,EXP,,US-ASTRAZENECA-2018SF65861,ASTRAZENECA,,53.0,YR,,F,Y,145.2,KG,20190906.0,,,US,US,2019,Q3,Adult
164062812,16406281,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q3,Impaired healing,,2019,Q3,2,F,20180821.0,20190906.0,20190607,20190912,EXP,,DE-MYLANLABS-2019M1052964,MYLAN,,57.0,YR,,M,Y,,,20190912.0,,MD,DE,DE,2019,Q3,Adult
164062812,16406281,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q3,Necrotising fasciitis,,2019,Q3,2,F,20180821.0,20190906.0,20190607,20190912,EXP,,DE-MYLANLABS-2019M1052964,MYLAN,,57.0,YR,,M,Y,,,20190912.0,,MD,DE,DE,2019,Q3,Adult
164062812,16406281,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q3,Wound dehiscence,,2019,Q3,2,F,20180821.0,20190906.0,20190607,20190912,EXP,,DE-MYLANLABS-2019M1052964,MYLAN,,57.0,YR,,M,Y,,,20190912.0,,MD,DE,DE,2019,Q3,Adult
164069824,16406982,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 UNIT, TID",,,,,,,,2.0,DF,,TID,2019,Q3,Acute respiratory failure,,2019,Q3,4,F,20190601.0,20190722.0,20190608,20190725,EXP,,US-UNITED THERAPEUTICS-UNT-2019-009958,UNITED THERAPEUTICS,,57.0,YR,,F,Y,122.45,KG,20190725.0,,OT,US,US,2019,Q3,Adult
164069824,16406982,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 UNIT, TID",,,,,,,,2.0,DF,,TID,2019,Q3,Anaemia,,2019,Q3,4,F,20190601.0,20190722.0,20190608,20190725,EXP,,US-UNITED THERAPEUTICS-UNT-2019-009958,UNITED THERAPEUTICS,,57.0,YR,,F,Y,122.45,KG,20190725.0,,OT,US,US,2019,Q3,Adult
164069824,16406982,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 UNIT, TID",,,,,,,,2.0,DF,,TID,2019,Q3,Back pain,,2019,Q3,4,F,20190601.0,20190722.0,20190608,20190725,EXP,,US-UNITED THERAPEUTICS-UNT-2019-009958,UNITED THERAPEUTICS,,57.0,YR,,F,Y,122.45,KG,20190725.0,,OT,US,US,2019,Q3,Adult
164069824,16406982,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 UNIT, TID",,,,,,,,2.0,DF,,TID,2019,Q3,Cardiac failure congestive,,2019,Q3,4,F,20190601.0,20190722.0,20190608,20190725,EXP,,US-UNITED THERAPEUTICS-UNT-2019-009958,UNITED THERAPEUTICS,,57.0,YR,,F,Y,122.45,KG,20190725.0,,OT,US,US,2019,Q3,Adult
164069824,16406982,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 UNIT, TID",,,,,,,,2.0,DF,,TID,2019,Q3,Chest pain,,2019,Q3,4,F,20190601.0,20190722.0,20190608,20190725,EXP,,US-UNITED THERAPEUTICS-UNT-2019-009958,UNITED THERAPEUTICS,,57.0,YR,,F,Y,122.45,KG,20190725.0,,OT,US,US,2019,Q3,Adult
164069824,16406982,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 UNIT, TID",,,,,,,,2.0,DF,,TID,2019,Q3,Cough,,2019,Q3,4,F,20190601.0,20190722.0,20190608,20190725,EXP,,US-UNITED THERAPEUTICS-UNT-2019-009958,UNITED THERAPEUTICS,,57.0,YR,,F,Y,122.45,KG,20190725.0,,OT,US,US,2019,Q3,Adult
164069824,16406982,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 UNIT, TID",,,,,,,,2.0,DF,,TID,2019,Q3,Dyspnoea exertional,,2019,Q3,4,F,20190601.0,20190722.0,20190608,20190725,EXP,,US-UNITED THERAPEUTICS-UNT-2019-009958,UNITED THERAPEUTICS,,57.0,YR,,F,Y,122.45,KG,20190725.0,,OT,US,US,2019,Q3,Adult
164069824,16406982,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 UNIT, TID",,,,,,,,2.0,DF,,TID,2019,Q3,Dyspnoea paroxysmal nocturnal,,2019,Q3,4,F,20190601.0,20190722.0,20190608,20190725,EXP,,US-UNITED THERAPEUTICS-UNT-2019-009958,UNITED THERAPEUTICS,,57.0,YR,,F,Y,122.45,KG,20190725.0,,OT,US,US,2019,Q3,Adult
164069824,16406982,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 UNIT, TID",,,,,,,,2.0,DF,,TID,2019,Q3,Hypoxia,,2019,Q3,4,F,20190601.0,20190722.0,20190608,20190725,EXP,,US-UNITED THERAPEUTICS-UNT-2019-009958,UNITED THERAPEUTICS,,57.0,YR,,F,Y,122.45,KG,20190725.0,,OT,US,US,2019,Q3,Adult
164069824,16406982,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 UNIT, TID",,,,,,,,2.0,DF,,TID,2019,Q3,Pickwickian syndrome,,2019,Q3,4,F,20190601.0,20190722.0,20190608,20190725,EXP,,US-UNITED THERAPEUTICS-UNT-2019-009958,UNITED THERAPEUTICS,,57.0,YR,,F,Y,122.45,KG,20190725.0,,OT,US,US,2019,Q3,Adult
164069824,16406982,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 UNIT, TID",,,,,,,,2.0,DF,,TID,2019,Q3,Pulmonary hypertension,,2019,Q3,4,F,20190601.0,20190722.0,20190608,20190725,EXP,,US-UNITED THERAPEUTICS-UNT-2019-009958,UNITED THERAPEUTICS,,57.0,YR,,F,Y,122.45,KG,20190725.0,,OT,US,US,2019,Q3,Adult
164069824,16406982,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 UNIT, TID",,,,,,,,2.0,DF,,TID,2019,Q3,Pyrexia,,2019,Q3,4,F,20190601.0,20190722.0,20190608,20190725,EXP,,US-UNITED THERAPEUTICS-UNT-2019-009958,UNITED THERAPEUTICS,,57.0,YR,,F,Y,122.45,KG,20190725.0,,OT,US,US,2019,Q3,Adult
164069824,16406982,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 UNIT, TID",,,,,,,,2.0,DF,,TID,2019,Q3,Swelling,,2019,Q3,4,F,20190601.0,20190722.0,20190608,20190725,EXP,,US-UNITED THERAPEUTICS-UNT-2019-009958,UNITED THERAPEUTICS,,57.0,YR,,F,Y,122.45,KG,20190725.0,,OT,US,US,2019,Q3,Adult
164133002,16413300,32,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,INJECTION,,2019,Q3,Plasma cell myeloma,,2019,Q3,2,F,201902.0,20190724.0,20190611,20190801,PER,,US-CELGENEUS-USA-20190602271,CELGENE,,77.0,YR,,M,Y,,,20190801.0,,MD,US,US,2019,Q3,Elderly
164133002,16413300,33,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,INJECTION,,2019,Q3,Plasma cell myeloma,,2019,Q3,2,F,201902.0,20190724.0,20190611,20190801,PER,,US-CELGENEUS-USA-20190602271,CELGENE,,77.0,YR,,M,Y,,,20190801.0,,MD,US,US,2019,Q3,Elderly
164288412,16428841,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,INJECTION,,2019,Q3,Cellulitis,,2019,Q3,2,F,2018.0,20190705.0,20190613,20190708,EXP,,PHHY2019GB134083,SANDOZ,,85.0,YR,,M,Y,,,20190709.0,,OT,GB,GB,2019,Q3,Elderly
164288412,16428841,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,INJECTION,,2019,Q3,Labelled drug-drug interaction medication error,,2019,Q3,2,F,2018.0,20190705.0,20190613,20190708,EXP,,PHHY2019GB134083,SANDOZ,,85.0,YR,,M,Y,,,20190709.0,,OT,GB,GB,2019,Q3,Elderly
164386322,16438632,7,SS,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q3,Acute kidney injury,,2019,Q3,2,F,2018.0,20190731.0,20190617,20190806,EXP,PT-EMA-DD-20190508-HV_A-123303,PT-ACCORD-132410,ACCORD,,71.0,YR,E,M,Y,,,20190806.0,,OT,PT,PT,2019,Q3,Elderly
164386322,16438632,7,SS,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q3,Arrhythmia,,2019,Q3,2,F,2018.0,20190731.0,20190617,20190806,EXP,PT-EMA-DD-20190508-HV_A-123303,PT-ACCORD-132410,ACCORD,,71.0,YR,E,M,Y,,,20190806.0,,OT,PT,PT,2019,Q3,Elderly
164386322,16438632,7,SS,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q3,Atrial fibrillation,,2019,Q3,2,F,2018.0,20190731.0,20190617,20190806,EXP,PT-EMA-DD-20190508-HV_A-123303,PT-ACCORD-132410,ACCORD,,71.0,YR,E,M,Y,,,20190806.0,,OT,PT,PT,2019,Q3,Elderly
164386322,16438632,7,SS,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q3,Bradycardia,,2019,Q3,2,F,2018.0,20190731.0,20190617,20190806,EXP,PT-EMA-DD-20190508-HV_A-123303,PT-ACCORD-132410,ACCORD,,71.0,YR,E,M,Y,,,20190806.0,,OT,PT,PT,2019,Q3,Elderly
164386322,16438632,7,SS,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q3,Dehydration,,2019,Q3,2,F,2018.0,20190731.0,20190617,20190806,EXP,PT-EMA-DD-20190508-HV_A-123303,PT-ACCORD-132410,ACCORD,,71.0,YR,E,M,Y,,,20190806.0,,OT,PT,PT,2019,Q3,Elderly
164386322,16438632,7,SS,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q3,Dizziness,,2019,Q3,2,F,2018.0,20190731.0,20190617,20190806,EXP,PT-EMA-DD-20190508-HV_A-123303,PT-ACCORD-132410,ACCORD,,71.0,YR,E,M,Y,,,20190806.0,,OT,PT,PT,2019,Q3,Elderly
164386322,16438632,7,SS,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q3,Haematocrit increased,,2019,Q3,2,F,2018.0,20190731.0,20190617,20190806,EXP,PT-EMA-DD-20190508-HV_A-123303,PT-ACCORD-132410,ACCORD,,71.0,YR,E,M,Y,,,20190806.0,,OT,PT,PT,2019,Q3,Elderly
164386322,16438632,7,SS,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q3,Haemoglobin increased,,2019,Q3,2,F,2018.0,20190731.0,20190617,20190806,EXP,PT-EMA-DD-20190508-HV_A-123303,PT-ACCORD-132410,ACCORD,,71.0,YR,E,M,Y,,,20190806.0,,OT,PT,PT,2019,Q3,Elderly
164386322,16438632,7,SS,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q3,Hypotension,,2019,Q3,2,F,2018.0,20190731.0,20190617,20190806,EXP,PT-EMA-DD-20190508-HV_A-123303,PT-ACCORD-132410,ACCORD,,71.0,YR,E,M,Y,,,20190806.0,,OT,PT,PT,2019,Q3,Elderly
164386322,16438632,7,SS,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q3,Hypovolaemia,,2019,Q3,2,F,2018.0,20190731.0,20190617,20190806,EXP,PT-EMA-DD-20190508-HV_A-123303,PT-ACCORD-132410,ACCORD,,71.0,YR,E,M,Y,,,20190806.0,,OT,PT,PT,2019,Q3,Elderly
164386322,16438632,7,SS,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q3,Left atrial dilatation,,2019,Q3,2,F,2018.0,20190731.0,20190617,20190806,EXP,PT-EMA-DD-20190508-HV_A-123303,PT-ACCORD-132410,ACCORD,,71.0,YR,E,M,Y,,,20190806.0,,OT,PT,PT,2019,Q3,Elderly
164386322,16438632,7,SS,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q3,Mucosal dryness,,2019,Q3,2,F,2018.0,20190731.0,20190617,20190806,EXP,PT-EMA-DD-20190508-HV_A-123303,PT-ACCORD-132410,ACCORD,,71.0,YR,E,M,Y,,,20190806.0,,OT,PT,PT,2019,Q3,Elderly
164386322,16438632,7,SS,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q3,Presyncope,,2019,Q3,2,F,2018.0,20190731.0,20190617,20190806,EXP,PT-EMA-DD-20190508-HV_A-123303,PT-ACCORD-132410,ACCORD,,71.0,YR,E,M,Y,,,20190806.0,,OT,PT,PT,2019,Q3,Elderly
164386322,16438632,7,SS,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q3,Skin disorder,,2019,Q3,2,F,2018.0,20190731.0,20190617,20190806,EXP,PT-EMA-DD-20190508-HV_A-123303,PT-ACCORD-132410,ACCORD,,71.0,YR,E,M,Y,,,20190806.0,,OT,PT,PT,2019,Q3,Elderly
164386322,16438632,7,SS,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q3,Syncope,,2019,Q3,2,F,2018.0,20190731.0,20190617,20190806,EXP,PT-EMA-DD-20190508-HV_A-123303,PT-ACCORD-132410,ACCORD,,71.0,YR,E,M,Y,,,20190806.0,,OT,PT,PT,2019,Q3,Elderly
164386322,16438632,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q3,Acute kidney injury,,2019,Q3,2,F,2018.0,20190731.0,20190617,20190806,EXP,PT-EMA-DD-20190508-HV_A-123303,PT-ACCORD-132410,ACCORD,,71.0,YR,E,M,Y,,,20190806.0,,OT,PT,PT,2019,Q3,Elderly
164386322,16438632,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q3,Arrhythmia,,2019,Q3,2,F,2018.0,20190731.0,20190617,20190806,EXP,PT-EMA-DD-20190508-HV_A-123303,PT-ACCORD-132410,ACCORD,,71.0,YR,E,M,Y,,,20190806.0,,OT,PT,PT,2019,Q3,Elderly
164386322,16438632,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q3,Atrial fibrillation,,2019,Q3,2,F,2018.0,20190731.0,20190617,20190806,EXP,PT-EMA-DD-20190508-HV_A-123303,PT-ACCORD-132410,ACCORD,,71.0,YR,E,M,Y,,,20190806.0,,OT,PT,PT,2019,Q3,Elderly
164386322,16438632,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q3,Bradycardia,,2019,Q3,2,F,2018.0,20190731.0,20190617,20190806,EXP,PT-EMA-DD-20190508-HV_A-123303,PT-ACCORD-132410,ACCORD,,71.0,YR,E,M,Y,,,20190806.0,,OT,PT,PT,2019,Q3,Elderly
164386322,16438632,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q3,Dehydration,,2019,Q3,2,F,2018.0,20190731.0,20190617,20190806,EXP,PT-EMA-DD-20190508-HV_A-123303,PT-ACCORD-132410,ACCORD,,71.0,YR,E,M,Y,,,20190806.0,,OT,PT,PT,2019,Q3,Elderly
164386322,16438632,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q3,Dizziness,,2019,Q3,2,F,2018.0,20190731.0,20190617,20190806,EXP,PT-EMA-DD-20190508-HV_A-123303,PT-ACCORD-132410,ACCORD,,71.0,YR,E,M,Y,,,20190806.0,,OT,PT,PT,2019,Q3,Elderly
164386322,16438632,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q3,Haematocrit increased,,2019,Q3,2,F,2018.0,20190731.0,20190617,20190806,EXP,PT-EMA-DD-20190508-HV_A-123303,PT-ACCORD-132410,ACCORD,,71.0,YR,E,M,Y,,,20190806.0,,OT,PT,PT,2019,Q3,Elderly
164386322,16438632,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q3,Haemoglobin increased,,2019,Q3,2,F,2018.0,20190731.0,20190617,20190806,EXP,PT-EMA-DD-20190508-HV_A-123303,PT-ACCORD-132410,ACCORD,,71.0,YR,E,M,Y,,,20190806.0,,OT,PT,PT,2019,Q3,Elderly
164386322,16438632,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q3,Hypotension,,2019,Q3,2,F,2018.0,20190731.0,20190617,20190806,EXP,PT-EMA-DD-20190508-HV_A-123303,PT-ACCORD-132410,ACCORD,,71.0,YR,E,M,Y,,,20190806.0,,OT,PT,PT,2019,Q3,Elderly
164386322,16438632,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q3,Hypovolaemia,,2019,Q3,2,F,2018.0,20190731.0,20190617,20190806,EXP,PT-EMA-DD-20190508-HV_A-123303,PT-ACCORD-132410,ACCORD,,71.0,YR,E,M,Y,,,20190806.0,,OT,PT,PT,2019,Q3,Elderly
164386322,16438632,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q3,Left atrial dilatation,,2019,Q3,2,F,2018.0,20190731.0,20190617,20190806,EXP,PT-EMA-DD-20190508-HV_A-123303,PT-ACCORD-132410,ACCORD,,71.0,YR,E,M,Y,,,20190806.0,,OT,PT,PT,2019,Q3,Elderly
164386322,16438632,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q3,Mucosal dryness,,2019,Q3,2,F,2018.0,20190731.0,20190617,20190806,EXP,PT-EMA-DD-20190508-HV_A-123303,PT-ACCORD-132410,ACCORD,,71.0,YR,E,M,Y,,,20190806.0,,OT,PT,PT,2019,Q3,Elderly
164386322,16438632,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q3,Presyncope,,2019,Q3,2,F,2018.0,20190731.0,20190617,20190806,EXP,PT-EMA-DD-20190508-HV_A-123303,PT-ACCORD-132410,ACCORD,,71.0,YR,E,M,Y,,,20190806.0,,OT,PT,PT,2019,Q3,Elderly
164386322,16438632,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q3,Skin disorder,,2019,Q3,2,F,2018.0,20190731.0,20190617,20190806,EXP,PT-EMA-DD-20190508-HV_A-123303,PT-ACCORD-132410,ACCORD,,71.0,YR,E,M,Y,,,20190806.0,,OT,PT,PT,2019,Q3,Elderly
164386322,16438632,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q3,Syncope,,2019,Q3,2,F,2018.0,20190731.0,20190617,20190806,EXP,PT-EMA-DD-20190508-HV_A-123303,PT-ACCORD-132410,ACCORD,,71.0,YR,E,M,Y,,,20190806.0,,OT,PT,PT,2019,Q3,Elderly
164545044,16454504,29,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,20 INTERNATIONAL UNITS MILLIONS,,,,,,,,20.0,IU,INJECTION,,2019,Q3,Asthenia,,2019,Q3,4,F,20190606.0,20190705.0,20190619,20190712,EXP,,US-CELGENEUS-USA-20190606794,CELGENE,,77.0,YR,,M,Y,83.8,KG,20190712.0,,MD,US,US,2019,Q3,Elderly
164545044,16454504,29,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,20 INTERNATIONAL UNITS MILLIONS,,,,,,,,20.0,IU,INJECTION,,2019,Q3,Delirium,,2019,Q3,4,F,20190606.0,20190705.0,20190619,20190712,EXP,,US-CELGENEUS-USA-20190606794,CELGENE,,77.0,YR,,M,Y,83.8,KG,20190712.0,,MD,US,US,2019,Q3,Elderly
164545044,16454504,29,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,20 INTERNATIONAL UNITS MILLIONS,,,,,,,,20.0,IU,INJECTION,,2019,Q3,Hyperglycaemia,,2019,Q3,4,F,20190606.0,20190705.0,20190619,20190712,EXP,,US-CELGENEUS-USA-20190606794,CELGENE,,77.0,YR,,M,Y,83.8,KG,20190712.0,,MD,US,US,2019,Q3,Elderly
164545044,16454504,30,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,6 INTERNATIONAL UNITS MILLIONS,,,,,,,,6.0,IU,UNKNOWN,,2019,Q3,Asthenia,,2019,Q3,4,F,20190606.0,20190705.0,20190619,20190712,EXP,,US-CELGENEUS-USA-20190606794,CELGENE,,77.0,YR,,M,Y,83.8,KG,20190712.0,,MD,US,US,2019,Q3,Elderly
164545044,16454504,30,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,6 INTERNATIONAL UNITS MILLIONS,,,,,,,,6.0,IU,UNKNOWN,,2019,Q3,Delirium,,2019,Q3,4,F,20190606.0,20190705.0,20190619,20190712,EXP,,US-CELGENEUS-USA-20190606794,CELGENE,,77.0,YR,,M,Y,83.8,KG,20190712.0,,MD,US,US,2019,Q3,Elderly
164545044,16454504,30,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,6 INTERNATIONAL UNITS MILLIONS,,,,,,,,6.0,IU,UNKNOWN,,2019,Q3,Hyperglycaemia,,2019,Q3,4,F,20190606.0,20190705.0,20190619,20190712,EXP,,US-CELGENEUS-USA-20190606794,CELGENE,,77.0,YR,,M,Y,83.8,KG,20190712.0,,MD,US,US,2019,Q3,Elderly
164735482,16473548,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,INJECTION,,2019,Q3,Cellulitis,,2019,Q3,2,F,2018.0,20190711.0,20190625,20190718,EXP,,GB-PFIZER INC-2019259879,PFIZER,,85.0,YR,,M,Y,,,20190718.0,,CN,GB,GB,2019,Q3,Elderly
164735482,16473548,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,INJECTION,,2019,Q3,Labelled drug-drug interaction medication error,,2019,Q3,2,F,2018.0,20190711.0,20190625,20190718,EXP,,GB-PFIZER INC-2019259879,PFIZER,,85.0,YR,,M,Y,,,20190718.0,,CN,GB,GB,2019,Q3,Elderly
164755042,16475504,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,15 UNIT,,,U,,,,,15.0,DF,,,2019,Q3,Pain in extremity,,2019,Q3,2,F,20181016.0,20190828.0,20190625,20190904,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-061130,BRISTOL MYERS SQUIBB,,63.0,YR,,M,Y,112.7,KG,20190904.0,,OT,US,US,2019,Q3,Adult
164819572,16481957,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2019,Q3,Hip fracture,,2019,Q3,2,F,20190617.0,20190730.0,20190627,20190807,EXP,,US-SA-2019SA169775,SANOFI AVENTIS,,65.0,YR,E,F,Y,,,20190807.0,,CN,US,US,2019,Q3,Elderly
164819572,16481957,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2019,Q3,Type 2 diabetes mellitus,,2019,Q3,2,F,20190617.0,20190730.0,20190627,20190807,EXP,,US-SA-2019SA169775,SANOFI AVENTIS,,65.0,YR,E,F,Y,,,20190807.0,,CN,US,US,2019,Q3,Elderly
165000581,16500058,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK (NK IE, NACH BZ)",,,U,,,,,,,,,2019,Q3,Dyspnoea,,2019,Q3,1,I,20170505.0,20190628.0,20190701,20190701,EXP,,PHHY2019DE150163,SANDOZ,,53.0,YR,,M,Y,166.0,KG,20190701.0,,OT,DE,DE,2019,Q3,Adult
165000581,16500058,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK (NK IE, NACH BZ)",,,U,,,,,,,,,2019,Q3,Product prescribing error,,2019,Q3,1,I,20170505.0,20190628.0,20190701,20190701,EXP,,PHHY2019DE150163,SANDOZ,,53.0,YR,,M,Y,166.0,KG,20190701.0,,OT,DE,DE,2019,Q3,Adult
165003991,16500399,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,LISPRO + GLARGINE: 52 UNIT/DAY,,,U,,,,,,,,,2019,Q3,Amyloidosis,Amyloidosis,2019,Q3,1,I,,20190617.0,20190701,20190701,EXP,,JP-ALVOGEN-2019-ALVOGEN-100354,ALVOGEN,"IWAYA K, ZAKO T, FUKUNAGA J, SORGJERD KM, OGATA K, KOGURE K, ET AL. TOXICITY OF INSULIN-DERIVED AMYLOIDOSIS: A CASE REPORT. BMC ENDOCR DISORD. 2019 JUN 13;19(1):61.",58.0,YR,,M,Y,,,20190701.0,,OT,JP,JP,2019,Q3,Adult
165003991,16500399,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,LISPRO + GLARGINE: 52 UNIT/DAY,,,U,,,,,,,,,2019,Q3,Condition aggravated,Condition aggravated,2019,Q3,1,I,,20190617.0,20190701,20190701,EXP,,JP-ALVOGEN-2019-ALVOGEN-100354,ALVOGEN,"IWAYA K, ZAKO T, FUKUNAGA J, SORGJERD KM, OGATA K, KOGURE K, ET AL. TOXICITY OF INSULIN-DERIVED AMYLOIDOSIS: A CASE REPORT. BMC ENDOCR DISORD. 2019 JUN 13;19(1):61.",58.0,YR,,M,Y,,,20190701.0,,OT,JP,JP,2019,Q3,Adult
165003991,16500399,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,LISPRO + GLARGINE: 52 UNIT/DAY,,,U,,,,,,,,,2019,Q3,Renal impairment,Renal impairment,2019,Q3,1,I,,20190617.0,20190701,20190701,EXP,,JP-ALVOGEN-2019-ALVOGEN-100354,ALVOGEN,"IWAYA K, ZAKO T, FUKUNAGA J, SORGJERD KM, OGATA K, KOGURE K, ET AL. TOXICITY OF INSULIN-DERIVED AMYLOIDOSIS: A CASE REPORT. BMC ENDOCR DISORD. 2019 JUN 13;19(1):61.",58.0,YR,,M,Y,,,20190701.0,,OT,JP,JP,2019,Q3,Adult
165219735,16521973,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,U,,,,,,,,2019,Q3,Cardiac disorder,,2019,Q3,5,F,20181122.0,20190920.0,20190702,20190926,EXP,,FR-MYLANLABS-2019M1061210,MYLAN,,68.0,YR,,F,Y,83.3,KG,20190926.0,,MD,FR,FR,2019,Q3,Elderly
165219735,16521973,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,U,,,,,,,,2019,Q3,Diabetes mellitus,,2019,Q3,5,F,20181122.0,20190920.0,20190702,20190926,EXP,,FR-MYLANLABS-2019M1061210,MYLAN,,68.0,YR,,F,Y,83.3,KG,20190926.0,,MD,FR,FR,2019,Q3,Elderly
165219735,16521973,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,U,,,,,,,,2019,Q3,Fluid overload,,2019,Q3,5,F,20181122.0,20190920.0,20190702,20190926,EXP,,FR-MYLANLABS-2019M1061210,MYLAN,,68.0,YR,,F,Y,83.3,KG,20190926.0,,MD,FR,FR,2019,Q3,Elderly
165219735,16521973,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,U,,,,,,,,2019,Q3,Haematuria,,2019,Q3,5,F,20181122.0,20190920.0,20190702,20190926,EXP,,FR-MYLANLABS-2019M1061210,MYLAN,,68.0,YR,,F,Y,83.3,KG,20190926.0,,MD,FR,FR,2019,Q3,Elderly
165219735,16521973,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,U,,,,,,,,2019,Q3,Hyperkalaemia,,2019,Q3,5,F,20181122.0,20190920.0,20190702,20190926,EXP,,FR-MYLANLABS-2019M1061210,MYLAN,,68.0,YR,,F,Y,83.3,KG,20190926.0,,MD,FR,FR,2019,Q3,Elderly
165219735,16521973,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,U,,,,,,,,2019,Q3,Hypertension,,2019,Q3,5,F,20181122.0,20190920.0,20190702,20190926,EXP,,FR-MYLANLABS-2019M1061210,MYLAN,,68.0,YR,,F,Y,83.3,KG,20190926.0,,MD,FR,FR,2019,Q3,Elderly
165219735,16521973,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,U,,,,,,,,2019,Q3,Hypomagnesaemia,,2019,Q3,5,F,20181122.0,20190920.0,20190702,20190926,EXP,,FR-MYLANLABS-2019M1061210,MYLAN,,68.0,YR,,F,Y,83.3,KG,20190926.0,,MD,FR,FR,2019,Q3,Elderly
165219735,16521973,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,U,,,,,,,,2019,Q3,Nausea,,2019,Q3,5,F,20181122.0,20190920.0,20190702,20190926,EXP,,FR-MYLANLABS-2019M1061210,MYLAN,,68.0,YR,,F,Y,83.3,KG,20190926.0,,MD,FR,FR,2019,Q3,Elderly
165219735,16521973,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,U,,,,,,,,2019,Q3,Pyelonephritis,,2019,Q3,5,F,20181122.0,20190920.0,20190702,20190926,EXP,,FR-MYLANLABS-2019M1061210,MYLAN,,68.0,YR,,F,Y,83.3,KG,20190926.0,,MD,FR,FR,2019,Q3,Elderly
165219735,16521973,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,U,,,,,,,,2019,Q3,Renal impairment,,2019,Q3,5,F,20181122.0,20190920.0,20190702,20190926,EXP,,FR-MYLANLABS-2019M1061210,MYLAN,,68.0,YR,,F,Y,83.3,KG,20190926.0,,MD,FR,FR,2019,Q3,Elderly
165219735,16521973,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,U,,,,,,,,2019,Q3,Serum sickness,,2019,Q3,5,F,20181122.0,20190920.0,20190702,20190926,EXP,,FR-MYLANLABS-2019M1061210,MYLAN,,68.0,YR,,F,Y,83.3,KG,20190926.0,,MD,FR,FR,2019,Q3,Elderly
165322071,16532207,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,INJECTION,,2019,Q3,Angina pectoris,,2019,Q3,1,I,,20190329.0,20190705,20190705,EXP,,CA-ALVOGEN-2019-ALVOGEN-099556,ALVOGEN,,61.0,YR,,F,Y,,,20190705.0,,OT,CA,US,2019,Q3,Adult
165322071,16532207,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,INJECTION,,2019,Q3,Arterial occlusive disease,,2019,Q3,1,I,,20190329.0,20190705,20190705,EXP,,CA-ALVOGEN-2019-ALVOGEN-099556,ALVOGEN,,61.0,YR,,F,Y,,,20190705.0,,OT,CA,US,2019,Q3,Adult
165322071,16532207,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,INJECTION,,2019,Q3,Arthritis,,2019,Q3,1,I,,20190329.0,20190705,20190705,EXP,,CA-ALVOGEN-2019-ALVOGEN-099556,ALVOGEN,,61.0,YR,,F,Y,,,20190705.0,,OT,CA,US,2019,Q3,Adult
165322071,16532207,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,INJECTION,,2019,Q3,Asthenia,,2019,Q3,1,I,,20190329.0,20190705,20190705,EXP,,CA-ALVOGEN-2019-ALVOGEN-099556,ALVOGEN,,61.0,YR,,F,Y,,,20190705.0,,OT,CA,US,2019,Q3,Adult
165322071,16532207,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,INJECTION,,2019,Q3,Blood pressure increased,,2019,Q3,1,I,,20190329.0,20190705,20190705,EXP,,CA-ALVOGEN-2019-ALVOGEN-099556,ALVOGEN,,61.0,YR,,F,Y,,,20190705.0,,OT,CA,US,2019,Q3,Adult
165322071,16532207,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,INJECTION,,2019,Q3,Cataract,,2019,Q3,1,I,,20190329.0,20190705,20190705,EXP,,CA-ALVOGEN-2019-ALVOGEN-099556,ALVOGEN,,61.0,YR,,F,Y,,,20190705.0,,OT,CA,US,2019,Q3,Adult
165322071,16532207,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,INJECTION,,2019,Q3,Chest discomfort,,2019,Q3,1,I,,20190329.0,20190705,20190705,EXP,,CA-ALVOGEN-2019-ALVOGEN-099556,ALVOGEN,,61.0,YR,,F,Y,,,20190705.0,,OT,CA,US,2019,Q3,Adult
165322071,16532207,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,INJECTION,,2019,Q3,Fatigue,,2019,Q3,1,I,,20190329.0,20190705,20190705,EXP,,CA-ALVOGEN-2019-ALVOGEN-099556,ALVOGEN,,61.0,YR,,F,Y,,,20190705.0,,OT,CA,US,2019,Q3,Adult
165322071,16532207,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,INJECTION,,2019,Q3,Gangrene,,2019,Q3,1,I,,20190329.0,20190705,20190705,EXP,,CA-ALVOGEN-2019-ALVOGEN-099556,ALVOGEN,,61.0,YR,,F,Y,,,20190705.0,,OT,CA,US,2019,Q3,Adult
165322071,16532207,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,INJECTION,,2019,Q3,Gastric disorder,,2019,Q3,1,I,,20190329.0,20190705,20190705,EXP,,CA-ALVOGEN-2019-ALVOGEN-099556,ALVOGEN,,61.0,YR,,F,Y,,,20190705.0,,OT,CA,US,2019,Q3,Adult
165322071,16532207,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,INJECTION,,2019,Q3,Headache,,2019,Q3,1,I,,20190329.0,20190705,20190705,EXP,,CA-ALVOGEN-2019-ALVOGEN-099556,ALVOGEN,,61.0,YR,,F,Y,,,20190705.0,,OT,CA,US,2019,Q3,Adult
165322071,16532207,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,INJECTION,,2019,Q3,Nausea,,2019,Q3,1,I,,20190329.0,20190705,20190705,EXP,,CA-ALVOGEN-2019-ALVOGEN-099556,ALVOGEN,,61.0,YR,,F,Y,,,20190705.0,,OT,CA,US,2019,Q3,Adult
165322071,16532207,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,INJECTION,,2019,Q3,Palpitations,,2019,Q3,1,I,,20190329.0,20190705,20190705,EXP,,CA-ALVOGEN-2019-ALVOGEN-099556,ALVOGEN,,61.0,YR,,F,Y,,,20190705.0,,OT,CA,US,2019,Q3,Adult
165322071,16532207,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,INJECTION,,2019,Q3,Rheumatoid arthritis,,2019,Q3,1,I,,20190329.0,20190705,20190705,EXP,,CA-ALVOGEN-2019-ALVOGEN-099556,ALVOGEN,,61.0,YR,,F,Y,,,20190705.0,,OT,CA,US,2019,Q3,Adult
165322071,16532207,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,INJECTION,,2019,Q3,Sinusitis,,2019,Q3,1,I,,20190329.0,20190705,20190705,EXP,,CA-ALVOGEN-2019-ALVOGEN-099556,ALVOGEN,,61.0,YR,,F,Y,,,20190705.0,,OT,CA,US,2019,Q3,Adult
165326692,16532669,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"100 IU, UNK",,,,,,,,100.0,IU,,,2019,Q3,Cardiac failure,,2019,Q3,2,F,201906.0,20190801.0,20190705,20190812,EXP,,US-INTERCEPT-PM2019001105,INTERCEPT PHARMACEUTICALS,,75.0,YR,,M,Y,,,20190812.0,,MD,US,US,2019,Q3,Elderly
165415951,16541595,4,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,6IU,,,,,,,,,,,,2019,Q3,Myocardial infarction,,2019,Q3,1,I,,20190627.0,20190708,20190708,EXP,,BR-NOVOPROD-671139,NOVO NORDISK,,54.0,YR,,M,Y,,,20190708.0,,CN,BR,BR,2019,Q3,Adult
165429431,16542943,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, UNK",,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q3,Amyloidosis,,2019,Q3,1,I,,20190625.0,20190709,20190709,EXP,,JP-SA-2019SA175267,SANOFI AVENTIS,"IWAYA K., ZAKO T., FUKUNAGA J., SORGJERD K.M., OGATA K., KOGURE K., ET AL.,. TOXICITY OF INSULIN-DERIVED AMYLOIDOSIS: A CASE REPORT. BMC ENDOCRINE DISORDERS. 2019;19(1):1-6",58.0,YR,A,M,Y,,,20190709.0,,OT,JP,JP,2019,Q3,Adult
165429431,16542943,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, UNK",,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q3,Necrosis,,2019,Q3,1,I,,20190625.0,20190709,20190709,EXP,,JP-SA-2019SA175267,SANOFI AVENTIS,"IWAYA K., ZAKO T., FUKUNAGA J., SORGJERD K.M., OGATA K., KOGURE K., ET AL.,. TOXICITY OF INSULIN-DERIVED AMYLOIDOSIS: A CASE REPORT. BMC ENDOCRINE DISORDERS. 2019;19(1):1-6",58.0,YR,A,M,Y,,,20190709.0,,OT,JP,JP,2019,Q3,Adult
165631261,16563126,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"NK IE, NACH BZ",,,U,,,,20563.0,,,,,2019,Q3,Hypoglycaemia,,2019,Q3,1,I,,20190702.0,20190711,20190711,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201907001919,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20190711.0,,CN,DE,DE,2019,Q3,Adult
165631261,16563126,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"NK IE, NACH BZ",,,U,,,,20563.0,,,,,2019,Q3,Product administration error,,2019,Q3,1,I,,20190702.0,20190711,20190711,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201907001919,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20190711.0,,CN,DE,DE,2019,Q3,Adult
165631261,16563126,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"NK IE, NACH BZ",,,U,,,,20563.0,,,,,2019,Q3,Urinary tract infection,,2019,Q3,1,I,,20190702.0,20190711,20190711,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201907001919,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20190711.0,,CN,DE,DE,2019,Q3,Adult
165632551,16563255,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"NK IE, NACH SCHEMA",,,U,,,,,,,,,2019,Q3,Acute kidney injury,,2019,Q3,1,I,,20190708.0,20190711,20190711,EXP,,PHHY2019DE157951,SANDOZ,,78.0,YR,,F,Y,,,20190712.0,,OT,DE,DE,2019,Q3,Elderly
165632551,16563255,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"NK IE, NACH SCHEMA",,,U,,,,,,,,,2019,Q3,Anuria,,2019,Q3,1,I,,20190708.0,20190711,20190711,EXP,,PHHY2019DE157951,SANDOZ,,78.0,YR,,F,Y,,,20190712.0,,OT,DE,DE,2019,Q3,Elderly
165632551,16563255,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"NK IE, NACH SCHEMA",,,U,,,,,,,,,2019,Q3,Overdose,,2019,Q3,1,I,,20190708.0,20190711,20190711,EXP,,PHHY2019DE157951,SANDOZ,,78.0,YR,,F,Y,,,20190712.0,,OT,DE,DE,2019,Q3,Elderly
165632551,16563255,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"NK IE, NACH SCHEMA",,,U,,,,,,,,,2019,Q3,Therapeutic drug monitoring analysis not performed,,2019,Q3,1,I,,20190708.0,20190711,20190711,EXP,,PHHY2019DE157951,SANDOZ,,78.0,YR,,F,Y,,,20190712.0,,OT,DE,DE,2019,Q3,Elderly
165632751,16563275,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"NK IE, NACH BZ",,,U,,,,,,,,,2019,Q3,Diarrhoea,,2019,Q3,1,I,20170625.0,20190708.0,20190711,20190711,EXP,,PHHY2019DE158284,SANDOZ,,66.0,YR,,F,Y,,,20190712.0,,OT,DE,DE,2019,Q3,Elderly
165637113,16563711,6,C,LISPRO,INSULIN LISPRO,1,Subcutaneous,IU,,,,,,,,,,,,2019,Q3,Blood glucose increased,,2019,Q3,3,F,201906.0,20190808.0,20190712,20190814,PER,,US-ASTRAZENECA-2019SE99229,ASTRAZENECA,,491.0,MON,,M,Y,66.7,KG,20190814.0,,,US,US,2019,Q3,Elderly
165637113,16563711,6,C,LISPRO,INSULIN LISPRO,1,Subcutaneous,IU,,,,,,,,,,,,2019,Q3,Circumstance or information capable of leading to medication error,,2019,Q3,3,F,201906.0,20190808.0,20190712,20190814,PER,,US-ASTRAZENECA-2019SE99229,ASTRAZENECA,,491.0,MON,,M,Y,66.7,KG,20190814.0,,,US,US,2019,Q3,Elderly
165637113,16563711,6,C,LISPRO,INSULIN LISPRO,1,Subcutaneous,IU,,,,,,,,,,,,2019,Q3,Product administration error,,2019,Q3,3,F,201906.0,20190808.0,20190712,20190814,PER,,US-ASTRAZENECA-2019SE99229,ASTRAZENECA,,491.0,MON,,M,Y,66.7,KG,20190814.0,,,US,US,2019,Q3,Elderly
165637113,16563711,6,C,LISPRO,INSULIN LISPRO,1,Subcutaneous,IU,,,,,,,,,,,,2019,Q3,Wrong technique in product usage process,,2019,Q3,3,F,201906.0,20190808.0,20190712,20190814,PER,,US-ASTRAZENECA-2019SE99229,ASTRAZENECA,,491.0,MON,,M,Y,66.7,KG,20190814.0,,,US,US,2019,Q3,Elderly
165643701,16564370,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"NK IE, ACCORDING TO SCHEME",,,,,,,,,,,,2019,Q3,Acute kidney injury,,2019,Q3,1,I,,20190705.0,20190712,20190712,EXP,DE-BFARM-19007904,DE-ACCORD-138303,ACCORD,,78.0,YR,E,F,Y,,,20190712.0,,PH,DE,DE,2019,Q3,Elderly
165643701,16564370,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"NK IE, ACCORDING TO SCHEME",,,,,,,,,,,,2019,Q3,Anuria,,2019,Q3,1,I,,20190705.0,20190712,20190712,EXP,DE-BFARM-19007904,DE-ACCORD-138303,ACCORD,,78.0,YR,E,F,Y,,,20190712.0,,PH,DE,DE,2019,Q3,Elderly
165643701,16564370,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"NK IE, ACCORDING TO SCHEME",,,,,,,,,,,,2019,Q3,Medication error,,2019,Q3,1,I,,20190705.0,20190712,20190712,EXP,DE-BFARM-19007904,DE-ACCORD-138303,ACCORD,,78.0,YR,E,F,Y,,,20190712.0,,PH,DE,DE,2019,Q3,Elderly
165643701,16564370,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"NK IE, ACCORDING TO SCHEME",,,,,,,,,,,,2019,Q3,Overdose,,2019,Q3,1,I,,20190705.0,20190712,20190712,EXP,DE-BFARM-19007904,DE-ACCORD-138303,ACCORD,,78.0,YR,E,F,Y,,,20190712.0,,PH,DE,DE,2019,Q3,Elderly
165643701,16564370,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"NK IE, ACCORDING TO SCHEME",,,,,,,,,,,,2019,Q3,Therapeutic drug monitoring analysis not performed,,2019,Q3,1,I,,20190705.0,20190712,20190712,EXP,DE-BFARM-19007904,DE-ACCORD-138303,ACCORD,,78.0,YR,E,F,Y,,,20190712.0,,PH,DE,DE,2019,Q3,Elderly
165669451,16566945,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q3,Hypoglycaemia,,2019,Q3,1,I,,20190702.0,20190712,20190712,EXP,,DE-NOVOPROD-671301,NOVO NORDISK,,55.0,YR,,F,Y,,,20190712.0,,PH,DE,DE,2019,Q3,Adult
165669451,16566945,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q3,Product administration error,,2019,Q3,1,I,,20190702.0,20190712,20190712,EXP,,DE-NOVOPROD-671301,NOVO NORDISK,,55.0,YR,,F,Y,,,20190712.0,,PH,DE,DE,2019,Q3,Adult
165669451,16566945,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q3,Treatment noncompliance,,2019,Q3,1,I,,20190702.0,20190712,20190712,EXP,,DE-NOVOPROD-671301,NOVO NORDISK,,55.0,YR,,F,Y,,,20190712.0,,PH,DE,DE,2019,Q3,Adult
165669451,16566945,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q3,Urinary tract infection,,2019,Q3,1,I,,20190702.0,20190712,20190712,EXP,,DE-NOVOPROD-671301,NOVO NORDISK,,55.0,YR,,F,Y,,,20190712.0,,PH,DE,DE,2019,Q3,Adult
165684531,16568453,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,,16.0,IU,Y,U,,,20563.0,16.0,IU,,QD,2019,Q3,Chest pain,,2019,Q3,1,I,20180616.0,20190702.0,20190712,20190712,EXP,IT-MINISAL02-560546,IT-ELI_LILLY_AND_COMPANY-IT201907001965,ELI LILLY AND CO,,86.0,YR,,M,Y,,,20190712.0,,CN,IT,IT,2019,Q3,Elderly
165684531,16568453,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,,16.0,IU,Y,U,,,20563.0,16.0,IU,,QD,2019,Q3,Hypoglycaemia,,2019,Q3,1,I,20180616.0,20190702.0,20190712,20190712,EXP,IT-MINISAL02-560546,IT-ELI_LILLY_AND_COMPANY-IT201907001965,ELI LILLY AND CO,,86.0,YR,,M,Y,,,20190712.0,,CN,IT,IT,2019,Q3,Elderly
165684531,16568453,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,,16.0,IU,Y,U,,,20563.0,16.0,IU,,QD,2019,Q3,Product administration error,,2019,Q3,1,I,20180616.0,20190702.0,20190712,20190712,EXP,IT-MINISAL02-560546,IT-ELI_LILLY_AND_COMPANY-IT201907001965,ELI LILLY AND CO,,86.0,YR,,M,Y,,,20190712.0,,CN,IT,IT,2019,Q3,Elderly
165686141,16568614,3,C,lispro Insulin,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q3,Chest pain,,2019,Q3,1,I,20190624.0,20190706.0,20190712,20190712,EXP,,CO-BAXTER-2019BAX013809,BAXTER,,64.0,YR,,M,Y,64.0,KG,20190712.0,,OT,CO,CO,2019,Q3,Adult
165686141,16568614,3,C,lispro Insulin,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q3,Death,,2019,Q3,1,I,20190624.0,20190706.0,20190712,20190712,EXP,,CO-BAXTER-2019BAX013809,BAXTER,,64.0,YR,,M,Y,64.0,KG,20190712.0,,OT,CO,CO,2019,Q3,Adult
165686141,16568614,3,C,lispro Insulin,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q3,Dyspnoea,,2019,Q3,1,I,20190624.0,20190706.0,20190712,20190712,EXP,,CO-BAXTER-2019BAX013809,BAXTER,,64.0,YR,,M,Y,64.0,KG,20190712.0,,OT,CO,CO,2019,Q3,Adult
165698401,16569840,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q3,Blood glucose decreased,,2019,Q3,1,I,,20190701.0,20190715,20190715,EXP,,US-SA-2019SA179894,SANOFI AVENTIS,,74.0,YR,E,M,Y,,,20190715.0,,CN,US,US,2019,Q3,Elderly
165698401,16569840,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q3,Haemorrhoids,,2019,Q3,1,I,,20190701.0,20190715,20190715,EXP,,US-SA-2019SA179894,SANOFI AVENTIS,,74.0,YR,E,M,Y,,,20190715.0,,CN,US,US,2019,Q3,Elderly
165698401,16569840,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q3,Macular degeneration,,2019,Q3,1,I,,20190701.0,20190715,20190715,EXP,,US-SA-2019SA179894,SANOFI AVENTIS,,74.0,YR,E,M,Y,,,20190715.0,,CN,US,US,2019,Q3,Elderly
165698401,16569840,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q3,Nasopharyngitis,,2019,Q3,1,I,,20190701.0,20190715,20190715,EXP,,US-SA-2019SA179894,SANOFI AVENTIS,,74.0,YR,E,M,Y,,,20190715.0,,CN,US,US,2019,Q3,Elderly
165698401,16569840,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q3,Stress,,2019,Q3,1,I,,20190701.0,20190715,20190715,EXP,,US-SA-2019SA179894,SANOFI AVENTIS,,74.0,YR,E,M,Y,,,20190715.0,,CN,US,US,2019,Q3,Elderly
165698401,16569840,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q3,Tremor,,2019,Q3,1,I,,20190701.0,20190715,20190715,EXP,,US-SA-2019SA179894,SANOFI AVENTIS,,74.0,YR,E,M,Y,,,20190715.0,,CN,US,US,2019,Q3,Elderly
165698401,16569840,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q3,Visual impairment,,2019,Q3,1,I,,20190701.0,20190715,20190715,EXP,,US-SA-2019SA179894,SANOFI AVENTIS,,74.0,YR,E,M,Y,,,20190715.0,,CN,US,US,2019,Q3,Elderly
165699151,16569915,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, QD",,,Y,,,,,16.0,IU,SOLUTION FOR INJECTION,QD,2019,Q3,Chest pain,,2019,Q3,1,I,20180616.0,20190705.0,20190715,20190715,EXP,IT-MINISAL02-560546,IT-SA-2019SA183789,SANOFI AVENTIS,,86.0,YR,E,M,Y,,,20190715.0,,MD,IT,IT,2019,Q3,Elderly
165699151,16569915,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, QD",,,Y,,,,,16.0,IU,SOLUTION FOR INJECTION,QD,2019,Q3,Cold sweat,,2019,Q3,1,I,20180616.0,20190705.0,20190715,20190715,EXP,IT-MINISAL02-560546,IT-SA-2019SA183789,SANOFI AVENTIS,,86.0,YR,E,M,Y,,,20190715.0,,MD,IT,IT,2019,Q3,Elderly
165699151,16569915,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, QD",,,Y,,,,,16.0,IU,SOLUTION FOR INJECTION,QD,2019,Q3,Hypoglycaemia,,2019,Q3,1,I,20180616.0,20190705.0,20190715,20190715,EXP,IT-MINISAL02-560546,IT-SA-2019SA183789,SANOFI AVENTIS,,86.0,YR,E,M,Y,,,20190715.0,,MD,IT,IT,2019,Q3,Elderly
165699151,16569915,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, QD",,,Y,,,,,16.0,IU,SOLUTION FOR INJECTION,QD,2019,Q3,Malaise,,2019,Q3,1,I,20180616.0,20190705.0,20190715,20190715,EXP,IT-MINISAL02-560546,IT-SA-2019SA183789,SANOFI AVENTIS,,86.0,YR,E,M,Y,,,20190715.0,,MD,IT,IT,2019,Q3,Elderly
165699151,16569915,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, QD",,,Y,,,,,16.0,IU,SOLUTION FOR INJECTION,QD,2019,Q3,Product administration error,,2019,Q3,1,I,20180616.0,20190705.0,20190715,20190715,EXP,IT-MINISAL02-560546,IT-SA-2019SA183789,SANOFI AVENTIS,,86.0,YR,E,M,Y,,,20190715.0,,MD,IT,IT,2019,Q3,Elderly
165701891,16570189,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,209196.0,,,,,2019,Q3,Hypoglycaemia,,2019,Q3,1,I,,20190705.0,20190715,20190715,EXP,,DE-SA-2019SA183821,SANOFI AVENTIS,,55.0,YR,A,F,Y,,,20190715.0,,PH,DE,DE,2019,Q3,Adult
165701891,16570189,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,209196.0,,,,,2019,Q3,Product administration error,,2019,Q3,1,I,,20190705.0,20190715,20190715,EXP,,DE-SA-2019SA183821,SANOFI AVENTIS,,55.0,YR,A,F,Y,,,20190715.0,,PH,DE,DE,2019,Q3,Adult
165701891,16570189,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,209196.0,,,,,2019,Q3,Urinary tract infection,,2019,Q3,1,I,,20190705.0,20190715,20190715,EXP,,DE-SA-2019SA183821,SANOFI AVENTIS,,55.0,YR,A,F,Y,,,20190715.0,,PH,DE,DE,2019,Q3,Adult
165725961,16572596,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q3,Blood glucose increased,,2019,Q3,1,I,,20190708.0,20190715,20190715,PER,,US-SA-2019SA184740,SANOFI AVENTIS,,72.0,YR,E,F,Y,,,20190715.0,,CN,US,US,2019,Q3,Elderly
165725961,16572596,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q3,Inappropriate schedule of product administration,,2019,Q3,1,I,,20190708.0,20190715,20190715,PER,,US-SA-2019SA184740,SANOFI AVENTIS,,72.0,YR,E,F,Y,,,20190715.0,,CN,US,US,2019,Q3,Elderly
165823681,16582368,5,C,Insulin lispro,INSULIN LISPRO,1,,"NK IE, ACCORDING TO BZ",,,,,,,,,,,,2019,Q3,Diarrhoea,,2019,Q3,1,I,20170625.0,20190710.0,20190717,20190717,EXP,,DE-TEVA-2019-DE-1077176,TEVA,,66.0,YR,,F,Y,,,20190717.0,,PH,DE,DE,2019,Q3,Elderly
165840251,16584025,12,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q3,Dyspnoea,,2019,Q3,1,I,20190715.0,,20190716,20190716,DIR,,,FDA-CTU,,83.0,YR,,M,N,125.55,KG,20190716.0,N,OT,US,US,2019,Q3,Elderly
165852081,16585208,7,C,Insulin lispro,INSULIN LISPRO,1,,"NK IE, BY SCHEME",,,U,,,,,,,,,2019,Q3,Acute kidney injury,,2019,Q3,1,I,,20190710.0,20190717,20190717,EXP,,DE-TEVA-2019-DE-1077142,TEVA,,78.0,YR,,F,Y,,,20190717.0,,PH,DE,DE,2019,Q3,Elderly
165852081,16585208,7,C,Insulin lispro,INSULIN LISPRO,1,,"NK IE, BY SCHEME",,,U,,,,,,,,,2019,Q3,Anuria,,2019,Q3,1,I,,20190710.0,20190717,20190717,EXP,,DE-TEVA-2019-DE-1077142,TEVA,,78.0,YR,,F,Y,,,20190717.0,,PH,DE,DE,2019,Q3,Elderly
165852081,16585208,7,C,Insulin lispro,INSULIN LISPRO,1,,"NK IE, BY SCHEME",,,U,,,,,,,,,2019,Q3,Overdose,,2019,Q3,1,I,,20190710.0,20190717,20190717,EXP,,DE-TEVA-2019-DE-1077142,TEVA,,78.0,YR,,F,Y,,,20190717.0,,PH,DE,DE,2019,Q3,Elderly
165852081,16585208,7,C,Insulin lispro,INSULIN LISPRO,1,,"NK IE, BY SCHEME",,,U,,,,,,,,,2019,Q3,Therapeutic drug monitoring analysis not performed,,2019,Q3,1,I,,20190710.0,20190717,20190717,EXP,,DE-TEVA-2019-DE-1077142,TEVA,,78.0,YR,,F,Y,,,20190717.0,,PH,DE,DE,2019,Q3,Elderly
165869122,16586912,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 U, TID",,,U,,,,,,,SOLUTION FOR INJECTION,Q8H,2019,Q3,Blood glucose decreased,,2019,Q3,2,F,,20190731.0,20190717,20190809,PER,,US-SA-2019SA186416,SANOFI AVENTIS,,81.0,YR,E,F,Y,,,20190809.0,,OT,US,US,2019,Q3,Elderly
165869122,16586912,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 U, TID",,,U,,,,,,,SOLUTION FOR INJECTION,Q8H,2019,Q3,Cough,,2019,Q3,2,F,,20190731.0,20190717,20190809,PER,,US-SA-2019SA186416,SANOFI AVENTIS,,81.0,YR,E,F,Y,,,20190809.0,,OT,US,US,2019,Q3,Elderly
165922712,16592271,3,SS,Insulin Lispro,INSULIN LISPRO,1,,,,,U,U,,,,,,,,2019,Q3,Blood glucose fluctuation,,2019,Q3,2,F,,20190705.0,20190718,20190718,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201907006318,ELI LILLY AND CO,"LIU YIN-PING, DONG LING-FANG, WANG YAN.MEDICATION ANALYSIS AND PHARMACEUTICAL CARE ON A CASE OF GESTATIONAL DIABETES MELLITUS WITH INSULIN ALLERGY.CHINESE JOURNAL OF DRUG APPLICATION AND MONITORING 2019;16 (2):.",31.0,YR,,F,Y,92.0,KG,20190718.0,,OT,CN,CN,2019,Q3,Young Adult
165922712,16592271,3,SS,Insulin Lispro,INSULIN LISPRO,1,,,,,U,U,,,,,,,,2019,Q3,Blood glucose increased,,2019,Q3,2,F,,20190705.0,20190718,20190718,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201907006318,ELI LILLY AND CO,"LIU YIN-PING, DONG LING-FANG, WANG YAN.MEDICATION ANALYSIS AND PHARMACEUTICAL CARE ON A CASE OF GESTATIONAL DIABETES MELLITUS WITH INSULIN ALLERGY.CHINESE JOURNAL OF DRUG APPLICATION AND MONITORING 2019;16 (2):.",31.0,YR,,F,Y,92.0,KG,20190718.0,,OT,CN,CN,2019,Q3,Young Adult
165922712,16592271,3,SS,Insulin Lispro,INSULIN LISPRO,1,,,,,U,U,,,,,,,,2019,Q3,Drug hypersensitivity,,2019,Q3,2,F,,20190705.0,20190718,20190718,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201907006318,ELI LILLY AND CO,"LIU YIN-PING, DONG LING-FANG, WANG YAN.MEDICATION ANALYSIS AND PHARMACEUTICAL CARE ON A CASE OF GESTATIONAL DIABETES MELLITUS WITH INSULIN ALLERGY.CHINESE JOURNAL OF DRUG APPLICATION AND MONITORING 2019;16 (2):.",31.0,YR,,F,Y,92.0,KG,20190718.0,,OT,CN,CN,2019,Q3,Young Adult
165922712,16592271,3,SS,Insulin Lispro,INSULIN LISPRO,1,,,,,U,U,,,,,,,,2019,Q3,Injection site urticaria,,2019,Q3,2,F,,20190705.0,20190718,20190718,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201907006318,ELI LILLY AND CO,"LIU YIN-PING, DONG LING-FANG, WANG YAN.MEDICATION ANALYSIS AND PHARMACEUTICAL CARE ON A CASE OF GESTATIONAL DIABETES MELLITUS WITH INSULIN ALLERGY.CHINESE JOURNAL OF DRUG APPLICATION AND MONITORING 2019;16 (2):.",31.0,YR,,F,Y,92.0,KG,20190718.0,,OT,CN,CN,2019,Q3,Young Adult
165922712,16592271,3,SS,Insulin Lispro,INSULIN LISPRO,1,,,,,U,U,,,,,,,,2019,Q3,Maternal exposure during pregnancy,,2019,Q3,2,F,,20190705.0,20190718,20190718,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201907006318,ELI LILLY AND CO,"LIU YIN-PING, DONG LING-FANG, WANG YAN.MEDICATION ANALYSIS AND PHARMACEUTICAL CARE ON A CASE OF GESTATIONAL DIABETES MELLITUS WITH INSULIN ALLERGY.CHINESE JOURNAL OF DRUG APPLICATION AND MONITORING 2019;16 (2):.",31.0,YR,,F,Y,92.0,KG,20190718.0,,OT,CN,CN,2019,Q3,Young Adult
165930381,16593038,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 IU, TOTAL",40.0,IU,D,,,,,40.0,IU,SOLUTION FOR INJECTION,,2019,Q3,Hypoglycaemia,,2019,Q3,1,I,20181223.0,20190711.0,20190718,20190718,EXP,IT-MINISAL02-561503,IT-SA-2019SA187879,SANOFI AVENTIS,,80.0,YR,E,M,Y,,,20190718.0,,MD,IT,IT,2019,Q3,Elderly
165930381,16593038,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 IU, TOTAL",40.0,IU,D,,,,,40.0,IU,SOLUTION FOR INJECTION,,2019,Q3,Malaise,,2019,Q3,1,I,20181223.0,20190711.0,20190718,20190718,EXP,IT-MINISAL02-561503,IT-SA-2019SA187879,SANOFI AVENTIS,,80.0,YR,E,M,Y,,,20190718.0,,MD,IT,IT,2019,Q3,Elderly
165949132,16594913,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"16 U, DAILY",,,,, C798638,,20563.0,16.0,IU,,QD,2019,Q3,Back pain,,2019,Q3,2,F,,20190710.0,20190718,20190723,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201907006482,ELI LILLY AND CO,,63.0,YR,,M,Y,75.0,KG,20190722.0,,CN,CN,CN,2019,Q3,Adult
165949132,16594913,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"16 U, DAILY",,,,, C798638,,20563.0,16.0,IU,,QD,2019,Q3,Blood glucose increased,,2019,Q3,2,F,,20190710.0,20190718,20190723,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201907006482,ELI LILLY AND CO,,63.0,YR,,M,Y,75.0,KG,20190722.0,,CN,CN,CN,2019,Q3,Adult
165949132,16594913,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"16 U, DAILY",,,,, C798638,,20563.0,16.0,IU,,QD,2019,Q3,Fat tissue increased,,2019,Q3,2,F,,20190710.0,20190718,20190723,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201907006482,ELI LILLY AND CO,,63.0,YR,,M,Y,75.0,KG,20190722.0,,CN,CN,CN,2019,Q3,Adult
165949132,16594913,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"16 U, DAILY",,,,, C798638,,20563.0,16.0,IU,,QD,2019,Q3,Joint stiffness,,2019,Q3,2,F,,20190710.0,20190718,20190723,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201907006482,ELI LILLY AND CO,,63.0,YR,,M,Y,75.0,KG,20190722.0,,CN,CN,CN,2019,Q3,Adult
165949132,16594913,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"16 U, DAILY",,,,, C798638,,20563.0,16.0,IU,,QD,2019,Q3,Musculoskeletal stiffness,,2019,Q3,2,F,,20190710.0,20190718,20190723,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201907006482,ELI LILLY AND CO,,63.0,YR,,M,Y,75.0,KG,20190722.0,,CN,CN,CN,2019,Q3,Adult
165949132,16594913,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"16 U, DAILY",,,,, C798638,,20563.0,16.0,IU,,QD,2019,Q3,Protein urine present,,2019,Q3,2,F,,20190710.0,20190718,20190723,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201907006482,ELI LILLY AND CO,,63.0,YR,,M,Y,75.0,KG,20190722.0,,CN,CN,CN,2019,Q3,Adult
165949132,16594913,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"16 U, DAILY",,,,, C798638,,20563.0,16.0,IU,,QD,2019,Q3,Swelling,,2019,Q3,2,F,,20190710.0,20190718,20190723,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201907006482,ELI LILLY AND CO,,63.0,YR,,M,Y,75.0,KG,20190722.0,,CN,CN,CN,2019,Q3,Adult
165949132,16594913,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, C798638,,20563.0,,,,,2019,Q3,Back pain,,2019,Q3,2,F,,20190710.0,20190718,20190723,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201907006482,ELI LILLY AND CO,,63.0,YR,,M,Y,75.0,KG,20190722.0,,CN,CN,CN,2019,Q3,Adult
165949132,16594913,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, C798638,,20563.0,,,,,2019,Q3,Blood glucose increased,,2019,Q3,2,F,,20190710.0,20190718,20190723,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201907006482,ELI LILLY AND CO,,63.0,YR,,M,Y,75.0,KG,20190722.0,,CN,CN,CN,2019,Q3,Adult
165949132,16594913,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, C798638,,20563.0,,,,,2019,Q3,Fat tissue increased,,2019,Q3,2,F,,20190710.0,20190718,20190723,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201907006482,ELI LILLY AND CO,,63.0,YR,,M,Y,75.0,KG,20190722.0,,CN,CN,CN,2019,Q3,Adult
165949132,16594913,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, C798638,,20563.0,,,,,2019,Q3,Joint stiffness,,2019,Q3,2,F,,20190710.0,20190718,20190723,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201907006482,ELI LILLY AND CO,,63.0,YR,,M,Y,75.0,KG,20190722.0,,CN,CN,CN,2019,Q3,Adult
165949132,16594913,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, C798638,,20563.0,,,,,2019,Q3,Musculoskeletal stiffness,,2019,Q3,2,F,,20190710.0,20190718,20190723,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201907006482,ELI LILLY AND CO,,63.0,YR,,M,Y,75.0,KG,20190722.0,,CN,CN,CN,2019,Q3,Adult
165949132,16594913,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, C798638,,20563.0,,,,,2019,Q3,Protein urine present,,2019,Q3,2,F,,20190710.0,20190718,20190723,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201907006482,ELI LILLY AND CO,,63.0,YR,,M,Y,75.0,KG,20190722.0,,CN,CN,CN,2019,Q3,Adult
165949132,16594913,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, C798638,,20563.0,,,,,2019,Q3,Swelling,,2019,Q3,2,F,,20190710.0,20190718,20190723,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201907006482,ELI LILLY AND CO,,63.0,YR,,M,Y,75.0,KG,20190722.0,,CN,CN,CN,2019,Q3,Adult
166007011,16600701,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,"10 IU, 3X/DAY (INJECT 10 UNITS SUBCUTANEOUSLY THREE TIMES DAILY WITH MEALS)",,,,,,,,10.0,IU,INJECTION,TID,2019,Q3,Confusional state,,2019,Q3,1,I,,20160720.0,20190719,20190719,PER,,US-PFIZER INC-2016354812,PFIZER,,65.0,YR,,M,Y,89.8,KG,20190719.0,,MD,US,US,2019,Q3,Elderly
166089051,16608905,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q3,Amyloidosis,,2019,Q3,1,I,,20190715.0,20190722,20190722,EXP,,JP-TEVA-2019-JP-1081388,TEVA,"IWAYA K, ZAKO T, FUKUNAGA J, SORGJERD KM, OGATA K, KOGURE K, ET AL. TOXICITY OF INSULIN-DERIVED AMYLOIDOSIS: A CASE REPORT. BMC-ENDOCR-DISORD 2019;19(1):61.",58.0,YR,,M,Y,,,20190722.0,,OT,JP,JP,2019,Q3,Adult
166089051,16608905,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q3,Fat necrosis,,2019,Q3,1,I,,20190715.0,20190722,20190722,EXP,,JP-TEVA-2019-JP-1081388,TEVA,"IWAYA K, ZAKO T, FUKUNAGA J, SORGJERD KM, OGATA K, KOGURE K, ET AL. TOXICITY OF INSULIN-DERIVED AMYLOIDOSIS: A CASE REPORT. BMC-ENDOCR-DISORD 2019;19(1):61.",58.0,YR,,M,Y,,,20190722.0,,OT,JP,JP,2019,Q3,Adult
166089051,16608905,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q3,Injection site mass,,2019,Q3,1,I,,20190715.0,20190722,20190722,EXP,,JP-TEVA-2019-JP-1081388,TEVA,"IWAYA K, ZAKO T, FUKUNAGA J, SORGJERD KM, OGATA K, KOGURE K, ET AL. TOXICITY OF INSULIN-DERIVED AMYLOIDOSIS: A CASE REPORT. BMC-ENDOCR-DISORD 2019;19(1):61.",58.0,YR,,M,Y,,,20190722.0,,OT,JP,JP,2019,Q3,Adult
166100741,16610074,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Abdominal pain,,2019,Q3,1,I,,20190717.0,20190722,20190722,EXP,,CA-PFIZER INC-2019310601,PFIZER,,24.0,YR,,F,Y,95.0,KG,20190722.0,,PH,CA,CA,2019,Q3,Young Adult
166100741,16610074,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Diabetic ketoacidosis,,2019,Q3,1,I,,20190717.0,20190722,20190722,EXP,,CA-PFIZER INC-2019310601,PFIZER,,24.0,YR,,F,Y,95.0,KG,20190722.0,,PH,CA,CA,2019,Q3,Young Adult
166100741,16610074,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Malaise,,2019,Q3,1,I,,20190717.0,20190722,20190722,EXP,,CA-PFIZER INC-2019310601,PFIZER,,24.0,YR,,F,Y,95.0,KG,20190722.0,,PH,CA,CA,2019,Q3,Young Adult
166100741,16610074,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Pulmonary embolism,,2019,Q3,1,I,,20190717.0,20190722,20190722,EXP,,CA-PFIZER INC-2019310601,PFIZER,,24.0,YR,,F,Y,95.0,KG,20190722.0,,PH,CA,CA,2019,Q3,Young Adult
166186881,16618688,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"1 DOSAGE FORM, DAILY",486.0,DF,Y,U,,,20563.0,1.0,DF,,QD,2019,Q3,Hypoglycaemia,,2019,Q3,1,I,20190502.0,20190715.0,20190723,20190723,EXP,IT-MINISAL02-563396,IT-ELI_LILLY_AND_COMPANY-IT201907008441,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20190723.0,,CN,IT,IT,2019,Q3,Elderly
166186881,16618688,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"1 DOSAGE FORM, DAILY",486.0,DF,Y,U,,,20563.0,1.0,DF,,QD,2019,Q3,Sopor,,2019,Q3,1,I,20190502.0,20190715.0,20190723,20190723,EXP,IT-MINISAL02-563396,IT-ELI_LILLY_AND_COMPANY-IT201907008441,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20190723.0,,CN,IT,IT,2019,Q3,Elderly
166201901,16620190,28,C,INSULIN LISPRO DCI,,2,,,,,,,,,,,,,,2019,Q3,Deep vein thrombosis,,2019,Q3,1,I,20190226.0,20190325.0,20190723,20190723,EXP,,US-IGSA-SR10008089,GRIFOLS,,51.0,YR,,F,Y,69.0,KG,20190723.0,,OT,US,US,2019,Q3,Adult
166201901,16620190,28,C,INSULIN LISPRO DCI,,2,,,,,,,,,,,,,,2019,Q3,Pain,,2019,Q3,1,I,20190226.0,20190325.0,20190723,20190723,EXP,,US-IGSA-SR10008089,GRIFOLS,,51.0,YR,,F,Y,69.0,KG,20190723.0,,OT,US,US,2019,Q3,Adult
166201901,16620190,28,C,INSULIN LISPRO DCI,,2,,,,,,,,,,,,,,2019,Q3,Pulmonary embolism,,2019,Q3,1,I,20190226.0,20190325.0,20190723,20190723,EXP,,US-IGSA-SR10008089,GRIFOLS,,51.0,YR,,F,Y,69.0,KG,20190723.0,,OT,US,US,2019,Q3,Adult
166256182,16625618,6,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,TID,2019,Q3,Seizure,,2019,Q3,2,F,20190719.0,20190725.0,20190724,20190731,EXP,,DE-ABBVIE-19K-062-2860383-00,ABBVIE,,81.0,YR,,M,Y,,,20190731.0,,CN,DE,DE,2019,Q3,Elderly
166268621,16626862,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"4 U, TID",,,,,,,,,,SOLUTION FOR INJECTION,Q8H,2019,Q3,Blood glucose decreased,,2019,Q3,1,I,2019.0,20190715.0,20190724,20190724,PER,,US-SA-2019SA195067,SANOFI AVENTIS,,66.0,YR,E,F,Y,76.19,KG,20190724.0,,CN,US,US,2019,Q3,Elderly
166268621,16626862,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"4 U, TID",,,,,,,,,,SOLUTION FOR INJECTION,Q8H,2019,Q3,Nervousness,,2019,Q3,1,I,2019.0,20190715.0,20190724,20190724,PER,,US-SA-2019SA195067,SANOFI AVENTIS,,66.0,YR,E,F,Y,76.19,KG,20190724.0,,CN,US,US,2019,Q3,Elderly
166268621,16626862,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"4 U, TID",,,,,,,,,,SOLUTION FOR INJECTION,Q8H,2019,Q3,Product dose omission,,2019,Q3,1,I,2019.0,20190715.0,20190724,20190724,PER,,US-SA-2019SA195067,SANOFI AVENTIS,,66.0,YR,E,F,Y,76.19,KG,20190724.0,,CN,US,US,2019,Q3,Elderly
166268621,16626862,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"4 U, TID",,,,,,,,,,SOLUTION FOR INJECTION,Q8H,2019,Q3,Pruritus,,2019,Q3,1,I,2019.0,20190715.0,20190724,20190724,PER,,US-SA-2019SA195067,SANOFI AVENTIS,,66.0,YR,E,F,Y,76.19,KG,20190724.0,,CN,US,US,2019,Q3,Elderly
166268621,16626862,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"4 U, TID",,,,,,,,,,SOLUTION FOR INJECTION,Q8H,2019,Q3,Pruritus generalised,,2019,Q3,1,I,2019.0,20190715.0,20190724,20190724,PER,,US-SA-2019SA195067,SANOFI AVENTIS,,66.0,YR,E,F,Y,76.19,KG,20190724.0,,CN,US,US,2019,Q3,Elderly
166268621,16626862,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"4 U, TID",,,,,,,,,,SOLUTION FOR INJECTION,Q8H,2019,Q3,Skin erosion,,2019,Q3,1,I,2019.0,20190715.0,20190724,20190724,PER,,US-SA-2019SA195067,SANOFI AVENTIS,,66.0,YR,E,F,Y,76.19,KG,20190724.0,,CN,US,US,2019,Q3,Elderly
166268621,16626862,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"4 U, TID",,,,,,,,,,SOLUTION FOR INJECTION,Q8H,2019,Q3,Tremor,,2019,Q3,1,I,2019.0,20190715.0,20190724,20190724,PER,,US-SA-2019SA195067,SANOFI AVENTIS,,66.0,YR,E,F,Y,76.19,KG,20190724.0,,CN,US,US,2019,Q3,Elderly
166295461,16629546,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 DF, QD",486.0,DF,Y,,,,,1.0,DF,SOLUTION FOR INJECTION,QD,2019,Q3,Hypoglycaemia,,2019,Q3,1,I,20190502.0,20190718.0,20190725,20190725,EXP,IT-MINISAL02-563396,IT-SA-2019SA196915,SANOFI AVENTIS,,72.0,YR,E,F,Y,,,20190725.0,,MD,IT,IT,2019,Q3,Elderly
166295461,16629546,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 DF, QD",486.0,DF,Y,,,,,1.0,DF,SOLUTION FOR INJECTION,QD,2019,Q3,Sopor,,2019,Q3,1,I,20190502.0,20190718.0,20190725,20190725,EXP,IT-MINISAL02-563396,IT-SA-2019SA196915,SANOFI AVENTIS,,72.0,YR,E,F,Y,,,20190725.0,,MD,IT,IT,2019,Q3,Elderly
166353751,16635375,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,52 U/DAY FOR 15 YEARS,,,U,, UNKNOWN,,,,,INJECTION,,2019,Q3,Amyloidosis,,2019,Q3,1,I,,20190716.0,20190726,20190726,EXP,,JP-MICRO LABS LIMITED-ML2019-01739,MICRO LABS,"IWAYA K, ZAKO T, FUKUNAGA J, SORGJERD K, OGATA K, KOGURE K, KOSANO H, NORITAKE M, MAEDA M, ANDO Y, KATSURA Y, NAGASE T. TOXICITY OF INSULIN-DERIVED AMYLOIDOSIS: A CASE REPORT.. BMC ENDOCRINE DISORDERS. 2019;19(1):61.",58.0,YR,,M,Y,,,20190726.0,,OT,JP,JP,2019,Q3,Adult
166353751,16635375,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,52 U/DAY FOR 15 YEARS,,,U,, UNKNOWN,,,,,INJECTION,,2019,Q3,Fat necrosis,,2019,Q3,1,I,,20190716.0,20190726,20190726,EXP,,JP-MICRO LABS LIMITED-ML2019-01739,MICRO LABS,"IWAYA K, ZAKO T, FUKUNAGA J, SORGJERD K, OGATA K, KOGURE K, KOSANO H, NORITAKE M, MAEDA M, ANDO Y, KATSURA Y, NAGASE T. TOXICITY OF INSULIN-DERIVED AMYLOIDOSIS: A CASE REPORT.. BMC ENDOCRINE DISORDERS. 2019;19(1):61.",58.0,YR,,M,Y,,,20190726.0,,OT,JP,JP,2019,Q3,Adult
166353751,16635375,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,52 U/DAY FOR 15 YEARS,,,U,, UNKNOWN,,,,,INJECTION,,2019,Q3,Renal impairment,,2019,Q3,1,I,,20190716.0,20190726,20190726,EXP,,JP-MICRO LABS LIMITED-ML2019-01739,MICRO LABS,"IWAYA K, ZAKO T, FUKUNAGA J, SORGJERD K, OGATA K, KOGURE K, KOSANO H, NORITAKE M, MAEDA M, ANDO Y, KATSURA Y, NAGASE T. TOXICITY OF INSULIN-DERIVED AMYLOIDOSIS: A CASE REPORT.. BMC ENDOCRINE DISORDERS. 2019;19(1):61.",58.0,YR,,M,Y,,,20190726.0,,OT,JP,JP,2019,Q3,Adult
166390941,16639094,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"21 INTERNATIONAL UNIT, DAILY",,,,,,,20563.0,21.0,IU,,QD,2019,Q3,Anembryonic gestation,,2019,Q3,1,I,20160411.0,20190716.0,20190726,20190726,EXP,,FI-ELI_LILLY_AND_COMPANY-FI201907008620,ELI LILLY AND CO,,30.0,YR,,F,Y,69.0,KG,20190726.0,,CN,FI,FI,2019,Q3,Young Adult
166390941,16639094,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"21 INTERNATIONAL UNIT, DAILY",,,,,,,20563.0,21.0,IU,,QD,2019,Q3,Exposure during pregnancy,,2019,Q3,1,I,20160411.0,20190716.0,20190726,20190726,EXP,,FI-ELI_LILLY_AND_COMPANY-FI201907008620,ELI LILLY AND CO,,30.0,YR,,F,Y,69.0,KG,20190726.0,,CN,FI,FI,2019,Q3,Young Adult
166416821,16641682,3,C,"insulin lispro (HUMALOG KWIKPEN) 100 unit/mL , 70 U SQ DAILY per SS",,2,,,,,,,,,,,,,,2019,Q3,Euglycaemic diabetic ketoacidosis,,2019,Q3,1,I,20190723.0,,20190726,20190726,DIR,,,FDA-CTU,,50.0,YR,,F,N,101.2,KG,20190726.0,N,PH,US,US,2019,Q3,Adult
166418932,16641893,3,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q3,Anaemia,,2019,Q3,2,F,,20190828.0,20190729,20190903,EXP,,"US-BRECKENRIDGE PHARMACEUTICAL, INC.-2071403",BRECKENRIDGE,,42.0,YR,,F,Y,103.64,KG,20190903.0,,MD,US,US,2019,Q3,Adult
166445272,16644527,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,14-16 UNITS 10 MINUTES BEFORE THE MAIN MEALS,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q3,Loss of consciousness,,2019,Q3,2,F,,20190806.0,20190729,20190813,EXP,,PL-SA-2019SA199623,SANOFI AVENTIS,"ZASADZI?SKA G., ODYNIEC J.W., CYPRYK K.,. POST-GRADUATE DIABETES TREATMENT?2019?02?COMMON INSULIN THERAPY ERRORS IN DAILY PRACTICE. WE AVOID COMPLICATIONS. POMORSKA. 2019;251:92-213",68.0,YR,E,F,Y,,,20190813.0,,,COUNTRY NOT SPECIFIED,PL,2019,Q3,Elderly
166445272,16644527,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,14-16 UNITS 10 MINUTES BEFORE THE MAIN MEALS,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q3,Neuroglycopenia,,2019,Q3,2,F,,20190806.0,20190729,20190813,EXP,,PL-SA-2019SA199623,SANOFI AVENTIS,"ZASADZI?SKA G., ODYNIEC J.W., CYPRYK K.,. POST-GRADUATE DIABETES TREATMENT?2019?02?COMMON INSULIN THERAPY ERRORS IN DAILY PRACTICE. WE AVOID COMPLICATIONS. POMORSKA. 2019;251:92-213",68.0,YR,E,F,Y,,,20190813.0,,,COUNTRY NOT SPECIFIED,PL,2019,Q3,Elderly
166445272,16644527,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,14-16 UNITS 10 MINUTES BEFORE THE MAIN MEALS,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q3,Wrong product administered,,2019,Q3,2,F,,20190806.0,20190729,20190813,EXP,,PL-SA-2019SA199623,SANOFI AVENTIS,"ZASADZI?SKA G., ODYNIEC J.W., CYPRYK K.,. POST-GRADUATE DIABETES TREATMENT?2019?02?COMMON INSULIN THERAPY ERRORS IN DAILY PRACTICE. WE AVOID COMPLICATIONS. POMORSKA. 2019;251:92-213",68.0,YR,E,F,Y,,,20190813.0,,,COUNTRY NOT SPECIFIED,PL,2019,Q3,Elderly
166445511,16644551,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,14-16 UNITS FOR 10 MINUTES BEFORE THE MAIN MEALS,,,U,U,,,20563.0,14.0,IU,,,2019,Q3,Glycosylated haemoglobin increased,,2019,Q3,1,I,,20190531.0,20190729,20190729,EXP,,PL-ELI_LILLY_AND_COMPANY-PL201907013790,ELI LILLY AND CO,ZASADZINSKA G..FREQUENT ERRORS OF INSULIN THERAPY IN EVERYDAY MEDICAL PRACTICE (ORIGINAL TITLE: CZESTE BLEDY INSULINOTERAPII W CODZIENNEJ PRAKTYCE LEKARSKIEJ).DIABETOLOGIA PO DYPLOMIE. 2019;2:32673:.,68.0,YR,,F,Y,,,20190729.0,,OT,PL,PL,2019,Q3,Elderly
166445511,16644551,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,14-16 UNITS FOR 10 MINUTES BEFORE THE MAIN MEALS,,,U,U,,,20563.0,14.0,IU,,,2019,Q3,Loss of consciousness,,2019,Q3,1,I,,20190531.0,20190729,20190729,EXP,,PL-ELI_LILLY_AND_COMPANY-PL201907013790,ELI LILLY AND CO,ZASADZINSKA G..FREQUENT ERRORS OF INSULIN THERAPY IN EVERYDAY MEDICAL PRACTICE (ORIGINAL TITLE: CZESTE BLEDY INSULINOTERAPII W CODZIENNEJ PRAKTYCE LEKARSKIEJ).DIABETOLOGIA PO DYPLOMIE. 2019;2:32673:.,68.0,YR,,F,Y,,,20190729.0,,OT,PL,PL,2019,Q3,Elderly
166445511,16644551,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,14-16 UNITS FOR 10 MINUTES BEFORE THE MAIN MEALS,,,U,U,,,20563.0,14.0,IU,,,2019,Q3,Neuroglycopenia,,2019,Q3,1,I,,20190531.0,20190729,20190729,EXP,,PL-ELI_LILLY_AND_COMPANY-PL201907013790,ELI LILLY AND CO,ZASADZINSKA G..FREQUENT ERRORS OF INSULIN THERAPY IN EVERYDAY MEDICAL PRACTICE (ORIGINAL TITLE: CZESTE BLEDY INSULINOTERAPII W CODZIENNEJ PRAKTYCE LEKARSKIEJ).DIABETOLOGIA PO DYPLOMIE. 2019;2:32673:.,68.0,YR,,F,Y,,,20190729.0,,OT,PL,PL,2019,Q3,Elderly
166445511,16644551,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,14-16 UNITS FOR 10 MINUTES BEFORE THE MAIN MEALS,,,U,U,,,20563.0,14.0,IU,,,2019,Q3,Wrong product administered,,2019,Q3,1,I,,20190531.0,20190729,20190729,EXP,,PL-ELI_LILLY_AND_COMPANY-PL201907013790,ELI LILLY AND CO,ZASADZINSKA G..FREQUENT ERRORS OF INSULIN THERAPY IN EVERYDAY MEDICAL PRACTICE (ORIGINAL TITLE: CZESTE BLEDY INSULINOTERAPII W CODZIENNEJ PRAKTYCE LEKARSKIEJ).DIABETOLOGIA PO DYPLOMIE. 2019;2:32673:.,68.0,YR,,F,Y,,,20190729.0,,OT,PL,PL,2019,Q3,Elderly
166445511,16644551,2,SS,Insulin Lispro,INSULIN LISPRO,1,,14-16 UNITS FOR 10 MINUTES BEFORE THE MAIN MEALS,,,U,U,,,20563.0,16.0,IU,,,2019,Q3,Glycosylated haemoglobin increased,,2019,Q3,1,I,,20190531.0,20190729,20190729,EXP,,PL-ELI_LILLY_AND_COMPANY-PL201907013790,ELI LILLY AND CO,ZASADZINSKA G..FREQUENT ERRORS OF INSULIN THERAPY IN EVERYDAY MEDICAL PRACTICE (ORIGINAL TITLE: CZESTE BLEDY INSULINOTERAPII W CODZIENNEJ PRAKTYCE LEKARSKIEJ).DIABETOLOGIA PO DYPLOMIE. 2019;2:32673:.,68.0,YR,,F,Y,,,20190729.0,,OT,PL,PL,2019,Q3,Elderly
166445511,16644551,2,SS,Insulin Lispro,INSULIN LISPRO,1,,14-16 UNITS FOR 10 MINUTES BEFORE THE MAIN MEALS,,,U,U,,,20563.0,16.0,IU,,,2019,Q3,Loss of consciousness,,2019,Q3,1,I,,20190531.0,20190729,20190729,EXP,,PL-ELI_LILLY_AND_COMPANY-PL201907013790,ELI LILLY AND CO,ZASADZINSKA G..FREQUENT ERRORS OF INSULIN THERAPY IN EVERYDAY MEDICAL PRACTICE (ORIGINAL TITLE: CZESTE BLEDY INSULINOTERAPII W CODZIENNEJ PRAKTYCE LEKARSKIEJ).DIABETOLOGIA PO DYPLOMIE. 2019;2:32673:.,68.0,YR,,F,Y,,,20190729.0,,OT,PL,PL,2019,Q3,Elderly
166445511,16644551,2,SS,Insulin Lispro,INSULIN LISPRO,1,,14-16 UNITS FOR 10 MINUTES BEFORE THE MAIN MEALS,,,U,U,,,20563.0,16.0,IU,,,2019,Q3,Neuroglycopenia,,2019,Q3,1,I,,20190531.0,20190729,20190729,EXP,,PL-ELI_LILLY_AND_COMPANY-PL201907013790,ELI LILLY AND CO,ZASADZINSKA G..FREQUENT ERRORS OF INSULIN THERAPY IN EVERYDAY MEDICAL PRACTICE (ORIGINAL TITLE: CZESTE BLEDY INSULINOTERAPII W CODZIENNEJ PRAKTYCE LEKARSKIEJ).DIABETOLOGIA PO DYPLOMIE. 2019;2:32673:.,68.0,YR,,F,Y,,,20190729.0,,OT,PL,PL,2019,Q3,Elderly
166445511,16644551,2,SS,Insulin Lispro,INSULIN LISPRO,1,,14-16 UNITS FOR 10 MINUTES BEFORE THE MAIN MEALS,,,U,U,,,20563.0,16.0,IU,,,2019,Q3,Wrong product administered,,2019,Q3,1,I,,20190531.0,20190729,20190729,EXP,,PL-ELI_LILLY_AND_COMPANY-PL201907013790,ELI LILLY AND CO,ZASADZINSKA G..FREQUENT ERRORS OF INSULIN THERAPY IN EVERYDAY MEDICAL PRACTICE (ORIGINAL TITLE: CZESTE BLEDY INSULINOTERAPII W CODZIENNEJ PRAKTYCE LEKARSKIEJ).DIABETOLOGIA PO DYPLOMIE. 2019;2:32673:.,68.0,YR,,F,Y,,,20190729.0,,OT,PL,PL,2019,Q3,Elderly
166448251,16644825,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2019,Q3,Device operational issue,,2019,Q3,1,I,,20190722.0,20190729,20190729,PER,,US-SA-2019SA201724,SANOFI AVENTIS,,75.0,YR,E,F,Y,,,20190729.0,,CN,US,US,2019,Q3,Elderly
166448251,16644825,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2019,Q3,Drug ineffective,,2019,Q3,1,I,,20190722.0,20190729,20190729,PER,,US-SA-2019SA201724,SANOFI AVENTIS,,75.0,YR,E,F,Y,,,20190729.0,,CN,US,US,2019,Q3,Elderly
166448251,16644825,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2019,Q3,Product contamination,,2019,Q3,1,I,,20190722.0,20190729,20190729,PER,,US-SA-2019SA201724,SANOFI AVENTIS,,75.0,YR,E,F,Y,,,20190729.0,,CN,US,US,2019,Q3,Elderly
166448251,16644825,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2019,Q3,Product dose omission,,2019,Q3,1,I,,20190722.0,20190729,20190729,PER,,US-SA-2019SA201724,SANOFI AVENTIS,,75.0,YR,E,F,Y,,,20190729.0,,CN,US,US,2019,Q3,Elderly
166448251,16644825,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2019,Q3,Wrong technique in device usage process,,2019,Q3,1,I,,20190722.0,20190729,20190729,PER,,US-SA-2019SA201724,SANOFI AVENTIS,,75.0,YR,E,F,Y,,,20190729.0,,CN,US,US,2019,Q3,Elderly
166466672,16646667,1,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,U,,,,,,,,2019,Q3,Blood glucose increased,,2019,Q3,2,F,,20190722.0,20190730,20190802,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201907012936,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20190802.0,,CN,CN,CN,2019,Q3,Adult
166512721,16651272,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"17.5 IU, QD",,,Y,,,,,17.5,IU,SOLUTION FOR INJECTION,QD,2019,Q3,Hypoglycaemia,,2019,Q3,1,I,20190501.0,20190725.0,20190731,20190731,EXP,IT-MINISAL02-564849,IT-SA-2019SA202653,SANOFI AVENTIS,,11.0,YR,C,F,Y,39.0,KG,20190731.0,,MD,IT,IT,2019,Q3,Child
166512721,16651272,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"17.5 IU, QD",,,Y,,,,,17.5,IU,SOLUTION FOR INJECTION,QD,2019,Q3,Salivary hypersecretion,,2019,Q3,1,I,20190501.0,20190725.0,20190731,20190731,EXP,IT-MINISAL02-564849,IT-SA-2019SA202653,SANOFI AVENTIS,,11.0,YR,C,F,Y,39.0,KG,20190731.0,,MD,IT,IT,2019,Q3,Child
166512721,16651272,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"17.5 IU, QD",,,Y,,,,,17.5,IU,SOLUTION FOR INJECTION,QD,2019,Q3,Tremor,,2019,Q3,1,I,20190501.0,20190725.0,20190731,20190731,EXP,IT-MINISAL02-564849,IT-SA-2019SA202653,SANOFI AVENTIS,,11.0,YR,C,F,Y,39.0,KG,20190731.0,,MD,IT,IT,2019,Q3,Child
166512721,16651272,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"17.5 IU, QD",,,Y,,,,,17.5,IU,SOLUTION FOR INJECTION,QD,2019,Q3,Trismus,,2019,Q3,1,I,20190501.0,20190725.0,20190731,20190731,EXP,IT-MINISAL02-564849,IT-SA-2019SA202653,SANOFI AVENTIS,,11.0,YR,C,F,Y,39.0,KG,20190731.0,,MD,IT,IT,2019,Q3,Child
166512721,16651272,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"17.5 IU, QD",,,Y,,,,,17.5,IU,SOLUTION FOR INJECTION,QD,2019,Q3,Unresponsive to stimuli,,2019,Q3,1,I,20190501.0,20190725.0,20190731,20190731,EXP,IT-MINISAL02-564849,IT-SA-2019SA202653,SANOFI AVENTIS,,11.0,YR,C,F,Y,39.0,KG,20190731.0,,MD,IT,IT,2019,Q3,Child
166541151,16654115,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q3,Blood glucose decreased,,2019,Q3,1,I,,20190718.0,20190731,20190731,PER,,US-SA-2019SA197027,SANOFI AVENTIS,,77.0,YR,E,F,Y,61.2,KG,20190731.0,,CN,US,US,2019,Q3,Elderly
166541151,16654115,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q3,Hypoaesthesia,,2019,Q3,1,I,,20190718.0,20190731,20190731,PER,,US-SA-2019SA197027,SANOFI AVENTIS,,77.0,YR,E,F,Y,61.2,KG,20190731.0,,CN,US,US,2019,Q3,Elderly
166541151,16654115,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q3,Intentional dose omission,,2019,Q3,1,I,,20190718.0,20190731,20190731,PER,,US-SA-2019SA197027,SANOFI AVENTIS,,77.0,YR,E,F,Y,61.2,KG,20190731.0,,CN,US,US,2019,Q3,Elderly
166541151,16654115,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q3,Muscular weakness,,2019,Q3,1,I,,20190718.0,20190731,20190731,PER,,US-SA-2019SA197027,SANOFI AVENTIS,,77.0,YR,E,F,Y,61.2,KG,20190731.0,,CN,US,US,2019,Q3,Elderly
166544191,16654419,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"14 INTERNATIONAL UNIT, DAILY",,,U,U,,,20563.0,14.0,IU,,QD,2019,Q3,Hypoglycaemia,,2019,Q3,1,I,20190608.0,20190722.0,20190731,20190731,EXP,IT-MINISAL02-564418,IT-ELI_LILLY_AND_COMPANY-IT201907011933,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20190731.0,,CN,IT,IT,2019,Q3,Adult
166544191,16654419,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"14 INTERNATIONAL UNIT, DAILY",,,U,U,,,20563.0,14.0,IU,,QD,2019,Q3,Sopor,,2019,Q3,1,I,20190608.0,20190722.0,20190731,20190731,EXP,IT-MINISAL02-564418,IT-ELI_LILLY_AND_COMPANY-IT201907011933,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20190731.0,,CN,IT,IT,2019,Q3,Adult
166567712,16656771,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q3,Cystic fibrosis,,2019,Q3,2,F,20190728.0,20190814.0,20190801,20190815,EXP,,US-GILEAD-2019-0421175,GILEAD,,68.0,YR,E,M,Y,,,20190815.0,,OT,US,US,2019,Q3,Elderly
166567712,16656771,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q3,Diabetes mellitus inadequate control,,2019,Q3,2,F,20190728.0,20190814.0,20190801,20190815,EXP,,US-GILEAD-2019-0421175,GILEAD,,68.0,YR,E,M,Y,,,20190815.0,,OT,US,US,2019,Q3,Elderly
166577752,16657775,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,INJECT 3 TIMES DAILY (BEFORE MEALS),,,,,,,,,,,TID,2019,Q3,Asthma,,2019,Q3,2,F,20190702.0,20190815.0,20190801,20190821,EXP,,US-TESAROUBC-2019-TSO01676-US,TESARO,,47.0,YR,,F,Y,70.0,KG,20190821.0,,CN,US,US,2019,Q3,Adult
166577752,16657775,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,INJECT 3 TIMES DAILY (BEFORE MEALS),,,,,,,,,,,TID,2019,Q3,Fatigue,,2019,Q3,2,F,20190702.0,20190815.0,20190801,20190821,EXP,,US-TESAROUBC-2019-TSO01676-US,TESARO,,47.0,YR,,F,Y,70.0,KG,20190821.0,,CN,US,US,2019,Q3,Adult
166577752,16657775,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,INJECT 3 TIMES DAILY (BEFORE MEALS),,,,,,,,,,,TID,2019,Q3,Hypotension,,2019,Q3,2,F,20190702.0,20190815.0,20190801,20190821,EXP,,US-TESAROUBC-2019-TSO01676-US,TESARO,,47.0,YR,,F,Y,70.0,KG,20190821.0,,CN,US,US,2019,Q3,Adult
166577752,16657775,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,INJECT 3 TIMES DAILY (BEFORE MEALS),,,,,,,,,,,TID,2019,Q3,Mean cell haemoglobin decreased,,2019,Q3,2,F,20190702.0,20190815.0,20190801,20190821,EXP,,US-TESAROUBC-2019-TSO01676-US,TESARO,,47.0,YR,,F,Y,70.0,KG,20190821.0,,CN,US,US,2019,Q3,Adult
166577752,16657775,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,INJECT 3 TIMES DAILY (BEFORE MEALS),,,,,,,,,,,TID,2019,Q3,Mean cell volume abnormal,,2019,Q3,2,F,20190702.0,20190815.0,20190801,20190821,EXP,,US-TESAROUBC-2019-TSO01676-US,TESARO,,47.0,YR,,F,Y,70.0,KG,20190821.0,,CN,US,US,2019,Q3,Adult
166577752,16657775,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,INJECT 3 TIMES DAILY (BEFORE MEALS),,,,,,,,,,,TID,2019,Q3,Nausea,,2019,Q3,2,F,20190702.0,20190815.0,20190801,20190821,EXP,,US-TESAROUBC-2019-TSO01676-US,TESARO,,47.0,YR,,F,Y,70.0,KG,20190821.0,,CN,US,US,2019,Q3,Adult
166577752,16657775,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,INJECT 3 TIMES DAILY (BEFORE MEALS),,,,,,,,,,,TID,2019,Q3,Platelet count decreased,,2019,Q3,2,F,20190702.0,20190815.0,20190801,20190821,EXP,,US-TESAROUBC-2019-TSO01676-US,TESARO,,47.0,YR,,F,Y,70.0,KG,20190821.0,,CN,US,US,2019,Q3,Adult
166577752,16657775,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,INJECT 3 TIMES DAILY (BEFORE MEALS),,,,,,,,,,,TID,2019,Q3,Pneumonia,,2019,Q3,2,F,20190702.0,20190815.0,20190801,20190821,EXP,,US-TESAROUBC-2019-TSO01676-US,TESARO,,47.0,YR,,F,Y,70.0,KG,20190821.0,,CN,US,US,2019,Q3,Adult
166577752,16657775,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,INJECT 3 TIMES DAILY (BEFORE MEALS),,,,,,,,,,,TID,2019,Q3,Red cell distribution width increased,,2019,Q3,2,F,20190702.0,20190815.0,20190801,20190821,EXP,,US-TESAROUBC-2019-TSO01676-US,TESARO,,47.0,YR,,F,Y,70.0,KG,20190821.0,,CN,US,US,2019,Q3,Adult
166577752,16657775,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,INJECT 3 TIMES DAILY (BEFORE MEALS),,,,,,,,,,,TID,2019,Q3,Underdose,,2019,Q3,2,F,20190702.0,20190815.0,20190801,20190821,EXP,,US-TESAROUBC-2019-TSO01676-US,TESARO,,47.0,YR,,F,Y,70.0,KG,20190821.0,,CN,US,US,2019,Q3,Adult
166577752,16657775,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,INJECT 3 TIMES DAILY (BEFORE MEALS),,,,,,,,,,,TID,2019,Q3,Urinary tract infection,,2019,Q3,2,F,20190702.0,20190815.0,20190801,20190821,EXP,,US-TESAROUBC-2019-TSO01676-US,TESARO,,47.0,YR,,F,Y,70.0,KG,20190821.0,,CN,US,US,2019,Q3,Adult
166577752,16657775,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,INJECT 3 TIMES DAILY (BEFORE MEALS),,,,,,,,,,,TID,2019,Q3,Weight decreased,,2019,Q3,2,F,20190702.0,20190815.0,20190801,20190821,EXP,,US-TESAROUBC-2019-TSO01676-US,TESARO,,47.0,YR,,F,Y,70.0,KG,20190821.0,,CN,US,US,2019,Q3,Adult
166612651,16661265,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 UNITS, TID WITH FOOD",,,,,,,,,,INJECTION,TID,2019,Q3,Acute myocardial infarction,,2019,Q3,1,I,20130825.0,20181017.0,20190802,20190802,PER,,US-ENDO PHARMACEUTICALS INC-2018-042671,ENDO,,49.0,YR,,M,Y,131.97,KG,20190802.0,,LW,US,US,2019,Q3,Adult
166612651,16661265,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 UNITS, TID WITH FOOD",,,,,,,,,,INJECTION,TID,2019,Q3,Cerebrovascular accident,,2019,Q3,1,I,20130825.0,20181017.0,20190802,20190802,PER,,US-ENDO PHARMACEUTICALS INC-2018-042671,ENDO,,49.0,YR,,M,Y,131.97,KG,20190802.0,,LW,US,US,2019,Q3,Adult
166612651,16661265,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 UNITS, TID WITH FOOD",,,,,,,,,,INJECTION,TID,2019,Q3,Deep vein thrombosis,,2019,Q3,1,I,20130825.0,20181017.0,20190802,20190802,PER,,US-ENDO PHARMACEUTICALS INC-2018-042671,ENDO,,49.0,YR,,M,Y,131.97,KG,20190802.0,,LW,US,US,2019,Q3,Adult
166612651,16661265,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 UNITS, TID WITH FOOD",,,,,,,,,,INJECTION,TID,2019,Q3,Prescribed overdose,,2019,Q3,1,I,20130825.0,20181017.0,20190802,20190802,PER,,US-ENDO PHARMACEUTICALS INC-2018-042671,ENDO,,49.0,YR,,M,Y,131.97,KG,20190802.0,,LW,US,US,2019,Q3,Adult
166619021,16661902,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q3,Abdominal pain upper,,2019,Q3,1,I,20190212.0,20190401.0,20190802,20190802,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20190802.0,,MD,DE,DE,2019,Q3,Elderly
166619021,16661902,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q3,Amylase increased,,2019,Q3,1,I,20190212.0,20190401.0,20190802,20190802,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20190802.0,,MD,DE,DE,2019,Q3,Elderly
166619021,16661902,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q3,Arthralgia,,2019,Q3,1,I,20190212.0,20190401.0,20190802,20190802,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20190802.0,,MD,DE,DE,2019,Q3,Elderly
166619021,16661902,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q3,Blood creatine phosphokinase MB increased,,2019,Q3,1,I,20190212.0,20190401.0,20190802,20190802,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20190802.0,,MD,DE,DE,2019,Q3,Elderly
166619021,16661902,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q3,Blood creatine phosphokinase increased,,2019,Q3,1,I,20190212.0,20190401.0,20190802,20190802,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20190802.0,,MD,DE,DE,2019,Q3,Elderly
166619021,16661902,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q3,Chest pain,,2019,Q3,1,I,20190212.0,20190401.0,20190802,20190802,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20190802.0,,MD,DE,DE,2019,Q3,Elderly
166619021,16661902,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q3,Connective tissue disorder,,2019,Q3,1,I,20190212.0,20190401.0,20190802,20190802,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20190802.0,,MD,DE,DE,2019,Q3,Elderly
166619021,16661902,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q3,Dry eye,,2019,Q3,1,I,20190212.0,20190401.0,20190802,20190802,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20190802.0,,MD,DE,DE,2019,Q3,Elderly
166619021,16661902,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q3,Dry mouth,,2019,Q3,1,I,20190212.0,20190401.0,20190802,20190802,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20190802.0,,MD,DE,DE,2019,Q3,Elderly
166619021,16661902,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q3,Dry skin,,2019,Q3,1,I,20190212.0,20190401.0,20190802,20190802,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20190802.0,,MD,DE,DE,2019,Q3,Elderly
166619021,16661902,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q3,Headache,,2019,Q3,1,I,20190212.0,20190401.0,20190802,20190802,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20190802.0,,MD,DE,DE,2019,Q3,Elderly
166619021,16661902,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q3,Hyperglycaemia,,2019,Q3,1,I,20190212.0,20190401.0,20190802,20190802,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20190802.0,,MD,DE,DE,2019,Q3,Elderly
166619021,16661902,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q3,Myocardial infarction,,2019,Q3,1,I,20190212.0,20190401.0,20190802,20190802,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20190802.0,,MD,DE,DE,2019,Q3,Elderly
166619021,16661902,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q3,Nausea,,2019,Q3,1,I,20190212.0,20190401.0,20190802,20190802,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20190802.0,,MD,DE,DE,2019,Q3,Elderly
166619021,16661902,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q3,Pain,,2019,Q3,1,I,20190212.0,20190401.0,20190802,20190802,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20190802.0,,MD,DE,DE,2019,Q3,Elderly
166619021,16661902,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q3,Pain in extremity,,2019,Q3,1,I,20190212.0,20190401.0,20190802,20190802,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20190802.0,,MD,DE,DE,2019,Q3,Elderly
166619021,16661902,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q3,Paraesthesia,,2019,Q3,1,I,20190212.0,20190401.0,20190802,20190802,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20190802.0,,MD,DE,DE,2019,Q3,Elderly
166619021,16661902,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q3,Prescribed underdose,,2019,Q3,1,I,20190212.0,20190401.0,20190802,20190802,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20190802.0,,MD,DE,DE,2019,Q3,Elderly
166619021,16661902,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q3,Pruritus,,2019,Q3,1,I,20190212.0,20190401.0,20190802,20190802,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20190802.0,,MD,DE,DE,2019,Q3,Elderly
166619021,16661902,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q3,Skin disorder,,2019,Q3,1,I,20190212.0,20190401.0,20190802,20190802,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20190802.0,,MD,DE,DE,2019,Q3,Elderly
166619021,16661902,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q3,Skin fissures,,2019,Q3,1,I,20190212.0,20190401.0,20190802,20190802,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20190802.0,,MD,DE,DE,2019,Q3,Elderly
166644551,16664455,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"9 U, EACH MORNING",,,U,U,,,20563.0,9.0,IU,,QD,2019,Q3,Asthenia,,2019,Q3,1,I,201906.0,20190628.0,20190802,20190802,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201907000624,ELI LILLY AND CO,,51.0,YR,,F,Y,,,20190802.0,,CN,CN,CN,2019,Q3,Adult
166644551,16664455,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"9 U, EACH MORNING",,,U,U,,,20563.0,9.0,IU,,QD,2019,Q3,Dizziness,,2019,Q3,1,I,201906.0,20190628.0,20190802,20190802,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201907000624,ELI LILLY AND CO,,51.0,YR,,F,Y,,,20190802.0,,CN,CN,CN,2019,Q3,Adult
166644551,16664455,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"9 U, EACH MORNING",,,U,U,,,20563.0,9.0,IU,,QD,2019,Q3,Dysstasia,,2019,Q3,1,I,201906.0,20190628.0,20190802,20190802,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201907000624,ELI LILLY AND CO,,51.0,YR,,F,Y,,,20190802.0,,CN,CN,CN,2019,Q3,Adult
166644551,16664455,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"9 U, EACH MORNING",,,U,U,,,20563.0,9.0,IU,,QD,2019,Q3,Hypertension,,2019,Q3,1,I,201906.0,20190628.0,20190802,20190802,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201907000624,ELI LILLY AND CO,,51.0,YR,,F,Y,,,20190802.0,,CN,CN,CN,2019,Q3,Adult
166644551,16664455,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"9 U, EACH MORNING",,,U,U,,,20563.0,9.0,IU,,QD,2019,Q3,Hypoglycaemia,,2019,Q3,1,I,201906.0,20190628.0,20190802,20190802,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201907000624,ELI LILLY AND CO,,51.0,YR,,F,Y,,,20190802.0,,CN,CN,CN,2019,Q3,Adult
166644551,16664455,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"9 U, EACH MORNING",,,U,U,,,20563.0,9.0,IU,,QD,2019,Q3,Hypotension,,2019,Q3,1,I,201906.0,20190628.0,20190802,20190802,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201907000624,ELI LILLY AND CO,,51.0,YR,,F,Y,,,20190802.0,,CN,CN,CN,2019,Q3,Adult
166644551,16664455,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"36 U, DAILY",,,U,U,,,20563.0,36.0,IU,,QD,2019,Q3,Asthenia,,2019,Q3,1,I,201906.0,20190628.0,20190802,20190802,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201907000624,ELI LILLY AND CO,,51.0,YR,,F,Y,,,20190802.0,,CN,CN,CN,2019,Q3,Adult
166644551,16664455,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"36 U, DAILY",,,U,U,,,20563.0,36.0,IU,,QD,2019,Q3,Dizziness,,2019,Q3,1,I,201906.0,20190628.0,20190802,20190802,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201907000624,ELI LILLY AND CO,,51.0,YR,,F,Y,,,20190802.0,,CN,CN,CN,2019,Q3,Adult
166644551,16664455,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"36 U, DAILY",,,U,U,,,20563.0,36.0,IU,,QD,2019,Q3,Dysstasia,,2019,Q3,1,I,201906.0,20190628.0,20190802,20190802,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201907000624,ELI LILLY AND CO,,51.0,YR,,F,Y,,,20190802.0,,CN,CN,CN,2019,Q3,Adult
166644551,16664455,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"36 U, DAILY",,,U,U,,,20563.0,36.0,IU,,QD,2019,Q3,Hypertension,,2019,Q3,1,I,201906.0,20190628.0,20190802,20190802,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201907000624,ELI LILLY AND CO,,51.0,YR,,F,Y,,,20190802.0,,CN,CN,CN,2019,Q3,Adult
166644551,16664455,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"36 U, DAILY",,,U,U,,,20563.0,36.0,IU,,QD,2019,Q3,Hypoglycaemia,,2019,Q3,1,I,201906.0,20190628.0,20190802,20190802,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201907000624,ELI LILLY AND CO,,51.0,YR,,F,Y,,,20190802.0,,CN,CN,CN,2019,Q3,Adult
166644551,16664455,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"36 U, DAILY",,,U,U,,,20563.0,36.0,IU,,QD,2019,Q3,Hypotension,,2019,Q3,1,I,201906.0,20190628.0,20190802,20190802,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201907000624,ELI LILLY AND CO,,51.0,YR,,F,Y,,,20190802.0,,CN,CN,CN,2019,Q3,Adult
166644551,16664455,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"7 U, EACH EVENING",,,U,U,,,20563.0,7.0,IU,,QD,2019,Q3,Asthenia,,2019,Q3,1,I,201906.0,20190628.0,20190802,20190802,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201907000624,ELI LILLY AND CO,,51.0,YR,,F,Y,,,20190802.0,,CN,CN,CN,2019,Q3,Adult
166644551,16664455,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"7 U, EACH EVENING",,,U,U,,,20563.0,7.0,IU,,QD,2019,Q3,Dizziness,,2019,Q3,1,I,201906.0,20190628.0,20190802,20190802,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201907000624,ELI LILLY AND CO,,51.0,YR,,F,Y,,,20190802.0,,CN,CN,CN,2019,Q3,Adult
166644551,16664455,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"7 U, EACH EVENING",,,U,U,,,20563.0,7.0,IU,,QD,2019,Q3,Dysstasia,,2019,Q3,1,I,201906.0,20190628.0,20190802,20190802,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201907000624,ELI LILLY AND CO,,51.0,YR,,F,Y,,,20190802.0,,CN,CN,CN,2019,Q3,Adult
166644551,16664455,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"7 U, EACH EVENING",,,U,U,,,20563.0,7.0,IU,,QD,2019,Q3,Hypertension,,2019,Q3,1,I,201906.0,20190628.0,20190802,20190802,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201907000624,ELI LILLY AND CO,,51.0,YR,,F,Y,,,20190802.0,,CN,CN,CN,2019,Q3,Adult
166644551,16664455,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"7 U, EACH EVENING",,,U,U,,,20563.0,7.0,IU,,QD,2019,Q3,Hypoglycaemia,,2019,Q3,1,I,201906.0,20190628.0,20190802,20190802,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201907000624,ELI LILLY AND CO,,51.0,YR,,F,Y,,,20190802.0,,CN,CN,CN,2019,Q3,Adult
166644551,16664455,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"7 U, EACH EVENING",,,U,U,,,20563.0,7.0,IU,,QD,2019,Q3,Hypotension,,2019,Q3,1,I,201906.0,20190628.0,20190802,20190802,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201907000624,ELI LILLY AND CO,,51.0,YR,,F,Y,,,20190802.0,,CN,CN,CN,2019,Q3,Adult
166644641,16664464,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"22 U, DAILY, EACH MORNING",,,,, ASKU,,20563.0,24.0,IU,,QD,2019,Q3,Peripheral swelling,,2019,Q3,1,I,,20190723.0,20190802,20190802,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201907013816,ELI LILLY AND CO,,58.0,YR,,F,Y,70.0,KG,20190802.0,,CN,CN,CN,2019,Q3,Adult
166644641,16664464,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,,"22 U, DAILY, EACH MORNING",,,,,,,,22.0,IU,,QD,2019,Q3,Peripheral swelling,,2019,Q3,1,I,,20190723.0,20190802,20190802,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201907013816,ELI LILLY AND CO,,58.0,YR,,F,Y,70.0,KG,20190802.0,,CN,CN,CN,2019,Q3,Adult
166710762,16671076,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2019,Q3,Acute lymphocytic leukaemia recurrent,,2019,Q3,2,F,201902.0,20190830.0,20190805,20190903,EXP,,US-TAKEDA-2019TUS031931,TAKEDA,,47.0,YR,,M,Y,,,20190903.0,,CN,US,US,2019,Q3,Adult
166710762,16671076,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2019,Q3,Catheter site infection,,2019,Q3,2,F,201902.0,20190830.0,20190805,20190903,EXP,,US-TAKEDA-2019TUS031931,TAKEDA,,47.0,YR,,M,Y,,,20190903.0,,CN,US,US,2019,Q3,Adult
166710762,16671076,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2019,Q3,Deep vein thrombosis,,2019,Q3,2,F,201902.0,20190830.0,20190805,20190903,EXP,,US-TAKEDA-2019TUS031931,TAKEDA,,47.0,YR,,M,Y,,,20190903.0,,CN,US,US,2019,Q3,Adult
166710762,16671076,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2019,Q3,Herpes virus infection,,2019,Q3,2,F,201902.0,20190830.0,20190805,20190903,EXP,,US-TAKEDA-2019TUS031931,TAKEDA,,47.0,YR,,M,Y,,,20190903.0,,CN,US,US,2019,Q3,Adult
166710762,16671076,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2019,Q3,Meningitis staphylococcal,,2019,Q3,2,F,201902.0,20190830.0,20190805,20190903,EXP,,US-TAKEDA-2019TUS031931,TAKEDA,,47.0,YR,,M,Y,,,20190903.0,,CN,US,US,2019,Q3,Adult
166710762,16671076,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2019,Q3,Neck pain,,2019,Q3,2,F,201902.0,20190830.0,20190805,20190903,EXP,,US-TAKEDA-2019TUS031931,TAKEDA,,47.0,YR,,M,Y,,,20190903.0,,CN,US,US,2019,Q3,Adult
166710762,16671076,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2019,Q3,Pain in extremity,,2019,Q3,2,F,201902.0,20190830.0,20190805,20190903,EXP,,US-TAKEDA-2019TUS031931,TAKEDA,,47.0,YR,,M,Y,,,20190903.0,,CN,US,US,2019,Q3,Adult
166710762,16671076,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2019,Q3,Pulmonary embolism,,2019,Q3,2,F,201902.0,20190830.0,20190805,20190903,EXP,,US-TAKEDA-2019TUS031931,TAKEDA,,47.0,YR,,M,Y,,,20190903.0,,CN,US,US,2019,Q3,Adult
166710762,16671076,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2019,Q3,Sinusitis,,2019,Q3,2,F,201902.0,20190830.0,20190805,20190903,EXP,,US-TAKEDA-2019TUS031931,TAKEDA,,47.0,YR,,M,Y,,,20190903.0,,CN,US,US,2019,Q3,Adult
166722851,16672285,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"28 U, EACH MORNING",,,,,,,20563.0,28.0,IU,,QD,2019,Q3,Blood glucose decreased,,2019,Q3,1,I,,20190627.0,20190806,20190806,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201906014318,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20190806.0,,CN,CN,CN,2019,Q3,Adult
166722851,16672285,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"28 U, EACH MORNING",,,,,,,20563.0,28.0,IU,,QD,2019,Q3,Blood glucose increased,,2019,Q3,1,I,,20190627.0,20190806,20190806,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201906014318,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20190806.0,,CN,CN,CN,2019,Q3,Adult
166722851,16672285,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"28 U, EACH MORNING",,,,,,,20563.0,28.0,IU,,QD,2019,Q3,Body fat disorder,,2019,Q3,1,I,,20190627.0,20190806,20190806,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201906014318,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20190806.0,,CN,CN,CN,2019,Q3,Adult
166722851,16672285,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"28 U, EACH MORNING",,,,,,,20563.0,28.0,IU,,QD,2019,Q3,Confusional state,,2019,Q3,1,I,,20190627.0,20190806,20190806,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201906014318,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20190806.0,,CN,CN,CN,2019,Q3,Adult
166722851,16672285,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"28 U, EACH MORNING",,,,,,,20563.0,28.0,IU,,QD,2019,Q3,Discomfort,,2019,Q3,1,I,,20190627.0,20190806,20190806,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201906014318,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20190806.0,,CN,CN,CN,2019,Q3,Adult
166722851,16672285,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"28 U, EACH MORNING",,,,,,,20563.0,28.0,IU,,QD,2019,Q3,Dizziness,,2019,Q3,1,I,,20190627.0,20190806,20190806,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201906014318,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20190806.0,,CN,CN,CN,2019,Q3,Adult
166722851,16672285,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"16 U, DAILY (AT NOON)",,,,,,,20563.0,16.0,IU,,QD,2019,Q3,Blood glucose decreased,,2019,Q3,1,I,,20190627.0,20190806,20190806,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201906014318,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20190806.0,,CN,CN,CN,2019,Q3,Adult
166722851,16672285,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"16 U, DAILY (AT NOON)",,,,,,,20563.0,16.0,IU,,QD,2019,Q3,Blood glucose increased,,2019,Q3,1,I,,20190627.0,20190806,20190806,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201906014318,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20190806.0,,CN,CN,CN,2019,Q3,Adult
166722851,16672285,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"16 U, DAILY (AT NOON)",,,,,,,20563.0,16.0,IU,,QD,2019,Q3,Body fat disorder,,2019,Q3,1,I,,20190627.0,20190806,20190806,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201906014318,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20190806.0,,CN,CN,CN,2019,Q3,Adult
166722851,16672285,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"16 U, DAILY (AT NOON)",,,,,,,20563.0,16.0,IU,,QD,2019,Q3,Confusional state,,2019,Q3,1,I,,20190627.0,20190806,20190806,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201906014318,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20190806.0,,CN,CN,CN,2019,Q3,Adult
166722851,16672285,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"16 U, DAILY (AT NOON)",,,,,,,20563.0,16.0,IU,,QD,2019,Q3,Discomfort,,2019,Q3,1,I,,20190627.0,20190806,20190806,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201906014318,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20190806.0,,CN,CN,CN,2019,Q3,Adult
166722851,16672285,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"16 U, DAILY (AT NOON)",,,,,,,20563.0,16.0,IU,,QD,2019,Q3,Dizziness,,2019,Q3,1,I,,20190627.0,20190806,20190806,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201906014318,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20190806.0,,CN,CN,CN,2019,Q3,Adult
166722851,16672285,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"28 U, EACH EVENING (AT NIGHT)",,,,,,,20563.0,28.0,IU,,QD,2019,Q3,Blood glucose decreased,,2019,Q3,1,I,,20190627.0,20190806,20190806,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201906014318,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20190806.0,,CN,CN,CN,2019,Q3,Adult
166722851,16672285,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"28 U, EACH EVENING (AT NIGHT)",,,,,,,20563.0,28.0,IU,,QD,2019,Q3,Blood glucose increased,,2019,Q3,1,I,,20190627.0,20190806,20190806,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201906014318,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20190806.0,,CN,CN,CN,2019,Q3,Adult
166722851,16672285,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"28 U, EACH EVENING (AT NIGHT)",,,,,,,20563.0,28.0,IU,,QD,2019,Q3,Body fat disorder,,2019,Q3,1,I,,20190627.0,20190806,20190806,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201906014318,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20190806.0,,CN,CN,CN,2019,Q3,Adult
166722851,16672285,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"28 U, EACH EVENING (AT NIGHT)",,,,,,,20563.0,28.0,IU,,QD,2019,Q3,Confusional state,,2019,Q3,1,I,,20190627.0,20190806,20190806,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201906014318,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20190806.0,,CN,CN,CN,2019,Q3,Adult
166722851,16672285,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"28 U, EACH EVENING (AT NIGHT)",,,,,,,20563.0,28.0,IU,,QD,2019,Q3,Discomfort,,2019,Q3,1,I,,20190627.0,20190806,20190806,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201906014318,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20190806.0,,CN,CN,CN,2019,Q3,Adult
166722851,16672285,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"28 U, EACH EVENING (AT NIGHT)",,,,,,,20563.0,28.0,IU,,QD,2019,Q3,Dizziness,,2019,Q3,1,I,,20190627.0,20190806,20190806,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201906014318,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20190806.0,,CN,CN,CN,2019,Q3,Adult
166750583,16675058,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, QID",,,,,,,,,,,QID,2019,Q3,Abdominal pain upper,,2019,Q3,3,F,2019.0,20190829.0,20190806,20190916,EXP,,DE-GILEAD-2019-0422210,GILEAD,,77.0,YR,E,M,Y,,,20190916.0,,CN,DE,DE,2019,Q3,Elderly
166750583,16675058,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, QID",,,,,,,,,,,QID,2019,Q3,Disturbance in attention,,2019,Q3,3,F,2019.0,20190829.0,20190806,20190916,EXP,,DE-GILEAD-2019-0422210,GILEAD,,77.0,YR,E,M,Y,,,20190916.0,,CN,DE,DE,2019,Q3,Elderly
166750583,16675058,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, QID",,,,,,,,,,,QID,2019,Q3,Dizziness,,2019,Q3,3,F,2019.0,20190829.0,20190806,20190916,EXP,,DE-GILEAD-2019-0422210,GILEAD,,77.0,YR,E,M,Y,,,20190916.0,,CN,DE,DE,2019,Q3,Elderly
166750583,16675058,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, QID",,,,,,,,,,,QID,2019,Q3,Eye disorder,,2019,Q3,3,F,2019.0,20190829.0,20190806,20190916,EXP,,DE-GILEAD-2019-0422210,GILEAD,,77.0,YR,E,M,Y,,,20190916.0,,CN,DE,DE,2019,Q3,Elderly
166750583,16675058,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, QID",,,,,,,,,,,QID,2019,Q3,Frequent bowel movements,,2019,Q3,3,F,2019.0,20190829.0,20190806,20190916,EXP,,DE-GILEAD-2019-0422210,GILEAD,,77.0,YR,E,M,Y,,,20190916.0,,CN,DE,DE,2019,Q3,Elderly
166750583,16675058,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, QID",,,,,,,,,,,QID,2019,Q3,Gastrointestinal pain,,2019,Q3,3,F,2019.0,20190829.0,20190806,20190916,EXP,,DE-GILEAD-2019-0422210,GILEAD,,77.0,YR,E,M,Y,,,20190916.0,,CN,DE,DE,2019,Q3,Elderly
166750583,16675058,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, QID",,,,,,,,,,,QID,2019,Q3,Headache,,2019,Q3,3,F,2019.0,20190829.0,20190806,20190916,EXP,,DE-GILEAD-2019-0422210,GILEAD,,77.0,YR,E,M,Y,,,20190916.0,,CN,DE,DE,2019,Q3,Elderly
166750583,16675058,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, QID",,,,,,,,,,,QID,2019,Q3,Intestinal haemorrhage,,2019,Q3,3,F,2019.0,20190829.0,20190806,20190916,EXP,,DE-GILEAD-2019-0422210,GILEAD,,77.0,YR,E,M,Y,,,20190916.0,,CN,DE,DE,2019,Q3,Elderly
166750583,16675058,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, QID",,,,,,,,,,,QID,2019,Q3,Off label use,,2019,Q3,3,F,2019.0,20190829.0,20190806,20190916,EXP,,DE-GILEAD-2019-0422210,GILEAD,,77.0,YR,E,M,Y,,,20190916.0,,CN,DE,DE,2019,Q3,Elderly
166750583,16675058,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, QID",,,,,,,,,,,QID,2019,Q3,Underdose,,2019,Q3,3,F,2019.0,20190829.0,20190806,20190916,EXP,,DE-GILEAD-2019-0422210,GILEAD,,77.0,YR,E,M,Y,,,20190916.0,,CN,DE,DE,2019,Q3,Elderly
166750583,16675058,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, QID",,,,,,,,,,,QID,2019,Q3,Vision blurred,,2019,Q3,3,F,2019.0,20190829.0,20190806,20190916,EXP,,DE-GILEAD-2019-0422210,GILEAD,,77.0,YR,E,M,Y,,,20190916.0,,CN,DE,DE,2019,Q3,Elderly
166754711,16675471,8,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,,,,,,,,,,2019,Q3,Arthralgia,,2019,Q3,1,I,,20190729.0,20190806,20190806,EXP,,CA-ROCHE-2366059,ROCHE,,62.0,YR,,M,Y,,,20190806.0,,OT,CA,CA,2019,Q3,Adult
166754711,16675471,8,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,,,,,,,,,,2019,Q3,Drug ineffective,,2019,Q3,1,I,,20190729.0,20190806,20190806,EXP,,CA-ROCHE-2366059,ROCHE,,62.0,YR,,M,Y,,,20190806.0,,OT,CA,CA,2019,Q3,Adult
166754711,16675471,8,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,,,,,,,,,,2019,Q3,Gait disturbance,,2019,Q3,1,I,,20190729.0,20190806,20190806,EXP,,CA-ROCHE-2366059,ROCHE,,62.0,YR,,M,Y,,,20190806.0,,OT,CA,CA,2019,Q3,Adult
166754711,16675471,8,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,,,,,,,,,,2019,Q3,Hepatic enzyme increased,,2019,Q3,1,I,,20190729.0,20190806,20190806,EXP,,CA-ROCHE-2366059,ROCHE,,62.0,YR,,M,Y,,,20190806.0,,OT,CA,CA,2019,Q3,Adult
166754711,16675471,8,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,,,,,,,,,,2019,Q3,Musculoskeletal stiffness,,2019,Q3,1,I,,20190729.0,20190806,20190806,EXP,,CA-ROCHE-2366059,ROCHE,,62.0,YR,,M,Y,,,20190806.0,,OT,CA,CA,2019,Q3,Adult
166754711,16675471,8,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,,,,,,,,,,2019,Q3,Oedema peripheral,,2019,Q3,1,I,,20190729.0,20190806,20190806,EXP,,CA-ROCHE-2366059,ROCHE,,62.0,YR,,M,Y,,,20190806.0,,OT,CA,CA,2019,Q3,Adult
166754711,16675471,8,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,,,,,,,,,,2019,Q3,Pain in extremity,,2019,Q3,1,I,,20190729.0,20190806,20190806,EXP,,CA-ROCHE-2366059,ROCHE,,62.0,YR,,M,Y,,,20190806.0,,OT,CA,CA,2019,Q3,Adult
166754711,16675471,8,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,,,,,,,,,,2019,Q3,Peripheral swelling,,2019,Q3,1,I,,20190729.0,20190806,20190806,EXP,,CA-ROCHE-2366059,ROCHE,,62.0,YR,,M,Y,,,20190806.0,,OT,CA,CA,2019,Q3,Adult
166754711,16675471,8,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,,,,,,,,,,2019,Q3,Pharyngitis,,2019,Q3,1,I,,20190729.0,20190806,20190806,EXP,,CA-ROCHE-2366059,ROCHE,,62.0,YR,,M,Y,,,20190806.0,,OT,CA,CA,2019,Q3,Adult
166754711,16675471,8,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,,,,,,,,,,2019,Q3,Poor venous access,,2019,Q3,1,I,,20190729.0,20190806,20190806,EXP,,CA-ROCHE-2366059,ROCHE,,62.0,YR,,M,Y,,,20190806.0,,OT,CA,CA,2019,Q3,Adult
166754711,16675471,8,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,,,,,,,,,,2019,Q3,Pruritus,,2019,Q3,1,I,,20190729.0,20190806,20190806,EXP,,CA-ROCHE-2366059,ROCHE,,62.0,YR,,M,Y,,,20190806.0,,OT,CA,CA,2019,Q3,Adult
166754711,16675471,8,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,,,,,,,,,,2019,Q3,Swelling,,2019,Q3,1,I,,20190729.0,20190806,20190806,EXP,,CA-ROCHE-2366059,ROCHE,,62.0,YR,,M,Y,,,20190806.0,,OT,CA,CA,2019,Q3,Adult
166754711,16675471,8,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,,,,,,,,,,2019,Q3,Therapeutic response decreased,,2019,Q3,1,I,,20190729.0,20190806,20190806,EXP,,CA-ROCHE-2366059,ROCHE,,62.0,YR,,M,Y,,,20190806.0,,OT,CA,CA,2019,Q3,Adult
166754711,16675471,8,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,,,,,,,,,,2019,Q3,Tremor,,2019,Q3,1,I,,20190729.0,20190806,20190806,EXP,,CA-ROCHE-2366059,ROCHE,,62.0,YR,,M,Y,,,20190806.0,,OT,CA,CA,2019,Q3,Adult
166754711,16675471,8,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,,,,,,,,,,2019,Q3,Vomiting,,2019,Q3,1,I,,20190729.0,20190806,20190806,EXP,,CA-ROCHE-2366059,ROCHE,,62.0,YR,,M,Y,,,20190806.0,,OT,CA,CA,2019,Q3,Adult
166854091,16685409,6,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 IU, UNK",,,,,,,209196.0,2.0,IU,,,2019,Q3,Fall,,2019,Q3,1,I,20181223.0,20190730.0,20190809,20190809,EXP,,FR-SA-2019SA219039,SANOFI AVENTIS,,86.0,YR,E,F,Y,51.0,KG,20190809.0,,MD,FR,FR,2019,Q3,Elderly
166896571,16689657,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 U SQ TID,,,,,,,,,,,,2019,Q3,Drug ineffective for unapproved indication,,2019,Q3,1,I,201811.0,20181214.0,20190809,20190809,EXP,,US-ACTELION-A-NJ2018-183879,ACTELION,,62.0,YR,,F,Y,,,20190809.0,,PH,US,US,2019,Q3,Adult
166896571,16689657,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 U SQ TID,,,,,,,,,,,,2019,Q3,Dyspnoea,,2019,Q3,1,I,201811.0,20181214.0,20190809,20190809,EXP,,US-ACTELION-A-NJ2018-183879,ACTELION,,62.0,YR,,F,Y,,,20190809.0,,PH,US,US,2019,Q3,Adult
166896571,16689657,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 U SQ TID,,,,,,,,,,,,2019,Q3,Facial paralysis,,2019,Q3,1,I,201811.0,20181214.0,20190809,20190809,EXP,,US-ACTELION-A-NJ2018-183879,ACTELION,,62.0,YR,,F,Y,,,20190809.0,,PH,US,US,2019,Q3,Adult
166896571,16689657,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 U SQ TID,,,,,,,,,,,,2019,Q3,Peripheral nerve palsy,,2019,Q3,1,I,201811.0,20181214.0,20190809,20190809,EXP,,US-ACTELION-A-NJ2018-183879,ACTELION,,62.0,YR,,F,Y,,,20190809.0,,PH,US,US,2019,Q3,Adult
166901441,16690144,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"NK IE, NACH SCHEMA, 08:00 UND 17:00 UHR",,,U,,,,,,,,,2019,Q3,Haematochezia,,2019,Q3,1,I,,20190805.0,20190809,20190809,EXP,,PHHY2019DE183846,SANDOZ,,85.0,YR,,F,Y,,,20190809.0,,OT,DE,DE,2019,Q3,Elderly
166901441,16690144,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"NK IE, NACH SCHEMA, 08:00 UND 17:00 UHR",,,U,,,,,,,,,2019,Q3,Haemorrhage,,2019,Q3,1,I,,20190805.0,20190809,20190809,EXP,,PHHY2019DE183846,SANDOZ,,85.0,YR,,F,Y,,,20190809.0,,OT,DE,DE,2019,Q3,Elderly
166922871,16692287,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"NK IE, NACH PATIENTEN-SCHEMA",,,U,,,,,,,,,2019,Q3,Loss of consciousness,,2019,Q3,1,I,,20190805.0,20190812,20190812,EXP,,PHHY2019DE183870,NOVARTIS,,54.0,YR,,M,Y,,,20190812.0,,OT,DE,DE,2019,Q3,Adult
166922871,16692287,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"NK IE, NACH PATIENTEN-SCHEMA",,,U,,,,,,,,,2019,Q3,Syncope,,2019,Q3,1,I,,20190805.0,20190812,20190812,EXP,,PHHY2019DE183870,NOVARTIS,,54.0,YR,,M,Y,,,20190812.0,,OT,DE,DE,2019,Q3,Adult
166922871,16692287,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"NK IE, NACH PATIENTEN-SCHEMA",,,U,,,,,,,,,2019,Q3,Ventricular arrhythmia,,2019,Q3,1,I,,20190805.0,20190812,20190812,EXP,,PHHY2019DE183870,NOVARTIS,,54.0,YR,,M,Y,,,20190812.0,,OT,DE,DE,2019,Q3,Adult
166949501,16694950,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK (NK IE, NACH SCHEMA)",,,U,,,,,,,,,2019,Q3,Haemoptysis,,2019,Q3,1,I,20171109.0,20190805.0,20190812,20190812,EXP,,PHHY2019DE182315,NOVARTIS,,77.0,YR,,M,Y,,,20190813.0,,OT,DE,DE,2019,Q3,Elderly
166950661,16695066,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"22 U, EACH MORNING",,,Y,,,,20563.0,22.0,IU,,QD,2019,Q3,Abdominal discomfort,,2019,Q3,1,I,,20190731.0,20190812,20190812,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201908000911,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20190812.0,,CN,CN,CN,2019,Q3,Adult
166950661,16695066,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"22 U, EACH MORNING",,,Y,,,,20563.0,22.0,IU,,QD,2019,Q3,Blood glucose decreased,,2019,Q3,1,I,,20190731.0,20190812,20190812,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201908000911,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20190812.0,,CN,CN,CN,2019,Q3,Adult
166950661,16695066,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"22 U, EACH MORNING",,,Y,,,,20563.0,22.0,IU,,QD,2019,Q3,Blood glucose increased,,2019,Q3,1,I,,20190731.0,20190812,20190812,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201908000911,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20190812.0,,CN,CN,CN,2019,Q3,Adult
166950661,16695066,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"22 U, EACH MORNING",,,Y,,,,20563.0,22.0,IU,,QD,2019,Q3,Hunger,,2019,Q3,1,I,,20190731.0,20190812,20190812,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201908000911,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20190812.0,,CN,CN,CN,2019,Q3,Adult
166950661,16695066,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"22 U, EACH MORNING",,,Y,,,,20563.0,22.0,IU,,QD,2019,Q3,Palpitations,,2019,Q3,1,I,,20190731.0,20190812,20190812,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201908000911,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20190812.0,,CN,CN,CN,2019,Q3,Adult
166950661,16695066,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"22 U, EACH MORNING",,,Y,,,,20563.0,22.0,IU,,QD,2019,Q3,Tremor,,2019,Q3,1,I,,20190731.0,20190812,20190812,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201908000911,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20190812.0,,CN,CN,CN,2019,Q3,Adult
166950661,16695066,2,I,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"10 U, DAILY (NIGHT)",,,Y,,,,20563.0,10.0,IU,,QD,2019,Q3,Abdominal discomfort,,2019,Q3,1,I,,20190731.0,20190812,20190812,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201908000911,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20190812.0,,CN,CN,CN,2019,Q3,Adult
166950661,16695066,2,I,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"10 U, DAILY (NIGHT)",,,Y,,,,20563.0,10.0,IU,,QD,2019,Q3,Blood glucose decreased,,2019,Q3,1,I,,20190731.0,20190812,20190812,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201908000911,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20190812.0,,CN,CN,CN,2019,Q3,Adult
166950661,16695066,2,I,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"10 U, DAILY (NIGHT)",,,Y,,,,20563.0,10.0,IU,,QD,2019,Q3,Blood glucose increased,,2019,Q3,1,I,,20190731.0,20190812,20190812,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201908000911,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20190812.0,,CN,CN,CN,2019,Q3,Adult
166950661,16695066,2,I,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"10 U, DAILY (NIGHT)",,,Y,,,,20563.0,10.0,IU,,QD,2019,Q3,Hunger,,2019,Q3,1,I,,20190731.0,20190812,20190812,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201908000911,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20190812.0,,CN,CN,CN,2019,Q3,Adult
166950661,16695066,2,I,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"10 U, DAILY (NIGHT)",,,Y,,,,20563.0,10.0,IU,,QD,2019,Q3,Palpitations,,2019,Q3,1,I,,20190731.0,20190812,20190812,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201908000911,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20190812.0,,CN,CN,CN,2019,Q3,Adult
166950661,16695066,2,I,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"10 U, DAILY (NIGHT)",,,Y,,,,20563.0,10.0,IU,,QD,2019,Q3,Tremor,,2019,Q3,1,I,,20190731.0,20190812,20190812,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201908000911,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20190812.0,,CN,CN,CN,2019,Q3,Adult
166950661,16695066,3,I,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"12 U, EACH MORNING",,,Y,,,,20563.0,12.0,IU,,QD,2019,Q3,Abdominal discomfort,,2019,Q3,1,I,,20190731.0,20190812,20190812,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201908000911,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20190812.0,,CN,CN,CN,2019,Q3,Adult
166950661,16695066,3,I,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"12 U, EACH MORNING",,,Y,,,,20563.0,12.0,IU,,QD,2019,Q3,Blood glucose decreased,,2019,Q3,1,I,,20190731.0,20190812,20190812,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201908000911,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20190812.0,,CN,CN,CN,2019,Q3,Adult
166950661,16695066,3,I,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"12 U, EACH MORNING",,,Y,,,,20563.0,12.0,IU,,QD,2019,Q3,Blood glucose increased,,2019,Q3,1,I,,20190731.0,20190812,20190812,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201908000911,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20190812.0,,CN,CN,CN,2019,Q3,Adult
166950661,16695066,3,I,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"12 U, EACH MORNING",,,Y,,,,20563.0,12.0,IU,,QD,2019,Q3,Hunger,,2019,Q3,1,I,,20190731.0,20190812,20190812,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201908000911,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20190812.0,,CN,CN,CN,2019,Q3,Adult
166950661,16695066,3,I,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"12 U, EACH MORNING",,,Y,,,,20563.0,12.0,IU,,QD,2019,Q3,Palpitations,,2019,Q3,1,I,,20190731.0,20190812,20190812,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201908000911,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20190812.0,,CN,CN,CN,2019,Q3,Adult
166950661,16695066,3,I,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"12 U, EACH MORNING",,,Y,,,,20563.0,12.0,IU,,QD,2019,Q3,Tremor,,2019,Q3,1,I,,20190731.0,20190812,20190812,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201908000911,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20190812.0,,CN,CN,CN,2019,Q3,Adult
166950661,16695066,4,I,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"8 U, DAILY (NOON)",,,Y,,,,20563.0,8.0,IU,,QD,2019,Q3,Abdominal discomfort,,2019,Q3,1,I,,20190731.0,20190812,20190812,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201908000911,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20190812.0,,CN,CN,CN,2019,Q3,Adult
166950661,16695066,4,I,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"8 U, DAILY (NOON)",,,Y,,,,20563.0,8.0,IU,,QD,2019,Q3,Blood glucose decreased,,2019,Q3,1,I,,20190731.0,20190812,20190812,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201908000911,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20190812.0,,CN,CN,CN,2019,Q3,Adult
166950661,16695066,4,I,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"8 U, DAILY (NOON)",,,Y,,,,20563.0,8.0,IU,,QD,2019,Q3,Blood glucose increased,,2019,Q3,1,I,,20190731.0,20190812,20190812,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201908000911,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20190812.0,,CN,CN,CN,2019,Q3,Adult
166950661,16695066,4,I,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"8 U, DAILY (NOON)",,,Y,,,,20563.0,8.0,IU,,QD,2019,Q3,Hunger,,2019,Q3,1,I,,20190731.0,20190812,20190812,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201908000911,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20190812.0,,CN,CN,CN,2019,Q3,Adult
166950661,16695066,4,I,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"8 U, DAILY (NOON)",,,Y,,,,20563.0,8.0,IU,,QD,2019,Q3,Palpitations,,2019,Q3,1,I,,20190731.0,20190812,20190812,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201908000911,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20190812.0,,CN,CN,CN,2019,Q3,Adult
166950661,16695066,4,I,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"8 U, DAILY (NOON)",,,Y,,,,20563.0,8.0,IU,,QD,2019,Q3,Tremor,,2019,Q3,1,I,,20190731.0,20190812,20190812,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201908000911,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20190812.0,,CN,CN,CN,2019,Q3,Adult
166950661,16695066,5,I,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"10 U, DAILY (AT NIGHT)",,,Y,,,,20563.0,10.0,IU,,QD,2019,Q3,Abdominal discomfort,,2019,Q3,1,I,,20190731.0,20190812,20190812,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201908000911,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20190812.0,,CN,CN,CN,2019,Q3,Adult
166950661,16695066,5,I,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"10 U, DAILY (AT NIGHT)",,,Y,,,,20563.0,10.0,IU,,QD,2019,Q3,Blood glucose decreased,,2019,Q3,1,I,,20190731.0,20190812,20190812,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201908000911,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20190812.0,,CN,CN,CN,2019,Q3,Adult
166950661,16695066,5,I,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"10 U, DAILY (AT NIGHT)",,,Y,,,,20563.0,10.0,IU,,QD,2019,Q3,Blood glucose increased,,2019,Q3,1,I,,20190731.0,20190812,20190812,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201908000911,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20190812.0,,CN,CN,CN,2019,Q3,Adult
166950661,16695066,5,I,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"10 U, DAILY (AT NIGHT)",,,Y,,,,20563.0,10.0,IU,,QD,2019,Q3,Hunger,,2019,Q3,1,I,,20190731.0,20190812,20190812,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201908000911,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20190812.0,,CN,CN,CN,2019,Q3,Adult
166950661,16695066,5,I,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"10 U, DAILY (AT NIGHT)",,,Y,,,,20563.0,10.0,IU,,QD,2019,Q3,Palpitations,,2019,Q3,1,I,,20190731.0,20190812,20190812,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201908000911,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20190812.0,,CN,CN,CN,2019,Q3,Adult
166950661,16695066,5,I,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"10 U, DAILY (AT NIGHT)",,,Y,,,,20563.0,10.0,IU,,QD,2019,Q3,Tremor,,2019,Q3,1,I,,20190731.0,20190812,20190812,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201908000911,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20190812.0,,CN,CN,CN,2019,Q3,Adult
166950661,16695066,6,I,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"10 U, EACH MORNING",,,Y,,,,20563.0,10.0,IU,,QD,2019,Q3,Abdominal discomfort,,2019,Q3,1,I,,20190731.0,20190812,20190812,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201908000911,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20190812.0,,CN,CN,CN,2019,Q3,Adult
166950661,16695066,6,I,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"10 U, EACH MORNING",,,Y,,,,20563.0,10.0,IU,,QD,2019,Q3,Blood glucose decreased,,2019,Q3,1,I,,20190731.0,20190812,20190812,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201908000911,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20190812.0,,CN,CN,CN,2019,Q3,Adult
166950661,16695066,6,I,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"10 U, EACH MORNING",,,Y,,,,20563.0,10.0,IU,,QD,2019,Q3,Blood glucose increased,,2019,Q3,1,I,,20190731.0,20190812,20190812,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201908000911,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20190812.0,,CN,CN,CN,2019,Q3,Adult
166950661,16695066,6,I,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"10 U, EACH MORNING",,,Y,,,,20563.0,10.0,IU,,QD,2019,Q3,Hunger,,2019,Q3,1,I,,20190731.0,20190812,20190812,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201908000911,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20190812.0,,CN,CN,CN,2019,Q3,Adult
166950661,16695066,6,I,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"10 U, EACH MORNING",,,Y,,,,20563.0,10.0,IU,,QD,2019,Q3,Palpitations,,2019,Q3,1,I,,20190731.0,20190812,20190812,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201908000911,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20190812.0,,CN,CN,CN,2019,Q3,Adult
166950661,16695066,6,I,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"10 U, EACH MORNING",,,Y,,,,20563.0,10.0,IU,,QD,2019,Q3,Tremor,,2019,Q3,1,I,,20190731.0,20190812,20190812,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201908000911,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20190812.0,,CN,CN,CN,2019,Q3,Adult
166950661,16695066,7,I,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"6 U, DAILY (NOON)",,,Y,,,,20563.0,6.0,IU,,QD,2019,Q3,Abdominal discomfort,,2019,Q3,1,I,,20190731.0,20190812,20190812,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201908000911,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20190812.0,,CN,CN,CN,2019,Q3,Adult
166950661,16695066,7,I,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"6 U, DAILY (NOON)",,,Y,,,,20563.0,6.0,IU,,QD,2019,Q3,Blood glucose decreased,,2019,Q3,1,I,,20190731.0,20190812,20190812,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201908000911,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20190812.0,,CN,CN,CN,2019,Q3,Adult
166950661,16695066,7,I,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"6 U, DAILY (NOON)",,,Y,,,,20563.0,6.0,IU,,QD,2019,Q3,Blood glucose increased,,2019,Q3,1,I,,20190731.0,20190812,20190812,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201908000911,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20190812.0,,CN,CN,CN,2019,Q3,Adult
166950661,16695066,7,I,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"6 U, DAILY (NOON)",,,Y,,,,20563.0,6.0,IU,,QD,2019,Q3,Hunger,,2019,Q3,1,I,,20190731.0,20190812,20190812,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201908000911,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20190812.0,,CN,CN,CN,2019,Q3,Adult
166950661,16695066,7,I,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"6 U, DAILY (NOON)",,,Y,,,,20563.0,6.0,IU,,QD,2019,Q3,Palpitations,,2019,Q3,1,I,,20190731.0,20190812,20190812,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201908000911,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20190812.0,,CN,CN,CN,2019,Q3,Adult
166950661,16695066,7,I,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"6 U, DAILY (NOON)",,,Y,,,,20563.0,6.0,IU,,QD,2019,Q3,Tremor,,2019,Q3,1,I,,20190731.0,20190812,20190812,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201908000911,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20190812.0,,CN,CN,CN,2019,Q3,Adult
166950661,16695066,8,I,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"8 U, DAILY (NIGHT)",,,Y,,,,20563.0,8.0,IU,,QD,2019,Q3,Abdominal discomfort,,2019,Q3,1,I,,20190731.0,20190812,20190812,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201908000911,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20190812.0,,CN,CN,CN,2019,Q3,Adult
166950661,16695066,8,I,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"8 U, DAILY (NIGHT)",,,Y,,,,20563.0,8.0,IU,,QD,2019,Q3,Blood glucose decreased,,2019,Q3,1,I,,20190731.0,20190812,20190812,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201908000911,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20190812.0,,CN,CN,CN,2019,Q3,Adult
166950661,16695066,8,I,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"8 U, DAILY (NIGHT)",,,Y,,,,20563.0,8.0,IU,,QD,2019,Q3,Blood glucose increased,,2019,Q3,1,I,,20190731.0,20190812,20190812,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201908000911,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20190812.0,,CN,CN,CN,2019,Q3,Adult
166950661,16695066,8,I,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"8 U, DAILY (NIGHT)",,,Y,,,,20563.0,8.0,IU,,QD,2019,Q3,Hunger,,2019,Q3,1,I,,20190731.0,20190812,20190812,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201908000911,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20190812.0,,CN,CN,CN,2019,Q3,Adult
166950661,16695066,8,I,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"8 U, DAILY (NIGHT)",,,Y,,,,20563.0,8.0,IU,,QD,2019,Q3,Palpitations,,2019,Q3,1,I,,20190731.0,20190812,20190812,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201908000911,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20190812.0,,CN,CN,CN,2019,Q3,Adult
166950661,16695066,8,I,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"8 U, DAILY (NIGHT)",,,Y,,,,20563.0,8.0,IU,,QD,2019,Q3,Tremor,,2019,Q3,1,I,,20190731.0,20190812,20190812,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201908000911,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20190812.0,,CN,CN,CN,2019,Q3,Adult
166952931,16695293,8,C,Insulin lispro,INSULIN LISPRO,1,,"NK IU, ACCORDING TO SCHEDULE (NK IE, NACH SCHEMA)",,,,, UNKNOWN,,,,,,,2019,Q3,Haemoptysis,,2019,Q3,1,I,20171109.0,20190806.0,20190813,20190813,EXP,,DE-DRREDDYS-GER/GER/19/0112924,DR REDDYS,,77.0,YR,,M,Y,,,20190813.0,,PH,DE,DE,2019,Q3,Elderly
166953731,16695373,6,C,Insulin lispro,INSULIN LISPRO,1,,"NK IE, NACH SCHEMA (NK IE, ACCORDING TO SCHEME)",,,,, UNKNOWN,,,,,,,2019,Q3,Condition aggravated,,2019,Q3,1,I,,20190806.0,20190813,20190813,EXP,,DE-DRREDDYS-GER/GER/19/0112926,DR REDDYS,,77.0,YR,,M,Y,,,20190813.0,,PH,DE,DE,2019,Q3,Elderly
166953731,16695373,6,C,Insulin lispro,INSULIN LISPRO,1,,"NK IE, NACH SCHEMA (NK IE, ACCORDING TO SCHEME)",,,,, UNKNOWN,,,,,,,2019,Q3,Dyspnoea,,2019,Q3,1,I,,20190806.0,20190813,20190813,EXP,,DE-DRREDDYS-GER/GER/19/0112926,DR REDDYS,,77.0,YR,,M,Y,,,20190813.0,,PH,DE,DE,2019,Q3,Elderly
167015221,16701522,5,C,Insulin lispro,INSULIN LISPRO,1,,NK IE,,,U,,,,,,,,,2019,Q3,Haemoptysis,,2019,Q3,1,I,20171109.0,20190807.0,20190814,20190814,EXP,DE-ADRED-02837-02,DE-TORRENT-00015154,TORRENT,,77.0,YR,E,M,Y,,,20190814.0,,PH,DE,DE,2019,Q3,Elderly
167079112,16707911,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10,IU,TWICE DAILY",,,,,,,,,,,,2019,Q3,Cytokine release syndrome,,2019,Q3,2,F,20190723.0,20190822.0,20190815,20190826,EXP,,US-GILEAD-2019-0420218,GILEAD,,69.0,YR,E,M,Y,104.0,KG,20190826.0,,MD,US,US,2019,Q3,Elderly
167079112,16707911,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10,IU,TWICE DAILY",,,,,,,,,,,,2019,Q3,Hypotension,,2019,Q3,2,F,20190723.0,20190822.0,20190815,20190826,EXP,,US-GILEAD-2019-0420218,GILEAD,,69.0,YR,E,M,Y,104.0,KG,20190826.0,,MD,US,US,2019,Q3,Elderly
167079112,16707911,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10,IU,TWICE DAILY",,,,,,,,,,,,2019,Q3,Neutropenia,,2019,Q3,2,F,20190723.0,20190822.0,20190815,20190826,EXP,,US-GILEAD-2019-0420218,GILEAD,,69.0,YR,E,M,Y,104.0,KG,20190826.0,,MD,US,US,2019,Q3,Elderly
167079112,16707911,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10,IU,TWICE DAILY",,,,,,,,,,,,2019,Q3,Pyrexia,,2019,Q3,2,F,20190723.0,20190822.0,20190815,20190826,EXP,,US-GILEAD-2019-0420218,GILEAD,,69.0,YR,E,M,Y,104.0,KG,20190826.0,,MD,US,US,2019,Q3,Elderly
167079112,16707911,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10,IU,TWICE DAILY",,,,,,,,,,,,2019,Q3,Sepsis,,2019,Q3,2,F,20190723.0,20190822.0,20190815,20190826,EXP,,US-GILEAD-2019-0420218,GILEAD,,69.0,YR,E,M,Y,104.0,KG,20190826.0,,MD,US,US,2019,Q3,Elderly
167079171,16707917,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2019,Q3,Nervous system disorder,,2019,Q3,1,I,20190403.0,20190404.0,20190815,20190815,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-036715,BRISTOL MYERS SQUIBB,,65.0,YR,,M,Y,68.0,KG,20190815.0,,OT,US,US,2019,Q3,Elderly
167096911,16709691,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q3,Drug reaction with eosinophilia and systemic symptoms,,2019,Q3,1,I,20190724.0,20190812.0,20190816,20190816,EXP,,PHHY2019IT188360,SANDOZ,,59.0,YR,,,Y,,,20190816.0,,OT,IT,IT,2019,Q3,Adult
167096911,16709691,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q3,Erythema,,2019,Q3,1,I,20190724.0,20190812.0,20190816,20190816,EXP,,PHHY2019IT188360,SANDOZ,,59.0,YR,,,Y,,,20190816.0,,OT,IT,IT,2019,Q3,Adult
167096911,16709691,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q3,Oedema,,2019,Q3,1,I,20190724.0,20190812.0,20190816,20190816,EXP,,PHHY2019IT188360,SANDOZ,,59.0,YR,,,Y,,,20190816.0,,OT,IT,IT,2019,Q3,Adult
167096911,16709691,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q3,Pyrexia,,2019,Q3,1,I,20190724.0,20190812.0,20190816,20190816,EXP,,PHHY2019IT188360,SANDOZ,,59.0,YR,,,Y,,,20190816.0,,OT,IT,IT,2019,Q3,Adult
167096911,16709691,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q3,Sepsis,,2019,Q3,1,I,20190724.0,20190812.0,20190816,20190816,EXP,,PHHY2019IT188360,SANDOZ,,59.0,YR,,,Y,,,20190816.0,,OT,IT,IT,2019,Q3,Adult
167116363,16711636,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2019,Q3,Blood glucose abnormal,,2019,Q3,3,F,,20190823.0,20190816,20190903,PER,,US-SA-2019SA221630,SANOFI AVENTIS,,62.0,YR,A,F,Y,,,20190903.0,,OT,US,US,2019,Q3,Adult
167116363,16711636,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2019,Q3,Blood glucose increased,,2019,Q3,3,F,,20190823.0,20190816,20190903,PER,,US-SA-2019SA221630,SANOFI AVENTIS,,62.0,YR,A,F,Y,,,20190903.0,,OT,US,US,2019,Q3,Adult
167116363,16711636,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2019,Q3,Diabetes mellitus inadequate control,,2019,Q3,3,F,,20190823.0,20190816,20190903,PER,,US-SA-2019SA221630,SANOFI AVENTIS,,62.0,YR,A,F,Y,,,20190903.0,,OT,US,US,2019,Q3,Adult
167116363,16711636,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2019,Q3,Drug ineffective,,2019,Q3,3,F,,20190823.0,20190816,20190903,PER,,US-SA-2019SA221630,SANOFI AVENTIS,,62.0,YR,A,F,Y,,,20190903.0,,OT,US,US,2019,Q3,Adult
167134082,16713408,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Abdominal pain upper,,2019,Q3,2,F,2019.0,20190917.0,20190818,20190925,EXP,,DE-009507513-1908DEU005297,MERCK,,76.0,YR,,M,Y,,,20190925.0,,CN,DE,DE,2019,Q3,Elderly
167134082,16713408,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Disturbance in attention,,2019,Q3,2,F,2019.0,20190917.0,20190818,20190925,EXP,,DE-009507513-1908DEU005297,MERCK,,76.0,YR,,M,Y,,,20190925.0,,CN,DE,DE,2019,Q3,Elderly
167134082,16713408,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Dizziness,,2019,Q3,2,F,2019.0,20190917.0,20190818,20190925,EXP,,DE-009507513-1908DEU005297,MERCK,,76.0,YR,,M,Y,,,20190925.0,,CN,DE,DE,2019,Q3,Elderly
167134082,16713408,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Eye disorder,,2019,Q3,2,F,2019.0,20190917.0,20190818,20190925,EXP,,DE-009507513-1908DEU005297,MERCK,,76.0,YR,,M,Y,,,20190925.0,,CN,DE,DE,2019,Q3,Elderly
167134082,16713408,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Frequent bowel movements,,2019,Q3,2,F,2019.0,20190917.0,20190818,20190925,EXP,,DE-009507513-1908DEU005297,MERCK,,76.0,YR,,M,Y,,,20190925.0,,CN,DE,DE,2019,Q3,Elderly
167134082,16713408,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Gastrointestinal pain,,2019,Q3,2,F,2019.0,20190917.0,20190818,20190925,EXP,,DE-009507513-1908DEU005297,MERCK,,76.0,YR,,M,Y,,,20190925.0,,CN,DE,DE,2019,Q3,Elderly
167134082,16713408,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Headache,,2019,Q3,2,F,2019.0,20190917.0,20190818,20190925,EXP,,DE-009507513-1908DEU005297,MERCK,,76.0,YR,,M,Y,,,20190925.0,,CN,DE,DE,2019,Q3,Elderly
167134082,16713408,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Intestinal haemorrhage,,2019,Q3,2,F,2019.0,20190917.0,20190818,20190925,EXP,,DE-009507513-1908DEU005297,MERCK,,76.0,YR,,M,Y,,,20190925.0,,CN,DE,DE,2019,Q3,Elderly
167134082,16713408,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Off label use,,2019,Q3,2,F,2019.0,20190917.0,20190818,20190925,EXP,,DE-009507513-1908DEU005297,MERCK,,76.0,YR,,M,Y,,,20190925.0,,CN,DE,DE,2019,Q3,Elderly
167134082,16713408,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Underdose,,2019,Q3,2,F,2019.0,20190917.0,20190818,20190925,EXP,,DE-009507513-1908DEU005297,MERCK,,76.0,YR,,M,Y,,,20190925.0,,CN,DE,DE,2019,Q3,Elderly
167134082,16713408,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Vision blurred,,2019,Q3,2,F,2019.0,20190917.0,20190818,20190925,EXP,,DE-009507513-1908DEU005297,MERCK,,76.0,YR,,M,Y,,,20190925.0,,CN,DE,DE,2019,Q3,Elderly
167146091,16714609,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE,,,,,,,,,,,,2019,Q3,Drug reaction with eosinophilia and systemic symptoms,,2019,Q3,1,I,20190724.0,20190809.0,20190819,20190819,EXP,IT-MINISAL02-568249,IT-ACCORD-152024,ACCORD,,59.0,YR,,,Y,,,20190819.0,,MD,IT,IT,2019,Q3,Adult
167146091,16714609,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE,,,,,,,,,,,,2019,Q3,Erythema,,2019,Q3,1,I,20190724.0,20190809.0,20190819,20190819,EXP,IT-MINISAL02-568249,IT-ACCORD-152024,ACCORD,,59.0,YR,,,Y,,,20190819.0,,MD,IT,IT,2019,Q3,Adult
167146091,16714609,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE,,,,,,,,,,,,2019,Q3,Oedema,,2019,Q3,1,I,20190724.0,20190809.0,20190819,20190819,EXP,IT-MINISAL02-568249,IT-ACCORD-152024,ACCORD,,59.0,YR,,,Y,,,20190819.0,,MD,IT,IT,2019,Q3,Adult
167146091,16714609,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE,,,,,,,,,,,,2019,Q3,Pyrexia,,2019,Q3,1,I,20190724.0,20190809.0,20190819,20190819,EXP,IT-MINISAL02-568249,IT-ACCORD-152024,ACCORD,,59.0,YR,,,Y,,,20190819.0,,MD,IT,IT,2019,Q3,Adult
167146091,16714609,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE,,,,,,,,,,,,2019,Q3,Sepsis,,2019,Q3,1,I,20190724.0,20190809.0,20190819,20190819,EXP,IT-MINISAL02-568249,IT-ACCORD-152024,ACCORD,,59.0,YR,,,Y,,,20190819.0,,MD,IT,IT,2019,Q3,Adult
167169531,16716953,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"NK IE, ACCORDING TO SCHEME",,,,,,,,,,,,2019,Q3,Haemoptysis,,2019,Q3,1,I,20171109.0,20190804.0,20190819,20190819,EXP,DE-ADRED-02837-02,DE-BAUSCH-BL-2019-022600,BAUSCH AND LOMB,,77.0,YR,,M,Y,,,20190819.0,,PH,DE,DE,2019,Q3,Elderly
167178891,16717889,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ACCORDING TO SCHEME,,,,,,,,,,,,2019,Q3,Haemoptysis,,2019,Q3,1,I,20171109.0,20190805.0,20190819,20190819,EXP,DE-BFARM-19009297,DE-ALLERGAN-1933535US,ALLERGAN,,77.0,YR,,M,Y,,,20190819.0,,PH,DE,DE,2019,Q3,Elderly
167216581,16721658,8,C,Insulin lispro,INSULIN LISPRO,1,,"NK IE, ACCORDING TO SCHEME",,,,,,,,,,,,2019,Q3,Haemoptysis,,2019,Q3,1,I,20171109.0,20190814.0,20190820,20190820,EXP,,DE-TEVA-2019-DE-1094046,TEVA,,77.0,YR,,M,Y,,,20190820.0,,PH,DE,DE,2019,Q3,Elderly
167235091,16723509,1,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,Y,U,,,,,,INJECTION,,2019,Q3,Blood glucose abnormal,,2019,Q3,1,I,,20190815.0,20190821,20190821,EXP,,US-ELI_LILLY_AND_COMPANY-US201908008227,ELI LILLY AND CO,,8.0,YR,,M,Y,,,20190821.0,,CN,US,US,2019,Q3,Child
167235091,16723509,1,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,Y,U,,,,,,INJECTION,,2019,Q3,Drug ineffective,,2019,Q3,1,I,,20190815.0,20190821,20190821,EXP,,US-ELI_LILLY_AND_COMPANY-US201908008227,ELI LILLY AND CO,,8.0,YR,,M,Y,,,20190821.0,,CN,US,US,2019,Q3,Child
167257501,16725750,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"20 U, EACH MORNING",,,Y,U,,,20563.0,20.0,IU,,QD,2019,Q3,Blood glucose decreased,,2019,Q3,1,I,,20190711.0,20190821,20190821,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201907007211,ELI LILLY AND CO,,63.0,YR,,F,Y,,,20190821.0,,CN,CN,CN,2019,Q3,Adult
167257501,16725750,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"20 U, EACH MORNING",,,Y,U,,,20563.0,20.0,IU,,QD,2019,Q3,Blood glucose fluctuation,,2019,Q3,1,I,,20190711.0,20190821,20190821,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201907007211,ELI LILLY AND CO,,63.0,YR,,F,Y,,,20190821.0,,CN,CN,CN,2019,Q3,Adult
167257501,16725750,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"20 U, EACH MORNING",,,Y,U,,,20563.0,20.0,IU,,QD,2019,Q3,Unresponsive to stimuli,,2019,Q3,1,I,,20190711.0,20190821,20190821,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201907007211,ELI LILLY AND CO,,63.0,YR,,F,Y,,,20190821.0,,CN,CN,CN,2019,Q3,Adult
167257501,16725750,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"20 U, EACH MORNING",,,Y,U,,,20563.0,20.0,IU,,QD,2019,Q3,Visual impairment,,2019,Q3,1,I,,20190711.0,20190821,20190821,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201907007211,ELI LILLY AND CO,,63.0,YR,,F,Y,,,20190821.0,,CN,CN,CN,2019,Q3,Adult
167257501,16725750,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"10 U, EACH EVENING",,,Y,U,,,20563.0,10.0,IU,,QD,2019,Q3,Blood glucose decreased,,2019,Q3,1,I,,20190711.0,20190821,20190821,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201907007211,ELI LILLY AND CO,,63.0,YR,,F,Y,,,20190821.0,,CN,CN,CN,2019,Q3,Adult
167257501,16725750,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"10 U, EACH EVENING",,,Y,U,,,20563.0,10.0,IU,,QD,2019,Q3,Blood glucose fluctuation,,2019,Q3,1,I,,20190711.0,20190821,20190821,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201907007211,ELI LILLY AND CO,,63.0,YR,,F,Y,,,20190821.0,,CN,CN,CN,2019,Q3,Adult
167257501,16725750,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"10 U, EACH EVENING",,,Y,U,,,20563.0,10.0,IU,,QD,2019,Q3,Unresponsive to stimuli,,2019,Q3,1,I,,20190711.0,20190821,20190821,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201907007211,ELI LILLY AND CO,,63.0,YR,,F,Y,,,20190821.0,,CN,CN,CN,2019,Q3,Adult
167257501,16725750,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"10 U, EACH EVENING",,,Y,U,,,20563.0,10.0,IU,,QD,2019,Q3,Visual impairment,,2019,Q3,1,I,,20190711.0,20190821,20190821,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201907007211,ELI LILLY AND CO,,63.0,YR,,F,Y,,,20190821.0,,CN,CN,CN,2019,Q3,Adult
167257501,16725750,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,Y,U,,,20563.0,,,,,2019,Q3,Blood glucose decreased,,2019,Q3,1,I,,20190711.0,20190821,20190821,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201907007211,ELI LILLY AND CO,,63.0,YR,,F,Y,,,20190821.0,,CN,CN,CN,2019,Q3,Adult
167257501,16725750,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,Y,U,,,20563.0,,,,,2019,Q3,Blood glucose fluctuation,,2019,Q3,1,I,,20190711.0,20190821,20190821,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201907007211,ELI LILLY AND CO,,63.0,YR,,F,Y,,,20190821.0,,CN,CN,CN,2019,Q3,Adult
167257501,16725750,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,Y,U,,,20563.0,,,,,2019,Q3,Unresponsive to stimuli,,2019,Q3,1,I,,20190711.0,20190821,20190821,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201907007211,ELI LILLY AND CO,,63.0,YR,,F,Y,,,20190821.0,,CN,CN,CN,2019,Q3,Adult
167257501,16725750,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,Y,U,,,20563.0,,,,,2019,Q3,Visual impairment,,2019,Q3,1,I,,20190711.0,20190821,20190821,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201907007211,ELI LILLY AND CO,,63.0,YR,,F,Y,,,20190821.0,,CN,CN,CN,2019,Q3,Adult
167261001,16726100,6,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"NK IE, BY SCHEME",,,,,,,,,,,,2019,Q3,Condition aggravated,,2019,Q3,1,I,,20190814.0,20190821,20190821,EXP,,DE-TEVA-2019-DE-1094122,TEVA,,77.0,YR,,M,Y,,,20190821.0,,PH,DE,DE,2019,Q3,Elderly
167261001,16726100,6,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"NK IE, BY SCHEME",,,,,,,,,,,,2019,Q3,Dyspnoea,,2019,Q3,1,I,,20190814.0,20190821,20190821,EXP,,DE-TEVA-2019-DE-1094122,TEVA,,77.0,YR,,M,Y,,,20190821.0,,PH,DE,DE,2019,Q3,Elderly
167275992,16727599,3,C,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q3,Abdominal pain upper,,2019,Q3,2,F,2019.0,20190903.0,20190822,20190917,EXP,,DE-AUROBINDO-AUR-APL-2019-055393,AUROBINDO,,76.0,YR,,M,Y,,,20190917.0,,CN,DE,DE,2019,Q3,Elderly
167275992,16727599,3,C,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q3,Disturbance in attention,,2019,Q3,2,F,2019.0,20190903.0,20190822,20190917,EXP,,DE-AUROBINDO-AUR-APL-2019-055393,AUROBINDO,,76.0,YR,,M,Y,,,20190917.0,,CN,DE,DE,2019,Q3,Elderly
167275992,16727599,3,C,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q3,Dizziness,,2019,Q3,2,F,2019.0,20190903.0,20190822,20190917,EXP,,DE-AUROBINDO-AUR-APL-2019-055393,AUROBINDO,,76.0,YR,,M,Y,,,20190917.0,,CN,DE,DE,2019,Q3,Elderly
167275992,16727599,3,C,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q3,Eye disorder,,2019,Q3,2,F,2019.0,20190903.0,20190822,20190917,EXP,,DE-AUROBINDO-AUR-APL-2019-055393,AUROBINDO,,76.0,YR,,M,Y,,,20190917.0,,CN,DE,DE,2019,Q3,Elderly
167275992,16727599,3,C,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q3,Frequent bowel movements,,2019,Q3,2,F,2019.0,20190903.0,20190822,20190917,EXP,,DE-AUROBINDO-AUR-APL-2019-055393,AUROBINDO,,76.0,YR,,M,Y,,,20190917.0,,CN,DE,DE,2019,Q3,Elderly
167275992,16727599,3,C,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q3,Gastrointestinal pain,,2019,Q3,2,F,2019.0,20190903.0,20190822,20190917,EXP,,DE-AUROBINDO-AUR-APL-2019-055393,AUROBINDO,,76.0,YR,,M,Y,,,20190917.0,,CN,DE,DE,2019,Q3,Elderly
167275992,16727599,3,C,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q3,Headache,,2019,Q3,2,F,2019.0,20190903.0,20190822,20190917,EXP,,DE-AUROBINDO-AUR-APL-2019-055393,AUROBINDO,,76.0,YR,,M,Y,,,20190917.0,,CN,DE,DE,2019,Q3,Elderly
167275992,16727599,3,C,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q3,Intestinal haemorrhage,,2019,Q3,2,F,2019.0,20190903.0,20190822,20190917,EXP,,DE-AUROBINDO-AUR-APL-2019-055393,AUROBINDO,,76.0,YR,,M,Y,,,20190917.0,,CN,DE,DE,2019,Q3,Elderly
167275992,16727599,3,C,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q3,Off label use,,2019,Q3,2,F,2019.0,20190903.0,20190822,20190917,EXP,,DE-AUROBINDO-AUR-APL-2019-055393,AUROBINDO,,76.0,YR,,M,Y,,,20190917.0,,CN,DE,DE,2019,Q3,Elderly
167275992,16727599,3,C,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q3,Underdose,,2019,Q3,2,F,2019.0,20190903.0,20190822,20190917,EXP,,DE-AUROBINDO-AUR-APL-2019-055393,AUROBINDO,,76.0,YR,,M,Y,,,20190917.0,,CN,DE,DE,2019,Q3,Elderly
167328591,16732859,8,C,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2019,Q3,Haemoptysis,,2019,Q3,1,I,20171109.0,20190808.0,20190823,20190823,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2019RR-218355,RANBAXY,,77.0,YR,,M,Y,,,20190823.0,,OT,NL,DE,2019,Q3,Elderly
167360262,16736026,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2019,Q3,Cardio-respiratory arrest,,2019,Q3,2,F,20190319.0,20190903.0,20190823,20190906,EXP,IT-MINISAL02-538366,IT-MYLANLABS-2019M1078787,MYLAN,,56.0,YR,,F,Y,,,20190906.0,,MD,IT,IT,2019,Q3,Adult
167360262,16736026,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2019,Q3,Coma,,2019,Q3,2,F,20190319.0,20190903.0,20190823,20190906,EXP,IT-MINISAL02-538366,IT-MYLANLABS-2019M1078787,MYLAN,,56.0,YR,,F,Y,,,20190906.0,,MD,IT,IT,2019,Q3,Adult
167360262,16736026,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2019,Q3,Medication error,,2019,Q3,2,F,20190319.0,20190903.0,20190823,20190906,EXP,IT-MINISAL02-538366,IT-MYLANLABS-2019M1078787,MYLAN,,56.0,YR,,F,Y,,,20190906.0,,MD,IT,IT,2019,Q3,Adult
167360262,16736026,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2019,Q3,Off label use,,2019,Q3,2,F,20190319.0,20190903.0,20190823,20190906,EXP,IT-MINISAL02-538366,IT-MYLANLABS-2019M1078787,MYLAN,,56.0,YR,,F,Y,,,20190906.0,,MD,IT,IT,2019,Q3,Adult
167360262,16736026,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2019,Q3,Overdose,,2019,Q3,2,F,20190319.0,20190903.0,20190823,20190906,EXP,IT-MINISAL02-538366,IT-MYLANLABS-2019M1078787,MYLAN,,56.0,YR,,F,Y,,,20190906.0,,MD,IT,IT,2019,Q3,Adult
167360262,16736026,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2019,Q3,Respiratory failure,,2019,Q3,2,F,20190319.0,20190903.0,20190823,20190906,EXP,IT-MINISAL02-538366,IT-MYLANLABS-2019M1078787,MYLAN,,56.0,YR,,F,Y,,,20190906.0,,MD,IT,IT,2019,Q3,Adult
167418671,16741867,13,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Acute kidney injury,,2019,Q3,1,I,,20190822.0,20190826,20190826,EXP,,PT-MYLANLABS-2019M1079326,MYLAN,"GOUVEIA C, DUQUE S, CAMPOS L.. HYPOVOLEMIC LIPOTHYMIA - A CASE OF IATROGENIC TO EMPAGLIFLOZIN. REVISTA PORTUGUESA DE DIABETES. 2019;14 (1):74-74",71.0,YR,,M,Y,,,20190826.0,,MD,PT,PT,2019,Q3,Elderly
167418671,16741867,13,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Hypovolaemia,,2019,Q3,1,I,,20190822.0,20190826,20190826,EXP,,PT-MYLANLABS-2019M1079326,MYLAN,"GOUVEIA C, DUQUE S, CAMPOS L.. HYPOVOLEMIC LIPOTHYMIA - A CASE OF IATROGENIC TO EMPAGLIFLOZIN. REVISTA PORTUGUESA DE DIABETES. 2019;14 (1):74-74",71.0,YR,,M,Y,,,20190826.0,,MD,PT,PT,2019,Q3,Elderly
167418671,16741867,13,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Presyncope,,2019,Q3,1,I,,20190822.0,20190826,20190826,EXP,,PT-MYLANLABS-2019M1079326,MYLAN,"GOUVEIA C, DUQUE S, CAMPOS L.. HYPOVOLEMIC LIPOTHYMIA - A CASE OF IATROGENIC TO EMPAGLIFLOZIN. REVISTA PORTUGUESA DE DIABETES. 2019;14 (1):74-74",71.0,YR,,M,Y,,,20190826.0,,MD,PT,PT,2019,Q3,Elderly
167419451,16741945,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"34 INTERNATIONAL UNIT, UNKNOWN",,,U,U,,,20563.0,34.0,IU,,,2019,Q3,Hyperhidrosis,,2019,Q3,1,I,20190508.0,20190812.0,20190826,20190826,EXP,IT-MINISAL02-568758,IT-ELI_LILLY_AND_COMPANY-IT201908006044,ELI LILLY AND CO,,83.0,YR,,F,Y,,,20190826.0,,CN,IT,IT,2019,Q3,Elderly
167419451,16741945,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"34 INTERNATIONAL UNIT, UNKNOWN",,,U,U,,,20563.0,34.0,IU,,,2019,Q3,Hypoglycaemia,,2019,Q3,1,I,20190508.0,20190812.0,20190826,20190826,EXP,IT-MINISAL02-568758,IT-ELI_LILLY_AND_COMPANY-IT201908006044,ELI LILLY AND CO,,83.0,YR,,F,Y,,,20190826.0,,CN,IT,IT,2019,Q3,Elderly
167419451,16741945,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"34 INTERNATIONAL UNIT, UNKNOWN",,,U,U,,,20563.0,34.0,IU,,,2019,Q3,Hypokalaemia,,2019,Q3,1,I,20190508.0,20190812.0,20190826,20190826,EXP,IT-MINISAL02-568758,IT-ELI_LILLY_AND_COMPANY-IT201908006044,ELI LILLY AND CO,,83.0,YR,,F,Y,,,20190826.0,,CN,IT,IT,2019,Q3,Elderly
167419451,16741945,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"34 INTERNATIONAL UNIT, UNKNOWN",,,U,U,,,20563.0,34.0,IU,,,2019,Q3,Medication error,,2019,Q3,1,I,20190508.0,20190812.0,20190826,20190826,EXP,IT-MINISAL02-568758,IT-ELI_LILLY_AND_COMPANY-IT201908006044,ELI LILLY AND CO,,83.0,YR,,F,Y,,,20190826.0,,CN,IT,IT,2019,Q3,Elderly
167419451,16741945,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"34 INTERNATIONAL UNIT, UNKNOWN",,,U,U,,,20563.0,34.0,IU,,,2019,Q3,Oedema,,2019,Q3,1,I,20190508.0,20190812.0,20190826,20190826,EXP,IT-MINISAL02-568758,IT-ELI_LILLY_AND_COMPANY-IT201908006044,ELI LILLY AND CO,,83.0,YR,,F,Y,,,20190826.0,,CN,IT,IT,2019,Q3,Elderly
167419451,16741945,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"34 INTERNATIONAL UNIT, UNKNOWN",,,U,U,,,20563.0,34.0,IU,,,2019,Q3,Unresponsive to stimuli,,2019,Q3,1,I,20190508.0,20190812.0,20190826,20190826,EXP,IT-MINISAL02-568758,IT-ELI_LILLY_AND_COMPANY-IT201908006044,ELI LILLY AND CO,,83.0,YR,,F,Y,,,20190826.0,,CN,IT,IT,2019,Q3,Elderly
167419451,16741945,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"34 INTERNATIONAL UNIT, UNKNOWN",,,U,U,,,20563.0,34.0,IU,,,2019,Q3,Vomiting,,2019,Q3,1,I,20190508.0,20190812.0,20190826,20190826,EXP,IT-MINISAL02-568758,IT-ELI_LILLY_AND_COMPANY-IT201908006044,ELI LILLY AND CO,,83.0,YR,,F,Y,,,20190826.0,,CN,IT,IT,2019,Q3,Elderly
167429531,16742953,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"36-45-42IU, TID",,,U,,,,,,,SOLUTION FOR INJECTION,Q8H,2019,Q3,Cutaneous amyloidosis,,2019,Q3,1,I,2012.0,20190704.0,20190827,20190827,EXP,,CZ-SA-2019SA181704,SANOFI AVENTIS,MARESOVA A.. AMYLOIDOSIS - A CASE OF PATIENT WITH NODULAR AMYLOIDOSIS AT INZULIN INJECTION SITES. DERMATOL PRAXI. 2019;13(2):83-85,73.0,YR,E,M,Y,,,20190827.0,,MD,CZ,CZ,2019,Q3,Elderly
167429531,16742953,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"36-45-42IU, TID",,,U,,,,,,,SOLUTION FOR INJECTION,Q8H,2019,Q3,Injection site reaction,,2019,Q3,1,I,2012.0,20190704.0,20190827,20190827,EXP,,CZ-SA-2019SA181704,SANOFI AVENTIS,MARESOVA A.. AMYLOIDOSIS - A CASE OF PATIENT WITH NODULAR AMYLOIDOSIS AT INZULIN INJECTION SITES. DERMATOL PRAXI. 2019;13(2):83-85,73.0,YR,E,M,Y,,,20190827.0,,MD,CZ,CZ,2019,Q3,Elderly
167429531,16742953,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12IU ? 24IU ? 24IU, TID",,,U,,,,,,,SOLUTION FOR INJECTION,Q8H,2019,Q3,Cutaneous amyloidosis,,2019,Q3,1,I,2012.0,20190704.0,20190827,20190827,EXP,,CZ-SA-2019SA181704,SANOFI AVENTIS,MARESOVA A.. AMYLOIDOSIS - A CASE OF PATIENT WITH NODULAR AMYLOIDOSIS AT INZULIN INJECTION SITES. DERMATOL PRAXI. 2019;13(2):83-85,73.0,YR,E,M,Y,,,20190827.0,,MD,CZ,CZ,2019,Q3,Elderly
167429531,16742953,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12IU ? 24IU ? 24IU, TID",,,U,,,,,,,SOLUTION FOR INJECTION,Q8H,2019,Q3,Injection site reaction,,2019,Q3,1,I,2012.0,20190704.0,20190827,20190827,EXP,,CZ-SA-2019SA181704,SANOFI AVENTIS,MARESOVA A.. AMYLOIDOSIS - A CASE OF PATIENT WITH NODULAR AMYLOIDOSIS AT INZULIN INJECTION SITES. DERMATOL PRAXI. 2019;13(2):83-85,73.0,YR,E,M,Y,,,20190827.0,,MD,CZ,CZ,2019,Q3,Elderly
167442021,16744202,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 IU, UNK",,,U,,,,,15.0,IU,,,2019,Q3,Drug interaction,,2019,Q3,1,I,20190613.0,20190823.0,20190827,20190827,EXP,,PHHY2019IT197764,SANDOZ,,88.0,YR,,M,Y,,,20190827.0,,OT,IT,IT,2019,Q3,Elderly
167442021,16744202,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 IU, UNK",,,U,,,,,15.0,IU,,,2019,Q3,Haematuria,,2019,Q3,1,I,20190613.0,20190823.0,20190827,20190827,EXP,,PHHY2019IT197764,SANDOZ,,88.0,YR,,M,Y,,,20190827.0,,OT,IT,IT,2019,Q3,Elderly
167446951,16744695,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q3,Acute kidney injury,,2019,Q3,1,I,2019.0,20190820.0,20190827,20190827,EXP,,PT-MYLANLABS-2019M1078968,MYLAN,"GOUVEIA C. C, DUQUE S, CAMPOS L. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN. REVISTA PORTUGUESA DE DIABETES. 2019;14(1):74-P050",71.0,YR,,M,Y,,,20190827.0,,MD,PT,PT,2019,Q3,Elderly
167446951,16744695,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q3,Bradycardia,,2019,Q3,1,I,2019.0,20190820.0,20190827,20190827,EXP,,PT-MYLANLABS-2019M1078968,MYLAN,"GOUVEIA C. C, DUQUE S, CAMPOS L. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN. REVISTA PORTUGUESA DE DIABETES. 2019;14(1):74-P050",71.0,YR,,M,Y,,,20190827.0,,MD,PT,PT,2019,Q3,Elderly
167446951,16744695,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q3,Hypotension,,2019,Q3,1,I,2019.0,20190820.0,20190827,20190827,EXP,,PT-MYLANLABS-2019M1078968,MYLAN,"GOUVEIA C. C, DUQUE S, CAMPOS L. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN. REVISTA PORTUGUESA DE DIABETES. 2019;14(1):74-P050",71.0,YR,,M,Y,,,20190827.0,,MD,PT,PT,2019,Q3,Elderly
167446951,16744695,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q3,Hypovolaemia,,2019,Q3,1,I,2019.0,20190820.0,20190827,20190827,EXP,,PT-MYLANLABS-2019M1078968,MYLAN,"GOUVEIA C. C, DUQUE S, CAMPOS L. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN. REVISTA PORTUGUESA DE DIABETES. 2019;14(1):74-P050",71.0,YR,,M,Y,,,20190827.0,,MD,PT,PT,2019,Q3,Elderly
167446951,16744695,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q3,Presyncope,,2019,Q3,1,I,2019.0,20190820.0,20190827,20190827,EXP,,PT-MYLANLABS-2019M1078968,MYLAN,"GOUVEIA C. C, DUQUE S, CAMPOS L. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN. REVISTA PORTUGUESA DE DIABETES. 2019;14(1):74-P050",71.0,YR,,M,Y,,,20190827.0,,MD,PT,PT,2019,Q3,Elderly
167507411,16750741,8,C,INSULIN LISPRO W/INSULIN LISPRO PROTAMINE SUS,,2,Unknown,"UNK, Q.AM 40 UNITS",,,D,,,,,,,,QD,2019,Q3,Bradycardia,,2019,Q3,1,I,,20190815.0,20190828,20190828,EXP,,US-APOTEX-2019AP021015,APOTEX,"COOK RM, GARCIA-GAYOSO AS, TWILLA JD.. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELEASS, BRADYCARDIC ARREST.. AMERICAN JOURNAL OF THERAPEUTICS.. 2019;26 (4):E543-E545.",72.0,YR,,F,Y,,,20190828.0,,OT,US,US,2019,Q3,Elderly
167507411,16750741,8,C,INSULIN LISPRO W/INSULIN LISPRO PROTAMINE SUS,,2,Unknown,"UNK, Q.AM 40 UNITS",,,D,,,,,,,,QD,2019,Q3,Cardiac arrest,,2019,Q3,1,I,,20190815.0,20190828,20190828,EXP,,US-APOTEX-2019AP021015,APOTEX,"COOK RM, GARCIA-GAYOSO AS, TWILLA JD.. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELEASS, BRADYCARDIC ARREST.. AMERICAN JOURNAL OF THERAPEUTICS.. 2019;26 (4):E543-E545.",72.0,YR,,F,Y,,,20190828.0,,OT,US,US,2019,Q3,Elderly
167507411,16750741,8,C,INSULIN LISPRO W/INSULIN LISPRO PROTAMINE SUS,,2,Unknown,"UNK, Q.AM 40 UNITS",,,D,,,,,,,,QD,2019,Q3,Drug interaction,,2019,Q3,1,I,,20190815.0,20190828,20190828,EXP,,US-APOTEX-2019AP021015,APOTEX,"COOK RM, GARCIA-GAYOSO AS, TWILLA JD.. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELEASS, BRADYCARDIC ARREST.. AMERICAN JOURNAL OF THERAPEUTICS.. 2019;26 (4):E543-E545.",72.0,YR,,F,Y,,,20190828.0,,OT,US,US,2019,Q3,Elderly
167507411,16750741,8,C,INSULIN LISPRO W/INSULIN LISPRO PROTAMINE SUS,,2,Unknown,"UNK, Q.AM 40 UNITS",,,D,,,,,,,,QD,2019,Q3,Pulseless electrical activity,,2019,Q3,1,I,,20190815.0,20190828,20190828,EXP,,US-APOTEX-2019AP021015,APOTEX,"COOK RM, GARCIA-GAYOSO AS, TWILLA JD.. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELEASS, BRADYCARDIC ARREST.. AMERICAN JOURNAL OF THERAPEUTICS.. 2019;26 (4):E543-E545.",72.0,YR,,F,Y,,,20190828.0,,OT,US,US,2019,Q3,Elderly
167507411,16750741,9,C,INSULIN LISPRO W/INSULIN LISPRO PROTAMINE SUS,,2,Unknown,"UNK, 60 UNITS EVERY EVENING",,,D,,,,,,,,,2019,Q3,Bradycardia,,2019,Q3,1,I,,20190815.0,20190828,20190828,EXP,,US-APOTEX-2019AP021015,APOTEX,"COOK RM, GARCIA-GAYOSO AS, TWILLA JD.. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELEASS, BRADYCARDIC ARREST.. AMERICAN JOURNAL OF THERAPEUTICS.. 2019;26 (4):E543-E545.",72.0,YR,,F,Y,,,20190828.0,,OT,US,US,2019,Q3,Elderly
167507411,16750741,9,C,INSULIN LISPRO W/INSULIN LISPRO PROTAMINE SUS,,2,Unknown,"UNK, 60 UNITS EVERY EVENING",,,D,,,,,,,,,2019,Q3,Cardiac arrest,,2019,Q3,1,I,,20190815.0,20190828,20190828,EXP,,US-APOTEX-2019AP021015,APOTEX,"COOK RM, GARCIA-GAYOSO AS, TWILLA JD.. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELEASS, BRADYCARDIC ARREST.. AMERICAN JOURNAL OF THERAPEUTICS.. 2019;26 (4):E543-E545.",72.0,YR,,F,Y,,,20190828.0,,OT,US,US,2019,Q3,Elderly
167507411,16750741,9,C,INSULIN LISPRO W/INSULIN LISPRO PROTAMINE SUS,,2,Unknown,"UNK, 60 UNITS EVERY EVENING",,,D,,,,,,,,,2019,Q3,Drug interaction,,2019,Q3,1,I,,20190815.0,20190828,20190828,EXP,,US-APOTEX-2019AP021015,APOTEX,"COOK RM, GARCIA-GAYOSO AS, TWILLA JD.. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELEASS, BRADYCARDIC ARREST.. AMERICAN JOURNAL OF THERAPEUTICS.. 2019;26 (4):E543-E545.",72.0,YR,,F,Y,,,20190828.0,,OT,US,US,2019,Q3,Elderly
167507411,16750741,9,C,INSULIN LISPRO W/INSULIN LISPRO PROTAMINE SUS,,2,Unknown,"UNK, 60 UNITS EVERY EVENING",,,D,,,,,,,,,2019,Q3,Pulseless electrical activity,,2019,Q3,1,I,,20190815.0,20190828,20190828,EXP,,US-APOTEX-2019AP021015,APOTEX,"COOK RM, GARCIA-GAYOSO AS, TWILLA JD.. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELEASS, BRADYCARDIC ARREST.. AMERICAN JOURNAL OF THERAPEUTICS.. 2019;26 (4):E543-E545.",72.0,YR,,F,Y,,,20190828.0,,OT,US,US,2019,Q3,Elderly
167516541,16751654,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2019,Q3,Dehydration,,2019,Q3,1,I,,20190821.0,20190828,20190828,EXP,,CA-PFIZER INC-2019364302,PFIZER,,72.0,YR,,F,Y,,,20190828.0,,OT,CA,CA,2019,Q3,Elderly
167518991,16751899,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,, UNKNOWN,,,,,,,2019,Q3,Drug reaction with eosinophilia and systemic symptoms,,2019,Q3,1,I,20190724.0,20190820.0,20190828,20190828,EXP,IT-MINISAL02-568249,IT-TEVA-2019-IT-1097406,TEVA,,59.0,YR,,,Y,,,20190828.0,,MD,IT,IT,2019,Q3,Adult
167518991,16751899,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,, UNKNOWN,,,,,,,2019,Q3,Erythema,,2019,Q3,1,I,20190724.0,20190820.0,20190828,20190828,EXP,IT-MINISAL02-568249,IT-TEVA-2019-IT-1097406,TEVA,,59.0,YR,,,Y,,,20190828.0,,MD,IT,IT,2019,Q3,Adult
167518991,16751899,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,, UNKNOWN,,,,,,,2019,Q3,Oedema,,2019,Q3,1,I,20190724.0,20190820.0,20190828,20190828,EXP,IT-MINISAL02-568249,IT-TEVA-2019-IT-1097406,TEVA,,59.0,YR,,,Y,,,20190828.0,,MD,IT,IT,2019,Q3,Adult
167518991,16751899,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,, UNKNOWN,,,,,,,2019,Q3,Pyrexia,,2019,Q3,1,I,20190724.0,20190820.0,20190828,20190828,EXP,IT-MINISAL02-568249,IT-TEVA-2019-IT-1097406,TEVA,,59.0,YR,,,Y,,,20190828.0,,MD,IT,IT,2019,Q3,Adult
167518991,16751899,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,, UNKNOWN,,,,,,,2019,Q3,Sepsis,,2019,Q3,1,I,20190724.0,20190820.0,20190828,20190828,EXP,IT-MINISAL02-568249,IT-TEVA-2019-IT-1097406,TEVA,,59.0,YR,,,Y,,,20190828.0,,MD,IT,IT,2019,Q3,Adult
167541633,16754163,9,C,Lispro,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE,,,,,,,,,,INJECTION,BID,2019,Q3,Full blood count decreased,,2019,Q3,3,F,2019.0,20190910.0,20190829,20190912,EXP,,US-CELGENEUS-USA-20190809382,CELGENE,,62.0,YR,,F,Y,69.01,KG,20190912.0,,MD,US,US,2019,Q3,Adult
167541633,16754163,9,C,Lispro,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE,,,,,,,,,,INJECTION,BID,2019,Q3,Pneumonia,,2019,Q3,3,F,2019.0,20190910.0,20190829,20190912,EXP,,US-CELGENEUS-USA-20190809382,CELGENE,,62.0,YR,,F,Y,69.01,KG,20190912.0,,MD,US,US,2019,Q3,Adult
167541633,16754163,9,C,Lispro,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE,,,,,,,,,,INJECTION,BID,2019,Q3,Renal disorder,,2019,Q3,3,F,2019.0,20190910.0,20190829,20190912,EXP,,US-CELGENEUS-USA-20190809382,CELGENE,,62.0,YR,,F,Y,69.01,KG,20190912.0,,MD,US,US,2019,Q3,Adult
167541633,16754163,9,C,Lispro,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE,,,,,,,,,,INJECTION,BID,2019,Q3,Sepsis,,2019,Q3,3,F,2019.0,20190910.0,20190829,20190912,EXP,,US-CELGENEUS-USA-20190809382,CELGENE,,62.0,YR,,F,Y,69.01,KG,20190912.0,,MD,US,US,2019,Q3,Adult
167569212,16756921,37,C,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2019,Q3,Pneumonitis,,2019,Q3,2,F,20190815.0,20190909.0,20190829,20190916,PER,,US-CELGENEUS-USA-20190810207,CELGENE,,71.0,YR,,F,Y,63.0,KG,20190916.0,,OT,US,US,2019,Q3,Elderly
167588221,16758822,9,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q3,Pyrexia,,2019,Q3,1,I,20190606.0,,20190711,20190711,DIR,,,FDA-CTU,,60.0,YR,,M,N,76.9,KG,20190711.0,Y,OT,US,US,2019,Q3,Adult
167642751,16764275,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,15 INTERNATIONAL UNIT,,,U,,,,,15.0,IU,,,2019,Q3,Drug interaction,,2019,Q3,1,I,20190613.0,20190821.0,20190902,20190902,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-082550,BRISTOL MYERS SQUIBB,,88.0,YR,,M,Y,,,20190902.0,,MD,IT,IT,2019,Q3,Elderly
167642751,16764275,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,15 INTERNATIONAL UNIT,,,U,,,,,15.0,IU,,,2019,Q3,Haematuria,,2019,Q3,1,I,20190613.0,20190821.0,20190902,20190902,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-082550,BRISTOL MYERS SQUIBB,,88.0,YR,,M,Y,,,20190902.0,,MD,IT,IT,2019,Q3,Elderly
167659191,16765919,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2019,Q3,On and off phenomenon,,2019,Q3,1,I,2019.0,20190805.0,20190903,20190903,EXP,,DE-ABBVIE-19K-062-2879301-00,ABBVIE,,75.0,YR,,M,Y,,,20190903.0,,CN,DE,DE,2019,Q3,Elderly
167659191,16765919,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2019,Q3,Sepsis,,2019,Q3,1,I,2019.0,20190805.0,20190903,20190903,EXP,,DE-ABBVIE-19K-062-2879301-00,ABBVIE,,75.0,YR,,M,Y,,,20190903.0,,CN,DE,DE,2019,Q3,Elderly
167659191,16765919,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2019,Q3,Stoma site inflammation,,2019,Q3,1,I,2019.0,20190805.0,20190903,20190903,EXP,,DE-ABBVIE-19K-062-2879301-00,ABBVIE,,75.0,YR,,M,Y,,,20190903.0,,CN,DE,DE,2019,Q3,Elderly
167678401,16767840,10,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Dehydration,,2019,Q3,1,I,,20190827.0,20190903,20190903,EXP,,PT-MYLANLABS-2019M1081775,MYLAN,"GOUVEIA CC, DUQUE S, CAMPOS L. LIPOT?MIA POR HIPOVOL?MIA ? UM CASO DE IATROGENIA ? EMPAGLIFLOZINA?. REV PORT DIABETES. 2019;14(1):75",71.0,YR,,M,Y,,,20190903.0,,MD,PT,PT,2019,Q3,Elderly
167678401,16767840,10,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Dizziness,,2019,Q3,1,I,,20190827.0,20190903,20190903,EXP,,PT-MYLANLABS-2019M1081775,MYLAN,"GOUVEIA CC, DUQUE S, CAMPOS L. LIPOT?MIA POR HIPOVOL?MIA ? UM CASO DE IATROGENIA ? EMPAGLIFLOZINA?. REV PORT DIABETES. 2019;14(1):75",71.0,YR,,M,Y,,,20190903.0,,MD,PT,PT,2019,Q3,Elderly
167678401,16767840,10,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Drug interaction,,2019,Q3,1,I,,20190827.0,20190903,20190903,EXP,,PT-MYLANLABS-2019M1081775,MYLAN,"GOUVEIA CC, DUQUE S, CAMPOS L. LIPOT?MIA POR HIPOVOL?MIA ? UM CASO DE IATROGENIA ? EMPAGLIFLOZINA?. REV PORT DIABETES. 2019;14(1):75",71.0,YR,,M,Y,,,20190903.0,,MD,PT,PT,2019,Q3,Elderly
167678401,16767840,10,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Presyncope,,2019,Q3,1,I,,20190827.0,20190903,20190903,EXP,,PT-MYLANLABS-2019M1081775,MYLAN,"GOUVEIA CC, DUQUE S, CAMPOS L. LIPOT?MIA POR HIPOVOL?MIA ? UM CASO DE IATROGENIA ? EMPAGLIFLOZINA?. REV PORT DIABETES. 2019;14(1):75",71.0,YR,,M,Y,,,20190903.0,,MD,PT,PT,2019,Q3,Elderly
167678401,16767840,10,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Renal injury,,2019,Q3,1,I,,20190827.0,20190903,20190903,EXP,,PT-MYLANLABS-2019M1081775,MYLAN,"GOUVEIA CC, DUQUE S, CAMPOS L. LIPOT?MIA POR HIPOVOL?MIA ? UM CASO DE IATROGENIA ? EMPAGLIFLOZINA?. REV PORT DIABETES. 2019;14(1):75",71.0,YR,,M,Y,,,20190903.0,,MD,PT,PT,2019,Q3,Elderly
167708951,16770895,5,C,"INSULIN LISPRO PROTAMINE, INSULIN LISPRO",,2,Unknown,"INSULIN LISPRO PROTAMINE/INSULIN LISPRO (75/25), EVERY MORNING",,,U,, UNKNOWN,,,40.0,IU,UNKNOWN,,2019,Q3,Cardiac arrest,,2019,Q3,1,I,,20190820.0,20190904,20190904,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-19-46794,HIKMA,"COOK R, GARCIA-GAYOSO A, TWILLA J. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST; DOI: 10.1097/MJT.0000000000000804. AMERICAN JOURNAL OF THERAPEUTICS. 2019;26(4):543-545.",72.0,YR,,F,Y,,,20190904.0,,PH,US,US,2019,Q3,Elderly
167708951,16770895,5,C,"INSULIN LISPRO PROTAMINE, INSULIN LISPRO",,2,Unknown,"INSULIN LISPRO PROTAMINE/INSULIN LISPRO (75/25), EVERY MORNING",,,U,, UNKNOWN,,,40.0,IU,UNKNOWN,,2019,Q3,Drug interaction,,2019,Q3,1,I,,20190820.0,20190904,20190904,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-19-46794,HIKMA,"COOK R, GARCIA-GAYOSO A, TWILLA J. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST; DOI: 10.1097/MJT.0000000000000804. AMERICAN JOURNAL OF THERAPEUTICS. 2019;26(4):543-545.",72.0,YR,,F,Y,,,20190904.0,,PH,US,US,2019,Q3,Elderly
167708951,16770895,5,C,"INSULIN LISPRO PROTAMINE, INSULIN LISPRO",,2,Unknown,"INSULIN LISPRO PROTAMINE/INSULIN LISPRO (75/25), EVERY MORNING",,,U,, UNKNOWN,,,40.0,IU,UNKNOWN,,2019,Q3,Hypotension,,2019,Q3,1,I,,20190820.0,20190904,20190904,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-19-46794,HIKMA,"COOK R, GARCIA-GAYOSO A, TWILLA J. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST; DOI: 10.1097/MJT.0000000000000804. AMERICAN JOURNAL OF THERAPEUTICS. 2019;26(4):543-545.",72.0,YR,,F,Y,,,20190904.0,,PH,US,US,2019,Q3,Elderly
167708951,16770895,5,C,"INSULIN LISPRO PROTAMINE, INSULIN LISPRO",,2,Unknown,"INSULIN LISPRO PROTAMINE/INSULIN LISPRO (75/25), EVERY MORNING",,,U,, UNKNOWN,,,40.0,IU,UNKNOWN,,2019,Q3,Negative cardiac inotropic effect,,2019,Q3,1,I,,20190820.0,20190904,20190904,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-19-46794,HIKMA,"COOK R, GARCIA-GAYOSO A, TWILLA J. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST; DOI: 10.1097/MJT.0000000000000804. AMERICAN JOURNAL OF THERAPEUTICS. 2019;26(4):543-545.",72.0,YR,,F,Y,,,20190904.0,,PH,US,US,2019,Q3,Elderly
167708951,16770895,5,C,"INSULIN LISPRO PROTAMINE, INSULIN LISPRO",,2,Unknown,"INSULIN LISPRO PROTAMINE/INSULIN LISPRO (75/25), EVERY MORNING",,,U,, UNKNOWN,,,40.0,IU,UNKNOWN,,2019,Q3,Nodal arrhythmia,,2019,Q3,1,I,,20190820.0,20190904,20190904,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-19-46794,HIKMA,"COOK R, GARCIA-GAYOSO A, TWILLA J. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST; DOI: 10.1097/MJT.0000000000000804. AMERICAN JOURNAL OF THERAPEUTICS. 2019;26(4):543-545.",72.0,YR,,F,Y,,,20190904.0,,PH,US,US,2019,Q3,Elderly
167708951,16770895,5,C,"INSULIN LISPRO PROTAMINE, INSULIN LISPRO",,2,Unknown,"INSULIN LISPRO PROTAMINE/INSULIN LISPRO (75/25), EVERY MORNING",,,U,, UNKNOWN,,,40.0,IU,UNKNOWN,,2019,Q3,Potentiating drug interaction,,2019,Q3,1,I,,20190820.0,20190904,20190904,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-19-46794,HIKMA,"COOK R, GARCIA-GAYOSO A, TWILLA J. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST; DOI: 10.1097/MJT.0000000000000804. AMERICAN JOURNAL OF THERAPEUTICS. 2019;26(4):543-545.",72.0,YR,,F,Y,,,20190904.0,,PH,US,US,2019,Q3,Elderly
167708951,16770895,5,C,"INSULIN LISPRO PROTAMINE, INSULIN LISPRO",,2,Unknown,"INSULIN LISPRO PROTAMINE/INSULIN LISPRO (75/25), EVERY MORNING",,,U,, UNKNOWN,,,40.0,IU,UNKNOWN,,2019,Q3,Pulseless electrical activity,,2019,Q3,1,I,,20190820.0,20190904,20190904,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-19-46794,HIKMA,"COOK R, GARCIA-GAYOSO A, TWILLA J. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST; DOI: 10.1097/MJT.0000000000000804. AMERICAN JOURNAL OF THERAPEUTICS. 2019;26(4):543-545.",72.0,YR,,F,Y,,,20190904.0,,PH,US,US,2019,Q3,Elderly
167708951,16770895,6,C,"INSULIN LISPRO PROTAMINE, INSULIN LISPRO",,2,Unknown,"INSULIN LISPRO PROTAMINE/INSULIN LISPRO (75/25), EVERY EVENING",,,U,, UNKNOWN,,,60.0,IU,UNKNOWN,,2019,Q3,Cardiac arrest,,2019,Q3,1,I,,20190820.0,20190904,20190904,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-19-46794,HIKMA,"COOK R, GARCIA-GAYOSO A, TWILLA J. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST; DOI: 10.1097/MJT.0000000000000804. AMERICAN JOURNAL OF THERAPEUTICS. 2019;26(4):543-545.",72.0,YR,,F,Y,,,20190904.0,,PH,US,US,2019,Q3,Elderly
167708951,16770895,6,C,"INSULIN LISPRO PROTAMINE, INSULIN LISPRO",,2,Unknown,"INSULIN LISPRO PROTAMINE/INSULIN LISPRO (75/25), EVERY EVENING",,,U,, UNKNOWN,,,60.0,IU,UNKNOWN,,2019,Q3,Drug interaction,,2019,Q3,1,I,,20190820.0,20190904,20190904,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-19-46794,HIKMA,"COOK R, GARCIA-GAYOSO A, TWILLA J. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST; DOI: 10.1097/MJT.0000000000000804. AMERICAN JOURNAL OF THERAPEUTICS. 2019;26(4):543-545.",72.0,YR,,F,Y,,,20190904.0,,PH,US,US,2019,Q3,Elderly
167708951,16770895,6,C,"INSULIN LISPRO PROTAMINE, INSULIN LISPRO",,2,Unknown,"INSULIN LISPRO PROTAMINE/INSULIN LISPRO (75/25), EVERY EVENING",,,U,, UNKNOWN,,,60.0,IU,UNKNOWN,,2019,Q3,Hypotension,,2019,Q3,1,I,,20190820.0,20190904,20190904,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-19-46794,HIKMA,"COOK R, GARCIA-GAYOSO A, TWILLA J. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST; DOI: 10.1097/MJT.0000000000000804. AMERICAN JOURNAL OF THERAPEUTICS. 2019;26(4):543-545.",72.0,YR,,F,Y,,,20190904.0,,PH,US,US,2019,Q3,Elderly
167708951,16770895,6,C,"INSULIN LISPRO PROTAMINE, INSULIN LISPRO",,2,Unknown,"INSULIN LISPRO PROTAMINE/INSULIN LISPRO (75/25), EVERY EVENING",,,U,, UNKNOWN,,,60.0,IU,UNKNOWN,,2019,Q3,Negative cardiac inotropic effect,,2019,Q3,1,I,,20190820.0,20190904,20190904,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-19-46794,HIKMA,"COOK R, GARCIA-GAYOSO A, TWILLA J. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST; DOI: 10.1097/MJT.0000000000000804. AMERICAN JOURNAL OF THERAPEUTICS. 2019;26(4):543-545.",72.0,YR,,F,Y,,,20190904.0,,PH,US,US,2019,Q3,Elderly
167708951,16770895,6,C,"INSULIN LISPRO PROTAMINE, INSULIN LISPRO",,2,Unknown,"INSULIN LISPRO PROTAMINE/INSULIN LISPRO (75/25), EVERY EVENING",,,U,, UNKNOWN,,,60.0,IU,UNKNOWN,,2019,Q3,Nodal arrhythmia,,2019,Q3,1,I,,20190820.0,20190904,20190904,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-19-46794,HIKMA,"COOK R, GARCIA-GAYOSO A, TWILLA J. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST; DOI: 10.1097/MJT.0000000000000804. AMERICAN JOURNAL OF THERAPEUTICS. 2019;26(4):543-545.",72.0,YR,,F,Y,,,20190904.0,,PH,US,US,2019,Q3,Elderly
167708951,16770895,6,C,"INSULIN LISPRO PROTAMINE, INSULIN LISPRO",,2,Unknown,"INSULIN LISPRO PROTAMINE/INSULIN LISPRO (75/25), EVERY EVENING",,,U,, UNKNOWN,,,60.0,IU,UNKNOWN,,2019,Q3,Potentiating drug interaction,,2019,Q3,1,I,,20190820.0,20190904,20190904,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-19-46794,HIKMA,"COOK R, GARCIA-GAYOSO A, TWILLA J. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST; DOI: 10.1097/MJT.0000000000000804. AMERICAN JOURNAL OF THERAPEUTICS. 2019;26(4):543-545.",72.0,YR,,F,Y,,,20190904.0,,PH,US,US,2019,Q3,Elderly
167708951,16770895,6,C,"INSULIN LISPRO PROTAMINE, INSULIN LISPRO",,2,Unknown,"INSULIN LISPRO PROTAMINE/INSULIN LISPRO (75/25), EVERY EVENING",,,U,, UNKNOWN,,,60.0,IU,UNKNOWN,,2019,Q3,Pulseless electrical activity,,2019,Q3,1,I,,20190820.0,20190904,20190904,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-19-46794,HIKMA,"COOK R, GARCIA-GAYOSO A, TWILLA J. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST; DOI: 10.1097/MJT.0000000000000804. AMERICAN JOURNAL OF THERAPEUTICS. 2019;26(4):543-545.",72.0,YR,,F,Y,,,20190904.0,,PH,US,US,2019,Q3,Elderly
167713682,16771368,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 UNIT/ML: INJECT 1-6 UNITS UNDER SKIN EVERY 4 HOURS,,,,,,,,,,,,2019,Q3,Infective pulmonary exacerbation of cystic fibrosis,,2019,Q3,2,F,201908.0,20190919.0,20190904,20190926,EXP,,US-VERTEX PHARMACEUTICALS-2019-008376,VERTEX,,18.0,YR,,M,Y,,,20190926.0,,OT,US,US,2019,Q3,Youth
167713682,16771368,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 UNIT/ML: INJECT 1-6 UNITS UNDER SKIN EVERY 4 HOURS,,,,,,,,,,,,2019,Q3,Weight decreased,,2019,Q3,2,F,201908.0,20190919.0,20190904,20190926,EXP,,US-VERTEX PHARMACEUTICALS-2019-008376,VERTEX,,18.0,YR,,M,Y,,,20190926.0,,OT,US,US,2019,Q3,Youth
167745071,16774507,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,Y,U,,,20563.0,,,INJECTION,,2019,Q3,Blood glucose abnormal,,2019,Q3,1,I,20190801.0,20190822.0,20190905,20190905,EXP,,US-ELI_LILLY_AND_COMPANY-US201908010697,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20190905.0,,CN,US,US,2019,Q3,Adult
167747662,16774766,34,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q3,Rectal adenocarcinoma,,2019,Q3,2,F,20190723.0,20190830.0,20190905,20190911,EXP,,US-UCBSA-2019037590,UCB,,65.0,YR,,F,Y,111.0,KG,20190911.0,,MD,US,US,2019,Q3,Elderly
167762381,16776238,8,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Arthralgia,,2019,Q3,1,I,,20190903.0,20190905,20190905,EXP,,CA-PFIZER INC-2019382221,PFIZER,,62.0,YR,,M,Y,,,20190905.0,,OT,CA,CA,2019,Q3,Adult
167762381,16776238,8,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Drug ineffective,,2019,Q3,1,I,,20190903.0,20190905,20190905,EXP,,CA-PFIZER INC-2019382221,PFIZER,,62.0,YR,,M,Y,,,20190905.0,,OT,CA,CA,2019,Q3,Adult
167762381,16776238,8,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Gait disturbance,,2019,Q3,1,I,,20190903.0,20190905,20190905,EXP,,CA-PFIZER INC-2019382221,PFIZER,,62.0,YR,,M,Y,,,20190905.0,,OT,CA,CA,2019,Q3,Adult
167762381,16776238,8,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Hepatic enzyme increased,,2019,Q3,1,I,,20190903.0,20190905,20190905,EXP,,CA-PFIZER INC-2019382221,PFIZER,,62.0,YR,,M,Y,,,20190905.0,,OT,CA,CA,2019,Q3,Adult
167762381,16776238,8,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Musculoskeletal stiffness,,2019,Q3,1,I,,20190903.0,20190905,20190905,EXP,,CA-PFIZER INC-2019382221,PFIZER,,62.0,YR,,M,Y,,,20190905.0,,OT,CA,CA,2019,Q3,Adult
167762381,16776238,8,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Oedema peripheral,,2019,Q3,1,I,,20190903.0,20190905,20190905,EXP,,CA-PFIZER INC-2019382221,PFIZER,,62.0,YR,,M,Y,,,20190905.0,,OT,CA,CA,2019,Q3,Adult
167762381,16776238,8,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Pain in extremity,,2019,Q3,1,I,,20190903.0,20190905,20190905,EXP,,CA-PFIZER INC-2019382221,PFIZER,,62.0,YR,,M,Y,,,20190905.0,,OT,CA,CA,2019,Q3,Adult
167762381,16776238,8,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Peripheral swelling,,2019,Q3,1,I,,20190903.0,20190905,20190905,EXP,,CA-PFIZER INC-2019382221,PFIZER,,62.0,YR,,M,Y,,,20190905.0,,OT,CA,CA,2019,Q3,Adult
167762381,16776238,8,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Pharyngitis,,2019,Q3,1,I,,20190903.0,20190905,20190905,EXP,,CA-PFIZER INC-2019382221,PFIZER,,62.0,YR,,M,Y,,,20190905.0,,OT,CA,CA,2019,Q3,Adult
167762381,16776238,8,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Poor venous access,,2019,Q3,1,I,,20190903.0,20190905,20190905,EXP,,CA-PFIZER INC-2019382221,PFIZER,,62.0,YR,,M,Y,,,20190905.0,,OT,CA,CA,2019,Q3,Adult
167762381,16776238,8,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Pruritus,,2019,Q3,1,I,,20190903.0,20190905,20190905,EXP,,CA-PFIZER INC-2019382221,PFIZER,,62.0,YR,,M,Y,,,20190905.0,,OT,CA,CA,2019,Q3,Adult
167762381,16776238,8,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Swelling,,2019,Q3,1,I,,20190903.0,20190905,20190905,EXP,,CA-PFIZER INC-2019382221,PFIZER,,62.0,YR,,M,Y,,,20190905.0,,OT,CA,CA,2019,Q3,Adult
167762381,16776238,8,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Therapeutic response decreased,,2019,Q3,1,I,,20190903.0,20190905,20190905,EXP,,CA-PFIZER INC-2019382221,PFIZER,,62.0,YR,,M,Y,,,20190905.0,,OT,CA,CA,2019,Q3,Adult
167762381,16776238,8,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Tremor,,2019,Q3,1,I,,20190903.0,20190905,20190905,EXP,,CA-PFIZER INC-2019382221,PFIZER,,62.0,YR,,M,Y,,,20190905.0,,OT,CA,CA,2019,Q3,Adult
167762381,16776238,8,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Vomiting,,2019,Q3,1,I,,20190903.0,20190905,20190905,EXP,,CA-PFIZER INC-2019382221,PFIZER,,62.0,YR,,M,Y,,,20190905.0,,OT,CA,CA,2019,Q3,Adult
167776351,16777635,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"5 U, BID(MORNING AND NIGHT)",,,,, ASKU,,20563.0,5.0,IU,,BID,2019,Q3,Immune system disorder,,2019,Q3,1,I,,20190826.0,20190905,20190905,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201908013651,ELI LILLY AND CO,,33.0,YR,,F,Y,50.0,KG,20190905.0,,CN,CN,CN,2019,Q3,Young Adult
167776351,16777635,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"5 U, BID(MORNING AND NIGHT)",,,,, ASKU,,20563.0,5.0,IU,,BID,2019,Q3,Nasopharyngitis,,2019,Q3,1,I,,20190826.0,20190905,20190905,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201908013651,ELI LILLY AND CO,,33.0,YR,,F,Y,50.0,KG,20190905.0,,CN,CN,CN,2019,Q3,Young Adult
167776351,16777635,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"5 U, BID(MORNING AND NIGHT)",,,,, ASKU,,20563.0,5.0,IU,,BID,2019,Q3,Swelling,,2019,Q3,1,I,,20190826.0,20190905,20190905,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201908013651,ELI LILLY AND CO,,33.0,YR,,F,Y,50.0,KG,20190905.0,,CN,CN,CN,2019,Q3,Young Adult
167776351,16777635,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"10 U, TID(MORNING, NOON AND NIGHT)",,,,, ASKU,,20563.0,10.0,IU,,TID,2019,Q3,Immune system disorder,,2019,Q3,1,I,,20190826.0,20190905,20190905,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201908013651,ELI LILLY AND CO,,33.0,YR,,F,Y,50.0,KG,20190905.0,,CN,CN,CN,2019,Q3,Young Adult
167776351,16777635,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"10 U, TID(MORNING, NOON AND NIGHT)",,,,, ASKU,,20563.0,10.0,IU,,TID,2019,Q3,Nasopharyngitis,,2019,Q3,1,I,,20190826.0,20190905,20190905,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201908013651,ELI LILLY AND CO,,33.0,YR,,F,Y,50.0,KG,20190905.0,,CN,CN,CN,2019,Q3,Young Adult
167776351,16777635,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"10 U, TID(MORNING, NOON AND NIGHT)",,,,, ASKU,,20563.0,10.0,IU,,TID,2019,Q3,Swelling,,2019,Q3,1,I,,20190826.0,20190905,20190905,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201908013651,ELI LILLY AND CO,,33.0,YR,,F,Y,50.0,KG,20190905.0,,CN,CN,CN,2019,Q3,Young Adult
167811701,16781170,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100 UNITS 5 UNITS DAILY,,,U,,,,,,,,,2019,Q3,Glycosylated haemoglobin increased,,2019,Q3,1,I,,20190829.0,20190906,20190906,PER,,US-SA-2019SA245886,SANOFI AVENTIS,,81.0,YR,E,M,Y,,,20190906.0,,CN,US,US,2019,Q3,Elderly
167817861,16781786,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"12IU ? 24IU ? 24IU, TID",,,U,U,,,20563.0,12.0,IU,,QD,2019,Q3,Cutaneous amyloidosis,,2019,Q3,1,I,2012.0,20190828.0,20190906,20190906,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201908014087,ELI LILLY AND CO,,73.0,YR,,M,Y,,,20190906.0,,CN,CZ,CZ,2019,Q3,Elderly
167817861,16781786,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"12IU ? 24IU ? 24IU, TID",,,U,U,,,20563.0,12.0,IU,,QD,2019,Q3,Injection site reaction,,2019,Q3,1,I,2012.0,20190828.0,20190906,20190906,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201908014087,ELI LILLY AND CO,,73.0,YR,,M,Y,,,20190906.0,,CN,CZ,CZ,2019,Q3,Elderly
167817861,16781786,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"12IU ? 24IU ? 24IU, TID",,,U,U,,,20563.0,24.0,IU,,BID,2019,Q3,Cutaneous amyloidosis,,2019,Q3,1,I,2012.0,20190828.0,20190906,20190906,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201908014087,ELI LILLY AND CO,,73.0,YR,,M,Y,,,20190906.0,,CN,CZ,CZ,2019,Q3,Elderly
167817861,16781786,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"12IU ? 24IU ? 24IU, TID",,,U,U,,,20563.0,24.0,IU,,BID,2019,Q3,Injection site reaction,,2019,Q3,1,I,2012.0,20190828.0,20190906,20190906,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201908014087,ELI LILLY AND CO,,73.0,YR,,M,Y,,,20190906.0,,CN,CZ,CZ,2019,Q3,Elderly
167817861,16781786,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"36-45-42IU, TID",,,U,U,,,20563.0,36.0,IU,,QD,2019,Q3,Cutaneous amyloidosis,,2019,Q3,1,I,2012.0,20190828.0,20190906,20190906,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201908014087,ELI LILLY AND CO,,73.0,YR,,M,Y,,,20190906.0,,CN,CZ,CZ,2019,Q3,Elderly
167817861,16781786,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"36-45-42IU, TID",,,U,U,,,20563.0,36.0,IU,,QD,2019,Q3,Injection site reaction,,2019,Q3,1,I,2012.0,20190828.0,20190906,20190906,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201908014087,ELI LILLY AND CO,,73.0,YR,,M,Y,,,20190906.0,,CN,CZ,CZ,2019,Q3,Elderly
167817861,16781786,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"36-45-42IU, TID",,,U,U,,,20563.0,45.0,IU,,QD,2019,Q3,Cutaneous amyloidosis,,2019,Q3,1,I,2012.0,20190828.0,20190906,20190906,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201908014087,ELI LILLY AND CO,,73.0,YR,,M,Y,,,20190906.0,,CN,CZ,CZ,2019,Q3,Elderly
167817861,16781786,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"36-45-42IU, TID",,,U,U,,,20563.0,45.0,IU,,QD,2019,Q3,Injection site reaction,,2019,Q3,1,I,2012.0,20190828.0,20190906,20190906,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201908014087,ELI LILLY AND CO,,73.0,YR,,M,Y,,,20190906.0,,CN,CZ,CZ,2019,Q3,Elderly
167817861,16781786,5,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"36-45-42IU, TID",,,U,U,,,20563.0,42.0,IU,,QD,2019,Q3,Cutaneous amyloidosis,,2019,Q3,1,I,2012.0,20190828.0,20190906,20190906,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201908014087,ELI LILLY AND CO,,73.0,YR,,M,Y,,,20190906.0,,CN,CZ,CZ,2019,Q3,Elderly
167817861,16781786,5,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"36-45-42IU, TID",,,U,U,,,20563.0,42.0,IU,,QD,2019,Q3,Injection site reaction,,2019,Q3,1,I,2012.0,20190828.0,20190906,20190906,EXP,,CZ-ELI_LILLY_AND_COMPANY-CZ201908014087,ELI LILLY AND CO,,73.0,YR,,M,Y,,,20190906.0,,CN,CZ,CZ,2019,Q3,Elderly
167842661,16784266,8,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q3,Arthralgia,,2019,Q3,1,I,,20190903.0,20190909,20190909,EXP,,CA-ORION CORPORATION ORION PHARMA-TREX2019-3250,ORION,,62.0,YR,,M,Y,,,20190909.0,,OT,CA,CA,2019,Q3,Adult
167842661,16784266,8,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q3,Drug ineffective,,2019,Q3,1,I,,20190903.0,20190909,20190909,EXP,,CA-ORION CORPORATION ORION PHARMA-TREX2019-3250,ORION,,62.0,YR,,M,Y,,,20190909.0,,OT,CA,CA,2019,Q3,Adult
167842661,16784266,8,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q3,Gait disturbance,,2019,Q3,1,I,,20190903.0,20190909,20190909,EXP,,CA-ORION CORPORATION ORION PHARMA-TREX2019-3250,ORION,,62.0,YR,,M,Y,,,20190909.0,,OT,CA,CA,2019,Q3,Adult
167842661,16784266,8,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q3,Hepatic enzyme increased,,2019,Q3,1,I,,20190903.0,20190909,20190909,EXP,,CA-ORION CORPORATION ORION PHARMA-TREX2019-3250,ORION,,62.0,YR,,M,Y,,,20190909.0,,OT,CA,CA,2019,Q3,Adult
167842661,16784266,8,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q3,Musculoskeletal stiffness,,2019,Q3,1,I,,20190903.0,20190909,20190909,EXP,,CA-ORION CORPORATION ORION PHARMA-TREX2019-3250,ORION,,62.0,YR,,M,Y,,,20190909.0,,OT,CA,CA,2019,Q3,Adult
167842661,16784266,8,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q3,Oedema peripheral,,2019,Q3,1,I,,20190903.0,20190909,20190909,EXP,,CA-ORION CORPORATION ORION PHARMA-TREX2019-3250,ORION,,62.0,YR,,M,Y,,,20190909.0,,OT,CA,CA,2019,Q3,Adult
167842661,16784266,8,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q3,Pain in extremity,,2019,Q3,1,I,,20190903.0,20190909,20190909,EXP,,CA-ORION CORPORATION ORION PHARMA-TREX2019-3250,ORION,,62.0,YR,,M,Y,,,20190909.0,,OT,CA,CA,2019,Q3,Adult
167842661,16784266,8,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q3,Peripheral swelling,,2019,Q3,1,I,,20190903.0,20190909,20190909,EXP,,CA-ORION CORPORATION ORION PHARMA-TREX2019-3250,ORION,,62.0,YR,,M,Y,,,20190909.0,,OT,CA,CA,2019,Q3,Adult
167842661,16784266,8,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q3,Pharyngitis,,2019,Q3,1,I,,20190903.0,20190909,20190909,EXP,,CA-ORION CORPORATION ORION PHARMA-TREX2019-3250,ORION,,62.0,YR,,M,Y,,,20190909.0,,OT,CA,CA,2019,Q3,Adult
167842661,16784266,8,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q3,Poor venous access,,2019,Q3,1,I,,20190903.0,20190909,20190909,EXP,,CA-ORION CORPORATION ORION PHARMA-TREX2019-3250,ORION,,62.0,YR,,M,Y,,,20190909.0,,OT,CA,CA,2019,Q3,Adult
167842661,16784266,8,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q3,Pruritus,,2019,Q3,1,I,,20190903.0,20190909,20190909,EXP,,CA-ORION CORPORATION ORION PHARMA-TREX2019-3250,ORION,,62.0,YR,,M,Y,,,20190909.0,,OT,CA,CA,2019,Q3,Adult
167842661,16784266,8,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q3,Swelling,,2019,Q3,1,I,,20190903.0,20190909,20190909,EXP,,CA-ORION CORPORATION ORION PHARMA-TREX2019-3250,ORION,,62.0,YR,,M,Y,,,20190909.0,,OT,CA,CA,2019,Q3,Adult
167842661,16784266,8,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q3,Therapeutic response decreased,,2019,Q3,1,I,,20190903.0,20190909,20190909,EXP,,CA-ORION CORPORATION ORION PHARMA-TREX2019-3250,ORION,,62.0,YR,,M,Y,,,20190909.0,,OT,CA,CA,2019,Q3,Adult
167842661,16784266,8,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q3,Tremor,,2019,Q3,1,I,,20190903.0,20190909,20190909,EXP,,CA-ORION CORPORATION ORION PHARMA-TREX2019-3250,ORION,,62.0,YR,,M,Y,,,20190909.0,,OT,CA,CA,2019,Q3,Adult
167842661,16784266,8,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q3,Vomiting,,2019,Q3,1,I,,20190903.0,20190909,20190909,EXP,,CA-ORION CORPORATION ORION PHARMA-TREX2019-3250,ORION,,62.0,YR,,M,Y,,,20190909.0,,OT,CA,CA,2019,Q3,Adult
167878881,16787888,1,PS,Liprolog Lispro,INSULIN LISPRO,1,Subcutaneous,"60 INTERNATIONAL UNIT, UNKNOWN",,,,U,,,20563.0,60.0,IU,,,2019,Q3,Dyspnoea,,2019,Q3,1,I,20190817.0,20190828.0,20190909,20190909,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201908014340,ELI LILLY AND CO,,31.0,YR,,M,Y,,,20190909.0,,CN,DE,DE,2019,Q3,Young Adult
168012791,16801279,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2019,Q3,Differentiation syndrome,,2019,Q3,1,I,20150806.0,20160607.0,20190912,20190912,EXP,,US-AGIOS-1606US00466,AGIOS PHARMACEUTICALS,,53.0,YR,,M,Y,73.0,KG,20190912.0,,MD,US,US,2019,Q3,Adult
168024912,16802491,42,C,INSULIN LISPRO (HUMALOG),,2,Intravenous (not otherwise specified),,,,,,,,,3.0,ML,,,2019,Q3,Lung infection,,2019,Q3,2,F,20190820.0,20190912.0,20190912,20190919,EXP,,US-ABBVIE-19P-163-2897942-00,ABBVIE,,25.0,YR,,M,Y,140.5,KG,20190919.0,,MD,US,US,2019,Q3,Young Adult
168027291,16802729,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, C945507,,20563.0,,,,,2019,Q3,Blood glucose abnormal,,2019,Q3,1,I,,20190815.0,20190912,20190912,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201908007417,ELI LILLY AND CO,,56.0,YR,,F,Y,70.0,KG,20190912.0,,CN,CN,CN,2019,Q3,Adult
168027291,16802729,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, C945507,,20563.0,,,,,2019,Q3,Blood glucose increased,,2019,Q3,1,I,,20190815.0,20190912,20190912,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201908007417,ELI LILLY AND CO,,56.0,YR,,F,Y,70.0,KG,20190912.0,,CN,CN,CN,2019,Q3,Adult
168027291,16802729,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, C945507,,20563.0,,,,,2019,Q3,Cardiac disorder,,2019,Q3,1,I,,20190815.0,20190912,20190912,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201908007417,ELI LILLY AND CO,,56.0,YR,,F,Y,70.0,KG,20190912.0,,CN,CN,CN,2019,Q3,Adult
168027291,16802729,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, C945507,,20563.0,,,,,2019,Q3,Hypoglycaemia,,2019,Q3,1,I,,20190815.0,20190912,20190912,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201908007417,ELI LILLY AND CO,,56.0,YR,,F,Y,70.0,KG,20190912.0,,CN,CN,CN,2019,Q3,Adult
168027291,16802729,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, C945507,,20563.0,,,,,2019,Q3,Neuropathy peripheral,,2019,Q3,1,I,,20190815.0,20190912,20190912,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201908007417,ELI LILLY AND CO,,56.0,YR,,F,Y,70.0,KG,20190912.0,,CN,CN,CN,2019,Q3,Adult
168027291,16802729,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, C945507,,20563.0,,,,,2019,Q3,Oedema,,2019,Q3,1,I,,20190815.0,20190912,20190912,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201908007417,ELI LILLY AND CO,,56.0,YR,,F,Y,70.0,KG,20190912.0,,CN,CN,CN,2019,Q3,Adult
168027291,16802729,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, C945507,,20563.0,,,,,2019,Q3,Pericardial effusion,,2019,Q3,1,I,,20190815.0,20190912,20190912,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201908007417,ELI LILLY AND CO,,56.0,YR,,F,Y,70.0,KG,20190912.0,,CN,CN,CN,2019,Q3,Adult
168027291,16802729,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, C945507,,20563.0,,,,,2019,Q3,Weight decreased,,2019,Q3,1,I,,20190815.0,20190912,20190912,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201908007417,ELI LILLY AND CO,,56.0,YR,,F,Y,70.0,KG,20190912.0,,CN,CN,CN,2019,Q3,Adult
168027291,16802729,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"40 OR 50 U, DAILY",,,,, C945507,,20563.0,50.0,IU,,QD,2019,Q3,Blood glucose abnormal,,2019,Q3,1,I,,20190815.0,20190912,20190912,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201908007417,ELI LILLY AND CO,,56.0,YR,,F,Y,70.0,KG,20190912.0,,CN,CN,CN,2019,Q3,Adult
168027291,16802729,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"40 OR 50 U, DAILY",,,,, C945507,,20563.0,50.0,IU,,QD,2019,Q3,Blood glucose increased,,2019,Q3,1,I,,20190815.0,20190912,20190912,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201908007417,ELI LILLY AND CO,,56.0,YR,,F,Y,70.0,KG,20190912.0,,CN,CN,CN,2019,Q3,Adult
168027291,16802729,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"40 OR 50 U, DAILY",,,,, C945507,,20563.0,50.0,IU,,QD,2019,Q3,Cardiac disorder,,2019,Q3,1,I,,20190815.0,20190912,20190912,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201908007417,ELI LILLY AND CO,,56.0,YR,,F,Y,70.0,KG,20190912.0,,CN,CN,CN,2019,Q3,Adult
168027291,16802729,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"40 OR 50 U, DAILY",,,,, C945507,,20563.0,50.0,IU,,QD,2019,Q3,Hypoglycaemia,,2019,Q3,1,I,,20190815.0,20190912,20190912,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201908007417,ELI LILLY AND CO,,56.0,YR,,F,Y,70.0,KG,20190912.0,,CN,CN,CN,2019,Q3,Adult
168027291,16802729,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"40 OR 50 U, DAILY",,,,, C945507,,20563.0,50.0,IU,,QD,2019,Q3,Neuropathy peripheral,,2019,Q3,1,I,,20190815.0,20190912,20190912,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201908007417,ELI LILLY AND CO,,56.0,YR,,F,Y,70.0,KG,20190912.0,,CN,CN,CN,2019,Q3,Adult
168027291,16802729,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"40 OR 50 U, DAILY",,,,, C945507,,20563.0,50.0,IU,,QD,2019,Q3,Oedema,,2019,Q3,1,I,,20190815.0,20190912,20190912,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201908007417,ELI LILLY AND CO,,56.0,YR,,F,Y,70.0,KG,20190912.0,,CN,CN,CN,2019,Q3,Adult
168027291,16802729,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"40 OR 50 U, DAILY",,,,, C945507,,20563.0,50.0,IU,,QD,2019,Q3,Pericardial effusion,,2019,Q3,1,I,,20190815.0,20190912,20190912,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201908007417,ELI LILLY AND CO,,56.0,YR,,F,Y,70.0,KG,20190912.0,,CN,CN,CN,2019,Q3,Adult
168027291,16802729,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"40 OR 50 U, DAILY",,,,, C945507,,20563.0,50.0,IU,,QD,2019,Q3,Weight decreased,,2019,Q3,1,I,,20190815.0,20190912,20190912,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201908007417,ELI LILLY AND CO,,56.0,YR,,F,Y,70.0,KG,20190912.0,,CN,CN,CN,2019,Q3,Adult
168035681,16803568,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8UI-6UI-8UI,,,Y,, UNKNOWN,,,,,,,2019,Q3,Coma,Coma,2019,Q3,1,I,20190723.0,20190829.0,20190913,20190913,EXP,FR-AFSSAPS-AM20191298,FR-ZYDUS-040659,ZYDUS PHARM,,55.0,YR,,F,Y,64.0,KG,20190913.0,,PH,FR,FR,2019,Q3,Adult
168035681,16803568,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8UI-6UI-8UI,,,Y,, UNKNOWN,,,,,,,2019,Q3,Epileptic encephalopathy,Epileptic encephalopathy,2019,Q3,1,I,20190723.0,20190829.0,20190913,20190913,EXP,FR-AFSSAPS-AM20191298,FR-ZYDUS-040659,ZYDUS PHARM,,55.0,YR,,F,Y,64.0,KG,20190913.0,,PH,FR,FR,2019,Q3,Adult
168038711,16803871,3,C,INSULIN LISPRO W/INSULIN LISPRO PROTAMINE SUS,,2,Unknown,40 UNITS EVERY MORNING AND 60 UNITS EVERY EVENING,,,,,,,,,,,,2019,Q3,Acidosis,,2019,Q3,1,I,,20190905.0,20190913,20190913,EXP,,US-STRIDES ARCOLAB LIMITED-2019SP008511,STRIDES,"COOK RMD, GARCIA-GAYOSO AS, TWILLA JD.. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST.. AM-J-THER. 2019;26(4):E543-E545",72.0,YR,,F,Y,,,20190913.0,,PH,US,US,2019,Q3,Elderly
168038711,16803871,3,C,INSULIN LISPRO W/INSULIN LISPRO PROTAMINE SUS,,2,Unknown,40 UNITS EVERY MORNING AND 60 UNITS EVERY EVENING,,,,,,,,,,,,2019,Q3,Blood creatinine increased,,2019,Q3,1,I,,20190905.0,20190913,20190913,EXP,,US-STRIDES ARCOLAB LIMITED-2019SP008511,STRIDES,"COOK RMD, GARCIA-GAYOSO AS, TWILLA JD.. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST.. AM-J-THER. 2019;26(4):E543-E545",72.0,YR,,F,Y,,,20190913.0,,PH,US,US,2019,Q3,Elderly
168038711,16803871,3,C,INSULIN LISPRO W/INSULIN LISPRO PROTAMINE SUS,,2,Unknown,40 UNITS EVERY MORNING AND 60 UNITS EVERY EVENING,,,,,,,,,,,,2019,Q3,Bradycardia,,2019,Q3,1,I,,20190905.0,20190913,20190913,EXP,,US-STRIDES ARCOLAB LIMITED-2019SP008511,STRIDES,"COOK RMD, GARCIA-GAYOSO AS, TWILLA JD.. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST.. AM-J-THER. 2019;26(4):E543-E545",72.0,YR,,F,Y,,,20190913.0,,PH,US,US,2019,Q3,Elderly
168038711,16803871,3,C,INSULIN LISPRO W/INSULIN LISPRO PROTAMINE SUS,,2,Unknown,40 UNITS EVERY MORNING AND 60 UNITS EVERY EVENING,,,,,,,,,,,,2019,Q3,Cardiac arrest,,2019,Q3,1,I,,20190905.0,20190913,20190913,EXP,,US-STRIDES ARCOLAB LIMITED-2019SP008511,STRIDES,"COOK RMD, GARCIA-GAYOSO AS, TWILLA JD.. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST.. AM-J-THER. 2019;26(4):E543-E545",72.0,YR,,F,Y,,,20190913.0,,PH,US,US,2019,Q3,Elderly
168038711,16803871,3,C,INSULIN LISPRO W/INSULIN LISPRO PROTAMINE SUS,,2,Unknown,40 UNITS EVERY MORNING AND 60 UNITS EVERY EVENING,,,,,,,,,,,,2019,Q3,Condition aggravated,,2019,Q3,1,I,,20190905.0,20190913,20190913,EXP,,US-STRIDES ARCOLAB LIMITED-2019SP008511,STRIDES,"COOK RMD, GARCIA-GAYOSO AS, TWILLA JD.. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST.. AM-J-THER. 2019;26(4):E543-E545",72.0,YR,,F,Y,,,20190913.0,,PH,US,US,2019,Q3,Elderly
168038711,16803871,3,C,INSULIN LISPRO W/INSULIN LISPRO PROTAMINE SUS,,2,Unknown,40 UNITS EVERY MORNING AND 60 UNITS EVERY EVENING,,,,,,,,,,,,2019,Q3,Dizziness,,2019,Q3,1,I,,20190905.0,20190913,20190913,EXP,,US-STRIDES ARCOLAB LIMITED-2019SP008511,STRIDES,"COOK RMD, GARCIA-GAYOSO AS, TWILLA JD.. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST.. AM-J-THER. 2019;26(4):E543-E545",72.0,YR,,F,Y,,,20190913.0,,PH,US,US,2019,Q3,Elderly
168038711,16803871,3,C,INSULIN LISPRO W/INSULIN LISPRO PROTAMINE SUS,,2,Unknown,40 UNITS EVERY MORNING AND 60 UNITS EVERY EVENING,,,,,,,,,,,,2019,Q3,Drug interaction,,2019,Q3,1,I,,20190905.0,20190913,20190913,EXP,,US-STRIDES ARCOLAB LIMITED-2019SP008511,STRIDES,"COOK RMD, GARCIA-GAYOSO AS, TWILLA JD.. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST.. AM-J-THER. 2019;26(4):E543-E545",72.0,YR,,F,Y,,,20190913.0,,PH,US,US,2019,Q3,Elderly
168038711,16803871,3,C,INSULIN LISPRO W/INSULIN LISPRO PROTAMINE SUS,,2,Unknown,40 UNITS EVERY MORNING AND 60 UNITS EVERY EVENING,,,,,,,,,,,,2019,Q3,Hypoperfusion,,2019,Q3,1,I,,20190905.0,20190913,20190913,EXP,,US-STRIDES ARCOLAB LIMITED-2019SP008511,STRIDES,"COOK RMD, GARCIA-GAYOSO AS, TWILLA JD.. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST.. AM-J-THER. 2019;26(4):E543-E545",72.0,YR,,F,Y,,,20190913.0,,PH,US,US,2019,Q3,Elderly
168038711,16803871,3,C,INSULIN LISPRO W/INSULIN LISPRO PROTAMINE SUS,,2,Unknown,40 UNITS EVERY MORNING AND 60 UNITS EVERY EVENING,,,,,,,,,,,,2019,Q3,Hypotension,,2019,Q3,1,I,,20190905.0,20190913,20190913,EXP,,US-STRIDES ARCOLAB LIMITED-2019SP008511,STRIDES,"COOK RMD, GARCIA-GAYOSO AS, TWILLA JD.. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST.. AM-J-THER. 2019;26(4):E543-E545",72.0,YR,,F,Y,,,20190913.0,,PH,US,US,2019,Q3,Elderly
168038711,16803871,3,C,INSULIN LISPRO W/INSULIN LISPRO PROTAMINE SUS,,2,Unknown,40 UNITS EVERY MORNING AND 60 UNITS EVERY EVENING,,,,,,,,,,,,2019,Q3,Pulseless electrical activity,,2019,Q3,1,I,,20190905.0,20190913,20190913,EXP,,US-STRIDES ARCOLAB LIMITED-2019SP008511,STRIDES,"COOK RMD, GARCIA-GAYOSO AS, TWILLA JD.. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST.. AM-J-THER. 2019;26(4):E543-E545",72.0,YR,,F,Y,,,20190913.0,,PH,US,US,2019,Q3,Elderly
168054001,16805400,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,U,,,,,,,,2019,Q3,Acute kidney injury,,2019,Q3,1,I,,20190906.0,20190913,20190913,EXP,,PT-MYLANLABS-2019M1085548,MYLAN,,71.0,YR,,M,Y,,,20190913.0,,MD,PT,PT,2019,Q3,Elderly
168054001,16805400,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,U,,,,,,,,2019,Q3,Arrhythmia,,2019,Q3,1,I,,20190906.0,20190913,20190913,EXP,,PT-MYLANLABS-2019M1085548,MYLAN,,71.0,YR,,M,Y,,,20190913.0,,MD,PT,PT,2019,Q3,Elderly
168054001,16805400,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,U,,,,,,,,2019,Q3,Bradycardia,,2019,Q3,1,I,,20190906.0,20190913,20190913,EXP,,PT-MYLANLABS-2019M1085548,MYLAN,,71.0,YR,,M,Y,,,20190913.0,,MD,PT,PT,2019,Q3,Elderly
168054001,16805400,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,U,,,,,,,,2019,Q3,Dehydration,,2019,Q3,1,I,,20190906.0,20190913,20190913,EXP,,PT-MYLANLABS-2019M1085548,MYLAN,,71.0,YR,,M,Y,,,20190913.0,,MD,PT,PT,2019,Q3,Elderly
168054001,16805400,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,U,,,,,,,,2019,Q3,Hypotension,,2019,Q3,1,I,,20190906.0,20190913,20190913,EXP,,PT-MYLANLABS-2019M1085548,MYLAN,,71.0,YR,,M,Y,,,20190913.0,,MD,PT,PT,2019,Q3,Elderly
168054001,16805400,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,U,,,,,,,,2019,Q3,Presyncope,,2019,Q3,1,I,,20190906.0,20190913,20190913,EXP,,PT-MYLANLABS-2019M1085548,MYLAN,,71.0,YR,,M,Y,,,20190913.0,,MD,PT,PT,2019,Q3,Elderly
168054001,16805400,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,U,,,,,,,,2019,Q3,Syncope,,2019,Q3,1,I,,20190906.0,20190913,20190913,EXP,,PT-MYLANLABS-2019M1085548,MYLAN,,71.0,YR,,M,Y,,,20190913.0,,MD,PT,PT,2019,Q3,Elderly
168057231,16805723,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,26.0,DF,D,,,,209196.0,26.0,DF,,,2019,Q3,Hyperhidrosis,,2019,Q3,1,I,20190702.0,20190909.0,20190913,20190913,EXP,IT-MINISAL02-572480,IT-SA-2019SA251537,SANOFI AVENTIS,,75.0,YR,E,M,Y,,,20190913.0,,MD,IT,IT,2019,Q3,Elderly
168057231,16805723,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,26.0,DF,D,,,,209196.0,26.0,DF,,,2019,Q3,Nervousness,,2019,Q3,1,I,20190702.0,20190909.0,20190913,20190913,EXP,IT-MINISAL02-572480,IT-SA-2019SA251537,SANOFI AVENTIS,,75.0,YR,E,M,Y,,,20190913.0,,MD,IT,IT,2019,Q3,Elderly
168057231,16805723,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,26.0,DF,D,,,,209196.0,26.0,DF,,,2019,Q3,Product administration error,,2019,Q3,1,I,20190702.0,20190909.0,20190913,20190913,EXP,IT-MINISAL02-572480,IT-SA-2019SA251537,SANOFI AVENTIS,,75.0,YR,E,M,Y,,,20190913.0,,MD,IT,IT,2019,Q3,Elderly
168067911,16806791,7,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,"40 UNITS IN AM, 60 UNITS IN PM DAILY",,,,,,,,,,,,2019,Q3,Cardiac arrest,,2019,Q3,1,I,,20190910.0,20190913,20190913,EXP,,US-ENDO PHARMACEUTICALS INC-2019-108039,ENDO,,72.0,YR,,F,Y,,,20190913.0,,PH,US,US,2019,Q3,Elderly
168067911,16806791,7,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,"40 UNITS IN AM, 60 UNITS IN PM DAILY",,,,,,,,,,,,2019,Q3,Hypovolaemic shock,,2019,Q3,1,I,,20190910.0,20190913,20190913,EXP,,US-ENDO PHARMACEUTICALS INC-2019-108039,ENDO,,72.0,YR,,F,Y,,,20190913.0,,PH,US,US,2019,Q3,Elderly
168067911,16806791,7,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,"40 UNITS IN AM, 60 UNITS IN PM DAILY",,,,,,,,,,,,2019,Q3,Potentiating drug interaction,,2019,Q3,1,I,,20190910.0,20190913,20190913,EXP,,US-ENDO PHARMACEUTICALS INC-2019-108039,ENDO,,72.0,YR,,F,Y,,,20190913.0,,PH,US,US,2019,Q3,Elderly
168109491,16810949,15,C,INSULINE LISPRO,,2,Unknown,"1 DF, Q8H (0-2 EENHEDENSUBCUTAAN3DD)",,,U,,,,,1.0,DF,,Q8H,2019,Q3,Drug interaction,,2019,Q3,1,I,20190813.0,20190909.0,20190916,20190916,EXP,,PHHY2019NL211577,SANDOZ,,69.0,YR,,M,Y,133.0,KG,20190916.0,,OT,NL,NL,2019,Q3,Elderly
168109491,16810949,15,C,INSULINE LISPRO,,2,Unknown,"1 DF, Q8H (0-2 EENHEDENSUBCUTAAN3DD)",,,U,,,,,1.0,DF,,Q8H,2019,Q3,Hypercalcaemia,,2019,Q3,1,I,20190813.0,20190909.0,20190916,20190916,EXP,,PHHY2019NL211577,SANDOZ,,69.0,YR,,M,Y,133.0,KG,20190916.0,,OT,NL,NL,2019,Q3,Elderly
168176381,16817638,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q3,Blindness,,2019,Q3,1,I,,20190910.0,20190917,20190917,EXP,,US-SA-2019SA254590,SANOFI AVENTIS,,63.0,YR,A,F,Y,,,20190917.0,,CN,US,US,2019,Q3,Adult
168176381,16817638,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q3,Blood glucose increased,,2019,Q3,1,I,,20190910.0,20190917,20190917,EXP,,US-SA-2019SA254590,SANOFI AVENTIS,,63.0,YR,A,F,Y,,,20190917.0,,CN,US,US,2019,Q3,Adult
168193851,16819385,8,C,INSULIN LISPRO PROTAMINE/INSULIN LISPRO,,2,Unknown,40 UNITS EVERY MORNING AND 60 UNITS EVERY EVENING,,,U,,,,,,,,,2019,Q3,Acidosis,,2019,Q3,1,I,,20190909.0,20190917,20190917,EXP,,US-TEVA-2019-US-1108596,TEVA,"COOK RMD, GARCIA-GAYOSO AS, TWILLA JD. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST. AM-J-THER 2019;26(4):E543-E545.",72.0,YR,,F,Y,,,20190917.0,,OT,US,US,2019,Q3,Elderly
168193851,16819385,8,C,INSULIN LISPRO PROTAMINE/INSULIN LISPRO,,2,Unknown,40 UNITS EVERY MORNING AND 60 UNITS EVERY EVENING,,,U,,,,,,,,,2019,Q3,Bradycardia,,2019,Q3,1,I,,20190909.0,20190917,20190917,EXP,,US-TEVA-2019-US-1108596,TEVA,"COOK RMD, GARCIA-GAYOSO AS, TWILLA JD. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST. AM-J-THER 2019;26(4):E543-E545.",72.0,YR,,F,Y,,,20190917.0,,OT,US,US,2019,Q3,Elderly
168193851,16819385,8,C,INSULIN LISPRO PROTAMINE/INSULIN LISPRO,,2,Unknown,40 UNITS EVERY MORNING AND 60 UNITS EVERY EVENING,,,U,,,,,,,,,2019,Q3,Cardiac arrest,,2019,Q3,1,I,,20190909.0,20190917,20190917,EXP,,US-TEVA-2019-US-1108596,TEVA,"COOK RMD, GARCIA-GAYOSO AS, TWILLA JD. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST. AM-J-THER 2019;26(4):E543-E545.",72.0,YR,,F,Y,,,20190917.0,,OT,US,US,2019,Q3,Elderly
168193851,16819385,8,C,INSULIN LISPRO PROTAMINE/INSULIN LISPRO,,2,Unknown,40 UNITS EVERY MORNING AND 60 UNITS EVERY EVENING,,,U,,,,,,,,,2019,Q3,Drug interaction,,2019,Q3,1,I,,20190909.0,20190917,20190917,EXP,,US-TEVA-2019-US-1108596,TEVA,"COOK RMD, GARCIA-GAYOSO AS, TWILLA JD. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST. AM-J-THER 2019;26(4):E543-E545.",72.0,YR,,F,Y,,,20190917.0,,OT,US,US,2019,Q3,Elderly
168193851,16819385,8,C,INSULIN LISPRO PROTAMINE/INSULIN LISPRO,,2,Unknown,40 UNITS EVERY MORNING AND 60 UNITS EVERY EVENING,,,U,,,,,,,,,2019,Q3,Hypoperfusion,,2019,Q3,1,I,,20190909.0,20190917,20190917,EXP,,US-TEVA-2019-US-1108596,TEVA,"COOK RMD, GARCIA-GAYOSO AS, TWILLA JD. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST. AM-J-THER 2019;26(4):E543-E545.",72.0,YR,,F,Y,,,20190917.0,,OT,US,US,2019,Q3,Elderly
168193851,16819385,8,C,INSULIN LISPRO PROTAMINE/INSULIN LISPRO,,2,Unknown,40 UNITS EVERY MORNING AND 60 UNITS EVERY EVENING,,,U,,,,,,,,,2019,Q3,Hypotension,,2019,Q3,1,I,,20190909.0,20190917,20190917,EXP,,US-TEVA-2019-US-1108596,TEVA,"COOK RMD, GARCIA-GAYOSO AS, TWILLA JD. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST. AM-J-THER 2019;26(4):E543-E545.",72.0,YR,,F,Y,,,20190917.0,,OT,US,US,2019,Q3,Elderly
168193851,16819385,8,C,INSULIN LISPRO PROTAMINE/INSULIN LISPRO,,2,Unknown,40 UNITS EVERY MORNING AND 60 UNITS EVERY EVENING,,,U,,,,,,,,,2019,Q3,Hypovolaemic shock,,2019,Q3,1,I,,20190909.0,20190917,20190917,EXP,,US-TEVA-2019-US-1108596,TEVA,"COOK RMD, GARCIA-GAYOSO AS, TWILLA JD. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST. AM-J-THER 2019;26(4):E543-E545.",72.0,YR,,F,Y,,,20190917.0,,OT,US,US,2019,Q3,Elderly
168193851,16819385,8,C,INSULIN LISPRO PROTAMINE/INSULIN LISPRO,,2,Unknown,40 UNITS EVERY MORNING AND 60 UNITS EVERY EVENING,,,U,,,,,,,,,2019,Q3,Pulse absent,,2019,Q3,1,I,,20190909.0,20190917,20190917,EXP,,US-TEVA-2019-US-1108596,TEVA,"COOK RMD, GARCIA-GAYOSO AS, TWILLA JD. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST. AM-J-THER 2019;26(4):E543-E545.",72.0,YR,,F,Y,,,20190917.0,,OT,US,US,2019,Q3,Elderly
168193851,16819385,8,C,INSULIN LISPRO PROTAMINE/INSULIN LISPRO,,2,Unknown,40 UNITS EVERY MORNING AND 60 UNITS EVERY EVENING,,,U,,,,,,,,,2019,Q3,Rebound tachycardia,,2019,Q3,1,I,,20190909.0,20190917,20190917,EXP,,US-TEVA-2019-US-1108596,TEVA,"COOK RMD, GARCIA-GAYOSO AS, TWILLA JD. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST. AM-J-THER 2019;26(4):E543-E545.",72.0,YR,,F,Y,,,20190917.0,,OT,US,US,2019,Q3,Elderly
168218721,16821872,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,INTERNAL DRUG,,,U,,,,,,,,,2019,Q3,Acquired haemophilia,,2019,Q3,1,I,,20190909.0,20190918,20190918,EXP,,JP-MYLANLABS-2019M1086991,MYLAN,"SHIMIZU T, NOGAMI K, MIZUTANI C, IMADA K. ACQUIRED HEMOPHILIA A WITH HIGH-TITER FACTOR VIII INHIBITOR DEVELOPING SUBSEQUENT TO CLOPIDOGREL ADMINISTRATION. RINSHO-KETSUEKI 2019;60(4):291-295.. 2019;60(4):291-295",80.0,YR,,F,Y,,,20190918.0,,OT,JP,JP,2019,Q3,Elderly
168222211,16822221,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"22 INTERNATIONAL UNIT, DAILY",11770.0,IU,Y,U,,,20563.0,22.0,IU,,QD,2019,Q3,Asthenia,,2019,Q3,1,I,20190625.0,20190909.0,20190918,20190918,EXP,IT-MINISAL02-573466,IT-ELI_LILLY_AND_COMPANY-IT201909004765,ELI LILLY AND CO,,79.0,YR,,M,Y,,,20190918.0,,CN,IT,IT,2019,Q3,Elderly
168222211,16822221,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"22 INTERNATIONAL UNIT, DAILY",11770.0,IU,Y,U,,,20563.0,22.0,IU,,QD,2019,Q3,Drug interaction,,2019,Q3,1,I,20190625.0,20190909.0,20190918,20190918,EXP,IT-MINISAL02-573466,IT-ELI_LILLY_AND_COMPANY-IT201909004765,ELI LILLY AND CO,,79.0,YR,,M,Y,,,20190918.0,,CN,IT,IT,2019,Q3,Elderly
168222211,16822221,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"22 INTERNATIONAL UNIT, DAILY",11770.0,IU,Y,U,,,20563.0,22.0,IU,,QD,2019,Q3,Hyperhidrosis,,2019,Q3,1,I,20190625.0,20190909.0,20190918,20190918,EXP,IT-MINISAL02-573466,IT-ELI_LILLY_AND_COMPANY-IT201909004765,ELI LILLY AND CO,,79.0,YR,,M,Y,,,20190918.0,,CN,IT,IT,2019,Q3,Elderly
168222211,16822221,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"22 INTERNATIONAL UNIT, DAILY",11770.0,IU,Y,U,,,20563.0,22.0,IU,,QD,2019,Q3,Hypoglycaemia,,2019,Q3,1,I,20190625.0,20190909.0,20190918,20190918,EXP,IT-MINISAL02-573466,IT-ELI_LILLY_AND_COMPANY-IT201909004765,ELI LILLY AND CO,,79.0,YR,,M,Y,,,20190918.0,,CN,IT,IT,2019,Q3,Elderly
168222211,16822221,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"22 INTERNATIONAL UNIT, DAILY",11770.0,IU,Y,U,,,20563.0,22.0,IU,,QD,2019,Q3,Malaise,,2019,Q3,1,I,20190625.0,20190909.0,20190918,20190918,EXP,IT-MINISAL02-573466,IT-ELI_LILLY_AND_COMPANY-IT201909004765,ELI LILLY AND CO,,79.0,YR,,M,Y,,,20190918.0,,CN,IT,IT,2019,Q3,Elderly
168225662,16822566,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK (100 UNIT/ML; DIRECTED PER SLIDING SCALE, 4-0-10)",,,,,,,,,,SOLUTION FOR INJECTION,,2019,Q3,Depression,,2019,Q3,2,F,,20190920.0,20190918,20190927,PER,,US-PFIZER INC-2015330930,PFIZER,,45.0,YR,,F,Y,61.22,KG,20190927.0,,OT,US,US,2019,Q3,Adult
168225662,16822566,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IU, DAILY, (USE CARB RATIO 1:10 BREAKFAST 1:7 LUNCH AND DINNER PLUS SLIDING SCALE OF 1:50}150)",,,,,,,,50.0,IU,SOLUTION FOR INJECTION,,2019,Q3,Depression,,2019,Q3,2,F,,20190920.0,20190918,20190927,PER,,US-PFIZER INC-2015330930,PFIZER,,45.0,YR,,F,Y,61.22,KG,20190927.0,,OT,US,US,2019,Q3,Adult
168231801,16823180,2,I,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"22 IU, QD",11770.0,IU,Y,,,,,22.0,IU,,QD,2019,Q3,Asthenia,,2019,Q3,1,I,20190625.0,20190912.0,20190918,20190918,EXP,IT-MINISAL02-573466,IT-SA-2019SA255989,SANOFI AVENTIS,,79.0,YR,E,M,Y,,,20190918.0,,MD,IT,IT,2019,Q3,Elderly
168231801,16823180,2,I,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"22 IU, QD",11770.0,IU,Y,,,,,22.0,IU,,QD,2019,Q3,Drug interaction,,2019,Q3,1,I,20190625.0,20190912.0,20190918,20190918,EXP,IT-MINISAL02-573466,IT-SA-2019SA255989,SANOFI AVENTIS,,79.0,YR,E,M,Y,,,20190918.0,,MD,IT,IT,2019,Q3,Elderly
168231801,16823180,2,I,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"22 IU, QD",11770.0,IU,Y,,,,,22.0,IU,,QD,2019,Q3,Hyperhidrosis,,2019,Q3,1,I,20190625.0,20190912.0,20190918,20190918,EXP,IT-MINISAL02-573466,IT-SA-2019SA255989,SANOFI AVENTIS,,79.0,YR,E,M,Y,,,20190918.0,,MD,IT,IT,2019,Q3,Elderly
168231801,16823180,2,I,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"22 IU, QD",11770.0,IU,Y,,,,,22.0,IU,,QD,2019,Q3,Hypoglycaemia,,2019,Q3,1,I,20190625.0,20190912.0,20190918,20190918,EXP,IT-MINISAL02-573466,IT-SA-2019SA255989,SANOFI AVENTIS,,79.0,YR,E,M,Y,,,20190918.0,,MD,IT,IT,2019,Q3,Elderly
168231801,16823180,2,I,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"22 IU, QD",11770.0,IU,Y,,,,,22.0,IU,,QD,2019,Q3,Malaise,,2019,Q3,1,I,20190625.0,20190912.0,20190918,20190918,EXP,IT-MINISAL02-573466,IT-SA-2019SA255989,SANOFI AVENTIS,,79.0,YR,E,M,Y,,,20190918.0,,MD,IT,IT,2019,Q3,Elderly
168241022,16824102,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,SHORT-TERM INSULIN ANALOG LISPRO,,,,,,,,,,,,2019,Q3,Diabetes mellitus inadequate control,,2019,Q3,2,F,2017.0,20190916.0,20190918,20190925,EXP,,CZ-MYLANLABS-2019M1086406,MYLAN,TUHACKOVA M.. ATYPICAL HYPOGLYCEMIA IN A TYPE 2 DIABETIC TREATED WITH ORAL ANTIDIABETICS.. KAZUISTIKY V DIABETOLOGII.. 2019;1:6-7,63.0,YR,,M,Y,,,20190925.0,,MD,CZ,CZ,2019,Q3,Adult
168241022,16824102,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,SHORT-TERM INSULIN ANALOG LISPRO,,,,,,,,,,,,2019,Q3,Glycosylated haemoglobin increased,,2019,Q3,2,F,2017.0,20190916.0,20190918,20190925,EXP,,CZ-MYLANLABS-2019M1086406,MYLAN,TUHACKOVA M.. ATYPICAL HYPOGLYCEMIA IN A TYPE 2 DIABETIC TREATED WITH ORAL ANTIDIABETICS.. KAZUISTIKY V DIABETOLOGII.. 2019;1:6-7,63.0,YR,,M,Y,,,20190925.0,,MD,CZ,CZ,2019,Q3,Adult
168241022,16824102,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,SHORT-TERM INSULIN ANALOG LISPRO,,,,,,,,,,,,2019,Q3,Hypoglycaemia,,2019,Q3,2,F,2017.0,20190916.0,20190918,20190925,EXP,,CZ-MYLANLABS-2019M1086406,MYLAN,TUHACKOVA M.. ATYPICAL HYPOGLYCEMIA IN A TYPE 2 DIABETIC TREATED WITH ORAL ANTIDIABETICS.. KAZUISTIKY V DIABETOLOGII.. 2019;1:6-7,63.0,YR,,M,Y,,,20190925.0,,MD,CZ,CZ,2019,Q3,Adult
168302542,16830254,3,C,INSULINA LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,,,,,,,,,2019,Q3,Chronic myeloid leukaemia,,2019,Q3,2,F,20190915.0,20190920.0,20190920,20190927,EXP,,CO-TAKEDA-2019TUS052964,TAKEDA,,58.0,YR,,F,Y,61.0,KG,20190927.0,,OT,CO,CO,2019,Q3,Adult
168302542,16830254,3,C,INSULINA LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,,,,,,,,,2019,Q3,Leukopenia,,2019,Q3,2,F,20190915.0,20190920.0,20190920,20190927,EXP,,CO-TAKEDA-2019TUS052964,TAKEDA,,58.0,YR,,F,Y,61.0,KG,20190927.0,,OT,CO,CO,2019,Q3,Adult
168303521,16830352,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q3,Hypersensitivity,,2019,Q3,1,I,,20181023.0,20190920,20190920,PER,,US-ALVOGEN-2018-ALVOGEN-097797,ALVOGEN,,69.0,YR,,F,Y,79.83,KG,20190920.0,,MD,US,US,2019,Q3,Elderly
168314011,16831401,8,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,40 UNITS EVERY MORNING AND 60 UNITS EVERY EVENING,,,U,, UNKNOWN,,,,,,,2019,Q3,Acidosis,,2019,Q3,1,I,,20190906.0,20190920,20190920,EXP,,US-ZYDUS-040804,ZYDUS PHARM,"COOK RMD, GARCIA-GAYOSO AS, TWILLA JD. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST. AM-J-THER 2019;26(4):E543-E545.",72.0,YR,E,F,Y,,,20190919.0,,PH,US,US,2019,Q3,Elderly
168314011,16831401,8,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,40 UNITS EVERY MORNING AND 60 UNITS EVERY EVENING,,,U,, UNKNOWN,,,,,,,2019,Q3,Cardiac arrest,,2019,Q3,1,I,,20190906.0,20190920,20190920,EXP,,US-ZYDUS-040804,ZYDUS PHARM,"COOK RMD, GARCIA-GAYOSO AS, TWILLA JD. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST. AM-J-THER 2019;26(4):E543-E545.",72.0,YR,E,F,Y,,,20190919.0,,PH,US,US,2019,Q3,Elderly
168314011,16831401,8,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,40 UNITS EVERY MORNING AND 60 UNITS EVERY EVENING,,,U,, UNKNOWN,,,,,,,2019,Q3,Dizziness,,2019,Q3,1,I,,20190906.0,20190920,20190920,EXP,,US-ZYDUS-040804,ZYDUS PHARM,"COOK RMD, GARCIA-GAYOSO AS, TWILLA JD. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST. AM-J-THER 2019;26(4):E543-E545.",72.0,YR,E,F,Y,,,20190919.0,,PH,US,US,2019,Q3,Elderly
168314011,16831401,8,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,40 UNITS EVERY MORNING AND 60 UNITS EVERY EVENING,,,U,, UNKNOWN,,,,,,,2019,Q3,Drug interaction,,2019,Q3,1,I,,20190906.0,20190920,20190920,EXP,,US-ZYDUS-040804,ZYDUS PHARM,"COOK RMD, GARCIA-GAYOSO AS, TWILLA JD. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST. AM-J-THER 2019;26(4):E543-E545.",72.0,YR,E,F,Y,,,20190919.0,,PH,US,US,2019,Q3,Elderly
168314011,16831401,8,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,40 UNITS EVERY MORNING AND 60 UNITS EVERY EVENING,,,U,, UNKNOWN,,,,,,,2019,Q3,Hypoperfusion,,2019,Q3,1,I,,20190906.0,20190920,20190920,EXP,,US-ZYDUS-040804,ZYDUS PHARM,"COOK RMD, GARCIA-GAYOSO AS, TWILLA JD. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST. AM-J-THER 2019;26(4):E543-E545.",72.0,YR,E,F,Y,,,20190919.0,,PH,US,US,2019,Q3,Elderly
168314011,16831401,8,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,40 UNITS EVERY MORNING AND 60 UNITS EVERY EVENING,,,U,, UNKNOWN,,,,,,,2019,Q3,Hypotension,,2019,Q3,1,I,,20190906.0,20190920,20190920,EXP,,US-ZYDUS-040804,ZYDUS PHARM,"COOK RMD, GARCIA-GAYOSO AS, TWILLA JD. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST. AM-J-THER 2019;26(4):E543-E545.",72.0,YR,E,F,Y,,,20190919.0,,PH,US,US,2019,Q3,Elderly
168314011,16831401,8,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,40 UNITS EVERY MORNING AND 60 UNITS EVERY EVENING,,,U,, UNKNOWN,,,,,,,2019,Q3,Hypovolaemic shock,,2019,Q3,1,I,,20190906.0,20190920,20190920,EXP,,US-ZYDUS-040804,ZYDUS PHARM,"COOK RMD, GARCIA-GAYOSO AS, TWILLA JD. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST. AM-J-THER 2019;26(4):E543-E545.",72.0,YR,E,F,Y,,,20190919.0,,PH,US,US,2019,Q3,Elderly
168314011,16831401,8,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,40 UNITS EVERY MORNING AND 60 UNITS EVERY EVENING,,,U,, UNKNOWN,,,,,,,2019,Q3,Nodal arrhythmia,,2019,Q3,1,I,,20190906.0,20190920,20190920,EXP,,US-ZYDUS-040804,ZYDUS PHARM,"COOK RMD, GARCIA-GAYOSO AS, TWILLA JD. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST. AM-J-THER 2019;26(4):E543-E545.",72.0,YR,E,F,Y,,,20190919.0,,PH,US,US,2019,Q3,Elderly
168314011,16831401,8,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,40 UNITS EVERY MORNING AND 60 UNITS EVERY EVENING,,,U,, UNKNOWN,,,,,,,2019,Q3,Pulseless electrical activity,,2019,Q3,1,I,,20190906.0,20190920,20190920,EXP,,US-ZYDUS-040804,ZYDUS PHARM,"COOK RMD, GARCIA-GAYOSO AS, TWILLA JD. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST. AM-J-THER 2019;26(4):E543-E545.",72.0,YR,E,F,Y,,,20190919.0,,PH,US,US,2019,Q3,Elderly
168381091,16838109,16,C,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q3,Acquired haemophilia,,2019,Q3,1,I,,20190909.0,20190923,20190923,EXP,,JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2019RR-221358,RANBAXY,"SHIMIZU T, NOGAMI K, MIZUTANI C, IMADA K. ACQUIRED HEMOPHILIA A WITH HIGH-TITER FACTOR VIII INHIBITOR DEVELOPING SUBSEQUENT TO CLOPIDOGREL ADMINISTRATION. RINSHO KETSUEKI. 2019;JAN 9; 60(4):291-295",80.0,YR,,M,Y,,,20190923.0,,OT,JP,JP,2019,Q3,Elderly
168381091,16838109,16,C,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q3,Haemorrhage subcutaneous,,2019,Q3,1,I,,20190909.0,20190923,20190923,EXP,,JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2019RR-221358,RANBAXY,"SHIMIZU T, NOGAMI K, MIZUTANI C, IMADA K. ACQUIRED HEMOPHILIA A WITH HIGH-TITER FACTOR VIII INHIBITOR DEVELOPING SUBSEQUENT TO CLOPIDOGREL ADMINISTRATION. RINSHO KETSUEKI. 2019;JAN 9; 60(4):291-295",80.0,YR,,M,Y,,,20190923.0,,OT,JP,JP,2019,Q3,Elderly
168456421,16845642,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,5-7-7 UNITS,,,U,,,,,,,,Q8H,2019,Q3,Decreased appetite,,2019,Q3,1,I,20160119.0,20190919.0,20190924,20190924,EXP,,JP-SAKK-2019SA261777AA,SANOFI AVENTIS,,68.0,YR,E,F,Y,40.0,KG,20190924.0,,MD,JP,JP,2019,Q3,Elderly
168456421,16845642,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,5-7-7 UNITS,,,U,,,,,,,,Q8H,2019,Q3,Depressed level of consciousness,,2019,Q3,1,I,20160119.0,20190919.0,20190924,20190924,EXP,,JP-SAKK-2019SA261777AA,SANOFI AVENTIS,,68.0,YR,E,F,Y,40.0,KG,20190924.0,,MD,JP,JP,2019,Q3,Elderly
168456421,16845642,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,5-7-7 UNITS,,,U,,,,,,,,Q8H,2019,Q3,Physical deconditioning,,2019,Q3,1,I,20160119.0,20190919.0,20190924,20190924,EXP,,JP-SAKK-2019SA261777AA,SANOFI AVENTIS,,68.0,YR,E,F,Y,40.0,KG,20190924.0,,MD,JP,JP,2019,Q3,Elderly
168456421,16845642,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,5-7-7 UNITS,,,U,,,,,,,,Q8H,2019,Q3,Polydipsia,,2019,Q3,1,I,20160119.0,20190919.0,20190924,20190924,EXP,,JP-SAKK-2019SA261777AA,SANOFI AVENTIS,,68.0,YR,E,F,Y,40.0,KG,20190924.0,,MD,JP,JP,2019,Q3,Elderly
168456421,16845642,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,5-7-7 UNITS,,,U,,,,,,,,Q8H,2019,Q3,Polyuria,,2019,Q3,1,I,20160119.0,20190919.0,20190924,20190924,EXP,,JP-SAKK-2019SA261777AA,SANOFI AVENTIS,,68.0,YR,E,F,Y,40.0,KG,20190924.0,,MD,JP,JP,2019,Q3,Elderly
168456421,16845642,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,5-7-7 UNITS,,,U,,,,,,,,Q8H,2019,Q3,Vomiting,,2019,Q3,1,I,20160119.0,20190919.0,20190924,20190924,EXP,,JP-SAKK-2019SA261777AA,SANOFI AVENTIS,,68.0,YR,E,F,Y,40.0,KG,20190924.0,,MD,JP,JP,2019,Q3,Elderly
168473922,16847392,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Anaemia,,2019,Q3,2,F,20190217.0,20190916.0,20190924,20190927,EXP,,US-ACTELION-A-NJ2019-187625,ACTELION,,72.0,YR,,M,Y,,,20190927.0,,PH,US,US,2019,Q3,Elderly
168473922,16847392,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Anxiety,,2019,Q3,2,F,20190217.0,20190916.0,20190924,20190927,EXP,,US-ACTELION-A-NJ2019-187625,ACTELION,,72.0,YR,,M,Y,,,20190927.0,,PH,US,US,2019,Q3,Elderly
168473922,16847392,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Asthenia,,2019,Q3,2,F,20190217.0,20190916.0,20190924,20190927,EXP,,US-ACTELION-A-NJ2019-187625,ACTELION,,72.0,YR,,M,Y,,,20190927.0,,PH,US,US,2019,Q3,Elderly
168473922,16847392,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Atrial flutter,,2019,Q3,2,F,20190217.0,20190916.0,20190924,20190927,EXP,,US-ACTELION-A-NJ2019-187625,ACTELION,,72.0,YR,,M,Y,,,20190927.0,,PH,US,US,2019,Q3,Elderly
168473922,16847392,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Brain natriuretic peptide increased,,2019,Q3,2,F,20190217.0,20190916.0,20190924,20190927,EXP,,US-ACTELION-A-NJ2019-187625,ACTELION,,72.0,YR,,M,Y,,,20190927.0,,PH,US,US,2019,Q3,Elderly
168473922,16847392,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Cardiac failure,,2019,Q3,2,F,20190217.0,20190916.0,20190924,20190927,EXP,,US-ACTELION-A-NJ2019-187625,ACTELION,,72.0,YR,,M,Y,,,20190927.0,,PH,US,US,2019,Q3,Elderly
168473922,16847392,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Catheterisation cardiac,,2019,Q3,2,F,20190217.0,20190916.0,20190924,20190927,EXP,,US-ACTELION-A-NJ2019-187625,ACTELION,,72.0,YR,,M,Y,,,20190927.0,,PH,US,US,2019,Q3,Elderly
168473922,16847392,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Decreased appetite,,2019,Q3,2,F,20190217.0,20190916.0,20190924,20190927,EXP,,US-ACTELION-A-NJ2019-187625,ACTELION,,72.0,YR,,M,Y,,,20190927.0,,PH,US,US,2019,Q3,Elderly
168473922,16847392,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Depression,,2019,Q3,2,F,20190217.0,20190916.0,20190924,20190927,EXP,,US-ACTELION-A-NJ2019-187625,ACTELION,,72.0,YR,,M,Y,,,20190927.0,,PH,US,US,2019,Q3,Elderly
168473922,16847392,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Dyspnoea,,2019,Q3,2,F,20190217.0,20190916.0,20190924,20190927,EXP,,US-ACTELION-A-NJ2019-187625,ACTELION,,72.0,YR,,M,Y,,,20190927.0,,PH,US,US,2019,Q3,Elderly
168473922,16847392,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Dyspnoea exertional,,2019,Q3,2,F,20190217.0,20190916.0,20190924,20190927,EXP,,US-ACTELION-A-NJ2019-187625,ACTELION,,72.0,YR,,M,Y,,,20190927.0,,PH,US,US,2019,Q3,Elderly
168473922,16847392,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Fatigue,,2019,Q3,2,F,20190217.0,20190916.0,20190924,20190927,EXP,,US-ACTELION-A-NJ2019-187625,ACTELION,,72.0,YR,,M,Y,,,20190927.0,,PH,US,US,2019,Q3,Elderly
168473922,16847392,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Haemoglobin decreased,,2019,Q3,2,F,20190217.0,20190916.0,20190924,20190927,EXP,,US-ACTELION-A-NJ2019-187625,ACTELION,,72.0,YR,,M,Y,,,20190927.0,,PH,US,US,2019,Q3,Elderly
168473922,16847392,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Heart rate decreased,,2019,Q3,2,F,20190217.0,20190916.0,20190924,20190927,EXP,,US-ACTELION-A-NJ2019-187625,ACTELION,,72.0,YR,,M,Y,,,20190927.0,,PH,US,US,2019,Q3,Elderly
168473922,16847392,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Hyperkalaemia,,2019,Q3,2,F,20190217.0,20190916.0,20190924,20190927,EXP,,US-ACTELION-A-NJ2019-187625,ACTELION,,72.0,YR,,M,Y,,,20190927.0,,PH,US,US,2019,Q3,Elderly
168473922,16847392,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Hypokalaemia,,2019,Q3,2,F,20190217.0,20190916.0,20190924,20190927,EXP,,US-ACTELION-A-NJ2019-187625,ACTELION,,72.0,YR,,M,Y,,,20190927.0,,PH,US,US,2019,Q3,Elderly
168473922,16847392,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Hyponatraemia,,2019,Q3,2,F,20190217.0,20190916.0,20190924,20190927,EXP,,US-ACTELION-A-NJ2019-187625,ACTELION,,72.0,YR,,M,Y,,,20190927.0,,PH,US,US,2019,Q3,Elderly
168473922,16847392,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Hypotension,,2019,Q3,2,F,20190217.0,20190916.0,20190924,20190927,EXP,,US-ACTELION-A-NJ2019-187625,ACTELION,,72.0,YR,,M,Y,,,20190927.0,,PH,US,US,2019,Q3,Elderly
168473922,16847392,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Hypoxia,,2019,Q3,2,F,20190217.0,20190916.0,20190924,20190927,EXP,,US-ACTELION-A-NJ2019-187625,ACTELION,,72.0,YR,,M,Y,,,20190927.0,,PH,US,US,2019,Q3,Elderly
168473922,16847392,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Orthopnoea,,2019,Q3,2,F,20190217.0,20190916.0,20190924,20190927,EXP,,US-ACTELION-A-NJ2019-187625,ACTELION,,72.0,YR,,M,Y,,,20190927.0,,PH,US,US,2019,Q3,Elderly
168473922,16847392,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Pericardial drainage,,2019,Q3,2,F,20190217.0,20190916.0,20190924,20190927,EXP,,US-ACTELION-A-NJ2019-187625,ACTELION,,72.0,YR,,M,Y,,,20190927.0,,PH,US,US,2019,Q3,Elderly
168473922,16847392,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Pericardial effusion,,2019,Q3,2,F,20190217.0,20190916.0,20190924,20190927,EXP,,US-ACTELION-A-NJ2019-187625,ACTELION,,72.0,YR,,M,Y,,,20190927.0,,PH,US,US,2019,Q3,Elderly
168473922,16847392,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Pleural effusion,,2019,Q3,2,F,20190217.0,20190916.0,20190924,20190927,EXP,,US-ACTELION-A-NJ2019-187625,ACTELION,,72.0,YR,,M,Y,,,20190927.0,,PH,US,US,2019,Q3,Elderly
168473922,16847392,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Productive cough,,2019,Q3,2,F,20190217.0,20190916.0,20190924,20190927,EXP,,US-ACTELION-A-NJ2019-187625,ACTELION,,72.0,YR,,M,Y,,,20190927.0,,PH,US,US,2019,Q3,Elderly
168473922,16847392,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Pulmonary hypertension,,2019,Q3,2,F,20190217.0,20190916.0,20190924,20190927,EXP,,US-ACTELION-A-NJ2019-187625,ACTELION,,72.0,YR,,M,Y,,,20190927.0,,PH,US,US,2019,Q3,Elderly
168473922,16847392,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Renal failure,,2019,Q3,2,F,20190217.0,20190916.0,20190924,20190927,EXP,,US-ACTELION-A-NJ2019-187625,ACTELION,,72.0,YR,,M,Y,,,20190927.0,,PH,US,US,2019,Q3,Elderly
168473922,16847392,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Serositis,,2019,Q3,2,F,20190217.0,20190916.0,20190924,20190927,EXP,,US-ACTELION-A-NJ2019-187625,ACTELION,,72.0,YR,,M,Y,,,20190927.0,,PH,US,US,2019,Q3,Elderly
168473922,16847392,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Transfusion,,2019,Q3,2,F,20190217.0,20190916.0,20190924,20190927,EXP,,US-ACTELION-A-NJ2019-187625,ACTELION,,72.0,YR,,M,Y,,,20190927.0,,PH,US,US,2019,Q3,Elderly
168473922,16847392,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q3,Wheezing,,2019,Q3,2,F,20190217.0,20190916.0,20190924,20190927,EXP,,US-ACTELION-A-NJ2019-187625,ACTELION,,72.0,YR,,M,Y,,,20190927.0,,PH,US,US,2019,Q3,Elderly
168494721,16849472,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 INTERNATIONAL UNIT, TID",,,,,,,,4.0,IU,,TID,2019,Q3,Pituitary-dependent Cushing's syndrome,,2019,Q3,1,I,,20190917.0,20190925,20190925,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201909009044,ELI LILLY AND CO,,69.0,YR,,F,Y,67.0,KG,20190925.0,,CN,JP,JP,2019,Q3,Elderly
168559041,16855904,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q3,Ketoacidosis,,2019,Q3,1,I,20190904.0,20190925.0,20190926,20190926,EXP,,"SE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-12-104311",BOEHRINGER INGELHEIM,,42.0,YR,,F,Y,,,20190926.0,,MD,SE,SE,2019,Q3,Adult
168649111,16864911,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q3,Obstructive airways disorder,,2019,Q3,1,I,20190913.0,20190926.0,20190929,20190929,PER,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-US-104512",BOEHRINGER INGELHEIM,,57.0,YR,,F,Y,,,20190930.0,,OT,US,US,2019,Q3,Adult
168649111,16864911,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q3,Tachycardia,,2019,Q3,1,I,20190913.0,20190926.0,20190929,20190929,PER,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-US-104512",BOEHRINGER INGELHEIM,,57.0,YR,,F,Y,,,20190930.0,,OT,US,US,2019,Q3,Adult
168649111,16864911,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q3,Urticaria,,2019,Q3,1,I,20190913.0,20190926.0,20190929,20190929,PER,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-US-104512",BOEHRINGER INGELHEIM,,57.0,YR,,F,Y,,,20190930.0,,OT,US,US,2019,Q3,Adult
168661751,16866175,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q3,Blood glucose decreased,,2019,Q3,1,I,20180122.0,,20190805,20190805,DIR,,,FDA-CTU,,49.0,YR,,F,N,,,20190425.0,N,PH,US,US,2019,Q3,Adult
168661751,16866175,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q3,Fall,,2019,Q3,1,I,20180122.0,,20190805,20190805,DIR,,,FDA-CTU,,49.0,YR,,F,N,,,20190425.0,N,PH,US,US,2019,Q3,Adult
168661751,16866175,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q3,Fracture,,2019,Q3,1,I,20180122.0,,20190805,20190805,DIR,,,FDA-CTU,,49.0,YR,,F,N,,,20190425.0,N,PH,US,US,2019,Q3,Adult
110763303,11076330,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, QID",,,U,,,,,,,,QID,2019,Q4,Ocular myasthenia,,2019,Q4,3,F,20150417.0,20191101.0,20150429,20191107,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-026164,BRISTOL MYERS SQUIBB,,65.0,YR,,M,Y,96.1,KG,20191107.0,,CN,MX,US,2019,Q4,Elderly
1296291718,12962917,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONE TIME ONLY,,,,,,,,10.0,IU,,QD,2019,Q4,Acute respiratory failure,,2019,Q4,18,F,20160826.0,20191017.0,20161122,20191022,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20191022.0,,MD,US,US,2019,Q4,Elderly
1296291718,12962917,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONE TIME ONLY,,,,,,,,10.0,IU,,QD,2019,Q4,Fluid overload,,2019,Q4,18,F,20160826.0,20191017.0,20161122,20191022,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20191022.0,,MD,US,US,2019,Q4,Elderly
1296291718,12962917,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONE TIME ONLY,,,,,,,,10.0,IU,,QD,2019,Q4,Haemoptysis,,2019,Q4,18,F,20160826.0,20191017.0,20161122,20191022,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20191022.0,,MD,US,US,2019,Q4,Elderly
1296291718,12962917,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONE TIME ONLY,,,,,,,,10.0,IU,,QD,2019,Q4,Hyperkalaemia,,2019,Q4,18,F,20160826.0,20191017.0,20161122,20191022,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20191022.0,,MD,US,US,2019,Q4,Elderly
1296291718,12962917,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONE TIME ONLY,,,,,,,,10.0,IU,,QD,2019,Q4,Iron deficiency anaemia,,2019,Q4,18,F,20160826.0,20191017.0,20161122,20191022,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20191022.0,,MD,US,US,2019,Q4,Elderly
1296291718,12962917,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONE TIME ONLY,,,,,,,,10.0,IU,,QD,2019,Q4,Pleural effusion,,2019,Q4,18,F,20160826.0,20191017.0,20161122,20191022,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20191022.0,,MD,US,US,2019,Q4,Elderly
1296291718,12962917,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONE TIME ONLY,,,,,,,,10.0,IU,,QD,2019,Q4,Pneumonia,,2019,Q4,18,F,20160826.0,20191017.0,20161122,20191022,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20191022.0,,MD,US,US,2019,Q4,Elderly
1296291718,12962917,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONE TIME ONLY,,,,,,,,10.0,IU,,QD,2019,Q4,Pulmonary oedema,,2019,Q4,18,F,20160826.0,20191017.0,20161122,20191022,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20191022.0,,MD,US,US,2019,Q4,Elderly
1296291718,12962917,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONE TIME ONLY,,,,,,,,10.0,IU,,QD,2019,Q4,Sepsis,,2019,Q4,18,F,20160826.0,20191017.0,20161122,20191022,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20191022.0,,MD,US,US,2019,Q4,Elderly
1296291718,12962917,52,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ONE TIME ONLY,,,,,,,,10.0,IU,,QD,2019,Q4,Tumour lysis syndrome,,2019,Q4,18,F,20160826.0,20191017.0,20161122,20191022,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20191022.0,,MD,US,US,2019,Q4,Elderly
1296291718,12962917,53,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,WITH GLUCOSE TESTING,,,,,,,,,,,,2019,Q4,Acute respiratory failure,,2019,Q4,18,F,20160826.0,20191017.0,20161122,20191022,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20191022.0,,MD,US,US,2019,Q4,Elderly
1296291718,12962917,53,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,WITH GLUCOSE TESTING,,,,,,,,,,,,2019,Q4,Fluid overload,,2019,Q4,18,F,20160826.0,20191017.0,20161122,20191022,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20191022.0,,MD,US,US,2019,Q4,Elderly
1296291718,12962917,53,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,WITH GLUCOSE TESTING,,,,,,,,,,,,2019,Q4,Haemoptysis,,2019,Q4,18,F,20160826.0,20191017.0,20161122,20191022,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20191022.0,,MD,US,US,2019,Q4,Elderly
1296291718,12962917,53,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,WITH GLUCOSE TESTING,,,,,,,,,,,,2019,Q4,Hyperkalaemia,,2019,Q4,18,F,20160826.0,20191017.0,20161122,20191022,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20191022.0,,MD,US,US,2019,Q4,Elderly
1296291718,12962917,53,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,WITH GLUCOSE TESTING,,,,,,,,,,,,2019,Q4,Iron deficiency anaemia,,2019,Q4,18,F,20160826.0,20191017.0,20161122,20191022,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20191022.0,,MD,US,US,2019,Q4,Elderly
1296291718,12962917,53,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,WITH GLUCOSE TESTING,,,,,,,,,,,,2019,Q4,Pleural effusion,,2019,Q4,18,F,20160826.0,20191017.0,20161122,20191022,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20191022.0,,MD,US,US,2019,Q4,Elderly
1296291718,12962917,53,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,WITH GLUCOSE TESTING,,,,,,,,,,,,2019,Q4,Pneumonia,,2019,Q4,18,F,20160826.0,20191017.0,20161122,20191022,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20191022.0,,MD,US,US,2019,Q4,Elderly
1296291718,12962917,53,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,WITH GLUCOSE TESTING,,,,,,,,,,,,2019,Q4,Pulmonary oedema,,2019,Q4,18,F,20160826.0,20191017.0,20161122,20191022,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20191022.0,,MD,US,US,2019,Q4,Elderly
1296291718,12962917,53,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,WITH GLUCOSE TESTING,,,,,,,,,,,,2019,Q4,Sepsis,,2019,Q4,18,F,20160826.0,20191017.0,20161122,20191022,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20191022.0,,MD,US,US,2019,Q4,Elderly
1296291718,12962917,53,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,WITH GLUCOSE TESTING,,,,,,,,,,,,2019,Q4,Tumour lysis syndrome,,2019,Q4,18,F,20160826.0,20191017.0,20161122,20191022,EXP,,US-ROCHE-1824980,ROCHE,,86.0,YR,,M,Y,86.9,KG,20191022.0,,MD,US,US,2019,Q4,Elderly
1428105410,14281054,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,QHS,,,U,,,,,,,,,2019,Q4,Abdominal pain,,2019,Q4,10,F,20170405.0,20191118.0,20171213,20191129,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-033144,BRISTOL MYERS SQUIBB,,46.0,YR,,F,Y,,,20191129.0,,OT,CA,CA,2019,Q4,Adult
1428105410,14281054,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,QHS,,,U,,,,,,,,,2019,Q4,Adverse event,,2019,Q4,10,F,20170405.0,20191118.0,20171213,20191129,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-033144,BRISTOL MYERS SQUIBB,,46.0,YR,,F,Y,,,20191129.0,,OT,CA,CA,2019,Q4,Adult
1428105410,14281054,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,QHS,,,U,,,,,,,,,2019,Q4,Blood alkaline phosphatase increased,,2019,Q4,10,F,20170405.0,20191118.0,20171213,20191129,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-033144,BRISTOL MYERS SQUIBB,,46.0,YR,,F,Y,,,20191129.0,,OT,CA,CA,2019,Q4,Adult
1428105410,14281054,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,QHS,,,U,,,,,,,,,2019,Q4,Breast mass,,2019,Q4,10,F,20170405.0,20191118.0,20171213,20191129,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-033144,BRISTOL MYERS SQUIBB,,46.0,YR,,F,Y,,,20191129.0,,OT,CA,CA,2019,Q4,Adult
1428105410,14281054,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,QHS,,,U,,,,,,,,,2019,Q4,Cystitis,,2019,Q4,10,F,20170405.0,20191118.0,20171213,20191129,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-033144,BRISTOL MYERS SQUIBB,,46.0,YR,,F,Y,,,20191129.0,,OT,CA,CA,2019,Q4,Adult
1428105410,14281054,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,QHS,,,U,,,,,,,,,2019,Q4,Hepatic steatosis,,2019,Q4,10,F,20170405.0,20191118.0,20171213,20191129,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-033144,BRISTOL MYERS SQUIBB,,46.0,YR,,F,Y,,,20191129.0,,OT,CA,CA,2019,Q4,Adult
1428105410,14281054,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,QHS,,,U,,,,,,,,,2019,Q4,Hospitalisation,,2019,Q4,10,F,20170405.0,20191118.0,20171213,20191129,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-033144,BRISTOL MYERS SQUIBB,,46.0,YR,,F,Y,,,20191129.0,,OT,CA,CA,2019,Q4,Adult
1428105410,14281054,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,QHS,,,U,,,,,,,,,2019,Q4,Impaired healing,,2019,Q4,10,F,20170405.0,20191118.0,20171213,20191129,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-033144,BRISTOL MYERS SQUIBB,,46.0,YR,,F,Y,,,20191129.0,,OT,CA,CA,2019,Q4,Adult
1428105410,14281054,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,QHS,,,U,,,,,,,,,2019,Q4,Lower respiratory tract infection,,2019,Q4,10,F,20170405.0,20191118.0,20171213,20191129,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-033144,BRISTOL MYERS SQUIBB,,46.0,YR,,F,Y,,,20191129.0,,OT,CA,CA,2019,Q4,Adult
1428105410,14281054,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,QHS,,,U,,,,,,,,,2019,Q4,Malaise,,2019,Q4,10,F,20170405.0,20191118.0,20171213,20191129,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-033144,BRISTOL MYERS SQUIBB,,46.0,YR,,F,Y,,,20191129.0,,OT,CA,CA,2019,Q4,Adult
1428105410,14281054,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,QHS,,,U,,,,,,,,,2019,Q4,Mastitis,,2019,Q4,10,F,20170405.0,20191118.0,20171213,20191129,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-033144,BRISTOL MYERS SQUIBB,,46.0,YR,,F,Y,,,20191129.0,,OT,CA,CA,2019,Q4,Adult
1428105410,14281054,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,QHS,,,U,,,,,,,,,2019,Q4,Myocardial infarction,,2019,Q4,10,F,20170405.0,20191118.0,20171213,20191129,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-033144,BRISTOL MYERS SQUIBB,,46.0,YR,,F,Y,,,20191129.0,,OT,CA,CA,2019,Q4,Adult
1428105410,14281054,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,QHS,,,U,,,,,,,,,2019,Q4,Nasopharyngitis,,2019,Q4,10,F,20170405.0,20191118.0,20171213,20191129,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-033144,BRISTOL MYERS SQUIBB,,46.0,YR,,F,Y,,,20191129.0,,OT,CA,CA,2019,Q4,Adult
1428105410,14281054,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,QHS,,,U,,,,,,,,,2019,Q4,Pancreatic cyst,,2019,Q4,10,F,20170405.0,20191118.0,20171213,20191129,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-033144,BRISTOL MYERS SQUIBB,,46.0,YR,,F,Y,,,20191129.0,,OT,CA,CA,2019,Q4,Adult
1428105410,14281054,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,QHS,,,U,,,,,,,,,2019,Q4,Pneumonia,,2019,Q4,10,F,20170405.0,20191118.0,20171213,20191129,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-033144,BRISTOL MYERS SQUIBB,,46.0,YR,,F,Y,,,20191129.0,,OT,CA,CA,2019,Q4,Adult
1428105410,14281054,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,QHS,,,U,,,,,,,,,2019,Q4,Productive cough,,2019,Q4,10,F,20170405.0,20191118.0,20171213,20191129,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-033144,BRISTOL MYERS SQUIBB,,46.0,YR,,F,Y,,,20191129.0,,OT,CA,CA,2019,Q4,Adult
1428105410,14281054,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,QHS,,,U,,,,,,,,,2019,Q4,Upper respiratory tract infection,,2019,Q4,10,F,20170405.0,20191118.0,20171213,20191129,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-033144,BRISTOL MYERS SQUIBB,,46.0,YR,,F,Y,,,20191129.0,,OT,CA,CA,2019,Q4,Adult
1428105410,14281054,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,QHS,,,U,,,,,,,,,2019,Q4,Urinary tract infection,,2019,Q4,10,F,20170405.0,20191118.0,20171213,20191129,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-033144,BRISTOL MYERS SQUIBB,,46.0,YR,,F,Y,,,20191129.0,,OT,CA,CA,2019,Q4,Adult
1428105410,14281054,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,QHS,,,U,,,,,,,,,2019,Q4,Wheezing,,2019,Q4,10,F,20170405.0,20191118.0,20171213,20191129,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-033144,BRISTOL MYERS SQUIBB,,46.0,YR,,F,Y,,,20191129.0,,OT,CA,CA,2019,Q4,Adult
145303312,14530331,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, DAILY",,,,,,,,1.0,IU,,,2019,Q4,Diabetic complication,,2019,Q4,2,F,200505.0,20191210.0,20180214,20191213,EXP,,US-PFIZER INC-2015401526,PFIZER,,49.0,YR,,M,Y,98.0,KG,20191213.0,,CN,US,US,2019,Q4,Adult
1455403311,14554033,24,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,INJECTION,,2019,Q4,Diarrhoea,,2019,Q4,11,F,20180211.0,20191010.0,20180220,20191014,EXP,,CA-CELGENEUS-CAN-20180205858,CELGENE,,77.0,YR,,M,Y,67.6,KG,20191014.0,,OT,CA,CA,2019,Q4,Elderly
1455403311,14554033,24,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,INJECTION,,2019,Q4,Klebsiella infection,,2019,Q4,11,F,20180211.0,20191010.0,20180220,20191014,EXP,,CA-CELGENEUS-CAN-20180205858,CELGENE,,77.0,YR,,M,Y,67.6,KG,20191014.0,,OT,CA,CA,2019,Q4,Elderly
1455403311,14554033,24,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,INJECTION,,2019,Q4,Pneumonia,,2019,Q4,11,F,20180211.0,20191010.0,20180220,20191014,EXP,,CA-CELGENEUS-CAN-20180205858,CELGENE,,77.0,YR,,M,Y,67.6,KG,20191014.0,,OT,CA,CA,2019,Q4,Elderly
1455403311,14554033,24,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,INJECTION,,2019,Q4,Sepsis,,2019,Q4,11,F,20180211.0,20191010.0,20180220,20191014,EXP,,CA-CELGENEUS-CAN-20180205858,CELGENE,,77.0,YR,,M,Y,67.6,KG,20191014.0,,OT,CA,CA,2019,Q4,Elderly
1455403311,14554033,24,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,INJECTION,,2019,Q4,Septic shock,,2019,Q4,11,F,20180211.0,20191010.0,20180220,20191014,EXP,,CA-CELGENEUS-CAN-20180205858,CELGENE,,77.0,YR,,M,Y,67.6,KG,20191014.0,,OT,CA,CA,2019,Q4,Elderly
145681967,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2019,Q4,Arthralgia,,2019,Q4,7,F,2017.0,20191127.0,20180223,20191211,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20191211.0,,MD,US,US,2019,Q4,Adult
145681967,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2019,Q4,Cataract,,2019,Q4,7,F,2017.0,20191127.0,20180223,20191211,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20191211.0,,MD,US,US,2019,Q4,Adult
145681967,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2019,Q4,Clostridium difficile colitis,,2019,Q4,7,F,2017.0,20191127.0,20180223,20191211,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20191211.0,,MD,US,US,2019,Q4,Adult
145681967,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2019,Q4,Coxsackie viral infection,,2019,Q4,7,F,2017.0,20191127.0,20180223,20191211,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20191211.0,,MD,US,US,2019,Q4,Adult
145681967,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2019,Q4,Dry eye,,2019,Q4,7,F,2017.0,20191127.0,20180223,20191211,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20191211.0,,MD,US,US,2019,Q4,Adult
145681967,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2019,Q4,Dysgeusia,,2019,Q4,7,F,2017.0,20191127.0,20180223,20191211,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20191211.0,,MD,US,US,2019,Q4,Adult
145681967,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2019,Q4,Headache,,2019,Q4,7,F,2017.0,20191127.0,20180223,20191211,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20191211.0,,MD,US,US,2019,Q4,Adult
145681967,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2019,Q4,Hyperhidrosis,,2019,Q4,7,F,2017.0,20191127.0,20180223,20191211,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20191211.0,,MD,US,US,2019,Q4,Adult
145681967,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2019,Q4,Hypoacusis,,2019,Q4,7,F,2017.0,20191127.0,20180223,20191211,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20191211.0,,MD,US,US,2019,Q4,Adult
145681967,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2019,Q4,Hypogammaglobulinaemia,,2019,Q4,7,F,2017.0,20191127.0,20180223,20191211,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20191211.0,,MD,US,US,2019,Q4,Adult
145681967,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2019,Q4,Influenza like illness,,2019,Q4,7,F,2017.0,20191127.0,20180223,20191211,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20191211.0,,MD,US,US,2019,Q4,Adult
145681967,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2019,Q4,Myalgia,,2019,Q4,7,F,2017.0,20191127.0,20180223,20191211,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20191211.0,,MD,US,US,2019,Q4,Adult
145681967,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2019,Q4,Neuropathy peripheral,,2019,Q4,7,F,2017.0,20191127.0,20180223,20191211,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20191211.0,,MD,US,US,2019,Q4,Adult
145681967,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2019,Q4,Pollakiuria,,2019,Q4,7,F,2017.0,20191127.0,20180223,20191211,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20191211.0,,MD,US,US,2019,Q4,Adult
145681967,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2019,Q4,Product administration error,,2019,Q4,7,F,2017.0,20191127.0,20180223,20191211,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20191211.0,,MD,US,US,2019,Q4,Adult
145681967,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2019,Q4,Pyrexia,,2019,Q4,7,F,2017.0,20191127.0,20180223,20191211,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20191211.0,,MD,US,US,2019,Q4,Adult
145681967,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2019,Q4,Rash morbilliform,,2019,Q4,7,F,2017.0,20191127.0,20180223,20191211,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20191211.0,,MD,US,US,2019,Q4,Adult
145681967,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2019,Q4,Stevens-Johnson syndrome,,2019,Q4,7,F,2017.0,20191127.0,20180223,20191211,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20191211.0,,MD,US,US,2019,Q4,Adult
145681967,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2019,Q4,Urinary incontinence,,2019,Q4,7,F,2017.0,20191127.0,20180223,20191211,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20191211.0,,MD,US,US,2019,Q4,Adult
145681967,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2019,Q4,Vision blurred,,2019,Q4,7,F,2017.0,20191127.0,20180223,20191211,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20191211.0,,MD,US,US,2019,Q4,Adult
145681967,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2019,Q4,Vitamin D abnormal,,2019,Q4,7,F,2017.0,20191127.0,20180223,20191211,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20191211.0,,MD,US,US,2019,Q4,Adult
145681967,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2019,Q4,Weight decreased,,2019,Q4,7,F,2017.0,20191127.0,20180223,20191211,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20191211.0,,MD,US,US,2019,Q4,Adult
148362794,14836279,9,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Drug resistance,,2019,Q4,4,F,20180414.0,20191203.0,20180502,20191216,EXP,,US-ROCHE-2114200,ROCHE,,58.0,YR,,F,Y,86.26,KG,20191216.0,,CN,US,US,2019,Q4,Adult
148362794,14836279,9,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Therapeutic response shortened,,2019,Q4,4,F,20180414.0,20191203.0,20180502,20191216,EXP,,US-ROCHE-2114200,ROCHE,,58.0,YR,,F,Y,86.26,KG,20191216.0,,CN,US,US,2019,Q4,Adult
148362794,14836279,9,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Urinary tract infection,,2019,Q4,4,F,20180414.0,20191203.0,20180502,20191216,EXP,,US-ROCHE-2114200,ROCHE,,58.0,YR,,F,Y,86.26,KG,20191216.0,,CN,US,US,2019,Q4,Adult
148362794,14836279,9,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,White blood cell count increased,,2019,Q4,4,F,20180414.0,20191203.0,20180502,20191216,EXP,,US-ROCHE-2114200,ROCHE,,58.0,YR,,F,Y,86.26,KG,20191216.0,,CN,US,US,2019,Q4,Adult
148802432,14880243,166,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Anxiety,,2019,Q4,2,F,2009.0,20191222.0,20180511,20191229,EXP,,US-ASTRAZENECA-2018SE59203,ASTRAZENECA,,40.0,YR,,F,Y,121.6,KG,20191230.0,,,US,US,2019,Q4,Adult
148802432,14880243,166,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Chronic kidney disease,,2019,Q4,2,F,2009.0,20191222.0,20180511,20191229,EXP,,US-ASTRAZENECA-2018SE59203,ASTRAZENECA,,40.0,YR,,F,Y,121.6,KG,20191230.0,,,US,US,2019,Q4,Adult
150168663,15016866,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Chronic kidney disease,,2019,Q4,3,F,2007.0,20191007.0,20180615,20191009,EXP,,GB-ASTRAZENECA-2018SE76205,ASTRAZENECA,,25.0,YR,,M,Y,113.4,KG,20191010.0,,,US,US,2019,Q4,Young Adult
150168663,15016866,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,End stage renal disease,,2019,Q4,3,F,2007.0,20191007.0,20180615,20191009,EXP,,GB-ASTRAZENECA-2018SE76205,ASTRAZENECA,,25.0,YR,,M,Y,113.4,KG,20191010.0,,,US,US,2019,Q4,Young Adult
150168663,15016866,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Nephrogenic anaemia,,2019,Q4,3,F,2007.0,20191007.0,20180615,20191009,EXP,,GB-ASTRAZENECA-2018SE76205,ASTRAZENECA,,25.0,YR,,M,Y,113.4,KG,20191010.0,,,US,US,2019,Q4,Young Adult
150168663,15016866,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Renal failure,,2019,Q4,3,F,2007.0,20191007.0,20180615,20191009,EXP,,GB-ASTRAZENECA-2018SE76205,ASTRAZENECA,,25.0,YR,,M,Y,113.4,KG,20191010.0,,,US,US,2019,Q4,Young Adult
151564902,15156490,6,C,LISPRO 50LIS50NPL,,2,,,,,,,,,,,,,,2019,Q4,Acute generalised exanthematous pustulosis,,2019,Q4,2,F,,20191016.0,20180717,20191022,EXP,,CA-TEVA-2018-CA-924441,TEVA,,50.0,YR,,F,Y,66.0,KG,20191022.0,,MD,CA,CA,2019,Q4,Adult
151564902,15156490,6,C,LISPRO 50LIS50NPL,,2,,,,,,,,,,,,,,2019,Q4,Blood bilirubin increased,,2019,Q4,2,F,,20191016.0,20180717,20191022,EXP,,CA-TEVA-2018-CA-924441,TEVA,,50.0,YR,,F,Y,66.0,KG,20191022.0,,MD,CA,CA,2019,Q4,Adult
151564902,15156490,6,C,LISPRO 50LIS50NPL,,2,,,,,,,,,,,,,,2019,Q4,Drug hypersensitivity,,2019,Q4,2,F,,20191016.0,20180717,20191022,EXP,,CA-TEVA-2018-CA-924441,TEVA,,50.0,YR,,F,Y,66.0,KG,20191022.0,,MD,CA,CA,2019,Q4,Adult
151564902,15156490,6,C,LISPRO 50LIS50NPL,,2,,,,,,,,,,,,,,2019,Q4,Transaminases increased,,2019,Q4,2,F,,20191016.0,20180717,20191022,EXP,,CA-TEVA-2018-CA-924441,TEVA,,50.0,YR,,F,Y,66.0,KG,20191022.0,,MD,CA,CA,2019,Q4,Adult
154238564,15423856,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK (NK IE, NACH BZ) (IU, ACCORDING TO BLOOD GLUCOSE)",,,D,,,,,,,,,2019,Q4,Cardiac failure,,2019,Q4,4,F,20170717.0,20191122.0,20180925,20191127,EXP,,DE-MYLANLABS-2018M1069454,MYLAN,,77.0,YR,,M,Y,59.0,KG,20191127.0,,PH,DE,DE,2019,Q4,Elderly
154238564,15423856,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK (NK IE, NACH BZ) (IU, ACCORDING TO BLOOD GLUCOSE)",,,D,,,,,,,,,2019,Q4,Cardiac failure chronic,,2019,Q4,4,F,20170717.0,20191122.0,20180925,20191127,EXP,,DE-MYLANLABS-2018M1069454,MYLAN,,77.0,YR,,M,Y,59.0,KG,20191127.0,,PH,DE,DE,2019,Q4,Elderly
154238564,15423856,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK (NK IE, NACH BZ) (IU, ACCORDING TO BLOOD GLUCOSE)",,,D,,,,,,,,,2019,Q4,Chest discomfort,,2019,Q4,4,F,20170717.0,20191122.0,20180925,20191127,EXP,,DE-MYLANLABS-2018M1069454,MYLAN,,77.0,YR,,M,Y,59.0,KG,20191127.0,,PH,DE,DE,2019,Q4,Elderly
154238564,15423856,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK (NK IE, NACH BZ) (IU, ACCORDING TO BLOOD GLUCOSE)",,,D,,,,,,,,,2019,Q4,Dizziness,,2019,Q4,4,F,20170717.0,20191122.0,20180925,20191127,EXP,,DE-MYLANLABS-2018M1069454,MYLAN,,77.0,YR,,M,Y,59.0,KG,20191127.0,,PH,DE,DE,2019,Q4,Elderly
154238564,15423856,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK (NK IE, NACH BZ) (IU, ACCORDING TO BLOOD GLUCOSE)",,,D,,,,,,,,,2019,Q4,Dyspnoea,,2019,Q4,4,F,20170717.0,20191122.0,20180925,20191127,EXP,,DE-MYLANLABS-2018M1069454,MYLAN,,77.0,YR,,M,Y,59.0,KG,20191127.0,,PH,DE,DE,2019,Q4,Elderly
154238564,15423856,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK (NK IE, NACH BZ) (IU, ACCORDING TO BLOOD GLUCOSE)",,,D,,,,,,,,,2019,Q4,Dyspnoea exertional,,2019,Q4,4,F,20170717.0,20191122.0,20180925,20191127,EXP,,DE-MYLANLABS-2018M1069454,MYLAN,,77.0,YR,,M,Y,59.0,KG,20191127.0,,PH,DE,DE,2019,Q4,Elderly
154842183,15484218,11,C,Lispro Insulin,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q4,Cerebrovascular accident,,2019,Q4,3,F,20191217.0,20191220.0,20181010,20191231,EXP,,US-UCBSA-2018045398,UCB,,63.0,YR,,M,Y,,,20191231.0,,CN,US,US,2019,Q4,Adult
154842183,15484218,11,C,Lispro Insulin,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q4,Hypokalaemia,,2019,Q4,3,F,20191217.0,20191220.0,20181010,20191231,EXP,,US-UCBSA-2018045398,UCB,,63.0,YR,,M,Y,,,20191231.0,,CN,US,US,2019,Q4,Adult
154842183,15484218,11,C,Lispro Insulin,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q4,Myoclonus,,2019,Q4,3,F,20191217.0,20191220.0,20181010,20191231,EXP,,US-UCBSA-2018045398,UCB,,63.0,YR,,M,Y,,,20191231.0,,CN,US,US,2019,Q4,Adult
154842183,15484218,11,C,Lispro Insulin,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q4,Off label use,,2019,Q4,3,F,20191217.0,20191220.0,20181010,20191231,EXP,,US-UCBSA-2018045398,UCB,,63.0,YR,,M,Y,,,20191231.0,,CN,US,US,2019,Q4,Adult
154842183,15484218,11,C,Lispro Insulin,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q4,Overdose,,2019,Q4,3,F,20191217.0,20191220.0,20181010,20191231,EXP,,US-UCBSA-2018045398,UCB,,63.0,YR,,M,Y,,,20191231.0,,CN,US,US,2019,Q4,Adult
154842183,15484218,11,C,Lispro Insulin,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q4,Product dose omission,,2019,Q4,3,F,20191217.0,20191220.0,20181010,20191231,EXP,,US-UCBSA-2018045398,UCB,,63.0,YR,,M,Y,,,20191231.0,,CN,US,US,2019,Q4,Adult
154842183,15484218,11,C,Lispro Insulin,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q4,Seizure,,2019,Q4,3,F,20191217.0,20191220.0,20181010,20191231,EXP,,US-UCBSA-2018045398,UCB,,63.0,YR,,M,Y,,,20191231.0,,CN,US,US,2019,Q4,Adult
154842183,15484218,11,C,Lispro Insulin,INSULIN LISPRO,1,,,,,,U,,,,,,,,2019,Q4,Urine analysis abnormal,,2019,Q4,3,F,20191217.0,20191220.0,20181010,20191231,EXP,,US-UCBSA-2018045398,UCB,,63.0,YR,,M,Y,,,20191231.0,,CN,US,US,2019,Q4,Adult
1549343212,15493432,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2019,Q4,Acute kidney injury,,2019,Q4,12,F,20180419.0,20191024.0,20181012,20191104,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20191104.0,,CN,DE,DE,2019,Q4,Elderly
1549343212,15493432,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2019,Q4,Adrenomegaly,,2019,Q4,12,F,20180419.0,20191024.0,20181012,20191104,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20191104.0,,CN,DE,DE,2019,Q4,Elderly
1549343212,15493432,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2019,Q4,Blood pressure increased,,2019,Q4,12,F,20180419.0,20191024.0,20181012,20191104,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20191104.0,,CN,DE,DE,2019,Q4,Elderly
1549343212,15493432,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2019,Q4,Chest pain,,2019,Q4,12,F,20180419.0,20191024.0,20181012,20191104,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20191104.0,,CN,DE,DE,2019,Q4,Elderly
1549343212,15493432,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2019,Q4,Colitis,,2019,Q4,12,F,20180419.0,20191024.0,20181012,20191104,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20191104.0,,CN,DE,DE,2019,Q4,Elderly
1549343212,15493432,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2019,Q4,Device related infection,,2019,Q4,12,F,20180419.0,20191024.0,20181012,20191104,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20191104.0,,CN,DE,DE,2019,Q4,Elderly
1549343212,15493432,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2019,Q4,Dyspnoea,,2019,Q4,12,F,20180419.0,20191024.0,20181012,20191104,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20191104.0,,CN,DE,DE,2019,Q4,Elderly
1549343212,15493432,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2019,Q4,Heparin-induced thrombocytopenia,,2019,Q4,12,F,20180419.0,20191024.0,20181012,20191104,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20191104.0,,CN,DE,DE,2019,Q4,Elderly
1549343212,15493432,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2019,Q4,Hyperglycaemia,,2019,Q4,12,F,20180419.0,20191024.0,20181012,20191104,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20191104.0,,CN,DE,DE,2019,Q4,Elderly
1549343212,15493432,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2019,Q4,Hypertensive crisis,,2019,Q4,12,F,20180419.0,20191024.0,20181012,20191104,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20191104.0,,CN,DE,DE,2019,Q4,Elderly
1549343212,15493432,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2019,Q4,Klebsiella infection,,2019,Q4,12,F,20180419.0,20191024.0,20181012,20191104,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20191104.0,,CN,DE,DE,2019,Q4,Elderly
1549343212,15493432,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2019,Q4,Malignant neoplasm progression,,2019,Q4,12,F,20180419.0,20191024.0,20181012,20191104,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20191104.0,,CN,DE,DE,2019,Q4,Elderly
1549343212,15493432,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2019,Q4,Meningitis,,2019,Q4,12,F,20180419.0,20191024.0,20181012,20191104,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20191104.0,,CN,DE,DE,2019,Q4,Elderly
1549343212,15493432,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2019,Q4,Metastases to meninges,,2019,Q4,12,F,20180419.0,20191024.0,20181012,20191104,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20191104.0,,CN,DE,DE,2019,Q4,Elderly
1549343212,15493432,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2019,Q4,Pulmonary oedema,,2019,Q4,12,F,20180419.0,20191024.0,20181012,20191104,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20191104.0,,CN,DE,DE,2019,Q4,Elderly
1549343212,15493432,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2019,Q4,Retinal detachment,,2019,Q4,12,F,20180419.0,20191024.0,20181012,20191104,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20191104.0,,CN,DE,DE,2019,Q4,Elderly
1549343212,15493432,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2019,Q4,Retinopathy,,2019,Q4,12,F,20180419.0,20191024.0,20181012,20191104,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20191104.0,,CN,DE,DE,2019,Q4,Elderly
1549343212,15493432,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2019,Q4,Tachycardia,,2019,Q4,12,F,20180419.0,20191024.0,20181012,20191104,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20191104.0,,CN,DE,DE,2019,Q4,Elderly
1549343212,15493432,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2019,Q4,Urosepsis,,2019,Q4,12,F,20180419.0,20191024.0,20181012,20191104,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20191104.0,,CN,DE,DE,2019,Q4,Elderly
154969607,15496960,67,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q4,Addison's disease,,2019,Q4,7,F,20180819.0,20191021.0,20181015,20191025,EXP,,US-ROCHE-2186872,ROCHE,,56.0,YR,,F,Y,73.5,KG,20191025.0,,MD,US,US,2019,Q4,Adult
154969607,15496960,67,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q4,Hyperthyroidism,,2019,Q4,7,F,20180819.0,20191021.0,20181015,20191025,EXP,,US-ROCHE-2186872,ROCHE,,56.0,YR,,F,Y,73.5,KG,20191025.0,,MD,US,US,2019,Q4,Adult
154969607,15496960,67,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q4,Hypothyroidism,,2019,Q4,7,F,20180819.0,20191021.0,20181015,20191025,EXP,,US-ROCHE-2186872,ROCHE,,56.0,YR,,F,Y,73.5,KG,20191025.0,,MD,US,US,2019,Q4,Adult
155063482,15506348,39,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q4,Brachiocephalic vein thrombosis,,2019,Q4,2,F,20180625.0,20191118.0,20181016,20191120,PER,,US-AMGEN-USACT2018100894,AMGEN,,56.0,YR,A,M,Y,,,20191120.0,,MD,US,US,2019,Q4,Adult
1561693710,15616937,19,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,2-10 UNITS,,,,,,,,,,UNKNOWN,TID,2019,Q4,Candida pneumonia,,2019,Q4,10,F,20180919.0,20191025.0,20181114,20191030,EXP,,US-CELGENEUS-USA-20180909031,CELGENE,,77.0,YR,,M,Y,,,20191030.0,,OT,US,US,2019,Q4,Elderly
1561693710,15616937,20,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,15 IU (INTERNATIONAL UNIT),,,,,,,,5.0,IU,UNKNOWN,TID,2019,Q4,Candida pneumonia,,2019,Q4,10,F,20180919.0,20191025.0,20181114,20191030,EXP,,US-CELGENEUS-USA-20180909031,CELGENE,,77.0,YR,,M,Y,,,20191030.0,,OT,US,US,2019,Q4,Elderly
156336954,15633695,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,,,,,,SOLUTION FOR INJECTION,,2019,Q4,Cholelithiasis,,2019,Q4,4,F,201411.0,20190925.0,20181119,20191004,EXP,,US-SA-2018SA315877,SANOFI AVENTIS,,66.0,YR,E,F,Y,,,20191004.0,,CN,US,US,2019,Q4,Elderly
156336954,15633695,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,,,,,,SOLUTION FOR INJECTION,,2019,Q4,Drug hypersensitivity,,2019,Q4,4,F,201411.0,20190925.0,20181119,20191004,EXP,,US-SA-2018SA315877,SANOFI AVENTIS,,66.0,YR,E,F,Y,,,20191004.0,,CN,US,US,2019,Q4,Elderly
156336954,15633695,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,,,,,,SOLUTION FOR INJECTION,,2019,Q4,Drug ineffective,,2019,Q4,4,F,201411.0,20190925.0,20181119,20191004,EXP,,US-SA-2018SA315877,SANOFI AVENTIS,,66.0,YR,E,F,Y,,,20191004.0,,CN,US,US,2019,Q4,Elderly
156336954,15633695,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,,,,,,SOLUTION FOR INJECTION,,2019,Q4,Haemorrhage,,2019,Q4,4,F,201411.0,20190925.0,20181119,20191004,EXP,,US-SA-2018SA315877,SANOFI AVENTIS,,66.0,YR,E,F,Y,,,20191004.0,,CN,US,US,2019,Q4,Elderly
156336954,15633695,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,,,,,,SOLUTION FOR INJECTION,,2019,Q4,Hepatitis B,,2019,Q4,4,F,201411.0,20190925.0,20181119,20191004,EXP,,US-SA-2018SA315877,SANOFI AVENTIS,,66.0,YR,E,F,Y,,,20191004.0,,CN,US,US,2019,Q4,Elderly
156336954,15633695,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,,,,,,SOLUTION FOR INJECTION,,2019,Q4,Injection site bruising,,2019,Q4,4,F,201411.0,20190925.0,20181119,20191004,EXP,,US-SA-2018SA315877,SANOFI AVENTIS,,66.0,YR,E,F,Y,,,20191004.0,,CN,US,US,2019,Q4,Elderly
156336954,15633695,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,,,,,,SOLUTION FOR INJECTION,,2019,Q4,Injection site indentation,,2019,Q4,4,F,201411.0,20190925.0,20181119,20191004,EXP,,US-SA-2018SA315877,SANOFI AVENTIS,,66.0,YR,E,F,Y,,,20191004.0,,CN,US,US,2019,Q4,Elderly
156336954,15633695,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,,,,,,SOLUTION FOR INJECTION,,2019,Q4,Pancreatitis,,2019,Q4,4,F,201411.0,20190925.0,20181119,20191004,EXP,,US-SA-2018SA315877,SANOFI AVENTIS,,66.0,YR,E,F,Y,,,20191004.0,,CN,US,US,2019,Q4,Elderly
156336954,15633695,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,,,,,,SOLUTION FOR INJECTION,,2019,Q4,Walking aid user,,2019,Q4,4,F,201411.0,20190925.0,20181119,20191004,EXP,,US-SA-2018SA315877,SANOFI AVENTIS,,66.0,YR,E,F,Y,,,20191004.0,,CN,US,US,2019,Q4,Elderly
1567028913,15670289,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 INTERNATIONAL UNIT, QD,(25/75: + 20U 20U / D)",,,U,U,,,,40.0,IU,SOLUTION FOR INJECTION,QD,2019,Q4,Chest pain,,2019,Q4,13,F,,20190926.0,20181129,20191001,EXP,,PT-MYLANLABS-2018M1088222,MYLAN,,54.0,YR,,F,Y,,,20191001.0,,CN,PT,PT,2019,Q4,Adult
1567028913,15670289,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 INTERNATIONAL UNIT, QD,(25/75: + 20U 20U / D)",,,U,U,,,,40.0,IU,SOLUTION FOR INJECTION,QD,2019,Q4,Headache,,2019,Q4,13,F,,20190926.0,20181129,20191001,EXP,,PT-MYLANLABS-2018M1088222,MYLAN,,54.0,YR,,F,Y,,,20191001.0,,CN,PT,PT,2019,Q4,Adult
1567028913,15670289,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 INTERNATIONAL UNIT, QD,(25/75: + 20U 20U / D)",,,U,U,,,,40.0,IU,SOLUTION FOR INJECTION,QD,2019,Q4,Ischaemic stroke,,2019,Q4,13,F,,20190926.0,20181129,20191001,EXP,,PT-MYLANLABS-2018M1088222,MYLAN,,54.0,YR,,F,Y,,,20191001.0,,CN,PT,PT,2019,Q4,Adult
1567028913,15670289,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"25/75: 40 IU, QD",,,U,U,,,,,,SOLUTION FOR INJECTION,QD,2019,Q4,Chest pain,,2019,Q4,13,F,,20190926.0,20181129,20191001,EXP,,PT-MYLANLABS-2018M1088222,MYLAN,,54.0,YR,,F,Y,,,20191001.0,,CN,PT,PT,2019,Q4,Adult
1567028913,15670289,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"25/75: 40 IU, QD",,,U,U,,,,,,SOLUTION FOR INJECTION,QD,2019,Q4,Headache,,2019,Q4,13,F,,20190926.0,20181129,20191001,EXP,,PT-MYLANLABS-2018M1088222,MYLAN,,54.0,YR,,F,Y,,,20191001.0,,CN,PT,PT,2019,Q4,Adult
1567028913,15670289,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"25/75: 40 IU, QD",,,U,U,,,,,,SOLUTION FOR INJECTION,QD,2019,Q4,Ischaemic stroke,,2019,Q4,13,F,,20190926.0,20181129,20191001,EXP,,PT-MYLANLABS-2018M1088222,MYLAN,,54.0,YR,,F,Y,,,20191001.0,,CN,PT,PT,2019,Q4,Adult
157797728,15779772,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, UNK",,,U,,,,,1.0,DF,,,2019,Q4,Blood thyroid stimulating hormone increased,,2019,Q4,8,F,20181218.0,20191112.0,20190102,20191122,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-121478,BRISTOL MYERS SQUIBB,,64.0,YR,,M,Y,,,20191122.0,,CN,DE,DE,2019,Q4,Adult
157797728,15779772,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, UNK",,,U,,,,,1.0,DF,,,2019,Q4,Bronchial carcinoma,,2019,Q4,8,F,20181218.0,20191112.0,20190102,20191122,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-121478,BRISTOL MYERS SQUIBB,,64.0,YR,,M,Y,,,20191122.0,,CN,DE,DE,2019,Q4,Adult
157797728,15779772,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, UNK",,,U,,,,,1.0,DF,,,2019,Q4,Constipation,,2019,Q4,8,F,20181218.0,20191112.0,20190102,20191122,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-121478,BRISTOL MYERS SQUIBB,,64.0,YR,,M,Y,,,20191122.0,,CN,DE,DE,2019,Q4,Adult
157797728,15779772,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, UNK",,,U,,,,,1.0,DF,,,2019,Q4,Dry skin,,2019,Q4,8,F,20181218.0,20191112.0,20190102,20191122,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-121478,BRISTOL MYERS SQUIBB,,64.0,YR,,M,Y,,,20191122.0,,CN,DE,DE,2019,Q4,Adult
157797728,15779772,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, UNK",,,U,,,,,1.0,DF,,,2019,Q4,Epistaxis,,2019,Q4,8,F,20181218.0,20191112.0,20190102,20191122,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-121478,BRISTOL MYERS SQUIBB,,64.0,YR,,M,Y,,,20191122.0,,CN,DE,DE,2019,Q4,Adult
157797728,15779772,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, UNK",,,U,,,,,1.0,DF,,,2019,Q4,Fatigue,,2019,Q4,8,F,20181218.0,20191112.0,20190102,20191122,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-121478,BRISTOL MYERS SQUIBB,,64.0,YR,,M,Y,,,20191122.0,,CN,DE,DE,2019,Q4,Adult
157797728,15779772,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, UNK",,,U,,,,,1.0,DF,,,2019,Q4,Headache,,2019,Q4,8,F,20181218.0,20191112.0,20190102,20191122,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-121478,BRISTOL MYERS SQUIBB,,64.0,YR,,M,Y,,,20191122.0,,CN,DE,DE,2019,Q4,Adult
157797728,15779772,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, UNK",,,U,,,,,1.0,DF,,,2019,Q4,Hypertension,,2019,Q4,8,F,20181218.0,20191112.0,20190102,20191122,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-121478,BRISTOL MYERS SQUIBB,,64.0,YR,,M,Y,,,20191122.0,,CN,DE,DE,2019,Q4,Adult
157797728,15779772,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, UNK",,,U,,,,,1.0,DF,,,2019,Q4,Myalgia,,2019,Q4,8,F,20181218.0,20191112.0,20190102,20191122,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-121478,BRISTOL MYERS SQUIBB,,64.0,YR,,M,Y,,,20191122.0,,CN,DE,DE,2019,Q4,Adult
157797728,15779772,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, UNK",,,U,,,,,1.0,DF,,,2019,Q4,Myocardial infarction,,2019,Q4,8,F,20181218.0,20191112.0,20190102,20191122,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-121478,BRISTOL MYERS SQUIBB,,64.0,YR,,M,Y,,,20191122.0,,CN,DE,DE,2019,Q4,Adult
157797728,15779772,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, UNK",,,U,,,,,1.0,DF,,,2019,Q4,Pulmonary oedema,,2019,Q4,8,F,20181218.0,20191112.0,20190102,20191122,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-121478,BRISTOL MYERS SQUIBB,,64.0,YR,,M,Y,,,20191122.0,,CN,DE,DE,2019,Q4,Adult
158440358,15844035,48,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2019,Q4,Cardiac disorder,,2019,Q4,8,F,20181126.0,20191206.0,20190118,20191213,EXP,,PHHY2018FR197254,NOVARTIS,,69.0,YR,,F,Y,77.0,KG,20191213.0,,MD,FR,FR,2019,Q4,Elderly
158440358,15844035,48,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2019,Q4,Diabetes mellitus inadequate control,,2019,Q4,8,F,20181126.0,20191206.0,20190118,20191213,EXP,,PHHY2018FR197254,NOVARTIS,,69.0,YR,,F,Y,77.0,KG,20191213.0,,MD,FR,FR,2019,Q4,Elderly
158440358,15844035,48,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2019,Q4,Haematuria,,2019,Q4,8,F,20181126.0,20191206.0,20190118,20191213,EXP,,PHHY2018FR197254,NOVARTIS,,69.0,YR,,F,Y,77.0,KG,20191213.0,,MD,FR,FR,2019,Q4,Elderly
158440358,15844035,48,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2019,Q4,Hyperkalaemia,,2019,Q4,8,F,20181126.0,20191206.0,20190118,20191213,EXP,,PHHY2018FR197254,NOVARTIS,,69.0,YR,,F,Y,77.0,KG,20191213.0,,MD,FR,FR,2019,Q4,Elderly
158440358,15844035,48,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2019,Q4,Hypertension,,2019,Q4,8,F,20181126.0,20191206.0,20190118,20191213,EXP,,PHHY2018FR197254,NOVARTIS,,69.0,YR,,F,Y,77.0,KG,20191213.0,,MD,FR,FR,2019,Q4,Elderly
158440358,15844035,48,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2019,Q4,Hypomagnesaemia,,2019,Q4,8,F,20181126.0,20191206.0,20190118,20191213,EXP,,PHHY2018FR197254,NOVARTIS,,69.0,YR,,F,Y,77.0,KG,20191213.0,,MD,FR,FR,2019,Q4,Elderly
158440358,15844035,48,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2019,Q4,Nausea,,2019,Q4,8,F,20181126.0,20191206.0,20190118,20191213,EXP,,PHHY2018FR197254,NOVARTIS,,69.0,YR,,F,Y,77.0,KG,20191213.0,,MD,FR,FR,2019,Q4,Elderly
158440358,15844035,48,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2019,Q4,Overdose,,2019,Q4,8,F,20181126.0,20191206.0,20190118,20191213,EXP,,PHHY2018FR197254,NOVARTIS,,69.0,YR,,F,Y,77.0,KG,20191213.0,,MD,FR,FR,2019,Q4,Elderly
158440358,15844035,48,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2019,Q4,Pyelonephritis,,2019,Q4,8,F,20181126.0,20191206.0,20190118,20191213,EXP,,PHHY2018FR197254,NOVARTIS,,69.0,YR,,F,Y,77.0,KG,20191213.0,,MD,FR,FR,2019,Q4,Elderly
158440358,15844035,48,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2019,Q4,Renal impairment,,2019,Q4,8,F,20181126.0,20191206.0,20190118,20191213,EXP,,PHHY2018FR197254,NOVARTIS,,69.0,YR,,F,Y,77.0,KG,20191213.0,,MD,FR,FR,2019,Q4,Elderly
158440358,15844035,48,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2019,Q4,Serum sickness,,2019,Q4,8,F,20181126.0,20191206.0,20190118,20191213,EXP,,PHHY2018FR197254,NOVARTIS,,69.0,YR,,F,Y,77.0,KG,20191213.0,,MD,FR,FR,2019,Q4,Elderly
158561174,15856117,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"STRENGTH: 100 UNITS/ML 3 ML; VIAL MED CORRECTIVE SCALE, WMHS",,,,,,,,,,,,2019,Q4,Lower gastrointestinal haemorrhage,,2019,Q4,4,F,20160322.0,20191219.0,20190123,20191221,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-002903",BOEHRINGER INGELHEIM,,79.0,YR,,M,Y,87.08,KG,20191221.0,,CN,US,US,2019,Q4,Elderly
159314677,15931467,22,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,7 UNITS WITH BREAKFAST 11 UNITS WITH LUNCH AND 10 UNITS AT LUNCH,,,,,,,,,,FORMULATION UNKNOWN,,2019,Q4,Abdominal pain,,2019,Q4,7,F,201811.0,20191204.0,20190207,20191212,EXP,,CO-ASTELLAS-2019US004522,ASTELLAS,,65.0,YR,,M,Y,,,20191212.0,,CN,CO,CO,2019,Q4,Elderly
159314677,15931467,22,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,7 UNITS WITH BREAKFAST 11 UNITS WITH LUNCH AND 10 UNITS AT LUNCH,,,,,,,,,,FORMULATION UNKNOWN,,2019,Q4,Abdominal pain upper,,2019,Q4,7,F,201811.0,20191204.0,20190207,20191212,EXP,,CO-ASTELLAS-2019US004522,ASTELLAS,,65.0,YR,,M,Y,,,20191212.0,,CN,CO,CO,2019,Q4,Elderly
159314677,15931467,22,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,7 UNITS WITH BREAKFAST 11 UNITS WITH LUNCH AND 10 UNITS AT LUNCH,,,,,,,,,,FORMULATION UNKNOWN,,2019,Q4,Blood potassium increased,,2019,Q4,7,F,201811.0,20191204.0,20190207,20191212,EXP,,CO-ASTELLAS-2019US004522,ASTELLAS,,65.0,YR,,M,Y,,,20191212.0,,CN,CO,CO,2019,Q4,Elderly
159314677,15931467,22,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,7 UNITS WITH BREAKFAST 11 UNITS WITH LUNCH AND 10 UNITS AT LUNCH,,,,,,,,,,FORMULATION UNKNOWN,,2019,Q4,Bronchitis,,2019,Q4,7,F,201811.0,20191204.0,20190207,20191212,EXP,,CO-ASTELLAS-2019US004522,ASTELLAS,,65.0,YR,,M,Y,,,20191212.0,,CN,CO,CO,2019,Q4,Elderly
159314677,15931467,22,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,7 UNITS WITH BREAKFAST 11 UNITS WITH LUNCH AND 10 UNITS AT LUNCH,,,,,,,,,,FORMULATION UNKNOWN,,2019,Q4,Diarrhoea,,2019,Q4,7,F,201811.0,20191204.0,20190207,20191212,EXP,,CO-ASTELLAS-2019US004522,ASTELLAS,,65.0,YR,,M,Y,,,20191212.0,,CN,CO,CO,2019,Q4,Elderly
159314677,15931467,22,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,7 UNITS WITH BREAKFAST 11 UNITS WITH LUNCH AND 10 UNITS AT LUNCH,,,,,,,,,,FORMULATION UNKNOWN,,2019,Q4,Graft loss,,2019,Q4,7,F,201811.0,20191204.0,20190207,20191212,EXP,,CO-ASTELLAS-2019US004522,ASTELLAS,,65.0,YR,,M,Y,,,20191212.0,,CN,CO,CO,2019,Q4,Elderly
159314677,15931467,22,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,7 UNITS WITH BREAKFAST 11 UNITS WITH LUNCH AND 10 UNITS AT LUNCH,,,,,,,,,,FORMULATION UNKNOWN,,2019,Q4,Kidney transplant rejection,,2019,Q4,7,F,201811.0,20191204.0,20190207,20191212,EXP,,CO-ASTELLAS-2019US004522,ASTELLAS,,65.0,YR,,M,Y,,,20191212.0,,CN,CO,CO,2019,Q4,Elderly
159314677,15931467,22,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,7 UNITS WITH BREAKFAST 11 UNITS WITH LUNCH AND 10 UNITS AT LUNCH,,,,,,,,,,FORMULATION UNKNOWN,,2019,Q4,Nephritis,,2019,Q4,7,F,201811.0,20191204.0,20190207,20191212,EXP,,CO-ASTELLAS-2019US004522,ASTELLAS,,65.0,YR,,M,Y,,,20191212.0,,CN,CO,CO,2019,Q4,Elderly
159314677,15931467,22,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,7 UNITS WITH BREAKFAST 11 UNITS WITH LUNCH AND 10 UNITS AT LUNCH,,,,,,,,,,FORMULATION UNKNOWN,,2019,Q4,Peripheral swelling,,2019,Q4,7,F,201811.0,20191204.0,20190207,20191212,EXP,,CO-ASTELLAS-2019US004522,ASTELLAS,,65.0,YR,,M,Y,,,20191212.0,,CN,CO,CO,2019,Q4,Elderly
159314677,15931467,22,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,7 UNITS WITH BREAKFAST 11 UNITS WITH LUNCH AND 10 UNITS AT LUNCH,,,,,,,,,,FORMULATION UNKNOWN,,2019,Q4,Pyrexia,,2019,Q4,7,F,201811.0,20191204.0,20190207,20191212,EXP,,CO-ASTELLAS-2019US004522,ASTELLAS,,65.0,YR,,M,Y,,,20191212.0,,CN,CO,CO,2019,Q4,Elderly
159314677,15931467,22,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,7 UNITS WITH BREAKFAST 11 UNITS WITH LUNCH AND 10 UNITS AT LUNCH,,,,,,,,,,FORMULATION UNKNOWN,,2019,Q4,Weight decreased,,2019,Q4,7,F,201811.0,20191204.0,20190207,20191212,EXP,,CO-ASTELLAS-2019US004522,ASTELLAS,,65.0,YR,,M,Y,,,20191212.0,,CN,CO,CO,2019,Q4,Elderly
160147986,16014798,13,C,INSULINE LISPRO,,2,Subcutaneous,1 DOSAGE FORM,,,U,,,,,1.0,DF,,,2019,Q4,Hepatitis,,2019,Q4,6,F,20181129.0,20190925.0,20190227,20191002,EXP,,ES-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-019935,BRISTOL MYERS SQUIBB,,61.0,YR,,M,Y,80.0,KG,20191002.0,,OT,ES,ES,2019,Q4,Adult
160147986,16014798,13,C,INSULINE LISPRO,,2,Subcutaneous,1 DOSAGE FORM,,,U,,,,,1.0,DF,,,2019,Q4,Hepatotoxicity,,2019,Q4,6,F,20181129.0,20190925.0,20190227,20191002,EXP,,ES-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-019935,BRISTOL MYERS SQUIBB,,61.0,YR,,M,Y,80.0,KG,20191002.0,,OT,ES,ES,2019,Q4,Adult
160654476,16065447,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q4,Abdominal distension,,2019,Q4,6,F,201708.0,20191204.0,20190313,20191210,EXP,,US-SA-2019SA066355,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20191210.0,,OT,US,US,2019,Q4,Young Adult
160654476,16065447,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q4,Abdominal pain,,2019,Q4,6,F,201708.0,20191204.0,20190313,20191210,EXP,,US-SA-2019SA066355,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20191210.0,,OT,US,US,2019,Q4,Young Adult
160654476,16065447,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q4,Ascites,,2019,Q4,6,F,201708.0,20191204.0,20190313,20191210,EXP,,US-SA-2019SA066355,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20191210.0,,OT,US,US,2019,Q4,Young Adult
160654476,16065447,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q4,Back pain,,2019,Q4,6,F,201708.0,20191204.0,20190313,20191210,EXP,,US-SA-2019SA066355,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20191210.0,,OT,US,US,2019,Q4,Young Adult
160654476,16065447,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q4,Cough,,2019,Q4,6,F,201708.0,20191204.0,20190313,20191210,EXP,,US-SA-2019SA066355,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20191210.0,,OT,US,US,2019,Q4,Young Adult
160654476,16065447,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q4,Cytomegalovirus viraemia,,2019,Q4,6,F,201708.0,20191204.0,20190313,20191210,EXP,,US-SA-2019SA066355,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20191210.0,,OT,US,US,2019,Q4,Young Adult
160654476,16065447,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q4,Decreased appetite,,2019,Q4,6,F,201708.0,20191204.0,20190313,20191210,EXP,,US-SA-2019SA066355,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20191210.0,,OT,US,US,2019,Q4,Young Adult
160654476,16065447,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q4,Diarrhoea,,2019,Q4,6,F,201708.0,20191204.0,20190313,20191210,EXP,,US-SA-2019SA066355,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20191210.0,,OT,US,US,2019,Q4,Young Adult
160654476,16065447,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q4,Dyspepsia,,2019,Q4,6,F,201708.0,20191204.0,20190313,20191210,EXP,,US-SA-2019SA066355,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20191210.0,,OT,US,US,2019,Q4,Young Adult
160654476,16065447,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q4,Dyspnoea,,2019,Q4,6,F,201708.0,20191204.0,20190313,20191210,EXP,,US-SA-2019SA066355,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20191210.0,,OT,US,US,2019,Q4,Young Adult
160654476,16065447,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q4,Gastric cancer,,2019,Q4,6,F,201708.0,20191204.0,20190313,20191210,EXP,,US-SA-2019SA066355,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20191210.0,,OT,US,US,2019,Q4,Young Adult
160654476,16065447,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q4,Gastritis,,2019,Q4,6,F,201708.0,20191204.0,20190313,20191210,EXP,,US-SA-2019SA066355,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20191210.0,,OT,US,US,2019,Q4,Young Adult
160654476,16065447,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q4,Hypotension,,2019,Q4,6,F,201708.0,20191204.0,20190313,20191210,EXP,,US-SA-2019SA066355,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20191210.0,,OT,US,US,2019,Q4,Young Adult
160654476,16065447,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q4,Hypoxia,,2019,Q4,6,F,201708.0,20191204.0,20190313,20191210,EXP,,US-SA-2019SA066355,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20191210.0,,OT,US,US,2019,Q4,Young Adult
160654476,16065447,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q4,Lung consolidation,,2019,Q4,6,F,201708.0,20191204.0,20190313,20191210,EXP,,US-SA-2019SA066355,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20191210.0,,OT,US,US,2019,Q4,Young Adult
160654476,16065447,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q4,Malnutrition,,2019,Q4,6,F,201708.0,20191204.0,20190313,20191210,EXP,,US-SA-2019SA066355,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20191210.0,,OT,US,US,2019,Q4,Young Adult
160654476,16065447,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q4,Pneumonia,,2019,Q4,6,F,201708.0,20191204.0,20190313,20191210,EXP,,US-SA-2019SA066355,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20191210.0,,OT,US,US,2019,Q4,Young Adult
160654476,16065447,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q4,Product use in unapproved indication,,2019,Q4,6,F,201708.0,20191204.0,20190313,20191210,EXP,,US-SA-2019SA066355,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20191210.0,,OT,US,US,2019,Q4,Young Adult
160654476,16065447,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q4,Pulmonary arterial pressure decreased,,2019,Q4,6,F,201708.0,20191204.0,20190313,20191210,EXP,,US-SA-2019SA066355,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20191210.0,,OT,US,US,2019,Q4,Young Adult
160654476,16065447,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q4,Pulmonary embolism,,2019,Q4,6,F,201708.0,20191204.0,20190313,20191210,EXP,,US-SA-2019SA066355,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20191210.0,,OT,US,US,2019,Q4,Young Adult
160654476,16065447,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2019,Q4,Tachycardia,,2019,Q4,6,F,201708.0,20191204.0,20190313,20191210,EXP,,US-SA-2019SA066355,SANOFI AVENTIS,,33.0,YR,A,F,Y,,,20191210.0,,OT,US,US,2019,Q4,Young Adult
1608836710,16088367,10,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q4,Acute kidney injury,,2019,Q4,10,F,2018.0,20191218.0,20190319,20191226,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,,71.0,YR,,M,Y,,,20191226.0,,OT,PT,PT,2019,Q4,Elderly
1608836710,16088367,10,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q4,Arrhythmia,,2019,Q4,10,F,2018.0,20191218.0,20190319,20191226,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,,71.0,YR,,M,Y,,,20191226.0,,OT,PT,PT,2019,Q4,Elderly
1608836710,16088367,10,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q4,Atrial fibrillation,,2019,Q4,10,F,2018.0,20191218.0,20190319,20191226,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,,71.0,YR,,M,Y,,,20191226.0,,OT,PT,PT,2019,Q4,Elderly
1608836710,16088367,10,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q4,Bradycardia,,2019,Q4,10,F,2018.0,20191218.0,20190319,20191226,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,,71.0,YR,,M,Y,,,20191226.0,,OT,PT,PT,2019,Q4,Elderly
1608836710,16088367,10,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q4,Dehydration,,2019,Q4,10,F,2018.0,20191218.0,20190319,20191226,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,,71.0,YR,,M,Y,,,20191226.0,,OT,PT,PT,2019,Q4,Elderly
1608836710,16088367,10,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q4,Dizziness,,2019,Q4,10,F,2018.0,20191218.0,20190319,20191226,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,,71.0,YR,,M,Y,,,20191226.0,,OT,PT,PT,2019,Q4,Elderly
1608836710,16088367,10,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q4,Haematocrit increased,,2019,Q4,10,F,2018.0,20191218.0,20190319,20191226,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,,71.0,YR,,M,Y,,,20191226.0,,OT,PT,PT,2019,Q4,Elderly
1608836710,16088367,10,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q4,Haemoglobin increased,,2019,Q4,10,F,2018.0,20191218.0,20190319,20191226,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,,71.0,YR,,M,Y,,,20191226.0,,OT,PT,PT,2019,Q4,Elderly
1608836710,16088367,10,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q4,Heart rate irregular,,2019,Q4,10,F,2018.0,20191218.0,20190319,20191226,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,,71.0,YR,,M,Y,,,20191226.0,,OT,PT,PT,2019,Q4,Elderly
1608836710,16088367,10,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q4,Hypotension,,2019,Q4,10,F,2018.0,20191218.0,20190319,20191226,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,,71.0,YR,,M,Y,,,20191226.0,,OT,PT,PT,2019,Q4,Elderly
1608836710,16088367,10,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q4,Hypovolaemia,,2019,Q4,10,F,2018.0,20191218.0,20190319,20191226,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,,71.0,YR,,M,Y,,,20191226.0,,OT,PT,PT,2019,Q4,Elderly
1608836710,16088367,10,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q4,Left atrial dilatation,,2019,Q4,10,F,2018.0,20191218.0,20190319,20191226,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,,71.0,YR,,M,Y,,,20191226.0,,OT,PT,PT,2019,Q4,Elderly
1608836710,16088367,10,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q4,Mucosal dryness,,2019,Q4,10,F,2018.0,20191218.0,20190319,20191226,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,,71.0,YR,,M,Y,,,20191226.0,,OT,PT,PT,2019,Q4,Elderly
1608836710,16088367,10,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q4,Oedema peripheral,,2019,Q4,10,F,2018.0,20191218.0,20190319,20191226,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,,71.0,YR,,M,Y,,,20191226.0,,OT,PT,PT,2019,Q4,Elderly
1608836710,16088367,10,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q4,Presyncope,,2019,Q4,10,F,2018.0,20191218.0,20190319,20191226,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,,71.0,YR,,M,Y,,,20191226.0,,OT,PT,PT,2019,Q4,Elderly
1608836710,16088367,10,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q4,Pulmonary congestion,,2019,Q4,10,F,2018.0,20191218.0,20190319,20191226,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,,71.0,YR,,M,Y,,,20191226.0,,OT,PT,PT,2019,Q4,Elderly
1608836710,16088367,10,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q4,Renal disorder,,2019,Q4,10,F,2018.0,20191218.0,20190319,20191226,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,,71.0,YR,,M,Y,,,20191226.0,,OT,PT,PT,2019,Q4,Elderly
1608836710,16088367,10,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q4,Renal injury,,2019,Q4,10,F,2018.0,20191218.0,20190319,20191226,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,,71.0,YR,,M,Y,,,20191226.0,,OT,PT,PT,2019,Q4,Elderly
1608836710,16088367,10,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q4,Skin disorder,,2019,Q4,10,F,2018.0,20191218.0,20190319,20191226,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,,71.0,YR,,M,Y,,,20191226.0,,OT,PT,PT,2019,Q4,Elderly
1608836710,16088367,10,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q4,Syncope,,2019,Q4,10,F,2018.0,20191218.0,20190319,20191226,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,,71.0,YR,,M,Y,,,20191226.0,,OT,PT,PT,2019,Q4,Elderly
1608836710,16088367,31,C,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q4,Acute kidney injury,,2019,Q4,10,F,2018.0,20191218.0,20190319,20191226,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,,71.0,YR,,M,Y,,,20191226.0,,OT,PT,PT,2019,Q4,Elderly
1608836710,16088367,31,C,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q4,Arrhythmia,,2019,Q4,10,F,2018.0,20191218.0,20190319,20191226,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,,71.0,YR,,M,Y,,,20191226.0,,OT,PT,PT,2019,Q4,Elderly
1608836710,16088367,31,C,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q4,Atrial fibrillation,,2019,Q4,10,F,2018.0,20191218.0,20190319,20191226,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,,71.0,YR,,M,Y,,,20191226.0,,OT,PT,PT,2019,Q4,Elderly
1608836710,16088367,31,C,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q4,Bradycardia,,2019,Q4,10,F,2018.0,20191218.0,20190319,20191226,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,,71.0,YR,,M,Y,,,20191226.0,,OT,PT,PT,2019,Q4,Elderly
1608836710,16088367,31,C,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q4,Dehydration,,2019,Q4,10,F,2018.0,20191218.0,20190319,20191226,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,,71.0,YR,,M,Y,,,20191226.0,,OT,PT,PT,2019,Q4,Elderly
1608836710,16088367,31,C,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q4,Dizziness,,2019,Q4,10,F,2018.0,20191218.0,20190319,20191226,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,,71.0,YR,,M,Y,,,20191226.0,,OT,PT,PT,2019,Q4,Elderly
1608836710,16088367,31,C,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q4,Haematocrit increased,,2019,Q4,10,F,2018.0,20191218.0,20190319,20191226,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,,71.0,YR,,M,Y,,,20191226.0,,OT,PT,PT,2019,Q4,Elderly
1608836710,16088367,31,C,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q4,Haemoglobin increased,,2019,Q4,10,F,2018.0,20191218.0,20190319,20191226,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,,71.0,YR,,M,Y,,,20191226.0,,OT,PT,PT,2019,Q4,Elderly
1608836710,16088367,31,C,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q4,Heart rate irregular,,2019,Q4,10,F,2018.0,20191218.0,20190319,20191226,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,,71.0,YR,,M,Y,,,20191226.0,,OT,PT,PT,2019,Q4,Elderly
1608836710,16088367,31,C,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q4,Hypotension,,2019,Q4,10,F,2018.0,20191218.0,20190319,20191226,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,,71.0,YR,,M,Y,,,20191226.0,,OT,PT,PT,2019,Q4,Elderly
1608836710,16088367,31,C,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q4,Hypovolaemia,,2019,Q4,10,F,2018.0,20191218.0,20190319,20191226,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,,71.0,YR,,M,Y,,,20191226.0,,OT,PT,PT,2019,Q4,Elderly
1608836710,16088367,31,C,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q4,Left atrial dilatation,,2019,Q4,10,F,2018.0,20191218.0,20190319,20191226,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,,71.0,YR,,M,Y,,,20191226.0,,OT,PT,PT,2019,Q4,Elderly
1608836710,16088367,31,C,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q4,Mucosal dryness,,2019,Q4,10,F,2018.0,20191218.0,20190319,20191226,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,,71.0,YR,,M,Y,,,20191226.0,,OT,PT,PT,2019,Q4,Elderly
1608836710,16088367,31,C,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q4,Oedema peripheral,,2019,Q4,10,F,2018.0,20191218.0,20190319,20191226,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,,71.0,YR,,M,Y,,,20191226.0,,OT,PT,PT,2019,Q4,Elderly
1608836710,16088367,31,C,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q4,Presyncope,,2019,Q4,10,F,2018.0,20191218.0,20190319,20191226,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,,71.0,YR,,M,Y,,,20191226.0,,OT,PT,PT,2019,Q4,Elderly
1608836710,16088367,31,C,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q4,Pulmonary congestion,,2019,Q4,10,F,2018.0,20191218.0,20190319,20191226,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,,71.0,YR,,M,Y,,,20191226.0,,OT,PT,PT,2019,Q4,Elderly
1608836710,16088367,31,C,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q4,Renal disorder,,2019,Q4,10,F,2018.0,20191218.0,20190319,20191226,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,,71.0,YR,,M,Y,,,20191226.0,,OT,PT,PT,2019,Q4,Elderly
1608836710,16088367,31,C,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q4,Renal injury,,2019,Q4,10,F,2018.0,20191218.0,20190319,20191226,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,,71.0,YR,,M,Y,,,20191226.0,,OT,PT,PT,2019,Q4,Elderly
1608836710,16088367,31,C,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q4,Skin disorder,,2019,Q4,10,F,2018.0,20191218.0,20190319,20191226,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,,71.0,YR,,M,Y,,,20191226.0,,OT,PT,PT,2019,Q4,Elderly
1608836710,16088367,31,C,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q4,Syncope,,2019,Q4,10,F,2018.0,20191218.0,20190319,20191226,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,,71.0,YR,,M,Y,,,20191226.0,,OT,PT,PT,2019,Q4,Elderly
161236886,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q4,Acute kidney injury,,2019,Q4,6,F,2018.0,20191203.0,20190327,20191210,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"GOUVEIA C. C, DUQUE S. CAMPOS L. LIPOTHYMIA DUE TO HYPOVOLAEMIA - A CASE OF IATROGENESIS TO EMPAGLIFLOZINE. REVISTA PORTUGUESA DE DIABETES. 2019;14 (1):74-P050",71.0,YR,,M,Y,,,20191210.0,,MD,PT,PT,2019,Q4,Elderly
161236886,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q4,Arrhythmia,,2019,Q4,6,F,2018.0,20191203.0,20190327,20191210,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"GOUVEIA C. C, DUQUE S. CAMPOS L. LIPOTHYMIA DUE TO HYPOVOLAEMIA - A CASE OF IATROGENESIS TO EMPAGLIFLOZINE. REVISTA PORTUGUESA DE DIABETES. 2019;14 (1):74-P050",71.0,YR,,M,Y,,,20191210.0,,MD,PT,PT,2019,Q4,Elderly
161236886,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q4,Atrial fibrillation,,2019,Q4,6,F,2018.0,20191203.0,20190327,20191210,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"GOUVEIA C. C, DUQUE S. CAMPOS L. LIPOTHYMIA DUE TO HYPOVOLAEMIA - A CASE OF IATROGENESIS TO EMPAGLIFLOZINE. REVISTA PORTUGUESA DE DIABETES. 2019;14 (1):74-P050",71.0,YR,,M,Y,,,20191210.0,,MD,PT,PT,2019,Q4,Elderly
161236886,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q4,Bradycardia,,2019,Q4,6,F,2018.0,20191203.0,20190327,20191210,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"GOUVEIA C. C, DUQUE S. CAMPOS L. LIPOTHYMIA DUE TO HYPOVOLAEMIA - A CASE OF IATROGENESIS TO EMPAGLIFLOZINE. REVISTA PORTUGUESA DE DIABETES. 2019;14 (1):74-P050",71.0,YR,,M,Y,,,20191210.0,,MD,PT,PT,2019,Q4,Elderly
161236886,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q4,Dehydration,,2019,Q4,6,F,2018.0,20191203.0,20190327,20191210,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"GOUVEIA C. C, DUQUE S. CAMPOS L. LIPOTHYMIA DUE TO HYPOVOLAEMIA - A CASE OF IATROGENESIS TO EMPAGLIFLOZINE. REVISTA PORTUGUESA DE DIABETES. 2019;14 (1):74-P050",71.0,YR,,M,Y,,,20191210.0,,MD,PT,PT,2019,Q4,Elderly
161236886,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q4,Dizziness,,2019,Q4,6,F,2018.0,20191203.0,20190327,20191210,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"GOUVEIA C. C, DUQUE S. CAMPOS L. LIPOTHYMIA DUE TO HYPOVOLAEMIA - A CASE OF IATROGENESIS TO EMPAGLIFLOZINE. REVISTA PORTUGUESA DE DIABETES. 2019;14 (1):74-P050",71.0,YR,,M,Y,,,20191210.0,,MD,PT,PT,2019,Q4,Elderly
161236886,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q4,Drug interaction,,2019,Q4,6,F,2018.0,20191203.0,20190327,20191210,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"GOUVEIA C. C, DUQUE S. CAMPOS L. LIPOTHYMIA DUE TO HYPOVOLAEMIA - A CASE OF IATROGENESIS TO EMPAGLIFLOZINE. REVISTA PORTUGUESA DE DIABETES. 2019;14 (1):74-P050",71.0,YR,,M,Y,,,20191210.0,,MD,PT,PT,2019,Q4,Elderly
161236886,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q4,Haematocrit increased,,2019,Q4,6,F,2018.0,20191203.0,20190327,20191210,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"GOUVEIA C. C, DUQUE S. CAMPOS L. LIPOTHYMIA DUE TO HYPOVOLAEMIA - A CASE OF IATROGENESIS TO EMPAGLIFLOZINE. REVISTA PORTUGUESA DE DIABETES. 2019;14 (1):74-P050",71.0,YR,,M,Y,,,20191210.0,,MD,PT,PT,2019,Q4,Elderly
161236886,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q4,Haemoglobin increased,,2019,Q4,6,F,2018.0,20191203.0,20190327,20191210,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"GOUVEIA C. C, DUQUE S. CAMPOS L. LIPOTHYMIA DUE TO HYPOVOLAEMIA - A CASE OF IATROGENESIS TO EMPAGLIFLOZINE. REVISTA PORTUGUESA DE DIABETES. 2019;14 (1):74-P050",71.0,YR,,M,Y,,,20191210.0,,MD,PT,PT,2019,Q4,Elderly
161236886,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q4,Heart rate irregular,,2019,Q4,6,F,2018.0,20191203.0,20190327,20191210,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"GOUVEIA C. C, DUQUE S. CAMPOS L. LIPOTHYMIA DUE TO HYPOVOLAEMIA - A CASE OF IATROGENESIS TO EMPAGLIFLOZINE. REVISTA PORTUGUESA DE DIABETES. 2019;14 (1):74-P050",71.0,YR,,M,Y,,,20191210.0,,MD,PT,PT,2019,Q4,Elderly
161236886,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q4,Hypotension,,2019,Q4,6,F,2018.0,20191203.0,20190327,20191210,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"GOUVEIA C. C, DUQUE S. CAMPOS L. LIPOTHYMIA DUE TO HYPOVOLAEMIA - A CASE OF IATROGENESIS TO EMPAGLIFLOZINE. REVISTA PORTUGUESA DE DIABETES. 2019;14 (1):74-P050",71.0,YR,,M,Y,,,20191210.0,,MD,PT,PT,2019,Q4,Elderly
161236886,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q4,Hypovolaemia,,2019,Q4,6,F,2018.0,20191203.0,20190327,20191210,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"GOUVEIA C. C, DUQUE S. CAMPOS L. LIPOTHYMIA DUE TO HYPOVOLAEMIA - A CASE OF IATROGENESIS TO EMPAGLIFLOZINE. REVISTA PORTUGUESA DE DIABETES. 2019;14 (1):74-P050",71.0,YR,,M,Y,,,20191210.0,,MD,PT,PT,2019,Q4,Elderly
161236886,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q4,Left atrial dilatation,,2019,Q4,6,F,2018.0,20191203.0,20190327,20191210,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"GOUVEIA C. C, DUQUE S. CAMPOS L. LIPOTHYMIA DUE TO HYPOVOLAEMIA - A CASE OF IATROGENESIS TO EMPAGLIFLOZINE. REVISTA PORTUGUESA DE DIABETES. 2019;14 (1):74-P050",71.0,YR,,M,Y,,,20191210.0,,MD,PT,PT,2019,Q4,Elderly
161236886,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q4,Mucosal dryness,,2019,Q4,6,F,2018.0,20191203.0,20190327,20191210,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"GOUVEIA C. C, DUQUE S. CAMPOS L. LIPOTHYMIA DUE TO HYPOVOLAEMIA - A CASE OF IATROGENESIS TO EMPAGLIFLOZINE. REVISTA PORTUGUESA DE DIABETES. 2019;14 (1):74-P050",71.0,YR,,M,Y,,,20191210.0,,MD,PT,PT,2019,Q4,Elderly
161236886,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q4,Presyncope,,2019,Q4,6,F,2018.0,20191203.0,20190327,20191210,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"GOUVEIA C. C, DUQUE S. CAMPOS L. LIPOTHYMIA DUE TO HYPOVOLAEMIA - A CASE OF IATROGENESIS TO EMPAGLIFLOZINE. REVISTA PORTUGUESA DE DIABETES. 2019;14 (1):74-P050",71.0,YR,,M,Y,,,20191210.0,,MD,PT,PT,2019,Q4,Elderly
161236886,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q4,Skin disorder,,2019,Q4,6,F,2018.0,20191203.0,20190327,20191210,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"GOUVEIA C. C, DUQUE S. CAMPOS L. LIPOTHYMIA DUE TO HYPOVOLAEMIA - A CASE OF IATROGENESIS TO EMPAGLIFLOZINE. REVISTA PORTUGUESA DE DIABETES. 2019;14 (1):74-P050",71.0,YR,,M,Y,,,20191210.0,,MD,PT,PT,2019,Q4,Elderly
161236886,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q4,Syncope,,2019,Q4,6,F,2018.0,20191203.0,20190327,20191210,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"GOUVEIA C. C, DUQUE S. CAMPOS L. LIPOTHYMIA DUE TO HYPOVOLAEMIA - A CASE OF IATROGENESIS TO EMPAGLIFLOZINE. REVISTA PORTUGUESA DE DIABETES. 2019;14 (1):74-P050",71.0,YR,,M,Y,,,20191210.0,,MD,PT,PT,2019,Q4,Elderly
161607623,16160762,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,0-5 UNITS AND MILD CORRECTIVE SCALE,,,,,,,,,,,,2019,Q4,Pneumonia cytomegaloviral,,2019,Q4,3,F,20190323.0,20191026.0,20190405,20191108,EXP,,US-ROCHE-2292788,ROCHE,,68.0,YR,,M,Y,82.17,KG,20191108.0,,MD,US,US,2019,Q4,Elderly
161607623,16160762,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,0-5 UNITS AND MILD CORRECTIVE SCALE,,,,,,,,,,,,2019,Q4,Pneumonia pseudomonal,,2019,Q4,3,F,20190323.0,20191026.0,20190405,20191108,EXP,,US-ROCHE-2292788,ROCHE,,68.0,YR,,M,Y,82.17,KG,20191108.0,,MD,US,US,2019,Q4,Elderly
161607623,16160762,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,0-5 UNITS AND MILD CORRECTIVE SCALE,,,,,,,,,,,,2019,Q4,Respiratory tract infection,,2019,Q4,3,F,20190323.0,20191026.0,20190405,20191108,EXP,,US-ROCHE-2292788,ROCHE,,68.0,YR,,M,Y,82.17,KG,20191108.0,,MD,US,US,2019,Q4,Elderly
161986573,16198657,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNKNOWN,,,,,,,,,,,,2019,Q4,Pleural effusion,,2019,Q4,3,F,20180831.0,20191111.0,20190415,20191114,EXP,,DE-MYLANLABS-2019M1034722,MYLAN,,77.0,YR,,F,Y,,,20191114.0,,MD,DE,DE,2019,Q4,Elderly
161997666,16199766,11,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2019,Q4,Cutaneous sarcoidosis,,2019,Q4,6,F,20190404.0,20191121.0,20190415,20191127,EXP,,BR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-036992,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,96.0,KG,20191127.0,,OT,BR,BR,2019,Q4,Elderly
161997666,16199766,11,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2019,Q4,Epiglottic oedema,,2019,Q4,6,F,20190404.0,20191121.0,20190415,20191127,EXP,,BR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-036992,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,96.0,KG,20191127.0,,OT,BR,BR,2019,Q4,Elderly
162176972,16217697,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q4,Device operational issue,,2019,Q4,2,F,,20191122.0,20190419,20191127,PER,,US-SA-2019SA108401,SANOFI AVENTIS,,74.0,YR,E,F,Y,,,20191127.0,,CN,US,US,2019,Q4,Elderly
162176972,16217697,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q4,Glycosylated haemoglobin increased,,2019,Q4,2,F,,20191122.0,20190419,20191127,PER,,US-SA-2019SA108401,SANOFI AVENTIS,,74.0,YR,E,F,Y,,,20191127.0,,CN,US,US,2019,Q4,Elderly
162176972,16217697,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q4,Inappropriate schedule of product administration,,2019,Q4,2,F,,20191122.0,20190419,20191127,PER,,US-SA-2019SA108401,SANOFI AVENTIS,,74.0,YR,E,F,Y,,,20191127.0,,CN,US,US,2019,Q4,Elderly
162176972,16217697,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q4,Injury associated with device,,2019,Q4,2,F,,20191122.0,20190419,20191127,PER,,US-SA-2019SA108401,SANOFI AVENTIS,,74.0,YR,E,F,Y,,,20191127.0,,CN,US,US,2019,Q4,Elderly
162176972,16217697,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q4,Product dose omission,,2019,Q4,2,F,,20191122.0,20190419,20191127,PER,,US-SA-2019SA108401,SANOFI AVENTIS,,74.0,YR,E,F,Y,,,20191127.0,,CN,US,US,2019,Q4,Elderly
162176972,16217697,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q4,Product storage error,,2019,Q4,2,F,,20191122.0,20190419,20191127,PER,,US-SA-2019SA108401,SANOFI AVENTIS,,74.0,YR,E,F,Y,,,20191127.0,,CN,US,US,2019,Q4,Elderly
162405145,16240514,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DOSAGE FORM,,,U,U,,,,300.0,DF,INJECTION,,2019,Q4,Acute kidney injury,,2019,Q4,5,F,20180419.0,20191209.0,20190425,20191213,EXP,,DE-MYLANLABS-2019M1037770,MYLAN,,71.0,YR,,M,Y,,,20191213.0,,MD,DE,DE,2019,Q4,Elderly
162405145,16240514,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DOSAGE FORM,,,U,U,,,,300.0,DF,INJECTION,,2019,Q4,Colitis,,2019,Q4,5,F,20180419.0,20191209.0,20190425,20191213,EXP,,DE-MYLANLABS-2019M1037770,MYLAN,,71.0,YR,,M,Y,,,20191213.0,,MD,DE,DE,2019,Q4,Elderly
162405145,16240514,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DOSAGE FORM,,,U,U,,,,300.0,DF,INJECTION,,2019,Q4,Device related infection,,2019,Q4,5,F,20180419.0,20191209.0,20190425,20191213,EXP,,DE-MYLANLABS-2019M1037770,MYLAN,,71.0,YR,,M,Y,,,20191213.0,,MD,DE,DE,2019,Q4,Elderly
162405145,16240514,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DOSAGE FORM,,,U,U,,,,300.0,DF,INJECTION,,2019,Q4,Heparin-induced thrombocytopenia,,2019,Q4,5,F,20180419.0,20191209.0,20190425,20191213,EXP,,DE-MYLANLABS-2019M1037770,MYLAN,,71.0,YR,,M,Y,,,20191213.0,,MD,DE,DE,2019,Q4,Elderly
162405145,16240514,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DOSAGE FORM,,,U,U,,,,300.0,DF,INJECTION,,2019,Q4,Hyperglycaemia,,2019,Q4,5,F,20180419.0,20191209.0,20190425,20191213,EXP,,DE-MYLANLABS-2019M1037770,MYLAN,,71.0,YR,,M,Y,,,20191213.0,,MD,DE,DE,2019,Q4,Elderly
162405145,16240514,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DOSAGE FORM,,,U,U,,,,300.0,DF,INJECTION,,2019,Q4,Malignant neoplasm progression,,2019,Q4,5,F,20180419.0,20191209.0,20190425,20191213,EXP,,DE-MYLANLABS-2019M1037770,MYLAN,,71.0,YR,,M,Y,,,20191213.0,,MD,DE,DE,2019,Q4,Elderly
162405145,16240514,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DOSAGE FORM,,,U,U,,,,300.0,DF,INJECTION,,2019,Q4,Meningitis,,2019,Q4,5,F,20180419.0,20191209.0,20190425,20191213,EXP,,DE-MYLANLABS-2019M1037770,MYLAN,,71.0,YR,,M,Y,,,20191213.0,,MD,DE,DE,2019,Q4,Elderly
162405145,16240514,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DOSAGE FORM,,,U,U,,,,300.0,DF,INJECTION,,2019,Q4,Metastases to meninges,,2019,Q4,5,F,20180419.0,20191209.0,20190425,20191213,EXP,,DE-MYLANLABS-2019M1037770,MYLAN,,71.0,YR,,M,Y,,,20191213.0,,MD,DE,DE,2019,Q4,Elderly
162405145,16240514,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DOSAGE FORM,,,U,U,,,,300.0,DF,INJECTION,,2019,Q4,Retinal detachment,,2019,Q4,5,F,20180419.0,20191209.0,20190425,20191213,EXP,,DE-MYLANLABS-2019M1037770,MYLAN,,71.0,YR,,M,Y,,,20191213.0,,MD,DE,DE,2019,Q4,Elderly
162405145,16240514,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DOSAGE FORM,,,U,U,,,,300.0,DF,INJECTION,,2019,Q4,Retinopathy,,2019,Q4,5,F,20180419.0,20191209.0,20190425,20191213,EXP,,DE-MYLANLABS-2019M1037770,MYLAN,,71.0,YR,,M,Y,,,20191213.0,,MD,DE,DE,2019,Q4,Elderly
162405145,16240514,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 DOSAGE FORM,,,U,U,,,,300.0,DF,INJECTION,,2019,Q4,Urosepsis,,2019,Q4,5,F,20180419.0,20191209.0,20190425,20191213,EXP,,DE-MYLANLABS-2019M1037770,MYLAN,,71.0,YR,,M,Y,,,20191213.0,,MD,DE,DE,2019,Q4,Elderly
162535923,16253592,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Diabetes mellitus inadequate control,,2019,Q4,3,F,2017.0,20191011.0,20190430,20191031,EXP,,CZ-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-041668,BRISTOL MYERS SQUIBB,TUHACKOVA M. ATYPICAL HYPOGLYCEMIA IN A TYPE 2 DIABETIC TREATED WITH ORAL ANTIDIABETICS. KAZUISTIKY V DIABETOLOGII. 2019;1:6-7,63.0,YR,,M,Y,,,20191031.0,,OT,CZ,CZ,2019,Q4,Adult
162535923,16253592,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Glycosylated haemoglobin increased,,2019,Q4,3,F,2017.0,20191011.0,20190430,20191031,EXP,,CZ-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-041668,BRISTOL MYERS SQUIBB,TUHACKOVA M. ATYPICAL HYPOGLYCEMIA IN A TYPE 2 DIABETIC TREATED WITH ORAL ANTIDIABETICS. KAZUISTIKY V DIABETOLOGII. 2019;1:6-7,63.0,YR,,M,Y,,,20191031.0,,OT,CZ,CZ,2019,Q4,Adult
162535923,16253592,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Hypoglycaemia,,2019,Q4,3,F,2017.0,20191011.0,20190430,20191031,EXP,,CZ-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-041668,BRISTOL MYERS SQUIBB,TUHACKOVA M. ATYPICAL HYPOGLYCEMIA IN A TYPE 2 DIABETIC TREATED WITH ORAL ANTIDIABETICS. KAZUISTIKY V DIABETOLOGII. 2019;1:6-7,63.0,YR,,M,Y,,,20191031.0,,OT,CZ,CZ,2019,Q4,Adult
162543565,16254356,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Arrhythmia,,2019,Q4,5,F,20190415.0,20191009.0,20190430,20191018,EXP,,JP-ACTELION-A-CH2019-189687,ACTELION,,51.0,YR,,M,Y,71.2,KG,20191018.0,,MD,JP,JP,2019,Q4,Adult
162543565,16254356,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Ascites,,2019,Q4,5,F,20190415.0,20191009.0,20190430,20191018,EXP,,JP-ACTELION-A-CH2019-189687,ACTELION,,51.0,YR,,M,Y,71.2,KG,20191018.0,,MD,JP,JP,2019,Q4,Adult
162543565,16254356,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Condition aggravated,,2019,Q4,5,F,20190415.0,20191009.0,20190430,20191018,EXP,,JP-ACTELION-A-CH2019-189687,ACTELION,,51.0,YR,,M,Y,71.2,KG,20191018.0,,MD,JP,JP,2019,Q4,Adult
162543565,16254356,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Fall,,2019,Q4,5,F,20190415.0,20191009.0,20190430,20191018,EXP,,JP-ACTELION-A-CH2019-189687,ACTELION,,51.0,YR,,M,Y,71.2,KG,20191018.0,,MD,JP,JP,2019,Q4,Adult
162543565,16254356,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Oedema,,2019,Q4,5,F,20190415.0,20191009.0,20190430,20191018,EXP,,JP-ACTELION-A-CH2019-189687,ACTELION,,51.0,YR,,M,Y,71.2,KG,20191018.0,,MD,JP,JP,2019,Q4,Adult
162543565,16254356,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Pulmonary arterial hypertension,,2019,Q4,5,F,20190415.0,20191009.0,20190430,20191018,EXP,,JP-ACTELION-A-CH2019-189687,ACTELION,,51.0,YR,,M,Y,71.2,KG,20191018.0,,MD,JP,JP,2019,Q4,Adult
163314523,16331452,3,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,209196.0,,,,,2019,Q4,Acute kidney injury,,2019,Q4,3,F,2018.0,20190514.0,20190520,20191210,EXP,,PT-SA-2019SA132016,SANOFI AVENTIS,"GOUVEIA C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,E,M,Y,,,20191210.0,,,COUNTRY NOT SPECIFIED,PT,2019,Q4,Elderly
163314523,16331452,3,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,209196.0,,,,,2019,Q4,Arrhythmia,,2019,Q4,3,F,2018.0,20190514.0,20190520,20191210,EXP,,PT-SA-2019SA132016,SANOFI AVENTIS,"GOUVEIA C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,E,M,Y,,,20191210.0,,,COUNTRY NOT SPECIFIED,PT,2019,Q4,Elderly
163314523,16331452,3,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,209196.0,,,,,2019,Q4,Atrial fibrillation,,2019,Q4,3,F,2018.0,20190514.0,20190520,20191210,EXP,,PT-SA-2019SA132016,SANOFI AVENTIS,"GOUVEIA C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,E,M,Y,,,20191210.0,,,COUNTRY NOT SPECIFIED,PT,2019,Q4,Elderly
163314523,16331452,3,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,209196.0,,,,,2019,Q4,Bradycardia,,2019,Q4,3,F,2018.0,20190514.0,20190520,20191210,EXP,,PT-SA-2019SA132016,SANOFI AVENTIS,"GOUVEIA C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,E,M,Y,,,20191210.0,,,COUNTRY NOT SPECIFIED,PT,2019,Q4,Elderly
163314523,16331452,3,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,209196.0,,,,,2019,Q4,Dehydration,,2019,Q4,3,F,2018.0,20190514.0,20190520,20191210,EXP,,PT-SA-2019SA132016,SANOFI AVENTIS,"GOUVEIA C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,E,M,Y,,,20191210.0,,,COUNTRY NOT SPECIFIED,PT,2019,Q4,Elderly
163314523,16331452,3,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,209196.0,,,,,2019,Q4,Dizziness,,2019,Q4,3,F,2018.0,20190514.0,20190520,20191210,EXP,,PT-SA-2019SA132016,SANOFI AVENTIS,"GOUVEIA C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,E,M,Y,,,20191210.0,,,COUNTRY NOT SPECIFIED,PT,2019,Q4,Elderly
163314523,16331452,3,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,209196.0,,,,,2019,Q4,Haematocrit increased,,2019,Q4,3,F,2018.0,20190514.0,20190520,20191210,EXP,,PT-SA-2019SA132016,SANOFI AVENTIS,"GOUVEIA C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,E,M,Y,,,20191210.0,,,COUNTRY NOT SPECIFIED,PT,2019,Q4,Elderly
163314523,16331452,3,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,209196.0,,,,,2019,Q4,Haemoglobin increased,,2019,Q4,3,F,2018.0,20190514.0,20190520,20191210,EXP,,PT-SA-2019SA132016,SANOFI AVENTIS,"GOUVEIA C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,E,M,Y,,,20191210.0,,,COUNTRY NOT SPECIFIED,PT,2019,Q4,Elderly
163314523,16331452,3,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,209196.0,,,,,2019,Q4,Hypotension,,2019,Q4,3,F,2018.0,20190514.0,20190520,20191210,EXP,,PT-SA-2019SA132016,SANOFI AVENTIS,"GOUVEIA C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,E,M,Y,,,20191210.0,,,COUNTRY NOT SPECIFIED,PT,2019,Q4,Elderly
163314523,16331452,3,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,209196.0,,,,,2019,Q4,Hypovolaemia,,2019,Q4,3,F,2018.0,20190514.0,20190520,20191210,EXP,,PT-SA-2019SA132016,SANOFI AVENTIS,"GOUVEIA C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,E,M,Y,,,20191210.0,,,COUNTRY NOT SPECIFIED,PT,2019,Q4,Elderly
163314523,16331452,3,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,209196.0,,,,,2019,Q4,Left atrial dilatation,,2019,Q4,3,F,2018.0,20190514.0,20190520,20191210,EXP,,PT-SA-2019SA132016,SANOFI AVENTIS,"GOUVEIA C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,E,M,Y,,,20191210.0,,,COUNTRY NOT SPECIFIED,PT,2019,Q4,Elderly
163314523,16331452,3,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,209196.0,,,,,2019,Q4,Mucosal dryness,,2019,Q4,3,F,2018.0,20190514.0,20190520,20191210,EXP,,PT-SA-2019SA132016,SANOFI AVENTIS,"GOUVEIA C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,E,M,Y,,,20191210.0,,,COUNTRY NOT SPECIFIED,PT,2019,Q4,Elderly
163314523,16331452,3,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,209196.0,,,,,2019,Q4,Presyncope,,2019,Q4,3,F,2018.0,20190514.0,20190520,20191210,EXP,,PT-SA-2019SA132016,SANOFI AVENTIS,"GOUVEIA C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,E,M,Y,,,20191210.0,,,COUNTRY NOT SPECIFIED,PT,2019,Q4,Elderly
163314523,16331452,3,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,209196.0,,,,,2019,Q4,Skin disorder,,2019,Q4,3,F,2018.0,20190514.0,20190520,20191210,EXP,,PT-SA-2019SA132016,SANOFI AVENTIS,"GOUVEIA C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,E,M,Y,,,20191210.0,,,COUNTRY NOT SPECIFIED,PT,2019,Q4,Elderly
163314523,16331452,3,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,209196.0,,,,,2019,Q4,Syncope,,2019,Q4,3,F,2018.0,20190514.0,20190520,20191210,EXP,,PT-SA-2019SA132016,SANOFI AVENTIS,"GOUVEIA C., DUQUE S., CAMPOS L.. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN?. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,E,M,Y,,,20191210.0,,,COUNTRY NOT SPECIFIED,PT,2019,Q4,Elderly
163358452,16335845,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"70 U, QD",,,,,,,209196.0,,,SOLUTION FOR INJECTION,QD,2019,Q4,Adverse event,,2019,Q4,2,F,1970.0,20191125.0,20190521,20191204,EXP,,US-SA-2019SA130757,SANOFI AVENTIS,,68.0,YR,E,M,Y,,,20191205.0,,CN,US,US,2019,Q4,Elderly
163358452,16335845,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"70 U, QD",,,,,,,209196.0,,,SOLUTION FOR INJECTION,QD,2019,Q4,Diabetes mellitus inadequate control,,2019,Q4,2,F,1970.0,20191125.0,20190521,20191204,EXP,,US-SA-2019SA130757,SANOFI AVENTIS,,68.0,YR,E,M,Y,,,20191205.0,,CN,US,US,2019,Q4,Elderly
163358452,16335845,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"70 U, QD",,,,,,,209196.0,,,SOLUTION FOR INJECTION,QD,2019,Q4,Disability,,2019,Q4,2,F,1970.0,20191125.0,20190521,20191204,EXP,,US-SA-2019SA130757,SANOFI AVENTIS,,68.0,YR,E,M,Y,,,20191205.0,,CN,US,US,2019,Q4,Elderly
163358452,16335845,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"70 U, QD",,,,,,,209196.0,,,SOLUTION FOR INJECTION,QD,2019,Q4,Hypertension,,2019,Q4,2,F,1970.0,20191125.0,20190521,20191204,EXP,,US-SA-2019SA130757,SANOFI AVENTIS,,68.0,YR,E,M,Y,,,20191205.0,,CN,US,US,2019,Q4,Elderly
163358452,16335845,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"70 U, QD",,,,,,,209196.0,,,SOLUTION FOR INJECTION,QD,2019,Q4,Hypoacusis,,2019,Q4,2,F,1970.0,20191125.0,20190521,20191204,EXP,,US-SA-2019SA130757,SANOFI AVENTIS,,68.0,YR,E,M,Y,,,20191205.0,,CN,US,US,2019,Q4,Elderly
163358452,16335845,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"70 U, QD",,,,,,,209196.0,,,SOLUTION FOR INJECTION,QD,2019,Q4,Insulin resistance,,2019,Q4,2,F,1970.0,20191125.0,20190521,20191204,EXP,,US-SA-2019SA130757,SANOFI AVENTIS,,68.0,YR,E,M,Y,,,20191205.0,,CN,US,US,2019,Q4,Elderly
163358452,16335845,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"70 U, QD",,,,,,,209196.0,,,SOLUTION FOR INJECTION,QD,2019,Q4,Loss of consciousness,,2019,Q4,2,F,1970.0,20191125.0,20190521,20191204,EXP,,US-SA-2019SA130757,SANOFI AVENTIS,,68.0,YR,E,M,Y,,,20191205.0,,CN,US,US,2019,Q4,Elderly
163358452,16335845,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"70 U, QD",,,,,,,209196.0,,,SOLUTION FOR INJECTION,QD,2019,Q4,Nervousness,,2019,Q4,2,F,1970.0,20191125.0,20190521,20191204,EXP,,US-SA-2019SA130757,SANOFI AVENTIS,,68.0,YR,E,M,Y,,,20191205.0,,CN,US,US,2019,Q4,Elderly
163358452,16335845,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"70 U, QD",,,,,,,209196.0,,,SOLUTION FOR INJECTION,QD,2019,Q4,Pain,,2019,Q4,2,F,1970.0,20191125.0,20190521,20191204,EXP,,US-SA-2019SA130757,SANOFI AVENTIS,,68.0,YR,E,M,Y,,,20191205.0,,CN,US,US,2019,Q4,Elderly
163358452,16335845,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"70 U, QD",,,,,,,209196.0,,,SOLUTION FOR INJECTION,QD,2019,Q4,Road traffic accident,,2019,Q4,2,F,1970.0,20191125.0,20190521,20191204,EXP,,US-SA-2019SA130757,SANOFI AVENTIS,,68.0,YR,E,M,Y,,,20191205.0,,CN,US,US,2019,Q4,Elderly
163358452,16335845,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"70 U, QD",,,,,,,209196.0,,,SOLUTION FOR INJECTION,QD,2019,Q4,Unevaluable event,,2019,Q4,2,F,1970.0,20191125.0,20190521,20191204,EXP,,US-SA-2019SA130757,SANOFI AVENTIS,,68.0,YR,E,M,Y,,,20191205.0,,CN,US,US,2019,Q4,Elderly
163668742,16366874,30,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Acute kidney injury,,2019,Q4,2,F,20160713.0,20191017.0,20190529,20191025,EXP,,US-ASTRAZENECA-2019SE78241,ASTRAZENECA,,24503.0,DY,,M,Y,,,20191025.0,,,US,US,2019,Q4,Elderly
163668742,16366874,30,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Chronic kidney disease,,2019,Q4,2,F,20160713.0,20191017.0,20190529,20191025,EXP,,US-ASTRAZENECA-2019SE78241,ASTRAZENECA,,24503.0,DY,,M,Y,,,20191025.0,,,US,US,2019,Q4,Elderly
163668742,16366874,30,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Renal failure,,2019,Q4,2,F,20160713.0,20191017.0,20190529,20191025,EXP,,US-ASTRAZENECA-2019SE78241,ASTRAZENECA,,24503.0,DY,,M,Y,,,20191025.0,,,US,US,2019,Q4,Elderly
163881482,16388148,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0-10 UNITS,,,,,,,,,,,,2019,Q4,Bacteraemia,,2019,Q4,2,F,20180206.0,20191001.0,20190604,20191009,EXP,,US-ROCHE-2072922,ROCHE,,67.0,YR,,M,Y,94.1,KG,20191009.0,,MD,US,US,2019,Q4,Elderly
163881482,16388148,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0-10 UNITS,,,,,,,,,,,,2019,Q4,Device related sepsis,,2019,Q4,2,F,20180206.0,20191001.0,20190604,20191009,EXP,,US-ROCHE-2072922,ROCHE,,67.0,YR,,M,Y,94.1,KG,20191009.0,,MD,US,US,2019,Q4,Elderly
163881482,16388148,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0-10 UNITS,,,,,,,,,,,,2019,Q4,Pyrexia,,2019,Q4,2,F,20180206.0,20191001.0,20190604,20191009,EXP,,US-ROCHE-2072922,ROCHE,,67.0,YR,,M,Y,94.1,KG,20191009.0,,MD,US,US,2019,Q4,Elderly
164010533,16401053,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,INJECTION,,2019,Q4,Cellulitis,,2019,Q4,3,F,20181025.0,20191025.0,20190606,20191031,EXP,,GB-GILEAD-2019-0412193,GILEAD,,85.0,YR,E,M,Y,,,20191031.0,,CN,GB,GB,2019,Q4,Elderly
164545816,16454581,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2019,Q4,Arthritis,,2019,Q4,6,F,20181209.0,20191225.0,20190619,20191231,EXP,,SE-MYLANLABS-2019M1057100,MYLAN,,82.0,YR,,M,Y,80.0,KG,20191231.0,,OT,SE,SE,2019,Q4,Elderly
164545816,16454581,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2019,Q4,Dysphagia,,2019,Q4,6,F,20181209.0,20191225.0,20190619,20191231,EXP,,SE-MYLANLABS-2019M1057100,MYLAN,,82.0,YR,,M,Y,80.0,KG,20191231.0,,OT,SE,SE,2019,Q4,Elderly
164545816,16454581,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2019,Q4,Dyspnoea,,2019,Q4,6,F,20181209.0,20191225.0,20190619,20191231,EXP,,SE-MYLANLABS-2019M1057100,MYLAN,,82.0,YR,,M,Y,80.0,KG,20191231.0,,OT,SE,SE,2019,Q4,Elderly
164545816,16454581,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2019,Q4,Fall,,2019,Q4,6,F,20181209.0,20191225.0,20190619,20191231,EXP,,SE-MYLANLABS-2019M1057100,MYLAN,,82.0,YR,,M,Y,80.0,KG,20191231.0,,OT,SE,SE,2019,Q4,Elderly
164545816,16454581,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2019,Q4,Pain in extremity,,2019,Q4,6,F,20181209.0,20191225.0,20190619,20191231,EXP,,SE-MYLANLABS-2019M1057100,MYLAN,,82.0,YR,,M,Y,80.0,KG,20191231.0,,OT,SE,SE,2019,Q4,Elderly
164545816,16454581,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2019,Q4,Scratch,,2019,Q4,6,F,20181209.0,20191225.0,20190619,20191231,EXP,,SE-MYLANLABS-2019M1057100,MYLAN,,82.0,YR,,M,Y,80.0,KG,20191231.0,,OT,SE,SE,2019,Q4,Elderly
164545816,16454581,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2019,Q4,Subarachnoid haemorrhage,,2019,Q4,6,F,20181209.0,20191225.0,20190619,20191231,EXP,,SE-MYLANLABS-2019M1057100,MYLAN,,82.0,YR,,M,Y,80.0,KG,20191231.0,,OT,SE,SE,2019,Q4,Elderly
164545816,16454581,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2019,Q4,Tachycardia,,2019,Q4,6,F,20181209.0,20191225.0,20190619,20191231,EXP,,SE-MYLANLABS-2019M1057100,MYLAN,,82.0,YR,,M,Y,80.0,KG,20191231.0,,OT,SE,SE,2019,Q4,Elderly
164735483,16473548,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,INJECTION,,2019,Q4,Cellulitis,,2019,Q4,3,F,20181025.0,20191113.0,20190625,20191119,EXP,,GB-PFIZER INC-2019259879,PFIZER,,85.0,YR,,M,Y,,,20191119.0,,MD,GB,GB,2019,Q4,Elderly
166512722,16651272,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"17.5 IU, QD",,,Y,,,,,17.5,IU,SOLUTION FOR INJECTION,QD,2019,Q4,Hypoglycaemia,,2019,Q4,2,F,20190501.0,20191023.0,20190731,20191028,EXP,IT-MINISAL02-564849,IT-SA-2019SA202653,SANOFI AVENTIS,,11.0,YR,C,F,Y,39.0,KG,20191028.0,,MD,IT,IT,2019,Q4,Child
166512722,16651272,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"17.5 IU, QD",,,Y,,,,,17.5,IU,SOLUTION FOR INJECTION,QD,2019,Q4,Salivary hypersecretion,,2019,Q4,2,F,20190501.0,20191023.0,20190731,20191028,EXP,IT-MINISAL02-564849,IT-SA-2019SA202653,SANOFI AVENTIS,,11.0,YR,C,F,Y,39.0,KG,20191028.0,,MD,IT,IT,2019,Q4,Child
166512722,16651272,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"17.5 IU, QD",,,Y,,,,,17.5,IU,SOLUTION FOR INJECTION,QD,2019,Q4,Tremor,,2019,Q4,2,F,20190501.0,20191023.0,20190731,20191028,EXP,IT-MINISAL02-564849,IT-SA-2019SA202653,SANOFI AVENTIS,,11.0,YR,C,F,Y,39.0,KG,20191028.0,,MD,IT,IT,2019,Q4,Child
166512722,16651272,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"17.5 IU, QD",,,Y,,,,,17.5,IU,SOLUTION FOR INJECTION,QD,2019,Q4,Trismus,,2019,Q4,2,F,20190501.0,20191023.0,20190731,20191028,EXP,IT-MINISAL02-564849,IT-SA-2019SA202653,SANOFI AVENTIS,,11.0,YR,C,F,Y,39.0,KG,20191028.0,,MD,IT,IT,2019,Q4,Child
166512722,16651272,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"17.5 IU, QD",,,Y,,,,,17.5,IU,SOLUTION FOR INJECTION,QD,2019,Q4,Unresponsive to stimuli,,2019,Q4,2,F,20190501.0,20191023.0,20190731,20191028,EXP,IT-MINISAL02-564849,IT-SA-2019SA202653,SANOFI AVENTIS,,11.0,YR,C,F,Y,39.0,KG,20191028.0,,MD,IT,IT,2019,Q4,Child
166619023,16661902,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Abdominal pain upper,,2019,Q4,3,F,20190212.0,20191210.0,20190802,20191219,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20191219.0,,MD,DE,DE,2019,Q4,Elderly
166619023,16661902,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Amylase increased,,2019,Q4,3,F,20190212.0,20191210.0,20190802,20191219,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20191219.0,,MD,DE,DE,2019,Q4,Elderly
166619023,16661902,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Arthralgia,,2019,Q4,3,F,20190212.0,20191210.0,20190802,20191219,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20191219.0,,MD,DE,DE,2019,Q4,Elderly
166619023,16661902,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Blood creatine phosphokinase MB increased,,2019,Q4,3,F,20190212.0,20191210.0,20190802,20191219,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20191219.0,,MD,DE,DE,2019,Q4,Elderly
166619023,16661902,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Blood creatine phosphokinase increased,,2019,Q4,3,F,20190212.0,20191210.0,20190802,20191219,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20191219.0,,MD,DE,DE,2019,Q4,Elderly
166619023,16661902,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Bronchitis,,2019,Q4,3,F,20190212.0,20191210.0,20190802,20191219,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20191219.0,,MD,DE,DE,2019,Q4,Elderly
166619023,16661902,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Chest pain,,2019,Q4,3,F,20190212.0,20191210.0,20190802,20191219,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20191219.0,,MD,DE,DE,2019,Q4,Elderly
166619023,16661902,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Connective tissue disorder,,2019,Q4,3,F,20190212.0,20191210.0,20190802,20191219,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20191219.0,,MD,DE,DE,2019,Q4,Elderly
166619023,16661902,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Dry eye,,2019,Q4,3,F,20190212.0,20191210.0,20190802,20191219,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20191219.0,,MD,DE,DE,2019,Q4,Elderly
166619023,16661902,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Dry mouth,,2019,Q4,3,F,20190212.0,20191210.0,20190802,20191219,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20191219.0,,MD,DE,DE,2019,Q4,Elderly
166619023,16661902,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Dry skin,,2019,Q4,3,F,20190212.0,20191210.0,20190802,20191219,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20191219.0,,MD,DE,DE,2019,Q4,Elderly
166619023,16661902,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Embolism,,2019,Q4,3,F,20190212.0,20191210.0,20190802,20191219,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20191219.0,,MD,DE,DE,2019,Q4,Elderly
166619023,16661902,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Headache,,2019,Q4,3,F,20190212.0,20191210.0,20190802,20191219,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20191219.0,,MD,DE,DE,2019,Q4,Elderly
166619023,16661902,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Hyperglycaemia,,2019,Q4,3,F,20190212.0,20191210.0,20190802,20191219,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20191219.0,,MD,DE,DE,2019,Q4,Elderly
166619023,16661902,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Myocardial infarction,,2019,Q4,3,F,20190212.0,20191210.0,20190802,20191219,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20191219.0,,MD,DE,DE,2019,Q4,Elderly
166619023,16661902,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Nausea,,2019,Q4,3,F,20190212.0,20191210.0,20190802,20191219,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20191219.0,,MD,DE,DE,2019,Q4,Elderly
166619023,16661902,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Pain,,2019,Q4,3,F,20190212.0,20191210.0,20190802,20191219,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20191219.0,,MD,DE,DE,2019,Q4,Elderly
166619023,16661902,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Pain in extremity,,2019,Q4,3,F,20190212.0,20191210.0,20190802,20191219,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20191219.0,,MD,DE,DE,2019,Q4,Elderly
166619023,16661902,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Paraesthesia,,2019,Q4,3,F,20190212.0,20191210.0,20190802,20191219,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20191219.0,,MD,DE,DE,2019,Q4,Elderly
166619023,16661902,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Prescribed underdose,,2019,Q4,3,F,20190212.0,20191210.0,20190802,20191219,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20191219.0,,MD,DE,DE,2019,Q4,Elderly
166619023,16661902,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Pruritus,,2019,Q4,3,F,20190212.0,20191210.0,20190802,20191219,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20191219.0,,MD,DE,DE,2019,Q4,Elderly
166619023,16661902,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Skin disorder,,2019,Q4,3,F,20190212.0,20191210.0,20190802,20191219,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20191219.0,,MD,DE,DE,2019,Q4,Elderly
166619023,16661902,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Skin fissures,,2019,Q4,3,F,20190212.0,20191210.0,20190802,20191219,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-033015,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20191219.0,,MD,DE,DE,2019,Q4,Elderly
166710763,16671076,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2019,Q4,Acute lymphocytic leukaemia recurrent,,2019,Q4,3,F,201902.0,20191113.0,20190805,20191118,EXP,,US-TAKEDA-2019TUS031931,TAKEDA,,47.0,YR,,M,Y,,,20191118.0,,CN,US,US,2019,Q4,Adult
166710763,16671076,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2019,Q4,Bone pain,,2019,Q4,3,F,201902.0,20191113.0,20190805,20191118,EXP,,US-TAKEDA-2019TUS031931,TAKEDA,,47.0,YR,,M,Y,,,20191118.0,,CN,US,US,2019,Q4,Adult
166710763,16671076,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2019,Q4,Catheter site infection,,2019,Q4,3,F,201902.0,20191113.0,20190805,20191118,EXP,,US-TAKEDA-2019TUS031931,TAKEDA,,47.0,YR,,M,Y,,,20191118.0,,CN,US,US,2019,Q4,Adult
166710763,16671076,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2019,Q4,Deep vein thrombosis,,2019,Q4,3,F,201902.0,20191113.0,20190805,20191118,EXP,,US-TAKEDA-2019TUS031931,TAKEDA,,47.0,YR,,M,Y,,,20191118.0,,CN,US,US,2019,Q4,Adult
166710763,16671076,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2019,Q4,Herpes virus infection,,2019,Q4,3,F,201902.0,20191113.0,20190805,20191118,EXP,,US-TAKEDA-2019TUS031931,TAKEDA,,47.0,YR,,M,Y,,,20191118.0,,CN,US,US,2019,Q4,Adult
166710763,16671076,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2019,Q4,Meningitis staphylococcal,,2019,Q4,3,F,201902.0,20191113.0,20190805,20191118,EXP,,US-TAKEDA-2019TUS031931,TAKEDA,,47.0,YR,,M,Y,,,20191118.0,,CN,US,US,2019,Q4,Adult
166710763,16671076,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2019,Q4,Neck pain,,2019,Q4,3,F,201902.0,20191113.0,20190805,20191118,EXP,,US-TAKEDA-2019TUS031931,TAKEDA,,47.0,YR,,M,Y,,,20191118.0,,CN,US,US,2019,Q4,Adult
166710763,16671076,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2019,Q4,Night sweats,,2019,Q4,3,F,201902.0,20191113.0,20190805,20191118,EXP,,US-TAKEDA-2019TUS031931,TAKEDA,,47.0,YR,,M,Y,,,20191118.0,,CN,US,US,2019,Q4,Adult
166710763,16671076,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2019,Q4,Pain in extremity,,2019,Q4,3,F,201902.0,20191113.0,20190805,20191118,EXP,,US-TAKEDA-2019TUS031931,TAKEDA,,47.0,YR,,M,Y,,,20191118.0,,CN,US,US,2019,Q4,Adult
166710763,16671076,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2019,Q4,Pulmonary embolism,,2019,Q4,3,F,201902.0,20191113.0,20190805,20191118,EXP,,US-TAKEDA-2019TUS031931,TAKEDA,,47.0,YR,,M,Y,,,20191118.0,,CN,US,US,2019,Q4,Adult
166710763,16671076,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2019,Q4,Sinusitis,,2019,Q4,3,F,201902.0,20191113.0,20190805,20191118,EXP,,US-TAKEDA-2019TUS031931,TAKEDA,,47.0,YR,,M,Y,,,20191118.0,,CN,US,US,2019,Q4,Adult
166710763,16671076,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2019,Q4,Tremor,,2019,Q4,3,F,201902.0,20191113.0,20190805,20191118,EXP,,US-TAKEDA-2019TUS031931,TAKEDA,,47.0,YR,,M,Y,,,20191118.0,,CN,US,US,2019,Q4,Adult
166896572,16689657,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 U SQ TID,,,,,,,,,,,,2019,Q4,Drug ineffective for unapproved indication,,2019,Q4,2,F,201811.0,20191011.0,20190809,20191022,EXP,,US-ACTELION-A-NJ2018-183879,ACTELION,,62.0,YR,,F,Y,,,20191022.0,,PH,US,US,2019,Q4,Adult
166896572,16689657,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 U SQ TID,,,,,,,,,,,,2019,Q4,Dyspnoea,,2019,Q4,2,F,201811.0,20191011.0,20190809,20191022,EXP,,US-ACTELION-A-NJ2018-183879,ACTELION,,62.0,YR,,F,Y,,,20191022.0,,PH,US,US,2019,Q4,Adult
166896572,16689657,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 U SQ TID,,,,,,,,,,,,2019,Q4,Facial paralysis,,2019,Q4,2,F,201811.0,20191011.0,20190809,20191022,EXP,,US-ACTELION-A-NJ2018-183879,ACTELION,,62.0,YR,,F,Y,,,20191022.0,,PH,US,US,2019,Q4,Adult
166896572,16689657,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 U SQ TID,,,,,,,,,,,,2019,Q4,Peripheral nerve palsy,,2019,Q4,2,F,201811.0,20191011.0,20190809,20191022,EXP,,US-ACTELION-A-NJ2018-183879,ACTELION,,62.0,YR,,F,Y,,,20191022.0,,PH,US,US,2019,Q4,Adult
167079172,16707917,28,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2019,Q4,Nervous system disorder,,2019,Q4,2,F,20190403.0,20191212.0,20190815,20191219,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-036715,BRISTOL MYERS SQUIBB,,65.0,YR,,M,Y,68.0,KG,20191219.0,,OT,US,US,2019,Q4,Elderly
167400934,16740093,8,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPENSION,,2,,"(75/25), 2X/DAY,  40 UNITS EVERY MORNING AND 60 UNITS EVERY EVENING)",,,,,,,,,,,BID,2019,Q4,Bradycardia,,2019,Q4,4,F,,20190926.0,20190826,20191003,EXP,,US-PFIZER INC-2019357314,PFIZER,"COOK, R.. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST. AMERICAN JOURNAL OF THERAPEUTICS. 2019;26 (4):10.1097/MJT.0000000000000804",72.0,YR,,F,Y,,,20191003.0,,PH,US,US,2019,Q4,Elderly
167400934,16740093,8,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPENSION,,2,,"(75/25), 2X/DAY,  40 UNITS EVERY MORNING AND 60 UNITS EVERY EVENING)",,,,,,,,,,,BID,2019,Q4,Cardiac arrest,,2019,Q4,4,F,,20190926.0,20190826,20191003,EXP,,US-PFIZER INC-2019357314,PFIZER,"COOK, R.. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST. AMERICAN JOURNAL OF THERAPEUTICS. 2019;26 (4):10.1097/MJT.0000000000000804",72.0,YR,,F,Y,,,20191003.0,,PH,US,US,2019,Q4,Elderly
167400934,16740093,8,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPENSION,,2,,"(75/25), 2X/DAY,  40 UNITS EVERY MORNING AND 60 UNITS EVERY EVENING)",,,,,,,,,,,BID,2019,Q4,Drug interaction,,2019,Q4,4,F,,20190926.0,20190826,20191003,EXP,,US-PFIZER INC-2019357314,PFIZER,"COOK, R.. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST. AMERICAN JOURNAL OF THERAPEUTICS. 2019;26 (4):10.1097/MJT.0000000000000804",72.0,YR,,F,Y,,,20191003.0,,PH,US,US,2019,Q4,Elderly
167400934,16740093,8,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPENSION,,2,,"(75/25), 2X/DAY,  40 UNITS EVERY MORNING AND 60 UNITS EVERY EVENING)",,,,,,,,,,,BID,2019,Q4,Hypotension,,2019,Q4,4,F,,20190926.0,20190826,20191003,EXP,,US-PFIZER INC-2019357314,PFIZER,"COOK, R.. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST. AMERICAN JOURNAL OF THERAPEUTICS. 2019;26 (4):10.1097/MJT.0000000000000804",72.0,YR,,F,Y,,,20191003.0,,PH,US,US,2019,Q4,Elderly
167400934,16740093,8,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPENSION,,2,,"(75/25), 2X/DAY,  40 UNITS EVERY MORNING AND 60 UNITS EVERY EVENING)",,,,,,,,,,,BID,2019,Q4,Pulseless electrical activity,,2019,Q4,4,F,,20190926.0,20190826,20191003,EXP,,US-PFIZER INC-2019357314,PFIZER,"COOK, R.. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST. AMERICAN JOURNAL OF THERAPEUTICS. 2019;26 (4):10.1097/MJT.0000000000000804",72.0,YR,,F,Y,,,20191003.0,,PH,US,US,2019,Q4,Elderly
167419452,16741945,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"34 INTERNATIONAL UNIT, UNKNOWN",,,U,,,,20563.0,34.0,IU,,,2019,Q4,Hyperhidrosis,,2019,Q4,2,F,20190508.0,20191009.0,20190826,20191016,EXP,IT-MINISAL02-568758,IT-ELI_LILLY_AND_COMPANY-IT201908006044,ELI LILLY AND CO,,83.0,YR,,F,Y,,,20191016.0,,CN,IT,IT,2019,Q4,Elderly
167419452,16741945,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"34 INTERNATIONAL UNIT, UNKNOWN",,,U,,,,20563.0,34.0,IU,,,2019,Q4,Hypoglycaemia,,2019,Q4,2,F,20190508.0,20191009.0,20190826,20191016,EXP,IT-MINISAL02-568758,IT-ELI_LILLY_AND_COMPANY-IT201908006044,ELI LILLY AND CO,,83.0,YR,,F,Y,,,20191016.0,,CN,IT,IT,2019,Q4,Elderly
167419452,16741945,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"34 INTERNATIONAL UNIT, UNKNOWN",,,U,,,,20563.0,34.0,IU,,,2019,Q4,Hypokalaemia,,2019,Q4,2,F,20190508.0,20191009.0,20190826,20191016,EXP,IT-MINISAL02-568758,IT-ELI_LILLY_AND_COMPANY-IT201908006044,ELI LILLY AND CO,,83.0,YR,,F,Y,,,20191016.0,,CN,IT,IT,2019,Q4,Elderly
167419452,16741945,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"34 INTERNATIONAL UNIT, UNKNOWN",,,U,,,,20563.0,34.0,IU,,,2019,Q4,Medication error,,2019,Q4,2,F,20190508.0,20191009.0,20190826,20191016,EXP,IT-MINISAL02-568758,IT-ELI_LILLY_AND_COMPANY-IT201908006044,ELI LILLY AND CO,,83.0,YR,,F,Y,,,20191016.0,,CN,IT,IT,2019,Q4,Elderly
167419452,16741945,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"34 INTERNATIONAL UNIT, UNKNOWN",,,U,,,,20563.0,34.0,IU,,,2019,Q4,Oedema,,2019,Q4,2,F,20190508.0,20191009.0,20190826,20191016,EXP,IT-MINISAL02-568758,IT-ELI_LILLY_AND_COMPANY-IT201908006044,ELI LILLY AND CO,,83.0,YR,,F,Y,,,20191016.0,,CN,IT,IT,2019,Q4,Elderly
167419452,16741945,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"34 INTERNATIONAL UNIT, UNKNOWN",,,U,,,,20563.0,34.0,IU,,,2019,Q4,Unresponsive to stimuli,,2019,Q4,2,F,20190508.0,20191009.0,20190826,20191016,EXP,IT-MINISAL02-568758,IT-ELI_LILLY_AND_COMPANY-IT201908006044,ELI LILLY AND CO,,83.0,YR,,F,Y,,,20191016.0,,CN,IT,IT,2019,Q4,Elderly
167419452,16741945,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"34 INTERNATIONAL UNIT, UNKNOWN",,,U,,,,20563.0,34.0,IU,,,2019,Q4,Vomiting,,2019,Q4,2,F,20190508.0,20191009.0,20190826,20191016,EXP,IT-MINISAL02-568758,IT-ELI_LILLY_AND_COMPANY-IT201908006044,ELI LILLY AND CO,,83.0,YR,,F,Y,,,20191016.0,,CN,IT,IT,2019,Q4,Elderly
167490166,16749016,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,INJECT 1-7 UNITS,,,,,,,,,,,,2019,Q4,Blood glucose decreased,,2019,Q4,6,F,201907.0,20191125.0,20190828,20191201,EXP,,US-VERTEX PHARMACEUTICALS-2019-008019,VERTEX,,11.0,YR,,M,Y,40.0,KG,20191201.0,,OT,US,US,2019,Q4,Child
167490166,16749016,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,INJECT 1-7 UNITS,,,,,,,,,,,,2019,Q4,Infective pulmonary exacerbation of cystic fibrosis,,2019,Q4,6,F,201907.0,20191125.0,20190828,20191201,EXP,,US-VERTEX PHARMACEUTICALS-2019-008019,VERTEX,,11.0,YR,,M,Y,40.0,KG,20191201.0,,OT,US,US,2019,Q4,Child
167490166,16749016,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,INJECT 1-7 UNITS,,,,,,,,,,,,2019,Q4,Lower respiratory tract infection,,2019,Q4,6,F,201907.0,20191125.0,20190828,20191201,EXP,,US-VERTEX PHARMACEUTICALS-2019-008019,VERTEX,,11.0,YR,,M,Y,40.0,KG,20191201.0,,OT,US,US,2019,Q4,Child
167514014,16751401,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,25 UNITS-75 UNITS/ML,,,,,,,,,,,,2019,Q4,Infective pulmonary exacerbation of cystic fibrosis,,2019,Q4,4,F,2019.0,20191011.0,20190828,20191021,EXP,,US-VERTEX PHARMACEUTICALS-2019-008040,VERTEX,,18.0,YR,,M,Y,,,20191021.0,,OT,US,US,2019,Q4,Youth
167514014,16751401,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,25 UNITS-75 UNITS/ML,,,,,,,,,,,,2019,Q4,Pneumonia,,2019,Q4,4,F,2019.0,20191011.0,20190828,20191021,EXP,,US-VERTEX PHARMACEUTICALS-2019-008040,VERTEX,,18.0,YR,,M,Y,,,20191021.0,,OT,US,US,2019,Q4,Youth
167541635,16754163,10,C,Lispro,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE,,,,,,,,,,INJECTION,BID,2019,Q4,End stage renal disease,,2019,Q4,5,F,20190821.0,20191022.0,20190829,20191025,EXP,,US-CELGENEUS-USA-20190809382,CELGENE,,62.0,YR,,F,Y,69.01,KG,20191025.0,,MD,US,US,2019,Q4,Adult
167541635,16754163,10,C,Lispro,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE,,,,,,,,,,INJECTION,BID,2019,Q4,Haematocrit decreased,,2019,Q4,5,F,20190821.0,20191022.0,20190829,20191025,EXP,,US-CELGENEUS-USA-20190809382,CELGENE,,62.0,YR,,F,Y,69.01,KG,20191025.0,,MD,US,US,2019,Q4,Adult
167541635,16754163,10,C,Lispro,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE,,,,,,,,,,INJECTION,BID,2019,Q4,Haemoglobin decreased,,2019,Q4,5,F,20190821.0,20191022.0,20190829,20191025,EXP,,US-CELGENEUS-USA-20190809382,CELGENE,,62.0,YR,,F,Y,69.01,KG,20191025.0,,MD,US,US,2019,Q4,Adult
167541635,16754163,10,C,Lispro,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE,,,,,,,,,,INJECTION,BID,2019,Q4,Pneumonia,,2019,Q4,5,F,20190821.0,20191022.0,20190829,20191025,EXP,,US-CELGENEUS-USA-20190809382,CELGENE,,62.0,YR,,F,Y,69.01,KG,20191025.0,,MD,US,US,2019,Q4,Adult
167541635,16754163,10,C,Lispro,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE,,,,,,,,,,INJECTION,BID,2019,Q4,Red blood cell count decreased,,2019,Q4,5,F,20190821.0,20191022.0,20190829,20191025,EXP,,US-CELGENEUS-USA-20190809382,CELGENE,,62.0,YR,,F,Y,69.01,KG,20191025.0,,MD,US,US,2019,Q4,Adult
167541635,16754163,10,C,Lispro,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE,,,,,,,,,,INJECTION,BID,2019,Q4,Sepsis,,2019,Q4,5,F,20190821.0,20191022.0,20190829,20191025,EXP,,US-CELGENEUS-USA-20190809382,CELGENE,,62.0,YR,,F,Y,69.01,KG,20191025.0,,MD,US,US,2019,Q4,Adult
167546111,16754611,3,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Diarrhoea,,2019,Q4,1,I,20190824.0,,20190828,20190828,DIR,,,FDA-CTU,,29.0,YR,,F,N,99.8,KG,20190828.0,N,PH,US,US,2019,Q4,Young Adult
167546111,16754611,3,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Leukopenia,,2019,Q4,1,I,20190824.0,,20190828,20190828,DIR,,,FDA-CTU,,29.0,YR,,F,N,99.8,KG,20190828.0,N,PH,US,US,2019,Q4,Young Adult
167546111,16754611,3,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Nausea,,2019,Q4,1,I,20190824.0,,20190828,20190828,DIR,,,FDA-CTU,,29.0,YR,,F,N,99.8,KG,20190828.0,N,PH,US,US,2019,Q4,Young Adult
167546111,16754611,3,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Neutropenia,,2019,Q4,1,I,20190824.0,,20190828,20190828,DIR,,,FDA-CTU,,29.0,YR,,F,N,99.8,KG,20190828.0,N,PH,US,US,2019,Q4,Young Adult
167546111,16754611,3,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Platelet count decreased,,2019,Q4,1,I,20190824.0,,20190828,20190828,DIR,,,FDA-CTU,,29.0,YR,,F,N,99.8,KG,20190828.0,N,PH,US,US,2019,Q4,Young Adult
167546111,16754611,3,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Pneumonia,,2019,Q4,1,I,20190824.0,,20190828,20190828,DIR,,,FDA-CTU,,29.0,YR,,F,N,99.8,KG,20190828.0,N,PH,US,US,2019,Q4,Young Adult
167546111,16754611,3,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,White blood cell count decreased,,2019,Q4,1,I,20190824.0,,20190828,20190828,DIR,,,FDA-CTU,,29.0,YR,,F,N,99.8,KG,20190828.0,N,PH,US,US,2019,Q4,Young Adult
167780522,16778052,5,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE,,2,,INSULIN LISPRO PROTAMINE/INSULIN LISPRO (75/25): 40 UNITS EVERY MORNING AND 60 UNITS EVERY EVENING,,,U,,,,,,,,BID,2019,Q4,Cardiac arrest,,2019,Q4,2,F,,20190926.0,20190905,20191002,EXP,,US-BAUSCH-BL-2019-024375,BAUSCH AND LOMB,"COOK R, GARCIA-GAYOSO A, TWILLA J. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST. AMERICAN JOURNAL OF THERAPEUTICS. 2019;26(4):E543-E545. DOI:10.1097/MJT.0000000000000804",72.0,YR,,F,Y,,,20191002.0,,PH,US,US,2019,Q4,Elderly
167780522,16778052,5,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE,,2,,INSULIN LISPRO PROTAMINE/INSULIN LISPRO (75/25): 40 UNITS EVERY MORNING AND 60 UNITS EVERY EVENING,,,U,,,,,,,,BID,2019,Q4,Drug interaction,,2019,Q4,2,F,,20190926.0,20190905,20191002,EXP,,US-BAUSCH-BL-2019-024375,BAUSCH AND LOMB,"COOK R, GARCIA-GAYOSO A, TWILLA J. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST. AMERICAN JOURNAL OF THERAPEUTICS. 2019;26(4):E543-E545. DOI:10.1097/MJT.0000000000000804",72.0,YR,,F,Y,,,20191002.0,,PH,US,US,2019,Q4,Elderly
167780522,16778052,5,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE,,2,,INSULIN LISPRO PROTAMINE/INSULIN LISPRO (75/25): 40 UNITS EVERY MORNING AND 60 UNITS EVERY EVENING,,,U,,,,,,,,BID,2019,Q4,Pulseless electrical activity,,2019,Q4,2,F,,20190926.0,20190905,20191002,EXP,,US-BAUSCH-BL-2019-024375,BAUSCH AND LOMB,"COOK R, GARCIA-GAYOSO A, TWILLA J. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST. AMERICAN JOURNAL OF THERAPEUTICS. 2019;26(4):E543-E545. DOI:10.1097/MJT.0000000000000804",72.0,YR,,F,Y,,,20191002.0,,PH,US,US,2019,Q4,Elderly
167780522,16778052,5,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE,,2,,INSULIN LISPRO PROTAMINE/INSULIN LISPRO (75/25): 40 UNITS EVERY MORNING AND 60 UNITS EVERY EVENING,,,U,,,,,,,,BID,2019,Q4,Toxicity to various agents,,2019,Q4,2,F,,20190926.0,20190905,20191002,EXP,,US-BAUSCH-BL-2019-024375,BAUSCH AND LOMB,"COOK R, GARCIA-GAYOSO A, TWILLA J. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST. AMERICAN JOURNAL OF THERAPEUTICS. 2019;26(4):E543-E545. DOI:10.1097/MJT.0000000000000804",72.0,YR,,F,Y,,,20191002.0,,PH,US,US,2019,Q4,Elderly
167824601,16782460,2,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Euglycaemic diabetic ketoacidosis,,2019,Q4,1,I,20190905.0,,20190906,20190906,DIR,,,FDA-CTU,,40.0,YR,,M,N,64.0,KG,20190906.0,N,PH,US,US,2019,Q4,Adult
167824601,16782460,2,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Off label use,,2019,Q4,1,I,20190905.0,,20190906,20190906,DIR,,,FDA-CTU,,40.0,YR,,M,N,64.0,KG,20190906.0,N,PH,US,US,2019,Q4,Adult
167849632,16784963,16,C,Insulin lispro,INSULIN LISPRO,1,,PRN,,,U,, UNK,,,100.0,IU,,,2019,Q4,Asthenia,,2019,Q4,2,F,20190818.0,20191002.0,20190909,20191014,EXP,,US-BTG-201900162,BTG PHARM,,60.0,YR,,F,Y,157.0,KG,20191014.0,,CN,US,US,2019,Q4,Adult
167849632,16784963,16,C,Insulin lispro,INSULIN LISPRO,1,,PRN,,,U,, UNK,,,100.0,IU,,,2019,Q4,Pain in extremity,,2019,Q4,2,F,20190818.0,20191002.0,20190909,20191014,EXP,,US-BTG-201900162,BTG PHARM,,60.0,YR,,F,Y,157.0,KG,20191014.0,,CN,US,US,2019,Q4,Adult
167902751,16790275,11,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Condition aggravated,,2019,Q4,1,I,,,20190909,20190909,DIR,,,FDA-CTU,,24.0,YR,,F,N,,,20190909.0,N,OT,US,US,2019,Q4,Young Adult
167902751,16790275,11,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Lung disorder,,2019,Q4,1,I,,,20190909,20190909,DIR,,,FDA-CTU,,24.0,YR,,F,N,,,20190909.0,N,OT,US,US,2019,Q4,Young Adult
167902751,16790275,11,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Maternal drugs affecting foetus,,2019,Q4,1,I,,,20190909,20190909,DIR,,,FDA-CTU,,24.0,YR,,F,N,,,20190909.0,N,OT,US,US,2019,Q4,Young Adult
167902751,16790275,11,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Maternal exposure timing unspecified,,2019,Q4,1,I,,,20190909,20190909,DIR,,,FDA-CTU,,24.0,YR,,F,N,,,20190909.0,N,OT,US,US,2019,Q4,Young Adult
167949201,16794920,6,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Paraesthesia,,2019,Q4,1,I,20190822.0,,20190910,20190910,DIR,,,FDA-CTU,,83.0,YR,,M,N,88.4,KG,20190910.0,N,PH,US,US,2019,Q4,Elderly
168054003,16805400,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,U,,,,,,,,2019,Q4,Acute kidney injury,,2019,Q4,3,F,2018.0,20191031.0,20190913,20191105,EXP,,PT-MYLANLABS-2019M1085548,MYLAN,"GOUVEIA, C C, DUQUE S, CAMPOS L. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20191105.0,,MD,PT,PT,2019,Q4,Elderly
168054003,16805400,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,U,,,,,,,,2019,Q4,Arrhythmia,,2019,Q4,3,F,2018.0,20191031.0,20190913,20191105,EXP,,PT-MYLANLABS-2019M1085548,MYLAN,"GOUVEIA, C C, DUQUE S, CAMPOS L. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20191105.0,,MD,PT,PT,2019,Q4,Elderly
168054003,16805400,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,U,,,,,,,,2019,Q4,Atrial fibrillation,,2019,Q4,3,F,2018.0,20191031.0,20190913,20191105,EXP,,PT-MYLANLABS-2019M1085548,MYLAN,"GOUVEIA, C C, DUQUE S, CAMPOS L. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20191105.0,,MD,PT,PT,2019,Q4,Elderly
168054003,16805400,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,U,,,,,,,,2019,Q4,Bradycardia,,2019,Q4,3,F,2018.0,20191031.0,20190913,20191105,EXP,,PT-MYLANLABS-2019M1085548,MYLAN,"GOUVEIA, C C, DUQUE S, CAMPOS L. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20191105.0,,MD,PT,PT,2019,Q4,Elderly
168054003,16805400,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,U,,,,,,,,2019,Q4,Dehydration,,2019,Q4,3,F,2018.0,20191031.0,20190913,20191105,EXP,,PT-MYLANLABS-2019M1085548,MYLAN,"GOUVEIA, C C, DUQUE S, CAMPOS L. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20191105.0,,MD,PT,PT,2019,Q4,Elderly
168054003,16805400,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,U,,,,,,,,2019,Q4,Dizziness,,2019,Q4,3,F,2018.0,20191031.0,20190913,20191105,EXP,,PT-MYLANLABS-2019M1085548,MYLAN,"GOUVEIA, C C, DUQUE S, CAMPOS L. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20191105.0,,MD,PT,PT,2019,Q4,Elderly
168054003,16805400,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,U,,,,,,,,2019,Q4,Haematocrit increased,,2019,Q4,3,F,2018.0,20191031.0,20190913,20191105,EXP,,PT-MYLANLABS-2019M1085548,MYLAN,"GOUVEIA, C C, DUQUE S, CAMPOS L. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20191105.0,,MD,PT,PT,2019,Q4,Elderly
168054003,16805400,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,U,,,,,,,,2019,Q4,Haemoglobin increased,,2019,Q4,3,F,2018.0,20191031.0,20190913,20191105,EXP,,PT-MYLANLABS-2019M1085548,MYLAN,"GOUVEIA, C C, DUQUE S, CAMPOS L. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20191105.0,,MD,PT,PT,2019,Q4,Elderly
168054003,16805400,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,U,,,,,,,,2019,Q4,Hypotension,,2019,Q4,3,F,2018.0,20191031.0,20190913,20191105,EXP,,PT-MYLANLABS-2019M1085548,MYLAN,"GOUVEIA, C C, DUQUE S, CAMPOS L. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20191105.0,,MD,PT,PT,2019,Q4,Elderly
168054003,16805400,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,U,,,,,,,,2019,Q4,Hypovolaemia,,2019,Q4,3,F,2018.0,20191031.0,20190913,20191105,EXP,,PT-MYLANLABS-2019M1085548,MYLAN,"GOUVEIA, C C, DUQUE S, CAMPOS L. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20191105.0,,MD,PT,PT,2019,Q4,Elderly
168054003,16805400,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,U,,,,,,,,2019,Q4,Left atrial dilatation,,2019,Q4,3,F,2018.0,20191031.0,20190913,20191105,EXP,,PT-MYLANLABS-2019M1085548,MYLAN,"GOUVEIA, C C, DUQUE S, CAMPOS L. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20191105.0,,MD,PT,PT,2019,Q4,Elderly
168054003,16805400,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,U,,,,,,,,2019,Q4,Mucosal dryness,,2019,Q4,3,F,2018.0,20191031.0,20190913,20191105,EXP,,PT-MYLANLABS-2019M1085548,MYLAN,"GOUVEIA, C C, DUQUE S, CAMPOS L. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20191105.0,,MD,PT,PT,2019,Q4,Elderly
168054003,16805400,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,U,,,,,,,,2019,Q4,Presyncope,,2019,Q4,3,F,2018.0,20191031.0,20190913,20191105,EXP,,PT-MYLANLABS-2019M1085548,MYLAN,"GOUVEIA, C C, DUQUE S, CAMPOS L. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20191105.0,,MD,PT,PT,2019,Q4,Elderly
168054003,16805400,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,U,,,,,,,,2019,Q4,Skin disorder,,2019,Q4,3,F,2018.0,20191031.0,20190913,20191105,EXP,,PT-MYLANLABS-2019M1085548,MYLAN,"GOUVEIA, C C, DUQUE S, CAMPOS L. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20191105.0,,MD,PT,PT,2019,Q4,Elderly
168054003,16805400,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,U,,,,,,,,2019,Q4,Syncope,,2019,Q4,3,F,2018.0,20191031.0,20190913,20191105,EXP,,PT-MYLANLABS-2019M1085548,MYLAN,"GOUVEIA, C C, DUQUE S, CAMPOS L. LIPOTHYMIA BY HYPOVOLAEMIA - A CASE OF IATROGENY TO EMPAGLIFLOZIN. REVISTA PORTUGUESA DE DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20191105.0,,MD,PT,PT,2019,Q4,Elderly
168108007,16810800,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Agitation,,2019,Q4,7,F,20190819.0,20191023.0,20190916,20191028,EXP,,US-GILEAD-2019-0427928,GILEAD,,62.0,YR,A,F,Y,,,20191028.0,,OT,US,US,2019,Q4,Adult
168108007,16810800,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Anger,,2019,Q4,7,F,20190819.0,20191023.0,20190916,20191028,EXP,,US-GILEAD-2019-0427928,GILEAD,,62.0,YR,A,F,Y,,,20191028.0,,OT,US,US,2019,Q4,Adult
168108007,16810800,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Aphasia,,2019,Q4,7,F,20190819.0,20191023.0,20190916,20191028,EXP,,US-GILEAD-2019-0427928,GILEAD,,62.0,YR,A,F,Y,,,20191028.0,,OT,US,US,2019,Q4,Adult
168108007,16810800,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Central nervous system lymphoma,,2019,Q4,7,F,20190819.0,20191023.0,20190916,20191028,EXP,,US-GILEAD-2019-0427928,GILEAD,,62.0,YR,A,F,Y,,,20191028.0,,OT,US,US,2019,Q4,Adult
168108007,16810800,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Confusional state,,2019,Q4,7,F,20190819.0,20191023.0,20190916,20191028,EXP,,US-GILEAD-2019-0427928,GILEAD,,62.0,YR,A,F,Y,,,20191028.0,,OT,US,US,2019,Q4,Adult
168108007,16810800,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Cytokine release syndrome,,2019,Q4,7,F,20190819.0,20191023.0,20190916,20191028,EXP,,US-GILEAD-2019-0427928,GILEAD,,62.0,YR,A,F,Y,,,20191028.0,,OT,US,US,2019,Q4,Adult
168108007,16810800,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Death,,2019,Q4,7,F,20190819.0,20191023.0,20190916,20191028,EXP,,US-GILEAD-2019-0427928,GILEAD,,62.0,YR,A,F,Y,,,20191028.0,,OT,US,US,2019,Q4,Adult
168108007,16810800,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Enterococcal infection,,2019,Q4,7,F,20190819.0,20191023.0,20190916,20191028,EXP,,US-GILEAD-2019-0427928,GILEAD,,62.0,YR,A,F,Y,,,20191028.0,,OT,US,US,2019,Q4,Adult
168108007,16810800,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Lethargy,,2019,Q4,7,F,20190819.0,20191023.0,20190916,20191028,EXP,,US-GILEAD-2019-0427928,GILEAD,,62.0,YR,A,F,Y,,,20191028.0,,OT,US,US,2019,Q4,Adult
168108007,16810800,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Lung consolidation,,2019,Q4,7,F,20190819.0,20191023.0,20190916,20191028,EXP,,US-GILEAD-2019-0427928,GILEAD,,62.0,YR,A,F,Y,,,20191028.0,,OT,US,US,2019,Q4,Adult
168108007,16810800,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Neurotoxicity,,2019,Q4,7,F,20190819.0,20191023.0,20190916,20191028,EXP,,US-GILEAD-2019-0427928,GILEAD,,62.0,YR,A,F,Y,,,20191028.0,,OT,US,US,2019,Q4,Adult
168108007,16810800,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Pleural effusion,,2019,Q4,7,F,20190819.0,20191023.0,20190916,20191028,EXP,,US-GILEAD-2019-0427928,GILEAD,,62.0,YR,A,F,Y,,,20191028.0,,OT,US,US,2019,Q4,Adult
168108007,16810800,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Renal impairment,,2019,Q4,7,F,20190819.0,20191023.0,20190916,20191028,EXP,,US-GILEAD-2019-0427928,GILEAD,,62.0,YR,A,F,Y,,,20191028.0,,OT,US,US,2019,Q4,Adult
168108007,16810800,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Respiratory distress,,2019,Q4,7,F,20190819.0,20191023.0,20190916,20191028,EXP,,US-GILEAD-2019-0427928,GILEAD,,62.0,YR,A,F,Y,,,20191028.0,,OT,US,US,2019,Q4,Adult
168108007,16810800,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Tachypnoea,,2019,Q4,7,F,20190819.0,20191023.0,20190916,20191028,EXP,,US-GILEAD-2019-0427928,GILEAD,,62.0,YR,A,F,Y,,,20191028.0,,OT,US,US,2019,Q4,Adult
168108007,16810800,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Traumatic intracranial haemorrhage,,2019,Q4,7,F,20190819.0,20191023.0,20190916,20191028,EXP,,US-GILEAD-2019-0427928,GILEAD,,62.0,YR,A,F,Y,,,20191028.0,,OT,US,US,2019,Q4,Adult
168144902,16814490,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q4,Diabetic ketoacidosis,,2019,Q4,2,F,20181210.0,20191023.0,20190917,20191030,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-102539",BOEHRINGER INGELHEIM,,40.0,YR,,M,Y,,,20191030.0,,MD,JP,JP,2019,Q4,Adult
168144902,16814490,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q4,Product use in unapproved indication,,2019,Q4,2,F,20181210.0,20191023.0,20190917,20191030,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-102539",BOEHRINGER INGELHEIM,,40.0,YR,,M,Y,,,20191030.0,,MD,JP,JP,2019,Q4,Adult
168144902,16814490,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q4,Vomiting,,2019,Q4,2,F,20181210.0,20191023.0,20190917,20191030,EXP,,"JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-NB-102539",BOEHRINGER INGELHEIM,,40.0,YR,,M,Y,,,20191030.0,,MD,JP,JP,2019,Q4,Adult
168176382,16817638,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Blindness,,2019,Q4,2,F,,20191008.0,20190917,20191016,EXP,,US-SA-2019SA254590,SANOFI AVENTIS,,63.0,YR,A,F,Y,,,20191016.0,,OT,US,US,2019,Q4,Adult
168176382,16817638,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Blood glucose increased,,2019,Q4,2,F,,20191008.0,20190917,20191016,EXP,,US-SA-2019SA254590,SANOFI AVENTIS,,63.0,YR,A,F,Y,,,20191016.0,,OT,US,US,2019,Q4,Adult
168222212,16822221,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"22 INTERNATIONAL UNIT, DAILY",11770.0,IU,Y,U,,,20563.0,22.0,IU,,QD,2019,Q4,Asthenia,,2019,Q4,2,F,20190625.0,20191108.0,20190918,20191113,EXP,IT-MINISAL02-573466,IT-ELI_LILLY_AND_COMPANY-IT201909004765,ELI LILLY AND CO,,79.0,YR,,M,Y,,,20191113.0,,CN,IT,IT,2019,Q4,Elderly
168222212,16822221,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"22 INTERNATIONAL UNIT, DAILY",11770.0,IU,Y,U,,,20563.0,22.0,IU,,QD,2019,Q4,Drug interaction,,2019,Q4,2,F,20190625.0,20191108.0,20190918,20191113,EXP,IT-MINISAL02-573466,IT-ELI_LILLY_AND_COMPANY-IT201909004765,ELI LILLY AND CO,,79.0,YR,,M,Y,,,20191113.0,,CN,IT,IT,2019,Q4,Elderly
168222212,16822221,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"22 INTERNATIONAL UNIT, DAILY",11770.0,IU,Y,U,,,20563.0,22.0,IU,,QD,2019,Q4,Hyperhidrosis,,2019,Q4,2,F,20190625.0,20191108.0,20190918,20191113,EXP,IT-MINISAL02-573466,IT-ELI_LILLY_AND_COMPANY-IT201909004765,ELI LILLY AND CO,,79.0,YR,,M,Y,,,20191113.0,,CN,IT,IT,2019,Q4,Elderly
168222212,16822221,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"22 INTERNATIONAL UNIT, DAILY",11770.0,IU,Y,U,,,20563.0,22.0,IU,,QD,2019,Q4,Hypoglycaemia,,2019,Q4,2,F,20190625.0,20191108.0,20190918,20191113,EXP,IT-MINISAL02-573466,IT-ELI_LILLY_AND_COMPANY-IT201909004765,ELI LILLY AND CO,,79.0,YR,,M,Y,,,20191113.0,,CN,IT,IT,2019,Q4,Elderly
168222212,16822221,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"22 INTERNATIONAL UNIT, DAILY",11770.0,IU,Y,U,,,20563.0,22.0,IU,,QD,2019,Q4,Malaise,,2019,Q4,2,F,20190625.0,20191108.0,20190918,20191113,EXP,IT-MINISAL02-573466,IT-ELI_LILLY_AND_COMPANY-IT201909004765,ELI LILLY AND CO,,79.0,YR,,M,Y,,,20191113.0,,CN,IT,IT,2019,Q4,Elderly
168302546,16830254,3,C,INSULINA LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2019,Q4,Bone marrow failure,,2019,Q4,6,F,20190915.0,20191102.0,20190920,20191107,EXP,,CO-TAKEDA-2019TUS052964,TAKEDA,,58.0,YR,,F,Y,61.0,KG,20191107.0,,OT,CO,CO,2019,Q4,Adult
168302546,16830254,3,C,INSULINA LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2019,Q4,Chronic myeloid leukaemia,,2019,Q4,6,F,20190915.0,20191102.0,20190920,20191107,EXP,,CO-TAKEDA-2019TUS052964,TAKEDA,,58.0,YR,,F,Y,61.0,KG,20191107.0,,OT,CO,CO,2019,Q4,Adult
168302546,16830254,3,C,INSULINA LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2019,Q4,Leukopenia,,2019,Q4,6,F,20190915.0,20191102.0,20190920,20191107,EXP,,CO-TAKEDA-2019TUS052964,TAKEDA,,58.0,YR,,F,Y,61.0,KG,20191107.0,,OT,CO,CO,2019,Q4,Adult
168428522,16842852,14,C,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2019,Q4,Acquired haemophilia,,2019,Q4,2,F,,20191002.0,20190924,20191003,EXP,,JP-TEVA-2019-JP-1112316,TEVA,"SHIMIZU T, NOGAMI K, MIZUTANI C, IMADA K. ACQUIRED HEMOPHILIA A WITH HIGH-TITER FACTOR VIII INHIBITOR DEVELOPING SUBSEQUENT TO CLOPIDOGREL ADMINISTRATION. RINSHO-KETSUEKI 2019;60(4):291-295.",80.0,YR,,F,Y,,,20191003.0,,OT,JP,JP,2019,Q4,Elderly
168456422,16845642,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,5-7-7 UNITS,,,U,,,,,,,,Q8H,2019,Q4,Decreased appetite,,2019,Q4,2,F,20160119.0,20191008.0,20190924,20191014,EXP,,JP-SAKK-2019SA261777AA,SANOFI AVENTIS,,68.0,YR,E,F,Y,40.0,KG,20191014.0,,MD,JP,JP,2019,Q4,Elderly
168456422,16845642,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,5-7-7 UNITS,,,U,,,,,,,,Q8H,2019,Q4,Depressed level of consciousness,,2019,Q4,2,F,20160119.0,20191008.0,20190924,20191014,EXP,,JP-SAKK-2019SA261777AA,SANOFI AVENTIS,,68.0,YR,E,F,Y,40.0,KG,20191014.0,,MD,JP,JP,2019,Q4,Elderly
168456422,16845642,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,5-7-7 UNITS,,,U,,,,,,,,Q8H,2019,Q4,Physical deconditioning,,2019,Q4,2,F,20160119.0,20191008.0,20190924,20191014,EXP,,JP-SAKK-2019SA261777AA,SANOFI AVENTIS,,68.0,YR,E,F,Y,40.0,KG,20191014.0,,MD,JP,JP,2019,Q4,Elderly
168456422,16845642,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,5-7-7 UNITS,,,U,,,,,,,,Q8H,2019,Q4,Polydipsia,,2019,Q4,2,F,20160119.0,20191008.0,20190924,20191014,EXP,,JP-SAKK-2019SA261777AA,SANOFI AVENTIS,,68.0,YR,E,F,Y,40.0,KG,20191014.0,,MD,JP,JP,2019,Q4,Elderly
168456422,16845642,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,5-7-7 UNITS,,,U,,,,,,,,Q8H,2019,Q4,Polyuria,,2019,Q4,2,F,20160119.0,20191008.0,20190924,20191014,EXP,,JP-SAKK-2019SA261777AA,SANOFI AVENTIS,,68.0,YR,E,F,Y,40.0,KG,20191014.0,,MD,JP,JP,2019,Q4,Elderly
168456422,16845642,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,5-7-7 UNITS,,,U,,,,,,,,Q8H,2019,Q4,Vomiting,,2019,Q4,2,F,20160119.0,20191008.0,20190924,20191014,EXP,,JP-SAKK-2019SA261777AA,SANOFI AVENTIS,,68.0,YR,E,F,Y,40.0,KG,20191014.0,,MD,JP,JP,2019,Q4,Elderly
168491381,16849138,3,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Pancreatitis acute,,2019,Q4,1,I,20190923.0,,20190924,20190924,DIR,,,FDA-CTU,,47.0,YR,,M,N,100.0,KG,20190924.0,N,PH,US,US,2019,Q4,Adult
168494722,16849472,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 INTERNATIONAL UNIT, TID",,,,,,,,4.0,IU,,TID,2019,Q4,Pituitary-dependent Cushing's syndrome,,2019,Q4,2,F,20190801.0,20191004.0,20190925,20191014,EXP,,JP-ELI_LILLY_AND_COMPANY-JP201909009044,ELI LILLY AND CO,,69.0,YR,,F,Y,67.0,KG,20191014.0,,CN,JP,JP,2019,Q4,Elderly
168604002,16860400,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, QD 3 IU (MORNING), 2 IU (AFTERNOON) AND 2 IU (NIGHT)",,,,,,,,,,INJECTION,QD,2019,Q4,Blister,,2019,Q4,2,F,201907.0,20191223.0,20190927,20191230,EXP,,PHHY2019BR224485,NOVARTIS,,63.0,YR,,F,Y,67.0,KG,20191230.0,,CN,BR,BR,2019,Q4,Adult
168604002,16860400,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, QD 3 IU (MORNING), 2 IU (AFTERNOON) AND 2 IU (NIGHT)",,,,,,,,,,INJECTION,QD,2019,Q4,Eye haemorrhage,,2019,Q4,2,F,201907.0,20191223.0,20190927,20191230,EXP,,PHHY2019BR224485,NOVARTIS,,63.0,YR,,F,Y,67.0,KG,20191230.0,,CN,BR,BR,2019,Q4,Adult
168604002,16860400,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, QD 3 IU (MORNING), 2 IU (AFTERNOON) AND 2 IU (NIGHT)",,,,,,,,,,INJECTION,QD,2019,Q4,Eye swelling,,2019,Q4,2,F,201907.0,20191223.0,20190927,20191230,EXP,,PHHY2019BR224485,NOVARTIS,,63.0,YR,,F,Y,67.0,KG,20191230.0,,CN,BR,BR,2019,Q4,Adult
168604002,16860400,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, QD 3 IU (MORNING), 2 IU (AFTERNOON) AND 2 IU (NIGHT)",,,,,,,,,,INJECTION,QD,2019,Q4,Retinal detachment,,2019,Q4,2,F,201907.0,20191223.0,20190927,20191230,EXP,,PHHY2019BR224485,NOVARTIS,,63.0,YR,,F,Y,67.0,KG,20191230.0,,CN,BR,BR,2019,Q4,Adult
168732832,16873283,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6+6+6,,,,,,,,,,,,2019,Q4,Diabetic foot,,2019,Q4,2,F,20190709.0,20191001.0,20191001,20191009,EXP,,PT-ASTRAZENECA-2019SF36992,ASTRAZENECA,,21609.0,DY,,M,Y,140.0,KG,20191009.0,,,PT,PT,2019,Q4,Elderly
168732832,16873283,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6+6+6,,,,,,,,,,,,2019,Q4,Finger amputation,,2019,Q4,2,F,20190709.0,20191001.0,20191001,20191009,EXP,,PT-ASTRAZENECA-2019SF36992,ASTRAZENECA,,21609.0,DY,,M,Y,140.0,KG,20191009.0,,,PT,PT,2019,Q4,Elderly
168732832,16873283,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6+6+6,,,,,,,,,,,,2019,Q4,Hypovolaemia,,2019,Q4,2,F,20190709.0,20191001.0,20191001,20191009,EXP,,PT-ASTRAZENECA-2019SF36992,ASTRAZENECA,,21609.0,DY,,M,Y,140.0,KG,20191009.0,,,PT,PT,2019,Q4,Elderly
168732832,16873283,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6+6+6,,,,,,,,,,,,2019,Q4,Injury,,2019,Q4,2,F,20190709.0,20191001.0,20191001,20191009,EXP,,PT-ASTRAZENECA-2019SF36992,ASTRAZENECA,,21609.0,DY,,M,Y,140.0,KG,20191009.0,,,PT,PT,2019,Q4,Elderly
168732832,16873283,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6+6+6,,,,,,,,,,,,2019,Q4,Necrosis,,2019,Q4,2,F,20190709.0,20191001.0,20191001,20191009,EXP,,PT-ASTRAZENECA-2019SF36992,ASTRAZENECA,,21609.0,DY,,M,Y,140.0,KG,20191009.0,,,PT,PT,2019,Q4,Elderly
168732832,16873283,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6+6+6,,,,,,,,,,,,2019,Q4,Toe amputation,,2019,Q4,2,F,20190709.0,20191001.0,20191001,20191009,EXP,,PT-ASTRAZENECA-2019SF36992,ASTRAZENECA,,21609.0,DY,,M,Y,140.0,KG,20191009.0,,,PT,PT,2019,Q4,Elderly
168744011,16874401,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"3 DOSAGE FORM, UNKNOWN",,,,,,,20563.0,3.0,DF,,,2019,Q4,Hypoglycaemia,,2019,Q4,1,I,20190715.0,20190918.0,20191001,20191001,EXP,IT-MINISAL02-575175,IT-ELI_LILLY_AND_COMPANY-IT201909009354,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20191001.0,,CN,IT,IT,2019,Q4,Adult
168744011,16874401,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"3 DOSAGE FORM, UNKNOWN",,,,,,,20563.0,3.0,DF,,,2019,Q4,Sopor,,2019,Q4,1,I,20190715.0,20190918.0,20191001,20191001,EXP,IT-MINISAL02-575175,IT-ELI_LILLY_AND_COMPANY-IT201909009354,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20191001.0,,CN,IT,IT,2019,Q4,Adult
168770381,16877038,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Death,,2019,Q4,1,I,20190921.0,20191001.0,20191002,20191002,EXP,,US-ROCHE-2429375,ROCHE,,72.0,YR,,M,Y,,,20191002.0,,CN,US,US,2019,Q4,Elderly
168793712,16879371,6,C,"INSULIN LISPRO PROTAMINE, INSULIN LISPRO",,2,,"INSULIN LISPRO PROTAMINE/INSULIN LISPRO (75/25), EVERY EVENING",,,U,," UNKNOWN,UNKNOWN",,,60.0,IU,,,2019,Q4,Acidosis,,2019,Q4,2,F,,20191104.0,20191003,20191110,EXP,,US-DRREDDYS-USA/USA/19/0114625,DR REDDYS,"COOK RMD, GARCIA-GAYOSO AS, TWILLA JD. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST. AMERICAN JOURNAL OF THERAPEUTICS. 2019;26(4):E543-E545. DOI: 10.1097/MJT.0000000000000804.",72.0,YR,,F,Y,,,20191110.0,,PH,US,US,2019,Q4,Elderly
168793712,16879371,6,C,"INSULIN LISPRO PROTAMINE, INSULIN LISPRO",,2,,"INSULIN LISPRO PROTAMINE/INSULIN LISPRO (75/25), EVERY EVENING",,,U,," UNKNOWN,UNKNOWN",,,60.0,IU,,,2019,Q4,Cardiac arrest,,2019,Q4,2,F,,20191104.0,20191003,20191110,EXP,,US-DRREDDYS-USA/USA/19/0114625,DR REDDYS,"COOK RMD, GARCIA-GAYOSO AS, TWILLA JD. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST. AMERICAN JOURNAL OF THERAPEUTICS. 2019;26(4):E543-E545. DOI: 10.1097/MJT.0000000000000804.",72.0,YR,,F,Y,,,20191110.0,,PH,US,US,2019,Q4,Elderly
168793712,16879371,6,C,"INSULIN LISPRO PROTAMINE, INSULIN LISPRO",,2,,"INSULIN LISPRO PROTAMINE/INSULIN LISPRO (75/25), EVERY EVENING",,,U,," UNKNOWN,UNKNOWN",,,60.0,IU,,,2019,Q4,Drug clearance increased,,2019,Q4,2,F,,20191104.0,20191003,20191110,EXP,,US-DRREDDYS-USA/USA/19/0114625,DR REDDYS,"COOK RMD, GARCIA-GAYOSO AS, TWILLA JD. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST. AMERICAN JOURNAL OF THERAPEUTICS. 2019;26(4):E543-E545. DOI: 10.1097/MJT.0000000000000804.",72.0,YR,,F,Y,,,20191110.0,,PH,US,US,2019,Q4,Elderly
168793712,16879371,6,C,"INSULIN LISPRO PROTAMINE, INSULIN LISPRO",,2,,"INSULIN LISPRO PROTAMINE/INSULIN LISPRO (75/25), EVERY EVENING",,,U,," UNKNOWN,UNKNOWN",,,60.0,IU,,,2019,Q4,Drug interaction,,2019,Q4,2,F,,20191104.0,20191003,20191110,EXP,,US-DRREDDYS-USA/USA/19/0114625,DR REDDYS,"COOK RMD, GARCIA-GAYOSO AS, TWILLA JD. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST. AMERICAN JOURNAL OF THERAPEUTICS. 2019;26(4):E543-E545. DOI: 10.1097/MJT.0000000000000804.",72.0,YR,,F,Y,,,20191110.0,,PH,US,US,2019,Q4,Elderly
168793712,16879371,6,C,"INSULIN LISPRO PROTAMINE, INSULIN LISPRO",,2,,"INSULIN LISPRO PROTAMINE/INSULIN LISPRO (75/25), EVERY EVENING",,,U,," UNKNOWN,UNKNOWN",,,60.0,IU,,,2019,Q4,Drug level increased,,2019,Q4,2,F,,20191104.0,20191003,20191110,EXP,,US-DRREDDYS-USA/USA/19/0114625,DR REDDYS,"COOK RMD, GARCIA-GAYOSO AS, TWILLA JD. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST. AMERICAN JOURNAL OF THERAPEUTICS. 2019;26(4):E543-E545. DOI: 10.1097/MJT.0000000000000804.",72.0,YR,,F,Y,,,20191110.0,,PH,US,US,2019,Q4,Elderly
168793712,16879371,6,C,"INSULIN LISPRO PROTAMINE, INSULIN LISPRO",,2,,"INSULIN LISPRO PROTAMINE/INSULIN LISPRO (75/25), EVERY EVENING",,,U,," UNKNOWN,UNKNOWN",,,60.0,IU,,,2019,Q4,Hypoperfusion,,2019,Q4,2,F,,20191104.0,20191003,20191110,EXP,,US-DRREDDYS-USA/USA/19/0114625,DR REDDYS,"COOK RMD, GARCIA-GAYOSO AS, TWILLA JD. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST. AMERICAN JOURNAL OF THERAPEUTICS. 2019;26(4):E543-E545. DOI: 10.1097/MJT.0000000000000804.",72.0,YR,,F,Y,,,20191110.0,,PH,US,US,2019,Q4,Elderly
168793712,16879371,6,C,"INSULIN LISPRO PROTAMINE, INSULIN LISPRO",,2,,"INSULIN LISPRO PROTAMINE/INSULIN LISPRO (75/25), EVERY EVENING",,,U,," UNKNOWN,UNKNOWN",,,60.0,IU,,,2019,Q4,Hypovolaemic shock,,2019,Q4,2,F,,20191104.0,20191003,20191110,EXP,,US-DRREDDYS-USA/USA/19/0114625,DR REDDYS,"COOK RMD, GARCIA-GAYOSO AS, TWILLA JD. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST. AMERICAN JOURNAL OF THERAPEUTICS. 2019;26(4):E543-E545. DOI: 10.1097/MJT.0000000000000804.",72.0,YR,,F,Y,,,20191110.0,,PH,US,US,2019,Q4,Elderly
168793712,16879371,6,C,"INSULIN LISPRO PROTAMINE, INSULIN LISPRO",,2,,"INSULIN LISPRO PROTAMINE/INSULIN LISPRO (75/25), EVERY EVENING",,,U,," UNKNOWN,UNKNOWN",,,60.0,IU,,,2019,Q4,Nodal arrhythmia,,2019,Q4,2,F,,20191104.0,20191003,20191110,EXP,,US-DRREDDYS-USA/USA/19/0114625,DR REDDYS,"COOK RMD, GARCIA-GAYOSO AS, TWILLA JD. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST. AMERICAN JOURNAL OF THERAPEUTICS. 2019;26(4):E543-E545. DOI: 10.1097/MJT.0000000000000804.",72.0,YR,,F,Y,,,20191110.0,,PH,US,US,2019,Q4,Elderly
168793712,16879371,6,C,"INSULIN LISPRO PROTAMINE, INSULIN LISPRO",,2,,"INSULIN LISPRO PROTAMINE/INSULIN LISPRO (75/25), EVERY EVENING",,,U,," UNKNOWN,UNKNOWN",,,60.0,IU,,,2019,Q4,Pulseless electrical activity,,2019,Q4,2,F,,20191104.0,20191003,20191110,EXP,,US-DRREDDYS-USA/USA/19/0114625,DR REDDYS,"COOK RMD, GARCIA-GAYOSO AS, TWILLA JD. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST. AMERICAN JOURNAL OF THERAPEUTICS. 2019;26(4):E543-E545. DOI: 10.1097/MJT.0000000000000804.",72.0,YR,,F,Y,,,20191110.0,,PH,US,US,2019,Q4,Elderly
168793712,16879371,6,C,"INSULIN LISPRO PROTAMINE, INSULIN LISPRO",,2,,"INSULIN LISPRO PROTAMINE/INSULIN LISPRO (75/25), EVERY EVENING",,,U,," UNKNOWN,UNKNOWN",,,60.0,IU,,,2019,Q4,Sinus tachycardia,,2019,Q4,2,F,,20191104.0,20191003,20191110,EXP,,US-DRREDDYS-USA/USA/19/0114625,DR REDDYS,"COOK RMD, GARCIA-GAYOSO AS, TWILLA JD. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST. AMERICAN JOURNAL OF THERAPEUTICS. 2019;26(4):E543-E545. DOI: 10.1097/MJT.0000000000000804.",72.0,YR,,F,Y,,,20191110.0,,PH,US,US,2019,Q4,Elderly
168793712,16879371,6,C,"INSULIN LISPRO PROTAMINE, INSULIN LISPRO",,2,,"INSULIN LISPRO PROTAMINE/INSULIN LISPRO (75/25), EVERY EVENING",,,U,," UNKNOWN,UNKNOWN",,,60.0,IU,,,2019,Q4,Toxicity to various agents,,2019,Q4,2,F,,20191104.0,20191003,20191110,EXP,,US-DRREDDYS-USA/USA/19/0114625,DR REDDYS,"COOK RMD, GARCIA-GAYOSO AS, TWILLA JD. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST. AMERICAN JOURNAL OF THERAPEUTICS. 2019;26(4):E543-E545. DOI: 10.1097/MJT.0000000000000804.",72.0,YR,,F,Y,,,20191110.0,,PH,US,US,2019,Q4,Elderly
168793712,16879371,7,C,"INSULIN LISPRO PROTAMINE, INSULIN LISPRO",,2,,"INSULIN LISPRO PROTAMINE/INSULIN LISPRO (75/25), EVERY MORNING",,,U,," UNKNOWN,UNKNOWN",,,40.0,IU,,,2019,Q4,Acidosis,,2019,Q4,2,F,,20191104.0,20191003,20191110,EXP,,US-DRREDDYS-USA/USA/19/0114625,DR REDDYS,"COOK RMD, GARCIA-GAYOSO AS, TWILLA JD. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST. AMERICAN JOURNAL OF THERAPEUTICS. 2019;26(4):E543-E545. DOI: 10.1097/MJT.0000000000000804.",72.0,YR,,F,Y,,,20191110.0,,PH,US,US,2019,Q4,Elderly
168793712,16879371,7,C,"INSULIN LISPRO PROTAMINE, INSULIN LISPRO",,2,,"INSULIN LISPRO PROTAMINE/INSULIN LISPRO (75/25), EVERY MORNING",,,U,," UNKNOWN,UNKNOWN",,,40.0,IU,,,2019,Q4,Cardiac arrest,,2019,Q4,2,F,,20191104.0,20191003,20191110,EXP,,US-DRREDDYS-USA/USA/19/0114625,DR REDDYS,"COOK RMD, GARCIA-GAYOSO AS, TWILLA JD. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST. AMERICAN JOURNAL OF THERAPEUTICS. 2019;26(4):E543-E545. DOI: 10.1097/MJT.0000000000000804.",72.0,YR,,F,Y,,,20191110.0,,PH,US,US,2019,Q4,Elderly
168793712,16879371,7,C,"INSULIN LISPRO PROTAMINE, INSULIN LISPRO",,2,,"INSULIN LISPRO PROTAMINE/INSULIN LISPRO (75/25), EVERY MORNING",,,U,," UNKNOWN,UNKNOWN",,,40.0,IU,,,2019,Q4,Drug clearance increased,,2019,Q4,2,F,,20191104.0,20191003,20191110,EXP,,US-DRREDDYS-USA/USA/19/0114625,DR REDDYS,"COOK RMD, GARCIA-GAYOSO AS, TWILLA JD. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST. AMERICAN JOURNAL OF THERAPEUTICS. 2019;26(4):E543-E545. DOI: 10.1097/MJT.0000000000000804.",72.0,YR,,F,Y,,,20191110.0,,PH,US,US,2019,Q4,Elderly
168793712,16879371,7,C,"INSULIN LISPRO PROTAMINE, INSULIN LISPRO",,2,,"INSULIN LISPRO PROTAMINE/INSULIN LISPRO (75/25), EVERY MORNING",,,U,," UNKNOWN,UNKNOWN",,,40.0,IU,,,2019,Q4,Drug interaction,,2019,Q4,2,F,,20191104.0,20191003,20191110,EXP,,US-DRREDDYS-USA/USA/19/0114625,DR REDDYS,"COOK RMD, GARCIA-GAYOSO AS, TWILLA JD. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST. AMERICAN JOURNAL OF THERAPEUTICS. 2019;26(4):E543-E545. DOI: 10.1097/MJT.0000000000000804.",72.0,YR,,F,Y,,,20191110.0,,PH,US,US,2019,Q4,Elderly
168793712,16879371,7,C,"INSULIN LISPRO PROTAMINE, INSULIN LISPRO",,2,,"INSULIN LISPRO PROTAMINE/INSULIN LISPRO (75/25), EVERY MORNING",,,U,," UNKNOWN,UNKNOWN",,,40.0,IU,,,2019,Q4,Drug level increased,,2019,Q4,2,F,,20191104.0,20191003,20191110,EXP,,US-DRREDDYS-USA/USA/19/0114625,DR REDDYS,"COOK RMD, GARCIA-GAYOSO AS, TWILLA JD. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST. AMERICAN JOURNAL OF THERAPEUTICS. 2019;26(4):E543-E545. DOI: 10.1097/MJT.0000000000000804.",72.0,YR,,F,Y,,,20191110.0,,PH,US,US,2019,Q4,Elderly
168793712,16879371,7,C,"INSULIN LISPRO PROTAMINE, INSULIN LISPRO",,2,,"INSULIN LISPRO PROTAMINE/INSULIN LISPRO (75/25), EVERY MORNING",,,U,," UNKNOWN,UNKNOWN",,,40.0,IU,,,2019,Q4,Hypoperfusion,,2019,Q4,2,F,,20191104.0,20191003,20191110,EXP,,US-DRREDDYS-USA/USA/19/0114625,DR REDDYS,"COOK RMD, GARCIA-GAYOSO AS, TWILLA JD. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST. AMERICAN JOURNAL OF THERAPEUTICS. 2019;26(4):E543-E545. DOI: 10.1097/MJT.0000000000000804.",72.0,YR,,F,Y,,,20191110.0,,PH,US,US,2019,Q4,Elderly
168793712,16879371,7,C,"INSULIN LISPRO PROTAMINE, INSULIN LISPRO",,2,,"INSULIN LISPRO PROTAMINE/INSULIN LISPRO (75/25), EVERY MORNING",,,U,," UNKNOWN,UNKNOWN",,,40.0,IU,,,2019,Q4,Hypovolaemic shock,,2019,Q4,2,F,,20191104.0,20191003,20191110,EXP,,US-DRREDDYS-USA/USA/19/0114625,DR REDDYS,"COOK RMD, GARCIA-GAYOSO AS, TWILLA JD. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST. AMERICAN JOURNAL OF THERAPEUTICS. 2019;26(4):E543-E545. DOI: 10.1097/MJT.0000000000000804.",72.0,YR,,F,Y,,,20191110.0,,PH,US,US,2019,Q4,Elderly
168793712,16879371,7,C,"INSULIN LISPRO PROTAMINE, INSULIN LISPRO",,2,,"INSULIN LISPRO PROTAMINE/INSULIN LISPRO (75/25), EVERY MORNING",,,U,," UNKNOWN,UNKNOWN",,,40.0,IU,,,2019,Q4,Nodal arrhythmia,,2019,Q4,2,F,,20191104.0,20191003,20191110,EXP,,US-DRREDDYS-USA/USA/19/0114625,DR REDDYS,"COOK RMD, GARCIA-GAYOSO AS, TWILLA JD. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST. AMERICAN JOURNAL OF THERAPEUTICS. 2019;26(4):E543-E545. DOI: 10.1097/MJT.0000000000000804.",72.0,YR,,F,Y,,,20191110.0,,PH,US,US,2019,Q4,Elderly
168793712,16879371,7,C,"INSULIN LISPRO PROTAMINE, INSULIN LISPRO",,2,,"INSULIN LISPRO PROTAMINE/INSULIN LISPRO (75/25), EVERY MORNING",,,U,," UNKNOWN,UNKNOWN",,,40.0,IU,,,2019,Q4,Pulseless electrical activity,,2019,Q4,2,F,,20191104.0,20191003,20191110,EXP,,US-DRREDDYS-USA/USA/19/0114625,DR REDDYS,"COOK RMD, GARCIA-GAYOSO AS, TWILLA JD. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST. AMERICAN JOURNAL OF THERAPEUTICS. 2019;26(4):E543-E545. DOI: 10.1097/MJT.0000000000000804.",72.0,YR,,F,Y,,,20191110.0,,PH,US,US,2019,Q4,Elderly
168793712,16879371,7,C,"INSULIN LISPRO PROTAMINE, INSULIN LISPRO",,2,,"INSULIN LISPRO PROTAMINE/INSULIN LISPRO (75/25), EVERY MORNING",,,U,," UNKNOWN,UNKNOWN",,,40.0,IU,,,2019,Q4,Sinus tachycardia,,2019,Q4,2,F,,20191104.0,20191003,20191110,EXP,,US-DRREDDYS-USA/USA/19/0114625,DR REDDYS,"COOK RMD, GARCIA-GAYOSO AS, TWILLA JD. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST. AMERICAN JOURNAL OF THERAPEUTICS. 2019;26(4):E543-E545. DOI: 10.1097/MJT.0000000000000804.",72.0,YR,,F,Y,,,20191110.0,,PH,US,US,2019,Q4,Elderly
168793712,16879371,7,C,"INSULIN LISPRO PROTAMINE, INSULIN LISPRO",,2,,"INSULIN LISPRO PROTAMINE/INSULIN LISPRO (75/25), EVERY MORNING",,,U,," UNKNOWN,UNKNOWN",,,40.0,IU,,,2019,Q4,Toxicity to various agents,,2019,Q4,2,F,,20191104.0,20191003,20191110,EXP,,US-DRREDDYS-USA/USA/19/0114625,DR REDDYS,"COOK RMD, GARCIA-GAYOSO AS, TWILLA JD. CONCOMITANT USE OF NIFEDIPINE AND CLARITHROMYCIN LEADING TO PULSELESS, BRADYCARDIC ARREST. AMERICAN JOURNAL OF THERAPEUTICS. 2019;26(4):E543-E545. DOI: 10.1097/MJT.0000000000000804.",72.0,YR,,F,Y,,,20191110.0,,PH,US,US,2019,Q4,Elderly
168846801,16884680,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q4,Concomitant disease aggravated,,2019,Q4,1,I,,20190927.0,20191004,20191004,EXP,,CZ-MYLANLABS-2019M1091762,MYLAN,"TUHACKOVA M, BROZ J, KVAPIL M.. ATYPICAL HYPOGLYCAEMIA IN A TYPE 2 DIABETES MELLITUS PATIENT TREATED WITH ORAL ANTIDIABETICS.. KAZUISTIKY V DIABETOLOGII.. 2019;17(1):6-7",63.0,YR,,M,Y,,,20191004.0,,OT,CZ,CZ,2019,Q4,Adult
168846801,16884680,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q4,Hypoglycaemia,,2019,Q4,1,I,,20190927.0,20191004,20191004,EXP,,CZ-MYLANLABS-2019M1091762,MYLAN,"TUHACKOVA M, BROZ J, KVAPIL M.. ATYPICAL HYPOGLYCAEMIA IN A TYPE 2 DIABETES MELLITUS PATIENT TREATED WITH ORAL ANTIDIABETICS.. KAZUISTIKY V DIABETOLOGII.. 2019;17(1):6-7",63.0,YR,,M,Y,,,20191004.0,,OT,CZ,CZ,2019,Q4,Adult
168846801,16884680,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q4,Therapy non-responder,,2019,Q4,1,I,,20190927.0,20191004,20191004,EXP,,CZ-MYLANLABS-2019M1091762,MYLAN,"TUHACKOVA M, BROZ J, KVAPIL M.. ATYPICAL HYPOGLYCAEMIA IN A TYPE 2 DIABETES MELLITUS PATIENT TREATED WITH ORAL ANTIDIABETICS.. KAZUISTIKY V DIABETOLOGII.. 2019;17(1):6-7",63.0,YR,,M,Y,,,20191004.0,,OT,CZ,CZ,2019,Q4,Adult
168864902,16886490,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Acute left ventricular failure,,2019,Q4,2,F,20131028.0,20191211.0,20191004,20191219,EXP,,US-ASTRAZENECA-2019SF39880,ASTRAZENECA,,20989.0,DY,,F,Y,99.8,KG,20191219.0,,,US,US,2019,Q4,Elderly
168864902,16886490,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Acute respiratory failure,,2019,Q4,2,F,20131028.0,20191211.0,20191004,20191219,EXP,,US-ASTRAZENECA-2019SF39880,ASTRAZENECA,,20989.0,DY,,F,Y,99.8,KG,20191219.0,,,US,US,2019,Q4,Elderly
168864902,16886490,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Cardiac failure,,2019,Q4,2,F,20131028.0,20191211.0,20191004,20191219,EXP,,US-ASTRAZENECA-2019SF39880,ASTRAZENECA,,20989.0,DY,,F,Y,99.8,KG,20191219.0,,,US,US,2019,Q4,Elderly
168864902,16886490,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Cardiac failure congestive,,2019,Q4,2,F,20131028.0,20191211.0,20191004,20191219,EXP,,US-ASTRAZENECA-2019SF39880,ASTRAZENECA,,20989.0,DY,,F,Y,99.8,KG,20191219.0,,,US,US,2019,Q4,Elderly
168864902,16886490,28,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Acute left ventricular failure,,2019,Q4,2,F,20131028.0,20191211.0,20191004,20191219,EXP,,US-ASTRAZENECA-2019SF39880,ASTRAZENECA,,20989.0,DY,,F,Y,99.8,KG,20191219.0,,,US,US,2019,Q4,Elderly
168864902,16886490,28,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Acute respiratory failure,,2019,Q4,2,F,20131028.0,20191211.0,20191004,20191219,EXP,,US-ASTRAZENECA-2019SF39880,ASTRAZENECA,,20989.0,DY,,F,Y,99.8,KG,20191219.0,,,US,US,2019,Q4,Elderly
168864902,16886490,28,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Cardiac failure,,2019,Q4,2,F,20131028.0,20191211.0,20191004,20191219,EXP,,US-ASTRAZENECA-2019SF39880,ASTRAZENECA,,20989.0,DY,,F,Y,99.8,KG,20191219.0,,,US,US,2019,Q4,Elderly
168864902,16886490,28,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Cardiac failure congestive,,2019,Q4,2,F,20131028.0,20191211.0,20191004,20191219,EXP,,US-ASTRAZENECA-2019SF39880,ASTRAZENECA,,20989.0,DY,,F,Y,99.8,KG,20191219.0,,,US,US,2019,Q4,Elderly
168919822,16891982,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,INJECTION,,2019,Q4,Cellulitis,,2019,Q4,2,F,2018.0,20191007.0,20191007,20191009,EXP,,GB-MYLANLABS-2019M1093001,MYLAN,,84.0,YR,,M,Y,,,20191009.0,,CN,GB,GB,2019,Q4,Elderly
168919822,16891982,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,INJECTION,,2019,Q4,Drug interaction,,2019,Q4,2,F,2018.0,20191007.0,20191007,20191009,EXP,,GB-MYLANLABS-2019M1093001,MYLAN,,84.0,YR,,M,Y,,,20191009.0,,CN,GB,GB,2019,Q4,Elderly
168922983,16892298,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 IU, QD",2760.0,IU,U,,,,,20.0,IU,SOLUTION FOR INJECTION,QD,2019,Q4,Confusional state,,2019,Q4,3,F,20190519.0,20190930.0,20191007,20191104,EXP,IT-MINISAL02-577026,IT-SA-2019SA271650,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20191104.0,,MD,IT,IT,2019,Q4,Adult
168922983,16892298,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 IU, QD",2760.0,IU,U,,,,,20.0,IU,SOLUTION FOR INJECTION,QD,2019,Q4,Hypoglycaemia,,2019,Q4,3,F,20190519.0,20190930.0,20191007,20191104,EXP,IT-MINISAL02-577026,IT-SA-2019SA271650,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20191104.0,,MD,IT,IT,2019,Q4,Adult
168922983,16892298,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 IU, QD",2760.0,IU,U,,,,,20.0,IU,SOLUTION FOR INJECTION,QD,2019,Q4,Seizure,,2019,Q4,3,F,20190519.0,20190930.0,20191007,20191104,EXP,IT-MINISAL02-577026,IT-SA-2019SA271650,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20191104.0,,MD,IT,IT,2019,Q4,Adult
168940561,16894056,2,I,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 IU, QD",,,Y,,,,,30.0,IU,SOLUTION FOR INJECTION,QD,2019,Q4,Bradycardia,,2019,Q4,1,I,20190806.0,20190930.0,20191008,20191008,EXP,IT-MINISAL02-576602,IT-SA-2019SA271378,SANOFI AVENTIS,,51.0,YR,A,M,Y,,,20191008.0,,MD,IT,IT,2019,Q4,Adult
168940561,16894056,2,I,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 IU, QD",,,Y,,,,,30.0,IU,SOLUTION FOR INJECTION,QD,2019,Q4,Chest pain,,2019,Q4,1,I,20190806.0,20190930.0,20191008,20191008,EXP,IT-MINISAL02-576602,IT-SA-2019SA271378,SANOFI AVENTIS,,51.0,YR,A,M,Y,,,20191008.0,,MD,IT,IT,2019,Q4,Adult
168940561,16894056,2,I,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 IU, QD",,,Y,,,,,30.0,IU,SOLUTION FOR INJECTION,QD,2019,Q4,Drug interaction,,2019,Q4,1,I,20190806.0,20190930.0,20191008,20191008,EXP,IT-MINISAL02-576602,IT-SA-2019SA271378,SANOFI AVENTIS,,51.0,YR,A,M,Y,,,20191008.0,,MD,IT,IT,2019,Q4,Adult
168940561,16894056,2,I,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 IU, QD",,,Y,,,,,30.0,IU,SOLUTION FOR INJECTION,QD,2019,Q4,Hyperhidrosis,,2019,Q4,1,I,20190806.0,20190930.0,20191008,20191008,EXP,IT-MINISAL02-576602,IT-SA-2019SA271378,SANOFI AVENTIS,,51.0,YR,A,M,Y,,,20191008.0,,MD,IT,IT,2019,Q4,Adult
168940561,16894056,2,I,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 IU, QD",,,Y,,,,,30.0,IU,SOLUTION FOR INJECTION,QD,2019,Q4,Hypoglycaemia,,2019,Q4,1,I,20190806.0,20190930.0,20191008,20191008,EXP,IT-MINISAL02-576602,IT-SA-2019SA271378,SANOFI AVENTIS,,51.0,YR,A,M,Y,,,20191008.0,,MD,IT,IT,2019,Q4,Adult
168940561,16894056,2,I,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 IU, QD",,,Y,,,,,30.0,IU,SOLUTION FOR INJECTION,QD,2019,Q4,Hypotension,,2019,Q4,1,I,20190806.0,20190930.0,20191008,20191008,EXP,IT-MINISAL02-576602,IT-SA-2019SA271378,SANOFI AVENTIS,,51.0,YR,A,M,Y,,,20191008.0,,MD,IT,IT,2019,Q4,Adult
168982671,16898267,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"20 INTERNATIONAL UNIT, DAILY",,,U,U,,,20563.0,20.0,IU,,QD,2019,Q4,Confusional state,,2019,Q4,1,I,20190519.0,20190927.0,20191009,20191009,EXP,IT-MINISAL02-577026,IT-ELI_LILLY_AND_COMPANY-IT201909014261,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20191009.0,,CN,IT,IT,2019,Q4,Adult
168982671,16898267,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"20 INTERNATIONAL UNIT, DAILY",,,U,U,,,20563.0,20.0,IU,,QD,2019,Q4,Fall,,2019,Q4,1,I,20190519.0,20190927.0,20191009,20191009,EXP,IT-MINISAL02-577026,IT-ELI_LILLY_AND_COMPANY-IT201909014261,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20191009.0,,CN,IT,IT,2019,Q4,Adult
168982671,16898267,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"20 INTERNATIONAL UNIT, DAILY",,,U,U,,,20563.0,20.0,IU,,QD,2019,Q4,Head injury,,2019,Q4,1,I,20190519.0,20190927.0,20191009,20191009,EXP,IT-MINISAL02-577026,IT-ELI_LILLY_AND_COMPANY-IT201909014261,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20191009.0,,CN,IT,IT,2019,Q4,Adult
168982671,16898267,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"20 INTERNATIONAL UNIT, DAILY",,,U,U,,,20563.0,20.0,IU,,QD,2019,Q4,Hypoglycaemia,,2019,Q4,1,I,20190519.0,20190927.0,20191009,20191009,EXP,IT-MINISAL02-577026,IT-ELI_LILLY_AND_COMPANY-IT201909014261,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20191009.0,,CN,IT,IT,2019,Q4,Adult
168982671,16898267,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"20 INTERNATIONAL UNIT, DAILY",,,U,U,,,20563.0,20.0,IU,,QD,2019,Q4,Seizure,,2019,Q4,1,I,20190519.0,20190927.0,20191009,20191009,EXP,IT-MINISAL02-577026,IT-ELI_LILLY_AND_COMPANY-IT201909014261,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20191009.0,,CN,IT,IT,2019,Q4,Adult
168994441,16899444,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"30 INTERNATIONAL UNIT, DAILY",,,Y,U,,,20563.0,30.0,IU,,QD,2019,Q4,Bradycardia,,2019,Q4,1,I,20190806.0,20190927.0,20191009,20191009,EXP,IT-MINISAL02-576602,IT-ELI_LILLY_AND_COMPANY-IT201909014080,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20191009.0,,CN,IT,IT,2019,Q4,Adult
168994441,16899444,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"30 INTERNATIONAL UNIT, DAILY",,,Y,U,,,20563.0,30.0,IU,,QD,2019,Q4,Chest pain,,2019,Q4,1,I,20190806.0,20190927.0,20191009,20191009,EXP,IT-MINISAL02-576602,IT-ELI_LILLY_AND_COMPANY-IT201909014080,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20191009.0,,CN,IT,IT,2019,Q4,Adult
168994441,16899444,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"30 INTERNATIONAL UNIT, DAILY",,,Y,U,,,20563.0,30.0,IU,,QD,2019,Q4,Drug interaction,,2019,Q4,1,I,20190806.0,20190927.0,20191009,20191009,EXP,IT-MINISAL02-576602,IT-ELI_LILLY_AND_COMPANY-IT201909014080,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20191009.0,,CN,IT,IT,2019,Q4,Adult
168994441,16899444,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"30 INTERNATIONAL UNIT, DAILY",,,Y,U,,,20563.0,30.0,IU,,QD,2019,Q4,Hyperhidrosis,,2019,Q4,1,I,20190806.0,20190927.0,20191009,20191009,EXP,IT-MINISAL02-576602,IT-ELI_LILLY_AND_COMPANY-IT201909014080,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20191009.0,,CN,IT,IT,2019,Q4,Adult
168994441,16899444,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"30 INTERNATIONAL UNIT, DAILY",,,Y,U,,,20563.0,30.0,IU,,QD,2019,Q4,Hypoglycaemia,,2019,Q4,1,I,20190806.0,20190927.0,20191009,20191009,EXP,IT-MINISAL02-576602,IT-ELI_LILLY_AND_COMPANY-IT201909014080,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20191009.0,,CN,IT,IT,2019,Q4,Adult
168994441,16899444,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"30 INTERNATIONAL UNIT, DAILY",,,Y,U,,,20563.0,30.0,IU,,QD,2019,Q4,Hypotension,,2019,Q4,1,I,20190806.0,20190927.0,20191009,20191009,EXP,IT-MINISAL02-576602,IT-ELI_LILLY_AND_COMPANY-IT201909014080,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20191009.0,,CN,IT,IT,2019,Q4,Adult
169004911,16900491,114,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q4,Abdominal pain,,2019,Q4,1,I,,20190930.0,20191009,20191009,EXP,,CA-TEVA-2019-CA-1116773,TEVA,,62.0,YR,,F,Y,67.0,KG,20191009.0,,OT,CA,CA,2019,Q4,Adult
169004911,16900491,114,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q4,Abscess,,2019,Q4,1,I,,20190930.0,20191009,20191009,EXP,,CA-TEVA-2019-CA-1116773,TEVA,,62.0,YR,,F,Y,67.0,KG,20191009.0,,OT,CA,CA,2019,Q4,Adult
169004911,16900491,114,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q4,Adrenal insufficiency,,2019,Q4,1,I,,20190930.0,20191009,20191009,EXP,,CA-TEVA-2019-CA-1116773,TEVA,,62.0,YR,,F,Y,67.0,KG,20191009.0,,OT,CA,CA,2019,Q4,Adult
169004911,16900491,114,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q4,Alanine aminotransferase increased,,2019,Q4,1,I,,20190930.0,20191009,20191009,EXP,,CA-TEVA-2019-CA-1116773,TEVA,,62.0,YR,,F,Y,67.0,KG,20191009.0,,OT,CA,CA,2019,Q4,Adult
169004911,16900491,114,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q4,Ascites,,2019,Q4,1,I,,20190930.0,20191009,20191009,EXP,,CA-TEVA-2019-CA-1116773,TEVA,,62.0,YR,,F,Y,67.0,KG,20191009.0,,OT,CA,CA,2019,Q4,Adult
169004911,16900491,114,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q4,Asthenia,,2019,Q4,1,I,,20190930.0,20191009,20191009,EXP,,CA-TEVA-2019-CA-1116773,TEVA,,62.0,YR,,F,Y,67.0,KG,20191009.0,,OT,CA,CA,2019,Q4,Adult
169004911,16900491,114,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q4,Blood alkaline phosphatase increased,,2019,Q4,1,I,,20190930.0,20191009,20191009,EXP,,CA-TEVA-2019-CA-1116773,TEVA,,62.0,YR,,F,Y,67.0,KG,20191009.0,,OT,CA,CA,2019,Q4,Adult
169004911,16900491,114,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q4,Blood bilirubin increased,,2019,Q4,1,I,,20190930.0,20191009,20191009,EXP,,CA-TEVA-2019-CA-1116773,TEVA,,62.0,YR,,F,Y,67.0,KG,20191009.0,,OT,CA,CA,2019,Q4,Adult
169004911,16900491,114,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q4,Blood potassium decreased,,2019,Q4,1,I,,20190930.0,20191009,20191009,EXP,,CA-TEVA-2019-CA-1116773,TEVA,,62.0,YR,,F,Y,67.0,KG,20191009.0,,OT,CA,CA,2019,Q4,Adult
169004911,16900491,114,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q4,Blood pressure diastolic abnormal,,2019,Q4,1,I,,20190930.0,20191009,20191009,EXP,,CA-TEVA-2019-CA-1116773,TEVA,,62.0,YR,,F,Y,67.0,KG,20191009.0,,OT,CA,CA,2019,Q4,Adult
169004911,16900491,114,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q4,Blood pressure increased,,2019,Q4,1,I,,20190930.0,20191009,20191009,EXP,,CA-TEVA-2019-CA-1116773,TEVA,,62.0,YR,,F,Y,67.0,KG,20191009.0,,OT,CA,CA,2019,Q4,Adult
169004911,16900491,114,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q4,Depression,,2019,Q4,1,I,,20190930.0,20191009,20191009,EXP,,CA-TEVA-2019-CA-1116773,TEVA,,62.0,YR,,F,Y,67.0,KG,20191009.0,,OT,CA,CA,2019,Q4,Adult
169004911,16900491,114,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q4,Diverticulitis,,2019,Q4,1,I,,20190930.0,20191009,20191009,EXP,,CA-TEVA-2019-CA-1116773,TEVA,,62.0,YR,,F,Y,67.0,KG,20191009.0,,OT,CA,CA,2019,Q4,Adult
169004911,16900491,114,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q4,Endometrial disorder,,2019,Q4,1,I,,20190930.0,20191009,20191009,EXP,,CA-TEVA-2019-CA-1116773,TEVA,,62.0,YR,,F,Y,67.0,KG,20191009.0,,OT,CA,CA,2019,Q4,Adult
169004911,16900491,114,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q4,Enterococcus test positive,,2019,Q4,1,I,,20190930.0,20191009,20191009,EXP,,CA-TEVA-2019-CA-1116773,TEVA,,62.0,YR,,F,Y,67.0,KG,20191009.0,,OT,CA,CA,2019,Q4,Adult
169004911,16900491,114,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q4,Fibrosis,,2019,Q4,1,I,,20190930.0,20191009,20191009,EXP,,CA-TEVA-2019-CA-1116773,TEVA,,62.0,YR,,F,Y,67.0,KG,20191009.0,,OT,CA,CA,2019,Q4,Adult
169004911,16900491,114,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q4,Gamma-glutamyltransferase increased,,2019,Q4,1,I,,20190930.0,20191009,20191009,EXP,,CA-TEVA-2019-CA-1116773,TEVA,,62.0,YR,,F,Y,67.0,KG,20191009.0,,OT,CA,CA,2019,Q4,Adult
169004911,16900491,114,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q4,Gastrointestinal disorder,,2019,Q4,1,I,,20190930.0,20191009,20191009,EXP,,CA-TEVA-2019-CA-1116773,TEVA,,62.0,YR,,F,Y,67.0,KG,20191009.0,,OT,CA,CA,2019,Q4,Adult
169004911,16900491,114,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q4,Generalised oedema,,2019,Q4,1,I,,20190930.0,20191009,20191009,EXP,,CA-TEVA-2019-CA-1116773,TEVA,,62.0,YR,,F,Y,67.0,KG,20191009.0,,OT,CA,CA,2019,Q4,Adult
169004911,16900491,114,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q4,Heart rate increased,,2019,Q4,1,I,,20190930.0,20191009,20191009,EXP,,CA-TEVA-2019-CA-1116773,TEVA,,62.0,YR,,F,Y,67.0,KG,20191009.0,,OT,CA,CA,2019,Q4,Adult
169004911,16900491,114,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q4,Hepatic congestion,,2019,Q4,1,I,,20190930.0,20191009,20191009,EXP,,CA-TEVA-2019-CA-1116773,TEVA,,62.0,YR,,F,Y,67.0,KG,20191009.0,,OT,CA,CA,2019,Q4,Adult
169004911,16900491,114,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q4,Herpes zoster,,2019,Q4,1,I,,20190930.0,20191009,20191009,EXP,,CA-TEVA-2019-CA-1116773,TEVA,,62.0,YR,,F,Y,67.0,KG,20191009.0,,OT,CA,CA,2019,Q4,Adult
169004911,16900491,114,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q4,Hypersensitivity,,2019,Q4,1,I,,20190930.0,20191009,20191009,EXP,,CA-TEVA-2019-CA-1116773,TEVA,,62.0,YR,,F,Y,67.0,KG,20191009.0,,OT,CA,CA,2019,Q4,Adult
169004911,16900491,114,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q4,Hypoglycaemia,,2019,Q4,1,I,,20190930.0,20191009,20191009,EXP,,CA-TEVA-2019-CA-1116773,TEVA,,62.0,YR,,F,Y,67.0,KG,20191009.0,,OT,CA,CA,2019,Q4,Adult
169004911,16900491,114,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q4,Hypotension,,2019,Q4,1,I,,20190930.0,20191009,20191009,EXP,,CA-TEVA-2019-CA-1116773,TEVA,,62.0,YR,,F,Y,67.0,KG,20191009.0,,OT,CA,CA,2019,Q4,Adult
169004911,16900491,114,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q4,Increased appetite,,2019,Q4,1,I,,20190930.0,20191009,20191009,EXP,,CA-TEVA-2019-CA-1116773,TEVA,,62.0,YR,,F,Y,67.0,KG,20191009.0,,OT,CA,CA,2019,Q4,Adult
169004911,16900491,114,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q4,Influenza,,2019,Q4,1,I,,20190930.0,20191009,20191009,EXP,,CA-TEVA-2019-CA-1116773,TEVA,,62.0,YR,,F,Y,67.0,KG,20191009.0,,OT,CA,CA,2019,Q4,Adult
169004911,16900491,114,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q4,Infusion related reaction,,2019,Q4,1,I,,20190930.0,20191009,20191009,EXP,,CA-TEVA-2019-CA-1116773,TEVA,,62.0,YR,,F,Y,67.0,KG,20191009.0,,OT,CA,CA,2019,Q4,Adult
169004911,16900491,114,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q4,Injection site extravasation,,2019,Q4,1,I,,20190930.0,20191009,20191009,EXP,,CA-TEVA-2019-CA-1116773,TEVA,,62.0,YR,,F,Y,67.0,KG,20191009.0,,OT,CA,CA,2019,Q4,Adult
169004911,16900491,114,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q4,Intensive care unit acquired weakness,,2019,Q4,1,I,,20190930.0,20191009,20191009,EXP,,CA-TEVA-2019-CA-1116773,TEVA,,62.0,YR,,F,Y,67.0,KG,20191009.0,,OT,CA,CA,2019,Q4,Adult
169004911,16900491,114,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q4,Intervertebral disc protrusion,,2019,Q4,1,I,,20190930.0,20191009,20191009,EXP,,CA-TEVA-2019-CA-1116773,TEVA,,62.0,YR,,F,Y,67.0,KG,20191009.0,,OT,CA,CA,2019,Q4,Adult
169004911,16900491,114,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q4,Joint effusion,,2019,Q4,1,I,,20190930.0,20191009,20191009,EXP,,CA-TEVA-2019-CA-1116773,TEVA,,62.0,YR,,F,Y,67.0,KG,20191009.0,,OT,CA,CA,2019,Q4,Adult
169004911,16900491,114,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q4,Joint swelling,,2019,Q4,1,I,,20190930.0,20191009,20191009,EXP,,CA-TEVA-2019-CA-1116773,TEVA,,62.0,YR,,F,Y,67.0,KG,20191009.0,,OT,CA,CA,2019,Q4,Adult
169004911,16900491,114,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q4,Micturition disorder,,2019,Q4,1,I,,20190930.0,20191009,20191009,EXP,,CA-TEVA-2019-CA-1116773,TEVA,,62.0,YR,,F,Y,67.0,KG,20191009.0,,OT,CA,CA,2019,Q4,Adult
169004911,16900491,114,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q4,Myelopathy,,2019,Q4,1,I,,20190930.0,20191009,20191009,EXP,,CA-TEVA-2019-CA-1116773,TEVA,,62.0,YR,,F,Y,67.0,KG,20191009.0,,OT,CA,CA,2019,Q4,Adult
169004911,16900491,114,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q4,Myopathy,,2019,Q4,1,I,,20190930.0,20191009,20191009,EXP,,CA-TEVA-2019-CA-1116773,TEVA,,62.0,YR,,F,Y,67.0,KG,20191009.0,,OT,CA,CA,2019,Q4,Adult
169004911,16900491,114,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q4,Nasopharyngitis,,2019,Q4,1,I,,20190930.0,20191009,20191009,EXP,,CA-TEVA-2019-CA-1116773,TEVA,,62.0,YR,,F,Y,67.0,KG,20191009.0,,OT,CA,CA,2019,Q4,Adult
169004911,16900491,114,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q4,Nausea,,2019,Q4,1,I,,20190930.0,20191009,20191009,EXP,,CA-TEVA-2019-CA-1116773,TEVA,,62.0,YR,,F,Y,67.0,KG,20191009.0,,OT,CA,CA,2019,Q4,Adult
169004911,16900491,114,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q4,Nerve compression,,2019,Q4,1,I,,20190930.0,20191009,20191009,EXP,,CA-TEVA-2019-CA-1116773,TEVA,,62.0,YR,,F,Y,67.0,KG,20191009.0,,OT,CA,CA,2019,Q4,Adult
169004911,16900491,114,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q4,Neuropathy peripheral,,2019,Q4,1,I,,20190930.0,20191009,20191009,EXP,,CA-TEVA-2019-CA-1116773,TEVA,,62.0,YR,,F,Y,67.0,KG,20191009.0,,OT,CA,CA,2019,Q4,Adult
169004911,16900491,114,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q4,Neutropenia,,2019,Q4,1,I,,20190930.0,20191009,20191009,EXP,,CA-TEVA-2019-CA-1116773,TEVA,,62.0,YR,,F,Y,67.0,KG,20191009.0,,OT,CA,CA,2019,Q4,Adult
169004911,16900491,114,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q4,Osteoarthritis,,2019,Q4,1,I,,20190930.0,20191009,20191009,EXP,,CA-TEVA-2019-CA-1116773,TEVA,,62.0,YR,,F,Y,67.0,KG,20191009.0,,OT,CA,CA,2019,Q4,Adult
169004911,16900491,114,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q4,Pancytopenia,,2019,Q4,1,I,,20190930.0,20191009,20191009,EXP,,CA-TEVA-2019-CA-1116773,TEVA,,62.0,YR,,F,Y,67.0,KG,20191009.0,,OT,CA,CA,2019,Q4,Adult
169004911,16900491,114,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q4,Peripheral sensorimotor neuropathy,,2019,Q4,1,I,,20190930.0,20191009,20191009,EXP,,CA-TEVA-2019-CA-1116773,TEVA,,62.0,YR,,F,Y,67.0,KG,20191009.0,,OT,CA,CA,2019,Q4,Adult
169004911,16900491,114,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q4,Peritonitis,,2019,Q4,1,I,,20190930.0,20191009,20191009,EXP,,CA-TEVA-2019-CA-1116773,TEVA,,62.0,YR,,F,Y,67.0,KG,20191009.0,,OT,CA,CA,2019,Q4,Adult
169004911,16900491,114,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q4,Pneumonia,,2019,Q4,1,I,,20190930.0,20191009,20191009,EXP,,CA-TEVA-2019-CA-1116773,TEVA,,62.0,YR,,F,Y,67.0,KG,20191009.0,,OT,CA,CA,2019,Q4,Adult
169004911,16900491,114,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q4,Pseudomonal bacteraemia,,2019,Q4,1,I,,20190930.0,20191009,20191009,EXP,,CA-TEVA-2019-CA-1116773,TEVA,,62.0,YR,,F,Y,67.0,KG,20191009.0,,OT,CA,CA,2019,Q4,Adult
169004911,16900491,114,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q4,Rheumatoid arthritis,,2019,Q4,1,I,,20190930.0,20191009,20191009,EXP,,CA-TEVA-2019-CA-1116773,TEVA,,62.0,YR,,F,Y,67.0,KG,20191009.0,,OT,CA,CA,2019,Q4,Adult
169004911,16900491,114,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q4,Septic shock,,2019,Q4,1,I,,20190930.0,20191009,20191009,EXP,,CA-TEVA-2019-CA-1116773,TEVA,,62.0,YR,,F,Y,67.0,KG,20191009.0,,OT,CA,CA,2019,Q4,Adult
169004911,16900491,114,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q4,Therapeutic response decreased,,2019,Q4,1,I,,20190930.0,20191009,20191009,EXP,,CA-TEVA-2019-CA-1116773,TEVA,,62.0,YR,,F,Y,67.0,KG,20191009.0,,OT,CA,CA,2019,Q4,Adult
169004911,16900491,114,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q4,Vomiting,,2019,Q4,1,I,,20190930.0,20191009,20191009,EXP,,CA-TEVA-2019-CA-1116773,TEVA,,62.0,YR,,F,Y,67.0,KG,20191009.0,,OT,CA,CA,2019,Q4,Adult
169004911,16900491,114,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q4,Weight decreased,,2019,Q4,1,I,,20190930.0,20191009,20191009,EXP,,CA-TEVA-2019-CA-1116773,TEVA,,62.0,YR,,F,Y,67.0,KG,20191009.0,,OT,CA,CA,2019,Q4,Adult
169004911,16900491,114,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q4,Weight increased,,2019,Q4,1,I,,20190930.0,20191009,20191009,EXP,,CA-TEVA-2019-CA-1116773,TEVA,,62.0,YR,,F,Y,67.0,KG,20191009.0,,OT,CA,CA,2019,Q4,Adult
169075702,16907570,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2019,Q4,Arthritis,,2019,Q4,2,F,20181209.0,20191217.0,20191011,20191229,EXP,,SE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-094840,BRISTOL MYERS SQUIBB,,82.0,YR,,M,Y,80.0,KG,20191229.0,,OT,SE,SE,2019,Q4,Elderly
169075702,16907570,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2019,Q4,Dysphagia,,2019,Q4,2,F,20181209.0,20191217.0,20191011,20191229,EXP,,SE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-094840,BRISTOL MYERS SQUIBB,,82.0,YR,,M,Y,80.0,KG,20191229.0,,OT,SE,SE,2019,Q4,Elderly
169075702,16907570,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2019,Q4,Dyspnoea,,2019,Q4,2,F,20181209.0,20191217.0,20191011,20191229,EXP,,SE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-094840,BRISTOL MYERS SQUIBB,,82.0,YR,,M,Y,80.0,KG,20191229.0,,OT,SE,SE,2019,Q4,Elderly
169075702,16907570,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2019,Q4,Fall,,2019,Q4,2,F,20181209.0,20191217.0,20191011,20191229,EXP,,SE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-094840,BRISTOL MYERS SQUIBB,,82.0,YR,,M,Y,80.0,KG,20191229.0,,OT,SE,SE,2019,Q4,Elderly
169075702,16907570,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2019,Q4,Pain in extremity,,2019,Q4,2,F,20181209.0,20191217.0,20191011,20191229,EXP,,SE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-094840,BRISTOL MYERS SQUIBB,,82.0,YR,,M,Y,80.0,KG,20191229.0,,OT,SE,SE,2019,Q4,Elderly
169075702,16907570,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2019,Q4,Scratch,,2019,Q4,2,F,20181209.0,20191217.0,20191011,20191229,EXP,,SE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-094840,BRISTOL MYERS SQUIBB,,82.0,YR,,M,Y,80.0,KG,20191229.0,,OT,SE,SE,2019,Q4,Elderly
169075702,16907570,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2019,Q4,Subarachnoid haemorrhage,,2019,Q4,2,F,20181209.0,20191217.0,20191011,20191229,EXP,,SE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-094840,BRISTOL MYERS SQUIBB,,82.0,YR,,M,Y,80.0,KG,20191229.0,,OT,SE,SE,2019,Q4,Elderly
169075702,16907570,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2019,Q4,Syncope,,2019,Q4,2,F,20181209.0,20191217.0,20191011,20191229,EXP,,SE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-094840,BRISTOL MYERS SQUIBB,,82.0,YR,,M,Y,80.0,KG,20191229.0,,OT,SE,SE,2019,Q4,Elderly
169075702,16907570,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2019,Q4,Tachycardia,,2019,Q4,2,F,20181209.0,20191217.0,20191011,20191229,EXP,,SE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-094840,BRISTOL MYERS SQUIBB,,82.0,YR,,M,Y,80.0,KG,20191229.0,,OT,SE,SE,2019,Q4,Elderly
169116751,16911675,18,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"UNK, TWO TIMES A DAY",,,,,,,,,,,BID,2019,Q4,Asthma,,2019,Q4,1,I,,20191003.0,20191013,20191013,EXP,,CA-AUROBINDO-AUR-APL-2019-065720,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20191014.0,,CN,CA,CA,2019,Q4,Elderly
169116751,16911675,18,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"UNK, TWO TIMES A DAY",,,,,,,,,,,BID,2019,Q4,Blood count abnormal,,2019,Q4,1,I,,20191003.0,20191013,20191013,EXP,,CA-AUROBINDO-AUR-APL-2019-065720,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20191014.0,,CN,CA,CA,2019,Q4,Elderly
169116751,16911675,18,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"UNK, TWO TIMES A DAY",,,,,,,,,,,BID,2019,Q4,Chest discomfort,,2019,Q4,1,I,,20191003.0,20191013,20191013,EXP,,CA-AUROBINDO-AUR-APL-2019-065720,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20191014.0,,CN,CA,CA,2019,Q4,Elderly
169116751,16911675,18,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"UNK, TWO TIMES A DAY",,,,,,,,,,,BID,2019,Q4,Cough,,2019,Q4,1,I,,20191003.0,20191013,20191013,EXP,,CA-AUROBINDO-AUR-APL-2019-065720,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20191014.0,,CN,CA,CA,2019,Q4,Elderly
169116751,16911675,18,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"UNK, TWO TIMES A DAY",,,,,,,,,,,BID,2019,Q4,Diaphragmatic disorder,,2019,Q4,1,I,,20191003.0,20191013,20191013,EXP,,CA-AUROBINDO-AUR-APL-2019-065720,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20191014.0,,CN,CA,CA,2019,Q4,Elderly
169116751,16911675,18,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"UNK, TWO TIMES A DAY",,,,,,,,,,,BID,2019,Q4,Discomfort,,2019,Q4,1,I,,20191003.0,20191013,20191013,EXP,,CA-AUROBINDO-AUR-APL-2019-065720,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20191014.0,,CN,CA,CA,2019,Q4,Elderly
169116751,16911675,18,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"UNK, TWO TIMES A DAY",,,,,,,,,,,BID,2019,Q4,Dyspnoea,,2019,Q4,1,I,,20191003.0,20191013,20191013,EXP,,CA-AUROBINDO-AUR-APL-2019-065720,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20191014.0,,CN,CA,CA,2019,Q4,Elderly
169116751,16911675,18,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"UNK, TWO TIMES A DAY",,,,,,,,,,,BID,2019,Q4,Hypoxia,,2019,Q4,1,I,,20191003.0,20191013,20191013,EXP,,CA-AUROBINDO-AUR-APL-2019-065720,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20191014.0,,CN,CA,CA,2019,Q4,Elderly
169116751,16911675,18,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"UNK, TWO TIMES A DAY",,,,,,,,,,,BID,2019,Q4,Left ventricular hypertrophy,,2019,Q4,1,I,,20191003.0,20191013,20191013,EXP,,CA-AUROBINDO-AUR-APL-2019-065720,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20191014.0,,CN,CA,CA,2019,Q4,Elderly
169116751,16911675,18,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"UNK, TWO TIMES A DAY",,,,,,,,,,,BID,2019,Q4,Obstructive airways disorder,,2019,Q4,1,I,,20191003.0,20191013,20191013,EXP,,CA-AUROBINDO-AUR-APL-2019-065720,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20191014.0,,CN,CA,CA,2019,Q4,Elderly
169116751,16911675,18,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"UNK, TWO TIMES A DAY",,,,,,,,,,,BID,2019,Q4,Oedema peripheral,,2019,Q4,1,I,,20191003.0,20191013,20191013,EXP,,CA-AUROBINDO-AUR-APL-2019-065720,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20191014.0,,CN,CA,CA,2019,Q4,Elderly
169116751,16911675,18,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"UNK, TWO TIMES A DAY",,,,,,,,,,,BID,2019,Q4,Oropharyngeal pain,,2019,Q4,1,I,,20191003.0,20191013,20191013,EXP,,CA-AUROBINDO-AUR-APL-2019-065720,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20191014.0,,CN,CA,CA,2019,Q4,Elderly
169116751,16911675,18,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"UNK, TWO TIMES A DAY",,,,,,,,,,,BID,2019,Q4,Pyrexia,,2019,Q4,1,I,,20191003.0,20191013,20191013,EXP,,CA-AUROBINDO-AUR-APL-2019-065720,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20191014.0,,CN,CA,CA,2019,Q4,Elderly
169116751,16911675,18,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"UNK, TWO TIMES A DAY",,,,,,,,,,,BID,2019,Q4,Therapeutic product effect incomplete,,2019,Q4,1,I,,20191003.0,20191013,20191013,EXP,,CA-AUROBINDO-AUR-APL-2019-065720,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20191014.0,,CN,CA,CA,2019,Q4,Elderly
169116751,16911675,18,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"UNK, TWO TIMES A DAY",,,,,,,,,,,BID,2019,Q4,Weight increased,,2019,Q4,1,I,,20191003.0,20191013,20191013,EXP,,CA-AUROBINDO-AUR-APL-2019-065720,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20191014.0,,CN,CA,CA,2019,Q4,Elderly
169116751,16911675,18,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"UNK, TWO TIMES A DAY",,,,,,,,,,,BID,2019,Q4,Wheezing,,2019,Q4,1,I,,20191003.0,20191013,20191013,EXP,,CA-AUROBINDO-AUR-APL-2019-065720,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20191014.0,,CN,CA,CA,2019,Q4,Elderly
169121182,16912118,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,1 INTERNATIONAL UNIT,,,,,,,,1.0,IU,,,2019,Q4,Encephalopathy,,2019,Q4,2,F,20171218.0,20191010.0,20191014,20191018,PER,,FR-AMGEN-FRANI2018076444,AMGEN,,69.0,YR,E,M,Y,77.0,KG,20191018.0,,MD,FR,FR,2019,Q4,Elderly
169141351,16914135,10,C,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,U,, UNKNOWN,,,,,,,2019,Q4,Confusional state,,2019,Q4,1,I,,20191001.0,20191014,20191014,EXP,,US-GRANULES INDIA LIMITED-2075616,GRANULES INDIA,,46.0,YR,,F,Y,177.0,KG,20191014.0,,MD,US,US,2019,Q4,Adult
169141351,16914135,10,C,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,U,, UNKNOWN,,,,,,,2019,Q4,Deafness,,2019,Q4,1,I,,20191001.0,20191014,20191014,EXP,,US-GRANULES INDIA LIMITED-2075616,GRANULES INDIA,,46.0,YR,,F,Y,177.0,KG,20191014.0,,MD,US,US,2019,Q4,Adult
169141351,16914135,10,C,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,U,, UNKNOWN,,,,,,,2019,Q4,Hallucination,,2019,Q4,1,I,,20191001.0,20191014,20191014,EXP,,US-GRANULES INDIA LIMITED-2075616,GRANULES INDIA,,46.0,YR,,F,Y,177.0,KG,20191014.0,,MD,US,US,2019,Q4,Adult
169141351,16914135,10,C,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,U,, UNKNOWN,,,,,,,2019,Q4,Myoclonus,,2019,Q4,1,I,,20191001.0,20191014,20191014,EXP,,US-GRANULES INDIA LIMITED-2075616,GRANULES INDIA,,46.0,YR,,F,Y,177.0,KG,20191014.0,,MD,US,US,2019,Q4,Adult
169141351,16914135,10,C,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,U,, UNKNOWN,,,,,,,2019,Q4,Toxicity to various agents,,2019,Q4,1,I,,20191001.0,20191014,20191014,EXP,,US-GRANULES INDIA LIMITED-2075616,GRANULES INDIA,,46.0,YR,,F,Y,177.0,KG,20191014.0,,MD,US,US,2019,Q4,Adult
169253291,16925329,9,C,Insulin Lispro TID as needed with meals,,2,,,,,,,,,,,,,,2019,Q4,Decubitus ulcer,,2019,Q4,1,I,20191014.0,,20191016,20191016,DIR,,,FDA-CTU,,75.0,YR,,M,N,82.7,KG,20191016.0,N,,US,US,2019,Q4,Elderly
169253291,16925329,9,C,Insulin Lispro TID as needed with meals,,2,,,,,,,,,,,,,,2019,Q4,Hypotension,,2019,Q4,1,I,20191014.0,,20191016,20191016,DIR,,,FDA-CTU,,75.0,YR,,M,N,82.7,KG,20191016.0,N,,US,US,2019,Q4,Elderly
169253291,16925329,9,C,Insulin Lispro TID as needed with meals,,2,,,,,,,,,,,,,,2019,Q4,Pyrexia,,2019,Q4,1,I,20191014.0,,20191016,20191016,DIR,,,FDA-CTU,,75.0,YR,,M,N,82.7,KG,20191016.0,N,,US,US,2019,Q4,Elderly
169253291,16925329,9,C,Insulin Lispro TID as needed with meals,,2,,,,,,,,,,,,,,2019,Q4,Unresponsive to stimuli,,2019,Q4,1,I,20191014.0,,20191016,20191016,DIR,,,FDA-CTU,,75.0,YR,,M,N,82.7,KG,20191016.0,N,,US,US,2019,Q4,Elderly
169253291,16925329,9,C,Insulin Lispro TID as needed with meals,,2,,,,,,,,,,,,,,2019,Q4,Wound complication,,2019,Q4,1,I,20191014.0,,20191016,20191016,DIR,,,FDA-CTU,,75.0,YR,,M,N,82.7,KG,20191016.0,N,,US,US,2019,Q4,Elderly
169263312,16926331,11,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,16 IU (INTERNATIONAL UNIT),,,,,,,,16.0,IU,UNKNOWN,QD,2019,Q4,Diarrhoea,,2019,Q4,2,F,201809.0,20191120.0,20191016,20191127,EXP,,JP-CELGENEUS-JPN-20191005347,CELGENE,,66.0,YR,,F,Y,61.4,KG,20191127.0,,MD,JP,JP,2019,Q4,Elderly
169263312,16926331,11,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,16 IU (INTERNATIONAL UNIT),,,,,,,,16.0,IU,UNKNOWN,QD,2019,Q4,Neuropathy peripheral,,2019,Q4,2,F,201809.0,20191120.0,20191016,20191127,EXP,,JP-CELGENEUS-JPN-20191005347,CELGENE,,66.0,YR,,F,Y,61.4,KG,20191127.0,,MD,JP,JP,2019,Q4,Elderly
169263312,16926331,11,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,16 IU (INTERNATIONAL UNIT),,,,,,,,16.0,IU,UNKNOWN,QD,2019,Q4,Oedema peripheral,,2019,Q4,2,F,201809.0,20191120.0,20191016,20191127,EXP,,JP-CELGENEUS-JPN-20191005347,CELGENE,,66.0,YR,,F,Y,61.4,KG,20191127.0,,MD,JP,JP,2019,Q4,Elderly
169315993,16931599,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,AS NECESSARY,,,,,,,,,,,,2019,Q4,Bursitis infective,,2019,Q4,3,F,201709.0,20191220.0,20191017,20191231,EXP,,US-BAYER-2019-188164,BAYER,,77.0,YR,E,F,Y,77.18,KG,20191231.0,,CN,US,US,2019,Q4,Elderly
169315993,16931599,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,AS NECESSARY,,,,,,,,,,,,2019,Q4,Coronary artery occlusion,,2019,Q4,3,F,201709.0,20191220.0,20191017,20191231,EXP,,US-BAYER-2019-188164,BAYER,,77.0,YR,E,F,Y,77.18,KG,20191231.0,,CN,US,US,2019,Q4,Elderly
169315993,16931599,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,AS NECESSARY,,,,,,,,,,,,2019,Q4,Haemarthrosis,,2019,Q4,3,F,201709.0,20191220.0,20191017,20191231,EXP,,US-BAYER-2019-188164,BAYER,,77.0,YR,E,F,Y,77.18,KG,20191231.0,,CN,US,US,2019,Q4,Elderly
169315993,16931599,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,AS NECESSARY,,,,,,,,,,,,2019,Q4,Haematoma,,2019,Q4,3,F,201709.0,20191220.0,20191017,20191231,EXP,,US-BAYER-2019-188164,BAYER,,77.0,YR,E,F,Y,77.18,KG,20191231.0,,CN,US,US,2019,Q4,Elderly
169320081,16932008,1,PS,Liprolog Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,,,2019,Q4,Diabetic metabolic decompensation,,2019,Q4,1,I,20190831.0,20191010.0,20191017,20191017,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201910005806,ELI LILLY AND CO,,15.0,YR,,F,Y,93.0,KG,20191017.0,,CN,DE,DE,2019,Q4,Youth
169320081,16932008,1,PS,Liprolog Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,,,2019,Q4,Product administration error,,2019,Q4,1,I,20190831.0,20191010.0,20191017,20191017,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201910005806,ELI LILLY AND CO,,15.0,YR,,F,Y,93.0,KG,20191017.0,,CN,DE,DE,2019,Q4,Youth
169320081,16932008,1,PS,Liprolog Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,,,2019,Q4,Treatment noncompliance,,2019,Q4,1,I,20190831.0,20191010.0,20191017,20191017,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201910005806,ELI LILLY AND CO,,15.0,YR,,F,Y,93.0,KG,20191017.0,,CN,DE,DE,2019,Q4,Youth
169340261,16934026,16,C,Insulin lispro (HUMALOG),,2,,,,,,,,,,,,,,2019,Q4,Aphasia,,2019,Q4,1,I,20190819.0,,20190826,20190826,DIR,,,FDA-CTU,,68.0,YR,,M,N,78.3,KG,20190826.0,N,,US,US,2019,Q4,Elderly
169340261,16934026,16,C,Insulin lispro (HUMALOG),,2,,,,,,,,,,,,,,2019,Q4,Brain midline shift,,2019,Q4,1,I,20190819.0,,20190826,20190826,DIR,,,FDA-CTU,,68.0,YR,,M,N,78.3,KG,20190826.0,N,,US,US,2019,Q4,Elderly
169340261,16934026,16,C,Insulin lispro (HUMALOG),,2,,,,,,,,,,,,,,2019,Q4,Brain oedema,,2019,Q4,1,I,20190819.0,,20190826,20190826,DIR,,,FDA-CTU,,68.0,YR,,M,N,78.3,KG,20190826.0,N,,US,US,2019,Q4,Elderly
169340261,16934026,16,C,Insulin lispro (HUMALOG),,2,,,,,,,,,,,,,,2019,Q4,Cerebrovascular accident,,2019,Q4,1,I,20190819.0,,20190826,20190826,DIR,,,FDA-CTU,,68.0,YR,,M,N,78.3,KG,20190826.0,N,,US,US,2019,Q4,Elderly
169340261,16934026,16,C,Insulin lispro (HUMALOG),,2,,,,,,,,,,,,,,2019,Q4,Condition aggravated,,2019,Q4,1,I,20190819.0,,20190826,20190826,DIR,,,FDA-CTU,,68.0,YR,,M,N,78.3,KG,20190826.0,N,,US,US,2019,Q4,Elderly
169340261,16934026,16,C,Insulin lispro (HUMALOG),,2,,,,,,,,,,,,,,2019,Q4,Dysarthria,,2019,Q4,1,I,20190819.0,,20190826,20190826,DIR,,,FDA-CTU,,68.0,YR,,M,N,78.3,KG,20190826.0,N,,US,US,2019,Q4,Elderly
169340261,16934026,16,C,Insulin lispro (HUMALOG),,2,,,,,,,,,,,,,,2019,Q4,Fall,,2019,Q4,1,I,20190819.0,,20190826,20190826,DIR,,,FDA-CTU,,68.0,YR,,M,N,78.3,KG,20190826.0,N,,US,US,2019,Q4,Elderly
169340261,16934026,16,C,Insulin lispro (HUMALOG),,2,,,,,,,,,,,,,,2019,Q4,Hemiparesis,,2019,Q4,1,I,20190819.0,,20190826,20190826,DIR,,,FDA-CTU,,68.0,YR,,M,N,78.3,KG,20190826.0,N,,US,US,2019,Q4,Elderly
169355331,16935533,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,8 U,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q4,Blood glucose decreased,,2019,Q4,1,I,20191012.0,20191013.0,20191018,20191018,PER,,US-SA-2019SA286469,SANOFI AVENTIS,,61.0,YR,A,F,Y,,,20191018.0,,CN,US,US,2019,Q4,Adult
169355331,16935533,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,8 U,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q4,Blood glucose increased,,2019,Q4,1,I,20191012.0,20191013.0,20191018,20191018,PER,,US-SA-2019SA286469,SANOFI AVENTIS,,61.0,YR,A,F,Y,,,20191018.0,,CN,US,US,2019,Q4,Adult
169355331,16935533,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,8 U,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q4,Incorrect dose administered by product,,2019,Q4,1,I,20191012.0,20191013.0,20191018,20191018,PER,,US-SA-2019SA286469,SANOFI AVENTIS,,61.0,YR,A,F,Y,,,20191018.0,,CN,US,US,2019,Q4,Adult
169355331,16935533,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,8 U,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q4,Wrong product administered,,2019,Q4,1,I,20191012.0,20191013.0,20191018,20191018,PER,,US-SA-2019SA286469,SANOFI AVENTIS,,61.0,YR,A,F,Y,,,20191018.0,,CN,US,US,2019,Q4,Adult
169356411,16935641,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 UNIT/ML, TID",,,,,,,,,,,,2019,Q4,Psychotic disorder,,2019,Q4,1,I,20190922.0,20191010.0,20191018,20191018,EXP,,US-VERTEX PHARMACEUTICALS-2019-009932,VERTEX,,40.0,YR,,M,Y,57.0,KG,20191018.0,,MD,US,US,2019,Q4,Adult
169385033,16938503,30,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Renal impairment,,2019,Q4,3,F,20190903.0,20191030.0,20191019,20191125,PER,,PHHO2019US009702,NOVARTIS,,50.0,YR,,F,Y,110.2,KG,20191125.0,,OT,US,US,2019,Q4,Adult
169385033,16938503,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Renal impairment,,2019,Q4,3,F,20190903.0,20191030.0,20191019,20191125,PER,,PHHO2019US009702,NOVARTIS,,50.0,YR,,F,Y,110.2,KG,20191125.0,,OT,US,US,2019,Q4,Adult
169385033,16938503,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Renal impairment,,2019,Q4,3,F,20190903.0,20191030.0,20191019,20191125,PER,,PHHO2019US009702,NOVARTIS,,50.0,YR,,F,Y,110.2,KG,20191125.0,,OT,US,US,2019,Q4,Adult
169385033,16938503,33,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Renal impairment,,2019,Q4,3,F,20190903.0,20191030.0,20191019,20191125,PER,,PHHO2019US009702,NOVARTIS,,50.0,YR,,F,Y,110.2,KG,20191125.0,,OT,US,US,2019,Q4,Adult
169390671,16939067,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q4,Acute kidney injury,,2019,Q4,1,I,,20191016.0,20191020,20191020,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-108533",BOEHRINGER INGELHEIM,"NAIMARK D, MAHMOOD T, PUCKRIN R, SUGAR L. STAPHYLOCOCCUS-ASSOCIATED GLOMERULONEPHRITIS MIMICKING HENOCH-SCH?NLEIN PURPURA AND CRYOGLOBULINEMIC VASCULITIS IN A PATIENT WITH AN EPIDURAL ABSCESS: A CASE REPORT AND BRIEF REVIEW OF THE LITERATURE. CANADIAN JOURNAL OF KIDNEY HEALTH AND DISEASE. 2018;5:.",64.0,YR,,M,Y,,,20191021.0,,OT,CA,CA,2019,Q4,Adult
169390671,16939067,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q4,Extradural abscess,,2019,Q4,1,I,,20191016.0,20191020,20191020,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-108533",BOEHRINGER INGELHEIM,"NAIMARK D, MAHMOOD T, PUCKRIN R, SUGAR L. STAPHYLOCOCCUS-ASSOCIATED GLOMERULONEPHRITIS MIMICKING HENOCH-SCH?NLEIN PURPURA AND CRYOGLOBULINEMIC VASCULITIS IN A PATIENT WITH AN EPIDURAL ABSCESS: A CASE REPORT AND BRIEF REVIEW OF THE LITERATURE. CANADIAN JOURNAL OF KIDNEY HEALTH AND DISEASE. 2018;5:.",64.0,YR,,M,Y,,,20191021.0,,OT,CA,CA,2019,Q4,Adult
169390671,16939067,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q4,Post streptococcal glomerulonephritis,,2019,Q4,1,I,,20191016.0,20191020,20191020,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-BI-108533",BOEHRINGER INGELHEIM,"NAIMARK D, MAHMOOD T, PUCKRIN R, SUGAR L. STAPHYLOCOCCUS-ASSOCIATED GLOMERULONEPHRITIS MIMICKING HENOCH-SCH?NLEIN PURPURA AND CRYOGLOBULINEMIC VASCULITIS IN A PATIENT WITH AN EPIDURAL ABSCESS: A CASE REPORT AND BRIEF REVIEW OF THE LITERATURE. CANADIAN JOURNAL OF KIDNEY HEALTH AND DISEASE. 2018;5:.",64.0,YR,,M,Y,,,20191021.0,,OT,CA,CA,2019,Q4,Adult
169409431,16940943,14,C,Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Appendix disorder,,2019,Q4,1,I,20190615.0,,20191018,20191018,DIR,,,FDA-CTU,,48.0,YR,,M,N,90.0,KG,20191018.0,N,MD,US,US,2019,Q4,Adult
169409431,16940943,14,C,Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Gastrointestinal necrosis,,2019,Q4,1,I,20190615.0,,20191018,20191018,DIR,,,FDA-CTU,,48.0,YR,,M,N,90.0,KG,20191018.0,N,MD,US,US,2019,Q4,Adult
169409431,16940943,14,C,Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Ileus,,2019,Q4,1,I,20190615.0,,20191018,20191018,DIR,,,FDA-CTU,,48.0,YR,,M,N,90.0,KG,20191018.0,N,MD,US,US,2019,Q4,Adult
169409431,16940943,14,C,Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Ischaemia,,2019,Q4,1,I,20190615.0,,20191018,20191018,DIR,,,FDA-CTU,,48.0,YR,,M,N,90.0,KG,20191018.0,N,MD,US,US,2019,Q4,Adult
169426593,16942659,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q4,Abdominal discomfort,,2019,Q4,3,F,20181021.0,20191213.0,20191021,20191226,EXP,,US-ACTELION-A-NJ2018-180946,ACTELION,,62.0,YR,,M,Y,,,20191226.0,,OT,US,US,2019,Q4,Adult
169426593,16942659,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q4,Anaemia,,2019,Q4,3,F,20181021.0,20191213.0,20191021,20191226,EXP,,US-ACTELION-A-NJ2018-180946,ACTELION,,62.0,YR,,M,Y,,,20191226.0,,OT,US,US,2019,Q4,Adult
169426593,16942659,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q4,Asthenia,,2019,Q4,3,F,20181021.0,20191213.0,20191021,20191226,EXP,,US-ACTELION-A-NJ2018-180946,ACTELION,,62.0,YR,,M,Y,,,20191226.0,,OT,US,US,2019,Q4,Adult
169426593,16942659,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q4,Catheter site erythema,,2019,Q4,3,F,20181021.0,20191213.0,20191021,20191226,EXP,,US-ACTELION-A-NJ2018-180946,ACTELION,,62.0,YR,,M,Y,,,20191226.0,,OT,US,US,2019,Q4,Adult
169426593,16942659,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q4,Diarrhoea,,2019,Q4,3,F,20181021.0,20191213.0,20191021,20191226,EXP,,US-ACTELION-A-NJ2018-180946,ACTELION,,62.0,YR,,M,Y,,,20191226.0,,OT,US,US,2019,Q4,Adult
169426593,16942659,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q4,Drug intolerance,,2019,Q4,3,F,20181021.0,20191213.0,20191021,20191226,EXP,,US-ACTELION-A-NJ2018-180946,ACTELION,,62.0,YR,,M,Y,,,20191226.0,,OT,US,US,2019,Q4,Adult
169426593,16942659,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q4,Fall,,2019,Q4,3,F,20181021.0,20191213.0,20191021,20191226,EXP,,US-ACTELION-A-NJ2018-180946,ACTELION,,62.0,YR,,M,Y,,,20191226.0,,OT,US,US,2019,Q4,Adult
169426593,16942659,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q4,Fatigue,,2019,Q4,3,F,20181021.0,20191213.0,20191021,20191226,EXP,,US-ACTELION-A-NJ2018-180946,ACTELION,,62.0,YR,,M,Y,,,20191226.0,,OT,US,US,2019,Q4,Adult
169426593,16942659,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q4,Haemoglobin decreased,,2019,Q4,3,F,20181021.0,20191213.0,20191021,20191226,EXP,,US-ACTELION-A-NJ2018-180946,ACTELION,,62.0,YR,,M,Y,,,20191226.0,,OT,US,US,2019,Q4,Adult
169426593,16942659,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q4,Headache,,2019,Q4,3,F,20181021.0,20191213.0,20191021,20191226,EXP,,US-ACTELION-A-NJ2018-180946,ACTELION,,62.0,YR,,M,Y,,,20191226.0,,OT,US,US,2019,Q4,Adult
169426593,16942659,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q4,Hepatic mass,,2019,Q4,3,F,20181021.0,20191213.0,20191021,20191226,EXP,,US-ACTELION-A-NJ2018-180946,ACTELION,,62.0,YR,,M,Y,,,20191226.0,,OT,US,US,2019,Q4,Adult
169426593,16942659,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q4,Insomnia,,2019,Q4,3,F,20181021.0,20191213.0,20191021,20191226,EXP,,US-ACTELION-A-NJ2018-180946,ACTELION,,62.0,YR,,M,Y,,,20191226.0,,OT,US,US,2019,Q4,Adult
169426593,16942659,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q4,Nausea,,2019,Q4,3,F,20181021.0,20191213.0,20191021,20191226,EXP,,US-ACTELION-A-NJ2018-180946,ACTELION,,62.0,YR,,M,Y,,,20191226.0,,OT,US,US,2019,Q4,Adult
169426593,16942659,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q4,Pain,,2019,Q4,3,F,20181021.0,20191213.0,20191021,20191226,EXP,,US-ACTELION-A-NJ2018-180946,ACTELION,,62.0,YR,,M,Y,,,20191226.0,,OT,US,US,2019,Q4,Adult
169426593,16942659,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q4,Pain in extremity,,2019,Q4,3,F,20181021.0,20191213.0,20191021,20191226,EXP,,US-ACTELION-A-NJ2018-180946,ACTELION,,62.0,YR,,M,Y,,,20191226.0,,OT,US,US,2019,Q4,Adult
169426593,16942659,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q4,Peritoneal haemorrhage,,2019,Q4,3,F,20181021.0,20191213.0,20191021,20191226,EXP,,US-ACTELION-A-NJ2018-180946,ACTELION,,62.0,YR,,M,Y,,,20191226.0,,OT,US,US,2019,Q4,Adult
169426593,16942659,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q4,Restlessness,,2019,Q4,3,F,20181021.0,20191213.0,20191021,20191226,EXP,,US-ACTELION-A-NJ2018-180946,ACTELION,,62.0,YR,,M,Y,,,20191226.0,,OT,US,US,2019,Q4,Adult
169426593,16942659,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q4,Skin laceration,,2019,Q4,3,F,20181021.0,20191213.0,20191021,20191226,EXP,,US-ACTELION-A-NJ2018-180946,ACTELION,,62.0,YR,,M,Y,,,20191226.0,,OT,US,US,2019,Q4,Adult
169426593,16942659,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q4,Vomiting,,2019,Q4,3,F,20181021.0,20191213.0,20191021,20191226,EXP,,US-ACTELION-A-NJ2018-180946,ACTELION,,62.0,YR,,M,Y,,,20191226.0,,OT,US,US,2019,Q4,Adult
169445032,16944503,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,No adverse event,,2019,Q4,2,F,,20191221.0,20191022,20191224,PER,,PHHO2019US007959,NOVARTIS,,40.0,YR,,F,Y,90.22,KG,20191224.0,,OT,US,US,2019,Q4,Adult
169445032,16944503,41,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,No adverse event,,2019,Q4,2,F,,20191221.0,20191022,20191224,PER,,PHHO2019US007959,NOVARTIS,,40.0,YR,,F,Y,90.22,KG,20191224.0,,OT,US,US,2019,Q4,Adult
169532521,16953252,9,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPENSION,,2,,UNK,,,,,,,,,,,,2019,Q4,Arthralgia,,2019,Q4,1,I,,20191018.0,20191023,20191023,EXP,,CA-PFIZER INC-2019455844,PFIZER,,62.0,YR,,F,Y,,,20191023.0,,OT,CA,CA,2019,Q4,Adult
169532521,16953252,9,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPENSION,,2,,UNK,,,,,,,,,,,,2019,Q4,Bronchitis,,2019,Q4,1,I,,20191018.0,20191023,20191023,EXP,,CA-PFIZER INC-2019455844,PFIZER,,62.0,YR,,F,Y,,,20191023.0,,OT,CA,CA,2019,Q4,Adult
169532521,16953252,9,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPENSION,,2,,UNK,,,,,,,,,,,,2019,Q4,Death,,2019,Q4,1,I,,20191018.0,20191023,20191023,EXP,,CA-PFIZER INC-2019455844,PFIZER,,62.0,YR,,F,Y,,,20191023.0,,OT,CA,CA,2019,Q4,Adult
169532521,16953252,9,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPENSION,,2,,UNK,,,,,,,,,,,,2019,Q4,Dementia,,2019,Q4,1,I,,20191018.0,20191023,20191023,EXP,,CA-PFIZER INC-2019455844,PFIZER,,62.0,YR,,F,Y,,,20191023.0,,OT,CA,CA,2019,Q4,Adult
169532521,16953252,9,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPENSION,,2,,UNK,,,,,,,,,,,,2019,Q4,Drug ineffective,,2019,Q4,1,I,,20191018.0,20191023,20191023,EXP,,CA-PFIZER INC-2019455844,PFIZER,,62.0,YR,,F,Y,,,20191023.0,,OT,CA,CA,2019,Q4,Adult
169532521,16953252,9,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPENSION,,2,,UNK,,,,,,,,,,,,2019,Q4,Ear infection,,2019,Q4,1,I,,20191018.0,20191023,20191023,EXP,,CA-PFIZER INC-2019455844,PFIZER,,62.0,YR,,F,Y,,,20191023.0,,OT,CA,CA,2019,Q4,Adult
169532521,16953252,9,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPENSION,,2,,UNK,,,,,,,,,,,,2019,Q4,Gait disturbance,,2019,Q4,1,I,,20191018.0,20191023,20191023,EXP,,CA-PFIZER INC-2019455844,PFIZER,,62.0,YR,,F,Y,,,20191023.0,,OT,CA,CA,2019,Q4,Adult
169532521,16953252,9,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPENSION,,2,,UNK,,,,,,,,,,,,2019,Q4,Hepatic enzyme increased,,2019,Q4,1,I,,20191018.0,20191023,20191023,EXP,,CA-PFIZER INC-2019455844,PFIZER,,62.0,YR,,F,Y,,,20191023.0,,OT,CA,CA,2019,Q4,Adult
169532521,16953252,9,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPENSION,,2,,UNK,,,,,,,,,,,,2019,Q4,Hepatic steatosis,,2019,Q4,1,I,,20191018.0,20191023,20191023,EXP,,CA-PFIZER INC-2019455844,PFIZER,,62.0,YR,,F,Y,,,20191023.0,,OT,CA,CA,2019,Q4,Adult
169532521,16953252,9,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPENSION,,2,,UNK,,,,,,,,,,,,2019,Q4,Joint swelling,,2019,Q4,1,I,,20191018.0,20191023,20191023,EXP,,CA-PFIZER INC-2019455844,PFIZER,,62.0,YR,,F,Y,,,20191023.0,,OT,CA,CA,2019,Q4,Adult
169532521,16953252,9,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPENSION,,2,,UNK,,,,,,,,,,,,2019,Q4,Liver disorder,,2019,Q4,1,I,,20191018.0,20191023,20191023,EXP,,CA-PFIZER INC-2019455844,PFIZER,,62.0,YR,,F,Y,,,20191023.0,,OT,CA,CA,2019,Q4,Adult
169532521,16953252,9,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPENSION,,2,,UNK,,,,,,,,,,,,2019,Q4,Liver injury,,2019,Q4,1,I,,20191018.0,20191023,20191023,EXP,,CA-PFIZER INC-2019455844,PFIZER,,62.0,YR,,F,Y,,,20191023.0,,OT,CA,CA,2019,Q4,Adult
169532521,16953252,9,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPENSION,,2,,UNK,,,,,,,,,,,,2019,Q4,Loss of personal independence in daily activities,,2019,Q4,1,I,,20191018.0,20191023,20191023,EXP,,CA-PFIZER INC-2019455844,PFIZER,,62.0,YR,,F,Y,,,20191023.0,,OT,CA,CA,2019,Q4,Adult
169532521,16953252,9,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPENSION,,2,,UNK,,,,,,,,,,,,2019,Q4,Musculoskeletal stiffness,,2019,Q4,1,I,,20191018.0,20191023,20191023,EXP,,CA-PFIZER INC-2019455844,PFIZER,,62.0,YR,,F,Y,,,20191023.0,,OT,CA,CA,2019,Q4,Adult
169532521,16953252,9,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPENSION,,2,,UNK,,,,,,,,,,,,2019,Q4,Nasopharyngitis,,2019,Q4,1,I,,20191018.0,20191023,20191023,EXP,,CA-PFIZER INC-2019455844,PFIZER,,62.0,YR,,F,Y,,,20191023.0,,OT,CA,CA,2019,Q4,Adult
169532521,16953252,9,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPENSION,,2,,UNK,,,,,,,,,,,,2019,Q4,Noninfective encephalitis,,2019,Q4,1,I,,20191018.0,20191023,20191023,EXP,,CA-PFIZER INC-2019455844,PFIZER,,62.0,YR,,F,Y,,,20191023.0,,OT,CA,CA,2019,Q4,Adult
169532521,16953252,9,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPENSION,,2,,UNK,,,,,,,,,,,,2019,Q4,Oedema peripheral,,2019,Q4,1,I,,20191018.0,20191023,20191023,EXP,,CA-PFIZER INC-2019455844,PFIZER,,62.0,YR,,F,Y,,,20191023.0,,OT,CA,CA,2019,Q4,Adult
169532521,16953252,9,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPENSION,,2,,UNK,,,,,,,,,,,,2019,Q4,Pain in extremity,,2019,Q4,1,I,,20191018.0,20191023,20191023,EXP,,CA-PFIZER INC-2019455844,PFIZER,,62.0,YR,,F,Y,,,20191023.0,,OT,CA,CA,2019,Q4,Adult
169532521,16953252,9,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPENSION,,2,,UNK,,,,,,,,,,,,2019,Q4,Peripheral swelling,,2019,Q4,1,I,,20191018.0,20191023,20191023,EXP,,CA-PFIZER INC-2019455844,PFIZER,,62.0,YR,,F,Y,,,20191023.0,,OT,CA,CA,2019,Q4,Adult
169532521,16953252,9,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPENSION,,2,,UNK,,,,,,,,,,,,2019,Q4,Pharyngitis,,2019,Q4,1,I,,20191018.0,20191023,20191023,EXP,,CA-PFIZER INC-2019455844,PFIZER,,62.0,YR,,F,Y,,,20191023.0,,OT,CA,CA,2019,Q4,Adult
169532521,16953252,9,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPENSION,,2,,UNK,,,,,,,,,,,,2019,Q4,Poor venous access,,2019,Q4,1,I,,20191018.0,20191023,20191023,EXP,,CA-PFIZER INC-2019455844,PFIZER,,62.0,YR,,F,Y,,,20191023.0,,OT,CA,CA,2019,Q4,Adult
169532521,16953252,9,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPENSION,,2,,UNK,,,,,,,,,,,,2019,Q4,Pruritus,,2019,Q4,1,I,,20191018.0,20191023,20191023,EXP,,CA-PFIZER INC-2019455844,PFIZER,,62.0,YR,,F,Y,,,20191023.0,,OT,CA,CA,2019,Q4,Adult
169532521,16953252,9,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPENSION,,2,,UNK,,,,,,,,,,,,2019,Q4,Rheumatoid arthritis,,2019,Q4,1,I,,20191018.0,20191023,20191023,EXP,,CA-PFIZER INC-2019455844,PFIZER,,62.0,YR,,F,Y,,,20191023.0,,OT,CA,CA,2019,Q4,Adult
169532521,16953252,9,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPENSION,,2,,UNK,,,,,,,,,,,,2019,Q4,Seizure,,2019,Q4,1,I,,20191018.0,20191023,20191023,EXP,,CA-PFIZER INC-2019455844,PFIZER,,62.0,YR,,F,Y,,,20191023.0,,OT,CA,CA,2019,Q4,Adult
169532521,16953252,9,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPENSION,,2,,UNK,,,,,,,,,,,,2019,Q4,Swelling,,2019,Q4,1,I,,20191018.0,20191023,20191023,EXP,,CA-PFIZER INC-2019455844,PFIZER,,62.0,YR,,F,Y,,,20191023.0,,OT,CA,CA,2019,Q4,Adult
169532521,16953252,9,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPENSION,,2,,UNK,,,,,,,,,,,,2019,Q4,Therapeutic product effect decreased,,2019,Q4,1,I,,20191018.0,20191023,20191023,EXP,,CA-PFIZER INC-2019455844,PFIZER,,62.0,YR,,F,Y,,,20191023.0,,OT,CA,CA,2019,Q4,Adult
169532521,16953252,9,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPENSION,,2,,UNK,,,,,,,,,,,,2019,Q4,Therapeutic response decreased,,2019,Q4,1,I,,20191018.0,20191023,20191023,EXP,,CA-PFIZER INC-2019455844,PFIZER,,62.0,YR,,F,Y,,,20191023.0,,OT,CA,CA,2019,Q4,Adult
169532521,16953252,9,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPENSION,,2,,UNK,,,,,,,,,,,,2019,Q4,Tremor,,2019,Q4,1,I,,20191018.0,20191023,20191023,EXP,,CA-PFIZER INC-2019455844,PFIZER,,62.0,YR,,F,Y,,,20191023.0,,OT,CA,CA,2019,Q4,Adult
169532521,16953252,9,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPENSION,,2,,UNK,,,,,,,,,,,,2019,Q4,Vomiting,,2019,Q4,1,I,,20191018.0,20191023,20191023,EXP,,CA-PFIZER INC-2019455844,PFIZER,,62.0,YR,,F,Y,,,20191023.0,,OT,CA,CA,2019,Q4,Adult
169564231,16956423,5,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Abdominal pain upper,,2019,Q4,1,I,20191023.0,,20191023,20191023,DIR,,,FDA-CTU,,60.0,YR,,F,N,103.5,KG,20191023.0,N,MD,US,US,2019,Q4,Adult
169564231,16956423,5,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Hepatomegaly,,2019,Q4,1,I,20191023.0,,20191023,20191023,DIR,,,FDA-CTU,,60.0,YR,,F,N,103.5,KG,20191023.0,N,MD,US,US,2019,Q4,Adult
169568941,16956894,5,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Gastrointestinal haemorrhage,,2019,Q4,1,I,20190826.0,,20191023,20191023,DIR,,,FDA-CTU,,83.0,WK,,F,N,68.0,KG,20191023.0,N,PH,US,US,2019,Q4,Elderly
169568941,16956894,5,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Hypotension,,2019,Q4,1,I,20190826.0,,20191023,20191023,DIR,,,FDA-CTU,,83.0,WK,,F,N,68.0,KG,20191023.0,N,PH,US,US,2019,Q4,Elderly
169568941,16956894,5,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Tachycardia,,2019,Q4,1,I,20190826.0,,20191023,20191023,DIR,,,FDA-CTU,,83.0,WK,,F,N,68.0,KG,20191023.0,N,PH,US,US,2019,Q4,Elderly
169572153,16957215,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,Y,,,,20563.0,,,SOLUTION FOR INJECTION,,2019,Q4,Blood glucose abnormal,,2019,Q4,3,F,20190925.0,20191113.0,20191024,20191126,EXP,,US-ELI_LILLY_AND_COMPANY-US201910008461,ELI LILLY AND CO,,14.0,YR,,F,Y,,,20191126.0,,CN,US,US,2019,Q4,Youth
169572153,16957215,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,Y,,,,20563.0,,,SOLUTION FOR INJECTION,,2019,Q4,Blood glucose increased,,2019,Q4,3,F,20190925.0,20191113.0,20191024,20191126,EXP,,US-ELI_LILLY_AND_COMPANY-US201910008461,ELI LILLY AND CO,,14.0,YR,,F,Y,,,20191126.0,,CN,US,US,2019,Q4,Youth
169572153,16957215,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,Y,,,,20563.0,,,SOLUTION FOR INJECTION,,2019,Q4,Blood ketone body present,,2019,Q4,3,F,20190925.0,20191113.0,20191024,20191126,EXP,,US-ELI_LILLY_AND_COMPANY-US201910008461,ELI LILLY AND CO,,14.0,YR,,F,Y,,,20191126.0,,CN,US,US,2019,Q4,Youth
169572153,16957215,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,Y,,,,20563.0,,,SOLUTION FOR INJECTION,,2019,Q4,Dehydration,,2019,Q4,3,F,20190925.0,20191113.0,20191024,20191126,EXP,,US-ELI_LILLY_AND_COMPANY-US201910008461,ELI LILLY AND CO,,14.0,YR,,F,Y,,,20191126.0,,CN,US,US,2019,Q4,Youth
169572153,16957215,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,Y,,,,20563.0,,,SOLUTION FOR INJECTION,,2019,Q4,Diabetic ketoacidosis,,2019,Q4,3,F,20190925.0,20191113.0,20191024,20191126,EXP,,US-ELI_LILLY_AND_COMPANY-US201910008461,ELI LILLY AND CO,,14.0,YR,,F,Y,,,20191126.0,,CN,US,US,2019,Q4,Youth
169572153,16957215,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,Y,,,,20563.0,,,SOLUTION FOR INJECTION,,2019,Q4,Urticaria,,2019,Q4,3,F,20190925.0,20191113.0,20191024,20191126,EXP,,US-ELI_LILLY_AND_COMPANY-US201910008461,ELI LILLY AND CO,,14.0,YR,,F,Y,,,20191126.0,,CN,US,US,2019,Q4,Youth
169572153,16957215,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,Y,,,,20563.0,,,SOLUTION FOR INJECTION,,2019,Q4,Vomiting,,2019,Q4,3,F,20190925.0,20191113.0,20191024,20191126,EXP,,US-ELI_LILLY_AND_COMPANY-US201910008461,ELI LILLY AND CO,,14.0,YR,,F,Y,,,20191126.0,,CN,US,US,2019,Q4,Youth
169572153,16957215,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,Y,, C991690C,,20563.0,,,SOLUTION FOR INJECTION,,2019,Q4,Blood glucose abnormal,,2019,Q4,3,F,20190925.0,20191113.0,20191024,20191126,EXP,,US-ELI_LILLY_AND_COMPANY-US201910008461,ELI LILLY AND CO,,14.0,YR,,F,Y,,,20191126.0,,CN,US,US,2019,Q4,Youth
169572153,16957215,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,Y,, C991690C,,20563.0,,,SOLUTION FOR INJECTION,,2019,Q4,Blood glucose increased,,2019,Q4,3,F,20190925.0,20191113.0,20191024,20191126,EXP,,US-ELI_LILLY_AND_COMPANY-US201910008461,ELI LILLY AND CO,,14.0,YR,,F,Y,,,20191126.0,,CN,US,US,2019,Q4,Youth
169572153,16957215,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,Y,, C991690C,,20563.0,,,SOLUTION FOR INJECTION,,2019,Q4,Blood ketone body present,,2019,Q4,3,F,20190925.0,20191113.0,20191024,20191126,EXP,,US-ELI_LILLY_AND_COMPANY-US201910008461,ELI LILLY AND CO,,14.0,YR,,F,Y,,,20191126.0,,CN,US,US,2019,Q4,Youth
169572153,16957215,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,Y,, C991690C,,20563.0,,,SOLUTION FOR INJECTION,,2019,Q4,Dehydration,,2019,Q4,3,F,20190925.0,20191113.0,20191024,20191126,EXP,,US-ELI_LILLY_AND_COMPANY-US201910008461,ELI LILLY AND CO,,14.0,YR,,F,Y,,,20191126.0,,CN,US,US,2019,Q4,Youth
169572153,16957215,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,Y,, C991690C,,20563.0,,,SOLUTION FOR INJECTION,,2019,Q4,Diabetic ketoacidosis,,2019,Q4,3,F,20190925.0,20191113.0,20191024,20191126,EXP,,US-ELI_LILLY_AND_COMPANY-US201910008461,ELI LILLY AND CO,,14.0,YR,,F,Y,,,20191126.0,,CN,US,US,2019,Q4,Youth
169572153,16957215,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,Y,, C991690C,,20563.0,,,SOLUTION FOR INJECTION,,2019,Q4,Urticaria,,2019,Q4,3,F,20190925.0,20191113.0,20191024,20191126,EXP,,US-ELI_LILLY_AND_COMPANY-US201910008461,ELI LILLY AND CO,,14.0,YR,,F,Y,,,20191126.0,,CN,US,US,2019,Q4,Youth
169572153,16957215,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,Y,, C991690C,,20563.0,,,SOLUTION FOR INJECTION,,2019,Q4,Vomiting,,2019,Q4,3,F,20190925.0,20191113.0,20191024,20191126,EXP,,US-ELI_LILLY_AND_COMPANY-US201910008461,ELI LILLY AND CO,,14.0,YR,,F,Y,,,20191126.0,,CN,US,US,2019,Q4,Youth
169598661,16959866,9,C,INSULIN LISPRO-INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,,,,,,,,,,2019,Q4,Arthralgia,,2019,Q4,1,I,,20191018.0,20191025,20191025,EXP,,CA-ORION CORPORATION ORION PHARMA-TREX2019-4636,ORION,,62.0,YR,,F,Y,,,20191025.0,,OT,CA,CA,2019,Q4,Adult
169598661,16959866,9,C,INSULIN LISPRO-INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,,,,,,,,,,2019,Q4,Bronchitis,,2019,Q4,1,I,,20191018.0,20191025,20191025,EXP,,CA-ORION CORPORATION ORION PHARMA-TREX2019-4636,ORION,,62.0,YR,,F,Y,,,20191025.0,,OT,CA,CA,2019,Q4,Adult
169598661,16959866,9,C,INSULIN LISPRO-INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,,,,,,,,,,2019,Q4,Death,,2019,Q4,1,I,,20191018.0,20191025,20191025,EXP,,CA-ORION CORPORATION ORION PHARMA-TREX2019-4636,ORION,,62.0,YR,,F,Y,,,20191025.0,,OT,CA,CA,2019,Q4,Adult
169598661,16959866,9,C,INSULIN LISPRO-INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,,,,,,,,,,2019,Q4,Dementia,,2019,Q4,1,I,,20191018.0,20191025,20191025,EXP,,CA-ORION CORPORATION ORION PHARMA-TREX2019-4636,ORION,,62.0,YR,,F,Y,,,20191025.0,,OT,CA,CA,2019,Q4,Adult
169598661,16959866,9,C,INSULIN LISPRO-INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,,,,,,,,,,2019,Q4,Drug ineffective,,2019,Q4,1,I,,20191018.0,20191025,20191025,EXP,,CA-ORION CORPORATION ORION PHARMA-TREX2019-4636,ORION,,62.0,YR,,F,Y,,,20191025.0,,OT,CA,CA,2019,Q4,Adult
169598661,16959866,9,C,INSULIN LISPRO-INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,,,,,,,,,,2019,Q4,Ear infection,,2019,Q4,1,I,,20191018.0,20191025,20191025,EXP,,CA-ORION CORPORATION ORION PHARMA-TREX2019-4636,ORION,,62.0,YR,,F,Y,,,20191025.0,,OT,CA,CA,2019,Q4,Adult
169598661,16959866,9,C,INSULIN LISPRO-INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,,,,,,,,,,2019,Q4,Gait disturbance,,2019,Q4,1,I,,20191018.0,20191025,20191025,EXP,,CA-ORION CORPORATION ORION PHARMA-TREX2019-4636,ORION,,62.0,YR,,F,Y,,,20191025.0,,OT,CA,CA,2019,Q4,Adult
169598661,16959866,9,C,INSULIN LISPRO-INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,,,,,,,,,,2019,Q4,Hepatic enzyme increased,,2019,Q4,1,I,,20191018.0,20191025,20191025,EXP,,CA-ORION CORPORATION ORION PHARMA-TREX2019-4636,ORION,,62.0,YR,,F,Y,,,20191025.0,,OT,CA,CA,2019,Q4,Adult
169598661,16959866,9,C,INSULIN LISPRO-INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,,,,,,,,,,2019,Q4,Hepatic steatosis,,2019,Q4,1,I,,20191018.0,20191025,20191025,EXP,,CA-ORION CORPORATION ORION PHARMA-TREX2019-4636,ORION,,62.0,YR,,F,Y,,,20191025.0,,OT,CA,CA,2019,Q4,Adult
169598661,16959866,9,C,INSULIN LISPRO-INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,,,,,,,,,,2019,Q4,Joint swelling,,2019,Q4,1,I,,20191018.0,20191025,20191025,EXP,,CA-ORION CORPORATION ORION PHARMA-TREX2019-4636,ORION,,62.0,YR,,F,Y,,,20191025.0,,OT,CA,CA,2019,Q4,Adult
169598661,16959866,9,C,INSULIN LISPRO-INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,,,,,,,,,,2019,Q4,Liver disorder,,2019,Q4,1,I,,20191018.0,20191025,20191025,EXP,,CA-ORION CORPORATION ORION PHARMA-TREX2019-4636,ORION,,62.0,YR,,F,Y,,,20191025.0,,OT,CA,CA,2019,Q4,Adult
169598661,16959866,9,C,INSULIN LISPRO-INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,,,,,,,,,,2019,Q4,Liver injury,,2019,Q4,1,I,,20191018.0,20191025,20191025,EXP,,CA-ORION CORPORATION ORION PHARMA-TREX2019-4636,ORION,,62.0,YR,,F,Y,,,20191025.0,,OT,CA,CA,2019,Q4,Adult
169598661,16959866,9,C,INSULIN LISPRO-INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,,,,,,,,,,2019,Q4,Loss of personal independence in daily activities,,2019,Q4,1,I,,20191018.0,20191025,20191025,EXP,,CA-ORION CORPORATION ORION PHARMA-TREX2019-4636,ORION,,62.0,YR,,F,Y,,,20191025.0,,OT,CA,CA,2019,Q4,Adult
169598661,16959866,9,C,INSULIN LISPRO-INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,,,,,,,,,,2019,Q4,Musculoskeletal stiffness,,2019,Q4,1,I,,20191018.0,20191025,20191025,EXP,,CA-ORION CORPORATION ORION PHARMA-TREX2019-4636,ORION,,62.0,YR,,F,Y,,,20191025.0,,OT,CA,CA,2019,Q4,Adult
169598661,16959866,9,C,INSULIN LISPRO-INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,,,,,,,,,,2019,Q4,Nasopharyngitis,,2019,Q4,1,I,,20191018.0,20191025,20191025,EXP,,CA-ORION CORPORATION ORION PHARMA-TREX2019-4636,ORION,,62.0,YR,,F,Y,,,20191025.0,,OT,CA,CA,2019,Q4,Adult
169598661,16959866,9,C,INSULIN LISPRO-INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,,,,,,,,,,2019,Q4,Noninfective encephalitis,,2019,Q4,1,I,,20191018.0,20191025,20191025,EXP,,CA-ORION CORPORATION ORION PHARMA-TREX2019-4636,ORION,,62.0,YR,,F,Y,,,20191025.0,,OT,CA,CA,2019,Q4,Adult
169598661,16959866,9,C,INSULIN LISPRO-INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,,,,,,,,,,2019,Q4,Oedema peripheral,,2019,Q4,1,I,,20191018.0,20191025,20191025,EXP,,CA-ORION CORPORATION ORION PHARMA-TREX2019-4636,ORION,,62.0,YR,,F,Y,,,20191025.0,,OT,CA,CA,2019,Q4,Adult
169598661,16959866,9,C,INSULIN LISPRO-INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,,,,,,,,,,2019,Q4,Pain in extremity,,2019,Q4,1,I,,20191018.0,20191025,20191025,EXP,,CA-ORION CORPORATION ORION PHARMA-TREX2019-4636,ORION,,62.0,YR,,F,Y,,,20191025.0,,OT,CA,CA,2019,Q4,Adult
169598661,16959866,9,C,INSULIN LISPRO-INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,,,,,,,,,,2019,Q4,Peripheral swelling,,2019,Q4,1,I,,20191018.0,20191025,20191025,EXP,,CA-ORION CORPORATION ORION PHARMA-TREX2019-4636,ORION,,62.0,YR,,F,Y,,,20191025.0,,OT,CA,CA,2019,Q4,Adult
169598661,16959866,9,C,INSULIN LISPRO-INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,,,,,,,,,,2019,Q4,Pharyngitis,,2019,Q4,1,I,,20191018.0,20191025,20191025,EXP,,CA-ORION CORPORATION ORION PHARMA-TREX2019-4636,ORION,,62.0,YR,,F,Y,,,20191025.0,,OT,CA,CA,2019,Q4,Adult
169598661,16959866,9,C,INSULIN LISPRO-INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,,,,,,,,,,2019,Q4,Poor venous access,,2019,Q4,1,I,,20191018.0,20191025,20191025,EXP,,CA-ORION CORPORATION ORION PHARMA-TREX2019-4636,ORION,,62.0,YR,,F,Y,,,20191025.0,,OT,CA,CA,2019,Q4,Adult
169598661,16959866,9,C,INSULIN LISPRO-INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,,,,,,,,,,2019,Q4,Pruritus,,2019,Q4,1,I,,20191018.0,20191025,20191025,EXP,,CA-ORION CORPORATION ORION PHARMA-TREX2019-4636,ORION,,62.0,YR,,F,Y,,,20191025.0,,OT,CA,CA,2019,Q4,Adult
169598661,16959866,9,C,INSULIN LISPRO-INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,,,,,,,,,,2019,Q4,Rheumatoid arthritis,,2019,Q4,1,I,,20191018.0,20191025,20191025,EXP,,CA-ORION CORPORATION ORION PHARMA-TREX2019-4636,ORION,,62.0,YR,,F,Y,,,20191025.0,,OT,CA,CA,2019,Q4,Adult
169598661,16959866,9,C,INSULIN LISPRO-INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,,,,,,,,,,2019,Q4,Seizure,,2019,Q4,1,I,,20191018.0,20191025,20191025,EXP,,CA-ORION CORPORATION ORION PHARMA-TREX2019-4636,ORION,,62.0,YR,,F,Y,,,20191025.0,,OT,CA,CA,2019,Q4,Adult
169598661,16959866,9,C,INSULIN LISPRO-INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,,,,,,,,,,2019,Q4,Swelling,,2019,Q4,1,I,,20191018.0,20191025,20191025,EXP,,CA-ORION CORPORATION ORION PHARMA-TREX2019-4636,ORION,,62.0,YR,,F,Y,,,20191025.0,,OT,CA,CA,2019,Q4,Adult
169598661,16959866,9,C,INSULIN LISPRO-INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,,,,,,,,,,2019,Q4,Therapeutic response decreased,,2019,Q4,1,I,,20191018.0,20191025,20191025,EXP,,CA-ORION CORPORATION ORION PHARMA-TREX2019-4636,ORION,,62.0,YR,,F,Y,,,20191025.0,,OT,CA,CA,2019,Q4,Adult
169598661,16959866,9,C,INSULIN LISPRO-INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,,,,,,,,,,2019,Q4,Tremor,,2019,Q4,1,I,,20191018.0,20191025,20191025,EXP,,CA-ORION CORPORATION ORION PHARMA-TREX2019-4636,ORION,,62.0,YR,,F,Y,,,20191025.0,,OT,CA,CA,2019,Q4,Adult
169598661,16959866,9,C,INSULIN LISPRO-INSULIN LISPRO PROTAMINE SUSPENSION,,2,Unknown,,,,,,,,,,,,,2019,Q4,Vomiting,,2019,Q4,1,I,,20191018.0,20191025,20191025,EXP,,CA-ORION CORPORATION ORION PHARMA-TREX2019-4636,ORION,,62.0,YR,,F,Y,,,20191025.0,,OT,CA,CA,2019,Q4,Adult
169635361,16963536,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q4,Abdominal pain,,2019,Q4,1,I,,20191021.0,20191025,20191025,EXP,,CA-TEVA-2019-CA-1126860,TEVA,,72.0,YR,,F,Y,,,20191025.0,,OT,CA,CA,2019,Q4,Elderly
169635361,16963536,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q4,Dehydration,,2019,Q4,1,I,,20191021.0,20191025,20191025,EXP,,CA-TEVA-2019-CA-1126860,TEVA,,72.0,YR,,F,Y,,,20191025.0,,OT,CA,CA,2019,Q4,Elderly
169635361,16963536,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q4,Pyrexia,,2019,Q4,1,I,,20191021.0,20191025,20191025,EXP,,CA-TEVA-2019-CA-1126860,TEVA,,72.0,YR,,F,Y,,,20191025.0,,OT,CA,CA,2019,Q4,Elderly
169635361,16963536,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q4,Small intestinal obstruction,,2019,Q4,1,I,,20191021.0,20191025,20191025,EXP,,CA-TEVA-2019-CA-1126860,TEVA,,72.0,YR,,F,Y,,,20191025.0,,OT,CA,CA,2019,Q4,Elderly
169635361,16963536,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q4,Urinary tract obstruction,,2019,Q4,1,I,,20191021.0,20191025,20191025,EXP,,CA-TEVA-2019-CA-1126860,TEVA,,72.0,YR,,F,Y,,,20191025.0,,OT,CA,CA,2019,Q4,Elderly
169643921,16964392,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Lung disorder,,2019,Q4,1,I,,,20190909,20190909,DIR,,,FDA-CTU,,24.0,YR,,F,N,,,20190909.0,N,OT,US,US,2019,Q4,Young Adult
169643921,16964392,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Maternal exposure during pregnancy,,2019,Q4,1,I,,,20190909,20190909,DIR,,,FDA-CTU,,24.0,YR,,F,N,,,20190909.0,N,OT,US,US,2019,Q4,Young Adult
169643921,16964392,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Pregnancy,,2019,Q4,1,I,,,20190909,20190909,DIR,,,FDA-CTU,,24.0,YR,,F,N,,,20190909.0,N,OT,US,US,2019,Q4,Young Adult
169652232,16965223,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2019,Q4,Cerebral haemorrhage,,2019,Q4,2,F,20190722.0,20191023.0,20191028,20191031,EXP,FR-AFSSAPS-AM20191545,FR-SA-2019SA295981,SANOFI AVENTIS,,81.0,YR,E,M,Y,93.0,KG,20191031.0,,MD,FR,FR,2019,Q4,Elderly
169652232,16965223,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2019,Q4,Coma,,2019,Q4,2,F,20190722.0,20191023.0,20191028,20191031,EXP,FR-AFSSAPS-AM20191545,FR-SA-2019SA295981,SANOFI AVENTIS,,81.0,YR,E,M,Y,93.0,KG,20191031.0,,MD,FR,FR,2019,Q4,Elderly
169652232,16965223,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2019,Q4,Head injury,,2019,Q4,2,F,20190722.0,20191023.0,20191028,20191031,EXP,FR-AFSSAPS-AM20191545,FR-SA-2019SA295981,SANOFI AVENTIS,,81.0,YR,E,M,Y,93.0,KG,20191031.0,,MD,FR,FR,2019,Q4,Elderly
169652232,16965223,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2019,Q4,Hypotension,,2019,Q4,2,F,20190722.0,20191023.0,20191028,20191031,EXP,FR-AFSSAPS-AM20191545,FR-SA-2019SA295981,SANOFI AVENTIS,,81.0,YR,E,M,Y,93.0,KG,20191031.0,,MD,FR,FR,2019,Q4,Elderly
169652232,16965223,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2019,Q4,Intraventricular haemorrhage,,2019,Q4,2,F,20190722.0,20191023.0,20191028,20191031,EXP,FR-AFSSAPS-AM20191545,FR-SA-2019SA295981,SANOFI AVENTIS,,81.0,YR,E,M,Y,93.0,KG,20191031.0,,MD,FR,FR,2019,Q4,Elderly
169652232,16965223,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2019,Q4,Malaise,,2019,Q4,2,F,20190722.0,20191023.0,20191028,20191031,EXP,FR-AFSSAPS-AM20191545,FR-SA-2019SA295981,SANOFI AVENTIS,,81.0,YR,E,M,Y,93.0,KG,20191031.0,,MD,FR,FR,2019,Q4,Elderly
169652232,16965223,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2019,Q4,Subarachnoid haemorrhage,,2019,Q4,2,F,20190722.0,20191023.0,20191028,20191031,EXP,FR-AFSSAPS-AM20191545,FR-SA-2019SA295981,SANOFI AVENTIS,,81.0,YR,E,M,Y,93.0,KG,20191031.0,,MD,FR,FR,2019,Q4,Elderly
169678902,16967890,60,C,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),,,,,,,,,3.0,ML,,,2019,Q4,Septic shock,,2019,Q4,2,F,20191020.0,20191112.0,20191028,20191115,EXP,,US-ABBVIE-19P-163-2972968-00,ABBVIE,,25.0,YR,,M,Y,143.0,KG,20191115.0,,MD,US,US,2019,Q4,Young Adult
169687622,16968762,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 IU, UNKNOWN FREQ. (BEFORE EACH MEAL)",,,,,,,,5.0,IU,FORMULATION UNKNOWN,,2019,Q4,Blood creatinine increased,,2019,Q4,2,F,2019.0,20191107.0,20191029,20191114,EXP,,CO-ASTELLAS-2018US041326,ASTELLAS,,74.0,YR,,M,Y,65.0,KG,20191114.0,,CN,CO,CO,2019,Q4,Elderly
169687622,16968762,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 IU, UNKNOWN FREQ. (BEFORE EACH MEAL)",,,,,,,,5.0,IU,FORMULATION UNKNOWN,,2019,Q4,Cardio-respiratory arrest,,2019,Q4,2,F,2019.0,20191107.0,20191029,20191114,EXP,,CO-ASTELLAS-2018US041326,ASTELLAS,,74.0,YR,,M,Y,65.0,KG,20191114.0,,CN,CO,CO,2019,Q4,Elderly
169687622,16968762,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 IU, UNKNOWN FREQ. (BEFORE EACH MEAL)",,,,,,,,5.0,IU,FORMULATION UNKNOWN,,2019,Q4,Diarrhoea,,2019,Q4,2,F,2019.0,20191107.0,20191029,20191114,EXP,,CO-ASTELLAS-2018US041326,ASTELLAS,,74.0,YR,,M,Y,65.0,KG,20191114.0,,CN,CO,CO,2019,Q4,Elderly
169687622,16968762,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 IU, UNKNOWN FREQ. (BEFORE EACH MEAL)",,,,,,,,5.0,IU,FORMULATION UNKNOWN,,2019,Q4,Extremity necrosis,,2019,Q4,2,F,2019.0,20191107.0,20191029,20191114,EXP,,CO-ASTELLAS-2018US041326,ASTELLAS,,74.0,YR,,M,Y,65.0,KG,20191114.0,,CN,CO,CO,2019,Q4,Elderly
169687622,16968762,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 IU, UNKNOWN FREQ. (BEFORE EACH MEAL)",,,,,,,,5.0,IU,FORMULATION UNKNOWN,,2019,Q4,Gait disturbance,,2019,Q4,2,F,2019.0,20191107.0,20191029,20191114,EXP,,CO-ASTELLAS-2018US041326,ASTELLAS,,74.0,YR,,M,Y,65.0,KG,20191114.0,,CN,CO,CO,2019,Q4,Elderly
169687622,16968762,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 IU, UNKNOWN FREQ. (BEFORE EACH MEAL)",,,,,,,,5.0,IU,FORMULATION UNKNOWN,,2019,Q4,Hypoglycaemia,,2019,Q4,2,F,2019.0,20191107.0,20191029,20191114,EXP,,CO-ASTELLAS-2018US041326,ASTELLAS,,74.0,YR,,M,Y,65.0,KG,20191114.0,,CN,CO,CO,2019,Q4,Elderly
169687622,16968762,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 IU, UNKNOWN FREQ. (BEFORE EACH MEAL)",,,,,,,,5.0,IU,FORMULATION UNKNOWN,,2019,Q4,Hypotension,,2019,Q4,2,F,2019.0,20191107.0,20191029,20191114,EXP,,CO-ASTELLAS-2018US041326,ASTELLAS,,74.0,YR,,M,Y,65.0,KG,20191114.0,,CN,CO,CO,2019,Q4,Elderly
169687622,16968762,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 IU, UNKNOWN FREQ. (BEFORE EACH MEAL)",,,,,,,,5.0,IU,FORMULATION UNKNOWN,,2019,Q4,Immunosuppressant drug level decreased,,2019,Q4,2,F,2019.0,20191107.0,20191029,20191114,EXP,,CO-ASTELLAS-2018US041326,ASTELLAS,,74.0,YR,,M,Y,65.0,KG,20191114.0,,CN,CO,CO,2019,Q4,Elderly
169687622,16968762,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 IU, UNKNOWN FREQ. (BEFORE EACH MEAL)",,,,,,,,5.0,IU,FORMULATION UNKNOWN,,2019,Q4,Impaired healing,,2019,Q4,2,F,2019.0,20191107.0,20191029,20191114,EXP,,CO-ASTELLAS-2018US041326,ASTELLAS,,74.0,YR,,M,Y,65.0,KG,20191114.0,,CN,CO,CO,2019,Q4,Elderly
169687622,16968762,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 IU, UNKNOWN FREQ. (BEFORE EACH MEAL)",,,,,,,,5.0,IU,FORMULATION UNKNOWN,,2019,Q4,Inappropriate schedule of product administration,,2019,Q4,2,F,2019.0,20191107.0,20191029,20191114,EXP,,CO-ASTELLAS-2018US041326,ASTELLAS,,74.0,YR,,M,Y,65.0,KG,20191114.0,,CN,CO,CO,2019,Q4,Elderly
169687622,16968762,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 IU, UNKNOWN FREQ. (BEFORE EACH MEAL)",,,,,,,,5.0,IU,FORMULATION UNKNOWN,,2019,Q4,Limb injury,,2019,Q4,2,F,2019.0,20191107.0,20191029,20191114,EXP,,CO-ASTELLAS-2018US041326,ASTELLAS,,74.0,YR,,M,Y,65.0,KG,20191114.0,,CN,CO,CO,2019,Q4,Elderly
169687622,16968762,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 IU, UNKNOWN FREQ. (BEFORE EACH MEAL)",,,,,,,,5.0,IU,FORMULATION UNKNOWN,,2019,Q4,Localised infection,,2019,Q4,2,F,2019.0,20191107.0,20191029,20191114,EXP,,CO-ASTELLAS-2018US041326,ASTELLAS,,74.0,YR,,M,Y,65.0,KG,20191114.0,,CN,CO,CO,2019,Q4,Elderly
169687622,16968762,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 IU, UNKNOWN FREQ. (BEFORE EACH MEAL)",,,,,,,,5.0,IU,FORMULATION UNKNOWN,,2019,Q4,Pain in extremity,,2019,Q4,2,F,2019.0,20191107.0,20191029,20191114,EXP,,CO-ASTELLAS-2018US041326,ASTELLAS,,74.0,YR,,M,Y,65.0,KG,20191114.0,,CN,CO,CO,2019,Q4,Elderly
169687622,16968762,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 IU, UNKNOWN FREQ. (BEFORE EACH MEAL)",,,,,,,,5.0,IU,FORMULATION UNKNOWN,,2019,Q4,Renal disorder,,2019,Q4,2,F,2019.0,20191107.0,20191029,20191114,EXP,,CO-ASTELLAS-2018US041326,ASTELLAS,,74.0,YR,,M,Y,65.0,KG,20191114.0,,CN,CO,CO,2019,Q4,Elderly
169687622,16968762,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 IU, UNKNOWN FREQ. (BEFORE EACH MEAL)",,,,,,,,5.0,IU,FORMULATION UNKNOWN,,2019,Q4,Sepsis,,2019,Q4,2,F,2019.0,20191107.0,20191029,20191114,EXP,,CO-ASTELLAS-2018US041326,ASTELLAS,,74.0,YR,,M,Y,65.0,KG,20191114.0,,CN,CO,CO,2019,Q4,Elderly
169687622,16968762,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 IU, UNKNOWN FREQ. (BEFORE EACH MEAL)",,,,,,,,5.0,IU,FORMULATION UNKNOWN,,2019,Q4,Thyroid hormones increased,,2019,Q4,2,F,2019.0,20191107.0,20191029,20191114,EXP,,CO-ASTELLAS-2018US041326,ASTELLAS,,74.0,YR,,M,Y,65.0,KG,20191114.0,,CN,CO,CO,2019,Q4,Elderly
169687622,16968762,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 IU, UNKNOWN FREQ. (BEFORE EACH MEAL)",,,,,,,,5.0,IU,FORMULATION UNKNOWN,,2019,Q4,Wound,,2019,Q4,2,F,2019.0,20191107.0,20191029,20191114,EXP,,CO-ASTELLAS-2018US041326,ASTELLAS,,74.0,YR,,M,Y,65.0,KG,20191114.0,,CN,CO,CO,2019,Q4,Elderly
169708231,16970823,2,C,INSULIN LISPRO (HUMALOG),,2,,,,,,,,,,,,,,2019,Q4,Diplopia,,2019,Q4,1,I,20190103.0,,20190912,20190912,DIR,,,FDA-CTU,,70.0,YR,,F,N,95.25,KG,20190830.0,N,CN,US,US,2019,Q4,Elderly
169708231,16970823,2,C,INSULIN LISPRO (HUMALOG),,2,,,,,,,,,,,,,,2019,Q4,Fatigue,,2019,Q4,1,I,20190103.0,,20190912,20190912,DIR,,,FDA-CTU,,70.0,YR,,F,N,95.25,KG,20190830.0,N,CN,US,US,2019,Q4,Elderly
169708231,16970823,2,C,INSULIN LISPRO (HUMALOG),,2,,,,,,,,,,,,,,2019,Q4,Lethargy,,2019,Q4,1,I,20190103.0,,20190912,20190912,DIR,,,FDA-CTU,,70.0,YR,,F,N,95.25,KG,20190830.0,N,CN,US,US,2019,Q4,Elderly
169708231,16970823,2,C,INSULIN LISPRO (HUMALOG),,2,,,,,,,,,,,,,,2019,Q4,Oropharyngeal pain,,2019,Q4,1,I,20190103.0,,20190912,20190912,DIR,,,FDA-CTU,,70.0,YR,,F,N,95.25,KG,20190830.0,N,CN,US,US,2019,Q4,Elderly
169708231,16970823,2,C,INSULIN LISPRO (HUMALOG),,2,,,,,,,,,,,,,,2019,Q4,Therapy cessation,,2019,Q4,1,I,20190103.0,,20190912,20190912,DIR,,,FDA-CTU,,70.0,YR,,F,N,95.25,KG,20190830.0,N,CN,US,US,2019,Q4,Elderly
169708231,16970823,2,C,INSULIN LISPRO (HUMALOG),,2,,,,,,,,,,,,,,2019,Q4,Tooth fracture,,2019,Q4,1,I,20190103.0,,20190912,20190912,DIR,,,FDA-CTU,,70.0,YR,,F,N,95.25,KG,20190830.0,N,CN,US,US,2019,Q4,Elderly
169708231,16970823,2,C,INSULIN LISPRO (HUMALOG),,2,,,,,,,,,,,,,,2019,Q4,Tooth infection,,2019,Q4,1,I,20190103.0,,20190912,20190912,DIR,,,FDA-CTU,,70.0,YR,,F,N,95.25,KG,20190830.0,N,CN,US,US,2019,Q4,Elderly
169708231,16970823,2,C,INSULIN LISPRO (HUMALOG),,2,,,,,,,,,,,,,,2019,Q4,Transient global amnesia,,2019,Q4,1,I,20190103.0,,20190912,20190912,DIR,,,FDA-CTU,,70.0,YR,,F,N,95.25,KG,20190830.0,N,CN,US,US,2019,Q4,Elderly
169708231,16970823,2,C,INSULIN LISPRO (HUMALOG),,2,,,,,,,,,,,,,,2019,Q4,Transient ischaemic attack,,2019,Q4,1,I,20190103.0,,20190912,20190912,DIR,,,FDA-CTU,,70.0,YR,,F,N,95.25,KG,20190830.0,N,CN,US,US,2019,Q4,Elderly
169710313,16971031,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,PRN,,,,,,,,,,,,2019,Q4,Arrhythmia,,2019,Q4,3,F,20190923.0,20191211.0,20191029,20191219,EXP,,NL-VERTEX PHARMACEUTICALS-2019-009178,VERTEX,,52.0,YR,,F,Y,75.0,KG,20191219.0,,MD,NL,NL,2019,Q4,Adult
169864128,16986412,67,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2019,Q4,Hypotension,,2019,Q4,8,F,20191026.0,20191218.0,20191101,20191230,EXP,,NVSC2019US019491,NOVARTIS,,59.0,YR,,F,Y,66.65,KG,20191230.0,,MD,US,US,2019,Q4,Adult
169864128,16986412,68,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2019,Q4,Hypotension,,2019,Q4,8,F,20191026.0,20191218.0,20191101,20191230,EXP,,NVSC2019US019491,NOVARTIS,,59.0,YR,,F,Y,66.65,KG,20191230.0,,MD,US,US,2019,Q4,Adult
169903124,16990312,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Blood culture positive,,2019,Q4,4,F,20191016.0,20191105.0,20191104,20191119,PER,,US-ACTELION-A-NJ2019-197666,ACTELION,,40.0,YR,,F,Y,68.03,KG,20191119.0,,OT,US,US,2019,Q4,Adult
169903124,16990312,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Catheter management,,2019,Q4,4,F,20191016.0,20191105.0,20191104,20191119,PER,,US-ACTELION-A-NJ2019-197666,ACTELION,,40.0,YR,,F,Y,68.03,KG,20191119.0,,OT,US,US,2019,Q4,Adult
169903124,16990312,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Chills,,2019,Q4,4,F,20191016.0,20191105.0,20191104,20191119,PER,,US-ACTELION-A-NJ2019-197666,ACTELION,,40.0,YR,,F,Y,68.03,KG,20191119.0,,OT,US,US,2019,Q4,Adult
169903124,16990312,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Device related infection,,2019,Q4,4,F,20191016.0,20191105.0,20191104,20191119,PER,,US-ACTELION-A-NJ2019-197666,ACTELION,,40.0,YR,,F,Y,68.03,KG,20191119.0,,OT,US,US,2019,Q4,Adult
169903124,16990312,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Diarrhoea,,2019,Q4,4,F,20191016.0,20191105.0,20191104,20191119,PER,,US-ACTELION-A-NJ2019-197666,ACTELION,,40.0,YR,,F,Y,68.03,KG,20191119.0,,OT,US,US,2019,Q4,Adult
169903124,16990312,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Headache,,2019,Q4,4,F,20191016.0,20191105.0,20191104,20191119,PER,,US-ACTELION-A-NJ2019-197666,ACTELION,,40.0,YR,,F,Y,68.03,KG,20191119.0,,OT,US,US,2019,Q4,Adult
169903124,16990312,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Hypoperfusion,,2019,Q4,4,F,20191016.0,20191105.0,20191104,20191119,PER,,US-ACTELION-A-NJ2019-197666,ACTELION,,40.0,YR,,F,Y,68.03,KG,20191119.0,,OT,US,US,2019,Q4,Adult
169903124,16990312,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Hypotension,,2019,Q4,4,F,20191016.0,20191105.0,20191104,20191119,PER,,US-ACTELION-A-NJ2019-197666,ACTELION,,40.0,YR,,F,Y,68.03,KG,20191119.0,,OT,US,US,2019,Q4,Adult
169903124,16990312,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Ischaemic hepatitis,,2019,Q4,4,F,20191016.0,20191105.0,20191104,20191119,PER,,US-ACTELION-A-NJ2019-197666,ACTELION,,40.0,YR,,F,Y,68.03,KG,20191119.0,,OT,US,US,2019,Q4,Adult
169903124,16990312,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Pyrexia,,2019,Q4,4,F,20191016.0,20191105.0,20191104,20191119,PER,,US-ACTELION-A-NJ2019-197666,ACTELION,,40.0,YR,,F,Y,68.03,KG,20191119.0,,OT,US,US,2019,Q4,Adult
169903124,16990312,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Septic shock,,2019,Q4,4,F,20191016.0,20191105.0,20191104,20191119,PER,,US-ACTELION-A-NJ2019-197666,ACTELION,,40.0,YR,,F,Y,68.03,KG,20191119.0,,OT,US,US,2019,Q4,Adult
169903124,16990312,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Serratia test positive,,2019,Q4,4,F,20191016.0,20191105.0,20191104,20191119,PER,,US-ACTELION-A-NJ2019-197666,ACTELION,,40.0,YR,,F,Y,68.03,KG,20191119.0,,OT,US,US,2019,Q4,Adult
169903124,16990312,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Thrombocytopenia,,2019,Q4,4,F,20191016.0,20191105.0,20191104,20191119,PER,,US-ACTELION-A-NJ2019-197666,ACTELION,,40.0,YR,,F,Y,68.03,KG,20191119.0,,OT,US,US,2019,Q4,Adult
169904361,16990436,2,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Blood glucose increased,,2019,Q4,1,I,20191023.0,,20191103,20191103,DIR,,,FDA-CTU,,76.0,YR,,M,N,94.5,KG,20191103.0,N,CN,US,US,2019,Q4,Elderly
169904361,16990436,2,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Drug ineffective,,2019,Q4,1,I,20191023.0,,20191103,20191103,DIR,,,FDA-CTU,,76.0,YR,,M,N,94.5,KG,20191103.0,N,CN,US,US,2019,Q4,Elderly
169904361,16990436,2,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Insulin resistance,,2019,Q4,1,I,20191023.0,,20191103,20191103,DIR,,,FDA-CTU,,76.0,YR,,M,N,94.5,KG,20191103.0,N,CN,US,US,2019,Q4,Elderly
169904361,16990436,2,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Product substitution issue,,2019,Q4,1,I,20191023.0,,20191103,20191103,DIR,,,FDA-CTU,,76.0,YR,,M,N,94.5,KG,20191103.0,N,CN,US,US,2019,Q4,Elderly
169910091,16991009,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Wrong technique in device usage process,,2019,Q4,1,I,,20191030.0,20191104,20191104,PER,,US-SA-2019SA304870,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20191104.0,,CN,US,US,2019,Q4,Adult
169938461,16993846,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q4,Acute myocardial infarction,,2019,Q4,1,I,20190929.0,20191022.0,20191105,20191105,EXP,,US-BAYER-2019-192331,BAYER,,64.0,YR,A,M,Y,82.99,KG,20191031.0,,CN,US,US,2019,Q4,Adult
169938461,16993846,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q4,Blood loss anaemia,,2019,Q4,1,I,20190929.0,20191022.0,20191105,20191105,EXP,,US-BAYER-2019-192331,BAYER,,64.0,YR,A,M,Y,82.99,KG,20191031.0,,CN,US,US,2019,Q4,Adult
169938461,16993846,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q4,Melaena,,2019,Q4,1,I,20190929.0,20191022.0,20191105,20191105,EXP,,US-BAYER-2019-192331,BAYER,,64.0,YR,A,M,Y,82.99,KG,20191031.0,,CN,US,US,2019,Q4,Adult
169938461,16993846,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q4,Nausea,,2019,Q4,1,I,20190929.0,20191022.0,20191105,20191105,EXP,,US-BAYER-2019-192331,BAYER,,64.0,YR,A,M,Y,82.99,KG,20191031.0,,CN,US,US,2019,Q4,Adult
169938461,16993846,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q4,Peptic ulcer haemorrhage,,2019,Q4,1,I,20190929.0,20191022.0,20191105,20191105,EXP,,US-BAYER-2019-192331,BAYER,,64.0,YR,A,M,Y,82.99,KG,20191031.0,,CN,US,US,2019,Q4,Adult
170000061,17000006,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q4,Acute kidney injury,,2019,Q4,1,I,,20191031.0,20191106,20191106,EXP,,PT-MYLANLABS-2019M1104637,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA DUE TO HYPOVOLAEMIA - A CASE OF IATROGENESIS TO EMPAGLIFLOZIN",71.0,YR,,M,Y,,,20191106.0,,MD,PT,PT,2019,Q4,Elderly
170000061,17000006,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q4,Dizziness,,2019,Q4,1,I,,20191031.0,20191106,20191106,EXP,,PT-MYLANLABS-2019M1104637,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA DUE TO HYPOVOLAEMIA - A CASE OF IATROGENESIS TO EMPAGLIFLOZIN",71.0,YR,,M,Y,,,20191106.0,,MD,PT,PT,2019,Q4,Elderly
170000061,17000006,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q4,Hypovolaemia,,2019,Q4,1,I,,20191031.0,20191106,20191106,EXP,,PT-MYLANLABS-2019M1104637,MYLAN,"GOUVEIA C. C., DUQUE S., CAMPOS L.. LIPOTHYMIA DUE TO HYPOVOLAEMIA - A CASE OF IATROGENESIS TO EMPAGLIFLOZIN",71.0,YR,,M,Y,,,20191106.0,,MD,PT,PT,2019,Q4,Elderly
170007601,17000760,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2019,Q4,Diabetes insipidus,,2019,Q4,1,I,,20191028.0,20191106,20191106,EXP,,US-PFIZER INC-2019469264,PFIZER,"HERITY, L.. DELAYED ONSET OF CENTRAL DIABETES INSIPIDUS WITH KETAMINE SEDATION: A REPORT OF 2 CASES. JOURNAL OF PHARMACY PRACTICE. 2019;10.1177/0897190019882266",23.0,YR,,M,Y,86.2,KG,20191106.0,,PH,US,US,2019,Q4,Youth
170040181,17004018,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN (SLIDING SCALE)",,,Y,U,,,20563.0,,,,,2019,Q4,Rash,,2019,Q4,1,I,,20191029.0,20191107,20191107,EXP,,US-ELI_LILLY_AND_COMPANY-US201910015499,ELI LILLY AND CO,,9.0,YR,,F,Y,,,20191107.0,,CN,US,US,2019,Q4,Child
170040181,17004018,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN (SLIDING SCALE)",,,Y,U,,,20563.0,,,,,2019,Q4,Urticaria,,2019,Q4,1,I,,20191029.0,20191107,20191107,EXP,,US-ELI_LILLY_AND_COMPANY-US201910015499,ELI LILLY AND CO,,9.0,YR,,F,Y,,,20191107.0,,CN,US,US,2019,Q4,Child
170040181,17004018,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN (SLIDING SCALE)",,,Y,U,,,20563.0,,,,,2019,Q4,Vaginal haemorrhage,,2019,Q4,1,I,,20191029.0,20191107,20191107,EXP,,US-ELI_LILLY_AND_COMPANY-US201910015499,ELI LILLY AND CO,,9.0,YR,,F,Y,,,20191107.0,,CN,US,US,2019,Q4,Child
170040181,17004018,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN (SLIDING SCALE)",,,Y,U,,,20563.0,,,,,2019,Q4,Vomiting,,2019,Q4,1,I,,20191029.0,20191107,20191107,EXP,,US-ELI_LILLY_AND_COMPANY-US201910015499,ELI LILLY AND CO,,9.0,YR,,F,Y,,,20191107.0,,CN,US,US,2019,Q4,Child
170073931,17007393,8,C,INSULIN LISPRO;INSULIN LISPRO PROTAMINE,,2,Unknown,"UNK, (75/25) 40 UNITS EVERY MORNING AND 60 UNITS EVERY EVENING",,,,,,,,,,,,2019,Q4,Cardiac arrest,,2019,Q4,1,I,,20190816.0,20191108,20191108,PER,,US-LUPIN PHARMACEUTICALS INC.-2019-05484,LUPIN,,72.0,YR,,F,Y,,,20191108.0,,PH,US,US,2019,Q4,Elderly
170073931,17007393,8,C,INSULIN LISPRO;INSULIN LISPRO PROTAMINE,,2,Unknown,"UNK, (75/25) 40 UNITS EVERY MORNING AND 60 UNITS EVERY EVENING",,,,,,,,,,,,2019,Q4,Drug interaction,,2019,Q4,1,I,,20190816.0,20191108,20191108,PER,,US-LUPIN PHARMACEUTICALS INC.-2019-05484,LUPIN,,72.0,YR,,F,Y,,,20191108.0,,PH,US,US,2019,Q4,Elderly
170082551,17008255,16,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10-23 UNITS, TID PRN",,,,,,,,,,,,2019,Q4,Nausea,,2019,Q4,1,I,20190208.0,20190212.0,20191108,20191108,EXP,,US-KARYOPHARM-2019KPT000106,KARYOPHARM THERAPEUTICS,,56.0,YR,,F,Y,110.0,KG,20191108.0,,MD,US,US,2019,Q4,Adult
170082551,17008255,16,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10-23 UNITS, TID PRN",,,,,,,,,,,,2019,Q4,Vomiting,,2019,Q4,1,I,20190208.0,20190212.0,20191108,20191108,EXP,,US-KARYOPHARM-2019KPT000106,KARYOPHARM THERAPEUTICS,,56.0,YR,,F,Y,110.0,KG,20191108.0,,MD,US,US,2019,Q4,Adult
170125662,17012566,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"60 U, UNKNOWN",,,U,U,,,,60.0,IU,,,2019,Q4,Blood glucose increased,,2019,Q4,2,F,,20191105.0,20191109,20191125,EXP,,US-ELI_LILLY_AND_COMPANY-US201911001733,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20191125.0,,CN,US,US,2019,Q4,Elderly
170125662,17012566,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"60 U, UNKNOWN",,,U,U,,,,60.0,IU,,,2019,Q4,Visual impairment,,2019,Q4,2,F,,20191105.0,20191109,20191125,EXP,,US-ELI_LILLY_AND_COMPANY-US201911001733,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20191125.0,,CN,US,US,2019,Q4,Elderly
170224211,17022421,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,32 IU,,,,,,,,32.0,IU,,,2019,Q4,Cerebral haemorrhage,,2019,Q4,1,I,20191021.0,20191101.0,20191112,20191112,EXP,IT-MINISAL02-583429,IT-JNJFOC-20191107126,JOHNSON AND JOHNSON,,67.0,YR,,M,Y,,,20191112.0,,MD,IT,IT,2019,Q4,Elderly
170224211,17022421,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,32 IU,,,,,,,,32.0,IU,,,2019,Q4,Loss of consciousness,,2019,Q4,1,I,20191021.0,20191101.0,20191112,20191112,EXP,IT-MINISAL02-583429,IT-JNJFOC-20191107126,JOHNSON AND JOHNSON,,67.0,YR,,M,Y,,,20191112.0,,MD,IT,IT,2019,Q4,Elderly
170224211,17022421,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,32 IU,,,,,,,,32.0,IU,,,2019,Q4,Neurological symptom,,2019,Q4,1,I,20191021.0,20191101.0,20191112,20191112,EXP,IT-MINISAL02-583429,IT-JNJFOC-20191107126,JOHNSON AND JOHNSON,,67.0,YR,,M,Y,,,20191112.0,,MD,IT,IT,2019,Q4,Elderly
170224211,17022421,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,32 IU,,,,,,,,32.0,IU,,,2019,Q4,Respiratory arrest,,2019,Q4,1,I,20191021.0,20191101.0,20191112,20191112,EXP,IT-MINISAL02-583429,IT-JNJFOC-20191107126,JOHNSON AND JOHNSON,,67.0,YR,,M,Y,,,20191112.0,,MD,IT,IT,2019,Q4,Elderly
170235681,17023568,10,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q4,Cerebrovascular accident,,2019,Q4,1,I,,20191030.0,20191113,20191113,EXP,,PT-AUROBINDO-AUR-APL-2019-071930,AUROBINDO,,42.0,YR,,F,Y,,,20191113.0,,OT,PT,PT,2019,Q4,Adult
170235681,17023568,10,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2019,Q4,Treatment noncompliance,,2019,Q4,1,I,,20191030.0,20191113,20191113,EXP,,PT-AUROBINDO-AUR-APL-2019-071930,AUROBINDO,,42.0,YR,,F,Y,,,20191113.0,,OT,PT,PT,2019,Q4,Adult
170247151,17024715,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Cough,Cough,2019,Q4,1,I,20190913.0,20190918.0,20191113,20191113,PER,,US-ALVOGEN-2019-ALVOGEN-101769,ALVOGEN,,68.0,YR,,F,Y,,,20191113.0,,CN,US,US,2019,Q4,Elderly
170247151,17024715,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Sinusitis,Sinusitis,2019,Q4,1,I,20190913.0,20190918.0,20191113,20191113,PER,,US-ALVOGEN-2019-ALVOGEN-101769,ALVOGEN,,68.0,YR,,F,Y,,,20191113.0,,CN,US,US,2019,Q4,Elderly
170280151,17028015,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,, UNK,,,,,,,2019,Q4,Cerebrovascular accident,,2019,Q4,1,I,,20191101.0,20191113,20191113,EXP,,PT-BAUSCH-BL-2019-059929,BAUSCH AND LOMB,"COCHICHO J, SILVA J, NARANJO S, RAIMUNDO R, MENDES A, VIANA S. AVC NO DOENTE JOVEM: UM CASO DE INVESTIGACAO ETIOLOGICA COM MULTIPLAS RESPOSTAS. MEDICINA INTERNA - CONGRESSOS NACIONAIS. 2019;.",42.0,YR,,F,Y,,,20191113.0,,MD,PT,PT,2019,Q4,Adult
170280151,17028015,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,, UNK,,,,,,,2019,Q4,Treatment noncompliance,,2019,Q4,1,I,,20191101.0,20191113,20191113,EXP,,PT-BAUSCH-BL-2019-059929,BAUSCH AND LOMB,"COCHICHO J, SILVA J, NARANJO S, RAIMUNDO R, MENDES A, VIANA S. AVC NO DOENTE JOVEM: UM CASO DE INVESTIGACAO ETIOLOGICA COM MULTIPLAS RESPOSTAS. MEDICINA INTERNA - CONGRESSOS NACIONAIS. 2019;.",42.0,YR,,F,Y,,,20191113.0,,MD,PT,PT,2019,Q4,Adult
170281501,17028150,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,FOR USE WITH INSULIN PUMP,,,,,,,,,,,,2019,Q4,Infective pulmonary exacerbation of cystic fibrosis,,2019,Q4,1,I,20191029.0,20191106.0,20191113,20191113,EXP,,US-VERTEX PHARMACEUTICALS-2019-010957,VERTEX,,39.0,YR,,F,Y,58.0,KG,20191113.0,,MD,US,US,2019,Q4,Adult
170334031,17033403,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,U,,,,,,,,Q12H,2019,Q4,Blood glucose increased,,2019,Q4,1,I,,20191104.0,20191114,20191114,PER,,US-SA-2019SA308136,SANOFI AVENTIS,,74.0,YR,E,F,Y,,,20191114.0,,OT,US,US,2019,Q4,Elderly
170382831,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2019,Q4,Abdominal pain,,2019,Q4,1,I,,20190930.0,20191115,20191115,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20191115.0,,OT,CA,CA,2019,Q4,Adult
170382831,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2019,Q4,Abscess,,2019,Q4,1,I,,20190930.0,20191115,20191115,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20191115.0,,OT,CA,CA,2019,Q4,Adult
170382831,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2019,Q4,Adrenal insufficiency,,2019,Q4,1,I,,20190930.0,20191115,20191115,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20191115.0,,OT,CA,CA,2019,Q4,Adult
170382831,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2019,Q4,Alanine aminotransferase increased,,2019,Q4,1,I,,20190930.0,20191115,20191115,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20191115.0,,OT,CA,CA,2019,Q4,Adult
170382831,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2019,Q4,Ascites,,2019,Q4,1,I,,20190930.0,20191115,20191115,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20191115.0,,OT,CA,CA,2019,Q4,Adult
170382831,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2019,Q4,Asthenia,,2019,Q4,1,I,,20190930.0,20191115,20191115,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20191115.0,,OT,CA,CA,2019,Q4,Adult
170382831,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2019,Q4,Blood alkaline phosphatase increased,,2019,Q4,1,I,,20190930.0,20191115,20191115,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20191115.0,,OT,CA,CA,2019,Q4,Adult
170382831,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2019,Q4,Blood bilirubin increased,,2019,Q4,1,I,,20190930.0,20191115,20191115,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20191115.0,,OT,CA,CA,2019,Q4,Adult
170382831,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2019,Q4,Blood potassium decreased,,2019,Q4,1,I,,20190930.0,20191115,20191115,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20191115.0,,OT,CA,CA,2019,Q4,Adult
170382831,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2019,Q4,Blood pressure diastolic abnormal,,2019,Q4,1,I,,20190930.0,20191115,20191115,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20191115.0,,OT,CA,CA,2019,Q4,Adult
170382831,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2019,Q4,Blood pressure increased,,2019,Q4,1,I,,20190930.0,20191115,20191115,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20191115.0,,OT,CA,CA,2019,Q4,Adult
170382831,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2019,Q4,Depression,,2019,Q4,1,I,,20190930.0,20191115,20191115,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20191115.0,,OT,CA,CA,2019,Q4,Adult
170382831,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2019,Q4,Diverticulitis,,2019,Q4,1,I,,20190930.0,20191115,20191115,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20191115.0,,OT,CA,CA,2019,Q4,Adult
170382831,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2019,Q4,Endometrial disorder,,2019,Q4,1,I,,20190930.0,20191115,20191115,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20191115.0,,OT,CA,CA,2019,Q4,Adult
170382831,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2019,Q4,Enterococcus test positive,,2019,Q4,1,I,,20190930.0,20191115,20191115,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20191115.0,,OT,CA,CA,2019,Q4,Adult
170382831,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2019,Q4,Fibrosis,,2019,Q4,1,I,,20190930.0,20191115,20191115,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20191115.0,,OT,CA,CA,2019,Q4,Adult
170382831,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2019,Q4,Gamma-glutamyltransferase increased,,2019,Q4,1,I,,20190930.0,20191115,20191115,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20191115.0,,OT,CA,CA,2019,Q4,Adult
170382831,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2019,Q4,Gastrointestinal disorder,,2019,Q4,1,I,,20190930.0,20191115,20191115,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20191115.0,,OT,CA,CA,2019,Q4,Adult
170382831,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2019,Q4,Generalised oedema,,2019,Q4,1,I,,20190930.0,20191115,20191115,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20191115.0,,OT,CA,CA,2019,Q4,Adult
170382831,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2019,Q4,Heart rate increased,,2019,Q4,1,I,,20190930.0,20191115,20191115,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20191115.0,,OT,CA,CA,2019,Q4,Adult
170382831,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2019,Q4,Hepatic congestion,,2019,Q4,1,I,,20190930.0,20191115,20191115,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20191115.0,,OT,CA,CA,2019,Q4,Adult
170382831,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2019,Q4,Herpes zoster,,2019,Q4,1,I,,20190930.0,20191115,20191115,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20191115.0,,OT,CA,CA,2019,Q4,Adult
170382831,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2019,Q4,Hypersensitivity,,2019,Q4,1,I,,20190930.0,20191115,20191115,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20191115.0,,OT,CA,CA,2019,Q4,Adult
170382831,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2019,Q4,Hypoglycaemia,,2019,Q4,1,I,,20190930.0,20191115,20191115,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20191115.0,,OT,CA,CA,2019,Q4,Adult
170382831,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2019,Q4,Hypotension,,2019,Q4,1,I,,20190930.0,20191115,20191115,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20191115.0,,OT,CA,CA,2019,Q4,Adult
170382831,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2019,Q4,Increased appetite,,2019,Q4,1,I,,20190930.0,20191115,20191115,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20191115.0,,OT,CA,CA,2019,Q4,Adult
170382831,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2019,Q4,Influenza,,2019,Q4,1,I,,20190930.0,20191115,20191115,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20191115.0,,OT,CA,CA,2019,Q4,Adult
170382831,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2019,Q4,Infusion related reaction,,2019,Q4,1,I,,20190930.0,20191115,20191115,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20191115.0,,OT,CA,CA,2019,Q4,Adult
170382831,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2019,Q4,Injection site extravasation,,2019,Q4,1,I,,20190930.0,20191115,20191115,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20191115.0,,OT,CA,CA,2019,Q4,Adult
170382831,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2019,Q4,Intensive care unit acquired weakness,,2019,Q4,1,I,,20190930.0,20191115,20191115,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20191115.0,,OT,CA,CA,2019,Q4,Adult
170382831,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2019,Q4,Intervertebral disc protrusion,,2019,Q4,1,I,,20190930.0,20191115,20191115,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20191115.0,,OT,CA,CA,2019,Q4,Adult
170382831,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2019,Q4,Joint effusion,,2019,Q4,1,I,,20190930.0,20191115,20191115,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20191115.0,,OT,CA,CA,2019,Q4,Adult
170382831,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2019,Q4,Joint swelling,,2019,Q4,1,I,,20190930.0,20191115,20191115,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20191115.0,,OT,CA,CA,2019,Q4,Adult
170382831,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2019,Q4,Micturition disorder,,2019,Q4,1,I,,20190930.0,20191115,20191115,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20191115.0,,OT,CA,CA,2019,Q4,Adult
170382831,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2019,Q4,Myelopathy,,2019,Q4,1,I,,20190930.0,20191115,20191115,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20191115.0,,OT,CA,CA,2019,Q4,Adult
170382831,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2019,Q4,Myopathy,,2019,Q4,1,I,,20190930.0,20191115,20191115,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20191115.0,,OT,CA,CA,2019,Q4,Adult
170382831,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2019,Q4,Nasopharyngitis,,2019,Q4,1,I,,20190930.0,20191115,20191115,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20191115.0,,OT,CA,CA,2019,Q4,Adult
170382831,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2019,Q4,Nausea,,2019,Q4,1,I,,20190930.0,20191115,20191115,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20191115.0,,OT,CA,CA,2019,Q4,Adult
170382831,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2019,Q4,Nerve compression,,2019,Q4,1,I,,20190930.0,20191115,20191115,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20191115.0,,OT,CA,CA,2019,Q4,Adult
170382831,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2019,Q4,Neuropathy peripheral,,2019,Q4,1,I,,20190930.0,20191115,20191115,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20191115.0,,OT,CA,CA,2019,Q4,Adult
170382831,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2019,Q4,Neutropenia,,2019,Q4,1,I,,20190930.0,20191115,20191115,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20191115.0,,OT,CA,CA,2019,Q4,Adult
170382831,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2019,Q4,Osteoarthritis,,2019,Q4,1,I,,20190930.0,20191115,20191115,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20191115.0,,OT,CA,CA,2019,Q4,Adult
170382831,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2019,Q4,Pancytopenia,,2019,Q4,1,I,,20190930.0,20191115,20191115,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20191115.0,,OT,CA,CA,2019,Q4,Adult
170382831,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2019,Q4,Peripheral sensorimotor neuropathy,,2019,Q4,1,I,,20190930.0,20191115,20191115,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20191115.0,,OT,CA,CA,2019,Q4,Adult
170382831,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2019,Q4,Peritonitis,,2019,Q4,1,I,,20190930.0,20191115,20191115,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20191115.0,,OT,CA,CA,2019,Q4,Adult
170382831,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2019,Q4,Pneumonia,,2019,Q4,1,I,,20190930.0,20191115,20191115,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20191115.0,,OT,CA,CA,2019,Q4,Adult
170382831,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2019,Q4,Pseudomonal bacteraemia,,2019,Q4,1,I,,20190930.0,20191115,20191115,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20191115.0,,OT,CA,CA,2019,Q4,Adult
170382831,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2019,Q4,Rheumatoid arthritis,,2019,Q4,1,I,,20190930.0,20191115,20191115,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20191115.0,,OT,CA,CA,2019,Q4,Adult
170382831,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2019,Q4,Septic shock,,2019,Q4,1,I,,20190930.0,20191115,20191115,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20191115.0,,OT,CA,CA,2019,Q4,Adult
170382831,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2019,Q4,Therapeutic response decreased,,2019,Q4,1,I,,20190930.0,20191115,20191115,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20191115.0,,OT,CA,CA,2019,Q4,Adult
170382831,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2019,Q4,Vomiting,,2019,Q4,1,I,,20190930.0,20191115,20191115,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20191115.0,,OT,CA,CA,2019,Q4,Adult
170382831,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2019,Q4,Weight decreased,,2019,Q4,1,I,,20190930.0,20191115,20191115,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20191115.0,,OT,CA,CA,2019,Q4,Adult
170382831,17038283,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2019,Q4,Weight increased,,2019,Q4,1,I,,20190930.0,20191115,20191115,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,,F,Y,67.0,KG,20191115.0,,OT,CA,CA,2019,Q4,Adult
170384581,17038458,12,C,insulin lispro,INSULIN LISPRO,1,,SUB-Q; BEFORE MEALS,,,,,,,,,,,TID,2019,Q4,Abdominal pain,,2019,Q4,1,I,2019.0,20191007.0,20191115,20191115,EXP,,"US-IPSEN BIOPHARMACEUTICALS, INC.-2019-18421",IPSEN,,53.0,YR,,F,Y,73.5,KG,20191115.0,,OT,US,US,2019,Q4,Adult
170384581,17038458,12,C,insulin lispro,INSULIN LISPRO,1,,SUB-Q; BEFORE MEALS,,,,,,,,,,,TID,2019,Q4,Diarrhoea,,2019,Q4,1,I,2019.0,20191007.0,20191115,20191115,EXP,,"US-IPSEN BIOPHARMACEUTICALS, INC.-2019-18421",IPSEN,,53.0,YR,,F,Y,73.5,KG,20191115.0,,OT,US,US,2019,Q4,Adult
170384581,17038458,12,C,insulin lispro,INSULIN LISPRO,1,,SUB-Q; BEFORE MEALS,,,,,,,,,,,TID,2019,Q4,Liver function test increased,,2019,Q4,1,I,2019.0,20191007.0,20191115,20191115,EXP,,"US-IPSEN BIOPHARMACEUTICALS, INC.-2019-18421",IPSEN,,53.0,YR,,F,Y,73.5,KG,20191115.0,,OT,US,US,2019,Q4,Adult
170384581,17038458,12,C,insulin lispro,INSULIN LISPRO,1,,SUB-Q; BEFORE MEALS,,,,,,,,,,,TID,2019,Q4,Malnutrition,,2019,Q4,1,I,2019.0,20191007.0,20191115,20191115,EXP,,"US-IPSEN BIOPHARMACEUTICALS, INC.-2019-18421",IPSEN,,53.0,YR,,F,Y,73.5,KG,20191115.0,,OT,US,US,2019,Q4,Adult
170384581,17038458,12,C,insulin lispro,INSULIN LISPRO,1,,SUB-Q; BEFORE MEALS,,,,,,,,,,,TID,2019,Q4,Nausea,,2019,Q4,1,I,2019.0,20191007.0,20191115,20191115,EXP,,"US-IPSEN BIOPHARMACEUTICALS, INC.-2019-18421",IPSEN,,53.0,YR,,F,Y,73.5,KG,20191115.0,,OT,US,US,2019,Q4,Adult
170384581,17038458,12,C,insulin lispro,INSULIN LISPRO,1,,SUB-Q; BEFORE MEALS,,,,,,,,,,,TID,2019,Q4,Vomiting,,2019,Q4,1,I,2019.0,20191007.0,20191115,20191115,EXP,,"US-IPSEN BIOPHARMACEUTICALS, INC.-2019-18421",IPSEN,,53.0,YR,,F,Y,73.5,KG,20191115.0,,OT,US,US,2019,Q4,Adult
170393611,17039361,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,,,2019,Q4,Inappropriate schedule of product administration,,2019,Q4,1,I,,20191108.0,20191115,20191115,PER,,US-SA-2019SA313389,SANOFI AVENTIS,,69.0,YR,E,F,Y,,,20191115.0,,CN,US,US,2019,Q4,Elderly
170393611,17039361,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,,,2019,Q4,Product storage error,,2019,Q4,1,I,,20191108.0,20191115,20191115,PER,,US-SA-2019SA313389,SANOFI AVENTIS,,69.0,YR,E,F,Y,,,20191115.0,,CN,US,US,2019,Q4,Elderly
170393611,17039361,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,,,2019,Q4,Renal surgery,,2019,Q4,1,I,,20191108.0,20191115,20191115,PER,,US-SA-2019SA313389,SANOFI AVENTIS,,69.0,YR,E,F,Y,,,20191115.0,,CN,US,US,2019,Q4,Elderly
170408631,17040863,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,SOLUTION FOR INJECTION,,2019,Q4,Pancreatic carcinoma,,2019,Q4,1,I,,20191108.0,20191118,20191118,EXP,,FR-SA-2019SA317242,SANOFI AVENTIS,,72.0,YR,E,M,Y,,,20191118.0,,MD,FR,FR,2019,Q4,Elderly
170412531,17041253,41,C,Lispro Insulin (insulin lispro),,2,,,,,,,,,,,,,,2019,Q4,Hypotension,,2019,Q4,1,I,20191026.0,20191112.0,20191118,20191118,EXP,US-002147023-NVSC2019US019491,US-CHEPLA-C20192985,CHEPLAPHARM,,59.0,YR,,F,Y,66.65,KG,20191118.0,,CN,NL,US,2019,Q4,Adult
170412531,17041253,41,C,Lispro Insulin (insulin lispro),,2,,,,,,,,,,,,,,2019,Q4,Pyrexia,,2019,Q4,1,I,20191026.0,20191112.0,20191118,20191118,EXP,US-002147023-NVSC2019US019491,US-CHEPLA-C20192985,CHEPLAPHARM,,59.0,YR,,F,Y,66.65,KG,20191118.0,,CN,NL,US,2019,Q4,Adult
170412531,17041253,41,C,Lispro Insulin (insulin lispro),,2,,,,,,,,,,,,,,2019,Q4,Seroma,,2019,Q4,1,I,20191026.0,20191112.0,20191118,20191118,EXP,US-002147023-NVSC2019US019491,US-CHEPLA-C20192985,CHEPLAPHARM,,59.0,YR,,F,Y,66.65,KG,20191118.0,,CN,NL,US,2019,Q4,Adult
170436321,17043632,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Hyperglycaemia,,2019,Q4,1,I,20190909.0,,20191017,20191017,DIR,,,FDA-CTU,,38.0,YR,,F,N,143.7,KG,20191017.0,N,OT,US,US,2019,Q4,Adult
170436321,17043632,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Infusion site rash,,2019,Q4,1,I,20190909.0,,20191017,20191017,DIR,,,FDA-CTU,,38.0,YR,,F,N,143.7,KG,20191017.0,N,OT,US,US,2019,Q4,Adult
170436321,17043632,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Palpitations,,2019,Q4,1,I,20190909.0,,20191017,20191017,DIR,,,FDA-CTU,,38.0,YR,,F,N,143.7,KG,20191017.0,N,OT,US,US,2019,Q4,Adult
170439012,17043901,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,, UNK,,,,,,,2019,Q4,Treatment noncompliance,,2019,Q4,2,F,,20191113.0,20191118,20191120,EXP,,PT-PFIZER INC-2019493033,PFIZER,"COCHICHO, J.. STROKE IN YOUNG PATIENTS: A CASE OF ETIOLOGICAL INVESTIGATION WITH MULTIPLE RESPONSES.. INTERNAL MEDICINE - NATIONAL CONGRESSES. 2019;25CNMI19",42.0,YR,,F,Y,,,20191120.0,,MD,PT,PT,2019,Q4,Adult
170443141,17044314,18,C,Insulin Lispro,INSULIN LISPRO,1,Oral,,,,,,,,,,,UNKNOWN,,2019,Q4,Abdominal pain,,2019,Q4,1,I,,20191111.0,20191118,20191118,EXP,,CA-CELGENEUS-CAN-20191103657,CELGENE,,72.0,YR,,F,Y,,,20191118.0,,OT,CA,CA,2019,Q4,Elderly
170443141,17044314,18,C,Insulin Lispro,INSULIN LISPRO,1,Oral,,,,,,,,,,,UNKNOWN,,2019,Q4,Dehydration,,2019,Q4,1,I,,20191111.0,20191118,20191118,EXP,,CA-CELGENEUS-CAN-20191103657,CELGENE,,72.0,YR,,F,Y,,,20191118.0,,OT,CA,CA,2019,Q4,Elderly
170443141,17044314,18,C,Insulin Lispro,INSULIN LISPRO,1,Oral,,,,,,,,,,,UNKNOWN,,2019,Q4,Pyrexia,,2019,Q4,1,I,,20191111.0,20191118,20191118,EXP,,CA-CELGENEUS-CAN-20191103657,CELGENE,,72.0,YR,,F,Y,,,20191118.0,,OT,CA,CA,2019,Q4,Elderly
170443141,17044314,18,C,Insulin Lispro,INSULIN LISPRO,1,Oral,,,,,,,,,,,UNKNOWN,,2019,Q4,Small intestinal obstruction,,2019,Q4,1,I,,20191111.0,20191118,20191118,EXP,,CA-CELGENEUS-CAN-20191103657,CELGENE,,72.0,YR,,F,Y,,,20191118.0,,OT,CA,CA,2019,Q4,Elderly
170443141,17044314,18,C,Insulin Lispro,INSULIN LISPRO,1,Oral,,,,,,,,,,,UNKNOWN,,2019,Q4,Urinary tract obstruction,,2019,Q4,1,I,,20191111.0,20191118,20191118,EXP,,CA-CELGENEUS-CAN-20191103657,CELGENE,,72.0,YR,,F,Y,,,20191118.0,,OT,CA,CA,2019,Q4,Elderly
170479931,17047993,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Abdominal discomfort,,2019,Q4,1,I,201910.0,20191115.0,20191119,20191119,PER,,US-GILEAD-2019-0437930,GILEAD,,61.0,YR,A,F,Y,,,20191119.0,,CN,US,US,2019,Q4,Adult
170479931,17047993,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Decreased appetite,,2019,Q4,1,I,201910.0,20191115.0,20191119,20191119,PER,,US-GILEAD-2019-0437930,GILEAD,,61.0,YR,A,F,Y,,,20191119.0,,CN,US,US,2019,Q4,Adult
170479931,17047993,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Fatigue,,2019,Q4,1,I,201910.0,20191115.0,20191119,20191119,PER,,US-GILEAD-2019-0437930,GILEAD,,61.0,YR,A,F,Y,,,20191119.0,,CN,US,US,2019,Q4,Adult
170479931,17047993,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Flatulence,,2019,Q4,1,I,201910.0,20191115.0,20191119,20191119,PER,,US-GILEAD-2019-0437930,GILEAD,,61.0,YR,A,F,Y,,,20191119.0,,CN,US,US,2019,Q4,Adult
170479931,17047993,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Product dose omission,,2019,Q4,1,I,201910.0,20191115.0,20191119,20191119,PER,,US-GILEAD-2019-0437930,GILEAD,,61.0,YR,A,F,Y,,,20191119.0,,CN,US,US,2019,Q4,Adult
170479931,17047993,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Somnolence,,2019,Q4,1,I,201910.0,20191115.0,20191119,20191119,PER,,US-GILEAD-2019-0437930,GILEAD,,61.0,YR,A,F,Y,,,20191119.0,,CN,US,US,2019,Q4,Adult
170519161,17051916,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"5 U, EACH MORNING",,,U,U, C933644C,,,5.0,IU,INJECTION,QD,2019,Q4,Blood glucose decreased,,2019,Q4,1,I,,20191111.0,20191120,20191120,EXP,,US-ELI_LILLY_AND_COMPANY-US201911004576,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20191120.0,,CN,US,US,2019,Q4,Elderly
170519161,17051916,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"5 U, EACH MORNING",,,U,U, C933644C,,,5.0,IU,INJECTION,QD,2019,Q4,Fibromyalgia,,2019,Q4,1,I,,20191111.0,20191120,20191120,EXP,,US-ELI_LILLY_AND_COMPANY-US201911004576,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20191120.0,,CN,US,US,2019,Q4,Elderly
170519161,17051916,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"5 U, EACH MORNING",,,U,U, C933644C,,,5.0,IU,INJECTION,QD,2019,Q4,Influenza,,2019,Q4,1,I,,20191111.0,20191120,20191120,EXP,,US-ELI_LILLY_AND_COMPANY-US201911004576,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20191120.0,,CN,US,US,2019,Q4,Elderly
170519161,17051916,3,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"10 U, DAILY (LUNCH)",,,U,U, C933644C,,,10.0,IU,INJECTION,QD,2019,Q4,Blood glucose decreased,,2019,Q4,1,I,,20191111.0,20191120,20191120,EXP,,US-ELI_LILLY_AND_COMPANY-US201911004576,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20191120.0,,CN,US,US,2019,Q4,Elderly
170519161,17051916,3,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"10 U, DAILY (LUNCH)",,,U,U, C933644C,,,10.0,IU,INJECTION,QD,2019,Q4,Fibromyalgia,,2019,Q4,1,I,,20191111.0,20191120,20191120,EXP,,US-ELI_LILLY_AND_COMPANY-US201911004576,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20191120.0,,CN,US,US,2019,Q4,Elderly
170519161,17051916,3,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"10 U, DAILY (LUNCH)",,,U,U, C933644C,,,10.0,IU,INJECTION,QD,2019,Q4,Influenza,,2019,Q4,1,I,,20191111.0,20191120,20191120,EXP,,US-ELI_LILLY_AND_COMPANY-US201911004576,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20191120.0,,CN,US,US,2019,Q4,Elderly
170519161,17051916,4,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"15 U, DAILY (DINNER)",,,U,U, C933644C,,,15.0,IU,INJECTION,QD,2019,Q4,Blood glucose decreased,,2019,Q4,1,I,,20191111.0,20191120,20191120,EXP,,US-ELI_LILLY_AND_COMPANY-US201911004576,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20191120.0,,CN,US,US,2019,Q4,Elderly
170519161,17051916,4,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"15 U, DAILY (DINNER)",,,U,U, C933644C,,,15.0,IU,INJECTION,QD,2019,Q4,Fibromyalgia,,2019,Q4,1,I,,20191111.0,20191120,20191120,EXP,,US-ELI_LILLY_AND_COMPANY-US201911004576,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20191120.0,,CN,US,US,2019,Q4,Elderly
170519161,17051916,4,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"15 U, DAILY (DINNER)",,,U,U, C933644C,,,15.0,IU,INJECTION,QD,2019,Q4,Influenza,,2019,Q4,1,I,,20191111.0,20191120,20191120,EXP,,US-ELI_LILLY_AND_COMPANY-US201911004576,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20191120.0,,CN,US,US,2019,Q4,Elderly
170526911,17052691,1,PS,INSULIN LISPRO 100/U/ML (GENERIC),INSULIN LISPRO,1,Subcutaneous,?          OTHER DOSE:SLIDING SCALE 3X DAILY SUBQ?,,,Y,D,,,,,,,TID,2019,Q4,Anxiety,,2019,Q4,1,I,20191002.0,,20191021,20191021,DIR,,,FDA-CTU,,39.0,YR,,M,N,102.33,KG,20191021.0,N,OT,US,US,2019,Q4,Adult
170526911,17052691,1,PS,INSULIN LISPRO 100/U/ML (GENERIC),INSULIN LISPRO,1,Subcutaneous,?          OTHER DOSE:SLIDING SCALE 3X DAILY SUBQ?,,,Y,D,,,,,,,TID,2019,Q4,Blood glucose increased,,2019,Q4,1,I,20191002.0,,20191021,20191021,DIR,,,FDA-CTU,,39.0,YR,,M,N,102.33,KG,20191021.0,N,OT,US,US,2019,Q4,Adult
170526911,17052691,1,PS,INSULIN LISPRO 100/U/ML (GENERIC),INSULIN LISPRO,1,Subcutaneous,?          OTHER DOSE:SLIDING SCALE 3X DAILY SUBQ?,,,Y,D,,,,,,,TID,2019,Q4,Confusional state,,2019,Q4,1,I,20191002.0,,20191021,20191021,DIR,,,FDA-CTU,,39.0,YR,,M,N,102.33,KG,20191021.0,N,OT,US,US,2019,Q4,Adult
170526911,17052691,1,PS,INSULIN LISPRO 100/U/ML (GENERIC),INSULIN LISPRO,1,Subcutaneous,?          OTHER DOSE:SLIDING SCALE 3X DAILY SUBQ?,,,Y,D,,,,,,,TID,2019,Q4,Crying,,2019,Q4,1,I,20191002.0,,20191021,20191021,DIR,,,FDA-CTU,,39.0,YR,,M,N,102.33,KG,20191021.0,N,OT,US,US,2019,Q4,Adult
170526911,17052691,1,PS,INSULIN LISPRO 100/U/ML (GENERIC),INSULIN LISPRO,1,Subcutaneous,?          OTHER DOSE:SLIDING SCALE 3X DAILY SUBQ?,,,Y,D,,,,,,,TID,2019,Q4,Depression,,2019,Q4,1,I,20191002.0,,20191021,20191021,DIR,,,FDA-CTU,,39.0,YR,,M,N,102.33,KG,20191021.0,N,OT,US,US,2019,Q4,Adult
170526911,17052691,1,PS,INSULIN LISPRO 100/U/ML (GENERIC),INSULIN LISPRO,1,Subcutaneous,?          OTHER DOSE:SLIDING SCALE 3X DAILY SUBQ?,,,Y,D,,,,,,,TID,2019,Q4,Irritability,,2019,Q4,1,I,20191002.0,,20191021,20191021,DIR,,,FDA-CTU,,39.0,YR,,M,N,102.33,KG,20191021.0,N,OT,US,US,2019,Q4,Adult
170526911,17052691,1,PS,INSULIN LISPRO 100/U/ML (GENERIC),INSULIN LISPRO,1,Subcutaneous,?          OTHER DOSE:SLIDING SCALE 3X DAILY SUBQ?,,,Y,D,,,,,,,TID,2019,Q4,Somnolence,,2019,Q4,1,I,20191002.0,,20191021,20191021,DIR,,,FDA-CTU,,39.0,YR,,M,N,102.33,KG,20191021.0,N,OT,US,US,2019,Q4,Adult
170572511,17057251,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"1 DOSAGE FORM, DAILY",3.0,DF,Y,,,,20563.0,1.0,DF,,QD,2019,Q4,Asthenia,,2019,Q4,1,I,20190927.0,20191111.0,20191121,20191121,EXP,IT-MINISAL02-586343,IT-ELI_LILLY_AND_COMPANY-IT201911005209,ELI LILLY AND CO,,81.0,YR,,M,Y,,,20191121.0,,CN,IT,IT,2019,Q4,Elderly
170572511,17057251,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"1 DOSAGE FORM, DAILY",3.0,DF,Y,,,,20563.0,1.0,DF,,QD,2019,Q4,Dysarthria,,2019,Q4,1,I,20190927.0,20191111.0,20191121,20191121,EXP,IT-MINISAL02-586343,IT-ELI_LILLY_AND_COMPANY-IT201911005209,ELI LILLY AND CO,,81.0,YR,,M,Y,,,20191121.0,,CN,IT,IT,2019,Q4,Elderly
170572511,17057251,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"1 DOSAGE FORM, DAILY",3.0,DF,Y,,,,20563.0,1.0,DF,,QD,2019,Q4,Headache,,2019,Q4,1,I,20190927.0,20191111.0,20191121,20191121,EXP,IT-MINISAL02-586343,IT-ELI_LILLY_AND_COMPANY-IT201911005209,ELI LILLY AND CO,,81.0,YR,,M,Y,,,20191121.0,,CN,IT,IT,2019,Q4,Elderly
170572511,17057251,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"1 DOSAGE FORM, DAILY",3.0,DF,Y,,,,20563.0,1.0,DF,,QD,2019,Q4,Hypoglycaemia,,2019,Q4,1,I,20190927.0,20191111.0,20191121,20191121,EXP,IT-MINISAL02-586343,IT-ELI_LILLY_AND_COMPANY-IT201911005209,ELI LILLY AND CO,,81.0,YR,,M,Y,,,20191121.0,,CN,IT,IT,2019,Q4,Elderly
170572511,17057251,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"1 DOSAGE FORM, DAILY",3.0,DF,Y,,,,20563.0,1.0,DF,,QD,2019,Q4,Vomiting,,2019,Q4,1,I,20190927.0,20191111.0,20191121,20191121,EXP,IT-MINISAL02-586343,IT-ELI_LILLY_AND_COMPANY-IT201911005209,ELI LILLY AND CO,,81.0,YR,,M,Y,,,20191121.0,,CN,IT,IT,2019,Q4,Elderly
170591421,17059142,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,,,,,,,SOLUTION FOR INJECTION,,2019,Q4,Abdominal pain upper,,2019,Q4,1,I,20191021.0,20191024.0,20191121,20191121,EXP,,US-ELI_LILLY_AND_COMPANY-US201910013489,ELI LILLY AND CO,,12.0,YR,,F,Y,,,20191121.0,,CN,US,US,2019,Q4,Child
170591421,17059142,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,,,,,,,SOLUTION FOR INJECTION,,2019,Q4,Blood glucose increased,,2019,Q4,1,I,20191021.0,20191024.0,20191121,20191121,EXP,,US-ELI_LILLY_AND_COMPANY-US201910013489,ELI LILLY AND CO,,12.0,YR,,F,Y,,,20191121.0,,CN,US,US,2019,Q4,Child
170591421,17059142,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,,,,,,,SOLUTION FOR INJECTION,,2019,Q4,Drug ineffective,,2019,Q4,1,I,20191021.0,20191024.0,20191121,20191121,EXP,,US-ELI_LILLY_AND_COMPANY-US201910013489,ELI LILLY AND CO,,12.0,YR,,F,Y,,,20191121.0,,CN,US,US,2019,Q4,Child
170591421,17059142,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,,,,,,,SOLUTION FOR INJECTION,,2019,Q4,Headache,,2019,Q4,1,I,20191021.0,20191024.0,20191121,20191121,EXP,,US-ELI_LILLY_AND_COMPANY-US201910013489,ELI LILLY AND CO,,12.0,YR,,F,Y,,,20191121.0,,CN,US,US,2019,Q4,Child
170591421,17059142,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,,,,,,,SOLUTION FOR INJECTION,,2019,Q4,Nausea,,2019,Q4,1,I,20191021.0,20191024.0,20191121,20191121,EXP,,US-ELI_LILLY_AND_COMPANY-US201910013489,ELI LILLY AND CO,,12.0,YR,,F,Y,,,20191121.0,,CN,US,US,2019,Q4,Child
170615531,17061553,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,Y,U,,,,,,,,2019,Q4,Diabetes mellitus inadequate control,,2019,Q4,1,I,,20191115.0,20191121,20191121,EXP,,CZ-MYLANLABS-2019M1112128,MYLAN,KO?KOV? M.. KOMBINACE DULAGLUTIDU S INZUL?NEM V L??B? DIABETU 2. TYPU. KAZUISTIKY V DIABETOLOGII. 2019;17 (3):41-4,54.0,YR,,M,Y,,,20191121.0,,MD,CZ,CZ,2019,Q4,Adult
170615531,17061553,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,Y,U,,,,,,,,2019,Q4,Hypoglycaemia,,2019,Q4,1,I,,20191115.0,20191121,20191121,EXP,,CZ-MYLANLABS-2019M1112128,MYLAN,KO?KOV? M.. KOMBINACE DULAGLUTIDU S INZUL?NEM V L??B? DIABETU 2. TYPU. KAZUISTIKY V DIABETOLOGII. 2019;17 (3):41-4,54.0,YR,,M,Y,,,20191121.0,,MD,CZ,CZ,2019,Q4,Adult
170615531,17061553,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,Y,U,,,,,,,,2019,Q4,Weight increased,,2019,Q4,1,I,,20191115.0,20191121,20191121,EXP,,CZ-MYLANLABS-2019M1112128,MYLAN,KO?KOV? M.. KOMBINACE DULAGLUTIDU S INZUL?NEM V L??B? DIABETU 2. TYPU. KAZUISTIKY V DIABETOLOGII. 2019;17 (3):41-4,54.0,YR,,M,Y,,,20191121.0,,MD,CZ,CZ,2019,Q4,Adult
170638201,17063820,4,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,,2,Unknown,,,,,, UNKNOWN,,,,,,,2019,Q4,Headache,Headache,2019,Q4,1,I,201909.0,20191003.0,20191122,20191122,EXP,,US-ZYDUS-042126,ZYDUS PHARM,,47.0,YR,,F,Y,,,20191122.0,,MD,US,US,2019,Q4,Adult
170670851,17067085,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 + 10 + 10 U / DAY,3.0,DF,Y,,,,,,,SOLUTION FOR INJECTION,Q8H,2019,Q4,Asthenia,,2019,Q4,1,I,20190927.0,20191114.0,20191122,20191122,EXP,IT-MINISAL02-586343,IT-SA-2019SA318164,SANOFI AVENTIS,,81.0,YR,E,M,Y,,,20191122.0,,MD,IT,IT,2019,Q4,Elderly
170670851,17067085,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 + 10 + 10 U / DAY,3.0,DF,Y,,,,,,,SOLUTION FOR INJECTION,Q8H,2019,Q4,Drug interaction,,2019,Q4,1,I,20190927.0,20191114.0,20191122,20191122,EXP,IT-MINISAL02-586343,IT-SA-2019SA318164,SANOFI AVENTIS,,81.0,YR,E,M,Y,,,20191122.0,,MD,IT,IT,2019,Q4,Elderly
170670851,17067085,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 + 10 + 10 U / DAY,3.0,DF,Y,,,,,,,SOLUTION FOR INJECTION,Q8H,2019,Q4,Dysarthria,,2019,Q4,1,I,20190927.0,20191114.0,20191122,20191122,EXP,IT-MINISAL02-586343,IT-SA-2019SA318164,SANOFI AVENTIS,,81.0,YR,E,M,Y,,,20191122.0,,MD,IT,IT,2019,Q4,Elderly
170670851,17067085,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 + 10 + 10 U / DAY,3.0,DF,Y,,,,,,,SOLUTION FOR INJECTION,Q8H,2019,Q4,Headache,,2019,Q4,1,I,20190927.0,20191114.0,20191122,20191122,EXP,IT-MINISAL02-586343,IT-SA-2019SA318164,SANOFI AVENTIS,,81.0,YR,E,M,Y,,,20191122.0,,MD,IT,IT,2019,Q4,Elderly
170670851,17067085,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 + 10 + 10 U / DAY,3.0,DF,Y,,,,,,,SOLUTION FOR INJECTION,Q8H,2019,Q4,Hypoglycaemia,,2019,Q4,1,I,20190927.0,20191114.0,20191122,20191122,EXP,IT-MINISAL02-586343,IT-SA-2019SA318164,SANOFI AVENTIS,,81.0,YR,E,M,Y,,,20191122.0,,MD,IT,IT,2019,Q4,Elderly
170670851,17067085,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 + 10 + 10 U / DAY,3.0,DF,Y,,,,,,,SOLUTION FOR INJECTION,Q8H,2019,Q4,Vomiting,,2019,Q4,1,I,20190927.0,20191114.0,20191122,20191122,EXP,IT-MINISAL02-586343,IT-SA-2019SA318164,SANOFI AVENTIS,,81.0,YR,E,M,Y,,,20191122.0,,MD,IT,IT,2019,Q4,Elderly
170670901,17067090,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),UNK,,,,,,,,,,,,2019,Q4,Hepatitis E,,2019,Q4,1,I,2018.0,20191118.0,20191122,20191122,EXP,,CZ-MYLANLABS-2019M1112361,MYLAN,VONDRAKOVA M. KDY MENE MUZE ZNAMENAT I VICE ANEB SULIQUA A SPOKOJENOST PACIENTA SE ZJEDNODUSENIM REZIMU. KAZUISTIKY V DIABETOLOGII. 2019;17(3):20-21,50.0,YR,,M,Y,,,20191122.0,,MD,CZ,CZ,2019,Q4,Adult
170670901,17067090,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),UNK,,,,,,,,,,,,2019,Q4,Hypoglycaemia,,2019,Q4,1,I,2018.0,20191118.0,20191122,20191122,EXP,,CZ-MYLANLABS-2019M1112361,MYLAN,VONDRAKOVA M. KDY MENE MUZE ZNAMENAT I VICE ANEB SULIQUA A SPOKOJENOST PACIENTA SE ZJEDNODUSENIM REZIMU. KAZUISTIKY V DIABETOLOGII. 2019;17(3):20-21,50.0,YR,,M,Y,,,20191122.0,,MD,CZ,CZ,2019,Q4,Adult
170719391,17071939,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 IU, TOTAL",3.0,IU,Y,,,,,3.0,IU,SOLUTION FOR INJECTION,,2019,Q4,Decreased activity,,2019,Q4,1,I,20191020.0,20191119.0,20191125,20191125,EXP,IT-MINISAL02-587228,IT-SA-2019SA322364,SANOFI AVENTIS,,10.0,YR,C,M,Y,,,20191125.0,,MD,IT,IT,2019,Q4,Child
170719391,17071939,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 IU, TOTAL",3.0,IU,Y,,,,,3.0,IU,SOLUTION FOR INJECTION,,2019,Q4,Hypoglycaemia,,2019,Q4,1,I,20191020.0,20191119.0,20191125,20191125,EXP,IT-MINISAL02-587228,IT-SA-2019SA322364,SANOFI AVENTIS,,10.0,YR,C,M,Y,,,20191125.0,,MD,IT,IT,2019,Q4,Child
170719391,17071939,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 IU, TOTAL",3.0,IU,Y,,,,,3.0,IU,SOLUTION FOR INJECTION,,2019,Q4,Loss of consciousness,,2019,Q4,1,I,20191020.0,20191119.0,20191125,20191125,EXP,IT-MINISAL02-587228,IT-SA-2019SA322364,SANOFI AVENTIS,,10.0,YR,C,M,Y,,,20191125.0,,MD,IT,IT,2019,Q4,Child
170719391,17071939,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 IU, TOTAL",3.0,IU,Y,,,,,3.0,IU,SOLUTION FOR INJECTION,,2019,Q4,Pallor,,2019,Q4,1,I,20191020.0,20191119.0,20191125,20191125,EXP,IT-MINISAL02-587228,IT-SA-2019SA322364,SANOFI AVENTIS,,10.0,YR,C,M,Y,,,20191125.0,,MD,IT,IT,2019,Q4,Child
170719391,17071939,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 IU, TOTAL",3.0,IU,Y,,,,,3.0,IU,SOLUTION FOR INJECTION,,2019,Q4,Seizure,,2019,Q4,1,I,20191020.0,20191119.0,20191125,20191125,EXP,IT-MINISAL02-587228,IT-SA-2019SA322364,SANOFI AVENTIS,,10.0,YR,C,M,Y,,,20191125.0,,MD,IT,IT,2019,Q4,Child
170730691,17073069,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"3 INTERNATIONAL UNIT, UNKNOWN",3.0,IU,Y,U,,,20563.0,3.0,IU,,,2019,Q4,Decreased activity,,2019,Q4,1,I,20191020.0,20191114.0,20191125,20191125,EXP,IT-MINISAL02-587228,IT-ELI_LILLY_AND_COMPANY-IT201911007197,ELI LILLY AND CO,,10.0,YR,,M,Y,,,20191125.0,,CN,IT,IT,2019,Q4,Child
170730691,17073069,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"3 INTERNATIONAL UNIT, UNKNOWN",3.0,IU,Y,U,,,20563.0,3.0,IU,,,2019,Q4,Drug interaction,,2019,Q4,1,I,20191020.0,20191114.0,20191125,20191125,EXP,IT-MINISAL02-587228,IT-ELI_LILLY_AND_COMPANY-IT201911007197,ELI LILLY AND CO,,10.0,YR,,M,Y,,,20191125.0,,CN,IT,IT,2019,Q4,Child
170730691,17073069,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"3 INTERNATIONAL UNIT, UNKNOWN",3.0,IU,Y,U,,,20563.0,3.0,IU,,,2019,Q4,Hypoglycaemia,,2019,Q4,1,I,20191020.0,20191114.0,20191125,20191125,EXP,IT-MINISAL02-587228,IT-ELI_LILLY_AND_COMPANY-IT201911007197,ELI LILLY AND CO,,10.0,YR,,M,Y,,,20191125.0,,CN,IT,IT,2019,Q4,Child
170730691,17073069,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"3 INTERNATIONAL UNIT, UNKNOWN",3.0,IU,Y,U,,,20563.0,3.0,IU,,,2019,Q4,Loss of consciousness,,2019,Q4,1,I,20191020.0,20191114.0,20191125,20191125,EXP,IT-MINISAL02-587228,IT-ELI_LILLY_AND_COMPANY-IT201911007197,ELI LILLY AND CO,,10.0,YR,,M,Y,,,20191125.0,,CN,IT,IT,2019,Q4,Child
170730691,17073069,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"3 INTERNATIONAL UNIT, UNKNOWN",3.0,IU,Y,U,,,20563.0,3.0,IU,,,2019,Q4,Pallor,,2019,Q4,1,I,20191020.0,20191114.0,20191125,20191125,EXP,IT-MINISAL02-587228,IT-ELI_LILLY_AND_COMPANY-IT201911007197,ELI LILLY AND CO,,10.0,YR,,M,Y,,,20191125.0,,CN,IT,IT,2019,Q4,Child
170730691,17073069,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"3 INTERNATIONAL UNIT, UNKNOWN",3.0,IU,Y,U,,,20563.0,3.0,IU,,,2019,Q4,Seizure,,2019,Q4,1,I,20191020.0,20191114.0,20191125,20191125,EXP,IT-MINISAL02-587228,IT-ELI_LILLY_AND_COMPANY-IT201911007197,ELI LILLY AND CO,,10.0,YR,,M,Y,,,20191125.0,,CN,IT,IT,2019,Q4,Child
170738591,17073859,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,75/25?56 INTERNATIONAL UNITS?PER MILLILITRE,,,,,,,,,,,,2019,Q4,Body height decreased,Body height decreased,2019,Q4,1,I,201901.0,20190507.0,20191126,20191126,PER,,US-ALVOGEN-2019-ALVOGEN-100990,ALVOGEN,,64.0,YR,,F,Y,99.79,KG,20191125.0,,MD,US,US,2019,Q4,Adult
170738591,17073859,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,75/25?56 INTERNATIONAL UNITS?PER MILLILITRE,,,,,,,,,,,,2019,Q4,Neck pain,Neck pain,2019,Q4,1,I,201901.0,20190507.0,20191126,20191126,PER,,US-ALVOGEN-2019-ALVOGEN-100990,ALVOGEN,,64.0,YR,,F,Y,99.79,KG,20191125.0,,MD,US,US,2019,Q4,Adult
170738591,17073859,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,75/25?56 INTERNATIONAL UNITS?PER MILLILITRE,,,,,,,,,,,,2019,Q4,Persistent depressive disorder,Persistent depressive disorder,2019,Q4,1,I,201901.0,20190507.0,20191126,20191126,PER,,US-ALVOGEN-2019-ALVOGEN-100990,ALVOGEN,,64.0,YR,,F,Y,99.79,KG,20191125.0,,MD,US,US,2019,Q4,Adult
170748281,17074828,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"82 INTERNATIONAL UNIT, QD",,,U,,,,,82.0,IU,,QD,2019,Q4,Cerebral haemorrhage,,2019,Q4,1,I,20190818.0,20191113.0,20191126,20191126,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-109587,BRISTOL MYERS SQUIBB,,77.0,YR,,M,Y,,,20191126.0,,MD,IT,IT,2019,Q4,Elderly
170748281,17074828,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"82 INTERNATIONAL UNIT, QD",,,U,,,,,82.0,IU,,QD,2019,Q4,Haematuria,,2019,Q4,1,I,20190818.0,20191113.0,20191126,20191126,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-109587,BRISTOL MYERS SQUIBB,,77.0,YR,,M,Y,,,20191126.0,,MD,IT,IT,2019,Q4,Elderly
170748281,17074828,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"82 INTERNATIONAL UNIT, QD",,,U,,,,,82.0,IU,,QD,2019,Q4,Medication error,,2019,Q4,1,I,20190818.0,20191113.0,20191126,20191126,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-109587,BRISTOL MYERS SQUIBB,,77.0,YR,,M,Y,,,20191126.0,,MD,IT,IT,2019,Q4,Elderly
170748281,17074828,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"82 INTERNATIONAL UNIT, QD",,,U,,,,,82.0,IU,,QD,2019,Q4,Overdose,,2019,Q4,1,I,20190818.0,20191113.0,20191126,20191126,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-109587,BRISTOL MYERS SQUIBB,,77.0,YR,,M,Y,,,20191126.0,,MD,IT,IT,2019,Q4,Elderly
170750441,17075044,6,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Acute myocardial infarction,,2019,Q4,1,I,20191125.0,,20191125,20191125,DIR,,,FDA-CTU,,62.0,YR,,F,N,60.9,KG,20191125.0,N,PH,US,US,2019,Q4,Adult
170750441,17075044,6,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Cardiac arrest,,2019,Q4,1,I,20191125.0,,20191125,20191125,DIR,,,FDA-CTU,,62.0,YR,,F,N,60.9,KG,20191125.0,N,PH,US,US,2019,Q4,Adult
170750441,17075044,6,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Heart rate irregular,,2019,Q4,1,I,20191125.0,,20191125,20191125,DIR,,,FDA-CTU,,62.0,YR,,F,N,60.9,KG,20191125.0,N,PH,US,US,2019,Q4,Adult
170750441,17075044,6,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Mean arterial pressure increased,,2019,Q4,1,I,20191125.0,,20191125,20191125,DIR,,,FDA-CTU,,62.0,YR,,F,N,60.9,KG,20191125.0,N,PH,US,US,2019,Q4,Adult
170750441,17075044,6,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Ventricular tachycardia,,2019,Q4,1,I,20191125.0,,20191125,20191125,DIR,,,FDA-CTU,,62.0,YR,,F,N,60.9,KG,20191125.0,N,PH,US,US,2019,Q4,Adult
170765071,17076507,11,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"12 UNITS, UNKNOWN FREQ.",,,,,,,,,,FORMULATION UNKNOWN,,2019,Q4,Cardiac valve disease,,2019,Q4,1,I,2012.0,20191119.0,20191126,20191126,EXP,,CO-ASTELLAS-2019US046798,ASTELLAS,,57.0,YR,,M,Y,62.0,KG,20191126.0,,CN,CO,CO,2019,Q4,Adult
170765071,17076507,11,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"12 UNITS, UNKNOWN FREQ.",,,,,,,,,,FORMULATION UNKNOWN,,2019,Q4,Coronary artery occlusion,,2019,Q4,1,I,2012.0,20191119.0,20191126,20191126,EXP,,CO-ASTELLAS-2019US046798,ASTELLAS,,57.0,YR,,M,Y,62.0,KG,20191126.0,,CN,CO,CO,2019,Q4,Adult
170765071,17076507,11,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"12 UNITS, UNKNOWN FREQ.",,,,,,,,,,FORMULATION UNKNOWN,,2019,Q4,Immunodeficiency,,2019,Q4,1,I,2012.0,20191119.0,20191126,20191126,EXP,,CO-ASTELLAS-2019US046798,ASTELLAS,,57.0,YR,,M,Y,62.0,KG,20191126.0,,CN,CO,CO,2019,Q4,Adult
170765071,17076507,11,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,"12 UNITS, UNKNOWN FREQ.",,,,,,,,,,FORMULATION UNKNOWN,,2019,Q4,Pyrexia,,2019,Q4,1,I,2012.0,20191119.0,20191126,20191126,EXP,,CO-ASTELLAS-2019US046798,ASTELLAS,,57.0,YR,,M,Y,62.0,KG,20191126.0,,CN,CO,CO,2019,Q4,Adult
170807741,17080774,5,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Deep vein thrombosis,,2019,Q4,1,I,20191022.0,,20191126,20191126,DIR,,,FDA-CTU,,66.0,YR,,M,N,109.0,KG,20191126.0,N,PH,US,US,2019,Q4,Elderly
170807741,17080774,5,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Fall,,2019,Q4,1,I,20191022.0,,20191126,20191126,DIR,,,FDA-CTU,,66.0,YR,,M,N,109.0,KG,20191126.0,N,PH,US,US,2019,Q4,Elderly
170807741,17080774,5,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Haemoptysis,,2019,Q4,1,I,20191022.0,,20191126,20191126,DIR,,,FDA-CTU,,66.0,YR,,M,N,109.0,KG,20191126.0,N,PH,US,US,2019,Q4,Elderly
170807741,17080774,5,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Pneumonia,,2019,Q4,1,I,20191022.0,,20191126,20191126,DIR,,,FDA-CTU,,66.0,YR,,M,N,109.0,KG,20191126.0,N,PH,US,US,2019,Q4,Elderly
170807741,17080774,5,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Pulmonary artery thrombosis,,2019,Q4,1,I,20191022.0,,20191126,20191126,DIR,,,FDA-CTU,,66.0,YR,,M,N,109.0,KG,20191126.0,N,PH,US,US,2019,Q4,Elderly
170807741,17080774,5,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Sepsis,,2019,Q4,1,I,20191022.0,,20191126,20191126,DIR,,,FDA-CTU,,66.0,YR,,M,N,109.0,KG,20191126.0,N,PH,US,US,2019,Q4,Elderly
170807741,17080774,5,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Syncope,,2019,Q4,1,I,20191022.0,,20191126,20191126,DIR,,,FDA-CTU,,66.0,YR,,M,N,109.0,KG,20191126.0,N,PH,US,US,2019,Q4,Elderly
170832731,17083273,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1.2 U, QD",,,U,,,,,,,INJECTION,QD,2019,Q4,Pneumonia,,2019,Q4,1,I,20191030.0,20191120.0,20191127,20191127,PER,,US-SA-2019SA326252,SANOFI AVENTIS,,57.0,YR,A,F,Y,73.5,KG,20191127.0,,CN,US,US,2019,Q4,Adult
170855451,17085545,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"20-30 U, PRN",,,,, C991690C,,20563.0,20.0,IU,SOLUTION FOR INJECTION,,2019,Q4,Blood glucose increased,,2019,Q4,1,I,,20191104.0,20191128,20191128,EXP,,US-ELI_LILLY_AND_COMPANY-US201911002100,ELI LILLY AND CO,,57.0,YR,,M,Y,,,20191128.0,,CN,US,US,2019,Q4,Adult
170855451,17085545,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"20-30 U, PRN",,,,, C991690C,,20563.0,20.0,IU,SOLUTION FOR INJECTION,,2019,Q4,Drug ineffective,,2019,Q4,1,I,,20191104.0,20191128,20191128,EXP,,US-ELI_LILLY_AND_COMPANY-US201911002100,ELI LILLY AND CO,,57.0,YR,,M,Y,,,20191128.0,,CN,US,US,2019,Q4,Adult
170945741,17094574,3,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,5.0,IU,,,2019,Q4,Anaemia,,2019,Q4,1,I,20190826.0,20191117.0,20191129,20191129,EXP,IT-MINISAL02-586529,IT-ACCORD-162316,ACCORD,,81.0,YR,,F,Y,60.0,KG,20191129.0,,PH,IT,IT,2019,Q4,Elderly
170945741,17094574,3,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,5.0,IU,,,2019,Q4,Gastric haemorrhage,,2019,Q4,1,I,20190826.0,20191117.0,20191129,20191129,EXP,IT-MINISAL02-586529,IT-ACCORD-162316,ACCORD,,81.0,YR,,F,Y,60.0,KG,20191129.0,,PH,IT,IT,2019,Q4,Elderly
170948542,17094854,6,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Liver disorder,,2019,Q4,2,F,20191007.0,20191128.0,20191130,20191211,EXP,IT-MINISAL02-587117,IT-ACCORD-162171,ACCORD,,78.0,YR,,M,Y,85.0,KG,20191211.0,,MD,IT,IT,2019,Q4,Elderly
170948542,17094854,6,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Rhabdomyolysis,,2019,Q4,2,F,20191007.0,20191128.0,20191130,20191211,EXP,IT-MINISAL02-587117,IT-ACCORD-162171,ACCORD,,78.0,YR,,M,Y,85.0,KG,20191211.0,,MD,IT,IT,2019,Q4,Elderly
170955491,17095549,4,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Inappropriate schedule of product administration,,2019,Q4,1,I,20191104.0,,20191104,20191104,DIR,,,FDA-CTU,,62.0,YR,,F,N,,,20191104.0,N,,US,US,2019,Q4,Adult
170955491,17095549,4,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Nausea,,2019,Q4,1,I,20191104.0,,20191104,20191104,DIR,,,FDA-CTU,,62.0,YR,,F,N,,,20191104.0,N,,US,US,2019,Q4,Adult
170955491,17095549,4,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Product dose omission,,2019,Q4,1,I,20191104.0,,20191104,20191104,DIR,,,FDA-CTU,,62.0,YR,,F,N,,,20191104.0,N,,US,US,2019,Q4,Adult
171006703,17100670,44,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 U, UNK",,,U,,,,,,,INJECTION,,2019,Q4,Myocardial infarction,,2019,Q4,3,F,20191030.0,20191203.0,20191202,20191209,PER,,US-SA-2019SA329465,SANOFI AVENTIS,,56.0,YR,A,F,Y,73.5,KG,20191209.0,,PH,US,US,2019,Q4,Adult
171006703,17100670,44,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 U, UNK",,,U,,,,,,,INJECTION,,2019,Q4,Pneumonia,,2019,Q4,3,F,20191030.0,20191203.0,20191202,20191209,PER,,US-SA-2019SA329465,SANOFI AVENTIS,,56.0,YR,A,F,Y,73.5,KG,20191209.0,,PH,US,US,2019,Q4,Adult
171006703,17100670,45,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 U, UNK",,,U,,,,,,,INJECTION,,2019,Q4,Myocardial infarction,,2019,Q4,3,F,20191030.0,20191203.0,20191202,20191209,PER,,US-SA-2019SA329465,SANOFI AVENTIS,,56.0,YR,A,F,Y,73.5,KG,20191209.0,,PH,US,US,2019,Q4,Adult
171006703,17100670,45,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 U, UNK",,,U,,,,,,,INJECTION,,2019,Q4,Pneumonia,,2019,Q4,3,F,20191030.0,20191203.0,20191202,20191209,PER,,US-SA-2019SA329465,SANOFI AVENTIS,,56.0,YR,A,F,Y,73.5,KG,20191209.0,,PH,US,US,2019,Q4,Adult
171033023,17103302,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2019,Q4,Liver disorder,,2019,Q4,3,F,20191007.0,20191219.0,20191203,20191231,EXP,,IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2019RR-229517,RANBAXY,,78.0,YR,,M,Y,85.0,KG,20191231.0,,OT,NL,IT,2019,Q4,Elderly
171033023,17103302,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2019,Q4,Rhabdomyolysis,,2019,Q4,3,F,20191007.0,20191219.0,20191203,20191231,EXP,,IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2019RR-229517,RANBAXY,,78.0,YR,,M,Y,85.0,KG,20191231.0,,OT,NL,IT,2019,Q4,Elderly
171040261,17104026,3,C,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2019,Q4,Diabetes mellitus inadequate control,,2019,Q4,1,I,,20191121.0,20191203,20191203,EXP,,CZ-AUROBINDO-AUR-APL-2019-076278,AUROBINDO,KO?KOV? M.. KOMBINACE DULAGLUTIDU S INZUL?NEM V L??B? DIABETU 2. TYPU. KAZUISTIKY V DIABETOLOGII. 2019;17(3):41-4,54.0,YR,,M,Y,,,20191203.0,,MD,CZ,CZ,2019,Q4,Adult
171040261,17104026,3,C,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2019,Q4,Hypoglycaemia,,2019,Q4,1,I,,20191121.0,20191203,20191203,EXP,,CZ-AUROBINDO-AUR-APL-2019-076278,AUROBINDO,KO?KOV? M.. KOMBINACE DULAGLUTIDU S INZUL?NEM V L??B? DIABETU 2. TYPU. KAZUISTIKY V DIABETOLOGII. 2019;17(3):41-4,54.0,YR,,M,Y,,,20191203.0,,MD,CZ,CZ,2019,Q4,Adult
171040261,17104026,3,C,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,,,2019,Q4,Weight increased,,2019,Q4,1,I,,20191121.0,20191203,20191203,EXP,,CZ-AUROBINDO-AUR-APL-2019-076278,AUROBINDO,KO?KOV? M.. KOMBINACE DULAGLUTIDU S INZUL?NEM V L??B? DIABETU 2. TYPU. KAZUISTIKY V DIABETOLOGII. 2019;17(3):41-4,54.0,YR,,M,Y,,,20191203.0,,MD,CZ,CZ,2019,Q4,Adult
171077463,17107746,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"SLIDING SCALE, ONCE DAILY",,,U,,,,,,,,,2019,Q4,Dysphagia,,2019,Q4,3,F,20191123.0,20191211.0,20191203,20191216,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-114743,BRISTOL MYERS SQUIBB,,80.0,YR,,M,Y,88.9,KG,20191216.0,,OT,US,US,2019,Q4,Elderly
171080132,17108013,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"11 U, EACH MORNING",,,U,U,,,20563.0,11.0,IU,INJECTION,QD,2019,Q4,Back injury,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"11 U, EACH MORNING",,,U,U,,,20563.0,11.0,IU,INJECTION,QD,2019,Q4,Blood glucose increased,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"11 U, EACH MORNING",,,U,U,,,20563.0,11.0,IU,INJECTION,QD,2019,Q4,Fall,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"11 U, EACH MORNING",,,U,U,,,20563.0,11.0,IU,INJECTION,QD,2019,Q4,Foot fracture,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"11 U, EACH MORNING",,,U,U,,,20563.0,11.0,IU,INJECTION,QD,2019,Q4,Gait disturbance,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"11 U, EACH MORNING",,,U,U,,,20563.0,11.0,IU,INJECTION,QD,2019,Q4,Head injury,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"11 U, EACH MORNING",,,U,U,,,20563.0,11.0,IU,INJECTION,QD,2019,Q4,Hypoaesthesia,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"11 U, EACH MORNING",,,U,U,,,20563.0,11.0,IU,INJECTION,QD,2019,Q4,Incorrect dose administered,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"11 U, EACH MORNING",,,U,U,,,20563.0,11.0,IU,INJECTION,QD,2019,Q4,Joint injury,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"11 U, EACH MORNING",,,U,U,,,20563.0,11.0,IU,INJECTION,QD,2019,Q4,Neck injury,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"11 U, EACH MORNING",,,U,U,,,20563.0,11.0,IU,INJECTION,QD,2019,Q4,Underdose,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"21 U, EACH EVENING",,,U,U,,,20563.0,21.0,IU,INJECTION,QD,2019,Q4,Back injury,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"21 U, EACH EVENING",,,U,U,,,20563.0,21.0,IU,INJECTION,QD,2019,Q4,Blood glucose increased,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"21 U, EACH EVENING",,,U,U,,,20563.0,21.0,IU,INJECTION,QD,2019,Q4,Fall,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"21 U, EACH EVENING",,,U,U,,,20563.0,21.0,IU,INJECTION,QD,2019,Q4,Foot fracture,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"21 U, EACH EVENING",,,U,U,,,20563.0,21.0,IU,INJECTION,QD,2019,Q4,Gait disturbance,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"21 U, EACH EVENING",,,U,U,,,20563.0,21.0,IU,INJECTION,QD,2019,Q4,Head injury,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"21 U, EACH EVENING",,,U,U,,,20563.0,21.0,IU,INJECTION,QD,2019,Q4,Hypoaesthesia,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"21 U, EACH EVENING",,,U,U,,,20563.0,21.0,IU,INJECTION,QD,2019,Q4,Incorrect dose administered,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"21 U, EACH EVENING",,,U,U,,,20563.0,21.0,IU,INJECTION,QD,2019,Q4,Joint injury,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"21 U, EACH EVENING",,,U,U,,,20563.0,21.0,IU,INJECTION,QD,2019,Q4,Neck injury,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"21 U, EACH EVENING",,,U,U,,,20563.0,21.0,IU,INJECTION,QD,2019,Q4,Underdose,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"3 U, UNKNOWN",,,U,U,,,20563.0,3.0,IU,INJECTION,,2019,Q4,Back injury,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"3 U, UNKNOWN",,,U,U,,,20563.0,3.0,IU,INJECTION,,2019,Q4,Blood glucose increased,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"3 U, UNKNOWN",,,U,U,,,20563.0,3.0,IU,INJECTION,,2019,Q4,Fall,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"3 U, UNKNOWN",,,U,U,,,20563.0,3.0,IU,INJECTION,,2019,Q4,Foot fracture,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"3 U, UNKNOWN",,,U,U,,,20563.0,3.0,IU,INJECTION,,2019,Q4,Gait disturbance,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"3 U, UNKNOWN",,,U,U,,,20563.0,3.0,IU,INJECTION,,2019,Q4,Head injury,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"3 U, UNKNOWN",,,U,U,,,20563.0,3.0,IU,INJECTION,,2019,Q4,Hypoaesthesia,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"3 U, UNKNOWN",,,U,U,,,20563.0,3.0,IU,INJECTION,,2019,Q4,Incorrect dose administered,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"3 U, UNKNOWN",,,U,U,,,20563.0,3.0,IU,INJECTION,,2019,Q4,Joint injury,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"3 U, UNKNOWN",,,U,U,,,20563.0,3.0,IU,INJECTION,,2019,Q4,Neck injury,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"3 U, UNKNOWN",,,U,U,,,20563.0,3.0,IU,INJECTION,,2019,Q4,Underdose,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,4,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,,,,INJECTION,,2019,Q4,Back injury,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,4,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,,,,INJECTION,,2019,Q4,Blood glucose increased,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,4,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,,,,INJECTION,,2019,Q4,Fall,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,4,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,,,,INJECTION,,2019,Q4,Foot fracture,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,4,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,,,,INJECTION,,2019,Q4,Gait disturbance,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,4,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,,,,INJECTION,,2019,Q4,Head injury,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,4,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,,,,INJECTION,,2019,Q4,Hypoaesthesia,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,4,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,,,,INJECTION,,2019,Q4,Incorrect dose administered,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,4,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,,,,INJECTION,,2019,Q4,Joint injury,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,4,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,,,,INJECTION,,2019,Q4,Neck injury,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,4,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,,,,INJECTION,,2019,Q4,Underdose,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,5,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"21 U, EACH EVENING",,,U,U, C971006G,,,21.0,IU,INJECTION,QD,2019,Q4,Back injury,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,5,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"21 U, EACH EVENING",,,U,U, C971006G,,,21.0,IU,INJECTION,QD,2019,Q4,Blood glucose increased,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,5,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"21 U, EACH EVENING",,,U,U, C971006G,,,21.0,IU,INJECTION,QD,2019,Q4,Fall,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,5,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"21 U, EACH EVENING",,,U,U, C971006G,,,21.0,IU,INJECTION,QD,2019,Q4,Foot fracture,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,5,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"21 U, EACH EVENING",,,U,U, C971006G,,,21.0,IU,INJECTION,QD,2019,Q4,Gait disturbance,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,5,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"21 U, EACH EVENING",,,U,U, C971006G,,,21.0,IU,INJECTION,QD,2019,Q4,Head injury,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,5,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"21 U, EACH EVENING",,,U,U, C971006G,,,21.0,IU,INJECTION,QD,2019,Q4,Hypoaesthesia,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,5,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"21 U, EACH EVENING",,,U,U, C971006G,,,21.0,IU,INJECTION,QD,2019,Q4,Incorrect dose administered,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,5,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"21 U, EACH EVENING",,,U,U, C971006G,,,21.0,IU,INJECTION,QD,2019,Q4,Joint injury,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,5,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"21 U, EACH EVENING",,,U,U, C971006G,,,21.0,IU,INJECTION,QD,2019,Q4,Neck injury,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,5,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"21 U, EACH EVENING",,,U,U, C971006G,,,21.0,IU,INJECTION,QD,2019,Q4,Underdose,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,6,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"3 U, UNKNOWN",,,U,U, C971006G,,,3.0,IU,INJECTION,,2019,Q4,Back injury,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,6,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"3 U, UNKNOWN",,,U,U, C971006G,,,3.0,IU,INJECTION,,2019,Q4,Blood glucose increased,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,6,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"3 U, UNKNOWN",,,U,U, C971006G,,,3.0,IU,INJECTION,,2019,Q4,Fall,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,6,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"3 U, UNKNOWN",,,U,U, C971006G,,,3.0,IU,INJECTION,,2019,Q4,Foot fracture,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,6,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"3 U, UNKNOWN",,,U,U, C971006G,,,3.0,IU,INJECTION,,2019,Q4,Gait disturbance,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,6,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"3 U, UNKNOWN",,,U,U, C971006G,,,3.0,IU,INJECTION,,2019,Q4,Head injury,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,6,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"3 U, UNKNOWN",,,U,U, C971006G,,,3.0,IU,INJECTION,,2019,Q4,Hypoaesthesia,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,6,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"3 U, UNKNOWN",,,U,U, C971006G,,,3.0,IU,INJECTION,,2019,Q4,Incorrect dose administered,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,6,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"3 U, UNKNOWN",,,U,U, C971006G,,,3.0,IU,INJECTION,,2019,Q4,Joint injury,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,6,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"3 U, UNKNOWN",,,U,U, C971006G,,,3.0,IU,INJECTION,,2019,Q4,Neck injury,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,6,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"3 U, UNKNOWN",,,U,U, C971006G,,,3.0,IU,INJECTION,,2019,Q4,Underdose,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,7,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"5 U, EACH MORNING",,,U,U, C971006G,,,5.0,IU,INJECTION,QD,2019,Q4,Back injury,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,7,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"5 U, EACH MORNING",,,U,U, C971006G,,,5.0,IU,INJECTION,QD,2019,Q4,Blood glucose increased,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,7,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"5 U, EACH MORNING",,,U,U, C971006G,,,5.0,IU,INJECTION,QD,2019,Q4,Fall,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,7,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"5 U, EACH MORNING",,,U,U, C971006G,,,5.0,IU,INJECTION,QD,2019,Q4,Foot fracture,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,7,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"5 U, EACH MORNING",,,U,U, C971006G,,,5.0,IU,INJECTION,QD,2019,Q4,Gait disturbance,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,7,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"5 U, EACH MORNING",,,U,U, C971006G,,,5.0,IU,INJECTION,QD,2019,Q4,Head injury,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,7,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"5 U, EACH MORNING",,,U,U, C971006G,,,5.0,IU,INJECTION,QD,2019,Q4,Hypoaesthesia,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,7,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"5 U, EACH MORNING",,,U,U, C971006G,,,5.0,IU,INJECTION,QD,2019,Q4,Incorrect dose administered,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,7,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"5 U, EACH MORNING",,,U,U, C971006G,,,5.0,IU,INJECTION,QD,2019,Q4,Joint injury,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,7,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"5 U, EACH MORNING",,,U,U, C971006G,,,5.0,IU,INJECTION,QD,2019,Q4,Neck injury,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,7,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"5 U, EACH MORNING",,,U,U, C971006G,,,5.0,IU,INJECTION,QD,2019,Q4,Underdose,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,8,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"10 U, EACH EVENING",,,U,U, C971006G,,,10.0,IU,INJECTION,QD,2019,Q4,Back injury,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,8,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"10 U, EACH EVENING",,,U,U, C971006G,,,10.0,IU,INJECTION,QD,2019,Q4,Blood glucose increased,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,8,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"10 U, EACH EVENING",,,U,U, C971006G,,,10.0,IU,INJECTION,QD,2019,Q4,Fall,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,8,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"10 U, EACH EVENING",,,U,U, C971006G,,,10.0,IU,INJECTION,QD,2019,Q4,Foot fracture,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,8,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"10 U, EACH EVENING",,,U,U, C971006G,,,10.0,IU,INJECTION,QD,2019,Q4,Gait disturbance,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,8,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"10 U, EACH EVENING",,,U,U, C971006G,,,10.0,IU,INJECTION,QD,2019,Q4,Head injury,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,8,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"10 U, EACH EVENING",,,U,U, C971006G,,,10.0,IU,INJECTION,QD,2019,Q4,Hypoaesthesia,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,8,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"10 U, EACH EVENING",,,U,U, C971006G,,,10.0,IU,INJECTION,QD,2019,Q4,Incorrect dose administered,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,8,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"10 U, EACH EVENING",,,U,U, C971006G,,,10.0,IU,INJECTION,QD,2019,Q4,Joint injury,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,8,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"10 U, EACH EVENING",,,U,U, C971006G,,,10.0,IU,INJECTION,QD,2019,Q4,Neck injury,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171080132,17108013,8,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"10 U, EACH EVENING",,,U,U, C971006G,,,10.0,IU,INJECTION,QD,2019,Q4,Underdose,,2019,Q4,2,F,20191126.0,20191127.0,20191203,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911014048,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171094161,17109416,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,5 IU,,,,, UNKNOWN,,,5.0,IU,,,2019,Q4,Anaemia,,2019,Q4,1,I,20190826.0,20191126.0,20191204,20191204,EXP,IT-MINISAL02-586529,IT-TEVA-2019-IT-1145686,TEVA,,81.0,YR,,F,Y,60.0,KG,20191204.0,,PH,IT,IT,2019,Q4,Elderly
171094161,17109416,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,5 IU,,,,, UNKNOWN,,,5.0,IU,,,2019,Q4,Gastric haemorrhage,,2019,Q4,1,I,20190826.0,20191126.0,20191204,20191204,EXP,IT-MINISAL02-586529,IT-TEVA-2019-IT-1145686,TEVA,,81.0,YR,,F,Y,60.0,KG,20191204.0,,PH,IT,IT,2019,Q4,Elderly
171094301,17109430,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,"15 INTERNATIONAL UNIT, DAILY WITH MEALS",,,,,,,,15.0,IU,,,2019,Q4,Acute kidney injury,,2019,Q4,1,I,,20191126.0,20191204,20191204,EXP,,US-EMCURE PHARMACEUTICALS LTD-2019-EPL-1117,EMCURE,"YEDDI A, SHAH P, AWAD O, ABDALLAH MA, NNODIM I.. ACETAZOLAMIDE-ASSOCIATED HYPEROSMOLAR HYPERGLYCEMIC NONKETOTIC SYNDROME.. AMERICAN JOURNAL OF THERAPEUTICS. 2019",22.0,YR,,F,Y,,,20191204.0,,MD,US,US,2019,Q4,Youth
171094301,17109430,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,"15 INTERNATIONAL UNIT, DAILY WITH MEALS",,,,,,,,15.0,IU,,,2019,Q4,Hyperglycaemic hyperosmolar nonketotic syndrome,Hyperglycaemic hyperosmolar nonketotic syndrome,2019,Q4,1,I,,20191126.0,20191204,20191204,EXP,,US-EMCURE PHARMACEUTICALS LTD-2019-EPL-1117,EMCURE,"YEDDI A, SHAH P, AWAD O, ABDALLAH MA, NNODIM I.. ACETAZOLAMIDE-ASSOCIATED HYPEROSMOLAR HYPERGLYCEMIC NONKETOTIC SYNDROME.. AMERICAN JOURNAL OF THERAPEUTICS. 2019",22.0,YR,,F,Y,,,20191204.0,,MD,US,US,2019,Q4,Youth
171094301,17109430,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,"15 INTERNATIONAL UNIT, DAILY WITH MEALS",,,,,,,,15.0,IU,,,2019,Q4,Off label use,,2019,Q4,1,I,,20191126.0,20191204,20191204,EXP,,US-EMCURE PHARMACEUTICALS LTD-2019-EPL-1117,EMCURE,"YEDDI A, SHAH P, AWAD O, ABDALLAH MA, NNODIM I.. ACETAZOLAMIDE-ASSOCIATED HYPEROSMOLAR HYPERGLYCEMIC NONKETOTIC SYNDROME.. AMERICAN JOURNAL OF THERAPEUTICS. 2019",22.0,YR,,F,Y,,,20191204.0,,MD,US,US,2019,Q4,Youth
171094301,17109430,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"70 UNITS OF SCHEDULED LISPRO INSULIN WITH EACH MEAL, IN ADDITION TO 120 UNITS OF LISPRO INSULIN GIVE",,,,,,,,,,,,2019,Q4,Acute kidney injury,,2019,Q4,1,I,,20191126.0,20191204,20191204,EXP,,US-EMCURE PHARMACEUTICALS LTD-2019-EPL-1117,EMCURE,"YEDDI A, SHAH P, AWAD O, ABDALLAH MA, NNODIM I.. ACETAZOLAMIDE-ASSOCIATED HYPEROSMOLAR HYPERGLYCEMIC NONKETOTIC SYNDROME.. AMERICAN JOURNAL OF THERAPEUTICS. 2019",22.0,YR,,F,Y,,,20191204.0,,MD,US,US,2019,Q4,Youth
171094301,17109430,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"70 UNITS OF SCHEDULED LISPRO INSULIN WITH EACH MEAL, IN ADDITION TO 120 UNITS OF LISPRO INSULIN GIVE",,,,,,,,,,,,2019,Q4,Hyperglycaemic hyperosmolar nonketotic syndrome,Hyperglycaemic hyperosmolar nonketotic syndrome,2019,Q4,1,I,,20191126.0,20191204,20191204,EXP,,US-EMCURE PHARMACEUTICALS LTD-2019-EPL-1117,EMCURE,"YEDDI A, SHAH P, AWAD O, ABDALLAH MA, NNODIM I.. ACETAZOLAMIDE-ASSOCIATED HYPEROSMOLAR HYPERGLYCEMIC NONKETOTIC SYNDROME.. AMERICAN JOURNAL OF THERAPEUTICS. 2019",22.0,YR,,F,Y,,,20191204.0,,MD,US,US,2019,Q4,Youth
171094301,17109430,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"70 UNITS OF SCHEDULED LISPRO INSULIN WITH EACH MEAL, IN ADDITION TO 120 UNITS OF LISPRO INSULIN GIVE",,,,,,,,,,,,2019,Q4,Off label use,,2019,Q4,1,I,,20191126.0,20191204,20191204,EXP,,US-EMCURE PHARMACEUTICALS LTD-2019-EPL-1117,EMCURE,"YEDDI A, SHAH P, AWAD O, ABDALLAH MA, NNODIM I.. ACETAZOLAMIDE-ASSOCIATED HYPEROSMOLAR HYPERGLYCEMIC NONKETOTIC SYNDROME.. AMERICAN JOURNAL OF THERAPEUTICS. 2019",22.0,YR,,F,Y,,,20191204.0,,MD,US,US,2019,Q4,Youth
171113532,17111353,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"22 U, EACH MORNING (20-22 UNITS/2 UNITS INCREASED OR DECREASED AS PER BLOOD GLUCOSE)",,,,, C991470A,,20563.0,22.0,IU,,QD,2019,Q4,Abdominal distension,,2019,Q4,2,F,20191203.0,20191205.0,20191204,20191217,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201911012330,ELI LILLY AND CO,,69.0,YR,,F,Y,78.0,KG,20191217.0,,CN,CN,CN,2019,Q4,Elderly
171113532,17111353,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"22 U, EACH MORNING (20-22 UNITS/2 UNITS INCREASED OR DECREASED AS PER BLOOD GLUCOSE)",,,,, C991470A,,20563.0,22.0,IU,,QD,2019,Q4,Blood glucose fluctuation,,2019,Q4,2,F,20191203.0,20191205.0,20191204,20191217,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201911012330,ELI LILLY AND CO,,69.0,YR,,F,Y,78.0,KG,20191217.0,,CN,CN,CN,2019,Q4,Elderly
171113532,17111353,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"22 U, EACH MORNING (20-22 UNITS/2 UNITS INCREASED OR DECREASED AS PER BLOOD GLUCOSE)",,,,, C991470A,,20563.0,22.0,IU,,QD,2019,Q4,Blood glucose increased,,2019,Q4,2,F,20191203.0,20191205.0,20191204,20191217,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201911012330,ELI LILLY AND CO,,69.0,YR,,F,Y,78.0,KG,20191217.0,,CN,CN,CN,2019,Q4,Elderly
171113532,17111353,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"22 U, EACH MORNING (20-22 UNITS/2 UNITS INCREASED OR DECREASED AS PER BLOOD GLUCOSE)",,,,, C991470A,,20563.0,22.0,IU,,QD,2019,Q4,Gastric ulcer,,2019,Q4,2,F,20191203.0,20191205.0,20191204,20191217,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201911012330,ELI LILLY AND CO,,69.0,YR,,F,Y,78.0,KG,20191217.0,,CN,CN,CN,2019,Q4,Elderly
171113532,17111353,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"22 U, EACH MORNING (20-22 UNITS/2 UNITS INCREASED OR DECREASED AS PER BLOOD GLUCOSE)",,,,, C991470A,,20563.0,22.0,IU,,QD,2019,Q4,Gastrointestinal disorder,,2019,Q4,2,F,20191203.0,20191205.0,20191204,20191217,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201911012330,ELI LILLY AND CO,,69.0,YR,,F,Y,78.0,KG,20191217.0,,CN,CN,CN,2019,Q4,Elderly
171113532,17111353,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"22 U, EACH MORNING (20-22 UNITS/2 UNITS INCREASED OR DECREASED AS PER BLOOD GLUCOSE)",,,,, C991470A,,20563.0,22.0,IU,,QD,2019,Q4,Generalised oedema,,2019,Q4,2,F,20191203.0,20191205.0,20191204,20191217,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201911012330,ELI LILLY AND CO,,69.0,YR,,F,Y,78.0,KG,20191217.0,,CN,CN,CN,2019,Q4,Elderly
171113532,17111353,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"22 U, EACH MORNING (20-22 UNITS/2 UNITS INCREASED OR DECREASED AS PER BLOOD GLUCOSE)",,,,, C991470A,,20563.0,22.0,IU,,QD,2019,Q4,Hypertension,,2019,Q4,2,F,20191203.0,20191205.0,20191204,20191217,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201911012330,ELI LILLY AND CO,,69.0,YR,,F,Y,78.0,KG,20191217.0,,CN,CN,CN,2019,Q4,Elderly
171113532,17111353,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"22 U, EACH MORNING (20-22 UNITS/2 UNITS INCREASED OR DECREASED AS PER BLOOD GLUCOSE)",,,,, C991470A,,20563.0,22.0,IU,,QD,2019,Q4,Neuropathy peripheral,,2019,Q4,2,F,20191203.0,20191205.0,20191204,20191217,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201911012330,ELI LILLY AND CO,,69.0,YR,,F,Y,78.0,KG,20191217.0,,CN,CN,CN,2019,Q4,Elderly
171113532,17111353,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"14 U, DAILY (NOON)",,,,, C991470A,,20563.0,14.0,IU,,QD,2019,Q4,Abdominal distension,,2019,Q4,2,F,20191203.0,20191205.0,20191204,20191217,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201911012330,ELI LILLY AND CO,,69.0,YR,,F,Y,78.0,KG,20191217.0,,CN,CN,CN,2019,Q4,Elderly
171113532,17111353,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"14 U, DAILY (NOON)",,,,, C991470A,,20563.0,14.0,IU,,QD,2019,Q4,Blood glucose fluctuation,,2019,Q4,2,F,20191203.0,20191205.0,20191204,20191217,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201911012330,ELI LILLY AND CO,,69.0,YR,,F,Y,78.0,KG,20191217.0,,CN,CN,CN,2019,Q4,Elderly
171113532,17111353,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"14 U, DAILY (NOON)",,,,, C991470A,,20563.0,14.0,IU,,QD,2019,Q4,Blood glucose increased,,2019,Q4,2,F,20191203.0,20191205.0,20191204,20191217,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201911012330,ELI LILLY AND CO,,69.0,YR,,F,Y,78.0,KG,20191217.0,,CN,CN,CN,2019,Q4,Elderly
171113532,17111353,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"14 U, DAILY (NOON)",,,,, C991470A,,20563.0,14.0,IU,,QD,2019,Q4,Gastric ulcer,,2019,Q4,2,F,20191203.0,20191205.0,20191204,20191217,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201911012330,ELI LILLY AND CO,,69.0,YR,,F,Y,78.0,KG,20191217.0,,CN,CN,CN,2019,Q4,Elderly
171113532,17111353,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"14 U, DAILY (NOON)",,,,, C991470A,,20563.0,14.0,IU,,QD,2019,Q4,Gastrointestinal disorder,,2019,Q4,2,F,20191203.0,20191205.0,20191204,20191217,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201911012330,ELI LILLY AND CO,,69.0,YR,,F,Y,78.0,KG,20191217.0,,CN,CN,CN,2019,Q4,Elderly
171113532,17111353,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"14 U, DAILY (NOON)",,,,, C991470A,,20563.0,14.0,IU,,QD,2019,Q4,Generalised oedema,,2019,Q4,2,F,20191203.0,20191205.0,20191204,20191217,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201911012330,ELI LILLY AND CO,,69.0,YR,,F,Y,78.0,KG,20191217.0,,CN,CN,CN,2019,Q4,Elderly
171113532,17111353,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"14 U, DAILY (NOON)",,,,, C991470A,,20563.0,14.0,IU,,QD,2019,Q4,Hypertension,,2019,Q4,2,F,20191203.0,20191205.0,20191204,20191217,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201911012330,ELI LILLY AND CO,,69.0,YR,,F,Y,78.0,KG,20191217.0,,CN,CN,CN,2019,Q4,Elderly
171113532,17111353,2,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"14 U, DAILY (NOON)",,,,, C991470A,,20563.0,14.0,IU,,QD,2019,Q4,Neuropathy peripheral,,2019,Q4,2,F,20191203.0,20191205.0,20191204,20191217,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201911012330,ELI LILLY AND CO,,69.0,YR,,F,Y,78.0,KG,20191217.0,,CN,CN,CN,2019,Q4,Elderly
171113532,17111353,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"15 U, EACH EVENING",,,,, C991470A,,20563.0,15.0,IU,,QD,2019,Q4,Abdominal distension,,2019,Q4,2,F,20191203.0,20191205.0,20191204,20191217,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201911012330,ELI LILLY AND CO,,69.0,YR,,F,Y,78.0,KG,20191217.0,,CN,CN,CN,2019,Q4,Elderly
171113532,17111353,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"15 U, EACH EVENING",,,,, C991470A,,20563.0,15.0,IU,,QD,2019,Q4,Blood glucose fluctuation,,2019,Q4,2,F,20191203.0,20191205.0,20191204,20191217,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201911012330,ELI LILLY AND CO,,69.0,YR,,F,Y,78.0,KG,20191217.0,,CN,CN,CN,2019,Q4,Elderly
171113532,17111353,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"15 U, EACH EVENING",,,,, C991470A,,20563.0,15.0,IU,,QD,2019,Q4,Blood glucose increased,,2019,Q4,2,F,20191203.0,20191205.0,20191204,20191217,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201911012330,ELI LILLY AND CO,,69.0,YR,,F,Y,78.0,KG,20191217.0,,CN,CN,CN,2019,Q4,Elderly
171113532,17111353,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"15 U, EACH EVENING",,,,, C991470A,,20563.0,15.0,IU,,QD,2019,Q4,Gastric ulcer,,2019,Q4,2,F,20191203.0,20191205.0,20191204,20191217,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201911012330,ELI LILLY AND CO,,69.0,YR,,F,Y,78.0,KG,20191217.0,,CN,CN,CN,2019,Q4,Elderly
171113532,17111353,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"15 U, EACH EVENING",,,,, C991470A,,20563.0,15.0,IU,,QD,2019,Q4,Gastrointestinal disorder,,2019,Q4,2,F,20191203.0,20191205.0,20191204,20191217,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201911012330,ELI LILLY AND CO,,69.0,YR,,F,Y,78.0,KG,20191217.0,,CN,CN,CN,2019,Q4,Elderly
171113532,17111353,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"15 U, EACH EVENING",,,,, C991470A,,20563.0,15.0,IU,,QD,2019,Q4,Generalised oedema,,2019,Q4,2,F,20191203.0,20191205.0,20191204,20191217,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201911012330,ELI LILLY AND CO,,69.0,YR,,F,Y,78.0,KG,20191217.0,,CN,CN,CN,2019,Q4,Elderly
171113532,17111353,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"15 U, EACH EVENING",,,,, C991470A,,20563.0,15.0,IU,,QD,2019,Q4,Hypertension,,2019,Q4,2,F,20191203.0,20191205.0,20191204,20191217,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201911012330,ELI LILLY AND CO,,69.0,YR,,F,Y,78.0,KG,20191217.0,,CN,CN,CN,2019,Q4,Elderly
171113532,17111353,3,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"15 U, EACH EVENING",,,,, C991470A,,20563.0,15.0,IU,,QD,2019,Q4,Neuropathy peripheral,,2019,Q4,2,F,20191203.0,20191205.0,20191204,20191217,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201911012330,ELI LILLY AND CO,,69.0,YR,,F,Y,78.0,KG,20191217.0,,CN,CN,CN,2019,Q4,Elderly
171113532,17111353,4,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"22 U, EACH MORNING",,,,, C991470A,,20563.0,22.0,IU,,QD,2019,Q4,Abdominal distension,,2019,Q4,2,F,20191203.0,20191205.0,20191204,20191217,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201911012330,ELI LILLY AND CO,,69.0,YR,,F,Y,78.0,KG,20191217.0,,CN,CN,CN,2019,Q4,Elderly
171113532,17111353,4,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"22 U, EACH MORNING",,,,, C991470A,,20563.0,22.0,IU,,QD,2019,Q4,Blood glucose fluctuation,,2019,Q4,2,F,20191203.0,20191205.0,20191204,20191217,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201911012330,ELI LILLY AND CO,,69.0,YR,,F,Y,78.0,KG,20191217.0,,CN,CN,CN,2019,Q4,Elderly
171113532,17111353,4,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"22 U, EACH MORNING",,,,, C991470A,,20563.0,22.0,IU,,QD,2019,Q4,Blood glucose increased,,2019,Q4,2,F,20191203.0,20191205.0,20191204,20191217,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201911012330,ELI LILLY AND CO,,69.0,YR,,F,Y,78.0,KG,20191217.0,,CN,CN,CN,2019,Q4,Elderly
171113532,17111353,4,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"22 U, EACH MORNING",,,,, C991470A,,20563.0,22.0,IU,,QD,2019,Q4,Gastric ulcer,,2019,Q4,2,F,20191203.0,20191205.0,20191204,20191217,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201911012330,ELI LILLY AND CO,,69.0,YR,,F,Y,78.0,KG,20191217.0,,CN,CN,CN,2019,Q4,Elderly
171113532,17111353,4,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"22 U, EACH MORNING",,,,, C991470A,,20563.0,22.0,IU,,QD,2019,Q4,Gastrointestinal disorder,,2019,Q4,2,F,20191203.0,20191205.0,20191204,20191217,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201911012330,ELI LILLY AND CO,,69.0,YR,,F,Y,78.0,KG,20191217.0,,CN,CN,CN,2019,Q4,Elderly
171113532,17111353,4,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"22 U, EACH MORNING",,,,, C991470A,,20563.0,22.0,IU,,QD,2019,Q4,Generalised oedema,,2019,Q4,2,F,20191203.0,20191205.0,20191204,20191217,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201911012330,ELI LILLY AND CO,,69.0,YR,,F,Y,78.0,KG,20191217.0,,CN,CN,CN,2019,Q4,Elderly
171113532,17111353,4,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"22 U, EACH MORNING",,,,, C991470A,,20563.0,22.0,IU,,QD,2019,Q4,Hypertension,,2019,Q4,2,F,20191203.0,20191205.0,20191204,20191217,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201911012330,ELI LILLY AND CO,,69.0,YR,,F,Y,78.0,KG,20191217.0,,CN,CN,CN,2019,Q4,Elderly
171113532,17111353,4,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"22 U, EACH MORNING",,,,, C991470A,,20563.0,22.0,IU,,QD,2019,Q4,Neuropathy peripheral,,2019,Q4,2,F,20191203.0,20191205.0,20191204,20191217,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201911012330,ELI LILLY AND CO,,69.0,YR,,F,Y,78.0,KG,20191217.0,,CN,CN,CN,2019,Q4,Elderly
171113532,17111353,5,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"14 U, BID",,,,, C991470A,,20563.0,14.0,IU,,BID,2019,Q4,Abdominal distension,,2019,Q4,2,F,20191203.0,20191205.0,20191204,20191217,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201911012330,ELI LILLY AND CO,,69.0,YR,,F,Y,78.0,KG,20191217.0,,CN,CN,CN,2019,Q4,Elderly
171113532,17111353,5,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"14 U, BID",,,,, C991470A,,20563.0,14.0,IU,,BID,2019,Q4,Blood glucose fluctuation,,2019,Q4,2,F,20191203.0,20191205.0,20191204,20191217,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201911012330,ELI LILLY AND CO,,69.0,YR,,F,Y,78.0,KG,20191217.0,,CN,CN,CN,2019,Q4,Elderly
171113532,17111353,5,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"14 U, BID",,,,, C991470A,,20563.0,14.0,IU,,BID,2019,Q4,Blood glucose increased,,2019,Q4,2,F,20191203.0,20191205.0,20191204,20191217,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201911012330,ELI LILLY AND CO,,69.0,YR,,F,Y,78.0,KG,20191217.0,,CN,CN,CN,2019,Q4,Elderly
171113532,17111353,5,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"14 U, BID",,,,, C991470A,,20563.0,14.0,IU,,BID,2019,Q4,Gastric ulcer,,2019,Q4,2,F,20191203.0,20191205.0,20191204,20191217,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201911012330,ELI LILLY AND CO,,69.0,YR,,F,Y,78.0,KG,20191217.0,,CN,CN,CN,2019,Q4,Elderly
171113532,17111353,5,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"14 U, BID",,,,, C991470A,,20563.0,14.0,IU,,BID,2019,Q4,Gastrointestinal disorder,,2019,Q4,2,F,20191203.0,20191205.0,20191204,20191217,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201911012330,ELI LILLY AND CO,,69.0,YR,,F,Y,78.0,KG,20191217.0,,CN,CN,CN,2019,Q4,Elderly
171113532,17111353,5,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"14 U, BID",,,,, C991470A,,20563.0,14.0,IU,,BID,2019,Q4,Generalised oedema,,2019,Q4,2,F,20191203.0,20191205.0,20191204,20191217,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201911012330,ELI LILLY AND CO,,69.0,YR,,F,Y,78.0,KG,20191217.0,,CN,CN,CN,2019,Q4,Elderly
171113532,17111353,5,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"14 U, BID",,,,, C991470A,,20563.0,14.0,IU,,BID,2019,Q4,Hypertension,,2019,Q4,2,F,20191203.0,20191205.0,20191204,20191217,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201911012330,ELI LILLY AND CO,,69.0,YR,,F,Y,78.0,KG,20191217.0,,CN,CN,CN,2019,Q4,Elderly
171113532,17111353,5,SS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"14 U, BID",,,,, C991470A,,20563.0,14.0,IU,,BID,2019,Q4,Neuropathy peripheral,,2019,Q4,2,F,20191203.0,20191205.0,20191204,20191217,EXP,,CN-ELI_LILLY_AND_COMPANY-CN201911012330,ELI LILLY AND CO,,69.0,YR,,F,Y,78.0,KG,20191217.0,,CN,CN,CN,2019,Q4,Elderly
171158551,17115855,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNK",,,,,,,,,,SOLUTION FOR INJECTION,,2019,Q4,Diabetic ketoacidosis,,2019,Q4,1,I,20191024.0,20191128.0,20191205,20191205,EXP,IT-MINISAL02-589208,IT-SA-2019SA331803,SANOFI AVENTIS,,16.0,YR,T,M,Y,,,20191205.0,,MD,IT,IT,2019,Q4,Youth
171158551,17115855,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNK",,,,,,,,,,SOLUTION FOR INJECTION,,2019,Q4,Drug abuse,,2019,Q4,1,I,20191024.0,20191128.0,20191205,20191205,EXP,IT-MINISAL02-589208,IT-SA-2019SA331803,SANOFI AVENTIS,,16.0,YR,T,M,Y,,,20191205.0,,MD,IT,IT,2019,Q4,Youth
171158551,17115855,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNK",,,,,,,,,,SOLUTION FOR INJECTION,,2019,Q4,Drug ineffective,,2019,Q4,1,I,20191024.0,20191128.0,20191205,20191205,EXP,IT-MINISAL02-589208,IT-SA-2019SA331803,SANOFI AVENTIS,,16.0,YR,T,M,Y,,,20191205.0,,MD,IT,IT,2019,Q4,Youth
171158551,17115855,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNK",,,,,,,,,,SOLUTION FOR INJECTION,,2019,Q4,Hyperglycaemia,,2019,Q4,1,I,20191024.0,20191128.0,20191205,20191205,EXP,IT-MINISAL02-589208,IT-SA-2019SA331803,SANOFI AVENTIS,,16.0,YR,T,M,Y,,,20191205.0,,MD,IT,IT,2019,Q4,Youth
171158551,17115855,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNK",,,,,,,,,,SOLUTION FOR INJECTION,,2019,Q4,Hyperhidrosis,,2019,Q4,1,I,20191024.0,20191128.0,20191205,20191205,EXP,IT-MINISAL02-589208,IT-SA-2019SA331803,SANOFI AVENTIS,,16.0,YR,T,M,Y,,,20191205.0,,MD,IT,IT,2019,Q4,Youth
171158551,17115855,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNK",,,,,,,,,,SOLUTION FOR INJECTION,,2019,Q4,Ketoacidosis,,2019,Q4,1,I,20191024.0,20191128.0,20191205,20191205,EXP,IT-MINISAL02-589208,IT-SA-2019SA331803,SANOFI AVENTIS,,16.0,YR,T,M,Y,,,20191205.0,,MD,IT,IT,2019,Q4,Youth
171158551,17115855,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNK",,,,,,,,,,SOLUTION FOR INJECTION,,2019,Q4,Sopor,,2019,Q4,1,I,20191024.0,20191128.0,20191205,20191205,EXP,IT-MINISAL02-589208,IT-SA-2019SA331803,SANOFI AVENTIS,,16.0,YR,T,M,Y,,,20191205.0,,MD,IT,IT,2019,Q4,Youth
171195621,17119562,7,C,Insulin lispro,INSULIN LISPRO,1,Intravenous (not otherwise specified),UNK,,,U,,,,,,,UNK,,2019,Q4,Hepatitis E,,2019,Q4,1,I,2018.0,20191125.0,20191206,20191206,EXP,,CZ-AUROBINDO-AUR-APL-2019-103112,AUROBINDO,VONDRAKOVA M. KDY MENE MUZE ZNAMENAT I VICE ANEB SULIQUA A SPOKOJENOST PACIENTA SE ZJEDNODUSENIM REZIMU. KAZUISTIKY V DIABETOLOGII. 2019;17(3):20-21,50.0,YR,,M,Y,,,20191206.0,,MD,CZ,CZ,2019,Q4,Adult
171195621,17119562,7,C,Insulin lispro,INSULIN LISPRO,1,Intravenous (not otherwise specified),UNK,,,U,,,,,,,UNK,,2019,Q4,Hypoglycaemia,,2019,Q4,1,I,2018.0,20191125.0,20191206,20191206,EXP,,CZ-AUROBINDO-AUR-APL-2019-103112,AUROBINDO,VONDRAKOVA M. KDY MENE MUZE ZNAMENAT I VICE ANEB SULIQUA A SPOKOJENOST PACIENTA SE ZJEDNODUSENIM REZIMU. KAZUISTIKY V DIABETOLOGII. 2019;17(3):20-21,50.0,YR,,M,Y,,,20191206.0,,MD,CZ,CZ,2019,Q4,Adult
171196962,17119696,6,C,INSULINA LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Liver disorder,,2019,Q4,2,F,20191007.0,20191209.0,20191206,20191217,EXP,IT-MINISAL02-587117,IT-TEVA-2019-IT-1147037,TEVA,,78.0,YR,,M,Y,85.0,KG,20191217.0,,MD,IT,IT,2019,Q4,Elderly
171196962,17119696,6,C,INSULINA LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Rhabdomyolysis,,2019,Q4,2,F,20191007.0,20191209.0,20191206,20191217,EXP,IT-MINISAL02-587117,IT-TEVA-2019-IT-1147037,TEVA,,78.0,YR,,M,Y,85.0,KG,20191217.0,,MD,IT,IT,2019,Q4,Elderly
171204801,17120480,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,, C933644C,,20563.0,,,INJECTION,,2019,Q4,Visual impairment,,2019,Q4,1,I,,20191204.0,20191206,20191206,EXP,,US-ELI_LILLY_AND_COMPANY-US201912002063,ELI LILLY AND CO,,46.0,YR,,M,Y,,,20191206.0,,CN,US,US,2019,Q4,Adult
171204801,17120480,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,,,,20563.0,,,INJECTION,,2019,Q4,Visual impairment,,2019,Q4,1,I,,20191204.0,20191206,20191206,EXP,,US-ELI_LILLY_AND_COMPANY-US201912002063,ELI LILLY AND CO,,46.0,YR,,M,Y,,,20191206.0,,CN,US,US,2019,Q4,Adult
171208651,17120865,2,C,Insulin lispro,INSULIN LISPRO,1,,UNK,,,U,U,,,,,,,,2019,Q4,Drug ineffective,,2019,Q4,1,I,,20170519.0,20191206,20191206,PER,,US-UCBSA-2017020347,UCB,,45.0,YR,,M,Y,,,20191206.0,,OT,US,US,2019,Q4,Adult
171248151,17124815,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),,,,,,,,,,,,,2019,Q4,Hepatitis E,,2019,Q4,1,I,2018.0,20191127.0,20191206,20191206,EXP,,CZ-BAUSCH-BL-2019-063850,BAUSCH AND LOMB,VONDRAKOVA M. KDY MENE MUZE ZNAMENAT I VICE ANEB SULIQUA A SPOKOJENOST PACIENTA SE ZJEDNODUSENIM REZIMU. KAZUISTIKY V DIABETOLOGII. 2019;17(3):20-21.,50.0,YR,,M,Y,,,20191206.0,,MD,CZ,CZ,2019,Q4,Adult
171248151,17124815,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),,,,,,,,,,,,,2019,Q4,Hypoglycaemia,,2019,Q4,1,I,2018.0,20191127.0,20191206,20191206,EXP,,CZ-BAUSCH-BL-2019-063850,BAUSCH AND LOMB,VONDRAKOVA M. KDY MENE MUZE ZNAMENAT I VICE ANEB SULIQUA A SPOKOJENOST PACIENTA SE ZJEDNODUSENIM REZIMU. KAZUISTIKY V DIABETOLOGII. 2019;17(3):20-21.,50.0,YR,,M,Y,,,20191206.0,,MD,CZ,CZ,2019,Q4,Adult
171249031,17124903,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q4,Liver disorder,,2019,Q4,1,I,20191007.0,20191205.0,20191206,20191206,EXP,IT-MINISAL02-587117,IT-PFIZER INC-2019527747,PFIZER,,78.0,YR,,M,Y,85.0,KG,20191206.0,,MD,IT,IT,2019,Q4,Elderly
171249031,17124903,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q4,Rhabdomyolysis,,2019,Q4,1,I,20191007.0,20191205.0,20191206,20191206,EXP,IT-MINISAL02-587117,IT-PFIZER INC-2019527747,PFIZER,,78.0,YR,,M,Y,85.0,KG,20191206.0,,MD,IT,IT,2019,Q4,Elderly
171273661,17127366,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"15 U, PRN (SLIDING SCALE, DAILY)",,,,,,,,15.0,IU,INJECTION,,2019,Q4,Myelofibrosis,,2019,Q4,1,I,201910.0,20191127.0,20191209,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911013165,ELI LILLY AND CO,,77.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171273661,17127366,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"15 U, PRN (SLIDING SCALE, DAILY)",,,,, C933644C,,,15.0,IU,INJECTION,,2019,Q4,Myelofibrosis,,2019,Q4,1,I,201910.0,20191127.0,20191209,20191209,EXP,,US-ELI_LILLY_AND_COMPANY-US201911013165,ELI LILLY AND CO,,77.0,YR,,F,Y,,,20191209.0,,CN,US,US,2019,Q4,Elderly
171301321,17130132,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,SOLUTION FOR INJECTION,,2019,Q4,Agitation,,2019,Q4,1,I,20190705.0,20191205.0,20191209,20191209,EXP,,IT-BIODELIVERY SCIENCES INTERNATIONAL-2019BDSI0972,BIODELIVERY SCIENCES INTERNATIONAL,,90.0,YR,,F,Y,,,20191209.0,,MD,IT,IT,2019,Q4,Elderly
171301321,17130132,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,SOLUTION FOR INJECTION,,2019,Q4,Loss of consciousness,,2019,Q4,1,I,20190705.0,20191205.0,20191209,20191209,EXP,,IT-BIODELIVERY SCIENCES INTERNATIONAL-2019BDSI0972,BIODELIVERY SCIENCES INTERNATIONAL,,90.0,YR,,F,Y,,,20191209.0,,MD,IT,IT,2019,Q4,Elderly
171301321,17130132,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,SOLUTION FOR INJECTION,,2019,Q4,Miosis,,2019,Q4,1,I,20190705.0,20191205.0,20191209,20191209,EXP,,IT-BIODELIVERY SCIENCES INTERNATIONAL-2019BDSI0972,BIODELIVERY SCIENCES INTERNATIONAL,,90.0,YR,,F,Y,,,20191209.0,,MD,IT,IT,2019,Q4,Elderly
171301321,17130132,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,SOLUTION FOR INJECTION,,2019,Q4,Toxicity to various agents,,2019,Q4,1,I,20190705.0,20191205.0,20191209,20191209,EXP,,IT-BIODELIVERY SCIENCES INTERNATIONAL-2019BDSI0972,BIODELIVERY SCIENCES INTERNATIONAL,,90.0,YR,,F,Y,,,20191209.0,,MD,IT,IT,2019,Q4,Elderly
171332221,17133222,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNK",,,,,,,,,,SOLUTION FOR INJECTION,,2019,Q4,Accidental overdose,,2019,Q4,1,I,20191024.0,20191202.0,20191210,20191210,EXP,,CH-SA-2019SA334204,SANOFI AVENTIS,,17.0,YR,T,M,Y,,,20191210.0,,MD,CH,CH,2019,Q4,Youth
171332221,17133222,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNK",,,,,,,,,,SOLUTION FOR INJECTION,,2019,Q4,Confusional state,,2019,Q4,1,I,20191024.0,20191202.0,20191210,20191210,EXP,,CH-SA-2019SA334204,SANOFI AVENTIS,,17.0,YR,T,M,Y,,,20191210.0,,MD,CH,CH,2019,Q4,Youth
171332221,17133222,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNK",,,,,,,,,,SOLUTION FOR INJECTION,,2019,Q4,Epilepsy,,2019,Q4,1,I,20191024.0,20191202.0,20191210,20191210,EXP,,CH-SA-2019SA334204,SANOFI AVENTIS,,17.0,YR,T,M,Y,,,20191210.0,,MD,CH,CH,2019,Q4,Youth
171332221,17133222,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNK",,,,,,,,,,SOLUTION FOR INJECTION,,2019,Q4,Hypoglycaemia,,2019,Q4,1,I,20191024.0,20191202.0,20191210,20191210,EXP,,CH-SA-2019SA334204,SANOFI AVENTIS,,17.0,YR,T,M,Y,,,20191210.0,,MD,CH,CH,2019,Q4,Youth
171332221,17133222,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNK",,,,,,,,,,SOLUTION FOR INJECTION,,2019,Q4,Tachycardia,,2019,Q4,1,I,20191024.0,20191202.0,20191210,20191210,EXP,,CH-SA-2019SA334204,SANOFI AVENTIS,,17.0,YR,T,M,Y,,,20191210.0,,MD,CH,CH,2019,Q4,Youth
171357812,17135781,6,C,Insulin Lispro Protamine,INSULIN LISPRO,1,Unknown,,,,,,,,,,,SUSPENSION,,2019,Q4,Death,,2019,Q4,2,F,20190529.0,20191206.0,20191210,20191212,EXP,,US-CELGENEUS-USA-20190601929,CELGENE,,77.0,YR,,M,Y,,,20191212.0,,MD,US,US,2019,Q4,Elderly
171357812,17135781,6,C,Insulin Lispro Protamine,INSULIN LISPRO,1,Unknown,,,,,,,,,,,SUSPENSION,,2019,Q4,Fluid overload,,2019,Q4,2,F,20190529.0,20191206.0,20191210,20191212,EXP,,US-CELGENEUS-USA-20190601929,CELGENE,,77.0,YR,,M,Y,,,20191212.0,,MD,US,US,2019,Q4,Elderly
171368971,17136897,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK (ACCORDING TO BLOOD GLUCOSE),,,,,,,,,,,,2019,Q4,Abdominal pain,,2019,Q4,1,I,,20191202.0,20191210,20191210,EXP,,DE-NOVOPROD-700170,NOVO NORDISK,,18.0,YR,,M,Y,83.0,KG,20191210.0,,MD,DE,DE,2019,Q4,Youth
171368971,17136897,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK (ACCORDING TO BLOOD GLUCOSE),,,,,,,,,,,,2019,Q4,Hyperglycaemia,,2019,Q4,1,I,,20191202.0,20191210,20191210,EXP,,DE-NOVOPROD-700170,NOVO NORDISK,,18.0,YR,,M,Y,83.0,KG,20191210.0,,MD,DE,DE,2019,Q4,Youth
171368971,17136897,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK (ACCORDING TO BLOOD GLUCOSE),,,,,,,,,,,,2019,Q4,Product dose omission,,2019,Q4,1,I,,20191202.0,20191210,20191210,EXP,,DE-NOVOPROD-700170,NOVO NORDISK,,18.0,YR,,M,Y,83.0,KG,20191210.0,,MD,DE,DE,2019,Q4,Youth
171368971,17136897,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK (ACCORDING TO BLOOD GLUCOSE),,,,,,,,,,,,2019,Q4,Skin fissures,,2019,Q4,1,I,,20191202.0,20191210,20191210,EXP,,DE-NOVOPROD-700170,NOVO NORDISK,,18.0,YR,,M,Y,83.0,KG,20191210.0,,MD,DE,DE,2019,Q4,Youth
171368971,17136897,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK (ACCORDING TO BLOOD GLUCOSE),,,,,,,,,,,,2019,Q4,Somnolence,,2019,Q4,1,I,,20191202.0,20191210,20191210,EXP,,DE-NOVOPROD-700170,NOVO NORDISK,,18.0,YR,,M,Y,83.0,KG,20191210.0,,MD,DE,DE,2019,Q4,Youth
171368971,17136897,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK (ACCORDING TO BLOOD GLUCOSE),,,,,,,,,,,,2019,Q4,Vomiting,,2019,Q4,1,I,,20191202.0,20191210,20191210,EXP,,DE-NOVOPROD-700170,NOVO NORDISK,,18.0,YR,,M,Y,83.0,KG,20191210.0,,MD,DE,DE,2019,Q4,Youth
171413451,17141345,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,ACCORDING TO BZ (BLOOD SUGAR),,,,,,,209196.0,,,,,2019,Q4,Abdominal pain,,2019,Q4,1,I,,20191205.0,20191211,20191211,EXP,,DE-SA-2019SA337725,SANOFI AVENTIS,,18.0,YR,A,M,Y,83.0,KG,20191211.0,,MD,DE,DE,2019,Q4,Youth
171413451,17141345,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,ACCORDING TO BZ (BLOOD SUGAR),,,,,,,209196.0,,,,,2019,Q4,Hyperglycaemia,,2019,Q4,1,I,,20191205.0,20191211,20191211,EXP,,DE-SA-2019SA337725,SANOFI AVENTIS,,18.0,YR,A,M,Y,83.0,KG,20191211.0,,MD,DE,DE,2019,Q4,Youth
171413451,17141345,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,ACCORDING TO BZ (BLOOD SUGAR),,,,,,,209196.0,,,,,2019,Q4,Product dose omission,,2019,Q4,1,I,,20191205.0,20191211,20191211,EXP,,DE-SA-2019SA337725,SANOFI AVENTIS,,18.0,YR,A,M,Y,83.0,KG,20191211.0,,MD,DE,DE,2019,Q4,Youth
171413451,17141345,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,ACCORDING TO BZ (BLOOD SUGAR),,,,,,,209196.0,,,,,2019,Q4,Skin fissures,,2019,Q4,1,I,,20191205.0,20191211,20191211,EXP,,DE-SA-2019SA337725,SANOFI AVENTIS,,18.0,YR,A,M,Y,83.0,KG,20191211.0,,MD,DE,DE,2019,Q4,Youth
171413451,17141345,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,ACCORDING TO BZ (BLOOD SUGAR),,,,,,,209196.0,,,,,2019,Q4,Somnolence,,2019,Q4,1,I,,20191205.0,20191211,20191211,EXP,,DE-SA-2019SA337725,SANOFI AVENTIS,,18.0,YR,A,M,Y,83.0,KG,20191211.0,,MD,DE,DE,2019,Q4,Youth
171413451,17141345,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,ACCORDING TO BZ (BLOOD SUGAR),,,,,,,209196.0,,,,,2019,Q4,Vomiting,,2019,Q4,1,I,,20191205.0,20191211,20191211,EXP,,DE-SA-2019SA337725,SANOFI AVENTIS,,18.0,YR,A,M,Y,83.0,KG,20191211.0,,MD,DE,DE,2019,Q4,Youth
171419801,17141980,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,U,, UNK,,,,,,,2019,Q4,Arthritis,,2019,Q4,1,I,20181209.0,20191205.0,20191211,20191211,EXP,,SE-ELI_LILLY_AND_COMPANY-SE201912003159,ELI LILLY AND CO,,82.0,YR,,M,Y,80.0,KG,20191211.0,,CN,SE,SE,2019,Q4,Elderly
171419801,17141980,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,U,, UNK,,,,,,,2019,Q4,Dysphagia,,2019,Q4,1,I,20181209.0,20191205.0,20191211,20191211,EXP,,SE-ELI_LILLY_AND_COMPANY-SE201912003159,ELI LILLY AND CO,,82.0,YR,,M,Y,80.0,KG,20191211.0,,CN,SE,SE,2019,Q4,Elderly
171419801,17141980,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,U,, UNK,,,,,,,2019,Q4,Dyspnoea,,2019,Q4,1,I,20181209.0,20191205.0,20191211,20191211,EXP,,SE-ELI_LILLY_AND_COMPANY-SE201912003159,ELI LILLY AND CO,,82.0,YR,,M,Y,80.0,KG,20191211.0,,CN,SE,SE,2019,Q4,Elderly
171419801,17141980,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,U,, UNK,,,,,,,2019,Q4,Fall,,2019,Q4,1,I,20181209.0,20191205.0,20191211,20191211,EXP,,SE-ELI_LILLY_AND_COMPANY-SE201912003159,ELI LILLY AND CO,,82.0,YR,,M,Y,80.0,KG,20191211.0,,CN,SE,SE,2019,Q4,Elderly
171419801,17141980,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,U,, UNK,,,,,,,2019,Q4,Pain in extremity,,2019,Q4,1,I,20181209.0,20191205.0,20191211,20191211,EXP,,SE-ELI_LILLY_AND_COMPANY-SE201912003159,ELI LILLY AND CO,,82.0,YR,,M,Y,80.0,KG,20191211.0,,CN,SE,SE,2019,Q4,Elderly
171419801,17141980,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,U,, UNK,,,,,,,2019,Q4,Scratch,,2019,Q4,1,I,20181209.0,20191205.0,20191211,20191211,EXP,,SE-ELI_LILLY_AND_COMPANY-SE201912003159,ELI LILLY AND CO,,82.0,YR,,M,Y,80.0,KG,20191211.0,,CN,SE,SE,2019,Q4,Elderly
171419801,17141980,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,U,, UNK,,,,,,,2019,Q4,Subarachnoid haemorrhage,,2019,Q4,1,I,20181209.0,20191205.0,20191211,20191211,EXP,,SE-ELI_LILLY_AND_COMPANY-SE201912003159,ELI LILLY AND CO,,82.0,YR,,M,Y,80.0,KG,20191211.0,,CN,SE,SE,2019,Q4,Elderly
171419801,17141980,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,U,, UNK,,,,,,,2019,Q4,Tachycardia,,2019,Q4,1,I,20181209.0,20191205.0,20191211,20191211,EXP,,SE-ELI_LILLY_AND_COMPANY-SE201912003159,ELI LILLY AND CO,,82.0,YR,,M,Y,80.0,KG,20191211.0,,CN,SE,SE,2019,Q4,Elderly
171425562,17142556,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q4,Dyspnoea,,2019,Q4,2,F,20191108.0,20191212.0,20191211,20191226,EXP,,US-ACTELION PHARMACEUTICALS LTD.-A-NJ2019-199079,ACTELION,,64.0,YR,,F,Y,,,20191226.0,,OT,US,US,2019,Q4,Adult
171425562,17142556,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q4,Lung adenocarcinoma,,2019,Q4,2,F,20191108.0,20191212.0,20191211,20191226,EXP,,US-ACTELION PHARMACEUTICALS LTD.-A-NJ2019-199079,ACTELION,,64.0,YR,,F,Y,,,20191226.0,,OT,US,US,2019,Q4,Adult
171425562,17142556,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q4,Metastases to bone,,2019,Q4,2,F,20191108.0,20191212.0,20191211,20191226,EXP,,US-ACTELION PHARMACEUTICALS LTD.-A-NJ2019-199079,ACTELION,,64.0,YR,,F,Y,,,20191226.0,,OT,US,US,2019,Q4,Adult
171425562,17142556,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2019,Q4,Metastases to liver,,2019,Q4,2,F,20191108.0,20191212.0,20191211,20191226,EXP,,US-ACTELION PHARMACEUTICALS LTD.-A-NJ2019-199079,ACTELION,,64.0,YR,,F,Y,,,20191226.0,,OT,US,US,2019,Q4,Adult
171427181,17142718,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 IU, QD (5 U+10+10) (1 DF QD)",,,,,,,,20.0,IU,,QD,2019,Q4,Arthralgia,,2019,Q4,1,I,20191001.0,20191202.0,20191211,20191211,EXP,IT-MINISAL02-590980,IT-NOVOPROD-700147,NOVO NORDISK,,18.0,YR,,F,Y,,,20191211.0,,MD,IT,IT,2019,Q4,Youth
171427181,17142718,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 IU, QD (5 U+10+10) (1 DF QD)",,,,,,,,20.0,IU,,QD,2019,Q4,Drug ineffective,,2019,Q4,1,I,20191001.0,20191202.0,20191211,20191211,EXP,IT-MINISAL02-590980,IT-NOVOPROD-700147,NOVO NORDISK,,18.0,YR,,F,Y,,,20191211.0,,MD,IT,IT,2019,Q4,Youth
171427181,17142718,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 IU, QD (5 U+10+10) (1 DF QD)",,,,,,,,20.0,IU,,QD,2019,Q4,Headache,,2019,Q4,1,I,20191001.0,20191202.0,20191211,20191211,EXP,IT-MINISAL02-590980,IT-NOVOPROD-700147,NOVO NORDISK,,18.0,YR,,F,Y,,,20191211.0,,MD,IT,IT,2019,Q4,Youth
171427181,17142718,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 IU, QD (5 U+10+10) (1 DF QD)",,,,,,,,20.0,IU,,QD,2019,Q4,Hyperglycaemia,,2019,Q4,1,I,20191001.0,20191202.0,20191211,20191211,EXP,IT-MINISAL02-590980,IT-NOVOPROD-700147,NOVO NORDISK,,18.0,YR,,F,Y,,,20191211.0,,MD,IT,IT,2019,Q4,Youth
171427181,17142718,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 IU, QD (5 U+10+10) (1 DF QD)",,,,,,,,20.0,IU,,QD,2019,Q4,Nausea,,2019,Q4,1,I,20191001.0,20191202.0,20191211,20191211,EXP,IT-MINISAL02-590980,IT-NOVOPROD-700147,NOVO NORDISK,,18.0,YR,,F,Y,,,20191211.0,,MD,IT,IT,2019,Q4,Youth
171427181,17142718,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 IU, QD (5 U+10+10) (1 DF QD)",,,,,,,,20.0,IU,,QD,2019,Q4,Urine abnormality,,2019,Q4,1,I,20191001.0,20191202.0,20191211,20191211,EXP,IT-MINISAL02-590980,IT-NOVOPROD-700147,NOVO NORDISK,,18.0,YR,,F,Y,,,20191211.0,,MD,IT,IT,2019,Q4,Youth
171427181,17142718,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"25 IU, QD (5 U+10+10 )",,,,,,,,25.0,IU,,QD,2019,Q4,Arthralgia,,2019,Q4,1,I,20191001.0,20191202.0,20191211,20191211,EXP,IT-MINISAL02-590980,IT-NOVOPROD-700147,NOVO NORDISK,,18.0,YR,,F,Y,,,20191211.0,,MD,IT,IT,2019,Q4,Youth
171427181,17142718,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"25 IU, QD (5 U+10+10 )",,,,,,,,25.0,IU,,QD,2019,Q4,Drug ineffective,,2019,Q4,1,I,20191001.0,20191202.0,20191211,20191211,EXP,IT-MINISAL02-590980,IT-NOVOPROD-700147,NOVO NORDISK,,18.0,YR,,F,Y,,,20191211.0,,MD,IT,IT,2019,Q4,Youth
171427181,17142718,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"25 IU, QD (5 U+10+10 )",,,,,,,,25.0,IU,,QD,2019,Q4,Headache,,2019,Q4,1,I,20191001.0,20191202.0,20191211,20191211,EXP,IT-MINISAL02-590980,IT-NOVOPROD-700147,NOVO NORDISK,,18.0,YR,,F,Y,,,20191211.0,,MD,IT,IT,2019,Q4,Youth
171427181,17142718,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"25 IU, QD (5 U+10+10 )",,,,,,,,25.0,IU,,QD,2019,Q4,Hyperglycaemia,,2019,Q4,1,I,20191001.0,20191202.0,20191211,20191211,EXP,IT-MINISAL02-590980,IT-NOVOPROD-700147,NOVO NORDISK,,18.0,YR,,F,Y,,,20191211.0,,MD,IT,IT,2019,Q4,Youth
171427181,17142718,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"25 IU, QD (5 U+10+10 )",,,,,,,,25.0,IU,,QD,2019,Q4,Nausea,,2019,Q4,1,I,20191001.0,20191202.0,20191211,20191211,EXP,IT-MINISAL02-590980,IT-NOVOPROD-700147,NOVO NORDISK,,18.0,YR,,F,Y,,,20191211.0,,MD,IT,IT,2019,Q4,Youth
171427181,17142718,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"25 IU, QD (5 U+10+10 )",,,,,,,,25.0,IU,,QD,2019,Q4,Urine abnormality,,2019,Q4,1,I,20191001.0,20191202.0,20191211,20191211,EXP,IT-MINISAL02-590980,IT-NOVOPROD-700147,NOVO NORDISK,,18.0,YR,,F,Y,,,20191211.0,,MD,IT,IT,2019,Q4,Youth
171445461,17144546,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 DF, QD",,,,,,,209196.0,1.0,DF,SOLUTION FOR INJECTION,QD,2019,Q4,Arthralgia,,2019,Q4,1,I,20191001.0,20191205.0,20191212,20191212,EXP,IT-MINISAL02-590980,IT-SA-2019SA337958,SANOFI AVENTIS,,18.0,YR,A,F,Y,,,20191212.0,,MD,IT,IT,2019,Q4,Youth
171445461,17144546,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 DF, QD",,,,,,,209196.0,1.0,DF,SOLUTION FOR INJECTION,QD,2019,Q4,Drug ineffective,,2019,Q4,1,I,20191001.0,20191205.0,20191212,20191212,EXP,IT-MINISAL02-590980,IT-SA-2019SA337958,SANOFI AVENTIS,,18.0,YR,A,F,Y,,,20191212.0,,MD,IT,IT,2019,Q4,Youth
171445461,17144546,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 DF, QD",,,,,,,209196.0,1.0,DF,SOLUTION FOR INJECTION,QD,2019,Q4,Headache,,2019,Q4,1,I,20191001.0,20191205.0,20191212,20191212,EXP,IT-MINISAL02-590980,IT-SA-2019SA337958,SANOFI AVENTIS,,18.0,YR,A,F,Y,,,20191212.0,,MD,IT,IT,2019,Q4,Youth
171445461,17144546,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 DF, QD",,,,,,,209196.0,1.0,DF,SOLUTION FOR INJECTION,QD,2019,Q4,Hyperglycaemia,,2019,Q4,1,I,20191001.0,20191205.0,20191212,20191212,EXP,IT-MINISAL02-590980,IT-SA-2019SA337958,SANOFI AVENTIS,,18.0,YR,A,F,Y,,,20191212.0,,MD,IT,IT,2019,Q4,Youth
171445461,17144546,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 DF, QD",,,,,,,209196.0,1.0,DF,SOLUTION FOR INJECTION,QD,2019,Q4,Nausea,,2019,Q4,1,I,20191001.0,20191205.0,20191212,20191212,EXP,IT-MINISAL02-590980,IT-SA-2019SA337958,SANOFI AVENTIS,,18.0,YR,A,F,Y,,,20191212.0,,MD,IT,IT,2019,Q4,Youth
171445461,17144546,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 DF, QD",,,,,,,209196.0,1.0,DF,SOLUTION FOR INJECTION,QD,2019,Q4,Urine abnormality,,2019,Q4,1,I,20191001.0,20191205.0,20191212,20191212,EXP,IT-MINISAL02-590980,IT-SA-2019SA337958,SANOFI AVENTIS,,18.0,YR,A,F,Y,,,20191212.0,,MD,IT,IT,2019,Q4,Youth
171445461,17144546,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,209196.0,,,SOLUTION FOR INJECTION,,2019,Q4,Arthralgia,,2019,Q4,1,I,20191001.0,20191205.0,20191212,20191212,EXP,IT-MINISAL02-590980,IT-SA-2019SA337958,SANOFI AVENTIS,,18.0,YR,A,F,Y,,,20191212.0,,MD,IT,IT,2019,Q4,Youth
171445461,17144546,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,209196.0,,,SOLUTION FOR INJECTION,,2019,Q4,Drug ineffective,,2019,Q4,1,I,20191001.0,20191205.0,20191212,20191212,EXP,IT-MINISAL02-590980,IT-SA-2019SA337958,SANOFI AVENTIS,,18.0,YR,A,F,Y,,,20191212.0,,MD,IT,IT,2019,Q4,Youth
171445461,17144546,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,209196.0,,,SOLUTION FOR INJECTION,,2019,Q4,Headache,,2019,Q4,1,I,20191001.0,20191205.0,20191212,20191212,EXP,IT-MINISAL02-590980,IT-SA-2019SA337958,SANOFI AVENTIS,,18.0,YR,A,F,Y,,,20191212.0,,MD,IT,IT,2019,Q4,Youth
171445461,17144546,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,209196.0,,,SOLUTION FOR INJECTION,,2019,Q4,Hyperglycaemia,,2019,Q4,1,I,20191001.0,20191205.0,20191212,20191212,EXP,IT-MINISAL02-590980,IT-SA-2019SA337958,SANOFI AVENTIS,,18.0,YR,A,F,Y,,,20191212.0,,MD,IT,IT,2019,Q4,Youth
171445461,17144546,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,209196.0,,,SOLUTION FOR INJECTION,,2019,Q4,Nausea,,2019,Q4,1,I,20191001.0,20191205.0,20191212,20191212,EXP,IT-MINISAL02-590980,IT-SA-2019SA337958,SANOFI AVENTIS,,18.0,YR,A,F,Y,,,20191212.0,,MD,IT,IT,2019,Q4,Youth
171445461,17144546,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,209196.0,,,SOLUTION FOR INJECTION,,2019,Q4,Urine abnormality,,2019,Q4,1,I,20191001.0,20191205.0,20191212,20191212,EXP,IT-MINISAL02-590980,IT-SA-2019SA337958,SANOFI AVENTIS,,18.0,YR,A,F,Y,,,20191212.0,,MD,IT,IT,2019,Q4,Youth
171449432,17144943,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,3 IN 1 DAY AND AFTER BLOOD SUGAR VALUE,,,,,,,,5.0,IU,,,2019,Q4,C-reactive protein increased,,2019,Q4,2,F,20191205.0,20191206.0,20191212,20191217,EXP,,DE-ABBVIE-19K-062-3188931-00,ABBVIE,,78.0,YR,,M,Y,,,20191217.0,,MD,DE,DE,2019,Q4,Elderly
171449432,17144943,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,3 IN 1 DAY AND AFTER BLOOD SUGAR VALUE,,,,,,,,5.0,IU,,,2019,Q4,General physical health deterioration,,2019,Q4,2,F,20191205.0,20191206.0,20191212,20191217,EXP,,DE-ABBVIE-19K-062-3188931-00,ABBVIE,,78.0,YR,,M,Y,,,20191217.0,,MD,DE,DE,2019,Q4,Elderly
171449432,17144943,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,3 IN 1 DAY AND AFTER BLOOD SUGAR VALUE,,,,,,,,5.0,IU,,,2019,Q4,Peritonitis,,2019,Q4,2,F,20191205.0,20191206.0,20191212,20191217,EXP,,DE-ABBVIE-19K-062-3188931-00,ABBVIE,,78.0,YR,,M,Y,,,20191217.0,,MD,DE,DE,2019,Q4,Elderly
171474121,17147412,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,"NK IE, NACH SCHEMA",,,,,,,,,,,,2019,Q4,Condition aggravated,,2019,Q4,1,I,,20191206.0,20191212,20191212,EXP,,DE-MYLANLABS-2019M1122261,MYLAN,,77.0,YR,,M,Y,,,20191212.0,,PH,DE,DE,2019,Q4,Elderly
171474121,17147412,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,"NK IE, NACH SCHEMA",,,,,,,,,,,,2019,Q4,Dyspnoea,,2019,Q4,1,I,,20191206.0,20191212,20191212,EXP,,DE-MYLANLABS-2019M1122261,MYLAN,,77.0,YR,,M,Y,,,20191212.0,,PH,DE,DE,2019,Q4,Elderly
171476652,17147665,1,PS,Liprolog Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,20563.0,,,,,2019,Q4,Ketoacidosis,,2019,Q4,2,F,,20191205.0,20191212,20191218,EXP,,NZ-ELI_LILLY_AND_COMPANY-DE201912000711,ELI LILLY AND CO,,18.0,YR,,M,Y,,,20191218.0,,OT,NZ,DE,2019,Q4,Youth
171476652,17147665,1,PS,Liprolog Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,20563.0,,,,,2019,Q4,Product storage error,,2019,Q4,2,F,,20191205.0,20191212,20191218,EXP,,NZ-ELI_LILLY_AND_COMPANY-DE201912000711,ELI LILLY AND CO,,18.0,YR,,M,Y,,,20191218.0,,OT,NZ,DE,2019,Q4,Youth
171516501,17151650,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,,,,20563.0,,,,,2019,Q4,Abdominal pain,,2019,Q4,1,I,,20191202.0,20191213,20191213,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201912001125,ELI LILLY AND CO,,18.0,YR,,M,Y,83.0,KG,20191213.0,,CN,DE,DE,2019,Q4,Youth
171516501,17151650,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,,,,20563.0,,,,,2019,Q4,Hyperglycaemia,,2019,Q4,1,I,,20191202.0,20191213,20191213,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201912001125,ELI LILLY AND CO,,18.0,YR,,M,Y,83.0,KG,20191213.0,,CN,DE,DE,2019,Q4,Youth
171516501,17151650,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,,,,20563.0,,,,,2019,Q4,Product dose omission,,2019,Q4,1,I,,20191202.0,20191213,20191213,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201912001125,ELI LILLY AND CO,,18.0,YR,,M,Y,83.0,KG,20191213.0,,CN,DE,DE,2019,Q4,Youth
171516501,17151650,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,,,,20563.0,,,,,2019,Q4,Skin fissures,,2019,Q4,1,I,,20191202.0,20191213,20191213,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201912001125,ELI LILLY AND CO,,18.0,YR,,M,Y,83.0,KG,20191213.0,,CN,DE,DE,2019,Q4,Youth
171516501,17151650,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,,,,20563.0,,,,,2019,Q4,Somnolence,,2019,Q4,1,I,,20191202.0,20191213,20191213,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201912001125,ELI LILLY AND CO,,18.0,YR,,M,Y,83.0,KG,20191213.0,,CN,DE,DE,2019,Q4,Youth
171516501,17151650,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,,,,20563.0,,,,,2019,Q4,Vomiting,,2019,Q4,1,I,,20191202.0,20191213,20191213,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201912001125,ELI LILLY AND CO,,18.0,YR,,M,Y,83.0,KG,20191213.0,,CN,DE,DE,2019,Q4,Youth
171517061,17151706,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,"30 IU, UNK",,,D,,,,209196.0,30.0,IU,SOLUTION FOR INJECTION,,2019,Q4,Intentional overdose,,2019,Q4,1,I,20180513.0,20191206.0,20191213,20191213,EXP,SE-MPA-2019-010718,SE-SA-2019SA340700,SANOFI AVENTIS,,20.0,YR,A,M,Y,,,20191213.0,,OT,SE,SE,2019,Q4,Youth
171517061,17151706,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,"30 IU, UNK",,,D,,,,209196.0,30.0,IU,SOLUTION FOR INJECTION,,2019,Q4,Intentional self-injury,,2019,Q4,1,I,20180513.0,20191206.0,20191213,20191213,EXP,SE-MPA-2019-010718,SE-SA-2019SA340700,SANOFI AVENTIS,,20.0,YR,A,M,Y,,,20191213.0,,OT,SE,SE,2019,Q4,Youth
171517061,17151706,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,"30 IU, UNK",,,D,,,,209196.0,30.0,IU,SOLUTION FOR INJECTION,,2019,Q4,Tachycardia,,2019,Q4,1,I,20180513.0,20191206.0,20191213,20191213,EXP,SE-MPA-2019-010718,SE-SA-2019SA340700,SANOFI AVENTIS,,20.0,YR,A,M,Y,,,20191213.0,,OT,SE,SE,2019,Q4,Youth
171536751,17153675,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"14 U, UNK",,,U,,,,,14.0,DF,,,2019,Q4,Diarrhoea,,2019,Q4,1,I,20180605.0,20180608.0,20191213,20191213,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-053990,BRISTOL MYERS SQUIBB,,59.0,YR,,M,Y,79.96,KG,20191213.0,,OT,US,US,2019,Q4,Adult
171536751,17153675,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"14 U, UNK",,,U,,,,,14.0,DF,,,2019,Q4,Enteritis,,2019,Q4,1,I,20180605.0,20180608.0,20191213,20191213,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-053990,BRISTOL MYERS SQUIBB,,59.0,YR,,M,Y,79.96,KG,20191213.0,,OT,US,US,2019,Q4,Adult
171549581,17154958,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, TID",,,U,,,,,,,,TID,2019,Q4,Alanine aminotransferase abnormal,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, TID",,,U,,,,,,,,TID,2019,Q4,Back pain,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, TID",,,U,,,,,,,,TID,2019,Q4,Blood albumin abnormal,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, TID",,,U,,,,,,,,TID,2019,Q4,Blood bilirubin abnormal,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, TID",,,U,,,,,,,,TID,2019,Q4,Blood calcium abnormal,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, TID",,,U,,,,,,,,TID,2019,Q4,Blood chloride abnormal,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, TID",,,U,,,,,,,,TID,2019,Q4,Chills,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, TID",,,U,,,,,,,,TID,2019,Q4,Cytokine release syndrome,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, TID",,,U,,,,,,,,TID,2019,Q4,Depression,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, TID",,,U,,,,,,,,TID,2019,Q4,Diarrhoea,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, TID",,,U,,,,,,,,TID,2019,Q4,Epistaxis,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, TID",,,U,,,,,,,,TID,2019,Q4,Globulin abnormal,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, TID",,,U,,,,,,,,TID,2019,Q4,Haematocrit abnormal,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, TID",,,U,,,,,,,,TID,2019,Q4,Haemoglobin urine present,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, TID",,,U,,,,,,,,TID,2019,Q4,Heart rate increased,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, TID",,,U,,,,,,,,TID,2019,Q4,Heparin-induced thrombocytopenia,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, TID",,,U,,,,,,,,TID,2019,Q4,Hypophagia,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, TID",,,U,,,,,,,,TID,2019,Q4,Liver disorder,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, TID",,,U,,,,,,,,TID,2019,Q4,Peripheral swelling,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, TID",,,U,,,,,,,,TID,2019,Q4,Pyrexia,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, TID",,,U,,,,,,,,TID,2019,Q4,Red blood cell count abnormal,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, TID",,,U,,,,,,,,TID,2019,Q4,Seizure,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, TID",,,U,,,,,,,,TID,2019,Q4,Tachycardia,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, TID",,,U,,,,,,,,TID,2019,Q4,Tremor,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, TID",,,U,,,,,,,,TID,2019,Q4,Tumour lysis syndrome,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, TID",,,U,,,,,,,,TID,2019,Q4,White blood cell count abnormal,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,(NIGHTLY),,,U,,,,,,,,,2019,Q4,Alanine aminotransferase abnormal,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,(NIGHTLY),,,U,,,,,,,,,2019,Q4,Back pain,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,(NIGHTLY),,,U,,,,,,,,,2019,Q4,Blood albumin abnormal,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,(NIGHTLY),,,U,,,,,,,,,2019,Q4,Blood bilirubin abnormal,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,(NIGHTLY),,,U,,,,,,,,,2019,Q4,Blood calcium abnormal,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,(NIGHTLY),,,U,,,,,,,,,2019,Q4,Blood chloride abnormal,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,(NIGHTLY),,,U,,,,,,,,,2019,Q4,Chills,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,(NIGHTLY),,,U,,,,,,,,,2019,Q4,Cytokine release syndrome,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,(NIGHTLY),,,U,,,,,,,,,2019,Q4,Depression,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,(NIGHTLY),,,U,,,,,,,,,2019,Q4,Diarrhoea,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,(NIGHTLY),,,U,,,,,,,,,2019,Q4,Epistaxis,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,(NIGHTLY),,,U,,,,,,,,,2019,Q4,Globulin abnormal,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,(NIGHTLY),,,U,,,,,,,,,2019,Q4,Haematocrit abnormal,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,(NIGHTLY),,,U,,,,,,,,,2019,Q4,Haemoglobin urine present,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,(NIGHTLY),,,U,,,,,,,,,2019,Q4,Heart rate increased,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,(NIGHTLY),,,U,,,,,,,,,2019,Q4,Heparin-induced thrombocytopenia,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,(NIGHTLY),,,U,,,,,,,,,2019,Q4,Hypophagia,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,(NIGHTLY),,,U,,,,,,,,,2019,Q4,Liver disorder,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,(NIGHTLY),,,U,,,,,,,,,2019,Q4,Peripheral swelling,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,(NIGHTLY),,,U,,,,,,,,,2019,Q4,Pyrexia,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,(NIGHTLY),,,U,,,,,,,,,2019,Q4,Red blood cell count abnormal,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,(NIGHTLY),,,U,,,,,,,,,2019,Q4,Seizure,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,(NIGHTLY),,,U,,,,,,,,,2019,Q4,Tachycardia,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,(NIGHTLY),,,U,,,,,,,,,2019,Q4,Tremor,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,(NIGHTLY),,,U,,,,,,,,,2019,Q4,Tumour lysis syndrome,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,(NIGHTLY),,,U,,,,,,,,,2019,Q4,White blood cell count abnormal,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,30,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Alanine aminotransferase abnormal,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,30,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Back pain,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,30,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Blood albumin abnormal,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,30,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Blood bilirubin abnormal,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,30,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Blood calcium abnormal,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,30,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Blood chloride abnormal,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,30,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Chills,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,30,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Cytokine release syndrome,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,30,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Depression,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,30,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Diarrhoea,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,30,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Epistaxis,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,30,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Globulin abnormal,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,30,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Haematocrit abnormal,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,30,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Haemoglobin urine present,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,30,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Heart rate increased,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,30,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Heparin-induced thrombocytopenia,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,30,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Hypophagia,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,30,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Liver disorder,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,30,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Peripheral swelling,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,30,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Pyrexia,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,30,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Red blood cell count abnormal,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,30,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Seizure,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,30,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Tachycardia,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,30,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Tremor,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,30,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Tumour lysis syndrome,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171549581,17154958,30,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,White blood cell count abnormal,,2019,Q4,1,I,20191021.0,20191021.0,20191214,20191214,EXP,,NVSC2019US022619,NOVARTIS,,70.0,YR,,F,Y,79.0,KG,20191214.0,,OT,US,US,2019,Q4,Elderly
171563071,17156307,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"7 U, UNKNOWN (AFTER EACH MEAL)",,,,, C933644C,,20563.0,7.0,IU,INJECTION,,2019,Q4,Blood glucose increased,,2019,Q4,1,I,,20191209.0,20191216,20191216,EXP,,US-ELI_LILLY_AND_COMPANY-US201912004519,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20191216.0,,CN,US,US,2019,Q4,Elderly
171563071,17156307,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"20 U, UNKNOWN (AFTER EACH MEAL)",,,,, C933644C,,20563.0,20.0,IU,INJECTION,,2019,Q4,Blood glucose increased,,2019,Q4,1,I,,20191209.0,20191216,20191216,EXP,,US-ELI_LILLY_AND_COMPANY-US201912004519,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20191216.0,,CN,US,US,2019,Q4,Elderly
171582351,17158235,14,SS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,,,,D,,,,,,,,,2019,Q4,Suspected suicide,,2019,Q4,1,I,,20191206.0,20191216,20191216,EXP,,US-009507513-1912USA004742,MERCK,,61.0,YR,,F,Y,,,20191216.0,,MD,US,US,2019,Q4,Adult
171596141,17159614,3,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"17 IU, QD (6IU BEFORE BREAKFAST AND 11IU BEFORE MEAL)",,,,,,,,17.0,IU,,QD,2019,Q4,Blood glucose decreased,,2019,Q4,1,I,201909.0,20191203.0,20191216,20191216,EXP,,MX-NOVOPROD-701648,NOVO NORDISK,,82.0,YR,,F,Y,58.0,KG,20191216.0,,CN,MX,MX,2019,Q4,Elderly
171596141,17159614,3,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"17 IU, QD (6IU BEFORE BREAKFAST AND 11IU BEFORE MEAL)",,,,,,,,17.0,IU,,QD,2019,Q4,Blood glucose increased,,2019,Q4,1,I,201909.0,20191203.0,20191216,20191216,EXP,,MX-NOVOPROD-701648,NOVO NORDISK,,82.0,YR,,F,Y,58.0,KG,20191216.0,,CN,MX,MX,2019,Q4,Elderly
171596141,17159614,3,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"17 IU, QD (6IU BEFORE BREAKFAST AND 11IU BEFORE MEAL)",,,,,,,,17.0,IU,,QD,2019,Q4,Hyperglycaemia,,2019,Q4,1,I,201909.0,20191203.0,20191216,20191216,EXP,,MX-NOVOPROD-701648,NOVO NORDISK,,82.0,YR,,F,Y,58.0,KG,20191216.0,,CN,MX,MX,2019,Q4,Elderly
171596141,17159614,3,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"17 IU, QD (6IU BEFORE BREAKFAST AND 11IU BEFORE MEAL)",,,,,,,,17.0,IU,,QD,2019,Q4,Neoplasm malignant,,2019,Q4,1,I,201909.0,20191203.0,20191216,20191216,EXP,,MX-NOVOPROD-701648,NOVO NORDISK,,82.0,YR,,F,Y,58.0,KG,20191216.0,,CN,MX,MX,2019,Q4,Elderly
171596141,17159614,4,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"6 IU, QD (2 IU, BEFORE BREAKFAST, 4 IU BEFORE MEAL )",,,,,,,,6.0,IU,,QD,2019,Q4,Blood glucose decreased,,2019,Q4,1,I,201909.0,20191203.0,20191216,20191216,EXP,,MX-NOVOPROD-701648,NOVO NORDISK,,82.0,YR,,F,Y,58.0,KG,20191216.0,,CN,MX,MX,2019,Q4,Elderly
171596141,17159614,4,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"6 IU, QD (2 IU, BEFORE BREAKFAST, 4 IU BEFORE MEAL )",,,,,,,,6.0,IU,,QD,2019,Q4,Blood glucose increased,,2019,Q4,1,I,201909.0,20191203.0,20191216,20191216,EXP,,MX-NOVOPROD-701648,NOVO NORDISK,,82.0,YR,,F,Y,58.0,KG,20191216.0,,CN,MX,MX,2019,Q4,Elderly
171596141,17159614,4,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"6 IU, QD (2 IU, BEFORE BREAKFAST, 4 IU BEFORE MEAL )",,,,,,,,6.0,IU,,QD,2019,Q4,Hyperglycaemia,,2019,Q4,1,I,201909.0,20191203.0,20191216,20191216,EXP,,MX-NOVOPROD-701648,NOVO NORDISK,,82.0,YR,,F,Y,58.0,KG,20191216.0,,CN,MX,MX,2019,Q4,Elderly
171596141,17159614,4,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"6 IU, QD (2 IU, BEFORE BREAKFAST, 4 IU BEFORE MEAL )",,,,,,,,6.0,IU,,QD,2019,Q4,Neoplasm malignant,,2019,Q4,1,I,201909.0,20191203.0,20191216,20191216,EXP,,MX-NOVOPROD-701648,NOVO NORDISK,,82.0,YR,,F,Y,58.0,KG,20191216.0,,CN,MX,MX,2019,Q4,Elderly
171596141,17159614,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"17 IU, QD (6IU BEFORE BREAKFAST AND 11IU BEFORE MEAL)",,,,,,,,17.0,IU,,QD,2019,Q4,Blood glucose decreased,,2019,Q4,1,I,201909.0,20191203.0,20191216,20191216,EXP,,MX-NOVOPROD-701648,NOVO NORDISK,,82.0,YR,,F,Y,58.0,KG,20191216.0,,CN,MX,MX,2019,Q4,Elderly
171596141,17159614,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"17 IU, QD (6IU BEFORE BREAKFAST AND 11IU BEFORE MEAL)",,,,,,,,17.0,IU,,QD,2019,Q4,Blood glucose increased,,2019,Q4,1,I,201909.0,20191203.0,20191216,20191216,EXP,,MX-NOVOPROD-701648,NOVO NORDISK,,82.0,YR,,F,Y,58.0,KG,20191216.0,,CN,MX,MX,2019,Q4,Elderly
171596141,17159614,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"17 IU, QD (6IU BEFORE BREAKFAST AND 11IU BEFORE MEAL)",,,,,,,,17.0,IU,,QD,2019,Q4,Hyperglycaemia,,2019,Q4,1,I,201909.0,20191203.0,20191216,20191216,EXP,,MX-NOVOPROD-701648,NOVO NORDISK,,82.0,YR,,F,Y,58.0,KG,20191216.0,,CN,MX,MX,2019,Q4,Elderly
171596141,17159614,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"17 IU, QD (6IU BEFORE BREAKFAST AND 11IU BEFORE MEAL)",,,,,,,,17.0,IU,,QD,2019,Q4,Neoplasm malignant,,2019,Q4,1,I,201909.0,20191203.0,20191216,20191216,EXP,,MX-NOVOPROD-701648,NOVO NORDISK,,82.0,YR,,F,Y,58.0,KG,20191216.0,,CN,MX,MX,2019,Q4,Elderly
171604321,17160432,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2019,Q4,Drug reaction with eosinophilia and systemic symptoms,,2019,Q4,1,I,20190724.0,20191209.0,20191216,20191216,EXP,IT-MINISAL02-568249,IT-MYLANLABS-2019M1122966,MYLAN,,59.0,YR,,,Y,,,20191216.0,,MD,IT,IT,2019,Q4,Adult
171604321,17160432,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2019,Q4,Erythema,,2019,Q4,1,I,20190724.0,20191209.0,20191216,20191216,EXP,IT-MINISAL02-568249,IT-MYLANLABS-2019M1122966,MYLAN,,59.0,YR,,,Y,,,20191216.0,,MD,IT,IT,2019,Q4,Adult
171604321,17160432,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2019,Q4,Oedema,,2019,Q4,1,I,20190724.0,20191209.0,20191216,20191216,EXP,IT-MINISAL02-568249,IT-MYLANLABS-2019M1122966,MYLAN,,59.0,YR,,,Y,,,20191216.0,,MD,IT,IT,2019,Q4,Adult
171604321,17160432,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2019,Q4,Pyrexia,,2019,Q4,1,I,20190724.0,20191209.0,20191216,20191216,EXP,IT-MINISAL02-568249,IT-MYLANLABS-2019M1122966,MYLAN,,59.0,YR,,,Y,,,20191216.0,,MD,IT,IT,2019,Q4,Adult
171604321,17160432,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2019,Q4,Sepsis,,2019,Q4,1,I,20190724.0,20191209.0,20191216,20191216,EXP,IT-MINISAL02-568249,IT-MYLANLABS-2019M1122966,MYLAN,,59.0,YR,,,Y,,,20191216.0,,MD,IT,IT,2019,Q4,Adult
171626061,17162606,2,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Chills,,2019,Q4,1,I,20191008.0,,20191216,20191216,DIR,,,FDA-CTU,,43.0,YR,,F,N,120.0,KG,20191216.0,N,PH,US,US,2019,Q4,Adult
171626061,17162606,2,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Cyanosis,,2019,Q4,1,I,20191008.0,,20191216,20191216,DIR,,,FDA-CTU,,43.0,YR,,F,N,120.0,KG,20191216.0,N,PH,US,US,2019,Q4,Adult
171626061,17162606,2,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2019,Q4,Livedo reticularis,,2019,Q4,1,I,20191008.0,,20191216,20191216,DIR,,,FDA-CTU,,43.0,YR,,F,N,120.0,KG,20191216.0,N,PH,US,US,2019,Q4,Adult
171630621,17163062,8,C,Insulin lispro 5units BI,,2,,,,,,,,,,,,,,2019,Q4,Agitation,,2019,Q4,1,I,20160105.0,,20191216,20191216,DIR,,,FDA-CTU,,77.0,YR,,P,N,78.6,KG,20191216.0,N,PH,US,US,2019,Q4,Elderly
171630621,17163062,8,C,Insulin lispro 5units BI,,2,,,,,,,,,,,,,,2019,Q4,Aphasia,,2019,Q4,1,I,20160105.0,,20191216,20191216,DIR,,,FDA-CTU,,77.0,YR,,P,N,78.6,KG,20191216.0,N,PH,US,US,2019,Q4,Elderly
171630621,17163062,8,C,Insulin lispro 5units BI,,2,,,,,,,,,,,,,,2019,Q4,Haemorrhagic stroke,,2019,Q4,1,I,20160105.0,,20191216,20191216,DIR,,,FDA-CTU,,77.0,YR,,P,N,78.6,KG,20191216.0,N,PH,US,US,2019,Q4,Elderly
171653651,17165365,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2019,Q4,Arthritis,,2019,Q4,1,I,20181209.0,20191205.0,20191217,20191217,EXP,,SE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-118060,BRISTOL MYERS SQUIBB,,82.0,YR,,M,Y,80.0,KG,20191217.0,,OT,SE,SE,2019,Q4,Elderly
171653651,17165365,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2019,Q4,Dysphagia,,2019,Q4,1,I,20181209.0,20191205.0,20191217,20191217,EXP,,SE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-118060,BRISTOL MYERS SQUIBB,,82.0,YR,,M,Y,80.0,KG,20191217.0,,OT,SE,SE,2019,Q4,Elderly
171653651,17165365,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2019,Q4,Dyspnoea,,2019,Q4,1,I,20181209.0,20191205.0,20191217,20191217,EXP,,SE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-118060,BRISTOL MYERS SQUIBB,,82.0,YR,,M,Y,80.0,KG,20191217.0,,OT,SE,SE,2019,Q4,Elderly
171653651,17165365,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2019,Q4,Fall,,2019,Q4,1,I,20181209.0,20191205.0,20191217,20191217,EXP,,SE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-118060,BRISTOL MYERS SQUIBB,,82.0,YR,,M,Y,80.0,KG,20191217.0,,OT,SE,SE,2019,Q4,Elderly
171653651,17165365,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2019,Q4,Pain in extremity,,2019,Q4,1,I,20181209.0,20191205.0,20191217,20191217,EXP,,SE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-118060,BRISTOL MYERS SQUIBB,,82.0,YR,,M,Y,80.0,KG,20191217.0,,OT,SE,SE,2019,Q4,Elderly
171653651,17165365,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2019,Q4,Scratch,,2019,Q4,1,I,20181209.0,20191205.0,20191217,20191217,EXP,,SE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-118060,BRISTOL MYERS SQUIBB,,82.0,YR,,M,Y,80.0,KG,20191217.0,,OT,SE,SE,2019,Q4,Elderly
171653651,17165365,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2019,Q4,Subarachnoid haemorrhage,,2019,Q4,1,I,20181209.0,20191205.0,20191217,20191217,EXP,,SE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-118060,BRISTOL MYERS SQUIBB,,82.0,YR,,M,Y,80.0,KG,20191217.0,,OT,SE,SE,2019,Q4,Elderly
171653651,17165365,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2019,Q4,Tachycardia,,2019,Q4,1,I,20181209.0,20191205.0,20191217,20191217,EXP,,SE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-118060,BRISTOL MYERS SQUIBB,,82.0,YR,,M,Y,80.0,KG,20191217.0,,OT,SE,SE,2019,Q4,Elderly
171680891,17168089,48,C,INSULIN LISPRO,INSULIN LISPRO,1,,1 U,,,U,,,,,,,INJECTION,,2019,Q4,Pneumonia,,2019,Q4,1,I,20191030.0,20191211.0,20191218,20191218,EXP,,US-SA-2019SA348163,SANOFI AVENTIS,,26.0,YR,A,F,Y,73.5,KG,20191218.0,,CN,US,US,2019,Q4,Young Adult
171680891,17168089,49,C,INSULIN LISPRO,INSULIN LISPRO,1,,1 U,,,U,,,,,,,INJECTION,,2019,Q4,Pneumonia,,2019,Q4,1,I,20191030.0,20191211.0,20191218,20191218,EXP,,US-SA-2019SA348163,SANOFI AVENTIS,,26.0,YR,A,F,Y,73.5,KG,20191218.0,,CN,US,US,2019,Q4,Young Adult
171829481,17182948,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,50-60 U X 1 X 1 DAYS,,,,,,,,,,UNKNOWN,QD,2019,Q4,Vitamin B1 deficiency,,2019,Q4,1,I,20191016.0,20191213.0,20191220,20191220,EXP,,US-CELGENEUS-USA-20191205924,CELGENE,,78.0,YR,,M,Y,90.0,KG,20191220.0,,MD,US,US,2019,Q4,Elderly
171855581,17185558,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2019,Q4,Cyanosis,,2019,Q4,1,I,20191215.0,20191217.0,20191220,20191220,PER,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2019-US-120798",BOEHRINGER INGELHEIM,,68.0,YR,,F,Y,,,20191220.0,,PH,US,US,2019,Q4,Elderly
171930251,17193025,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 UNK, QD",,,U,,,,,,,INJECTION,QD,2019,Q4,Myocardial infarction,,2019,Q4,1,I,20191030.0,20191212.0,20191223,20191223,PER,,US-SA-2019SA350912,SANOFI AVENTIS,,57.0,YR,A,F,Y,73.5,KG,20191223.0,,CN,US,US,2019,Q4,Adult
171930251,17193025,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 UNK, QD",,,U,,,,,,,INJECTION,QD,2019,Q4,Pneumonia,,2019,Q4,1,I,20191030.0,20191212.0,20191223,20191223,PER,,US-SA-2019SA350912,SANOFI AVENTIS,,57.0,YR,A,F,Y,73.5,KG,20191223.0,,CN,US,US,2019,Q4,Adult
171992951,17199295,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Anaemia,,2019,Q4,1,I,20191101.0,20191213.0,20191225,20191225,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-120861,BRISTOL MYERS SQUIBB,,74.0,YR,,M,Y,,,20191225.0,,MD,IT,IT,2019,Q4,Elderly
171992951,17199295,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Dyspnoea,,2019,Q4,1,I,20191101.0,20191213.0,20191225,20191225,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-120861,BRISTOL MYERS SQUIBB,,74.0,YR,,M,Y,,,20191225.0,,MD,IT,IT,2019,Q4,Elderly
171992951,17199295,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Gravitational oedema,,2019,Q4,1,I,20191101.0,20191213.0,20191225,20191225,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-120861,BRISTOL MYERS SQUIBB,,74.0,YR,,M,Y,,,20191225.0,,MD,IT,IT,2019,Q4,Elderly
171992951,17199295,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Haematoma,,2019,Q4,1,I,20191101.0,20191213.0,20191225,20191225,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-120861,BRISTOL MYERS SQUIBB,,74.0,YR,,M,Y,,,20191225.0,,MD,IT,IT,2019,Q4,Elderly
171992951,17199295,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,International normalised ratio increased,,2019,Q4,1,I,20191101.0,20191213.0,20191225,20191225,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-120861,BRISTOL MYERS SQUIBB,,74.0,YR,,M,Y,,,20191225.0,,MD,IT,IT,2019,Q4,Elderly
171992951,17199295,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2019,Q4,Weight increased,,2019,Q4,1,I,20191101.0,20191213.0,20191225,20191225,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-120861,BRISTOL MYERS SQUIBB,,74.0,YR,,M,Y,,,20191225.0,,MD,IT,IT,2019,Q4,Elderly
171995431,17199543,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"20 U, TID",,,U,U,,,20563.0,20.0,IU,INJECTION,TID,2019,Q4,Blood glucose increased,,2019,Q4,1,I,,20191212.0,20191226,20191226,EXP,,US-ELI_LILLY_AND_COMPANY-US201912007405,ELI LILLY AND CO,,70.0,YR,,M,Y,,,20191226.0,,CN,US,US,2019,Q4,Elderly
171995431,17199543,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"20 U, TID",,,U,U, C933644C,,20563.0,20.0,IU,INJECTION,TID,2019,Q4,Blood glucose increased,,2019,Q4,1,I,,20191212.0,20191226,20191226,EXP,,US-ELI_LILLY_AND_COMPANY-US201912007405,ELI LILLY AND CO,,70.0,YR,,M,Y,,,20191226.0,,CN,US,US,2019,Q4,Elderly
172036641,17203664,1,PS,Insulin  Lispro,INSULIN LISPRO,1,Intravenous bolus,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,,,2019,Q4,Amyloidosis,,2019,Q4,1,I,,20191217.0,20191226,20191226,EXP,,TR-ELI_LILLY_AND_COMPANY-TR201912010668,ELI LILLY AND CO,,52.0,YR,,M,Y,,,20191226.0,,CN,TR,TR,2019,Q4,Adult
172036641,17203664,1,PS,Insulin  Lispro,INSULIN LISPRO,1,Intravenous bolus,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,,,2019,Q4,Injection site mass,,2019,Q4,1,I,,20191217.0,20191226,20191226,EXP,,TR-ELI_LILLY_AND_COMPANY-TR201912010668,ELI LILLY AND CO,,52.0,YR,,M,Y,,,20191226.0,,CN,TR,TR,2019,Q4,Adult
172039361,17203936,2,I,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 + 10 + 10 U / DAY,,,Y,,,,,1.0,DF,,QD,2019,Q4,Bradyphrenia,,2019,Q4,1,I,20191030.0,20191216.0,20191226,20191226,EXP,IT-MINISAL02-593336,IT-SA-2019SA350377,SANOFI AVENTIS,,52.0,YR,A,M,Y,,,20191226.0,,MD,IT,IT,2019,Q4,Adult
172039361,17203936,2,I,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 + 10 + 10 U / DAY,,,Y,,,,,1.0,DF,,QD,2019,Q4,Drug interaction,,2019,Q4,1,I,20191030.0,20191216.0,20191226,20191226,EXP,IT-MINISAL02-593336,IT-SA-2019SA350377,SANOFI AVENTIS,,52.0,YR,A,M,Y,,,20191226.0,,MD,IT,IT,2019,Q4,Adult
172039361,17203936,2,I,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 + 10 + 10 U / DAY,,,Y,,,,,1.0,DF,,QD,2019,Q4,Hypoglycaemia,,2019,Q4,1,I,20191030.0,20191216.0,20191226,20191226,EXP,IT-MINISAL02-593336,IT-SA-2019SA350377,SANOFI AVENTIS,,52.0,YR,A,M,Y,,,20191226.0,,MD,IT,IT,2019,Q4,Adult
172039361,17203936,2,I,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 + 10 + 10 U / DAY,,,Y,,,,,1.0,DF,,QD,2019,Q4,Hypokinesia,,2019,Q4,1,I,20191030.0,20191216.0,20191226,20191226,EXP,IT-MINISAL02-593336,IT-SA-2019SA350377,SANOFI AVENTIS,,52.0,YR,A,M,Y,,,20191226.0,,MD,IT,IT,2019,Q4,Adult
172039361,17203936,2,I,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 + 10 + 10 U / DAY,,,Y,,,,,1.0,DF,,QD,2019,Q4,Sopor,,2019,Q4,1,I,20191030.0,20191216.0,20191226,20191226,EXP,IT-MINISAL02-593336,IT-SA-2019SA350377,SANOFI AVENTIS,,52.0,YR,A,M,Y,,,20191226.0,,MD,IT,IT,2019,Q4,Adult
172060331,17206033,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10E AT BREAKFAST, 4 E TO LUNCH, 4 E FOR DINNER AND 2E LATER",,,U,, 9F143A,,209196.0,,,SOLUTION FOR INJECTION,,2019,Q4,Blood glucose decreased,,2019,Q4,1,I,,20191128.0,20191227,20191227,EXP,,SE-SA-2019SA334071,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20191227.0,,CN,SE,SE,2019,Q4,Elderly
172060331,17206033,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10E AT BREAKFAST, 4 E TO LUNCH, 4 E FOR DINNER AND 2E LATER",,,U,, 9F143A,,209196.0,,,SOLUTION FOR INJECTION,,2019,Q4,Blood insulin abnormal,,2019,Q4,1,I,,20191128.0,20191227,20191227,EXP,,SE-SA-2019SA334071,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20191227.0,,CN,SE,SE,2019,Q4,Elderly
172060331,17206033,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10E AT BREAKFAST, 4 E TO LUNCH, 4 E FOR DINNER AND 2E LATER",,,U,, 9F143A,,209196.0,,,SOLUTION FOR INJECTION,,2019,Q4,Cold sweat,,2019,Q4,1,I,,20191128.0,20191227,20191227,EXP,,SE-SA-2019SA334071,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20191227.0,,CN,SE,SE,2019,Q4,Elderly
172060331,17206033,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10E AT BREAKFAST, 4 E TO LUNCH, 4 E FOR DINNER AND 2E LATER",,,U,, 9F143A,,209196.0,,,SOLUTION FOR INJECTION,,2019,Q4,Diabetic coma,,2019,Q4,1,I,,20191128.0,20191227,20191227,EXP,,SE-SA-2019SA334071,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20191227.0,,CN,SE,SE,2019,Q4,Elderly
172060331,17206033,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10E AT BREAKFAST, 4 E TO LUNCH, 4 E FOR DINNER AND 2E LATER",,,U,, 9F143A,,209196.0,,,SOLUTION FOR INJECTION,,2019,Q4,Injection site bruising,,2019,Q4,1,I,,20191128.0,20191227,20191227,EXP,,SE-SA-2019SA334071,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20191227.0,,CN,SE,SE,2019,Q4,Elderly
172060331,17206033,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10E AT BREAKFAST, 4 E TO LUNCH, 4 E FOR DINNER AND 2E LATER",,,U,, 9F143A,,209196.0,,,SOLUTION FOR INJECTION,,2019,Q4,Injection site reaction,,2019,Q4,1,I,,20191128.0,20191227,20191227,EXP,,SE-SA-2019SA334071,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20191227.0,,CN,SE,SE,2019,Q4,Elderly
172060331,17206033,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10E AT BREAKFAST, 4 E TO LUNCH, 4 E FOR DINNER AND 2E LATER",,,U,, 9F143A,,209196.0,,,SOLUTION FOR INJECTION,,2019,Q4,Malaise,,2019,Q4,1,I,,20191128.0,20191227,20191227,EXP,,SE-SA-2019SA334071,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20191227.0,,CN,SE,SE,2019,Q4,Elderly
172060331,17206033,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10E AT BREAKFAST, 4 E TO LUNCH, 4 E FOR DINNER AND 2E LATER",,,U,, 9F143A,,209196.0,,,SOLUTION FOR INJECTION,,2019,Q4,Tremor,,2019,Q4,1,I,,20191128.0,20191227,20191227,EXP,,SE-SA-2019SA334071,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20191227.0,,CN,SE,SE,2019,Q4,Elderly
172060331,17206033,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10E AT BREAKFAST, 4 E TO LUNCH, 4 E FOR DINNER AND 2E LATER",,,U,, 9F143A,,209196.0,,,SOLUTION FOR INJECTION,,2019,Q4,Weight increased,,2019,Q4,1,I,,20191128.0,20191227,20191227,EXP,,SE-SA-2019SA334071,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20191227.0,,CN,SE,SE,2019,Q4,Elderly
172060331,17206033,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, TID (8 E IN THE MORNING, LOWERED TO 3 E LUNCH AND 4 E FOR DINNER)",,,U,,,,209196.0,,,SOLUTION FOR INJECTION,Q8H,2019,Q4,Blood glucose decreased,,2019,Q4,1,I,,20191128.0,20191227,20191227,EXP,,SE-SA-2019SA334071,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20191227.0,,CN,SE,SE,2019,Q4,Elderly
172060331,17206033,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, TID (8 E IN THE MORNING, LOWERED TO 3 E LUNCH AND 4 E FOR DINNER)",,,U,,,,209196.0,,,SOLUTION FOR INJECTION,Q8H,2019,Q4,Blood insulin abnormal,,2019,Q4,1,I,,20191128.0,20191227,20191227,EXP,,SE-SA-2019SA334071,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20191227.0,,CN,SE,SE,2019,Q4,Elderly
172060331,17206033,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, TID (8 E IN THE MORNING, LOWERED TO 3 E LUNCH AND 4 E FOR DINNER)",,,U,,,,209196.0,,,SOLUTION FOR INJECTION,Q8H,2019,Q4,Cold sweat,,2019,Q4,1,I,,20191128.0,20191227,20191227,EXP,,SE-SA-2019SA334071,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20191227.0,,CN,SE,SE,2019,Q4,Elderly
172060331,17206033,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, TID (8 E IN THE MORNING, LOWERED TO 3 E LUNCH AND 4 E FOR DINNER)",,,U,,,,209196.0,,,SOLUTION FOR INJECTION,Q8H,2019,Q4,Diabetic coma,,2019,Q4,1,I,,20191128.0,20191227,20191227,EXP,,SE-SA-2019SA334071,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20191227.0,,CN,SE,SE,2019,Q4,Elderly
172060331,17206033,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, TID (8 E IN THE MORNING, LOWERED TO 3 E LUNCH AND 4 E FOR DINNER)",,,U,,,,209196.0,,,SOLUTION FOR INJECTION,Q8H,2019,Q4,Injection site bruising,,2019,Q4,1,I,,20191128.0,20191227,20191227,EXP,,SE-SA-2019SA334071,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20191227.0,,CN,SE,SE,2019,Q4,Elderly
172060331,17206033,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, TID (8 E IN THE MORNING, LOWERED TO 3 E LUNCH AND 4 E FOR DINNER)",,,U,,,,209196.0,,,SOLUTION FOR INJECTION,Q8H,2019,Q4,Injection site reaction,,2019,Q4,1,I,,20191128.0,20191227,20191227,EXP,,SE-SA-2019SA334071,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20191227.0,,CN,SE,SE,2019,Q4,Elderly
172060331,17206033,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, TID (8 E IN THE MORNING, LOWERED TO 3 E LUNCH AND 4 E FOR DINNER)",,,U,,,,209196.0,,,SOLUTION FOR INJECTION,Q8H,2019,Q4,Malaise,,2019,Q4,1,I,,20191128.0,20191227,20191227,EXP,,SE-SA-2019SA334071,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20191227.0,,CN,SE,SE,2019,Q4,Elderly
172060331,17206033,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, TID (8 E IN THE MORNING, LOWERED TO 3 E LUNCH AND 4 E FOR DINNER)",,,U,,,,209196.0,,,SOLUTION FOR INJECTION,Q8H,2019,Q4,Tremor,,2019,Q4,1,I,,20191128.0,20191227,20191227,EXP,,SE-SA-2019SA334071,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20191227.0,,CN,SE,SE,2019,Q4,Elderly
172060331,17206033,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, TID (8 E IN THE MORNING, LOWERED TO 3 E LUNCH AND 4 E FOR DINNER)",,,U,,,,209196.0,,,SOLUTION FOR INJECTION,Q8H,2019,Q4,Weight increased,,2019,Q4,1,I,,20191128.0,20191227,20191227,EXP,,SE-SA-2019SA334071,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20191227.0,,CN,SE,SE,2019,Q4,Elderly
172060331,17206033,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,, 9F156A,,209196.0,,,SOLUTION FOR INJECTION,,2019,Q4,Blood glucose decreased,,2019,Q4,1,I,,20191128.0,20191227,20191227,EXP,,SE-SA-2019SA334071,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20191227.0,,CN,SE,SE,2019,Q4,Elderly
172060331,17206033,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,, 9F156A,,209196.0,,,SOLUTION FOR INJECTION,,2019,Q4,Blood insulin abnormal,,2019,Q4,1,I,,20191128.0,20191227,20191227,EXP,,SE-SA-2019SA334071,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20191227.0,,CN,SE,SE,2019,Q4,Elderly
172060331,17206033,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,, 9F156A,,209196.0,,,SOLUTION FOR INJECTION,,2019,Q4,Cold sweat,,2019,Q4,1,I,,20191128.0,20191227,20191227,EXP,,SE-SA-2019SA334071,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20191227.0,,CN,SE,SE,2019,Q4,Elderly
172060331,17206033,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,, 9F156A,,209196.0,,,SOLUTION FOR INJECTION,,2019,Q4,Diabetic coma,,2019,Q4,1,I,,20191128.0,20191227,20191227,EXP,,SE-SA-2019SA334071,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20191227.0,,CN,SE,SE,2019,Q4,Elderly
172060331,17206033,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,, 9F156A,,209196.0,,,SOLUTION FOR INJECTION,,2019,Q4,Injection site bruising,,2019,Q4,1,I,,20191128.0,20191227,20191227,EXP,,SE-SA-2019SA334071,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20191227.0,,CN,SE,SE,2019,Q4,Elderly
172060331,17206033,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,, 9F156A,,209196.0,,,SOLUTION FOR INJECTION,,2019,Q4,Injection site reaction,,2019,Q4,1,I,,20191128.0,20191227,20191227,EXP,,SE-SA-2019SA334071,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20191227.0,,CN,SE,SE,2019,Q4,Elderly
172060331,17206033,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,, 9F156A,,209196.0,,,SOLUTION FOR INJECTION,,2019,Q4,Malaise,,2019,Q4,1,I,,20191128.0,20191227,20191227,EXP,,SE-SA-2019SA334071,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20191227.0,,CN,SE,SE,2019,Q4,Elderly
172060331,17206033,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,, 9F156A,,209196.0,,,SOLUTION FOR INJECTION,,2019,Q4,Tremor,,2019,Q4,1,I,,20191128.0,20191227,20191227,EXP,,SE-SA-2019SA334071,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20191227.0,,CN,SE,SE,2019,Q4,Elderly
172060331,17206033,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,, 9F156A,,209196.0,,,SOLUTION FOR INJECTION,,2019,Q4,Weight increased,,2019,Q4,1,I,,20191128.0,20191227,20191227,EXP,,SE-SA-2019SA334071,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20191227.0,,CN,SE,SE,2019,Q4,Elderly
172062921,17206292,4,SS,Liprolog Lispro,INSULIN LISPRO,1,,"15 U, EACH EVENING",,,U,U,,,,15.0,IU,,QD,2019,Q4,Blood glucose increased,,2019,Q4,1,I,20191216.0,20191216.0,20191227,20191227,EXP,,PL-ELI_LILLY_AND_COMPANY-PL201912009543,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20191227.0,,CN,PL,PL,2019,Q4,Adult
172062921,17206292,4,SS,Liprolog Lispro,INSULIN LISPRO,1,,"15 U, EACH EVENING",,,U,U,,,,15.0,IU,,QD,2019,Q4,Decreased appetite,,2019,Q4,1,I,20191216.0,20191216.0,20191227,20191227,EXP,,PL-ELI_LILLY_AND_COMPANY-PL201912009543,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20191227.0,,CN,PL,PL,2019,Q4,Adult
172062921,17206292,4,SS,Liprolog Lispro,INSULIN LISPRO,1,,"15 U, EACH EVENING",,,U,U,,,,15.0,IU,,QD,2019,Q4,Feeling abnormal,,2019,Q4,1,I,20191216.0,20191216.0,20191227,20191227,EXP,,PL-ELI_LILLY_AND_COMPANY-PL201912009543,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20191227.0,,CN,PL,PL,2019,Q4,Adult
172062921,17206292,4,SS,Liprolog Lispro,INSULIN LISPRO,1,,"15 U, EACH EVENING",,,U,U,,,,15.0,IU,,QD,2019,Q4,Hyperglycaemia,,2019,Q4,1,I,20191216.0,20191216.0,20191227,20191227,EXP,,PL-ELI_LILLY_AND_COMPANY-PL201912009543,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20191227.0,,CN,PL,PL,2019,Q4,Adult
172062921,17206292,4,SS,Liprolog Lispro,INSULIN LISPRO,1,,"15 U, EACH EVENING",,,U,U,,,,15.0,IU,,QD,2019,Q4,Malaise,,2019,Q4,1,I,20191216.0,20191216.0,20191227,20191227,EXP,,PL-ELI_LILLY_AND_COMPANY-PL201912009543,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20191227.0,,CN,PL,PL,2019,Q4,Adult
172062921,17206292,4,SS,Liprolog Lispro,INSULIN LISPRO,1,,"15 U, EACH EVENING",,,U,U,,,,15.0,IU,,QD,2019,Q4,Neoplasm malignant,,2019,Q4,1,I,20191216.0,20191216.0,20191227,20191227,EXP,,PL-ELI_LILLY_AND_COMPANY-PL201912009543,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20191227.0,,CN,PL,PL,2019,Q4,Adult
172062921,17206292,4,SS,Liprolog Lispro,INSULIN LISPRO,1,,"15 U, EACH EVENING",,,U,U,,,,15.0,IU,,QD,2019,Q4,Vomiting,,2019,Q4,1,I,20191216.0,20191216.0,20191227,20191227,EXP,,PL-ELI_LILLY_AND_COMPANY-PL201912009543,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20191227.0,,CN,PL,PL,2019,Q4,Adult
172086511,17208651,1,PS,Liprolog Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,,,2019,Q4,Hyperglycaemia,,2019,Q4,1,I,20180906.0,20191219.0,20191227,20191227,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201912010660,ELI LILLY AND CO,,15.0,YR,,F,Y,63.0,KG,20191227.0,,CN,DE,DE,2019,Q4,Youth
172086511,17208651,1,PS,Liprolog Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,,,2019,Q4,Product administration error,,2019,Q4,1,I,20180906.0,20191219.0,20191227,20191227,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201912010660,ELI LILLY AND CO,,15.0,YR,,F,Y,63.0,KG,20191227.0,,CN,DE,DE,2019,Q4,Youth
172086511,17208651,1,PS,Liprolog Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,,,2019,Q4,Treatment noncompliance,,2019,Q4,1,I,20180906.0,20191219.0,20191227,20191227,EXP,,DE-ELI_LILLY_AND_COMPANY-DE201912010660,ELI LILLY AND CO,,15.0,YR,,F,Y,63.0,KG,20191227.0,,CN,DE,DE,2019,Q4,Youth
172144531,17214453,3,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2019,Q4,Device malfunction,,2019,Q4,1,I,20191217.0,20191217.0,20191230,20191230,PER,,US-JNJFOC-20191233219,JOHNSON AND JOHNSON,,46.0,YR,,M,Y,97.61,KG,20191230.0,,CN,US,US,2019,Q4,Adult
172144531,17214453,3,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2019,Q4,Underdose,,2019,Q4,1,I,20191217.0,20191217.0,20191230,20191230,PER,,US-JNJFOC-20191233219,JOHNSON AND JOHNSON,,46.0,YR,,M,Y,97.61,KG,20191230.0,,CN,US,US,2019,Q4,Adult
172156311,17215631,8,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Subcutaneous,,,,,,,,,,,SOLUTION,,2019,Q4,Nausea,,2019,Q4,1,I,20190103.0,20191219.0,20191230,20191230,EXP,IT-MINISAL02-593219,IT-FRESENIUS KABI-FK201914376,FRESENIUS KABI,,75.0,YR,,F,Y,77.0,KG,20191230.0,,OT,NL,IT,2019,Q4,Elderly
172156311,17215631,8,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Subcutaneous,,,,,,,,,,,SOLUTION,,2019,Q4,Pain,,2019,Q4,1,I,20190103.0,20191219.0,20191230,20191230,EXP,IT-MINISAL02-593219,IT-FRESENIUS KABI-FK201914376,FRESENIUS KABI,,75.0,YR,,F,Y,77.0,KG,20191230.0,,OT,NL,IT,2019,Q4,Elderly
172156311,17215631,8,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Subcutaneous,,,,,,,,,,,SOLUTION,,2019,Q4,Renal failure,,2019,Q4,1,I,20190103.0,20191219.0,20191230,20191230,EXP,IT-MINISAL02-593219,IT-FRESENIUS KABI-FK201914376,FRESENIUS KABI,,75.0,YR,,F,Y,77.0,KG,20191230.0,,OT,NL,IT,2019,Q4,Elderly
172156311,17215631,8,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,Subcutaneous,,,,,,,,,,,SOLUTION,,2019,Q4,Vomiting,,2019,Q4,1,I,20190103.0,20191219.0,20191230,20191230,EXP,IT-MINISAL02-593219,IT-FRESENIUS KABI-FK201914376,FRESENIUS KABI,,75.0,YR,,F,Y,77.0,KG,20191230.0,,OT,NL,IT,2019,Q4,Elderly
172199881,17219988,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,1 U,,,U,,,,,,,INJECTION,,2019,Q4,Myocardial infarction,,2019,Q4,1,I,20191030.0,20191223.0,20191231,20191231,PER,,US-SA-2019SA360385,SANOFI AVENTIS,,57.0,YR,A,F,Y,73.5,KG,20191231.0,,CN,US,US,2019,Q4,Adult
172199881,17219988,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,1 U,,,U,,,,,,,INJECTION,,2019,Q4,Pneumonia,,2019,Q4,1,I,20191030.0,20191223.0,20191231,20191231,PER,,US-SA-2019SA360385,SANOFI AVENTIS,,57.0,YR,A,F,Y,73.5,KG,20191231.0,,CN,US,US,2019,Q4,Adult
83922125,8392212,37,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2019,Q4,Acute kidney injury,,2019,Q4,5,F,20120114.0,20191001.0,20120206,20191004,EXP,,US-CELGENEUS-163-21880-12012638,CELGENE,"MIKHAEL J. LENALIDOMIDE AND DEXAMETHASONE IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA AND IMPAIRED RENAL FUNCTION: PRE1003, A PRECOG STUDY. BLOOD CANCER JOURNAL. 2018 AUG 29;.",66.0,YR,,F,Y,66.4,KG,20191004.0,,OT,US,US,2019,Q4,Elderly
83922125,8392212,37,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2019,Q4,Pancytopenia,,2019,Q4,5,F,20120114.0,20191001.0,20120206,20191004,EXP,,US-CELGENEUS-163-21880-12012638,CELGENE,"MIKHAEL J. LENALIDOMIDE AND DEXAMETHASONE IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA AND IMPAIRED RENAL FUNCTION: PRE1003, A PRECOG STUDY. BLOOD CANCER JOURNAL. 2018 AUG 29;.",66.0,YR,,F,Y,66.4,KG,20191004.0,,OT,US,US,2019,Q4,Elderly
83922125,8392212,37,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2019,Q4,Peripheral arterial occlusive disease,,2019,Q4,5,F,20120114.0,20191001.0,20120206,20191004,EXP,,US-CELGENEUS-163-21880-12012638,CELGENE,"MIKHAEL J. LENALIDOMIDE AND DEXAMETHASONE IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA AND IMPAIRED RENAL FUNCTION: PRE1003, A PRECOG STUDY. BLOOD CANCER JOURNAL. 2018 AUG 29;.",66.0,YR,,F,Y,66.4,KG,20191004.0,,OT,US,US,2019,Q4,Elderly
83922125,8392212,37,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2019,Q4,Pneumonia,,2019,Q4,5,F,20120114.0,20191001.0,20120206,20191004,EXP,,US-CELGENEUS-163-21880-12012638,CELGENE,"MIKHAEL J. LENALIDOMIDE AND DEXAMETHASONE IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA AND IMPAIRED RENAL FUNCTION: PRE1003, A PRECOG STUDY. BLOOD CANCER JOURNAL. 2018 AUG 29;.",66.0,YR,,F,Y,66.4,KG,20191004.0,,OT,US,US,2019,Q4,Elderly
83922125,8392212,37,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2019,Q4,Septic shock,,2019,Q4,5,F,20120114.0,20191001.0,20120206,20191004,EXP,,US-CELGENEUS-163-21880-12012638,CELGENE,"MIKHAEL J. LENALIDOMIDE AND DEXAMETHASONE IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA AND IMPAIRED RENAL FUNCTION: PRE1003, A PRECOG STUDY. BLOOD CANCER JOURNAL. 2018 AUG 29;.",66.0,YR,,F,Y,66.4,KG,20191004.0,,OT,US,US,2019,Q4,Elderly
